data_1ah2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ah2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.389 0.614 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -132.38 153.71 81.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.799 . . . . 0.0 109.384 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 9' ' ' SER . 35.5 Cg_endo -77.68 171.94 16.6 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.857 2.371 . . . . 0.0 111.119 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.7 OUTLIER -52.14 -19.06 1.73 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.542 -0.724 . . . . 0.0 110.473 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 6' ' ' TRP . . . -63.16 -52.25 48.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.566 ' CD1' ' NE2' ' A' ' 220' ' ' HIS . 0.0 OUTLIER -83.9 -20.21 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -1.223 . . . . 0.0 109.662 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -64.34 -26.39 68.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.91 -1.118 . . . . 0.0 109.658 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 22.1 ttm105 -96.32 -0.66 49.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 110.627 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 8' ' ' ILE . 3.2 m -99.77 17.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.585 -1.322 . . . . 0.0 110.29 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER 39.91 45.81 1.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.56 -0.713 . . . . 0.0 109.827 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.713 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.22 -27.28 0.34 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.0 Cg_endo -74.28 -56.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.847 -1.251 . . . . 0.0 108.847 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.76 -31.63 0.86 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.98 -43.9 51.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 13' ' ' ALA . 6.3 m170 -66.85 -15.5 63.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -0.787 . . . . 0.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -96.25 -24.82 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 0.0 109.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.43 ' NH1' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -69.15 -32.04 71.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.73 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.65 -16.67 5.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 144.58 56.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -1.147 . . . . 0.0 109.179 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -133.53 1.5 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.023 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 230' ' ' GLN . . . 57.57 6.49 2.46 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 22' ' ' THR . 1.4 t -66.49 134.01 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.371 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.57 -4.74 37.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 28.2 t -98.97 170.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -1.167 . . . . 0.0 109.275 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.563 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -140.46 128.85 22.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.894 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.417 HG12 ' CG1' ' A' ' 119' ' ' VAL . 1.9 t -133.97 134.88 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -92.35 154.51 18.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.23 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -127.56 87.0 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.983 -1.073 . . . . 0.0 108.768 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.53 ' HG ' ' HB ' ' A' ' 93' ' ' VAL . 5.5 mp -65.27 95.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 20.9 p-10 -144.93 -144.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.488 HG21 ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -145.04 27.78 1.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.107 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.06 119.8 0.9 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -103.96 11.54 8.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.948 -0.736 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER 51.84 126.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.994 0.902 . . . . 0.0 111.17 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.84 115.36 10.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.003 -1.06 . . . . 0.0 108.882 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.529 ' NE2' ' HA ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -145.24 157.34 53.4 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.0 Cg_endo -78.52 0.96 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.702 2.268 . . . . 0.0 110.378 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.09 -15.95 14.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.103 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.13 119.07 35.84 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 108.841 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -96.64 105.08 17.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.492 HD13 HG23 ' A' ' 35' ' ' ILE . 1.7 mm -69.47 112.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.335 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.446 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 2.4 mmt85 -100.26 -19.78 16.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.173 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 156.71 28.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . -177.1 140.45 4.9 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.981 -1.305 . . . . 0.0 110.021 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.45 126.82 14.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -1.086 . . . . 0.0 109.297 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -104.3 116.53 32.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.134 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CD2' ' OE1' ' A' ' 107' ' ' GLN . 42.3 m-85 -104.1 -57.0 2.1 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.19 -0.944 . . . . 0.0 109.828 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.57 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 1.5 p -42.06 148.88 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 50' ' ' VAL . 29.2 Cg_endo . . . . . 0 C--N 1.311 -1.421 0 C-N-CA 122.035 1.824 . . . . 0.0 109.986 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.36 0.6 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -15.39 18.44 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.36 -0.837 . . . . 0.0 108.767 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 2.4 mp0 -128.67 112.24 14.03 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 13.8 t70 83.31 157.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.498 0.666 . . . . 0.0 109.768 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.96 -20.92 0.51 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.488 ' ND2' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -145.22 -83.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.617 -0.931 . . . . 0.0 108.899 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 64' ' ' THR . . . 159.55 -54.48 0.35 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 215' ' ' SER . 30.0 t-80 -46.31 -57.79 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 110.159 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -38.43 -57.58 1.81 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.527 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 0.6 OUTLIER -51.13 -47.5 61.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -1.143 . . . . 0.0 109.434 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.586 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -52.08 -55.84 18.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.325 -0.86 . . . . 0.0 109.473 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 219' ' ' PRO . 39.9 t -53.51 -34.01 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 64' ' ' THR . . . -58.85 -55.56 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.222 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.38 75.54 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.544 HG21 ' CD2' ' A' ' 220' ' ' HIS . 21.4 m -73.84 -18.54 60.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 108.122 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 219' ' ' PRO . 4.9 mt -98.85 -30.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . . . -170.13 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 112.101 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -44.87 121.27 2.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.661 -1.274 . . . . 0.0 108.607 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 84' ' ' PRO . 17.0 mt -43.74 151.91 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.982 . . . . 0.0 110.532 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 46.5 t-20 -105.69 64.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.0 109.412 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.584 ' O ' ' CB ' ' A' ' 76' ' ' SER . 86.0 m-20 -94.53 -1.36 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.504 -0.748 . . . . 0.0 110.098 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 5.0 t 91.18 -34.47 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -85.51 133.5 29.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.88 -175.63 45.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 200' ' ' GLN . 5.1 m -76.01 -174.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.2 -1.177 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' A' ' 17' ' ' HIS . 1.6 tp -141.0 113.58 8.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.306 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.49 -165.74 21.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.551 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 6.8 t -80.28 -32.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.281 . . . . 0.0 109.453 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 71' ' ' ALA . . . -104.6 148.12 35.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.056 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' CG ' ' O ' ' A' ' 22' ' ' THR . 37.9 Cg_endo -84.87 -63.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 110.383 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -113.92 -87.64 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.324 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 59.8 170.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.449 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.446 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 26.0 mm-40 -93.38 85.51 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mt -79.28 109.88 14.04 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 3.2 m-85 -91.18 -177.35 4.86 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.951 0.881 . . . . 0.0 110.448 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.458 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -147.28 96.09 2.65 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -99.81 78.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -51.88 89.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 91' ' ' VAL . 12.6 p -98.72 -23.69 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 108.929 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.456 ' N ' HG11 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -111.84 162.95 14.73 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.49 152.81 17.95 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.172 -1.193 . . . . 0.0 109.04 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -76.44 174.64 10.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.641 -0.917 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 t -68.62 -18.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.503 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -73.87 -18.37 60.93 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.505 ' O ' ' NE2' ' A' ' 107' ' ' GLN . 19.0 m -88.07 -52.29 5.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.498 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.3 mt -62.27 -30.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.0 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.52 -50.9 14.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 108.981 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.584 ' OE1' ' CD2' ' A' ' 49' ' ' PHE . 2.7 pp0? -61.82 -23.93 66.55 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 109.552 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.17 -36.62 20.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.37 -13.8 58.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 108.973 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -97.13 -32.88 11.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -67.56 -21.29 65.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.618 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -86.21 -19.37 30.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -55.54 -34.13 59.81 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 114' ' ' ASN . 0.1 OUTLIER -101.95 -61.7 1.35 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.464 -1.021 . . . . 0.0 109.161 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.455 ' O ' ' SD ' ' A' ' 117' ' ' MET . 1.3 m-20 -104.16 40.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 108.921 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.618 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -94.23 21.05 44.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.563 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 41.14 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.527 -0.984 . . . . 0.0 110.428 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -85.53 -22.14 28.26 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 111.239 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 83.5 t -129.38 165.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.327 -1.483 . . . . 0.0 110.232 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -166.7 128.1 1.7 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 148' ' ' VAL . 6.3 t-20 -105.8 153.68 21.56 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.57 -1.331 . . . . 0.0 110.128 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.545 ' CD1' ' CG1' ' A' ' 147' ' ' VAL . 5.0 mp -135.84 92.82 2.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 62.01 7.21 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.258 -0.901 . . . . 0.0 108.72 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 4.0 pp -147.64 173.74 12.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . -176.92 97.45 0.11 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 2.4 m -96.52 146.71 31.78 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.63 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.1 Cg_endo -77.37 -5.38 15.59 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.474 2.116 . . . . 0.0 109.359 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.5 t -98.54 107.64 43.6 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.756 -0.59 . . . . 0.0 110.224 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 33.0 Cg_endo -76.97 165.83 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.01 1.807 . . . . 0.0 109.609 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.69 132.78 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.654 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.92 65.72 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 64.4 m -63.88 -31.99 73.36 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.9 tp -75.85 -34.86 60.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -30.32 68.05 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.386 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.485 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 4.0 tp60 -70.33 -25.61 63.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.9 -48.69 20.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.049 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -63.25 -26.46 40.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.3 -36.75 85.03 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.0 t -77.62 -17.77 57.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.887 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.52 -38.11 22.18 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.686 -1.259 . . . . 0.0 111.248 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.802 -1.186 . . . . 0.0 108.571 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -25.32 67.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -112.62 -16.58 12.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.126 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.46 84.99 1.16 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.95 105.23 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -1.028 . . . . 0.0 108.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.81 118.75 8.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.871 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.545 ' CG1' ' CD1' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -112.94 139.28 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.216 -0.928 . . . . 0.0 109.14 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.56 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 14.5 p -127.17 68.14 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.918 -1.114 . . . . 0.0 110.114 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.63 156.51 1.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.076 -1.015 . . . . 0.0 110.95 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.456 ' HB3' ' OG1' ' A' ' 218' ' ' THR . . . -84.45 -174.57 5.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.6 -0.688 . . . . 0.0 110.032 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.3 OUTLIER -91.95 -85.09 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.836 -0.54 . . . . 0.0 109.78 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -178.61 -114.29 0.41 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 154' ' ' SER . 0.4 OUTLIER 177.72 34.51 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER 87.06 102.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.321 0.581 . . . . 0.0 109.537 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.534 ' N ' ' NE2' ' A' ' 185' ' ' GLN . . . -172.0 95.75 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 66.07 171.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -1.166 . . . . 0.0 109.647 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.78 51.9 4.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 0.8 OUTLIER -148.96 170.31 18.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -1.168 . . . . 0.0 109.645 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.11 -171.47 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.0 110.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.495 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -62.42 176.04 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.582 1.182 . . . . 0.0 112.186 -178.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 126' ' ' SER . 8.8 m-85 -128.73 127.6 23.5 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.8 Cg_endo -72.33 -45.73 0.43 Allowed 'Cis proline' 0 C--N 1.301 -1.944 0 O-C-N 123.14 1.074 . . . . 0.0 110.726 3.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 160' ' ' SER . . . 27.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.158 0.98 . . . . 0.0 109.645 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.742 ' N ' ' O ' ' A' ' 162' ' ' PRO . 7.0 ttt180 -39.35 -60.25 0.95 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.758 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.58 ' O ' ' CB ' ' A' ' 166' ' ' ALA . 55.0 p90 -120.02 -164.66 1.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 165' ' ' TYR . . . 85.98 26.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.775 0.797 . . . . 0.0 109.011 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 55.01 20.26 3.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.32 131.67 51.41 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.45 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 4.4 mtp -76.19 151.49 36.89 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.34 129.21 55.73 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 32.1 t -100.17 165.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 109.235 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.07 167.66 24.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 214' ' ' THR . . . -96.17 168.91 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' ' 194' ' ' ALA . 13.5 p -135.64 178.79 6.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 109.5 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 176' ' ' GLN . 14.2 t0 -108.41 -142.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.771 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 175' ' ' ASP . 12.0 tt0 -35.45 -63.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.988 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -122.16 -60.93 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.838 -1.164 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.77 -19.7 1.03 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.033 -1.042 . . . . 0.0 111.224 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -47.17 164.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.767 -1.208 . . . . 0.0 109.338 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -69.93 132.86 46.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.332 -0.855 . . . . 0.0 109.729 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -55.72 -154.25 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 m -117.15 -27.34 6.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -119.62 14.04 12.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.716 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.9 t -77.41 142.36 39.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.144 -0.973 . . . . 0.0 109.296 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.534 ' NE2' ' N ' ' A' ' 155' ' ' GLY . 5.9 tt0 -90.69 166.15 13.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -141.65 173.53 11.42 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 -179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.646 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.62 -178.63 48.39 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.11 68.06 5.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -1.178 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.77 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 256' ' ' LEU . 3.2 tp -72.75 142.54 48.14 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.067 -1.255 . . . . 0.0 109.521 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 8.4 t0 -101.67 -57.34 2.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.542 ' CG2' HG23 ' A' ' 171' ' ' VAL . 3.8 tt -151.25 -178.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.539 HG23 ' CA ' ' A' ' 260' ' ' GLY . 6.0 m -149.66 -179.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.314 -0.867 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.503 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -175.01 172.78 1.1 Allowed Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 30.8 Cg_endo -72.0 116.55 4.75 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.067 1.845 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.94 44.69 1.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.646 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 40.6 t -124.45 54.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -1.092 . . . . 0.0 108.415 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.646 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 24.3 t-20 127.36 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 22.7 m -160.33 105.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-O 122.32 1.057 . . . . 0.0 109.689 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -80.96 135.87 35.94 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.586 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 1.3 t -149.05 -157.09 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 5.0 t -84.02 176.18 9.02 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.983 0.896 . . . . 0.0 110.758 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.641 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -162.7 155.55 16.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.7 Cg_endo -70.41 161.99 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.008 1.805 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 81.71 15.04 76.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.529 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 5.5 m 68.8 35.17 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.674 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -133.89 161.8 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 110.366 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 201' ' ' SER . 0.0 OUTLIER -114.56 170.23 8.46 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.19 151.26 17.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.775 -1.203 . . . . 0.0 110.281 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -106.97 146.13 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.129 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.453 HD13 ' HE3' ' A' ' 216' ' ' MET . 0.0 OUTLIER -152.99 162.31 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -125.16 141.29 52.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.086 -1.009 . . . . 0.0 109.736 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.512 ' N ' ' SD ' ' A' ' 216' ' ' MET . . . 166.38 167.8 27.59 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.442 ' HB ' ' HB1' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -85.78 -17.53 35.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -1.092 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.569 ' O ' ' CD ' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -65.08 -39.46 93.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.46 -0.775 . . . . 0.0 109.118 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.529 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -68.87 -44.96 72.22 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.051 0.929 . . . . 0.0 109.84 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.81 -19.65 64.29 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.861 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.613 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 28.6 m -64.5 -52.36 53.24 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.737 -1.227 . . . . 0.0 111.086 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -66.38 -9.88 25.55 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.864 1.709 . . . . 0.0 110.656 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.566 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -71.55 -39.24 70.79 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.63 -34.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.513 ' HB1' HG13 ' A' ' 148' ' ' VAL . . . -58.43 -39.1 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -71.4 -50.07 22.81 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -45.92 -51.46 13.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -1.194 . . . . 0.0 108.604 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -41.47 72.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.57 -49.57 61.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.117 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.63 -45.08 73.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 229' ' ' LYS . 76.2 t -54.99 -65.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -43.39 -37.71 2.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.21 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.441 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 9.8 tm0? -57.86 -57.01 14.66 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.083 -1.01 . . . . 0.0 109.897 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -54.23 -19.13 4.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.204 -0.935 . . . . 0.0 108.905 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.491 ' N ' ' HG3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -140.7 86.43 12.06 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.249 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.97 -2.93 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.677 2.251 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -10.81 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -73.73 178.49 4.76 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.73 173.62 8.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.253 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.24 -20.1 25.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.1 t -79.89 -65.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.969 -1.082 . . . . 0.0 109.106 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.1 mp0 -46.86 -34.68 5.59 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.427 HD12 HG22 ' A' ' 240' ' ' ILE . 24.0 mt -65.8 -48.33 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -50.25 -34.8 24.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.868 -1.145 . . . . 0.0 108.978 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -62.89 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.883 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.484 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.9 t60 -48.11 -51.47 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.907 . . . . 0.0 110.434 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.489 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.3 OUTLIER -63.17 -27.22 69.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 110.894 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 61.9 tttt -73.31 -52.04 15.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.024 -1.047 . . . . 0.0 110.228 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 14.0 t-20 -78.73 -10.11 59.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 110.454 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 25.5 p -94.42 -37.41 11.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.893 -1.129 . . . . 0.0 110.121 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -64.82 136.1 56.51 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.401 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 259' ' ' SER . 15.5 m -45.93 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 108.913 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 0.7 OUTLIER -145.4 87.07 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 110.131 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 257' ' ' TYR . 5.8 mp . . . . . 0 C--N 1.306 -1.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.584 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.449 ' O ' HD21 ' A' ' 190' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.401 0.62 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 251' ' ' LEU . 31.7 m-85 -88.78 -77.43 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.494 -0.754 . . . . 0.0 110.211 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 42.9 90.41 0.01 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 250' ' ' SER . 1.8 m 61.37 103.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.937 -1.331 . . . . 0.0 107.967 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.539 ' CA ' HG23 ' A' ' 193' ' ' VAL . . . -139.74 -27.09 0.24 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.371 -1.395 . . . . 0.0 111.651 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.24 146.62 28.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.335 -1.686 . . . . 0.0 108.949 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.68 155.2 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.98 . . . . 0.0 110.056 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.45 117.38 2.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.537 1.16 . . . . 0.0 107.942 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -12.67 61.85 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.975 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.498 ' HG2' ' NH1' ' A' ' 269' ' ' ARG . 11.5 tt0 -66.73 -41.33 88.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.004 -1.06 . . . . 0.0 109.137 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.475 ' HA ' ' NH2' ' A' ' 269' ' ' ARG . . . -82.38 -14.0 55.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -93.45 -16.41 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.183 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 269' ' ' ARG . 74.0 p -118.11 -60.46 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.498 ' NH1' ' HG2' ' A' ' 265' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.573 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 24.6 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.321 0.581 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.28 81.89 30.41 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.023 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HD2' HG13 ' A' ' 8' ' ' ILE . 33.7 Cg_endo -77.7 159.84 31.51 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.621 2.214 . . . . 0.0 111.347 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CZ3' ' O ' ' A' ' 176' ' ' GLN . 2.6 p-90 -57.88 -26.3 61.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.683 -0.635 . . . . 0.0 110.573 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 8' ' ' ILE . . . -89.33 53.88 3.86 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.508 HD12 ' NE2' ' A' ' 220' ' ' HIS . 14.6 mm -151.55 -50.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 109.517 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -80.26 -13.02 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.42 -28.8 61.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 8' ' ' ILE . 2.8 m -88.61 24.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 1.0 OUTLIER 50.14 45.76 25.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.675 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -82.85 -32.3 0.55 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 111.774 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -74.31 -55.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.18 -28.45 0.77 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.61 -41.98 36.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 109.239 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -66.27 -24.25 66.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.524 -0.735 . . . . 0.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -92.73 -31.04 15.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.604 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -30.09 56.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.612 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.46 19.63 3.43 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.533 ' CD1' ' CG2' ' A' ' 268' ' ' THR . 3.2 mt -101.9 120.62 40.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -1.151 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -97.98 -24.59 15.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.294 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.35 -1.31 13.35 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 22' ' ' THR . 67.3 p -71.74 117.73 13.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.116 -1.226 . . . . 0.0 109.389 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.13 -16.54 4.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 19.1 t -89.75 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.218 -1.166 . . . . 0.0 109.395 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HB3' ' CG ' ' A' ' 117' ' ' MET . 25.9 mttp -138.89 122.75 17.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.04 127.49 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -85.12 151.31 24.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.969 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 30' ' ' VAL . 35.2 t -115.14 78.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.468 ' CD2' HG23 ' A' ' 93' ' ' VAL . 5.6 mp -71.72 114.88 10.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 123' ' ' SER . 5.5 m-20 -175.75 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.513 1.149 . . . . 0.0 108.898 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.546 HG23 ' CB ' ' A' ' 60' ' ' ASN . 7.5 p -141.97 -73.59 0.31 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.593 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -160.18 -129.04 1.01 Allowed Glycine 0 C--N 1.3 -1.437 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.553 HG12 ' CB ' ' A' ' 90' ' ' ALA . 1.4 mm -170.82 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.469 ' OG ' ' OG1' ' A' ' 64' ' ' THR . 1.1 m -46.68 129.89 11.36 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 109.202 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.74 104.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.452 ' NE2' ' HA ' ' A' ' 206' ' ' SER . 0.2 OUTLIER -130.52 151.52 78.79 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 109.005 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -12.39 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.555 2.17 . . . . 0.0 110.377 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 8.8 m-20 -88.21 -31.51 19.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 ' HB2' ' A' ' 38' ' ' HIS . 5.0 mt -89.34 115.79 27.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.4 t-20 -78.37 104.28 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 108.747 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 HG21 ' O ' ' A' ' 88' ' ' LEU . 1.4 mt -96.02 -177.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.502 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 2.1 tpt85 -152.69 -39.47 0.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -175.96 166.94 38.43 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.36 174.83 45.6 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.794 -1.416 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -170.1 153.15 4.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.389 -1.065 . . . . 0.0 109.816 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 1.4 p -121.02 142.01 50.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.008 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE2' ' CA ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -126.0 -26.88 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.0 111.187 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.618 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 1.1 t -42.14 -51.86 10.1 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.855 -1.153 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 39.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 C-N-CA 123.144 2.563 . . . . 0.0 109.704 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.479 0.657 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -103.93 9.84 36.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.45 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 35.9 mt-30 -117.3 116.21 26.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 65.47 148.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.689 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 138.1 -6.4 3.4 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' CB ' HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -142.21 -78.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.088 -1.242 . . . . 0.0 109.922 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.18 -47.11 1.0 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.267 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.488 ' NE2' ' CE ' ' A' ' 216' ' ' MET . 14.6 t-160 -56.36 -61.3 2.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 0.0 110.268 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -41.25 -41.92 3.06 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.469 ' OG1' ' OG ' ' A' ' 36' ' ' SER . 25.6 m -61.25 -47.32 86.57 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.276 -1.132 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.482 ' CD2' ' CB ' ' A' ' 201' ' ' SER . 0.2 OUTLIER -55.14 -50.26 69.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 70' ' ' ILE . 30.1 t -60.03 -32.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.131 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.28 87.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 109.776 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.488 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -74.3 -25.75 69.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.541 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 83.1 m -79.31 -9.63 59.63 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.916 -1.344 . . . . 0.0 108.293 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 66' ' ' VAL . 17.3 mt -106.46 -26.78 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.351 -0.843 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -165.3 21.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.69 -1.257 . . . . 0.0 111.727 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.516 ' HB1' ' N ' ' A' ' 81' ' ' GLY . . . -41.53 127.77 3.09 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.918 -1.114 . . . . 0.0 109.322 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 60.2 mt -58.98 163.14 3.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 80' ' ' LEU . 6.0 p30 -118.91 72.85 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.553 -0.717 . . . . 0.0 109.206 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -116.79 -117.8 0.32 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.245 -0.909 . . . . 0.0 108.978 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 p -129.33 -48.71 1.19 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 109.52 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -90.59 69.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.203 -0.936 . . . . 0.0 109.832 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.47 158.1 13.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.436 ' HA ' ' OG ' ' A' ' 3' ' ' SER . 33.7 m -69.33 -153.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -1.203 . . . . 0.0 109.388 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 74' ' ' ASN . 14.4 tp -151.47 118.41 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.941 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.516 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -98.68 -149.73 25.09 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.13 -38.05 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.303 . . . . 0.0 109.045 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -93.86 135.1 25.22 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CG ' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.94 -63.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.613 2.208 . . . . 0.0 111.103 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -119.07 47.5 1.66 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.91 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.93 164.38 22.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.097 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.502 ' OE1' ' CD ' ' A' ' 44' ' ' ARG . 40.1 mm-40 -85.61 104.24 15.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 ' O ' HG21 ' A' ' 43' ' ' ILE . 6.3 mt -96.53 116.74 29.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.577 ' CE2' ' HE3' ' A' ' 117' ' ' MET . 11.5 m-85 -97.4 156.01 16.65 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -123.47 101.18 7.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.431 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.46 HG23 HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -102.58 160.14 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.904 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.464 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 2.0 tttt -116.93 111.16 19.24 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.432 -0.793 . . . . 0.0 109.415 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.492 ' CG1' HG12 ' A' ' 105' ' ' ILE . 12.1 t -115.25 -28.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.392 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HG ' HG13 ' A' ' 93' ' ' VAL . 3.1 mp -132.74 175.05 9.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 110.017 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.36 170.9 39.53 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.243 . . . . 0.0 108.9 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.07 162.86 13.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.748 -0.854 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.25 -15.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -19.73 57.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.553 ' CB ' ' CG2' ' A' ' 50' ' ' VAL . 60.6 p -87.98 -47.62 8.4 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.773 0.797 . . . . 0.0 109.094 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.506 HG22 HD11 ' A' ' 105' ' ' ILE . 2.2 mt -68.35 -34.13 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.91 -39.35 51.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.588 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 1.9 tt0 -70.52 -31.31 68.35 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.065 -1.022 . . . . 0.0 109.07 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.589 ' CA ' ' CE2' ' A' ' 49' ' ' PHE . . . -75.11 -39.49 37.16 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.4 mt -66.57 -33.13 74.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -1.088 . . . . 0.0 109.692 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 -17.98 23.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 107' ' ' GLN . 80.1 t90 -73.15 -18.02 61.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.655 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -90.85 6.72 43.28 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.223 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -96.99 -46.89 2.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.29 -80.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.147 -1.208 . . . . 0.0 108.274 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -95.83 62.56 2.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.655 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -122.34 -161.21 11.19 Favored Glycine 0 C--N 1.286 -2.205 0 CA-C-O 122.575 1.097 . . . . 0.0 112.034 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.577 ' HE3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -126.41 162.87 24.58 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.415 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.53 ' CG2' ' HE3' ' A' ' 229' ' ' LYS . 2.5 t -105.91 156.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.837 -1.164 . . . . 0.0 109.611 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.2 121.34 1.69 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.723 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.464 ' O ' HD13 ' A' ' 122' ' ' LEU . 13.2 t-20 -98.48 158.32 15.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.071 -1.018 . . . . 0.0 109.954 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 121' ' ' ASN . 7.0 mp -138.02 101.77 4.51 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 32' ' ' ASP . 20.6 p -85.53 62.11 7.27 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.9 178.87 7.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.433 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.587 ' CA ' ' CB ' ' A' ' 160' ' ' SER . . . 165.65 107.96 0.21 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.97 154.43 48.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.98 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 33.4 Cg_endo -77.18 -3.84 14.15 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.517 2.144 . . . . 0.0 109.195 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.408 ' O ' ' CE1' ' A' ' 161' ' ' TYR . 2.7 t -103.99 101.04 23.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 35.7 Cg_endo -77.95 166.03 25.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.335 2.023 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -153.73 125.21 7.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.65 66.56 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 15.5 m -67.08 -28.8 68.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' A' ' 161' ' ' TYR . 0.3 OUTLIER -70.37 -36.62 74.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -65.94 -58.44 5.54 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.431 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 134' ' ' GLU . 2.4 tp-100 -42.12 -28.13 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' GLU . . . -74.96 -49.61 19.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.707 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -33.14 46.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -61.61 -39.58 91.76 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -71.08 -22.94 62.04 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.99 -2.23 47.36 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.002 -1.062 . . . . 0.0 110.187 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -95.34 -34.16 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 108.859 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 64.4 m -66.1 -24.4 66.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 108.86 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -88.79 -13.1 40.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -0.821 . . . . 0.0 109.325 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.26 71.13 1.0 Allowed Glycine 0 C--N 1.302 -1.36 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 147' ' ' VAL . 84.9 t -112.99 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.448 -1.03 . . . . 0.0 109.499 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.449 HD11 ' OD1' ' A' ' 237' ' ' ASN . 5.0 tp -60.48 100.81 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.094 -1.003 . . . . 0.0 108.772 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -104.11 140.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.22 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.455 HG11 ' HA ' ' A' ' 121' ' ' ASN . 3.7 p -129.16 125.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 108.879 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 170' ' ' ALA . . . -105.18 146.85 28.66 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.995 -1.066 . . . . 0.0 110.431 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -81.45 169.66 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.56 -68.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 143.23 121.63 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 154' ' ' SER . 12.7 p-10 -86.7 33.35 0.65 Allowed 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.756 -0.849 . . . . 0.0 109.917 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER 162.33 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.31 -103.4 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.56 -168.66 2.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.7 44.89 3.3 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -159.66 150.16 19.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -1.198 . . . . 0.0 109.045 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.2 pt -80.85 176.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.39 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.587 ' CB ' ' CA ' ' A' ' 125' ' ' GLY . 0.7 OUTLIER -108.66 163.44 13.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 111.823 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.433 ' CE2' HD21 ' A' ' 133' ' ' LEU . 10.2 p90 -89.89 146.06 34.49 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 164' ' ' ARG . 44.0 Cg_endo -71.37 -26.6 8.09 Favored 'Cis proline' 0 C--N 1.297 -2.179 0 O-C-N 122.404 0.687 . . . . 0.0 110.722 4.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.73 -178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -77.4 -47.55 19.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.719 -1.238 . . . . 0.0 110.011 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -48.0 -171.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.316 1.055 . . . . 0.0 110.906 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.23 1.34 12.45 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.736 -0.602 . . . . 0.0 110.104 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.68 18.98 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.147 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -168.24 161.56 12.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.9 mmm -104.2 138.71 40.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.591 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -100.75 127.1 47.3 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.528 -0.732 . . . . 0.0 109.294 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.4 t -98.55 165.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.189 -0.944 . . . . 0.0 109.717 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -135.39 -158.0 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -144.74 147.01 32.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.925 -1.338 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 197' ' ' VAL . 0.4 OUTLIER -114.34 155.69 25.78 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 4.2 p-10 -59.63 -160.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 109.664 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.53 ' O ' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -45.65 -67.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.465 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -102.12 -57.81 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.369 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.2 OUTLIER -176.17 106.63 0.08 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.403 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.693 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 1.1 t30 -136.65 -39.13 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.693 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 13.5 ttt180 116.51 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.692 0.758 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -39.24 161.32 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.185 0.516 . . . . 0.0 109.638 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -119.86 -49.09 2.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 0.0 110.475 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.518 ' CE2' ' OG1' ' A' ' 214' ' ' THR . 31.3 p90 -49.49 -21.41 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.433 ' HB2' ' OG1' ' A' ' 214' ' ' THR . 1.6 t -69.94 117.2 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.015 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.54 116.94 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CG ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -121.41 167.8 12.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.528 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -165.34 -166.61 24.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.34 64.11 7.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.14 -1.212 . . . . 0.0 109.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 170.81 33.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' ASP . 5.3 tp -79.27 102.2 8.45 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.04 -1.271 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 24.4 t70 -41.79 -67.83 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 110.277 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 260' ' ' GLY . 3.9 tt -157.77 169.98 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.199 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 260' ' ' GLY . 7.9 m -108.76 162.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.695 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.556 ' CB ' ' CD ' ' A' ' 195' ' ' PRO . . . -152.88 -176.68 0.61 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 194' ' ' ALA . 34.3 Cg_endo -78.15 115.48 3.75 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.771 1.648 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -144.09 18.48 2.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.627 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 10.3 t -109.14 55.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 108.729 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.627 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 20.4 t-20 131.19 121.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 16.4 m -164.63 111.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.94 0.876 . . . . 0.0 108.724 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.8 OUTLIER -99.68 125.2 45.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.482 ' CB ' ' CD2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -130.85 -166.57 1.71 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 109.304 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -83.5 172.96 11.89 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.627 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -147.5 165.36 19.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.627 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.5 Cg_endo -71.27 164.48 35.59 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.085 1.857 . . . . 0.0 110.533 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 92.0 -54.73 2.93 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 9.5 p 141.39 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -137.93 -178.37 5.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.934 -1.104 . . . . 0.0 110.371 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.536 ' N ' ' OG1' ' A' ' 207' ' ' THR . 36.7 m-85 -106.37 -160.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -172.97 163.04 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.987 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 42.3 p -151.72 108.55 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 108.875 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 199' ' ' VAL . 0.4 OUTLIER -139.87 160.74 39.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.719 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.85 133.22 55.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -169.09 148.54 12.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.518 ' OG1' ' CE2' ' A' ' 183' ' ' PHE . 32.9 m -72.64 -31.44 65.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -1.186 . . . . 0.0 109.302 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 16.8 t -67.74 -9.18 41.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.488 ' CE ' ' NE2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -86.22 -22.26 27.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.898 . . . . 0.0 109.877 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -84.65 -17.31 39.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.617 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 32.9 m -62.87 -42.76 79.88 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 111.904 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.2 Cg_endo -71.27 -13.47 30.86 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.575 1.517 . . . . 0.0 110.277 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.508 ' NE2' HD12 ' A' ' 8' ' ' ILE . 8.4 m80 -72.42 -40.08 67.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 171' ' ' VAL . 55.9 t -71.09 -39.29 74.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.78 -45.58 67.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -62.4 -45.19 96.44 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.58 -60.36 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.266 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -48.59 -33.68 10.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.763 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.93 -46.54 90.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 109.037 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 30.4 mt -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.149 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 229' ' ' LYS . 97.5 t -64.75 -64.94 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 109.756 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.53 ' HE3' ' CG2' ' A' ' 119' ' ' VAL . 7.6 ttmm -42.97 -35.98 1.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.127 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 45.1 tp60 -60.95 -51.92 67.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 231' ' ' LYS . 3.1 ttpp -55.62 -18.56 8.0 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 3.5 m120 -165.49 82.78 1.1 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.383 -0.823 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.469 ' N ' ' O ' ' A' ' 229' ' ' LYS . 36.1 Cg_endo -78.81 0.24 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.689 2.259 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -6.36 48.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -75.84 -176.73 3.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.1 164.76 12.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.389 0.614 . . . . 0.0 109.616 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.449 ' OD1' HD11 ' A' ' 146' ' ' LEU . 6.6 t30 -52.61 -29.05 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -78.17 -61.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.141 -0.975 . . . . 0.0 109.422 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.7 OUTLIER -39.98 -37.78 0.63 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.019 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 2.5 mt -77.1 -46.63 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.634 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -49.67 -31.33 10.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 52.3 m-20 -72.93 -47.13 48.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.964 -1.085 . . . . 0.0 110.389 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.498 ' O ' HG22 ' A' ' 247' ' ' THR . 3.5 t60 -63.15 -35.88 81.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.411 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -81.87 -35.67 29.04 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -68.89 -34.43 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 243' ' ' HIS . 3.7 p-10 -84.65 -30.42 24.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.44 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 243' ' ' HIS . 1.7 p -72.06 -30.13 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -40.52 117.44 0.81 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.521 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' ALA . 0.2 OUTLIER -43.9 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -126.18 71.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 261' ' ' LEU . 1.9 mp . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.968 . . . . 0.0 109.741 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.645 ' CD2' ' CG ' ' A' ' 186' ' ' TYR . 2.6 tm? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.234 0.54 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -61.28 -57.53 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.14 -0.975 . . . . 0.0 109.089 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.48 -81.65 1.69 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 191' ' ' ASP . 57.7 m -78.53 -55.43 5.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.388 -1.066 . . . . 0.0 109.137 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.474 ' O ' HG13 ' A' ' 192' ' ' ILE . . . 135.26 -135.53 7.95 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.43 ' HB2' HD13 ' A' ' 251' ' ' LEU . 1.4 tp -105.06 178.1 4.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.349 -1.089 . . . . 0.0 109.076 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.468 HG23 HD12 ' A' ' 192' ' ' ILE . 3.0 t -122.67 156.29 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -166.23 119.6 1.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.327 1.06 . . . . 0.0 108.457 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.73 -13.01 61.24 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.152 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.402 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 15.8 tt0 -75.47 -25.96 57.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 109.664 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.21 55.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.679 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' A' ' 247' ' ' THR . . . -113.67 -20.67 11.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 21' ' ' LEU . 61.8 p -102.31 -46.51 4.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.119 -0.988 . . . . 0.0 109.229 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.427 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.46 ' OG ' HG11 ' A' ' 79' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.298 0.57 . . . . 0.0 109.641 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.641 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 2.9 t -136.75 46.81 1.62 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.915 . . . . 0.0 110.108 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 36.4 Cg_endo -77.5 165.6 27.04 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.936 1.758 . . . . 0.0 110.424 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 7.1 p-90 -67.05 -13.19 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 109.464 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 11' ' ' VAL . . . -83.89 -15.75 69.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.57 ' CD1' ' NE2' ' A' ' 220' ' ' HIS . 1.1 mp -116.38 -6.75 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -1.202 . . . . 0.0 109.045 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.92 -22.43 21.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 21.37 12.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.036 -1.04 . . . . 0.0 110.621 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 7' ' ' GLY . 28.1 m -110.06 18.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.963 -1.086 . . . . 0.0 109.339 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 27.8 mm-40 57.07 17.63 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 110.571 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.653 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.54 -43.03 87.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.86 -53.87 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 N-CA-C 107.874 -1.625 . . . . 0.0 107.874 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB2' ' OE2' ' A' ' 265' ' ' GLU . . . -44.75 -30.74 1.01 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.47 54.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 16.0 m170 -65.62 -10.83 39.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.601 -0.687 . . . . 0.0 109.175 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -83.43 -56.87 3.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -36.21 63.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.456 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.92 4.01 9.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.457 ' CD1' HG23 ' A' ' 268' ' ' THR . 0.3 OUTLIER -63.82 137.68 58.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.133 . . . . 0.0 109.365 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -123.77 -12.4 7.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.086 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 71.55 -9.39 4.66 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -49.13 135.43 16.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -1.122 . . . . 0.0 109.336 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.18 0.55 47.78 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 27' ' ' LYS . 47.5 t -112.44 163.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.127 -1.219 . . . . 0.0 109.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HG3' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -148.83 131.35 15.78 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 119' ' ' VAL . 17.4 t -128.69 154.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.325 -0.859 . . . . 0.0 109.723 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -98.76 150.17 22.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.911 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 89' ' ' TYR . 39.0 t -122.7 80.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.919 -1.113 . . . . 0.0 108.387 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.518 ' CD2' HG22 ' A' ' 93' ' ' VAL . 6.6 mp -71.07 126.41 29.51 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER 170.21 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.264 -0.897 . . . . 0.0 109.258 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -49.05 -59.76 3.35 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . 179.38 -109.85 0.27 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.555 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER 165.6 102.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 p -49.73 125.88 12.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.814 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 m -55.12 101.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.074 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.56 ' CD2' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -119.4 153.39 53.7 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.812 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 35.6 Cg_endo -78.5 -12.69 15.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.516 2.144 . . . . 0.0 109.939 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -90.25 -37.58 14.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 72' ' ' ALA . 62.2 mt -88.87 113.49 24.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.792 . . . . 0.0 109.545 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 119.36 16.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.432 HD13 ' CG2' ' A' ' 35' ' ' ILE . 39.1 mm -92.66 94.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.073 -1.017 . . . . 0.0 109.395 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.506 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -79.81 -21.01 44.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.993 . . . . 0.0 109.265 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.593 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -169.32 163.9 37.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.91 119.5 0.83 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.37 163.47 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -1.096 . . . . 0.0 108.727 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 92' ' ' LYS . 2.5 t -150.85 136.95 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 110.427 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -127.29 -30.31 2.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.2 t -49.05 129.42 15.42 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.313 -1.321 0 C-N-CA 122.64 2.226 . . . . 0.0 111.125 -179.569 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.69 0.757 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -92.71 3.8 54.93 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.181 -0.95 . . . . 0.0 109.159 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 1.5 mt-30 -96.56 116.21 28.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.217 -0.927 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.7 OUTLIER 52.21 171.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.637 0.732 . . . . 0.0 110.133 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . -179.57 -33.31 0.06 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -175.68 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.345 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.62 -47.24 0.97 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -45.32 -50.07 12.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.398 -1.06 . . . . 0.0 110.155 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -54.54 -80.94 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.409 -0.901 . . . . 0.0 110.934 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 0.7 OUTLIER -33.42 -45.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.818 -0.813 . . . . 0.0 110.898 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.578 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 44.9 t-80 -57.51 -54.01 51.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.971 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 70' ' ' ILE . 13.5 t -58.76 -32.62 47.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.426 -0.796 . . . . 0.0 109.189 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.72 -49.27 78.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.844 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.31 -28.65 71.05 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 7.7 m -71.59 -17.12 62.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.062 -1.258 . . . . 0.0 108.473 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 66' ' ' VAL . 30.3 mt -92.66 -32.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.401 -0.812 . . . . 0.0 110.411 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . . . -179.65 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.661 -1.274 . . . . 0.0 111.52 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -46.1 156.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.734 -1.229 . . . . 0.0 108.358 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 96.6 mt -78.95 166.69 22.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.932 -1.105 . . . . 0.0 109.925 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 80' ' ' LEU . 55.0 t30 -117.29 87.38 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.84 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -118.39 -118.92 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.291 -0.881 . . . . 0.0 108.737 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -113.45 -40.54 3.84 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 109.279 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.79 165.56 2.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.404 -0.81 . . . . 0.0 109.7 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.27 -167.23 53.16 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.46 HG11 ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -114.0 -167.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -1.178 . . . . 0.0 109.397 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 74' ' ' ASN . 8.5 tp -130.36 122.37 27.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.57 -149.31 13.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.79 -66.67 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.263 . . . . 0.0 109.666 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . . . -71.45 134.3 84.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 22' ' ' THR . 40.1 Cg_endo -84.95 -60.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.752 2.302 . . . . 0.0 111.236 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -105.92 45.38 0.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.793 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 83' ' ' ALA . . . -85.5 164.72 17.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.07 -1.018 . . . . 0.0 109.646 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 2.6 tt0 -101.55 80.19 2.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 HD12 ' HB ' ' A' ' 70' ' ' ILE . 6.6 mt -73.3 144.17 46.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.312 -0.867 . . . . 0.0 109.746 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.6 ' CZ ' ' HE2' ' A' ' 117' ' ' MET . 2.8 m-85 -118.48 161.52 19.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.03 92.32 3.28 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.643 -1.286 . . . . 0.0 109.914 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.89 149.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.131 -0.981 . . . . 0.0 109.315 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.475 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 4.4 mttp -100.29 105.61 17.17 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.539 ' CG1' HG21 ' A' ' 105' ' ' ILE . 2.1 t -104.55 -14.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.813 . . . . 0.0 110.08 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.55 -174.7 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.771 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -110.75 -177.41 20.63 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 59' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.452 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.48 157.8 21.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.746 -0.855 . . . . 0.0 109.786 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 130' ' ' SER . 43.7 t -68.53 -19.61 24.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.526 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 33.4 t -72.91 -22.69 60.7 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.446 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 57.4 m -83.1 -63.8 1.29 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.539 HG21 ' CG1' ' A' ' 93' ' ' VAL . 2.3 mt -47.93 -27.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 110' ' ' GLU . . . -69.08 -47.91 64.03 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.597 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -64.79 -28.83 69.84 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.033 -1.042 . . . . 0.0 109.404 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -80.55 -26.77 53.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.527 HD21 ' ND2' ' A' ' 167' ' ' ASN . 16.4 mt -87.23 -24.15 24.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -1.227 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 7.1 pt-20 -100.63 -25.94 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.251 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.53 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 83.1 t90 -71.65 -17.06 62.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -93.42 -0.38 56.51 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.876 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.93 -28.47 10.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -97.2 -35.41 10.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -1.22 . . . . 0.0 109.503 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -140.12 27.66 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.394 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.579 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -87.99 -153.32 25.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.6 ' HE2' ' CZ ' ' A' ' 89' ' ' TYR . 12.1 mmt -125.22 -176.54 3.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.366 -1.079 . . . . 0.0 110.432 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.666 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -71.84 -17.08 62.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.749 -0.595 . . . . 0.0 110.163 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.666 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.6 t -136.74 168.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -169.6 132.48 1.21 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.534 ' C ' ' CD1' ' A' ' 122' ' ' LEU . 1.6 m120 -130.91 147.39 52.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.0 109.741 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -142.07 124.78 15.93 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.094 -1.004 . . . . 0.0 109.187 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.424 ' HB3' ' OG ' ' A' ' 215' ' ' SER . 0.7 OUTLIER -93.17 62.14 3.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.897 -1.127 . . . . 0.0 109.065 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 124' ' ' LEU . 1.2 mt -99.72 -178.7 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 160' ' ' SER . . . 175.05 74.88 0.05 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 3.4 m -124.62 147.73 56.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 109.494 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.524 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -81.07 15.42 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.787 2.325 . . . . 0.0 110.119 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.534 ' N ' ' CD ' ' A' ' 129' ' ' PRO . 14.1 t -116.03 50.36 0.76 Allowed Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.602 -0.687 . . . . 0.0 111.48 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 128' ' ' SER . 33.8 Cg_endo -72.57 178.58 6.07 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.343 2.028 . . . . 0.0 109.772 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.487 ' HB2' HG23 ' A' ' 102' ' ' VAL . 3.7 t -152.49 154.08 34.77 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.16 64.92 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.0 m -71.61 -26.76 62.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' O ' ' HB1' ' A' ' 136' ' ' ALA . 2.2 tp -72.39 -38.3 68.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -68.08 -47.62 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.64 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -26.47 12.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 133' ' ' LEU . . . -67.32 -44.81 78.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -52.29 -40.38 31.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.416 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 1.6 m120 -58.07 -41.79 84.12 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -20.16 63.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.63 1.75 25.42 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.872 -1.143 . . . . 0.0 112.044 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -104.49 -41.24 5.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.427 -1.421 . . . . 0.0 108.409 178.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -20.03 57.8 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.38 -25.83 20.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.44 52.66 4.12 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 147' ' ' VAL . 86.5 t -105.4 109.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -1.093 . . . . 0.0 109.267 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.7 tp -58.5 123.13 15.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.053 -1.029 . . . . 0.0 109.104 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -120.25 141.69 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.015 . . . . 0.0 109.297 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.457 HG21 ' HG3' ' A' ' 169' ' ' MET . 1.2 t -137.97 123.91 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' A' ' 163' ' ' ALA . . . -118.75 147.94 43.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.004 -1.06 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -52.2 160.4 0.78 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.618 -0.676 . . . . 0.0 110.213 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -71.06 -79.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 185' ' ' GLN . . . 149.54 119.32 0.97 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.437 ' OD1' ' CG ' ' A' ' 183' ' ' PHE . 3.6 m-20 -91.59 57.66 3.33 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.799 -0.824 . . . . 0.0 109.391 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.07 -96.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.49 84.47 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -170.61 179.51 3.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.62 56.7 4.89 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -179.75 171.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -1.077 . . . . 0.0 108.675 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -118.85 -173.34 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.008 -1.057 . . . . 0.0 110.38 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.518 ' HB3' ' HA2' ' A' ' 125' ' ' GLY . 2.6 m -70.89 -174.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.806 1.289 . . . . 0.0 112.521 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.452 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 93.6 m-85 -123.81 126.97 25.59 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.723 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.3 Cg_endo -72.62 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.301 -1.949 0 C-N-CA 123.939 -1.276 . . . . 0.0 109.791 2.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.524 ' HA ' ' HB1' ' A' ' 149' ' ' ALA . . . 31.7 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.238 1.018 . . . . 0.0 108.901 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 162' ' ' PRO . 17.5 ttm180 -44.12 -62.73 1.05 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.589 ' O ' ' CB ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -172.28 -166.12 0.38 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 165' ' ' TYR . . . 89.73 -7.09 0.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.746 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.653 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 0.9 OUTLIER 159.73 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.719 -0.613 . . . . 0.0 109.596 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 167' ' ' ASN . . . 164.77 149.49 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.433 -1.307 . . . . 0.0 112.648 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -80.19 -174.43 4.52 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 175.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 189' ' ' GLY . . . -122.66 118.88 29.18 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.345 -1.472 . . . . 0.0 110.515 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 151' ' ' SER . 19.0 t -89.52 166.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.544 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -136.9 -176.89 14.61 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.582 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 214' ' ' THR . . . -130.31 150.21 51.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.979 . . . . 0.0 109.601 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 175' ' ' ASP . 33.2 p -157.79 155.06 29.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' THR . 18.8 p-10 -58.9 -150.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.846 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.519 ' HG2' ' ND2' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -94.48 -31.48 13.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.952 . . . . 0.0 109.983 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 176' ' ' GLN . 0.0 OUTLIER -96.29 -89.39 0.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.96 80.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -140.28 165.18 28.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -98.38 19.07 15.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.354 -0.841 . . . . 0.0 109.647 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 64.15 -152.46 0.3 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 182' ' ' SER . 0.6 OUTLIER -112.0 9.86 20.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.393 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -150.48 -92.48 0.06 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' PHE . 3.7 t 39.29 80.76 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.476 -0.765 . . . . 0.0 110.455 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 152' ' ' GLY . 1.9 mp0 -65.67 146.27 55.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 0.0 109.122 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -123.54 166.41 15.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.126 -0.983 . . . . 0.0 109.541 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . 155.59 175.5 26.69 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -52.82 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.156 . . . . 0.0 109.273 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 160.81 -33.76 0.4 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.478 HD22 ' O ' ' A' ' 257' ' ' TYR . 7.9 tp -52.21 111.78 0.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.238 -1.154 . . . . 0.0 109.622 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.28 -28.75 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.85 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 258' ' ' GLY . 2.5 tt -156.8 166.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.607 -1.308 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 260' ' ' GLY . 12.4 m -123.68 174.63 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -0.821 . . . . 0.0 109.283 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.548 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -168.78 177.81 1.14 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.223 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 34.4 Cg_endo -76.61 119.33 5.15 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.455 2.103 . . . . 0.0 110.629 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.47 42.15 1.41 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 19.9 t -133.45 81.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.234 -1.156 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER 84.22 122.83 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.011 0.91 . . . . 0.0 108.574 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.44 HG22 ' HG2' ' A' ' 216' ' ' MET . 19.3 m -156.81 108.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 122.137 0.97 . . . . 0.0 109.383 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 31.5 mt-30 -78.77 143.79 35.78 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.578 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -159.11 -162.1 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.329 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 15.0 t -86.04 -177.55 6.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.629 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -168.45 169.44 4.96 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.629 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -72.31 168.55 23.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.335 2.023 . . . . 0.0 110.538 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.53 72.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.505 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 4.2 p 56.36 36.7 27.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -1.113 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -122.58 147.68 46.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.078 -1.014 . . . . 0.0 109.807 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.22 19.28 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.49 165.67 4.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.028 . . . . 0.0 110.205 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.1 OUTLIER -103.33 146.3 28.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.482 -0.762 . . . . 0.0 109.435 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.564 HD12 ' CD2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -139.01 107.91 5.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.777 . . . . 0.0 109.169 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.07 140.83 56.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.1 -1.0 . . . . 0.0 109.344 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.35 2.39 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.503 ' CG2' ' HB1' ' A' ' 173' ' ' ALA . 19.4 m -68.38 -23.58 64.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 0.0 109.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 123' ' ' SER . 9.9 t -67.11 -20.07 65.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.643 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.511 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -78.77 -10.49 59.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 194' ' ' ALA . . . -86.38 -5.76 59.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.638 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.64 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -76.95 -39.05 2.13 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.5 Cg_endo -71.98 -25.59 19.46 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.527 1.484 . . . . 0.0 110.744 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.57 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 13.1 m80 -66.78 -37.75 85.19 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.72 -52.14 34.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.466 ' HB2' ' OD1' ' A' ' 121' ' ' ASN . . . -48.09 -33.2 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.378 -0.826 . . . . 0.0 108.94 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.4 -53.08 23.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -53.52 -62.44 1.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.419 -1.048 . . . . 0.0 109.286 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.524 ' CA ' HD13 ' A' ' 244' ' ' LEU . . . -43.01 -40.88 3.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.23 78.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.216 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mt -52.94 -29.12 26.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.33 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 229' ' ' LYS . 96.1 t -74.19 -51.51 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.547 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -43.92 -47.62 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.458 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 28.3 tp60 -63.3 -41.8 98.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 231' ' ' LYS . 13.3 tptt -62.98 -11.49 19.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.046 -1.034 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.96 90.89 1.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.19 -0.944 . . . . 0.0 109.764 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 36.9 Cg_endo -81.44 17.88 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.724 2.283 . . . . 0.0 110.834 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.3 t -122.12 5.32 9.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 110.004 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -91.5 -179.65 5.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.909 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.4 OUTLIER -110.37 167.73 9.98 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -58.64 -35.75 73.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 109.426 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -66.66 -64.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.21 -0.931 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.464 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -45.34 -39.78 7.12 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.357 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 236' ' ' SER . 59.7 mt -57.72 -49.41 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.57 -0.706 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' ASN . 49.1 ttp180 -56.12 -60.65 3.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.552 ' HA ' ' HE3' ' A' ' 245' ' ' LYS . 2.3 t-20 -37.69 -62.72 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.66 -0.65 . . . . 0.0 110.91 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.497 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.1 t60 -50.4 -40.75 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.597 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.524 HD13 ' CA ' ' A' ' 225' ' ' ALA . 0.2 OUTLIER -70.63 -37.56 73.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 111.327 -178.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 4.0 ptpt -63.36 -55.46 24.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.868 -1.145 . . . . 0.0 109.975 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.598 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -70.78 -27.1 63.66 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.547 -0.72 . . . . 0.0 111.035 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 6.0 p -71.57 -30.75 66.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.802 -1.186 . . . . 0.0 109.627 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 261' ' ' LEU . . . -52.33 130.76 31.91 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 261' ' ' LEU . 1.6 m -42.97 111.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.211 -0.931 . . . . 0.0 108.784 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.4 p -69.14 98.0 0.96 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -0.804 . . . . 0.0 110.369 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.305 -1.342 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.428 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.478 ' O ' HD22 ' A' ' 190' ' ' LEU . 42.6 m-85 -55.3 -60.97 2.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.154 -0.966 . . . . 0.0 108.475 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 124.71 58.97 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.432 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 3.1 t 83.73 -57.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.926 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 193' ' ' VAL . . . 140.36 -171.29 24.03 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.525 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 248' ' ' ALA . 12.7 tp -75.25 162.29 28.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.954 . . . . 0.0 109.695 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.37 154.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.182 -0.949 . . . . 0.0 109.969 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.403 ' CB ' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -160.71 117.18 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.652 1.215 . . . . 0.0 108.177 178.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.6 61.0 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.526 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' A' ' 15' ' ' ALA . 7.6 tp10 -82.47 -40.47 21.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.964 -1.085 . . . . 0.0 109.603 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.8 -11.75 59.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 0.0 109.301 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' A' ' 247' ' ' THR . . . -89.69 -38.88 13.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.457 HG23 ' CD1' ' A' ' 21' ' ' LEU . 44.6 p -87.89 -52.9 5.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.442 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.404 ' C ' ' HD3' ' A' ' 269' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.429 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.1 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.76 0.791 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 8' ' ' ILE . 15.8 m -76.99 111.89 19.34 Favored Pre-proline 0 C--N 1.29 -2.007 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -80.48 -166.52 0.42 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.827 2.351 . . . . 0.0 111.813 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.593 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -33.29 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.219 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.515 ' HA3' ' NE2' ' A' ' 220' ' ' HIS . . . -52.06 -83.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 8' ' ' ILE . 2.9 mm -43.84 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.479 -1.012 . . . . 0.0 109.187 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 162.78 -56.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -125.49 26.52 6.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 HG22 ' HB1' ' A' ' 13' ' ' ALA . 21.7 m -112.65 20.04 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.875 -1.14 . . . . 0.0 109.903 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 5.3 mm-40 65.83 15.59 10.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.577 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.649 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -66.33 -37.17 14.96 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.5 Cg_endo -73.02 -55.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.981 0 N-CA-C 108.424 -1.414 . . . . 0.0 108.424 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.74 -29.52 0.53 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 11.1 m170 -69.04 -7.29 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.817 . . . . 0.0 109.569 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.26 -22.58 14.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.112 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.496 ' NH2' ' HA ' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -81.26 4.89 18.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.34 47.13 5.03 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -149.22 150.89 33.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -1.086 . . . . 0.0 109.102 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 24' ' ' SER . 1.7 t -161.15 38.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.866 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 56.94 9.79 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.515 ' N ' ' HG3' ' A' ' 230' ' ' GLN . 55.5 p -57.78 119.45 6.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.77 27.92 9.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 27' ' ' LYS . 88.1 t -122.83 167.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -1.211 . . . . 0.0 109.789 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' HG2' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -136.24 132.62 36.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.117 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.36 123.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 110.121 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HB2' HG23 ' A' ' 91' ' ' VAL . . . -84.97 162.63 19.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.82 90.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.515 ' CD2' HG22 ' A' ' 93' ' ' VAL . 5.9 mp -79.83 102.37 9.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 63' ' ' GLY . 47.9 p30 -166.2 -154.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.006 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.473 ' HB ' ' HA3' ' A' ' 59' ' ' GLY . 6.6 p -43.0 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.566 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -164.06 -132.8 1.39 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 34' ' ' GLY . 30.5 mm -165.58 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.507 ' CB ' ' HB3' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -62.88 137.47 58.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 109.171 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -63.05 122.39 15.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.591 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -133.18 154.54 81.22 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.4 Cg_endo -79.68 -31.91 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.715 2.276 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -86.33 -3.19 58.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.0 109.836 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 67' ' ' ALA . 16.8 mt -105.77 123.6 48.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.065 -1.022 . . . . 0.0 109.724 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.12 91.43 7.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 109.87 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.75 152.07 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.563 ' O ' ' CE1' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -160.71 23.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.338 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.607 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -170.0 144.76 8.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.93 114.69 0.71 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.1 157.68 44.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -1.032 . . . . 0.0 109.294 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.28 133.75 3.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.993 -1.067 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.8 -36.38 3.9 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.609 -0.682 . . . . 0.0 109.634 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG22 ' C ' ' A' ' 93' ' ' VAL . 11.2 t -43.69 107.49 0.59 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.374 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--N 1.315 -1.229 0 C-N-CA 122.706 2.271 . . . . 0.0 110.704 -179.738 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.129 0.49 . . . . 0.0 109.858 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.42 ' OG1' ' C ' ' A' ' 55' ' ' SER . 0.1 OUTLIER 61.69 4.28 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.121 -0.987 . . . . 0.0 110.114 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' ASP . 30.2 mt-30 -147.03 138.69 24.25 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.753 -1.217 . . . . 0.0 109.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 57' ' ' GLN . 45.2 t0 57.8 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 60' ' ' ASN . . . -153.7 67.21 0.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 2.8 t-20 84.99 -33.43 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.885 . . . . 0.0 109.893 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.54 10.82 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLY . 20.5 t-160 -51.08 -66.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -40.85 -72.92 0.22 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 63' ' ' GLY . 96.5 m -35.38 -48.07 0.46 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.827 -0.807 . . . . 0.0 110.735 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.51 ' NE2' ' HB2' ' A' ' 201' ' ' SER . 22.0 t-80 -51.73 -53.36 40.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.254 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.5 t -60.64 -31.35 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.34 -0.85 . . . . 0.0 108.785 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 41' ' ' LEU . . . -55.79 -48.58 75.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.397 -0.814 . . . . 0.0 109.526 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 70' ' ' ILE . . . -67.41 -43.03 88.68 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 219' ' ' PRO . 1.1 m -52.07 -21.88 3.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.449 -1.618 . . . . 0.0 107.773 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 83' ' ' ALA . 55.9 mt -94.3 -30.68 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.497 -0.752 . . . . 0.0 110.949 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -165.57 44.38 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.506 -1.371 . . . . 0.0 112.323 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -60.92 124.47 20.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.635 -1.291 . . . . 0.0 108.82 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 93.2 mt -79.33 156.75 27.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.992 -1.068 . . . . 0.0 109.314 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 42.3 t30 -139.54 63.63 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.087 -1.008 . . . . 0.0 109.975 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -89.75 -13.92 35.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.042 0.925 . . . . 0.0 109.28 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.8 -45.93 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -115.1 157.25 15.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.526 -0.734 . . . . 0.0 109.135 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.83 164.35 35.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.43 -150.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.366 -1.079 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 6.3 tp -147.02 106.42 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.984 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.43 -163.48 4.62 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.505 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 0.6 OUTLIER -78.91 -53.67 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -1.108 . . . . 0.0 109.427 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -110.84 101.9 50.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.18 -0.95 . . . . 0.0 108.707 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.457 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 37.6 Cg_endo -83.03 -53.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.902 2.401 . . . . 0.0 111.303 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.48 18.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.152 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.18 23.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.525 -1.359 . . . . 0.0 109.203 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' OH ' ' A' ' 89' ' ' TYR . 44.0 mt-10 -74.33 150.57 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 109.082 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' A' ' 71' ' ' ALA . 88.1 mt -125.25 97.98 5.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.953 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.607 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 m-30 -82.29 113.66 20.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.262 -0.899 . . . . 0.0 109.419 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.525 ' HB3' HG12 ' A' ' 35' ' ' ILE . . . -78.77 108.91 12.55 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.073 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.49 ' HB ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -108.38 73.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.766 -1.209 . . . . 0.0 109.959 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -41.65 113.4 0.41 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.551 ' CG1' HG12 ' A' ' 105' ' ' ILE . 5.0 t -123.06 -24.71 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.135 -0.978 . . . . 0.0 109.928 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -126.76 172.2 10.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 110.173 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.92 -158.65 16.5 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.217 -1.167 . . . . 0.0 109.183 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 m -121.47 157.35 30.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.872 -0.781 . . . . 0.0 109.983 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.452 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 0.9 OUTLIER -67.24 -28.89 44.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.549 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 75.1 m -72.52 -18.53 61.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 105' ' ' ILE . 9.2 p -77.44 -57.76 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.652 -0.655 . . . . 0.0 109.382 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.551 HG12 ' CG1' ' A' ' 93' ' ' VAL . 1.3 mt -63.4 -24.15 35.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -67.06 -44.54 79.89 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.624 -0.673 . . . . 0.0 109.572 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.582 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -77.39 -24.26 50.56 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.624 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.559 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -72.51 -27.98 68.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.68 -30.7 14.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -76.14 -30.06 58.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 108.96 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -65.67 -22.96 66.68 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.61 ' CA ' ' CA ' ' A' ' 116' ' ' GLY . . . -81.33 -21.85 38.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -56.52 -39.35 84.4 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.58 -49.97 6.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -127.93 70.27 1.34 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.61 ' CA ' ' CA ' ' A' ' 112' ' ' ALA . . . -105.79 23.72 28.79 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.602 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.2 OUTLIER 30.7 -159.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.129 0.966 . . . . 0.0 111.509 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.515 ' CB ' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -96.22 -20.21 18.74 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.437 -0.789 . . . . 0.0 111.026 -178.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG21 ' C ' ' A' ' 118' ' ' HIS . 2.6 t -136.51 158.5 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.435 -1.415 . . . . 0.0 111.351 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.81 128.51 2.42 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.522 ' ND2' HG11 ' A' ' 148' ' ' VAL . 11.9 t-20 -107.01 158.33 17.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.649 -1.282 . . . . 0.0 110.49 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.447 HD11 HG13 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -127.54 98.88 5.38 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -85.58 64.89 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.403 -0.81 . . . . 0.0 108.944 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.463 HD12 HD12 ' A' ' 105' ' ' ILE . 0.3 OUTLIER -150.31 168.49 23.91 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.413 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -164.76 76.53 0.15 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.59 147.62 34.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.19 -1.182 . . . . 0.0 109.475 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.482 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -77.3 -34.59 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.295 1.997 . . . . 0.0 109.122 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -46.79 104.6 0.42 Allowed Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.71 -0.619 . . . . 0.0 109.38 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 34.5 Cg_endo -78.6 168.99 20.46 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.48 2.12 . . . . 0.0 110.161 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.3 p -173.34 120.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 110.622 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -24.88 65.76 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 79.7 m -63.37 -29.12 70.48 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HB2' ' OG ' ' A' ' 130' ' ' SER . 2.1 tt -75.88 -35.87 59.7 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 6.5 tm-20 -77.04 -19.45 57.15 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.074 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -78.13 -24.01 47.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.05 -45.33 20.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.341 -0.943 . . . . 0.0 108.631 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.57 -28.92 42.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 134' ' ' GLU . 62.6 t30 -62.33 -34.77 77.28 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -79.88 -22.42 42.88 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.87 -27.69 63.03 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.4 m -69.4 -39.38 77.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -58.07 -23.93 56.53 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.231 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.65 -14.2 16.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.303 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.434 ' C ' ' HB2' ' A' ' 237' ' ' ASN . . . 68.16 75.37 0.51 Allowed Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.71 111.72 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.468 -1.019 . . . . 0.0 109.399 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.89 113.72 6.56 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -112.54 142.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.013 -1.054 . . . . 0.0 110.379 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.53 HG11 ' N ' ' A' ' 149' ' ' ALA . 2.7 t -119.44 167.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.53 ' N ' HG11 ' A' ' 148' ' ' VAL . . . -153.64 128.16 9.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.974 -1.079 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -61.08 156.06 18.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -88.16 -54.18 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.55 ' CA ' ' HB2' ' A' ' 185' ' ' GLN . . . 146.79 128.75 1.92 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 154' ' ' SER . 51.1 p-10 -83.66 60.96 6.02 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 122.166 -0.608 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER 91.97 104.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.356 0.598 . . . . 0.0 109.953 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . -173.45 61.97 0.13 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 77.29 164.22 0.23 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.324 -1.104 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.65 56.6 4.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -145.85 161.75 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.52 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.45 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -100.53 -174.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.376 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.547 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 0.7 OUTLIER -107.02 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.142 0.972 . . . . 0.0 111.576 -178.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.485 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.7 m-85 -108.8 134.15 20.43 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.682 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.2 Cg_endo -72.95 -56.91 0.14 OUTLIER 'Cis proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.043 -1.232 . . . . 0.0 111.018 3.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 160' ' ' SER . . . 37.74 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.284 1.04 . . . . 0.0 109.412 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -43.73 -34.94 1.66 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.1 m-85 -44.67 -178.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.289 1.042 . . . . 0.0 111.615 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 167' ' ' ASN . . . -95.92 -60.01 1.73 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -44.67 -67.47 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.206 1.003 . . . . 0.0 108.65 179.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -71.97 139.29 48.57 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.8 mmm -104.71 143.29 33.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.999 -1.063 . . . . 0.0 109.912 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -94.99 108.16 20.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 34.6 t -87.53 165.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.27 -175.47 13.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -117.6 157.77 25.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -1.095 . . . . 0.0 109.199 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.53 ' CG2' HG22 ' A' ' 193' ' ' VAL . 18.6 p -135.35 168.13 19.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 110.049 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.08 -162.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -83.84 -19.86 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -71.37 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 109.277 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.472 ' O ' ' HB ' ' A' ' 174' ' ' THR . 2.7 m-20 -153.14 -59.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.288 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.611 ' ND2' ' CD1' ' A' ' 257' ' ' TYR . 8.6 t-20 -147.23 148.9 31.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.574 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 163.08 -70.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.428 0.633 . . . . 0.0 109.541 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . 48.91 178.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.641 -0.662 . . . . 0.0 109.809 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -34.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 154' ' ' SER . 7.7 p90 -106.49 -3.61 20.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.89 112.16 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.55 ' HB2' ' CA ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -67.96 105.61 2.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 108.846 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -109.22 -169.99 1.58 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.466 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.581 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . -174.77 -142.12 3.92 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.132 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.51 71.59 5.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -1.044 . . . . 0.0 110.42 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.01 64.81 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.769 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 191' ' ' ASP . 0.5 OUTLIER -61.74 149.49 39.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.29 -1.124 . . . . 0.0 109.161 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -61.54 -60.98 2.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.495 HD12 ' CG1' ' A' ' 262' ' ' VAL . 14.7 tt -160.73 165.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 120.984 -1.072 . . . . 0.0 109.619 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 174' ' ' THR . 27.3 m -122.48 161.38 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.214 -0.929 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -153.41 158.18 32.75 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.432 ' CB ' ' HZ3' ' A' ' 6' ' ' TRP . 34.6 Cg_endo -76.02 121.22 6.08 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 121.984 1.789 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -163.13 52.88 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.287 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 45.1 t -100.87 64.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -1.185 . . . . 0.0 108.4 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.65 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 12.6 t-20 119.45 129.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 6.2 m -165.51 116.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 121.965 0.888 . . . . 0.0 108.822 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 20.2 pt20 -94.73 138.18 32.88 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.556 0.694 . . . . 0.0 109.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.51 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -135.43 -152.79 0.48 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.0 109.188 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.7 p -88.62 178.94 6.37 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.216 -0.928 . . . . 0.0 110.537 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.645 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -145.45 164.09 28.29 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.645 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 33.5 Cg_endo -69.9 155.85 64.43 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.57 1.514 . . . . 0.0 110.437 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.05 -60.49 4.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 2.0 p 151.6 38.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.975 -0.72 . . . . 0.0 109.577 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -122.77 170.8 9.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.172 -0.955 . . . . 0.0 109.935 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -108.73 177.74 4.69 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.409 -0.807 . . . . 0.0 108.98 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -162.78 166.93 23.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.079 -1.013 . . . . 0.0 110.209 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.4 OUTLIER -144.08 122.05 12.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.585 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.494 ' CD2' ' C ' ' A' ' 210' ' ' SER . 0.2 OUTLIER -136.33 156.19 48.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.083 -1.01 . . . . 0.0 109.878 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 212' ' ' ASN . 16.2 p30 -117.83 131.54 56.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 109.041 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.62 28.62 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.605 -1.283 . . . . 0.0 109.914 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.0 m -76.57 -29.02 56.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -1.081 . . . . 0.0 108.813 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 218' ' ' THR . 0.3 OUTLIER -59.35 -24.74 63.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 108.85 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.499 ' HG2' ' CG2' ' A' ' 199' ' ' VAL . 0.0 OUTLIER -77.8 -29.29 50.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -84.51 -5.19 59.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.912 . . . . 0.0 108.751 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.59 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 0.9 OUTLIER -66.22 -52.72 36.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.436 -0.79 . . . . 0.0 110.15 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.6 Cg_endo -72.16 -9.16 24.06 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.259 1.972 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.515 ' NE2' ' HA3' ' A' ' 7' ' ' GLY . 1.6 m80 -74.7 -43.51 54.73 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.407 HG23 HG23 ' A' ' 262' ' ' VAL . 84.3 t -75.05 -39.86 44.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 219' ' ' PRO . . . -52.95 -35.43 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -69.66 -50.58 30.04 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.444 ' HA ' HD13 ' A' ' 227' ' ' LEU . . . -44.21 -49.72 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 108.955 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.408 ' HB3' ' CD1' ' A' ' 244' ' ' LEU . . . -57.93 -43.88 86.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 108.881 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.07 -41.51 64.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 109.317 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 224' ' ' ALA . 17.1 mt -62.19 -34.67 76.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 108.873 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 231' ' ' LYS . 99.1 t -62.15 -60.38 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 109.032 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.515 ' HD2' ' CB ' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -44.62 -41.86 6.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 108.992 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' A' ' 24' ' ' SER . 1.4 tm0? -59.83 -57.53 12.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 228' ' ' VAL . 1.9 ptpt -62.21 -11.22 13.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.093 -1.004 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.527 ' OD1' ' CD1' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -156.42 80.79 3.68 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.803 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.15 -4.79 13.39 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.686 2.257 . . . . 0.0 110.086 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -14.21 22.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.527 ' CD1' ' OD1' ' A' ' 232' ' ' ASN . 29.5 m0 -71.67 175.79 5.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.117 . . . . 0.0 109.624 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 t -118.16 173.86 6.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.434 ' HB2' ' C ' ' A' ' 144' ' ' GLY . 40.0 t30 -54.8 -17.14 3.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 -62.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.07 59.3 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.646 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 77.7 mt -68.78 -54.26 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.452 -0.78 . . . . 0.0 110.854 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -66.85 -31.18 71.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.949 -1.094 . . . . 0.0 110.95 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 33.2 t-20 -73.04 -40.55 65.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.688 -1.257 . . . . 0.0 110.355 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.467 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.3 OUTLIER -75.45 -32.68 60.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.776 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.408 ' CD1' ' HB3' ' A' ' 225' ' ' ALA . 0.3 OUTLIER -77.72 -32.35 52.82 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.244 -0.91 . . . . 0.0 109.969 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.1 tttt -80.97 -28.77 35.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 108.686 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 4.6 t-20 -83.59 -18.27 38.83 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 266' ' ' ALA . 2.6 p -88.49 -30.15 19.6 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.207 1.003 . . . . 0.0 109.226 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.16 126.68 9.56 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.298 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.421 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 17.2 m -74.89 145.32 42.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.42 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.4 OUTLIER -115.47 126.47 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.878 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 179' ' ' ASN . 8.0 mp . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 179' ' ' ASN . 15.6 m-30 -44.33 -50.78 8.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.038 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 72.41 -128.68 13.56 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 191' ' ' ASP . 13.6 t -44.53 -45.02 9.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -1.128 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' A' ' 251' ' ' LEU . . . 121.25 -138.01 12.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 13.3 tp -96.62 168.42 10.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -1.046 . . . . 0.0 109.178 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.495 ' CG1' HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -117.62 156.08 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.45 ' ND2' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -166.99 120.12 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.361 1.076 . . . . 0.0 108.771 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 268' ' ' THR . . . -75.26 0.97 14.76 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -35.31 40.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 247' ' ' THR . . . -83.58 -10.51 58.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 247' ' ' THR . . . -100.29 -26.71 13.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.696 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 264' ' ' ALA . 19.1 p -79.65 -42.06 25.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.728 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.496 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.44 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 58.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.51 ' CG1' HG23 ' A' ' 8' ' ' ILE . 1.2 m -145.22 115.0 4.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.42 171.29 17.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.437 2.092 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -15.96 1.31 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.455 -0.778 . . . . 0.0 110.737 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.89 24.58 6.61 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.645 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -154.81 14.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.797 -1.413 . . . . 0.0 109.931 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -90.79 -37.36 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.709 -1.244 . . . . 0.0 110.351 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.551 ' HB3' ' CD2' ' A' ' 261' ' ' LEU . 4.4 mtm180 -92.91 23.34 4.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.045 . . . . 0.0 110.256 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 8' ' ' ILE . 11.1 m -111.82 19.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' VAL . 63.2 mm-40 39.94 36.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.415 -0.803 . . . . 0.0 109.679 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -73.42 -32.7 1.69 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 112.156 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.5 Cg_endo -74.46 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 N-CA-C 108.797 -1.271 . . . . 0.0 108.797 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.35 -30.49 1.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.67 -44.34 61.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.254 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -71.66 -5.86 36.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.652 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.87 -24.72 13.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.028 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -46.99 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.07 -53.0 0.57 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mp -49.71 141.39 9.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -1.084 . . . . 0.0 109.346 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -164.17 59.1 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.925 -1.109 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . 46.19 21.04 0.6 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.493 ' N ' ' C ' ' A' ' 22' ' ' THR . 2.6 p -40.28 -24.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.7 -0.882 . . . . 0.0 111.329 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -152.28 54.36 0.46 Allowed Glycine 0 N--CA 1.493 2.458 0 C-N-CA 118.86 -1.638 . . . . 0.0 111.386 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 60.7 t -122.75 168.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -1.22 . . . . 0.0 108.781 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 117' ' ' MET . 5.4 mttm -136.63 117.54 14.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 110.214 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 89' ' ' TYR . 11.8 t -115.44 139.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.14 147.65 25.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 110.085 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -119.25 83.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -75.59 96.35 3.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.894 -0.504 . . . . 0.0 109.983 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 33' ' ' THR . 0.2 OUTLIER -167.5 -159.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.95 -1.094 . . . . 0.0 109.104 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -44.5 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.047 -1.033 . . . . 0.0 109.124 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.517 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -168.62 -124.15 0.71 Allowed Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 34' ' ' GLY . 34.3 mm -161.45 93.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ILE . 16.6 p -40.62 118.9 1.01 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.863 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.07 103.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.36 154.07 71.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.395 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.71 1.26 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.695 2.264 . . . . 0.0 110.496 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD1' HG22 ' A' ' 202' ' ' THR . 3.0 p30 -108.55 1.1 21.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.641 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.38 116.6 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.05 138.22 58.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.3 mm -119.84 100.27 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.624 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -118.56 12.0 13.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.54 146.57 10.5 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.28 99.5 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.078 -1.248 . . . . 0.0 110.212 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.08 117.78 23.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -1.054 . . . . 0.0 108.163 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 p -112.67 115.54 28.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 110.832 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CZ ' ' HA2' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.74 -36.7 11.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.564 ' CG1' ' HD2' ' A' ' 51' ' ' PRO . 9.9 t -45.22 149.49 0.92 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 50' ' ' VAL . 27.9 Cg_endo . . . . . 0 C--N 1.306 -1.664 0 C-N-CA 121.892 1.728 . . . . 0.0 110.927 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.509 ' O ' ' OG1' ' A' ' 56' ' ' THR . 72.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.182 0.515 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 55' ' ' SER . 1.4 p 79.44 -8.98 1.53 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ASP . 2.2 mm-40 -100.99 172.87 6.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.814 . . . . 0.0 109.184 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 57' ' ' GLN . 0.9 OUTLIER 49.9 175.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.625 0.726 . . . . 0.0 110.191 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.33 -64.71 0.32 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -145.3 -61.87 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -1.113 . . . . 0.0 109.577 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.8 -35.79 0.67 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -54.99 -62.76 1.45 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -1.132 . . . . 0.0 109.47 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.96 -41.33 13.76 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -57.65 -44.59 85.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -1.126 . . . . 0.0 109.444 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.581 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 0.3 OUTLIER -59.51 -59.48 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.505 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 70' ' ' ILE . 11.1 t -51.59 -30.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.269 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.54 -54.02 46.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.378 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.468 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -73.53 -17.15 78.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.581 HG21 ' CD2' ' A' ' 220' ' ' HIS . 28.6 m -82.58 -14.51 54.71 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.058 -1.26 . . . . 0.0 107.87 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.52 HD13 ' CG1' ' A' ' 66' ' ' VAL . 46.3 mt -101.75 -27.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.535 -0.728 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -161.36 22.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.785 -1.197 . . . . 0.0 111.842 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -38.73 100.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.031 -1.043 . . . . 0.0 109.323 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 72' ' ' ALA . 8.8 mt -44.58 172.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.29 -0.882 . . . . 0.0 110.514 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.495 ' HB3' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -105.18 103.53 13.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.443 -0.786 . . . . 0.0 109.433 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -142.01 -118.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.171 -0.956 . . . . 0.0 108.905 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.28 -39.29 0.53 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.429 ' O ' ' CD1' ' A' ' 77' ' ' ILE . 1.3 pp -88.42 65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.07 152.19 6.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 17.4 m -68.28 -146.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.289 -1.124 . . . . 0.0 109.527 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 74' ' ' ASN . 24.9 tp -139.83 107.11 5.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.874 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.436 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -65.98 -153.23 0.18 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.07 -32.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.239 . . . . 0.0 109.582 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -120.65 100.21 46.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.298 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 22' ' ' THR . 37.0 Cg_endo -81.72 -54.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.805 2.337 . . . . 0.0 110.534 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -82.55 30.93 0.41 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.684 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.56 168.64 10.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.939 -1.101 . . . . 0.0 109.222 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -96.12 92.03 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.146 -0.971 . . . . 0.0 108.87 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.447 ' CD1' ' HB1' ' A' ' 71' ' ' ALA . 1.5 mt -71.76 139.77 49.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.333 -0.854 . . . . 0.0 109.949 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 3.0 m-85 -120.82 147.95 44.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.93 98.82 6.38 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.347 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.537 ' CG2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -96.39 61.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.132 -0.98 . . . . 0.0 108.76 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 33' ' ' THR . 2.0 ttmt -34.73 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.468 0.652 . . . . 0.0 110.364 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -110.83 7.33 8.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.523 HD13 ' CD2' ' A' ' 124' ' ' LEU . 88.1 mt -145.99 173.62 12.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.245 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.55 144.17 9.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.415 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.286 -1.126 . . . . 0.0 108.711 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -95.36 -176.27 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.626 0.727 . . . . 0.0 109.534 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.03 -14.92 19.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.7 m -80.77 -18.06 48.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.69 -45.28 11.82 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.495 HG23 HD11 ' A' ' 105' ' ' ILE . 2.8 mt -70.97 -44.64 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.42 -0.912 . . . . 0.0 108.588 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -37.11 86.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 109.023 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 8.1 tp60 -65.16 -45.23 85.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.597 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -66.9 -31.87 79.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.456 HD22 HD23 ' A' ' 122' ' ' LEU . 10.3 mt -71.68 -28.5 63.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -1.198 . . . . 0.0 108.934 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.7 -22.28 46.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -63.62 -23.03 67.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.636 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -92.69 -15.64 26.48 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.935 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -66.86 -31.1 77.24 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.16 -28.49 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -1.102 . . . . 0.0 109.265 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -132.1 35.41 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.636 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -83.53 158.07 35.23 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.565 ' N ' ' SD ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -106.55 -179.93 4.08 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 -179.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.517 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.6 m170 -50.31 -30.2 11.48 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 t -136.68 160.82 37.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.018 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -168.04 106.63 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.535 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 9.7 m120 -91.54 156.56 17.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.825 -1.172 . . . . 0.0 111.046 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD23 HD22 ' A' ' 109' ' ' LEU . 6.6 mp -129.22 103.02 6.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -85.04 64.72 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.278 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.523 ' CD2' HD13 ' A' ' 94' ' ' LEU . 1.5 pp 177.66 175.48 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.988 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.522 ' O ' ' CD ' ' A' ' 129' ' ' PRO . . . 157.5 -99.6 0.19 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.602 ' CB ' ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER 62.55 -175.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.394 -1.062 . . . . 0.0 110.076 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 126' ' ' SER . 37.0 Cg_endo -83.21 -10.35 10.15 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.749 2.299 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.652 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -57.2 -44.13 99.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 111.96 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 128' ' ' SER . 30.1 Cg_endo -71.22 177.37 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.119 1.88 . . . . 0.0 111.022 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.7 t -118.43 173.9 6.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.45 1.119 . . . . 0.0 111.259 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.21 60.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 132' ' ' THR . 22.0 m -76.41 -26.77 55.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -39.74 61.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 165' ' ' TYR . 1.0 OUTLIER -66.92 -43.48 83.2 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.457 178.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -55.61 -26.75 45.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.94 75.46 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.325 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.68 -24.28 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.4 ' O ' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -68.78 -29.53 67.92 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.38 -22.75 35.3 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.67 -37.13 31.38 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 120.88 -1.137 . . . . 0.0 110.8 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 167' ' ' ASN . 4.5 m -73.32 -24.64 60.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.915 -1.116 . . . . 0.0 108.236 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 138' ' ' ASN . 3.2 m -55.63 -28.95 58.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -87.08 -28.49 22.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.469 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.41 -7.43 24.63 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.75 110.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.181 -1.188 . . . . 0.0 109.811 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.526 ' CD1' ' OD1' ' A' ' 237' ' ' ASN . 3.5 tp -68.23 96.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 108.794 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 2.0 t -88.05 154.66 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.064 -1.022 . . . . 0.0 109.916 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.551 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 0.8 OUTLIER -140.87 104.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.55 ' CB ' ' HG2' ' A' ' 162' ' ' PRO . . . -92.96 148.22 22.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.902 . . . . 0.0 110.469 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.508 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.01 169.58 9.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.499 ' CB ' HG23 ' A' ' 214' ' ' THR . 0.1 OUTLIER -61.32 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.015 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 153' ' ' ASN . . . -168.68 -68.5 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.192 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 152' ' ' GLY . 19.4 t-20 88.98 6.4 0.14 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.301 0.572 . . . . 0.0 109.822 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 153' ' ' ASN . 27.6 t 175.59 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -132.76 -101.93 0.81 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.488 ' N ' ' HG2' ' A' ' 185' ' ' GLN . . . 178.61 78.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.348 -1.089 . . . . 0.0 109.605 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' TYR . . . 56.26 13.49 7.21 Favored Glycine 0 C--N 1.288 -2.136 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.38 147.52 33.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -1.222 . . . . 0.0 109.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.472 HG21 ' HA ' ' A' ' 186' ' ' TYR . 4.5 pt -74.56 176.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.989 -1.069 . . . . 0.0 109.85 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -102.58 165.8 10.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.798 . . . . 0.0 112.082 -177.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.1 OUTLIER -80.29 144.48 58.09 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 174.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 164' ' ' ARG . 42.8 Cg_endo -72.97 -28.09 7.45 Favored 'Cis proline' 0 C--N 1.289 -2.579 0 O-C-N 122.676 0.829 . . . . 0.0 110.581 3.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -29.13 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.741 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 162' ' ' PRO . 19.3 ttp180 -67.95 -52.4 36.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.711 -1.243 . . . . 0.0 109.553 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -41.08 -178.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.645 1.212 . . . . 0.0 111.269 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.38 -0.38 9.85 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.5 ' HB3' ' OG1' ' A' ' 141' ' ' THR . 1.9 m-80 -87.12 22.51 2.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.438 -0.789 . . . . 0.0 109.427 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -171.32 145.91 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.414 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 29.8 mtp -81.4 152.95 27.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.008 -1.057 . . . . 0.0 109.938 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.16 132.56 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.9 t -99.24 165.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.032 -1.043 . . . . 0.0 110.136 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.53 173.69 20.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 214' ' ' THR . . . -135.02 152.38 51.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -1.221 . . . . 0.0 109.552 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 p -116.39 163.1 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.22 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 12.8 p-10 -62.38 179.01 0.35 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.036 -1.04 . . . . 0.0 109.248 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.93 -29.66 43.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -94.03 -90.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.422 -0.799 . . . . 0.0 109.647 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 7.0 t30 -150.02 -20.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.196 -0.94 . . . . 0.0 111.091 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 178' ' ' ASN . 8.3 t30 -56.57 -160.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.711 -1.243 . . . . 0.0 109.647 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.574 ' HG2' ' CD1' ' A' ' 256' ' ' LEU . 0.3 OUTLIER -93.73 135.83 34.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.024 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 180' ' ' ARG . . . -43.59 161.75 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -101.37 12.52 37.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 109.564 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.577 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -153.32 29.9 0.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 110.082 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.423 ' OG ' ' CG2' ' A' ' 214' ' ' THR . 9.1 t -121.21 156.77 31.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.257 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.488 ' HG2' ' N ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.5 137.32 54.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CE1' HD23 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -141.04 176.98 8.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.547 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 137.91 133.27 3.1 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.064 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . 35.65 102.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.12 -0.635 . . . . 0.0 111.613 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 116.81 -5.25 18.66 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.77 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.554 ' CD2' ' CD2' ' A' ' 186' ' ' TYR . 8.9 tp -61.72 107.89 0.9 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.878 -1.366 . . . . 0.0 110.237 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 25.0 t70 -75.9 -56.63 4.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.469 ' HA ' ' CB ' ' A' ' 259' ' ' SER . 2.5 tt -149.1 169.75 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.106 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 10.0 m -123.26 164.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -163.44 177.96 1.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 109.025 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 32.8 Cg_endo -76.49 116.98 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.408 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -134.63 54.95 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 37.4 t -149.01 101.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.524 -0.986 . . . . 0.0 108.586 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.592 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.3 OUTLIER 73.91 107.11 0.07 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.125 0.964 . . . . 0.0 111.276 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.557 HG11 ' ND2' ' A' ' 212' ' ' ASN . 17.4 m -163.41 109.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 16.9 pt20 -84.7 148.16 26.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.608 0.718 . . . . 0.0 110.773 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.581 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -145.31 -151.56 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' THR . . . . . 0.451 HG22 ' OD1' ' A' ' 40' ' ' ASP . 74.2 p -90.18 172.11 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.625 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -159.99 164.49 19.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.625 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -70.63 164.02 36.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.948 1.765 . . . . 0.0 110.393 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.84 78.88 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.76 32.42 22.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -1.114 . . . . 0.0 109.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -118.32 150.94 38.65 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.049 -1.032 . . . . 0.0 109.817 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -92.74 172.45 8.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -145.68 118.21 8.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.868 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.5 OUTLIER -91.19 111.56 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 0.6 OUTLIER -175.47 147.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 110.361 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.592 ' HB2' ' N ' ' A' ' 198' ' ' ASN . 11.3 t-20 -136.11 -162.86 1.32 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.859 0.838 . . . . 0.0 109.161 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 150.73 -174.78 29.97 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.499 HG23 ' CB ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -70.54 -42.33 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.703 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 150' ' ' ALA . 1.4 m -66.07 -16.07 63.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 110.403 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.52 ' HB3' ' OD1' ' A' ' 212' ' ' ASN . 1.5 mpp? -91.07 -16.6 27.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.115 . . . . 0.0 109.754 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 194' ' ' ALA . . . -87.64 -13.18 43.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 108.688 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.614 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 2.6 m -63.07 -43.84 82.77 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.63 -0.669 . . . . 0.0 111.349 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -72.75 -26.7 15.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.123 1.882 . . . . 0.0 111.583 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.581 ' CD2' HG21 ' A' ' 69' ' ' THR . 16.7 m170 -67.11 -45.55 76.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.869 -1.144 . . . . 0.0 108.177 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 262' ' ' VAL . 67.2 t -67.63 -45.74 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.512 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -54.18 -33.93 59.27 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.74 -52.46 42.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.12 2.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -1.076 . . . . 0.0 109.168 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.517 ' CA ' HD13 ' A' ' 244' ' ' LEU . . . -47.47 -26.73 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 227' ' ' LEU . . . -64.75 -59.21 4.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 226' ' ' ALA . 4.8 mt -46.48 -36.91 7.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 108.45 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.16 -56.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.609 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.517 ' HD3' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -45.38 -39.32 6.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -48.5 81.48 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.298 -0.876 . . . . 0.0 109.02 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -67.26 -7.45 24.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.584 ' HB3' ' CG ' ' A' ' 235' ' ' TRP . 81.9 m-20 -160.21 78.88 2.56 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.4 -28.4 3.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.636 2.224 . . . . 0.0 111.099 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.85 0.68 54.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.584 ' CG ' ' HB3' ' A' ' 232' ' ' ASN . 11.9 m0 -71.56 -178.69 2.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 109.674 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.62 167.71 10.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.552 -0.718 . . . . 0.0 110.214 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.526 ' OD1' ' CD1' ' A' ' 146' ' ' LEU . 17.2 t-20 -51.2 -39.85 57.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 0.0 109.543 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -74.08 -59.34 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.278 -0.888 . . . . 0.0 109.465 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 238' ' ' VAL . 8.1 tp-100 -39.76 -36.56 0.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.305 0.574 . . . . 0.0 110.121 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.444 HD12 ' HE3' ' A' ' 229' ' ' LYS . 66.6 mt -77.87 -46.52 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 110.43 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 15.8 ttp180 -52.81 -40.47 63.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.919 -1.113 . . . . 0.0 110.523 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -63.14 -35.19 79.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -0.941 . . . . 0.0 110.612 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -71.62 -43.21 66.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.389 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.558 HD23 ' CG1' ' A' ' 262' ' ' VAL . 0.4 OUTLIER -77.22 -22.48 52.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 110.245 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -82.77 -24.59 33.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 0.0 109.352 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -90.2 -21.87 21.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.918 . . . . 0.0 109.214 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 266' ' ' ALA . 2.3 p -87.66 -29.72 20.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 110.055 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -40.02 116.43 0.65 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.844 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.535 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 1.0 OUTLIER -65.76 163.77 15.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.93 . . . . 0.0 109.214 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.501 ' N ' ' CG2' ' A' ' 249' ' ' THR . 5.9 p -115.78 114.46 24.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.337 -0.852 . . . . 0.0 109.524 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.469 HD21 ' OD1' ' A' ' 178' ' ' ASN . 5.8 mp . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.717 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.603 HD11 ' CD1' ' A' ' 257' ' ' TYR . 2.7 tm? . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.603 ' CD1' HD11 ' A' ' 256' ' ' LEU . 4.7 m-85 -65.58 -47.31 76.2 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 259' ' ' SER . . . 55.89 58.36 14.49 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.469 ' CB ' ' HA ' ' A' ' 192' ' ' ILE . 0.0 OUTLIER 171.18 -84.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -1.191 . . . . 0.0 109.093 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 132.35 -163.3 24.02 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 10' ' ' ARG . 5.0 tp -98.11 177.93 5.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.707 -0.878 . . . . 0.0 109.257 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.558 ' CG1' HD23 ' A' ' 244' ' ' LEU . 0.6 OUTLIER -110.22 155.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 110.208 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.535 ' ND2' ' OG1' ' A' ' 249' ' ' THR . 0.1 OUTLIER -150.72 116.42 5.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.884 1.326 . . . . 0.0 108.657 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -79.78 -25.39 40.96 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.622 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 265' ' ' GLU . 7.6 tp10 -71.78 -41.89 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.589 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 247' ' ' THR . . . -76.55 0.76 18.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -113.69 -3.61 13.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.52 -35.85 4.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.636 ' HB2' ' N ' ' A' ' 80' ' ' LEU . 1.9 p . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.547 ' CG2' ' C ' ' A' ' 3' ' ' SER . 0.1 OUTLIER -165.64 73.46 1.33 Allowed Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.432 -0.792 . . . . 0.0 109.169 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD2' ' CG1' ' A' ' 8' ' ' ILE . 34.7 Cg_endo -77.46 165.31 27.54 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.51 2.14 . . . . 0.0 110.29 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -39.08 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.665 -0.647 . . . . 0.0 110.176 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PRO . . . -68.35 -62.64 4.02 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.57 ' O ' ' CB ' ' A' ' 9' ' ' SER . 47.0 mm -62.62 159.97 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -1.1 . . . . 0.0 109.515 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 4.4 m 89.38 -34.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.888 -0.508 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -27.89 61.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.297 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.69 22.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 0.0 109.662 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HG2' ' CB ' ' A' ' 265' ' ' GLU . 6.8 tp-100 52.89 49.41 20.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.697 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.51 -30.24 0.44 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 112.053 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.32 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB1' ' OE1' ' A' ' 12' ' ' GLN . . . -43.88 -31.19 0.81 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -66.1 -55.81 14.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.263 -0.898 . . . . 0.0 108.579 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.411 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 9.8 m-70 -66.35 -8.25 24.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.0 109.563 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -83.81 -35.95 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 5.91 8.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.85 43.73 5.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 2.2 mm? -99.71 133.67 43.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -1.094 . . . . 0.0 109.101 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.49 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -120.35 -37.96 2.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.494 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 81.31 -22.01 5.62 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -49.47 110.82 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.267 . . . . 0.0 109.078 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.73 -11.06 1.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 27' ' ' LYS . 48.2 t -110.57 170.04 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -1.235 . . . . 0.0 109.314 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 3.1 mttt -139.97 131.24 26.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.908 . . . . 0.0 109.364 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.527 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 48.7 t -124.34 145.29 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.018 . . . . 0.0 110.448 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -101.97 146.77 27.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.415 HG22 HD21 ' A' ' 88' ' ' LEU . 25.6 t -120.63 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 109.27 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.518 HD13 ' CG2' ' A' ' 91' ' ' VAL . 4.8 mp -65.83 93.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -147.03 -156.43 0.71 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 20.7 p -67.53 -24.75 65.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.355 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 161.05 -105.32 0.26 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.6 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 10.3 mt 135.65 101.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.0 OUTLIER -71.88 139.22 48.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -55.18 165.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -177.24 160.51 1.45 Allowed Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.161 -0.962 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.4 Cg_endo -78.49 -23.5 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 110.181 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 73' ' ' LEU . 1.4 t0 -102.48 -2.98 27.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.1 mt -102.46 160.88 14.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.266 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.445 ' HA ' HD13 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -112.51 119.35 37.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 mm -123.48 96.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.679 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -90.57 -28.73 18.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 108.951 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.94 -176.1 38.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.64 128.46 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -131.51 165.1 24.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.444 -1.033 . . . . 0.0 108.551 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.501 ' OG ' ' CG ' ' A' ' 51' ' ' PRO . 46.2 t -149.1 142.59 25.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.084 . . . . 0.0 110.486 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.608 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 23.5 m-85 -123.92 -35.63 2.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -41.96 -53.8 7.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 39.1 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 122.981 2.454 . . . . 0.0 111.633 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -111.69 2.07 17.04 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' ASP . 5.5 mm-40 -103.72 156.21 17.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 8.8 t70 55.13 166.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 109.611 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . -171.78 -54.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 2.1 t30 -165.78 -83.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -1.077 . . . . 0.0 108.985 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . -175.74 -34.17 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' A' ' 62' ' ' HIS . 3.0 t-160 -58.84 -64.73 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.406 -1.055 . . . . 0.0 109.531 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -47.67 -67.38 1.56 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.0 m -40.11 -52.37 2.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.569 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 2.6 t-80 -52.81 -50.78 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.858 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 70' ' ' ILE . 24.3 t -57.49 -32.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 109.231 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.52 -51.05 71.52 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.296 -0.877 . . . . 0.0 109.696 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.543 ' CA ' ' HB1' ' A' ' 72' ' ' ALA . . . -72.85 -17.88 78.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.528 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 6.4 m -80.65 -17.28 51.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.168 -1.195 . . . . 0.0 108.246 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 88' ' ' LEU . 23.1 mt -92.62 -31.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.615 -0.678 . . . . 0.0 109.944 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . . . -174.55 33.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.38 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.543 ' HB1' ' CA ' ' A' ' 68' ' ' GLY . . . -37.27 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 109.665 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' ASP . 12.8 mt -39.85 159.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 80' ' ' LEU . 7.6 t-20 -114.72 166.29 11.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 74' ' ' ASN . 0.4 OUTLIER 172.18 -93.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.407 -0.808 . . . . 0.0 109.28 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 -38.17 0.77 Allowed 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.762 -0.586 . . . . 0.0 109.48 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.4 pt -111.2 168.95 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.4 ' HA3' ' OD2' ' A' ' 40' ' ' ASP . . . 70.01 155.31 1.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 20.0 m -75.4 -154.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.276 -1.132 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.636 ' N ' ' HB2' ' A' ' 3' ' ' SER . 0.3 OUTLIER -145.9 122.35 11.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.482 -0.761 . . . . 0.0 109.423 -178.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.75 -163.79 4.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 4.7 t -82.57 -36.84 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.325 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . . . -95.0 147.17 32.6 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.3 Cg_endo -83.61 -61.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.873 2.382 . . . . 0.0 110.407 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 86' ' ' ALA . 6.6 m120 -99.53 -87.87 0.35 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.01 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 57.26 157.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.866 . . . . 0.0 109.701 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.554 ' HG3' ' CE ' ' A' ' 27' ' ' LYS . 20.5 mm-40 -108.97 94.74 5.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 108.774 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 70' ' ' ILE . 2.5 mt -79.98 150.75 30.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.07 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.519 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 3.9 m-85 -127.29 154.48 44.86 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -0.794 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -123.73 104.09 8.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -108.03 78.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -178.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 33' ' ' THR . 10.8 tttt -44.75 96.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.9 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -114.02 -9.8 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 109.084 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 124' ' ' LEU . 77.3 mt -115.62 174.11 6.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.348 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -111.19 147.83 17.84 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.472 ' HA ' HG23 ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -1.117 . . . . 0.0 109.666 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 155.99 28.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.801 -0.823 . . . . 0.0 109.8 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.48 ' O ' HG11 ' A' ' 102' ' ' VAL . 83.9 t -67.21 -15.25 19.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.557 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -72.27 -27.77 62.7 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.524 ' CB ' ' CG2' ' A' ' 50' ' ' VAL . 65.8 p -80.03 -53.47 6.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 109.34 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.494 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 2.2 mt -61.55 -33.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.445 ' O ' ' CD ' ' A' ' 110' ' ' GLU . . . -65.17 -46.44 80.85 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.528 -0.732 . . . . 0.0 110.0 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.608 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -68.31 -40.86 81.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.558 -1.339 . . . . 0.0 108.873 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 31' ' ' LEU . . . -61.77 -21.05 60.36 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.7 mt -92.98 -51.01 5.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.903 -1.351 . . . . 0.0 110.579 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.445 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -76.56 -6.97 54.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.862 -1.149 . . . . 0.0 109.646 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.634 ' CZ3' ' CA ' ' A' ' 116' ' ' GLY . 70.9 t90 -89.47 -9.76 48.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.679 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.55 -11.93 44.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.515 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -86.95 -22.93 43.52 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 -76.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -110.01 10.34 24.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 110.925 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -104.46 52.13 0.76 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.011 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.6 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 37.91 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.189 0.995 . . . . 0.0 112.905 178.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.614 ' CE1' HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -94.72 -29.14 14.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.369 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.614 HG21 ' CE1' ' A' ' 118' ' ' HIS . 1.9 t -97.43 153.82 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.323 -1.486 . . . . 0.0 109.004 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -169.23 113.71 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.963 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.541 ' C ' ' CD1' ' A' ' 122' ' ' LEU . 2.3 m120 -112.36 152.98 27.96 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.56 121.66 19.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.277 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.407 ' CB ' ' NE2' ' A' ' 62' ' ' HIS . 18.2 m -85.59 66.35 9.61 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.484 ' HB3' HD12 ' A' ' 94' ' ' LEU . 2.2 pp -154.9 178.8 9.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.704 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.539 ' HA3' ' HB2' ' A' ' 160' ' ' SER . . . 156.23 113.33 0.42 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.77 158.48 34.73 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.445 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 31.6 Cg_endo -74.71 -3.64 14.2 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.165 1.91 . . . . 0.0 108.646 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.7 t -117.66 76.33 10.27 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -77.18 163.67 30.17 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.335 2.023 . . . . 0.0 110.909 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.29 146.27 46.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.449 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.89 -14.79 63.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.2 m -79.65 -23.59 42.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.23 -40.39 30.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -75.61 -41.46 54.3 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.495 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -61.55 -23.6 66.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.07 -42.77 65.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 2.1 t -68.81 -26.25 32.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.06 -33.11 75.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.5 -22.48 35.06 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -79.39 -19.21 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.08 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -35.62 40.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.03 -1.044 . . . . 0.0 108.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.4 p -54.85 -30.63 58.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.11 -17.83 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.8 78.86 0.65 Allowed Glycine 0 N--CA 1.475 1.273 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 118' ' ' HIS . 48.6 t -119.17 111.95 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -1.082 . . . . 0.0 109.387 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.63 102.74 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.926 -1.109 . . . . 0.0 109.268 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -98.73 143.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.519 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 0.9 OUTLIER -135.58 116.15 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.483 ' CB ' ' HG2' ' A' ' 162' ' ' PRO . . . -104.77 148.4 26.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 109.614 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.58 162.46 25.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.226 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -69.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.0 109.877 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 160.72 -17.2 0.2 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.309 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.553 ' OD1' ' CD2' ' A' ' 183' ' ' PHE . 59.1 t-20 41.12 35.72 0.4 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.638 -0.919 . . . . 0.0 109.918 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -90.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 156.22 70.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.67 170.4 14.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -1.109 . . . . 0.0 109.296 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.91 52.82 4.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.0 OUTLIER 162.77 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -1.123 . . . . 0.0 109.121 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.425 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.6 OUTLIER -89.07 -177.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.159 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.539 ' HB2' ' HA3' ' A' ' 125' ' ' GLY . 0.7 OUTLIER -102.46 166.67 10.41 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.773 0.797 . . . . 0.0 111.595 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.566 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 2.4 m-85 -85.39 144.86 41.23 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 164' ' ' ARG . 45.2 Cg_endo -75.21 -31.02 5.59 Favored 'Cis proline' 0 C--N 1.293 -2.346 0 O-C-N 122.429 0.699 . . . . 0.0 111.016 3.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . -17.78 -47.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -52.57 -54.8 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.078 -1.014 . . . . 0.0 110.583 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -42.36 -178.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.558 1.171 . . . . 0.0 111.229 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.75 0.81 8.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.043 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.11 21.56 4.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 108.865 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.14 20.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.425 ' HA ' ' CG ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -112.23 132.49 54.9 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -106.87 123.07 47.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.4 t -90.34 166.13 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -137.94 166.81 25.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.507 ' HB1' ' HB ' ' A' ' 214' ' ' THR . . . -117.15 140.84 49.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -1.144 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.7 p -109.23 174.65 5.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.91 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.25 -147.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.652 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -69.62 -53.45 18.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -86.23 -82.75 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.923 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.518 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 33.4 p-10 -166.23 43.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -105.93 166.44 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.517 ' NH2' HG13 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -72.74 106.38 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 180' ' ' ARG . . . -43.55 130.9 5.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 109.43 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.6 m -60.75 -30.36 69.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.038 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.553 ' CD2' ' OD1' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -92.54 -14.43 28.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 11.5 t -76.99 154.89 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.23 140.41 37.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CE2' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -123.9 171.19 9.88 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.418 -0.801 . . . . 0.0 109.339 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.587 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.51 142.31 4.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.37 118.47 6.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -1.122 . . . . 0.0 109.185 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 122.9 -6.53 9.53 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.477 HD22 HG12 ' A' ' 193' ' ' VAL . 49.3 tp -45.81 154.63 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.181 -1.188 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.5 OUTLIER -99.51 -55.53 2.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.5 tt -151.87 172.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 0.0 109.872 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.517 HG13 ' NH2' ' A' ' 180' ' ' ARG . 8.3 m -136.83 166.83 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.292 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.431 ' HB3' ' HD2' ' A' ' 195' ' ' PRO . . . -168.99 167.71 5.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.169 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.441 ' HD3' HD12 ' A' ' 261' ' ' LEU . 35.3 Cg_endo -77.99 117.24 4.12 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.481 2.121 . . . . 0.0 110.284 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -142.6 22.08 2.36 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 31.6 t -89.01 58.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -1.149 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.641 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 17.8 t-20 131.69 122.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 4.8 m -167.01 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.075 0.94 . . . . 0.0 109.075 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 29.3 mt-30 -87.41 141.52 28.57 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.597 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.569 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -148.7 -147.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.4 166.4 11.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.017 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.628 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.11 159.13 40.62 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.6 Cg_endo -71.71 167.4 26.63 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.41 2.073 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 77.76 4.04 84.71 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 78.04 33.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -1.0 . . . . 0.0 109.404 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -127.89 157.59 40.1 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.106 -0.996 . . . . 0.0 109.708 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -94.98 179.55 5.18 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 203' ' ' TYR . . . -156.54 178.55 10.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.844 -1.16 . . . . 0.0 110.914 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 55.0 p -159.72 110.54 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.43 HD22 ' C ' ' A' ' 210' ' ' SER . 1.7 mt -126.7 162.69 25.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' A' ' 212' ' ' ASN . 2.1 p-10 -129.46 125.1 35.66 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.532 ' HA2' ' CE2' ' A' ' 183' ' ' PHE . . . 175.32 159.46 21.42 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.507 ' HB ' ' HB1' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -61.6 -30.2 70.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.916 . . . . 0.0 109.291 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.477 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 13.7 m -61.13 -27.3 68.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.469 ' HG2' ' CG2' ' A' ' 199' ' ' VAL . 0.7 OUTLIER -74.54 -24.32 58.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.335 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.461 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -85.38 -24.71 27.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.783 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 96.5 m -53.35 -44.33 97.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 111.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 218' ' ' THR . 31.0 Cg_endo -73.95 -24.56 15.08 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.727 1.618 . . . . 0.0 110.847 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -62.35 -41.23 98.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.27 -48.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.404 ' O ' ' HB1' ' A' ' 226' ' ' ALA . . . -49.24 -28.59 4.78 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.4 -58.5 4.22 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.28 -61.24 2.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -1.162 . . . . 0.0 109.289 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 229' ' ' LYS . . . -47.03 -41.75 17.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.426 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . . . -55.6 -44.23 76.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 22.4 mt -57.9 -47.22 83.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.227 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 46.9 t -55.94 -52.85 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.158 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 233' ' ' PRO . 0.0 OUTLIER -49.21 -38.95 27.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.449 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -60.1 -54.1 49.96 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.011 -1.056 . . . . 0.0 108.714 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -51.36 -20.97 1.95 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 108.551 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 176.82 89.29 0.11 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.729 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.554 ' N ' ' O ' ' A' ' 229' ' ' LYS . 36.4 Cg_endo -79.98 -24.88 5.49 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.792 2.328 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -53.2 -21.54 5.32 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -56.99 176.56 0.1 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 240' ' ' ILE . 0.6 OUTLIER -105.24 171.72 7.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 110.023 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -55.72 -45.95 77.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.488 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.3 t -74.33 -51.53 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -40.72 -41.16 1.47 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 109.345 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 236' ' ' SER . 2.9 mt -74.46 -45.08 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 242' ' ' ASN . 1.6 ttm-85 -47.96 -71.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 241' ' ' ARG . 1.2 m-80 -35.15 -36.63 0.06 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.812 -0.555 . . . . 0.0 110.701 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.54 ' O ' ' CG2' ' A' ' 247' ' ' THR . 1.4 t60 -69.0 -52.63 26.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.522 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.48 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 0.0 OUTLIER -66.91 -17.19 64.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.938 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -45.32 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.3 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 246' ' ' ASN . 1.2 m-20 -91.15 -5.26 55.28 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.15 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 243' ' ' HIS . 70.5 p -103.33 -52.55 2.99 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.912 -1.117 . . . . 0.0 110.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 244' ' ' LEU . . . -43.41 151.48 0.17 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.791 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 31.5 m -70.68 157.64 37.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 54.7 p -129.7 111.47 12.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 178' ' ' ASN . 4.0 mp . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.628 ' CD2' ' CE2' ' A' ' 186' ' ' TYR . 2.7 tm? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 256' ' ' LEU . 8.2 m-30 -64.08 -74.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.106 -0.996 . . . . 0.0 108.333 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 156.61 -177.26 33.66 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.6 t -46.74 -24.8 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 108.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.436 ' O ' HG21 ' A' ' 193' ' ' VAL . . . 119.28 -137.49 12.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.441 HD12 ' HD3' ' A' ' 195' ' ' PRO . 12.9 tp -102.47 169.1 8.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.989 . . . . 0.0 108.494 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.27 157.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.878 -1.139 . . . . 0.0 110.311 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -164.94 118.08 1.25 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.458 1.123 . . . . 0.0 107.977 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.46 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -68.99 -20.51 64.17 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.093 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.476 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 79.3 tt0 -68.96 -16.58 63.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.0 109.8 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -98.75 0.18 43.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -0.977 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -132.49 1.32 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.156 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 264' ' ' ALA . 2.8 p -101.67 -41.79 6.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.025 -1.047 . . . . 0.0 109.89 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.494 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.816 ' HB3' ' N ' ' A' ' 80' ' ' LEU . 51.9 m . . . . . 0 C--O 1.213 -0.856 0 CA-C-O 121.086 0.47 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 178.3 66.2 0.1 Allowed Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 34.4 Cg_endo -76.67 173.98 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.457 2.105 . . . . 0.0 110.381 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.538 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -55.22 -11.94 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.588 -0.695 . . . . 0.0 110.899 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.66 -62.42 1.25 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.72 -1.238 . . . . 0.0 110.732 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -71.58 -0.78 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.114 -1.227 . . . . 0.0 110.247 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -104.61 -15.86 15.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.855 -1.153 . . . . 0.0 109.726 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.46 0.32 50.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.903 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.5 26.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 O-C-N 120.764 -1.21 . . . . 0.0 110.258 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.46 ' HG3' ' HB2' ' A' ' 265' ' ' GLU . 21.2 mm100 46.59 55.88 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -89.07 -30.05 0.36 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.49 -0.756 . . . . 0.0 112.364 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.2 Cg_endo -74.15 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 109.026 -1.182 . . . . 0.0 109.026 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 -29.08 1.66 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.2 -39.52 40.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 109.161 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 27.4 m170 -65.76 -24.9 67.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -99.62 -16.68 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.787 -1.196 . . . . 0.0 110.631 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -66.55 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.017 -1.052 . . . . 0.0 109.742 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.528 ' C ' ' CD1' ' A' ' 21' ' ' LEU . . . 173.48 17.06 0.02 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.591 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -134.85 153.99 51.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.505 -1.585 . . . . 0.0 108.659 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -138.92 42.23 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.522 ' HA2' ' NE2' ' A' ' 230' ' ' GLN . . . 50.52 14.79 1.05 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.6 OUTLIER -87.26 103.67 15.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -1.13 . . . . 0.0 109.884 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.74 -4.03 2.39 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.437 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG22 ' OE1' ' A' ' 230' ' ' GLN . 29.2 t -123.57 166.83 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 120.693 -1.475 . . . . 0.0 109.918 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -136.15 126.11 25.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.55 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 119' ' ' VAL . 57.8 t -113.41 161.79 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.513 -0.742 . . . . 0.0 109.708 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.417 ' HB3' HG23 ' A' ' 91' ' ' VAL . . . -118.67 151.69 37.49 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.42 HG13 HD12 ' A' ' 35' ' ' ILE . 3.2 t -127.01 84.8 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.134 -0.979 . . . . 0.0 108.536 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.545 HD13 ' CB ' ' A' ' 91' ' ' VAL . 7.4 mp -73.13 93.46 1.82 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.4 p-10 -157.33 -161.78 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.973 -1.079 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.544 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 40.9 p -41.57 -51.55 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.84 . . . . 0.0 109.978 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.76 -47.12 0.48 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 3.9 mt 73.95 105.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.47 158.13 27.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.815 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 101.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.556 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -104.96 148.56 36.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 32.9 Cg_endo -75.63 -17.13 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 110.583 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.469 ' O ' HD22 ' A' ' 41' ' ' LEU . 10.1 t70 -96.68 27.32 3.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.973 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 40' ' ' ASP . 13.9 mt -143.72 134.48 25.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 26.4 t-20 -86.03 66.2 9.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.131 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 44' ' ' ARG . 3.4 mt -73.31 163.25 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.457 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.519 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.9 OUTLIER -150.22 9.22 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.72 173.04 38.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.88 116.33 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -116.06 163.92 15.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -1.086 . . . . 0.0 109.365 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.39 113.66 19.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 7.5 m-85 -110.67 -21.81 11.92 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 93' ' ' VAL . 1.4 t -63.72 126.09 89.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 110.005 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 C--N 1.312 -1.383 0 C-N-CA 122.358 2.038 . . . . 0.0 109.712 178.321 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 1.4 m . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 121.741 0.781 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.411 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 7.7 t -103.89 -11.29 17.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.381 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 3.0 pm0 -81.57 110.54 17.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.664 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 33.3 t70 63.18 153.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.451 ' HA3' ' HB ' ' A' ' 33' ' ' THR . . . -154.77 -63.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.48 ' HB2' HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -131.74 -53.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.131 . . . . 0.0 109.305 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.19 -33.6 1.23 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.228 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -61.23 -48.09 83.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.24 . . . . 0.0 109.874 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.04 -43.58 96.86 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 35' ' ' ILE . 59.9 m -61.0 -37.87 84.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -1.144 . . . . 0.0 109.614 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.598 ' CD2' ' CD1' ' A' ' 211' ' ' LEU . 7.9 t-80 -63.68 -53.75 46.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 109.747 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 219' ' ' PRO . 3.7 t -60.89 -28.45 43.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.42 -0.8 . . . . 0.0 109.29 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.77 85.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.739 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 202' ' ' THR . . . -66.11 -42.84 94.25 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 219' ' ' PRO . 3.9 m -58.12 -24.98 60.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.189 -1.183 . . . . 0.0 109.059 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.461 HD13 HG13 ' A' ' 66' ' ' VAL . 32.9 mt -82.85 -30.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.895 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -137.6 -51.47 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.991 -1.068 . . . . 0.0 111.11 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.589 ' CB ' ' N ' ' A' ' 81' ' ' GLY . . . 40.21 79.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 42' ' ' ASN . 13.6 mt -34.71 155.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.362 -0.836 . . . . 0.0 111.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.48 ' HB2' HD12 ' A' ' 80' ' ' LEU . 1.3 t30 -99.84 120.98 40.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.556 -0.715 . . . . 0.0 109.918 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -167.47 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.047 -1.033 . . . . 0.0 109.044 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 -7.39 0.26 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.212 -0.93 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.5 pt -106.8 67.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.66 -1.275 . . . . 0.0 109.513 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.03 177.01 14.66 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.496 ' C ' ' OG ' ' A' ' 3' ' ' SER . 25.7 m -81.32 -166.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.304 -1.115 . . . . 0.0 109.84 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.816 ' N ' ' HB3' ' A' ' 3' ' ' SER . 15.8 tp -133.73 140.7 47.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 0.0 109.51 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.589 ' N ' ' CB ' ' A' ' 72' ' ' ALA . . . -91.76 -169.02 41.2 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.6 t -88.25 -36.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.93 -1.335 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.444 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -126.24 102.93 26.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.12 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 37.9 Cg_endo -84.75 -62.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.652 2.235 . . . . 0.0 109.858 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.62 -27.17 10.53 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.088 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 83' ' ' ALA . . . -47.0 139.04 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 109.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.2 mp0 -74.79 97.35 3.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.263 -0.898 . . . . 0.0 109.225 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mt -80.97 120.18 24.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.051 -1.031 . . . . 0.0 109.443 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 11.9 m-85 -104.77 153.37 21.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.341 -0.85 . . . . 0.0 109.432 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -115.21 101.9 9.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.545 ' CB ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -96.98 67.11 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -37.58 95.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.901 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 ' CD2' ' A' ' 31' ' ' LEU . 3.3 t -113.7 -23.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.406 -0.809 . . . . 0.0 108.969 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -92.98 173.34 7.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.314 -0.866 . . . . 0.0 108.719 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' ALA . . . -98.03 -17.69 29.17 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.13 152.51 42.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.892 -0.769 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 41.0 t -68.27 -19.43 24.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -75.03 -18.51 60.33 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -91.3 -37.19 13.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.505 -0.747 . . . . 0.0 109.426 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.429 ' HA ' HG12 ' A' ' 93' ' ' VAL . 1.1 mt -77.04 -26.94 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -80.76 -44.33 18.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 104' ' ' SER . 10.1 pt20 -70.75 -31.11 67.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 0.0 109.009 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.93 -39.35 46.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -62.25 -39.66 93.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -1.128 . . . . 0.0 109.462 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 110' ' ' GLU . 1.6 tp10 -78.42 -19.64 52.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.132 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.645 ' CE3' ' HA3' ' A' ' 116' ' ' GLY . 84.8 t90 -65.95 -25.09 66.96 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.914 -1.116 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -88.45 -5.35 58.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.958 -1.089 . . . . 0.0 109.175 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -94.7 -6.59 60.69 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 19.7 t-20 -134.93 -4.71 2.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER 171.11 30.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.803 -1.186 . . . . 0.0 110.697 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.713 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -138.88 57.99 0.62 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.298 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.599 ' SD ' ' CG ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER 63.22 175.57 0.16 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.447 -1.031 . . . . 0.0 112.26 176.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.685 ' N ' ' CD2' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -104.0 -35.38 8.13 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 28' ' ' VAL . 3.4 t -98.34 156.18 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.662 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -172.37 131.01 0.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 108.966 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.523 ' C ' ' CD1' ' A' ' 122' ' ' LEU . 3.0 m120 -117.58 148.25 42.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.564 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -125.22 114.48 19.03 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.132 -0.98 . . . . 0.0 108.951 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 123' ' ' SER . 2.8 t -86.5 61.61 6.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 HD22 ' CB ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.9 -173.71 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.872 0.844 . . . . 0.0 110.077 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 170.4 100.52 0.14 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -97.68 149.45 35.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.144 -1.209 . . . . 0.0 109.83 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.2 -5.39 15.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.351 2.034 . . . . 0.0 108.374 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.3 t -110.14 112.09 57.7 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.87 165.23 31.86 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.944 1.763 . . . . 0.0 109.881 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 120.54 6.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 110.5 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.34 65.49 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 52.9 m -63.38 -29.19 70.53 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -35.31 60.77 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.446 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -75.14 -25.14 58.17 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.137 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.63 -24.23 59.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.48 -40.88 25.36 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.072 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.496 HG13 ' CB ' ' A' ' 167' ' ' ASN . 1.7 t -68.3 -30.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.72 -35.9 82.08 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.489 ' OG ' ' OE2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -78.17 -21.23 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -76.56 -29.7 56.77 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -73.96 -24.21 59.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 108.541 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -57.74 -38.82 76.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 0.0 108.878 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.34 -14.42 16.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 108.878 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.63 81.52 0.99 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 94.1 t -119.23 109.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.6 tp -74.59 116.8 15.69 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -109.08 144.54 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -129.45 111.42 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.041 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.486 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . . . -94.33 148.59 22.06 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.502 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -62.96 162.29 11.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.738 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.45 ' HB3' HG23 ' A' ' 214' ' ' THR . 44.9 t -49.57 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 110.721 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.637 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 133.15 133.67 3.41 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -102.37 63.5 0.88 Allowed 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.617 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -117.69 75.2 0.98 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.435 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 154' ' ' SER . . . -3.33 -62.2 0.0 OUTLIER Glycine 0 N--CA 1.507 3.409 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 154' ' ' SER . . . -46.77 173.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -1.102 . . . . 0.0 109.561 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.14 58.62 4.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 m -143.17 134.76 26.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.154 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.457 HD13 ' C ' ' A' ' 163' ' ' ALA . 6.8 pt -87.19 177.68 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.5 OUTLIER -87.05 160.89 18.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.362 -0.836 . . . . 0.0 111.818 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.449 ' CZ ' ' HD2' ' A' ' 164' ' ' ARG . 5.1 m-85 -83.5 141.99 42.67 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 164' ' ' ARG . 45.0 Cg_endo -74.73 -30.75 5.77 Favored 'Cis proline' 0 C--N 1.3 -2.023 0 O-C-N 122.421 0.695 . . . . 0.0 111.489 3.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -15.72 -50.21 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-O 121.124 0.488 . . . . 0.0 111.87 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 162' ' ' PRO . 10.9 ttm180 -50.39 -59.76 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.172 -0.955 . . . . 0.0 110.36 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -46.34 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.462 1.125 . . . . 0.0 111.046 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.93 -2.55 9.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.496 ' CB ' HG13 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -81.65 7.9 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 109.398 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.77 139.99 18.49 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -85.28 146.66 26.94 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.013 -1.054 . . . . 0.0 109.626 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -109.73 123.76 50.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.3 t -84.3 166.08 2.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.965 -1.085 . . . . 0.0 109.764 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.577 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -129.85 -176.67 14.52 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -134.35 150.03 50.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -1.2 . . . . 0.0 109.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 179' ' ' ASN . 71.0 p -134.21 153.35 51.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -172.05 1.86 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -23.56 64.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.054 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.79 -87.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.513 ' ND2' HD23 ' A' ' 251' ' ' LEU . 0.3 OUTLIER 177.13 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.99 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 174' ' ' THR . 7.7 t-20 -136.35 -161.21 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.438 ' HG2' ' NH1' ' A' ' 180' ' ' ARG . 2.5 mtp85 -87.87 12.51 12.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 180' ' ' ARG . . . 72.2 4.42 5.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.56 -6.61 0.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 112.195 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 181' ' ' ALA . 39.3 p90 -134.89 -5.58 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.318 -1.489 . . . . 0.0 110.286 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.3 t -78.08 132.17 37.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 108.403 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 152' ' ' GLY . 0.8 OUTLIER -88.79 149.29 23.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.097 . . . . 0.0 110.83 -178.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.655 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -121.68 176.44 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 108.918 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.655 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.53 178.62 47.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.46 145.45 50.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.248 . . . . 0.0 109.577 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.61 7.8 88.19 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.36 141.03 58.7 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.127 -1.22 . . . . 0.0 108.719 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.543 ' OD1' ' CE ' ' A' ' 245' ' ' LYS . 35.9 t0 -84.4 -79.75 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 110.935 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.532 ' CD1' HG23 ' A' ' 262' ' ' VAL . 0.2 OUTLIER -154.13 -161.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.072 . . . . 0.0 110.151 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 26.9 m -124.94 168.91 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.908 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.52 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -159.92 177.2 2.16 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.538 ' HB3' ' CH2' ' A' ' 6' ' ' TRP . 33.7 Cg_endo -76.47 115.99 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.173 1.915 . . . . 0.0 110.571 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.31 53.44 0.65 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 39.0 t -138.12 87.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.597 ' HB3' ' O ' ' A' ' 197' ' ' VAL . 7.6 t30 81.53 119.88 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 4.3 m -162.35 114.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.078 0.942 . . . . 0.0 108.974 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -76.31 122.84 25.01 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.751 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.577 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -131.72 -169.54 2.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.524 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' THR . . . . . 0.488 HG22 ' HA3' ' A' ' 68' ' ' GLY . 0.8 OUTLIER -81.89 173.4 12.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.307 -0.871 . . . . 0.0 110.307 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.623 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -151.36 166.95 14.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.3 Cg_endo -73.45 166.11 30.71 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.127 1.885 . . . . 0.0 110.704 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.43 -60.7 4.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 4.7 p 150.81 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 122.025 -0.691 . . . . 0.0 109.826 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -142.8 -179.37 6.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.542 ' N ' ' OG1' ' A' ' 207' ' ' THR . 0.0 OUTLIER -130.89 165.71 22.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.532 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.95 149.15 15.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.1 t -93.09 140.18 29.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.598 ' CD1' ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -145.94 151.19 37.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 213' ' ' GLY . 1.3 t-20 -104.95 168.45 9.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 212' ' ' ASN . . . 147.51 168.52 14.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.2 OUTLIER -85.43 -38.07 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -1.059 . . . . 0.0 109.049 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.509 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 1.4 t -60.04 -15.25 21.26 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.465 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 25.3 mmt -64.99 -35.34 80.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.393 -0.817 . . . . 0.0 109.599 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.46 ' O ' HG12 ' A' ' 171' ' ' VAL . . . -84.44 -6.77 59.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.769 . . . . 0.0 110.783 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.597 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.5 m -69.06 -45.1 29.87 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 111.734 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.7 Cg_endo -73.37 -16.11 24.8 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.979 1.786 . . . . 0.0 111.118 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -74.57 -41.27 60.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 108.424 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.2 t -71.18 -41.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.482 ' HB3' ' OD1' ' A' ' 121' ' ' ASN . . . -55.71 -37.96 69.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.097 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.23 -49.59 45.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.48 -60.49 3.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -1.192 . . . . 0.0 109.603 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.449 ' HA ' HD13 ' A' ' 244' ' ' LEU . . . -44.56 -47.53 10.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.779 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.59 57.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.963 -1.086 . . . . 0.0 109.184 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 39.2 mt -52.13 -40.56 61.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.186 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 229' ' ' LYS . 68.7 t -58.79 -49.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 108.759 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.475 ' HD2' HG21 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -45.68 -45.69 14.3 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.522 ' NE2' ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -60.78 -48.67 80.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.426 -0.796 . . . . 0.0 110.132 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.417 ' C ' ' CG ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -59.14 -14.38 10.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.278 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.417 ' CG ' ' C ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -174.68 95.63 0.29 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.951 . . . . 0.0 110.004 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.7 -20.27 9.33 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.591 2.194 . . . . 0.0 110.379 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.99 -42.82 95.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 0.0 110.188 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -52.39 173.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' SER . . . . . 0.534 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.1 OUTLIER -135.8 158.63 43.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.995 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 236' ' ' SER . 1.5 m120 -15.78 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 236' ' ' SER . 2.9 t -73.79 -65.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.013 -1.054 . . . . 0.0 110.329 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -40.51 -27.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.27 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 238' ' ' VAL . 63.7 mt -82.02 -49.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.561 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -56.27 -22.5 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.127 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 243' ' ' HIS . 2.4 t-20 -71.07 -69.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.768 -1.208 . . . . 0.0 110.339 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.429 ' O ' ' OG1' ' A' ' 247' ' ' THR . 9.9 t60 -55.84 -39.72 71.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.81 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 225' ' ' ALA . 0.1 OUTLIER -64.46 -43.06 95.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 111.001 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -77.48 -21.99 51.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.976 -1.078 . . . . 0.0 109.647 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.58 -19.94 28.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.071 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 0.9 OUTLIER -87.91 -27.22 22.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.303 1.049 . . . . 0.0 109.107 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -46.68 131.63 11.37 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.726 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 92.9 m -52.96 133.95 37.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.018 . . . . 0.0 109.767 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 99.4 p -93.06 94.2 8.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.513 HD23 ' ND2' ' A' ' 178' ' ' ASN . 5.7 mp . . . . . 0 C--N 1.304 -1.387 0 O-C-N 121.178 -0.951 . . . . 0.0 109.936 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.964 0.412 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.477 ' OH ' ' OD1' ' A' ' 179' ' ' ASN . 12.9 m-30 -83.98 10.09 10.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 38.93 74.84 0.11 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 2.8 t 84.56 -58.61 0.1 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.692 -0.887 . . . . 0.0 109.794 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 144.05 -131.57 4.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.487 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 52.6 tp -94.8 166.31 12.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.637 -0.919 . . . . 0.0 109.659 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.532 HG23 ' CD1' ' A' ' 192' ' ' ILE . 5.5 t -104.97 156.64 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.351 -0.843 . . . . 0.0 109.725 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -168.09 118.88 0.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.303 1.049 . . . . 0.0 108.543 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.67 -15.89 59.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -67.65 -41.19 84.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.711 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.36 -8.42 59.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -99.59 -21.77 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.218 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.503 ' O ' ' C ' ' A' ' 269' ' ' ARG . 25.2 p -112.54 -55.69 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.181 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 268' ' ' THR . 3.1 ttt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 66.8 m . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -140.52 106.45 6.5 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.85 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.97 178.02 8.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.367 2.044 . . . . 0.0 109.771 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -5.6 16.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.1 -63.29 1.74 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.491 HD13 ' NE2' ' A' ' 220' ' ' HIS . 1.7 mp -75.82 113.39 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.11 -1.229 . . . . 0.0 109.146 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 11.8 p 168.1 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.405 ' HB3' ' CD2' ' A' ' 261' ' ' LEU . 2.3 mmt180 -77.81 -21.68 51.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -86.41 14.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.081 -1.012 . . . . 0.0 109.894 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.475 ' OE1' ' CB ' ' A' ' 15' ' ' ALA . 22.2 mm-40 45.05 57.92 4.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.476 -0.765 . . . . 0.0 109.69 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.701 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.07 -30.94 0.47 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.451 -0.781 . . . . 0.0 111.82 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 33.1 Cg_endo -76.14 -55.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.232 1.288 . . . . 0.0 109.0 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HA ' ' OD1' ' A' ' 18' ' ' ASN . . . -49.64 -27.34 4.52 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.203 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.87 -32.84 24.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.863 -1.148 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 22.1 m170 -75.75 -20.79 58.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -110.31 -25.77 9.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.584 -1.322 . . . . 0.0 110.38 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 3.9 tpm_? -56.16 -25.35 46.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.0 -1.062 . . . . 0.0 109.47 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.87 0.7 3.87 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.432 HD12 HG23 ' A' ' 268' ' ' THR . 2.4 mt -102.81 151.83 21.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -1.178 . . . . 0.0 109.172 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.483 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -137.78 -2.66 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.183 -0.948 . . . . 0.0 110.853 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 22' ' ' THR . . . 48.83 18.6 1.11 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.489 ' HA ' ' CB ' ' A' ' 85' ' ' ASN . 40.7 t -72.86 9.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.569 -0.96 . . . . 0.0 111.405 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.37 37.25 1.9 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.281 -1.437 . . . . 0.0 110.144 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.93 163.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.857 -1.378 . . . . 0.0 110.025 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.571 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . 21.3 mttp -127.12 128.62 46.5 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.532 -0.73 . . . . 0.0 109.115 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 43.6 t -131.5 153.79 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.028 -1.045 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.23 160.27 19.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.066 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.534 ' CG1' ' OD2' ' A' ' 32' ' ' ASP . 7.2 t -133.09 90.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.109 -0.994 . . . . 0.0 108.919 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.515 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 8.7 mp -80.44 123.43 28.05 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 7.8 p30 173.48 -164.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.908 -1.12 . . . . 0.0 109.815 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.3 p -42.38 -65.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -172.28 -132.37 1.49 Allowed Glycine 0 C--N 1.302 -1.341 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 34' ' ' GLY . 30.3 mm -165.32 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.46 ' HB3' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -53.09 142.39 20.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.989 . . . . 0.0 109.267 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 117.16 13.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 152.74 72.36 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.196 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 -21.33 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.532 2.155 . . . . 0.0 110.713 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -81.01 -17.32 50.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 67' ' ' ALA . 29.8 mt -101.39 149.75 23.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.07 88.26 2.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.134 -0.979 . . . . 0.0 109.392 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.92 100.01 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.555 ' CG ' ' HB2' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -93.81 -11.42 31.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.27 -0.894 . . . . 0.0 109.31 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.624 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -174.65 169.59 42.57 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.78 130.33 1.92 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -131.07 170.78 14.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.375 -1.074 . . . . 0.0 108.944 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.456 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 93.8 p -140.84 112.74 7.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.097 -1.002 . . . . 0.0 110.493 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' VAL . 3.7 m-85 -106.92 -47.71 3.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.401 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 51' ' ' PRO . 2.6 t -39.99 144.54 0.52 Allowed Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' N ' HG11 ' A' ' 50' ' ' VAL . 32.2 Cg_endo . . . . . 0 C--N 1.313 -1.317 0 C-N-CA 122.516 2.144 . . . . 0.0 110.43 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.7 OUTLIER -77.86 -0.36 27.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 108.689 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -129.32 146.43 51.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 179.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 15.1 t70 64.03 154.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.72 -30.32 0.12 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -167.29 -55.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -1.171 . . . . 0.0 109.374 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.94 -10.37 3.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -54.18 11.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -1.168 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.476 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -58.62 -39.98 94.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 36' ' ' SER . 2.9 m -63.8 -32.74 74.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -1.096 . . . . 0.0 108.973 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.573 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 0.6 OUTLIER -67.21 -57.25 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 110.257 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.437 ' O ' HG11 ' A' ' 66' ' ' VAL . 13.4 t -60.17 -32.47 50.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.341 -0.849 . . . . 0.0 109.796 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB2' HD12 ' A' ' 41' ' ' LEU . . . -65.17 -43.04 93.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.691 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -73.49 -38.33 52.16 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.521 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.527 HG22 ' CE1' ' A' ' 220' ' ' HIS . 29.8 m -65.09 -21.66 66.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 108.919 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 219' ' ' PRO . 49.6 mt -89.86 -23.58 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 109.352 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -126.46 -57.51 1.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 111.703 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.581 ' CB ' ' N ' ' A' ' 81' ' ' GLY . . . 36.68 87.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.29 149.82 32.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.733 -1.229 . . . . 0.0 109.762 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 11.4 p30 -91.77 87.29 6.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 76' ' ' SER . 14.8 p30 -126.84 -120.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.204 -0.935 . . . . 0.0 108.828 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.423 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -124.43 -34.51 2.89 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.076 -1.015 . . . . 0.0 109.38 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.0 pt -100.32 67.39 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.305 -0.872 . . . . 0.0 109.486 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.24 158.99 9.54 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 34.8 m -87.31 -135.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.175 -1.191 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.6 tp -140.64 123.09 16.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.697 -1.252 . . . . 0.0 110.263 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.581 ' N ' ' CB ' ' A' ' 72' ' ' ALA . . . -87.57 -153.02 24.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.452 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.87 -60.18 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.906 -1.35 . . . . 0.0 109.332 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -89.36 112.56 52.15 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.246 -0.909 . . . . 0.0 109.174 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -84.69 -62.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.519 2.146 . . . . 0.0 110.947 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.489 ' CB ' ' HA ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -81.74 18.5 1.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.24 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.99 143.69 32.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.876 -1.14 . . . . 0.0 109.11 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 4.9 pt-20 -84.69 115.1 22.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.913 -1.117 . . . . 0.0 109.198 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mt -92.4 123.75 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.93 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.624 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 13.0 m-85 -106.59 152.61 23.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB3' ' CG1' ' A' ' 35' ' ' ILE . . . -113.69 102.83 10.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.366 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.515 ' HB ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -99.76 69.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 108.93 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -38.28 112.07 0.2 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.312 0.577 . . . . 0.0 110.199 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.506 HG11 HG12 ' A' ' 105' ' ' ILE . 2.1 t -120.19 -17.67 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.256 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.45 172.97 7.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 96' ' ' ALA . . . -122.48 12.4 8.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 C--N 1.288 -2.079 0 O-C-N 121.979 -0.718 . . . . 0.0 109.796 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.465 ' O ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -67.2 150.98 48.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.883 . . . . 0.0 110.284 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.521 HG12 ' CB ' ' A' ' 130' ' ' SER . 44.9 t -68.47 -20.8 25.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.485 ' HB2' HG21 ' A' ' 50' ' ' VAL . 60.2 p -79.25 -55.04 5.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.506 HG12 HG11 ' A' ' 93' ' ' VAL . 1.3 mt -62.29 -25.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 -45.75 68.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.593 -0.692 . . . . 0.0 110.167 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.545 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -67.12 -39.41 86.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.933 -1.104 . . . . 0.0 108.638 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.85 -19.23 73.26 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.51 -42.45 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -1.233 . . . . 0.0 110.184 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.442 ' HB2' ' CB ' ' A' ' 139' ' ' SER . 6.5 pt-20 -94.86 -2.64 50.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.005 -1.059 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 71.4 t90 -86.21 -14.95 42.38 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.784 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.51 -7.19 59.65 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.415 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -91.27 -46.42 3.82 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.654 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.67 -71.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.129 -1.218 . . . . 0.0 110.028 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -109.48 35.25 3.38 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.784 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -114.88 -153.92 10.62 Favored Glycine 0 C--N 1.291 -1.92 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.596 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.596 ' HE2' ' CZ ' ' A' ' 89' ' ' TYR . 17.9 mmt -118.59 -172.92 2.37 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.882 0.849 . . . . 0.0 111.46 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.653 ' CE1' ' CE ' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -86.16 -27.86 24.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.831 -0.543 . . . . 0.0 110.223 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.619 ' CG2' ' NE2' ' A' ' 118' ' ' HIS . 15.5 t -114.02 159.77 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.848 -1.157 . . . . 0.0 109.569 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.475 ' O ' HG11 ' A' ' 147' ' ' VAL . . . -163.9 114.16 1.29 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.606 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 6.4 t-20 -98.53 159.27 15.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.05 . . . . 0.0 110.441 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.417 HD11 ' C ' ' A' ' 121' ' ' ASN . 3.7 mp -131.99 104.51 6.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.3 59.35 5.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 125' ' ' GLY . 1.4 pp -154.49 -175.19 5.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.386 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 173.57 103.09 0.16 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.361 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.51 148.69 35.31 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.297 -1.119 . . . . 0.0 108.914 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -75.95 -2.1 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.348 2.032 . . . . 0.0 109.554 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 m -103.63 110.53 64.04 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.768 -0.583 . . . . 0.0 110.108 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.39 169.04 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.232 1.954 . . . . 0.0 109.33 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.521 ' CB ' HG12 ' A' ' 102' ' ' VAL . 1.4 m -159.52 126.83 4.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.872 -1.143 . . . . 0.0 110.965 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.34 65.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 m -64.32 -30.06 71.12 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -34.23 66.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HA ' ' OH ' ' A' ' 165' ' ' TYR . 26.8 tt0 -68.29 -53.39 24.77 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.412 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -51.21 -25.97 6.29 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.06 -1.025 . . . . 0.0 108.296 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.69 -49.26 26.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.627 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.446 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 16.2 t -65.81 -20.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.86 -37.81 85.15 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.94 -27.79 60.34 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -75.99 -20.75 57.6 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 121.063 -1.023 . . . . 0.0 109.798 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -76.78 -33.56 58.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -24.62 58.33 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.829 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.9 OUTLIER -106.42 -22.19 12.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.646 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.18 62.16 2.13 Favored Glycine 0 C--N 1.301 -1.411 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 118' ' ' HIS . 48.4 t -103.22 118.84 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.43 115.43 17.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 108.797 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -111.34 132.45 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.129 -0.982 . . . . 0.0 109.884 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.606 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -114.18 166.66 7.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.6 132.72 15.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 0.0 109.67 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.467 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -53.26 155.79 2.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.435 -0.791 . . . . 0.0 109.499 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 185' ' ' GLN . 0.1 OUTLIER -61.81 -66.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 155.52 -16.08 0.48 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.6 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 153' ' ' ASN . 11.7 t-20 44.69 40.01 3.83 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.726 -0.867 . . . . 0.0 109.535 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.6 -26.79 9.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.477 ' N ' ' OE1' ' A' ' 185' ' ' GLN . . . 74.64 102.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 175.19 -177.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 109.547 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.543 ' HA2' ' CE1' ' A' ' 186' ' ' TYR . . . -94.29 59.56 1.94 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.4 t 169.86 154.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.182 . . . . 0.0 109.67 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -114.13 -171.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.821 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.6 OUTLIER -85.89 162.53 18.55 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.011 0.91 . . . . 0.0 112.012 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.49 139.86 20.96 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.2 Cg_endo -74.9 -36.74 2.49 Favored 'Cis proline' 0 C--N 1.294 -2.291 0 O-C-N 122.836 0.914 . . . . 0.0 110.992 3.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . 8.46 -71.93 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.961 0.886 . . . . 0.0 110.729 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.642 ' N ' ' O ' ' A' ' 162' ' ' PRO . 23.9 ttt-85 -45.93 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER 28.29 -161.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.801 1.286 . . . . 0.0 112.586 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -134.7 -31.0 1.07 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.449 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -100.93 19.13 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -135.75 167.15 21.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.454 ' HB3' ' CG ' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -122.68 136.04 54.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.006 -1.059 . . . . 0.0 109.538 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 190' ' ' LEU . . . -98.06 154.06 17.98 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 18.9 t -111.98 167.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.571 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -135.18 -158.99 8.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 193' ' ' VAL . . . -127.2 166.65 17.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.312 -1.11 . . . . 0.0 109.929 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 179' ' ' ASN . 22.8 p -139.19 150.74 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.543 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 179' ' ' ASN . 3.5 p30 -76.44 -174.09 2.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 110.176 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.13 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -81.73 -89.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.127 -0.983 . . . . 0.0 109.345 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.424 ' O ' HD21 ' A' ' 251' ' ' LEU . 1.4 m120 -174.93 67.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 174' ' ' THR . 38.2 t30 -146.43 -176.08 5.03 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.137 -0.977 . . . . 0.0 109.714 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.571 ' CD ' ' HB2' ' A' ' 257' ' ' TYR . 0.6 OUTLIER -66.04 3.7 0.8 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.56 -0.713 . . . . 0.0 111.887 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 180' ' ' ARG . . . 66.88 -145.94 0.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.133 -1.604 . . . . 0.0 108.413 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.21 -43.71 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.845 -1.159 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -87.75 35.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.447 -0.783 . . . . 0.0 110.499 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.7 t -94.11 127.59 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.477 ' OE1' ' N ' ' A' ' 155' ' ' GLY . 5.2 tp60 -66.23 114.38 5.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CE1' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -106.02 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.805 -179.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 143.32 158.33 7.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.3 97.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.492 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.451 ' C ' HD13 ' A' ' 159' ' ' ILE . . . 151.68 -23.4 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 257' ' ' TYR . 11.0 tp -59.31 127.13 30.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.18 -1.188 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.48 ' O ' ' HA3' ' A' ' 258' ' ' GLY . 0.4 OUTLIER -90.95 -54.46 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.627 -179.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 259' ' ' SER . 1.8 tt -158.02 167.48 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.168 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 173' ' ' ALA . 33.4 m -112.26 166.29 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.502 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -152.9 176.36 2.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 108.832 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.12 116.55 4.2 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.341 2.027 . . . . 0.0 110.465 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.15 16.86 1.53 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 18.6 t -88.3 61.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -1.085 . . . . 0.0 108.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.642 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER 108.51 125.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 23.7 m -162.65 111.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.955 0.883 . . . . 0.0 108.665 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.2 pt20 -89.22 127.62 35.77 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.573 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -135.13 -160.94 1.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.85 168.54 16.01 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 110.038 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.642 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.43 166.26 16.03 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.642 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.1 Cg_endo -73.79 168.8 23.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.135 1.89 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 71.04 17.22 75.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER 66.1 33.03 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -1.165 . . . . 0.0 109.713 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.56 163.14 23.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 201' ' ' SER . 2.7 m-85 -106.93 -172.95 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.466 ' HB1' ' CD1' ' A' ' 203' ' ' TYR . . . -171.0 139.62 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.5 m -106.75 108.78 20.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.448 HD11 ' HE3' ' A' ' 216' ' ' MET . 16.1 mt -107.43 154.26 21.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.943 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.36 84.84 2.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.97 150.88 22.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.7 m -65.02 -22.61 67.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -1.071 . . . . 0.0 109.469 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 3.4 t -71.36 -23.0 61.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.448 ' HE3' HD11 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -75.6 -16.12 60.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 194' ' ' ALA . . . -93.46 3.72 55.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 109.876 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.672 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 23.7 m -77.4 -35.69 1.36 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.986 . . . . 0.0 111.972 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.6 Cg_endo -73.41 -29.02 11.62 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.301 1.334 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.527 ' CE1' HG22 ' A' ' 69' ' ' THR . 29.9 m80 -59.63 -40.85 88.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.834 -1.166 . . . . 0.0 108.057 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.35 -43.32 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.36 -31.33 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -72.4 -59.77 4.38 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -43.69 -49.69 7.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.2 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 244' ' ' LEU . . . -54.21 -45.91 72.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.365 -0.835 . . . . 0.0 108.776 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 229' ' ' LYS . . . -51.93 -49.78 62.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.868 . . . . 0.0 109.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.6 mt -49.35 -50.12 41.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 108.973 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.29 -45.36 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.653 ' CE ' ' CE1' ' A' ' 118' ' ' HIS . 12.3 tppt? -49.64 -43.17 46.71 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.447 -0.783 . . . . 0.0 108.986 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.64 -45.96 91.8 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 231' ' ' LYS . 1.5 tppm? -62.53 -13.11 27.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 108.794 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -163.33 85.75 1.33 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 36.7 Cg_endo -80.4 31.85 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.37 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.5 t -146.94 11.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.873 -1.142 . . . . 0.0 109.914 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -87.36 -179.02 6.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 110.032 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.74 173.67 6.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.289 0.566 . . . . 0.0 109.648 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.404 ' OD1' ' CG2' ' A' ' 238' ' ' VAL . 8.5 p30 -62.99 -32.94 74.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.201 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.9 t -77.07 -61.98 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.925 0.869 . . . . 0.0 109.181 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 238' ' ' VAL . 4.1 mt-30 -42.65 -38.23 1.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.72 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 7.5 mt -74.04 -47.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 3.1 tmt_? -52.37 -20.66 2.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.414 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 1.6 t-20 -78.13 -38.06 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.852 -1.155 . . . . 0.0 109.945 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.485 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.0 t-160 -75.74 -40.47 55.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.153 -0.967 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 225' ' ' ALA . 0.5 OUTLIER -73.64 -32.92 64.28 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.511 -0.743 . . . . 0.0 110.333 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 1.3 tmtt? -77.93 -42.32 33.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.093 . . . . 0.0 108.983 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 0.9 OUTLIER -67.77 -22.83 65.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.552 -0.718 . . . . 0.0 109.989 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.511 HG23 ' CB ' ' A' ' 267' ' ' ALA . 2.3 p -91.85 -26.09 18.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.916 -1.115 . . . . 0.0 110.04 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -37.01 114.46 0.32 Allowed 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.794 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 250' ' ' SER . 65.9 m -45.06 164.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 0.0 109.08 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.476 ' N ' HG23 ' A' ' 249' ' ' THR . 23.2 t -115.58 102.2 9.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 251' ' ' LEU . 6.4 mp . . . . . 0 C--N 1.306 -1.324 0 O-C-N 121.265 -0.897 . . . . 0.0 110.0 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 258' ' ' GLY . 2.5 tp . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.647 ' O ' ' CG ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER 23.34 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 123.063 1.411 . . . . 0.0 111.774 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 256' ' ' LEU . . . 54.11 -136.14 42.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.455 ' HB2' HD13 ' A' ' 192' ' ' ILE . 6.8 m -101.54 -3.4 28.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.438 -1.037 . . . . 0.0 109.545 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.615 ' HA2' ' CE2' ' A' ' 257' ' ' TYR . . . 110.27 -112.63 3.35 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.755 -1.212 . . . . 0.0 110.726 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 37.7 tp -115.49 159.22 21.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.507 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -110.59 159.86 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.825 . . . . 0.0 109.191 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.425 ' OD1' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -168.05 119.24 0.82 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.363 1.078 . . . . 0.0 108.731 178.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.97 -15.12 62.99 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.317 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.447 ' CB ' ' HG3' ' A' ' 12' ' ' GLN . 78.8 tt0 -74.33 -26.81 60.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.014 -1.054 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -90.79 3.28 54.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.511 ' CB ' HG23 ' A' ' 247' ' ' THR . . . -128.69 0.82 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 269' ' ' ARG . 21.4 p -107.49 -42.49 4.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.222 -0.924 . . . . 0.0 109.09 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 268' ' ' THR . 9.5 mtm180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.521 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 14.9 m . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.455 0.645 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -138.28 148.65 60.42 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 108.982 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.78 166.29 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.382 2.055 . . . . 0.0 110.735 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -50.11 -19.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.491 -0.756 . . . . 0.0 110.556 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.61 -43.92 98.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.507 HD13 ' NE2' ' A' ' 220' ' ' HIS . 0.0 OUTLIER -90.6 -25.71 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.123 -1.222 . . . . 0.0 110.057 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 t -64.31 -20.58 66.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.932 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -0.68 38.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 111.398 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 8' ' ' ILE . 11.1 m -106.13 25.46 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 120.542 -1.349 . . . . 0.0 110.134 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.431 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 2.9 mp0 47.08 28.89 0.99 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.666 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -70.14 -36.17 5.86 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 111.704 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.42 -57.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.509 -1.381 . . . . 0.0 108.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.18 -33.52 0.94 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.62 60.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.162 -0.961 . . . . 0.0 108.819 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 1.3 m170 -73.08 -3.3 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.78 . . . . 0.0 109.444 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -53.35 5.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.076 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' CD ' HD11 ' A' ' 21' ' ' LEU . 1.9 ptp180 -54.86 -18.02 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.65 35.13 2.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD11 ' CD ' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -93.21 160.81 14.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.164 -1.198 . . . . 0.0 109.407 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -133.89 -53.32 0.86 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.762 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 83.73 -13.81 45.75 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 2.8 t -51.58 139.72 19.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -1.079 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.31 -15.81 11.83 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 118' ' ' HIS . 45.3 t -93.26 169.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -1.089 . . . . 0.0 109.173 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB2' ' CG ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -137.25 120.41 16.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.163 -0.961 . . . . 0.0 109.389 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.81 134.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.31 146.54 24.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.356 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG1' ' OD2' ' A' ' 32' ' ' ASP . 16.2 t -119.23 80.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.23 -0.919 . . . . 0.0 108.938 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.499 ' N ' HD11 ' A' ' 31' ' ' LEU . 8.5 mp -72.08 87.44 1.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 109.364 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 54.8 p30 -151.78 -148.51 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 1.2 p -56.86 -72.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.098 -1.001 . . . . 0.0 109.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.584 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -170.99 -110.47 0.24 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.584 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 157.12 115.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 38' ' ' HIS . 2.6 m -83.91 60.38 5.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 111.425 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.512 ' C ' ' O ' ' A' ' 36' ' ' SER . 15.0 t 23.18 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.773 0.797 . . . . 0.0 111.22 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -51.52 161.98 0.76 Allowed Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.11 -29.38 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.465 2.11 . . . . 0.0 110.332 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.26 18.05 13.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 109.565 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 38' ' ' HIS . 83.5 mt -125.42 124.42 41.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.908 . . . . 0.0 109.291 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.9 t-20 -74.82 120.36 20.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 mm -103.3 96.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.145 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HG2' ' CG ' ' A' ' 87' ' ' GLU . 4.8 tpm_? -88.28 -38.66 15.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.66 -166.11 32.68 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.5 171.16 16.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . . . -156.3 160.24 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.991 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 56' ' ' THR . 26.5 m -122.88 106.4 10.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.932 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -102.46 -33.17 9.62 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 109.159 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' CG1' ' HD2' ' A' ' 51' ' ' PRO . 70.5 t -49.33 142.53 10.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 0.0 109.028 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HD2' ' CG1' ' A' ' 50' ' ' VAL . 33.6 Cg_endo . . . . . 0 C--N 1.31 -1.481 0 C-N-CA 122.519 2.146 . . . . 0.0 110.449 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.457 0.646 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.46 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -52.26 -20.13 2.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 18.3 mt-30 -118.82 152.4 36.3 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.379 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 63.56 165.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.311 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . 169.78 -35.26 0.18 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 6.6 t30 173.72 -62.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . 168.72 -36.3 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.417 ' CD2' ' HE3' ' A' ' 216' ' ' MET . 0.1 OUTLIER -52.37 -22.69 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -1.098 . . . . 0.0 109.391 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 65' ' ' HIS . . . -72.48 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 63' ' ' GLY . 37.7 m -34.01 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.744 -0.857 . . . . 0.0 110.931 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.611 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -71.95 -52.83 15.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 110.282 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.497 ' O ' HD13 ' A' ' 70' ' ' ILE . 46.1 t -63.57 -37.02 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB2' HD12 ' A' ' 41' ' ' LEU . . . -59.72 -42.65 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.447 -0.783 . . . . 0.0 109.933 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.98 -28.2 62.99 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.571 HG21 ' CE1' ' A' ' 220' ' ' HIS . 62.1 m -69.89 -18.56 63.41 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.34 -1.094 . . . . 0.0 108.341 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 66' ' ' VAL . 7.3 mt -94.03 -38.49 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 110.004 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.456 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -175.62 46.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.867 -1.146 . . . . 0.0 111.156 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -45.14 108.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.804 -1.185 . . . . 0.0 108.924 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 84' ' ' PRO . 80.4 mt -42.26 142.28 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 109.935 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -86.28 109.46 18.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.283 -0.885 . . . . 0.0 108.977 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 76' ' ' SER . 4.9 m-20 -124.28 -5.01 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 88.5 -17.62 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 pt -104.09 66.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.175 -0.953 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 208' ' ' TYR . . . 147.56 -171.5 28.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 3' ' ' SER . 30.7 m -80.11 -163.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.324 -1.103 . . . . 0.0 109.6 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 4' ' ' VAL . 8.2 tp -142.53 115.2 8.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.865 . . . . 0.0 109.611 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.52 177.11 22.51 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.523 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 2.0 t -65.03 -50.96 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.286 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -85.77 148.08 47.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.355 -0.84 . . . . 0.0 108.943 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.467 ' CD ' ' O ' ' A' ' 22' ' ' THR . 38.0 Cg_endo -82.73 -61.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.752 2.301 . . . . 0.0 109.719 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 68.9 m-80 -95.98 -86.46 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 58.32 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.582 -0.699 . . . . 0.0 110.388 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.492 ' CG ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 mp0 -70.24 93.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 3.3 mt -78.11 104.97 9.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.126 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.489 ' CE2' ' HE3' ' A' ' 117' ' ' MET . 19.1 m-85 -94.06 147.92 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 108.89 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.4 105.81 13.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.974 -1.079 . . . . 0.0 109.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.481 ' CG2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -106.01 67.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.288 -0.882 . . . . 0.0 109.538 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 91' ' ' VAL . 15.3 ttmm -36.97 100.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.391 0.615 . . . . 0.0 109.58 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG2' ' HA3' ' A' ' 108' ' ' GLY . 0.9 OUTLIER -115.96 -16.68 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 124' ' ' LEU . 39.3 mt -118.79 169.12 10.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.807 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 167.19 12.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.247 -1.149 . . . . 0.0 109.246 179.812 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.13 145.54 26.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.765 -0.844 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.468 HG23 ' OG ' ' A' ' 130' ' ' SER . 1.2 t -67.24 -32.27 56.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -21.85 66.7 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.489 ' O ' ' NE2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -85.34 -62.31 1.56 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.669 -0.644 . . . . 0.0 109.268 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.495 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 1.3 mt -48.71 -27.12 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -75.42 -48.75 21.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.405 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -62.54 -20.38 64.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.212 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.515 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -82.66 -38.42 12.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.9 mt -65.37 -24.98 67.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.378 -1.072 . . . . 0.0 109.234 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -26.03 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.495 ' CE3' ' O ' ' A' ' 111' ' ' TRP . 55.4 t90 -72.68 -14.78 61.65 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.933 -1.105 . . . . 0.0 108.476 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.679 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -94.29 7.99 43.44 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.584 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -103.4 -45.16 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -86.21 -83.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.919 -1.341 . . . . 0.0 108.391 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.91 49.52 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -112.61 -156.13 12.6 Favored Glycine 0 C--N 1.289 -2.082 0 CA-C-O 122.376 0.987 . . . . 0.0 111.525 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -122.3 163.05 20.36 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.276 0.56 . . . . 0.0 109.558 -178.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.64 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -72.79 -16.75 61.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 108.699 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.7 t -125.02 161.09 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.03 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -159.77 156.98 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 108.793 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.407 ' ND2' HG11 ' A' ' 148' ' ' VAL . 14.1 t-20 -135.56 152.56 51.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.313 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.414 HD11 HG13 ' A' ' 147' ' ' VAL . 3.4 mp -135.47 81.9 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' A' ' 215' ' ' SER . 5.0 t -71.32 84.16 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.011 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.479 ' CD2' HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 177.43 176.54 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.391 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -176.07 93.85 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 0.6 OUTLIER -86.99 148.73 46.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.29 -1.124 . . . . 0.0 109.272 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.43 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -76.39 -9.26 18.81 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.385 2.057 . . . . 0.0 108.942 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -97.34 108.83 46.94 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HB3' ' CE2' ' A' ' 161' ' ' TYR . 31.9 Cg_endo -75.07 166.23 29.57 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.119 1.88 . . . . 0.0 109.831 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.468 ' OG ' HG23 ' A' ' 102' ' ' VAL . 43.8 m -157.75 118.96 3.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.987 -1.07 . . . . 0.0 110.532 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.68 66.03 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.9 m -61.75 -31.77 71.97 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.28 -33.72 61.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.455 ' OE1' ' OH ' ' A' ' 165' ' ' TYR . 4.4 tt0 -73.32 -22.79 60.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.802 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -25.56 58.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.1 -37.14 39.43 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.544 HG12 ' CB ' ' A' ' 167' ' ' ASN . 2.0 t -70.44 -29.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -64.19 -35.6 81.32 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.3 m -78.11 -22.8 48.36 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.52 -5.37 54.26 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -90.73 -43.15 10.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.214 -0.929 . . . . 0.0 109.143 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.5 m -64.21 -17.94 64.03 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.78 -14.12 23.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.455 -0.778 . . . . 0.0 109.371 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.84 62.85 4.22 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 118' ' ' HIS . 21.7 t -111.96 115.49 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -1.074 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.1 113.18 8.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.016 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -109.65 150.89 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.517 ' CG1' HG21 ' A' ' 218' ' ' THR . 2.7 t -123.56 166.59 18.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.51 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -157.38 135.42 10.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 110.264 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -61.17 171.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.471 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.4 OUTLIER -93.22 -39.07 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 109.944 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 132.53 120.91 2.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 47.11 1.29 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.905 -0.762 . . . . 0.0 109.473 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 155' ' ' GLY . 1.6 t -121.75 -91.93 0.55 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.455 ' N ' ' OG ' ' A' ' 154' ' ' SER . . . 150.51 95.95 0.14 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.23 173.26 16.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 0.0 109.634 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.98 42.24 3.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.493 ' O ' ' NE2' ' A' ' 185' ' ' GLN . 1.6 t -163.64 160.53 22.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -1.149 . . . . 0.0 109.321 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -173.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.09 -1.006 . . . . 0.0 110.148 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.531 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 69.7 m -67.28 -174.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.691 1.234 . . . . 0.0 111.389 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.488 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 12.7 m-85 -137.2 128.56 16.46 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.737 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.1 Cg_endo -70.91 -50.74 0.18 OUTLIER 'Cis proline' 0 C--N 1.3 -1.993 0 O-C-N 123.188 1.099 . . . . 0.0 110.419 4.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 160' ' ' SER . . . 30.89 -77.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.615 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.737 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -36.51 -39.97 0.22 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.363 178.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.2 m-85 -49.73 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.344 -0.847 . . . . 0.0 110.241 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.86 0.1 11.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.544 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -87.01 16.95 4.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.165 -0.959 . . . . 0.0 108.934 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.47 153.53 7.75 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.453 ' HG3' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.2 129.8 42.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.921 -1.112 . . . . 0.0 109.509 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -91.41 133.63 35.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 172' ' ' GLY . 38.5 t -104.75 165.15 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.766 -1.209 . . . . 0.0 110.088 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.541 ' N ' HG13 ' A' ' 171' ' ' VAL . . . -129.76 -169.98 12.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.14 155.51 44.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 197' ' ' VAL . 2.6 p -125.32 -174.31 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 -176.59 3.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 109.798 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.413 ' NE2' ' OD1' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -51.35 -27.29 9.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.002 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.413 ' OD1' ' NE2' ' A' ' 176' ' ' GLN . 27.4 m120 -114.78 -93.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.034 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 13.4 p30 -142.49 16.81 2.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.909 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.36 153.03 22.81 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.047 -1.033 . . . . 0.0 108.833 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.507 ' N ' ' OH ' ' A' ' 257' ' ' TYR . 0.5 OUTLIER -73.18 136.45 44.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -50.33 -172.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.516 -0.74 . . . . 0.0 110.148 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.4 t -116.06 -17.59 10.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -111.35 -19.91 12.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.494 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.5 t -48.36 134.81 14.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -79.59 157.25 27.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.652 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.1 OUTLIER -134.49 173.23 11.87 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.393 -0.817 . . . . 0.0 109.032 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 150.31 147.77 4.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.54 141.31 9.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.16 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.58 -11.24 46.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.5 tp -56.62 118.1 4.52 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.317 -1.108 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.5 OUTLIER -69.63 -75.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.985 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.468 ' HA ' ' OG ' ' A' ' 259' ' ' SER . 0.4 OUTLIER -145.22 -158.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 27.0 m -135.06 172.8 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.133 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.543 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -162.11 178.26 1.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 33.0 Cg_endo -76.19 114.02 3.81 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.097 1.864 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.05 40.07 1.44 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.628 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 53.9 t -123.46 82.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.628 ' HB3' ' O ' ' A' ' 197' ' ' VAL . 12.5 t-20 83.85 120.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.164 0.983 . . . . 0.0 108.449 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 199' ' ' VAL . 28.3 m -153.06 105.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 122.443 1.116 . . . . 0.0 109.105 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -83.54 109.31 17.28 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.327 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.611 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 1.4 t -123.99 -165.65 1.38 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 109.105 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 64' ' ' THR . 1.0 OUTLIER -69.24 176.72 3.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.213 -0.929 . . . . 0.0 110.268 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.628 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.6 OUTLIER -161.99 149.09 11.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.4 Cg_endo -69.99 173.48 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.277 1.985 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 79.97 8.79 87.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 1.0 OUTLIER 67.67 55.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.5 -1.0 . . . . 0.0 109.861 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 208' ' ' TYR . 4.2 t -155.85 -147.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.732 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.554 ' N ' ' CG2' ' A' ' 207' ' ' THR . 10.5 m-85 -146.36 -177.34 5.57 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.241 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.577 ' HB2' ' CD1' ' A' ' 203' ' ' TYR . . . 177.13 147.57 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.88 . . . . 0.0 110.373 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -118.86 142.27 47.89 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.72 122.38 3.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.857 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -72.84 160.7 31.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.139 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.16 156.3 8.53 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.431 HG23 ' HB2' ' A' ' 151' ' ' SER . 2.5 m -79.95 -27.36 39.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.187 . . . . 0.0 109.431 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.458 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 0.3 OUTLIER -74.75 -13.76 60.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.646 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.417 ' HE3' ' CD2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -85.57 -20.94 28.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.676 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 194' ' ' ALA . . . -95.35 -3.6 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.617 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 8.5 m -75.17 -43.94 4.56 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 111.307 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.5 Cg_endo -72.27 -13.29 28.16 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.614 1.543 . . . . 0.0 110.155 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.571 ' CE1' HG21 ' A' ' 69' ' ' THR . 6.2 m80 -70.99 -44.24 66.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 222' ' ' ALA . 46.2 t -66.54 -51.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -44.26 -37.35 3.19 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.694 -0.802 . . . . 0.0 108.865 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -66.69 -52.8 31.63 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.68 -56.95 10.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 109.656 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.65 23.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.974 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.043 -1.036 . . . . 0.0 110.042 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.4 mt -61.95 -46.65 88.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.035 -1.041 . . . . 0.0 109.658 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.556 ' O ' ' CG ' ' A' ' 231' ' ' LYS . 55.5 t -60.29 -43.7 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.436 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -53.09 -40.42 64.1 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.966 -1.084 . . . . 0.0 108.902 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.535 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -61.85 -56.02 23.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.266 -0.896 . . . . 0.0 110.348 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 228' ' ' VAL . 0.1 OUTLIER -52.0 -19.82 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.967 -1.083 . . . . 0.0 109.206 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.587 ' OD1' ' CG ' ' A' ' 235' ' ' TRP . 0.1 OUTLIER -132.85 94.11 22.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.915 . . . . 0.0 109.066 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.32 41.38 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.737 2.291 . . . . 0.0 110.862 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.9 t -164.22 13.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.0 111.869 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.587 ' CG ' ' OD1' ' A' ' 232' ' ' ASN . 26.4 m0 -92.89 174.31 7.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.434 -1.416 . . . . 0.0 109.559 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' SER . . . . . 0.416 ' O ' HD13 ' A' ' 240' ' ' ILE . 0.5 OUTLIER -104.76 174.01 6.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.527 -0.733 . . . . 0.0 109.148 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.466 ' OD1' HG21 ' A' ' 238' ' ' VAL . 27.3 p-10 -65.97 -25.58 67.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 109.736 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.466 HG21 ' OD1' ' A' ' 237' ' ' ASN . 2.7 t -78.77 -64.84 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.227 -0.92 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 238' ' ' VAL . 10.9 mm100 -44.68 -37.89 3.99 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.77 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 236' ' ' SER . 55.8 mt -68.4 -55.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 12.5 ttp180 -52.14 -21.89 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.029 . . . . 0.0 110.008 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -73.0 -59.8 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.524 ' O ' ' CG2' ' A' ' 247' ' ' THR . 19.8 t60 -52.61 -47.96 66.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.53 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -66.84 -37.82 85.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.344 -0.847 . . . . 0.0 110.05 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -59.05 -62.82 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.488 -0.758 . . . . 0.0 110.65 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -72.59 -10.71 60.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 111.558 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.53 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 2.9 p -81.34 -31.16 33.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.429 -1.419 . . . . 0.0 109.846 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -42.92 115.63 0.77 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.966 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -43.61 169.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.802 . . . . 0.0 109.928 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.7 p -121.94 106.2 11.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 109.881 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.536 ' CD2' ' HA2' ' A' ' 260' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.307 0 O-C-N 121.165 -0.959 . . . . 0.0 109.356 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.217 0.532 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.507 ' OH ' ' N ' ' A' ' 180' ' ' ARG . 50.5 m-85 -47.56 -60.65 2.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.049 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.76 20.75 74.51 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 191' ' ' ASP . 0.3 OUTLIER -167.57 -100.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 0.0 109.836 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' A' ' 251' ' ' LEU . . . 157.86 -160.57 30.83 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.583 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.49 ' O ' ' OG1' ' A' ' 249' ' ' THR . 9.4 tp -104.65 129.87 52.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.518 -0.99 . . . . 0.0 109.461 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 192' ' ' ILE . 0.0 OUTLIER -58.73 172.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.085 -1.009 . . . . 0.0 109.943 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.66 117.88 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 122.486 1.136 . . . . 0.0 108.408 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -74.28 -18.85 60.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.469 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 10.4 tt0 -95.49 -2.18 49.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.61 0.34 36.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -130.06 -1.04 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.865 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 269' ' ' ARG . 1.4 p -113.13 -35.69 5.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.562 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.529 ' OXT' ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.623 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.347 0.594 . . . . 0.0 109.62 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.665 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -143.07 44.09 0.5 Allowed Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 121.4 -0.812 . . . . 0.0 109.977 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.665 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.8 Cg_endo -78.06 172.39 15.6 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.653 1.568 . . . . 0.0 109.112 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -72.83 8.87 1.31 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 111.096 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 195' ' ' PRO . . . -110.12 -64.97 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.7 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.486 ' O ' HG21 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -56.46 -30.5 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.032 -1.275 . . . . 0.0 109.896 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 m -56.23 -34.56 66.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 109.849 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.03 -16.0 25.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.0 111.594 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 8' ' ' ILE . 3.0 m -85.35 15.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.299 -1.501 . . . . 0.0 110.387 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 74.6 mm-40 37.74 45.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.668 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -72.18 -35.17 3.21 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -72.9 -47.33 0.34 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 N-CA-C 108.162 -1.515 . . . . 0.0 108.162 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.25 -36.69 1.88 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -41.08 60.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.48 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 2.2 m-70 -63.45 -16.85 61.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.294 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -106.78 -24.76 11.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.783 -1.198 . . . . 0.0 109.915 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.4 mmp_? -63.47 -64.86 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.38 59.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.455 HD23 HG23 ' A' ' 268' ' ' THR . 1.7 mp -144.05 132.18 21.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -1.056 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 24' ' ' SER . 47.1 p -125.93 -8.08 6.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.364 -0.835 . . . . 0.0 109.986 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.87 11.5 4.39 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 22' ' ' THR . 12.3 p -60.16 -14.74 18.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 110.072 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.17 25.93 23.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' LYS . 57.7 t -132.0 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.001 -1.294 . . . . 0.0 110.091 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 22.9 mtmt -138.85 121.24 16.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.51 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 7.7 t -113.84 152.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.985 . . . . 0.0 110.294 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 120' ' ' ALA . . . -110.83 160.48 16.71 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.441 -0.787 . . . . 0.0 108.912 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.87 94.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 108.426 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 31' ' ' LEU . 5.8 mp -81.14 116.44 21.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -175.7 -161.72 0.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.941 -1.099 . . . . 0.0 110.26 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -46.78 -37.07 8.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.459 -0.776 . . . . 0.0 109.729 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 155.59 -103.52 0.24 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.588 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.0 mt 145.45 101.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 204' ' ' PRO . 0.4 OUTLIER -69.12 151.37 46.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.617 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 160.25 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -167.71 147.72 4.5 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 108.979 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.7 Cg_endo -77.14 -13.99 16.91 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.491 2.128 . . . . 0.0 110.477 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.31 5.27 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 108.918 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.1 mt -110.22 159.44 17.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.106 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.72 76.97 1.56 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.39 145.8 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 108.747 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.514 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.83 -20.95 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.913 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -178.22 153.31 12.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.82 -177.24 37.88 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.507 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 178.18 113.46 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 92' ' ' LYS . 25.1 m -105.44 111.07 23.65 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.517 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.484 ' CG ' ' HG2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -89.92 -22.72 21.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 93' ' ' VAL . 1.8 t -62.2 135.25 94.94 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.412 -0.805 . . . . 0.0 108.937 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.448 2.098 . . . . 0.0 110.672 179.742 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.586 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -73.98 13.46 0.53 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.643 -1.286 . . . . 0.0 111.103 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 56' ' ' THR . 31.5 mt-30 -147.59 174.74 11.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.533 -1.354 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -57.68 160.78 4.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.471 -0.768 . . . . 0.0 110.648 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.09 10.15 3.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -167.25 -65.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 109.353 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.27 -32.27 0.54 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -45.56 -65.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -46.02 -70.89 0.58 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 63' ' ' GLY . 22.6 m -33.59 -49.4 0.3 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.778 -0.837 . . . . 0.0 111.252 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.5 t-80 -57.92 -52.65 64.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.067 -1.021 . . . . 0.0 110.344 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 219' ' ' PRO . 25.4 t -57.17 -37.81 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.078 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.76 -41.11 97.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 202' ' ' THR . . . -68.26 -46.29 65.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.6 m -53.14 -29.22 30.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.431 -1.041 . . . . 0.0 108.974 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.0 mt -90.07 -24.31 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -120.22 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.938 -1.101 . . . . 0.0 111.9 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.576 ' CB ' ' N ' ' A' ' 81' ' ' GLY . . . 37.62 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.745 . . . . 0.0 109.868 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 mt -52.86 141.75 20.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.47 -1.394 . . . . 0.0 109.682 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.508 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 2.1 p-10 -89.78 116.36 27.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.513 ' N ' ' ND2' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -174.48 -105.87 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -45.98 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.348 -0.845 . . . . 0.0 109.224 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -72.07 169.87 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.521 ' N ' HG21 ' A' ' 77' ' ' ILE . . . 41.06 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.502 ' HB ' ' OG ' ' A' ' 3' ' ' SER . 27.4 m -115.91 -162.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.978 . . . . 0.0 109.1 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 3' ' ' SER . 1.9 tp -106.96 121.29 44.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.135 -0.978 . . . . 0.0 109.65 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.576 ' N ' ' CB ' ' A' ' 72' ' ' ALA . . . -88.48 -146.19 12.07 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.48 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 1.9 t -112.23 -34.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -1.225 . . . . 0.0 109.841 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -121.7 128.97 25.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.045 -1.035 . . . . 0.0 109.072 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 38.1 Cg_endo -85.36 -62.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.646 2.231 . . . . 0.0 110.618 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.4 37.04 1.2 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.337 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.44 129.06 34.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.45 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -61.49 87.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.326 -0.859 . . . . 0.0 109.373 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mt -76.49 124.33 27.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.078 -1.014 . . . . 0.0 109.741 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.596 ' CE2' ' HE2' ' A' ' 117' ' ' MET . 7.0 m-85 -115.57 152.18 33.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.476 -0.765 . . . . 0.0 109.185 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -119.05 98.81 6.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.052 -1.03 . . . . 0.0 110.334 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.508 ' HB ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.47 64.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.068 -1.02 . . . . 0.0 108.651 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 55' ' ' SER . 7.8 ttmt -37.34 121.91 0.87 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.549 0.69 . . . . 0.0 111.134 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 25.3 t -123.28 -36.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.476 HD23 HD11 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -130.16 179.56 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 33' ' ' THR . . . 154.79 -140.2 7.24 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 118.256 -1.926 . . . . 0.0 112.186 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 122.135 -0.627 . . . . 0.0 110.72 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.409 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.1 t -83.96 176.73 8.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.912 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 132' ' ' THR . 44.5 t -68.27 -13.39 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.09 -22.84 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.474 ' OG ' HG21 ' A' ' 50' ' ' VAL . 66.3 m -85.67 -43.6 13.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.49 HG22 HD11 ' A' ' 105' ' ' ILE . 1.6 mt -71.21 -23.27 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.52 25.15 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.681 -0.637 . . . . 0.0 109.413 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.484 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 3.5 tp-100 -69.98 -32.79 71.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 -39.05 27.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.7 -28.1 61.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -1.168 . . . . 0.0 109.707 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -92.33 -21.27 20.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.096 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.485 ' O ' ' CD2' ' A' ' 111' ' ' TRP . 64.7 t90 -76.85 -11.67 59.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.418 -0.801 . . . . 0.0 108.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.693 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -97.28 -1.37 44.88 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.302 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.62 -21.61 39.74 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -119.03 -5.84 10.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.132 . . . . 0.0 110.252 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -164.65 20.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.804 -1.185 . . . . 0.0 110.563 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -105.31 -152.77 21.29 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.732 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.596 ' HE2' ' CE2' ' A' ' 89' ' ' TYR . 10.6 mmt -120.56 -176.73 3.3 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.636 -0.92 . . . . 0.0 110.633 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.677 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -81.1 -25.75 36.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.217 -178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.677 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 2.4 t -114.77 158.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.575 -1.328 . . . . 0.0 109.738 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.515 ' O ' HG11 ' A' ' 147' ' ' VAL . . . -167.29 145.12 4.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.538 ' ND2' HG11 ' A' ' 148' ' ' VAL . 10.5 t-20 -115.35 162.18 17.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 109.454 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 121' ' ' ASN . 3.8 mp -144.97 113.56 6.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.196 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 10.8 m -92.7 68.99 4.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 178.54 177.02 0.47 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -0.925 . . . . 0.0 110.002 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 161' ' ' TYR . . . 172.17 -79.31 0.09 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER 81.86 162.0 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.762 -0.846 . . . . 0.0 110.032 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.472 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 34.8 Cg_endo -76.43 -14.55 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.514 2.143 . . . . 0.0 109.78 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.41 118.25 60.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.404 ' O ' ' OG ' ' A' ' 130' ' ' SER . 35.2 Cg_endo -77.77 165.97 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.159 1.906 . . . . 0.0 110.344 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 129' ' ' PRO . 49.8 m -168.68 106.41 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.899 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.7 -18.13 64.81 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.453 HG23 HG13 ' A' ' 102' ' ' VAL . 20.6 m -68.25 -29.21 67.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -42.05 37.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.12 -19.03 61.23 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.747 -1.181 . . . . 0.0 108.153 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 tt0 -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.61 -36.04 57.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 t -70.57 -29.67 39.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -38.57 84.08 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.1 -25.12 58.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -85.95 -6.82 58.99 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.6 m -86.57 -51.99 5.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.1 -1.0 . . . . 0.0 109.141 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -18.27 45.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -20.55 16.52 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 78.51 0.5 Allowed Glycine 0 N--CA 1.478 1.465 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.422 HG12 ' C ' ' A' ' 118' ' ' HIS . 22.1 t -131.43 118.11 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -1.061 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.91 122.19 26.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.515 HG11 ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -115.27 151.74 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.538 HG11 ' ND2' ' A' ' 121' ' ' ASN . 2.7 t -119.22 159.79 19.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.411 ' N ' HG11 ' A' ' 148' ' ' VAL . . . -146.88 135.1 21.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.869 -1.144 . . . . 0.0 110.409 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -67.12 174.83 2.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.664 -0.648 . . . . 0.0 109.553 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 15.2 t -73.03 -82.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 145.57 120.65 1.34 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.428 ' C ' ' OG ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -86.35 60.11 6.04 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 121.922 -0.752 . . . . 0.0 109.598 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' C ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 171.61 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.164 -0.96 . . . . 0.0 110.898 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . -19.69 -50.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.237 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.619 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 90.57 63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.786 0.803 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.16 -3.09 32.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 159' ' ' ILE . 15.0 m -134.22 122.83 23.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 0.0 109.562 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -51.18 179.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.424 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -105.92 173.3 6.37 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.554 1.169 . . . . 0.0 112.526 -177.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.565 ' O ' ' CA ' ' A' ' 125' ' ' GLY . 24.4 m-85 -108.94 144.75 30.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.1 Cg_endo -72.88 -31.82 4.91 Favored 'Cis proline' 0 C--N 1.297 -2.181 0 O-C-N 122.33 0.647 . . . . 0.0 111.27 4.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . -4.1 -61.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.604 0.716 . . . . 0.0 111.656 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 162' ' ' PRO . 9.6 tpt180 -48.77 -65.9 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.529 ' O ' ' CB ' ' A' ' 166' ' ' ALA . 38.1 p90 -121.75 -163.43 1.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.922 0.868 . . . . 0.0 110.676 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 165' ' ' TYR . . . 80.1 49.3 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.648 0.737 . . . . 0.0 109.589 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 166' ' ' ALA . 23.0 m-80 41.77 28.76 0.09 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -112.49 116.32 30.08 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.91 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 73.5 mmm -63.64 171.83 2.44 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.293 -0.88 . . . . 0.0 108.792 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -137.02 114.42 10.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 27.5 t -99.68 166.05 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -148.8 108.4 0.4 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -52.01 149.58 4.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.28 . . . . 0.0 109.541 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.468 ' HB2' ' C ' ' A' ' 180' ' ' ARG . 6.2 t0 -115.46 -149.5 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.131 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 177' ' ' ASN . 56.7 tt0 -40.3 -43.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.458 -0.776 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 7.4 m-20 164.47 119.86 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.94 38.38 28.69 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.216 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -132.07 -18.12 2.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.94 . . . . 0.0 110.282 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.468 ' C ' ' HB2' ' A' ' 175' ' ' ASP . 1.8 ttp85 66.79 126.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 109.188 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 183' ' ' PHE . . . -42.47 163.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.591 -0.693 . . . . 0.0 109.901 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.9 p -84.31 4.88 29.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.289 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 181' ' ' ALA . 6.2 p90 -137.93 11.74 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.7 t -87.75 105.58 17.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.399 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.578 ' HG2' ' N ' ' A' ' 155' ' ' GLY . 1.5 mp0 -52.38 154.46 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -0.962 . . . . 0.0 110.118 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.75 168.2 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 173.12 144.47 4.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.72 131.31 50.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.322 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.43 -1.15 39.95 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 191' ' ' ASP . 6.6 tp -60.94 146.79 45.55 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.28 -1.129 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.4 OUTLIER -73.68 -80.05 0.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.059 -1.026 . . . . 0.0 110.368 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.531 HG23 ' CB ' ' A' ' 259' ' ' SER . 0.2 OUTLIER -152.75 -169.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.781 -1.199 . . . . 0.0 109.516 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.527 ' N ' HG12 ' A' ' 192' ' ' ILE . 32.6 m -126.59 162.16 31.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.009 -1.057 . . . . 0.0 110.163 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 262' ' ' VAL . . . -145.76 140.4 15.68 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 7' ' ' GLY . 34.6 Cg_endo -76.17 112.95 3.59 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.449 2.099 . . . . 0.0 111.115 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.573 ' O ' ' C ' ' A' ' 197' ' ' VAL . . . -114.12 -67.79 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 78.0 t 5.52 71.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.613 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 9.5 t-20 99.13 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 7.3 m -163.41 110.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 122.149 0.976 . . . . 0.0 109.259 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.538 ' CG ' ' OG ' ' A' ' 210' ' ' SER . 6.3 mt-30 -77.43 129.52 35.86 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.587 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -135.95 -153.46 0.51 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.042 -1.036 . . . . 0.0 109.64 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' THR . . . . . 0.446 HG21 ' HA3' ' A' ' 68' ' ' GLY . 9.8 t -102.94 177.32 4.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.627 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -144.63 -179.45 0.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.627 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -73.38 -151.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.98 1.787 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . -37.62 -29.7 0.05 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' PRO . 17.8 t -48.39 -97.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.256 -1.144 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 206' ' ' SER . 5.2 t 175.53 -120.33 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 0.6 OUTLIER -78.33 -170.38 2.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.868 -1.145 . . . . 0.0 109.748 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.768 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.538 ' OG ' ' CG ' ' A' ' 200' ' ' GLN . 0.1 OUTLIER -174.21 139.34 0.62 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 216' ' ' MET . 0.1 OUTLIER -175.63 162.29 2.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -106.08 173.5 6.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.438 -0.788 . . . . 0.0 109.226 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 147.18 147.61 4.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 23.2 m -73.92 -22.5 59.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.131 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.442 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 71.2 m -74.15 -9.94 59.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.457 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -86.45 -19.59 29.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -90.36 -14.06 33.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.659 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -71.07 -39.28 8.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 0.0 111.452 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 218' ' ' THR . 31.7 Cg_endo -73.25 -28.63 12.32 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.761 1.641 . . . . 0.0 110.561 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -61.91 -35.67 79.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.464 HG23 HD12 ' A' ' 192' ' ' ILE . 33.8 t -75.73 -39.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -27.67 67.27 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.86 2.37 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -45.39 -42.09 9.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 109.334 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.52 95.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.775 . . . . 0.0 109.171 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.86 -40.91 73.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.165 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 21' ' ' LEU . 5.1 mt -61.88 -45.15 95.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 109.328 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 229' ' ' LYS . 75.7 t -57.9 -67.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.557 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -40.02 -43.04 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.709 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 14.9 tm0? -58.37 -54.11 50.71 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.224 -0.923 . . . . 0.0 110.018 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -17.26 8.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.188 -0.945 . . . . 0.0 108.917 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 m-20 -156.57 81.18 3.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.6 Cg_endo -81.14 40.32 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.757 2.305 . . . . 0.0 110.663 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.41 7.68 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.0 109.762 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.416 ' CZ2' ' ND2' ' A' ' 232' ' ' ASN . 45.1 m0 -91.05 175.03 7.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.775 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.37 8.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.11 -32.75 68.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.13 -0.981 . . . . 0.0 109.126 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.9 t -71.88 -63.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.31 -0.869 . . . . 0.0 109.09 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.8 OUTLIER -42.01 -42.06 2.73 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.379 0.609 . . . . 0.0 109.809 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 9.4 mm -63.06 -47.89 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.847 . . . . 0.0 109.302 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' ASN . 0.6 OUTLIER -58.41 -62.64 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -40.33 -43.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.439 -0.788 . . . . 0.0 110.422 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.492 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.9 t60 -70.67 -38.44 73.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.9 -1.125 . . . . 0.0 110.223 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.434 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.8 OUTLIER -73.3 -22.5 60.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.452 -0.78 . . . . 0.0 110.019 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -84.48 -34.33 23.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.349 -0.845 . . . . 0.0 108.942 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -85.97 -17.17 36.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.59 -0.694 . . . . 0.0 109.312 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 5.0 p -88.24 -34.26 17.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 109.402 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 259' ' ' SER . . . -47.04 133.83 11.05 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.463 ' OG1' ' OD1' ' A' ' 263' ' ' ASN . 2.9 m -57.87 152.4 16.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.704 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 259' ' ' SER . 25.8 p -120.48 98.63 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.884 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 C--N 1.306 -1.304 0 O-C-N 121.08 -1.012 . . . . 0.0 109.343 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.445 ' HA ' ' CE1' ' A' ' 186' ' ' TYR . 7.3 mt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.45 -46.43 10.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.9 -33.04 4.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.531 ' CB ' HG23 ' A' ' 192' ' ' ILE . 1.5 m -141.42 -98.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -1.135 . . . . 0.0 109.331 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 162.19 -124.56 1.31 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.169 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -84.65 135.11 34.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.592 -0.946 . . . . 0.0 110.163 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.507 ' N ' HD11 ' A' ' 261' ' ' LEU . 1.4 t -78.6 144.44 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.463 ' OD1' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -160.88 118.28 2.38 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.604 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.395 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 2.3 tm-20 -63.12 -28.86 70.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.15 -18.19 50.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.412 ' HA ' HG23 ' A' ' 247' ' ' THR . . . -107.11 9.87 30.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 269' ' ' ARG . 17.3 p -128.38 -67.53 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 268' ' ' THR . 8.3 tpt180 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.626 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -115.32 86.4 14.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.977 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 3' ' ' SER . 37.0 Cg_endo -80.87 -175.01 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.973 2.449 . . . . 0.0 111.575 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.628 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -55.58 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.442 0.639 . . . . 0.0 110.52 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 6' ' ' TRP . . . -40.12 -83.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.4 mp -41.65 102.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -1.029 . . . . 0.0 109.741 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER 167.9 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.202 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -93.47 4.44 53.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.316 -0.865 . . . . 0.0 109.895 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 12' ' ' GLN . 3.5 m -94.48 25.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.01 -1.056 . . . . 0.0 109.818 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 88.1 mm-40 43.03 46.96 4.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.67 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -81.45 -35.62 0.78 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 111.433 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.7 Cg_endo -74.42 -55.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.222 -1.491 . . . . 0.0 108.222 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.56 -34.63 3.45 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -71.47 -41.57 69.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.9 -1.125 . . . . 0.0 109.147 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 7.4 m170 -75.79 -2.9 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.702 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -115.08 -11.0 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.117 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -73.67 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 109.404 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.76 30.77 0.06 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -142.89 145.4 33.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.184 . . . . 0.0 109.391 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -123.6 -9.93 7.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -0.835 . . . . 0.0 109.711 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -7.47 16.66 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 22' ' ' THR . 51.7 p -60.05 94.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.553 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.28 -4.47 2.85 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.228 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.621 ' CG1' ' CE1' ' A' ' 118' ' ' HIS . 5.3 t -97.49 160.99 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.907 -1.349 . . . . 0.0 109.904 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.3 OUTLIER -125.84 117.29 23.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 110.016 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 13.7 t -107.37 145.1 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.597 -0.689 . . . . 0.0 109.315 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 119' ' ' VAL . . . -106.56 155.59 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.443 ' O ' HG11 ' A' ' 30' ' ' VAL . 41.7 t -128.59 86.69 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.476 HD13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 mp -81.72 90.33 6.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.665 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -157.03 -146.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 108.747 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -57.28 -73.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.586 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -166.46 -126.93 0.86 Allowed Glycine 0 N--CA 1.476 1.363 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.586 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 8.0 mt -167.4 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.525 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 20.5 t -47.82 141.5 5.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.042 -1.036 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.58 141.92 56.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.243 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.4 157.12 21.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.35 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 35.8 Cg_endo -78.75 -6.01 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.736 2.291 . . . . 0.0 111.111 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.47 -21.48 19.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 0.0 109.993 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.528 HD22 ' CA ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER -117.09 150.16 39.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.045 -1.034 . . . . 0.0 109.712 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 116.42 31.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.523 -0.735 . . . . 0.0 109.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.41 111.56 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.114 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 62.6 mmt-85 -118.79 11.23 12.61 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.642 ' HA3' ' CD2' ' A' ' 89' ' ' TYR . . . -174.34 142.57 6.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.17 84.82 0.15 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.487 -1.339 . . . . 0.0 110.645 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 124.49 45.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 108.652 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.552 ' HB2' ' CE ' ' A' ' 92' ' ' LYS . 6.5 p -111.43 117.77 33.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.001 -1.062 . . . . 0.0 110.416 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.59 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 21.4 m-85 -86.12 -77.77 0.3 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.285 -0.884 . . . . 0.0 108.732 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 77.5 t -38.94 94.39 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.939 -0.475 . . . . 0.0 109.739 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 49' ' ' PHE . 37.4 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 C-N-CA 122.274 1.982 . . . . 0.0 111.822 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.47 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.473 HG21 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -77.33 0.22 23.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 58' ' ' ASP . 2.0 mt-30 -110.92 -172.42 2.03 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.108 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 29.2 t70 -32.43 142.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.569 0.699 . . . . 0.0 110.916 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.3 -40.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -144.39 -65.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.478 -1.013 . . . . 0.0 109.319 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.48 -31.25 0.52 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.543 ' CE1' ' OG ' ' A' ' 215' ' ' SER . 2.5 t-160 -61.37 -43.43 98.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -57.4 -74.66 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.57 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -38.28 -49.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.51 -0.994 . . . . 0.0 110.557 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.584 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 12.9 t-80 -52.29 -50.79 61.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.502 HG11 ' CD1' ' A' ' 70' ' ' ILE . 31.4 t -62.27 -29.58 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.404 -0.81 . . . . 0.0 109.584 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.43 85.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.342 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.528 ' CA ' HD22 ' A' ' 41' ' ' LEU . . . -75.81 -23.09 73.3 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.547 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 8.3 m -74.58 -14.86 60.84 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.084 -1.245 . . . . 0.0 107.875 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.502 ' CD1' HG11 ' A' ' 66' ' ' VAL . 62.6 mt -94.73 -35.46 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.503 -0.748 . . . . 0.0 110.829 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -165.5 27.93 0.05 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 0.0 112.37 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 68' ' ' GLY . . . -44.19 153.87 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.444 -1.41 . . . . 0.0 108.635 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.436 ' C ' HD11 ' A' ' 80' ' ' LEU . 73.9 mt -75.86 171.95 13.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.95 -1.094 . . . . 0.0 110.205 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.492 ' HA ' ' HB2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -103.64 51.57 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.555 ' O ' ' C ' ' A' ' 76' ' ' SER . 0.1 OUTLIER -177.07 -115.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.568 ' O ' ' C ' ' A' ' 77' ' ' ILE . 12.3 m 22.28 71.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.335 -0.228 . . . . 0.0 110.956 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.568 ' C ' ' O ' ' A' ' 76' ' ' SER . 1.3 pp 14.79 57.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.664 0.745 . . . . 0.0 111.578 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' SER . . . -154.87 -161.27 10.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 73' ' ' LEU . 21.9 m -95.9 -161.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -1.132 . . . . 0.0 109.861 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 74' ' ' ASN . 20.2 tp -143.42 123.45 13.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.838 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.83 -148.9 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.511 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 40.7 t -100.16 -25.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.086 -1.243 . . . . 0.0 109.325 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . . . -99.65 137.14 20.18 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.977 . . . . 0.0 108.754 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.47 -61.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.72 2.28 . . . . 0.0 111.018 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -117.48 48.52 1.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.525 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.78 150.41 23.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.112 -0.992 . . . . 0.0 109.402 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -81.85 108.42 15.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 109.156 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' HB1' ' A' ' 71' ' ' ALA . 8.6 mt -85.45 124.94 32.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.642 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 7.6 m-85 -113.76 143.18 45.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.166 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -111.97 95.4 5.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.127 -0.983 . . . . 0.0 109.64 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.59 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.63 62.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.083 -1.011 . . . . 0.0 108.897 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.552 ' CE ' ' HB2' ' A' ' 48' ' ' SER . 12.2 ttpp -36.81 116.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.282 0.563 . . . . 0.0 110.077 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -122.58 0.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 124' ' ' LEU . 62.8 mt -119.34 174.7 6.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.46 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -119.6 146.08 18.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.008 179.769 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 155.18 20.85 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.769 -0.842 . . . . 0.0 109.654 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.496 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 20.0 t -67.75 -20.74 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -20.53 60.37 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -86.3 -47.33 9.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.68 -0.637 . . . . 0.0 109.581 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.457 ' HB ' HD13 ' A' ' 133' ' ' LEU . 1.5 mt -67.2 -34.17 67.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.189 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -71.92 -43.57 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.917 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -69.56 -31.19 69.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.813 -1.18 . . . . 0.0 109.882 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.4 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -82.19 -18.16 67.66 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 -34.5 27.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -1.149 . . . . 0.0 110.022 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.492 ' HG2' ' OG ' ' A' ' 139' ' ' SER . 3.9 mt-10 -90.1 -19.19 24.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.891 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.608 ' CE2' ' O ' ' A' ' 115' ' ' ASN . 84.5 t90 -68.18 -25.04 65.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.132 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.607 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -90.5 5.9 45.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.898 -1.126 . . . . 0.0 109.412 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -94.91 -36.49 5.5 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -106.19 -23.15 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -1.095 . . . . 0.0 109.224 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.608 ' O ' ' CE2' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -173.06 89.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.607 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . 172.8 50.75 0.05 OUTLIER Glycine 0 C--N 1.291 -1.971 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.469 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.582 ' HE3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER 62.52 163.3 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.473 -1.016 . . . . 0.0 112.062 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.65 ' CE1' ' CD ' ' A' ' 229' ' ' LYS . 9.7 p80 -98.15 -30.16 12.81 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 118' ' ' HIS . 4.8 t -95.84 157.72 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.836 -1.165 . . . . 0.0 108.901 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -167.5 124.57 1.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.552 ' ND2' HG11 ' A' ' 148' ' ' VAL . 15.7 t-20 -102.53 166.96 10.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.438 HD22 HD23 ' A' ' 124' ' ' LEU . 3.5 mp -146.88 112.65 5.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.865 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.2 t -90.14 62.38 5.48 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.438 HD23 HD22 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -146.93 -174.12 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.63 0.729 . . . . 0.0 110.213 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 161' ' ' TYR . . . 160.42 109.57 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.95 154.7 81.49 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.043 -1.269 . . . . 0.0 109.814 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.504 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -78.67 5.4 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.76 2.306 . . . . 0.0 110.099 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 m -110.63 82.43 2.88 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.726 -0.609 . . . . 0.0 109.992 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.4 Cg_endo -76.93 171.48 17.9 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.393 2.062 . . . . 0.0 110.754 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -144.01 134.47 24.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 108.977 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.56 66.17 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.9 m -70.91 -28.22 64.37 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -76.74 -24.74 53.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.299 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.55 -55.72 5.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.135 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.77 -25.01 16.99 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.33 53.69 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.67 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.533 HG13 ' ND2' ' A' ' 167' ' ' ASN . 2.2 t -71.94 -19.36 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 142' ' ' SER . 1.2 t30 -76.1 -29.39 57.89 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.492 ' OG ' ' HG2' ' A' ' 110' ' ' GLU . 1.0 OUTLIER -88.13 -19.05 27.5 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.239 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 145' ' ' VAL . . . -93.39 -26.21 17.35 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.636 -1.29 . . . . 0.0 110.558 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.98 -34.14 13.17 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 138' ' ' ASN . 8.0 t -67.54 -24.69 65.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -81.14 -16.95 51.53 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 237' ' ' ASN . . . 91.7 50.34 2.73 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 140' ' ' ALA . 70.7 t -113.75 111.11 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 109.234 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.8 tp -69.96 126.39 29.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.043 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -120.19 137.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.553 HG11 ' N ' ' A' ' 149' ' ' ALA . 8.9 t -121.05 166.77 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.553 ' N ' HG11 ' A' ' 148' ' ' VAL . . . -153.61 140.65 19.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.944 -1.098 . . . . 0.0 109.555 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -75.95 153.42 36.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.495 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 4.6 t -77.96 -71.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 185' ' ' GLN . . . 164.67 119.02 0.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -87.51 56.62 4.01 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 122.062 -0.669 . . . . 0.0 109.868 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.3 p -137.12 -108.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 185' ' ' GLN . . . -103.06 -95.98 2.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 167.58 74.16 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.324 -1.103 . . . . 0.0 109.89 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -106.91 43.63 1.65 Allowed Glycine 0 C--N 1.287 -2.166 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.2 p 80.53 131.68 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.832 -0.804 . . . . 0.0 109.657 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -55.08 -169.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.491 ' HB2' ' CA ' ' A' ' 125' ' ' GLY . 0.9 OUTLIER -139.08 164.64 29.23 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.573 -0.704 . . . . 0.0 111.822 -178.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.492 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 1.5 m-85 -79.45 145.52 63.83 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.3 Cg_endo -71.53 -33.96 3.51 Favored 'Cis proline' 0 C--N 1.295 -2.256 0 O-C-N 122.566 0.772 . . . . 0.0 110.942 4.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . -31.09 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.006 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -79.68 -49.14 12.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.802 -1.186 . . . . 0.0 109.987 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.496 ' O ' ' O ' ' A' ' 164' ' ' ARG . 2.7 m-85 -46.78 -179.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.006 0.908 . . . . 0.0 110.416 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.4 -8.12 23.62 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.746 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.533 ' ND2' HG13 ' A' ' 137' ' ' VAL . 10.7 p30 -88.65 20.84 3.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -159.16 142.11 14.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 108.893 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.441 ' HG3' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.41 131.91 41.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 109.671 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -95.47 114.82 26.62 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 108.857 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.3 t -94.19 165.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.569 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -144.23 -175.06 17.03 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.413 ' HB1' HG23 ' A' ' 214' ' ' THR . . . -123.64 164.24 19.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -1.074 . . . . 0.0 109.056 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p -142.74 167.85 21.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.466 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.5 OUTLIER -66.43 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.33 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.73 -32.62 11.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.97 . . . . 0.0 109.862 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.65 -78.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 178' ' ' ASN . 39.4 t-20 -173.07 45.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 109.741 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 24.4 t30 -135.9 167.27 21.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.044 -1.035 . . . . 0.0 109.553 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.489 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.5 ttt-85 -45.79 138.65 4.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.774 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.87 -134.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.643 -0.661 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 m -127.86 -31.53 2.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.883 -1.135 . . . . 0.0 109.734 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' SER . 24.5 p90 -123.47 -3.19 8.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.875 . . . . 0.0 109.65 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.3 OUTLIER -44.09 107.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 109.782 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -58.15 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.646 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.503 ' O ' ' O ' ' A' ' 185' ' ' GLN . 1.2 t80 -50.07 -167.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.758 0.789 . . . . 0.0 111.638 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.515 ' CA ' HD23 ' A' ' 190' ' ' LEU . . . -173.1 23.06 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.48 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.84 97.78 4.0 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.685 -0.891 . . . . 0.0 109.445 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.38 -22.67 28.79 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.515 HD23 ' CA ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -45.15 154.74 0.14 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.505 -0.997 . . . . 0.0 109.626 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.489 ' O ' HG21 ' A' ' 192' ' ' ILE . 51.9 t0 -55.03 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.815 . . . . 0.0 110.891 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.535 ' CB ' ' OG ' ' A' ' 259' ' ' SER . 0.5 OUTLIER -146.7 -157.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.913 -1.117 . . . . 0.0 110.064 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.514 ' N ' HG13 ' A' ' 192' ' ' ILE . 30.3 m -143.0 168.55 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.796 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -151.56 160.85 31.1 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.41 -0.806 . . . . 0.0 109.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.502 ' HD3' ' CD1' ' A' ' 261' ' ' LEU . 32.6 Cg_endo -74.87 115.23 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.06 60.9 0.4 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.321 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.628 ' HB ' ' CZ2' ' A' ' 6' ' ' TRP . 47.5 t -97.62 70.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER 111.62 119.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 216' ' ' MET . 1.7 m -156.27 112.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.07 0.938 . . . . 0.0 108.484 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 209' ' ' ALA . 0.6 OUTLIER -89.86 171.2 9.77 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.624 0.726 . . . . 0.0 110.071 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.584 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 20.4 m -167.56 -146.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.726 . . . . 0.0 109.074 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' THR . . . . . 0.439 HG22 HD13 ' A' ' 41' ' ' LEU . 77.1 p -92.68 150.08 20.91 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 110.068 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.569 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 2.1 t80 -140.55 142.46 29.07 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.3 Cg_endo -72.04 156.94 55.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.312 2.008 . . . . 0.0 110.986 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 36.41 54.48 1.31 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.4 t -179.83 -107.62 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.094 -1.239 . . . . 0.0 109.719 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.434 ' CG2' ' H ' ' A' ' 208' ' ' TYR . 4.3 t -175.45 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.438 -0.789 . . . . 0.0 109.119 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 201' ' ' SER . 0.1 OUTLIER -89.24 142.76 27.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.738 -1.226 . . . . 0.0 109.632 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -125.71 111.39 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.642 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.3 OUTLIER -83.08 132.35 35.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.491 ' CD1' ' SD ' ' A' ' 216' ' ' MET . 1.0 OUTLIER -167.24 138.72 3.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.97 . . . . 0.0 109.876 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -88.89 147.51 24.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 108.927 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 170.55 146.3 5.1 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.003 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.413 HG23 ' HB1' ' A' ' 173' ' ' ALA . 9.7 p -66.51 -27.17 67.56 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.274 -1.133 . . . . 0.0 108.521 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.543 ' OG ' ' CE1' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -55.63 -22.37 22.27 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.535 ' CB ' HG23 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -85.57 -29.79 23.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -82.36 -23.0 35.25 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.165 -0.959 . . . . 0.0 110.369 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.623 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 4.9 m -66.41 -46.15 59.52 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.895 -1.128 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.2 Cg_endo -73.07 -12.98 26.08 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.919 1.746 . . . . 0.0 109.931 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -74.11 -42.4 60.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.412 HG21 ' CG1' ' A' ' 262' ' ' VAL . 74.2 t -70.74 -48.83 55.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -46.11 -43.23 14.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.51 -45.37 96.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.08 39.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -1.041 . . . . 0.0 109.472 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.462 ' HA ' HD13 ' A' ' 244' ' ' LEU . . . -52.04 -34.58 43.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.24 86.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 0.0 109.214 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 67.3 mt -59.8 -29.23 68.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.424 HG13 HG21 ' A' ' 240' ' ' ILE . 36.4 t -69.57 -62.22 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.31 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -41.9 -47.07 4.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.695 . . . . 0.0 109.714 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.525 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 5.0 tp-100 -59.62 -49.38 77.99 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.167 -0.958 . . . . 0.0 109.751 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.458 ' HB2' HD21 ' A' ' 21' ' ' LEU . 6.0 tttm -54.31 -19.3 5.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 235' ' ' TRP . 19.0 m120 -160.93 92.05 1.54 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 109.967 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.6 -11.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.415 2.077 . . . . 0.0 110.303 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.3 m -87.49 -8.87 55.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 239' ' ' GLN . 25.3 m0 -69.65 179.62 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.556 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.18 178.22 5.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.513 ' HB3' ' HA2' ' A' ' 144' ' ' GLY . 18.7 p-10 -52.62 -25.63 11.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 109.42 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.67 -65.4 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.14 -0.975 . . . . 0.0 109.226 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 0.5 OUTLIER -44.76 -25.84 0.33 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.333 0.587 . . . . 0.0 109.967 -178.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.452 HD12 ' HG2' ' A' ' 229' ' ' LYS . 11.7 mt -92.06 -63.65 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 242' ' ' ASN . 15.2 ttp180 -58.2 -63.43 1.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 241' ' ' ARG . 46.3 t30 -37.83 -44.85 0.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 110.705 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.424 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.9 OUTLIER -64.39 -43.85 93.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 110.082 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.476 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 1.4 mt -68.57 -34.0 75.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.362 -0.836 . . . . 0.0 110.95 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.53 55.78 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.78 -4.38 26.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.606 -0.684 . . . . 0.0 109.567 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.4 p -98.48 -28.36 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.9 -1.125 . . . . 0.0 109.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -42.27 142.55 0.75 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 250' ' ' SER . 18.9 m -75.13 164.87 26.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.225 -0.922 . . . . 0.0 109.007 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 259' ' ' SER . 20.5 p -133.04 116.64 16.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.021 -1.05 . . . . 0.0 110.226 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.518 ' N ' HD13 ' A' ' 251' ' ' LEU . 6.8 mp . . . . . 0 N--CA 1.484 1.272 0 O-C-N 121.165 -0.959 . . . . 0.0 109.677 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 258' ' ' GLY . 13.3 m-30 -106.66 47.48 0.88 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 257' ' ' TYR . . . -30.66 -89.18 0.01 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.535 ' OG ' ' CB ' ' A' ' 192' ' ' ILE . 1.6 p -61.19 -96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.127 -1.219 . . . . 0.0 108.721 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 175.34 -132.35 2.15 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 28.3 tp -85.83 155.35 21.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.956 -0.732 . . . . 0.0 110.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.528 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 2.7 t -92.13 145.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.437 -0.79 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -169.66 119.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.367 1.08 . . . . 0.0 108.714 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -75.19 -17.28 60.4 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.702 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.451 ' HA ' ' OG1' ' A' ' 268' ' ' THR . 56.3 tt0 -61.52 -20.46 63.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.422 ' HB2' ' HB ' ' A' ' 247' ' ' THR . . . -84.27 -22.44 30.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.578 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -117.15 15.43 14.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.779 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 264' ' ' ALA . 11.0 p -118.88 -39.92 2.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 269' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.523 ' C ' ' O ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -22.51 85.2 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.867 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.564 ' HG2' ' CG1' ' A' ' 8' ' ' ILE . 36.6 Cg_endo -80.97 -176.19 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.911 2.407 . . . . 0.0 110.897 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.612 ' CE2' ' O ' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -24.64 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.407 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -114.31 -83.01 1.12 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.005 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.588 ' CG2' ' N ' ' A' ' 9' ' ' SER . 1.7 mm 49.52 -86.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.858 -0.789 . . . . 0.0 109.268 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.588 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -61.43 -12.46 14.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.91 -1.119 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -27.79 67.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.8 m -92.99 27.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 61.74 47.39 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.755 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -82.83 -31.48 0.52 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 111.676 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -75.11 -54.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 108.087 -1.543 . . . . 0.0 108.087 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.73 -35.75 1.97 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.61 -43.24 63.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.961 -1.087 . . . . 0.0 108.955 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.08 -2.99 33.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 -39.98 8.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.47 -55.72 9.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.44 -27.86 0.77 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 268' ' ' THR . 1.1 mt -49.95 111.58 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.207 -1.172 . . . . 0.0 109.305 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.466 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -96.42 -19.59 19.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -0.837 . . . . 0.0 109.927 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 78.18 -11.26 23.85 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 42.7 p -55.96 125.78 22.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -1.133 . . . . 0.0 109.609 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.83 -14.37 6.36 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.651 -1.261 . . . . 0.0 109.982 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.54 ' CG1' ' NE2' ' A' ' 118' ' ' HIS . 11.5 t -102.46 157.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.972 -1.311 . . . . 0.0 109.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -124.96 113.95 18.5 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.51 -0.744 . . . . 0.0 109.092 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.557 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 4.2 t -101.71 147.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 120' ' ' ALA . . . -110.17 159.5 17.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -0.9 . . . . 0.0 108.944 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 35' ' ' ILE . 1.6 t -136.85 92.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 108.751 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 6.0 mp -79.97 88.9 5.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -136.98 -160.13 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -94.1 28.02 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.442 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 58' ' ' ASP . . . 121.46 123.48 2.97 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.662 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.506 HD13 ' CG2' ' A' ' 30' ' ' VAL . 3.9 mt -86.84 -17.09 9.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.726 0.774 . . . . 0.0 109.751 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.486 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 2.9 t 62.31 156.3 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.677 -0.639 . . . . 0.0 109.393 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.6 t -86.71 157.05 19.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.079 -1.013 . . . . 0.0 110.154 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -169.9 172.84 2.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.5 Cg_endo -81.05 -27.02 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.503 2.136 . . . . 0.0 109.875 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 14.4 p30 -115.19 25.34 10.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.387 -0.82 . . . . 0.0 109.292 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 43' ' ' ILE . 19.7 mt -128.9 21.23 5.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.759 . . . . 0.0 109.11 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 41' ' ' LEU . 7.8 p-10 -25.54 123.55 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -88.96 91.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.346 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 3.3 tpm_? -56.41 -21.25 23.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.876 -1.14 . . . . 0.0 108.073 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 171.17 138.26 2.49 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.65 169.81 34.02 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.317 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HB1' ' CZ ' ' A' ' 49' ' ' PHE . . . -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.624 -0.927 . . . . 0.0 108.692 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 92' ' ' LYS . 3.1 p -123.94 120.18 31.76 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CZ ' ' HB1' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -122.31 -39.24 2.59 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.12 -0.987 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.545 ' HB ' ' CE ' ' A' ' 92' ' ' LYS . 4.2 t -67.66 131.59 92.82 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.162 1.908 . . . . 0.0 108.762 178.55 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 1.6 t -64.45 -2.52 2.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 55' ' ' SER . 7.4 mt-30 -88.27 155.77 19.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.031 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD2' ' CA ' ' A' ' 61' ' ' GLY . 8.3 t0 -73.07 145.98 46.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 110.08 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.34 -17.73 6.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.43 -64.7 1.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -1.083 . . . . 0.0 109.518 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' CA ' ' OD2' ' A' ' 58' ' ' ASP . . . 156.74 -16.97 0.4 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' A' ' 62' ' ' HIS . 2.9 t-160 -52.1 -61.47 2.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.274 . . . . 0.0 109.706 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -55.16 -77.02 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.014 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.522 ' CG2' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -33.05 -67.02 0.13 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.731 -0.864 . . . . 0.0 110.73 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.569 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 12.6 t-80 -42.66 -48.91 5.59 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 70' ' ' ILE . 27.7 t -58.39 -41.03 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.086 -1.009 . . . . 0.0 109.623 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -55.79 -49.5 73.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.294 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.76 -33.56 84.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.46 HG21 ' CE1' ' A' ' 220' ' ' HIS . 6.3 m -67.64 -20.73 65.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.176 -1.19 . . . . 0.0 109.07 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 66' ' ' VAL . 79.8 mt -88.16 -28.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.376 -0.827 . . . . 0.0 109.844 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.513 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -153.26 -37.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 111.484 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' CB ' ' CG1' ' A' ' 79' ' ' VAL . . . 32.81 72.51 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.522 -0.736 . . . . 0.0 109.92 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -38.32 150.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.515 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 6.3 t-20 -138.19 92.25 2.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.012 -1.055 . . . . 0.0 110.962 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 76' ' ' SER . 0.6 OUTLIER -97.66 -17.1 19.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.3 m 157.66 28.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.826 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' A' ' 40' ' ' ASP . 5.8 pt -125.84 52.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.794 -1.191 . . . . 0.0 109.998 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.516 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 42.99 -172.9 0.01 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.817 0.676 . . . . 0.0 111.515 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.591 ' CG1' ' CB ' ' A' ' 72' ' ' ALA . 38.5 t 78.93 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 122.175 -0.603 . . . . 0.0 110.645 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 74' ' ' ASN . 1.4 tp 56.64 92.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 109.87 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.65 -155.19 2.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -84.12 -51.29 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -1.221 . . . . 0.0 109.346 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.55 125.87 49.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.017 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.69 -60.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.701 2.267 . . . . 0.0 110.715 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 10.0 m120 -93.37 35.03 1.11 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.71 129.69 34.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 109.744 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 27' ' ' LYS . 1.8 mp0 -67.27 114.73 6.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.27 -0.893 . . . . 0.0 108.746 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.489 HD13 ' HB1' ' A' ' 71' ' ' ALA . 5.7 mt -97.93 115.55 28.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 110.616 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.579 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 28.1 m-85 -102.98 162.24 13.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.36 106.2 8.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.178 . . . . 0.0 110.37 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -107.13 67.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.545 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -42.6 104.38 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.9 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 50' ' ' VAL . 4.0 t -123.74 -25.67 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.549 -0.719 . . . . 0.0 109.085 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -91.42 176.14 6.67 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 110.085 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -116.87 173.88 14.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.159 -1.201 . . . . 0.0 109.766 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.471 ' O ' ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -77.5 157.36 30.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.8 -0.823 . . . . 0.0 110.009 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG23 ' CB ' ' A' ' 130' ' ' SER . 2.3 t -67.82 -23.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -20.18 60.77 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.48 ' HB2' HG21 ' A' ' 50' ' ' VAL . 56.9 p -80.89 -52.36 7.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.584 0.707 . . . . 0.0 109.386 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.471 ' HA ' HG13 ' A' ' 93' ' ' VAL . 1.2 mt -65.95 -32.88 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.689 . . . . 0.0 109.584 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.83 -36.49 70.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -71.39 -41.47 69.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.71 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.51 -14.92 81.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.21 -29.39 28.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.308 -1.113 . . . . 0.0 109.015 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.5 -28.81 18.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.585 ' CE3' ' O ' ' A' ' 111' ' ' TRP . 46.6 t90 -71.07 -15.32 62.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.634 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.13 -1.19 57.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.36 -0.838 . . . . 0.0 109.688 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.56 -33.71 2.62 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.703 -1.236 . . . . 0.0 111.136 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.68 -85.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.779 -1.424 . . . . 0.0 109.275 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -94.16 23.63 4.91 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -99.16 -146.0 19.48 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.991 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.57 ' HE2' ' CE2' ' A' ' 89' ' ' TYR . 4.6 mmt -133.15 179.43 6.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.434 -1.039 . . . . 0.0 110.33 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.54 ' NE2' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -88.42 -29.98 19.81 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.095 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 1.4 t -99.85 149.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 119.668 -1.895 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.49 ' O ' HG11 ' A' ' 147' ' ' VAL . . . -164.94 115.09 1.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.553 ' ND2' HG11 ' A' ' 148' ' ' VAL . 10.2 t-20 -89.22 160.28 17.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.978 . . . . 0.0 109.767 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.535 ' CD1' HG11 ' A' ' 147' ' ' VAL . 5.4 mp -147.76 109.47 4.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.999 -1.063 . . . . 0.0 109.877 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 67.86 3.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.966 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -132.66 172.88 11.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.918 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.79 104.28 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.83 162.48 43.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.102 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.547 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.4 Cg_endo -81.21 9.12 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.12 2.547 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.9 102.25 19.03 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.262 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.3 Cg_endo -78.76 178.19 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.688 2.259 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.538 ' CB ' HG23 ' A' ' 102' ' ' VAL . 5.0 m -175.92 119.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 109.487 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -19.96 65.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 23.6 m -69.05 -27.36 65.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.461 HD21 ' OH ' ' A' ' 161' ' ' TYR . 2.3 tp -81.57 -37.98 26.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.574 ' CG ' ' CE2' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -76.68 -21.43 55.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.53 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.95 -25.6 53.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 -32.04 30.48 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.53 ' CG1' ' ND2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -71.42 -36.1 59.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.13 -34.97 78.77 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.1 t -80.3 -19.1 47.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -90.68 -10.28 43.72 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.985 -1.072 . . . . 0.0 109.91 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 89.9 m -89.26 -40.15 13.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 109.133 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.21 -27.29 68.32 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.28 31.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.93 66.97 1.65 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 118' ' ' HIS . 14.5 t -117.05 109.75 28.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.401 -1.058 . . . . 0.0 109.597 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.9 104.89 3.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.168 -0.957 . . . . 0.0 109.337 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.535 HG11 ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.52 135.66 35.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.031 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.553 HG11 ' ND2' ' A' ' 121' ' ' ASN . 3.0 t -112.86 156.82 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 170' ' ' ALA . . . -138.42 137.07 36.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 109.804 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.13 171.54 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -89.28 -79.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.601 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.622 ' O ' ' CB ' ' A' ' 153' ' ' ASN . . . -152.76 -116.98 0.68 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 152' ' ' GLY . 22.7 t-20 135.6 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 123.395 0.678 . . . . 0.0 109.744 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.1 m -121.65 -98.02 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 109.6 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.43 ' HA2' ' CD ' ' A' ' 185' ' ' GLN . . . 179.06 47.38 0.08 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.27 172.56 6.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.16 . . . . 0.0 109.213 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.9 56.32 0.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.426 ' HA ' ' HA3' ' A' ' 187' ' ' GLY . 0.2 OUTLIER 175.27 156.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -1.135 . . . . 0.0 109.26 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 pt -100.12 -177.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.466 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -109.48 166.86 10.56 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.943 0.877 . . . . 0.0 112.518 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.461 ' OH ' HD21 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -85.03 149.41 53.02 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 164' ' ' ARG . 42.2 Cg_endo -71.68 -32.22 4.49 Favored 'Cis proline' 0 C--N 1.295 -2.254 0 O-C-N 122.408 0.688 . . . . 0.0 110.734 3.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . -25.4 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.721 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -65.42 -55.81 15.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.938 -1.101 . . . . 0.0 109.714 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.574 ' CE2' ' CG ' ' A' ' 134' ' ' GLU . 1.4 m-85 -42.58 -177.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.542 1.163 . . . . 0.0 111.6 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -115.56 2.44 13.8 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.53 ' ND2' ' CG1' ' A' ' 137' ' ' VAL . 9.3 m-20 -89.33 21.66 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 108.899 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.43 171.76 10.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.512 ' SD ' ' CG2' ' A' ' 148' ' ' VAL . 48.4 mtp -99.46 -177.82 3.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -151.5 115.39 4.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 23.7 t -107.46 165.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.057 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.86 -173.31 13.3 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.48 ' O ' ' HB1' ' A' ' 181' ' ' ALA . . . -118.88 164.13 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.134 . . . . 0.0 109.655 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.512 ' HA ' ' N ' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -138.15 175.6 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 0.0 109.69 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.481 ' N ' ' HA ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -89.91 -172.98 3.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.576 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -101.79 -21.49 14.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.78 -53.5 6.44 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.269 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -131.89 -94.09 0.37 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.472 -0.768 . . . . 0.0 109.751 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.528 ' OD1' ' CE1' ' A' ' 257' ' ' TYR . 0.7 OUTLIER -160.03 -154.47 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.197 -0.939 . . . . 0.0 109.59 -178.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER 58.11 4.3 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.512 ' N ' ' HA ' ' A' ' 174' ' ' THR . . . 36.24 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.582 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 182' ' ' SER . 4.9 t -145.92 21.84 1.42 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.175 -0.953 . . . . 0.0 108.996 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -168.66 26.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.833 . . . . 0.0 109.658 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -104.51 128.63 52.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 108.934 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.43 ' CD ' ' HA2' ' A' ' 155' ' ' GLY . 64.8 mm-40 -90.06 147.36 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 110.021 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.517 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.58 169.22 12.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . -170.93 152.25 17.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -44.06 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 138.64 -0.78 2.51 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.263 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.51 HD22 ' CA ' ' A' ' 258' ' ' GLY . 65.0 tp -50.33 145.81 5.86 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.829 -1.395 . . . . 0.0 108.745 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.6 OUTLIER -104.56 -63.75 1.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 111.103 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 248' ' ' ALA . 1.2 tt -151.47 163.87 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.375 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.604 ' CG2' ' CZ ' ' A' ' 257' ' ' TYR . 22.1 m -118.0 160.33 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.676 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.455 ' C ' ' OG1' ' A' ' 174' ' ' THR . . . -150.66 161.07 31.38 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.466 ' HA ' ' OG1' ' A' ' 174' ' ' THR . 32.7 Cg_endo -75.21 126.08 9.6 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.14 1.893 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.429 ' C ' ' OD1' ' A' ' 212' ' ' ASN . . . -152.21 62.13 0.39 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.632 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.612 ' O ' ' CE2' ' A' ' 6' ' ' TRP . 74.5 t -135.76 89.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 11.6 t-20 94.14 107.42 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 19.7 m -161.91 111.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.19 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 201' ' ' SER . 2.9 tt0 -85.97 147.37 26.26 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.569 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 7.4 t -146.76 -146.67 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' THR . . . . . 0.452 HG23 ' OD1' ' A' ' 40' ' ' ASP . 66.0 p -88.02 172.38 9.59 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.65 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -157.87 161.05 29.64 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.65 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.7 Cg_endo -70.42 165.29 32.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.136 1.891 . . . . 0.0 110.685 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 79.92 3.87 89.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.2 OUTLIER 77.69 32.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -1.088 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -129.79 158.03 40.56 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -91.51 -174.67 3.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.592 ' HB1' ' CG ' ' A' ' 203' ' ' TYR . . . -164.25 157.19 17.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.872 -1.142 . . . . 0.0 110.219 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 3.5 m -113.21 120.31 40.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 199' ' ' VAL . 0.3 OUTLIER -166.88 161.8 15.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 198' ' ' ASN . 0.2 OUTLIER -148.19 -160.48 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.973 -1.079 . . . . 0.0 111.153 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 130.49 157.95 9.15 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.452 ' HB ' ' HB1' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -60.94 -19.13 60.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.859 -1.377 . . . . 0.0 108.644 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.1 m -71.86 -32.71 67.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.47 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -82.27 -19.8 38.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.445 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -87.45 -26.5 23.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.611 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 26.2 m -57.2 -42.8 97.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.725 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 218' ' ' THR . 29.9 Cg_endo -71.93 -26.55 18.55 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.715 1.61 . . . . 0.0 111.132 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 69' ' ' THR . 0.4 OUTLIER -58.66 -40.37 83.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 222' ' ' ALA . 60.4 t -70.33 -47.66 65.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.455 ' O ' ' HB1' ' A' ' 226' ' ' ALA . . . -45.8 -31.89 2.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -73.78 -48.08 18.1 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -57.39 -65.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -1.232 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -45.64 -36.58 4.93 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 222' ' ' ALA . . . -58.84 -49.5 77.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.02 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.6 mt -49.96 -39.42 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 96.2 t -61.41 -52.47 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 108.902 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.527 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 19.1 mttm -44.33 -40.98 5.71 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.459 -0.776 . . . . 0.0 109.172 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.54 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 13.1 tp60 -62.93 -45.42 92.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 108.882 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -60.86 -14.21 20.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.472 -0.768 . . . . 0.0 109.045 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.88 80.93 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.356 -0.84 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.5 Cg_endo -78.89 8.24 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.711 2.274 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.44 -12.8 28.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.986 -1.071 . . . . 0.0 109.778 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -69.84 -179.69 1.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.99 170.81 7.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.595 -0.691 . . . . 0.0 109.359 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -62.22 -22.68 66.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -79.26 -63.63 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.112 -0.993 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.0 OUTLIER -42.96 -48.66 5.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 -178.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.418 HD12 ' HG2' ' A' ' 229' ' ' LYS . 71.9 mt -61.66 -49.15 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 0.0 109.546 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 243' ' ' HIS . 6.6 ttp180 -51.37 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ARG . 43.7 t30 -34.27 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.869 -0.519 . . . . 0.0 111.346 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 241' ' ' ARG . 1.6 t60 -72.52 -50.4 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.408 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.1 OUTLIER -67.68 -23.29 65.29 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.61 47.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.571 -0.706 . . . . 0.0 110.181 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.69 -9.31 57.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 110.376 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 1.3 p -94.11 -29.84 14.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.973 -1.079 . . . . 0.0 109.663 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 261' ' ' LEU . . . -40.25 129.27 2.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.555 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.469 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 6.0 m -75.98 89.57 2.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.546 ' HA ' ' CA ' ' A' ' 260' ' ' GLY . 3.3 t -81.9 140.13 34.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 111.82 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.978 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' A' ' 257' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.587 0.708 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -87.94 -4.72 58.8 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.532 -0.73 . . . . 0.0 111.776 -176.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 129.74 2.5 5.25 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.629 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 0.7 OUTLIER 79.2 -10.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -1.072 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 250' ' ' SER . . . 134.36 -165.82 24.31 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.069 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 58.3 tp -107.13 164.4 12.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.546 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -98.95 158.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.42 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.469 ' ND2' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -167.36 119.92 0.93 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -71.36 -5.31 31.6 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.358 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -83.23 -42.55 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 109.911 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.96 1.74 26.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -115.03 -26.57 7.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.671 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 264' ' ' ALA . 4.7 p -82.91 -38.8 22.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.597 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.529 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.41 76.72 15.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' TRP . 33.0 Cg_endo -77.8 164.56 27.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.409 2.073 . . . . 0.0 110.33 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.518 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -45.49 -26.86 0.63 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.519 ' HA3' ' CG1' ' A' ' 199' ' ' VAL . . . -72.26 -101.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -43.09 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -1.105 . . . . 0.0 109.142 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER 165.19 -43.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -1.6 58.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -0.832 . . . . 0.0 109.501 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 12' ' ' GLN . 20.1 m -101.3 14.94 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.125 -0.984 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.593 ' NE2' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 68.97 24.68 6.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.647 -0.658 . . . . 0.0 110.845 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.63 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -68.26 -39.87 18.39 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.906 -1.121 . . . . 0.0 110.895 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 32.2 Cg_endo -75.18 -60.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.205 -1.498 . . . . 0.0 108.205 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.518 ' HB2' ' NE2' ' A' ' 12' ' ' GLN . . . -45.99 -24.21 0.39 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.593 ' N ' ' NE2' ' A' ' 12' ' ' GLN . . . -81.19 -41.64 22.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.874 -1.141 . . . . 0.0 109.244 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.528 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 16.3 m170 -69.45 -19.68 63.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 109.626 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -87.15 -39.1 15.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' HB3' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.54 -17.58 62.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.45 8.7 26.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -74.03 132.04 41.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.481 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -115.43 -22.57 9.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 53.6 11.03 1.69 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 22' ' ' THR . 5.2 t -76.19 1.64 15.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -1.217 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.6 17.91 35.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' LYS . 60.7 t -123.18 167.02 17.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 120.935 -1.333 . . . . 0.0 109.995 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.575 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 1.7 mptt -134.74 137.06 43.13 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.466 HG11 HG13 ' A' ' 119' ' ' VAL . 39.1 t -135.01 129.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.024 -1.048 . . . . 0.0 110.296 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -84.83 155.66 21.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.532 ' CG1' ' OD2' ' A' ' 32' ' ' ASP . 6.5 t -134.22 87.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 108.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.513 ' N ' HD11 ' A' ' 31' ' ' LEU . 8.2 mp -74.27 99.91 3.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.532 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 1.1 m-20 -134.82 -161.61 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 96' ' ' ALA . 2.9 t -105.2 3.95 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.775 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 59' ' ' GLY . . . 144.97 121.83 1.49 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 58' ' ' ASP . 11.3 mt -90.08 -110.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.487 ' OG ' ' HA ' ' A' ' 204' ' ' PRO . 48.2 t 176.46 146.94 0.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.213 -0.93 . . . . 0.0 110.071 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -86.04 93.38 8.97 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.412 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -114.9 169.38 6.74 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.469 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 35.6 Cg_endo -77.38 -45.4 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.619 2.212 . . . . 0.0 110.04 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 73' ' ' LEU . 3.9 m-20 -74.27 -34.27 63.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.822 . . . . 0.0 109.261 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.3 135.11 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -109.71 94.7 5.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.7 mm -85.63 99.91 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.468 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 9.3 tpt180 -86.53 -18.74 30.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.684 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.521 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 162.32 176.37 34.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.57 47.55 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.142 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -146.03 160.25 42.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.978 . . . . 0.0 109.446 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.434 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 64.3 p -134.03 115.6 14.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 47' ' ' ALA . 45.3 m-85 -116.92 -54.98 2.39 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.499 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 22.9 t -39.81 128.45 1.53 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.585 -0.697 . . . . 0.0 109.91 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 122.345 2.03 . . . . 0.0 110.595 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.435 ' C ' ' HG3' ' A' ' 57' ' ' GLN . 1.4 m -63.36 -13.16 36.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.043 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HG3' ' C ' ' A' ' 56' ' ' THR . 13.1 mt-30 -143.95 150.8 38.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 t0 62.08 92.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.805 . . . . 0.0 109.704 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -112.85 -25.63 4.45 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.82 -38.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -1.176 . . . . 0.0 109.75 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.07 -10.67 3.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -75.85 -70.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.155 -1.203 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' A' ' 32' ' ' ASP . . . -48.17 -29.09 6.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 35' ' ' ILE . 9.2 m -68.14 -53.15 27.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -1.073 . . . . 0.0 109.445 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.9 t-80 -55.89 -43.64 77.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.737 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.533 ' HA ' ' CG2' ' A' ' 69' ' ' THR . 17.4 t -61.95 -34.2 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.36 -44.14 97.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.21 -42.02 58.63 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 66' ' ' VAL . 7.5 t -64.41 -15.3 60.32 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 120.366 -1.667 . . . . 0.0 107.851 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.437 HD13 ' CG1' ' A' ' 66' ' ' VAL . 31.7 mt -87.51 -38.84 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.321 -0.862 . . . . 0.0 109.93 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . . . -178.64 36.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.769 -1.207 . . . . 0.0 111.853 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -45.06 125.47 5.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.67 -1.269 . . . . 0.0 108.928 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 85.5 mt -54.33 161.26 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 75' ' ' ASN . 10.4 t-20 -106.92 134.26 50.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 74' ' ' ASN . 74.2 m-20 -162.14 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.817 0.817 . . . . 0.0 109.081 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -155.12 -39.96 0.09 Allowed 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -103.38 67.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.456 -0.777 . . . . 0.0 109.595 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.94 158.62 13.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.39 -159.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.35 -1.088 . . . . 0.0 109.354 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.4 tp -141.53 116.52 9.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.968 -1.082 . . . . 0.0 109.771 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' HA3' ' CA ' ' A' ' 71' ' ' ALA . . . -80.67 175.83 54.78 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.528 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 2.9 t -60.64 -42.53 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -1.185 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 71' ' ' ALA . . . -93.17 141.96 24.71 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.736 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.6 Cg_endo -84.25 -61.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.847 2.365 . . . . 0.0 110.692 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -120.48 49.87 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.436 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.17 159.59 27.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 108.979 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' OE1' ' CG ' ' A' ' 27' ' ' LYS . 25.9 mt-10 -89.37 89.16 7.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.979 -1.076 . . . . 0.0 108.972 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.6 142.89 42.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 110.236 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.559 ' CE1' ' SD ' ' A' ' 117' ' ' MET . 4.1 m-85 -126.4 152.97 45.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.37 94.47 4.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.017 -1.052 . . . . 0.0 109.456 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -98.57 63.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.284 -0.885 . . . . 0.0 108.917 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -31.67 109.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.197 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.427 HG23 HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -129.09 -10.37 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.374 -0.829 . . . . 0.0 109.433 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 124' ' ' LEU . 10.2 mt -103.81 -178.0 3.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 0.0 109.895 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.31 146.65 18.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.513 ' N ' ' OG1' ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.186 -1.185 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.04 155.59 32.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.879 -0.777 . . . . 0.0 109.8 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.56 -19.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -17.7 58.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -88.33 -35.42 17.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mt -77.11 -37.98 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 108.729 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.23 67.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -63.19 -45.55 91.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.507 -0.746 . . . . 0.0 108.992 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.22 -21.52 77.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.5 mt -82.57 -19.93 37.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -94.38 -30.23 14.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.376 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -69.24 -17.01 63.72 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.717 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.679 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -91.37 -11.54 37.53 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -80.86 -15.71 76.89 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -117.13 1.19 12.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.076 -1.249 . . . . 0.0 109.946 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 7.2 t30 172.46 29.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.999 -1.063 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -110.71 48.08 0.98 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.312 -1.423 . . . . 0.0 110.763 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.575 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 15.8 mmt 60.91 -173.79 0.13 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 111.452 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.656 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -95.74 -32.69 12.6 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.716 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.656 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 55.7 t -104.8 166.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.717 -1.239 . . . . 0.0 109.833 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.551 ' O ' ' CG1' ' A' ' 147' ' ' VAL . . . -169.35 117.04 0.62 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' HD13 ' A' ' 122' ' ' LEU . 16.5 t-20 -96.31 152.96 18.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 121' ' ' ASN . 6.4 mp -133.88 102.79 5.57 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.444 ' OG ' ' OG ' ' A' ' 215' ' ' SER . 0.1 OUTLIER -84.92 66.3 9.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 109.097 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.441 ' HB3' HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -152.86 172.22 17.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.333 -0.854 . . . . 0.0 109.617 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.58 104.42 0.18 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 160' ' ' SER . 0.3 OUTLIER -107.32 147.64 35.62 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.197 -1.178 . . . . 0.0 109.559 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.486 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 32.1 Cg_endo -74.0 -6.0 17.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.21 1.94 . . . . 0.0 108.934 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -103.95 100.32 20.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 32.7 Cg_endo -74.19 164.59 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.425 2.083 . . . . 0.0 110.944 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.05 135.92 17.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.91 63.59 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -77.88 -23.71 48.71 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.26 -40.57 30.21 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' OE2' ' CD1' ' A' ' 165' ' ' TYR . 1.9 mt-10 -76.85 -31.96 57.19 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.336 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -62.66 -26.82 68.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.48 60.83 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.917 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.495 ' CG1' ' CG ' ' A' ' 167' ' ' ASN . 1.3 t -63.26 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.54 -38.48 81.16 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.6 -23.75 53.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.91 -18.83 55.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.081 -1.012 . . . . 0.0 110.129 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -27.75 58.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.261 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -58.14 -30.81 66.63 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.162 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER -104.64 -12.0 16.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.476 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.85 62.16 4.98 Favored Glycine 0 N--CA 1.477 1.429 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 39.9 t -96.12 110.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.583 -0.951 . . . . 0.0 109.854 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.52 107.63 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' A' ' 120' ' ' ALA . 2.5 t -104.43 154.32 6.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.044 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 148' ' ' VAL . 12.0 p -141.13 112.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.515 ' CB ' ' HG2' ' A' ' 162' ' ' PRO . . . -100.9 149.82 23.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.124 -0.985 . . . . 0.0 110.384 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.496 ' CB ' ' OG1' ' A' ' 218' ' ' THR . . . -78.6 151.71 32.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.727 . . . . 0.0 109.472 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -55.98 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 155.19 115.02 0.52 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 185' ' ' GLN . 1.7 t-20 -99.96 53.16 0.91 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.951 -0.735 . . . . 0.0 109.178 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.45 ' N ' ' OE1' ' A' ' 185' ' ' GLN . 2.4 p -94.6 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.456 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 150.55 39.2 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.49 172.97 7.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 109.365 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.4 ' C ' ' HB2' ' A' ' 186' ' ' TYR . . . -103.71 56.71 0.57 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 p 172.36 124.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.042 -1.27 . . . . 0.0 109.862 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.503 HG22 ' HA2' ' A' ' 187' ' ' GLY . 1.0 OUTLIER -59.23 -171.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.234 -0.917 . . . . 0.0 110.166 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.549 ' HB2' ' CA ' ' A' ' 125' ' ' GLY . 0.8 OUTLIER -132.81 171.2 14.21 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.073 0.939 . . . . 0.0 112.795 -177.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.438 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 4.4 m-85 -82.61 146.41 53.22 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.602 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.4 Cg_endo -71.39 -30.29 5.63 Favored 'Cis proline' 0 C--N 1.293 -2.383 0 O-C-N 122.555 0.766 . . . . 0.0 110.436 3.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.625 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -70.5 -54.46 12.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 109.76 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -50.77 -170.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.177 0.989 . . . . 0.0 110.825 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.67 -16.73 8.19 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.495 ' CG ' ' CG1' ' A' ' 137' ' ' VAL . 4.4 m120 -57.08 -18.65 15.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 108.962 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -132.53 149.36 52.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.475 ' HA ' ' OD2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -89.87 130.1 36.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.907 -1.121 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 163' ' ' ALA . . . -92.55 117.97 30.51 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.7 t -92.33 164.58 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.268 1.032 . . . . 0.0 110.562 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -136.14 145.63 17.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.415 ' C ' HG21 ' A' ' 174' ' ' THR . . . -81.54 162.28 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.28 . . . . 0.0 110.14 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.498 ' CG2' ' HB ' ' A' ' 193' ' ' VAL . 73.1 p -144.58 170.83 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.528 -0.732 . . . . 0.0 109.46 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.433 ' OD1' ' CB ' ' A' ' 179' ' ' ASN . 0.7 OUTLIER -102.82 -166.59 1.29 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -67.67 -49.63 61.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.186 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' ASN . 8.3 m120 -59.59 -75.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.054 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' ASN . 1.5 m-20 162.77 41.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.0 109.642 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.433 ' CB ' ' OD1' ' A' ' 175' ' ' ASP . 0.9 OUTLIER -98.46 -149.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -107.82 18.99 20.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.468 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 180' ' ' ARG . . . 76.14 -162.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.0 109.905 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 t -100.53 -34.83 9.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.965 . . . . 0.0 110.204 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -108.12 -81.35 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 183' ' ' PHE . 3.3 t 32.05 100.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.128 0.49 . . . . 0.0 111.145 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' SER . 1.4 mp0 -45.49 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 0.0 109.815 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.524 ' CZ ' HD22 ' A' ' 256' ' ' LEU . 1.2 t80 -52.49 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 110.565 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 190' ' ' LEU . . . -145.26 20.97 1.91 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -35.76 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 79.2 50.51 5.76 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 187' ' ' GLY . 4.6 tp -75.62 144.8 41.56 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.568 -0.96 . . . . 0.0 109.465 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 169' ' ' MET . 1.2 m-20 -93.43 -46.01 7.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.208 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.543 ' CG2' HG23 ' A' ' 171' ' ' VAL . 1.5 tt -157.95 177.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.497 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.498 ' HB ' ' CG2' ' A' ' 174' ' ' THR . 31.6 m -138.79 172.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 109.663 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.518 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -173.55 174.44 1.1 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 33.6 Cg_endo -75.94 121.39 6.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.608 2.205 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -137.17 45.14 1.09 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.644 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 23.8 t -134.1 85.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.438 -1.036 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.644 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 19.5 t-20 103.33 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER 178.28 115.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.482 ' CB ' ' HA ' ' A' ' 210' ' ' SER . 1.7 pt20 -101.45 161.52 13.57 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.594 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -156.69 -158.67 0.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.546 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.62 174.06 11.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.579 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.9 OUTLIER -150.05 147.15 21.5 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 108.529 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 31.6 Cg_endo -69.91 129.96 18.33 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.721 1.614 . . . . 0.0 110.336 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 40.82 43.55 3.17 Favored Glycine 0 C--N 1.286 -2.243 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.598 ' O ' ' CG2' ' A' ' 207' ' ' THR . 0.9 OUTLIER -167.56 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.998 -1.295 . . . . 0.0 111.35 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.598 ' CG2' ' O ' ' A' ' 206' ' ' SER . 7.0 t 52.01 -143.24 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 111.032 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.58 ' N ' HG21 ' A' ' 207' ' ' THR . 0.1 OUTLIER -95.62 165.78 12.16 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.026 0.917 . . . . 0.0 111.639 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -158.03 162.2 38.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' A' ' 200' ' ' GLN . 0.6 OUTLIER -109.03 133.91 52.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.865 -1.147 . . . . 0.0 110.131 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.581 HD23 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -154.65 157.53 38.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -121.36 160.8 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 167.5 161.78 17.77 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.8 m -81.12 -28.9 34.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -1.181 . . . . 0.0 109.257 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.444 ' OG ' ' OG ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -68.08 -14.06 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.451 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 1.7 mpp? -87.95 -15.03 37.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -89.69 -8.87 51.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.657 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 86.5 m -77.35 -36.05 1.43 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 112.232 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 218' ' ' THR . 32.2 Cg_endo -73.66 -24.62 15.68 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.141 1.228 . . . . 0.0 110.264 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -62.38 -40.4 96.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.17 -40.41 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -51.5 -41.26 60.85 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -65.99 -59.64 7.28 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -42.1 -37.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.107 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.46 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.158 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.38 71.56 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.013 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.456 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 48.3 mt -55.62 -45.68 77.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 244' ' ' LEU . 31.5 t -56.0 -59.02 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 0.0 109.495 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.589 ' HD2' ' CE1' ' A' ' 118' ' ' HIS . 3.3 ttmm -44.68 -39.07 4.8 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.304 -0.872 . . . . 0.0 109.521 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.457 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -59.2 -54.95 41.12 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -56.63 -15.75 4.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 108.907 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.601 ' ND2' ' CZ3' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -166.83 84.16 0.89 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.485 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 37.4 Cg_endo -80.77 15.25 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.754 2.303 . . . . 0.0 111.17 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.87 -24.24 12.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.601 ' CZ3' ' ND2' ' A' ' 232' ' ' ASN . 32.3 m0 -62.71 175.14 0.86 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.9 m -99.71 176.37 5.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.649 -0.657 . . . . 0.0 109.758 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 238' ' ' VAL . 36.0 p30 -60.59 -22.18 63.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.431 -0.793 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -76.61 -64.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.177 -0.952 . . . . 0.0 109.277 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 238' ' ' VAL . 5.6 mm-40 -43.36 -35.58 1.59 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.547 0.689 . . . . 0.0 109.274 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.35 -46.28 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 110.187 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.487 ' CZ ' ' CB ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -63.53 -53.16 56.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.1 -28.36 66.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.421 ' CD2' HG22 ' A' ' 247' ' ' THR . 17.6 t60 -71.21 -62.93 1.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 109.31 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.485 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -59.72 -21.17 60.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.516 -0.74 . . . . 0.0 109.302 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.4 tptt -74.63 -52.85 10.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.597 -0.689 . . . . 0.0 110.281 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -11.83 59.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 3.0 p -88.43 -32.75 18.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.769 -1.207 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.6 150.3 9.53 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -63.54 167.07 5.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.7 t -131.22 97.57 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.305 -1.358 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 179.689 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 186' ' ' TYR . 1.1 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -61.04 -36.25 79.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -0.849 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 77.11 -120.42 5.61 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 191' ' ' ASP . 44.1 t -61.46 -78.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 193' ' ' VAL . . . 153.34 -153.08 24.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.494 ' HB3' ' OG1' ' A' ' 249' ' ' THR . 15.1 tp -69.53 164.47 23.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -1.19 . . . . 0.0 108.862 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.457 ' O ' ' OD1' ' A' ' 263' ' ' ASN . 0.1 OUTLIER -126.2 147.48 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -172.07 121.69 0.46 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 267' ' ' ALA . . . -70.01 -0.97 8.47 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.556 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 12' ' ' GLN . 39.8 tt0 -62.47 -57.92 9.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.853 -1.155 . . . . 0.0 108.981 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -71.65 -7.1 45.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 264' ' ' ALA . . . -95.11 -19.39 20.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.923 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 11.0 p -103.05 -52.15 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.0 -1.063 . . . . 0.0 109.318 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.526 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 13.3 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.826 0.822 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.598 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 10.6 m -158.69 51.53 0.45 Allowed Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.488 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 35.6 Cg_endo -77.32 156.18 32.89 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.703 1.602 . . . . 0.0 109.892 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -62.36 -15.28 47.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 110.005 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 220' ' ' HIS . . . -94.26 21.07 44.44 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -144.84 10.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -1.234 . . . . 0.0 109.639 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 t -101.13 -18.92 15.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -99.99 6.79 45.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.94 16.18 8.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 120.872 -1.142 . . . . 0.0 110.067 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 2.8 mp0 46.15 55.99 6.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.605 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.666 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -85.35 -34.34 0.51 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.549 -0.719 . . . . 0.0 111.972 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.0 Cg_endo -72.49 -57.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.0 -29.76 0.36 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 -45.35 38.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.069 . . . . 0.0 109.629 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.68 -17.77 64.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.363 -0.835 . . . . 0.0 110.433 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -39.67 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.882 -1.137 . . . . 0.0 109.829 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -52.38 -35.57 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.702 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.94 8.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.2 135.22 33.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -1.142 . . . . 0.0 109.219 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -130.34 10.13 5.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.798 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.529 ' CA ' ' HG3' ' A' ' 230' ' ' GLN . . . 66.71 -1.36 5.76 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.2 m -47.33 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 124.84 15.59 3.17 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.598 HG11 ' CE1' ' A' ' 118' ' ' HIS . 6.0 t -107.57 148.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.993 -1.298 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.772 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -115.84 115.51 26.38 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.447 0.641 . . . . 0.0 110.56 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.472 ' HB ' HD22 ' A' ' 88' ' ' LEU . 1.6 t -125.45 127.65 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.527 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 120' ' ' ALA . . . -95.23 156.38 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.112 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 35' ' ' ILE . 74.4 t -129.14 86.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.146 -0.971 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD11 HG22 ' A' ' 91' ' ' VAL . 5.0 mp -71.07 100.6 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.528 ' OD2' ' CA ' ' A' ' 63' ' ' GLY . 43.3 p-10 -160.13 -160.49 0.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.875 -1.141 . . . . 0.0 109.673 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.554 ' CG2' ' O ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -64.75 -51.27 63.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.657 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . -162.97 -112.88 0.28 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.808 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.559 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 153.81 -15.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 121.613 0.72 . . . . 0.0 109.152 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 51.37 168.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 110.6 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.495 ' HA ' HG13 ' A' ' 43' ' ' ILE . 11.4 t -105.12 45.67 0.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.926 0.87 . . . . 0.0 109.195 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -52.5 160.62 1.29 Allowed Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.709 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.05 -4.55 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.692 2.261 . . . . 0.0 110.451 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 73' ' ' LEU . 24.7 t0 -91.84 -60.89 1.75 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 67' ' ' ALA . 5.0 mt -70.34 151.51 45.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.215 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -105.32 73.95 1.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.295 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.495 HG13 ' HA ' ' A' ' 37' ' ' THR . 12.1 mm -42.5 114.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.553 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -108.63 -18.8 13.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.677 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.509 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -175.19 -175.81 42.95 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.22 147.01 4.77 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.311 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.53 144.2 46.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.424 -1.045 . . . . 0.0 109.139 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -120.76 121.02 37.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.146 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.593 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 3.1 m-85 -110.73 -38.51 5.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.192 -0.943 . . . . 0.0 109.868 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -42.93 -52.58 11.29 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.195 -0.941 . . . . 0.0 109.061 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 38.9 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 123.07 2.513 . . . . 0.0 110.717 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.561 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 46.72 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 109.916 -177.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' SER . 7.3 mm100 -95.9 155.69 16.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.876 -1.14 . . . . 0.0 108.45 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLN . 5.0 m-20 52.17 172.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.003 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.554 ' O ' ' CG2' ' A' ' 33' ' ' THR . . . 164.44 46.62 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 1.1 t30 80.47 -27.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -1.038 . . . . 0.0 110.452 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' O ' ' C ' ' A' ' 62' ' ' HIS . . . 128.11 -72.82 0.46 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.589 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.563 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.9 t-80 -11.44 -59.95 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.445 0.641 . . . . 0.0 111.917 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.528 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.88 -69.47 1.28 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.7 m -38.39 -41.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.563 -0.963 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 2.0 t-80 -56.61 -63.22 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 70' ' ' ILE . 16.5 t -49.09 -32.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 108.782 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 41' ' ' LEU . . . -55.39 -53.34 57.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.409 ' HA2' HD22 ' A' ' 41' ' ' LEU . . . -68.52 -22.11 74.85 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.547 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 6.6 m -73.94 -18.11 60.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.036 -1.273 . . . . 0.0 108.088 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 66' ' ' VAL . 56.8 mt -101.44 -25.84 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.492 -0.755 . . . . 0.0 111.309 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -162.02 25.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.316 -1.49 . . . . 0.0 112.647 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB2' ' N ' ' A' ' 80' ' ' LEU . . . -39.86 114.52 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 109.34 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.532 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 23.6 mt -73.54 167.48 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.68 125.99 53.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 3.1 p-10 -168.68 -109.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -0.969 . . . . 0.0 109.101 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -82.44 -73.52 0.39 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.472 HG13 ' OH ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -52.29 178.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.587 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -132.79 122.93 3.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.41 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.547 HG23 ' CE2' ' A' ' 208' ' ' TYR . 1.8 t -162.7 -64.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 3' ' ' SER . 1.1 tp 56.51 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.317 0.58 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -95.49 -143.44 14.54 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -106.57 -54.19 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.028 -1.278 . . . . 0.0 109.664 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -107.83 102.76 46.86 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 38.0 Cg_endo -85.57 -63.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.877 2.385 . . . . 0.0 110.919 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.413 ' OD1' ' OG ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -51.88 -17.39 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 143.33 56.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.253 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.772 ' OE1' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -79.56 126.16 30.53 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.978 -1.077 . . . . 0.0 109.082 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.472 HD22 ' HB ' ' A' ' 28' ' ' VAL . 15.0 mt -103.25 105.32 15.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.715 -1.241 . . . . 0.0 110.309 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.509 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 19.8 m-85 -85.72 142.35 29.07 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.27 -0.894 . . . . 0.0 108.775 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' CB ' HD11 ' A' ' 35' ' ' ILE . . . -105.23 104.68 14.46 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.615 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.475 ' O ' ' C ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -97.82 66.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.121 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 33' ' ' THR . 1.2 tttt -36.5 109.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.477 0.656 . . . . 0.0 110.018 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.476 HG11 HG12 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -125.06 -13.58 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -84.62 -170.96 3.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.986 0.898 . . . . 0.0 110.886 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.83 -99.54 2.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . . . . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.435 ' C ' ' OG ' ' A' ' 101' ' ' SER . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -177.94 142.72 0.3 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.731 -0.864 . . . . 0.0 108.703 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 129' ' ' PRO . 21.0 t -68.45 -21.05 25.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.543 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -74.85 -25.17 58.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.588 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -79.61 -67.11 0.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.553 HG23 ' CD1' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -50.52 -24.0 2.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -67.57 -56.42 9.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.68 -0.638 . . . . 0.0 110.051 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.593 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -65.69 -33.11 75.11 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.43 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.547 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -68.25 -30.83 73.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 mt -94.33 -4.67 48.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.116 -1.226 . . . . 0.0 109.465 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.96 -5.9 12.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 109.449 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -86.3 -17.73 33.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.617 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -83.49 -1.54 53.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -82.33 -46.35 6.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 -77.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -1.099 . . . . 0.0 108.588 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.82 63.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -106.82 -156.24 20.8 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.475 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.563 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 14.2 mmt -140.63 -179.92 6.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.854 -0.792 . . . . 0.0 109.734 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 27' ' ' LYS . 3.0 p80 -78.1 -31.04 49.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.444 -0.785 . . . . 0.0 110.088 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.557 HG22 ' CE1' ' A' ' 118' ' ' HIS . 94.7 t -130.67 165.05 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.73 -1.231 . . . . 0.0 110.956 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.518 ' N ' HG13 ' A' ' 119' ' ' VAL . . . -169.06 158.65 8.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.532 ' OD1' ' CB ' ' A' ' 222' ' ' ALA . 9.8 m120 -129.3 163.91 24.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.658 -1.276 . . . . 0.0 110.547 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.419 HD11 HG13 ' A' ' 147' ' ' VAL . 3.3 mp -139.49 99.55 3.76 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.471 -0.768 . . . . 0.0 108.945 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 67.73 10.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 108.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.85 -176.19 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.821 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 160' ' ' SER . . . 157.99 107.24 0.24 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.537 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -163.98 176.71 2.08 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.134 -1.215 . . . . 0.0 109.627 -179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 126' ' ' SER . 36.4 Cg_endo -81.34 -10.53 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.89 2.393 . . . . 0.0 109.766 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 1.1 t -50.03 -48.6 78.44 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.74 -0.6 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 128' ' ' SER . 31.1 Cg_endo -72.61 169.84 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.245 1.963 . . . . 0.0 110.955 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.25 179.58 5.2 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.701 1.239 . . . . 0.0 111.008 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 134' ' ' GLU . . . -63.52 -16.32 60.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -63.73 -36.01 82.46 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.553 ' CD1' HG23 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -66.71 -34.97 79.02 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.581 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 1.7 tt0 -60.25 -58.92 6.45 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.863 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 138' ' ' ASN . 96.5 mm-40 -45.51 -25.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 134' ' ' GLU . . . -67.79 -48.72 65.52 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.3 -26.14 38.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 11.9 t30 -62.33 -35.17 78.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 p -75.82 -25.38 56.26 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.1 -22.93 57.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.183 -0.948 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -30.5 67.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.966 . . . . 0.0 108.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.55 -34.19 49.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 108.969 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -98.71 -19.69 17.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 237' ' ' ASN . . . 82.98 14.13 75.86 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.3 t -48.4 102.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -1.095 . . . . 0.0 108.931 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.451 ' HB2' ' OD1' ' A' ' 237' ' ' ASN . 0.4 OUTLIER -69.1 103.55 1.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.285 -0.884 . . . . 0.0 109.426 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -102.51 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.522 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -122.9 113.92 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.4 32.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.922 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 214' ' ' THR . . . -64.08 172.53 2.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.809 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.479 ' CB ' HG22 ' A' ' 214' ' ' THR . 0.3 OUTLIER -69.0 -74.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 109.758 -179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 153.73 -13.01 0.56 Allowed Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.301 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 152' ' ' GLY . 4.4 m-20 22.9 48.62 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.3 OUTLIER 176.73 56.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.46 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . 161.79 51.84 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -54.51 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 110.252 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . 66.18 11.61 55.91 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 2.3 p 160.13 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.402 ' HA ' ' OE1' ' A' ' 185' ' ' GLN . 0.2 OUTLIER -112.29 -175.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.463 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -85.93 168.79 13.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.305 1.05 . . . . 0.0 111.801 -178.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.494 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -104.38 137.86 19.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 175.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.721 ' O ' ' N ' ' A' ' 164' ' ' ARG . 39.6 Cg_endo -73.24 -53.31 0.16 OUTLIER 'Cis proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.174 -1.178 . . . . 0.0 110.656 3.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 160' ' ' SER . . . 29.95 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.254 1.026 . . . . 0.0 110.116 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 162' ' ' PRO . 3.8 ttm180 -42.39 -46.86 4.82 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.329 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.581 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 14.7 m-85 -44.4 173.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.11 -0.994 . . . . 0.0 110.913 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 168' ' ' ALA . . . -98.8 -47.87 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.67 -0.644 . . . . 0.0 110.493 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.504 ' C ' ' ND2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -42.24 -27.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.882 0.848 . . . . 0.0 109.751 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -125.55 145.55 50.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.471 ' SD ' ' HG3' ' A' ' 241' ' ' ARG . 12.7 mtm -96.12 153.92 17.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -108.43 122.82 47.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.8 t -90.72 165.75 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 0.0 109.76 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.57 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.09 -176.62 14.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.82 162.44 27.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.992 -1.299 . . . . 0.0 109.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.1 p -133.45 172.27 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.789 . . . . 0.0 109.249 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 -156.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -90.05 -41.51 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -78.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.535 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.72 30.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 110.042 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.22 156.36 22.48 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.145 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.501 ' HD3' ' HB3' ' A' ' 256' ' ' LEU . 6.7 ttp85 -60.96 134.6 57.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 0.0 109.475 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' CE1' ' A' ' 183' ' ' PHE . . . -45.68 173.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.451 -0.78 . . . . 0.0 109.701 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.0 OUTLIER -108.27 11.17 27.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 109.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 2.3 p90 -134.73 -12.37 2.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.039 -1.038 . . . . 0.0 110.645 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 t -67.01 138.88 57.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.505 ' HG2' ' N ' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -93.83 143.02 26.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.115 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.47 -174.34 3.04 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.596 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.03 -171.85 44.09 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -85.67 64.39 8.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.127 . . . . 0.0 109.177 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.63 31.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -85.53 138.26 32.32 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.132 -1.216 . . . . 0.0 109.66 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -86.0 -72.68 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.629 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.529 ' CD1' HG23 ' A' ' 262' ' ' VAL . 0.3 OUTLIER -149.56 -162.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.245 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.531 HG21 ' CA ' ' A' ' 260' ' ' GLY . 27.2 m -143.28 175.97 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.53 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -167.61 177.16 1.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 108.946 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 33.2 Cg_endo -76.69 113.74 3.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 109.446 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.502 ' HA2' ' ND2' ' A' ' 212' ' ' ASN . . . -145.22 48.27 0.71 Allowed Glycine 0 N--CA 1.484 1.861 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.435 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 1.7 t -130.87 30.49 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.249 . . . . 0.0 109.068 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.561 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.1 OUTLIER 164.86 105.18 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.158 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.621 ' CG2' ' ND2' ' A' ' 212' ' ' ASN . 2.7 m -158.37 111.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -89.56 117.93 28.82 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.335 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.546 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -118.05 -151.45 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.929 . . . . 0.0 109.858 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' THR . . . . . 0.52 ' HA ' ' CD1' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -87.92 178.43 6.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.618 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -164.6 157.7 14.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.6 Cg_endo -70.07 166.0 29.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.233 1.956 . . . . 0.0 110.322 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 206' ' ' SER . . . 84.74 3.84 87.84 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 205' ' ' GLY . 6.9 t 74.84 43.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -1.078 . . . . 0.0 110.26 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -145.11 -179.91 6.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.547 ' CE2' HG23 ' A' ' 79' ' ' VAL . 2.9 m-30 -113.67 -174.13 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -165.31 164.77 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.828 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 50.5 m -124.8 114.56 19.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.504 -0.747 . . . . 0.0 109.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 211' ' ' LEU . 0.8 OUTLIER -173.96 138.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.407 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.621 ' ND2' ' CG2' ' A' ' 199' ' ' VAL . 2.9 t-20 -125.23 -157.43 0.78 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.165 0.983 . . . . 0.0 110.601 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 136.32 175.95 14.09 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.479 HG22 ' CB ' ' A' ' 151' ' ' SER . 0.2 OUTLIER -56.68 -41.52 77.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.984 -1.303 . . . . 0.0 109.346 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.5 m -57.69 -29.86 65.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 0.0 110.447 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.49 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 1.4 mpp? -90.95 -26.26 19.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.496 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.12 -6.2 59.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.977 -1.077 . . . . 0.0 109.441 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.608 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 1.2 m -73.05 -47.56 8.07 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -71.71 -8.39 23.03 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.098 1.865 . . . . 0.0 111.466 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.515 ' CE1' HG21 ' A' ' 69' ' ' THR . 5.7 m80 -77.19 -47.14 21.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.74 -41.39 85.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.532 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -57.65 -34.77 69.71 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.5 -54.83 26.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 264' ' ' ALA . . . -51.06 -38.3 50.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 108.867 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -59.08 -44.96 91.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 0.0 109.154 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.441 ' HA ' HG12 ' A' ' 26' ' ' VAL . . . -54.64 -53.61 52.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 108.985 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.464 HD13 HG13 ' A' ' 82' ' ' VAL . 69.9 mt -50.82 -31.53 17.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.025 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 58.3 t -68.3 -52.1 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.473 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.49 ' HD2' ' ND1' ' A' ' 118' ' ' HIS . 27.3 tttp -46.78 -42.06 16.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 108.822 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.529 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -62.22 -45.95 91.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.357 -0.839 . . . . 0.0 109.444 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 231' ' ' LYS . 11.6 tptm -56.4 -18.6 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 108.557 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.5 90.8 2.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 108.999 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.04 8.28 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.752 2.301 . . . . 0.0 110.876 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.14 8.33 10.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -82.33 -178.66 7.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.383 -0.823 . . . . 0.0 109.915 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -121.54 174.71 6.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.651 -0.655 . . . . 0.0 109.443 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -60.42 -27.05 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.06 -63.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.098 -1.001 . . . . 0.0 109.61 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -49.04 -39.79 28.72 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.546 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 236' ' ' SER . 84.0 mt -60.01 -58.12 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.486 -0.759 . . . . 0.0 109.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.471 ' HG3' ' SD ' ' A' ' 169' ' ' MET . 18.8 ttp180 -54.64 -72.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.9 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ARG . 4.8 t30 -35.03 -36.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.919 -0.488 . . . . 0.0 110.736 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.425 ' O ' ' OG1' ' A' ' 247' ' ' THR . 8.6 t60 -65.83 -51.56 57.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.996 -1.065 . . . . 0.0 110.107 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.479 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 3.6 mt -70.84 -23.84 62.42 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.295 -0.878 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -33.24 60.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 246' ' ' ASN . 2.8 t-20 -93.26 -14.97 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.2 p -87.32 -31.3 20.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.035 -1.041 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.496 ' HB2' ' CB ' ' A' ' 259' ' ' SER . . . -51.13 144.07 9.78 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 17.6 m -78.07 159.47 28.68 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.9 t -128.55 101.67 6.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.852 . . . . 0.0 109.945 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.666 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.576 ' CD1' ' CD2' ' A' ' 186' ' ' TYR . 2.0 mm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.615 0.722 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.47 ' O ' ' O ' ' A' ' 258' ' ' GLY . 72.3 m-85 -128.75 -83.74 0.57 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.73 -0.606 . . . . 0.0 109.601 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 50.39 99.39 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.496 ' CB ' ' HB2' ' A' ' 248' ' ' ALA . 0.9 OUTLIER 56.91 18.85 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.584 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.531 ' CA ' HG21 ' A' ' 193' ' ' VAL . . . -40.75 -61.04 1.99 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 249' ' ' THR . 5.9 tp -62.91 143.44 57.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.997 -1.296 . . . . 0.0 110.186 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 192' ' ' ILE . 3.6 t -118.54 125.83 74.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 116.19 6.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.772 1.273 . . . . 0.0 108.663 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 224' ' ' ALA . . . -77.64 -17.28 57.9 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.895 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.412 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 55.7 tt0 -55.65 -36.94 67.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 0.0 109.624 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.2 -19.47 39.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -98.23 -1.83 41.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.365 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.6 p -109.5 -39.06 5.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.655 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.589 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 5' ' ' PRO . 22.9 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 3' ' ' SER . 7.3 t -17.3 80.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.708 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -81.69 164.31 18.44 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.809 2.339 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -15.36 7.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.566 -0.709 . . . . 0.0 109.793 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.16 -64.23 1.67 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.1 mp -65.87 173.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.294 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 2.5 t 88.94 -39.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -25.12 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.335 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.55 20.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.939 -1.101 . . . . 0.0 110.089 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.541 ' OE1' ' CB ' ' A' ' 265' ' ' GLU . 0.0 OUTLIER 50.86 53.42 13.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 110.519 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.681 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.66 -30.41 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.944 -1.097 . . . . 0.0 111.988 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.8 Cg_endo -75.31 -59.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.11 -27.41 0.58 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.06 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -81.15 -40.56 23.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.922 -1.111 . . . . 0.0 108.935 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -73.11 -8.42 55.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.48 -39.02 5.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.599 -1.313 . . . . 0.0 110.23 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.41 68.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.868 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.09 -4.85 4.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 3.7 mm? -62.9 122.29 15.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.199 -1.177 . . . . 0.0 109.101 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.479 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -118.5 -30.81 5.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.535 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 78.8 -14.73 12.13 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -50.41 120.81 4.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -1.154 . . . . 0.0 109.001 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.09 0.71 30.0 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.493 HG11 ' HD2' ' A' ' 229' ' ' LYS . 39.4 t -99.37 164.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.236 -1.155 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.582 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 6.4 mttt -142.29 129.34 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 HG11 ' HB ' ' A' ' 119' ' ' VAL . 16.0 t -133.04 158.54 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.611 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.17 144.42 41.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 108.918 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.7 t -121.31 82.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.073 -1.017 . . . . 0.0 109.132 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 4.9 mp -64.7 91.64 0.09 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -144.72 -151.78 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.798 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.593 ' CG2' ' N ' ' A' ' 96' ' ' ALA . 72.9 p -80.35 -51.63 8.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.462 -1.398 . . . . 0.0 109.036 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -168.56 -114.47 0.3 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER 160.83 100.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.5 t -44.75 150.47 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.193 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.33 115.27 21.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.16 157.26 71.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.01 -37.48 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.6 2.2 . . . . 0.0 110.493 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD2' ' HA3' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -62.08 -18.94 62.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' CD2' ' HA2' ' A' ' 68' ' ' GLY . 14.5 mt -102.02 129.82 48.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.371 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 68.23 9.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.385 -0.822 . . . . 0.0 109.307 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.437 HD13 ' CG2' ' A' ' 35' ' ' ILE . 37.3 mm -57.26 139.02 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.491 ' HG2' ' HG2' ' A' ' 87' ' ' GLU . 20.3 tpt85 -121.54 -33.92 3.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.261 -0.899 . . . . 0.0 109.687 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -156.27 18.97 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.22 166.2 13.92 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -145.33 174.58 10.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.976 . . . . 0.0 108.961 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 92' ' ' LYS . 81.2 p -125.84 107.18 10.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 110.28 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 47' ' ' ALA . 2.7 m-85 -105.81 -36.83 6.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.514 HG11 ' HD2' ' A' ' 51' ' ' PRO . 2.1 t -41.82 145.97 0.65 Allowed Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.514 ' HD2' HG11 ' A' ' 50' ' ' VAL . 34.0 Cg_endo . . . . . 0 C--N 1.311 -1.415 0 C-N-CA 122.575 2.183 . . . . 0.0 110.81 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 56' ' ' THR . 1.2 m -77.74 -0.85 28.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.594 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 20.4 mt-30 -141.51 117.72 10.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.041 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 14.2 t70 64.56 92.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.837 . . . . 0.0 109.513 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.29 -27.89 5.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 t-20 -167.66 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.389 -1.065 . . . . 0.0 109.679 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 64' ' ' THR . . . 160.55 -42.18 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.216 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' GLY . 34.7 t-80 -54.16 -65.09 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 110.078 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -39.99 -74.77 0.13 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -40.1 -40.66 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 0.0 109.784 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.563 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.4 t-80 -55.37 -56.7 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.422 HG11 ' CB ' ' A' ' 219' ' ' PRO . 78.5 t -57.49 -44.44 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -54.67 -32.72 59.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.483 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 72' ' ' ALA . . . -79.39 -27.62 54.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -74.15 -15.61 61.02 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 mt -109.29 -21.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.455 -0.778 . . . . 0.0 110.049 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.575 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -117.56 -35.45 3.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 111.627 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.575 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -15.24 106.15 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 121.468 0.652 . . . . 0.0 111.646 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CA ' ' A' ' 84' ' ' PRO . 6.7 mt -85.0 153.82 22.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 109.749 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 48.9 p-10 -72.62 141.64 48.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 8.7 m-20 158.17 130.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -35.61 -39.11 0.13 Allowed 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -86.68 64.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.127 -0.983 . . . . 0.0 109.349 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA3' ' OD2' ' A' ' 40' ' ' ASP . . . 158.35 160.17 10.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -79.05 -112.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -1.112 . . . . 0.0 109.646 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -171.74 96.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.799 -1.188 . . . . 0.0 109.664 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.473 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -78.92 -160.49 18.02 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.42 HG13 HD13 ' A' ' 227' ' ' LEU . 1.4 t -107.65 -32.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.291 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -115.53 117.98 39.84 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 109.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CA ' HD22 ' A' ' 73' ' ' LEU . 37.6 Cg_endo -85.48 -59.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.724 2.282 . . . . 0.0 111.244 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.53 38.83 1.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.97 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.54 124.2 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 2.6 mt-10 -64.49 103.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.44 92.9 6.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 110.851 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CE2' ' HE2' ' A' ' 117' ' ' MET . 40.0 m-85 -77.63 146.57 36.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.4 ' HB3' HD11 ' A' ' 35' ' ' ILE . . . -103.25 106.59 17.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.767 -1.208 . . . . 0.0 109.029 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -95.1 67.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.988 0.899 . . . . 0.0 108.807 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 26.6 ttmt -35.12 94.05 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.005 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG2' ' HA3' ' A' ' 108' ' ' GLY . 2.2 t -118.39 -16.66 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 0.0 108.891 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.1 mt -116.47 175.17 5.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.389 -0.819 . . . . 0.0 110.167 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' A' ' 96' ' ' ALA . . . -107.36 -14.3 18.62 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.593 ' N ' ' CG2' ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.472 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 177.51 6.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.883 -0.775 . . . . 0.0 109.969 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 t -66.19 -22.02 29.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.574 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 3.6 t -69.96 -26.4 64.09 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' A' ' 50' ' ' VAL . 4.4 m -81.23 -44.49 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.538 -0.726 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.2 mt -68.14 -21.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.49 -52.22 16.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.681 -0.637 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 103' ' ' SER . 12.7 mm-40 -71.15 -30.4 66.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.689 -1.257 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.49 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -73.19 -24.07 76.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.79 -24.2 17.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -1.179 . . . . 0.0 109.906 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.33 -30.52 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 111' ' ' TRP . 69.4 t90 -72.65 -16.6 61.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.582 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -91.37 6.21 46.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -114.9 -50.38 0.48 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -70.08 -76.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.279 . . . . 0.0 108.732 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -105.71 41.07 1.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -92.39 -149.46 24.53 Favored Glycine 0 C--N 1.294 -1.782 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.582 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 7.1 mmt -140.3 -169.15 2.7 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.178 0.989 . . . . 0.0 110.933 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.0 m170 -70.21 -57.77 4.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.164 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.453 ' HB ' HG11 ' A' ' 28' ' ' VAL . 9.7 t -101.03 161.35 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 111.177 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -163.25 109.7 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.538 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 7.0 m120 -110.72 153.49 25.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.911 -1.118 . . . . 0.0 111.077 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -134.89 134.07 40.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -89.61 70.27 7.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.294 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.551 HD23 ' CB ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -150.4 -177.74 6.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.621 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.07 106.93 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.18 158.97 40.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.205 -1.173 . . . . 0.0 109.58 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -78.69 -17.1 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.633 2.222 . . . . 0.0 110.051 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -40.98 102.15 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.583 -0.698 . . . . 0.0 109.533 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 130' ' ' SER . 34.0 Cg_endo -77.42 166.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.409 2.073 . . . . 0.0 110.488 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 129' ' ' PRO . 2.1 m 172.53 121.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.436 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.58 -18.53 65.03 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.8 m -73.07 -25.73 61.01 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.62 -42.89 23.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.45 -25.82 57.77 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.546 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.4 tm0? -72.41 -22.75 61.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.3 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -64.06 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -59.45 -36.55 76.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.52 -24.48 50.0 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.29 59.42 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 121.232 -0.917 . . . . 0.0 109.917 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m -73.17 -36.53 66.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -24.76 58.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -105.15 -13.14 15.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.26 55.53 27.22 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 15.3 t -89.36 107.13 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.704 -0.88 . . . . 0.0 109.766 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.445 ' O ' HG11 ' A' ' 119' ' ' VAL . 15.6 tp -64.05 101.95 0.45 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.063 -1.023 . . . . 0.0 109.071 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 1.4 t -88.81 150.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.538 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -146.06 120.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.521 ' CB ' ' HG2' ' A' ' 162' ' ' PRO . . . -115.44 151.33 34.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.124 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.68 173.82 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -72.78 -67.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.034 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . 172.67 -23.67 0.08 OUTLIER Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.77 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 154' ' ' SER . 44.4 t-20 67.52 37.12 3.51 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.831 -0.805 . . . . 0.0 109.96 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 1.0 OUTLIER 79.23 72.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 110.213 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -115.84 -33.09 1.6 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -172.12 -178.39 2.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -1.193 . . . . 0.0 109.534 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.34 58.41 4.91 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER 162.25 129.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.982 . . . . 0.0 109.196 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 158' ' ' SER . 1.8 pt -48.66 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.359 -0.838 . . . . 0.0 110.007 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -126.91 164.68 20.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.227 -0.921 . . . . 0.0 111.896 -177.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.1 OUTLIER -77.78 142.37 65.41 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 175.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.8 Cg_endo -72.0 -29.3 6.35 Favored 'Cis proline' 0 C--N 1.298 -2.113 0 O-C-N 122.546 0.761 . . . . 0.0 110.594 3.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -35.12 -26.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.732 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -100.35 -32.03 11.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.542 -1.349 . . . . 0.0 110.608 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.51 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.6 m-85 -46.18 -179.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.172 -0.955 . . . . 0.0 110.798 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -93.96 -25.64 17.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.566 -0.709 . . . . 0.0 111.049 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.465 ' HB2' HG12 ' A' ' 137' ' ' VAL . 2.2 t-20 -97.98 23.08 8.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.81 -1.181 . . . . 0.0 110.061 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 162' ' ' PRO . . . -153.01 114.61 4.26 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.523 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 0.6 OUTLIER -78.26 167.45 21.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.128 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -118.61 123.77 45.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.331 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.0 t -92.86 166.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.141 -0.974 . . . . 0.0 109.242 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.556 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.66 -179.79 17.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -119.47 171.27 8.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 178' ' ' ASN . 1.5 p -122.86 167.88 12.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.526 ' CA ' ' HA ' ' A' ' 181' ' ' ALA . 49.6 p-10 -91.16 -177.57 4.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -69.51 -24.25 63.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.29 -79.22 0.17 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.456 ' O ' ' HB ' ' A' ' 174' ' ' THR . 0.1 OUTLIER -135.76 -79.4 0.42 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 110.363 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 0.8 OUTLIER -125.0 -164.49 1.29 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.206 -0.934 . . . . 0.0 109.681 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 81.43 -31.31 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.626 -0.672 . . . . 0.0 110.932 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.526 ' HA ' ' CA ' ' A' ' 175' ' ' ASP . . . 42.99 -155.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.957 -1.089 . . . . 0.0 109.454 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -126.64 -45.81 1.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 110.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.27 26.37 10.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.349 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.5 t -81.15 112.31 18.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.528 ' NE2' ' HA ' ' A' ' 154' ' ' SER . 3.3 tp-100 -74.88 156.8 36.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.8 171.41 14.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.613 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.578 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -173.56 146.83 9.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.05 100.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.46 16.16 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 256' ' ' LEU . 7.1 tp -53.79 151.08 6.7 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.107 -1.231 . . . . 0.0 108.824 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.523 ' CB ' ' HB3' ' A' ' 169' ' ' MET . 22.4 t70 -99.54 -69.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.53 ' CD1' HG21 ' A' ' 262' ' ' VAL . 7.6 tt -159.45 141.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.367 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.32 172.96 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -164.1 178.13 1.56 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.05 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 34.7 Cg_endo -77.64 117.61 4.32 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.284 1.989 . . . . 0.0 110.134 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -143.67 33.24 1.78 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.666 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 62.7 t -119.31 59.03 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -1.192 . . . . 0.0 108.88 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 12.9 t-20 123.9 121.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 11.6 m -166.4 110.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.946 0.879 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.6 mt-30 -80.46 122.97 27.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.334 0.588 . . . . 0.0 109.531 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.563 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.8 t -125.31 -163.16 1.17 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.643 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.5 p -79.27 166.8 21.76 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 110.115 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.623 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -149.16 156.62 40.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.3 Cg_endo -69.96 159.94 51.46 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.183 1.922 . . . . 0.0 110.629 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.476 ' O ' ' OG ' ' A' ' 206' ' ' SER . . . 74.84 31.28 58.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 205' ' ' GLY . 80.9 p 49.86 40.15 19.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -1.076 . . . . 0.0 109.905 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.22 155.36 40.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -103.58 165.43 11.04 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.186 -0.946 . . . . 0.0 108.819 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . 0.588 ' HB1' ' CG ' ' A' ' 203' ' ' TYR . . . -153.09 163.76 39.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.768 -1.208 . . . . 0.0 110.746 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.8 OUTLIER -121.27 108.21 13.46 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.516 HD13 ' CG ' ' A' ' 65' ' ' HIS . 11.0 mt -110.12 170.0 8.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.103 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 212' ' ' ASN . 2.4 p-10 -146.77 148.88 32.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.448 -0.782 . . . . 0.0 109.211 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.16 161.94 11.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 214' ' ' THR . 90.3 m -77.37 -17.32 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -1.129 . . . . 0.0 109.222 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 36.0 m -75.37 -19.25 59.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.118 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.432 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -79.71 -17.44 53.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 109.556 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 194' ' ' ALA . . . -89.8 -13.1 37.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 109.732 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.617 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 12.7 m -70.6 -42.73 14.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 111.489 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.9 Cg_endo -73.11 -15.45 25.77 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 121.672 1.581 . . . . 0.0 110.756 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -75.25 -40.44 58.91 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 192' ' ' ILE . 88.2 t -68.82 -49.64 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.535 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.27 -31.99 62.01 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.387 -0.821 . . . . 0.0 108.995 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.24 -53.87 33.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -49.25 -52.19 28.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -1.179 . . . . 0.0 109.237 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.37 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.404 -0.81 . . . . 0.0 109.061 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.73 -44.23 97.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.308 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.425 HD12 ' CB ' ' A' ' 16' ' ' ALA . 79.1 mt -55.8 -36.63 67.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.238 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 36.6 t -73.59 -40.88 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 109.995 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.52 ' NZ ' ' CD1' ' A' ' 240' ' ' ILE . 11.6 ttmm -52.38 -46.07 66.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.623 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 0.0 OUTLIER -62.78 -45.16 93.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -20.66 3.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.848 . . . . 0.0 108.792 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.62 85.06 0.53 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.758 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 35.1 Cg_endo -77.05 -16.16 16.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.07 -0.6 32.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -81.27 -177.33 6.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.75 169.13 11.04 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.64 . . . . 0.0 109.577 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -60.11 -16.06 28.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.68 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.51 -63.74 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.464 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -50.82 -38.86 51.21 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.031 -178.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.52 ' CD1' ' NZ ' ' A' ' 229' ' ' LYS . 62.5 mt -70.62 -44.61 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 110.294 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 4.8 ttp85 -57.3 -29.24 63.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 110.415 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.49 -29.63 25.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.75 -1.219 . . . . 0.0 110.278 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.485 ' O ' HG22 ' A' ' 247' ' ' THR . 0.6 OUTLIER -75.5 -57.86 3.63 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.934 -1.104 . . . . 0.0 108.126 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.495 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -60.05 -38.12 81.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.753 -0.592 . . . . 0.0 110.253 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 21.6 tttt -69.34 -49.96 50.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -74.62 -6.37 48.26 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.826 -0.547 . . . . 0.0 110.862 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.495 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.5 p -94.15 -30.76 14.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.697 -1.252 . . . . 0.0 109.832 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -44.24 137.44 3.5 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.7 m -92.19 105.9 18.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.187 -0.945 . . . . 0.0 109.862 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.468 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.5 OUTLIER -75.43 135.61 40.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.442 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.484 1.258 0 O-C-N 121.309 -0.869 . . . . 0.0 109.686 179.666 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.493 ' O ' HD21 ' A' ' 190' ' ' LEU . 13.8 mt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.59 ' N ' ' CD1' ' A' ' 257' ' ' TYR . 4.2 m-30 -71.4 -24.39 62.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.697 0.76 . . . . 0.0 109.121 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.69 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 192' ' ' ILE . 44.9 m -54.02 -48.49 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.941 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 192' ' ' ILE . . . 106.74 -131.37 10.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 192' ' ' ILE . 4.8 tp -81.65 179.17 7.94 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.365 -1.079 . . . . 0.0 109.898 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 192' ' ' ILE . 0.4 OUTLIER -120.32 140.67 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.492 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.45 118.43 1.39 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.468 1.128 . . . . 0.0 108.533 178.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -80.43 -7.19 59.04 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.698 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.541 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -57.53 -54.02 51.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.771 -1.206 . . . . 0.0 109.792 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.6 33.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.085 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -103.61 -14.91 15.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.819 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.427 HG23 HD22 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -106.04 -31.26 8.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.025 . . . . 0.0 109.981 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 268' ' ' THR . 1.4 ttp85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 1.9 m . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 t -131.83 81.27 63.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 109.208 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HG2' HG13 ' A' ' 8' ' ' ILE . 33.6 Cg_endo -77.27 157.23 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.507 2.138 . . . . 0.0 110.738 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -47.37 -38.0 12.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.648 -0.658 . . . . 0.0 109.916 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' TRP . . . -59.95 -43.81 97.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -107.33 50.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -1.155 . . . . 0.0 109.862 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -132.15 -42.88 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 109.593 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -86.61 -1.1 57.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.888 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' GLN . 16.2 m -88.42 20.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 120.994 -1.066 . . . . 0.0 109.85 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 263' ' ' ASN . 1.1 mt-30 41.4 42.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.745 . . . . 0.0 110.289 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.661 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -76.85 -35.37 1.42 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 111.481 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.2 Cg_endo -73.0 -56.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -42.93 -37.07 1.73 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.35 72.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.209 -0.932 . . . . 0.0 108.563 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 21.7 m170 -63.93 -14.34 52.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.89 -50.26 12.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.15 -14.58 25.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.52 -2.86 39.57 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 21' ' ' LEU . 1.6 tp -51.72 162.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.154 . . . . 0.0 109.655 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 -32.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 64.82 8.86 36.35 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.538 ' CB ' ' HB3' ' A' ' 85' ' ' ASN . 8.6 p -52.75 -31.8 40.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.964 . . . . 0.0 110.07 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.03 32.9 4.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -123.57 162.35 24.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.222 -1.164 . . . . 0.0 109.927 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.68 ' HE3' ' CD1' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -133.94 132.5 40.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.542 ' N ' ' HE2' ' A' ' 27' ' ' LYS . 1.1 t -128.41 103.68 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 109.789 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -74.16 162.46 28.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG13 HD13 ' A' ' 35' ' ' ILE . 42.6 t -135.16 89.08 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.011 -1.056 . . . . 0.0 108.894 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 91' ' ' VAL . 7.1 mp -76.56 109.78 10.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.472 ' OD2' ' CA ' ' A' ' 63' ' ' GLY . 44.4 p-10 -173.71 -164.92 0.23 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.895 -1.128 . . . . 0.0 110.123 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 19.6 p -42.9 -64.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.724 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -172.2 -116.19 0.39 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 156.58 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 p -69.25 151.5 46.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 109.599 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 t -70.94 162.21 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -0.869 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.585 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -166.29 162.7 12.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.8 Cg_endo -79.04 -5.78 14.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.701 2.267 . . . . 0.0 110.349 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -109.56 -17.07 13.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.137 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 67' ' ' ALA . 18.5 mt -100.7 141.29 33.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.267 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -111.8 67.05 0.64 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.104 -0.998 . . . . 0.0 109.229 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 42' ' ' ASN . 31.9 mm -43.06 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.379 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -81.88 -15.82 52.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.238 -0.914 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -171.28 152.41 18.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 163.79 29.2 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.51 167.61 28.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.544 ' OG ' ' CG2' ' A' ' 56' ' ' THR . 1.5 m -148.81 111.74 4.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 110.156 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 9.0 m-85 -99.02 -40.61 7.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.558 ' HB ' ' NZ ' ' A' ' 92' ' ' LYS . 76.3 t -51.73 120.4 15.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 108.986 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.31 -1.457 0 C-N-CA 122.618 2.212 . . . . 0.0 111.218 -179.404 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.447 ' C ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 120.912 0.387 . . . . 0.0 110.39 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.544 ' CG2' ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER 64.5 3.32 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.048 -1.033 . . . . 0.0 110.408 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.452 ' HG2' ' C ' ' A' ' 56' ' ' THR . 78.4 mm-40 -149.75 118.77 6.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.666 -1.271 . . . . 0.0 110.211 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' CB ' ' A' ' 204' ' ' PRO . 8.6 t0 57.27 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.404 -0.81 . . . . 0.0 110.106 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . -127.06 -8.07 4.75 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 63.8 t-20 176.31 -61.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -1.135 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.83 -18.33 0.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -68.13 0.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -1.086 . . . . 0.0 110.029 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.472 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -55.46 -22.83 32.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.473 HG23 ' HD3' ' A' ' 204' ' ' PRO . 56.7 m -72.42 -57.71 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.75 -1.441 . . . . 0.0 109.809 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.59 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.5 t-80 -59.04 -36.11 74.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 70' ' ' ILE . 67.1 t -67.92 -42.81 85.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.406 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.475 ' HB3' HG12 ' A' ' 35' ' ' ILE . . . -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.438 -0.789 . . . . 0.0 110.009 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.61 -40.27 86.04 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 28.2 m -63.72 -17.28 62.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.399 -1.059 . . . . 0.0 108.727 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 66' ' ' VAL . 36.9 mt -93.85 -22.28 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.439 -0.788 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.509 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -131.59 -52.67 1.0 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 111.228 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' CB ' ' N ' ' A' ' 81' ' ' GLY . . . 33.7 62.84 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.722 -0.611 . . . . 0.0 109.831 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' ' OD1' ' A' ' 42' ' ' ASN . 43.4 mt -43.34 147.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 1.7 m-20 -62.55 155.88 24.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 109.256 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m-20 145.8 129.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 28.5 t -37.03 -30.16 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.293 0.568 . . . . 0.0 109.765 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 75' ' ' ASN . 28.7 pt -84.65 143.54 11.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.92 155.07 0.38 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.458 HG21 ' N ' ' A' ' 80' ' ' LEU . 26.0 m -72.16 -141.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.317 -1.107 . . . . 0.0 109.683 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.496 ' O ' HD11 ' A' ' 8' ' ' ILE . 67.5 tp -138.81 128.07 24.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.089 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.613 ' N ' ' CB ' ' A' ' 72' ' ' ALA . . . -87.08 -177.07 49.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.412 HG11 ' HB3' ' A' ' 13' ' ' ALA . 2.5 t -93.68 -32.35 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -1.232 . . . . 0.0 109.264 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -116.34 98.53 51.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.081 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -83.13 -60.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.812 2.341 . . . . 0.0 110.496 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.538 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -71.71 0.38 8.95 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.671 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 83' ' ' ALA . . . -73.33 161.52 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.852 -1.155 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.51 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 2.1 mp0 -97.99 107.85 20.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.789 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.473 HD23 HD11 ' A' ' 70' ' ' ILE . 2.5 mt -90.47 127.5 36.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.637 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.68 ' CD1' ' HE3' ' A' ' 27' ' ' LYS . 3.6 m-85 -111.99 178.11 4.42 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.014 -1.054 . . . . 0.0 109.943 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.25 90.2 2.5 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -96.1 64.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.216 -0.928 . . . . 0.0 109.111 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.558 ' NZ ' ' HB ' ' A' ' 50' ' ' VAL . 3.1 ttpm? -41.06 121.32 1.53 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.33 0.586 . . . . 0.0 109.611 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 94' ' ' LEU . 1.2 t -131.7 3.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.953 . . . . 0.0 109.258 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.529 ' CD1' HG11 ' A' ' 93' ' ' VAL . 2.1 mp -141.29 173.92 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.669 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -98.31 -178.35 32.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.435 ' HA ' HG21 ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.194 -1.18 . . . . 0.0 109.397 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.26 160.29 22.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.627 -0.925 . . . . 0.0 109.818 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.78 -18.7 22.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 107' ' ' GLN . 8.7 t -80.47 -14.71 58.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -87.84 -44.08 11.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.589 -0.694 . . . . 0.0 109.16 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.479 HD11 HG23 ' A' ' 105' ' ' ILE . 2.4 mt -76.88 -32.47 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.92 -36.2 59.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 tt0 -70.88 -42.5 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.883 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.54 73.26 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.46 -45.29 72.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -1.106 . . . . 0.0 108.944 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 107' ' ' GLN . 9.9 pt-20 -72.27 -24.18 61.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.426 ' CZ3' HG12 ' A' ' 91' ' ' VAL . 82.7 t90 -69.99 -18.68 63.35 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.625 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.66 -0.69 48.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.322 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.502 ' HA3' ' NH1' ' A' ' 143' ' ' ARG . . . -107.15 -51.73 0.76 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -1.12 . . . . 0.0 109.143 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -120.99 34.65 5.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -102.37 -151.19 23.54 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.718 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.548 ' CE ' ' O ' ' A' ' 116' ' ' GLY . 2.6 mmt -144.14 -157.73 0.81 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.153 0.978 . . . . 0.0 110.965 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.642 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -90.83 -30.6 16.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.896 -178.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.642 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 2.1 t -111.51 154.14 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 119.857 -1.777 . . . . 0.0 110.502 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 147' ' ' VAL . . . -163.39 105.62 0.98 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 0.0 108.908 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.533 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 5.9 m120 -85.45 -178.75 6.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 148' ' ' VAL . 1.1 mp -152.38 100.23 2.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.48 ' N ' HD22 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -85.46 65.47 9.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.35 88.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -109.09 152.13 42.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.185 -1.185 . . . . 0.0 109.252 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.504 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -77.42 -23.43 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.426 2.084 . . . . 0.0 109.45 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -69.38 111.7 9.56 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.806 -0.559 . . . . 0.0 109.906 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.8 Cg_endo -82.66 170.63 12.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.407 2.071 . . . . 0.0 110.326 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.5 p -163.08 110.77 1.23 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.35 -29.49 70.23 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.2 m -58.23 -31.09 67.03 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.455 ' HB2' ' OG ' ' A' ' 130' ' ' SER . 0.5 OUTLIER -71.58 -36.58 70.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -59.44 5.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.81 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.2 OUTLIER -50.52 -23.4 2.47 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 108.723 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.72 -45.43 52.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.591 ' CG2' ' HA ' ' A' ' 166' ' ' ALA . 59.3 t -69.44 -21.68 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 8.4 m120 -62.94 -35.82 81.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -29.46 57.72 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -75.4 -13.24 60.38 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.1 m -80.52 -44.36 19.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.0 t -64.15 -13.8 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.502 ' NH1' ' HA3' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -96.85 -17.9 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.497 -0.752 . . . . 0.0 109.285 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.45 75.45 0.4 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 36.0 t -124.75 102.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.978 . . . . 0.0 110.48 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.6 tp -62.86 105.84 0.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 168' ' ' ALA . 2.3 t -97.24 156.98 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 110.881 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.533 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -136.36 146.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 163' ' ' ALA . . . -142.87 137.07 29.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.984 -1.073 . . . . 0.0 109.537 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.492 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.73 144.49 54.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.44 ' OG ' ' N ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -44.0 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 109.434 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 154' ' ' SER . . . 172.66 -22.35 0.07 OUTLIER Glycine 0 N--CA 1.496 2.692 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.821 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' SER . 3.4 p-10 30.74 36.25 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 122.235 -0.568 . . . . 0.0 111.486 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 3.5 t 160.47 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 110.121 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . -165.43 70.57 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.312 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . 45.95 -172.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -1.165 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.2 47.59 3.86 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.44 135.22 17.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.332 -1.099 . . . . 0.0 108.632 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.6 pt -57.9 -179.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.12 170.58 7.87 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.506 1.146 . . . . 0.0 112.599 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.444 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 77.8 m-85 -104.43 139.07 19.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.4 Cg_endo -73.54 -43.94 0.62 Allowed 'Cis proline' 0 C--N 1.295 -2.278 0 O-C-N 123.042 1.022 . . . . 0.0 110.816 3.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . 23.13 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.029 0.918 . . . . 0.0 110.057 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -39.88 -63.72 0.56 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.495 0.664 . . . . 0.0 109.791 177.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.567 ' O ' ' CB ' ' A' ' 166' ' ' ALA . 46.7 p90 -106.87 -166.45 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.899 0.856 . . . . 0.0 111.221 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . . . 86.39 34.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.926 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.431 ' O ' ' HB ' ' A' ' 147' ' ' VAL . 1.0 OUTLIER 45.92 26.32 0.38 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -110.88 114.4 27.71 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.48 ' HG3' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -67.82 127.48 32.96 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.011 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.533 ' N ' ' HB2' ' A' ' 191' ' ' ASP . . . -78.53 108.63 12.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 35.3 t -84.48 163.77 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.847 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.562 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -132.89 -172.78 13.1 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.45 ' O ' ' HB1' ' A' ' 181' ' ' ALA . . . -138.89 143.88 38.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.088 -1.242 . . . . 0.0 109.418 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.464 HG23 ' CE2' ' A' ' 257' ' ' TYR . 43.5 p -108.46 175.02 5.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 1.4 t70 -74.64 -163.93 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 109.665 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -53.56 -29.97 39.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.54 -79.91 0.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.991 . . . . 0.0 110.151 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.451 ' O ' ' ND2' ' A' ' 178' ' ' ASN . 9.5 p-10 -149.63 60.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 1.0 OUTLIER -125.19 162.52 24.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.956 -1.09 . . . . 0.0 109.666 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 7.5 mtp180 -62.56 112.82 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.52 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -43.68 171.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.48 -27.29 12.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 184' ' ' SER . 11.6 p90 -114.63 -21.71 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.998 -1.064 . . . . 0.0 109.804 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.423 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 10.8 t -55.65 126.93 27.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 109.26 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.455 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 27.7 mm-40 -85.23 154.67 21.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -138.81 173.27 11.75 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.161 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 168.01 148.44 5.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -43.55 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -1.112 . . . . 0.0 109.395 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 148.3 -16.38 1.31 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 256' ' ' LEU . 12.0 tp -45.97 126.17 7.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -1.127 . . . . 0.0 109.763 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.533 ' HB2' ' N ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -81.27 -62.0 1.78 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.5 ' CG1' ' HB3' ' A' ' 259' ' ' SER . 14.0 tt -155.65 168.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.412 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.57 HG22 ' CD2' ' A' ' 257' ' ' TYR . 3.0 m -122.11 161.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 0.0 110.073 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.585 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -150.09 -172.78 0.33 Allowed Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 31.9 Cg_endo -75.48 110.26 3.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.319 1.346 . . . . 0.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -130.25 41.02 1.58 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 26.8 t -142.88 91.58 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.585 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 19.7 t-20 89.34 115.29 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.574 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 2.5 m -173.49 118.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -99.87 142.62 31.11 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.491 0.663 . . . . 0.0 110.214 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.59 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -149.71 -148.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 109.304 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -94.13 158.51 15.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.229 -0.919 . . . . 0.0 110.087 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.601 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -135.4 155.82 78.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.7 Cg_endo -73.62 151.26 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.304 2.003 . . . . 0.0 111.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 30.61 73.15 0.05 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 9.1 t 168.45 -100.55 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.052 -1.263 . . . . 0.0 110.149 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 208' ' ' TYR . 6.5 t -172.41 -142.82 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.555 ' N ' ' CG2' ' A' ' 207' ' ' THR . 0.0 OUTLIER -91.06 157.27 17.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.528 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.28 139.44 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.2 OUTLIER -95.23 133.19 39.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 212' ' ' ASN . 1.1 pp -158.28 164.36 36.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.472 ' O ' HD11 ' A' ' 211' ' ' LEU . 2.0 m-80 -99.85 171.54 7.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 153.59 131.35 1.57 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 151' ' ' SER . 84.4 m -67.62 -25.32 65.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.465 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -68.43 -12.29 60.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.147 -0.971 . . . . 0.0 109.386 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.485 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -77.0 -26.6 54.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 194' ' ' ALA . . . -86.98 0.63 54.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.596 -0.69 . . . . 0.0 109.548 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.599 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 1.8 m -80.44 -45.79 1.34 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.269 -0.895 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 218' ' ' THR . 31.6 Cg_endo -73.48 -18.31 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.735 1.624 . . . . 0.0 110.985 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -70.7 -40.74 72.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.912 -1.118 . . . . 0.0 108.591 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 262' ' ' VAL . 55.8 t -74.35 -39.56 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.81 64.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -73.36 -52.34 8.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -53.15 -64.13 0.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 109.242 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -43.48 -46.13 6.71 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.21 44.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 109.072 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 17.7 mt -56.48 -37.9 70.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 84.3 t -56.58 -63.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.585 ' CD ' ' NE2' ' A' ' 118' ' ' HIS . 1.8 mtpt -48.18 -31.7 6.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 108.893 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.465 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.6 OUTLIER -61.79 -49.3 76.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -5.93 31.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 6.7 p30 -164.44 79.58 1.4 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.402 -0.811 . . . . 0.0 109.685 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 31.98 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.854 2.369 . . . . 0.0 111.149 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -12.15 5.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.78 -1.2 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.65 175.72 9.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.054 -1.029 . . . . 0.0 109.864 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.87 174.66 5.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.684 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.519 ' N ' ' ND2' ' A' ' 237' ' ' ASN . 0.8 OUTLIER -58.04 -28.3 64.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -77.68 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.266 -0.897 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' VAL . 16.1 mt-30 -42.9 -36.23 1.45 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.481 0.657 . . . . 0.0 109.488 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.441 HD12 ' CG ' ' A' ' 229' ' ' LYS . 50.4 mt -68.86 -56.33 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 109.633 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -43.31 -50.17 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 109.906 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -51.06 -60.98 2.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.784 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.468 ' O ' HG22 ' A' ' 247' ' ' THR . 2.5 t60 -55.14 -57.12 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.066 . . . . 0.0 109.822 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.3 -18.46 10.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.477 -0.765 . . . . 0.0 109.95 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER -83.42 -39.71 20.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 109.271 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.69 -30.08 66.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.269 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.5 ' O ' ' C ' ' A' ' 248' ' ' ALA . 1.7 p -78.92 -52.35 8.4 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.18 0.991 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -28.9 116.97 0.11 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 13.9 m -53.32 131.91 38.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.32 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.74 109.99 22.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.41 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.559 HD23 ' CE2' ' A' ' 257' ' ' TYR . 6.1 mp . . . . . 0 C--N 1.307 -1.272 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 190' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.57 ' CD2' HG22 ' A' ' 193' ' ' VAL . 27.9 m-85 -90.96 -61.42 1.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.38 -0.825 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.2 -120.69 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.5 ' HB3' ' CG1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -47.27 -44.05 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 108.995 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 249' ' ' THR . . . 110.97 -142.8 16.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -178.06 5.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 192' ' ' ILE . 3.7 t -129.57 146.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.459 -0.775 . . . . 0.0 110.55 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.479 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.02 121.23 1.23 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -94.23 -12.96 27.13 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.796 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.477 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 1.1 tm-20 -68.84 -15.74 63.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.812 -1.18 . . . . 0.0 109.685 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.25 1.89 39.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -122.82 -17.49 6.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.457 ' O ' ' OXT' ' A' ' 269' ' ' ARG . 0.7 OUTLIER -92.82 -38.88 11.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.776 -1.202 . . . . 0.0 109.364 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.457 ' OXT' ' O ' ' A' ' 268' ' ' THR . 10.2 ptm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.867 -1.064 . . . . 0.0 109.618 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.777 ' HB3' ' N ' ' A' ' 80' ' ' LEU . 1.1 m . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.371 0.605 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 170.43 100.21 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 109.22 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 8' ' ' ILE . 36.2 Cg_endo -78.8 174.77 11.79 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.632 2.221 . . . . 0.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.492 ' CZ2' ' HB2' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -48.02 -28.87 3.04 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.511 -0.743 . . . . 0.0 109.924 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.62 -42.16 55.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CG1' ' NE2' ' A' ' 220' ' ' HIS . 34.2 mt -109.57 73.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.923 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -42.32 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -93.68 6.71 47.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG22 ' HB1' ' A' ' 13' ' ' ALA . 15.8 m -98.2 19.71 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 109.647 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.471 ' CB ' ' HB2' ' A' ' 265' ' ' GLU . 34.8 mm-40 47.6 25.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 110.089 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.43 -42.3 83.97 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.9 . . . . 0.0 110.907 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.46 -44.09 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 18' ' ' ASN . . . -46.46 -37.06 7.25 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.67 64.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -64.93 -18.91 65.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.687 -0.633 . . . . 0.0 110.7 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 6.3 p-10 -113.1 -6.63 13.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.743 -1.223 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -83.2 -22.98 33.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.939 -1.1 . . . . 0.0 109.219 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.46 50.33 0.46 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -139.25 179.8 6.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.957 . . . . 0.0 109.968 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 1.1 t 157.76 100.09 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -55.65 0.93 0.09 OUTLIER Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.654 -0.653 . . . . 0.0 111.935 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 85' ' ' ASN . 71.9 m -28.45 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.811 1.306 . . . . 0.0 111.97 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -85.45 35.02 3.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 229' ' ' LYS . 44.1 t -125.78 165.43 23.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.124 -1.221 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 16.5 mttm -135.91 117.42 14.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.481 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG23 ' HB ' ' A' ' 119' ' ' VAL . 13.6 t -128.54 136.26 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.829 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.67 155.56 21.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 89' ' ' TYR . 2.2 t -130.84 85.04 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.132 -0.98 . . . . 0.0 108.953 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.492 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 6.9 mp -70.46 103.96 2.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 33' ' ' THR . 9.2 p30 -148.92 -143.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.234 -0.916 . . . . 0.0 109.152 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CG2' ' A' ' 33' ' ' THR . 13.4 t -135.68 79.71 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.035 -1.041 . . . . 0.0 110.054 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.412 ' HA3' ' ND2' ' A' ' 60' ' ' ASN . . . 90.69 120.8 2.3 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.513 HG22 ' CB ' ' A' ' 67' ' ' ALA . 2.8 mt -112.81 -24.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 122.111 0.958 . . . . 0.0 108.654 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 42.1 t 57.3 148.18 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.287 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -93.09 160.25 14.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.595 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -160.78 178.91 1.47 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 109.046 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.9 Cg_endo -78.0 -22.27 10.18 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.402 2.068 . . . . 0.0 110.183 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 74.9 m-20 -97.22 -55.14 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.336 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.476 HD22 ' HA2' ' A' ' 68' ' ' GLY . 17.4 mt -55.22 156.9 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.91 63.87 1.53 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 0.0 109.205 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 43' ' ' ILE . 7.4 mm -49.96 115.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -104.85 -8.13 18.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.99 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -174.13 177.12 46.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.15 158.65 19.65 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.468 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -152.98 162.49 41.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.69 -0.888 . . . . 0.0 108.833 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB3' ' HE2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -132.99 109.74 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 1.9 m-85 -107.61 -44.17 4.33 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.317 -0.864 . . . . 0.0 109.025 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.533 HG11 ' N ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -41.33 151.53 0.29 Allowed Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.533 ' N ' HG11 ' A' ' 50' ' ' VAL . 30.0 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.427 2.085 . . . . 0.0 111.005 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 t -79.03 0.97 25.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.029 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.37 106.68 12.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER 65.72 174.74 0.22 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 0.0 109.861 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.439 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 115.15 15.76 7.61 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.571 ' ND2' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -160.71 -71.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.985 . . . . 0.0 109.049 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.86 8.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -73.65 -57.19 4.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -1.22 . . . . 0.0 109.925 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.22 72.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.1 m -69.16 -40.91 77.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.496 ' CG ' HD13 ' A' ' 211' ' ' LEU . 27.1 t-80 -66.56 -53.16 37.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 69' ' ' THR . 39.4 t -58.99 -35.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 109.712 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.513 ' CB ' HG22 ' A' ' 35' ' ' ILE . . . -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 110.235 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 72' ' ' ALA . . . -70.16 -44.94 58.49 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.964 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 66' ' ' VAL . 12.3 t -64.46 -16.83 63.13 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.989 -1.301 . . . . 0.0 108.975 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.475 ' CG1' ' CB ' ' A' ' 219' ' ' PRO . 78.7 mt -93.02 -24.91 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.593 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -133.93 -43.1 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.879 -1.138 . . . . 0.0 110.902 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.593 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . 8.05 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.106 0.479 . . . . 0.0 111.636 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 22.2 mt -42.27 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.971 -1.081 . . . . 0.0 109.57 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.543 ' HB2' ' CD1' ' A' ' 80' ' ' LEU . 43.8 t30 -113.71 106.44 14.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.554 ' ND2' HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -154.64 -100.63 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 109.605 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.7 p -132.06 -32.6 1.39 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.347 -0.846 . . . . 0.0 110.147 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.554 HG12 ' ND2' ' A' ' 75' ' ' ASN . 27.9 pt -91.31 138.11 20.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.073 -1.017 . . . . 0.0 110.302 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 3' ' ' SER . . . 60.13 158.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.529 ' HA ' ' OG ' ' A' ' 3' ' ' SER . 5.6 m -70.19 -160.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.563 -0.963 . . . . 0.0 109.465 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.777 ' N ' ' HB3' ' A' ' 3' ' ' SER . 4.5 tp -135.15 131.35 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.429 -0.794 . . . . 0.0 110.241 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -77.43 -145.71 2.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.96 -28.47 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.93 -1.335 . . . . 0.0 109.051 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -110.68 125.91 29.86 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.46 -61.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.417 2.078 . . . . 0.0 110.875 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.526 ' CB ' ' OG ' ' A' ' 24' ' ' SER . 1.2 m-20 -103.36 39.88 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.504 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 24' ' ' SER . . . -83.4 168.46 16.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.008 -1.058 . . . . 0.0 109.6 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 72.8 mt-10 -113.6 92.42 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 70' ' ' ILE . 7.8 mt -97.13 135.81 38.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 109.635 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 27.7 m-85 -104.14 155.84 18.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.84 102.58 11.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 109.257 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -100.5 68.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.188 -0.945 . . . . 0.0 109.068 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 33' ' ' THR . 19.4 ttpt -36.61 103.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.345 0.593 . . . . 0.0 110.275 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 31' ' ' LEU . 1.4 t -115.48 -20.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 108.798 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.29 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.402 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 33' ' ' THR . . . -91.18 179.21 42.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.532 ' HB3' ' CB ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.179 -1.189 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.93 162.84 24.99 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.742 -0.858 . . . . 0.0 109.094 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' OG ' ' A' ' 130' ' ' SER . 58.2 t -68.67 -19.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 43.0 t -78.75 -19.86 51.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.0 m -79.2 -52.86 7.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.419 ' HA ' HG23 ' A' ' 93' ' ' VAL . 1.3 mt -63.47 -25.2 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.34 78.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.642 -0.661 . . . . 0.0 109.423 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -71.51 -32.39 68.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.987 -1.071 . . . . 0.0 108.991 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.63 -31.08 70.56 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.66 -25.18 21.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.18 -1.188 . . . . 0.0 110.384 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.63 -26.04 23.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -63.54 -22.15 66.73 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.605 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -86.78 -22.43 25.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -62.41 -43.64 98.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 1.8 p-10 -85.18 -38.64 18.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 31.5 m-20 -146.14 85.02 1.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.605 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -115.32 -165.33 14.62 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.474 ' HE3' ' O ' ' A' ' 116' ' ' GLY . 15.0 mmt -139.0 178.78 6.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.548 -0.972 . . . . 0.0 110.138 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.495 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.7 m170 -57.95 -39.99 79.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.557 -0.714 . . . . 0.0 110.732 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.465 ' HB ' HG23 ' A' ' 28' ' ' VAL . 19.0 t -130.56 167.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.861 -1.149 . . . . 0.0 111.104 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.35 114.78 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 222' ' ' ALA . 10.7 m120 -100.3 151.13 21.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.903 -1.123 . . . . 0.0 110.708 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.422 HD11 ' C ' ' A' ' 121' ' ' ASN . 6.9 mp -118.11 110.72 17.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.8 t -82.68 71.74 9.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 108.918 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.17 -174.14 2.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.351 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.527 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . 168.62 79.69 0.04 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -95.24 155.82 38.43 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.331 -1.099 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.41 -11.79 18.92 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.516 2.144 . . . . 0.0 109.571 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -83.27 115.54 59.68 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.619 -0.675 . . . . 0.0 109.442 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.58 167.92 21.98 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.258 1.972 . . . . 0.0 110.107 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 102' ' ' VAL . 11.0 m -155.98 117.24 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.07 -20.8 65.87 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.2 m -69.32 -26.95 64.96 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.8 mp -78.35 -36.21 46.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -38.25 69.0 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.167 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -67.52 -22.61 65.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.87 -32.71 40.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.576 -0.85 . . . . 0.0 108.748 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.29 -26.38 17.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.87 -35.35 80.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 m -79.65 -23.8 42.3 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.83 60.39 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.5 m -79.57 -34.47 40.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.941 . . . . 0.0 108.628 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -56.98 -28.04 61.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.83 -13.51 16.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.21 78.44 0.59 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.1 t -127.3 92.03 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -1.138 . . . . 0.0 110.155 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tp -57.02 120.53 8.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 108.599 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -107.56 152.07 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 110.22 -178.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.475 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 0.9 OUTLIER -141.62 103.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.42 150.33 21.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.06 -1.025 . . . . 0.0 110.412 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.535 ' CB ' ' OG1' ' A' ' 218' ' ' THR . . . -78.31 172.84 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.506 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -77.84 -79.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.0 109.254 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.75 -111.77 0.35 Allowed Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -176.3 28.72 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 29.3 t -128.36 -99.4 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.905 . . . . 0.0 109.73 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.39 55.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.32 -178.2 4.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 109.301 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.61 38.92 2.66 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -166.44 155.38 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -1.178 . . . . 0.0 108.672 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -97.52 -172.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.868 -1.145 . . . . 0.0 110.751 -179.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.527 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -80.43 163.77 23.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.172 0.987 . . . . 0.0 112.108 -177.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.432 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.2 m-85 -112.43 132.34 22.2 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.6 Cg_endo -73.97 -42.77 0.78 Allowed 'Cis proline' 0 C--N 1.299 -2.077 0 O-C-N 123.139 1.073 . . . . 0.0 111.041 3.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.508 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . 21.34 -73.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.869 0.843 . . . . 0.0 110.122 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -46.49 -71.59 0.07 Allowed 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.645 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.8 m-85 27.41 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.834 1.302 . . . . 0.0 113.03 178.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.5 -0.35 2.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -124.41 21.83 8.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -157.88 169.87 23.63 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.491 -0.755 . . . . 0.0 108.968 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.452 ' HB3' ' CG ' ' A' ' 191' ' ' ASP . 1.0 OUTLIER -111.48 157.82 19.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.69 129.91 54.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 31.2 t -91.86 164.63 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.894 -1.129 . . . . 0.0 109.459 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.77 -171.69 12.9 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -120.75 164.93 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -133.39 173.81 11.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.34 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 0.3 OUTLIER -85.36 -152.0 0.15 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 177' ' ' ASN . 5.1 pt20 -84.96 -29.91 24.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 176' ' ' GLN . 53.4 m-20 -96.33 -97.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.962 . . . . 0.0 109.947 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.77 19.23 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 0.0 109.856 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 3.1 t-20 -72.47 -151.96 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 109.087 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.541 ' HB2' ' CE2' ' A' ' 257' ' ' TYR . 22.3 ttp85 -132.93 16.64 4.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 58.39 164.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.735 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 t -121.2 -4.64 9.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.953 . . . . 0.0 109.914 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.565 ' O ' ' CG ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -106.4 29.13 7.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 109.832 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 185' ' ' GLN . 41.6 t -111.85 119.35 38.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 184' ' ' SER . 0.0 OUTLIER -43.89 113.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 109.176 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -113.71 168.15 10.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.915 . . . . 0.0 109.319 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.48 178.72 42.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.73 111.42 17.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 129.36 9.06 3.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 256' ' ' LEU . 14.2 tp -64.24 143.76 57.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.944 -1.327 . . . . 0.0 109.251 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 19.1 t70 -91.6 -70.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 261' ' ' LEU . 13.0 tt -140.81 169.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.838 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 260' ' ' GLY . 29.2 m -120.17 162.82 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -158.48 165.52 18.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.492 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 34.8 Cg_endo -77.09 115.99 4.1 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.465 2.11 . . . . 0.0 110.475 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.44 24.25 3.74 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.66 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 55.4 t -102.96 68.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -1.066 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.66 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.7 OUTLIER 110.33 122.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.072 0.939 . . . . 0.0 108.597 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 2.5 m -170.84 113.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -101.67 168.15 9.65 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.7 0.762 . . . . 0.0 110.125 -179.401 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 200' ' ' GLN . 4.3 m -168.32 -156.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.35 172.08 13.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.641 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -152.98 160.59 30.77 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -71.34 164.01 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.285 1.99 . . . . 0.0 110.655 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.7 82.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.99 34.43 5.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -1.056 . . . . 0.0 109.373 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -126.76 160.33 31.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.288 -0.882 . . . . 0.0 109.852 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.93 169.42 8.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.3 164.01 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.78 -1.2 . . . . 0.0 110.961 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.9 OUTLIER -123.34 124.17 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.496 HD13 ' CG ' ' A' ' 65' ' ' HIS . 2.1 mt -119.73 161.27 21.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.927 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 212' ' ' ASN . 1.1 p-10 -134.05 107.6 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -161.6 151.24 21.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.1 m -70.83 -21.89 62.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -1.114 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -72.24 -13.27 61.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.135 -0.978 . . . . 0.0 109.095 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.5 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -81.7 -13.52 57.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.724 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -88.9 -1.49 58.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.985 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.636 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 1.1 m -75.83 -40.5 3.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.254 -0.904 . . . . 0.0 111.379 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.6 Cg_endo -72.32 -12.95 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.698 1.599 . . . . 0.0 111.242 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.569 ' NE2' ' CG1' ' A' ' 8' ' ' ILE . 18.1 m80 -77.17 -51.45 10.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.044 -1.035 . . . . 0.0 108.507 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.476 HG23 HG23 ' A' ' 262' ' ' VAL . 98.8 t -63.07 -41.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.526 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -57.15 -40.42 77.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.805 . . . . 0.0 109.11 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.478 ' O ' ' HB1' ' A' ' 226' ' ' ALA . . . -59.18 -51.43 59.22 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 227' ' ' LEU . . . -53.2 -51.99 60.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.25 . . . . 0.0 110.021 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.07 -32.99 56.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.374 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 223' ' ' GLY . . . -63.55 -40.77 97.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.102 -0.999 . . . . 0.0 108.821 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 224' ' ' ALA . 54.3 mt -59.06 -51.31 70.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.823 . . . . 0.0 109.565 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' LYS . 76.3 t -57.54 -55.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 109.922 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.495 ' HD3' ' ND1' ' A' ' 118' ' ' HIS . 4.1 ttmm -42.28 -42.4 3.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.479 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -61.84 -48.09 82.13 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -57.22 -17.05 9.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.165 -0.96 . . . . 0.0 108.951 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 235' ' ' TRP . 2.3 m120 -172.45 90.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.696 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.1 -38.58 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.75 2.3 . . . . 0.0 110.66 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 235' ' ' TRP . 0.0 OUTLIER -47.42 -46.16 26.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 110.215 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.529 ' CD2' ' HB3' ' A' ' 232' ' ' ASN . 47.4 m0 -45.3 170.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.081 -1.012 . . . . 0.0 110.063 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.11 176.85 4.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.731 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -54.21 -20.08 6.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.956 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.4 t -78.33 -65.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.14 -0.975 . . . . 0.0 109.461 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 235' ' ' TRP . 1.0 OUTLIER -44.39 -43.17 7.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 241' ' ' ARG . 6.1 mt -59.65 -55.3 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -42.4 -35.81 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 110.435 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 245' ' ' LYS . 29.2 t-20 -72.55 -40.21 66.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.49 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.499 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.9 OUTLIER -70.47 -47.08 62.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.879 -1.138 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.45 -28.65 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.444 -0.785 . . . . 0.0 110.844 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.555 ' CG ' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -73.36 -48.99 29.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 109.903 -179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.555 ' N ' ' CG ' ' A' ' 245' ' ' LYS . 7.8 t-20 -74.06 -22.39 59.56 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.674 -0.641 . . . . 0.0 111.04 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 9.1 p -84.47 -32.2 24.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.791 -1.193 . . . . 0.0 109.95 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.52 130.28 44.35 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.74 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 250' ' ' SER . 2.4 m -48.48 164.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 249' ' ' THR . 49.0 m -129.15 97.8 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 109.5 -179.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.474 ' O ' HD21 ' A' ' 190' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.541 ' CE2' ' HB2' ' A' ' 180' ' ' ARG . 38.0 m-85 -76.2 -12.3 60.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 59.42 -154.3 30.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 250' ' ' SER . 6.0 t -44.92 -25.72 0.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.268 -1.137 . . . . 0.0 109.222 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 192' ' ' ILE . . . 125.49 -132.6 8.04 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -100.62 177.83 4.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -1.105 . . . . 0.0 109.309 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.476 HG23 HG23 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -111.41 156.86 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.414 ' CG ' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -170.75 121.08 0.57 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 122.35 1.071 . . . . 0.0 108.197 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.04 -17.61 59.58 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.031 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.471 ' HB2' ' CB ' ' A' ' 12' ' ' GLN . 29.5 tt0 -65.54 -43.2 90.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.049 . . . . 0.0 109.146 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.98 -13.98 62.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.265 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.474 ' HA ' HG23 ' A' ' 247' ' ' THR . . . -110.81 12.7 22.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 269' ' ' ARG . 4.4 p -119.23 -39.02 2.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.482 ' HG3' ' OXT' ' A' ' 269' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.914 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.682 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 5.2 t . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.682 ' CG2' ' O ' ' A' ' 3' ' ' SER . 2.5 m 59.95 41.25 0.53 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.939 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HD2' ' HB ' ' A' ' 8' ' ' ILE . 37.5 Cg_endo -82.24 -169.29 0.73 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.976 1.784 . . . . 0.0 110.454 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CG ' ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -32.92 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -83.08 -69.26 1.39 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.693 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 19.7 mm -33.57 90.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 122.042 -0.681 . . . . 0.0 110.323 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER 155.67 -55.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 17.7 tpp85 -75.42 -17.47 60.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.485 -0.759 . . . . 0.0 109.448 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.4 m -88.62 23.3 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 20.8 mm100 49.66 41.35 21.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.208 -0.933 . . . . 0.0 109.92 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.27 -33.02 0.52 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -73.63 -55.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 N-CA-C 108.528 -1.374 . . . . 0.0 108.528 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -42.36 -33.15 0.6 Allowed 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -72.18 -49.3 36.65 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 2.2 m170 -69.09 -6.05 25.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.06 -55.36 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.44 -27.85 2.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 109.158 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.32 23.38 2.92 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.533 HD23 ' CG2' ' A' ' 268' ' ' THR . 0.3 OUTLIER -67.17 173.13 4.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.179 -1.189 . . . . 0.0 109.34 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.533 ' HA ' ' HG3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -163.06 -35.55 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 110.553 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 26' ' ' VAL . . . 73.68 -5.34 23.84 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -44.0 134.08 4.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.132 -1.216 . . . . 0.0 109.665 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 7.92 56.04 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.591 ' CG1' ' NE2' ' A' ' 118' ' ' HIS . 27.0 t -107.86 164.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -1.217 . . . . 0.0 109.246 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 2.0 mptt -145.01 118.25 8.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.0 110.32 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.426 HG11 HG13 ' A' ' 119' ' ' VAL . 2.5 t -125.92 128.01 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.3 159.97 23.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -134.43 87.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.78 -1.2 . . . . 0.0 109.794 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' CG2' ' A' ' 91' ' ' VAL . 10.0 mp -66.74 126.17 28.15 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -177.79 -146.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.704 -1.247 . . . . 0.0 109.961 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -137.61 72.57 1.42 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.023 -1.048 . . . . 0.0 110.654 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 64' ' ' THR . . . 111.87 118.38 3.69 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.416 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 36' ' ' SER . 3.9 mm -115.26 -18.87 7.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.675 0.75 . . . . 0.0 109.11 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 33.0 104.61 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.818 0.818 . . . . 0.0 111.483 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -58.61 147.66 31.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 108.692 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.519 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -146.13 177.14 1.87 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.314 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 38' ' ' HIS . 33.6 Cg_endo -76.33 -4.95 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.215 1.943 . . . . 0.0 109.626 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 73' ' ' LEU . 2.6 t0 -114.97 -22.53 9.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.166 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.36 122.75 39.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -97.36 103.38 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 108.65 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 44' ' ' ARG . 3.9 mt -89.68 163.48 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.074 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.547 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 6.9 tpt180 -135.88 -32.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -163.51 161.94 34.53 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.44 165.71 36.75 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.971 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.44 165.02 17.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.522 -0.987 . . . . 0.0 109.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -126.53 142.07 51.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -116.38 -53.01 2.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.385 -0.822 . . . . 0.0 109.776 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.3 125.54 71.45 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 C-N-CA 122.425 2.084 . . . . 0.0 111.31 -179.092 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.501 2.118 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.434 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 8.8 t -56.6 -14.63 3.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.134 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 58' ' ' ASP . 47.7 mt-30 -108.92 143.5 38.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 57' ' ' GLN . 40.8 t0 61.34 136.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.462 -0.774 . . . . 0.0 110.392 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.27 -39.39 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.1 -35.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -1.031 . . . . 0.0 108.927 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.84 -16.97 4.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -68.31 -58.06 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 109.296 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -61.76 6.28 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLY . 3.3 m -45.82 -41.13 10.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -1.109 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 5.2 t-80 -58.83 -56.81 17.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.733 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 70' ' ' ILE . 41.8 t -55.45 -35.08 36.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.74 85.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.719 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 72' ' ' ALA . . . -75.15 -21.38 78.19 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.566 HG22 ' CE1' ' A' ' 220' ' ' HIS . 15.7 m -81.47 -11.51 59.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 108.166 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 66' ' ' VAL . 38.4 mt -103.51 -28.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -156.71 11.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.622 -1.299 . . . . 0.0 112.323 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB3' ' CA ' ' A' ' 68' ' ' GLY . . . -40.01 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.691 -1.256 . . . . 0.0 110.626 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 71' ' ' ALA . 9.7 mt -45.76 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.881 -1.137 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 6.8 t-20 -92.74 155.23 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.451 -0.781 . . . . 0.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 9.0 p-10 154.43 124.71 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 75' ' ' ASN . 22.8 t -41.59 -27.26 0.09 Allowed 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.869 -0.519 . . . . 0.0 109.734 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.8 pt -83.52 68.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 208' ' ' TYR . . . 123.36 146.93 7.2 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 201' ' ' SER . 10.2 m -64.31 -149.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.522 HD11 ' CA ' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -158.06 141.34 15.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.474 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -97.86 -144.6 17.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.513 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 0.5 OUTLIER -91.48 -72.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 0.0 109.896 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -63.04 144.08 97.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.533 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 37.3 Cg_endo -86.69 -64.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.369 2.046 . . . . 0.0 110.113 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 21.6 t-20 -105.76 -87.08 0.47 Allowed 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.001 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 54.79 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.105 -0.997 . . . . 0.0 110.08 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 7.6 mt-10 -95.49 107.71 19.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 71' ' ' ALA . 5.5 mt -92.91 106.56 18.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 109.974 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.581 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 14.2 m-85 -87.88 153.86 20.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.534 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.447 ' CB ' HG13 ' A' ' 35' ' ' ILE . . . -119.0 108.92 15.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.791 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -111.32 65.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.989 . . . . 0.0 110.214 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' VAL . 14.5 ttmm -38.83 114.5 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -143.38 21.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 120.97 -1.081 . . . . 0.0 111.327 -177.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' GLY . 22.6 mt -150.29 168.55 23.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.241 -1.537 . . . . 0.0 111.77 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 94' ' ' LEU . . . -46.34 -166.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.022 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.524 ' HB2' ' OG1' ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 CA-C-O 122.246 0.914 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.0 t -68.17 179.5 1.54 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.419 0.628 . . . . 0.0 109.407 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.562 ' CG2' ' OG ' ' A' ' 130' ' ' SER . 48.4 t -66.02 -14.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 m -75.07 -22.67 58.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.73 -53.34 4.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 109.261 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.484 ' HA ' HG21 ' A' ' 93' ' ' VAL . 2.3 mt -62.15 -45.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 102' ' ' VAL . . . -63.18 -47.28 83.31 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -52.23 -39.26 60.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.862 . . . . 0.0 109.442 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.28 39.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 109' ' ' LEU . 12.9 mt -66.03 -11.05 45.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -1.116 . . . . 0.0 109.12 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.9 -25.7 15.34 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.334 -0.854 . . . . 0.0 109.45 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -72.98 -15.15 61.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.617 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -96.22 -11.82 25.5 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.947 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -84.46 -26.2 40.24 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 115' ' ' ASN . 3.8 m120 -123.3 28.84 6.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 108.999 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER 162.73 32.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -102.98 -147.54 18.97 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.552 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 6.0 mmt -134.9 -178.74 5.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.614 -0.933 . . . . 0.0 109.779 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.634 ' CD2' ' O ' ' A' ' 27' ' ' LYS . 10.7 p80 -66.0 -40.37 91.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.78 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.588 HG22 ' CE1' ' A' ' 118' ' ' HIS . 55.5 t -120.57 165.6 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.833 -1.167 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.544 ' N ' ' CG1' ' A' ' 119' ' ' VAL . . . -169.02 132.08 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.467 ' O ' ' CD1' ' A' ' 122' ' ' LEU . 4.9 t-20 -90.34 167.85 12.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.792 -1.192 . . . . 0.0 109.785 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.562 ' CG ' HD13 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -149.54 105.24 3.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.98 . . . . 0.0 109.041 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 9.6 m -96.2 68.77 2.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 108.985 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.562 HD13 ' CG ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -111.35 -165.94 1.03 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.259 1.028 . . . . 0.0 110.091 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.42 105.03 1.51 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.482 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -168.91 172.76 2.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.251 . . . . 0.0 109.84 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.497 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 34.8 Cg_endo -79.15 4.66 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.796 2.331 . . . . 0.0 109.916 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.588 ' N ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -117.83 44.09 0.49 Allowed Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.556 -0.715 . . . . 0.0 111.464 -178.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.598 ' HB2' ' CE1' ' A' ' 161' ' ' TYR . 37.5 Cg_endo -76.42 173.71 14.03 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.951 1.767 . . . . 0.0 110.532 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.562 ' OG ' ' CG2' ' A' ' 102' ' ' VAL . 3.0 m -149.65 131.5 15.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.31 66.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.442 ' HB ' HG13 ' A' ' 102' ' ' VAL . 3.3 m -66.28 -29.94 70.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.462 HD12 HG21 ' A' ' 105' ' ' ILE . 0.6 OUTLIER -69.17 -35.22 76.06 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -63.37 -51.11 67.26 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -48.56 -26.49 2.23 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 133' ' ' LEU . . . -69.53 -45.67 68.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.921 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 165' ' ' TYR . 0.9 OUTLIER -62.95 -30.31 49.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 135' ' ' GLN . 21.6 m120 -60.33 -36.2 77.42 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.2 p -78.85 -22.54 45.95 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.14 54.41 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.096 -1.002 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 -46.53 16.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.038 -1.039 . . . . 0.0 108.747 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -29.98 8.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -86.2 -33.21 20.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.891 . . . . 0.0 109.092 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.76 61.93 1.49 Allowed Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.492 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 43.9 t -108.79 99.7 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.482 -1.01 . . . . 0.0 109.874 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.52 111.03 1.1 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.942 -1.099 . . . . 0.0 108.079 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -115.02 137.25 49.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 110.278 -178.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 121' ' ' ASN . 1.5 p -113.92 150.92 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 163' ' ' ALA . . . -134.3 144.4 48.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.962 -1.087 . . . . 0.0 110.422 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -57.79 152.74 15.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 109.8 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -59.15 -73.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.051 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 138.8 121.7 1.94 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -99.79 55.1 0.94 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.525 ' OG ' ' HG2' ' A' ' 185' ' ' GLN . 0.0 OUTLIER -91.53 -86.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.841 . . . . 0.0 109.774 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.427 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 146.3 83.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 179.64 176.65 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.374 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.59 43.19 3.19 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.5 OUTLIER -158.79 166.25 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -1.072 . . . . 0.0 108.83 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.536 HG12 ' CA ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -106.44 -174.48 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 109.666 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -71.33 157.84 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.817 0.818 . . . . 0.0 110.174 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -115.17 138.14 23.37 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 103.906 -2.628 . . . . 0.0 103.906 176.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.71 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.5 Cg_endo -72.64 -49.9 0.21 Allowed 'Cis proline' 0 C--N 1.295 -2.272 0 O-C-N 122.967 0.983 . . . . 0.0 111.826 4.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.522 ' HA ' ' CB ' ' A' ' 149' ' ' ALA . . . 36.21 -77.91 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -41.61 -55.23 2.98 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.625 ' CZ ' ' CG ' ' A' ' 162' ' ' PRO . 0.3 OUTLIER 46.9 -178.88 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.26 -16.73 12.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.432 ' OD1' HG12 ' A' ' 137' ' ' VAL . 30.0 p-10 -129.44 13.8 6.04 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -127.22 157.28 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.453 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -105.45 159.31 16.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.061 -1.024 . . . . 0.0 110.093 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -111.47 116.37 30.78 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.5 t -81.84 167.42 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -134.93 -165.57 10.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -143.48 137.99 28.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.934 -1.333 . . . . 0.0 110.666 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 p -109.15 168.58 9.27 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 181' ' ' ALA . 4.2 t70 -95.61 -40.14 9.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.29 1.043 . . . . 0.0 109.804 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -152.27 -103.62 0.05 Allowed 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -62.01 -48.85 78.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.722 -1.236 . . . . 0.0 107.72 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.545 ' CB ' HD23 ' A' ' 251' ' ' LEU . 0.5 OUTLIER 173.73 68.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 2.1 t-20 -97.03 -11.74 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.772 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.572 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 1.7 ttp180 82.07 12.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.366 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.471 ' HB3' ' CE1' ' A' ' 183' ' ' PHE . . . 53.97 -159.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.499 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.02 30.7 3.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 1.0 OUTLIER -152.36 -28.2 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.1 -1.0 . . . . 0.0 110.691 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -45.41 124.17 4.67 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.809 -1.182 . . . . 0.0 109.277 179.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.525 ' HG2' ' OG ' ' A' ' 154' ' ' SER . 1.3 mp0 -75.98 149.45 37.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.155 -0.966 . . . . 0.0 111.048 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.57 ' CZ ' HD21 ' A' ' 256' ' ' LEU . 0.8 OUTLIER -68.09 -174.73 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.488 0.661 . . . . 0.0 110.67 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.536 ' CA ' HG12 ' A' ' 159' ' ' ILE . . . -173.27 150.24 11.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -83.11 68.9 9.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -1.051 . . . . 0.0 109.005 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 118.56 41.71 0.61 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 189' ' ' GLY . 7.7 tp -41.22 150.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.469 -1.018 . . . . 0.0 109.283 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.473 ' O ' ' OG ' ' A' ' 259' ' ' SER . 0.5 OUTLIER -90.64 -60.85 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.542 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.508 HD12 ' CG2' ' A' ' 262' ' ' VAL . 14.3 tt -155.5 171.23 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 109.566 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 27.2 m -127.92 160.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.038 -1.039 . . . . 0.0 109.964 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -152.69 132.82 7.38 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -71.61 121.11 7.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.609 1.539 . . . . 0.0 110.283 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.27 61.23 0.55 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 50.1 t -102.08 66.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -1.186 . . . . 0.0 108.483 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASN . . . . . 0.65 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 2.2 t-20 111.48 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 6' ' ' TRP . 11.8 m -159.37 111.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 122.273 1.035 . . . . 0.0 108.77 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.3 pm0 -87.61 124.83 33.93 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.495 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . 0.58 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -135.85 -156.17 0.69 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.633 -0.667 . . . . 0.0 109.253 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 34.8 p -77.06 -177.92 4.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.042 0.925 . . . . 0.0 110.586 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' TYR . . . . . 0.609 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -156.94 151.83 21.07 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.4 Cg_endo -69.83 164.47 34.49 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.996 1.797 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 75.26 12.27 83.64 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 72.34 33.18 1.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.623 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -120.48 171.2 8.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.758 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.419 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 87.6 m-85 -122.73 176.2 6.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 176.91 175.38 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.654 -1.279 . . . . 0.0 110.782 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -135.07 131.07 36.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.527 -0.733 . . . . 0.0 109.419 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.412 HD21 ' C ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -148.01 108.06 4.05 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.969 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . 0.442 ' HB3' ' N ' ' A' ' 198' ' ' ASN . 18.8 p30 -63.87 169.4 4.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.389 -0.82 . . . . 0.0 108.908 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 156.69 7.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.39 -35.85 61.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.202 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -14.09 19.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 109.642 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' MET . . . . . 0.458 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -90.54 -24.01 20.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.899 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -89.52 -7.63 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 109.417 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.627 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 13.4 m -71.95 -41.52 9.03 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 111.505 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.1 Cg_endo -73.27 -21.08 20.51 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.699 1.599 . . . . 0.0 110.923 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.566 ' CE1' HG22 ' A' ' 69' ' ' THR . 3.8 m80 -64.34 -42.08 96.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.72 -47.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -46.89 -35.36 6.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -70.77 -56.08 7.67 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -46.62 -41.51 14.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.948 -1.325 . . . . 0.0 109.444 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.7 99.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 108.809 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.1 -45.54 75.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 21' ' ' LEU . 42.4 mt -59.21 -50.58 73.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 95.7 t -56.0 -49.06 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.973 -1.079 . . . . 0.0 109.57 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.611 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.5 OUTLIER -48.54 -42.97 34.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.519 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLN . . . . . 0.489 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.15 -45.52 93.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.911 -1.118 . . . . 0.0 109.574 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.414 ' HE3' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.59 -10.11 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.222 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 231' ' ' LYS . 5.0 m-80 -174.19 72.93 0.34 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.4 Cg_endo -79.39 -0.84 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.638 2.225 . . . . 0.0 110.735 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 42.4 m -84.1 -3.76 58.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.143 -0.973 . . . . 0.0 109.842 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' TRP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 239' ' ' GLN . 31.6 m0 -81.89 176.24 9.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.188 -0.945 . . . . 0.0 109.938 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.7 OUTLIER -103.47 159.57 15.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' SER . 6.6 p30 -45.28 -37.17 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.102 . . . . 0.0 109.826 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.8 t -72.74 -62.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.224 -0.922 . . . . 0.0 110.163 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 3.6 tp60 -41.22 -50.15 3.6 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.567 0.698 . . . . 0.0 109.483 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 229' ' ' LYS . 20.9 mt -57.07 -48.84 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.52 -0.737 . . . . 0.0 109.377 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -47.16 -38.56 12.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.76 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 22.9 t-20 -67.43 -38.13 84.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 109.743 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' HIS . . . . . 0.462 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.9 t60 -64.85 -43.97 91.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.826 . . . . 0.0 110.442 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.65 -29.89 56.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -78.87 -23.72 44.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 1.6 t30 -95.98 -17.87 20.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 2.6 p -90.46 -30.51 17.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.781 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.27 160.82 1.03 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.3 m -88.88 111.39 22.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.104 -0.998 . . . . 0.0 109.706 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -84.97 116.12 23.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.378 -0.826 . . . . 0.0 108.951 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.545 HD23 ' CB ' ' A' ' 178' ' ' ASN . 6.1 mp . . . . . 0 C--N 1.305 -1.359 0 O-C-N 121.058 -1.026 . . . . 0.0 109.53 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.573 HD11 ' CD1' ' A' ' 257' ' ' TYR . 2.7 tm? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.573 ' CD1' HD11 ' A' ' 256' ' ' LEU . 87.1 m-85 -63.27 -23.69 67.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.45 -98.28 0.27 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 191' ' ' ASP . 0.3 OUTLIER -84.07 -39.83 19.08 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.253 -1.146 . . . . 0.0 108.94 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 100.45 -122.1 7.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.7 161.25 17.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.813 -0.816 . . . . 0.0 108.804 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 192' ' ' ILE . 1.5 t -119.54 154.41 22.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 110.289 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -151.12 117.46 5.66 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.206 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.48 ' O ' ' HB ' ' A' ' 268' ' ' THR . . . -82.33 6.01 18.35 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.796 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 67.1 tt0 -94.54 -23.96 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.723 -1.236 . . . . 0.0 109.264 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -95.99 -16.73 21.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.167 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -98.53 -13.91 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' THR . . . . . 0.533 ' CG2' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -117.49 -9.85 10.77 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.055 -1.028 . . . . 0.0 109.066 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 268' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.73 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.437 ' CD ' ' HB2' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -83.09 -172.71 4.29 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -111.4 109.37 19.31 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.611 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -132.38 153.71 81.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.799 . . . . 0.0 109.384 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 9' ' ' SER . 35.5 Cg_endo -77.68 171.94 16.6 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.857 2.371 . . . . 0.0 111.119 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.7 OUTLIER -52.14 -19.06 1.73 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.542 -0.724 . . . . 0.0 110.473 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.497 ' N ' ' CD1' ' A' ' 6' ' ' TRP . . . -63.16 -52.25 48.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.566 ' CD1' ' NE2' ' A' ' 220' ' ' HIS . 0.0 OUTLIER -83.9 -20.21 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -1.223 . . . . 0.0 109.662 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -64.34 -26.39 68.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.91 -1.118 . . . . 0.0 109.658 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 22.1 ttm105 -96.32 -0.66 49.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 110.627 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 8' ' ' ILE . 3.2 m -99.77 17.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.585 -1.322 . . . . 0.0 110.29 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER 39.91 45.81 1.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.56 -0.713 . . . . 0.0 109.827 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.713 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.22 -27.28 0.34 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.0 Cg_endo -74.28 -56.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.847 -1.251 . . . . 0.0 108.847 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.76 -31.63 0.86 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.98 -43.9 51.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 13' ' ' ALA . 6.3 m170 -66.85 -15.5 63.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -0.787 . . . . 0.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -96.25 -24.82 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 0.0 109.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' NH1' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -69.15 -32.04 71.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.73 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.65 -16.67 5.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 144.58 56.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -1.147 . . . . 0.0 109.179 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -133.53 1.5 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.023 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 230' ' ' GLN . . . 57.57 6.49 2.46 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 22' ' ' THR . 1.4 t -66.49 134.01 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.371 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.57 -4.74 37.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.46 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 28.2 t -98.97 170.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -1.167 . . . . 0.0 109.275 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.563 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -140.46 128.85 22.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.894 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.417 HG12 ' CG1' ' A' ' 119' ' ' VAL . 1.9 t -133.97 134.88 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.415 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -92.35 154.51 18.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.23 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -127.56 87.0 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.983 -1.073 . . . . 0.0 108.768 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.53 ' HG ' ' HB ' ' A' ' 93' ' ' VAL . 5.5 mp -65.27 95.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 20.9 p-10 -144.93 -144.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.488 HG21 ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -145.04 27.78 1.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.107 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.06 119.8 0.9 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -103.96 11.54 8.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.948 -0.736 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER 51.84 126.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.994 0.902 . . . . 0.0 111.17 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.84 115.36 10.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.003 -1.06 . . . . 0.0 108.882 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.529 ' NE2' ' HA ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -145.24 157.34 53.4 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.499 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.0 Cg_endo -78.52 0.96 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.702 2.268 . . . . 0.0 110.378 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.09 -15.95 14.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.103 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.13 119.07 35.84 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 108.841 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -96.64 105.08 17.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.492 HD13 HG23 ' A' ' 35' ' ' ILE . 1.7 mm -69.47 112.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.335 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.446 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 2.4 mmt85 -100.26 -19.78 16.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.173 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 156.71 28.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . -177.1 140.45 4.9 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.981 -1.305 . . . . 0.0 110.021 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.45 126.82 14.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -1.086 . . . . 0.0 109.297 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -104.3 116.53 32.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.134 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CD2' ' OE1' ' A' ' 107' ' ' GLN . 42.3 m-85 -104.1 -57.0 2.1 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.19 -0.944 . . . . 0.0 109.828 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.57 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 1.5 p -42.06 148.88 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.57 ' HD2' ' CG2' ' A' ' 50' ' ' VAL . 29.2 Cg_endo -66.63 -168.27 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.035 1.824 . . . . 0.0 109.986 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 57.88 94.76 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.43 94.69 16.63 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.352 -1.087 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 34.7 Cg_endo -78.76 -64.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.784 2.323 . . . . 0.0 109.053 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -175.11 137.59 0.41 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.36 0.6 . . . . 0.0 109.523 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -15.39 18.44 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.36 -0.837 . . . . 0.0 108.767 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 2.4 mp0 -128.67 112.24 14.03 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 13.8 t70 83.31 157.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.498 0.666 . . . . 0.0 109.768 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.96 -20.92 0.51 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.488 ' ND2' HG21 ' A' ' 33' ' ' THR . 0.4 OUTLIER -145.22 -83.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.617 -0.931 . . . . 0.0 108.899 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 64' ' ' THR . . . 159.55 -54.48 0.35 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 215' ' ' SER . 30.0 t-80 -46.31 -57.79 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 110.159 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -38.43 -57.58 1.81 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.527 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 0.6 OUTLIER -51.13 -47.5 61.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -1.143 . . . . 0.0 109.434 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.586 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -52.08 -55.84 18.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.325 -0.86 . . . . 0.0 109.473 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 219' ' ' PRO . 39.9 t -53.51 -34.01 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 64' ' ' THR . . . -58.85 -55.56 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.222 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.38 75.54 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.544 HG21 ' CD2' ' A' ' 220' ' ' HIS . 21.4 m -73.84 -18.54 60.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 108.122 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 219' ' ' PRO . 4.9 mt -98.85 -30.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . . . -170.13 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 112.101 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -44.87 121.27 2.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.661 -1.274 . . . . 0.0 108.607 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 84' ' ' PRO . 17.0 mt -43.74 151.91 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.982 . . . . 0.0 110.532 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 46.5 t-20 -105.69 64.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.0 109.412 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.584 ' O ' ' CB ' ' A' ' 76' ' ' SER . 86.0 m-20 -94.53 -1.36 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.504 -0.748 . . . . 0.0 110.098 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 5.0 t 91.18 -34.47 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -85.51 133.5 29.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.88 -175.63 45.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 200' ' ' GLN . 5.1 m -76.01 -174.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.2 -1.177 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.557 HD22 ' CE1' ' A' ' 17' ' ' HIS . 1.6 tp -141.0 113.58 8.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.306 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -76.49 -165.74 21.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.551 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 6.8 t -80.28 -32.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.281 . . . . 0.0 109.453 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.553 ' CB ' ' HB3' ' A' ' 71' ' ' ALA . . . -104.6 148.12 35.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.056 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' CG ' ' O ' ' A' ' 22' ' ' THR . 37.9 Cg_endo -84.87 -63.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 110.383 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -113.92 -87.64 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.324 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . 59.8 170.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.449 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 26.0 mm-40 -93.38 85.51 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mt -79.28 109.88 14.04 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 3.2 m-85 -91.18 -177.35 4.86 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.951 0.881 . . . . 0.0 110.448 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -147.28 96.09 2.65 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -99.81 78.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -51.88 89.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.55 ' N ' ' O ' ' A' ' 91' ' ' VAL . 12.6 p -98.72 -23.69 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 108.929 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.456 ' N ' HG11 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -111.84 162.95 14.73 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.49 152.81 17.95 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.38 -18.29 3.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.172 -1.193 . . . . 0.0 109.04 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 m -52.98 -57.72 9.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.32 -21.25 0.12 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.816 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.8 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.739 -1.447 . . . . 0.0 110.015 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -52.63 179.06 0.08 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -76.44 174.64 10.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.641 -0.917 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.2 t -68.62 -18.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.503 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -73.87 -18.37 60.93 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.505 ' O ' ' NE2' ' A' ' 107' ' ' GLN . 19.0 m -88.07 -52.29 5.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.498 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.3 mt -62.27 -30.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.0 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.52 -50.9 14.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 108.981 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.584 ' OE1' ' CD2' ' A' ' 49' ' ' PHE . 2.7 pp0? -61.82 -23.93 66.55 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 109.552 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.17 -36.62 20.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -80.37 -13.8 58.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 108.973 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -97.13 -32.88 11.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -67.56 -21.29 65.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.618 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -86.21 -19.37 30.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -55.54 -34.13 59.81 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 114' ' ' ASN . 0.1 OUTLIER -101.95 -61.7 1.35 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.464 -1.021 . . . . 0.0 109.161 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' O ' ' SD ' ' A' ' 117' ' ' MET . 1.3 m-20 -104.16 40.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 108.921 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.618 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -94.23 21.05 44.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.563 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 41.14 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.527 -0.984 . . . . 0.0 110.428 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.641 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -85.53 -22.14 28.26 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 111.239 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 83.5 t -129.38 165.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.327 -1.483 . . . . 0.0 110.232 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -166.7 128.1 1.7 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 148' ' ' VAL . 6.3 t-20 -105.8 153.68 21.56 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.57 -1.331 . . . . 0.0 110.128 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.545 ' CD1' ' CG1' ' A' ' 147' ' ' VAL . 5.0 mp -135.84 92.82 2.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 62.01 7.21 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.258 -0.901 . . . . 0.0 108.72 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 4.0 pp -147.64 173.74 12.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . -176.92 97.45 0.11 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 2.4 m -96.52 146.71 31.78 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.63 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.1 Cg_endo -77.37 -5.38 15.59 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.474 2.116 . . . . 0.0 109.359 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.5 t -98.54 107.64 43.6 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.756 -0.59 . . . . 0.0 110.224 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 33.0 Cg_endo -76.97 165.83 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.01 1.807 . . . . 0.0 109.609 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.69 132.78 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.654 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.92 65.72 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 64.4 m -63.88 -31.99 73.36 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.9 tp -75.85 -34.86 60.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -30.32 68.05 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.386 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.485 ' O ' ' HG3' ' A' ' 135' ' ' GLN . 4.0 tp60 -70.33 -25.61 63.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.9 -48.69 20.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.049 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -63.25 -26.46 40.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.3 -36.75 85.03 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.0 t -77.62 -17.77 57.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.887 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.52 -38.11 22.18 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.686 -1.259 . . . . 0.0 111.248 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.802 -1.186 . . . . 0.0 108.571 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -25.32 67.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -112.62 -16.58 12.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.126 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.46 84.99 1.16 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.95 105.23 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -1.028 . . . . 0.0 108.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.81 118.75 8.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.871 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.545 ' CG1' ' CD1' ' A' ' 122' ' ' LEU . 0.1 OUTLIER -112.94 139.28 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.216 -0.928 . . . . 0.0 109.14 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.56 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 14.5 p -127.17 68.14 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.918 -1.114 . . . . 0.0 110.114 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.63 156.51 1.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.076 -1.015 . . . . 0.0 110.95 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.456 ' HB3' ' OG1' ' A' ' 218' ' ' THR . . . -84.45 -174.57 5.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.6 -0.688 . . . . 0.0 110.032 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.3 OUTLIER -91.95 -85.09 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.836 -0.54 . . . . 0.0 109.78 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -178.61 -114.29 0.41 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 154' ' ' SER . 0.4 OUTLIER 177.72 34.51 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER 87.06 102.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.321 0.581 . . . . 0.0 109.537 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.534 ' N ' ' NE2' ' A' ' 185' ' ' GLN . . . -172.0 95.75 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 66.07 171.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -1.166 . . . . 0.0 109.647 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.78 51.9 4.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 0.8 OUTLIER -148.96 170.31 18.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -1.168 . . . . 0.0 109.645 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.11 -171.47 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.0 110.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.495 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -62.42 176.04 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.582 1.182 . . . . 0.0 112.186 -178.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 126' ' ' SER . 8.8 m-85 -128.73 127.6 23.5 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.8 Cg_endo -72.33 -45.73 0.43 Allowed 'Cis proline' 0 C--N 1.301 -1.944 0 O-C-N 123.14 1.074 . . . . 0.0 110.726 3.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 160' ' ' SER . . . 27.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.158 0.98 . . . . 0.0 109.645 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.742 ' N ' ' O ' ' A' ' 162' ' ' PRO . 7.0 ttt180 -39.35 -60.25 0.95 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.758 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.58 ' O ' ' CB ' ' A' ' 166' ' ' ALA . 55.0 p90 -120.02 -164.66 1.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 165' ' ' TYR . . . 85.98 26.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.775 0.797 . . . . 0.0 109.011 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 55.01 20.26 3.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.32 131.67 51.41 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.45 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 4.4 mtp -76.19 151.49 36.89 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.34 129.21 55.73 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 32.1 t -100.17 165.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 109.235 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.07 167.66 24.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 214' ' ' THR . . . -96.17 168.91 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' ' 194' ' ' ALA . 13.5 p -135.64 178.79 6.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 109.5 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 176' ' ' GLN . 14.2 t0 -108.41 -142.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.771 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 175' ' ' ASP . 12.0 tt0 -35.45 -63.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.988 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -122.16 -60.93 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.838 -1.164 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.77 -19.7 1.03 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.033 -1.042 . . . . 0.0 111.224 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -47.17 164.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.767 -1.208 . . . . 0.0 109.338 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -69.93 132.86 46.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.332 -0.855 . . . . 0.0 109.729 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -55.72 -154.25 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 m -117.15 -27.34 6.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -119.62 14.04 12.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.716 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.9 t -77.41 142.36 39.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.144 -0.973 . . . . 0.0 109.296 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.534 ' NE2' ' N ' ' A' ' 155' ' ' GLY . 5.9 tt0 -90.69 166.15 13.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -141.65 173.53 11.42 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 -179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.646 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.62 -178.63 48.39 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.11 68.06 5.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -1.178 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.77 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 256' ' ' LEU . 3.2 tp -72.75 142.54 48.14 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.067 -1.255 . . . . 0.0 109.521 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 8.4 t0 -101.67 -57.34 2.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.542 ' CG2' HG23 ' A' ' 171' ' ' VAL . 3.8 tt -151.25 -178.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.539 HG23 ' CA ' ' A' ' 260' ' ' GLY . 6.0 m -149.66 -179.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.314 -0.867 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.503 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -175.01 172.78 1.1 Allowed Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 30.8 Cg_endo -72.0 116.55 4.75 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.067 1.845 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.94 44.69 1.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.646 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 40.6 t -124.45 54.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -1.092 . . . . 0.0 108.415 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.646 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 24.3 t-20 127.36 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 22.7 m -160.33 105.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-O 122.32 1.057 . . . . 0.0 109.689 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -80.96 135.87 35.94 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.586 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 1.3 t -149.05 -157.09 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 5.0 t -84.02 176.18 9.02 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.983 0.896 . . . . 0.0 110.758 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.641 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -162.7 155.55 16.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.7 Cg_endo -70.41 161.99 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.008 1.805 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 81.71 15.04 76.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.529 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 5.5 m 68.8 35.17 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.674 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -133.89 161.8 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 110.366 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 201' ' ' SER . 0.0 OUTLIER -114.56 170.23 8.46 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.19 151.26 17.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.775 -1.203 . . . . 0.0 110.281 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -106.97 146.13 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.129 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.453 HD13 ' HE3' ' A' ' 216' ' ' MET . 0.0 OUTLIER -152.99 162.31 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -125.16 141.29 52.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.086 -1.009 . . . . 0.0 109.736 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.512 ' N ' ' SD ' ' A' ' 216' ' ' MET . . . 166.38 167.8 27.59 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.442 ' HB ' ' HB1' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -85.78 -17.53 35.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -1.092 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.569 ' O ' ' CD ' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -65.08 -39.46 93.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.46 -0.775 . . . . 0.0 109.118 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.529 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -68.87 -44.96 72.22 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.051 0.929 . . . . 0.0 109.84 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -68.81 -19.65 64.29 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.861 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.613 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 28.6 m -64.5 -52.36 53.24 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.737 -1.227 . . . . 0.0 111.086 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -66.38 -9.88 25.55 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.864 1.709 . . . . 0.0 110.656 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.566 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -71.55 -39.24 70.79 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 47.0 t -76.63 -34.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.513 ' HB1' HG13 ' A' ' 148' ' ' VAL . . . -58.43 -39.1 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -71.4 -50.07 22.81 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -45.92 -51.46 13.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -1.194 . . . . 0.0 108.604 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -41.47 72.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.57 -49.57 61.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.117 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 39.3 mt -54.63 -45.08 73.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 229' ' ' LYS . 76.2 t -54.99 -65.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -43.39 -37.71 2.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.21 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.441 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 9.8 tm0? -57.86 -57.01 14.66 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.083 -1.01 . . . . 0.0 109.897 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -54.23 -19.13 4.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.204 -0.935 . . . . 0.0 108.905 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.491 ' N ' ' HG3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -140.7 86.43 12.06 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.249 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.97 -2.93 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.677 2.251 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -10.81 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -73.73 178.49 4.76 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.73 173.62 8.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.253 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.24 -20.1 25.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.1 t -79.89 -65.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.969 -1.082 . . . . 0.0 109.106 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.1 mp0 -46.86 -34.68 5.59 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.427 HD12 HG22 ' A' ' 240' ' ' ILE . 24.0 mt -65.8 -48.33 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -50.25 -34.8 24.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.868 -1.145 . . . . 0.0 108.978 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -62.89 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.883 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.484 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.9 t60 -48.11 -51.47 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.907 . . . . 0.0 110.434 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.489 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.3 OUTLIER -63.17 -27.22 69.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 110.894 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 61.9 tttt -73.31 -52.04 15.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.024 -1.047 . . . . 0.0 110.228 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 14.0 t-20 -78.73 -10.11 59.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 110.454 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 25.5 p -94.42 -37.41 11.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.893 -1.129 . . . . 0.0 110.121 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -64.82 136.1 56.51 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.401 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 259' ' ' SER . 15.5 m -45.93 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 108.913 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 0.7 OUTLIER -145.4 87.07 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 110.131 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 257' ' ' TYR . 5.8 mp -46.51 -50.8 16.56 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.584 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 122.08 -116.98 3.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 2.3 m 58.17 -179.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -1.063 . . . . 0.0 109.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.7 p -90.26 -23.8 21.11 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.264 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -175.48 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.905 -1.122 . . . . 0.0 110.466 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.449 ' O ' HD21 ' A' ' 190' ' ' LEU . 0.3 OUTLIER -50.5 -62.77 1.39 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.828 -1.17 . . . . 0.0 109.455 -179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 251' ' ' LEU . 31.7 m-85 -88.78 -77.43 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.494 -0.754 . . . . 0.0 110.211 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 42.9 90.41 0.01 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 250' ' ' SER . 1.8 m 61.37 103.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.937 -1.331 . . . . 0.0 107.967 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.539 ' CA ' HG23 ' A' ' 193' ' ' VAL . . . -139.74 -27.09 0.24 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.371 -1.395 . . . . 0.0 111.651 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.24 146.62 28.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.335 -1.686 . . . . 0.0 108.949 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.68 155.2 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.98 . . . . 0.0 110.056 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.45 117.38 2.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.537 1.16 . . . . 0.0 107.942 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -12.67 61.85 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.975 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.498 ' HG2' ' NH1' ' A' ' 269' ' ' ARG . 11.5 tt0 -66.73 -41.33 88.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.004 -1.06 . . . . 0.0 109.137 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.475 ' HA ' ' NH2' ' A' ' 269' ' ' ARG . . . -82.38 -14.0 55.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -93.45 -16.41 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.183 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 269' ' ' ARG . 74.0 p -118.11 -60.46 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.498 ' NH1' ' HG2' ' A' ' 265' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.573 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 135.86 46.53 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -0.888 . . . . 0.0 109.377 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 24.6 p -92.56 129.15 38.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 109.788 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.28 81.89 30.41 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.023 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HD2' HG13 ' A' ' 8' ' ' ILE . 33.7 Cg_endo -77.7 159.84 31.51 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.621 2.214 . . . . 0.0 111.347 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CZ3' ' O ' ' A' ' 176' ' ' GLN . 2.6 p-90 -57.88 -26.3 61.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.683 -0.635 . . . . 0.0 110.573 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 8' ' ' ILE . . . -89.33 53.88 3.86 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.508 HD12 ' NE2' ' A' ' 220' ' ' HIS . 14.6 mm -151.55 -50.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 109.517 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.407 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -80.26 -13.02 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.42 -28.8 61.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 8' ' ' ILE . 2.8 m -88.61 24.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 1.0 OUTLIER 50.14 45.76 25.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.675 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -82.85 -32.3 0.55 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 111.774 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -74.31 -55.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.18 -28.45 0.77 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.61 -41.98 36.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 109.239 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -66.27 -24.25 66.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.524 -0.735 . . . . 0.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -92.73 -31.04 15.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.604 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -30.09 56.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.612 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.46 19.63 3.43 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.533 ' CD1' ' CG2' ' A' ' 268' ' ' THR . 3.2 mt -101.9 120.62 40.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -1.151 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -97.98 -24.59 15.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.294 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.35 -1.31 13.35 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 22' ' ' THR . 67.3 p -71.74 117.73 13.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.116 -1.226 . . . . 0.0 109.389 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.13 -16.54 4.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 19.1 t -89.75 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.218 -1.166 . . . . 0.0 109.395 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' HB3' ' CG ' ' A' ' 117' ' ' MET . 25.9 mttp -138.89 122.75 17.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -127.04 127.49 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -85.12 151.31 24.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.969 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 30' ' ' VAL . 35.2 t -115.14 78.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.468 ' CD2' HG23 ' A' ' 93' ' ' VAL . 5.6 mp -71.72 114.88 10.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 123' ' ' SER . 5.5 m-20 -175.75 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.513 1.149 . . . . 0.0 108.898 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.546 HG23 ' CB ' ' A' ' 60' ' ' ASN . 7.5 p -141.97 -73.59 0.31 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.593 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -160.18 -129.04 1.01 Allowed Glycine 0 C--N 1.3 -1.437 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.553 HG12 ' CB ' ' A' ' 90' ' ' ALA . 1.4 mm -170.82 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.469 ' OG ' ' OG1' ' A' ' 64' ' ' THR . 1.1 m -46.68 129.89 11.36 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 109.202 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.74 104.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.452 ' NE2' ' HA ' ' A' ' 206' ' ' SER . 0.2 OUTLIER -130.52 151.52 78.79 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 109.005 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -12.39 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.555 2.17 . . . . 0.0 110.377 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 8.8 m-20 -88.21 -31.51 19.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 ' HB2' ' A' ' 38' ' ' HIS . 5.0 mt -89.34 115.79 27.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.4 t-20 -78.37 104.28 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 108.747 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 HG21 ' O ' ' A' ' 88' ' ' LEU . 1.4 mt -96.02 -177.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.502 ' CD ' ' OE1' ' A' ' 87' ' ' GLU . 2.1 tpt85 -152.69 -39.47 0.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -175.96 166.94 38.43 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.36 174.83 45.6 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.794 -1.416 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -170.1 153.15 4.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.389 -1.065 . . . . 0.0 109.816 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 1.4 p -121.02 142.01 50.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.008 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE2' ' CA ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -126.0 -26.88 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.0 111.187 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.618 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 1.1 t -42.14 -51.86 10.1 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.855 -1.153 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 39.2 Cg_endo -86.23 -159.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.144 2.563 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 53' ' ' GLU . . . -90.64 -51.43 2.69 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.529 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER 174.44 62.52 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.706 -0.879 . . . . 0.0 109.425 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 37.4 Cg_endo -81.85 -90.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.596 2.197 . . . . 0.0 110.504 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 p -151.27 136.07 17.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.504 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -103.93 9.84 36.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.45 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 35.9 mt-30 -117.3 116.21 26.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 65.47 148.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.689 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 138.1 -6.4 3.4 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' CB ' HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -142.21 -78.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.088 -1.242 . . . . 0.0 109.922 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.18 -47.11 1.0 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.267 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.488 ' NE2' ' CE ' ' A' ' 216' ' ' MET . 14.6 t-160 -56.36 -61.3 2.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 0.0 110.268 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -41.25 -41.92 3.06 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.469 ' OG1' ' OG ' ' A' ' 36' ' ' SER . 25.6 m -61.25 -47.32 86.57 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.276 -1.132 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.482 ' CD2' ' CB ' ' A' ' 201' ' ' SER . 0.2 OUTLIER -55.14 -50.26 69.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 70' ' ' ILE . 30.1 t -60.03 -32.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.131 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.28 87.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 109.776 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.488 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -74.3 -25.75 69.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.541 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 83.1 m -79.31 -9.63 59.63 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.916 -1.344 . . . . 0.0 108.293 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 66' ' ' VAL . 17.3 mt -106.46 -26.78 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.351 -0.843 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -165.3 21.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.69 -1.257 . . . . 0.0 111.727 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.516 ' HB1' ' N ' ' A' ' 81' ' ' GLY . . . -41.53 127.77 3.09 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.918 -1.114 . . . . 0.0 109.322 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 60.2 mt -58.98 163.14 3.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.471 ' HB3' HD12 ' A' ' 80' ' ' LEU . 6.0 p30 -118.91 72.85 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.553 -0.717 . . . . 0.0 109.206 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -116.79 -117.8 0.32 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.245 -0.909 . . . . 0.0 108.978 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 p -129.33 -48.71 1.19 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 109.52 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -90.59 69.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.203 -0.936 . . . . 0.0 109.832 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.47 158.1 13.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.436 ' HA ' ' OG ' ' A' ' 3' ' ' SER . 33.7 m -69.33 -153.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -1.203 . . . . 0.0 109.388 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 74' ' ' ASN . 14.4 tp -151.47 118.41 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.941 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.516 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -98.68 -149.73 25.09 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.13 -38.05 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.303 . . . . 0.0 109.045 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -93.86 135.1 25.22 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CG ' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.94 -63.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.613 2.208 . . . . 0.0 111.103 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -119.07 47.5 1.66 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.91 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.93 164.38 22.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.097 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' OE1' ' CD ' ' A' ' 44' ' ' ARG . 40.1 mm-40 -85.61 104.24 15.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 ' O ' HG21 ' A' ' 43' ' ' ILE . 6.3 mt -96.53 116.74 29.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.577 ' CE2' ' HE3' ' A' ' 117' ' ' MET . 11.5 m-85 -97.4 156.01 16.65 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -123.47 101.18 7.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.431 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.46 HG23 HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -102.58 160.14 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.904 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.464 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 2.0 tttt -116.93 111.16 19.24 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.432 -0.793 . . . . 0.0 109.415 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.492 ' CG1' HG12 ' A' ' 105' ' ' ILE . 12.1 t -115.25 -28.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.392 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HG ' HG13 ' A' ' 93' ' ' VAL . 3.1 mp -132.74 175.05 9.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 110.017 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.36 170.9 39.53 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.509 ' N ' ' OD1' ' A' ' 60' ' ' ASN . . . -59.45 -26.05 64.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.243 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.0 t -87.82 -54.25 4.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.63 57.86 0.07 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 60.37 1.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.328 -1.101 . . . . 0.0 109.3 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.22 -179.37 44.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.07 162.86 13.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.748 -0.854 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.25 -15.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -19.73 57.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.553 ' CB ' ' CG2' ' A' ' 50' ' ' VAL . 60.6 p -87.98 -47.62 8.4 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.773 0.797 . . . . 0.0 109.094 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.506 HG22 HD11 ' A' ' 105' ' ' ILE . 2.2 mt -68.35 -34.13 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.91 -39.35 51.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.588 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 1.9 tt0 -70.52 -31.31 68.35 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.065 -1.022 . . . . 0.0 109.07 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.589 ' CA ' ' CE2' ' A' ' 49' ' ' PHE . . . -75.11 -39.49 37.16 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.4 mt -66.57 -33.13 74.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -1.088 . . . . 0.0 109.692 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 -17.98 23.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.403 ' HB2' ' O ' ' A' ' 107' ' ' GLN . 80.1 t90 -73.15 -18.02 61.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.655 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -90.85 6.72 43.28 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.223 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -96.99 -46.89 2.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.29 -80.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.147 -1.208 . . . . 0.0 108.274 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -95.83 62.56 2.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.655 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -122.34 -161.21 11.19 Favored Glycine 0 C--N 1.286 -2.205 0 CA-C-O 122.575 1.097 . . . . 0.0 112.034 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.577 ' HE3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -126.41 162.87 24.58 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.415 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.53 ' CG2' ' HE3' ' A' ' 229' ' ' LYS . 2.5 t -105.91 156.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.837 -1.164 . . . . 0.0 109.611 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.2 121.34 1.69 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.723 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.464 ' O ' HD13 ' A' ' 122' ' ' LEU . 13.2 t-20 -98.48 158.32 15.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.071 -1.018 . . . . 0.0 109.954 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 121' ' ' ASN . 7.0 mp -138.02 101.77 4.51 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 32' ' ' ASP . 20.6 p -85.53 62.11 7.27 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.9 178.87 7.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.433 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.587 ' CA ' ' CB ' ' A' ' 160' ' ' SER . . . 165.65 107.96 0.21 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.97 154.43 48.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.98 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 33.4 Cg_endo -77.18 -3.84 14.15 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.517 2.144 . . . . 0.0 109.195 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.408 ' O ' ' CE1' ' A' ' 161' ' ' TYR . 2.7 t -103.99 101.04 23.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 35.7 Cg_endo -77.95 166.03 25.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.335 2.023 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -153.73 125.21 7.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.65 66.56 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 15.5 m -67.08 -28.8 68.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.433 HD21 ' CE2' ' A' ' 161' ' ' TYR . 0.3 OUTLIER -70.37 -36.62 74.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -65.94 -58.44 5.54 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.431 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 134' ' ' GLU . 2.4 tp-100 -42.12 -28.13 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' GLU . . . -74.96 -49.61 19.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.707 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -33.14 46.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -61.61 -39.58 91.76 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -71.08 -22.94 62.04 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.99 -2.23 47.36 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.002 -1.062 . . . . 0.0 110.187 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -95.34 -34.16 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 108.859 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 64.4 m -66.1 -24.4 66.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 108.86 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -88.79 -13.1 40.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -0.821 . . . . 0.0 109.325 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.26 71.13 1.0 Allowed Glycine 0 C--N 1.302 -1.36 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 147' ' ' VAL . 84.9 t -112.99 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.448 -1.03 . . . . 0.0 109.499 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.449 HD11 ' OD1' ' A' ' 237' ' ' ASN . 5.0 tp -60.48 100.81 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.094 -1.003 . . . . 0.0 108.772 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -104.11 140.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.22 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.455 HG11 ' HA ' ' A' ' 121' ' ' ASN . 3.7 p -129.16 125.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 108.879 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 170' ' ' ALA . . . -105.18 146.85 28.66 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.995 -1.066 . . . . 0.0 110.431 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -81.45 169.66 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.56 -68.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 143.23 121.63 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 154' ' ' SER . 12.7 p-10 -86.7 33.35 0.65 Allowed 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.756 -0.849 . . . . 0.0 109.917 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER 162.33 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.31 -103.4 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.56 -168.66 2.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.7 44.89 3.3 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -159.66 150.16 19.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -1.198 . . . . 0.0 109.045 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.2 pt -80.85 176.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.39 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.587 ' CB ' ' CA ' ' A' ' 125' ' ' GLY . 0.7 OUTLIER -108.66 163.44 13.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 111.823 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.433 ' CE2' HD21 ' A' ' 133' ' ' LEU . 10.2 p90 -89.89 146.06 34.49 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 164' ' ' ARG . 44.0 Cg_endo -71.37 -26.6 8.09 Favored 'Cis proline' 0 C--N 1.297 -2.179 0 O-C-N 122.404 0.687 . . . . 0.0 110.722 4.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.73 -178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -77.4 -47.55 19.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.719 -1.238 . . . . 0.0 110.011 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -48.0 -171.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.316 1.055 . . . . 0.0 110.906 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.23 1.34 12.45 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.736 -0.602 . . . . 0.0 110.104 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.68 18.98 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.147 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -168.24 161.56 12.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.9 mmm -104.2 138.71 40.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.591 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -100.75 127.1 47.3 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.528 -0.732 . . . . 0.0 109.294 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.4 t -98.55 165.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.189 -0.944 . . . . 0.0 109.717 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -135.39 -158.0 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -144.74 147.01 32.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.925 -1.338 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 197' ' ' VAL . 0.4 OUTLIER -114.34 155.69 25.78 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 4.2 p-10 -59.63 -160.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 109.664 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.53 ' O ' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -45.65 -67.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.465 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -102.12 -57.81 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.369 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.2 OUTLIER -176.17 106.63 0.08 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.403 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.693 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 1.1 t30 -136.65 -39.13 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.693 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 13.5 ttt180 116.51 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.692 0.758 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -39.24 161.32 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.185 0.516 . . . . 0.0 109.638 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -119.86 -49.09 2.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 0.0 110.475 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.518 ' CE2' ' OG1' ' A' ' 214' ' ' THR . 31.3 p90 -49.49 -21.41 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.433 ' HB2' ' OG1' ' A' ' 214' ' ' THR . 1.6 t -69.94 117.2 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.015 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.54 116.94 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CG ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -121.41 167.8 12.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.528 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -165.34 -166.61 24.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.34 64.11 7.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.14 -1.212 . . . . 0.0 109.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 170.81 33.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' ASP . 5.3 tp -79.27 102.2 8.45 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.04 -1.271 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 24.4 t70 -41.79 -67.83 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 110.277 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 260' ' ' GLY . 3.9 tt -157.77 169.98 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.199 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 260' ' ' GLY . 7.9 m -108.76 162.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.695 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.556 ' CB ' ' CD ' ' A' ' 195' ' ' PRO . . . -152.88 -176.68 0.61 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 194' ' ' ALA . 34.3 Cg_endo -78.15 115.48 3.75 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.771 1.648 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -144.09 18.48 2.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.627 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 10.3 t -109.14 55.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 108.729 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.627 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 20.4 t-20 131.19 121.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 16.4 m -164.63 111.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.94 0.876 . . . . 0.0 108.724 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.8 OUTLIER -99.68 125.2 45.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.482 ' CB ' ' CD2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -130.85 -166.57 1.71 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 109.304 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -83.5 172.96 11.89 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.627 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -147.5 165.36 19.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.627 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.5 Cg_endo -71.27 164.48 35.59 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.085 1.857 . . . . 0.0 110.533 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 92.0 -54.73 2.93 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 9.5 p 141.39 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -137.93 -178.37 5.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.934 -1.104 . . . . 0.0 110.371 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.536 ' N ' ' OG1' ' A' ' 207' ' ' THR . 36.7 m-85 -106.37 -160.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -172.97 163.04 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.987 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 42.3 p -151.72 108.55 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 108.875 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 199' ' ' VAL . 0.4 OUTLIER -139.87 160.74 39.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.719 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.85 133.22 55.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -169.09 148.54 12.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.518 ' OG1' ' CE2' ' A' ' 183' ' ' PHE . 32.9 m -72.64 -31.44 65.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -1.186 . . . . 0.0 109.302 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 16.8 t -67.74 -9.18 41.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.488 ' CE ' ' NE2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -86.22 -22.26 27.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.898 . . . . 0.0 109.877 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 195' ' ' PRO . . . -84.65 -17.31 39.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.617 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 32.9 m -62.87 -42.76 79.88 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 111.904 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.2 Cg_endo -71.27 -13.47 30.86 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.575 1.517 . . . . 0.0 110.277 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.508 ' NE2' HD12 ' A' ' 8' ' ' ILE . 8.4 m80 -72.42 -40.08 67.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 171' ' ' VAL . 55.9 t -71.09 -39.29 74.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.78 -45.58 67.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -62.4 -45.19 96.44 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.58 -60.36 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.266 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -48.59 -33.68 10.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.763 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.93 -46.54 90.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 109.037 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 30.4 mt -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.149 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 229' ' ' LYS . 97.5 t -64.75 -64.94 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 109.756 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.53 ' HE3' ' CG2' ' A' ' 119' ' ' VAL . 7.6 ttmm -42.97 -35.98 1.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.127 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.467 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 45.1 tp60 -60.95 -51.92 67.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 231' ' ' LYS . 3.1 ttpp -55.62 -18.56 8.0 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 3.5 m120 -165.49 82.78 1.1 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.383 -0.823 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.469 ' N ' ' O ' ' A' ' 229' ' ' LYS . 36.1 Cg_endo -78.81 0.24 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.689 2.259 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -6.36 48.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -75.84 -176.73 3.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.1 164.76 12.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.389 0.614 . . . . 0.0 109.616 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.449 ' OD1' HD11 ' A' ' 146' ' ' LEU . 6.6 t30 -52.61 -29.05 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -78.17 -61.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.141 -0.975 . . . . 0.0 109.422 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.7 OUTLIER -39.98 -37.78 0.63 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.019 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 2.5 mt -77.1 -46.63 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.634 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -49.67 -31.33 10.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 52.3 m-20 -72.93 -47.13 48.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.964 -1.085 . . . . 0.0 110.389 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.498 ' O ' HG22 ' A' ' 247' ' ' THR . 3.5 t60 -63.15 -35.88 81.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.411 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -81.87 -35.67 29.04 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -68.89 -34.43 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 243' ' ' HIS . 3.7 p-10 -84.65 -30.42 24.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.44 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 243' ' ' HIS . 1.7 p -72.06 -30.13 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -40.52 117.44 0.81 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.521 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' ALA . 0.2 OUTLIER -43.9 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -126.18 71.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' A' ' 261' ' ' LEU . 1.9 mp -54.66 -62.36 1.71 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.968 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 253' ' ' SER . . . 113.55 -82.81 0.31 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 252' ' ' GLY . 5.2 t 46.54 -171.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.211 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 255' ' ' ASN . 0.2 OUTLIER -59.18 -61.48 2.61 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.881 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 254' ' ' THR . 17.9 p-10 177.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.645 ' CD2' ' CG ' ' A' ' 186' ' ' TYR . 2.6 tm? -41.65 -51.81 3.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.765 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -61.28 -57.53 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.14 -0.975 . . . . 0.0 109.089 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.48 -81.65 1.69 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 191' ' ' ASP . 57.7 m -78.53 -55.43 5.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.388 -1.066 . . . . 0.0 109.137 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.474 ' O ' HG13 ' A' ' 192' ' ' ILE . . . 135.26 -135.53 7.95 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.43 ' HB2' HD13 ' A' ' 251' ' ' LEU . 1.4 tp -105.06 178.1 4.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.349 -1.089 . . . . 0.0 109.076 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.468 HG23 HD12 ' A' ' 192' ' ' ILE . 3.0 t -122.67 156.29 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -166.23 119.6 1.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.327 1.06 . . . . 0.0 108.457 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.73 -13.01 61.24 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.152 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.402 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 15.8 tt0 -75.47 -25.96 57.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 109.664 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.21 55.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.679 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' A' ' 247' ' ' THR . . . -113.67 -20.67 11.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.533 ' CG2' ' CD1' ' A' ' 21' ' ' LEU . 61.8 p -102.31 -46.51 4.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.119 -0.988 . . . . 0.0 109.229 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.43 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.427 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.231 0.539 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 151.54 12.82 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.168 -0.958 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.46 ' OG ' HG11 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -81.28 116.67 21.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.641 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 2.9 t -136.75 46.81 1.62 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.915 . . . . 0.0 110.108 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 36.4 Cg_endo -77.5 165.6 27.04 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.936 1.758 . . . . 0.0 110.424 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 7.1 p-90 -67.05 -13.19 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 109.464 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 11' ' ' VAL . . . -83.89 -15.75 69.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.57 ' CD1' ' NE2' ' A' ' 220' ' ' HIS . 1.1 mp -116.38 -6.75 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -1.202 . . . . 0.0 109.045 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.92 -22.43 21.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 21.37 12.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.036 -1.04 . . . . 0.0 110.621 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 7' ' ' GLY . 28.1 m -110.06 18.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.963 -1.086 . . . . 0.0 109.339 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 27.8 mm-40 57.07 17.63 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 110.571 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.54 -43.03 87.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.86 -53.87 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 N-CA-C 107.874 -1.625 . . . . 0.0 107.874 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB2' ' OE2' ' A' ' 265' ' ' GLU . . . -44.75 -30.74 1.01 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.47 54.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 16.0 m170 -65.62 -10.83 39.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.601 -0.687 . . . . 0.0 109.175 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -83.43 -56.87 3.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -36.21 63.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.456 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.92 4.01 9.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.457 ' CD1' HG23 ' A' ' 268' ' ' THR . 0.3 OUTLIER -63.82 137.68 58.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.133 . . . . 0.0 109.365 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.8 OUTLIER -123.77 -12.4 7.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.086 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 71.55 -9.39 4.66 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -49.13 135.43 16.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -1.122 . . . . 0.0 109.336 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.18 0.55 47.78 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 27' ' ' LYS . 47.5 t -112.44 163.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.127 -1.219 . . . . 0.0 109.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.55 ' HG3' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -148.83 131.35 15.78 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 119' ' ' VAL . 17.4 t -128.69 154.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.325 -0.859 . . . . 0.0 109.723 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -98.76 150.17 22.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.911 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 89' ' ' TYR . 39.0 t -122.7 80.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.919 -1.113 . . . . 0.0 108.387 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.518 ' CD2' HG22 ' A' ' 93' ' ' VAL . 6.6 mp -71.07 126.41 29.51 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.49 ' C ' ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER 170.21 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.264 -0.897 . . . . 0.0 109.258 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -49.05 -59.76 3.35 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . 179.38 -109.85 0.27 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.555 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER 165.6 102.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 p -49.73 125.88 12.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.814 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 m -55.12 101.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.074 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.56 ' CD2' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -119.4 153.39 53.7 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.812 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 35.6 Cg_endo -78.5 -12.69 15.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.516 2.144 . . . . 0.0 109.939 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -90.25 -37.58 14.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 72' ' ' ALA . 62.2 mt -88.87 113.49 24.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.792 . . . . 0.0 109.545 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 119.36 16.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.432 HD13 ' CG2' ' A' ' 35' ' ' ILE . 39.1 mm -92.66 94.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.073 -1.017 . . . . 0.0 109.395 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.506 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -79.81 -21.01 44.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.993 . . . . 0.0 109.265 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.593 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -169.32 163.9 37.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.91 119.5 0.83 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.37 163.47 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -1.096 . . . . 0.0 108.727 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.475 ' OG ' ' HD2' ' A' ' 92' ' ' LYS . 2.5 t -150.85 136.95 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 110.427 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -127.29 -30.31 2.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.2 t -49.05 129.42 15.42 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.56 172.08 14.9 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.64 2.226 . . . . 0.0 111.125 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.82 -66.38 1.93 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -165.99 86.32 0.94 Allowed Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.599 -0.942 . . . . 0.0 109.241 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' SER . 35.4 Cg_endo -75.58 -95.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.396 2.064 . . . . 0.0 110.549 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 4.3 m 60.16 134.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -92.71 3.8 54.93 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.181 -0.95 . . . . 0.0 109.159 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 1.5 mt-30 -96.56 116.21 28.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.217 -0.927 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.7 OUTLIER 52.21 171.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.637 0.732 . . . . 0.0 110.133 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . -179.57 -33.31 0.06 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -175.68 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.345 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.62 -47.24 0.97 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -45.32 -50.07 12.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.398 -1.06 . . . . 0.0 110.155 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -54.54 -80.94 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.409 -0.901 . . . . 0.0 110.934 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 0.7 OUTLIER -33.42 -45.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.818 -0.813 . . . . 0.0 110.898 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.578 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 44.9 t-80 -57.51 -54.01 51.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.971 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 70' ' ' ILE . 13.5 t -58.76 -32.62 47.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.426 -0.796 . . . . 0.0 109.189 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.72 -49.27 78.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.844 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.31 -28.65 71.05 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.438 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 7.7 m -71.59 -17.12 62.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.062 -1.258 . . . . 0.0 108.473 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 66' ' ' VAL . 30.3 mt -92.66 -32.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.401 -0.812 . . . . 0.0 110.411 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . . . -179.65 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.661 -1.274 . . . . 0.0 111.52 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -46.1 156.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.734 -1.229 . . . . 0.0 108.358 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 96.6 mt -78.95 166.69 22.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.932 -1.105 . . . . 0.0 109.925 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 80' ' ' LEU . 55.0 t30 -117.29 87.38 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.84 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -118.39 -118.92 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.291 -0.881 . . . . 0.0 108.737 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -113.45 -40.54 3.84 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 109.279 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.79 165.56 2.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.404 -0.81 . . . . 0.0 109.7 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.27 -167.23 53.16 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.46 HG11 ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -114.0 -167.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -1.178 . . . . 0.0 109.397 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 74' ' ' ASN . 8.5 tp -130.36 122.37 27.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.57 -149.31 13.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.79 -66.67 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.263 . . . . 0.0 109.666 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . . . -71.45 134.3 84.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 22' ' ' THR . 40.1 Cg_endo -84.95 -60.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.752 2.302 . . . . 0.0 111.236 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -105.92 45.38 0.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.793 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.442 ' HB1' ' HB2' ' A' ' 83' ' ' ALA . . . -85.5 164.72 17.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.07 -1.018 . . . . 0.0 109.646 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 2.6 tt0 -101.55 80.19 2.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 HD12 ' HB ' ' A' ' 70' ' ' ILE . 6.6 mt -73.3 144.17 46.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.312 -0.867 . . . . 0.0 109.746 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.6 ' CZ ' ' HE2' ' A' ' 117' ' ' MET . 2.8 m-85 -118.48 161.52 19.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -130.03 92.32 3.28 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.643 -1.286 . . . . 0.0 109.914 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.89 149.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.131 -0.981 . . . . 0.0 109.315 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 4.4 mttp -100.29 105.61 17.17 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.539 ' CG1' HG21 ' A' ' 105' ' ' ILE . 2.1 t -104.55 -14.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.813 . . . . 0.0 110.08 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.55 -174.7 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.771 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -110.75 -177.41 20.63 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 59' ' ' GLY . . . -68.0 -6.96 25.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.452 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.78 33.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.88 8.85 57.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 t -142.15 66.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -1.185 . . . . 0.0 109.668 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.47 178.92 13.16 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.48 157.8 21.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.746 -0.855 . . . . 0.0 109.786 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 130' ' ' SER . 43.7 t -68.53 -19.61 24.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.526 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 33.4 t -72.91 -22.69 60.7 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.446 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 57.4 m -83.1 -63.8 1.29 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.539 HG21 ' CG1' ' A' ' 93' ' ' VAL . 2.3 mt -47.93 -27.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 110' ' ' GLU . . . -69.08 -47.91 64.03 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.597 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -64.79 -28.83 69.84 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.033 -1.042 . . . . 0.0 109.404 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.48 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -80.55 -26.77 53.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.527 HD21 ' ND2' ' A' ' 167' ' ' ASN . 16.4 mt -87.23 -24.15 24.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -1.227 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 7.1 pt-20 -100.63 -25.94 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.251 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.53 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 83.1 t90 -71.65 -17.06 62.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.579 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -93.42 -0.38 56.51 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.876 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.93 -28.47 10.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -97.2 -35.41 10.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -1.22 . . . . 0.0 109.503 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -140.12 27.66 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.394 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.579 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -87.99 -153.32 25.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.6 ' HE2' ' CZ ' ' A' ' 89' ' ' TYR . 12.1 mmt -125.22 -176.54 3.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.366 -1.079 . . . . 0.0 110.432 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.666 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -71.84 -17.08 62.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.749 -0.595 . . . . 0.0 110.163 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.666 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.6 t -136.74 168.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -169.6 132.48 1.21 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.534 ' C ' ' CD1' ' A' ' 122' ' ' LEU . 1.6 m120 -130.91 147.39 52.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.0 109.741 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -142.07 124.78 15.93 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.094 -1.004 . . . . 0.0 109.187 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.424 ' HB3' ' OG ' ' A' ' 215' ' ' SER . 0.7 OUTLIER -93.17 62.14 3.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.897 -1.127 . . . . 0.0 109.065 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' A' ' 124' ' ' LEU . 1.2 mt -99.72 -178.7 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 160' ' ' SER . . . 175.05 74.88 0.05 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 3.4 m -124.62 147.73 56.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 109.494 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.524 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -81.07 15.42 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.787 2.325 . . . . 0.0 110.119 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.534 ' N ' ' CD ' ' A' ' 129' ' ' PRO . 14.1 t -116.03 50.36 0.76 Allowed Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.602 -0.687 . . . . 0.0 111.48 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 128' ' ' SER . 33.8 Cg_endo -72.57 178.58 6.07 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.343 2.028 . . . . 0.0 109.772 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.487 ' HB2' HG23 ' A' ' 102' ' ' VAL . 3.7 t -152.49 154.08 34.77 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.16 64.92 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.0 m -71.61 -26.76 62.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' O ' ' HB1' ' A' ' 136' ' ' ALA . 2.2 tp -72.39 -38.3 68.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -68.08 -47.62 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.64 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -26.47 12.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 133' ' ' LEU . . . -67.32 -44.81 78.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -52.29 -40.38 31.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.416 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 1.6 m120 -58.07 -41.79 84.12 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -20.16 63.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.63 1.75 25.42 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.872 -1.143 . . . . 0.0 112.044 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -104.49 -41.24 5.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.427 -1.421 . . . . 0.0 108.409 178.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -20.03 57.8 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.38 -25.83 20.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.44 52.66 4.12 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 147' ' ' VAL . 86.5 t -105.4 109.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -1.093 . . . . 0.0 109.267 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 24.7 tp -58.5 123.13 15.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.053 -1.029 . . . . 0.0 109.104 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -120.25 141.69 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.015 . . . . 0.0 109.297 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.457 HG21 ' HG3' ' A' ' 169' ' ' MET . 1.2 t -137.97 123.91 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' A' ' 163' ' ' ALA . . . -118.75 147.94 43.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.004 -1.06 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.487 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -52.2 160.4 0.78 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.618 -0.676 . . . . 0.0 110.213 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -71.06 -79.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 185' ' ' GLN . . . 149.54 119.32 0.97 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.437 ' OD1' ' CG ' ' A' ' 183' ' ' PHE . 3.6 m-20 -91.59 57.66 3.33 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.799 -0.824 . . . . 0.0 109.391 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.07 -96.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.49 84.47 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -170.61 179.51 3.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.62 56.7 4.89 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -179.75 171.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -1.077 . . . . 0.0 108.675 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -118.85 -173.34 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.008 -1.057 . . . . 0.0 110.38 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.518 ' HB3' ' HA2' ' A' ' 125' ' ' GLY . 2.6 m -70.89 -174.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.806 1.289 . . . . 0.0 112.521 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.452 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 93.6 m-85 -123.81 126.97 25.59 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.723 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.3 Cg_endo -72.62 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.301 -1.949 0 C-N-CA 123.939 -1.276 . . . . 0.0 109.791 2.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.524 ' HA ' ' HB1' ' A' ' 149' ' ' ALA . . . 31.7 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.238 1.018 . . . . 0.0 108.901 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 162' ' ' PRO . 17.5 ttm180 -44.12 -62.73 1.05 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.589 ' O ' ' CB ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -172.28 -166.12 0.38 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 165' ' ' TYR . . . 89.73 -7.09 0.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.746 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.653 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . 0.9 OUTLIER 159.73 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.719 -0.613 . . . . 0.0 109.596 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 167' ' ' ASN . . . 164.77 149.49 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.433 -1.307 . . . . 0.0 112.648 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -80.19 -174.43 4.52 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 175.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 189' ' ' GLY . . . -122.66 118.88 29.18 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.345 -1.472 . . . . 0.0 110.515 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 151' ' ' SER . 19.0 t -89.52 166.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.544 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -136.9 -176.89 14.61 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.582 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 214' ' ' THR . . . -130.31 150.21 51.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.979 . . . . 0.0 109.601 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 175' ' ' ASP . 33.2 p -157.79 155.06 29.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' THR . 18.8 p-10 -58.9 -150.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.846 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.519 ' HG2' ' ND2' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -94.48 -31.48 13.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.952 . . . . 0.0 109.983 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 176' ' ' GLN . 0.0 OUTLIER -96.29 -89.39 0.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.96 80.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -140.28 165.18 28.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -98.38 19.07 15.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.354 -0.841 . . . . 0.0 109.647 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 64.15 -152.46 0.3 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 182' ' ' SER . 0.6 OUTLIER -112.0 9.86 20.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.393 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.613 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -150.48 -92.48 0.06 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' PHE . 3.7 t 39.29 80.76 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.476 -0.765 . . . . 0.0 110.455 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 152' ' ' GLY . 1.9 mp0 -65.67 146.27 55.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 0.0 109.122 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -123.54 166.41 15.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.126 -0.983 . . . . 0.0 109.541 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . 155.59 175.5 26.69 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -52.82 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.156 . . . . 0.0 109.273 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 160.81 -33.76 0.4 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.478 HD22 ' O ' ' A' ' 257' ' ' TYR . 7.9 tp -52.21 111.78 0.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.238 -1.154 . . . . 0.0 109.622 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.28 -28.75 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.85 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 258' ' ' GLY . 2.5 tt -156.8 166.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.607 -1.308 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 260' ' ' GLY . 12.4 m -123.68 174.63 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -0.821 . . . . 0.0 109.283 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.548 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -168.78 177.81 1.14 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.223 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 34.4 Cg_endo -76.61 119.33 5.15 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.455 2.103 . . . . 0.0 110.629 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.47 42.15 1.41 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 19.9 t -133.45 81.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.234 -1.156 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER 84.22 122.83 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.011 0.91 . . . . 0.0 108.574 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.44 HG22 ' HG2' ' A' ' 216' ' ' MET . 19.3 m -156.81 108.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 122.137 0.97 . . . . 0.0 109.383 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 31.5 mt-30 -78.77 143.79 35.78 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.578 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -159.11 -162.1 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.329 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 15.0 t -86.04 -177.55 6.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.629 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -168.45 169.44 4.96 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.629 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -72.31 168.55 23.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.335 2.023 . . . . 0.0 110.538 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.53 72.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.505 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 4.2 p 56.36 36.7 27.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -1.113 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -122.58 147.68 46.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.078 -1.014 . . . . 0.0 109.807 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.22 19.28 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.49 165.67 4.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.028 . . . . 0.0 110.205 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.1 OUTLIER -103.33 146.3 28.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.482 -0.762 . . . . 0.0 109.435 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.564 HD12 ' CD2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -139.01 107.91 5.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.777 . . . . 0.0 109.169 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.07 140.83 56.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.1 -1.0 . . . . 0.0 109.344 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.35 2.39 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.503 ' CG2' ' HB1' ' A' ' 173' ' ' ALA . 19.4 m -68.38 -23.58 64.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 0.0 109.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 123' ' ' SER . 9.9 t -67.11 -20.07 65.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.643 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.511 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -78.77 -10.49 59.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 194' ' ' ALA . . . -86.38 -5.76 59.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.638 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.64 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -76.95 -39.05 2.13 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.64 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.5 Cg_endo -71.98 -25.59 19.46 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.527 1.484 . . . . 0.0 110.744 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.57 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 13.1 m80 -66.78 -37.75 85.19 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.72 -52.14 34.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.466 ' HB2' ' OD1' ' A' ' 121' ' ' ASN . . . -48.09 -33.2 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.378 -0.826 . . . . 0.0 108.94 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.4 -53.08 23.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -53.52 -62.44 1.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.419 -1.048 . . . . 0.0 109.286 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.524 ' CA ' HD13 ' A' ' 244' ' ' LEU . . . -43.01 -40.88 3.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.23 78.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.216 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mt -52.94 -29.12 26.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.33 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 229' ' ' LYS . 96.1 t -74.19 -51.51 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.547 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -43.92 -47.62 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.458 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 28.3 tp60 -63.3 -41.8 98.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 231' ' ' LYS . 13.3 tptt -62.98 -11.49 19.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.046 -1.034 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.96 90.89 1.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.19 -0.944 . . . . 0.0 109.764 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 36.9 Cg_endo -81.44 17.88 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.724 2.283 . . . . 0.0 110.834 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.3 t -122.12 5.32 9.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 110.004 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -91.5 -179.65 5.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.909 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.4 OUTLIER -110.37 167.73 9.98 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -58.64 -35.75 73.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 109.426 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.414 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -66.66 -64.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.21 -0.931 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.464 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -45.34 -39.78 7.12 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.357 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 236' ' ' SER . 59.7 mt -57.72 -49.41 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.57 -0.706 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' ASN . 49.1 ttp180 -56.12 -60.65 3.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.552 ' HA ' ' HE3' ' A' ' 245' ' ' LYS . 2.3 t-20 -37.69 -62.72 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.66 -0.65 . . . . 0.0 110.91 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.497 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.1 t60 -50.4 -40.75 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.597 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.524 HD13 ' CA ' ' A' ' 225' ' ' ALA . 0.2 OUTLIER -70.63 -37.56 73.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 111.327 -178.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 4.0 ptpt -63.36 -55.46 24.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.868 -1.145 . . . . 0.0 109.975 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.598 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -70.78 -27.1 63.66 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.547 -0.72 . . . . 0.0 111.035 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 6.0 p -71.57 -30.75 66.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.802 -1.186 . . . . 0.0 109.627 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 261' ' ' LEU . . . -52.33 130.76 31.91 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 261' ' ' LEU . 1.6 m -42.97 111.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.211 -0.931 . . . . 0.0 108.784 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.4 p -69.14 98.0 0.96 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -0.804 . . . . 0.0 110.369 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.5 mp -56.85 -65.43 0.62 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 253' ' ' SER . . . 171.77 -137.03 4.11 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 252' ' ' GLY . 10.7 p 43.24 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.09 . . . . 0.0 109.878 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 13.5 t -125.57 -3.27 7.29 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.835 -0.541 . . . . 0.0 109.927 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 254' ' ' THR . 2.9 t-20 172.93 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.021 . . . . 0.0 110.181 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.24 -61.29 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.964 -1.085 . . . . 0.0 109.159 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.478 ' O ' HD22 ' A' ' 190' ' ' LEU . 42.6 m-85 -55.3 -60.97 2.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.154 -0.966 . . . . 0.0 108.475 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 124.71 58.97 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.432 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 3.1 t 83.73 -57.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.926 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.466 ' O ' HG21 ' A' ' 193' ' ' VAL . . . 140.36 -171.29 24.03 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.525 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 248' ' ' ALA . 12.7 tp -75.25 162.29 28.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.954 . . . . 0.0 109.695 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.37 154.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.182 -0.949 . . . . 0.0 109.969 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.403 ' CB ' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -160.71 117.18 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.652 1.215 . . . . 0.0 108.177 178.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.6 61.0 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.526 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' A' ' 15' ' ' ALA . 7.6 tp10 -82.47 -40.47 21.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.964 -1.085 . . . . 0.0 109.603 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.8 -11.75 59.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 0.0 109.301 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.454 ' HA ' HG23 ' A' ' 247' ' ' THR . . . -89.69 -38.88 13.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.457 HG23 ' CD1' ' A' ' 21' ' ' LEU . 44.6 p -87.89 -52.9 5.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.442 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.404 ' C ' ' HD3' ' A' ' 269' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.429 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.362 0.601 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.402 ' HB3' HG12 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.53 165.88 24.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.253 -0.905 . . . . 0.0 109.874 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.1 m -101.3 55.19 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.864 . . . . 0.0 109.015 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 8' ' ' ILE . 15.8 m -76.99 111.89 19.34 Favored Pre-proline 0 C--N 1.29 -2.007 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -80.48 -166.52 0.42 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.827 2.351 . . . . 0.0 111.813 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.593 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -33.29 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.219 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.515 ' HA3' ' NE2' ' A' ' 220' ' ' HIS . . . -52.06 -83.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 8' ' ' ILE . 2.9 mm -43.84 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.479 -1.012 . . . . 0.0 109.187 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 162.78 -56.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -125.49 26.52 6.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG22 ' HB1' ' A' ' 13' ' ' ALA . 21.7 m -112.65 20.04 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.875 -1.14 . . . . 0.0 109.903 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 5.3 mm-40 65.83 15.59 10.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.577 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.649 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -66.33 -37.17 14.96 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.5 Cg_endo -73.02 -55.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.981 0 N-CA-C 108.424 -1.414 . . . . 0.0 108.424 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.74 -29.52 0.53 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 11.1 m170 -69.04 -7.29 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.817 . . . . 0.0 109.569 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.26 -22.58 14.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.112 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.496 ' NH2' ' HA ' ' A' ' 269' ' ' ARG . 0.2 OUTLIER -81.26 4.89 18.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.34 47.13 5.03 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -149.22 150.89 33.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -1.086 . . . . 0.0 109.102 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 24' ' ' SER . 1.7 t -161.15 38.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.866 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 56.94 9.79 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.515 ' N ' ' HG3' ' A' ' 230' ' ' GLN . 55.5 p -57.78 119.45 6.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.77 27.92 9.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 27' ' ' LYS . 88.1 t -122.83 167.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -1.211 . . . . 0.0 109.789 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' HG2' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -136.24 132.62 36.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.117 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.36 123.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 110.121 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HB2' HG23 ' A' ' 91' ' ' VAL . . . -84.97 162.63 19.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.82 90.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.515 ' CD2' HG22 ' A' ' 93' ' ' VAL . 5.9 mp -79.83 102.37 9.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' OD2' ' HA2' ' A' ' 63' ' ' GLY . 47.9 p30 -166.2 -154.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.006 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.473 ' HB ' ' HA3' ' A' ' 59' ' ' GLY . 6.6 p -43.0 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.566 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -164.06 -132.8 1.39 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 34' ' ' GLY . 30.5 mm -165.58 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.507 ' CB ' ' HB3' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -62.88 137.47 58.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 109.171 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -63.05 122.39 15.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.591 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -133.18 154.54 81.22 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.4 Cg_endo -79.68 -31.91 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.715 2.276 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -86.33 -3.19 58.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.0 109.836 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 67' ' ' ALA . 16.8 mt -105.77 123.6 48.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.065 -1.022 . . . . 0.0 109.724 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.12 91.43 7.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 109.87 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.75 152.07 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.563 ' O ' ' CE1' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -160.71 23.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.338 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.607 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -170.0 144.76 8.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.93 114.69 0.71 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.1 157.68 44.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -1.032 . . . . 0.0 109.294 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.28 133.75 3.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.993 -1.067 . . . . 0.0 110.139 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.8 -36.38 3.9 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.609 -0.682 . . . . 0.0 109.634 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG22 ' C ' ' A' ' 93' ' ' VAL . 11.2 t -43.69 107.49 0.59 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.374 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.89 167.68 23.36 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.706 2.271 . . . . 0.0 110.704 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.28 -41.59 2.47 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -177.49 89.01 0.24 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.369 -1.077 . . . . 0.0 109.188 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.567 ' O ' ' CB ' ' A' ' 55' ' ' SER . 36.2 Cg_endo -77.74 -82.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.867 2.378 . . . . 0.0 111.301 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 84.55 -50.04 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.42 ' OG1' ' C ' ' A' ' 55' ' ' SER . 0.1 OUTLIER 61.69 4.28 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.121 -0.987 . . . . 0.0 110.114 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' ASP . 30.2 mt-30 -147.03 138.69 24.25 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.753 -1.217 . . . . 0.0 109.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 57' ' ' GLN . 45.2 t0 57.8 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 60' ' ' ASN . . . -153.7 67.21 0.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 2.8 t-20 84.99 -33.43 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.885 . . . . 0.0 109.893 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.54 10.82 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLY . 20.5 t-160 -51.08 -66.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -40.85 -72.92 0.22 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 63' ' ' GLY . 96.5 m -35.38 -48.07 0.46 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.827 -0.807 . . . . 0.0 110.735 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.51 ' NE2' ' HB2' ' A' ' 201' ' ' SER . 22.0 t-80 -51.73 -53.36 40.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.254 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 70' ' ' ILE . 12.5 t -60.64 -31.35 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.34 -0.85 . . . . 0.0 108.785 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 41' ' ' LEU . . . -55.79 -48.58 75.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.397 -0.814 . . . . 0.0 109.526 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 70' ' ' ILE . . . -67.41 -43.03 88.68 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 219' ' ' PRO . 1.1 m -52.07 -21.88 3.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.449 -1.618 . . . . 0.0 107.773 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 83' ' ' ALA . 55.9 mt -94.3 -30.68 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.497 -0.752 . . . . 0.0 110.949 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -165.57 44.38 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.506 -1.371 . . . . 0.0 112.323 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -60.92 124.47 20.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.635 -1.291 . . . . 0.0 108.82 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 93.2 mt -79.33 156.75 27.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.992 -1.068 . . . . 0.0 109.314 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 42.3 t30 -139.54 63.63 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.087 -1.008 . . . . 0.0 109.975 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -89.75 -13.92 35.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.042 0.925 . . . . 0.0 109.28 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.8 -45.93 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -115.1 157.25 15.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.526 -0.734 . . . . 0.0 109.135 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.83 164.35 35.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.43 -150.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.366 -1.079 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 6.3 tp -147.02 106.42 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.984 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.43 -163.48 4.62 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.505 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 0.6 OUTLIER -78.91 -53.67 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -1.108 . . . . 0.0 109.427 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -110.84 101.9 50.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.18 -0.95 . . . . 0.0 108.707 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 37.6 Cg_endo -83.03 -53.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.902 2.401 . . . . 0.0 111.303 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.48 18.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.152 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.18 23.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.525 -1.359 . . . . 0.0 109.203 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' OH ' ' A' ' 89' ' ' TYR . 44.0 mt-10 -74.33 150.57 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 109.082 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' A' ' 71' ' ' ALA . 88.1 mt -125.25 97.98 5.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.953 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.607 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 m-30 -82.29 113.66 20.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.262 -0.899 . . . . 0.0 109.419 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.525 ' HB3' HG12 ' A' ' 35' ' ' ILE . . . -78.77 108.91 12.55 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.073 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.49 ' HB ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -108.38 73.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.766 -1.209 . . . . 0.0 109.959 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -41.65 113.4 0.41 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.551 ' CG1' HG12 ' A' ' 105' ' ' ILE . 5.0 t -123.06 -24.71 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.135 -0.978 . . . . 0.0 109.928 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mp -126.76 172.2 10.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 110.173 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.92 -158.65 16.5 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.56 -47.86 7.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -1.167 . . . . 0.0 109.183 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.2 p -69.29 -41.01 77.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.351 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.72 41.82 0.16 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 t -116.78 63.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.25 179.36 48.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 m -121.47 157.35 30.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.872 -0.781 . . . . 0.0 109.983 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.452 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 0.9 OUTLIER -67.24 -28.89 44.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.549 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 75.1 m -72.52 -18.53 61.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 105' ' ' ILE . 9.2 p -77.44 -57.76 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.652 -0.655 . . . . 0.0 109.382 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.551 HG12 ' CG1' ' A' ' 93' ' ' VAL . 1.3 mt -63.4 -24.15 35.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -67.06 -44.54 79.89 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.624 -0.673 . . . . 0.0 109.572 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.582 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -77.39 -24.26 50.56 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.624 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.559 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -72.51 -27.98 68.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.68 -30.7 14.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -76.14 -30.06 58.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 108.96 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -65.67 -22.96 66.68 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.61 ' CA ' ' CA ' ' A' ' 116' ' ' GLY . . . -81.33 -21.85 38.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -56.52 -39.35 84.4 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.58 -49.97 6.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -127.93 70.27 1.34 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.61 ' CA ' ' CA ' ' A' ' 112' ' ' ALA . . . -105.79 23.72 28.79 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.602 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.2 OUTLIER 30.7 -159.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.129 0.966 . . . . 0.0 111.509 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.515 ' CB ' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -96.22 -20.21 18.74 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.437 -0.789 . . . . 0.0 111.026 -178.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG21 ' C ' ' A' ' 118' ' ' HIS . 2.6 t -136.51 158.5 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.435 -1.415 . . . . 0.0 111.351 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.81 128.51 2.42 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.522 ' ND2' HG11 ' A' ' 148' ' ' VAL . 11.9 t-20 -107.01 158.33 17.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.649 -1.282 . . . . 0.0 110.49 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.447 HD11 HG13 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -127.54 98.88 5.38 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -85.58 64.89 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.403 -0.81 . . . . 0.0 108.944 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.463 HD12 HD12 ' A' ' 105' ' ' ILE . 0.3 OUTLIER -150.31 168.49 23.91 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.413 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.547 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -164.76 76.53 0.15 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.59 147.62 34.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.19 -1.182 . . . . 0.0 109.475 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.482 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -77.3 -34.59 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.295 1.997 . . . . 0.0 109.122 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -46.79 104.6 0.42 Allowed Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.71 -0.619 . . . . 0.0 109.38 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 34.5 Cg_endo -78.6 168.99 20.46 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.48 2.12 . . . . 0.0 110.161 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.3 p -173.34 120.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 110.622 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -24.88 65.76 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 79.7 m -63.37 -29.12 70.48 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HB2' ' OG ' ' A' ' 130' ' ' SER . 2.1 tt -75.88 -35.87 59.7 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 6.5 tm-20 -77.04 -19.45 57.15 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.074 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -78.13 -24.01 47.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.05 -45.33 20.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.341 -0.943 . . . . 0.0 108.631 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.57 -28.92 42.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 134' ' ' GLU . 62.6 t30 -62.33 -34.77 77.28 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -79.88 -22.42 42.88 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.87 -27.69 63.03 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.4 m -69.4 -39.38 77.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -58.07 -23.93 56.53 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.231 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.65 -14.2 16.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.303 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.434 ' C ' ' HB2' ' A' ' 237' ' ' ASN . . . 68.16 75.37 0.51 Allowed Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.71 111.72 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.468 -1.019 . . . . 0.0 109.399 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.89 113.72 6.56 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -112.54 142.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.013 -1.054 . . . . 0.0 110.379 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.53 HG11 ' N ' ' A' ' 149' ' ' ALA . 2.7 t -119.44 167.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' N ' HG11 ' A' ' 148' ' ' VAL . . . -153.64 128.16 9.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.974 -1.079 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.503 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -61.08 156.06 18.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -88.16 -54.18 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.55 ' CA ' ' HB2' ' A' ' 185' ' ' GLN . . . 146.79 128.75 1.92 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 154' ' ' SER . 51.1 p-10 -83.66 60.96 6.02 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 122.166 -0.608 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER 91.97 104.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.356 0.598 . . . . 0.0 109.953 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . -173.45 61.97 0.13 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 77.29 164.22 0.23 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.324 -1.104 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.65 56.6 4.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -145.85 161.75 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.52 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.45 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -100.53 -174.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.376 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.547 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 0.7 OUTLIER -107.02 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.142 0.972 . . . . 0.0 111.576 -178.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.485 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.7 m-85 -108.8 134.15 20.43 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.682 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.2 Cg_endo -72.95 -56.91 0.14 OUTLIER 'Cis proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.043 -1.232 . . . . 0.0 111.018 3.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 160' ' ' SER . . . 37.74 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.284 1.04 . . . . 0.0 109.412 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -43.73 -34.94 1.66 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.1 m-85 -44.67 -178.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.289 1.042 . . . . 0.0 111.615 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 167' ' ' ASN . . . -95.92 -60.01 1.73 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -44.67 -67.47 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.206 1.003 . . . . 0.0 108.65 179.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -71.97 139.29 48.57 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.8 mmm -104.71 143.29 33.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.999 -1.063 . . . . 0.0 109.912 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -94.99 108.16 20.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 34.6 t -87.53 165.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.27 -175.47 13.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -117.6 157.77 25.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -1.095 . . . . 0.0 109.199 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.53 ' CG2' HG22 ' A' ' 193' ' ' VAL . 18.6 p -135.35 168.13 19.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 110.049 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.08 -162.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -83.84 -19.86 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -71.37 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 109.277 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.472 ' O ' ' HB ' ' A' ' 174' ' ' THR . 2.7 m-20 -153.14 -59.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.288 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.611 ' ND2' ' CD1' ' A' ' 257' ' ' TYR . 8.6 t-20 -147.23 148.9 31.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.574 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 163.08 -70.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.428 0.633 . . . . 0.0 109.541 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . 48.91 178.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.641 -0.662 . . . . 0.0 109.809 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -34.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.477 ' HB2' ' HB2' ' A' ' 154' ' ' SER . 7.7 p90 -106.49 -3.61 20.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.89 112.16 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.55 ' HB2' ' CA ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -67.96 105.61 2.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 108.846 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -109.22 -169.99 1.58 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.466 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.581 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . -174.77 -142.12 3.92 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.132 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.51 71.59 5.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -1.044 . . . . 0.0 110.42 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.01 64.81 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.769 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 191' ' ' ASP . 0.5 OUTLIER -61.74 149.49 39.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.29 -1.124 . . . . 0.0 109.161 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -61.54 -60.98 2.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.495 HD12 ' CG1' ' A' ' 262' ' ' VAL . 14.7 tt -160.73 165.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 120.984 -1.072 . . . . 0.0 109.619 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.53 HG22 ' CG2' ' A' ' 174' ' ' THR . 27.3 m -122.48 161.38 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.214 -0.929 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -153.41 158.18 32.75 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.432 ' CB ' ' HZ3' ' A' ' 6' ' ' TRP . 34.6 Cg_endo -76.02 121.22 6.08 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 121.984 1.789 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -163.13 52.88 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.287 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 45.1 t -100.87 64.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -1.185 . . . . 0.0 108.4 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.65 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 12.6 t-20 119.45 129.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 6.2 m -165.51 116.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 121.965 0.888 . . . . 0.0 108.822 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 20.2 pt20 -94.73 138.18 32.88 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.556 0.694 . . . . 0.0 109.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.51 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -135.43 -152.79 0.48 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.0 109.188 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.7 p -88.62 178.94 6.37 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.216 -0.928 . . . . 0.0 110.537 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.645 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -145.45 164.09 28.29 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.645 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 33.5 Cg_endo -69.9 155.85 64.43 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.57 1.514 . . . . 0.0 110.437 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.05 -60.49 4.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 2.0 p 151.6 38.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.975 -0.72 . . . . 0.0 109.577 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -122.77 170.8 9.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.172 -0.955 . . . . 0.0 109.935 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -108.73 177.74 4.69 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.409 -0.807 . . . . 0.0 108.98 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -162.78 166.93 23.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.079 -1.013 . . . . 0.0 110.209 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.4 OUTLIER -144.08 122.05 12.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.585 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.494 ' CD2' ' C ' ' A' ' 210' ' ' SER . 0.2 OUTLIER -136.33 156.19 48.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.083 -1.01 . . . . 0.0 109.878 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 212' ' ' ASN . 16.2 p30 -117.83 131.54 56.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 109.041 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.62 28.62 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.605 -1.283 . . . . 0.0 109.914 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 89.0 m -76.57 -29.02 56.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -1.081 . . . . 0.0 108.813 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 218' ' ' THR . 0.3 OUTLIER -59.35 -24.74 63.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 108.85 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.499 ' HG2' ' CG2' ' A' ' 199' ' ' VAL . 0.0 OUTLIER -77.8 -29.29 50.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -84.51 -5.19 59.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.912 . . . . 0.0 108.751 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.59 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 0.9 OUTLIER -66.22 -52.72 36.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.436 -0.79 . . . . 0.0 110.15 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.6 Cg_endo -72.16 -9.16 24.06 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.259 1.972 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.515 ' NE2' ' HA3' ' A' ' 7' ' ' GLY . 1.6 m80 -74.7 -43.51 54.73 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.407 HG23 HG23 ' A' ' 262' ' ' VAL . 84.3 t -75.05 -39.86 44.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 219' ' ' PRO . . . -52.95 -35.43 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -69.66 -50.58 30.04 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.444 ' HA ' HD13 ' A' ' 227' ' ' LEU . . . -44.21 -49.72 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 108.955 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.408 ' HB3' ' CD1' ' A' ' 244' ' ' LEU . . . -57.93 -43.88 86.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 108.881 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.07 -41.51 64.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 109.317 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 224' ' ' ALA . 17.1 mt -62.19 -34.67 76.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 108.873 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' A' ' 231' ' ' LYS . 99.1 t -62.15 -60.38 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 109.032 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.515 ' HD2' ' CB ' ' A' ' 118' ' ' HIS . 0.3 OUTLIER -44.62 -41.86 6.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 108.992 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.515 ' HG3' ' N ' ' A' ' 24' ' ' SER . 1.4 tm0? -59.83 -57.53 12.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 228' ' ' VAL . 1.9 ptpt -62.21 -11.22 13.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.093 -1.004 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.527 ' OD1' ' CD1' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -156.42 80.79 3.68 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.803 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.15 -4.79 13.39 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.686 2.257 . . . . 0.0 110.086 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -14.21 22.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.527 ' CD1' ' OD1' ' A' ' 232' ' ' ASN . 29.5 m0 -71.67 175.79 5.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.117 . . . . 0.0 109.624 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 t -118.16 173.86 6.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.434 ' HB2' ' C ' ' A' ' 144' ' ' GLY . 40.0 t30 -54.8 -17.14 3.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 -62.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.07 59.3 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.646 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 77.7 mt -68.78 -54.26 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.452 -0.78 . . . . 0.0 110.854 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -66.85 -31.18 71.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.949 -1.094 . . . . 0.0 110.95 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 33.2 t-20 -73.04 -40.55 65.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.688 -1.257 . . . . 0.0 110.355 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.467 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.3 OUTLIER -75.45 -32.68 60.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.776 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.408 ' CD1' ' HB3' ' A' ' 225' ' ' ALA . 0.3 OUTLIER -77.72 -32.35 52.82 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.244 -0.91 . . . . 0.0 109.969 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.1 tttt -80.97 -28.77 35.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 108.686 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 4.6 t-20 -83.59 -18.27 38.83 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 266' ' ' ALA . 2.6 p -88.49 -30.15 19.6 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.207 1.003 . . . . 0.0 109.226 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.16 126.68 9.56 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.298 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.421 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 17.2 m -74.89 145.32 42.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.42 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.4 OUTLIER -115.47 126.47 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.878 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 179' ' ' ASN . 8.0 mp -71.76 -73.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 179.22 -32.27 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.585 ' HB2' ' CD2' ' A' ' 257' ' ' TYR . 71.0 m -68.77 172.32 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.255 . . . . 0.0 109.653 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 254' ' ' THR . 0.4 OUTLIER -147.52 16.77 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.586 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.41 -28.54 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.99 . . . . 0.0 109.676 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' TYR . 0.3 OUTLIER -121.04 -69.64 0.83 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 109.411 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 179' ' ' ASN . 15.6 m-30 -44.33 -50.78 8.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.038 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 72.41 -128.68 13.56 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 191' ' ' ASP . 13.6 t -44.53 -45.02 9.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -1.128 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' A' ' 251' ' ' LEU . . . 121.25 -138.01 12.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 13.3 tp -96.62 168.42 10.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -1.046 . . . . 0.0 109.178 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.495 ' CG1' HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -117.62 156.08 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.45 ' ND2' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -166.99 120.12 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.361 1.076 . . . . 0.0 108.771 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 268' ' ' THR . . . -75.26 0.97 14.76 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -35.31 40.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 247' ' ' THR . . . -83.58 -10.51 58.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.462 ' HA ' HG22 ' A' ' 247' ' ' THR . . . -100.29 -26.71 13.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.696 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 264' ' ' ALA . 19.1 p -79.65 -42.06 25.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.728 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.496 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.44 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.396 0.617 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.0 138.54 58.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.403 -0.81 . . . . 0.0 110.424 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 58.4 m -96.76 115.48 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.51 ' CG1' HG23 ' A' ' 8' ' ' ILE . 1.2 m -145.22 115.0 4.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.42 171.29 17.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.437 2.092 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -15.96 1.31 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.455 -0.778 . . . . 0.0 110.737 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.89 24.58 6.61 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.645 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -154.81 14.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.797 -1.413 . . . . 0.0 109.931 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -90.79 -37.36 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.709 -1.244 . . . . 0.0 110.351 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.551 ' HB3' ' CD2' ' A' ' 261' ' ' LEU . 4.4 mtm180 -92.91 23.34 4.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.045 . . . . 0.0 110.256 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 8' ' ' ILE . 11.1 m -111.82 19.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' C ' ' O ' ' A' ' 11' ' ' VAL . 63.2 mm-40 39.94 36.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.415 -0.803 . . . . 0.0 109.679 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -73.42 -32.7 1.69 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 112.156 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.5 Cg_endo -74.46 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 N-CA-C 108.797 -1.271 . . . . 0.0 108.797 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.35 -30.49 1.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.67 -44.34 61.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.254 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -71.66 -5.86 36.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.652 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.87 -24.72 13.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.028 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -46.99 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.07 -53.0 0.57 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mp -49.71 141.39 9.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -1.084 . . . . 0.0 109.346 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -164.17 59.1 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.925 -1.109 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . 46.19 21.04 0.6 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.493 ' N ' ' C ' ' A' ' 22' ' ' THR . 2.6 p -40.28 -24.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.7 -0.882 . . . . 0.0 111.329 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -152.28 54.36 0.46 Allowed Glycine 0 N--CA 1.493 2.458 0 C-N-CA 118.86 -1.638 . . . . 0.0 111.386 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 60.7 t -122.75 168.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -1.22 . . . . 0.0 108.781 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 117' ' ' MET . 5.4 mttm -136.63 117.54 14.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 110.214 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 89' ' ' TYR . 11.8 t -115.44 139.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -100.14 147.65 25.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 110.085 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.2 t -119.25 83.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -75.59 96.35 3.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.894 -0.504 . . . . 0.0 109.983 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' C ' ' A' ' 33' ' ' THR . 0.2 OUTLIER -167.5 -159.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.95 -1.094 . . . . 0.0 109.104 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -44.5 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.047 -1.033 . . . . 0.0 109.124 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.517 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -168.62 -124.15 0.71 Allowed Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 34' ' ' GLY . 34.3 mm -161.45 93.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ILE . 16.6 p -40.62 118.9 1.01 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.863 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.07 103.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.36 154.07 71.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.395 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.71 1.26 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.695 2.264 . . . . 0.0 110.496 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' OD1' HG22 ' A' ' 202' ' ' THR . 3.0 p30 -108.55 1.1 21.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.641 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.38 116.6 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.05 138.22 58.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.3 mm -119.84 100.27 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.624 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -118.56 12.0 13.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.54 146.57 10.5 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.28 99.5 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.078 -1.248 . . . . 0.0 110.212 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.08 117.78 23.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -1.054 . . . . 0.0 108.163 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 p -112.67 115.54 28.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 110.832 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.597 ' CZ ' ' HA2' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -95.74 -36.7 11.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.564 ' CG1' ' HD2' ' A' ' 51' ' ' PRO . 9.9 t -45.22 149.49 0.92 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.564 ' HD2' ' CG1' ' A' ' 50' ' ' VAL . 27.9 Cg_endo -68.42 156.13 66.72 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.892 1.728 . . . . 0.0 110.927 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.8 -44.52 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.527 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 42.11 60.57 9.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.792 -0.829 . . . . 0.0 110.967 178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.7 Cg_endo -81.28 -89.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.209 1.94 . . . . 0.0 109.879 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.509 ' O ' ' OG1' ' A' ' 56' ' ' THR . 72.2 m -135.38 -6.09 2.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.424 -0.798 . . . . 0.0 110.422 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 55' ' ' SER . 1.4 p 79.44 -8.98 1.53 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ASP . 2.2 mm-40 -100.99 172.87 6.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.814 . . . . 0.0 109.184 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 57' ' ' GLN . 0.9 OUTLIER 49.9 175.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.625 0.726 . . . . 0.0 110.191 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.33 -64.71 0.32 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -145.3 -61.87 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -1.113 . . . . 0.0 109.577 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.8 -35.79 0.67 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -54.99 -62.76 1.45 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -1.132 . . . . 0.0 109.47 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.96 -41.33 13.76 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 m -57.65 -44.59 85.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -1.126 . . . . 0.0 109.444 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.581 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 0.3 OUTLIER -59.51 -59.48 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.505 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 70' ' ' ILE . 11.1 t -51.59 -30.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.269 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.54 -54.02 46.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.378 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.468 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . -73.53 -17.15 78.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.581 HG21 ' CD2' ' A' ' 220' ' ' HIS . 28.6 m -82.58 -14.51 54.71 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.058 -1.26 . . . . 0.0 107.87 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.52 HD13 ' CG1' ' A' ' 66' ' ' VAL . 46.3 mt -101.75 -27.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.535 -0.728 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -161.36 22.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.785 -1.197 . . . . 0.0 111.842 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -38.73 100.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.031 -1.043 . . . . 0.0 109.323 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 72' ' ' ALA . 8.8 mt -44.58 172.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.29 -0.882 . . . . 0.0 110.514 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.495 ' HB3' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -105.18 103.53 13.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.443 -0.786 . . . . 0.0 109.433 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -142.01 -118.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.171 -0.956 . . . . 0.0 108.905 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.28 -39.29 0.53 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.429 ' O ' ' CD1' ' A' ' 77' ' ' ILE . 1.3 pp -88.42 65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.07 152.19 6.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 17.4 m -68.28 -146.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.289 -1.124 . . . . 0.0 109.527 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 74' ' ' ASN . 24.9 tp -139.83 107.11 5.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.874 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -65.98 -153.23 0.18 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.07 -32.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.239 . . . . 0.0 109.582 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -120.65 100.21 46.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.298 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 22' ' ' THR . 37.0 Cg_endo -81.72 -54.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.805 2.337 . . . . 0.0 110.534 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -82.55 30.93 0.41 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.684 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -94.56 168.64 10.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.939 -1.101 . . . . 0.0 109.222 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -96.12 92.03 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.146 -0.971 . . . . 0.0 108.87 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.447 ' CD1' ' HB1' ' A' ' 71' ' ' ALA . 1.5 mt -71.76 139.77 49.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.333 -0.854 . . . . 0.0 109.949 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 3.0 m-85 -120.82 147.95 44.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.93 98.82 6.38 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.347 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.537 ' CG2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -96.39 61.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.132 -0.98 . . . . 0.0 108.76 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 33' ' ' THR . 2.0 ttmt -34.73 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.468 0.652 . . . . 0.0 110.364 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 91' ' ' VAL . 0.3 OUTLIER -110.83 7.33 8.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.523 HD13 ' CD2' ' A' ' 124' ' ' LEU . 88.1 mt -145.99 173.62 12.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.245 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.55 144.17 9.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.415 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . . . -54.07 -71.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -1.126 . . . . 0.0 108.711 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.18 7.91 44.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 108.928 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' SER . . . -75.49 -52.69 6.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' GLY . 0.3 OUTLIER 45.48 77.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 108.742 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.55 179.91 50.24 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.703 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -95.36 -176.27 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.626 0.727 . . . . 0.0 109.534 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.03 -14.92 19.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.7 m -80.77 -18.06 48.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.69 -45.28 11.82 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.495 HG23 HD11 ' A' ' 105' ' ' ILE . 2.8 mt -70.97 -44.64 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.42 -0.912 . . . . 0.0 108.588 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -37.11 86.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 109.023 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 8.1 tp60 -65.16 -45.23 85.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.597 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -66.9 -31.87 79.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.456 HD22 HD23 ' A' ' 122' ' ' LEU . 10.3 mt -71.68 -28.5 63.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -1.198 . . . . 0.0 108.934 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.7 -22.28 46.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -63.62 -23.03 67.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.636 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -92.69 -15.64 26.48 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.935 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -66.86 -31.1 77.24 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.16 -28.49 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -1.102 . . . . 0.0 109.265 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -132.1 35.41 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.636 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -83.53 158.07 35.23 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.565 ' N ' ' SD ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -106.55 -179.93 4.08 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 -179.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.517 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.6 m170 -50.31 -30.2 11.48 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 t -136.68 160.82 37.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.018 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -168.04 106.63 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.535 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 9.7 m120 -91.54 156.56 17.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.825 -1.172 . . . . 0.0 111.046 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.456 HD23 HD22 ' A' ' 109' ' ' LEU . 6.6 mp -129.22 103.02 6.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -85.04 64.72 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.278 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.523 ' CD2' HD13 ' A' ' 94' ' ' LEU . 1.5 pp 177.66 175.48 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.988 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.522 ' O ' ' CD ' ' A' ' 129' ' ' PRO . . . 157.5 -99.6 0.19 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.602 ' CB ' ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER 62.55 -175.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.394 -1.062 . . . . 0.0 110.076 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 126' ' ' SER . 37.0 Cg_endo -83.21 -10.35 10.15 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.749 2.299 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.652 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -57.2 -44.13 99.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 111.96 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 128' ' ' SER . 30.1 Cg_endo -71.22 177.37 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.119 1.88 . . . . 0.0 111.022 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.7 t -118.43 173.9 6.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.45 1.119 . . . . 0.0 111.259 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.21 60.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.444 ' O ' HG21 ' A' ' 132' ' ' THR . 22.0 m -76.41 -26.77 55.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -39.74 61.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 165' ' ' TYR . 1.0 OUTLIER -66.92 -43.48 83.2 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.457 178.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -55.61 -26.75 45.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.94 75.46 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.325 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.68 -24.28 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.4 ' O ' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -68.78 -29.53 67.92 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.38 -22.75 35.3 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.67 -37.13 31.38 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 120.88 -1.137 . . . . 0.0 110.8 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 167' ' ' ASN . 4.5 m -73.32 -24.64 60.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.915 -1.116 . . . . 0.0 108.236 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 138' ' ' ASN . 3.2 m -55.63 -28.95 58.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -87.08 -28.49 22.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.469 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.41 -7.43 24.63 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.6 t -48.75 110.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.181 -1.188 . . . . 0.0 109.811 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.526 ' CD1' ' OD1' ' A' ' 237' ' ' ASN . 3.5 tp -68.23 96.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 108.794 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 2.0 t -88.05 154.66 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.064 -1.022 . . . . 0.0 109.916 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.551 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 0.8 OUTLIER -140.87 104.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.55 ' CB ' ' HG2' ' A' ' 162' ' ' PRO . . . -92.96 148.22 22.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.902 . . . . 0.0 110.469 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.508 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.01 169.58 9.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.499 ' CB ' HG23 ' A' ' 214' ' ' THR . 0.1 OUTLIER -61.32 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.015 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 153' ' ' ASN . . . -168.68 -68.5 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.192 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 152' ' ' GLY . 19.4 t-20 88.98 6.4 0.14 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.301 0.572 . . . . 0.0 109.822 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 153' ' ' ASN . 27.6 t 175.59 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -132.76 -101.93 0.81 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.488 ' N ' ' HG2' ' A' ' 185' ' ' GLN . . . 178.61 78.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.348 -1.089 . . . . 0.0 109.605 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' TYR . . . 56.26 13.49 7.21 Favored Glycine 0 C--N 1.288 -2.136 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.38 147.52 33.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -1.222 . . . . 0.0 109.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.472 HG21 ' HA ' ' A' ' 186' ' ' TYR . 4.5 pt -74.56 176.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.989 -1.069 . . . . 0.0 109.85 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -102.58 165.8 10.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.798 . . . . 0.0 112.082 -177.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.1 OUTLIER -80.29 144.48 58.09 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 174.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 164' ' ' ARG . 42.8 Cg_endo -72.97 -28.09 7.45 Favored 'Cis proline' 0 C--N 1.289 -2.579 0 O-C-N 122.676 0.829 . . . . 0.0 110.581 3.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -29.13 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.741 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 162' ' ' PRO . 19.3 ttp180 -67.95 -52.4 36.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.711 -1.243 . . . . 0.0 109.553 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -41.08 -178.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.645 1.212 . . . . 0.0 111.269 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.38 -0.38 9.85 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.5 ' HB3' ' OG1' ' A' ' 141' ' ' THR . 1.9 m-80 -87.12 22.51 2.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.438 -0.789 . . . . 0.0 109.427 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -171.32 145.91 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.414 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 29.8 mtp -81.4 152.95 27.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.008 -1.057 . . . . 0.0 109.938 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.16 132.56 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.9 t -99.24 165.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.032 -1.043 . . . . 0.0 110.136 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.53 173.69 20.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 214' ' ' THR . . . -135.02 152.38 51.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -1.221 . . . . 0.0 109.552 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 p -116.39 163.1 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.22 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 12.8 p-10 -62.38 179.01 0.35 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.036 -1.04 . . . . 0.0 109.248 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.93 -29.66 43.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -94.03 -90.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.422 -0.799 . . . . 0.0 109.647 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 7.0 t30 -150.02 -20.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.196 -0.94 . . . . 0.0 111.091 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 178' ' ' ASN . 8.3 t30 -56.57 -160.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.711 -1.243 . . . . 0.0 109.647 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.574 ' HG2' ' CD1' ' A' ' 256' ' ' LEU . 0.3 OUTLIER -93.73 135.83 34.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.024 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 180' ' ' ARG . . . -43.59 161.75 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -101.37 12.52 37.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 109.564 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.577 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -153.32 29.9 0.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 110.082 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.423 ' OG ' ' CG2' ' A' ' 214' ' ' THR . 9.1 t -121.21 156.77 31.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.257 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.488 ' HG2' ' N ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.5 137.32 54.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CE1' HD23 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -141.04 176.98 8.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.547 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 137.91 133.27 3.1 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.064 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . 35.65 102.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.12 -0.635 . . . . 0.0 111.613 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 116.81 -5.25 18.66 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.77 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.554 ' CD2' ' CD2' ' A' ' 186' ' ' TYR . 8.9 tp -61.72 107.89 0.9 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.878 -1.366 . . . . 0.0 110.237 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 25.0 t70 -75.9 -56.63 4.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.469 ' HA ' ' CB ' ' A' ' 259' ' ' SER . 2.5 tt -149.1 169.75 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.106 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 10.0 m -123.26 164.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -163.44 177.96 1.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 109.025 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 32.8 Cg_endo -76.49 116.98 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.408 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -134.63 54.95 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 37.4 t -149.01 101.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.524 -0.986 . . . . 0.0 108.586 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.592 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.3 OUTLIER 73.91 107.11 0.07 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.125 0.964 . . . . 0.0 111.276 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.557 HG11 ' ND2' ' A' ' 212' ' ' ASN . 17.4 m -163.41 109.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 16.9 pt20 -84.7 148.16 26.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.608 0.718 . . . . 0.0 110.773 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.581 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -145.31 -151.56 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.451 HG22 ' OD1' ' A' ' 40' ' ' ASP . 74.2 p -90.18 172.11 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.625 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -159.99 164.49 19.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.625 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -70.63 164.02 36.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.948 1.765 . . . . 0.0 110.393 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.84 78.88 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.76 32.42 22.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -1.114 . . . . 0.0 109.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -118.32 150.94 38.65 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.049 -1.032 . . . . 0.0 109.817 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -92.74 172.45 8.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -145.68 118.21 8.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.868 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.5 OUTLIER -91.19 111.56 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 0.6 OUTLIER -175.47 147.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 110.361 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.592 ' HB2' ' N ' ' A' ' 198' ' ' ASN . 11.3 t-20 -136.11 -162.86 1.32 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.859 0.838 . . . . 0.0 109.161 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 150.73 -174.78 29.97 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.499 HG23 ' CB ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -70.54 -42.33 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.703 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 150' ' ' ALA . 1.4 m -66.07 -16.07 63.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 110.403 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.52 ' HB3' ' OD1' ' A' ' 212' ' ' ASN . 1.5 mpp? -91.07 -16.6 27.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.115 . . . . 0.0 109.754 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 194' ' ' ALA . . . -87.64 -13.18 43.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 108.688 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.614 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 2.6 m -63.07 -43.84 82.77 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.63 -0.669 . . . . 0.0 111.349 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -72.75 -26.7 15.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.123 1.882 . . . . 0.0 111.583 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.581 ' CD2' HG21 ' A' ' 69' ' ' THR . 16.7 m170 -67.11 -45.55 76.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.869 -1.144 . . . . 0.0 108.177 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.419 HG23 HG22 ' A' ' 262' ' ' VAL . 67.2 t -67.63 -45.74 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.512 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -54.18 -33.93 59.27 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.74 -52.46 42.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.12 2.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -1.076 . . . . 0.0 109.168 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.517 ' CA ' HD13 ' A' ' 244' ' ' LEU . . . -47.47 -26.73 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' A' ' 227' ' ' LEU . . . -64.75 -59.21 4.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 226' ' ' ALA . 4.8 mt -46.48 -36.91 7.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 108.45 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.16 -56.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.609 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.517 ' HD3' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -45.38 -39.32 6.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -48.5 81.48 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.298 -0.876 . . . . 0.0 109.02 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -67.26 -7.45 24.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.584 ' HB3' ' CG ' ' A' ' 235' ' ' TRP . 81.9 m-20 -160.21 78.88 2.56 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.4 -28.4 3.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.636 2.224 . . . . 0.0 111.099 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.85 0.68 54.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.584 ' CG ' ' HB3' ' A' ' 232' ' ' ASN . 11.9 m0 -71.56 -178.69 2.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 109.674 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.62 167.71 10.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.552 -0.718 . . . . 0.0 110.214 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.526 ' OD1' ' CD1' ' A' ' 146' ' ' LEU . 17.2 t-20 -51.2 -39.85 57.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 0.0 109.543 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -74.08 -59.34 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.278 -0.888 . . . . 0.0 109.465 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 238' ' ' VAL . 8.1 tp-100 -39.76 -36.56 0.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.305 0.574 . . . . 0.0 110.121 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.444 HD12 ' HE3' ' A' ' 229' ' ' LYS . 66.6 mt -77.87 -46.52 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 110.43 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 15.8 ttp180 -52.81 -40.47 63.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.919 -1.113 . . . . 0.0 110.523 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -63.14 -35.19 79.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -0.941 . . . . 0.0 110.612 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -71.62 -43.21 66.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.389 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.558 HD23 ' CG1' ' A' ' 262' ' ' VAL . 0.4 OUTLIER -77.22 -22.48 52.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 110.245 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -82.77 -24.59 33.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 0.0 109.352 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -90.2 -21.87 21.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.918 . . . . 0.0 109.214 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 266' ' ' ALA . 2.3 p -87.66 -29.72 20.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 110.055 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -40.02 116.43 0.65 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.844 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.535 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 1.0 OUTLIER -65.76 163.77 15.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.93 . . . . 0.0 109.214 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.501 ' N ' ' CG2' ' A' ' 249' ' ' THR . 5.9 p -115.78 114.46 24.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.337 -0.852 . . . . 0.0 109.524 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.469 HD21 ' OD1' ' A' ' 178' ' ' ASN . 5.8 mp -63.26 -69.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.717 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 161.7 57.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.609 ' HB2' ' CD2' ' A' ' 257' ' ' TYR . 10.1 t -118.1 177.66 4.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -1.124 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.402 ' N ' ' OG ' ' A' ' 253' ' ' SER . 0.8 OUTLIER -114.53 -22.29 9.87 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 110.344 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.443 ' ND2' ' C ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -179.03 -24.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.743 -1.223 . . . . 0.0 111.169 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.603 HD11 ' CD1' ' A' ' 257' ' ' TYR . 2.7 tm? -53.35 -63.95 0.98 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.6 -1.312 . . . . 0.0 108.923 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.609 ' CD2' ' HB2' ' A' ' 253' ' ' SER . 4.7 m-85 -65.58 -47.31 76.2 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 259' ' ' SER . . . 55.89 58.36 14.49 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.469 ' CB ' ' HA ' ' A' ' 192' ' ' ILE . 0.0 OUTLIER 171.18 -84.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -1.191 . . . . 0.0 109.093 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 132.35 -163.3 24.02 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 10' ' ' ARG . 5.0 tp -98.11 177.93 5.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.707 -0.878 . . . . 0.0 109.257 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.558 ' CG1' HD23 ' A' ' 244' ' ' LEU . 0.6 OUTLIER -110.22 155.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 110.208 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.535 ' ND2' ' OG1' ' A' ' 249' ' ' THR . 0.1 OUTLIER -150.72 116.42 5.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.884 1.326 . . . . 0.0 108.657 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -79.78 -25.39 40.96 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.622 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 265' ' ' GLU . 7.6 tp10 -71.78 -41.89 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.589 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 247' ' ' THR . . . -76.55 0.76 18.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -113.69 -3.61 13.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.52 -35.85 4.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 142.74 44.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.481 -0.762 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.636 ' HB2' ' N ' ' A' ' 80' ' ' LEU . 1.9 p -65.97 89.07 0.12 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.972 -1.08 . . . . 0.0 110.585 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.547 ' CG2' ' C ' ' A' ' 3' ' ' SER . 0.1 OUTLIER -165.64 73.46 1.33 Allowed Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.432 -0.792 . . . . 0.0 109.169 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HD2' ' CG1' ' A' ' 8' ' ' ILE . 34.7 Cg_endo -77.46 165.31 27.54 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.51 2.14 . . . . 0.0 110.29 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -39.08 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.665 -0.647 . . . . 0.0 110.176 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PRO . . . -68.35 -62.64 4.02 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.57 ' O ' ' CB ' ' A' ' 9' ' ' SER . 47.0 mm -62.62 159.97 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -1.1 . . . . 0.0 109.515 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.57 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 4.4 m 89.38 -34.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.888 -0.508 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -27.89 61.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.297 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.69 22.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 0.0 109.662 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HG2' ' CB ' ' A' ' 265' ' ' GLU . 6.8 tp-100 52.89 49.41 20.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.697 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.51 -30.24 0.44 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 112.053 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.32 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB1' ' OE1' ' A' ' 12' ' ' GLN . . . -43.88 -31.19 0.81 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -66.1 -55.81 14.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.263 -0.898 . . . . 0.0 108.579 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.411 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 9.8 m-70 -66.35 -8.25 24.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.0 109.563 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -83.81 -35.95 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 5.91 8.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.85 43.73 5.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 2.2 mm? -99.71 133.67 43.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -1.094 . . . . 0.0 109.101 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.49 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -120.35 -37.96 2.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.494 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 81.31 -22.01 5.62 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -49.47 110.82 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.267 . . . . 0.0 109.078 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.73 -11.06 1.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 27' ' ' LYS . 48.2 t -110.57 170.04 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -1.235 . . . . 0.0 109.314 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 3.1 mttt -139.97 131.24 26.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.908 . . . . 0.0 109.364 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.527 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 48.7 t -124.34 145.29 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.018 . . . . 0.0 110.448 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -101.97 146.77 27.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.415 HG22 HD21 ' A' ' 88' ' ' LEU . 25.6 t -120.63 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 109.27 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.518 HD13 ' CG2' ' A' ' 91' ' ' VAL . 4.8 mp -65.83 93.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -147.03 -156.43 0.71 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 20.7 p -67.53 -24.75 65.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.355 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 161.05 -105.32 0.26 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.6 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 10.3 mt 135.65 101.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.0 OUTLIER -71.88 139.22 48.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -55.18 165.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -177.24 160.51 1.45 Allowed Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.161 -0.962 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.4 Cg_endo -78.49 -23.5 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 110.181 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 73' ' ' LEU . 1.4 t0 -102.48 -2.98 27.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.1 mt -102.46 160.88 14.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.266 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.445 ' HA ' HD13 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -112.51 119.35 37.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 mm -123.48 96.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.679 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -90.57 -28.73 18.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 108.951 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.94 -176.1 38.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.64 128.46 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -131.51 165.1 24.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.444 -1.033 . . . . 0.0 108.551 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.501 ' OG ' ' CG ' ' A' ' 51' ' ' PRO . 46.2 t -149.1 142.59 25.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.084 . . . . 0.0 110.486 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.608 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 23.5 m-85 -123.92 -35.63 2.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.585 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -41.96 -53.8 7.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HB2' ' CD ' ' A' ' 54' ' ' PRO . 39.1 Cg_endo -81.46 -160.4 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.981 2.454 . . . . 0.0 111.633 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -124.13 40.23 1.98 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.674 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 9.7 tp10 77.39 33.2 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.269 -1.136 . . . . 0.0 112.952 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 37.5 Cg_endo -80.67 -72.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.74 1.627 . . . . 0.0 109.954 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 m -137.61 139.63 40.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -111.69 2.07 17.04 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' ASP . 5.5 mm-40 -103.72 156.21 17.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 8.8 t70 55.13 166.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 109.611 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . -171.78 -54.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 2.1 t30 -165.78 -83.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -1.077 . . . . 0.0 108.985 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . -175.74 -34.17 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' A' ' 62' ' ' HIS . 3.0 t-160 -58.84 -64.73 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.406 -1.055 . . . . 0.0 109.531 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -47.67 -67.38 1.56 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.0 m -40.11 -52.37 2.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.569 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 2.6 t-80 -52.81 -50.78 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.858 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 70' ' ' ILE . 24.3 t -57.49 -32.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 109.231 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.52 -51.05 71.52 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.296 -0.877 . . . . 0.0 109.696 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.543 ' CA ' ' HB1' ' A' ' 72' ' ' ALA . . . -72.85 -17.88 78.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.528 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 6.4 m -80.65 -17.28 51.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.168 -1.195 . . . . 0.0 108.246 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 88' ' ' LEU . 23.1 mt -92.62 -31.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.615 -0.678 . . . . 0.0 109.944 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . . . -174.55 33.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.38 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.543 ' HB1' ' CA ' ' A' ' 68' ' ' GLY . . . -37.27 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 109.665 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' ASP . 12.8 mt -39.85 159.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 80' ' ' LEU . 7.6 t-20 -114.72 166.29 11.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 74' ' ' ASN . 0.4 OUTLIER 172.18 -93.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.407 -0.808 . . . . 0.0 109.28 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 -38.17 0.77 Allowed 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.762 -0.586 . . . . 0.0 109.48 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.4 pt -111.2 168.95 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.4 ' HA3' ' OD2' ' A' ' 40' ' ' ASP . . . 70.01 155.31 1.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.561 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 20.0 m -75.4 -154.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.276 -1.132 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.636 ' N ' ' HB2' ' A' ' 3' ' ' SER . 0.3 OUTLIER -145.9 122.35 11.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.482 -0.761 . . . . 0.0 109.423 -178.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.75 -163.79 4.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.411 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 4.7 t -82.57 -36.84 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.325 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . . . -95.0 147.17 32.6 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.3 Cg_endo -83.61 -61.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.873 2.382 . . . . 0.0 110.407 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 86' ' ' ALA . 6.6 m120 -99.53 -87.87 0.35 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.01 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 57.26 157.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.866 . . . . 0.0 109.701 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.554 ' HG3' ' CE ' ' A' ' 27' ' ' LYS . 20.5 mm-40 -108.97 94.74 5.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 108.774 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 70' ' ' ILE . 2.5 mt -79.98 150.75 30.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.07 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.519 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 3.9 m-85 -127.29 154.48 44.86 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -0.794 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -123.73 104.09 8.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -108.03 78.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -178.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 33' ' ' THR . 10.8 tttt -44.75 96.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.9 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -114.02 -9.8 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 109.084 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.484 HD12 ' HB3' ' A' ' 124' ' ' LEU . 77.3 mt -115.62 174.11 6.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.348 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -111.19 147.83 17.84 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.472 ' HA ' HG23 ' A' ' 33' ' ' THR . . . -59.2 -60.34 4.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -1.117 . . . . 0.0 109.666 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.23 -38.27 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.46 67.15 0.45 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -174.53 97.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -1.026 . . . . 0.0 108.945 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.62 -179.3 20.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 155.99 28.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.801 -0.823 . . . . 0.0 109.8 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.48 ' O ' HG11 ' A' ' 102' ' ' VAL . 83.9 t -67.21 -15.25 19.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.557 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -72.27 -27.77 62.7 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.524 ' CB ' ' CG2' ' A' ' 50' ' ' VAL . 65.8 p -80.03 -53.47 6.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 109.34 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.494 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 2.2 mt -61.55 -33.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.445 ' O ' ' CD ' ' A' ' 110' ' ' GLU . . . -65.17 -46.44 80.85 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.528 -0.732 . . . . 0.0 110.0 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.608 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -68.31 -40.86 81.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.558 -1.339 . . . . 0.0 108.873 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 31' ' ' LEU . . . -61.77 -21.05 60.36 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.7 mt -92.98 -51.01 5.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.903 -1.351 . . . . 0.0 110.579 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.445 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -76.56 -6.97 54.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.862 -1.149 . . . . 0.0 109.646 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.634 ' CZ3' ' CA ' ' A' ' 116' ' ' GLY . 70.9 t90 -89.47 -9.76 48.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.679 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.55 -11.93 44.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.515 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -86.95 -22.93 43.52 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 -76.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -110.01 10.34 24.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 110.925 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -104.46 52.13 0.76 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.011 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.6 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 37.91 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.189 0.995 . . . . 0.0 112.905 178.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.614 ' CE1' HG21 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -94.72 -29.14 14.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.369 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.614 HG21 ' CE1' ' A' ' 118' ' ' HIS . 1.9 t -97.43 153.82 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.323 -1.486 . . . . 0.0 109.004 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -169.23 113.71 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.963 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.541 ' C ' ' CD1' ' A' ' 122' ' ' LEU . 2.3 m120 -112.36 152.98 27.96 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.56 121.66 19.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.277 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.407 ' CB ' ' NE2' ' A' ' 62' ' ' HIS . 18.2 m -85.59 66.35 9.61 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.484 ' HB3' HD12 ' A' ' 94' ' ' LEU . 2.2 pp -154.9 178.8 9.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.704 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.539 ' HA3' ' HB2' ' A' ' 160' ' ' SER . . . 156.23 113.33 0.42 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.77 158.48 34.73 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.445 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 31.6 Cg_endo -74.71 -3.64 14.2 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.165 1.91 . . . . 0.0 108.646 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.7 t -117.66 76.33 10.27 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -77.18 163.67 30.17 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.335 2.023 . . . . 0.0 110.909 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.29 146.27 46.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.449 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.89 -14.79 63.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.2 m -79.65 -23.59 42.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.23 -40.39 30.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -75.61 -41.46 54.3 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.495 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -61.55 -23.6 66.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.07 -42.77 65.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 2.1 t -68.81 -26.25 32.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.06 -33.11 75.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.5 -22.48 35.06 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -79.39 -19.21 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.08 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -35.62 40.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.03 -1.044 . . . . 0.0 108.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.4 p -54.85 -30.63 58.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.508 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.11 -17.83 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.8 78.86 0.65 Allowed Glycine 0 N--CA 1.475 1.273 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 118' ' ' HIS . 48.6 t -119.17 111.95 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -1.082 . . . . 0.0 109.387 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.63 102.74 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.926 -1.109 . . . . 0.0 109.268 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -98.73 143.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.519 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 0.9 OUTLIER -135.58 116.15 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.483 ' CB ' ' HG2' ' A' ' 162' ' ' PRO . . . -104.77 148.4 26.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 109.614 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.58 162.46 25.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.226 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -69.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.0 109.877 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 160.72 -17.2 0.2 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.309 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.553 ' OD1' ' CD2' ' A' ' 183' ' ' PHE . 59.1 t-20 41.12 35.72 0.4 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.638 -0.919 . . . . 0.0 109.918 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -90.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 156.22 70.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.67 170.4 14.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -1.109 . . . . 0.0 109.296 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.91 52.82 4.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.0 OUTLIER 162.77 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -1.123 . . . . 0.0 109.121 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.425 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.6 OUTLIER -89.07 -177.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.159 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.539 ' HB2' ' HA3' ' A' ' 125' ' ' GLY . 0.7 OUTLIER -102.46 166.67 10.41 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.773 0.797 . . . . 0.0 111.595 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.566 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 2.4 m-85 -85.39 144.86 41.23 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 164' ' ' ARG . 45.2 Cg_endo -75.21 -31.02 5.59 Favored 'Cis proline' 0 C--N 1.293 -2.346 0 O-C-N 122.429 0.699 . . . . 0.0 111.016 3.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . -17.78 -47.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -52.57 -54.8 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.078 -1.014 . . . . 0.0 110.583 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -42.36 -178.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.558 1.171 . . . . 0.0 111.229 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.75 0.81 8.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.043 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.11 21.56 4.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 108.865 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.14 20.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.425 ' HA ' ' CG ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -112.23 132.49 54.9 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -106.87 123.07 47.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.4 t -90.34 166.13 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -137.94 166.81 25.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.507 ' HB1' ' HB ' ' A' ' 214' ' ' THR . . . -117.15 140.84 49.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -1.144 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.7 p -109.23 174.65 5.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.91 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.25 -147.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.652 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -69.62 -53.45 18.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -86.23 -82.75 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.923 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.518 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 33.4 p-10 -166.23 43.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -105.93 166.44 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.517 ' NH2' HG13 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -72.74 106.38 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 180' ' ' ARG . . . -43.55 130.9 5.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 109.43 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.6 m -60.75 -30.36 69.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.038 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.553 ' CD2' ' OD1' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -92.54 -14.43 28.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 11.5 t -76.99 154.89 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.23 140.41 37.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CE2' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -123.9 171.19 9.88 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.418 -0.801 . . . . 0.0 109.339 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.587 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.51 142.31 4.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.37 118.47 6.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -1.122 . . . . 0.0 109.185 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 122.9 -6.53 9.53 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.477 HD22 HG12 ' A' ' 193' ' ' VAL . 49.3 tp -45.81 154.63 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.181 -1.188 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.5 OUTLIER -99.51 -55.53 2.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 3.5 tt -151.87 172.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 0.0 109.872 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.517 HG13 ' NH2' ' A' ' 180' ' ' ARG . 8.3 m -136.83 166.83 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.292 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.431 ' HB3' ' HD2' ' A' ' 195' ' ' PRO . . . -168.99 167.71 5.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.169 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.441 ' HD3' HD12 ' A' ' 261' ' ' LEU . 35.3 Cg_endo -77.99 117.24 4.12 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.481 2.121 . . . . 0.0 110.284 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -142.6 22.08 2.36 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 31.6 t -89.01 58.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -1.149 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.641 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 17.8 t-20 131.69 122.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.549 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 4.8 m -167.01 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.075 0.94 . . . . 0.0 109.075 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 29.3 mt-30 -87.41 141.52 28.57 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.597 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.569 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -148.7 -147.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.4 166.4 11.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.017 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.628 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.11 159.13 40.62 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.6 Cg_endo -71.71 167.4 26.63 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.41 2.073 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 77.76 4.04 84.71 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 78.04 33.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -1.0 . . . . 0.0 109.404 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -127.89 157.59 40.1 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.106 -0.996 . . . . 0.0 109.708 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -94.98 179.55 5.18 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 203' ' ' TYR . . . -156.54 178.55 10.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.844 -1.16 . . . . 0.0 110.914 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 55.0 p -159.72 110.54 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.43 HD22 ' C ' ' A' ' 210' ' ' SER . 1.7 mt -126.7 162.69 25.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' A' ' 212' ' ' ASN . 2.1 p-10 -129.46 125.1 35.66 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.532 ' HA2' ' CE2' ' A' ' 183' ' ' PHE . . . 175.32 159.46 21.42 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.507 ' HB ' ' HB1' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -61.6 -30.2 70.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.916 . . . . 0.0 109.291 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.477 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 13.7 m -61.13 -27.3 68.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.469 ' HG2' ' CG2' ' A' ' 199' ' ' VAL . 0.7 OUTLIER -74.54 -24.32 58.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.335 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.461 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -85.38 -24.71 27.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.783 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 96.5 m -53.35 -44.33 97.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 111.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 218' ' ' THR . 31.0 Cg_endo -73.95 -24.56 15.08 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.727 1.618 . . . . 0.0 110.847 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -62.35 -41.23 98.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.27 -48.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.404 ' O ' ' HB1' ' A' ' 226' ' ' ALA . . . -49.24 -28.59 4.78 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.4 -58.5 4.22 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.28 -61.24 2.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -1.162 . . . . 0.0 109.289 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 229' ' ' LYS . . . -47.03 -41.75 17.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.426 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . . . -55.6 -44.23 76.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 22.4 mt -57.9 -47.22 83.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.227 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 46.9 t -55.94 -52.85 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.158 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 233' ' ' PRO . 0.0 OUTLIER -49.21 -38.95 27.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.449 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -60.1 -54.1 49.96 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.011 -1.056 . . . . 0.0 108.714 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -51.36 -20.97 1.95 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 108.551 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 176.82 89.29 0.11 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.729 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.554 ' N ' ' O ' ' A' ' 229' ' ' LYS . 36.4 Cg_endo -79.98 -24.88 5.49 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.792 2.328 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -53.2 -21.54 5.32 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -56.99 176.56 0.1 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 240' ' ' ILE . 0.6 OUTLIER -105.24 171.72 7.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 110.023 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -55.72 -45.95 77.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.488 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.3 t -74.33 -51.53 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -40.72 -41.16 1.47 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 109.345 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 236' ' ' SER . 2.9 mt -74.46 -45.08 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 242' ' ' ASN . 1.6 ttm-85 -47.96 -71.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 241' ' ' ARG . 1.2 m-80 -35.15 -36.63 0.06 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.812 -0.555 . . . . 0.0 110.701 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.54 ' O ' ' CG2' ' A' ' 247' ' ' THR . 1.4 t60 -69.0 -52.63 26.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.522 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.48 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 0.0 OUTLIER -66.91 -17.19 64.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.938 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -45.32 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.3 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 246' ' ' ASN . 1.2 m-20 -91.15 -5.26 55.28 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.15 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 243' ' ' HIS . 70.5 p -103.33 -52.55 2.99 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.912 -1.117 . . . . 0.0 110.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 244' ' ' LEU . . . -43.41 151.48 0.17 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.791 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 31.5 m -70.68 157.64 37.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 54.7 p -129.7 111.47 12.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 178' ' ' ASN . 4.0 mp -50.5 -59.22 4.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 109.373 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -170.91 -69.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.7 m -60.21 173.78 0.61 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -1.169 . . . . 0.0 109.251 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 76.0 p -143.56 28.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.674 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -159.33 -40.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.628 ' CD2' ' CE2' ' A' ' 186' ' ' TYR . 2.7 tm? -76.35 -65.5 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 256' ' ' LEU . 8.2 m-30 -64.08 -74.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.106 -0.996 . . . . 0.0 108.333 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 156.61 -177.26 33.66 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.6 t -46.74 -24.8 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 108.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.436 ' O ' HG21 ' A' ' 193' ' ' VAL . . . 119.28 -137.49 12.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.441 HD12 ' HD3' ' A' ' 195' ' ' PRO . 12.9 tp -102.47 169.1 8.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.989 . . . . 0.0 108.494 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.27 157.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.878 -1.139 . . . . 0.0 110.311 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -164.94 118.08 1.25 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.458 1.123 . . . . 0.0 107.977 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.46 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -68.99 -20.51 64.17 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.093 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.476 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 79.3 tt0 -68.96 -16.58 63.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.0 109.8 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -98.75 0.18 43.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -0.977 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -132.49 1.32 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.156 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 264' ' ' ALA . 2.8 p -101.67 -41.79 6.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.025 -1.047 . . . . 0.0 109.89 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.494 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 143.22 58.06 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.497 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.816 ' HB3' ' N ' ' A' ' 80' ' ' LEU . 51.9 m -62.05 111.92 2.13 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.941 -1.099 . . . . 0.0 110.056 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 178.3 66.2 0.1 Allowed Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 34.4 Cg_endo -76.67 173.98 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.457 2.105 . . . . 0.0 110.381 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.538 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -55.22 -11.94 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.588 -0.695 . . . . 0.0 110.899 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.66 -62.42 1.25 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.72 -1.238 . . . . 0.0 110.732 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -71.58 -0.78 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.114 -1.227 . . . . 0.0 110.247 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -104.61 -15.86 15.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.855 -1.153 . . . . 0.0 109.726 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.46 0.32 50.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.903 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.3 m -114.5 26.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 O-C-N 120.764 -1.21 . . . . 0.0 110.258 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.46 ' HG3' ' HB2' ' A' ' 265' ' ' GLU . 21.2 mm100 46.59 55.88 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -89.07 -30.05 0.36 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.49 -0.756 . . . . 0.0 112.364 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.2 Cg_endo -74.15 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 109.026 -1.182 . . . . 0.0 109.026 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 -29.08 1.66 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.2 -39.52 40.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 109.161 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 27.4 m170 -65.76 -24.9 67.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -99.62 -16.68 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.787 -1.196 . . . . 0.0 110.631 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -66.55 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.017 -1.052 . . . . 0.0 109.742 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' C ' ' CD1' ' A' ' 21' ' ' LEU . . . 173.48 17.06 0.02 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.591 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -134.85 153.99 51.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.505 -1.585 . . . . 0.0 108.659 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -138.92 42.23 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.522 ' HA2' ' NE2' ' A' ' 230' ' ' GLN . . . 50.52 14.79 1.05 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.6 OUTLIER -87.26 103.67 15.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -1.13 . . . . 0.0 109.884 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.74 -4.03 2.39 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.437 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG22 ' OE1' ' A' ' 230' ' ' GLN . 29.2 t -123.57 166.83 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 120.693 -1.475 . . . . 0.0 109.918 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -136.15 126.11 25.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.55 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.455 HG23 ' HB ' ' A' ' 119' ' ' VAL . 57.8 t -113.41 161.79 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.513 -0.742 . . . . 0.0 109.708 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.417 ' HB3' HG23 ' A' ' 91' ' ' VAL . . . -118.67 151.69 37.49 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.42 HG13 HD12 ' A' ' 35' ' ' ILE . 3.2 t -127.01 84.8 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.134 -0.979 . . . . 0.0 108.536 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.545 HD13 ' CB ' ' A' ' 91' ' ' VAL . 7.4 mp -73.13 93.46 1.82 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.4 p-10 -157.33 -161.78 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.973 -1.079 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.544 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 40.9 p -41.57 -51.55 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.84 . . . . 0.0 109.978 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.76 -47.12 0.48 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 34' ' ' GLY . 3.9 mt 73.95 105.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.47 158.13 27.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.815 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 101.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.556 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -104.96 148.56 36.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 32.9 Cg_endo -75.63 -17.13 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 110.583 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' O ' HD22 ' A' ' 41' ' ' LEU . 10.1 t70 -96.68 27.32 3.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.973 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 40' ' ' ASP . 13.9 mt -143.72 134.48 25.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 26.4 t-20 -86.03 66.2 9.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.131 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 44' ' ' ARG . 3.4 mt -73.31 163.25 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.457 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.519 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 0.9 OUTLIER -150.22 9.22 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.72 173.04 38.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.88 116.33 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HB1' ' CE1' ' A' ' 49' ' ' PHE . . . -116.06 163.92 15.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -1.086 . . . . 0.0 109.365 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -122.39 113.66 19.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 7.5 m-85 -110.67 -21.81 11.92 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 93' ' ' VAL . 1.4 t -63.72 126.09 89.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 110.005 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -80.6 154.26 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.358 2.038 . . . . 0.0 109.712 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 85.02 -60.89 4.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.48 ' O ' HG11 ' A' ' 50' ' ' VAL . 2.3 mt-10 -113.25 87.73 11.5 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.576 ' O ' ' C ' ' A' ' 55' ' ' SER . 31.8 Cg_endo -72.24 -72.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.793 2.329 . . . . 0.0 111.78 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.576 ' C ' ' O ' ' A' ' 54' ' ' PRO . 1.4 m -14.65 129.74 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.741 0.781 . . . . 0.0 111.709 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.411 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 7.7 t -103.89 -11.29 17.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.381 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 3.0 pm0 -81.57 110.54 17.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.664 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 33.3 t70 63.18 153.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.451 ' HA3' ' HB ' ' A' ' 33' ' ' THR . . . -154.77 -63.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.48 ' HB2' HG23 ' A' ' 33' ' ' THR . 1.0 OUTLIER -131.74 -53.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.131 . . . . 0.0 109.305 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.19 -33.6 1.23 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.228 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -61.23 -48.09 83.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.24 . . . . 0.0 109.874 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.04 -43.58 96.86 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 35' ' ' ILE . 59.9 m -61.0 -37.87 84.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -1.144 . . . . 0.0 109.614 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.598 ' CD2' ' CD1' ' A' ' 211' ' ' LEU . 7.9 t-80 -63.68 -53.75 46.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 109.747 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.531 HG11 ' HB3' ' A' ' 219' ' ' PRO . 3.7 t -60.89 -28.45 43.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.42 -0.8 . . . . 0.0 109.29 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -46.77 85.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.739 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 202' ' ' THR . . . -66.11 -42.84 94.25 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.458 HG23 ' HG2' ' A' ' 219' ' ' PRO . 3.9 m -58.12 -24.98 60.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.189 -1.183 . . . . 0.0 109.059 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.461 HD13 HG13 ' A' ' 66' ' ' VAL . 32.9 mt -82.85 -30.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.895 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.461 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -137.6 -51.47 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.991 -1.068 . . . . 0.0 111.11 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.589 ' CB ' ' N ' ' A' ' 81' ' ' GLY . . . 40.21 79.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 42' ' ' ASN . 13.6 mt -34.71 155.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.362 -0.836 . . . . 0.0 111.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.48 ' HB2' HD12 ' A' ' 80' ' ' LEU . 1.3 t30 -99.84 120.98 40.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.556 -0.715 . . . . 0.0 109.918 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -167.47 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.047 -1.033 . . . . 0.0 109.044 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 -7.39 0.26 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.212 -0.93 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.5 pt -106.8 67.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.66 -1.275 . . . . 0.0 109.513 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.03 177.01 14.66 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.496 ' C ' ' OG ' ' A' ' 3' ' ' SER . 25.7 m -81.32 -166.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.304 -1.115 . . . . 0.0 109.84 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.816 ' N ' ' HB3' ' A' ' 3' ' ' SER . 15.8 tp -133.73 140.7 47.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 0.0 109.51 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.589 ' N ' ' CB ' ' A' ' 72' ' ' ALA . . . -91.76 -169.02 41.2 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.6 t -88.25 -36.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.93 -1.335 . . . . 0.0 109.457 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.444 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -126.24 102.93 26.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.12 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 42' ' ' ASN . 37.9 Cg_endo -84.75 -62.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.652 2.235 . . . . 0.0 109.858 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.62 -27.17 10.53 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.088 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 83' ' ' ALA . . . -47.0 139.04 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 109.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.2 mp0 -74.79 97.35 3.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.263 -0.898 . . . . 0.0 109.225 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mt -80.97 120.18 24.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.051 -1.031 . . . . 0.0 109.443 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 11.9 m-85 -104.77 153.37 21.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.341 -0.85 . . . . 0.0 109.432 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -115.21 101.9 9.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.545 ' CB ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -96.98 67.11 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -37.58 95.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.901 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.51 HG22 ' CD2' ' A' ' 31' ' ' LEU . 3.3 t -113.7 -23.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.406 -0.809 . . . . 0.0 108.969 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -92.98 173.34 7.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.314 -0.866 . . . . 0.0 108.719 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 96' ' ' ALA . . . -98.03 -17.69 29.17 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 97' ' ' SER . . . 161.59 36.11 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 96' ' ' ALA . 2.5 m 80.97 8.73 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.68 -79.74 1.45 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -178.08 103.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -1.172 . . . . 0.0 109.434 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.48 178.64 51.57 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.13 152.51 42.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.892 -0.769 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 41.0 t -68.27 -19.43 24.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -75.03 -18.51 60.33 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -91.3 -37.19 13.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.505 -0.747 . . . . 0.0 109.426 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.429 ' HA ' HG12 ' A' ' 93' ' ' VAL . 1.1 mt -77.04 -26.94 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -80.76 -44.33 18.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.457 ' HG2' ' HA ' ' A' ' 104' ' ' SER . 10.1 pt20 -70.75 -31.11 67.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 0.0 109.009 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.93 -39.35 46.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -62.25 -39.66 93.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -1.128 . . . . 0.0 109.462 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 110' ' ' GLU . 1.6 tp10 -78.42 -19.64 52.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.132 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.645 ' CE3' ' HA3' ' A' ' 116' ' ' GLY . 84.8 t90 -65.95 -25.09 66.96 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.914 -1.116 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -88.45 -5.35 58.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.958 -1.089 . . . . 0.0 109.175 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -94.7 -6.59 60.69 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 19.7 t-20 -134.93 -4.71 2.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER 171.11 30.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.803 -1.186 . . . . 0.0 110.697 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.713 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -138.88 57.99 0.62 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.298 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.599 ' SD ' ' CG ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER 63.22 175.57 0.16 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.447 -1.031 . . . . 0.0 112.26 176.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.685 ' N ' ' CD2' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -104.0 -35.38 8.13 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.455 ' HB ' HG23 ' A' ' 28' ' ' VAL . 3.4 t -98.34 156.18 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.662 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -172.37 131.01 0.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 108.966 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.523 ' C ' ' CD1' ' A' ' 122' ' ' LEU . 3.0 m120 -117.58 148.25 42.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.564 ' N ' ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -125.22 114.48 19.03 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.132 -0.98 . . . . 0.0 108.951 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 123' ' ' SER . 2.8 t -86.5 61.61 6.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 HD22 ' CB ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.9 -173.71 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.872 0.844 . . . . 0.0 110.077 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 170.4 100.52 0.14 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -97.68 149.45 35.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.144 -1.209 . . . . 0.0 109.83 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.2 -5.39 15.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.351 2.034 . . . . 0.0 108.374 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.3 t -110.14 112.09 57.7 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.87 165.23 31.86 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.944 1.763 . . . . 0.0 109.881 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 120.54 6.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 110.5 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.34 65.49 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 52.9 m -63.38 -29.19 70.53 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -35.31 60.77 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.446 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -75.14 -25.14 58.17 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.137 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.63 -24.23 59.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.48 -40.88 25.36 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.072 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.496 HG13 ' CB ' ' A' ' 167' ' ' ASN . 1.7 t -68.3 -30.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.72 -35.9 82.08 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.489 ' OG ' ' OE2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -78.17 -21.23 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -76.56 -29.7 56.77 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -73.96 -24.21 59.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 108.541 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -57.74 -38.82 76.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 0.0 108.878 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.34 -14.42 16.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 108.878 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.63 81.52 0.99 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 94.1 t -119.23 109.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.6 tp -74.59 116.8 15.69 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -109.08 144.54 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -129.45 111.42 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.041 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.486 ' HB3' ' HG2' ' A' ' 162' ' ' PRO . . . -94.33 148.59 22.06 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.502 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -62.96 162.29 11.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.738 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.45 ' HB3' HG23 ' A' ' 214' ' ' THR . 44.9 t -49.57 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 110.721 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.637 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 133.15 133.67 3.41 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -102.37 63.5 0.88 Allowed 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.617 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -117.69 75.2 0.98 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.435 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 154' ' ' SER . . . -3.33 -62.2 0.0 OUTLIER Glycine 0 N--CA 1.507 3.409 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 154' ' ' SER . . . -46.77 173.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -1.102 . . . . 0.0 109.561 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.14 58.62 4.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 m -143.17 134.76 26.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.154 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.457 HD13 ' C ' ' A' ' 163' ' ' ALA . 6.8 pt -87.19 177.68 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.5 OUTLIER -87.05 160.89 18.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.362 -0.836 . . . . 0.0 111.818 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.449 ' CZ ' ' HD2' ' A' ' 164' ' ' ARG . 5.1 m-85 -83.5 141.99 42.67 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 164' ' ' ARG . 45.0 Cg_endo -74.73 -30.75 5.77 Favored 'Cis proline' 0 C--N 1.3 -2.023 0 O-C-N 122.421 0.695 . . . . 0.0 111.489 3.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -15.72 -50.21 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-O 121.124 0.488 . . . . 0.0 111.87 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 162' ' ' PRO . 10.9 ttm180 -50.39 -59.76 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.172 -0.955 . . . . 0.0 110.36 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -46.34 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.462 1.125 . . . . 0.0 111.046 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.93 -2.55 9.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.496 ' CB ' HG13 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -81.65 7.9 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 109.398 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -153.77 139.99 18.49 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.498 ' HB3' ' HB2' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -85.28 146.66 26.94 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.013 -1.054 . . . . 0.0 109.626 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -109.73 123.76 50.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.3 t -84.3 166.08 2.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.965 -1.085 . . . . 0.0 109.764 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.577 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -129.85 -176.67 14.52 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -134.35 150.03 50.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -1.2 . . . . 0.0 109.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 179' ' ' ASN . 71.0 p -134.21 153.35 51.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -172.05 1.86 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -23.56 64.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.054 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.79 -87.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.513 ' ND2' HD23 ' A' ' 251' ' ' LEU . 0.3 OUTLIER 177.13 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.99 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 174' ' ' THR . 7.7 t-20 -136.35 -161.21 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.438 ' HG2' ' NH1' ' A' ' 180' ' ' ARG . 2.5 mtp85 -87.87 12.51 12.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 180' ' ' ARG . . . 72.2 4.42 5.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.56 -6.61 0.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 112.195 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.418 ' CD2' ' O ' ' A' ' 181' ' ' ALA . 39.3 p90 -134.89 -5.58 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.318 -1.489 . . . . 0.0 110.286 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.3 t -78.08 132.17 37.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 108.403 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.637 ' HB2' ' O ' ' A' ' 152' ' ' GLY . 0.8 OUTLIER -88.79 149.29 23.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.097 . . . . 0.0 110.83 -178.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.655 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -121.68 176.44 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 108.918 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.655 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.53 178.62 47.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.46 145.45 50.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.248 . . . . 0.0 109.577 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.61 7.8 88.19 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.36 141.03 58.7 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.127 -1.22 . . . . 0.0 108.719 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.543 ' OD1' ' CE ' ' A' ' 245' ' ' LYS . 35.9 t0 -84.4 -79.75 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 110.935 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.532 ' CD1' HG23 ' A' ' 262' ' ' VAL . 0.2 OUTLIER -154.13 -161.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.072 . . . . 0.0 110.151 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 26.9 m -124.94 168.91 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.908 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.52 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -159.92 177.2 2.16 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.538 ' HB3' ' CH2' ' A' ' 6' ' ' TRP . 33.7 Cg_endo -76.47 115.99 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.173 1.915 . . . . 0.0 110.571 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.31 53.44 0.65 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.597 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 39.0 t -138.12 87.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.597 ' HB3' ' O ' ' A' ' 197' ' ' VAL . 7.6 t30 81.53 119.88 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 4.3 m -162.35 114.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.078 0.942 . . . . 0.0 108.974 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -76.31 122.84 25.01 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.751 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.577 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -131.72 -169.54 2.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.524 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.488 HG22 ' HA3' ' A' ' 68' ' ' GLY . 0.8 OUTLIER -81.89 173.4 12.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.307 -0.871 . . . . 0.0 110.307 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.623 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -151.36 166.95 14.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.3 Cg_endo -73.45 166.11 30.71 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.127 1.885 . . . . 0.0 110.704 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.43 -60.7 4.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 4.7 p 150.81 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 122.025 -0.691 . . . . 0.0 109.826 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -142.8 -179.37 6.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.542 ' N ' ' OG1' ' A' ' 207' ' ' THR . 0.0 OUTLIER -130.89 165.71 22.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.532 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.95 149.15 15.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.1 t -93.09 140.18 29.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.598 ' CD1' ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -145.94 151.19 37.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 213' ' ' GLY . 1.3 t-20 -104.95 168.45 9.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 212' ' ' ASN . . . 147.51 168.52 14.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.45 HG23 ' HB3' ' A' ' 151' ' ' SER . 0.2 OUTLIER -85.43 -38.07 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -1.059 . . . . 0.0 109.049 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.509 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 1.4 t -60.04 -15.25 21.26 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.465 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 25.3 mmt -64.99 -35.34 80.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.393 -0.817 . . . . 0.0 109.599 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.46 ' O ' HG12 ' A' ' 171' ' ' VAL . . . -84.44 -6.77 59.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.769 . . . . 0.0 110.783 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.597 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.5 m -69.06 -45.1 29.87 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 111.734 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.7 Cg_endo -73.37 -16.11 24.8 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.979 1.786 . . . . 0.0 111.118 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -74.57 -41.27 60.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 108.424 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.2 t -71.18 -41.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.482 ' HB3' ' OD1' ' A' ' 121' ' ' ASN . . . -55.71 -37.96 69.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.097 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.23 -49.59 45.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.48 -60.49 3.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -1.192 . . . . 0.0 109.603 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.449 ' HA ' HD13 ' A' ' 244' ' ' LEU . . . -44.56 -47.53 10.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.779 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.59 57.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.963 -1.086 . . . . 0.0 109.184 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 39.2 mt -52.13 -40.56 61.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.186 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 229' ' ' LYS . 68.7 t -58.79 -49.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 108.759 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.475 ' HD2' HG21 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -45.68 -45.69 14.3 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.522 ' NE2' ' HA2' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -60.78 -48.67 80.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.426 -0.796 . . . . 0.0 110.132 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.417 ' C ' ' CG ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -59.14 -14.38 10.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.278 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.417 ' CG ' ' C ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -174.68 95.63 0.29 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.951 . . . . 0.0 110.004 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.7 -20.27 9.33 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.591 2.194 . . . . 0.0 110.379 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.99 -42.82 95.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 0.0 110.188 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -52.39 173.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' SER . . . . . 0.534 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.1 OUTLIER -135.8 158.63 43.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.995 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 236' ' ' SER . 1.5 m120 -15.78 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 236' ' ' SER . 2.9 t -73.79 -65.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.013 -1.054 . . . . 0.0 110.329 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -40.51 -27.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.27 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 238' ' ' VAL . 63.7 mt -82.02 -49.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.561 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -56.27 -22.5 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.127 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 243' ' ' HIS . 2.4 t-20 -71.07 -69.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.768 -1.208 . . . . 0.0 110.339 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.429 ' O ' ' OG1' ' A' ' 247' ' ' THR . 9.9 t60 -55.84 -39.72 71.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.81 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 225' ' ' ALA . 0.1 OUTLIER -64.46 -43.06 95.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 111.001 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -77.48 -21.99 51.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.976 -1.078 . . . . 0.0 109.647 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.58 -19.94 28.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.071 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 0.9 OUTLIER -87.91 -27.22 22.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.303 1.049 . . . . 0.0 109.107 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -46.68 131.63 11.37 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.726 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 92.9 m -52.96 133.95 37.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.018 . . . . 0.0 109.767 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 99.4 p -93.06 94.2 8.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.513 HD23 ' ND2' ' A' ' 178' ' ' ASN . 5.7 mp -58.54 -63.96 1.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.178 -0.951 . . . . 0.0 109.936 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 157.1 66.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.502 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 0.2 OUTLIER -144.94 175.4 10.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.474 -1.015 . . . . 0.0 109.6 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 255' ' ' ASN . 28.8 p -111.7 -13.73 13.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.109 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 254' ' ' THR . 1.0 OUTLIER 178.51 -25.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.017 -1.052 . . . . 0.0 110.601 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.58 -49.99 74.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.95 -1.094 . . . . 0.0 109.953 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.502 ' HB2' ' OG ' ' A' ' 253' ' ' SER . 12.9 m-30 -83.98 10.09 10.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 38.93 74.84 0.11 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 2.8 t 84.56 -58.61 0.1 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.692 -0.887 . . . . 0.0 109.794 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 144.05 -131.57 4.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.487 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 52.6 tp -94.8 166.31 12.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.637 -0.919 . . . . 0.0 109.659 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.532 HG23 ' CD1' ' A' ' 192' ' ' ILE . 5.5 t -104.97 156.64 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.351 -0.843 . . . . 0.0 109.725 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -168.09 118.88 0.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.303 1.049 . . . . 0.0 108.543 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.67 -15.89 59.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.718 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -67.65 -41.19 84.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.711 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.36 -8.42 59.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -99.59 -21.77 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.218 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.503 ' O ' ' C ' ' A' ' 269' ' ' ARG . 25.2 p -112.54 -55.69 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.181 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 268' ' ' THR . 3.1 ttt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 1.8 tm0? -70.57 172.15 9.06 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 66.8 m -98.31 127.62 44.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.026 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -140.52 106.45 6.5 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.85 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.97 178.02 8.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.367 2.044 . . . . 0.0 109.771 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -5.6 16.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.1 -63.29 1.74 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.491 HD13 ' NE2' ' A' ' 220' ' ' HIS . 1.7 mp -75.82 113.39 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.11 -1.229 . . . . 0.0 109.146 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 11.8 p 168.1 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.405 ' HB3' ' CD2' ' A' ' 261' ' ' LEU . 2.3 mmt180 -77.81 -21.68 51.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -86.41 14.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.081 -1.012 . . . . 0.0 109.894 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.475 ' OE1' ' CB ' ' A' ' 15' ' ' ALA . 22.2 mm-40 45.05 57.92 4.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.476 -0.765 . . . . 0.0 109.69 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.701 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.07 -30.94 0.47 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.451 -0.781 . . . . 0.0 111.82 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 33.1 Cg_endo -76.14 -55.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.232 1.288 . . . . 0.0 109.0 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HA ' ' OD1' ' A' ' 18' ' ' ASN . . . -49.64 -27.34 4.52 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.203 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.87 -32.84 24.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.863 -1.148 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 22.1 m170 -75.75 -20.79 58.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.506 ' OD1' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -110.31 -25.77 9.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.584 -1.322 . . . . 0.0 110.38 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.467 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 3.9 tpm_? -56.16 -25.35 46.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.0 -1.062 . . . . 0.0 109.47 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.87 0.7 3.87 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.432 HD12 HG23 ' A' ' 268' ' ' THR . 2.4 mt -102.81 151.83 21.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -1.178 . . . . 0.0 109.172 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.483 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -137.78 -2.66 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.183 -0.948 . . . . 0.0 110.853 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 22' ' ' THR . . . 48.83 18.6 1.11 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.489 ' HA ' ' CB ' ' A' ' 85' ' ' ASN . 40.7 t -72.86 9.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.569 -0.96 . . . . 0.0 111.405 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.37 37.25 1.9 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.281 -1.437 . . . . 0.0 110.144 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.93 163.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.857 -1.378 . . . . 0.0 110.025 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.571 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . 21.3 mttp -127.12 128.62 46.5 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.532 -0.73 . . . . 0.0 109.115 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 43.6 t -131.5 153.79 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.028 -1.045 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.23 160.27 19.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.066 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.534 ' CG1' ' OD2' ' A' ' 32' ' ' ASP . 7.2 t -133.09 90.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.109 -0.994 . . . . 0.0 108.919 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.515 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 8.7 mp -80.44 123.43 28.05 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 7.8 p30 173.48 -164.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.908 -1.12 . . . . 0.0 109.815 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.3 p -42.38 -65.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -172.28 -132.37 1.49 Allowed Glycine 0 C--N 1.302 -1.341 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 34' ' ' GLY . 30.3 mm -165.32 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.46 ' HB3' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -53.09 142.39 20.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.989 . . . . 0.0 109.267 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 117.16 13.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 152.74 72.36 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.196 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 -21.33 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.532 2.155 . . . . 0.0 110.713 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -81.01 -17.32 50.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 67' ' ' ALA . 29.8 mt -101.39 149.75 23.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.07 88.26 2.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.134 -0.979 . . . . 0.0 109.392 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.92 100.01 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.555 ' CG ' ' HB2' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -93.81 -11.42 31.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.27 -0.894 . . . . 0.0 109.31 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.624 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -174.65 169.59 42.57 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.78 130.33 1.92 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -131.07 170.78 14.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.375 -1.074 . . . . 0.0 108.944 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.456 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 93.8 p -140.84 112.74 7.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.097 -1.002 . . . . 0.0 110.493 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 50' ' ' VAL . 3.7 m-85 -106.92 -47.71 3.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.401 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 51' ' ' PRO . 2.6 t -39.99 144.54 0.52 Allowed Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' N ' HG11 ' A' ' 50' ' ' VAL . 32.2 Cg_endo -72.04 177.3 7.29 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.516 2.144 . . . . 0.0 110.43 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' PRO . . . 59.13 23.04 56.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -26.5 88.63 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 122.471 -0.429 . . . . 0.0 111.584 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 36.5 Cg_endo -81.88 -72.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.762 2.308 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.583 -0.698 . . . . 0.0 109.161 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.458 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.7 OUTLIER -77.86 -0.36 27.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 108.689 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -129.32 146.43 51.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 179.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 15.1 t70 64.03 154.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.72 -30.32 0.12 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -167.29 -55.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -1.171 . . . . 0.0 109.374 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.94 -10.37 3.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -54.18 11.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -1.168 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.476 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -58.62 -39.98 94.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 36' ' ' SER . 2.9 m -63.8 -32.74 74.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -1.096 . . . . 0.0 108.973 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.573 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 0.6 OUTLIER -67.21 -57.25 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 110.257 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.437 ' O ' HG11 ' A' ' 66' ' ' VAL . 13.4 t -60.17 -32.47 50.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.341 -0.849 . . . . 0.0 109.796 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB2' HD12 ' A' ' 41' ' ' LEU . . . -65.17 -43.04 93.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.691 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -73.49 -38.33 52.16 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.521 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.527 HG22 ' CE1' ' A' ' 220' ' ' HIS . 29.8 m -65.09 -21.66 66.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 108.919 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 219' ' ' PRO . 49.6 mt -89.86 -23.58 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 109.352 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -126.46 -57.51 1.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 111.703 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.581 ' CB ' ' N ' ' A' ' 81' ' ' GLY . . . 36.68 87.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.29 149.82 32.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.733 -1.229 . . . . 0.0 109.762 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 11.4 p30 -91.77 87.29 6.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 76' ' ' SER . 14.8 p30 -126.84 -120.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.204 -0.935 . . . . 0.0 108.828 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.423 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -124.43 -34.51 2.89 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.076 -1.015 . . . . 0.0 109.38 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.0 pt -100.32 67.39 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.305 -0.872 . . . . 0.0 109.486 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.24 158.99 9.54 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 34.8 m -87.31 -135.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.175 -1.191 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.4 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 31.6 tp -140.64 123.09 16.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.697 -1.252 . . . . 0.0 110.263 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.581 ' N ' ' CB ' ' A' ' 72' ' ' ALA . . . -87.57 -153.02 24.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.452 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.87 -60.18 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.906 -1.35 . . . . 0.0 109.332 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -89.36 112.56 52.15 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.246 -0.909 . . . . 0.0 109.174 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -84.69 -62.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.519 2.146 . . . . 0.0 110.947 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.489 ' CB ' ' HA ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -81.74 18.5 1.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.24 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.99 143.69 32.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.876 -1.14 . . . . 0.0 109.11 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 4.9 pt-20 -84.69 115.1 22.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.913 -1.117 . . . . 0.0 109.198 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mt -92.4 123.75 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.93 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.624 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 13.0 m-85 -106.59 152.61 23.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.452 ' HB3' ' CG1' ' A' ' 35' ' ' ILE . . . -113.69 102.83 10.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.366 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.515 ' HB ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -99.76 69.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 108.93 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -38.28 112.07 0.2 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.312 0.577 . . . . 0.0 110.199 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.506 HG11 HG12 ' A' ' 105' ' ' ILE . 2.1 t -120.19 -17.67 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.256 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.45 172.97 7.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 96' ' ' ALA . . . -122.48 12.4 8.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 95' ' ' GLY . . . 71.05 3.69 4.76 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.979 -0.718 . . . . 0.0 109.796 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.2 -38.33 11.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.04 -9.94 3.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.08 98.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.064 -1.257 . . . . 0.0 110.005 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.13 179.6 52.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.465 ' O ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -67.2 150.98 48.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.883 . . . . 0.0 110.284 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.521 HG12 ' CB ' ' A' ' 130' ' ' SER . 44.9 t -68.47 -20.8 25.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.485 ' HB2' HG21 ' A' ' 50' ' ' VAL . 60.2 p -79.25 -55.04 5.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.506 HG12 HG11 ' A' ' 93' ' ' VAL . 1.3 mt -62.29 -25.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 -45.75 68.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.593 -0.692 . . . . 0.0 110.167 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.545 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -67.12 -39.41 86.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.933 -1.104 . . . . 0.0 108.638 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.85 -19.23 73.26 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.51 -42.45 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -1.233 . . . . 0.0 110.184 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' HB2' ' CB ' ' A' ' 139' ' ' SER . 6.5 pt-20 -94.86 -2.64 50.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.005 -1.059 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 71.4 t90 -86.21 -14.95 42.38 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.784 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.51 -7.19 59.65 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.415 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -91.27 -46.42 3.82 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.654 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.67 -71.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.129 -1.218 . . . . 0.0 110.028 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -109.48 35.25 3.38 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.784 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -114.88 -153.92 10.62 Favored Glycine 0 C--N 1.291 -1.92 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.596 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.596 ' HE2' ' CZ ' ' A' ' 89' ' ' TYR . 17.9 mmt -118.59 -172.92 2.37 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.882 0.849 . . . . 0.0 111.46 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.653 ' CE1' ' CE ' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -86.16 -27.86 24.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.831 -0.543 . . . . 0.0 110.223 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.619 ' CG2' ' NE2' ' A' ' 118' ' ' HIS . 15.5 t -114.02 159.77 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.848 -1.157 . . . . 0.0 109.569 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.475 ' O ' HG11 ' A' ' 147' ' ' VAL . . . -163.9 114.16 1.29 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.606 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 6.4 t-20 -98.53 159.27 15.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.05 . . . . 0.0 110.441 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.417 HD11 ' C ' ' A' ' 121' ' ' ASN . 3.7 mp -131.99 104.51 6.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.3 59.35 5.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.468 HD13 ' N ' ' A' ' 125' ' ' GLY . 1.4 pp -154.49 -175.19 5.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.386 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 173.57 103.09 0.16 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.361 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.51 148.69 35.31 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.297 -1.119 . . . . 0.0 108.914 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -75.95 -2.1 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.348 2.032 . . . . 0.0 109.554 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 m -103.63 110.53 64.04 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.768 -0.583 . . . . 0.0 110.108 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.39 169.04 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.232 1.954 . . . . 0.0 109.33 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.521 ' CB ' HG12 ' A' ' 102' ' ' VAL . 1.4 m -159.52 126.83 4.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.872 -1.143 . . . . 0.0 110.965 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.34 65.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 m -64.32 -30.06 71.12 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -34.23 66.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HA ' ' OH ' ' A' ' 165' ' ' TYR . 26.8 tt0 -68.29 -53.39 24.77 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.412 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -51.21 -25.97 6.29 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.06 -1.025 . . . . 0.0 108.296 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.69 -49.26 26.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.627 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.446 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 16.2 t -65.81 -20.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.86 -37.81 85.15 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.94 -27.79 60.34 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -75.99 -20.75 57.6 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 121.063 -1.023 . . . . 0.0 109.798 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -76.78 -33.56 58.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -24.62 58.33 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.829 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.9 OUTLIER -106.42 -22.19 12.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.646 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.18 62.16 2.13 Favored Glycine 0 C--N 1.301 -1.411 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 118' ' ' HIS . 48.4 t -103.22 118.84 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.43 115.43 17.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 108.797 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -111.34 132.45 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.129 -0.982 . . . . 0.0 109.884 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.606 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -114.18 166.66 7.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.6 132.72 15.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 0.0 109.67 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.467 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -53.26 155.79 2.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.435 -0.791 . . . . 0.0 109.499 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 185' ' ' GLN . 0.1 OUTLIER -61.81 -66.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 155.52 -16.08 0.48 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.6 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 153' ' ' ASN . 11.7 t-20 44.69 40.01 3.83 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.726 -0.867 . . . . 0.0 109.535 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.6 -26.79 9.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.477 ' N ' ' OE1' ' A' ' 185' ' ' GLN . . . 74.64 102.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 175.19 -177.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 109.547 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.543 ' HA2' ' CE1' ' A' ' 186' ' ' TYR . . . -94.29 59.56 1.94 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.4 t 169.86 154.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.182 . . . . 0.0 109.67 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -114.13 -171.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.821 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.6 OUTLIER -85.89 162.53 18.55 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.011 0.91 . . . . 0.0 112.012 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.49 139.86 20.96 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.2 Cg_endo -74.9 -36.74 2.49 Favored 'Cis proline' 0 C--N 1.294 -2.291 0 O-C-N 122.836 0.914 . . . . 0.0 110.992 3.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . 8.46 -71.93 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.961 0.886 . . . . 0.0 110.729 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.642 ' N ' ' O ' ' A' ' 162' ' ' PRO . 23.9 ttt-85 -45.93 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER 28.29 -161.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.801 1.286 . . . . 0.0 112.586 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -134.7 -31.0 1.07 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.449 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -100.93 19.13 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -135.75 167.15 21.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.454 ' HB3' ' CG ' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -122.68 136.04 54.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.006 -1.059 . . . . 0.0 109.538 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 190' ' ' LEU . . . -98.06 154.06 17.98 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 18.9 t -111.98 167.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.571 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -135.18 -158.99 8.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 193' ' ' VAL . . . -127.2 166.65 17.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.312 -1.11 . . . . 0.0 109.929 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 179' ' ' ASN . 22.8 p -139.19 150.74 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.543 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 179' ' ' ASN . 3.5 p30 -76.44 -174.09 2.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 110.176 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.13 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -81.73 -89.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.127 -0.983 . . . . 0.0 109.345 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.424 ' O ' HD21 ' A' ' 251' ' ' LEU . 1.4 m120 -174.93 67.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 174' ' ' THR . 38.2 t30 -146.43 -176.08 5.03 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.137 -0.977 . . . . 0.0 109.714 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.571 ' CD ' ' HB2' ' A' ' 257' ' ' TYR . 0.6 OUTLIER -66.04 3.7 0.8 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.56 -0.713 . . . . 0.0 111.887 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 180' ' ' ARG . . . 66.88 -145.94 0.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.133 -1.604 . . . . 0.0 108.413 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.21 -43.71 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.845 -1.159 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -87.75 35.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.447 -0.783 . . . . 0.0 110.499 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.7 t -94.11 127.59 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.477 ' OE1' ' N ' ' A' ' 155' ' ' GLY . 5.2 tp60 -66.23 114.38 5.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CE1' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -106.02 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.805 -179.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 143.32 158.33 7.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.3 97.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.492 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.451 ' C ' HD13 ' A' ' 159' ' ' ILE . . . 151.68 -23.4 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' A' ' 257' ' ' TYR . 11.0 tp -59.31 127.13 30.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.18 -1.188 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.48 ' O ' ' HA3' ' A' ' 258' ' ' GLY . 0.4 OUTLIER -90.95 -54.46 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.627 -179.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 259' ' ' SER . 1.8 tt -158.02 167.48 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.168 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 173' ' ' ALA . 33.4 m -112.26 166.29 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.502 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -152.9 176.36 2.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 108.832 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.12 116.55 4.2 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.341 2.027 . . . . 0.0 110.465 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.15 16.86 1.53 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 18.6 t -88.3 61.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -1.085 . . . . 0.0 108.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.642 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER 108.51 125.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 23.7 m -162.65 111.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.955 0.883 . . . . 0.0 108.665 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.2 pt20 -89.22 127.62 35.77 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.573 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -135.13 -160.94 1.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.85 168.54 16.01 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 110.038 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.642 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.43 166.26 16.03 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.642 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.1 Cg_endo -73.79 168.8 23.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.135 1.89 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 71.04 17.22 75.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER 66.1 33.03 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -1.165 . . . . 0.0 109.713 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.56 163.14 23.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 201' ' ' SER . 2.7 m-85 -106.93 -172.95 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.466 ' HB1' ' CD1' ' A' ' 203' ' ' TYR . . . -171.0 139.62 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.5 m -106.75 108.78 20.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.448 HD11 ' HE3' ' A' ' 216' ' ' MET . 16.1 mt -107.43 154.26 21.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.943 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.36 84.84 2.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.97 150.88 22.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.7 m -65.02 -22.61 67.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -1.071 . . . . 0.0 109.469 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 3.4 t -71.36 -23.0 61.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.448 ' HE3' HD11 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -75.6 -16.12 60.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 194' ' ' ALA . . . -93.46 3.72 55.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 109.876 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.672 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 23.7 m -77.4 -35.69 1.36 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.986 . . . . 0.0 111.972 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.6 Cg_endo -73.41 -29.02 11.62 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.301 1.334 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.527 ' CE1' HG22 ' A' ' 69' ' ' THR . 29.9 m80 -59.63 -40.85 88.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.834 -1.166 . . . . 0.0 108.057 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 63.5 t -70.35 -43.32 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.36 -31.33 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -72.4 -59.77 4.38 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -43.69 -49.69 7.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.2 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 244' ' ' LEU . . . -54.21 -45.91 72.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.365 -0.835 . . . . 0.0 108.776 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 229' ' ' LYS . . . -51.93 -49.78 62.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.868 . . . . 0.0 109.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.6 mt -49.35 -50.12 41.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 108.973 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.29 -45.36 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.653 ' CE ' ' CE1' ' A' ' 118' ' ' HIS . 12.3 tppt? -49.64 -43.17 46.71 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.447 -0.783 . . . . 0.0 108.986 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.64 -45.96 91.8 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 231' ' ' LYS . 1.5 tppm? -62.53 -13.11 27.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 108.794 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -163.33 85.75 1.33 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 36.7 Cg_endo -80.4 31.85 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.37 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.5 t -146.94 11.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.873 -1.142 . . . . 0.0 109.914 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -87.36 -179.02 6.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 110.032 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.74 173.67 6.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.289 0.566 . . . . 0.0 109.648 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.404 ' OD1' ' CG2' ' A' ' 238' ' ' VAL . 8.5 p30 -62.99 -32.94 74.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.201 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.9 t -77.07 -61.98 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.925 0.869 . . . . 0.0 109.181 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 238' ' ' VAL . 4.1 mt-30 -42.65 -38.23 1.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.72 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 7.5 mt -74.04 -47.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 3.1 tmt_? -52.37 -20.66 2.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.414 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 1.6 t-20 -78.13 -38.06 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.852 -1.155 . . . . 0.0 109.945 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.485 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.0 t-160 -75.74 -40.47 55.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.153 -0.967 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 225' ' ' ALA . 0.5 OUTLIER -73.64 -32.92 64.28 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.511 -0.743 . . . . 0.0 110.333 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 1.3 tmtt? -77.93 -42.32 33.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.093 . . . . 0.0 108.983 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 0.9 OUTLIER -67.77 -22.83 65.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.552 -0.718 . . . . 0.0 109.989 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.511 HG23 ' CB ' ' A' ' 267' ' ' ALA . 2.3 p -91.85 -26.09 18.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.916 -1.115 . . . . 0.0 110.04 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -37.01 114.46 0.32 Allowed 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.794 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 250' ' ' SER . 65.9 m -45.06 164.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 0.0 109.08 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.476 ' N ' HG23 ' A' ' 249' ' ' THR . 23.2 t -115.58 102.2 9.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 251' ' ' LEU . 6.4 mp -83.75 -35.69 24.19 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.265 -0.897 . . . . 0.0 110.0 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 130.73 69.01 0.1 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.598 ' HB3' ' CD1' ' A' ' 257' ' ' TYR . 0.3 OUTLIER -50.28 137.46 18.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -1.124 . . . . 0.0 109.99 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.6 t -98.93 -17.11 18.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -167.93 -44.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 258' ' ' GLY . 2.5 tp -148.37 -65.6 0.24 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.344 -0.847 . . . . 0.0 109.802 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.647 ' O ' ' CG ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER 23.34 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 123.063 1.411 . . . . 0.0 111.774 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 256' ' ' LEU . . . 54.11 -136.14 42.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.455 ' HB2' HD13 ' A' ' 192' ' ' ILE . 6.8 m -101.54 -3.4 28.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.438 -1.037 . . . . 0.0 109.545 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.615 ' HA2' ' CE2' ' A' ' 257' ' ' TYR . . . 110.27 -112.63 3.35 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.755 -1.212 . . . . 0.0 110.726 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 37.7 tp -115.49 159.22 21.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.507 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -110.59 159.86 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.825 . . . . 0.0 109.191 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.425 ' OD1' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -168.05 119.24 0.82 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.363 1.078 . . . . 0.0 108.731 178.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.97 -15.12 62.99 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.317 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.447 ' CB ' ' HG3' ' A' ' 12' ' ' GLN . 78.8 tt0 -74.33 -26.81 60.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.014 -1.054 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -90.79 3.28 54.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.511 ' CB ' HG23 ' A' ' 247' ' ' THR . . . -128.69 0.82 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 269' ' ' ARG . 21.4 p -107.49 -42.49 4.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.222 -0.924 . . . . 0.0 109.09 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 268' ' ' THR . 9.5 mtm180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.521 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.472 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.64 -177.11 1.44 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.221 -0.924 . . . . 0.0 108.769 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 14.9 m -117.91 113.67 22.08 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.642 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -138.28 148.65 60.42 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 108.982 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.78 166.29 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.382 2.055 . . . . 0.0 110.735 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -50.11 -19.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.491 -0.756 . . . . 0.0 110.556 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.61 -43.92 98.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.507 HD13 ' NE2' ' A' ' 220' ' ' HIS . 0.0 OUTLIER -90.6 -25.71 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.123 -1.222 . . . . 0.0 110.057 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 t -64.31 -20.58 66.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.932 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -0.68 38.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 111.398 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 8' ' ' ILE . 11.1 m -106.13 25.46 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 120.542 -1.349 . . . . 0.0 110.134 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.431 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 2.9 mp0 47.08 28.89 0.99 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -70.14 -36.17 5.86 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 111.704 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.42 -57.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.509 -1.381 . . . . 0.0 108.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.18 -33.52 0.94 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.62 60.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.162 -0.961 . . . . 0.0 108.819 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 1.3 m170 -73.08 -3.3 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.78 . . . . 0.0 109.444 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -53.35 5.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.076 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' CD ' HD11 ' A' ' 21' ' ' LEU . 1.9 ptp180 -54.86 -18.02 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.65 35.13 2.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD11 ' CD ' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -93.21 160.81 14.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.164 -1.198 . . . . 0.0 109.407 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -133.89 -53.32 0.86 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.762 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.535 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 83.73 -13.81 45.75 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 2.8 t -51.58 139.72 19.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -1.079 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.31 -15.81 11.83 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG11 ' CE1' ' A' ' 118' ' ' HIS . 45.3 t -93.26 169.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -1.089 . . . . 0.0 109.173 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB2' ' CG ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -137.25 120.41 16.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.163 -0.961 . . . . 0.0 109.389 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.81 134.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.31 146.54 24.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.356 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG1' ' OD2' ' A' ' 32' ' ' ASP . 16.2 t -119.23 80.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.23 -0.919 . . . . 0.0 108.938 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.499 ' N ' HD11 ' A' ' 31' ' ' LEU . 8.5 mp -72.08 87.44 1.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 109.364 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 54.8 p30 -151.78 -148.51 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 1.2 p -56.86 -72.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.098 -1.001 . . . . 0.0 109.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.584 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -170.99 -110.47 0.24 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.584 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 157.12 115.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 38' ' ' HIS . 2.6 m -83.91 60.38 5.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 111.425 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.512 ' C ' ' O ' ' A' ' 36' ' ' SER . 15.0 t 23.18 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.773 0.797 . . . . 0.0 111.22 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -51.52 161.98 0.76 Allowed Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.11 -29.38 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.465 2.11 . . . . 0.0 110.332 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.26 18.05 13.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 109.565 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 38' ' ' HIS . 83.5 mt -125.42 124.42 41.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.908 . . . . 0.0 109.291 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.9 t-20 -74.82 120.36 20.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 mm -103.3 96.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.145 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HG2' ' CG ' ' A' ' 87' ' ' GLU . 4.8 tpm_? -88.28 -38.66 15.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.66 -166.11 32.68 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.5 171.16 16.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB2' ' CE1' ' A' ' 49' ' ' PHE . . . -156.3 160.24 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.991 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 56' ' ' THR . 26.5 m -122.88 106.4 10.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.932 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -102.46 -33.17 9.62 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 109.159 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' CG1' ' HD2' ' A' ' 51' ' ' PRO . 70.5 t -49.33 142.53 10.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 0.0 109.028 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HD2' ' CG1' ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.56 -170.17 0.84 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.519 2.146 . . . . 0.0 110.449 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . 92.05 1.61 69.8 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 19.9 pt-20 39.61 56.51 6.46 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.97 . . . . 0.0 110.14 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.9 Cg_endo -77.29 -89.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.251 1.967 . . . . 0.0 110.187 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 3.3 p 161.4 136.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.794 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.46 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -52.26 -20.13 2.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 18.3 mt-30 -118.82 152.4 36.3 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.379 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 63.56 165.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.311 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . 169.78 -35.26 0.18 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 6.6 t30 173.72 -62.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . 168.72 -36.3 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.417 ' CD2' ' HE3' ' A' ' 216' ' ' MET . 0.1 OUTLIER -52.37 -22.69 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -1.098 . . . . 0.0 109.391 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 65' ' ' HIS . . . -72.48 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.476 ' C ' ' O ' ' A' ' 63' ' ' GLY . 37.7 m -34.01 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.744 -0.857 . . . . 0.0 110.931 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.611 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -71.95 -52.83 15.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 110.282 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.497 ' O ' HD13 ' A' ' 70' ' ' ILE . 46.1 t -63.57 -37.02 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB2' HD12 ' A' ' 41' ' ' LEU . . . -59.72 -42.65 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.447 -0.783 . . . . 0.0 109.933 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.98 -28.2 62.99 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.571 HG21 ' CE1' ' A' ' 220' ' ' HIS . 62.1 m -69.89 -18.56 63.41 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.34 -1.094 . . . . 0.0 108.341 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 66' ' ' VAL . 7.3 mt -94.03 -38.49 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 110.004 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.456 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -175.62 46.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.867 -1.146 . . . . 0.0 111.156 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -45.14 108.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.804 -1.185 . . . . 0.0 108.924 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 84' ' ' PRO . 80.4 mt -42.26 142.28 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 109.935 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -86.28 109.46 18.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.283 -0.885 . . . . 0.0 108.977 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 76' ' ' SER . 4.9 m-20 -124.28 -5.01 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 88.5 -17.62 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 pt -104.09 66.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.175 -0.953 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA3' ' OH ' ' A' ' 208' ' ' TYR . . . 147.56 -171.5 28.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 3' ' ' SER . 30.7 m -80.11 -163.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.324 -1.103 . . . . 0.0 109.6 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 8.2 tp -142.53 115.2 8.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.865 . . . . 0.0 109.611 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.52 177.11 22.51 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.523 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 2.0 t -65.03 -50.96 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.286 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -85.77 148.08 47.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.355 -0.84 . . . . 0.0 108.943 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.467 ' CD ' ' O ' ' A' ' 22' ' ' THR . 38.0 Cg_endo -82.73 -61.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.752 2.301 . . . . 0.0 109.719 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 68.9 m-80 -95.98 -86.46 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 58.32 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.582 -0.699 . . . . 0.0 110.388 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' CG ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 mp0 -70.24 93.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 3.3 mt -78.11 104.97 9.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.126 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.489 ' CE2' ' HE3' ' A' ' 117' ' ' MET . 19.1 m-85 -94.06 147.92 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 108.89 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.4 105.81 13.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.974 -1.079 . . . . 0.0 109.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.481 ' CG2' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -106.01 67.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.288 -0.882 . . . . 0.0 109.538 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 91' ' ' VAL . 15.3 ttmm -36.97 100.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.391 0.615 . . . . 0.0 109.58 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG2' ' HA3' ' A' ' 108' ' ' GLY . 0.9 OUTLIER -115.96 -16.68 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 124' ' ' LEU . 39.3 mt -118.79 169.12 10.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.807 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 167.19 12.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.58 -25.84 66.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -1.149 . . . . 0.0 109.246 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -49.81 74.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.78 2.33 14.5 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.8 74.28 1.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -1.145 . . . . 0.0 109.641 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.36 27.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.13 145.54 26.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.765 -0.844 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.468 HG23 ' OG ' ' A' ' 130' ' ' SER . 1.2 t -67.24 -32.27 56.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -21.85 66.7 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.489 ' O ' ' NE2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -85.34 -62.31 1.56 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.669 -0.644 . . . . 0.0 109.268 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.495 ' HA ' ' CG1' ' A' ' 93' ' ' VAL . 1.3 mt -48.71 -27.12 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -75.42 -48.75 21.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.405 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -62.54 -20.38 64.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.212 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.515 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -82.66 -38.42 12.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.9 mt -65.37 -24.98 67.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.378 -1.072 . . . . 0.0 109.234 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -26.03 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.495 ' CE3' ' O ' ' A' ' 111' ' ' TRP . 55.4 t90 -72.68 -14.78 61.65 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.933 -1.105 . . . . 0.0 108.476 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.679 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -94.29 7.99 43.44 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.584 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -103.4 -45.16 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -86.21 -83.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.919 -1.341 . . . . 0.0 108.391 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.91 49.52 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -112.61 -156.13 12.6 Favored Glycine 0 C--N 1.289 -2.082 0 CA-C-O 122.376 0.987 . . . . 0.0 111.525 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -122.3 163.05 20.36 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.276 0.56 . . . . 0.0 109.558 -178.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.64 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -72.79 -16.75 61.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 108.699 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.7 t -125.02 161.09 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.03 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -159.77 156.98 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 108.793 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.407 ' ND2' HG11 ' A' ' 148' ' ' VAL . 14.1 t-20 -135.56 152.56 51.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.313 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.414 HD11 HG13 ' A' ' 147' ' ' VAL . 3.4 mp -135.47 81.9 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' A' ' 215' ' ' SER . 5.0 t -71.32 84.16 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.011 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.479 ' CD2' HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 177.43 176.54 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.391 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -176.07 93.85 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 0.6 OUTLIER -86.99 148.73 46.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.29 -1.124 . . . . 0.0 109.272 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.43 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -76.39 -9.26 18.81 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.385 2.057 . . . . 0.0 108.942 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -97.34 108.83 46.94 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.446 ' HB3' ' CE2' ' A' ' 161' ' ' TYR . 31.9 Cg_endo -75.07 166.23 29.57 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.119 1.88 . . . . 0.0 109.831 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.468 ' OG ' HG23 ' A' ' 102' ' ' VAL . 43.8 m -157.75 118.96 3.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.987 -1.07 . . . . 0.0 110.532 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.68 66.03 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.9 m -61.75 -31.77 71.97 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.28 -33.72 61.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.455 ' OE1' ' OH ' ' A' ' 165' ' ' TYR . 4.4 tt0 -73.32 -22.79 60.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.802 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -25.56 58.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.1 -37.14 39.43 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.544 HG12 ' CB ' ' A' ' 167' ' ' ASN . 2.0 t -70.44 -29.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -64.19 -35.6 81.32 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.3 m -78.11 -22.8 48.36 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.52 -5.37 54.26 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -90.73 -43.15 10.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.214 -0.929 . . . . 0.0 109.143 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.5 m -64.21 -17.94 64.03 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.78 -14.12 23.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.455 -0.778 . . . . 0.0 109.371 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.84 62.85 4.22 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 118' ' ' HIS . 21.7 t -111.96 115.49 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -1.074 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.1 113.18 8.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.016 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -109.65 150.89 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.517 ' CG1' HG21 ' A' ' 218' ' ' THR . 2.7 t -123.56 166.59 18.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.51 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -157.38 135.42 10.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 110.264 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -61.17 171.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.471 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.4 OUTLIER -93.22 -39.07 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 109.944 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 132.53 120.91 2.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 47.11 1.29 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.905 -0.762 . . . . 0.0 109.473 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 155' ' ' GLY . 1.6 t -121.75 -91.93 0.55 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.455 ' N ' ' OG ' ' A' ' 154' ' ' SER . . . 150.51 95.95 0.14 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.23 173.26 16.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 0.0 109.634 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.98 42.24 3.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.493 ' O ' ' NE2' ' A' ' 185' ' ' GLN . 1.6 t -163.64 160.53 22.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -1.149 . . . . 0.0 109.321 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.16 -173.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.09 -1.006 . . . . 0.0 110.148 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.531 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 69.7 m -67.28 -174.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.691 1.234 . . . . 0.0 111.389 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.488 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 12.7 m-85 -137.2 128.56 16.46 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.737 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.1 Cg_endo -70.91 -50.74 0.18 OUTLIER 'Cis proline' 0 C--N 1.3 -1.993 0 O-C-N 123.188 1.099 . . . . 0.0 110.419 4.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 160' ' ' SER . . . 30.89 -77.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.615 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.737 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -36.51 -39.97 0.22 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.363 178.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.2 m-85 -49.73 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.344 -0.847 . . . . 0.0 110.241 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.86 0.1 11.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.544 ' CB ' HG12 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -87.01 16.95 4.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.165 -0.959 . . . . 0.0 108.934 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.47 153.53 7.75 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.453 ' HG3' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.2 129.8 42.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.921 -1.112 . . . . 0.0 109.509 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.513 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -91.41 133.63 35.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.541 HG13 ' N ' ' A' ' 172' ' ' GLY . 38.5 t -104.75 165.15 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.766 -1.209 . . . . 0.0 110.088 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.541 ' N ' HG13 ' A' ' 171' ' ' VAL . . . -129.76 -169.98 12.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.14 155.51 44.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 197' ' ' VAL . 2.6 p -125.32 -174.31 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 -176.59 3.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 109.798 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.413 ' NE2' ' OD1' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -51.35 -27.29 9.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.002 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.413 ' OD1' ' NE2' ' A' ' 176' ' ' GLN . 27.4 m120 -114.78 -93.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.034 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 13.4 p30 -142.49 16.81 2.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.909 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.36 153.03 22.81 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.047 -1.033 . . . . 0.0 108.833 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.507 ' N ' ' OH ' ' A' ' 257' ' ' TYR . 0.5 OUTLIER -73.18 136.45 44.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -50.33 -172.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.516 -0.74 . . . . 0.0 110.148 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.4 t -116.06 -17.59 10.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -111.35 -19.91 12.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.494 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.5 t -48.36 134.81 14.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -79.59 157.25 27.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.652 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.1 OUTLIER -134.49 173.23 11.87 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.393 -0.817 . . . . 0.0 109.032 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 150.31 147.77 4.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.54 141.31 9.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.16 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.58 -11.24 46.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.5 tp -56.62 118.1 4.52 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.317 -1.108 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.5 OUTLIER -69.63 -75.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.985 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.468 ' HA ' ' OG ' ' A' ' 259' ' ' SER . 0.4 OUTLIER -145.22 -158.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 27.0 m -135.06 172.8 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.133 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.543 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -162.11 178.26 1.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 33.0 Cg_endo -76.19 114.02 3.81 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.097 1.864 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.05 40.07 1.44 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.628 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 53.9 t -123.46 82.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.628 ' HB3' ' O ' ' A' ' 197' ' ' VAL . 12.5 t-20 83.85 120.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.164 0.983 . . . . 0.0 108.449 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 199' ' ' VAL . 28.3 m -153.06 105.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 122.443 1.116 . . . . 0.0 109.105 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -83.54 109.31 17.28 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.327 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.611 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 1.4 t -123.99 -165.65 1.38 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 109.105 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.458 ' HB ' HG23 ' A' ' 64' ' ' THR . 1.0 OUTLIER -69.24 176.72 3.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.213 -0.929 . . . . 0.0 110.268 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.628 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.6 OUTLIER -161.99 149.09 11.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.4 Cg_endo -69.99 173.48 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.277 1.985 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 79.97 8.79 87.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 1.0 OUTLIER 67.67 55.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.5 -1.0 . . . . 0.0 109.861 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.554 ' CG2' ' N ' ' A' ' 208' ' ' TYR . 4.2 t -155.85 -147.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.732 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.554 ' N ' ' CG2' ' A' ' 207' ' ' THR . 10.5 m-85 -146.36 -177.34 5.57 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.241 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.577 ' HB2' ' CD1' ' A' ' 203' ' ' TYR . . . 177.13 147.57 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.88 . . . . 0.0 110.373 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -118.86 142.27 47.89 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.72 122.38 3.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.857 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -72.84 160.7 31.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.139 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.16 156.3 8.53 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.431 HG23 ' HB2' ' A' ' 151' ' ' SER . 2.5 m -79.95 -27.36 39.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.187 . . . . 0.0 109.431 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.458 ' HB3' ' OG ' ' A' ' 123' ' ' SER . 0.3 OUTLIER -74.75 -13.76 60.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.646 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.417 ' HE3' ' CD2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -85.57 -20.94 28.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.676 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 194' ' ' ALA . . . -95.35 -3.6 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.617 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 8.5 m -75.17 -43.94 4.56 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 111.307 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.5 Cg_endo -72.27 -13.29 28.16 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.614 1.543 . . . . 0.0 110.155 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.571 ' CE1' HG21 ' A' ' 69' ' ' THR . 6.2 m80 -70.99 -44.24 66.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 222' ' ' ALA . 46.2 t -66.54 -51.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -44.26 -37.35 3.19 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.694 -0.802 . . . . 0.0 108.865 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -66.69 -52.8 31.63 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.68 -56.95 10.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 109.656 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.65 23.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.974 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.043 -1.036 . . . . 0.0 110.042 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 38.4 mt -61.95 -46.65 88.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.035 -1.041 . . . . 0.0 109.658 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.556 ' O ' ' CG ' ' A' ' 231' ' ' LYS . 55.5 t -60.29 -43.7 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.436 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -53.09 -40.42 64.1 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.966 -1.084 . . . . 0.0 108.902 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.535 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -61.85 -56.02 23.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.266 -0.896 . . . . 0.0 110.348 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 228' ' ' VAL . 0.1 OUTLIER -52.0 -19.82 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.967 -1.083 . . . . 0.0 109.206 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.587 ' OD1' ' CG ' ' A' ' 235' ' ' TRP . 0.1 OUTLIER -132.85 94.11 22.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.915 . . . . 0.0 109.066 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.32 41.38 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.737 2.291 . . . . 0.0 110.862 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.9 t -164.22 13.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.0 111.869 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.587 ' CG ' ' OD1' ' A' ' 232' ' ' ASN . 26.4 m0 -92.89 174.31 7.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.434 -1.416 . . . . 0.0 109.559 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' SER . . . . . 0.416 ' O ' HD13 ' A' ' 240' ' ' ILE . 0.5 OUTLIER -104.76 174.01 6.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.527 -0.733 . . . . 0.0 109.148 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.466 ' OD1' HG21 ' A' ' 238' ' ' VAL . 27.3 p-10 -65.97 -25.58 67.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 109.736 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.466 HG21 ' OD1' ' A' ' 237' ' ' ASN . 2.7 t -78.77 -64.84 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.227 -0.92 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 238' ' ' VAL . 10.9 mm100 -44.68 -37.89 3.99 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.77 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 236' ' ' SER . 55.8 mt -68.4 -55.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 12.5 ttp180 -52.14 -21.89 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.029 . . . . 0.0 110.008 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -73.0 -59.8 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.524 ' O ' ' CG2' ' A' ' 247' ' ' THR . 19.8 t60 -52.61 -47.96 66.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.53 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -66.84 -37.82 85.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.344 -0.847 . . . . 0.0 110.05 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -59.05 -62.82 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.488 -0.758 . . . . 0.0 110.65 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -72.59 -10.71 60.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 111.558 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.53 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 2.9 p -81.34 -31.16 33.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.429 -1.419 . . . . 0.0 109.846 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -42.92 115.63 0.77 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.966 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -43.61 169.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.802 . . . . 0.0 109.928 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.7 p -121.94 106.2 11.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 109.881 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.536 ' CD2' ' HA2' ' A' ' 260' ' ' GLY . 0.2 OUTLIER -63.03 -57.8 9.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.165 -0.959 . . . . 0.0 109.356 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 135.03 99.64 0.61 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.591 ' HB3' ' CD1' ' A' ' 257' ' ' TYR . 23.0 p -141.82 179.92 6.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -1.185 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 2.1 t -104.16 -24.52 13.15 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.59 -0.694 . . . . 0.0 109.958 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 254' ' ' THR . 2.6 t30 176.04 -24.33 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.353 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.5 -66.43 0.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.779 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' ' 253' ' ' SER . 50.5 m-85 -47.56 -60.65 2.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.049 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.76 20.75 74.51 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 191' ' ' ASP . 0.3 OUTLIER -167.57 -100.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 0.0 109.836 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' A' ' 251' ' ' LEU . . . 157.86 -160.57 30.83 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.583 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.49 ' O ' ' OG1' ' A' ' 249' ' ' THR . 9.4 tp -104.65 129.87 52.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.518 -0.99 . . . . 0.0 109.461 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 192' ' ' ILE . 0.0 OUTLIER -58.73 172.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.085 -1.009 . . . . 0.0 109.943 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.66 117.88 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 122.486 1.136 . . . . 0.0 108.408 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -74.28 -18.85 60.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.469 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 10.4 tt0 -95.49 -2.18 49.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.61 0.34 36.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -130.06 -1.04 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.865 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 269' ' ' ARG . 1.4 p -113.13 -35.69 5.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.562 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.529 ' OXT' ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.623 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.352 0.596 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.55 149.37 34.84 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.299 -0.876 . . . . 0.0 109.63 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -74.26 108.75 7.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 0.0 109.62 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.665 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -143.07 44.09 0.5 Allowed Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 121.4 -0.812 . . . . 0.0 109.977 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.665 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.8 Cg_endo -78.06 172.39 15.6 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.653 1.568 . . . . 0.0 109.112 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -72.83 8.87 1.31 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 111.096 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' A' ' 195' ' ' PRO . . . -110.12 -64.97 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.7 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.486 ' O ' HG21 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -56.46 -30.5 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.032 -1.275 . . . . 0.0 109.896 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 m -56.23 -34.56 66.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 109.849 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.03 -16.0 25.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.0 111.594 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 8' ' ' ILE . 3.0 m -85.35 15.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.299 -1.501 . . . . 0.0 110.387 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 74.6 mm-40 37.74 45.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.668 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -72.18 -35.17 3.21 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -72.9 -47.33 0.34 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 N-CA-C 108.162 -1.515 . . . . 0.0 108.162 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.25 -36.69 1.88 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -41.08 60.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.48 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 2.2 m-70 -63.45 -16.85 61.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.294 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -106.78 -24.76 11.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.783 -1.198 . . . . 0.0 109.915 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.4 mmp_? -63.47 -64.86 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.38 59.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.455 HD23 HG23 ' A' ' 268' ' ' THR . 1.7 mp -144.05 132.18 21.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -1.056 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 24' ' ' SER . 47.1 p -125.93 -8.08 6.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.364 -0.835 . . . . 0.0 109.986 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.87 11.5 4.39 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 22' ' ' THR . 12.3 p -60.16 -14.74 18.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 110.072 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.17 25.93 23.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' LYS . 57.7 t -132.0 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.001 -1.294 . . . . 0.0 110.091 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 22.9 mtmt -138.85 121.24 16.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.51 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 7.7 t -113.84 152.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.985 . . . . 0.0 110.294 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 120' ' ' ALA . . . -110.83 160.48 16.71 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.441 -0.787 . . . . 0.0 108.912 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.87 94.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 108.426 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 31' ' ' LEU . 5.8 mp -81.14 116.44 21.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -175.7 -161.72 0.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.941 -1.099 . . . . 0.0 110.26 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.491 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -46.78 -37.07 8.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.459 -0.776 . . . . 0.0 109.729 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 155.59 -103.52 0.24 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.588 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.0 mt 145.45 101.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 204' ' ' PRO . 0.4 OUTLIER -69.12 151.37 46.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.617 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 160.25 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -167.71 147.72 4.5 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 108.979 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.7 Cg_endo -77.14 -13.99 16.91 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.491 2.128 . . . . 0.0 110.477 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.31 5.27 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 108.918 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.1 mt -110.22 159.44 17.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.106 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.72 76.97 1.56 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.39 145.8 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 108.747 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.83 -20.95 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.913 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -178.22 153.31 12.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.82 -177.24 37.88 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.507 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 178.18 113.46 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 92' ' ' LYS . 25.1 m -105.44 111.07 23.65 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.517 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.484 ' CG ' ' HG2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -89.92 -22.72 21.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 93' ' ' VAL . 1.8 t -62.2 135.25 94.94 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.412 -0.805 . . . . 0.0 108.937 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.19 164.09 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.448 2.098 . . . . 0.0 110.672 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . 162.08 -69.12 0.23 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.605 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER 169.34 -51.01 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.306 -1.114 . . . . 0.0 109.825 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 53' ' ' GLU . 35.5 Cg_endo -77.85 -72.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.922 1.748 . . . . 0.0 109.246 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER 86.84 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.586 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -73.98 13.46 0.53 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.643 -1.286 . . . . 0.0 111.103 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 56' ' ' THR . 31.5 mt-30 -147.59 174.74 11.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.533 -1.354 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -57.68 160.78 4.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.471 -0.768 . . . . 0.0 110.648 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.09 10.15 3.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -167.25 -65.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 109.353 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.27 -32.27 0.54 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -45.56 -65.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -46.02 -70.89 0.58 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 63' ' ' GLY . 22.6 m -33.59 -49.4 0.3 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.778 -0.837 . . . . 0.0 111.252 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.5 t-80 -57.92 -52.65 64.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.067 -1.021 . . . . 0.0 110.344 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 219' ' ' PRO . 25.4 t -57.17 -37.81 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.078 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.76 -41.11 97.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' A' ' 202' ' ' THR . . . -68.26 -46.29 65.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.6 m -53.14 -29.22 30.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.431 -1.041 . . . . 0.0 108.974 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.0 mt -90.07 -24.31 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -120.22 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.938 -1.101 . . . . 0.0 111.9 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.576 ' CB ' ' N ' ' A' ' 81' ' ' GLY . . . 37.62 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.745 . . . . 0.0 109.868 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 mt -52.86 141.75 20.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.47 -1.394 . . . . 0.0 109.682 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.508 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 2.1 p-10 -89.78 116.36 27.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.513 ' N ' ' ND2' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -174.48 -105.87 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -45.98 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.348 -0.845 . . . . 0.0 109.224 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -72.07 169.87 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.521 ' N ' HG21 ' A' ' 77' ' ' ILE . . . 41.06 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.502 ' HB ' ' OG ' ' A' ' 3' ' ' SER . 27.4 m -115.91 -162.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.978 . . . . 0.0 109.1 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 3' ' ' SER . 1.9 tp -106.96 121.29 44.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.135 -0.978 . . . . 0.0 109.65 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.576 ' N ' ' CB ' ' A' ' 72' ' ' ALA . . . -88.48 -146.19 12.07 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.48 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 1.9 t -112.23 -34.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -1.225 . . . . 0.0 109.841 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -121.7 128.97 25.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.045 -1.035 . . . . 0.0 109.072 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 38.1 Cg_endo -85.36 -62.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.646 2.231 . . . . 0.0 110.618 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.4 37.04 1.2 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.337 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.44 129.06 34.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.45 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -61.49 87.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.326 -0.859 . . . . 0.0 109.373 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mt -76.49 124.33 27.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.078 -1.014 . . . . 0.0 109.741 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.596 ' CE2' ' HE2' ' A' ' 117' ' ' MET . 7.0 m-85 -115.57 152.18 33.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.476 -0.765 . . . . 0.0 109.185 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -119.05 98.81 6.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.052 -1.03 . . . . 0.0 110.334 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.508 ' HB ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.47 64.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.068 -1.02 . . . . 0.0 108.651 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 55' ' ' SER . 7.8 ttmt -37.34 121.91 0.87 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.549 0.69 . . . . 0.0 111.134 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 25.3 t -123.28 -36.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -130.16 179.56 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 33' ' ' THR . . . 154.79 -140.2 7.24 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 118.256 -1.926 . . . . 0.0 112.186 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 97' ' ' SER . . . -36.99 -60.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.135 -0.627 . . . . 0.0 110.72 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 96' ' ' ALA . 42.6 m -41.16 -49.54 3.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.85 88.37 1.56 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.491 ' HA ' HD21 ' A' ' 94' ' ' LEU . 22.7 m 59.44 79.33 0.23 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 99' ' ' SER . . . -46.57 176.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.28 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.1 t -83.96 176.73 8.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.912 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.453 HG13 HG23 ' A' ' 132' ' ' THR . 44.5 t -68.27 -13.39 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.09 -22.84 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.474 ' OG ' HG21 ' A' ' 50' ' ' VAL . 66.3 m -85.67 -43.6 13.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.49 HG22 HD11 ' A' ' 105' ' ' ILE . 1.6 mt -71.21 -23.27 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.52 25.15 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.681 -0.637 . . . . 0.0 109.413 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.484 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 3.5 tp-100 -69.98 -32.79 71.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 -39.05 27.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -73.7 -28.1 61.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -1.168 . . . . 0.0 109.707 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -92.33 -21.27 20.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.096 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.485 ' O ' ' CD2' ' A' ' 111' ' ' TRP . 64.7 t90 -76.85 -11.67 59.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.418 -0.801 . . . . 0.0 108.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.693 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -97.28 -1.37 44.88 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.302 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.62 -21.61 39.74 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -119.03 -5.84 10.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.132 . . . . 0.0 110.252 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -164.65 20.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.804 -1.185 . . . . 0.0 110.563 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -105.31 -152.77 21.29 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.732 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.596 ' HE2' ' CE2' ' A' ' 89' ' ' TYR . 10.6 mmt -120.56 -176.73 3.3 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.636 -0.92 . . . . 0.0 110.633 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.677 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -81.1 -25.75 36.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.217 -178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.677 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 2.4 t -114.77 158.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.575 -1.328 . . . . 0.0 109.738 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.515 ' O ' HG11 ' A' ' 147' ' ' VAL . . . -167.29 145.12 4.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.538 ' ND2' HG11 ' A' ' 148' ' ' VAL . 10.5 t-20 -115.35 162.18 17.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 109.454 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 121' ' ' ASN . 3.8 mp -144.97 113.56 6.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.196 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 10.8 m -92.7 68.99 4.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 178.54 177.02 0.47 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -0.925 . . . . 0.0 110.002 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 161' ' ' TYR . . . 172.17 -79.31 0.09 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER 81.86 162.0 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.762 -0.846 . . . . 0.0 110.032 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.472 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 34.8 Cg_endo -76.43 -14.55 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.514 2.143 . . . . 0.0 109.78 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.41 118.25 60.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.404 ' O ' ' OG ' ' A' ' 130' ' ' SER . 35.2 Cg_endo -77.77 165.97 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.159 1.906 . . . . 0.0 110.344 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 129' ' ' PRO . 49.8 m -168.68 106.41 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.899 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.7 -18.13 64.81 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.453 HG23 HG13 ' A' ' 102' ' ' VAL . 20.6 m -68.25 -29.21 67.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -42.05 37.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.12 -19.03 61.23 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.747 -1.181 . . . . 0.0 108.153 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 tt0 -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.61 -36.04 57.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.453 ' HA ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 t -70.57 -29.67 39.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -38.57 84.08 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.1 -25.12 58.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -85.95 -6.82 58.99 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.6 m -86.57 -51.99 5.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.1 -1.0 . . . . 0.0 109.141 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -18.27 45.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -20.55 16.52 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 78.51 0.5 Allowed Glycine 0 N--CA 1.478 1.465 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.422 HG12 ' C ' ' A' ' 118' ' ' HIS . 22.1 t -131.43 118.11 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -1.061 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.91 122.19 26.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.515 HG11 ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -115.27 151.74 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.538 HG11 ' ND2' ' A' ' 121' ' ' ASN . 2.7 t -119.22 159.79 19.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.411 ' N ' HG11 ' A' ' 148' ' ' VAL . . . -146.88 135.1 21.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.869 -1.144 . . . . 0.0 110.409 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -67.12 174.83 2.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.664 -0.648 . . . . 0.0 109.553 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 15.2 t -73.03 -82.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 145.57 120.65 1.34 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.428 ' C ' ' OG ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -86.35 60.11 6.04 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 121.922 -0.752 . . . . 0.0 109.598 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' C ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 171.61 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.164 -0.96 . . . . 0.0 110.898 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.619 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . -19.69 -50.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.237 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.619 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 90.57 63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.786 0.803 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.16 -3.09 32.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 159' ' ' ILE . 15.0 m -134.22 122.83 23.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 0.0 109.562 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -51.18 179.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.424 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -105.92 173.3 6.37 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.554 1.169 . . . . 0.0 112.526 -177.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.565 ' O ' ' CA ' ' A' ' 125' ' ' GLY . 24.4 m-85 -108.94 144.75 30.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.1 Cg_endo -72.88 -31.82 4.91 Favored 'Cis proline' 0 C--N 1.297 -2.181 0 O-C-N 122.33 0.647 . . . . 0.0 111.27 4.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . -4.1 -61.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.604 0.716 . . . . 0.0 111.656 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 162' ' ' PRO . 9.6 tpt180 -48.77 -65.9 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.529 ' O ' ' CB ' ' A' ' 166' ' ' ALA . 38.1 p90 -121.75 -163.43 1.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.922 0.868 . . . . 0.0 110.676 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 165' ' ' TYR . . . 80.1 49.3 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.648 0.737 . . . . 0.0 109.589 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 166' ' ' ALA . 23.0 m-80 41.77 28.76 0.09 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -112.49 116.32 30.08 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.91 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 73.5 mmm -63.64 171.83 2.44 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.293 -0.88 . . . . 0.0 108.792 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -137.02 114.42 10.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 27.5 t -99.68 166.05 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -148.8 108.4 0.4 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -52.01 149.58 4.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.28 . . . . 0.0 109.541 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.468 ' HB2' ' C ' ' A' ' 180' ' ' ARG . 6.2 t0 -115.46 -149.5 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.131 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 177' ' ' ASN . 56.7 tt0 -40.3 -43.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.458 -0.776 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 7.4 m-20 164.47 119.86 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.94 38.38 28.69 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.216 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -132.07 -18.12 2.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.94 . . . . 0.0 110.282 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.468 ' C ' ' HB2' ' A' ' 175' ' ' ASP . 1.8 ttp85 66.79 126.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 109.188 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 183' ' ' PHE . . . -42.47 163.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.591 -0.693 . . . . 0.0 109.901 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.9 p -84.31 4.88 29.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.289 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 181' ' ' ALA . 6.2 p90 -137.93 11.74 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.7 t -87.75 105.58 17.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.399 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.578 ' HG2' ' N ' ' A' ' 155' ' ' GLY . 1.5 mp0 -52.38 154.46 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -0.962 . . . . 0.0 110.118 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.75 168.2 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 173.12 144.47 4.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.72 131.31 50.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.322 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.43 -1.15 39.95 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 191' ' ' ASP . 6.6 tp -60.94 146.79 45.55 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.28 -1.129 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.4 OUTLIER -73.68 -80.05 0.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.059 -1.026 . . . . 0.0 110.368 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.531 HG23 ' CB ' ' A' ' 259' ' ' SER . 0.2 OUTLIER -152.75 -169.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.781 -1.199 . . . . 0.0 109.516 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.527 ' N ' HG12 ' A' ' 192' ' ' ILE . 32.6 m -126.59 162.16 31.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.009 -1.057 . . . . 0.0 110.163 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 262' ' ' VAL . . . -145.76 140.4 15.68 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.478 ' HG2' ' HA2' ' A' ' 7' ' ' GLY . 34.6 Cg_endo -76.17 112.95 3.59 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.449 2.099 . . . . 0.0 111.115 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.573 ' O ' ' C ' ' A' ' 197' ' ' VAL . . . -114.12 -67.79 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 78.0 t 5.52 71.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.613 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 9.5 t-20 99.13 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 7.3 m -163.41 110.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 122.149 0.976 . . . . 0.0 109.259 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.538 ' CG ' ' OG ' ' A' ' 210' ' ' SER . 6.3 mt-30 -77.43 129.52 35.86 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.587 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -135.95 -153.46 0.51 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.042 -1.036 . . . . 0.0 109.64 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.446 HG21 ' HA3' ' A' ' 68' ' ' GLY . 9.8 t -102.94 177.32 4.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.627 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -144.63 -179.45 0.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.627 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -73.38 -151.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.98 1.787 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . -37.62 -29.7 0.05 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' PRO . 17.8 t -48.39 -97.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.256 -1.144 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 206' ' ' SER . 5.2 t 175.53 -120.33 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' A' ' 208' ' ' TYR . 0.6 OUTLIER -78.33 -170.38 2.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.868 -1.145 . . . . 0.0 109.748 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.768 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.538 ' OG ' ' CG ' ' A' ' 200' ' ' GLN . 0.1 OUTLIER -174.21 139.34 0.62 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 216' ' ' MET . 0.1 OUTLIER -175.63 162.29 2.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -106.08 173.5 6.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.438 -0.788 . . . . 0.0 109.226 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 147.18 147.61 4.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 23.2 m -73.92 -22.5 59.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.131 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.442 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 71.2 m -74.15 -9.94 59.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.457 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -86.45 -19.59 29.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -90.36 -14.06 33.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.659 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -71.07 -39.28 8.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 0.0 111.452 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 218' ' ' THR . 31.7 Cg_endo -73.25 -28.63 12.32 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.761 1.641 . . . . 0.0 110.561 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -61.91 -35.67 79.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.464 HG23 HD12 ' A' ' 192' ' ' ILE . 33.8 t -75.73 -39.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -27.67 67.27 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.86 2.37 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -45.39 -42.09 9.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 109.334 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.52 95.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.775 . . . . 0.0 109.171 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.86 -40.91 73.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.165 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 21' ' ' LEU . 5.1 mt -61.88 -45.15 95.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 109.328 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 229' ' ' LYS . 75.7 t -57.9 -67.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.557 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -40.02 -43.04 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.709 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.476 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 14.9 tm0? -58.37 -54.11 50.71 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.224 -0.923 . . . . 0.0 110.018 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -17.26 8.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.188 -0.945 . . . . 0.0 108.917 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 m-20 -156.57 81.18 3.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.6 Cg_endo -81.14 40.32 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.757 2.305 . . . . 0.0 110.663 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.41 7.68 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.0 109.762 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.416 ' CZ2' ' ND2' ' A' ' 232' ' ' ASN . 45.1 m0 -91.05 175.03 7.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.775 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.37 8.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.11 -32.75 68.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.13 -0.981 . . . . 0.0 109.126 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.9 t -71.88 -63.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.31 -0.869 . . . . 0.0 109.09 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.8 OUTLIER -42.01 -42.06 2.73 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.379 0.609 . . . . 0.0 109.809 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 9.4 mm -63.06 -47.89 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.847 . . . . 0.0 109.302 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' ASN . 0.6 OUTLIER -58.41 -62.64 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -40.33 -43.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.439 -0.788 . . . . 0.0 110.422 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.492 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.9 t60 -70.67 -38.44 73.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.9 -1.125 . . . . 0.0 110.223 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.434 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.8 OUTLIER -73.3 -22.5 60.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.452 -0.78 . . . . 0.0 110.019 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -84.48 -34.33 23.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.349 -0.845 . . . . 0.0 108.942 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -85.97 -17.17 36.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.59 -0.694 . . . . 0.0 109.312 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 5.0 p -88.24 -34.26 17.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 109.402 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 259' ' ' SER . . . -47.04 133.83 11.05 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.463 ' OG1' ' OD1' ' A' ' 263' ' ' ASN . 2.9 m -57.87 152.4 16.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.704 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 259' ' ' SER . 25.8 p -120.48 98.63 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.884 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.4 mp -53.39 -62.53 1.6 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.08 -1.012 . . . . 0.0 109.343 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -178.65 -33.73 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.48 159.47 4.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.149 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 254' ' ' THR . 0.0 OUTLIER -141.17 30.17 1.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.669 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -167.77 -51.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.01 -1.056 . . . . 0.0 109.374 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.445 ' HA ' ' CE1' ' A' ' 186' ' ' TYR . 7.3 mt -63.43 -56.24 17.82 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 109.066 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.45 -46.43 10.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.9 -33.04 4.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.531 ' CB ' HG23 ' A' ' 192' ' ' ILE . 1.5 m -141.42 -98.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -1.135 . . . . 0.0 109.331 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 162.19 -124.56 1.31 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.169 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.507 HD11 ' N ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -84.65 135.11 34.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.592 -0.946 . . . . 0.0 110.163 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.507 ' N ' HD11 ' A' ' 261' ' ' LEU . 1.4 t -78.6 144.44 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.463 ' OD1' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -160.88 118.28 2.38 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.604 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.395 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 2.3 tm-20 -63.12 -28.86 70.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.15 -18.19 50.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.412 ' HA ' HG23 ' A' ' 247' ' ' THR . . . -107.11 9.87 30.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 269' ' ' ARG . 17.3 p -128.38 -67.53 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 268' ' ' THR . 8.3 tpt180 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.626 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.353 0.597 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' CD ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -72.83 135.2 45.16 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -86.13 128.86 34.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -115.32 86.4 14.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.977 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 3' ' ' SER . 37.0 Cg_endo -80.87 -175.01 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.973 2.449 . . . . 0.0 111.575 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.628 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -55.58 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.442 0.639 . . . . 0.0 110.52 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 6' ' ' TRP . . . -40.12 -83.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 9' ' ' SER . 2.4 mp -41.65 102.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -1.029 . . . . 0.0 109.741 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER 167.9 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.202 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -93.47 4.44 53.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.316 -0.865 . . . . 0.0 109.895 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 12' ' ' GLN . 3.5 m -94.48 25.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.01 -1.056 . . . . 0.0 109.818 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 88.1 mm-40 43.03 46.96 4.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.67 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -81.45 -35.62 0.78 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 111.433 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.7 Cg_endo -74.42 -55.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.222 -1.491 . . . . 0.0 108.222 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.56 -34.63 3.45 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . -71.47 -41.57 69.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.9 -1.125 . . . . 0.0 109.147 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.511 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 7.4 m170 -75.79 -2.9 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.702 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -115.08 -11.0 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.117 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -73.67 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 109.404 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.76 30.77 0.06 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -142.89 145.4 33.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.184 . . . . 0.0 109.391 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -123.6 -9.93 7.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -0.835 . . . . 0.0 109.711 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -7.47 16.66 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 22' ' ' THR . 51.7 p -60.05 94.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.553 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.28 -4.47 2.85 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.228 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.621 ' CG1' ' CE1' ' A' ' 118' ' ' HIS . 5.3 t -97.49 160.99 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.907 -1.349 . . . . 0.0 109.904 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.3 OUTLIER -125.84 117.29 23.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 110.016 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 13.7 t -107.37 145.1 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.597 -0.689 . . . . 0.0 109.315 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 119' ' ' VAL . . . -106.56 155.59 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.443 ' O ' HG11 ' A' ' 30' ' ' VAL . 41.7 t -128.59 86.69 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.476 HD13 ' HB ' ' A' ' 91' ' ' VAL . 2.5 mp -81.72 90.33 6.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.665 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -157.03 -146.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 108.747 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -57.28 -73.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.586 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -166.46 -126.93 0.86 Allowed Glycine 0 N--CA 1.476 1.363 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.586 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 8.0 mt -167.4 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.525 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 20.5 t -47.82 141.5 5.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.042 -1.036 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.58 141.92 56.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.243 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.4 157.12 21.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.35 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 35.8 Cg_endo -78.75 -6.01 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.736 2.291 . . . . 0.0 111.111 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.47 -21.48 19.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 0.0 109.993 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD22 ' CA ' ' A' ' 68' ' ' GLY . 0.2 OUTLIER -117.09 150.16 39.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.045 -1.034 . . . . 0.0 109.712 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 116.42 31.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.523 -0.735 . . . . 0.0 109.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.41 111.56 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.114 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 62.6 mmt-85 -118.79 11.23 12.61 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.642 ' HA3' ' CD2' ' A' ' 89' ' ' TYR . . . -174.34 142.57 6.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.17 84.82 0.15 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.487 -1.339 . . . . 0.0 110.645 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 124.49 45.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 108.652 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.552 ' HB2' ' CE ' ' A' ' 92' ' ' LYS . 6.5 p -111.43 117.77 33.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.001 -1.062 . . . . 0.0 110.416 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.59 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 21.4 m-85 -86.12 -77.77 0.3 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.285 -0.884 . . . . 0.0 108.732 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 77.5 t -38.94 94.39 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.939 -0.475 . . . . 0.0 109.739 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 49' ' ' PHE . 37.4 Cg_endo -87.63 154.59 7.61 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.274 1.982 . . . . 0.0 111.822 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . 100.1 26.95 8.05 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.387 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.638 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.4 OUTLIER 178.84 -70.41 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 CA-C-N 120.716 2.258 . . . . 0.0 114.138 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HD3' ' CB ' ' A' ' 53' ' ' GLU . 39.4 Cg_endo -76.79 -102.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.429 1.42 . . . . 0.0 112.849 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.631 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 3.5 t 144.4 175.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.473 HG21 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -77.33 0.22 23.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 58' ' ' ASP . 2.0 mt-30 -110.92 -172.42 2.03 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.108 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 29.2 t70 -32.43 142.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.569 0.699 . . . . 0.0 110.916 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.3 -40.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -144.39 -65.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.478 -1.013 . . . . 0.0 109.319 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.48 -31.25 0.52 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.543 ' CE1' ' OG ' ' A' ' 215' ' ' SER . 2.5 t-160 -61.37 -43.43 98.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -57.4 -74.66 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.57 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -38.28 -49.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.51 -0.994 . . . . 0.0 110.557 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.584 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 12.9 t-80 -52.29 -50.79 61.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG11 ' CD1' ' A' ' 70' ' ' ILE . 31.4 t -62.27 -29.58 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.404 -0.81 . . . . 0.0 109.584 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.43 85.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.342 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.528 ' CA ' HD22 ' A' ' 41' ' ' LEU . . . -75.81 -23.09 73.3 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.547 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 8.3 m -74.58 -14.86 60.84 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.084 -1.245 . . . . 0.0 107.875 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.502 ' CD1' HG11 ' A' ' 66' ' ' VAL . 62.6 mt -94.73 -35.46 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.503 -0.748 . . . . 0.0 110.829 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -165.5 27.93 0.05 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 0.0 112.37 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 68' ' ' GLY . . . -44.19 153.87 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.444 -1.41 . . . . 0.0 108.635 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.436 ' C ' HD11 ' A' ' 80' ' ' LEU . 73.9 mt -75.86 171.95 13.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.95 -1.094 . . . . 0.0 110.205 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.492 ' HA ' ' HB2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -103.64 51.57 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.555 ' O ' ' C ' ' A' ' 76' ' ' SER . 0.1 OUTLIER -177.07 -115.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.568 ' O ' ' C ' ' A' ' 77' ' ' ILE . 12.3 m 22.28 71.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.335 -0.228 . . . . 0.0 110.956 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.568 ' C ' ' O ' ' A' ' 76' ' ' SER . 1.3 pp 14.79 57.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.664 0.745 . . . . 0.0 111.578 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' SER . . . -154.87 -161.27 10.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 73' ' ' LEU . 21.9 m -95.9 -161.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -1.132 . . . . 0.0 109.861 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 74' ' ' ASN . 20.2 tp -143.42 123.45 13.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.838 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.83 -148.9 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.511 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 40.7 t -100.16 -25.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.086 -1.243 . . . . 0.0 109.325 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . . . -99.65 137.14 20.18 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.977 . . . . 0.0 108.754 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.47 -61.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.72 2.28 . . . . 0.0 111.018 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -117.48 48.52 1.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.525 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.78 150.41 23.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.112 -0.992 . . . . 0.0 109.402 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -81.85 108.42 15.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 109.156 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.461 HD13 ' HB1' ' A' ' 71' ' ' ALA . 8.6 mt -85.45 124.94 32.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.642 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 7.6 m-85 -113.76 143.18 45.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.166 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB3' HG13 ' A' ' 35' ' ' ILE . . . -111.97 95.4 5.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.127 -0.983 . . . . 0.0 109.64 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.59 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.63 62.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.083 -1.011 . . . . 0.0 108.897 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.552 ' CE ' ' HB2' ' A' ' 48' ' ' SER . 12.2 ttpp -36.81 116.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.282 0.563 . . . . 0.0 110.077 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -122.58 0.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.422 HD23 HD21 ' A' ' 124' ' ' LEU . 62.8 mt -119.34 174.7 6.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.46 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -119.6 146.08 18.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.26 -19.38 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.008 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.805 . . . . 0.0 109.347 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.34 42.97 0.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.7 p -178.1 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.095 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.81 179.4 17.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 155.18 20.85 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.769 -0.842 . . . . 0.0 109.654 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.496 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 20.0 t -67.75 -20.74 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -20.53 60.37 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -86.3 -47.33 9.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.68 -0.637 . . . . 0.0 109.581 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.457 ' HB ' HD13 ' A' ' 133' ' ' LEU . 1.5 mt -67.2 -34.17 67.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.189 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -71.92 -43.57 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.917 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -69.56 -31.19 69.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.813 -1.18 . . . . 0.0 109.882 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.4 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -82.19 -18.16 67.66 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 -34.5 27.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -1.149 . . . . 0.0 110.022 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.492 ' HG2' ' OG ' ' A' ' 139' ' ' SER . 3.9 mt-10 -90.1 -19.19 24.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.891 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.608 ' CE2' ' O ' ' A' ' 115' ' ' ASN . 84.5 t90 -68.18 -25.04 65.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.132 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.607 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -90.5 5.9 45.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.898 -1.126 . . . . 0.0 109.412 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -94.91 -36.49 5.5 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -106.19 -23.15 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -1.095 . . . . 0.0 109.224 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.608 ' O ' ' CE2' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -173.06 89.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.607 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . 172.8 50.75 0.05 OUTLIER Glycine 0 C--N 1.291 -1.971 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.469 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.582 ' HE3' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER 62.52 163.3 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.473 -1.016 . . . . 0.0 112.062 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.65 ' CE1' ' CD ' ' A' ' 229' ' ' LYS . 9.7 p80 -98.15 -30.16 12.81 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.576 HG22 ' CE1' ' A' ' 118' ' ' HIS . 4.8 t -95.84 157.72 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.836 -1.165 . . . . 0.0 108.901 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -167.5 124.57 1.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.552 ' ND2' HG11 ' A' ' 148' ' ' VAL . 15.7 t-20 -102.53 166.96 10.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.438 HD22 HD23 ' A' ' 124' ' ' LEU . 3.5 mp -146.88 112.65 5.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.865 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.2 t -90.14 62.38 5.48 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.438 HD23 HD22 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -146.93 -174.12 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.63 0.729 . . . . 0.0 110.213 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 161' ' ' TYR . . . 160.42 109.57 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.95 154.7 81.49 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.043 -1.269 . . . . 0.0 109.814 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.504 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -78.67 5.4 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.76 2.306 . . . . 0.0 110.099 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 m -110.63 82.43 2.88 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.726 -0.609 . . . . 0.0 109.992 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.4 Cg_endo -76.93 171.48 17.9 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.393 2.062 . . . . 0.0 110.754 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -144.01 134.47 24.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 108.977 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.56 66.17 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.9 m -70.91 -28.22 64.37 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD13 ' HB ' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -76.74 -24.74 53.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.299 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.55 -55.72 5.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.135 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.77 -25.01 16.99 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.33 53.69 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.67 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.533 HG13 ' ND2' ' A' ' 167' ' ' ASN . 2.2 t -71.94 -19.36 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' A' ' 142' ' ' SER . 1.2 t30 -76.1 -29.39 57.89 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.492 ' OG ' ' HG2' ' A' ' 110' ' ' GLU . 1.0 OUTLIER -88.13 -19.05 27.5 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.239 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 145' ' ' VAL . . . -93.39 -26.21 17.35 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.636 -1.29 . . . . 0.0 110.558 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.98 -34.14 13.17 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 138' ' ' ASN . 8.0 t -67.54 -24.69 65.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -81.14 -16.95 51.53 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.513 ' HA2' ' HB3' ' A' ' 237' ' ' ASN . . . 91.7 50.34 2.73 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 140' ' ' ALA . 70.7 t -113.75 111.11 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 109.234 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.8 tp -69.96 126.39 29.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.043 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -120.19 137.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.553 HG11 ' N ' ' A' ' 149' ' ' ALA . 8.9 t -121.05 166.77 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.553 ' N ' HG11 ' A' ' 148' ' ' VAL . . . -153.61 140.65 19.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.944 -1.098 . . . . 0.0 109.555 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -75.95 153.42 36.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.495 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 4.6 t -77.96 -71.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.486 ' HA3' ' HG3' ' A' ' 185' ' ' GLN . . . 164.67 119.02 0.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -87.51 56.62 4.01 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 122.062 -0.669 . . . . 0.0 109.868 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.3 p -137.12 -108.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 185' ' ' GLN . . . -103.06 -95.98 2.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 167.58 74.16 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.324 -1.103 . . . . 0.0 109.89 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -106.91 43.63 1.65 Allowed Glycine 0 C--N 1.287 -2.166 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.2 p 80.53 131.68 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.832 -0.804 . . . . 0.0 109.657 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -55.08 -169.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.491 ' HB2' ' CA ' ' A' ' 125' ' ' GLY . 0.9 OUTLIER -139.08 164.64 29.23 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.573 -0.704 . . . . 0.0 111.822 -178.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.492 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 1.5 m-85 -79.45 145.52 63.83 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.3 Cg_endo -71.53 -33.96 3.51 Favored 'Cis proline' 0 C--N 1.295 -2.256 0 O-C-N 122.566 0.772 . . . . 0.0 110.942 4.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . -31.09 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.006 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -79.68 -49.14 12.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.802 -1.186 . . . . 0.0 109.987 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.496 ' O ' ' O ' ' A' ' 164' ' ' ARG . 2.7 m-85 -46.78 -179.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.006 0.908 . . . . 0.0 110.416 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.4 -8.12 23.62 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.746 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.533 ' ND2' HG13 ' A' ' 137' ' ' VAL . 10.7 p30 -88.65 20.84 3.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -159.16 142.11 14.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 108.893 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.441 ' HG3' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.41 131.91 41.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 109.671 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -95.47 114.82 26.62 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 108.857 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.3 t -94.19 165.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.569 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -144.23 -175.06 17.03 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.413 ' HB1' HG23 ' A' ' 214' ' ' THR . . . -123.64 164.24 19.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -1.074 . . . . 0.0 109.056 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p -142.74 167.85 21.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.466 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.5 OUTLIER -66.43 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.33 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.73 -32.62 11.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.97 . . . . 0.0 109.862 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.65 -78.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 178' ' ' ASN . 39.4 t-20 -173.07 45.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 109.741 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 24.4 t30 -135.9 167.27 21.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.044 -1.035 . . . . 0.0 109.553 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.489 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.5 ttt-85 -45.79 138.65 4.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.774 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.87 -134.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.643 -0.661 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 m -127.86 -31.53 2.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.883 -1.135 . . . . 0.0 109.734 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' SER . 24.5 p90 -123.47 -3.19 8.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.875 . . . . 0.0 109.65 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.3 OUTLIER -44.09 107.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 109.782 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -58.15 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.646 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.503 ' O ' ' O ' ' A' ' 185' ' ' GLN . 1.2 t80 -50.07 -167.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.758 0.789 . . . . 0.0 111.638 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.515 ' CA ' HD23 ' A' ' 190' ' ' LEU . . . -173.1 23.06 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.48 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.84 97.78 4.0 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.685 -0.891 . . . . 0.0 109.445 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.38 -22.67 28.79 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.515 HD23 ' CA ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -45.15 154.74 0.14 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.505 -0.997 . . . . 0.0 109.626 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.489 ' O ' HG21 ' A' ' 192' ' ' ILE . 51.9 t0 -55.03 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.815 . . . . 0.0 110.891 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.535 ' CB ' ' OG ' ' A' ' 259' ' ' SER . 0.5 OUTLIER -146.7 -157.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.913 -1.117 . . . . 0.0 110.064 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.514 ' N ' HG13 ' A' ' 192' ' ' ILE . 30.3 m -143.0 168.55 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.796 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -151.56 160.85 31.1 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.41 -0.806 . . . . 0.0 109.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.502 ' HD3' ' CD1' ' A' ' 261' ' ' LEU . 32.6 Cg_endo -74.87 115.23 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.06 60.9 0.4 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.321 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.628 ' HB ' ' CZ2' ' A' ' 6' ' ' TRP . 47.5 t -97.62 70.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER 111.62 119.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 216' ' ' MET . 1.7 m -156.27 112.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.07 0.938 . . . . 0.0 108.484 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 209' ' ' ALA . 0.6 OUTLIER -89.86 171.2 9.77 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.624 0.726 . . . . 0.0 110.071 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.584 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 20.4 m -167.56 -146.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.726 . . . . 0.0 109.074 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.439 HG22 HD13 ' A' ' 41' ' ' LEU . 77.1 p -92.68 150.08 20.91 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 110.068 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.569 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 2.1 t80 -140.55 142.46 29.07 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.3 Cg_endo -72.04 156.94 55.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.312 2.008 . . . . 0.0 110.986 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 36.41 54.48 1.31 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.4 t -179.83 -107.62 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.094 -1.239 . . . . 0.0 109.719 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.434 ' CG2' ' H ' ' A' ' 208' ' ' TYR . 4.3 t -175.45 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.438 -0.789 . . . . 0.0 109.119 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 201' ' ' SER . 0.1 OUTLIER -89.24 142.76 27.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.738 -1.226 . . . . 0.0 109.632 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -125.71 111.39 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.642 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.3 OUTLIER -83.08 132.35 35.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.491 ' CD1' ' SD ' ' A' ' 216' ' ' MET . 1.0 OUTLIER -167.24 138.72 3.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.97 . . . . 0.0 109.876 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -88.89 147.51 24.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 108.927 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 170.55 146.3 5.1 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.003 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.413 HG23 ' HB1' ' A' ' 173' ' ' ALA . 9.7 p -66.51 -27.17 67.56 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.274 -1.133 . . . . 0.0 108.521 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.543 ' OG ' ' CE1' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -55.63 -22.37 22.27 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.535 ' CB ' HG23 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -85.57 -29.79 23.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -82.36 -23.0 35.25 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.165 -0.959 . . . . 0.0 110.369 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.623 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 4.9 m -66.41 -46.15 59.52 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.895 -1.128 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.2 Cg_endo -73.07 -12.98 26.08 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.919 1.746 . . . . 0.0 109.931 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -74.11 -42.4 60.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.412 HG21 ' CG1' ' A' ' 262' ' ' VAL . 74.2 t -70.74 -48.83 55.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -46.11 -43.23 14.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -61.51 -45.37 96.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.08 39.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -1.041 . . . . 0.0 109.472 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.462 ' HA ' HD13 ' A' ' 244' ' ' LEU . . . -52.04 -34.58 43.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.94 -47.24 86.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 0.0 109.214 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 67.3 mt -59.8 -29.23 68.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.424 HG13 HG21 ' A' ' 240' ' ' ILE . 36.4 t -69.57 -62.22 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.31 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -41.9 -47.07 4.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.695 . . . . 0.0 109.714 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.525 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 5.0 tp-100 -59.62 -49.38 77.99 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.167 -0.958 . . . . 0.0 109.751 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.458 ' HB2' HD21 ' A' ' 21' ' ' LEU . 6.0 tttm -54.31 -19.3 5.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.468 ' HB2' ' CD2' ' A' ' 235' ' ' TRP . 19.0 m120 -160.93 92.05 1.54 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 109.967 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.6 -11.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.415 2.077 . . . . 0.0 110.303 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.3 m -87.49 -8.87 55.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 239' ' ' GLN . 25.3 m0 -69.65 179.62 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.556 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.18 178.22 5.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.513 ' HB3' ' HA2' ' A' ' 144' ' ' GLY . 18.7 p-10 -52.62 -25.63 11.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 109.42 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.67 -65.4 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.14 -0.975 . . . . 0.0 109.226 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 0.5 OUTLIER -44.76 -25.84 0.33 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.333 0.587 . . . . 0.0 109.967 -178.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.452 HD12 ' HG2' ' A' ' 229' ' ' LYS . 11.7 mt -92.06 -63.65 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 242' ' ' ASN . 15.2 ttp180 -58.2 -63.43 1.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 241' ' ' ARG . 46.3 t30 -37.83 -44.85 0.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 110.705 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.424 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.9 OUTLIER -64.39 -43.85 93.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 110.082 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.476 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 1.4 mt -68.57 -34.0 75.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.362 -0.836 . . . . 0.0 110.95 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.53 55.78 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.78 -4.38 26.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.606 -0.684 . . . . 0.0 109.567 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.4 p -98.48 -28.36 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.9 -1.125 . . . . 0.0 109.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -42.27 142.55 0.75 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 250' ' ' SER . 18.9 m -75.13 164.87 26.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.225 -0.922 . . . . 0.0 109.007 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 259' ' ' SER . 20.5 p -133.04 116.64 16.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.021 -1.05 . . . . 0.0 110.226 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.518 ' N ' HD13 ' A' ' 251' ' ' LEU . 6.8 mp -86.5 -72.28 0.51 Allowed 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.165 -0.959 . . . . 0.0 109.677 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 253' ' ' SER . . . 166.2 -116.27 0.68 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 257' ' ' TYR . 4.6 m 72.89 174.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.339 -1.095 . . . . 0.0 110.117 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 255' ' ' ASN . 6.7 t -83.79 -29.65 27.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.173 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 254' ' ' THR . 0.8 OUTLIER 176.45 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.128 . . . . 0.0 110.202 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.412 ' HG ' ' ND2' ' A' ' 255' ' ' ASN . 2.2 mt -54.13 -31.97 53.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.029 . . . . 0.0 109.002 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.508 ' HB2' ' CB ' ' A' ' 253' ' ' SER . 13.3 m-30 -106.66 47.48 0.88 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 257' ' ' TYR . . . -30.66 -89.18 0.01 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.535 ' OG ' ' CB ' ' A' ' 192' ' ' ILE . 1.6 p -61.19 -96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.127 -1.219 . . . . 0.0 108.721 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 175.34 -132.35 2.15 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 28.3 tp -85.83 155.35 21.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.956 -0.732 . . . . 0.0 110.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.528 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 2.7 t -92.13 145.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.437 -0.79 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.451 ' ND2' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -169.66 119.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.367 1.08 . . . . 0.0 108.714 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -75.19 -17.28 60.4 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.702 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.451 ' HA ' ' OG1' ' A' ' 268' ' ' THR . 56.3 tt0 -61.52 -20.46 63.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.422 ' HB2' ' HB ' ' A' ' 247' ' ' THR . . . -84.27 -22.44 30.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.578 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -117.15 15.43 14.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.779 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 264' ' ' ALA . 11.0 p -118.88 -39.92 2.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 269' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.547 ' CG ' HD21 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -48.78 144.76 4.24 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.166 -0.959 . . . . 0.0 109.32 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -114.15 52.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.53 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.523 ' C ' ' O ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -22.51 85.2 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.867 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.564 ' HG2' ' CG1' ' A' ' 8' ' ' ILE . 36.6 Cg_endo -80.97 -176.19 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.911 2.407 . . . . 0.0 110.897 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.612 ' CE2' ' O ' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -24.64 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.407 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -114.31 -83.01 1.12 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.005 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.588 ' CG2' ' N ' ' A' ' 9' ' ' SER . 1.7 mm 49.52 -86.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.858 -0.789 . . . . 0.0 109.268 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.588 ' N ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -61.43 -12.46 14.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.91 -1.119 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -27.79 67.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.8 m -92.99 27.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 61.74 47.39 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.755 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -82.83 -31.48 0.52 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 111.676 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -75.11 -54.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 108.087 -1.543 . . . . 0.0 108.087 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.73 -35.75 1.97 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.61 -43.24 63.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.961 -1.087 . . . . 0.0 108.955 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.08 -2.99 33.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 -39.98 8.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.47 -55.72 9.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.44 -27.86 0.77 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 268' ' ' THR . 1.1 mt -49.95 111.58 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.207 -1.172 . . . . 0.0 109.305 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.466 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -96.42 -19.59 19.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -0.837 . . . . 0.0 109.927 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 78.18 -11.26 23.85 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 42.7 p -55.96 125.78 22.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -1.133 . . . . 0.0 109.609 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.83 -14.37 6.36 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.651 -1.261 . . . . 0.0 109.982 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.54 ' CG1' ' NE2' ' A' ' 118' ' ' HIS . 11.5 t -102.46 157.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.972 -1.311 . . . . 0.0 109.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -124.96 113.95 18.5 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.51 -0.744 . . . . 0.0 109.092 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.557 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 4.2 t -101.71 147.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 120' ' ' ALA . . . -110.17 159.5 17.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -0.9 . . . . 0.0 108.944 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.506 ' CG2' HD13 ' A' ' 35' ' ' ILE . 1.6 t -136.85 92.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 108.751 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . 6.0 mp -79.97 88.9 5.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -136.98 -160.13 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -94.1 28.02 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.442 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 58' ' ' ASP . . . 121.46 123.48 2.97 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.662 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.506 HD13 ' CG2' ' A' ' 30' ' ' VAL . 3.9 mt -86.84 -17.09 9.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.726 0.774 . . . . 0.0 109.751 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.486 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 2.9 t 62.31 156.3 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.677 -0.639 . . . . 0.0 109.393 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.6 t -86.71 157.05 19.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.079 -1.013 . . . . 0.0 110.154 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -169.9 172.84 2.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.5 Cg_endo -81.05 -27.02 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.503 2.136 . . . . 0.0 109.875 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 73' ' ' LEU . 14.4 p30 -115.19 25.34 10.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.387 -0.82 . . . . 0.0 109.292 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 43' ' ' ILE . 19.7 mt -128.9 21.23 5.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.759 . . . . 0.0 109.11 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 41' ' ' LEU . 7.8 p-10 -25.54 123.55 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -88.96 91.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.346 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 3.3 tpm_? -56.41 -21.25 23.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.876 -1.14 . . . . 0.0 108.073 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 171.17 138.26 2.49 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.65 169.81 34.02 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.317 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.583 ' HB1' ' CZ ' ' A' ' 49' ' ' PHE . . . -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.624 -0.927 . . . . 0.0 108.692 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 92' ' ' LYS . 3.1 p -123.94 120.18 31.76 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.583 ' CZ ' ' HB1' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -122.31 -39.24 2.59 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.12 -0.987 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.545 ' HB ' ' CE ' ' A' ' 92' ' ' LYS . 4.2 t -67.66 131.59 92.82 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.34 171.22 15.17 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.162 1.908 . . . . 0.0 108.762 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' C ' ' CG ' ' A' ' 53' ' ' GLU . . . 155.55 -88.31 0.12 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.558 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -158.42 -56.35 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.227 -1.161 . . . . 0.0 111.745 -178.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.558 ' HD3' ' HB2' ' A' ' 53' ' ' GLU . 36.6 Cg_endo -77.97 -97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.159 1.239 . . . . 0.0 111.111 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 173.22 -148.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.005 -1.059 . . . . 0.0 109.071 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 1.6 t -64.45 -2.52 2.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 55' ' ' SER . 7.4 mt-30 -88.27 155.77 19.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.031 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD2' ' CA ' ' A' ' 61' ' ' GLY . 8.3 t0 -73.07 145.98 46.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 110.08 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.34 -17.73 6.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.43 -64.7 1.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -1.083 . . . . 0.0 109.518 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' CA ' ' OD2' ' A' ' 58' ' ' ASP . . . 156.74 -16.97 0.4 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.443 ' CD2' ' C ' ' A' ' 62' ' ' HIS . 2.9 t-160 -52.1 -61.47 2.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.274 . . . . 0.0 109.706 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -55.16 -77.02 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.014 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.522 ' CG2' ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -33.05 -67.02 0.13 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.731 -0.864 . . . . 0.0 110.73 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.569 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 12.6 t-80 -42.66 -48.91 5.59 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 70' ' ' ILE . 27.7 t -58.39 -41.03 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.086 -1.009 . . . . 0.0 109.623 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.438 ' HB2' HD21 ' A' ' 41' ' ' LEU . . . -55.79 -49.5 73.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.294 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.76 -33.56 84.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.46 HG21 ' CE1' ' A' ' 220' ' ' HIS . 6.3 m -67.64 -20.73 65.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.176 -1.19 . . . . 0.0 109.07 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 66' ' ' VAL . 79.8 mt -88.16 -28.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.376 -0.827 . . . . 0.0 109.844 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.513 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -153.26 -37.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 111.484 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' CB ' ' CG1' ' A' ' 79' ' ' VAL . . . 32.81 72.51 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.522 -0.736 . . . . 0.0 109.92 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' C ' ' O ' ' A' ' 72' ' ' ALA . 1.0 OUTLIER -38.32 150.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.515 ' HB2' ' HA ' ' A' ' 80' ' ' LEU . 6.3 t-20 -138.19 92.25 2.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.012 -1.055 . . . . 0.0 110.962 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 76' ' ' SER . 0.6 OUTLIER -97.66 -17.1 19.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.3 m 157.66 28.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.826 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' A' ' 40' ' ' ASP . 5.8 pt -125.84 52.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.794 -1.191 . . . . 0.0 109.998 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.516 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 42.99 -172.9 0.01 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.817 0.676 . . . . 0.0 111.515 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.591 ' CG1' ' CB ' ' A' ' 72' ' ' ALA . 38.5 t 78.93 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 122.175 -0.603 . . . . 0.0 110.645 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.547 HD21 ' CG ' ' A' ' 2' ' ' GLN . 1.4 tp 56.64 92.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 109.87 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.65 -155.19 2.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -84.12 -51.29 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -1.221 . . . . 0.0 109.346 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.55 125.87 49.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.017 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.69 -60.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.701 2.267 . . . . 0.0 110.715 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 10.0 m120 -93.37 35.03 1.11 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.71 129.69 34.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 109.744 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 27' ' ' LYS . 1.8 mp0 -67.27 114.73 6.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.27 -0.893 . . . . 0.0 108.746 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.489 HD13 ' HB1' ' A' ' 71' ' ' ALA . 5.7 mt -97.93 115.55 28.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 110.616 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.579 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 28.1 m-85 -102.98 162.24 13.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.36 106.2 8.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.178 . . . . 0.0 110.37 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -107.13 67.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -42.6 104.38 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.9 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 50' ' ' VAL . 4.0 t -123.74 -25.67 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.549 -0.719 . . . . 0.0 109.085 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -91.42 176.14 6.67 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 110.085 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -116.87 173.88 14.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 -18.53 12.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.159 -1.201 . . . . 0.0 109.766 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.35 -55.08 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.78 29.17 0.7 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -146.0 77.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -1.16 . . . . 0.0 108.834 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.76 179.79 52.94 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.281 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.471 ' O ' ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -77.5 157.36 30.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.8 -0.823 . . . . 0.0 110.009 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG23 ' CB ' ' A' ' 130' ' ' SER . 2.3 t -67.82 -23.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -20.18 60.77 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.48 ' HB2' HG21 ' A' ' 50' ' ' VAL . 56.9 p -80.89 -52.36 7.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.584 0.707 . . . . 0.0 109.386 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.471 ' HA ' HG13 ' A' ' 93' ' ' VAL . 1.2 mt -65.95 -32.88 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.689 . . . . 0.0 109.584 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.83 -36.49 70.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -71.39 -41.47 69.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.71 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.51 -14.92 81.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.21 -29.39 28.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.308 -1.113 . . . . 0.0 109.015 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.5 -28.81 18.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.585 ' CE3' ' O ' ' A' ' 111' ' ' TRP . 46.6 t90 -71.07 -15.32 62.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.634 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.13 -1.19 57.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.36 -0.838 . . . . 0.0 109.688 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.56 -33.71 2.62 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.703 -1.236 . . . . 0.0 111.136 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.68 -85.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.779 -1.424 . . . . 0.0 109.275 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -94.16 23.63 4.91 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -99.16 -146.0 19.48 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.991 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.57 ' HE2' ' CE2' ' A' ' 89' ' ' TYR . 4.6 mmt -133.15 179.43 6.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.434 -1.039 . . . . 0.0 110.33 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.54 ' NE2' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -88.42 -29.98 19.81 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.095 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 1.4 t -99.85 149.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 119.668 -1.895 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.49 ' O ' HG11 ' A' ' 147' ' ' VAL . . . -164.94 115.09 1.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.553 ' ND2' HG11 ' A' ' 148' ' ' VAL . 10.2 t-20 -89.22 160.28 17.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.978 . . . . 0.0 109.767 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.535 ' CD1' HG11 ' A' ' 147' ' ' VAL . 5.4 mp -147.76 109.47 4.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.999 -1.063 . . . . 0.0 109.877 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 67.86 3.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.966 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -132.66 172.88 11.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.918 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.79 104.28 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.83 162.48 43.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.102 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.547 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.4 Cg_endo -81.21 9.12 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.12 2.547 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.9 102.25 19.03 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.262 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.3 Cg_endo -78.76 178.19 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.688 2.259 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.538 ' CB ' HG23 ' A' ' 102' ' ' VAL . 5.0 m -175.92 119.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 109.487 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -19.96 65.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 23.6 m -69.05 -27.36 65.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.461 HD21 ' OH ' ' A' ' 161' ' ' TYR . 2.3 tp -81.57 -37.98 26.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.574 ' CG ' ' CE2' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -76.68 -21.43 55.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.53 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.95 -25.6 53.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 -32.04 30.48 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.53 ' CG1' ' ND2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -71.42 -36.1 59.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.13 -34.97 78.77 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.1 t -80.3 -19.1 47.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -90.68 -10.28 43.72 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.985 -1.072 . . . . 0.0 109.91 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 89.9 m -89.26 -40.15 13.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 109.133 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.21 -27.29 68.32 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.28 31.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.93 66.97 1.65 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 118' ' ' HIS . 14.5 t -117.05 109.75 28.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.401 -1.058 . . . . 0.0 109.597 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.9 104.89 3.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.168 -0.957 . . . . 0.0 109.337 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.535 HG11 ' CD1' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.52 135.66 35.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.031 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.553 HG11 ' ND2' ' A' ' 121' ' ' ASN . 3.0 t -112.86 156.82 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 170' ' ' ALA . . . -138.42 137.07 36.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 109.804 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.13 171.54 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -89.28 -79.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.601 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.622 ' O ' ' CB ' ' A' ' 153' ' ' ASN . . . -152.76 -116.98 0.68 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 152' ' ' GLY . 22.7 t-20 135.6 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 123.395 0.678 . . . . 0.0 109.744 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.1 m -121.65 -98.02 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 109.6 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.43 ' HA2' ' CD ' ' A' ' 185' ' ' GLN . . . 179.06 47.38 0.08 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.27 172.56 6.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.16 . . . . 0.0 109.213 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.9 56.32 0.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.426 ' HA ' ' HA3' ' A' ' 187' ' ' GLY . 0.2 OUTLIER 175.27 156.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -1.135 . . . . 0.0 109.26 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 pt -100.12 -177.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.466 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -109.48 166.86 10.56 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.943 0.877 . . . . 0.0 112.518 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.461 ' OH ' HD21 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -85.03 149.41 53.02 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 164' ' ' ARG . 42.2 Cg_endo -71.68 -32.22 4.49 Favored 'Cis proline' 0 C--N 1.295 -2.254 0 O-C-N 122.408 0.688 . . . . 0.0 110.734 3.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . -25.4 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.721 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -65.42 -55.81 15.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.938 -1.101 . . . . 0.0 109.714 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.574 ' CE2' ' CG ' ' A' ' 134' ' ' GLU . 1.4 m-85 -42.58 -177.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.542 1.163 . . . . 0.0 111.6 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -115.56 2.44 13.8 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.53 ' ND2' ' CG1' ' A' ' 137' ' ' VAL . 9.3 m-20 -89.33 21.66 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 108.899 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.43 171.76 10.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.512 ' SD ' ' CG2' ' A' ' 148' ' ' VAL . 48.4 mtp -99.46 -177.82 3.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -151.5 115.39 4.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 23.7 t -107.46 165.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.057 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.86 -173.31 13.3 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.48 ' O ' ' HB1' ' A' ' 181' ' ' ALA . . . -118.88 164.13 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.134 . . . . 0.0 109.655 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.512 ' HA ' ' N ' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -138.15 175.6 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 0.0 109.69 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.481 ' N ' ' HA ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -89.91 -172.98 3.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.576 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -101.79 -21.49 14.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.78 -53.5 6.44 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.269 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -131.89 -94.09 0.37 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.472 -0.768 . . . . 0.0 109.751 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.528 ' OD1' ' CE1' ' A' ' 257' ' ' TYR . 0.7 OUTLIER -160.03 -154.47 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.197 -0.939 . . . . 0.0 109.59 -178.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' A' ' 181' ' ' ALA . 0.0 OUTLIER 58.11 4.3 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.512 ' N ' ' HA ' ' A' ' 174' ' ' THR . . . 36.24 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.582 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 182' ' ' SER . 4.9 t -145.92 21.84 1.42 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.175 -0.953 . . . . 0.0 108.996 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -168.66 26.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.833 . . . . 0.0 109.658 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -104.51 128.63 52.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 108.934 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.43 ' CD ' ' HA2' ' A' ' 155' ' ' GLY . 64.8 mm-40 -90.06 147.36 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 110.021 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.517 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.58 169.22 12.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . -170.93 152.25 17.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -44.06 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 138.64 -0.78 2.51 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.263 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.51 HD22 ' CA ' ' A' ' 258' ' ' GLY . 65.0 tp -50.33 145.81 5.86 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.829 -1.395 . . . . 0.0 108.745 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.6 OUTLIER -104.56 -63.75 1.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 111.103 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 248' ' ' ALA . 1.2 tt -151.47 163.87 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.375 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.604 ' CG2' ' CZ ' ' A' ' 257' ' ' TYR . 22.1 m -118.0 160.33 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.676 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.455 ' C ' ' OG1' ' A' ' 174' ' ' THR . . . -150.66 161.07 31.38 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.466 ' HA ' ' OG1' ' A' ' 174' ' ' THR . 32.7 Cg_endo -75.21 126.08 9.6 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.14 1.893 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.429 ' C ' ' OD1' ' A' ' 212' ' ' ASN . . . -152.21 62.13 0.39 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.632 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.612 ' O ' ' CE2' ' A' ' 6' ' ' TRP . 74.5 t -135.76 89.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 6' ' ' TRP . 11.6 t-20 94.14 107.42 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 19.7 m -161.91 111.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.19 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.477 ' HG3' ' N ' ' A' ' 201' ' ' SER . 2.9 tt0 -85.97 147.37 26.26 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.569 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 7.4 t -146.76 -146.67 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.452 HG23 ' OD1' ' A' ' 40' ' ' ASP . 66.0 p -88.02 172.38 9.59 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.65 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -157.87 161.05 29.64 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.65 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.7 Cg_endo -70.42 165.29 32.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.136 1.891 . . . . 0.0 110.685 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 79.92 3.87 89.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.2 OUTLIER 77.69 32.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -1.088 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -129.79 158.03 40.56 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -91.51 -174.67 3.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.592 ' HB1' ' CG ' ' A' ' 203' ' ' TYR . . . -164.25 157.19 17.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.872 -1.142 . . . . 0.0 110.219 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 3.5 m -113.21 120.31 40.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 199' ' ' VAL . 0.3 OUTLIER -166.88 161.8 15.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 198' ' ' ASN . 0.2 OUTLIER -148.19 -160.48 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.973 -1.079 . . . . 0.0 111.153 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 130.49 157.95 9.15 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.452 ' HB ' ' HB1' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -60.94 -19.13 60.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.859 -1.377 . . . . 0.0 108.644 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.1 m -71.86 -32.71 67.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.47 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -82.27 -19.8 38.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.445 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -87.45 -26.5 23.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.611 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 26.2 m -57.2 -42.8 97.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.725 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 218' ' ' THR . 29.9 Cg_endo -71.93 -26.55 18.55 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.715 1.61 . . . . 0.0 111.132 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.46 ' CE1' HG21 ' A' ' 69' ' ' THR . 0.4 OUTLIER -58.66 -40.37 83.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 222' ' ' ALA . 60.4 t -70.33 -47.66 65.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.455 ' O ' ' HB1' ' A' ' 226' ' ' ALA . . . -45.8 -31.89 2.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -73.78 -48.08 18.1 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -57.39 -65.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -1.232 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -45.64 -36.58 4.93 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 222' ' ' ALA . . . -58.84 -49.5 77.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.02 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.6 mt -49.96 -39.42 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 96.2 t -61.41 -52.47 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 108.902 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.527 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 19.1 mttm -44.33 -40.98 5.71 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.459 -0.776 . . . . 0.0 109.172 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.54 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 13.1 tp60 -62.93 -45.42 92.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 108.882 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -60.86 -14.21 20.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.472 -0.768 . . . . 0.0 109.045 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.88 80.93 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.356 -0.84 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.5 Cg_endo -78.89 8.24 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.711 2.274 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.44 -12.8 28.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.986 -1.071 . . . . 0.0 109.778 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -69.84 -179.69 1.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.99 170.81 7.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.595 -0.691 . . . . 0.0 109.359 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -62.22 -22.68 66.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -79.26 -63.63 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.112 -0.993 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.0 OUTLIER -42.96 -48.66 5.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 -178.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.418 HD12 ' HG2' ' A' ' 229' ' ' LYS . 71.9 mt -61.66 -49.15 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 0.0 109.546 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 243' ' ' HIS . 6.6 ttp180 -51.37 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ARG . 43.7 t30 -34.27 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.869 -0.519 . . . . 0.0 111.346 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 241' ' ' ARG . 1.6 t60 -72.52 -50.4 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.408 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.1 OUTLIER -67.68 -23.29 65.29 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.61 47.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.571 -0.706 . . . . 0.0 110.181 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.69 -9.31 57.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 110.376 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 1.3 p -94.11 -29.84 14.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.973 -1.079 . . . . 0.0 109.663 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 261' ' ' LEU . . . -40.25 129.27 2.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.555 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.469 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 6.0 m -75.98 89.57 2.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.546 ' HA ' ' CA ' ' A' ' 260' ' ' GLY . 3.3 t -81.9 140.13 34.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 111.82 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.79 -45.02 93.59 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -176.47 -36.47 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 3.5 m -62.08 176.33 0.59 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.393 -1.063 . . . . 0.0 109.679 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 10.8 t -140.53 10.02 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.969 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 254' ' ' THR . 2.7 t30 177.88 -52.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.702 -1.248 . . . . 0.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.614 ' CD1' ' N ' ' A' ' 257' ' ' TYR . 0.2 OUTLIER -45.27 -53.8 7.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -87.94 -4.72 58.8 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.532 -0.73 . . . . 0.0 111.776 -176.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 129.74 2.5 5.25 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.629 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 0.7 OUTLIER 79.2 -10.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -1.072 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 250' ' ' SER . . . 134.36 -165.82 24.31 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.069 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 58.3 tp -107.13 164.4 12.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.546 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 0.0 OUTLIER -98.95 158.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.42 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.469 ' ND2' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -167.36 119.92 0.93 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -71.36 -5.31 31.6 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.358 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -83.23 -42.55 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 109.911 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.96 1.74 26.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -115.03 -26.57 7.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.671 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 264' ' ' ALA . 4.7 p -82.91 -38.8 22.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.597 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.529 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.265 0.555 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.423 ' O ' HG21 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -61.04 140.92 57.73 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -75.53 122.05 23.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.808 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 2' ' ' GLN . 2.1 t -143.41 76.72 15.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' TRP . 33.0 Cg_endo -77.8 164.56 27.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.409 2.073 . . . . 0.0 110.33 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.518 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -45.49 -26.86 0.63 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.519 ' HA3' ' CG1' ' A' ' 199' ' ' VAL . . . -72.26 -101.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -43.09 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -1.105 . . . . 0.0 109.142 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER 165.19 -43.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -1.6 58.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -0.832 . . . . 0.0 109.501 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.407 ' O ' ' CB ' ' A' ' 12' ' ' GLN . 20.1 m -101.3 14.94 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.125 -0.984 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.593 ' NE2' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER 68.97 24.68 6.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.647 -0.658 . . . . 0.0 110.845 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.63 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -68.26 -39.87 18.39 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.906 -1.121 . . . . 0.0 110.895 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 32.2 Cg_endo -75.18 -60.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.205 -1.498 . . . . 0.0 108.205 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.518 ' HB2' ' NE2' ' A' ' 12' ' ' GLN . . . -45.99 -24.21 0.39 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.593 ' N ' ' NE2' ' A' ' 12' ' ' GLN . . . -81.19 -41.64 22.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.874 -1.141 . . . . 0.0 109.244 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.528 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 16.3 m170 -69.45 -19.68 63.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 109.626 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -87.15 -39.1 15.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' HB3' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.54 -17.58 62.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.45 8.7 26.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -74.03 132.04 41.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.481 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -115.43 -22.57 9.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 53.6 11.03 1.69 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 22' ' ' THR . 5.2 t -76.19 1.64 15.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -1.217 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.6 17.91 35.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 27' ' ' LYS . 60.7 t -123.18 167.02 17.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 120.935 -1.333 . . . . 0.0 109.995 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.575 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 1.7 mptt -134.74 137.06 43.13 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.466 HG11 HG13 ' A' ' 119' ' ' VAL . 39.1 t -135.01 129.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.024 -1.048 . . . . 0.0 110.296 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -84.83 155.66 21.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.532 ' CG1' ' OD2' ' A' ' 32' ' ' ASP . 6.5 t -134.22 87.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 108.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.513 ' N ' HD11 ' A' ' 31' ' ' LEU . 8.2 mp -74.27 99.91 3.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.532 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 1.1 m-20 -134.82 -161.61 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 96' ' ' ALA . 2.9 t -105.2 3.95 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.775 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 59' ' ' GLY . . . 144.97 121.83 1.49 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 58' ' ' ASP . 11.3 mt -90.08 -110.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.487 ' OG ' ' HA ' ' A' ' 204' ' ' PRO . 48.2 t 176.46 146.94 0.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.213 -0.93 . . . . 0.0 110.071 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -86.04 93.38 8.97 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.412 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -114.9 169.38 6.74 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.469 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 35.6 Cg_endo -77.38 -45.4 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.619 2.212 . . . . 0.0 110.04 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 73' ' ' LEU . 3.9 m-20 -74.27 -34.27 63.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.822 . . . . 0.0 109.261 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mt -57.3 135.11 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -109.71 94.7 5.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.7 mm -85.63 99.91 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.468 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 9.3 tpt180 -86.53 -18.74 30.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.684 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.521 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 162.32 176.37 34.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.57 47.55 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.142 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -146.03 160.25 42.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.978 . . . . 0.0 109.446 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.434 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 64.3 p -134.03 115.6 14.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 47' ' ' ALA . 45.3 m-85 -116.92 -54.98 2.39 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.499 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 22.9 t -39.81 128.45 1.53 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.585 -0.697 . . . . 0.0 109.91 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.32 -178.63 4.75 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.345 2.03 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . 110.9 -20.8 23.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.6 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 15.8 tt0 69.36 52.37 0.45 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.312 -1.11 . . . . 0.0 110.478 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.4 Cg_endo -77.34 -82.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.281 1.988 . . . . 0.0 109.775 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 54' ' ' PRO . 2.1 m 165.41 135.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.717 . . . . 0.0 109.469 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.435 ' C ' ' HG3' ' A' ' 57' ' ' GLN . 1.4 m -63.36 -13.16 36.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.043 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HG3' ' C ' ' A' ' 56' ' ' THR . 13.1 mt-30 -143.95 150.8 38.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 t0 62.08 92.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.805 . . . . 0.0 109.704 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -112.85 -25.63 4.45 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.82 -38.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -1.176 . . . . 0.0 109.75 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.07 -10.67 3.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -75.85 -70.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.155 -1.203 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.456 ' HA3' ' CB ' ' A' ' 32' ' ' ASP . . . -48.17 -29.09 6.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 35' ' ' ILE . 9.2 m -68.14 -53.15 27.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -1.073 . . . . 0.0 109.445 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.9 t-80 -55.89 -43.64 77.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.737 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.533 ' HA ' ' CG2' ' A' ' 69' ' ' THR . 17.4 t -61.95 -34.2 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.36 -44.14 97.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.21 -42.02 58.63 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 66' ' ' VAL . 7.5 t -64.41 -15.3 60.32 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 120.366 -1.667 . . . . 0.0 107.851 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.437 HD13 ' CG1' ' A' ' 66' ' ' VAL . 31.7 mt -87.51 -38.84 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.321 -0.862 . . . . 0.0 109.93 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 83' ' ' ALA . . . -178.64 36.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.769 -1.207 . . . . 0.0 111.853 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -45.06 125.47 5.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.67 -1.269 . . . . 0.0 108.928 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 85.5 mt -54.33 161.26 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 75' ' ' ASN . 10.4 t-20 -106.92 134.26 50.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 74' ' ' ASN . 74.2 m-20 -162.14 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.817 0.817 . . . . 0.0 109.081 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -155.12 -39.96 0.09 Allowed 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -103.38 67.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.456 -0.777 . . . . 0.0 109.595 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.94 158.62 13.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.39 -159.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.35 -1.088 . . . . 0.0 109.354 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.4 tp -141.53 116.52 9.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.968 -1.082 . . . . 0.0 109.771 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' HA3' ' CA ' ' A' ' 71' ' ' ALA . . . -80.67 175.83 54.78 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.528 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 2.9 t -60.64 -42.53 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -1.185 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 71' ' ' ALA . . . -93.17 141.96 24.71 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.736 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.6 Cg_endo -84.25 -61.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.847 2.365 . . . . 0.0 110.692 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -120.48 49.87 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.436 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.17 159.59 27.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 108.979 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' OE1' ' CG ' ' A' ' 27' ' ' LYS . 25.9 mt-10 -89.37 89.16 7.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.979 -1.076 . . . . 0.0 108.972 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.6 142.89 42.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 110.236 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.559 ' CE1' ' SD ' ' A' ' 117' ' ' MET . 4.1 m-85 -126.4 152.97 45.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.37 94.47 4.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.017 -1.052 . . . . 0.0 109.456 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -98.57 63.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.284 -0.885 . . . . 0.0 108.917 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -31.67 109.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.197 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.427 HG23 HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -129.09 -10.37 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.374 -0.829 . . . . 0.0 109.433 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 124' ' ' LEU . 10.2 mt -103.81 -178.0 3.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 0.0 109.895 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.31 146.65 18.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.513 ' N ' ' OG1' ' A' ' 33' ' ' THR . . . -67.17 -39.26 86.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -1.185 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.0 t -73.0 -37.5 66.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.22 68.27 0.38 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.45 94.59 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -1.021 . . . . 0.0 109.192 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.26 -178.98 19.43 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.04 155.59 32.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.879 -0.777 . . . . 0.0 109.8 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 t -69.56 -19.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -17.7 58.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -88.33 -35.42 17.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mt -77.11 -37.98 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 108.729 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.23 67.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -63.19 -45.55 91.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.507 -0.746 . . . . 0.0 108.992 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.22 -21.52 77.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.5 mt -82.57 -19.93 37.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -94.38 -30.23 14.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.376 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -69.24 -17.01 63.72 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.717 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.679 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -91.37 -11.54 37.53 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -80.86 -15.71 76.89 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -117.13 1.19 12.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.076 -1.249 . . . . 0.0 109.946 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 7.2 t30 172.46 29.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.999 -1.063 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -110.71 48.08 0.98 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.312 -1.423 . . . . 0.0 110.763 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.575 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 15.8 mmt 60.91 -173.79 0.13 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 111.452 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.656 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -95.74 -32.69 12.6 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.716 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.656 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 55.7 t -104.8 166.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.717 -1.239 . . . . 0.0 109.833 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.551 ' O ' ' CG1' ' A' ' 147' ' ' VAL . . . -169.35 117.04 0.62 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' O ' HD13 ' A' ' 122' ' ' LEU . 16.5 t-20 -96.31 152.96 18.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 121' ' ' ASN . 6.4 mp -133.88 102.79 5.57 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.444 ' OG ' ' OG ' ' A' ' 215' ' ' SER . 0.1 OUTLIER -84.92 66.3 9.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 109.097 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.441 ' HB3' HD12 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -152.86 172.22 17.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.333 -0.854 . . . . 0.0 109.617 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.58 104.42 0.18 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 160' ' ' SER . 0.3 OUTLIER -107.32 147.64 35.62 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.197 -1.178 . . . . 0.0 109.559 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.486 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 32.1 Cg_endo -74.0 -6.0 17.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.21 1.94 . . . . 0.0 108.934 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -103.95 100.32 20.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 32.7 Cg_endo -74.19 164.59 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.425 2.083 . . . . 0.0 110.944 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.05 135.92 17.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.91 63.59 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -77.88 -23.71 48.71 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.26 -40.57 30.21 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' OE2' ' CD1' ' A' ' 165' ' ' TYR . 1.9 mt-10 -76.85 -31.96 57.19 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.336 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -62.66 -26.82 68.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.48 60.83 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.917 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.495 ' CG1' ' CG ' ' A' ' 167' ' ' ASN . 1.3 t -63.26 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.54 -38.48 81.16 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.6 -23.75 53.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.91 -18.83 55.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.081 -1.012 . . . . 0.0 110.129 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -27.75 58.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.261 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -58.14 -30.81 66.63 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.162 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER -104.64 -12.0 16.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.476 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.85 62.16 4.98 Favored Glycine 0 N--CA 1.477 1.429 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 39.9 t -96.12 110.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.583 -0.951 . . . . 0.0 109.854 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.52 107.63 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' A' ' 120' ' ' ALA . 2.5 t -104.43 154.32 6.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.044 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 148' ' ' VAL . 12.0 p -141.13 112.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.515 ' CB ' ' HG2' ' A' ' 162' ' ' PRO . . . -100.9 149.82 23.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.124 -0.985 . . . . 0.0 110.384 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.496 ' CB ' ' OG1' ' A' ' 218' ' ' THR . . . -78.6 151.71 32.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.727 . . . . 0.0 109.472 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -55.98 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 155.19 115.02 0.52 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 185' ' ' GLN . 1.7 t-20 -99.96 53.16 0.91 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.951 -0.735 . . . . 0.0 109.178 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.45 ' N ' ' OE1' ' A' ' 185' ' ' GLN . 2.4 p -94.6 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.456 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 150.55 39.2 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.49 172.97 7.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 109.365 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.4 ' C ' ' HB2' ' A' ' 186' ' ' TYR . . . -103.71 56.71 0.57 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 p 172.36 124.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.042 -1.27 . . . . 0.0 109.862 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.503 HG22 ' HA2' ' A' ' 187' ' ' GLY . 1.0 OUTLIER -59.23 -171.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.234 -0.917 . . . . 0.0 110.166 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.549 ' HB2' ' CA ' ' A' ' 125' ' ' GLY . 0.8 OUTLIER -132.81 171.2 14.21 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.073 0.939 . . . . 0.0 112.795 -177.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.438 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 4.4 m-85 -82.61 146.41 53.22 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.602 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.4 Cg_endo -71.39 -30.29 5.63 Favored 'Cis proline' 0 C--N 1.293 -2.383 0 O-C-N 122.555 0.766 . . . . 0.0 110.436 3.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.625 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -70.5 -54.46 12.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 109.76 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -50.77 -170.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.177 0.989 . . . . 0.0 110.825 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.67 -16.73 8.19 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.495 ' CG ' ' CG1' ' A' ' 137' ' ' VAL . 4.4 m120 -57.08 -18.65 15.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 108.962 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -132.53 149.36 52.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.475 ' HA ' ' OD2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -89.87 130.1 36.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.907 -1.121 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 163' ' ' ALA . . . -92.55 117.97 30.51 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.564 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.7 t -92.33 164.58 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.268 1.032 . . . . 0.0 110.562 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -136.14 145.63 17.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.415 ' C ' HG21 ' A' ' 174' ' ' THR . . . -81.54 162.28 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.28 . . . . 0.0 110.14 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.498 ' CG2' ' HB ' ' A' ' 193' ' ' VAL . 73.1 p -144.58 170.83 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.528 -0.732 . . . . 0.0 109.46 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.433 ' OD1' ' CB ' ' A' ' 179' ' ' ASN . 0.7 OUTLIER -102.82 -166.59 1.29 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -67.67 -49.63 61.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.186 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' ASN . 8.3 m120 -59.59 -75.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.054 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' ASN . 1.5 m-20 162.77 41.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.0 109.642 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.433 ' CB ' ' OD1' ' A' ' 175' ' ' ASP . 0.9 OUTLIER -98.46 -149.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -107.82 18.99 20.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.468 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 180' ' ' ARG . . . 76.14 -162.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.0 109.905 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 t -100.53 -34.83 9.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.965 . . . . 0.0 110.204 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -108.12 -81.35 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 183' ' ' PHE . 3.3 t 32.05 100.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.128 0.49 . . . . 0.0 111.145 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' SER . 1.4 mp0 -45.49 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 0.0 109.815 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.524 ' CZ ' HD22 ' A' ' 256' ' ' LEU . 1.2 t80 -52.49 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 110.565 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 190' ' ' LEU . . . -145.26 20.97 1.91 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -35.76 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 79.2 50.51 5.76 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 187' ' ' GLY . 4.6 tp -75.62 144.8 41.56 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.568 -0.96 . . . . 0.0 109.465 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 169' ' ' MET . 1.2 m-20 -93.43 -46.01 7.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.208 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.543 ' CG2' HG23 ' A' ' 171' ' ' VAL . 1.5 tt -157.95 177.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.497 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.498 ' HB ' ' CG2' ' A' ' 174' ' ' THR . 31.6 m -138.79 172.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 109.663 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.518 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -173.55 174.44 1.1 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 33.6 Cg_endo -75.94 121.39 6.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.608 2.205 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -137.17 45.14 1.09 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.644 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 23.8 t -134.1 85.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.438 -1.036 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.644 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 19.5 t-20 103.33 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER 178.28 115.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.482 ' CB ' ' HA ' ' A' ' 210' ' ' SER . 1.7 pt20 -101.45 161.52 13.57 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.594 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -156.69 -158.67 0.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.546 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.62 174.06 11.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.579 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.9 OUTLIER -150.05 147.15 21.5 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 108.529 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 31.6 Cg_endo -69.91 129.96 18.33 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.721 1.614 . . . . 0.0 110.336 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 40.82 43.55 3.17 Favored Glycine 0 C--N 1.286 -2.243 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.598 ' O ' ' CG2' ' A' ' 207' ' ' THR . 0.9 OUTLIER -167.56 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.998 -1.295 . . . . 0.0 111.35 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.598 ' CG2' ' O ' ' A' ' 206' ' ' SER . 7.0 t 52.01 -143.24 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 111.032 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.58 ' N ' HG21 ' A' ' 207' ' ' THR . 0.1 OUTLIER -95.62 165.78 12.16 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.026 0.917 . . . . 0.0 111.639 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -158.03 162.2 38.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' A' ' 200' ' ' GLN . 0.6 OUTLIER -109.03 133.91 52.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.865 -1.147 . . . . 0.0 110.131 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.581 HD23 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -154.65 157.53 38.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -121.36 160.8 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 167.5 161.78 17.77 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.8 m -81.12 -28.9 34.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -1.181 . . . . 0.0 109.257 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.444 ' OG ' ' OG ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -68.08 -14.06 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.451 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 1.7 mpp? -87.95 -15.03 37.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -89.69 -8.87 51.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.657 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 86.5 m -77.35 -36.05 1.43 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 112.232 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 218' ' ' THR . 32.2 Cg_endo -73.66 -24.62 15.68 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.141 1.228 . . . . 0.0 110.264 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -62.38 -40.4 96.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.17 -40.41 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -51.5 -41.26 60.85 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -65.99 -59.64 7.28 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -42.1 -37.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.107 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.46 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.158 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.38 71.56 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.013 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.456 ' CD2' ' HB3' ' A' ' 21' ' ' LEU . 48.3 mt -55.62 -45.68 77.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 244' ' ' LEU . 31.5 t -56.0 -59.02 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 0.0 109.495 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.589 ' HD2' ' CE1' ' A' ' 118' ' ' HIS . 3.3 ttmm -44.68 -39.07 4.8 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.304 -0.872 . . . . 0.0 109.521 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.457 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -59.2 -54.95 41.12 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -56.63 -15.75 4.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 108.907 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.601 ' ND2' ' CZ3' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -166.83 84.16 0.89 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.485 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 37.4 Cg_endo -80.77 15.25 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.754 2.303 . . . . 0.0 111.17 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.87 -24.24 12.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.601 ' CZ3' ' ND2' ' A' ' 232' ' ' ASN . 32.3 m0 -62.71 175.14 0.86 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.9 m -99.71 176.37 5.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.649 -0.657 . . . . 0.0 109.758 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 238' ' ' VAL . 36.0 p30 -60.59 -22.18 63.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.431 -0.793 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -76.61 -64.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.177 -0.952 . . . . 0.0 109.277 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 238' ' ' VAL . 5.6 mm-40 -43.36 -35.58 1.59 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.547 0.689 . . . . 0.0 109.274 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.35 -46.28 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 110.187 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.487 ' CZ ' ' CB ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -63.53 -53.16 56.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.1 -28.36 66.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.421 ' CD2' HG22 ' A' ' 247' ' ' THR . 17.6 t60 -71.21 -62.93 1.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 109.31 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.485 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -59.72 -21.17 60.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.516 -0.74 . . . . 0.0 109.302 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.4 tptt -74.63 -52.85 10.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.597 -0.689 . . . . 0.0 110.281 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -11.83 59.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 3.0 p -88.43 -32.75 18.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.769 -1.207 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.6 150.3 9.53 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -63.54 167.07 5.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.7 t -131.22 97.57 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 8.2 mp -48.79 -27.68 3.15 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 115.33 37.24 1.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 1.5 m -164.34 157.59 17.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -1.2 . . . . 0.0 109.534 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.6 p -137.49 23.08 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.457 ' OD1' ' HG ' ' A' ' 256' ' ' LEU . 19.7 t-20 -96.92 -71.95 0.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 186' ' ' TYR . 1.1 mt -92.33 -52.1 4.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.775 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -61.04 -36.25 79.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -0.849 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 77.11 -120.42 5.61 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 191' ' ' ASP . 44.1 t -61.46 -78.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 193' ' ' VAL . . . 153.34 -153.08 24.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.494 ' HB3' ' OG1' ' A' ' 249' ' ' THR . 15.1 tp -69.53 164.47 23.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -1.19 . . . . 0.0 108.862 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.457 ' O ' ' OD1' ' A' ' 263' ' ' ASN . 0.1 OUTLIER -126.2 147.48 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -172.07 121.69 0.46 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 267' ' ' ALA . . . -70.01 -0.97 8.47 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.556 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 12' ' ' GLN . 39.8 tt0 -62.47 -57.92 9.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.853 -1.155 . . . . 0.0 108.981 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -71.65 -7.1 45.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 264' ' ' ALA . . . -95.11 -19.39 20.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.923 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 11.0 p -103.05 -52.15 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.0 -1.063 . . . . 0.0 109.318 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.514 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -69.44 101.11 1.5 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.526 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 13.3 m 35.55 46.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.826 0.822 . . . . 0.0 110.299 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.598 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 10.6 m -158.69 51.53 0.45 Allowed Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.488 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.598 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 35.6 Cg_endo -77.32 156.18 32.89 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.703 1.602 . . . . 0.0 109.892 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -62.36 -15.28 47.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 110.005 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 220' ' ' HIS . . . -94.26 21.07 44.44 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -144.84 10.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -1.234 . . . . 0.0 109.639 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 t -101.13 -18.92 15.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -99.99 6.79 45.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.94 16.18 8.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 120.872 -1.142 . . . . 0.0 110.067 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 2.8 mp0 46.15 55.99 6.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.605 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -85.35 -34.34 0.51 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.549 -0.719 . . . . 0.0 111.972 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.0 Cg_endo -72.49 -57.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.0 -29.76 0.36 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 -45.35 38.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.069 . . . . 0.0 109.629 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.68 -17.77 64.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.363 -0.835 . . . . 0.0 110.433 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -39.67 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.882 -1.137 . . . . 0.0 109.829 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -52.38 -35.57 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.702 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.94 8.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.2 135.22 33.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -1.142 . . . . 0.0 109.219 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.456 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -130.34 10.13 5.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.798 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.529 ' CA ' ' HG3' ' A' ' 230' ' ' GLN . . . 66.71 -1.36 5.76 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.2 m -47.33 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 124.84 15.59 3.17 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.598 HG11 ' CE1' ' A' ' 118' ' ' HIS . 6.0 t -107.57 148.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.993 -1.298 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.772 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -115.84 115.51 26.38 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.447 0.641 . . . . 0.0 110.56 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.472 ' HB ' HD22 ' A' ' 88' ' ' LEU . 1.6 t -125.45 127.65 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.527 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 120' ' ' ALA . . . -95.23 156.38 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.112 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 35' ' ' ILE . 74.4 t -129.14 86.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.146 -0.971 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD11 HG22 ' A' ' 91' ' ' VAL . 5.0 mp -71.07 100.6 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.528 ' OD2' ' CA ' ' A' ' 63' ' ' GLY . 43.3 p-10 -160.13 -160.49 0.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.875 -1.141 . . . . 0.0 109.673 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.554 ' CG2' ' O ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -64.75 -51.27 63.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.657 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . -162.97 -112.88 0.28 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.808 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.559 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 153.81 -15.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 121.613 0.72 . . . . 0.0 109.152 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 51.37 168.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 110.6 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.495 ' HA ' HG13 ' A' ' 43' ' ' ILE . 11.4 t -105.12 45.67 0.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.926 0.87 . . . . 0.0 109.195 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -52.5 160.62 1.29 Allowed Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.709 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.05 -4.55 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.692 2.261 . . . . 0.0 110.451 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 73' ' ' LEU . 24.7 t0 -91.84 -60.89 1.75 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 67' ' ' ALA . 5.0 mt -70.34 151.51 45.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.215 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -105.32 73.95 1.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.295 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG13 ' HA ' ' A' ' 37' ' ' THR . 12.1 mm -42.5 114.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.553 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -108.63 -18.8 13.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.677 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.509 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -175.19 -175.81 42.95 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.22 147.01 4.77 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.311 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.53 144.2 46.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.424 -1.045 . . . . 0.0 109.139 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -120.76 121.02 37.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.146 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.593 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 3.1 m-85 -110.73 -38.51 5.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.192 -0.943 . . . . 0.0 109.868 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -42.93 -52.58 11.29 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.195 -0.941 . . . . 0.0 109.061 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 38.9 Cg_endo -84.33 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.07 2.513 . . . . 0.0 110.717 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . 178.56 32.58 0.05 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.629 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 69.29 53.65 0.49 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.601 -0.941 . . . . 0.0 110.893 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 38.3 Cg_endo -83.89 -80.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.305 2.004 . . . . 0.0 110.353 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.561 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.3 OUTLIER -129.0 -25.7 2.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.841 -0.537 . . . . 0.0 110.398 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 46.72 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 109.916 -177.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' SER . 7.3 mm100 -95.9 155.69 16.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.876 -1.14 . . . . 0.0 108.45 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLN . 5.0 m-20 52.17 172.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.003 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.554 ' O ' ' CG2' ' A' ' 33' ' ' THR . . . 164.44 46.62 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 1.1 t30 80.47 -27.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -1.038 . . . . 0.0 110.452 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' O ' ' C ' ' A' ' 62' ' ' HIS . . . 128.11 -72.82 0.46 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.589 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.563 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.9 t-80 -11.44 -59.95 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.445 0.641 . . . . 0.0 111.917 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.88 -69.47 1.28 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.7 m -38.39 -41.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.563 -0.963 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 2.0 t-80 -56.61 -63.22 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 70' ' ' ILE . 16.5 t -49.09 -32.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 108.782 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.465 ' HB2' HD12 ' A' ' 41' ' ' LEU . . . -55.39 -53.34 57.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.409 ' HA2' HD22 ' A' ' 41' ' ' LEU . . . -68.52 -22.11 74.85 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.547 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 6.6 m -73.94 -18.11 60.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.036 -1.273 . . . . 0.0 108.088 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 66' ' ' VAL . 56.8 mt -101.44 -25.84 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.492 -0.755 . . . . 0.0 111.309 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -162.02 25.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.316 -1.49 . . . . 0.0 112.647 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB2' ' N ' ' A' ' 80' ' ' LEU . . . -39.86 114.52 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 109.34 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.532 ' CG ' ' O ' ' A' ' 40' ' ' ASP . 23.6 mt -73.54 167.48 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.68 125.99 53.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 3.1 p-10 -168.68 -109.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -0.969 . . . . 0.0 109.101 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -82.44 -73.52 0.39 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.472 HG13 ' OH ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -52.29 178.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.587 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -132.79 122.93 3.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.41 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.547 HG23 ' CE2' ' A' ' 208' ' ' TYR . 1.8 t -162.7 -64.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 3' ' ' SER . 1.1 tp 56.51 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.317 0.58 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -95.49 -143.44 14.54 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -106.57 -54.19 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.028 -1.278 . . . . 0.0 109.664 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -107.83 102.76 46.86 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 38.0 Cg_endo -85.57 -63.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.877 2.385 . . . . 0.0 110.919 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.413 ' OD1' ' OG ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -51.88 -17.39 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 143.33 56.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.253 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.772 ' OE1' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -79.56 126.16 30.53 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.978 -1.077 . . . . 0.0 109.082 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.472 HD22 ' HB ' ' A' ' 28' ' ' VAL . 15.0 mt -103.25 105.32 15.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.715 -1.241 . . . . 0.0 110.309 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.509 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 19.8 m-85 -85.72 142.35 29.07 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.27 -0.894 . . . . 0.0 108.775 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' CB ' HD11 ' A' ' 35' ' ' ILE . . . -105.23 104.68 14.46 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.615 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.475 ' O ' ' C ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -97.82 66.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.121 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 33' ' ' THR . 1.2 tttt -36.5 109.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.477 0.656 . . . . 0.0 110.018 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.476 HG11 HG12 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -125.06 -13.58 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mt -84.62 -170.96 3.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.986 0.898 . . . . 0.0 110.886 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.416 ' CA ' ' N ' ' A' ' 99' ' ' SER . . . -101.83 -99.54 2.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 97' ' ' SER . . . 48.67 83.91 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 96' ' ' ALA . 3.2 t 81.0 -8.21 1.45 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 99' ' ' SER . . . -122.46 -29.45 1.31 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' GLY . 0.9 OUTLIER 72.81 108.18 0.07 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.238 -1.154 . . . . 0.0 109.05 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 99' ' ' SER . . . -47.0 176.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -177.94 142.72 0.3 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.731 -0.864 . . . . 0.0 108.703 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.456 ' CG2' ' HA ' ' A' ' 129' ' ' PRO . 21.0 t -68.45 -21.05 25.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.543 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -74.85 -25.17 58.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.588 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -79.61 -67.11 0.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.553 HG23 ' CD1' ' A' ' 133' ' ' LEU . 1.0 OUTLIER -50.52 -24.0 2.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 102' ' ' VAL . . . -67.57 -56.42 9.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.68 -0.638 . . . . 0.0 110.051 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.593 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -65.69 -33.11 75.11 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.43 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.547 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -68.25 -30.83 73.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 mt -94.33 -4.67 48.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.116 -1.226 . . . . 0.0 109.465 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.96 -5.9 12.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 109.449 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -86.3 -17.73 33.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.617 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -83.49 -1.54 53.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -82.33 -46.35 6.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 -77.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -1.099 . . . . 0.0 108.588 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.82 63.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -106.82 -156.24 20.8 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.475 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.563 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 14.2 mmt -140.63 -179.92 6.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.854 -0.792 . . . . 0.0 109.734 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 27' ' ' LYS . 3.0 p80 -78.1 -31.04 49.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.444 -0.785 . . . . 0.0 110.088 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.557 HG22 ' CE1' ' A' ' 118' ' ' HIS . 94.7 t -130.67 165.05 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.73 -1.231 . . . . 0.0 110.956 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.518 ' N ' HG13 ' A' ' 119' ' ' VAL . . . -169.06 158.65 8.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.532 ' OD1' ' CB ' ' A' ' 222' ' ' ALA . 9.8 m120 -129.3 163.91 24.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.658 -1.276 . . . . 0.0 110.547 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.419 HD11 HG13 ' A' ' 147' ' ' VAL . 3.3 mp -139.49 99.55 3.76 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.471 -0.768 . . . . 0.0 108.945 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 67.73 10.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 108.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -163.85 -176.19 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.821 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 160' ' ' SER . . . 157.99 107.24 0.24 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.537 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -163.98 176.71 2.08 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.134 -1.215 . . . . 0.0 109.627 -179.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 126' ' ' SER . 36.4 Cg_endo -81.34 -10.53 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.89 2.393 . . . . 0.0 109.766 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 1.1 t -50.03 -48.6 78.44 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.74 -0.6 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 128' ' ' SER . 31.1 Cg_endo -72.61 169.84 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.245 1.963 . . . . 0.0 110.955 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.25 179.58 5.2 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.701 1.239 . . . . 0.0 111.008 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 134' ' ' GLU . . . -63.52 -16.32 60.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -63.73 -36.01 82.46 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.553 ' CD1' HG23 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -66.71 -34.97 79.02 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.581 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 1.7 tt0 -60.25 -58.92 6.45 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.863 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 138' ' ' ASN . 96.5 mm-40 -45.51 -25.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 134' ' ' GLU . . . -67.79 -48.72 65.52 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.3 -26.14 38.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 11.9 t30 -62.33 -35.17 78.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 p -75.82 -25.38 56.26 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.1 -22.93 57.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.183 -0.948 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -30.5 67.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.966 . . . . 0.0 108.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.55 -34.19 49.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 108.969 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -98.71 -19.69 17.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 237' ' ' ASN . . . 82.98 14.13 75.86 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.3 t -48.4 102.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -1.095 . . . . 0.0 108.931 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.451 ' HB2' ' OD1' ' A' ' 237' ' ' ASN . 0.4 OUTLIER -69.1 103.55 1.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.285 -0.884 . . . . 0.0 109.426 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -102.51 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.522 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -122.9 113.92 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.4 32.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.922 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 214' ' ' THR . . . -64.08 172.53 2.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.809 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.479 ' CB ' HG22 ' A' ' 214' ' ' THR . 0.3 OUTLIER -69.0 -74.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 109.758 -179.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 153.73 -13.01 0.56 Allowed Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.301 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 152' ' ' GLY . 4.4 m-20 22.9 48.62 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.3 OUTLIER 176.73 56.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.46 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . 161.79 51.84 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -54.51 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 110.252 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . 66.18 11.61 55.91 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 2.3 p 160.13 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.402 ' HA ' ' OE1' ' A' ' 185' ' ' GLN . 0.2 OUTLIER -112.29 -175.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.463 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -85.93 168.79 13.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.305 1.05 . . . . 0.0 111.801 -178.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.494 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -104.38 137.86 19.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 175.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.721 ' O ' ' N ' ' A' ' 164' ' ' ARG . 39.6 Cg_endo -73.24 -53.31 0.16 OUTLIER 'Cis proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.174 -1.178 . . . . 0.0 110.656 3.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 160' ' ' SER . . . 29.95 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.254 1.026 . . . . 0.0 110.116 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 162' ' ' PRO . 3.8 ttm180 -42.39 -46.86 4.82 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.329 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.581 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 14.7 m-85 -44.4 173.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.11 -0.994 . . . . 0.0 110.913 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 168' ' ' ALA . . . -98.8 -47.87 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.67 -0.644 . . . . 0.0 110.493 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.504 ' C ' ' ND2' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -42.24 -27.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.882 0.848 . . . . 0.0 109.751 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -125.55 145.55 50.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.471 ' SD ' ' HG3' ' A' ' 241' ' ' ARG . 12.7 mtm -96.12 153.92 17.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -108.43 122.82 47.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.8 t -90.72 165.75 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 0.0 109.76 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.57 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.09 -176.62 14.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.82 162.44 27.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.992 -1.299 . . . . 0.0 109.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.1 p -133.45 172.27 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.789 . . . . 0.0 109.249 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 -156.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -90.05 -41.51 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -78.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.535 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.72 30.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 110.042 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.22 156.36 22.48 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.145 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.501 ' HD3' ' HB3' ' A' ' 256' ' ' LEU . 6.7 ttp85 -60.96 134.6 57.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 0.0 109.475 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' CE1' ' A' ' 183' ' ' PHE . . . -45.68 173.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.451 -0.78 . . . . 0.0 109.701 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.0 OUTLIER -108.27 11.17 27.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 109.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 2.3 p90 -134.73 -12.37 2.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.039 -1.038 . . . . 0.0 110.645 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 t -67.01 138.88 57.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.505 ' HG2' ' N ' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -93.83 143.02 26.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.115 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.47 -174.34 3.04 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.596 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.03 -171.85 44.09 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -85.67 64.39 8.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.127 . . . . 0.0 109.177 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.63 31.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -85.53 138.26 32.32 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.132 -1.216 . . . . 0.0 109.66 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -86.0 -72.68 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.629 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.529 ' CD1' HG23 ' A' ' 262' ' ' VAL . 0.3 OUTLIER -149.56 -162.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.245 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.531 HG21 ' CA ' ' A' ' 260' ' ' GLY . 27.2 m -143.28 175.97 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.53 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -167.61 177.16 1.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 108.946 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 33.2 Cg_endo -76.69 113.74 3.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 109.446 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.502 ' HA2' ' ND2' ' A' ' 212' ' ' ASN . . . -145.22 48.27 0.71 Allowed Glycine 0 N--CA 1.484 1.861 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.435 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 1.7 t -130.87 30.49 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.249 . . . . 0.0 109.068 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.561 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.1 OUTLIER 164.86 105.18 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.158 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.621 ' CG2' ' ND2' ' A' ' 212' ' ' ASN . 2.7 m -158.37 111.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -89.56 117.93 28.82 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.335 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.546 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -118.05 -151.45 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.929 . . . . 0.0 109.858 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.52 ' HA ' ' CD1' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -87.92 178.43 6.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.618 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -164.6 157.7 14.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.6 Cg_endo -70.07 166.0 29.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.233 1.956 . . . . 0.0 110.322 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 206' ' ' SER . . . 84.74 3.84 87.84 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 205' ' ' GLY . 6.9 t 74.84 43.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -1.078 . . . . 0.0 110.26 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -145.11 -179.91 6.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.547 ' CE2' HG23 ' A' ' 79' ' ' VAL . 2.9 m-30 -113.67 -174.13 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -165.31 164.77 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.828 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 50.5 m -124.8 114.56 19.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.504 -0.747 . . . . 0.0 109.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 211' ' ' LEU . 0.8 OUTLIER -173.96 138.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.407 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.621 ' ND2' ' CG2' ' A' ' 199' ' ' VAL . 2.9 t-20 -125.23 -157.43 0.78 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.165 0.983 . . . . 0.0 110.601 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 136.32 175.95 14.09 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.479 HG22 ' CB ' ' A' ' 151' ' ' SER . 0.2 OUTLIER -56.68 -41.52 77.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.984 -1.303 . . . . 0.0 109.346 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.5 m -57.69 -29.86 65.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 0.0 110.447 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.49 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 1.4 mpp? -90.95 -26.26 19.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.496 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.12 -6.2 59.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.977 -1.077 . . . . 0.0 109.441 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.608 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 1.2 m -73.05 -47.56 8.07 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -71.71 -8.39 23.03 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.098 1.865 . . . . 0.0 111.466 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.515 ' CE1' HG21 ' A' ' 69' ' ' THR . 5.7 m80 -77.19 -47.14 21.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.74 -41.39 85.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.532 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -57.65 -34.77 69.71 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.5 -54.83 26.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 264' ' ' ALA . . . -51.06 -38.3 50.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 108.867 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -59.08 -44.96 91.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 0.0 109.154 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.441 ' HA ' HG12 ' A' ' 26' ' ' VAL . . . -54.64 -53.61 52.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 108.985 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.464 HD13 HG13 ' A' ' 82' ' ' VAL . 69.9 mt -50.82 -31.53 17.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.025 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 58.3 t -68.3 -52.1 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.473 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.49 ' HD2' ' ND1' ' A' ' 118' ' ' HIS . 27.3 tttp -46.78 -42.06 16.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 108.822 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.529 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -62.22 -45.95 91.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.357 -0.839 . . . . 0.0 109.444 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 231' ' ' LYS . 11.6 tptm -56.4 -18.6 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 108.557 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.5 90.8 2.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 108.999 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.04 8.28 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.752 2.301 . . . . 0.0 110.876 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.14 8.33 10.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -82.33 -178.66 7.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.383 -0.823 . . . . 0.0 109.915 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' SER . . . . . 0.429 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -121.54 174.71 6.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.651 -0.655 . . . . 0.0 109.443 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -60.42 -27.05 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.8 t -73.06 -63.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.098 -1.001 . . . . 0.0 109.61 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -49.04 -39.79 28.72 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.546 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 236' ' ' SER . 84.0 mt -60.01 -58.12 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.486 -0.759 . . . . 0.0 109.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.471 ' HG3' ' SD ' ' A' ' 169' ' ' MET . 18.8 ttp180 -54.64 -72.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.9 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ARG . 4.8 t30 -35.03 -36.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.919 -0.488 . . . . 0.0 110.736 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.425 ' O ' ' OG1' ' A' ' 247' ' ' THR . 8.6 t60 -65.83 -51.56 57.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.996 -1.065 . . . . 0.0 110.107 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.479 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 3.6 mt -70.84 -23.84 62.42 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.295 -0.878 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -33.24 60.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 246' ' ' ASN . 2.8 t-20 -93.26 -14.97 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.2 p -87.32 -31.3 20.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.035 -1.041 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.496 ' HB2' ' CB ' ' A' ' 259' ' ' SER . . . -51.13 144.07 9.78 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 17.6 m -78.07 159.47 28.68 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.9 t -128.55 101.67 6.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.852 . . . . 0.0 109.945 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -50.04 -38.9 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 119.78 67.41 0.29 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' SER . . . . . 0.516 ' HB2' ' HB2' ' A' ' 257' ' ' TYR . 3.2 m -132.34 -177.58 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -1.092 . . . . 0.0 109.635 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.539 HG23 ' N ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -80.11 -74.1 0.32 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.539 ' N ' HG23 ' A' ' 254' ' ' THR . 55.4 t30 -138.0 2.17 2.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.382 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.576 ' CD1' ' CD2' ' A' ' 186' ' ' TYR . 2.0 mm? -80.89 -10.81 59.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.957 -1.089 . . . . 0.0 109.636 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 253' ' ' SER . 72.3 m-85 -128.75 -83.74 0.57 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.73 -0.606 . . . . 0.0 109.601 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 50.39 99.39 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.496 ' CB ' ' HB2' ' A' ' 248' ' ' ALA . 0.9 OUTLIER 56.91 18.85 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.584 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.531 ' CA ' HG21 ' A' ' 193' ' ' VAL . . . -40.75 -61.04 1.99 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 249' ' ' THR . 5.9 tp -62.91 143.44 57.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.997 -1.296 . . . . 0.0 110.186 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.529 HG23 ' CD1' ' A' ' 192' ' ' ILE . 3.6 t -118.54 125.83 74.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 116.19 6.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.772 1.273 . . . . 0.0 108.663 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 224' ' ' ALA . . . -77.64 -17.28 57.9 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.895 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.412 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 55.7 tt0 -55.65 -36.94 67.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 0.0 109.624 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.2 -19.47 39.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -98.23 -1.83 41.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.365 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.6 p -109.5 -39.06 5.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.655 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.589 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' CB ' ' HA ' ' A' ' 76' ' ' SER . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.1 126.48 27.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.205 -0.935 . . . . 0.0 109.732 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 5' ' ' PRO . 22.9 m -120.19 47.29 1.79 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 3' ' ' SER . 7.3 t -17.3 80.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.708 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -81.69 164.31 18.44 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.809 2.339 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -15.36 7.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.566 -0.709 . . . . 0.0 109.793 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.16 -64.23 1.67 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.1 mp -65.87 173.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.294 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 2.5 t 88.94 -39.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -25.12 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.335 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.55 20.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.939 -1.101 . . . . 0.0 110.089 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.541 ' OE1' ' CB ' ' A' ' 265' ' ' GLU . 0.0 OUTLIER 50.86 53.42 13.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 110.519 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.681 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.66 -30.41 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.944 -1.097 . . . . 0.0 111.988 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.8 Cg_endo -75.31 -59.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.11 -27.41 0.58 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.06 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -81.15 -40.56 23.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.922 -1.111 . . . . 0.0 108.935 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -73.11 -8.42 55.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.48 -39.02 5.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.599 -1.313 . . . . 0.0 110.23 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.41 68.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.868 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.09 -4.85 4.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 3.7 mm? -62.9 122.29 15.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.199 -1.177 . . . . 0.0 109.101 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.479 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -118.5 -30.81 5.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.535 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 26' ' ' VAL . . . 78.8 -14.73 12.13 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -50.41 120.81 4.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -1.154 . . . . 0.0 109.001 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.09 0.71 30.0 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.493 HG11 ' HD2' ' A' ' 229' ' ' LYS . 39.4 t -99.37 164.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.236 -1.155 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.582 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 6.4 mttt -142.29 129.34 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 HG11 ' HB ' ' A' ' 119' ' ' VAL . 16.0 t -133.04 158.54 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.611 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.17 144.42 41.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 108.918 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.7 t -121.31 82.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.073 -1.017 . . . . 0.0 109.132 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 4.9 mp -64.7 91.64 0.09 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.544 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -144.72 -151.78 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.798 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.593 ' CG2' ' N ' ' A' ' 96' ' ' ALA . 72.9 p -80.35 -51.63 8.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.462 -1.398 . . . . 0.0 109.036 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -168.56 -114.47 0.3 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.4 OUTLIER 160.83 100.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.5 t -44.75 150.47 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.193 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.33 115.27 21.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.16 157.26 71.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.01 -37.48 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.6 2.2 . . . . 0.0 110.493 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' OD2' ' HA3' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -62.08 -18.94 62.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' CD2' ' HA2' ' A' ' 68' ' ' GLY . 14.5 mt -102.02 129.82 48.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.371 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 68.23 9.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.385 -0.822 . . . . 0.0 109.307 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.437 HD13 ' CG2' ' A' ' 35' ' ' ILE . 37.3 mm -57.26 139.02 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.491 ' HG2' ' HG2' ' A' ' 87' ' ' GLU . 20.3 tpt85 -121.54 -33.92 3.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.261 -0.899 . . . . 0.0 109.687 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -156.27 18.97 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.22 166.2 13.92 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -145.33 174.58 10.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.976 . . . . 0.0 108.961 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 92' ' ' LYS . 81.2 p -125.84 107.18 10.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 110.28 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 47' ' ' ALA . 2.7 m-85 -105.81 -36.83 6.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.514 HG11 ' HD2' ' A' ' 51' ' ' PRO . 2.1 t -41.82 145.97 0.65 Allowed Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 53' ' ' GLU . 34.0 Cg_endo -75.28 -63.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.575 2.183 . . . . 0.0 110.81 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -29.77 -38.13 0.02 OUTLIER Glycine 0 N--CA 1.499 2.886 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.525 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER 60.95 60.49 3.28 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 35.2 Cg_endo -77.98 -78.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.427 2.085 . . . . 0.0 110.022 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 54' ' ' PRO . 6.4 m -167.52 136.49 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.443 -0.785 . . . . 0.0 109.089 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 56' ' ' THR . 1.2 m -77.74 -0.85 28.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.594 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 20.4 mt-30 -141.51 117.72 10.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.041 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 14.2 t70 64.56 92.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.837 . . . . 0.0 109.513 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.29 -27.89 5.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 t-20 -167.66 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.389 -1.065 . . . . 0.0 109.679 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 64' ' ' THR . . . 160.55 -42.18 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.216 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' GLY . 34.7 t-80 -54.16 -65.09 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 110.078 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -39.99 -74.77 0.13 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -40.1 -40.66 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 0.0 109.784 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.563 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.4 t-80 -55.37 -56.7 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.422 HG11 ' CB ' ' A' ' 219' ' ' PRO . 78.5 t -57.49 -44.44 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -54.67 -32.72 59.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.483 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 72' ' ' ALA . . . -79.39 -27.62 54.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -74.15 -15.61 61.02 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 mt -109.29 -21.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.455 -0.778 . . . . 0.0 110.049 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.575 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -117.56 -35.45 3.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 111.627 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.575 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -15.24 106.15 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 121.468 0.652 . . . . 0.0 111.646 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CA ' ' A' ' 84' ' ' PRO . 6.7 mt -85.0 153.82 22.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 109.749 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 48.9 p-10 -72.62 141.64 48.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 8.7 m-20 158.17 130.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.511 ' HA ' ' CB ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -35.61 -39.11 0.13 Allowed 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -86.68 64.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.127 -0.983 . . . . 0.0 109.349 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA3' ' OD2' ' A' ' 40' ' ' ASP . . . 158.35 160.17 10.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -79.05 -112.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -1.112 . . . . 0.0 109.646 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -171.74 96.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.799 -1.188 . . . . 0.0 109.664 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.473 ' HA3' ' HB1' ' A' ' 72' ' ' ALA . . . -78.92 -160.49 18.02 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.42 HG13 HD13 ' A' ' 227' ' ' LEU . 1.4 t -107.65 -32.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.291 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -115.53 117.98 39.84 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 109.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CA ' HD22 ' A' ' 73' ' ' LEU . 37.6 Cg_endo -85.48 -59.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.724 2.282 . . . . 0.0 111.244 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.53 38.83 1.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.97 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.54 124.2 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 2.6 mt-10 -64.49 103.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.44 92.9 6.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 110.851 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CE2' ' HE2' ' A' ' 117' ' ' MET . 40.0 m-85 -77.63 146.57 36.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.4 ' HB3' HD11 ' A' ' 35' ' ' ILE . . . -103.25 106.59 17.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.767 -1.208 . . . . 0.0 109.029 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -95.1 67.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.988 0.899 . . . . 0.0 108.807 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 26.6 ttmt -35.12 94.05 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.005 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG2' ' HA3' ' A' ' 108' ' ' GLY . 2.2 t -118.39 -16.66 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 0.0 108.891 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.1 mt -116.47 175.17 5.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.389 -0.819 . . . . 0.0 110.167 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.587 ' O ' ' CB ' ' A' ' 96' ' ' ALA . . . -107.36 -14.3 18.62 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.593 ' N ' ' CG2' ' A' ' 33' ' ' THR . . . 150.54 -83.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.3 23.28 7.64 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 99' ' ' SER . . . -95.75 -95.34 1.76 Allowed Glycine 0 N--CA 1.479 1.524 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 98' ' ' GLY . 2.9 p 149.1 100.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.92 -178.8 0.18 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 177.51 6.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.883 -0.775 . . . . 0.0 109.969 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 t -66.19 -22.02 29.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.574 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 3.6 t -69.96 -26.4 64.09 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' A' ' 50' ' ' VAL . 4.4 m -81.23 -44.49 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.538 -0.726 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.2 mt -68.14 -21.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.49 -52.22 16.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.681 -0.637 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 103' ' ' SER . 12.7 mm-40 -71.15 -30.4 66.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.689 -1.257 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.49 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -73.19 -24.07 76.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.79 -24.2 17.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -1.179 . . . . 0.0 109.906 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.33 -30.52 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 111' ' ' TRP . 69.4 t90 -72.65 -16.6 61.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.582 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -91.37 6.21 46.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -114.9 -50.38 0.48 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -70.08 -76.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.279 . . . . 0.0 108.732 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -105.71 41.07 1.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -92.39 -149.46 24.53 Favored Glycine 0 C--N 1.294 -1.782 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.582 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 7.1 mmt -140.3 -169.15 2.7 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.178 0.989 . . . . 0.0 110.933 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.0 m170 -70.21 -57.77 4.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.164 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.453 ' HB ' HG11 ' A' ' 28' ' ' VAL . 9.7 t -101.03 161.35 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 111.177 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -163.25 109.7 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.538 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 7.0 m120 -110.72 153.49 25.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.911 -1.118 . . . . 0.0 111.077 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.604 ' N ' ' CD2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -134.89 134.07 40.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -89.61 70.27 7.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.294 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.551 HD23 ' CB ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -150.4 -177.74 6.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.621 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.07 106.93 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.18 158.97 40.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.205 -1.173 . . . . 0.0 109.58 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.442 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -78.69 -17.1 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.633 2.222 . . . . 0.0 110.051 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -40.98 102.15 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.583 -0.698 . . . . 0.0 109.533 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 130' ' ' SER . 34.0 Cg_endo -77.42 166.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.409 2.073 . . . . 0.0 110.488 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 129' ' ' PRO . 2.1 m 172.53 121.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.436 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.58 -18.53 65.03 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.8 m -73.07 -25.73 61.01 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.62 -42.89 23.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.45 -25.82 57.77 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.546 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.4 tm0? -72.41 -22.75 61.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.3 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -64.06 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -59.45 -36.55 76.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.52 -24.48 50.0 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.29 59.42 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 121.232 -0.917 . . . . 0.0 109.917 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m -73.17 -36.53 66.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -24.76 58.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -105.15 -13.14 15.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.26 55.53 27.22 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 15.3 t -89.36 107.13 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.704 -0.88 . . . . 0.0 109.766 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.445 ' O ' HG11 ' A' ' 119' ' ' VAL . 15.6 tp -64.05 101.95 0.45 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.063 -1.023 . . . . 0.0 109.071 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 1.4 t -88.81 150.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.538 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -146.06 120.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.521 ' CB ' ' HG2' ' A' ' 162' ' ' PRO . . . -115.44 151.33 34.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.124 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.68 173.82 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -72.78 -67.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.034 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . 172.67 -23.67 0.08 OUTLIER Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.77 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 154' ' ' SER . 44.4 t-20 67.52 37.12 3.51 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.831 -0.805 . . . . 0.0 109.96 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 1.0 OUTLIER 79.23 72.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 110.213 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -115.84 -33.09 1.6 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -172.12 -178.39 2.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -1.193 . . . . 0.0 109.534 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.34 58.41 4.91 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER 162.25 129.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.982 . . . . 0.0 109.196 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 158' ' ' SER . 1.8 pt -48.66 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.359 -0.838 . . . . 0.0 110.007 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -126.91 164.68 20.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.227 -0.921 . . . . 0.0 111.896 -177.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.1 OUTLIER -77.78 142.37 65.41 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 175.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.8 Cg_endo -72.0 -29.3 6.35 Favored 'Cis proline' 0 C--N 1.298 -2.113 0 O-C-N 122.546 0.761 . . . . 0.0 110.594 3.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . -35.12 -26.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.732 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -100.35 -32.03 11.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.542 -1.349 . . . . 0.0 110.608 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.51 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.6 m-85 -46.18 -179.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.172 -0.955 . . . . 0.0 110.798 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -93.96 -25.64 17.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.566 -0.709 . . . . 0.0 111.049 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.465 ' HB2' HG12 ' A' ' 137' ' ' VAL . 2.2 t-20 -97.98 23.08 8.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.81 -1.181 . . . . 0.0 110.061 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 162' ' ' PRO . . . -153.01 114.61 4.26 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.523 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 0.6 OUTLIER -78.26 167.45 21.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.128 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -118.61 123.77 45.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.331 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.556 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.0 t -92.86 166.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.141 -0.974 . . . . 0.0 109.242 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.556 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.66 -179.79 17.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -119.47 171.27 8.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 178' ' ' ASN . 1.5 p -122.86 167.88 12.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.526 ' CA ' ' HA ' ' A' ' 181' ' ' ALA . 49.6 p-10 -91.16 -177.57 4.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -69.51 -24.25 63.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.29 -79.22 0.17 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.456 ' O ' ' HB ' ' A' ' 174' ' ' THR . 0.1 OUTLIER -135.76 -79.4 0.42 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 110.363 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 0.8 OUTLIER -125.0 -164.49 1.29 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.206 -0.934 . . . . 0.0 109.681 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 81.43 -31.31 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.626 -0.672 . . . . 0.0 110.932 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.526 ' HA ' ' CA ' ' A' ' 175' ' ' ASP . . . 42.99 -155.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.957 -1.089 . . . . 0.0 109.454 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -126.64 -45.81 1.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 110.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.27 26.37 10.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.349 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.5 t -81.15 112.31 18.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.528 ' NE2' ' HA ' ' A' ' 154' ' ' SER . 3.3 tp-100 -74.88 156.8 36.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.8 171.41 14.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.613 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.578 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -173.56 146.83 9.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.05 100.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.46 16.16 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.493 HD21 ' O ' ' A' ' 256' ' ' LEU . 7.1 tp -53.79 151.08 6.7 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.107 -1.231 . . . . 0.0 108.824 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.523 ' CB ' ' HB3' ' A' ' 169' ' ' MET . 22.4 t70 -99.54 -69.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.53 ' CD1' HG21 ' A' ' 262' ' ' VAL . 7.6 tt -159.45 141.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.367 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 22.1 m -98.32 172.96 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -164.1 178.13 1.56 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.05 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 34.7 Cg_endo -77.64 117.61 4.32 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.284 1.989 . . . . 0.0 110.134 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -143.67 33.24 1.78 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.666 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 62.7 t -119.31 59.03 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -1.192 . . . . 0.0 108.88 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 12.9 t-20 123.9 121.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 11.6 m -166.4 110.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.946 0.879 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.6 mt-30 -80.46 122.97 27.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.334 0.588 . . . . 0.0 109.531 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.563 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.8 t -125.31 -163.16 1.17 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.643 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.5 p -79.27 166.8 21.76 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 110.115 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.623 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -149.16 156.62 40.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.3 Cg_endo -69.96 159.94 51.46 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.183 1.922 . . . . 0.0 110.629 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.476 ' O ' ' OG ' ' A' ' 206' ' ' SER . . . 74.84 31.28 58.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 205' ' ' GLY . 80.9 p 49.86 40.15 19.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -1.076 . . . . 0.0 109.905 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.22 155.36 40.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -103.58 165.43 11.04 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.186 -0.946 . . . . 0.0 108.819 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.588 ' HB1' ' CG ' ' A' ' 203' ' ' TYR . . . -153.09 163.76 39.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.768 -1.208 . . . . 0.0 110.746 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.8 OUTLIER -121.27 108.21 13.46 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.516 HD13 ' CG ' ' A' ' 65' ' ' HIS . 11.0 mt -110.12 170.0 8.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.103 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 212' ' ' ASN . 2.4 p-10 -146.77 148.88 32.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.448 -0.782 . . . . 0.0 109.211 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.16 161.94 11.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 214' ' ' THR . 90.3 m -77.37 -17.32 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -1.129 . . . . 0.0 109.222 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 36.0 m -75.37 -19.25 59.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.118 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.432 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -79.71 -17.44 53.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 109.556 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 194' ' ' ALA . . . -89.8 -13.1 37.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 109.732 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.617 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 12.7 m -70.6 -42.73 14.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 111.489 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.9 Cg_endo -73.11 -15.45 25.77 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 121.672 1.581 . . . . 0.0 110.756 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -75.25 -40.44 58.91 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 192' ' ' ILE . 88.2 t -68.82 -49.64 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.535 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.27 -31.99 62.01 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.387 -0.821 . . . . 0.0 108.995 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.24 -53.87 33.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -49.25 -52.19 28.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -1.179 . . . . 0.0 109.237 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.37 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.404 -0.81 . . . . 0.0 109.061 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.73 -44.23 97.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.308 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.425 HD12 ' CB ' ' A' ' 16' ' ' ALA . 79.1 mt -55.8 -36.63 67.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.238 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 36.6 t -73.59 -40.88 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 109.995 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.52 ' NZ ' ' CD1' ' A' ' 240' ' ' ILE . 11.6 ttmm -52.38 -46.07 66.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.623 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 0.0 OUTLIER -62.78 -45.16 93.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -20.66 3.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.848 . . . . 0.0 108.792 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.62 85.06 0.53 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.758 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 35.1 Cg_endo -77.05 -16.16 16.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.07 -0.6 32.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -81.27 -177.33 6.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.75 169.13 11.04 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.64 . . . . 0.0 109.577 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -60.11 -16.06 28.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.68 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.51 -63.74 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.464 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -50.82 -38.86 51.21 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.031 -178.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.52 ' CD1' ' NZ ' ' A' ' 229' ' ' LYS . 62.5 mt -70.62 -44.61 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 110.294 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.507 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 4.8 ttp85 -57.3 -29.24 63.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 110.415 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.49 -29.63 25.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.75 -1.219 . . . . 0.0 110.278 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.485 ' O ' HG22 ' A' ' 247' ' ' THR . 0.6 OUTLIER -75.5 -57.86 3.63 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.934 -1.104 . . . . 0.0 108.126 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.495 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -60.05 -38.12 81.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.753 -0.592 . . . . 0.0 110.253 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 21.6 tttt -69.34 -49.96 50.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -74.62 -6.37 48.26 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.826 -0.547 . . . . 0.0 110.862 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.495 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.5 p -94.15 -30.76 14.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.697 -1.252 . . . . 0.0 109.832 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -44.24 137.44 3.5 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.7 m -92.19 105.9 18.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.187 -0.945 . . . . 0.0 109.862 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.468 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.5 OUTLIER -75.43 135.61 40.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.442 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.3 -78.11 0.1 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.309 -0.869 . . . . 0.0 109.686 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -149.62 31.71 1.12 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.2 m -123.99 159.53 29.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.05 -1.265 . . . . 0.0 109.355 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.9 p -138.37 24.78 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.605 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -171.79 -34.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.493 ' O ' HD21 ' A' ' 190' ' ' LEU . 13.8 mt -70.61 -74.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.912 . . . . 0.0 109.167 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.59 ' N ' ' CD1' ' A' ' 257' ' ' TYR . 4.2 m-30 -71.4 -24.39 62.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.697 0.76 . . . . 0.0 109.121 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.69 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 192' ' ' ILE . 44.9 m -54.02 -48.49 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.941 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.471 ' O ' HG13 ' A' ' 192' ' ' ILE . . . 106.74 -131.37 10.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 192' ' ' ILE . 4.8 tp -81.65 179.17 7.94 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.365 -1.079 . . . . 0.0 109.898 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 192' ' ' ILE . 0.4 OUTLIER -120.32 140.67 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.492 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.45 118.43 1.39 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.468 1.128 . . . . 0.0 108.533 178.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -80.43 -7.19 59.04 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.698 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.541 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -57.53 -54.02 51.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.771 -1.206 . . . . 0.0 109.792 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.6 33.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.085 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -103.61 -14.91 15.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.819 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.427 HG23 HD22 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -106.04 -31.26 8.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.025 . . . . 0.0 109.981 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 268' ' ' THR . 1.4 ttp85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.2 169.49 13.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.297 -0.877 . . . . 0.0 109.339 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.414 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 1.9 m -77.25 116.38 17.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 t -131.83 81.27 63.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 109.208 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HG2' HG13 ' A' ' 8' ' ' ILE . 33.6 Cg_endo -77.27 157.23 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.507 2.138 . . . . 0.0 110.738 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -47.37 -38.0 12.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.648 -0.658 . . . . 0.0 109.916 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' TRP . . . -59.95 -43.81 97.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.496 HD11 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -107.33 50.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -1.155 . . . . 0.0 109.862 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -132.15 -42.88 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 109.593 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -86.61 -1.1 57.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.888 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' GLN . 16.2 m -88.42 20.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 120.994 -1.066 . . . . 0.0 109.85 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 263' ' ' ASN . 1.1 mt-30 41.4 42.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.745 . . . . 0.0 110.289 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.661 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -76.85 -35.37 1.42 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 111.481 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.2 Cg_endo -73.0 -56.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -42.93 -37.07 1.73 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.35 72.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.209 -0.932 . . . . 0.0 108.563 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 21.7 m170 -63.93 -14.34 52.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.89 -50.26 12.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.15 -14.58 25.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.52 -2.86 39.57 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 21' ' ' LEU . 1.6 tp -51.72 162.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.154 . . . . 0.0 109.655 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 -32.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 64.82 8.86 36.35 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.538 ' CB ' ' HB3' ' A' ' 85' ' ' ASN . 8.6 p -52.75 -31.8 40.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.964 . . . . 0.0 110.07 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.03 32.9 4.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.0 t -123.57 162.35 24.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.222 -1.164 . . . . 0.0 109.927 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.68 ' HE3' ' CD1' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -133.94 132.5 40.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.542 ' N ' ' HE2' ' A' ' 27' ' ' LYS . 1.1 t -128.41 103.68 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 109.789 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -74.16 162.46 28.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG13 HD13 ' A' ' 35' ' ' ILE . 42.6 t -135.16 89.08 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.011 -1.056 . . . . 0.0 108.894 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD13 HG22 ' A' ' 91' ' ' VAL . 7.1 mp -76.56 109.78 10.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.472 ' OD2' ' CA ' ' A' ' 63' ' ' GLY . 44.4 p-10 -173.71 -164.92 0.23 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.895 -1.128 . . . . 0.0 110.123 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 19.6 p -42.9 -64.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.724 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -172.2 -116.19 0.39 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.55 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.6 OUTLIER 156.58 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 p -69.25 151.5 46.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 109.599 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 t -70.94 162.21 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -0.869 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.585 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -166.29 162.7 12.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.8 Cg_endo -79.04 -5.78 14.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.701 2.267 . . . . 0.0 110.349 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -109.56 -17.07 13.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.137 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 67' ' ' ALA . 18.5 mt -100.7 141.29 33.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.267 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -111.8 67.05 0.64 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.104 -0.998 . . . . 0.0 109.229 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 42' ' ' ASN . 31.9 mm -43.06 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.379 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -81.88 -15.82 52.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.238 -0.914 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.599 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -171.28 152.41 18.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 163.79 29.2 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.51 167.61 28.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.544 ' OG ' ' CG2' ' A' ' 56' ' ' THR . 1.5 m -148.81 111.74 4.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 110.156 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 9.0 m-85 -99.02 -40.61 7.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.558 ' HB ' ' NZ ' ' A' ' 92' ' ' LYS . 76.3 t -51.73 120.4 15.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 108.986 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' GLY . 36.8 Cg_endo -79.71 -68.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.618 2.212 . . . . 0.0 111.218 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -33.43 -52.54 0.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -136.66 99.81 10.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.296 . . . . 0.0 109.974 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 36.5 Cg_endo -78.37 -95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.643 2.228 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 82.26 -66.27 0.1 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.041 -1.037 . . . . 0.0 110.39 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.544 ' CG2' ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER 64.5 3.32 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.048 -1.033 . . . . 0.0 110.408 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.452 ' HG2' ' C ' ' A' ' 56' ' ' THR . 78.4 mm-40 -149.75 118.77 6.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.666 -1.271 . . . . 0.0 110.211 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' CB ' ' A' ' 204' ' ' PRO . 8.6 t0 57.27 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.404 -0.81 . . . . 0.0 110.106 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . -127.06 -8.07 4.75 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 63.8 t-20 176.31 -61.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -1.135 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.83 -18.33 0.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -68.13 0.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -1.086 . . . . 0.0 110.029 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.472 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -55.46 -22.83 32.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.473 HG23 ' HD3' ' A' ' 204' ' ' PRO . 56.7 m -72.42 -57.71 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.75 -1.441 . . . . 0.0 109.809 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.59 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.5 t-80 -59.04 -36.11 74.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 70' ' ' ILE . 67.1 t -67.92 -42.81 85.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.406 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.475 ' HB3' HG12 ' A' ' 35' ' ' ILE . . . -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.438 -0.789 . . . . 0.0 110.009 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.61 -40.27 86.04 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.413 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 28.2 m -63.72 -17.28 62.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.399 -1.059 . . . . 0.0 108.727 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 66' ' ' VAL . 36.9 mt -93.85 -22.28 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.439 -0.788 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.509 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -131.59 -52.67 1.0 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 111.228 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' CB ' ' N ' ' A' ' 81' ' ' GLY . . . 33.7 62.84 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.722 -0.611 . . . . 0.0 109.831 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' ' OD1' ' A' ' 42' ' ' ASN . 43.4 mt -43.34 147.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 1.7 m-20 -62.55 155.88 24.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 109.256 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m-20 145.8 129.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 28.5 t -37.03 -30.16 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.293 0.568 . . . . 0.0 109.765 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 75' ' ' ASN . 28.7 pt -84.65 143.54 11.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.92 155.07 0.38 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.458 HG21 ' N ' ' A' ' 80' ' ' LEU . 26.0 m -72.16 -141.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.317 -1.107 . . . . 0.0 109.683 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.496 ' O ' HD11 ' A' ' 8' ' ' ILE . 67.5 tp -138.81 128.07 24.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.089 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.613 ' N ' ' CB ' ' A' ' 72' ' ' ALA . . . -87.08 -177.07 49.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.412 HG11 ' HB3' ' A' ' 13' ' ' ALA . 2.5 t -93.68 -32.35 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -1.232 . . . . 0.0 109.264 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -116.34 98.53 51.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.081 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -83.13 -60.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.812 2.341 . . . . 0.0 110.496 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.538 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -71.71 0.38 8.95 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.671 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 83' ' ' ALA . . . -73.33 161.52 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.852 -1.155 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.51 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 2.1 mp0 -97.99 107.85 20.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.789 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.473 HD23 HD11 ' A' ' 70' ' ' ILE . 2.5 mt -90.47 127.5 36.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.637 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.68 ' CD1' ' HE3' ' A' ' 27' ' ' LYS . 3.6 m-85 -111.99 178.11 4.42 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.014 -1.054 . . . . 0.0 109.943 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.25 90.2 2.5 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -96.1 64.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.216 -0.928 . . . . 0.0 109.111 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 54' ' ' PRO . 3.1 ttpm? -41.06 121.32 1.53 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.33 0.586 . . . . 0.0 109.611 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 94' ' ' LEU . 1.2 t -131.7 3.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.953 . . . . 0.0 109.258 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.529 ' CD1' HG11 ' A' ' 93' ' ' VAL . 2.1 mp -141.29 173.92 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.669 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -98.31 -178.35 32.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.435 ' HA ' HG21 ' A' ' 33' ' ' THR . . . -76.54 -63.07 1.42 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -1.18 . . . . 0.0 109.397 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.3 m -49.77 -29.95 8.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.932 . . . . 0.0 109.235 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.76 47.68 0.89 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -124.58 65.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -1.132 . . . . 0.0 109.852 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.55 38.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.26 160.29 22.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.627 -0.925 . . . . 0.0 109.818 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.78 -18.7 22.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 107' ' ' GLN . 8.7 t -80.47 -14.71 58.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -87.84 -44.08 11.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.589 -0.694 . . . . 0.0 109.16 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.479 HD11 HG23 ' A' ' 105' ' ' ILE . 2.4 mt -76.88 -32.47 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.92 -36.2 59.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 tt0 -70.88 -42.5 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.883 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.54 73.26 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.46 -45.29 72.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -1.106 . . . . 0.0 108.944 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 107' ' ' GLN . 9.9 pt-20 -72.27 -24.18 61.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.426 ' CZ3' HG12 ' A' ' 91' ' ' VAL . 82.7 t90 -69.99 -18.68 63.35 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.625 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.66 -0.69 48.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.322 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.502 ' HA3' ' NH1' ' A' ' 143' ' ' ARG . . . -107.15 -51.73 0.76 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -1.12 . . . . 0.0 109.143 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -120.99 34.65 5.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -102.37 -151.19 23.54 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.718 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.548 ' CE ' ' O ' ' A' ' 116' ' ' GLY . 2.6 mmt -144.14 -157.73 0.81 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.153 0.978 . . . . 0.0 110.965 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.642 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -90.83 -30.6 16.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.896 -178.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.642 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 2.1 t -111.51 154.14 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 119.857 -1.777 . . . . 0.0 110.502 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.437 ' O ' HG12 ' A' ' 147' ' ' VAL . . . -163.39 105.62 0.98 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 0.0 108.908 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.533 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 5.9 m120 -85.45 -178.75 6.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 148' ' ' VAL . 1.1 mp -152.38 100.23 2.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.48 ' N ' HD22 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -85.46 65.47 9.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.35 88.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -109.09 152.13 42.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.185 -1.185 . . . . 0.0 109.252 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.504 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -77.42 -23.43 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.426 2.084 . . . . 0.0 109.45 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -69.38 111.7 9.56 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.806 -0.559 . . . . 0.0 109.906 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.8 Cg_endo -82.66 170.63 12.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.407 2.071 . . . . 0.0 110.326 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.5 p -163.08 110.77 1.23 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.35 -29.49 70.23 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.2 m -58.23 -31.09 67.03 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.455 ' HB2' ' OG ' ' A' ' 130' ' ' SER . 0.5 OUTLIER -71.58 -36.58 70.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -59.44 5.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.81 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.2 OUTLIER -50.52 -23.4 2.47 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 108.723 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.72 -45.43 52.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.591 ' CG2' ' HA ' ' A' ' 166' ' ' ALA . 59.3 t -69.44 -21.68 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 8.4 m120 -62.94 -35.82 81.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -29.46 57.72 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 137' ' ' VAL . . . -75.4 -13.24 60.38 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.1 m -80.52 -44.36 19.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.0 t -64.15 -13.8 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.502 ' NH1' ' HA3' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -96.85 -17.9 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.497 -0.752 . . . . 0.0 109.285 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.45 75.45 0.4 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 36.0 t -124.75 102.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.978 . . . . 0.0 110.48 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.6 tp -62.86 105.84 0.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 168' ' ' ALA . 2.3 t -97.24 156.98 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 110.881 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.533 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -136.36 146.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 163' ' ' ALA . . . -142.87 137.07 29.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.984 -1.073 . . . . 0.0 109.537 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.492 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.73 144.49 54.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.44 ' OG ' ' N ' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -44.0 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 109.434 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 154' ' ' SER . . . 172.66 -22.35 0.07 OUTLIER Glycine 0 N--CA 1.496 2.692 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.821 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' SER . 3.4 p-10 30.74 36.25 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 122.235 -0.568 . . . . 0.0 111.486 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 3.5 t 160.47 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 110.121 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . -165.43 70.57 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.312 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . 45.95 -172.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -1.165 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.2 47.59 3.86 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.44 135.22 17.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.332 -1.099 . . . . 0.0 108.632 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.6 pt -57.9 -179.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.12 170.58 7.87 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.506 1.146 . . . . 0.0 112.599 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.444 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 77.8 m-85 -104.43 139.07 19.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.4 Cg_endo -73.54 -43.94 0.62 Allowed 'Cis proline' 0 C--N 1.295 -2.278 0 O-C-N 123.042 1.022 . . . . 0.0 110.816 3.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 160' ' ' SER . . . 23.13 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.029 0.918 . . . . 0.0 110.057 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -39.88 -63.72 0.56 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.495 0.664 . . . . 0.0 109.791 177.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.567 ' O ' ' CB ' ' A' ' 166' ' ' ALA . 46.7 p90 -106.87 -166.45 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.899 0.856 . . . . 0.0 111.221 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HA ' ' CG2' ' A' ' 137' ' ' VAL . . . 86.39 34.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.926 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.431 ' O ' ' HB ' ' A' ' 147' ' ' VAL . 1.0 OUTLIER 45.92 26.32 0.38 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -110.88 114.4 27.71 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.48 ' HG3' HG21 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -67.82 127.48 32.96 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.011 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.533 ' N ' ' HB2' ' A' ' 191' ' ' ASP . . . -78.53 108.63 12.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.562 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 35.3 t -84.48 163.77 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.847 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.562 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -132.89 -172.78 13.1 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.45 ' O ' ' HB1' ' A' ' 181' ' ' ALA . . . -138.89 143.88 38.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.088 -1.242 . . . . 0.0 109.418 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.464 HG23 ' CE2' ' A' ' 257' ' ' TYR . 43.5 p -108.46 175.02 5.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 1.4 t70 -74.64 -163.93 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 109.665 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -53.56 -29.97 39.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.54 -79.91 0.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.991 . . . . 0.0 110.151 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.451 ' O ' ' ND2' ' A' ' 178' ' ' ASN . 9.5 p-10 -149.63 60.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 1.0 OUTLIER -125.19 162.52 24.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.956 -1.09 . . . . 0.0 109.666 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 7.5 mtp180 -62.56 112.82 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.52 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -43.68 171.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.48 -27.29 12.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 184' ' ' SER . 11.6 p90 -114.63 -21.71 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.998 -1.064 . . . . 0.0 109.804 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.423 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 10.8 t -55.65 126.93 27.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 109.26 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.455 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 27.7 mm-40 -85.23 154.67 21.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -138.81 173.27 11.75 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.161 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 168.01 148.44 5.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -43.55 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -1.112 . . . . 0.0 109.395 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 148.3 -16.38 1.31 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.459 ' CD2' ' O ' ' A' ' 256' ' ' LEU . 12.0 tp -45.97 126.17 7.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -1.127 . . . . 0.0 109.763 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.533 ' HB2' ' N ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -81.27 -62.0 1.78 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.5 ' CG1' ' HB3' ' A' ' 259' ' ' SER . 14.0 tt -155.65 168.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.412 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.57 HG22 ' CD2' ' A' ' 257' ' ' TYR . 3.0 m -122.11 161.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 0.0 110.073 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.585 ' CB ' ' HD2' ' A' ' 195' ' ' PRO . . . -150.09 -172.78 0.33 Allowed Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.585 ' HD2' ' CB ' ' A' ' 194' ' ' ALA . 31.9 Cg_endo -75.48 110.26 3.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.319 1.346 . . . . 0.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -130.25 41.02 1.58 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 26.8 t -142.88 91.58 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.585 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 19.7 t-20 89.34 115.29 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.574 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 2.5 m -173.49 118.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -99.87 142.62 31.11 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.491 0.663 . . . . 0.0 110.214 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.59 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -149.71 -148.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 109.304 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -94.13 158.51 15.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.229 -0.919 . . . . 0.0 110.087 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.601 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -135.4 155.82 78.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.7 Cg_endo -73.62 151.26 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.304 2.003 . . . . 0.0 111.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 30.61 73.15 0.05 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 9.1 t 168.45 -100.55 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.052 -1.263 . . . . 0.0 110.149 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 208' ' ' TYR . 6.5 t -172.41 -142.82 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.555 ' N ' ' CG2' ' A' ' 207' ' ' THR . 0.0 OUTLIER -91.06 157.27 17.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.528 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.28 139.44 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.2 OUTLIER -95.23 133.19 39.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 212' ' ' ASN . 1.1 pp -158.28 164.36 36.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.472 ' O ' HD11 ' A' ' 211' ' ' LEU . 2.0 m-80 -99.85 171.54 7.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 153.59 131.35 1.57 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 151' ' ' SER . 84.4 m -67.62 -25.32 65.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.465 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -68.43 -12.29 60.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.147 -0.971 . . . . 0.0 109.386 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.485 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -77.0 -26.6 54.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 194' ' ' ALA . . . -86.98 0.63 54.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.596 -0.69 . . . . 0.0 109.548 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.599 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 1.8 m -80.44 -45.79 1.34 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.269 -0.895 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 218' ' ' THR . 31.6 Cg_endo -73.48 -18.31 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.735 1.624 . . . . 0.0 110.985 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -70.7 -40.74 72.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.912 -1.118 . . . . 0.0 108.591 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 262' ' ' VAL . 55.8 t -74.35 -39.56 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.81 64.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -73.36 -52.34 8.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -53.15 -64.13 0.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 109.242 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -43.48 -46.13 6.71 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.21 44.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 109.072 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 17.7 mt -56.48 -37.9 70.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 84.3 t -56.58 -63.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.585 ' CD ' ' NE2' ' A' ' 118' ' ' HIS . 1.8 mtpt -48.18 -31.7 6.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 108.893 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.465 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.6 OUTLIER -61.79 -49.3 76.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -5.93 31.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 6.7 p30 -164.44 79.58 1.4 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.402 -0.811 . . . . 0.0 109.685 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 31.98 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.854 2.369 . . . . 0.0 111.149 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -12.15 5.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.78 -1.2 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.65 175.72 9.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.054 -1.029 . . . . 0.0 109.864 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.87 174.66 5.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.684 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.519 ' ND2' ' N ' ' A' ' 237' ' ' ASN . 0.8 OUTLIER -58.04 -28.3 64.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -77.68 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.266 -0.897 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' VAL . 16.1 mt-30 -42.9 -36.23 1.45 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.481 0.657 . . . . 0.0 109.488 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.441 HD12 ' CG ' ' A' ' 229' ' ' LYS . 50.4 mt -68.86 -56.33 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 109.633 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -43.31 -50.17 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 109.906 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -51.06 -60.98 2.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.784 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.468 ' O ' HG22 ' A' ' 247' ' ' THR . 2.5 t60 -55.14 -57.12 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.066 . . . . 0.0 109.822 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.3 -18.46 10.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.477 -0.765 . . . . 0.0 109.95 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER -83.42 -39.71 20.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 109.271 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.69 -30.08 66.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.269 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.5 ' O ' ' C ' ' A' ' 248' ' ' ALA . 1.7 p -78.92 -52.35 8.4 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.18 0.991 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -28.9 116.97 0.11 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 13.9 m -53.32 131.91 38.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.32 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.74 109.99 22.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.41 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.559 HD23 ' CE2' ' A' ' 257' ' ' TYR . 6.1 mp -70.12 -76.31 0.1 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 175.78 31.42 0.04 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.534 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 162.02 40.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 109.423 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.8 p -124.38 8.58 8.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.653 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.41 -70.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 108.852 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 190' ' ' LEU . 0.3 OUTLIER -52.61 -56.81 12.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.523 -0.735 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.57 ' CD2' HG22 ' A' ' 193' ' ' VAL . 27.9 m-85 -90.96 -61.42 1.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.38 -0.825 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.2 -120.69 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.5 ' HB3' ' CG1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -47.27 -44.05 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 108.995 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 249' ' ' THR . . . 110.97 -142.8 16.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -178.06 5.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 192' ' ' ILE . 3.7 t -129.57 146.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.459 -0.775 . . . . 0.0 110.55 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.479 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.02 121.23 1.23 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.42 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 268' ' ' THR . . . -94.23 -12.96 27.13 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.796 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.477 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 1.1 tm-20 -68.84 -15.74 63.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.812 -1.18 . . . . 0.0 109.685 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.25 1.89 39.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -122.82 -17.49 6.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.457 ' O ' ' OXT' ' A' ' 269' ' ' ARG . 0.7 OUTLIER -92.82 -38.88 11.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.776 -1.202 . . . . 0.0 109.364 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.457 ' OXT' ' O ' ' A' ' 268' ' ' THR . 10.2 ptm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.867 -1.064 . . . . 0.0 109.618 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -71.03 166.19 21.88 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.777 ' HB3' ' N ' ' A' ' 80' ' ' LEU . 1.1 m -66.87 103.53 1.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.414 -0.804 . . . . 0.0 109.878 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 170.43 100.21 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 109.22 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 8' ' ' ILE . 36.2 Cg_endo -78.8 174.77 11.79 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.632 2.221 . . . . 0.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.492 ' CZ2' ' HB2' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -48.02 -28.87 3.04 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.511 -0.743 . . . . 0.0 109.924 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.62 -42.16 55.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CG1' ' NE2' ' A' ' 220' ' ' HIS . 34.2 mt -109.57 73.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.923 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -42.32 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -93.68 6.71 47.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG22 ' HB1' ' A' ' 13' ' ' ALA . 15.8 m -98.2 19.71 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 109.647 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.471 ' CB ' ' HB2' ' A' ' 265' ' ' GLU . 34.8 mm-40 47.6 25.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 110.089 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.43 -42.3 83.97 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.9 . . . . 0.0 110.907 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.46 -44.09 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 18' ' ' ASN . . . -46.46 -37.06 7.25 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.67 64.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -64.93 -18.91 65.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.687 -0.633 . . . . 0.0 110.7 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 6.3 p-10 -113.1 -6.63 13.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.743 -1.223 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -83.2 -22.98 33.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.939 -1.1 . . . . 0.0 109.219 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.46 50.33 0.46 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -139.25 179.8 6.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.957 . . . . 0.0 109.968 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 21' ' ' LEU . 1.1 t 157.76 100.09 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . -55.65 0.93 0.09 OUTLIER Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.654 -0.653 . . . . 0.0 111.935 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 85' ' ' ASN . 71.9 m -28.45 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.811 1.306 . . . . 0.0 111.97 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -85.45 35.02 3.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 229' ' ' LYS . 44.1 t -125.78 165.43 23.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.124 -1.221 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 16.5 mttm -135.91 117.42 14.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.481 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG23 ' HB ' ' A' ' 119' ' ' VAL . 13.6 t -128.54 136.26 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.829 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.67 155.56 21.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 89' ' ' TYR . 2.2 t -130.84 85.04 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.132 -0.98 . . . . 0.0 108.953 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.492 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 6.9 mp -70.46 103.96 2.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 33' ' ' THR . 9.2 p30 -148.92 -143.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.234 -0.916 . . . . 0.0 109.152 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 ' O ' ' CG2' ' A' ' 33' ' ' THR . 13.4 t -135.68 79.71 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.035 -1.041 . . . . 0.0 110.054 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.412 ' HA3' ' ND2' ' A' ' 60' ' ' ASN . . . 90.69 120.8 2.3 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.513 HG22 ' CB ' ' A' ' 67' ' ' ALA . 2.8 mt -112.81 -24.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 122.111 0.958 . . . . 0.0 108.654 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 42.1 t 57.3 148.18 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.287 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -93.09 160.25 14.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.595 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -160.78 178.91 1.47 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 109.046 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.9 Cg_endo -78.0 -22.27 10.18 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.402 2.068 . . . . 0.0 110.183 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 74.9 m-20 -97.22 -55.14 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.336 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.476 HD22 ' HA2' ' A' ' 68' ' ' GLY . 17.4 mt -55.22 156.9 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.91 63.87 1.53 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 0.0 109.205 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 43' ' ' ILE . 7.4 mm -49.96 115.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.526 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -104.85 -8.13 18.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.99 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -174.13 177.12 46.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.15 158.65 19.65 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.468 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 49' ' ' PHE . . . -152.98 162.49 41.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.69 -0.888 . . . . 0.0 108.833 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.468 ' HB3' ' HE2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -132.99 109.74 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.494 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 1.9 m-85 -107.61 -44.17 4.33 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.317 -0.864 . . . . 0.0 109.025 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.533 HG11 ' N ' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -41.33 151.53 0.29 Allowed Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.533 ' N ' HG11 ' A' ' 50' ' ' VAL . 30.0 Cg_endo -69.81 171.22 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.427 2.085 . . . . 0.0 111.005 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.63 -42.2 2.91 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp0 43.7 58.31 12.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.933 . . . . 0.0 111.058 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.2 Cg_endo -79.46 -71.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.511 2.141 . . . . 0.0 109.472 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.4 p -168.61 135.2 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 t -79.03 0.97 25.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.029 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.37 106.68 12.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER 65.72 174.74 0.22 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 0.0 109.861 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 115.15 15.76 7.61 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.571 ' ND2' ' N ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -160.71 -71.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.985 . . . . 0.0 109.049 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.86 8.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -73.65 -57.19 4.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -1.22 . . . . 0.0 109.925 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.22 72.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.1 m -69.16 -40.91 77.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.496 ' CG ' HD13 ' A' ' 211' ' ' LEU . 27.1 t-80 -66.56 -53.16 37.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 69' ' ' THR . 39.4 t -58.99 -35.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 109.712 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.513 ' CB ' HG22 ' A' ' 35' ' ' ILE . . . -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 110.235 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 72' ' ' ALA . . . -70.16 -44.94 58.49 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.964 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 66' ' ' VAL . 12.3 t -64.46 -16.83 63.13 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.989 -1.301 . . . . 0.0 108.975 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.475 ' CG1' ' CB ' ' A' ' 219' ' ' PRO . 78.7 mt -93.02 -24.91 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.593 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -133.93 -43.1 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.879 -1.138 . . . . 0.0 110.902 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.593 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . 8.05 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.106 0.479 . . . . 0.0 111.636 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 22.2 mt -42.27 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.971 -1.081 . . . . 0.0 109.57 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.543 ' HB2' ' CD1' ' A' ' 80' ' ' LEU . 43.8 t30 -113.71 106.44 14.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.554 ' ND2' HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -154.64 -100.63 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 109.605 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.7 p -132.06 -32.6 1.39 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.347 -0.846 . . . . 0.0 110.147 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.554 HG12 ' ND2' ' A' ' 75' ' ' ASN . 27.9 pt -91.31 138.11 20.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.073 -1.017 . . . . 0.0 110.302 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 3' ' ' SER . . . 60.13 158.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.529 ' HA ' ' OG ' ' A' ' 3' ' ' SER . 5.6 m -70.19 -160.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.563 -0.963 . . . . 0.0 109.465 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.777 ' N ' ' HB3' ' A' ' 3' ' ' SER . 4.5 tp -135.15 131.35 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.429 -0.794 . . . . 0.0 110.241 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -77.43 -145.71 2.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.96 -28.47 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.93 -1.335 . . . . 0.0 109.051 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -110.68 125.91 29.86 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.46 -61.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.417 2.078 . . . . 0.0 110.875 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.526 ' CB ' ' OG ' ' A' ' 24' ' ' SER . 1.2 m-20 -103.36 39.88 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.504 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 24' ' ' SER . . . -83.4 168.46 16.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.008 -1.058 . . . . 0.0 109.6 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 72.8 mt-10 -113.6 92.42 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 70' ' ' ILE . 7.8 mt -97.13 135.81 38.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 109.635 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.493 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 27.7 m-85 -104.14 155.84 18.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.84 102.58 11.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 109.257 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -100.5 68.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.188 -0.945 . . . . 0.0 109.068 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.506 ' HG3' ' HA ' ' A' ' 33' ' ' THR . 19.4 ttpt -36.61 103.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.345 0.593 . . . . 0.0 110.275 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 31' ' ' LEU . 1.4 t -115.48 -20.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 108.798 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.29 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.402 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 33' ' ' THR . . . -91.18 179.21 42.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.532 ' HB3' ' CB ' ' A' ' 60' ' ' ASN . . . -78.34 -19.65 53.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -1.189 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 t -116.05 -25.46 7.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.67 80.21 0.38 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.38 76.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -1.103 . . . . 0.0 109.375 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.85 -179.61 22.05 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.93 162.84 24.99 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.742 -0.858 . . . . 0.0 109.094 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' OG ' ' A' ' 130' ' ' SER . 58.2 t -68.67 -19.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 43.0 t -78.75 -19.86 51.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.0 m -79.2 -52.86 7.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.419 ' HA ' HG23 ' A' ' 93' ' ' VAL . 1.3 mt -63.47 -25.2 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.34 78.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.642 -0.661 . . . . 0.0 109.423 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -71.51 -32.39 68.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.987 -1.071 . . . . 0.0 108.991 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.63 -31.08 70.56 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.66 -25.18 21.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.18 -1.188 . . . . 0.0 110.384 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.63 -26.04 23.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -63.54 -22.15 66.73 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.605 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -86.78 -22.43 25.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -62.41 -43.64 98.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 1.8 p-10 -85.18 -38.64 18.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 31.5 m-20 -146.14 85.02 1.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.605 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -115.32 -165.33 14.62 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.474 ' HE3' ' O ' ' A' ' 116' ' ' GLY . 15.0 mmt -139.0 178.78 6.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.548 -0.972 . . . . 0.0 110.138 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.495 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.7 m170 -57.95 -39.99 79.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.557 -0.714 . . . . 0.0 110.732 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.465 ' HB ' HG23 ' A' ' 28' ' ' VAL . 19.0 t -130.56 167.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.861 -1.149 . . . . 0.0 111.104 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.35 114.78 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 222' ' ' ALA . 10.7 m120 -100.3 151.13 21.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.903 -1.123 . . . . 0.0 110.708 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.422 HD11 ' C ' ' A' ' 121' ' ' ASN . 6.9 mp -118.11 110.72 17.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.8 t -82.68 71.74 9.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 108.918 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.17 -174.14 2.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.351 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.527 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . 168.62 79.69 0.04 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -95.24 155.82 38.43 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.331 -1.099 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.41 -11.79 18.92 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.516 2.144 . . . . 0.0 109.571 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -83.27 115.54 59.68 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.619 -0.675 . . . . 0.0 109.442 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.58 167.92 21.98 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.258 1.972 . . . . 0.0 110.107 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 102' ' ' VAL . 11.0 m -155.98 117.24 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.07 -20.8 65.87 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.2 m -69.32 -26.95 64.96 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.8 mp -78.35 -36.21 46.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -38.25 69.0 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.167 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -67.52 -22.61 65.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.87 -32.71 40.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.576 -0.85 . . . . 0.0 108.748 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.29 -26.38 17.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.87 -35.35 80.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 m -79.65 -23.8 42.3 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.83 60.39 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.5 m -79.57 -34.47 40.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.941 . . . . 0.0 108.628 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -56.98 -28.04 61.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.83 -13.51 16.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.21 78.44 0.59 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.1 t -127.3 92.03 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -1.138 . . . . 0.0 110.155 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tp -57.02 120.53 8.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 108.599 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -107.56 152.07 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 110.22 -178.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.475 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 0.9 OUTLIER -141.62 103.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.42 150.33 21.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.06 -1.025 . . . . 0.0 110.412 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.535 ' CB ' ' OG1' ' A' ' 218' ' ' THR . . . -78.31 172.84 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.506 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -77.84 -79.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.0 109.254 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.75 -111.77 0.35 Allowed Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -176.3 28.72 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 29.3 t -128.36 -99.4 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.905 . . . . 0.0 109.73 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.39 55.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.32 -178.2 4.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 109.301 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.61 38.92 2.66 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -166.44 155.38 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -1.178 . . . . 0.0 108.672 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -97.52 -172.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.868 -1.145 . . . . 0.0 110.751 -179.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.527 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -80.43 163.77 23.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.172 0.987 . . . . 0.0 112.108 -177.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.432 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.2 m-85 -112.43 132.34 22.2 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.6 Cg_endo -73.97 -42.77 0.78 Allowed 'Cis proline' 0 C--N 1.299 -2.077 0 O-C-N 123.139 1.073 . . . . 0.0 111.041 3.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.508 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . 21.34 -73.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.869 0.843 . . . . 0.0 110.122 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -46.49 -71.59 0.07 Allowed 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.645 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.8 m-85 27.41 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.834 1.302 . . . . 0.0 113.03 178.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.5 -0.35 2.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -124.41 21.83 8.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 147' ' ' VAL . . . -157.88 169.87 23.63 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.491 -0.755 . . . . 0.0 108.968 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.452 ' HB3' ' CG ' ' A' ' 191' ' ' ASP . 1.0 OUTLIER -111.48 157.82 19.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.69 129.91 54.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 31.2 t -91.86 164.63 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.894 -1.129 . . . . 0.0 109.459 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.77 -171.69 12.9 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -120.75 164.93 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.415 HG21 ' HA ' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -133.39 173.81 11.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.34 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 0.3 OUTLIER -85.36 -152.0 0.15 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 177' ' ' ASN . 5.1 pt20 -84.96 -29.91 24.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.416 ' N ' ' HG3' ' A' ' 176' ' ' GLN . 53.4 m-20 -96.33 -97.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.962 . . . . 0.0 109.947 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.77 19.23 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 0.0 109.856 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 3.1 t-20 -72.47 -151.96 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 109.087 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.541 ' HB2' ' CE2' ' A' ' 257' ' ' TYR . 22.3 ttp85 -132.93 16.64 4.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 58.39 164.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.735 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 t -121.2 -4.64 9.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.953 . . . . 0.0 109.914 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.565 ' O ' ' CG ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -106.4 29.13 7.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 109.832 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 185' ' ' GLN . 41.6 t -111.85 119.35 38.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 184' ' ' SER . 0.0 OUTLIER -43.89 113.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 109.176 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -113.71 168.15 10.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.915 . . . . 0.0 109.319 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.48 178.72 42.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.73 111.42 17.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 129.36 9.06 3.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.474 HD21 ' O ' ' A' ' 256' ' ' LEU . 14.2 tp -64.24 143.76 57.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.944 -1.327 . . . . 0.0 109.251 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 19.1 t70 -91.6 -70.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 261' ' ' LEU . 13.0 tt -140.81 169.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.838 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 260' ' ' GLY . 29.2 m -120.17 162.82 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -158.48 165.52 18.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.492 ' HB2' ' CZ2' ' A' ' 6' ' ' TRP . 34.8 Cg_endo -77.09 115.99 4.1 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.465 2.11 . . . . 0.0 110.475 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.44 24.25 3.74 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.66 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 55.4 t -102.96 68.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -1.066 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.66 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.7 OUTLIER 110.33 122.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.072 0.939 . . . . 0.0 108.597 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.548 ' CG1' ' O ' ' A' ' 198' ' ' ASN . 2.5 m -170.84 113.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -101.67 168.15 9.65 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.7 0.762 . . . . 0.0 110.125 -179.401 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 200' ' ' GLN . 4.3 m -168.32 -156.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.35 172.08 13.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.641 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -152.98 160.59 30.77 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -71.34 164.01 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.285 1.99 . . . . 0.0 110.655 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.7 82.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.99 34.43 5.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -1.056 . . . . 0.0 109.373 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -126.76 160.33 31.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.288 -0.882 . . . . 0.0 109.852 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.93 169.42 8.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.3 164.01 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.78 -1.2 . . . . 0.0 110.961 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.9 OUTLIER -123.34 124.17 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.496 HD13 ' CG ' ' A' ' 65' ' ' HIS . 2.1 mt -119.73 161.27 21.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.927 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 212' ' ' ASN . 1.1 p-10 -134.05 107.6 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -161.6 151.24 21.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.1 m -70.83 -21.89 62.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -1.114 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -72.24 -13.27 61.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.135 -0.978 . . . . 0.0 109.095 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.5 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -81.7 -13.52 57.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.724 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -88.9 -1.49 58.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.985 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.636 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 1.1 m -75.83 -40.5 3.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.254 -0.904 . . . . 0.0 111.379 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.6 Cg_endo -72.32 -12.95 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.698 1.599 . . . . 0.0 111.242 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.569 ' NE2' ' CG1' ' A' ' 8' ' ' ILE . 18.1 m80 -77.17 -51.45 10.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.044 -1.035 . . . . 0.0 108.507 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.476 HG23 HG23 ' A' ' 262' ' ' VAL . 98.8 t -63.07 -41.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.526 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -57.15 -40.42 77.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.805 . . . . 0.0 109.11 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.478 ' O ' ' HB1' ' A' ' 226' ' ' ALA . . . -59.18 -51.43 59.22 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 227' ' ' LEU . . . -53.2 -51.99 60.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.25 . . . . 0.0 110.021 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.07 -32.99 56.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.374 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' A' ' 223' ' ' GLY . . . -63.55 -40.77 97.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.102 -0.999 . . . . 0.0 108.821 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 224' ' ' ALA . 54.3 mt -59.06 -51.31 70.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.823 . . . . 0.0 109.565 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' LYS . 76.3 t -57.54 -55.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 109.922 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.495 ' HD3' ' ND1' ' A' ' 118' ' ' HIS . 4.1 ttmm -42.28 -42.4 3.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.479 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -61.84 -48.09 82.13 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -57.22 -17.05 9.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.165 -0.96 . . . . 0.0 108.951 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.529 ' HB3' ' CD2' ' A' ' 235' ' ' TRP . 2.3 m120 -172.45 90.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.696 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.1 -38.58 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.75 2.3 . . . . 0.0 110.66 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 235' ' ' TRP . 0.0 OUTLIER -47.42 -46.16 26.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 110.215 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.529 ' CD2' ' HB3' ' A' ' 232' ' ' ASN . 47.4 m0 -45.3 170.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.081 -1.012 . . . . 0.0 110.063 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.11 176.85 4.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.731 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -54.21 -20.08 6.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.956 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.432 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.4 t -78.33 -65.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.14 -0.975 . . . . 0.0 109.461 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 235' ' ' TRP . 1.0 OUTLIER -44.39 -43.17 7.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 241' ' ' ARG . 6.1 mt -59.65 -55.3 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -42.4 -35.81 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 110.435 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 245' ' ' LYS . 29.2 t-20 -72.55 -40.21 66.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.49 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.499 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.9 OUTLIER -70.47 -47.08 62.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.879 -1.138 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.45 -28.65 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.444 -0.785 . . . . 0.0 110.844 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.555 ' CG ' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -73.36 -48.99 29.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 109.903 -179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.555 ' N ' ' CG ' ' A' ' 245' ' ' LYS . 7.8 t-20 -74.06 -22.39 59.56 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.674 -0.641 . . . . 0.0 111.04 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 9.1 p -84.47 -32.2 24.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.791 -1.193 . . . . 0.0 109.95 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.52 130.28 44.35 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.74 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 250' ' ' SER . 2.4 m -48.48 164.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 249' ' ' THR . 49.0 m -129.15 97.8 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 5.8 mp -57.21 -50.97 71.17 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.69 42.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 1.4 t -174.14 -172.87 0.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.82 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.9 t -147.55 13.22 1.05 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -122.45 -78.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.474 ' O ' HD21 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -59.3 -66.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.541 ' CE2' ' HB2' ' A' ' 180' ' ' ARG . 38.0 m-85 -76.2 -12.3 60.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 59.42 -154.3 30.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 250' ' ' SER . 6.0 t -44.92 -25.72 0.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.268 -1.137 . . . . 0.0 109.222 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 192' ' ' ILE . . . 125.49 -132.6 8.04 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -100.62 177.83 4.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -1.105 . . . . 0.0 109.309 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.476 HG23 HG23 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -111.41 156.86 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.414 ' CG ' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -170.75 121.08 0.57 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 122.35 1.071 . . . . 0.0 108.197 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.04 -17.61 59.58 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.031 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.471 ' HB2' ' CB ' ' A' ' 12' ' ' GLN . 29.5 tt0 -65.54 -43.2 90.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.049 . . . . 0.0 109.146 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.98 -13.98 62.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.265 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.474 ' HA ' HG23 ' A' ' 247' ' ' THR . . . -110.81 12.7 22.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 269' ' ' ARG . 4.4 p -119.23 -39.02 2.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.482 ' HG3' ' OXT' ' A' ' 269' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.914 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.363 0.601 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' O ' ' A' ' 3' ' ' SER . 0.9 OUTLIER -66.37 176.0 2.0 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.682 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 5.2 t -54.68 -158.38 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.682 ' CG2' ' O ' ' A' ' 3' ' ' SER . 2.5 m 59.95 41.25 0.53 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.939 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HD2' ' HB ' ' A' ' 8' ' ' ILE . 37.5 Cg_endo -82.24 -169.29 0.73 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.976 1.784 . . . . 0.0 110.454 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CG ' ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -32.92 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -83.08 -69.26 1.39 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.693 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 19.7 mm -33.57 90.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 122.042 -0.681 . . . . 0.0 110.323 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER 155.67 -55.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.442 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 17.7 tpp85 -75.42 -17.47 60.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.485 -0.759 . . . . 0.0 109.448 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.4 m -88.62 23.3 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 20.8 mm100 49.66 41.35 21.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.208 -0.933 . . . . 0.0 109.92 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.27 -33.02 0.52 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -73.63 -55.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 N-CA-C 108.528 -1.374 . . . . 0.0 108.528 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -42.36 -33.15 0.6 Allowed 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -72.18 -49.3 36.65 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 2.2 m170 -69.09 -6.05 25.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.06 -55.36 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.44 -27.85 2.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 109.158 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.32 23.38 2.92 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.533 HD23 ' CG2' ' A' ' 268' ' ' THR . 0.3 OUTLIER -67.17 173.13 4.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.179 -1.189 . . . . 0.0 109.34 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.533 ' HA ' ' HG3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -163.06 -35.55 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 110.553 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CG2' ' A' ' 26' ' ' VAL . . . 73.68 -5.34 23.84 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.1 OUTLIER -44.0 134.08 4.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.132 -1.216 . . . . 0.0 109.665 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 7.92 56.04 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.591 ' CG1' ' NE2' ' A' ' 118' ' ' HIS . 27.0 t -107.86 164.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -1.217 . . . . 0.0 109.246 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 2.0 mptt -145.01 118.25 8.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.0 110.32 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.426 HG11 HG13 ' A' ' 119' ' ' VAL . 2.5 t -125.92 128.01 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.3 159.97 23.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -134.43 87.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.78 -1.2 . . . . 0.0 109.794 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' CG2' ' A' ' 91' ' ' VAL . 10.0 mp -66.74 126.17 28.15 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -177.79 -146.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.704 -1.247 . . . . 0.0 109.961 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.524 ' OG1' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -137.61 72.57 1.42 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.023 -1.048 . . . . 0.0 110.654 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 64' ' ' THR . . . 111.87 118.38 3.69 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.416 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 36' ' ' SER . 3.9 mm -115.26 -18.87 7.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.675 0.75 . . . . 0.0 109.11 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 33.0 104.61 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.818 0.818 . . . . 0.0 111.483 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -58.61 147.66 31.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 108.692 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.519 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -146.13 177.14 1.87 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.314 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 38' ' ' HIS . 33.6 Cg_endo -76.33 -4.95 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.215 1.943 . . . . 0.0 109.626 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 73' ' ' LEU . 2.6 t0 -114.97 -22.53 9.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.166 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.36 122.75 39.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -97.36 103.38 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 108.65 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 44' ' ' ARG . 3.9 mt -89.68 163.48 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.074 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.547 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 6.9 tpt180 -135.88 -32.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -163.51 161.94 34.53 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.44 165.71 36.75 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.971 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.44 165.02 17.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.522 -0.987 . . . . 0.0 109.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -126.53 142.07 51.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -116.38 -53.01 2.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.385 -0.822 . . . . 0.0 109.776 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.603 HG13 ' HA2' ' A' ' 98' ' ' GLY . 81.1 t -57.3 125.54 71.45 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 108.724 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -74.96 176.49 9.84 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.425 2.084 . . . . 0.0 111.31 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' C ' ' HD3' ' A' ' 54' ' ' PRO . . . 120.78 10.15 7.16 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.638 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.5 tt0 54.26 44.99 2.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.498 -1.001 . . . . 0.0 111.163 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.648 ' O ' ' CB ' ' A' ' 55' ' ' SER . 36.5 Cg_endo -78.55 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.917 1.745 . . . . 0.0 110.432 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 69.3 m 117.13 135.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.434 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 8.8 t -56.6 -14.63 3.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.134 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' O ' ' O ' ' A' ' 58' ' ' ASP . 47.7 mt-30 -108.92 143.5 38.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 57' ' ' GLN . 40.8 t0 61.34 136.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.462 -0.774 . . . . 0.0 110.392 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.27 -39.39 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.1 -35.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -1.031 . . . . 0.0 108.927 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.84 -16.97 4.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -68.31 -58.06 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 109.296 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -61.76 6.28 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLY . 3.3 m -45.82 -41.13 10.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -1.109 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.58 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 5.2 t-80 -58.83 -56.81 17.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.733 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 70' ' ' ILE . 41.8 t -55.45 -35.08 36.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.64 -44.74 85.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.719 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 72' ' ' ALA . . . -75.15 -21.38 78.19 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.566 HG22 ' CE1' ' A' ' 220' ' ' HIS . 15.7 m -81.47 -11.51 59.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 108.166 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 66' ' ' VAL . 38.4 mt -103.51 -28.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -156.71 11.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.622 -1.299 . . . . 0.0 112.323 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB3' ' CA ' ' A' ' 68' ' ' GLY . . . -40.01 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.691 -1.256 . . . . 0.0 110.626 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 71' ' ' ALA . 9.7 mt -45.76 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.881 -1.137 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 6.8 t-20 -92.74 155.23 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.451 -0.781 . . . . 0.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 9.0 p-10 154.43 124.71 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 75' ' ' ASN . 22.8 t -41.59 -27.26 0.09 Allowed 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.869 -0.519 . . . . 0.0 109.734 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.8 pt -83.52 68.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 208' ' ' TYR . . . 123.36 146.93 7.2 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 201' ' ' SER . 10.2 m -64.31 -149.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.522 HD11 ' CA ' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -158.06 141.34 15.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.474 ' N ' ' HB1' ' A' ' 72' ' ' ALA . . . -97.86 -144.6 17.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.513 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 0.5 OUTLIER -91.48 -72.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 0.0 109.896 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -63.04 144.08 97.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.533 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 37.3 Cg_endo -86.69 -64.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.369 2.046 . . . . 0.0 110.113 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 21.6 t-20 -105.76 -87.08 0.47 Allowed 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.001 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 54.79 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.105 -0.997 . . . . 0.0 110.08 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 7.6 mt-10 -95.49 107.71 19.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 71' ' ' ALA . 5.5 mt -92.91 106.56 18.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 109.974 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.581 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 14.2 m-85 -87.88 153.86 20.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.534 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' CB ' HG13 ' A' ' 35' ' ' ILE . . . -119.0 108.92 15.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.791 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.524 ' CG2' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -111.32 65.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.989 . . . . 0.0 110.214 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' VAL . 14.5 ttmm -38.83 114.5 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -143.38 21.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 120.97 -1.081 . . . . 0.0 111.327 -177.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.568 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 22.6 mt -150.29 168.55 23.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.241 -1.537 . . . . 0.0 111.77 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 94' ' ' LEU . . . -46.34 -166.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.022 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 97' ' ' SER . . . 62.38 13.73 6.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER 150.77 -13.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.603 ' HA2' HG13 ' A' ' 50' ' ' VAL . . . -113.73 -100.27 2.4 Favored Glycine 0 N--CA 1.477 1.395 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.481 ' HB2' ' HA2' ' A' ' 95' ' ' GLY . 1.5 t 52.35 68.96 0.74 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.75 178.54 16.42 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.734 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.0 t -68.17 179.5 1.54 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.419 0.628 . . . . 0.0 109.407 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.562 ' CG2' ' OG ' ' A' ' 130' ' ' SER . 48.4 t -66.02 -14.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 m -75.07 -22.67 58.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.73 -53.34 4.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 109.261 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.484 ' HA ' HG21 ' A' ' 93' ' ' VAL . 2.3 mt -62.15 -45.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 102' ' ' VAL . . . -63.18 -47.28 83.31 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -52.23 -39.26 60.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.862 . . . . 0.0 109.442 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.28 39.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 109' ' ' LEU . 12.9 mt -66.03 -11.05 45.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -1.116 . . . . 0.0 109.12 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.9 -25.7 15.34 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.334 -0.854 . . . . 0.0 109.45 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -72.98 -15.15 61.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.617 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -96.22 -11.82 25.5 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.947 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -84.46 -26.2 40.24 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 115' ' ' ASN . 3.8 m120 -123.3 28.84 6.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 108.999 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER 162.73 32.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.617 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -102.98 -147.54 18.97 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.552 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 6.0 mmt -134.9 -178.74 5.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.614 -0.933 . . . . 0.0 109.779 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.634 ' CD2' ' O ' ' A' ' 27' ' ' LYS . 10.7 p80 -66.0 -40.37 91.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.78 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.588 HG22 ' CE1' ' A' ' 118' ' ' HIS . 55.5 t -120.57 165.6 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.833 -1.167 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.544 ' N ' ' CG1' ' A' ' 119' ' ' VAL . . . -169.02 132.08 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.467 ' O ' ' CD1' ' A' ' 122' ' ' LEU . 4.9 t-20 -90.34 167.85 12.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.792 -1.192 . . . . 0.0 109.785 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.562 ' CG ' HD13 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -149.54 105.24 3.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.98 . . . . 0.0 109.041 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 9.6 m -96.2 68.77 2.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 108.985 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.562 HD13 ' CG ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -111.35 -165.94 1.03 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.259 1.028 . . . . 0.0 110.091 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.42 105.03 1.51 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.482 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -168.91 172.76 2.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.251 . . . . 0.0 109.84 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.497 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 34.8 Cg_endo -79.15 4.66 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.796 2.331 . . . . 0.0 109.916 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.588 ' N ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -117.83 44.09 0.49 Allowed Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.556 -0.715 . . . . 0.0 111.464 -178.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.598 ' HB2' ' CE1' ' A' ' 161' ' ' TYR . 37.5 Cg_endo -76.42 173.71 14.03 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.951 1.767 . . . . 0.0 110.532 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.562 ' OG ' ' CG2' ' A' ' 102' ' ' VAL . 3.0 m -149.65 131.5 15.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.31 66.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.442 ' HB ' HG13 ' A' ' 102' ' ' VAL . 3.3 m -66.28 -29.94 70.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.462 HD12 HG21 ' A' ' 105' ' ' ILE . 0.6 OUTLIER -69.17 -35.22 76.06 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -63.37 -51.11 67.26 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HA ' ' OD1' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -48.56 -26.49 2.23 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 133' ' ' LEU . . . -69.53 -45.67 68.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.921 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.472 HG22 ' CZ ' ' A' ' 165' ' ' TYR . 0.9 OUTLIER -62.95 -30.31 49.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 135' ' ' GLN . 21.6 m120 -60.33 -36.2 77.42 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.2 p -78.85 -22.54 45.95 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.14 54.41 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.096 -1.002 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 -46.53 16.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.038 -1.039 . . . . 0.0 108.747 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -29.98 8.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -86.2 -33.21 20.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.891 . . . . 0.0 109.092 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.76 61.93 1.49 Allowed Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.492 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 43.9 t -108.79 99.7 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.482 -1.01 . . . . 0.0 109.874 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.1 tp -58.52 111.03 1.1 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.942 -1.099 . . . . 0.0 108.079 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -115.02 137.25 49.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 110.278 -178.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 121' ' ' ASN . 1.5 p -113.92 150.92 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 163' ' ' ALA . . . -134.3 144.4 48.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.962 -1.087 . . . . 0.0 110.422 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -57.79 152.74 15.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 109.8 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -59.15 -73.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.051 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 138.8 121.7 1.94 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -99.79 55.1 0.94 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.525 ' OG ' ' HG2' ' A' ' 185' ' ' GLN . 0.0 OUTLIER -91.53 -86.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.841 . . . . 0.0 109.774 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.427 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 146.3 83.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 179.64 176.65 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.374 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.59 43.19 3.19 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.5 OUTLIER -158.79 166.25 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -1.072 . . . . 0.0 108.83 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.536 HG12 ' CA ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -106.44 -174.48 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 109.666 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -71.33 157.84 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.817 0.818 . . . . 0.0 110.174 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -115.17 138.14 23.37 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 103.906 -2.628 . . . . 0.0 103.906 176.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.71 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.5 Cg_endo -72.64 -49.9 0.21 Allowed 'Cis proline' 0 C--N 1.295 -2.272 0 O-C-N 122.967 0.983 . . . . 0.0 111.826 4.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.522 ' HA ' ' CB ' ' A' ' 149' ' ' ALA . . . 36.21 -77.91 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -41.61 -55.23 2.98 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.625 ' CZ ' ' CG ' ' A' ' 162' ' ' PRO . 0.3 OUTLIER 46.9 -178.88 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.26 -16.73 12.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.432 ' OD1' HG12 ' A' ' 137' ' ' VAL . 30.0 p-10 -129.44 13.8 6.04 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -127.22 157.28 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.453 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -105.45 159.31 16.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.061 -1.024 . . . . 0.0 110.093 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -111.47 116.37 30.78 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.5 t -81.84 167.42 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -134.93 -165.57 10.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -143.48 137.99 28.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.934 -1.333 . . . . 0.0 110.666 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 p -109.15 168.58 9.27 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.412 ' HB2' ' HA ' ' A' ' 181' ' ' ALA . 4.2 t70 -95.61 -40.14 9.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.29 1.043 . . . . 0.0 109.804 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -152.27 -103.62 0.05 Allowed 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -62.01 -48.85 78.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.722 -1.236 . . . . 0.0 107.72 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.545 ' CB ' HD23 ' A' ' 251' ' ' LEU . 0.5 OUTLIER 173.73 68.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 2.1 t-20 -97.03 -11.74 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.772 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.572 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 1.7 ttp180 82.07 12.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.366 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.471 ' HB3' ' CE1' ' A' ' 183' ' ' PHE . . . 53.97 -159.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.499 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.02 30.7 3.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.61 ' N ' ' CD1' ' A' ' 183' ' ' PHE . 1.0 OUTLIER -152.36 -28.2 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.1 -1.0 . . . . 0.0 110.691 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -45.41 124.17 4.67 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.809 -1.182 . . . . 0.0 109.277 179.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.525 ' HG2' ' OG ' ' A' ' 154' ' ' SER . 1.3 mp0 -75.98 149.45 37.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.155 -0.966 . . . . 0.0 111.048 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.57 ' CZ ' HD21 ' A' ' 256' ' ' LEU . 0.8 OUTLIER -68.09 -174.73 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.488 0.661 . . . . 0.0 110.67 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.536 ' CA ' HG12 ' A' ' 159' ' ' ILE . . . -173.27 150.24 11.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -83.11 68.9 9.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -1.051 . . . . 0.0 109.005 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 118.56 41.71 0.61 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 189' ' ' GLY . 7.7 tp -41.22 150.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.469 -1.018 . . . . 0.0 109.283 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.473 ' O ' ' OG ' ' A' ' 259' ' ' SER . 0.5 OUTLIER -90.64 -60.85 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.542 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.508 HD12 ' CG2' ' A' ' 262' ' ' VAL . 14.3 tt -155.5 171.23 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 109.566 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 27.2 m -127.92 160.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.038 -1.039 . . . . 0.0 109.964 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -152.69 132.82 7.38 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -71.61 121.11 7.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.609 1.539 . . . . 0.0 110.283 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.27 61.23 0.55 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 50.1 t -102.08 66.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -1.186 . . . . 0.0 108.483 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASN . . . . . 0.65 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 2.2 t-20 111.48 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 6' ' ' TRP . 11.8 m -159.37 111.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 122.273 1.035 . . . . 0.0 108.77 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.3 pm0 -87.61 124.83 33.93 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.495 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . 0.58 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -135.85 -156.17 0.69 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.633 -0.667 . . . . 0.0 109.253 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 34.8 p -77.06 -177.92 4.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.042 0.925 . . . . 0.0 110.586 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' TYR . . . . . 0.609 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -156.94 151.83 21.07 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.4 Cg_endo -69.83 164.47 34.49 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.996 1.797 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 75.26 12.27 83.64 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 72.34 33.18 1.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.623 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -120.48 171.2 8.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.758 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.419 ' CE2' ' HA2' ' A' ' 78' ' ' GLY . 87.6 m-85 -122.73 176.2 6.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . 176.91 175.38 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.654 -1.279 . . . . 0.0 110.782 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -135.07 131.07 36.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.527 -0.733 . . . . 0.0 109.419 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.412 HD21 ' C ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -148.01 108.06 4.05 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.969 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.442 ' HB3' ' N ' ' A' ' 198' ' ' ASN . 18.8 p30 -63.87 169.4 4.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.389 -0.82 . . . . 0.0 108.908 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 156.69 7.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.39 -35.85 61.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.202 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -14.09 19.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 109.642 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' MET . . . . . 0.458 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -90.54 -24.01 20.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.899 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -89.52 -7.63 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 109.417 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.627 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 13.4 m -71.95 -41.52 9.03 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 111.505 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 218' ' ' THR . 30.1 Cg_endo -73.27 -21.08 20.51 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.699 1.599 . . . . 0.0 110.923 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.566 ' CE1' HG22 ' A' ' 69' ' ' THR . 3.8 m80 -64.34 -42.08 96.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.72 -47.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -46.89 -35.36 6.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -70.77 -56.08 7.67 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -46.62 -41.51 14.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.948 -1.325 . . . . 0.0 109.444 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.7 99.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 108.809 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.1 -45.54 75.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.502 HD23 ' CD2' ' A' ' 21' ' ' LEU . 42.4 mt -59.21 -50.58 73.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 95.7 t -56.0 -49.06 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.973 -1.079 . . . . 0.0 109.57 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.611 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.5 OUTLIER -48.54 -42.97 34.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.519 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLN . . . . . 0.489 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.15 -45.52 93.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.911 -1.118 . . . . 0.0 109.574 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.414 ' HE3' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.59 -10.11 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.222 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 231' ' ' LYS . 5.0 m-80 -174.19 72.93 0.34 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.4 Cg_endo -79.39 -0.84 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.638 2.225 . . . . 0.0 110.735 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 42.4 m -84.1 -3.76 58.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.143 -0.973 . . . . 0.0 109.842 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' TRP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 239' ' ' GLN . 31.6 m0 -81.89 176.24 9.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.188 -0.945 . . . . 0.0 109.938 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.7 OUTLIER -103.47 159.57 15.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' SER . 6.6 p30 -45.28 -37.17 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.102 . . . . 0.0 109.826 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.8 t -72.74 -62.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.224 -0.922 . . . . 0.0 110.163 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 3.6 tp60 -41.22 -50.15 3.6 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.567 0.698 . . . . 0.0 109.483 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 229' ' ' LYS . 20.9 mt -57.07 -48.84 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.52 -0.737 . . . . 0.0 109.377 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -47.16 -38.56 12.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.76 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 22.9 t-20 -67.43 -38.13 84.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 109.743 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' HIS . . . . . 0.462 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.9 t60 -64.85 -43.97 91.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.826 . . . . 0.0 110.442 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.65 -29.89 56.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 -178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -78.87 -23.72 44.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 1.6 t30 -95.98 -17.87 20.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 2.6 p -90.46 -30.51 17.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.781 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.27 160.82 1.03 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.3 m -88.88 111.39 22.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.104 -0.998 . . . . 0.0 109.706 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -84.97 116.12 23.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.378 -0.826 . . . . 0.0 108.951 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.545 HD23 ' CB ' ' A' ' 178' ' ' ASN . 6.1 mp -65.53 -72.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.058 -1.026 . . . . 0.0 109.53 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.18 28.84 0.1 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.29 145.84 34.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.228 -1.16 . . . . 0.0 109.333 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 43.3 p -131.95 6.72 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.405 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -114.58 -21.11 10.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.573 HD11 ' CD1' ' A' ' 257' ' ' TYR . 2.7 tm? -117.46 -70.08 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.344 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.573 ' CD1' HD11 ' A' ' 256' ' ' LEU . 87.1 m-85 -63.27 -23.69 67.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.45 -98.28 0.27 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 191' ' ' ASP . 0.3 OUTLIER -84.07 -39.83 19.08 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.253 -1.146 . . . . 0.0 108.94 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 100.45 -122.1 7.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.7 161.25 17.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.813 -0.816 . . . . 0.0 108.804 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.508 ' CG2' HD12 ' A' ' 192' ' ' ILE . 1.5 t -119.54 154.41 22.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 110.289 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -151.12 117.46 5.66 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.206 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.48 ' O ' ' HB ' ' A' ' 268' ' ' THR . . . -82.33 6.01 18.35 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.796 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 67.1 tt0 -94.54 -23.96 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.723 -1.236 . . . . 0.0 109.264 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -95.99 -16.73 21.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.167 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -98.53 -13.91 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' THR . . . . . 0.533 ' CG2' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -117.49 -9.85 10.77 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.055 -1.028 . . . . 0.0 109.066 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 268' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.73 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.389 0.614 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.659 HG12 ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -132.38 153.71 81.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.799 . . . . 0.0 109.384 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.659 ' HD2' HG12 ' A' ' 4' ' ' VAL . 35.5 Cg_endo -77.68 171.94 16.6 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.857 2.371 . . . . 0.0 111.119 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.7 OUTLIER -52.14 -19.06 1.73 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.542 -0.724 . . . . 0.0 110.473 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -63.16 -52.25 48.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.726 ' O ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -83.9 -20.21 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -1.223 . . . . 0.0 109.662 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -64.34 -26.39 68.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.91 -1.118 . . . . 0.0 109.658 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 22.1 ttm105 -96.32 -0.66 49.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 110.627 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 8' ' ' ILE . 3.2 m -99.77 17.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.585 -1.322 . . . . 0.0 110.29 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' A' ' 265' ' ' GLU . 0.9 OUTLIER 39.91 45.81 1.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.56 -0.713 . . . . 0.0 109.827 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.713 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.22 -27.28 0.34 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.0 Cg_endo -74.28 -56.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.847 -1.251 . . . . 0.0 108.847 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 19' ' ' ARG . . . -43.76 -31.63 0.86 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.98 -43.9 51.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.683 ' ND1' HD21 ' A' ' 80' ' ' LEU . 6.3 m170 -66.85 -15.5 63.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -0.787 . . . . 0.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -96.25 -24.82 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 0.0 109.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -69.15 -32.04 71.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.73 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.65 -16.67 5.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 144.58 56.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -1.147 . . . . 0.0 109.179 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -133.53 1.5 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.023 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.449 ' C ' ' HG3' ' A' ' 230' ' ' GLN . . . 57.57 6.49 2.46 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 22' ' ' THR . 1.4 t -66.49 134.01 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.371 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.57 -4.74 37.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 27' ' ' LYS . 28.2 t -98.97 170.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -1.167 . . . . 0.0 109.275 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -140.46 128.85 22.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.894 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.658 HG13 ' CG1' ' A' ' 119' ' ' VAL . 1.9 t -133.97 134.88 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.761 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -92.35 154.51 18.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.23 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -127.56 87.0 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.983 -1.073 . . . . 0.0 108.768 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.66 HD12 ' HB ' ' A' ' 91' ' ' VAL . 5.5 mp -65.27 95.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 20.9 p-10 -144.93 -144.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.737 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -145.04 27.78 1.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.107 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.06 119.8 0.9 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.61 ' CG1' ' HB2' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -103.96 11.54 8.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.948 -0.736 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER 51.84 126.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.994 0.902 . . . . 0.0 111.17 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.84 115.36 10.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.003 -1.06 . . . . 0.0 108.882 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.538 ' NE2' ' HA ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -145.24 157.34 53.4 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.0 Cg_endo -78.52 0.96 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.702 2.268 . . . . 0.0 110.378 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.09 -15.95 14.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.103 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 202' ' ' THR . 0.3 OUTLIER -114.13 119.07 35.84 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 108.841 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -96.64 105.08 17.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 43' ' ' ILE . 1.7 mm -69.47 112.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.335 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.446 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 2.4 mmt85 -100.26 -19.78 16.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.173 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 156.71 28.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . -177.1 140.45 4.9 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.981 -1.305 . . . . 0.0 110.021 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.45 126.82 14.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -1.086 . . . . 0.0 109.297 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -104.3 116.53 32.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.134 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CD2' ' OE1' ' A' ' 107' ' ' GLN . 42.3 m-85 -104.1 -57.0 2.1 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.19 -0.944 . . . . 0.0 109.828 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.86 HG23 ' HD2' ' A' ' 51' ' ' PRO . 1.5 p -42.06 148.88 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.86 ' HD2' HG23 ' A' ' 50' ' ' VAL . 29.2 Cg_endo . . . . . 0 C--N 1.311 -1.421 0 C-N-CA 122.035 1.824 . . . . 0.0 109.986 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.36 0.6 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -15.39 18.44 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.36 -0.837 . . . . 0.0 108.767 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 2.4 mp0 -128.67 112.24 14.03 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 13.8 t70 83.31 157.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.498 0.666 . . . . 0.0 109.768 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.96 -20.92 0.51 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.737 ' ND2' HG23 ' A' ' 33' ' ' THR . 0.4 OUTLIER -145.22 -83.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.617 -0.931 . . . . 0.0 108.899 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 64' ' ' THR . . . 159.55 -54.48 0.35 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 215' ' ' SER . 30.0 t-80 -46.31 -57.79 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 110.159 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -38.43 -57.58 1.81 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.532 ' CB ' ' HB3' ' A' ' 36' ' ' SER . 0.6 OUTLIER -51.13 -47.5 61.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -1.143 . . . . 0.0 109.434 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.59 ' CE1' ' CB ' ' A' ' 201' ' ' SER . 2.0 t60 -52.08 -55.84 18.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.325 -0.86 . . . . 0.0 109.473 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 219' ' ' PRO . 39.9 t -53.51 -34.01 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . . . -58.85 -55.56 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.222 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.38 75.54 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.732 HG21 ' O ' ' A' ' 216' ' ' MET . 21.4 m -73.84 -18.54 60.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 108.122 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 219' ' ' PRO . 4.9 mt -98.85 -30.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.624 ' CB ' ' HB3' ' A' ' 83' ' ' ALA . . . -170.13 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 112.101 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 81' ' ' GLY . . . -44.87 121.27 2.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.661 -1.274 . . . . 0.0 108.607 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 84' ' ' PRO . 17.0 mt -43.74 151.91 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.982 . . . . 0.0 110.532 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 46.5 t-20 -105.69 64.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.0 109.412 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.584 ' O ' ' CB ' ' A' ' 76' ' ' SER . 86.0 m-20 -94.53 -1.36 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.504 -0.748 . . . . 0.0 110.098 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 5.0 t 91.18 -34.47 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -85.51 133.5 29.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.88 -175.63 45.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 201' ' ' SER . 5.1 m -76.01 -174.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.2 -1.177 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.683 HD21 ' ND1' ' A' ' 17' ' ' HIS . 1.6 tp -141.0 113.58 8.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.306 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.86 ' H ' ' HB3' ' A' ' 72' ' ' ALA . . . -76.49 -165.74 21.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 6.8 t -80.28 -32.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.281 . . . . 0.0 109.453 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HB3' ' CB ' ' A' ' 71' ' ' ALA . . . -104.6 148.12 35.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.056 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' CG ' ' O ' ' A' ' 22' ' ' THR . 37.9 Cg_endo -84.87 -63.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 110.383 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 5.9 m-20 -113.92 -87.64 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.324 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 85' ' ' ASN . . . 59.8 170.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.449 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.446 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 26.0 mm-40 -93.38 85.51 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 2.7 mt -79.28 109.88 14.04 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.446 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 3.2 m-85 -91.18 -177.35 4.86 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.951 0.881 . . . . 0.0 110.448 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -147.28 96.09 2.65 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.761 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -99.81 78.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -51.88 89.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.576 HG13 ' HG ' ' A' ' 94' ' ' LEU . 12.6 p -98.72 -23.69 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 108.929 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.576 ' HG ' HG13 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -111.84 162.95 14.73 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.49 152.81 17.95 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.172 -1.193 . . . . 0.0 109.04 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -76.44 174.64 10.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.641 -0.917 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.684 HG11 ' CB ' ' A' ' 130' ' ' SER . 5.2 t -68.62 -18.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -73.87 -18.37 60.93 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 93' ' ' VAL . 19.0 m -88.07 -52.29 5.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.501 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.3 mt -62.27 -30.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.0 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 132' ' ' THR . . . -75.52 -50.9 14.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 108.981 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.584 ' OE1' ' CD2' ' A' ' 49' ' ' PHE . 2.7 pp0? -61.82 -23.93 66.55 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 109.552 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.17 -36.62 20.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.602 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . 15.0 mt -80.37 -13.8 58.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 108.973 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -97.13 -32.88 11.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -67.56 -21.29 65.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.791 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -86.21 -19.37 30.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -55.54 -34.13 59.81 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 114' ' ' ASN . 0.1 OUTLIER -101.95 -61.7 1.35 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.464 -1.021 . . . . 0.0 109.161 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.455 ' O ' ' SD ' ' A' ' 117' ' ' MET . 1.3 m-20 -104.16 40.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 108.921 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.791 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -94.23 21.05 44.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.599 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 41.14 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.527 -0.984 . . . . 0.0 110.428 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.884 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -85.53 -22.14 28.26 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 111.239 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.884 HG23 ' CE1' ' A' ' 118' ' ' HIS . 83.5 t -129.38 165.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.327 -1.483 . . . . 0.0 110.232 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.63 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -166.7 128.1 1.7 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.611 ' OD1' HG13 ' A' ' 148' ' ' VAL . 50.8 t30 -105.8 153.68 21.56 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.57 -1.331 . . . . 0.0 110.128 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.769 HD13 ' CG1' ' A' ' 147' ' ' VAL . 5.0 mp -135.84 92.82 2.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 62.01 7.21 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.258 -0.901 . . . . 0.0 108.72 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 124' ' ' LEU . 4.0 pp -147.64 173.74 12.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.659 ' N ' HD12 ' A' ' 124' ' ' LEU . . . -176.92 97.45 0.11 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 2.4 m -96.52 146.71 31.78 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.63 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.1 Cg_endo -77.37 -5.38 15.59 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.474 2.116 . . . . 0.0 109.359 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.5 t -98.54 107.64 43.6 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.756 -0.59 . . . . 0.0 110.224 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 33.0 Cg_endo -76.97 165.83 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.01 1.807 . . . . 0.0 109.609 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.684 ' CB ' HG11 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -170.69 132.78 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.654 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.92 65.72 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.426 HG22 ' CB ' ' A' ' 106' ' ' ALA . 64.4 m -63.88 -31.99 73.36 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 133' ' ' LEU . 13.9 tp -75.85 -34.86 60.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -30.32 68.05 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.386 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 135' ' ' GLN . 4.0 tp60 -70.33 -25.61 63.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -75.9 -48.69 20.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.049 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.073 HG21 ' HB1' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -63.25 -26.46 40.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.3 -36.75 85.03 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.0 t -77.62 -17.77 57.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.887 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.52 -38.11 22.18 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.686 -1.259 . . . . 0.0 111.248 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.802 -1.186 . . . . 0.0 108.571 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -25.32 67.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -112.62 -16.58 12.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.126 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.46 84.99 1.16 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.95 105.23 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -1.028 . . . . 0.0 108.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.81 118.75 8.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.871 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.769 ' CG1' HD13 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -112.94 139.28 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.216 -0.928 . . . . 0.0 109.14 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 222' ' ' ALA . 14.5 p -127.17 68.14 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.918 -1.114 . . . . 0.0 110.114 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -52.63 156.51 1.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.076 -1.015 . . . . 0.0 110.95 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.45 -174.57 5.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.6 -0.688 . . . . 0.0 110.032 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.3 OUTLIER -91.95 -85.09 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.836 -0.54 . . . . 0.0 109.78 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -178.61 -114.29 0.41 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 154' ' ' SER . 0.4 OUTLIER 177.72 34.51 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER 87.06 102.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.321 0.581 . . . . 0.0 109.537 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -172.0 95.75 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 66.07 171.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -1.166 . . . . 0.0 109.647 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.78 51.9 4.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 0.8 OUTLIER -148.96 170.31 18.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -1.168 . . . . 0.0 109.645 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.11 -171.47 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.0 110.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.523 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -62.42 176.04 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.582 1.182 . . . . 0.0 112.186 -178.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 126' ' ' SER . 8.8 m-85 -128.73 127.6 23.5 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.8 Cg_endo -72.33 -45.73 0.43 Allowed 'Cis proline' 0 C--N 1.301 -1.944 0 O-C-N 123.14 1.074 . . . . 0.0 110.726 3.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . . . 27.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.158 0.98 . . . . 0.0 109.645 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.742 ' N ' ' O ' ' A' ' 162' ' ' PRO . 7.0 ttt180 -39.35 -60.25 0.95 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.758 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 55.0 p90 -120.02 -164.66 1.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 1.073 ' HB1' HG21 ' A' ' 137' ' ' VAL . . . 85.98 26.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.775 0.797 . . . . 0.0 109.011 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 55.01 20.26 3.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.32 131.67 51.41 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.44 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 4.4 mtp -76.19 151.49 36.89 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.34 129.21 55.73 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 192' ' ' ILE . 32.1 t -100.17 165.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 109.235 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.07 167.66 24.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -96.17 168.91 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' ' 194' ' ' ALA . 13.5 p -135.64 178.79 6.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 109.5 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 176' ' ' GLN . 14.2 t0 -108.41 -142.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.771 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 175' ' ' ASP . 12.0 tt0 -35.45 -63.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.988 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -122.16 -60.93 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.838 -1.164 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -138.77 -19.7 1.03 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.033 -1.042 . . . . 0.0 111.224 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -47.17 164.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.767 -1.208 . . . . 0.0 109.338 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -69.93 132.86 46.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.332 -0.855 . . . . 0.0 109.729 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -55.72 -154.25 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 m -117.15 -27.34 6.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -119.62 14.04 12.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.716 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 1.9 t -77.41 142.36 39.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.144 -0.973 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 158' ' ' SER . 12.2 tt0 -90.69 166.15 13.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -141.65 173.53 11.42 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 -179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.646 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.62 -178.63 48.39 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.11 68.06 5.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -1.178 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.77 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.469 HD21 ' CG1' ' A' ' 193' ' ' VAL . 3.2 tp -72.75 142.54 48.14 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.067 -1.255 . . . . 0.0 109.521 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 8.4 t0 -101.67 -57.34 2.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.728 HG22 HG22 ' A' ' 171' ' ' VAL . 3.8 tt -151.25 -178.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.6 HG22 ' CA ' ' A' ' 260' ' ' GLY . 6.0 m -149.66 -179.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.314 -0.867 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -175.01 172.78 1.1 Allowed Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 30.8 Cg_endo -72.0 116.55 4.75 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.067 1.845 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.94 44.69 1.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.646 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 40.6 t -124.45 54.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -1.092 . . . . 0.0 108.415 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.646 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 24.3 t-20 127.36 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 211' ' ' LEU . 22.7 m -160.33 105.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-O 122.32 1.057 . . . . 0.0 109.689 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -80.96 135.87 35.94 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.811 ' HA ' HG21 ' A' ' 79' ' ' VAL . 1.3 t -149.05 -157.09 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.597 HG21 HD21 ' A' ' 41' ' ' LEU . 5.0 t -84.02 176.18 9.02 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.983 0.896 . . . . 0.0 110.758 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.666 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -162.7 155.55 16.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.666 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.7 Cg_endo -70.41 161.99 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.008 1.805 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 81.71 15.04 76.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.538 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 5.5 m 68.8 35.17 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.674 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -133.89 161.8 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 110.366 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 201' ' ' SER . 0.0 OUTLIER -114.56 170.23 8.46 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.19 151.26 17.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.775 -1.203 . . . . 0.0 110.281 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -106.97 146.13 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.129 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.75 ' O ' HG22 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -152.99 162.31 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 7.6 p-10 -125.16 141.29 52.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.086 -1.009 . . . . 0.0 109.736 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.512 ' N ' ' SD ' ' A' ' 216' ' ' MET . . . 166.38 167.8 27.59 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -85.78 -17.53 35.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -1.092 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.569 ' O ' ' CD ' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -65.08 -39.46 93.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.46 -0.775 . . . . 0.0 109.118 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.732 ' O ' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -68.87 -44.96 72.22 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.051 0.929 . . . . 0.0 109.84 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -68.81 -19.65 64.29 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.861 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.632 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 28.6 m -64.5 -52.36 53.24 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.737 -1.227 . . . . 0.0 111.086 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -66.38 -9.88 25.55 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.864 1.709 . . . . 0.0 110.656 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.566 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -71.55 -39.24 70.79 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 1.071 HG22 HG21 ' A' ' 262' ' ' VAL . 47.0 t -76.63 -34.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.757 ' HB2' HG11 ' A' ' 148' ' ' VAL . . . -58.43 -39.1 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -71.4 -50.07 22.81 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -45.92 -51.46 13.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -1.194 . . . . 0.0 108.604 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -41.47 72.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -51.57 -49.57 61.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.117 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 227' ' ' LEU . 39.3 mt -54.63 -45.08 73.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 76.2 t -54.99 -65.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.539 ' CG ' HD11 ' A' ' 240' ' ' ILE . 0.0 OUTLIER -43.39 -37.71 2.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.21 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.449 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 9.8 tm0? -57.86 -57.01 14.66 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.083 -1.01 . . . . 0.0 109.897 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -54.23 -19.13 4.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.204 -0.935 . . . . 0.0 108.905 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.492 ' N ' ' HG3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -140.7 86.43 12.06 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.249 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.97 -2.93 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.677 2.251 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -10.81 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -73.73 178.49 4.76 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.73 173.62 8.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.253 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.24 -20.1 25.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.1 t -79.89 -65.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.969 -1.082 . . . . 0.0 109.106 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.1 mp0 -46.86 -34.68 5.59 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.539 HD11 ' CG ' ' A' ' 229' ' ' LYS . 24.0 mt -65.8 -48.33 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -50.25 -34.8 24.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.868 -1.145 . . . . 0.0 108.978 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 239' ' ' GLN . 10.0 t-20 -62.89 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.883 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 247' ' ' THR . 2.9 t60 -48.11 -51.47 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.907 . . . . 0.0 110.434 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.522 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.3 OUTLIER -63.17 -27.22 69.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 110.894 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 61.9 tttt -73.31 -52.04 15.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.024 -1.047 . . . . 0.0 110.228 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 14.0 t-20 -78.73 -10.11 59.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 110.454 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 243' ' ' HIS . 25.5 p -94.42 -37.41 11.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.893 -1.129 . . . . 0.0 110.121 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -64.82 136.1 56.51 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.401 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 259' ' ' SER . 15.5 m -45.93 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 108.913 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 0.7 OUTLIER -145.4 87.07 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 110.131 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 257' ' ' TYR . 5.8 mp . . . . . 0 C--N 1.306 -1.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.584 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.401 0.62 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.513 ' HB3' ' HB2' ' A' ' 251' ' ' LEU . 31.7 m-85 -88.78 -77.43 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.494 -0.754 . . . . 0.0 110.211 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 42.9 90.41 0.01 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 250' ' ' SER . 1.8 m 61.37 103.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.937 -1.331 . . . . 0.0 107.967 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.6 ' CA ' HG22 ' A' ' 193' ' ' VAL . . . -139.74 -27.09 0.24 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.371 -1.395 . . . . 0.0 111.651 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 261' ' ' LEU . 0.3 OUTLIER -104.24 146.62 28.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.335 -1.686 . . . . 0.0 108.949 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 1.071 HG21 HG22 ' A' ' 221' ' ' VAL . 1.6 t -117.68 155.2 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.98 . . . . 0.0 110.056 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.45 117.38 2.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.537 1.16 . . . . 0.0 107.942 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -12.67 61.85 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.975 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.492 ' HG2' ' NH1' ' A' ' 269' ' ' ARG . 11.5 tt0 -66.73 -41.33 88.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.004 -1.06 . . . . 0.0 109.137 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.485 ' HA ' ' NH2' ' A' ' 269' ' ' ARG . . . -82.38 -14.0 55.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -93.45 -16.41 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.183 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 269' ' ' ARG . 74.0 p -118.11 -60.46 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 265' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.573 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 24.6 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.321 0.581 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.28 81.89 30.41 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.023 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HD2' HG13 ' A' ' 8' ' ' ILE . 33.7 Cg_endo -77.7 159.84 31.51 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.621 2.214 . . . . 0.0 111.347 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CZ3' ' O ' ' A' ' 176' ' ' GLN . 2.6 p-90 -57.88 -26.3 61.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.683 -0.635 . . . . 0.0 110.573 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 8' ' ' ILE . . . -89.33 53.88 3.86 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.476 HG13 ' HD2' ' A' ' 5' ' ' PRO . 14.6 mm -151.55 -50.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 109.517 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -80.26 -13.02 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.42 -28.8 61.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 8' ' ' ILE . 2.8 m -88.61 24.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 1.0 OUTLIER 50.14 45.76 25.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.678 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -82.85 -32.3 0.55 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 111.774 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -74.31 -55.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.18 -28.45 0.77 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.61 -41.98 36.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 109.239 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -66.27 -24.25 66.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.524 -0.735 . . . . 0.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -92.73 -31.04 15.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.604 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -30.09 56.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.612 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.638 ' C ' HD23 ' A' ' 21' ' ' LEU . . . 121.46 19.63 3.43 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.869 ' CD1' HG21 ' A' ' 268' ' ' THR . 3.2 mt -101.9 120.62 40.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -1.151 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -97.98 -24.59 15.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.294 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' A' ' 230' ' ' GLN . . . 69.35 -1.31 13.35 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 p -71.74 117.73 13.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.116 -1.226 . . . . 0.0 109.389 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.13 -16.54 4.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 27' ' ' LYS . 19.1 t -89.75 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.218 -1.166 . . . . 0.0 109.395 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.571 ' N ' HG12 ' A' ' 26' ' ' VAL . 25.9 mttp -138.89 122.75 17.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.736 HG22 ' HB ' ' A' ' 119' ' ' VAL . 61.5 t -127.04 127.49 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -85.12 151.31 24.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.969 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 30' ' ' VAL . 35.2 t -115.14 78.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.983 HD23 HG21 ' A' ' 93' ' ' VAL . 5.6 mp -71.72 114.88 10.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 123' ' ' SER . 5.5 m-20 -175.75 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.513 1.149 . . . . 0.0 108.898 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 60' ' ' ASN . 7.5 p -141.97 -73.59 0.31 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.593 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -160.18 -129.04 1.01 Allowed Glycine 0 C--N 1.3 -1.437 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.687 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 1.4 mm -170.82 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 204' ' ' PRO . 1.1 m -46.68 129.89 11.36 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 109.202 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.74 104.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.637 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -130.52 151.52 78.79 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 109.005 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -12.39 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.555 2.17 . . . . 0.0 110.377 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 8.8 m-20 -88.21 -31.51 19.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.637 HD12 ' HB2' ' A' ' 38' ' ' HIS . 5.0 mt -89.34 115.79 27.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.4 t-20 -78.37 104.28 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 108.747 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 44' ' ' ARG . 1.4 mt -96.02 -177.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.632 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.1 tpt85 -152.69 -39.47 0.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -175.96 166.94 38.43 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.36 174.83 45.6 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.794 -1.416 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -170.1 153.15 4.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.389 -1.065 . . . . 0.0 109.816 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 1.4 p -121.02 142.01 50.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.008 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE2' ' CA ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -126.0 -26.88 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.0 111.187 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.931 HG23 ' CB ' ' A' ' 104' ' ' SER . 1.1 t -42.14 -51.86 10.1 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.855 -1.153 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 39.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 C-N-CA 123.144 2.563 . . . . 0.0 109.704 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.479 0.657 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -103.93 9.84 36.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.45 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 35.9 mt-30 -117.3 116.21 26.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 65.47 148.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.689 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 138.1 -6.4 3.4 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' OD1' ' HB2' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -142.21 -78.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.088 -1.242 . . . . 0.0 109.922 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.18 -47.11 1.0 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.267 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.488 ' NE2' ' CE ' ' A' ' 216' ' ' MET . 14.6 t-160 -56.36 -61.3 2.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 0.0 110.268 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -41.25 -41.92 3.06 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 25.6 m -61.25 -47.32 86.57 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.276 -1.132 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.482 ' CD2' ' CB ' ' A' ' 201' ' ' SER . 0.2 OUTLIER -55.14 -50.26 69.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 219' ' ' PRO . 30.1 t -60.03 -32.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.131 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . . . -58.49 -46.28 87.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 109.776 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.653 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -74.3 -25.75 69.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.868 HG21 ' HG2' ' A' ' 219' ' ' PRO . 83.1 m -79.31 -9.63 59.63 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.916 -1.344 . . . . 0.0 108.293 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.664 ' CG2' HD21 ' A' ' 88' ' ' LEU . 17.3 mt -106.46 -26.78 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.351 -0.843 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . . . -165.3 21.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.69 -1.257 . . . . 0.0 111.727 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.91 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . -41.53 127.77 3.09 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.918 -1.114 . . . . 0.0 109.322 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 84' ' ' PRO . 60.2 mt -58.98 163.14 3.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 74' ' ' ASN . 2.0 p-10 -118.91 72.85 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.553 -0.717 . . . . 0.0 109.206 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -116.79 -117.8 0.32 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.245 -0.909 . . . . 0.0 108.978 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 p -129.33 -48.71 1.19 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 109.52 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -90.59 69.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.203 -0.936 . . . . 0.0 109.832 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.47 158.1 13.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 201' ' ' SER . 33.7 m -69.33 -153.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -1.203 . . . . 0.0 109.388 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 74' ' ' ASN . 14.4 tp -151.47 118.41 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.941 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.91 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -98.68 -149.73 25.09 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG12 HD11 ' A' ' 227' ' ' LEU . 2.3 t -103.13 -38.05 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.303 . . . . 0.0 109.045 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -93.86 135.1 25.22 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CG ' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.94 -63.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.613 2.208 . . . . 0.0 111.103 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -119.07 47.5 1.66 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.91 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -80.93 164.38 22.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.097 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.502 ' OE1' ' CD ' ' A' ' 44' ' ' ARG . 40.1 mm-40 -85.61 104.24 15.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.664 HD21 ' CG2' ' A' ' 70' ' ' ILE . 6.3 mt -96.53 116.74 29.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 11.5 m-85 -97.4 156.01 16.65 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.632 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . . . -123.47 101.18 7.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.431 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -102.58 160.14 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.904 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 2.0 tttt -116.93 111.16 19.24 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.432 -0.793 . . . . 0.0 109.415 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.983 HG21 HD23 ' A' ' 31' ' ' LEU . 12.1 t -115.25 -28.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.392 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.608 HD11 HD22 ' A' ' 124' ' ' LEU . 3.1 mp -132.74 175.05 9.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 110.017 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.36 170.9 39.53 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.528 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.243 . . . . 0.0 108.9 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.07 162.86 13.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.748 -0.854 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.25 -15.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -19.73 57.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.931 ' CB ' HG23 ' A' ' 50' ' ' VAL . 60.6 p -87.98 -47.62 8.4 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.773 0.797 . . . . 0.0 109.094 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.543 HG23 HG11 ' A' ' 93' ' ' VAL . 2.2 mt -68.35 -34.13 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.91 -39.35 51.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.588 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 6.5 tt0 -70.52 -31.31 68.35 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.065 -1.022 . . . . 0.0 109.07 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.589 ' CA ' ' CE2' ' A' ' 49' ' ' PHE . . . -75.11 -39.49 37.16 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.4 mt -66.57 -33.13 74.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -1.088 . . . . 0.0 109.692 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 -17.98 23.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.421 ' HB2' ' O ' ' A' ' 107' ' ' GLN . 80.1 t90 -73.15 -18.02 61.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -90.85 6.72 43.28 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.223 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -96.99 -46.89 2.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.29 -80.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.147 -1.208 . . . . 0.0 108.274 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -95.83 62.56 2.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.728 ' CA ' ' HE3' ' A' ' 117' ' ' MET . . . -122.34 -161.21 11.19 Favored Glycine 0 C--N 1.286 -2.205 0 CA-C-O 122.575 1.097 . . . . 0.0 112.034 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.728 ' HE3' ' CA ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -126.41 162.87 24.58 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.446 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.415 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.736 ' HB ' HG22 ' A' ' 28' ' ' VAL . 2.5 t -105.91 156.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.837 -1.164 . . . . 0.0 109.611 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.2 121.34 1.69 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.723 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.786 ' C ' HD12 ' A' ' 122' ' ' LEU . 15.0 t30 -98.48 158.32 15.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.071 -1.018 . . . . 0.0 109.954 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.786 HD12 ' C ' ' A' ' 121' ' ' ASN . 7.0 mp -138.02 101.77 4.51 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 32' ' ' ASP . 20.6 p -85.53 62.11 7.27 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.608 HD22 HD11 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -143.9 178.87 7.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.433 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.587 ' CA ' ' CB ' ' A' ' 160' ' ' SER . . . 165.65 107.96 0.21 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.97 154.43 48.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.98 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.528 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 33.4 Cg_endo -77.18 -3.84 14.15 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.517 2.144 . . . . 0.0 109.195 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.408 ' O ' ' CE1' ' A' ' 161' ' ' TYR . 2.7 t -103.99 101.04 23.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 35.7 Cg_endo -77.95 166.03 25.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.335 2.023 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -153.73 125.21 7.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.65 66.56 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 15.5 m -67.08 -28.8 68.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.677 HD22 ' CE2' ' A' ' 161' ' ' TYR . 0.3 OUTLIER -70.37 -36.62 74.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -65.94 -58.44 5.54 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.431 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 134' ' ' GLU . 2.4 tp-100 -42.12 -28.13 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' GLU . . . -74.96 -49.61 19.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.707 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -33.14 46.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -61.61 -39.58 91.76 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -71.08 -22.94 62.04 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.99 -2.23 47.36 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.002 -1.062 . . . . 0.0 110.187 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -95.34 -34.16 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 108.859 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 64.4 m -66.1 -24.4 66.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 108.86 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -88.79 -13.1 40.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -0.821 . . . . 0.0 109.325 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.26 71.13 1.0 Allowed Glycine 0 C--N 1.302 -1.36 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 84.9 t -112.99 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.448 -1.03 . . . . 0.0 109.499 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.421 HD23 HG13 ' A' ' 119' ' ' VAL . 5.0 tp -60.48 100.81 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.094 -1.003 . . . . 0.0 108.772 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.519 HG12 HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -104.11 140.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.22 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.16 125.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 108.879 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -105.18 146.85 28.66 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.995 -1.066 . . . . 0.0 110.431 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -81.45 169.66 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.56 -68.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 143.23 121.63 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 154' ' ' SER . 12.7 p-10 -86.7 33.35 0.65 Allowed 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.756 -0.849 . . . . 0.0 109.917 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER 162.33 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.31 -103.4 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.56 -168.66 2.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.7 44.89 3.3 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -159.66 150.16 19.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -1.198 . . . . 0.0 109.045 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.404 HG12 ' H ' ' A' ' 159' ' ' ILE . 2.2 pt -80.85 176.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.39 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.939 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -108.66 163.44 13.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 111.823 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.677 ' CE2' HD22 ' A' ' 133' ' ' LEU . 10.2 p90 -89.89 146.06 34.49 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 164' ' ' ARG . 44.0 Cg_endo -71.37 -26.6 8.09 Favored 'Cis proline' 0 C--N 1.297 -2.179 0 O-C-N 122.404 0.687 . . . . 0.0 110.722 4.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.939 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.73 -178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -77.4 -47.55 19.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.719 -1.238 . . . . 0.0 110.011 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -48.0 -171.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.316 1.055 . . . . 0.0 110.906 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.23 1.34 12.45 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.736 -0.602 . . . . 0.0 110.104 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.68 18.98 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.147 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -168.24 161.56 12.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.9 mmm -104.2 138.71 40.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.591 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -100.75 127.1 47.3 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.528 -0.732 . . . . 0.0 109.294 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.4 t -98.55 165.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.189 -0.944 . . . . 0.0 109.717 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -135.39 -158.0 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -144.74 147.01 32.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.925 -1.338 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.34 155.69 25.78 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 4.2 p-10 -59.63 -160.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 109.664 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.53 ' O ' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -45.65 -67.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.465 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -102.12 -57.81 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.369 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.2 OUTLIER -176.17 106.63 0.08 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.403 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.693 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 1.1 t30 -136.65 -39.13 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.693 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 13.5 ttt180 116.51 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.692 0.758 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -39.24 161.32 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.185 0.516 . . . . 0.0 109.638 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -119.86 -49.09 2.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 0.0 110.475 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.504 ' CE2' ' OG1' ' A' ' 214' ' ' THR . 31.3 p90 -49.49 -21.41 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 214' ' ' THR . 1.6 t -69.94 117.2 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.015 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -57.54 116.94 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CG ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -121.41 167.8 12.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.528 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -165.34 -166.61 24.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.34 64.11 7.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.14 -1.212 . . . . 0.0 109.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 170.81 33.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' ASP . 5.3 tp -79.27 102.2 8.45 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.04 -1.271 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 24.4 t70 -41.79 -67.83 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 110.277 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.694 HD11 ' O ' ' A' ' 261' ' ' LEU . 3.9 tt -157.77 169.98 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.199 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 260' ' ' GLY . 7.9 m -108.76 162.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.695 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 1.02 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -152.88 -176.68 0.61 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 1.02 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.3 Cg_endo -78.15 115.48 3.75 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.771 1.648 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -144.09 18.48 2.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.627 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 10.3 t -109.14 55.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 108.729 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 199' ' ' VAL . 20.4 t-20 131.19 121.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 198' ' ' ASN . 16.4 m -164.63 111.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.94 0.876 . . . . 0.0 108.724 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 7.2 pt20 -99.68 125.2 45.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.728 ' HA ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -130.85 -166.57 1.71 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 109.304 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -83.5 172.96 11.89 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.655 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -147.5 165.36 19.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.655 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.5 Cg_endo -71.27 164.48 35.59 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.085 1.857 . . . . 0.0 110.533 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 92.0 -54.73 2.93 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 9.5 p 141.39 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -137.93 -178.37 5.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.934 -1.104 . . . . 0.0 110.371 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.536 ' N ' ' OG1' ' A' ' 207' ' ' THR . 36.7 m-85 -106.37 -160.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -172.97 163.04 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.987 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 42.3 p -151.72 108.55 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 108.875 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.87 160.74 39.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.719 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.85 133.22 55.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -169.09 148.54 12.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 173' ' ' ALA . 32.9 m -72.64 -31.44 65.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -1.186 . . . . 0.0 109.302 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.518 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 16.8 t -67.74 -9.18 41.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.488 ' CE ' ' NE2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -86.22 -22.26 27.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.898 . . . . 0.0 109.877 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.729 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -84.65 -17.31 39.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.654 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 32.9 m -62.87 -42.76 79.88 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 111.904 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.868 ' HG2' HG21 ' A' ' 69' ' ' THR . 30.2 Cg_endo -71.27 -13.47 30.86 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.575 1.517 . . . . 0.0 110.277 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.625 ' CE1' HG23 ' A' ' 69' ' ' THR . 8.4 m80 -72.42 -40.08 67.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.09 -39.29 74.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.78 -45.58 67.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -62.4 -45.19 96.44 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.58 -60.36 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.266 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -48.59 -33.68 10.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.763 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -60.93 -46.54 90.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 109.037 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.53 HD11 HG12 ' A' ' 82' ' ' VAL . 30.4 mt -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.594 HG21 HD23 ' A' ' 244' ' ' LEU . 97.5 t -64.75 -64.94 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 109.756 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.573 ' HE3' HG23 ' A' ' 119' ' ' VAL . 7.6 ttmm -42.97 -35.98 1.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.127 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.469 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 45.1 tp60 -60.95 -51.92 67.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 231' ' ' LYS . 3.1 ttpp -55.62 -18.56 8.0 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 3.5 m120 -165.49 82.78 1.1 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.383 -0.823 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.1 Cg_endo -78.81 0.24 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.689 2.259 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -6.36 48.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -75.84 -176.73 3.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.834 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.0 OUTLIER -111.1 164.76 12.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.389 0.614 . . . . 0.0 109.616 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -29.05 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -78.17 -61.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.141 -0.975 . . . . 0.0 109.422 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.7 OUTLIER -39.98 -37.78 0.63 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.019 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 236' ' ' SER . 2.5 mt -77.1 -46.63 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.634 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -49.67 -31.33 10.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 52.3 m-20 -72.93 -47.13 48.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.964 -1.085 . . . . 0.0 110.389 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.503 ' HA ' ' OD1' ' A' ' 246' ' ' ASN . 3.5 t60 -63.15 -35.88 81.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -81.87 -35.67 29.04 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -68.89 -34.43 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 243' ' ' HIS . 3.7 p-10 -84.65 -30.42 24.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.44 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 267' ' ' ALA . 1.7 p -72.06 -30.13 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.682 ' HB1' HD12 ' A' ' 192' ' ' ILE . . . -40.52 117.44 0.81 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.521 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' ALA . 0.2 OUTLIER -43.9 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -126.18 71.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 261' ' ' LEU . 1.9 mp . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.968 . . . . 0.0 109.741 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.645 ' CD2' ' CG ' ' A' ' 186' ' ' TYR . 2.6 tm? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.234 0.54 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -61.28 -57.53 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.14 -0.975 . . . . 0.0 109.089 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.48 -81.65 1.69 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 191' ' ' ASP . 57.7 m -78.53 -55.43 5.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.388 -1.066 . . . . 0.0 109.137 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 135.26 -135.53 7.95 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.694 ' O ' HD11 ' A' ' 192' ' ' ILE . 1.4 tp -105.06 178.1 4.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.349 -1.089 . . . . 0.0 109.076 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.574 HG22 HD13 ' A' ' 192' ' ' ILE . 3.0 t -122.67 156.29 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -166.23 119.6 1.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.327 1.06 . . . . 0.0 108.457 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.73 -13.01 61.24 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.152 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 15.8 tt0 -75.47 -25.96 57.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 109.664 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.21 55.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.679 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.45 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -113.67 -20.67 11.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.869 HG21 ' CD1' ' A' ' 21' ' ' LEU . 61.8 p -102.31 -46.51 4.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.119 -0.988 . . . . 0.0 109.229 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 269' ' ' ARG . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.427 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.688 ' OG ' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.298 0.57 . . . . 0.0 109.641 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.667 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 2.9 t -136.75 46.81 1.62 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.915 . . . . 0.0 110.108 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 36.4 Cg_endo -77.5 165.6 27.04 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.936 1.758 . . . . 0.0 110.424 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 7.1 p-90 -67.05 -13.19 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 109.464 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 11' ' ' VAL . . . -83.89 -15.75 69.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.57 ' CD1' ' NE2' ' A' ' 220' ' ' HIS . 1.1 mp -116.38 -6.75 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -1.202 . . . . 0.0 109.045 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.92 -22.43 21.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 21.37 12.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.036 -1.04 . . . . 0.0 110.621 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 7' ' ' GLY . 28.1 m -110.06 18.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.963 -1.086 . . . . 0.0 109.339 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 27.8 mm-40 57.07 17.63 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 110.571 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.683 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.54 -43.03 87.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.86 -53.87 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 N-CA-C 107.874 -1.625 . . . . 0.0 107.874 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB1' ' OE2' ' A' ' 265' ' ' GLU . . . -44.75 -30.74 1.01 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.47 54.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 16.0 m170 -65.62 -10.83 39.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.601 -0.687 . . . . 0.0 109.175 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -83.43 -56.87 3.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -36.21 63.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.456 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.92 4.01 9.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.657 HD13 HG21 ' A' ' 268' ' ' THR . 0.3 OUTLIER -63.82 137.68 58.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.133 . . . . 0.0 109.365 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -123.77 -12.4 7.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.086 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 71.55 -9.39 4.66 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -49.13 135.43 16.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -1.122 . . . . 0.0 109.336 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.18 0.55 47.78 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.569 HG13 ' CD2' ' A' ' 118' ' ' HIS . 47.5 t -112.44 163.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.127 -1.219 . . . . 0.0 109.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -148.83 131.35 15.78 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 ' HB ' ' A' ' 119' ' ' VAL . 17.4 t -128.69 154.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.325 -0.859 . . . . 0.0 109.723 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -98.76 150.17 22.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.911 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.636 ' CG2' HD22 ' A' ' 88' ' ' LEU . 39.0 t -122.7 80.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.919 -1.113 . . . . 0.0 108.387 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.039 HD23 HG21 ' A' ' 93' ' ' VAL . 6.6 mp -71.07 126.41 29.51 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.973 ' HA ' HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER 170.21 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.264 -0.897 . . . . 0.0 109.258 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.855 HG21 ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -49.05 -59.76 3.35 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . 179.38 -109.85 0.27 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 165.6 102.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 p -49.73 125.88 12.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.814 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 m -55.12 101.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.074 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.593 ' CD2' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -119.4 153.39 53.7 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.812 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 35.6 Cg_endo -78.5 -12.69 15.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.516 2.144 . . . . 0.0 109.939 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -90.25 -37.58 14.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD21 ' HA2' ' A' ' 68' ' ' GLY . 62.2 mt -88.87 113.49 24.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.792 . . . . 0.0 109.545 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 119.36 16.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 mm -92.66 94.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.073 -1.017 . . . . 0.0 109.395 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -79.81 -21.01 44.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.993 . . . . 0.0 109.265 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -169.32 163.9 37.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.91 119.5 0.83 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.37 163.47 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -1.096 . . . . 0.0 108.727 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.493 ' OG ' ' HD2' ' A' ' 92' ' ' LYS . 2.5 t -150.85 136.95 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 110.427 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.619 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -127.29 -30.31 2.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 94' ' ' LEU . 55.2 t -49.05 129.42 15.42 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.313 -1.321 0 C-N-CA 122.64 2.226 . . . . 0.0 111.125 -179.569 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.69 0.757 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -92.71 3.8 54.93 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.181 -0.95 . . . . 0.0 109.159 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 1.5 mt-30 -96.56 116.21 28.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.217 -0.927 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.7 OUTLIER 52.21 171.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.637 0.732 . . . . 0.0 110.133 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.57 -33.31 0.06 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.855 ' HB2' HG21 ' A' ' 33' ' ' THR . 9.1 t30 -175.68 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.345 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.62 -47.24 0.97 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -45.32 -50.07 12.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.398 -1.06 . . . . 0.0 110.155 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -54.54 -80.94 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.409 -0.901 . . . . 0.0 110.934 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 0.7 OUTLIER -33.42 -45.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.818 -0.813 . . . . 0.0 110.898 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.723 ' CD2' HD11 ' A' ' 211' ' ' LEU . 44.9 t-80 -57.51 -54.01 51.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.971 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 70' ' ' ILE . 13.5 t -58.76 -32.62 47.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.426 -0.796 . . . . 0.0 109.189 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 70' ' ' ILE . . . -59.72 -49.27 78.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.763 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -70.31 -28.65 71.05 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.492 HG21 ' HG2' ' A' ' 219' ' ' PRO . 7.7 m -71.59 -17.12 62.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.062 -1.258 . . . . 0.0 108.473 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 66' ' ' VAL . 30.3 mt -92.66 -32.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.401 -0.812 . . . . 0.0 110.411 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 83' ' ' ALA . . . -179.65 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.661 -1.274 . . . . 0.0 111.52 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.763 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -46.1 156.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.734 -1.229 . . . . 0.0 108.358 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 73' ' ' LEU . 96.6 mt -78.95 166.69 22.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.932 -1.105 . . . . 0.0 109.925 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.99 ' HB2' HD13 ' A' ' 80' ' ' LEU . 55.0 t30 -117.29 87.38 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.84 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -118.39 -118.92 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.291 -0.881 . . . . 0.0 108.737 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -113.45 -40.54 3.84 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 109.279 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.79 165.56 2.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.404 -0.81 . . . . 0.0 109.7 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.27 -167.23 53.16 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.688 HG12 ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -114.0 -167.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -1.178 . . . . 0.0 109.397 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.99 HD13 ' HB2' ' A' ' 74' ' ' ASN . 8.5 tp -130.36 122.37 27.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 80' ' ' LEU . . . -86.57 -149.31 13.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG12 HD11 ' A' ' 227' ' ' LEU . 2.0 t -97.79 -66.67 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.263 . . . . 0.0 109.666 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -71.45 134.3 84.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 22' ' ' THR . 40.1 Cg_endo -84.95 -60.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.752 2.302 . . . . 0.0 111.236 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -105.92 45.38 0.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.793 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -85.5 164.72 17.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.07 -1.018 . . . . 0.0 109.646 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 2.6 tt0 -101.55 80.19 2.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.636 HD22 ' CG2' ' A' ' 30' ' ' VAL . 6.6 mt -73.3 144.17 46.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.312 -0.867 . . . . 0.0 109.746 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.604 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 2.8 m-85 -118.48 161.52 19.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.401 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -130.03 92.32 3.28 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.643 -1.286 . . . . 0.0 109.914 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.89 149.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.131 -0.981 . . . . 0.0 109.315 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 4.4 mttp -100.29 105.61 17.17 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.039 HG21 HD23 ' A' ' 31' ' ' LEU . 2.1 t -104.55 -14.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.813 . . . . 0.0 110.08 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.973 HD11 ' HA ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.55 -174.7 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.771 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -110.75 -177.41 20.63 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.452 179.914 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.48 157.8 21.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.746 -0.855 . . . . 0.0 109.786 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 130' ' ' SER . 43.7 t -68.53 -19.61 24.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.526 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 33.4 t -72.91 -22.69 60.7 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.456 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 57.4 m -83.1 -63.8 1.29 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.568 HG23 ' CG1' ' A' ' 93' ' ' VAL . 2.3 mt -47.93 -27.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 110' ' ' GLU . . . -69.08 -47.91 64.03 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.619 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -64.79 -28.83 69.84 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.033 -1.042 . . . . 0.0 109.404 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.493 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -80.55 -26.77 53.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.949 HD22 ' ND2' ' A' ' 167' ' ' ASN . 16.4 mt -87.23 -24.15 24.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -1.227 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 7.1 pt-20 -100.63 -25.94 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.251 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.53 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 83.1 t90 -71.65 -17.06 62.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -93.42 -0.38 56.51 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.876 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.93 -28.47 10.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -97.2 -35.41 10.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -1.22 . . . . 0.0 109.503 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -140.12 27.66 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.394 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.834 ' O ' ' HE2' ' A' ' 117' ' ' MET . . . -87.99 -153.32 25.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.834 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 12.1 mmt -125.22 -176.54 3.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.366 -1.079 . . . . 0.0 110.432 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.724 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -71.84 -17.08 62.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.749 -0.595 . . . . 0.0 110.163 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.724 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.6 t -136.74 168.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.6 132.48 1.21 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 1.02 ' C ' HD13 ' A' ' 122' ' ' LEU . 1.6 m120 -130.91 147.39 52.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.0 109.741 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.02 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -142.07 124.78 15.93 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.094 -1.004 . . . . 0.0 109.187 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.749 ' C ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -93.17 62.14 3.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.897 -1.127 . . . . 0.0 109.065 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.819 HD23 ' N ' ' A' ' 124' ' ' LEU . 1.2 mt -99.72 -178.7 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 160' ' ' SER . . . 175.05 74.88 0.05 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 3.4 m -124.62 147.73 56.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 109.494 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -81.07 15.42 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.787 2.325 . . . . 0.0 110.119 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.534 ' N ' ' CD ' ' A' ' 129' ' ' PRO . 14.1 t -116.03 50.36 0.76 Allowed Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.602 -0.687 . . . . 0.0 111.48 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -72.57 178.58 6.07 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.343 2.028 . . . . 0.0 109.772 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.581 ' HB2' HG21 ' A' ' 102' ' ' VAL . 3.7 t -152.49 154.08 34.77 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.16 64.92 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.0 m -71.61 -26.76 62.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.2 tp -72.39 -38.3 68.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -68.08 -47.62 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.64 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -52.48 -26.47 12.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -67.32 -44.81 78.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.082 HG23 ' HA ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -52.29 -40.38 31.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.536 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.458 ' N ' HG12 ' A' ' 137' ' ' VAL . 1.6 m120 -58.07 -41.79 84.12 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -20.16 63.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.63 1.75 25.42 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.872 -1.143 . . . . 0.0 112.044 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -104.49 -41.24 5.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.427 -1.421 . . . . 0.0 108.409 178.508 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -20.03 57.8 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.38 -25.83 20.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.44 52.66 4.12 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.5 t -105.4 109.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -1.093 . . . . 0.0 109.267 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 146' ' ' LEU . 24.7 tp -58.5 123.13 15.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.053 -1.029 . . . . 0.0 109.104 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -120.25 141.69 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.015 . . . . 0.0 109.297 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' HG3' ' A' ' 169' ' ' MET . 1.2 t -137.97 123.91 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.544 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -118.75 147.94 43.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.004 -1.06 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -52.2 160.4 0.78 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.618 -0.676 . . . . 0.0 110.213 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -71.06 -79.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 185' ' ' GLN . . . 149.54 119.32 0.97 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.437 ' OD1' ' CG ' ' A' ' 183' ' ' PHE . 3.6 m-20 -91.59 57.66 3.33 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.799 -0.824 . . . . 0.0 109.391 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.07 -96.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.49 84.47 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -170.61 179.51 3.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.62 56.7 4.89 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -179.75 171.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -1.077 . . . . 0.0 108.675 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.626 HD12 ' CB ' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -118.85 -173.34 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.008 -1.057 . . . . 0.0 110.38 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.56 ' HB3' ' HA2' ' A' ' 125' ' ' GLY . 2.6 m -70.89 -174.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.806 1.289 . . . . 0.0 112.521 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.429 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 93.6 m-85 -123.81 126.97 25.59 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.723 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.3 Cg_endo -72.62 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.301 -1.949 0 C-N-CA 123.939 -1.276 . . . . 0.0 109.791 2.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . . . 31.7 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.238 1.018 . . . . 0.0 108.901 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 162' ' ' PRO . 17.5 ttm180 -44.12 -62.73 1.05 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.717 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -172.28 -166.12 0.38 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 165' ' ' TYR . . . 89.73 -7.09 0.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.746 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 1.082 ' HA ' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER 159.73 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.719 -0.613 . . . . 0.0 109.596 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 167' ' ' ASN . . . 164.77 149.49 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.433 -1.307 . . . . 0.0 112.648 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -80.19 -174.43 4.52 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 175.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.626 ' CB ' HD12 ' A' ' 159' ' ' ILE . . . -122.66 118.88 29.18 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.345 -1.472 . . . . 0.0 110.515 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 151' ' ' SER . 19.0 t -89.52 166.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -136.9 -176.89 14.61 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.582 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -130.31 150.21 51.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.979 . . . . 0.0 109.601 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 173' ' ' ALA . 33.2 p -157.79 155.06 29.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' THR . 18.8 p-10 -58.9 -150.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.846 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.543 ' HG2' ' ND2' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -94.48 -31.48 13.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.952 . . . . 0.0 109.983 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.543 ' ND2' ' HG2' ' A' ' 176' ' ' GLN . 0.0 OUTLIER -96.29 -89.39 0.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.96 80.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -140.28 165.18 28.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 12.0 mtm180 -98.38 19.07 15.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.354 -0.841 . . . . 0.0 109.647 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 64.15 -152.46 0.3 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.6 OUTLIER -112.0 9.86 20.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.393 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -150.48 -92.48 0.06 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' PHE . 3.7 t 39.29 80.76 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.476 -0.765 . . . . 0.0 110.455 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 152' ' ' GLY . 1.9 mp0 -65.67 146.27 55.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 0.0 109.122 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -123.54 166.41 15.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.126 -0.983 . . . . 0.0 109.541 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . 155.59 175.5 26.69 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -52.82 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.156 . . . . 0.0 109.273 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 170' ' ' ALA . . . 160.81 -33.76 0.4 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' A' ' 190' ' ' LEU . 7.9 tp -52.21 111.78 0.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.238 -1.154 . . . . 0.0 109.622 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.28 -28.75 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.85 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 248' ' ' ALA . 2.5 tt -156.8 166.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.607 -1.308 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.882 HG22 ' O ' ' A' ' 260' ' ' GLY . 12.4 m -123.68 174.63 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -0.821 . . . . 0.0 109.283 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.982 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -168.78 177.81 1.14 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.223 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.979 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.4 Cg_endo -76.61 119.33 5.15 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.455 2.103 . . . . 0.0 110.629 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.47 42.15 1.41 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 19.9 t -133.45 81.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.234 -1.156 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 10.4 t-20 84.22 122.83 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.011 0.91 . . . . 0.0 108.574 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 199' ' ' VAL . 19.3 m -156.81 108.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 122.137 0.97 . . . . 0.0 109.383 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 31.5 mt-30 -78.77 143.79 35.78 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.611 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -159.11 -162.1 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.329 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.514 HG21 HD11 ' A' ' 41' ' ' LEU . 15.0 t -86.04 -177.55 6.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.657 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -168.45 169.44 4.96 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.657 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -72.31 168.55 23.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.335 2.023 . . . . 0.0 110.538 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.53 72.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.514 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 4.2 p 56.36 36.7 27.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -1.113 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -122.58 147.68 46.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.078 -1.014 . . . . 0.0 109.807 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.22 19.28 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.49 165.67 4.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.028 . . . . 0.0 110.205 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.76 ' O ' HD23 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -103.33 146.3 28.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.482 -0.762 . . . . 0.0 109.435 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -139.01 107.91 5.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.777 . . . . 0.0 109.169 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.07 140.83 56.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.1 -1.0 . . . . 0.0 109.344 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.35 2.39 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.783 HG23 ' HB2' ' A' ' 173' ' ' ALA . 19.4 m -68.38 -23.58 64.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 0.0 109.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.538 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 9.9 t -67.11 -20.07 65.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.643 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.525 ' HG2' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -78.77 -10.49 59.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.982 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -86.38 -5.76 59.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.638 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.647 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -76.95 -39.05 2.13 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.5 Cg_endo -71.98 -25.59 19.46 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.527 1.484 . . . . 0.0 110.744 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.57 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 13.1 m80 -66.78 -37.75 85.19 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.72 -52.14 34.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' A' ' 121' ' ' ASN . . . -48.09 -33.2 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.378 -0.826 . . . . 0.0 108.94 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.4 -53.08 23.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -53.52 -62.44 1.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.419 -1.048 . . . . 0.0 109.286 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 244' ' ' LEU . . . -43.01 -40.88 3.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.23 78.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.216 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 82' ' ' VAL . 7.1 mt -52.94 -29.12 26.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.33 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 229' ' ' LYS . 96.1 t -74.19 -51.51 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.505 ' HD3' ' CD2' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -43.92 -47.62 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.453 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 28.3 tp60 -63.3 -41.8 98.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.3 tptt -62.98 -11.49 19.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.046 -1.034 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.96 90.89 1.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.19 -0.944 . . . . 0.0 109.764 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.429 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 36.9 Cg_endo -81.44 17.88 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.724 2.283 . . . . 0.0 110.834 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.3 t -122.12 5.32 9.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 110.004 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -91.5 -179.65 5.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.909 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.457 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.4 OUTLIER -110.37 167.73 9.98 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -58.64 -35.75 73.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 109.426 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 238' ' ' VAL . 3.0 t -66.66 -64.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.21 -0.931 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -45.34 -39.78 7.12 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.357 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 236' ' ' SER . 59.7 mt -57.72 -49.41 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.57 -0.706 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' ASN . 49.1 ttp180 -56.12 -60.65 3.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.58 ' HA ' ' HE3' ' A' ' 245' ' ' LYS . 2.3 t-20 -37.69 -62.72 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.66 -0.65 . . . . 0.0 110.91 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.563 ' O ' HG23 ' A' ' 247' ' ' THR . 2.1 t60 -50.4 -40.75 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.597 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.758 HD12 ' HB2' ' A' ' 225' ' ' ALA . 0.2 OUTLIER -70.63 -37.56 73.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 111.327 -178.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.629 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 4.0 ptpt -63.36 -55.46 24.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.868 -1.145 . . . . 0.0 109.975 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.629 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 2.8 p-10 -70.78 -27.1 63.66 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.547 -0.72 . . . . 0.0 111.035 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 267' ' ' ALA . 6.0 p -71.57 -30.75 66.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.802 -1.186 . . . . 0.0 109.627 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -52.33 130.76 31.91 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 261' ' ' LEU . 1.6 m -42.97 111.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.211 -0.931 . . . . 0.0 108.784 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.4 p -69.14 98.0 0.96 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -0.804 . . . . 0.0 110.369 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.631 HD13 ' HA2' ' A' ' 260' ' ' GLY . 3.5 mp . . . . . 0 C--N 1.305 -1.342 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 256' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -55.3 -60.97 2.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.154 -0.966 . . . . 0.0 108.475 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 124.71 58.97 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.432 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 3.1 t 83.73 -57.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.926 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.882 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 140.36 -171.29 24.03 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.525 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.773 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 12.7 tp -75.25 162.29 28.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.954 . . . . 0.0 109.695 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.37 154.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.182 -0.949 . . . . 0.0 109.969 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.43 ' CB ' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -160.71 117.18 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.652 1.215 . . . . 0.0 108.177 178.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.6 61.0 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.526 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.823 ' OE2' ' HB1' ' A' ' 15' ' ' ALA . 7.6 tp10 -82.47 -40.47 21.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.964 -1.085 . . . . 0.0 109.603 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.8 -11.75 59.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 0.0 109.301 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.636 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -89.69 -38.88 13.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.657 HG21 HD13 ' A' ' 21' ' ' LEU . 44.6 p -87.89 -52.9 5.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.442 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.425 ' C ' ' HD3' ' A' ' 269' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.429 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.1 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.76 0.791 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.538 HG12 HG21 ' A' ' 8' ' ' ILE . 15.8 m -76.99 111.89 19.34 Favored Pre-proline 0 C--N 1.29 -2.007 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -80.48 -166.52 0.42 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.827 2.351 . . . . 0.0 111.813 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -33.29 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.219 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' HA3' ' NE2' ' A' ' 220' ' ' HIS . . . -52.06 -83.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.9 mm -43.84 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.479 -1.012 . . . . 0.0 109.187 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 162.78 -56.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -125.49 26.52 6.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.65 20.04 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.875 -1.14 . . . . 0.0 109.903 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG3' ' HB3' ' A' ' 263' ' ' ASN . 5.3 mm-40 65.83 15.59 10.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.577 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -66.33 -37.17 14.96 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.5 Cg_endo -73.02 -55.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.981 0 N-CA-C 108.424 -1.414 . . . . 0.0 108.424 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.74 -29.52 0.53 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 11.1 m170 -69.04 -7.29 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.817 . . . . 0.0 109.569 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.26 -22.58 14.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.112 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.871 ' HB3' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -81.26 4.89 18.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.34 47.13 5.03 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.871 HD21 ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -149.22 150.89 33.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -1.086 . . . . 0.0 109.102 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 24' ' ' SER . 1.7 t -161.15 38.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.866 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 56.94 9.79 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 22' ' ' THR . 55.5 p -57.78 119.45 6.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.77 27.92 9.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 27' ' ' LYS . 88.1 t -122.83 167.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -1.211 . . . . 0.0 109.789 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -136.24 132.62 36.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.117 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 119' ' ' VAL . 3.0 t -136.36 123.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 110.121 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.582 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -84.97 162.63 19.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.82 90.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.153 HD23 HG21 ' A' ' 93' ' ' VAL . 5.9 mp -79.83 102.37 9.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD2' ' HA2' ' A' ' 63' ' ' GLY . 47.9 p30 -166.2 -154.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.006 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 96' ' ' ALA . 6.6 p -43.0 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.564 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -164.06 -132.8 1.39 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.751 HG13 ' HB2' ' A' ' 90' ' ' ALA . 30.5 mm -165.58 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -62.88 137.47 58.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 109.171 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -63.05 122.39 15.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.591 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -133.18 154.54 81.22 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.4 Cg_endo -79.68 -31.91 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.715 2.276 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -86.33 -3.19 58.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.0 109.836 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.77 123.6 48.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.065 -1.022 . . . . 0.0 109.724 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.12 91.43 7.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 109.87 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.75 152.07 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.563 ' O ' ' CE1' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -160.71 23.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.338 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.614 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -170.0 144.76 8.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.93 114.69 0.71 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.1 157.68 44.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -1.032 . . . . 0.0 109.294 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 56' ' ' THR . 0.1 OUTLIER -165.28 133.75 3.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.993 -1.067 . . . . 0.0 110.139 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.8 -36.38 3.9 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.609 -0.682 . . . . 0.0 109.634 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HD3' ' A' ' 92' ' ' LYS . 11.2 t -43.69 107.49 0.59 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.374 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--N 1.315 -1.229 0 C-N-CA 122.706 2.271 . . . . 0.0 110.704 -179.738 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.129 0.49 . . . . 0.0 109.858 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 48' ' ' SER . 0.1 OUTLIER 61.69 4.28 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.121 -0.987 . . . . 0.0 110.114 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' ASP . 30.2 mt-30 -147.03 138.69 24.25 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.753 -1.217 . . . . 0.0 109.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 57' ' ' GLN . 45.2 t0 57.8 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 60' ' ' ASN . . . -153.7 67.21 0.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 2.8 t-20 84.99 -33.43 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.885 . . . . 0.0 109.893 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.54 10.82 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLY . 20.5 t-160 -51.08 -66.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -40.85 -72.92 0.22 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 96.5 m -35.38 -48.07 0.46 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.827 -0.807 . . . . 0.0 110.735 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.533 ' NE2' ' HB2' ' A' ' 201' ' ' SER . 22.0 t-80 -51.73 -53.36 40.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.254 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.552 HG13 ' HG3' ' A' ' 219' ' ' PRO . 12.5 t -60.64 -31.35 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.34 -0.85 . . . . 0.0 108.785 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -55.79 -48.58 75.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.397 -0.814 . . . . 0.0 109.526 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 70' ' ' ILE . . . -67.41 -43.03 88.68 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.429 HG21 ' HG2' ' A' ' 219' ' ' PRO . 1.1 m -52.07 -21.88 3.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.449 -1.618 . . . . 0.0 107.773 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 83' ' ' ALA . 55.9 mt -94.3 -30.68 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.497 -0.752 . . . . 0.0 110.949 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -165.57 44.38 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.506 -1.371 . . . . 0.0 112.323 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -60.92 124.47 20.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.635 -1.291 . . . . 0.0 108.82 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 93.2 mt -79.33 156.75 27.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.992 -1.068 . . . . 0.0 109.314 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 20.0 t-20 -139.54 63.63 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.087 -1.008 . . . . 0.0 109.975 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -89.75 -13.92 35.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.042 0.925 . . . . 0.0 109.28 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.8 -45.93 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -115.1 157.25 15.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.526 -0.734 . . . . 0.0 109.135 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.83 164.35 35.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.43 -150.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.366 -1.079 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 6.3 tp -147.02 106.42 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.984 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.43 -163.48 4.62 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.798 HG12 HD11 ' A' ' 227' ' ' LEU . 0.6 OUTLIER -78.91 -53.67 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -1.108 . . . . 0.0 109.427 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -110.84 101.9 50.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.18 -0.95 . . . . 0.0 108.707 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 37.6 Cg_endo -83.03 -53.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.902 2.401 . . . . 0.0 111.303 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.48 18.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.152 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.18 23.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.525 -1.359 . . . . 0.0 109.203 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 44.0 mt-10 -74.33 150.57 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 109.082 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 71' ' ' ALA . 88.1 mt -125.25 97.98 5.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.953 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 m-30 -82.29 113.66 20.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.262 -0.899 . . . . 0.0 109.419 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.751 ' HB2' HG13 ' A' ' 35' ' ' ILE . . . -78.77 108.91 12.55 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.073 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.582 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -108.38 73.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.766 -1.209 . . . . 0.0 109.959 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -41.65 113.4 0.41 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.153 HG21 HD23 ' A' ' 31' ' ' LEU . 5.0 t -123.06 -24.71 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.135 -0.978 . . . . 0.0 109.928 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.72 HD11 HD22 ' A' ' 124' ' ' LEU . 3.9 mp -126.76 172.2 10.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 110.173 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.92 -158.65 16.5 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.803 ' HA ' HG22 ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.217 -1.167 . . . . 0.0 109.183 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 m -121.47 157.35 30.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.872 -0.781 . . . . 0.0 109.983 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -28.89 44.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.549 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 75.1 m -72.52 -18.53 61.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 105' ' ' ILE . 9.2 p -77.44 -57.76 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.652 -0.655 . . . . 0.0 109.382 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.554 HG12 ' CG1' ' A' ' 93' ' ' VAL . 1.3 mt -63.4 -24.15 35.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.06 -44.54 79.89 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.624 -0.673 . . . . 0.0 109.572 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.607 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -77.39 -24.26 50.56 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.624 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -72.51 -27.98 68.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.68 -30.7 14.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -76.14 -30.06 58.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 108.96 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -65.67 -22.96 66.68 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.824 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -81.33 -21.85 38.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -56.52 -39.35 84.4 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.58 -49.97 6.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -127.93 70.27 1.34 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.824 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -105.79 23.72 28.79 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.617 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.2 OUTLIER 30.7 -159.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.129 0.966 . . . . 0.0 111.509 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.535 ' CB ' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -96.22 -20.21 18.74 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.437 -0.789 . . . . 0.0 111.026 -178.182 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 28' ' ' VAL . 2.6 t -136.51 158.5 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.435 -1.415 . . . . 0.0 111.351 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.81 128.51 2.42 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.962 HD22 HG21 ' A' ' 218' ' ' THR . 45.7 t30 -107.01 158.33 17.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.649 -1.282 . . . . 0.0 110.49 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.663 HD23 HD11 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -127.54 98.88 5.38 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -85.58 64.89 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.403 -0.81 . . . . 0.0 108.944 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.72 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -150.31 168.49 23.91 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.413 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.567 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -164.76 76.53 0.15 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -103.59 147.62 34.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.19 -1.182 . . . . 0.0 109.475 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -77.3 -34.59 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.295 1.997 . . . . 0.0 109.122 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -46.79 104.6 0.42 Allowed Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.71 -0.619 . . . . 0.0 109.38 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 34.5 Cg_endo -78.6 168.99 20.46 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.48 2.12 . . . . 0.0 110.161 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.3 p -173.34 120.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 110.622 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -24.88 65.76 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 79.7 m -63.37 -29.12 70.48 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.431 ' HB2' ' OG ' ' A' ' 130' ' ' SER . 2.1 tt -75.88 -35.87 59.7 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 6.5 tm-20 -77.04 -19.45 57.15 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.074 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -78.13 -24.01 47.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.05 -45.33 20.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.341 -0.943 . . . . 0.0 108.631 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.57 -28.92 42.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 134' ' ' GLU . 62.6 t30 -62.33 -34.77 77.28 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -79.88 -22.42 42.88 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.87 -27.69 63.03 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.4 m -69.4 -39.38 77.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -58.07 -23.93 56.53 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.231 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.65 -14.2 16.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.303 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.452 ' C ' ' HB2' ' A' ' 237' ' ' ASN . . . 68.16 75.37 0.51 Allowed Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.71 111.72 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.468 -1.019 . . . . 0.0 109.399 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.89 113.72 6.56 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -112.54 142.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.013 -1.054 . . . . 0.0 110.379 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 149' ' ' ALA . 2.7 t -119.44 167.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -153.64 128.16 9.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.974 -1.079 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.506 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -61.08 156.06 18.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -88.16 -54.18 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.562 ' CA ' ' HB2' ' A' ' 185' ' ' GLN . . . 146.79 128.75 1.92 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 154' ' ' SER . 51.1 p-10 -83.66 60.96 6.02 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 122.166 -0.608 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER 91.97 104.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.356 0.598 . . . . 0.0 109.953 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -173.45 61.97 0.13 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 77.29 164.22 0.23 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.324 -1.104 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.65 56.6 4.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -145.85 161.75 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.52 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.469 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -100.53 -174.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.376 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.871 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.02 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.142 0.972 . . . . 0.0 111.576 -178.394 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.453 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.7 m-85 -108.8 134.15 20.43 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.682 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.2 Cg_endo -72.95 -56.91 0.14 OUTLIER 'Cis proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.043 -1.232 . . . . 0.0 111.018 3.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 37.74 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.284 1.04 . . . . 0.0 109.412 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -43.73 -34.94 1.66 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.1 m-85 -44.67 -178.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.289 1.042 . . . . 0.0 111.615 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 167' ' ' ASN . . . -95.92 -60.01 1.73 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -44.67 -67.47 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.206 1.003 . . . . 0.0 108.65 179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -71.97 139.29 48.57 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.8 mmm -104.71 143.29 33.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.999 -1.063 . . . . 0.0 109.912 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -94.99 108.16 20.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 34.6 t -87.53 165.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.27 -175.47 13.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -117.6 157.77 25.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -1.095 . . . . 0.0 109.199 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.944 HG22 ' OD1' ' A' ' 179' ' ' ASN . 18.6 p -135.35 168.13 19.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 110.049 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.08 -162.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -83.84 -19.86 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.72 -71.37 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 109.277 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 174' ' ' THR . 2.7 m-20 -153.14 -59.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.288 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 1.004 ' ND2' HG21 ' A' ' 193' ' ' VAL . 8.6 t-20 -147.23 148.9 31.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.574 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 163.08 -70.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.428 0.633 . . . . 0.0 109.541 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . 48.91 178.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.641 -0.662 . . . . 0.0 109.809 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -34.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 154' ' ' SER . 7.7 p90 -106.49 -3.61 20.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 0.7 OUTLIER -45.89 112.16 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.562 ' HB2' ' CA ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -67.96 105.61 2.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 108.846 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -109.22 -169.99 1.58 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.466 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.581 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . -174.77 -142.12 3.92 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.132 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.51 71.59 5.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -1.044 . . . . 0.0 110.42 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.01 64.81 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.769 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 192' ' ' ILE . 0.5 OUTLIER -61.74 149.49 39.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.29 -1.124 . . . . 0.0 109.161 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -61.54 -60.98 2.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.692 ' O ' HD21 ' A' ' 190' ' ' LEU . 14.7 tt -160.73 165.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 120.984 -1.072 . . . . 0.0 109.619 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 1.004 HG21 ' ND2' ' A' ' 179' ' ' ASN . 27.3 m -122.48 161.38 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.214 -0.929 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -153.41 158.18 32.75 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.446 ' CB ' ' HZ3' ' A' ' 6' ' ' TRP . 34.6 Cg_endo -76.02 121.22 6.08 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 121.984 1.789 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -163.13 52.88 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.287 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 45.1 t -100.87 64.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -1.185 . . . . 0.0 108.4 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.735 ' O ' HG13 ' A' ' 199' ' ' VAL . 12.6 t-20 119.45 129.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 216' ' ' MET . 6.2 m -165.51 116.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 121.965 0.888 . . . . 0.0 108.822 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 20.2 pt20 -94.73 138.18 32.88 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.556 0.694 . . . . 0.0 109.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.533 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -135.43 -152.79 0.48 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.0 109.188 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.7 p -88.62 178.94 6.37 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.216 -0.928 . . . . 0.0 110.537 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.674 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -145.45 164.09 28.29 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.674 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 33.5 Cg_endo -69.9 155.85 64.43 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.57 1.514 . . . . 0.0 110.437 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.05 -60.49 4.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 2.0 p 151.6 38.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.975 -0.72 . . . . 0.0 109.577 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -122.77 170.8 9.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.172 -0.955 . . . . 0.0 109.935 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -108.73 177.74 4.69 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.409 -0.807 . . . . 0.0 108.98 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -162.78 166.93 23.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.079 -1.013 . . . . 0.0 110.209 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.931 ' C ' HD23 ' A' ' 211' ' ' LEU . 0.4 OUTLIER -144.08 122.05 12.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.585 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.931 HD23 ' C ' ' A' ' 210' ' ' SER . 0.2 OUTLIER -136.33 156.19 48.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.083 -1.01 . . . . 0.0 109.878 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 212' ' ' ASN . 16.2 p30 -117.83 131.54 56.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 109.041 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.62 28.62 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.605 -1.283 . . . . 0.0 109.914 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 151' ' ' SER . 89.0 m -76.57 -29.02 56.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -1.081 . . . . 0.0 108.813 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.455 ' O ' ' HB ' ' A' ' 218' ' ' THR . 0.3 OUTLIER -59.35 -24.74 63.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 108.85 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.886 ' HB3' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -77.8 -29.29 50.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.422 ' HB2' ' HA3' ' A' ' 196' ' ' GLY . . . -84.51 -5.19 59.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.912 . . . . 0.0 108.751 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.962 HG21 HD22 ' A' ' 121' ' ' ASN . 0.9 OUTLIER -66.22 -52.72 36.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.436 -0.79 . . . . 0.0 110.15 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.6 Cg_endo -72.16 -9.16 24.06 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.259 1.972 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.517 ' NE2' ' HA3' ' A' ' 7' ' ' GLY . 1.6 m80 -74.7 -43.51 54.73 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.3 t -75.05 -39.86 44.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 219' ' ' PRO . . . -52.95 -35.43 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -69.66 -50.58 30.04 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -44.21 -49.72 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 108.955 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.88 86.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 108.881 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.07 -41.51 64.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 109.317 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.798 HD11 HG12 ' A' ' 82' ' ' VAL . 17.1 mt -62.19 -34.67 76.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 108.873 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 231' ' ' LYS . 99.1 t -62.15 -60.38 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 109.032 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.591 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -44.62 -41.86 6.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 108.992 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 24' ' ' SER . 1.4 tm0? -59.83 -57.53 12.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 228' ' ' VAL . 1.9 ptpt -62.21 -11.22 13.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.093 -1.004 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.527 ' OD1' ' CD1' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -156.42 80.79 3.68 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.803 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.15 -4.79 13.39 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.686 2.257 . . . . 0.0 110.086 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -14.21 22.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.527 ' CD1' ' OD1' ' A' ' 232' ' ' ASN . 29.5 m0 -71.67 175.79 5.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.117 . . . . 0.0 109.624 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 t -118.16 173.86 6.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.526 ' HA ' HD12 ' A' ' 240' ' ' ILE . 40.0 t30 -54.8 -17.14 3.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 -62.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.07 59.3 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.646 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 237' ' ' ASN . 77.7 mt -68.78 -54.26 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.452 -0.78 . . . . 0.0 110.854 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -66.85 -31.18 71.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.949 -1.094 . . . . 0.0 110.95 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 33.2 t-20 -73.04 -40.55 65.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.688 -1.257 . . . . 0.0 110.355 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.428 ' O ' HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -75.45 -32.68 60.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.776 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.3 OUTLIER -77.72 -32.35 52.82 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.244 -0.91 . . . . 0.0 109.969 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.1 tttt -80.97 -28.77 35.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 108.686 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 4.6 t-20 -83.59 -18.27 38.83 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 267' ' ' ALA . 2.6 p -88.49 -30.15 19.6 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.207 1.003 . . . . 0.0 109.226 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.16 126.68 9.56 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.298 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.414 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 17.2 m -74.89 145.32 42.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.451 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.4 OUTLIER -115.47 126.47 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.878 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.0 mp . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 179' ' ' ASN . 15.6 m-30 -44.33 -50.78 8.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.038 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 72.41 -128.68 13.56 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 191' ' ' ASP . 13.6 t -44.53 -45.02 9.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -1.128 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.583 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 121.25 -138.01 12.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 261' ' ' LEU . 13.3 tp -96.62 168.42 10.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -1.046 . . . . 0.0 109.178 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.55 HG13 ' CD1' ' A' ' 192' ' ' ILE . 0.0 OUTLIER -117.62 156.08 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.48 ' HB3' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.99 120.12 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.361 1.076 . . . . 0.0 108.771 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 268' ' ' THR . . . -75.26 0.97 14.76 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -35.31 40.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.58 -10.51 58.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -100.29 -26.71 13.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.696 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 264' ' ' ALA . 19.1 p -79.65 -42.06 25.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.728 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.44 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.487 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 58.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.618 HG12 HG21 ' A' ' 8' ' ' ILE . 1.2 m -145.22 115.0 4.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.42 171.29 17.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.437 2.092 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -15.96 1.31 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.455 -0.778 . . . . 0.0 110.737 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.89 24.58 6.61 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.645 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.618 HG21 HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -154.81 14.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.797 -1.413 . . . . 0.0 109.931 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -90.79 -37.36 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.709 -1.244 . . . . 0.0 110.351 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.595 ' HB3' HD21 ' A' ' 261' ' ' LEU . 4.4 mtm180 -92.91 23.34 4.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.045 . . . . 0.0 110.256 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.447 HG22 ' C ' ' A' ' 8' ' ' ILE . 11.1 m -111.82 19.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.459 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 63.2 mm-40 39.94 36.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.415 -0.803 . . . . 0.0 109.679 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -73.42 -32.7 1.69 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 112.156 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.5 Cg_endo -74.46 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 N-CA-C 108.797 -1.271 . . . . 0.0 108.797 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.35 -30.49 1.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.67 -44.34 61.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.254 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -71.66 -5.86 36.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.652 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.87 -24.72 13.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.028 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -46.99 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.07 -53.0 0.57 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 21' ' ' LEU . 2.3 mp -49.71 141.39 9.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -1.084 . . . . 0.0 109.346 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -164.17 59.1 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.925 -1.109 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . 46.19 21.04 0.6 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.493 ' N ' ' C ' ' A' ' 22' ' ' THR . 2.6 p -40.28 -24.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.7 -0.882 . . . . 0.0 111.329 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -152.28 54.36 0.46 Allowed Glycine 0 N--CA 1.493 2.458 0 C-N-CA 118.86 -1.638 . . . . 0.0 111.386 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 27' ' ' LYS . 60.7 t -122.75 168.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -1.22 . . . . 0.0 108.781 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.595 ' N ' HG12 ' A' ' 26' ' ' VAL . 5.4 mttm -136.63 117.54 14.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 110.214 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' TYR . 11.8 t -115.44 139.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -100.14 147.65 25.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 110.085 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 70' ' ' ILE . 93.2 t -119.25 83.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.697 HD12 HG21 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -75.59 96.35 3.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.894 -0.504 . . . . 0.0 109.983 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -167.5 -159.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.95 -1.094 . . . . 0.0 109.104 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.827 HG21 ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -44.5 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.047 -1.033 . . . . 0.0 109.124 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -168.62 -124.15 0.71 Allowed Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 34' ' ' GLY . 34.3 mm -161.45 93.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ILE . 16.6 p -40.62 118.9 1.01 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.863 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.07 103.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.406 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -139.36 154.07 71.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.395 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.71 1.26 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.695 2.264 . . . . 0.0 110.496 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' CG ' HG21 ' A' ' 202' ' ' THR . 3.0 p30 -108.55 1.1 21.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.641 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.38 116.6 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.05 138.22 58.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.3 mm -119.84 100.27 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.624 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -118.56 12.0 13.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.54 146.57 10.5 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.28 99.5 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.078 -1.248 . . . . 0.0 110.212 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.08 117.78 23.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -1.054 . . . . 0.0 108.163 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.511 ' HB3' HG22 ' A' ' 56' ' ' THR . 2.6 p -112.67 115.54 28.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 110.832 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.894 ' HZ ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -95.74 -36.7 11.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.906 HG13 ' HD2' ' A' ' 51' ' ' PRO . 9.9 t -45.22 149.49 0.92 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.906 ' HD2' HG13 ' A' ' 50' ' ' VAL . 27.9 Cg_endo . . . . . 0 C--N 1.306 -1.664 0 C-N-CA 121.892 1.728 . . . . 0.0 110.927 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.714 ' C ' HG23 ' A' ' 56' ' ' THR . 72.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.182 0.515 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' C ' ' A' ' 55' ' ' SER . 1.4 p 79.44 -8.98 1.53 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ASP . 2.2 mm-40 -100.99 172.87 6.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.814 . . . . 0.0 109.184 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 57' ' ' GLN . 0.9 OUTLIER 49.9 175.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.625 0.726 . . . . 0.0 110.191 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 156.33 -64.71 0.32 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.827 ' HB2' HG21 ' A' ' 33' ' ' THR . 0.1 OUTLIER -145.3 -61.87 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -1.113 . . . . 0.0 109.577 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.8 -35.79 0.67 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -54.99 -62.76 1.45 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -1.132 . . . . 0.0 109.47 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.96 -41.33 13.76 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.9 m -57.65 -44.59 85.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -1.126 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.61 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 0.3 OUTLIER -59.51 -59.48 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.505 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 219' ' ' PRO . 11.1 t -51.59 -30.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.269 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -62.54 -54.02 46.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.378 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -73.53 -17.15 78.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 219' ' ' PRO . 28.6 m -82.58 -14.51 54.71 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.058 -1.26 . . . . 0.0 107.87 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.44 HD12 HG22 ' A' ' 30' ' ' VAL . 46.3 mt -101.75 -27.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.535 -0.728 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -161.36 22.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.785 -1.197 . . . . 0.0 111.842 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 81' ' ' GLY . . . -38.73 100.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.031 -1.043 . . . . 0.0 109.323 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 72' ' ' ALA . 8.8 mt -44.58 172.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.29 -0.882 . . . . 0.0 110.514 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.512 ' ND2' ' H ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -105.18 103.53 13.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.443 -0.786 . . . . 0.0 109.433 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -142.01 -118.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.171 -0.956 . . . . 0.0 108.905 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.28 -39.29 0.53 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.699 ' O ' HD12 ' A' ' 77' ' ' ILE . 1.3 pp -88.42 65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.07 152.19 6.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 80' ' ' LEU . 17.4 m -68.28 -146.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.289 -1.124 . . . . 0.0 109.527 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' N ' HG23 ' A' ' 79' ' ' VAL . 24.9 tp -139.83 107.11 5.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.874 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 72' ' ' ALA . . . -65.98 -153.23 0.18 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.07 -32.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.239 . . . . 0.0 109.582 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -120.65 100.21 46.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.298 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 22' ' ' THR . 37.0 Cg_endo -81.72 -54.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.805 2.337 . . . . 0.0 110.534 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -82.55 30.93 0.41 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.684 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.618 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -94.56 168.64 10.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.939 -1.101 . . . . 0.0 109.222 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -96.12 92.03 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.146 -0.971 . . . . 0.0 108.87 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 1.5 mt -71.76 139.77 49.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.333 -0.854 . . . . 0.0 109.949 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 3.0 m-85 -120.82 147.95 44.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.93 98.82 6.38 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.347 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.894 HG12 ' HZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -96.39 61.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.132 -0.98 . . . . 0.0 108.76 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' VAL . 2.0 ttmt -34.73 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.468 0.652 . . . . 0.0 110.364 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -110.83 7.33 8.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.051 HD11 HD22 ' A' ' 124' ' ' LEU . 88.1 mt -145.99 173.62 12.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.245 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 33' ' ' THR . . . -159.55 144.17 9.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 59' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.286 -1.126 . . . . 0.0 108.711 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -95.36 -176.27 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.626 0.727 . . . . 0.0 109.534 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.03 -14.92 19.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 13.7 m -80.77 -18.06 48.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.69 -45.28 11.82 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.814 ' HA ' HG22 ' A' ' 93' ' ' VAL . 2.8 mt -70.97 -44.64 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.42 -0.912 . . . . 0.0 108.588 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -37.11 86.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 109.023 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 8.1 tp60 -65.16 -45.23 85.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.625 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -66.9 -31.87 79.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.63 HD21 HD21 ' A' ' 122' ' ' LEU . 10.3 mt -71.68 -28.5 63.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -1.198 . . . . 0.0 108.934 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.7 -22.28 46.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -63.62 -23.03 67.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -92.69 -15.64 26.48 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.935 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -66.86 -31.1 77.24 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -111.16 -28.49 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -1.102 . . . . 0.0 109.265 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -132.1 35.41 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.675 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -83.53 158.07 35.23 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -106.55 -179.93 4.08 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 -179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.543 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.6 m170 -50.31 -30.2 11.48 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 120' ' ' ALA . 6.1 t -136.68 160.82 37.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.018 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.661 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -168.04 106.63 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.565 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 9.7 m120 -91.54 156.56 17.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.825 -1.172 . . . . 0.0 111.046 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.63 HD21 HD21 ' A' ' 109' ' ' LEU . 6.6 mp -129.22 103.02 6.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -85.04 64.72 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.278 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.051 HD22 HD11 ' A' ' 94' ' ' LEU . 1.5 pp 177.66 175.48 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.988 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.522 ' O ' ' CD ' ' A' ' 129' ' ' PRO . . . 157.5 -99.6 0.19 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.602 ' CB ' ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER 62.55 -175.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.394 -1.062 . . . . 0.0 110.076 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 126' ' ' SER . 37.0 Cg_endo -83.21 -10.35 10.15 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.749 2.299 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.682 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -57.2 -44.13 99.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 111.96 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 128' ' ' SER . 30.1 Cg_endo -71.22 177.37 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.119 1.88 . . . . 0.0 111.022 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.7 t -118.43 173.9 6.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.45 1.119 . . . . 0.0 111.259 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.21 60.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.0 m -76.41 -26.77 55.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -39.74 61.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 165' ' ' TYR . 1.0 OUTLIER -66.92 -43.48 83.2 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.457 178.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -55.61 -26.75 45.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.94 75.46 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.325 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.68 -24.28 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.4 ' O ' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -68.78 -29.53 67.92 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.38 -22.75 35.3 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.67 -37.13 31.38 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 120.88 -1.137 . . . . 0.0 110.8 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 167' ' ' ASN . 4.5 m -73.32 -24.64 60.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.915 -1.116 . . . . 0.0 108.236 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 138' ' ' ASN . 3.2 m -55.63 -28.95 58.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -87.08 -28.49 22.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.469 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.41 -7.43 24.63 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 117' ' ' MET . 21.6 t -48.75 110.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.181 -1.188 . . . . 0.0 109.811 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.647 HD12 ' OD1' ' A' ' 237' ' ' ASN . 3.5 tp -68.23 96.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 108.794 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.0 t -88.05 154.66 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.064 -1.022 . . . . 0.0 109.916 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -140.87 104.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.645 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -92.96 148.22 22.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.902 . . . . 0.0 110.469 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.01 169.58 9.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB2' ' CG2' ' A' ' 214' ' ' THR . 0.1 OUTLIER -61.32 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.015 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . -168.68 -68.5 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.192 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 19.4 t-20 88.98 6.4 0.14 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.301 0.572 . . . . 0.0 109.822 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 153' ' ' ASN . 27.6 t 175.59 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . -132.76 -101.93 0.81 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.507 ' N ' ' HG2' ' A' ' 185' ' ' GLN . . . 178.61 78.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.348 -1.089 . . . . 0.0 109.605 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' TYR . . . 56.26 13.49 7.21 Favored Glycine 0 C--N 1.288 -2.136 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.38 147.52 33.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -1.222 . . . . 0.0 109.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.65 HG23 ' HA ' ' A' ' 186' ' ' TYR . 4.5 pt -74.56 176.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.989 -1.069 . . . . 0.0 109.85 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.932 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -102.58 165.8 10.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.798 . . . . 0.0 112.082 -177.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.496 ' O ' ' HA3' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -80.29 144.48 58.09 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 174.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 42.8 Cg_endo -72.97 -28.09 7.45 Favored 'Cis proline' 0 C--N 1.289 -2.579 0 O-C-N 122.676 0.829 . . . . 0.0 110.581 3.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.13 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.741 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 162' ' ' PRO . 19.3 ttp180 -67.95 -52.4 36.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.711 -1.243 . . . . 0.0 109.553 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -41.08 -178.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.645 1.212 . . . . 0.0 111.269 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.38 -0.38 9.85 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.502 ' HB3' ' OG1' ' A' ' 141' ' ' THR . 1.9 m-80 -87.12 22.51 2.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.438 -0.789 . . . . 0.0 109.427 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -171.32 145.91 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.422 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 29.8 mtp -81.4 152.95 27.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.008 -1.057 . . . . 0.0 109.938 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.16 132.56 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.9 t -99.24 165.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.032 -1.043 . . . . 0.0 110.136 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.53 173.69 20.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -135.02 152.38 51.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -1.221 . . . . 0.0 109.552 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 p -116.39 163.1 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.22 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 12.8 p-10 -62.38 179.01 0.35 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.036 -1.04 . . . . 0.0 109.248 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.93 -29.66 43.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -94.03 -90.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.422 -0.799 . . . . 0.0 109.647 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 7.0 t30 -150.02 -20.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.196 -0.94 . . . . 0.0 111.091 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.48 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.3 t30 -56.57 -160.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.711 -1.243 . . . . 0.0 109.647 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.579 ' HG2' ' CD1' ' A' ' 256' ' ' LEU . 0.3 OUTLIER -93.73 135.83 34.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.024 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 180' ' ' ARG . . . -43.59 161.75 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -101.37 12.52 37.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 109.564 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.577 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -153.32 29.9 0.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 110.082 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.423 ' OG ' ' CG2' ' A' ' 214' ' ' THR . 9.1 t -121.21 156.77 31.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.257 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.5 137.32 54.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 1.08 ' CD2' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -141.04 176.98 8.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.547 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 137.91 133.27 3.1 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.064 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . 35.65 102.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.12 -0.635 . . . . 0.0 111.613 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 159' ' ' ILE . . . 116.81 -5.25 18.66 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.77 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.08 HD22 ' CD2' ' A' ' 186' ' ' TYR . 8.9 tp -61.72 107.89 0.9 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.878 -1.366 . . . . 0.0 110.237 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 25.0 t70 -75.9 -56.63 4.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 259' ' ' SER . 2.5 tt -149.1 169.75 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.106 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 10.0 m -123.26 164.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -163.44 177.96 1.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 109.025 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.8 Cg_endo -76.49 116.98 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.408 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -134.63 54.95 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 37.4 t -149.01 101.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.524 -0.986 . . . . 0.0 108.586 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.627 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.3 OUTLIER 73.91 107.11 0.07 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.125 0.964 . . . . 0.0 111.276 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.704 HG22 ' CB ' ' A' ' 212' ' ' ASN . 17.4 m -163.41 109.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 16.9 pt20 -84.7 148.16 26.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.608 0.718 . . . . 0.0 110.773 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.61 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -145.31 -151.56 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.422 HG21 ' CG ' ' A' ' 40' ' ' ASP . 74.2 p -90.18 172.11 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.648 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -159.99 164.49 19.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.648 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -70.63 164.02 36.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.948 1.765 . . . . 0.0 110.393 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.84 78.88 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.76 32.42 22.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -1.114 . . . . 0.0 109.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -118.32 150.94 38.65 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.049 -1.032 . . . . 0.0 109.817 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -92.74 172.45 8.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -145.68 118.21 8.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.868 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.5 OUTLIER -91.19 111.56 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 211' ' ' LEU . 0.6 OUTLIER -175.47 147.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 110.361 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.704 ' CB ' HG22 ' A' ' 199' ' ' VAL . 11.3 t-20 -136.11 -162.86 1.32 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.859 0.838 . . . . 0.0 109.161 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 150.73 -174.78 29.97 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -70.54 -42.33 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.703 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.45 ' HA ' ' CB ' ' A' ' 150' ' ' ALA . 1.4 m -66.07 -16.07 63.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 110.403 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.553 ' HB3' ' OD1' ' A' ' 212' ' ' ASN . 1.5 mpp? -91.07 -16.6 27.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.115 . . . . 0.0 109.754 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -87.64 -13.18 43.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 108.688 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.643 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 2.6 m -63.07 -43.84 82.77 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.63 -0.669 . . . . 0.0 111.349 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.804 ' HG2' HG21 ' A' ' 69' ' ' THR . 29.2 Cg_endo -72.75 -26.7 15.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.123 1.882 . . . . 0.0 111.583 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.598 ' NE2' HG23 ' A' ' 69' ' ' THR . 16.7 m170 -67.11 -45.55 76.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.869 -1.144 . . . . 0.0 108.177 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 262' ' ' VAL . 67.2 t -67.63 -45.74 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.512 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -54.18 -33.93 59.27 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -64.74 -52.46 42.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.12 2.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -1.076 . . . . 0.0 109.168 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 244' ' ' LEU . . . -47.47 -26.73 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -64.75 -59.21 4.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 226' ' ' ALA . 4.8 mt -46.48 -36.91 7.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 108.45 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.16 -56.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.609 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.572 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.38 -39.32 6.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -48.5 81.48 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.298 -0.876 . . . . 0.0 109.02 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -67.26 -7.45 24.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.599 ' HB3' ' CG ' ' A' ' 235' ' ' TRP . 81.9 m-20 -160.21 78.88 2.56 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.4 -28.4 3.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.636 2.224 . . . . 0.0 111.099 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.85 0.68 54.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.599 ' CG ' ' HB3' ' A' ' 232' ' ' ASN . 11.9 m0 -71.56 -178.69 2.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 109.674 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.62 167.71 10.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.552 -0.718 . . . . 0.0 110.214 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.647 ' OD1' HD12 ' A' ' 146' ' ' LEU . 17.2 t-20 -51.2 -39.85 57.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 0.0 109.543 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -74.08 -59.34 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.278 -0.888 . . . . 0.0 109.465 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 238' ' ' VAL . 46.8 tp60 -39.76 -36.56 0.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.305 0.574 . . . . 0.0 110.121 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.87 -46.52 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 110.43 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 15.8 ttp180 -52.81 -40.47 63.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.919 -1.113 . . . . 0.0 110.523 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -63.14 -35.19 79.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -0.941 . . . . 0.0 110.612 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -71.62 -43.21 66.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.389 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 225' ' ' ALA . 0.4 OUTLIER -77.22 -22.48 52.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 110.245 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -82.77 -24.59 33.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 0.0 109.352 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -90.2 -21.87 21.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.918 . . . . 0.0 109.214 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 248' ' ' ALA . 2.3 p -87.66 -29.72 20.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 110.055 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -40.02 116.43 0.65 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.844 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.501 ' CG2' ' N ' ' A' ' 250' ' ' SER . 1.0 OUTLIER -65.76 163.77 15.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.93 . . . . 0.0 109.214 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.501 ' N ' ' CG2' ' A' ' 249' ' ' THR . 5.9 p -115.78 114.46 24.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.337 -0.852 . . . . 0.0 109.524 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.662 HD11 ' HB2' ' A' ' 261' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.717 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.579 ' CD1' ' HG2' ' A' ' 180' ' ' ARG . 2.7 tm? . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.67 ' O ' HD23 ' A' ' 190' ' ' LEU . 4.7 m-85 -65.58 -47.31 76.2 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 259' ' ' SER . . . 55.89 58.36 14.49 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.48 ' CB ' ' HA ' ' A' ' 192' ' ' ILE . 0.0 OUTLIER 171.18 -84.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -1.191 . . . . 0.0 109.093 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 132.35 -163.3 24.02 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.662 ' HB2' HD11 ' A' ' 251' ' ' LEU . 5.0 tp -98.11 177.93 5.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.707 -0.878 . . . . 0.0 109.257 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 221' ' ' VAL . 0.6 OUTLIER -110.22 155.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 110.208 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.72 116.42 5.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.884 1.326 . . . . 0.0 108.657 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -79.78 -25.39 40.96 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.622 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.459 ' O ' ' OE2' ' A' ' 265' ' ' GLU . 7.6 tp10 -71.78 -41.89 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.589 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.55 0.76 18.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -113.69 -3.61 13.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.52 -35.85 4.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.693 ' HB2' ' N ' ' A' ' 80' ' ' LEU . 1.9 p . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 3' ' ' SER . 0.1 OUTLIER -165.64 73.46 1.33 Allowed Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.432 -0.792 . . . . 0.0 109.169 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HD2' ' CG1' ' A' ' 8' ' ' ILE . 34.7 Cg_endo -77.46 165.31 27.54 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.51 2.14 . . . . 0.0 110.29 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -39.08 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.665 -0.647 . . . . 0.0 110.176 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PRO . . . -68.35 -62.64 4.02 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.57 ' O ' ' CB ' ' A' ' 9' ' ' SER . 47.0 mm -62.62 159.97 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -1.1 . . . . 0.0 109.515 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.634 ' OG ' HG12 ' A' ' 4' ' ' VAL . 4.4 m 89.38 -34.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.888 -0.508 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -27.89 61.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.297 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.69 22.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 0.0 109.662 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.497 ' HG2' ' CB ' ' A' ' 265' ' ' GLU . 6.8 tp-100 52.89 49.41 20.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.697 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.51 -30.24 0.44 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 112.053 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.32 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.88 -31.19 0.81 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HB1' HD13 ' A' ' 227' ' ' LEU . . . -66.1 -55.81 14.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.263 -0.898 . . . . 0.0 108.579 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.409 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 9.8 m-70 -66.35 -8.25 24.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.0 109.563 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -83.81 -35.95 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 5.91 8.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.85 43.73 5.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 2.2 mm? -99.71 133.67 43.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -1.094 . . . . 0.0 109.101 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.503 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -120.35 -37.96 2.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.494 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 81.31 -22.01 5.62 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -49.47 110.82 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.267 . . . . 0.0 109.078 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.73 -11.06 1.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG12 ' N ' ' A' ' 27' ' ' LYS . 48.2 t -110.57 170.04 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -1.235 . . . . 0.0 109.314 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 3.1 mttt -139.97 131.24 26.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.908 . . . . 0.0 109.364 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 119' ' ' VAL . 48.7 t -124.34 145.29 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.018 . . . . 0.0 110.448 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -101.97 146.77 27.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.905 HG11 HD11 ' A' ' 35' ' ' ILE . 25.6 t -120.63 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 109.27 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.752 HD12 ' CG2' ' A' ' 91' ' ' VAL . 4.8 mp -65.83 93.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -147.03 -156.43 0.71 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 20.7 p -67.53 -24.75 65.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.355 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 161.05 -105.32 0.26 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.905 HD11 HG11 ' A' ' 30' ' ' VAL . 10.3 mt 135.65 101.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.0 OUTLIER -71.88 139.22 48.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -55.18 165.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.626 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -177.24 160.51 1.45 Allowed Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.161 -0.962 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.4 Cg_endo -78.49 -23.5 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 110.181 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 73' ' ' LEU . 1.4 t0 -102.48 -2.98 27.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 73' ' ' LEU . 14.1 mt -102.46 160.88 14.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.266 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 86' ' ' ALA . 40.6 t-20 -112.51 119.35 37.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 43' ' ' ILE . 6.7 mm -123.48 96.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.679 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -90.57 -28.73 18.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 108.951 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.94 -176.1 38.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.64 128.46 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -131.51 165.1 24.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.444 -1.033 . . . . 0.0 108.551 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.501 ' OG ' ' CG ' ' A' ' 51' ' ' PRO . 46.2 t -149.1 142.59 25.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.084 . . . . 0.0 110.486 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.631 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 23.5 m-85 -123.92 -35.63 2.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.944 HG23 ' CB ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -41.96 -53.8 7.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 50' ' ' VAL . 39.1 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 122.981 2.454 . . . . 0.0 111.633 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -111.69 2.07 17.04 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' ASP . 5.5 mm-40 -103.72 156.21 17.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 8.8 t70 55.13 166.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 109.611 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . -171.78 -54.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 2.1 t30 -165.78 -83.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -1.077 . . . . 0.0 108.985 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . -175.74 -34.17 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.439 ' C ' ' CD2' ' A' ' 62' ' ' HIS . 3.0 t-160 -58.84 -64.73 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.406 -1.055 . . . . 0.0 109.531 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 32' ' ' ASP . . . -47.67 -67.38 1.56 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.447 ' HA ' HG12 ' A' ' 35' ' ' ILE . 2.0 m -40.11 -52.37 2.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 2.6 t-80 -52.81 -50.78 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.858 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.743 HG12 HD11 ' A' ' 70' ' ' ILE . 24.3 t -57.49 -32.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 109.231 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -59.52 -51.05 71.52 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.296 -0.877 . . . . 0.0 109.696 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -72.85 -17.88 78.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.539 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 6.4 m -80.65 -17.28 51.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.168 -1.195 . . . . 0.0 108.246 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.743 HD11 HG12 ' A' ' 66' ' ' VAL . 23.1 mt -92.62 -31.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.615 -0.678 . . . . 0.0 109.944 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -174.55 33.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.38 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -37.27 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 109.665 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 41' ' ' LEU . 12.8 mt -39.85 159.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.987 ' HB2' HD12 ' A' ' 80' ' ' LEU . 7.6 t-20 -114.72 166.29 11.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 74' ' ' ASN . 0.4 OUTLIER 172.18 -93.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.407 -0.808 . . . . 0.0 109.28 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 -38.17 0.77 Allowed 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.762 -0.586 . . . . 0.0 109.48 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.518 HD11 ' HG2' ' A' ' 39' ' ' PRO . 4.4 pt -111.2 168.95 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.01 155.31 1.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 20.0 m -75.4 -154.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.276 -1.132 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.987 HD12 ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -145.9 122.35 11.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.482 -0.761 . . . . 0.0 109.423 -178.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.75 -163.79 4.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 4.7 t -82.57 -36.84 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.325 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.0 147.17 32.6 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.3 Cg_endo -83.61 -61.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.873 2.382 . . . . 0.0 110.407 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 86' ' ' ALA . 79.2 m-20 -99.53 -87.87 0.35 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.01 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.549 ' O ' ' ND2' ' A' ' 42' ' ' ASN . . . 57.26 157.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.866 . . . . 0.0 109.701 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' HG3' ' CE ' ' A' ' 27' ' ' LYS . 20.5 mm-40 -108.97 94.74 5.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 108.774 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 70' ' ' ILE . 2.5 mt -79.98 150.75 30.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.07 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.519 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 3.9 m-85 -127.29 154.48 44.86 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -0.794 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -123.73 104.09 8.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.752 ' CG2' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -108.03 78.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -178.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 33' ' ' THR . 10.8 tttt -44.75 96.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.9 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.594 HG11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -114.02 -9.8 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 109.084 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.3 mt -115.62 174.11 6.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.348 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -111.19 147.83 17.84 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -1.117 . . . . 0.0 109.666 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 155.99 28.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.801 -0.823 . . . . 0.0 109.8 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.21 -15.25 19.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.557 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -72.27 -27.77 62.7 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.944 ' CB ' HG23 ' A' ' 50' ' ' VAL . 65.8 p -80.03 -53.47 6.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 109.34 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.585 ' HA ' HG21 ' A' ' 93' ' ' VAL . 2.2 mt -61.55 -33.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.445 ' O ' ' CD ' ' A' ' 110' ' ' GLU . . . -65.17 -46.44 80.85 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.528 -0.732 . . . . 0.0 110.0 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.631 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -68.31 -40.86 81.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.558 -1.339 . . . . 0.0 108.873 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . -61.77 -21.05 60.36 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 109' ' ' LEU . 19.7 mt -92.98 -51.01 5.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.903 -1.351 . . . . 0.0 110.579 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.445 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -76.56 -6.97 54.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.862 -1.149 . . . . 0.0 109.646 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.652 ' CZ3' ' HA2' ' A' ' 116' ' ' GLY . 70.9 t90 -89.47 -9.76 48.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.55 -11.93 44.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.515 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -86.95 -22.93 43.52 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 -76.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -110.01 10.34 24.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 110.925 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -104.46 52.13 0.76 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.011 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.626 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 37.91 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.189 0.995 . . . . 0.0 112.905 178.074 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.763 ' O ' HG13 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -94.72 -29.14 14.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.369 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.746 HG22 ' NE2' ' A' ' 118' ' ' HIS . 1.9 t -97.43 153.82 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.323 -1.486 . . . . 0.0 109.004 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -169.23 113.71 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.963 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 1.05 ' C ' HD13 ' A' ' 122' ' ' LEU . 5.3 m-20 -112.36 152.98 27.96 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.05 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -136.56 121.66 19.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.277 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.407 ' CB ' ' NE2' ' A' ' 62' ' ' HIS . 18.2 m -85.59 66.35 9.61 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.9 178.8 9.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 160' ' ' SER . . . 156.23 113.33 0.42 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.77 158.48 34.73 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.469 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 31.6 Cg_endo -74.71 -3.64 14.2 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.165 1.91 . . . . 0.0 108.646 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.7 t -117.66 76.33 10.27 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -77.18 163.67 30.17 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.335 2.023 . . . . 0.0 110.909 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.29 146.27 46.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.449 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.89 -14.79 63.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.2 m -79.65 -23.59 42.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.23 -40.39 30.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -75.61 -41.46 54.3 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.495 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -61.55 -23.6 66.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.07 -42.77 65.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 2.1 t -68.81 -26.25 32.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.06 -33.11 75.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.5 -22.48 35.06 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -79.39 -19.21 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.08 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -35.62 40.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.03 -1.044 . . . . 0.0 108.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.4 p -54.85 -30.63 58.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.11 -17.83 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.8 78.86 0.65 Allowed Glycine 0 N--CA 1.475 1.273 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 118' ' ' HIS . 48.6 t -119.17 111.95 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -1.082 . . . . 0.0 109.387 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.63 102.74 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.926 -1.109 . . . . 0.0 109.268 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -98.73 143.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -135.58 116.15 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.757 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -104.77 148.4 26.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 109.614 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.58 162.46 25.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.226 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -69.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.0 109.877 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 160.72 -17.2 0.2 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.309 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 214' ' ' THR . 59.1 t-20 41.12 35.72 0.4 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.638 -0.919 . . . . 0.0 109.918 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -90.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 156.22 70.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.67 170.4 14.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -1.109 . . . . 0.0 109.296 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.91 52.82 4.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.0 OUTLIER 162.77 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -1.123 . . . . 0.0 109.121 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.432 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.6 OUTLIER -89.07 -177.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.159 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.882 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -102.46 166.67 10.41 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.773 0.797 . . . . 0.0 111.595 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.566 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 2.4 m-85 -85.39 144.86 41.23 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 45.2 Cg_endo -75.21 -31.02 5.59 Favored 'Cis proline' 0 C--N 1.293 -2.346 0 O-C-N 122.429 0.699 . . . . 0.0 111.016 3.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -17.78 -47.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -52.57 -54.8 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.078 -1.014 . . . . 0.0 110.583 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -42.36 -178.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.558 1.171 . . . . 0.0 111.229 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.75 0.81 8.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.043 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.11 21.56 4.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 108.865 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.14 20.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.419 ' HA ' ' CG ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -112.23 132.49 54.9 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -106.87 123.07 47.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 172' ' ' GLY . 25.4 t -90.34 166.13 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -137.94 166.81 25.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -117.15 140.84 49.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -1.144 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.408 HG23 ' HB ' ' A' ' 193' ' ' VAL . 11.7 p -109.23 174.65 5.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.91 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.25 -147.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.652 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -69.62 -53.45 18.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -86.23 -82.75 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.923 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.535 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 33.4 p-10 -166.23 43.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -105.93 166.44 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' NH2' HG11 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -72.74 106.38 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.824 ' HB3' ' HB3' ' A' ' 184' ' ' SER . . . -43.55 130.9 5.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 109.43 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.6 m -60.75 -30.36 69.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.038 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.553 ' CD2' ' OD1' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -92.54 -14.43 28.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.824 ' HB3' ' HB3' ' A' ' 181' ' ' ALA . 11.5 t -76.99 154.89 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.23 140.41 37.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CE2' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -123.9 171.19 9.88 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.418 -0.801 . . . . 0.0 109.339 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.587 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.51 142.31 4.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.37 118.47 6.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -1.122 . . . . 0.0 109.185 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 122.9 -6.53 9.53 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 257' ' ' TYR . 49.3 tp -45.81 154.63 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.181 -1.188 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.5 OUTLIER -99.51 -55.53 2.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.454 ' CD1' HG13 ' A' ' 262' ' ' VAL . 3.5 tt -151.87 172.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 0.0 109.872 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.477 HG11 ' NH2' ' A' ' 180' ' ' ARG . 8.3 m -136.83 166.83 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.292 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.736 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -168.99 167.71 5.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.169 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.736 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.99 117.24 4.12 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.481 2.121 . . . . 0.0 110.284 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -142.6 22.08 2.36 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 31.6 t -89.01 58.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -1.149 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.775 ' O ' HG13 ' A' ' 199' ' ' VAL . 17.8 t-20 131.69 122.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 198' ' ' ASN . 4.8 m -167.01 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.075 0.94 . . . . 0.0 109.075 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 29.3 mt-30 -87.41 141.52 28.57 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.597 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.588 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -148.7 -147.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -96.4 166.4 11.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.017 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.652 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.11 159.13 40.62 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.652 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.6 Cg_endo -71.71 167.4 26.63 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.41 2.073 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 77.76 4.04 84.71 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 78.04 33.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -1.0 . . . . 0.0 109.404 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -127.89 157.59 40.1 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.106 -0.996 . . . . 0.0 109.708 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -94.98 179.55 5.18 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.601 ' HB2' ' CG ' ' A' ' 203' ' ' TYR . . . -156.54 178.55 10.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.844 -1.16 . . . . 0.0 110.914 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.731 ' O ' HD23 ' A' ' 211' ' ' LEU . 55.0 p -159.72 110.54 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 210' ' ' SER . 1.7 mt -126.7 162.69 25.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.46 125.1 35.66 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.544 ' HA2' ' CE2' ' A' ' 183' ' ' PHE . . . 175.32 159.46 21.42 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.645 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -61.6 -30.2 70.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.916 . . . . 0.0 109.291 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 13.7 m -61.13 -27.3 68.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.485 ' HG2' ' CG2' ' A' ' 199' ' ' VAL . 0.7 OUTLIER -74.54 -24.32 58.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.335 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.476 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -85.38 -24.71 27.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.783 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.598 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 96.5 m -53.35 -44.33 97.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 111.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.0 Cg_endo -73.95 -24.56 15.08 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.727 1.618 . . . . 0.0 110.847 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -62.35 -41.23 98.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 192' ' ' ILE . 42.2 t -71.27 -48.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -49.24 -28.59 4.78 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.4 -58.5 4.22 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.28 -61.24 2.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -1.162 . . . . 0.0 109.289 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 229' ' ' LYS . . . -47.03 -41.75 17.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . . . -55.6 -44.23 76.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.589 HD13 ' HB1' ' A' ' 16' ' ' ALA . 22.4 mt -57.9 -47.22 83.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.227 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 46.9 t -55.94 -52.85 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.158 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 233' ' ' PRO . 0.0 OUTLIER -49.21 -38.95 27.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.465 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -60.1 -54.1 49.96 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.011 -1.056 . . . . 0.0 108.714 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -51.36 -20.97 1.95 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 108.551 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 176.82 89.29 0.11 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.729 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.554 ' N ' ' O ' ' A' ' 229' ' ' LYS . 36.4 Cg_endo -79.98 -24.88 5.49 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.792 2.328 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -53.2 -21.54 5.32 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -56.99 176.56 0.1 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.993 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.6 OUTLIER -105.24 171.72 7.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 110.023 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 237' ' ' ASN . 7.0 m-80 -55.72 -45.95 77.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.488 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.3 t -74.33 -51.53 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -40.72 -41.16 1.47 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 109.345 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 236' ' ' SER . 2.9 mt -74.46 -45.08 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 242' ' ' ASN . 1.6 ttm-85 -47.96 -71.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 241' ' ' ARG . 1.2 m-80 -35.15 -36.63 0.06 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.812 -0.555 . . . . 0.0 110.701 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.736 ' O ' HG23 ' A' ' 247' ' ' THR . 1.4 t-80 -69.0 -52.63 26.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.522 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.488 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.0 OUTLIER -66.91 -17.19 64.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.938 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -45.32 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.3 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 246' ' ' ASN . 1.2 m-20 -91.15 -5.26 55.28 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.15 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 243' ' ' HIS . 70.5 p -103.33 -52.55 2.99 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.912 -1.117 . . . . 0.0 110.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -43.41 151.48 0.17 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.791 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 250' ' ' SER . 31.5 m -70.68 157.64 37.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.404 ' N ' HG22 ' A' ' 249' ' ' THR . 54.7 p -129.7 111.47 12.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 178' ' ' ASN . 4.0 mp . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 256' ' ' LEU . 2.7 tm? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.8 ' O ' HD23 ' A' ' 190' ' ' LEU . 8.2 m-30 -64.08 -74.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.106 -0.996 . . . . 0.0 108.333 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 156.61 -177.26 33.66 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.6 t -46.74 -24.8 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 108.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.28 -137.49 12.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 261' ' ' LEU . 12.9 tp -102.47 169.1 8.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.989 . . . . 0.0 108.494 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.454 HG13 ' CD1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -111.27 157.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.878 -1.139 . . . . 0.0 110.311 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -164.94 118.08 1.25 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.458 1.123 . . . . 0.0 107.977 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.51 64.17 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.093 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.497 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 79.3 tt0 -68.96 -16.58 63.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.0 109.8 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -98.75 0.18 43.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -0.977 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -132.49 1.32 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.156 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -101.67 -41.79 6.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.025 -1.047 . . . . 0.0 109.89 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.494 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.909 ' O ' HG13 ' A' ' 4' ' ' VAL . 51.9 m . . . . . 0 C--O 1.213 -0.856 0 CA-C-O 121.086 0.47 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 178.3 66.2 0.1 Allowed Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 34.4 Cg_endo -76.67 173.98 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.457 2.105 . . . . 0.0 110.381 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -55.22 -11.94 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.588 -0.695 . . . . 0.0 110.899 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.66 -62.42 1.25 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.72 -1.238 . . . . 0.0 110.732 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -71.58 -0.78 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.114 -1.227 . . . . 0.0 110.247 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -104.61 -15.86 15.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.855 -1.153 . . . . 0.0 109.726 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.46 0.32 50.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.903 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 11' ' ' VAL . 3.3 m -114.5 26.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 O-C-N 120.764 -1.21 . . . . 0.0 110.258 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.474 ' HG3' ' HB2' ' A' ' 265' ' ' GLU . 21.2 mm100 46.59 55.88 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -89.07 -30.05 0.36 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.49 -0.756 . . . . 0.0 112.364 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.2 Cg_endo -74.15 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 109.026 -1.182 . . . . 0.0 109.026 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 -29.08 1.66 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.2 -39.52 40.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 109.161 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 27.4 m170 -65.76 -24.9 67.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -99.62 -16.68 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.787 -1.196 . . . . 0.0 110.631 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -66.55 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.017 -1.052 . . . . 0.0 109.742 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 1.056 ' C ' HD13 ' A' ' 21' ' ' LEU . . . 173.48 17.06 0.02 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.591 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.056 HD13 ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -134.85 153.99 51.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.505 -1.585 . . . . 0.0 108.659 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -138.92 42.23 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' HA2' ' NE2' ' A' ' 230' ' ' GLN . . . 50.52 14.79 1.05 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' ' C ' ' A' ' 22' ' ' THR . 0.6 OUTLIER -87.26 103.67 15.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -1.13 . . . . 0.0 109.884 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.74 -4.03 2.39 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.437 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG22 ' HD2' ' A' ' 229' ' ' LYS . 29.2 t -123.57 166.83 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 120.693 -1.475 . . . . 0.0 109.918 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -136.15 126.11 25.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.55 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 29' ' ' ALA . 57.8 t -113.41 161.79 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.513 -0.742 . . . . 0.0 109.708 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HB3' ' CB ' ' A' ' 120' ' ' ALA . . . -118.67 151.69 37.49 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.548 ' CG2' HD22 ' A' ' 88' ' ' LEU . 3.2 t -127.01 84.8 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.134 -0.979 . . . . 0.0 108.536 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.782 HD12 ' CG2' ' A' ' 91' ' ' VAL . 7.4 mp -73.13 93.46 1.82 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.4 p-10 -157.33 -161.78 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.973 -1.079 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.797 HG22 ' HA ' ' A' ' 96' ' ' ALA . 40.9 p -41.57 -51.55 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.84 . . . . 0.0 109.978 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.76 -47.12 0.48 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.642 HG23 ' HA ' ' A' ' 64' ' ' THR . 3.9 mt 73.95 105.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -65.47 158.13 27.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.815 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 101.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -104.96 148.56 36.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 32.9 Cg_endo -75.63 -17.13 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 110.583 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 41' ' ' LEU . 10.1 t70 -96.68 27.32 3.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.973 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.961 HD21 HG21 ' A' ' 202' ' ' THR . 13.9 mt -143.72 134.48 25.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.52 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 8.9 t30 -86.03 66.2 9.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.131 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 44' ' ' ARG . 3.4 mt -73.31 163.25 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.457 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -150.22 9.22 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.72 173.04 38.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.88 116.33 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . . . -116.06 163.92 15.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -1.086 . . . . 0.0 109.365 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.39 113.66 19.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 47' ' ' ALA . 7.5 m-85 -110.67 -21.81 11.92 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.692 HG21 ' O ' ' A' ' 94' ' ' LEU . 1.4 t -63.72 126.09 89.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 110.005 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 C--N 1.312 -1.383 0 C-N-CA 122.358 2.038 . . . . 0.0 109.712 178.321 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.439 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 1.4 m . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 121.741 0.781 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.409 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 7.7 t -103.89 -11.29 17.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.381 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 3.0 pm0 -81.57 110.54 17.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.664 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 33.3 t70 63.18 153.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.456 ' HA3' ' HB ' ' A' ' 33' ' ' THR . . . -154.77 -63.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.43 ' OD1' ' HB1' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -131.74 -53.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.131 . . . . 0.0 109.305 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.19 -33.6 1.23 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.228 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -61.23 -48.09 83.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.24 . . . . 0.0 109.874 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.04 -43.58 96.86 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.642 ' HA ' HG23 ' A' ' 35' ' ' ILE . 59.9 m -61.0 -37.87 84.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -1.144 . . . . 0.0 109.614 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.749 ' CD2' HD11 ' A' ' 211' ' ' LEU . 7.9 t-80 -63.68 -53.75 46.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 109.747 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' A' ' 219' ' ' PRO . 3.7 t -60.89 -28.45 43.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.42 -0.8 . . . . 0.0 109.29 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 70' ' ' ILE . . . -63.23 -46.77 85.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.739 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -66.11 -42.84 94.25 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -58.12 -24.98 60.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.189 -1.183 . . . . 0.0 109.059 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 67' ' ' ALA . 32.9 mt -82.85 -30.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.895 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -137.6 -51.47 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.991 -1.068 . . . . 0.0 111.11 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.1 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 40.21 79.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 42' ' ' ASN . 13.6 mt -34.71 155.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.362 -0.836 . . . . 0.0 111.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.464 ' OD1' HD22 ' A' ' 80' ' ' LEU . 1.3 t30 -99.84 120.98 40.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.556 -0.715 . . . . 0.0 109.918 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -167.47 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.047 -1.033 . . . . 0.0 109.044 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 -7.39 0.26 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.212 -0.93 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.5 pt -106.8 67.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.66 -1.275 . . . . 0.0 109.513 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.03 177.01 14.66 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.496 ' C ' ' OG ' ' A' ' 3' ' ' SER . 25.7 m -81.32 -166.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.304 -1.115 . . . . 0.0 109.84 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.85 ' N ' ' HB3' ' A' ' 3' ' ' SER . 15.8 tp -133.73 140.7 47.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 0.0 109.51 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 1.1 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -91.76 -169.02 41.2 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 227' ' ' LEU . 1.6 t -88.25 -36.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.93 -1.335 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -126.24 102.93 26.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.12 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 37.9 Cg_endo -84.75 -62.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.652 2.235 . . . . 0.0 109.858 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.62 -27.17 10.53 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.088 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -47.0 139.04 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 109.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.2 mp0 -74.79 97.35 3.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.263 -0.898 . . . . 0.0 109.225 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.548 HD22 ' CG2' ' A' ' 30' ' ' VAL . 2.7 mt -80.97 120.18 24.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.051 -1.031 . . . . 0.0 109.443 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 11.9 m-85 -104.77 153.37 21.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.341 -0.85 . . . . 0.0 109.432 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.456 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -115.21 101.9 9.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.782 ' CG2' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -96.98 67.11 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -37.58 95.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.901 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 105' ' ' ILE . 3.3 t -113.7 -23.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.406 -0.809 . . . . 0.0 108.969 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.692 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -92.98 173.34 7.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.314 -0.866 . . . . 0.0 108.719 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -98.03 -17.69 29.17 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.797 ' HA ' HG22 ' A' ' 33' ' ' THR . . . . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.13 152.51 42.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.892 -0.769 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 133' ' ' LEU . 41.0 t -68.27 -19.43 24.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -75.03 -18.51 60.33 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -91.3 -37.19 13.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.505 -0.747 . . . . 0.0 109.426 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.588 HG23 HG11 ' A' ' 93' ' ' VAL . 1.1 mt -77.04 -26.94 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 -44.33 18.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 104' ' ' SER . 10.1 pt20 -70.75 -31.11 67.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 0.0 109.009 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.93 -39.35 46.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -62.25 -39.66 93.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -1.128 . . . . 0.0 109.462 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 110' ' ' GLU . 1.6 tp10 -78.42 -19.64 52.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.132 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.674 ' CE3' ' HA3' ' A' ' 116' ' ' GLY . 84.8 t90 -65.95 -25.09 66.96 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.914 -1.116 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -88.45 -5.35 58.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.958 -1.089 . . . . 0.0 109.175 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -94.7 -6.59 60.69 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 19.7 t-20 -134.93 -4.71 2.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER 171.11 30.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.803 -1.186 . . . . 0.0 110.697 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.747 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -138.88 57.99 0.62 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.298 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.785 ' HE3' ' H ' ' A' ' 117' ' ' MET . 0.0 OUTLIER 63.22 175.57 0.16 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.447 -1.031 . . . . 0.0 112.26 176.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.685 ' CD2' ' N ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -104.0 -35.38 8.13 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.4 t -98.34 156.18 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.662 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.719 ' CB ' ' HB3' ' A' ' 29' ' ' ALA . . . -172.37 131.01 0.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 108.966 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 1.039 ' C ' HD13 ' A' ' 122' ' ' LEU . 3.0 m120 -117.58 148.25 42.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.039 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -125.22 114.48 19.03 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.132 -0.98 . . . . 0.0 108.951 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.446 ' C ' HD23 ' A' ' 124' ' ' LEU . 2.8 t -86.5 61.61 6.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.9 -173.71 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.872 0.844 . . . . 0.0 110.077 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 170.4 100.52 0.14 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -97.68 149.45 35.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.144 -1.209 . . . . 0.0 109.83 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.2 -5.39 15.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.351 2.034 . . . . 0.0 108.374 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.3 t -110.14 112.09 57.7 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.87 165.23 31.86 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.944 1.763 . . . . 0.0 109.881 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 120.54 6.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 110.5 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.34 65.49 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 52.9 m -63.38 -29.19 70.53 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -75.52 -35.31 60.77 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -75.14 -25.14 58.17 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.137 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.63 -24.23 59.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.48 -40.88 25.36 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.072 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.546 HG11 ' CB ' ' A' ' 167' ' ' ASN . 1.7 t -68.3 -30.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.72 -35.9 82.08 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.465 ' OG ' ' OE2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -78.17 -21.23 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' A' ' 145' ' ' VAL . . . -76.56 -29.7 56.77 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -73.96 -24.21 59.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 108.541 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -57.74 -38.82 76.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 0.0 108.878 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.34 -14.42 16.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 108.878 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.63 81.52 0.99 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 118' ' ' HIS . 94.1 t -119.23 109.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.6 tp -74.59 116.8 15.69 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.612 HG12 HD21 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -109.08 144.54 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -129.45 111.42 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.041 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.827 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -94.33 148.59 22.06 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.514 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -62.96 162.29 11.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.738 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 44.9 t -49.57 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 110.721 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.677 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 133.15 133.67 3.41 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -102.37 63.5 0.88 Allowed 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.617 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -117.69 75.2 0.98 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.435 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.63 ' O ' ' NE2' ' A' ' 185' ' ' GLN . . . -3.33 -62.2 0.0 OUTLIER Glycine 0 N--CA 1.507 3.409 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 154' ' ' SER . . . -46.77 173.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -1.102 . . . . 0.0 109.561 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.14 58.62 4.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 m -143.17 134.76 26.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.154 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.614 HD12 ' HB1' ' A' ' 163' ' ' ALA . 6.8 pt -87.19 177.68 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.972 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.5 OUTLIER -87.05 160.89 18.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.362 -0.836 . . . . 0.0 111.818 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.462 ' CZ ' ' HD2' ' A' ' 164' ' ' ARG . 5.1 m-85 -83.5 141.99 42.67 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.827 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 45.0 Cg_endo -74.73 -30.75 5.77 Favored 'Cis proline' 0 C--N 1.3 -2.023 0 O-C-N 122.421 0.695 . . . . 0.0 111.489 3.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.972 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -15.72 -50.21 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-O 121.124 0.488 . . . . 0.0 111.87 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 162' ' ' PRO . 10.9 ttm180 -50.39 -59.76 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.172 -0.955 . . . . 0.0 110.36 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -46.34 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.462 1.125 . . . . 0.0 111.046 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.93 -2.55 9.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.546 ' CB ' HG11 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -81.65 7.9 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 109.398 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . . . -153.77 139.99 18.49 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.544 ' SD ' HG23 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -85.28 146.66 26.94 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.013 -1.054 . . . . 0.0 109.626 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -109.73 123.76 50.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.3 t -84.3 166.08 2.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.965 -1.085 . . . . 0.0 109.764 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.577 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -129.85 -176.67 14.52 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.491 ' CB ' HG23 ' A' ' 214' ' ' THR . . . -134.35 150.03 50.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -1.2 . . . . 0.0 109.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 179' ' ' ASN . 71.0 p -134.21 153.35 51.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -172.05 1.86 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -23.56 64.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.054 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.79 -87.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.43 ' OD1' HD21 ' A' ' 251' ' ' LEU . 2.9 m-20 177.13 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.99 . . . . 0.0 109.824 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.686 ' O ' HG22 ' A' ' 174' ' ' THR . 7.7 t-20 -136.35 -161.21 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.662 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 mtp85 -87.87 12.51 12.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 72.2 4.42 5.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.56 -6.61 0.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 112.195 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.488 ' CE2' ' HB1' ' A' ' 181' ' ' ALA . 39.3 p90 -134.89 -5.58 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.318 -1.489 . . . . 0.0 110.286 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.3 t -78.08 132.17 37.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 108.403 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.677 ' HB2' ' O ' ' A' ' 152' ' ' GLY . 1.8 tp60 -88.79 149.29 23.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.097 . . . . 0.0 110.83 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.655 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -121.68 176.44 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 108.918 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.655 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.53 178.62 47.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.46 145.45 50.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.248 . . . . 0.0 109.577 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.61 7.8 88.19 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.36 141.03 58.7 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.127 -1.22 . . . . 0.0 108.719 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.543 ' OD1' ' CE ' ' A' ' 245' ' ' LYS . 35.9 t0 -84.4 -79.75 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 110.935 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.484 ' CG2' ' C ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -154.13 -161.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.072 . . . . 0.0 110.151 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 260' ' ' GLY . 26.9 m -124.94 168.91 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.908 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 1.026 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -159.92 177.2 2.16 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.946 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.7 Cg_endo -76.47 115.99 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.173 1.915 . . . . 0.0 110.571 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.31 53.44 0.65 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 39.0 t -138.12 87.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 199' ' ' VAL . 7.6 t30 81.53 119.88 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 198' ' ' ASN . 4.3 m -162.35 114.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.078 0.942 . . . . 0.0 108.974 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -76.31 122.84 25.01 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.751 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -131.72 -169.54 2.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.524 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.961 HG21 HD21 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.89 173.4 12.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.307 -0.871 . . . . 0.0 110.307 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.654 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -151.36 166.95 14.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.654 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.3 Cg_endo -73.45 166.11 30.71 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.127 1.885 . . . . 0.0 110.704 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.43 -60.7 4.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 4.7 p 150.81 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 122.025 -0.691 . . . . 0.0 109.826 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -142.8 -179.37 6.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.542 ' N ' ' OG1' ' A' ' 207' ' ' THR . 0.0 OUTLIER -130.89 165.71 22.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.532 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.95 149.15 15.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . 1.029 ' O ' HD23 ' A' ' 211' ' ' LEU . 1.1 t -93.09 140.18 29.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 1.029 HD23 ' O ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -145.94 151.19 37.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 213' ' ' GLY . 1.3 t-20 -104.95 168.45 9.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 212' ' ' ASN . . . 147.51 168.52 14.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.491 HG23 ' CB ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -85.43 -38.07 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -1.059 . . . . 0.0 109.049 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.545 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 1.4 t -60.04 -15.25 21.26 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.464 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 25.3 mmt -64.99 -35.34 80.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.393 -0.817 . . . . 0.0 109.599 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 1.026 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -84.44 -6.77 59.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.769 . . . . 0.0 110.783 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.627 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.5 m -69.06 -45.1 29.87 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 111.734 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.7 Cg_endo -73.37 -16.11 24.8 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.979 1.786 . . . . 0.0 111.118 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.443 ' NE2' HD12 ' A' ' 8' ' ' ILE . 6.4 m80 -74.57 -41.27 60.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 108.424 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 262' ' ' VAL . 60.2 t -71.18 -41.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.71 -37.96 69.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.097 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.23 -49.59 45.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.48 -60.49 3.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -1.192 . . . . 0.0 109.603 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -44.56 -47.53 10.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.779 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.59 57.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.963 -1.086 . . . . 0.0 109.184 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 82' ' ' VAL . 39.2 mt -52.13 -40.56 61.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.469 HG21 ' HG ' ' A' ' 244' ' ' LEU . 68.7 t -58.79 -49.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 108.759 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.57 ' HD2' HG22 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -45.68 -45.69 14.3 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -60.78 -48.67 80.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.426 -0.796 . . . . 0.0 110.132 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.417 ' C ' ' CG ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -59.14 -14.38 10.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.278 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.417 ' CG ' ' C ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -174.68 95.63 0.29 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.951 . . . . 0.0 110.004 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.7 -20.27 9.33 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.591 2.194 . . . . 0.0 110.379 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.99 -42.82 95.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 0.0 110.188 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -52.39 173.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.534 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.1 OUTLIER -135.8 158.63 43.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.995 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 236' ' ' SER . 1.1 m-80 -15.78 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 236' ' ' SER . 2.9 t -73.79 -65.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.013 -1.054 . . . . 0.0 110.329 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -40.51 -27.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.27 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 238' ' ' VAL . 63.7 mt -82.02 -49.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -56.27 -22.5 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.127 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 243' ' ' HIS . 2.4 t-20 -71.07 -69.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.768 -1.208 . . . . 0.0 110.339 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.413 ' N ' ' OD1' ' A' ' 242' ' ' ASN . 9.9 t60 -55.84 -39.72 71.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.81 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.1 OUTLIER -64.46 -43.06 95.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 111.001 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -77.48 -21.99 51.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.976 -1.078 . . . . 0.0 109.647 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.58 -19.94 28.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.071 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 267' ' ' ALA . 0.9 OUTLIER -87.91 -27.22 22.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.303 1.049 . . . . 0.0 109.107 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -46.68 131.63 11.37 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.726 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 92.9 m -52.96 133.95 37.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.018 . . . . 0.0 109.767 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 99.4 p -93.06 94.2 8.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 261' ' ' LEU . 5.7 mp . . . . . 0 C--N 1.304 -1.387 0 O-C-N 121.178 -0.951 . . . . 0.0 109.936 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.964 0.412 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.462 ' OH ' ' OD1' ' A' ' 179' ' ' ASN . 12.9 m-30 -83.98 10.09 10.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 38.93 74.84 0.11 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 2.8 t 84.56 -58.61 0.1 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.692 -0.887 . . . . 0.0 109.794 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.827 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 144.05 -131.57 4.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.487 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 52.6 tp -94.8 166.31 12.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.637 -0.919 . . . . 0.0 109.659 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 221' ' ' VAL . 5.5 t -104.97 156.64 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.351 -0.843 . . . . 0.0 109.725 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -168.09 118.88 0.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.303 1.049 . . . . 0.0 108.543 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 268' ' ' THR . . . -76.67 -15.89 59.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.718 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.474 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -67.65 -41.19 84.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.711 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.36 -8.42 59.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.404 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -99.59 -21.77 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.218 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.503 ' O ' ' C ' ' A' ' 269' ' ' ARG . 25.2 p -112.54 -55.69 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.181 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 268' ' ' THR . 3.1 ttt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 66.8 m . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -140.52 106.45 6.5 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.85 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.97 178.02 8.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.367 2.044 . . . . 0.0 109.771 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -5.6 16.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.1 -63.29 1.74 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 9' ' ' SER . 1.7 mp -75.82 113.39 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.11 -1.229 . . . . 0.0 109.146 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 11.8 p 168.1 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.848 ' HB3' HD21 ' A' ' 261' ' ' LEU . 2.3 mmt180 -77.81 -21.68 51.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 220' ' ' HIS . 4.0 m -86.41 14.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.081 -1.012 . . . . 0.0 109.894 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.521 ' OE1' ' HB3' ' A' ' 15' ' ' ALA . 22.2 mm-40 45.05 57.92 4.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.476 -0.765 . . . . 0.0 109.69 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.701 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.07 -30.94 0.47 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.451 -0.781 . . . . 0.0 111.82 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 33.1 Cg_endo -76.14 -55.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.232 1.288 . . . . 0.0 109.0 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . . . -49.64 -27.34 4.52 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.203 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.87 -32.84 24.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.863 -1.148 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 22.1 m170 -75.75 -20.79 58.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.505 ' OD1' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -110.31 -25.77 9.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.584 -1.322 . . . . 0.0 110.38 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 3.9 tpm_? -56.16 -25.35 46.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.0 -1.062 . . . . 0.0 109.47 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.87 0.7 3.87 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 268' ' ' THR . 2.4 mt -102.81 151.83 21.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -1.178 . . . . 0.0 109.172 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.483 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -137.78 -2.66 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.183 -0.948 . . . . 0.0 110.853 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 22' ' ' THR . . . 48.83 18.6 1.11 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.483 ' N ' ' C ' ' A' ' 22' ' ' THR . 40.7 t -72.86 9.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.569 -0.96 . . . . 0.0 111.405 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.37 37.25 1.9 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.281 -1.437 . . . . 0.0 110.144 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 27' ' ' LYS . 53.2 t -120.93 163.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.857 -1.378 . . . . 0.0 110.025 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . 21.3 mttp -127.12 128.62 46.5 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.532 -0.73 . . . . 0.0 109.115 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 43.6 t -131.5 153.79 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.028 -1.045 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -115.23 160.27 19.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.066 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 35' ' ' ILE . 7.2 t -133.09 90.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.109 -0.994 . . . . 0.0 108.919 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.973 HD23 HG21 ' A' ' 93' ' ' VAL . 8.7 mp -80.44 123.43 28.05 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 7.8 p30 173.48 -164.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.908 -1.12 . . . . 0.0 109.815 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.3 p -42.38 -65.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -172.28 -132.37 1.49 Allowed Glycine 0 C--N 1.302 -1.341 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.701 HG13 ' HB2' ' A' ' 90' ' ' ALA . 30.3 mm -165.32 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.46 ' HB3' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -53.09 142.39 20.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.989 . . . . 0.0 109.267 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 117.16 13.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 152.74 72.36 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.196 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 -21.33 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.532 2.155 . . . . 0.0 110.713 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -81.01 -17.32 50.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD21 ' HA2' ' A' ' 68' ' ' GLY . 29.8 mt -101.39 149.75 23.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.07 88.26 2.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.134 -0.979 . . . . 0.0 109.392 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 43' ' ' ILE . 23.4 mm -65.92 100.01 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -93.81 -11.42 31.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.27 -0.894 . . . . 0.0 109.31 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -174.65 169.59 42.57 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.78 130.33 1.92 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.07 170.78 14.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.375 -1.074 . . . . 0.0 108.944 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 93.8 p -140.84 112.74 7.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.097 -1.002 . . . . 0.0 110.493 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.941 ' CE2' HG12 ' A' ' 91' ' ' VAL . 3.7 m-85 -106.92 -47.71 3.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.401 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.711 HG21 ' O ' ' A' ' 94' ' ' LEU . 2.6 t -39.99 144.54 0.52 Allowed Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HD2' HG13 ' A' ' 50' ' ' VAL . 32.2 Cg_endo . . . . . 0 C--N 1.313 -1.317 0 C-N-CA 122.516 2.144 . . . . 0.0 110.43 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 48' ' ' SER . 0.7 OUTLIER -77.86 -0.36 27.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 108.689 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -129.32 146.43 51.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 179.245 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 15.1 t70 64.03 154.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.72 -30.32 0.12 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -167.29 -55.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -1.171 . . . . 0.0 109.374 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.94 -10.37 3.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -54.18 11.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -1.168 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -58.62 -39.98 94.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 36' ' ' SER . 2.9 m -63.8 -32.74 74.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -1.096 . . . . 0.0 108.973 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.733 ' CE1' ' HG ' ' A' ' 201' ' ' SER . 0.6 OUTLIER -67.21 -57.25 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 110.257 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.975 HG13 ' HB3' ' A' ' 219' ' ' PRO . 13.4 t -60.17 -32.47 50.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.341 -0.849 . . . . 0.0 109.796 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.4 ' C ' HD21 ' A' ' 41' ' ' LEU . . . -65.17 -43.04 93.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.691 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -73.49 -38.33 52.16 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.521 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.48 HG21 ' CE1' ' A' ' 220' ' ' HIS . 29.8 m -65.09 -21.66 66.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 108.919 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 219' ' ' PRO . 49.6 mt -89.86 -23.58 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 109.352 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -126.46 -57.51 1.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 111.703 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.082 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 36.68 87.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 73' ' ' LEU . 19.7 mt -60.29 149.82 32.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.733 -1.229 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 11.4 p30 -91.77 87.29 6.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 76' ' ' SER . 14.8 p30 -126.84 -120.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.204 -0.935 . . . . 0.0 108.828 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.423 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -124.43 -34.51 2.89 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.076 -1.015 . . . . 0.0 109.38 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.0 pt -100.32 67.39 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.305 -0.872 . . . . 0.0 109.486 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.24 158.99 9.54 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 34.8 m -87.31 -135.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.175 -1.191 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.47 ' N ' HG23 ' A' ' 79' ' ' VAL . 31.6 tp -140.64 123.09 16.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.697 -1.252 . . . . 0.0 110.263 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 1.082 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -87.57 -153.02 24.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.458 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.87 -60.18 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.906 -1.35 . . . . 0.0 109.332 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.688 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -89.36 112.56 52.15 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.246 -0.909 . . . . 0.0 109.174 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -84.69 -62.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.519 2.146 . . . . 0.0 110.947 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' CB ' ' HA ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -81.74 18.5 1.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.24 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.688 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -80.99 143.69 32.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.876 -1.14 . . . . 0.0 109.11 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 4.9 pt-20 -84.69 115.1 22.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.913 -1.117 . . . . 0.0 109.198 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 88' ' ' LEU . 4.1 mt -92.4 123.75 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.93 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 13.0 m-85 -106.59 152.61 23.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.701 ' HB2' HG13 ' A' ' 35' ' ' ILE . . . -113.69 102.83 10.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.366 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.941 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.76 69.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 108.93 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -38.28 112.07 0.2 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.312 0.577 . . . . 0.0 110.199 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.973 HG21 HD23 ' A' ' 31' ' ' LEU . 2.1 t -120.19 -17.67 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.256 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.711 ' O ' HG21 ' A' ' 50' ' ' VAL . 76.5 mt -98.45 172.97 7.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . -122.48 12.4 8.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 C--N 1.288 -2.079 0 O-C-N 121.979 -0.718 . . . . 0.0 109.796 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.2 150.98 48.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.883 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.564 HG21 ' OG ' ' A' ' 130' ' ' SER . 44.9 t -68.47 -20.8 25.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -79.25 -55.04 5.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.87 HG23 HG11 ' A' ' 93' ' ' VAL . 1.3 mt -62.29 -25.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 -45.75 68.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.593 -0.692 . . . . 0.0 110.167 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.545 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -67.12 -39.41 86.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.933 -1.104 . . . . 0.0 108.638 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.85 -19.23 73.26 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.51 -42.45 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -1.233 . . . . 0.0 110.184 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 139' ' ' SER . 6.5 pt-20 -94.86 -2.64 50.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.005 -1.059 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 71.4 t90 -86.21 -14.95 42.38 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.825 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.51 -7.19 59.65 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.415 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -91.27 -46.42 3.82 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.654 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.67 -71.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.129 -1.218 . . . . 0.0 110.028 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -109.48 35.25 3.38 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.825 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -114.88 -153.92 10.62 Favored Glycine 0 C--N 1.291 -1.92 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.596 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.78 ' HE1' ' O ' ' A' ' 116' ' ' GLY . 17.9 mmt -118.59 -172.92 2.37 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.882 0.849 . . . . 0.0 111.46 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.849 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -86.16 -27.86 24.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.831 -0.543 . . . . 0.0 110.223 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' HIS . 15.5 t -114.02 159.77 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.848 -1.157 . . . . 0.0 109.569 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.576 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -163.9 114.16 1.29 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.492 ' OD1' ' HB ' ' A' ' 148' ' ' VAL . 64.8 t30 -98.53 159.27 15.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.05 . . . . 0.0 110.441 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.609 HD23 HD21 ' A' ' 124' ' ' LEU . 3.7 mp -131.99 104.51 6.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.3 59.35 5.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.609 HD21 HD23 ' A' ' 122' ' ' LEU . 1.4 pp -154.49 -175.19 5.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.386 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 173.57 103.09 0.16 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.361 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.51 148.69 35.31 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.297 -1.119 . . . . 0.0 108.914 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -75.95 -2.1 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.348 2.032 . . . . 0.0 109.554 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 m -103.63 110.53 64.04 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.768 -0.583 . . . . 0.0 110.108 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.39 169.04 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.232 1.954 . . . . 0.0 109.33 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.564 ' OG ' HG21 ' A' ' 102' ' ' VAL . 1.4 m -159.52 126.83 4.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.872 -1.143 . . . . 0.0 110.965 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.34 65.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 m -64.32 -30.06 71.12 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -34.23 66.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.533 ' HA ' ' OH ' ' A' ' 165' ' ' TYR . 26.8 tt0 -68.29 -53.39 24.77 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.412 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -51.21 -25.97 6.29 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.06 -1.025 . . . . 0.0 108.296 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.69 -49.26 26.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.627 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.81 -20.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.86 -37.81 85.15 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.94 -27.79 60.34 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.99 -20.75 57.6 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 121.063 -1.023 . . . . 0.0 109.798 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -76.78 -33.56 58.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -24.62 58.33 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.829 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 143' ' ' ARG . 0.9 OUTLIER -106.42 -22.19 12.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.646 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.18 62.16 2.13 Favored Glycine 0 C--N 1.301 -1.411 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 48.4 t -103.22 118.84 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.43 115.43 17.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 108.797 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -111.34 132.45 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.129 -0.982 . . . . 0.0 109.884 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.785 HG12 ' O ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -114.18 166.66 7.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.806 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -150.6 132.72 15.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 0.0 109.67 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -53.26 155.79 2.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.435 -0.791 . . . . 0.0 109.499 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 185' ' ' GLN . 0.1 OUTLIER -61.81 -66.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 155.52 -16.08 0.48 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.6 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 153' ' ' ASN . 11.7 t-20 44.69 40.01 3.83 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.726 -0.867 . . . . 0.0 109.535 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.6 -26.79 9.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.64 102.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 175.19 -177.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 109.547 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 186' ' ' TYR . . . -94.29 59.56 1.94 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.4 t 169.86 154.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.182 . . . . 0.0 109.67 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.617 HD11 ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -114.13 -171.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.821 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.967 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.6 OUTLIER -85.89 162.53 18.55 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.011 0.91 . . . . 0.0 112.012 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.49 139.86 20.96 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.2 Cg_endo -74.9 -36.74 2.49 Favored 'Cis proline' 0 C--N 1.294 -2.291 0 O-C-N 122.836 0.914 . . . . 0.0 110.992 3.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.967 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 8.46 -71.93 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.961 0.886 . . . . 0.0 110.729 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.642 ' N ' ' O ' ' A' ' 162' ' ' PRO . 23.9 ttt-85 -45.93 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER 28.29 -161.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.801 1.286 . . . . 0.0 112.586 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -134.7 -31.0 1.07 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.449 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -100.93 19.13 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 147' ' ' VAL . . . -135.75 167.15 21.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.785 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -122.68 136.04 54.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.006 -1.059 . . . . 0.0 109.538 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 190' ' ' LEU . . . -98.06 154.06 17.98 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 18.9 t -111.98 167.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -135.18 -158.99 8.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 193' ' ' VAL . . . -127.2 166.65 17.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.312 -1.11 . . . . 0.0 109.929 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.612 ' CG2' HG23 ' A' ' 193' ' ' VAL . 22.8 p -139.19 150.74 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.543 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.461 ' OD2' ' HB3' ' A' ' 179' ' ' ASN . 3.5 p30 -76.44 -174.09 2.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 110.176 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.13 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -81.73 -89.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.127 -0.983 . . . . 0.0 109.345 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.767 ' C ' HD23 ' A' ' 251' ' ' LEU . 1.4 m120 -174.93 67.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 174' ' ' THR . 38.2 t30 -146.43 -176.08 5.03 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.137 -0.977 . . . . 0.0 109.714 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -66.04 3.7 0.8 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.56 -0.713 . . . . 0.0 111.887 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 66.88 -145.94 0.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.133 -1.604 . . . . 0.0 108.413 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.21 -43.71 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.845 -1.159 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -87.75 35.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.447 -0.783 . . . . 0.0 110.499 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.7 t -94.11 127.59 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 5.2 tp60 -66.23 114.38 5.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.561 ' CE1' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -106.02 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.805 -179.06 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 143.32 158.33 7.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.3 97.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.492 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.534 ' C ' HD11 ' A' ' 159' ' ' ILE . . . 151.68 -23.4 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.617 ' N ' HD11 ' A' ' 159' ' ' ILE . 11.0 tp -59.31 127.13 30.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.18 -1.188 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.499 ' O ' ' HA3' ' A' ' 258' ' ' GLY . 0.4 OUTLIER -90.95 -54.46 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.627 -179.058 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.791 HD12 ' HB2' ' A' ' 259' ' ' SER . 1.8 tt -158.02 167.48 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.168 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 260' ' ' GLY . 33.4 m -112.26 166.29 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.929 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -152.9 176.36 2.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 108.832 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.929 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.12 116.55 4.2 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.341 2.027 . . . . 0.0 110.465 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.15 16.86 1.53 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 18.6 t -88.3 61.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -1.085 . . . . 0.0 108.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.642 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 20.9 t-20 108.51 125.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 198' ' ' ASN . 23.7 m -162.65 111.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.955 0.883 . . . . 0.0 108.665 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 15.8 pt20 -89.22 127.62 35.77 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.733 ' HG ' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -135.13 -160.94 1.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.85 168.54 16.01 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 110.038 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.673 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.43 166.26 16.03 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.673 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.1 Cg_endo -73.79 168.8 23.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.135 1.89 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 71.04 17.22 75.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER 66.1 33.03 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -1.165 . . . . 0.0 109.713 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.56 163.14 23.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 201' ' ' SER . 2.7 m-85 -106.93 -172.95 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -171.0 139.62 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.5 m -106.75 108.78 20.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.43 154.26 21.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.943 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.36 84.84 2.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.97 150.88 22.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.7 m -65.02 -22.61 67.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -1.071 . . . . 0.0 109.469 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.65 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 3.4 t -71.36 -23.0 61.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.415 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -75.6 -16.12 60.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -93.46 3.72 55.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 109.876 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.672 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 23.7 m -77.4 -35.69 1.36 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.986 . . . . 0.0 111.972 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.975 ' HB3' HG13 ' A' ' 66' ' ' VAL . 30.6 Cg_endo -73.41 -29.02 11.62 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.301 1.334 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' A' ' 69' ' ' THR . 29.9 m80 -59.63 -40.85 88.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.834 -1.166 . . . . 0.0 108.057 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 262' ' ' VAL . 63.5 t -70.35 -43.32 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.36 -31.33 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -72.4 -59.77 4.38 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -43.69 -49.69 7.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.2 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.21 -45.91 72.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.365 -0.835 . . . . 0.0 108.776 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 229' ' ' LYS . . . -51.93 -49.78 62.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.868 . . . . 0.0 109.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.6 mt -49.35 -50.12 41.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 108.973 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.29 -45.36 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.595 ' HE3' ' CD2' ' A' ' 118' ' ' HIS . 12.3 tppt? -49.64 -43.17 46.71 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.447 -0.783 . . . . 0.0 108.986 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -61.64 -45.96 91.8 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.5 tppm? -62.53 -13.11 27.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 108.794 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -163.33 85.75 1.33 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.509 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 36.7 Cg_endo -80.4 31.85 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.37 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.5 t -146.94 11.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.873 -1.142 . . . . 0.0 109.914 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -87.36 -179.02 6.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 110.032 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.849 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -109.74 173.67 6.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.289 0.566 . . . . 0.0 109.648 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.585 ' OD1' HG23 ' A' ' 238' ' ' VAL . 8.5 p30 -62.99 -32.94 74.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.201 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.585 HG23 ' OD1' ' A' ' 237' ' ' ASN . 2.9 t -77.07 -61.98 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.925 0.869 . . . . 0.0 109.181 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 238' ' ' VAL . 4.1 mt-30 -42.65 -38.23 1.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.72 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 236' ' ' SER . 7.5 mt -74.04 -47.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 3.1 tmt_? -52.37 -20.66 2.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.414 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 1.6 t-20 -78.13 -38.06 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.852 -1.155 . . . . 0.0 109.945 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.41 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.0 t-160 -75.74 -40.47 55.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.153 -0.967 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.5 OUTLIER -73.64 -32.92 64.28 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.511 -0.743 . . . . 0.0 110.333 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 1.3 tmtt? -77.93 -42.32 33.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.093 . . . . 0.0 108.983 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 4.5 m-20 -67.77 -22.83 65.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.552 -0.718 . . . . 0.0 109.989 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.569 HG21 ' HB2' ' A' ' 267' ' ' ALA . 2.3 p -91.85 -26.09 18.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.916 -1.115 . . . . 0.0 110.04 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -37.01 114.46 0.32 Allowed 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.794 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 250' ' ' SER . 65.9 m -45.06 164.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 0.0 109.08 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.549 ' N ' HG22 ' A' ' 249' ' ' THR . 23.2 t -115.58 102.2 9.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 251' ' ' LEU . 6.4 mp . . . . . 0 C--N 1.306 -1.324 0 O-C-N 121.265 -0.897 . . . . 0.0 110.0 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 258' ' ' GLY . 2.5 tp . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.647 ' O ' ' CG ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER 23.34 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 123.063 1.411 . . . . 0.0 111.774 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 256' ' ' LEU . . . 54.11 -136.14 42.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.791 ' HB2' HD12 ' A' ' 192' ' ' ILE . 6.8 m -101.54 -3.4 28.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.438 -1.037 . . . . 0.0 109.545 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 110.27 -112.63 3.35 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.755 -1.212 . . . . 0.0 110.726 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 10' ' ' ARG . 37.7 tp -115.49 159.22 21.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.511 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -110.59 159.86 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.825 . . . . 0.0 109.191 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -168.05 119.24 0.82 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.363 1.078 . . . . 0.0 108.731 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 268' ' ' THR . . . -69.97 -15.12 62.99 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.317 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.465 ' HB3' ' HG3' ' A' ' 12' ' ' GLN . 78.8 tt0 -74.33 -26.81 60.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.014 -1.054 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 247' ' ' THR . . . -90.79 3.28 54.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 247' ' ' THR . . . -128.69 0.82 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 264' ' ' ALA . 21.4 p -107.49 -42.49 4.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.222 -0.924 . . . . 0.0 109.09 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 268' ' ' THR . 9.5 mtm180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.521 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 14.9 m . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.455 0.645 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.674 HG11 HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.28 148.65 60.42 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 108.982 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HB3' ' OE1' ' A' ' 200' ' ' GLN . 34.9 Cg_endo -77.78 166.29 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.382 2.055 . . . . 0.0 110.735 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 9' ' ' SER . 4.8 p-90 -50.11 -19.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.491 -0.756 . . . . 0.0 110.556 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.61 -43.92 98.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.674 HG21 HG11 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -90.6 -25.71 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.123 -1.222 . . . . 0.0 110.057 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 6' ' ' TRP . 18.7 t -64.31 -20.58 66.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.932 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -0.68 38.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 111.398 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.592 HG23 ' HB2' ' A' ' 13' ' ' ALA . 11.1 m -106.13 25.46 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 120.542 -1.349 . . . . 0.0 110.134 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.56 ' O ' ' HB3' ' A' ' 264' ' ' ALA . 2.9 mp0 47.08 28.89 0.99 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -70.14 -36.17 5.86 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 111.704 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.42 -57.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.509 -1.381 . . . . 0.0 108.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.18 -33.52 0.94 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.62 60.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.162 -0.961 . . . . 0.0 108.819 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 17' ' ' HIS . 1.3 m170 -73.08 -3.3 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.78 . . . . 0.0 109.444 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -53.35 5.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.076 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.644 ' HD2' HD13 ' A' ' 21' ' ' LEU . 1.9 ptp180 -54.86 -18.02 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.65 35.13 2.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -93.21 160.81 14.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.164 -1.198 . . . . 0.0 109.407 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -133.89 -53.32 0.86 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.762 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 83.73 -13.81 45.75 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 2.8 t -51.58 139.72 19.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -1.079 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.31 -15.81 11.83 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 27' ' ' LYS . 45.3 t -93.26 169.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -1.089 . . . . 0.0 109.173 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -137.25 120.41 16.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.163 -0.961 . . . . 0.0 109.389 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.81 134.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -90.31 146.54 24.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.356 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 30' ' ' VAL . 16.2 t -119.23 80.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.23 -0.919 . . . . 0.0 108.938 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.635 HD23 HG21 ' A' ' 93' ' ' VAL . 8.5 mp -72.08 87.44 1.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 109.364 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 54.8 p30 -151.78 -148.51 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 1.2 p -56.86 -72.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.098 -1.001 . . . . 0.0 109.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.584 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -170.99 -110.47 0.24 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.584 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 157.12 115.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 38' ' ' HIS . 2.6 m -83.91 60.38 5.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 111.425 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 37' ' ' THR . 15.0 t 23.18 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.773 0.797 . . . . 0.0 111.22 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.86 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -51.52 161.98 0.76 Allowed Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.11 -29.38 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.465 2.11 . . . . 0.0 110.332 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.632 ' OD1' HG21 ' A' ' 202' ' ' THR . 0.7 OUTLIER -95.26 18.05 13.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 109.565 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.86 HD12 ' HB2' ' A' ' 38' ' ' HIS . 83.5 mt -125.42 124.42 41.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.908 . . . . 0.0 109.291 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.9 t-20 -74.82 120.36 20.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 35' ' ' ILE . 21.7 mm -103.3 96.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.145 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HG2' ' CG ' ' A' ' 87' ' ' GLU . 4.8 tpm_? -88.28 -38.66 15.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.66 -166.11 32.68 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.5 171.16 16.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.65 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -156.3 160.24 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.991 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 56' ' ' THR . 26.5 m -122.88 106.4 10.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.932 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -102.46 -33.17 9.62 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 109.159 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.732 HG13 ' HD2' ' A' ' 51' ' ' PRO . 70.5 t -49.33 142.53 10.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 0.0 109.028 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.732 ' HD2' HG13 ' A' ' 50' ' ' VAL . 33.6 Cg_endo . . . . . 0 C--N 1.31 -1.481 0 C-N-CA 122.519 2.146 . . . . 0.0 110.449 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.403 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 3.3 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.457 0.646 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.473 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -52.26 -20.13 2.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 36' ' ' SER . 18.3 mt-30 -118.82 152.4 36.3 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.379 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 63.56 165.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.311 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 169.78 -35.26 0.18 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 6.6 t30 173.72 -62.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . 168.72 -36.3 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -22.69 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -1.098 . . . . 0.0 109.391 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 65' ' ' HIS . . . -72.48 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.832 HG23 HD11 ' A' ' 41' ' ' LEU . 37.7 m -34.01 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.744 -0.857 . . . . 0.0 110.931 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.626 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -71.95 -52.83 15.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 110.282 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 219' ' ' PRO . 46.1 t -63.57 -37.02 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.447 -0.783 . . . . 0.0 109.933 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.591 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -74.98 -28.2 62.99 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 220' ' ' HIS . 62.1 m -69.89 -18.56 63.41 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.34 -1.094 . . . . 0.0 108.341 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.416 HD12 ' O ' ' A' ' 66' ' ' VAL . 7.3 mt -94.03 -38.49 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 110.004 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.914 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -175.62 46.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.867 -1.146 . . . . 0.0 111.156 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -45.14 108.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.804 -1.185 . . . . 0.0 108.924 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.9 HD23 ' O ' ' A' ' 84' ' ' PRO . 80.4 mt -42.26 142.28 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 109.935 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -86.28 109.46 18.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.283 -0.885 . . . . 0.0 108.977 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 76' ' ' SER . 4.9 m-20 -124.28 -5.01 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 88.5 -17.62 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 pt -104.09 66.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.175 -0.953 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' ' OH ' ' A' ' 208' ' ' TYR . . . 147.56 -171.5 28.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 3' ' ' SER . 30.7 m -80.11 -163.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.324 -1.103 . . . . 0.0 109.6 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 tp -142.53 115.2 8.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.865 . . . . 0.0 109.611 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.52 177.11 22.51 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.523 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 2.0 t -65.03 -50.96 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.286 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.914 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . . . -85.77 148.08 47.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.355 -0.84 . . . . 0.0 108.943 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.9 ' O ' HD23 ' A' ' 73' ' ' LEU . 38.0 Cg_endo -82.73 -61.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.752 2.301 . . . . 0.0 109.719 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 68.9 m-80 -95.98 -86.46 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 58.32 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.582 -0.699 . . . . 0.0 110.388 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.485 ' CG ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 mp0 -70.24 93.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 3.3 mt -78.11 104.97 9.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.126 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -94.06 147.92 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 108.89 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.4 105.81 13.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.974 -1.079 . . . . 0.0 109.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.656 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -106.01 67.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.288 -0.882 . . . . 0.0 109.538 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 91' ' ' VAL . 15.3 ttmm -36.97 100.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.391 0.615 . . . . 0.0 109.58 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.647 HG13 ' HA ' ' A' ' 105' ' ' ILE . 0.9 OUTLIER -115.96 -16.68 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.029 HD11 HD22 ' A' ' 124' ' ' LEU . 39.3 mt -118.79 169.12 10.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.807 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 167.19 12.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 59' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.247 -1.149 . . . . 0.0 109.246 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.13 145.54 26.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.765 -0.844 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.822 HG21 ' OG ' ' A' ' 130' ' ' SER . 1.2 t -67.24 -32.27 56.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -21.85 66.7 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.642 ' HA ' ' NE2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -85.34 -62.31 1.56 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.669 -0.644 . . . . 0.0 109.268 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.647 ' HA ' HG13 ' A' ' 93' ' ' VAL . 1.3 mt -48.71 -27.12 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.42 -48.75 21.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.405 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.642 ' NE2' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -62.54 -20.38 64.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.212 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.53 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -82.66 -38.42 12.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.9 mt -65.37 -24.98 67.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.378 -1.072 . . . . 0.0 109.234 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -26.03 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.495 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 55.4 t90 -72.68 -14.78 61.65 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.933 -1.105 . . . . 0.0 108.476 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.733 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -94.29 7.99 43.44 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.584 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -103.4 -45.16 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -86.21 -83.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.919 -1.341 . . . . 0.0 108.391 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.91 49.52 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.733 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -112.61 -156.13 12.6 Favored Glycine 0 C--N 1.289 -2.082 0 CA-C-O 122.376 0.987 . . . . 0.0 111.525 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.636 ' HE3' ' C ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -122.3 163.05 20.36 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.276 0.56 . . . . 0.0 109.558 -178.272 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.774 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -72.79 -16.75 61.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 108.699 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 118' ' ' HIS . 4.7 t -125.02 161.09 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.03 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.988 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -159.77 156.98 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 108.793 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.467 ' C ' HD12 ' A' ' 122' ' ' LEU . 40.6 t30 -135.56 152.56 51.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.313 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 121' ' ' ASN . 3.4 mp -135.47 81.9 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.515 ' HG ' ' CB ' ' A' ' 215' ' ' SER . 5.0 t -71.32 84.16 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.011 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.029 HD22 HD11 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 177.43 176.54 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.391 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.532 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -176.07 93.85 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 0.6 OUTLIER -86.99 148.73 46.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.29 -1.124 . . . . 0.0 109.272 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.447 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -76.39 -9.26 18.81 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.385 2.057 . . . . 0.0 108.942 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -97.34 108.83 46.94 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 161' ' ' TYR . 31.9 Cg_endo -75.07 166.23 29.57 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.119 1.88 . . . . 0.0 109.831 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.822 ' OG ' HG21 ' A' ' 102' ' ' VAL . 43.8 m -157.75 118.96 3.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.987 -1.07 . . . . 0.0 110.532 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.68 66.03 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.9 m -61.75 -31.77 71.97 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.28 -33.72 61.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE1' ' OH ' ' A' ' 165' ' ' TYR . 4.4 tt0 -73.32 -22.79 60.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.802 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -25.56 58.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.1 -37.14 39.43 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.592 HG13 ' CG ' ' A' ' 167' ' ' ASN . 2.0 t -70.44 -29.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -64.19 -35.6 81.32 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.3 m -78.11 -22.8 48.36 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -91.52 -5.37 54.26 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -90.73 -43.15 10.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.214 -0.929 . . . . 0.0 109.143 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.5 m -64.21 -17.94 64.03 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.78 -14.12 23.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.455 -0.778 . . . . 0.0 109.371 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.84 62.85 4.22 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.96 115.49 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -1.074 . . . . 0.0 109.376 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.1 113.18 8.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.016 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.988 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -109.65 150.89 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 149' ' ' ALA . 2.7 t -123.56 166.59 18.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.51 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -157.38 135.42 10.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 110.264 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.492 ' N ' HG21 ' A' ' 218' ' ' THR . . . -61.17 171.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.4 OUTLIER -93.22 -39.07 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 109.944 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 132.53 120.91 2.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 47.11 1.29 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.905 -0.762 . . . . 0.0 109.473 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 155' ' ' GLY . 1.6 t -121.75 -91.93 0.55 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.455 ' N ' ' OG ' ' A' ' 154' ' ' SER . . . 150.51 95.95 0.14 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.23 173.26 16.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 0.0 109.634 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.98 42.24 3.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 t -163.64 160.53 22.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -1.149 . . . . 0.0 109.321 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.716 HD11 ' O ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -98.16 -173.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.09 -1.006 . . . . 0.0 110.148 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.532 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 69.7 m -67.28 -174.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.691 1.234 . . . . 0.0 111.389 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.465 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 12.7 m-85 -137.2 128.56 16.46 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.737 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.1 Cg_endo -70.91 -50.74 0.18 OUTLIER 'Cis proline' 0 C--N 1.3 -1.993 0 O-C-N 123.188 1.099 . . . . 0.0 110.419 4.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . 30.89 -77.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.615 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.737 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -36.51 -39.97 0.22 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.363 178.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.2 m-85 -49.73 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.344 -0.847 . . . . 0.0 110.241 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.86 0.1 11.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.592 ' CG ' HG13 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -87.01 16.95 4.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.165 -0.959 . . . . 0.0 108.934 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.47 153.53 7.75 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.404 ' HG3' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.2 129.8 42.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.921 -1.112 . . . . 0.0 109.509 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -91.41 133.63 35.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 172' ' ' GLY . 38.5 t -104.75 165.15 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.766 -1.209 . . . . 0.0 110.088 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.559 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -129.76 -169.98 12.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.14 155.51 44.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.454 HG23 ' HB ' ' A' ' 193' ' ' VAL . 2.6 p -125.32 -174.31 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 -176.59 3.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 109.798 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -27.29 9.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.002 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -114.78 -93.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.034 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 13.4 p30 -142.49 16.81 2.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.909 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.36 153.03 22.81 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.047 -1.033 . . . . 0.0 108.833 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.507 ' N ' ' OH ' ' A' ' 257' ' ' TYR . 0.5 OUTLIER -73.18 136.45 44.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -50.33 -172.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.516 -0.74 . . . . 0.0 110.148 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.4 t -116.06 -17.59 10.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -111.35 -19.91 12.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.494 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 8.5 t -48.36 134.81 14.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 152' ' ' GLY . 0.9 OUTLIER -79.59 157.25 27.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.652 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.1 OUTLIER -134.49 173.23 11.87 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.393 -0.817 . . . . 0.0 109.032 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 150.31 147.77 4.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.716 ' O ' HD11 ' A' ' 159' ' ' ILE . . . -49.54 141.31 9.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.16 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.58 -11.24 46.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.5 tp -56.62 118.1 4.52 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.317 -1.108 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 259' ' ' SER . 0.5 OUTLIER -69.63 -75.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.985 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.597 HD12 HG13 ' A' ' 262' ' ' VAL . 0.4 OUTLIER -145.22 -158.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 260' ' ' GLY . 27.0 m -135.06 172.8 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.133 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -162.11 178.26 1.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.0 Cg_endo -76.19 114.02 3.81 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.097 1.864 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.05 40.07 1.44 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 53.9 t -123.46 82.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.652 ' HB3' ' O ' ' A' ' 197' ' ' VAL . 12.5 t-20 83.85 120.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.164 0.983 . . . . 0.0 108.449 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 199' ' ' VAL . 28.3 m -153.06 105.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 122.443 1.116 . . . . 0.0 109.105 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -83.54 109.31 17.28 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.327 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.626 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 1.4 t -123.99 -165.65 1.38 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 109.105 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.632 HG21 ' OD1' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -69.24 176.72 3.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.213 -0.929 . . . . 0.0 110.268 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.649 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.6 OUTLIER -161.99 149.09 11.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.649 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.4 Cg_endo -69.99 173.48 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.277 1.985 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 79.97 8.79 87.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 1.0 OUTLIER 67.67 55.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.5 -1.0 . . . . 0.0 109.861 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.791 HG23 ' N ' ' A' ' 208' ' ' TYR . 4.2 t -155.85 -147.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.732 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.791 ' N ' HG23 ' A' ' 207' ' ' THR . 10.5 m-85 -146.36 -177.34 5.57 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.241 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 203' ' ' TYR . . . 177.13 147.57 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.88 . . . . 0.0 110.373 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.613 ' C ' HD23 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -118.86 142.27 47.89 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.131 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -158.72 122.38 3.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.857 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.433 ' CB ' ' H ' ' A' ' 198' ' ' ASN . 1.6 p-10 -72.84 160.7 31.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.139 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.16 156.3 8.53 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.5 m -79.95 -27.36 39.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.187 . . . . 0.0 109.431 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.515 ' CB ' ' HG ' ' A' ' 123' ' ' SER . 0.3 OUTLIER -74.75 -13.76 60.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.646 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -20.94 28.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.676 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -95.35 -3.6 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.644 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 8.5 m -75.17 -43.94 4.56 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 111.307 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.71 ' HG2' HG21 ' A' ' 69' ' ' THR . 30.5 Cg_endo -72.27 -13.29 28.16 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.614 1.543 . . . . 0.0 110.155 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.84 ' CE1' HG23 ' A' ' 69' ' ' THR . 6.2 m80 -70.99 -44.24 66.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 222' ' ' ALA . 46.2 t -66.54 -51.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -44.26 -37.35 3.19 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.694 -0.802 . . . . 0.0 108.865 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -66.69 -52.8 31.63 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.68 -56.95 10.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 109.656 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.65 23.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.974 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.043 -1.036 . . . . 0.0 110.042 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 82' ' ' VAL . 38.4 mt -61.95 -46.65 88.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.035 -1.041 . . . . 0.0 109.658 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.556 ' O ' ' CG ' ' A' ' 231' ' ' LYS . 55.5 t -60.29 -43.7 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.436 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -53.09 -40.42 64.1 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.966 -1.084 . . . . 0.0 108.902 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -61.85 -56.02 23.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.266 -0.896 . . . . 0.0 110.348 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 228' ' ' VAL . 0.1 OUTLIER -52.0 -19.82 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.967 -1.083 . . . . 0.0 109.206 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.587 ' OD1' ' CG ' ' A' ' 235' ' ' TRP . 0.1 OUTLIER -132.85 94.11 22.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.915 . . . . 0.0 109.066 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.32 41.38 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.737 2.291 . . . . 0.0 110.862 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.9 t -164.22 13.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.0 111.869 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.587 ' CG ' ' OD1' ' A' ' 232' ' ' ASN . 26.4 m0 -92.89 174.31 7.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.434 -1.416 . . . . 0.0 109.559 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.5 OUTLIER -104.76 174.01 6.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.527 -0.733 . . . . 0.0 109.148 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -65.97 -25.58 67.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 109.736 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.7 t -78.77 -64.84 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.227 -0.92 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 238' ' ' VAL . 10.9 mm100 -44.68 -37.89 3.99 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.77 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 236' ' ' SER . 55.8 mt -68.4 -55.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 12.5 ttp180 -52.14 -21.89 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.029 . . . . 0.0 110.008 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -73.0 -59.8 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.69 ' O ' HG23 ' A' ' 247' ' ' THR . 19.8 t60 -52.61 -47.96 66.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.554 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -66.84 -37.82 85.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.344 -0.847 . . . . 0.0 110.05 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -59.05 -62.82 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.488 -0.758 . . . . 0.0 110.65 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -72.59 -10.71 60.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 111.558 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 243' ' ' HIS . 2.9 p -81.34 -31.16 33.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.429 -1.419 . . . . 0.0 109.846 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -42.92 115.63 0.77 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.966 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.495 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 0.0 OUTLIER -43.61 169.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.802 . . . . 0.0 109.928 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.7 p -121.94 106.2 11.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 109.881 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.768 HD22 ' H ' ' A' ' 251' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.307 0 O-C-N 121.165 -0.959 . . . . 0.0 109.356 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.217 0.532 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.507 ' OH ' ' N ' ' A' ' 180' ' ' ARG . 50.5 m-85 -47.56 -60.65 2.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.049 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.76 20.75 74.51 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 191' ' ' ASP . 0.3 OUTLIER -167.57 -100.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 0.0 109.836 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.795 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 157.86 -160.57 30.83 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.583 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.603 ' CB ' HD11 ' A' ' 251' ' ' LEU . 9.4 tp -104.65 129.87 52.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.518 -0.99 . . . . 0.0 109.461 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -58.73 172.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.085 -1.009 . . . . 0.0 109.943 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.754 HD21 ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.66 117.88 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 122.486 1.136 . . . . 0.0 108.408 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 12' ' ' GLN . . . -74.28 -18.85 60.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.469 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 10.4 tt0 -95.49 -2.18 49.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.61 0.34 36.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -130.06 -1.04 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.865 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 269' ' ' ARG . 1.4 p -113.13 -35.69 5.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.562 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.529 ' OXT' ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.623 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.347 0.594 . . . . 0.0 109.62 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.7 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -143.07 44.09 0.5 Allowed Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 121.4 -0.812 . . . . 0.0 109.977 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.7 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.8 Cg_endo -78.06 172.39 15.6 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.653 1.568 . . . . 0.0 109.112 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -72.83 8.87 1.31 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 111.096 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -110.12 -64.97 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.7 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -56.46 -30.5 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.032 -1.275 . . . . 0.0 109.896 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 m -56.23 -34.56 66.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 109.849 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.03 -16.0 25.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.0 111.594 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 8' ' ' ILE . 3.0 m -85.35 15.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.299 -1.501 . . . . 0.0 110.387 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 74.6 mm-40 37.74 45.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.692 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -72.18 -35.17 3.21 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -72.9 -47.33 0.34 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 N-CA-C 108.162 -1.515 . . . . 0.0 108.162 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.25 -36.69 1.88 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -41.08 60.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.507 ' HE2' ' C ' ' A' ' 82' ' ' VAL . 2.2 m-70 -63.45 -16.85 61.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.294 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -106.78 -24.76 11.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.783 -1.198 . . . . 0.0 109.915 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.4 mmp_? -63.47 -64.86 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.413 ' C ' HD12 ' A' ' 21' ' ' LEU . . . 158.38 59.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.7 mp -144.05 132.18 21.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -1.056 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.426 ' C ' ' N ' ' A' ' 24' ' ' SER . 47.1 p -125.93 -8.08 6.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.364 -0.835 . . . . 0.0 109.986 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.87 11.5 4.39 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' ' C ' ' A' ' 22' ' ' THR . 12.3 p -60.16 -14.74 18.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 110.072 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.17 25.93 23.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 27' ' ' LYS . 57.7 t -132.0 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.001 -1.294 . . . . 0.0 110.091 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 22.9 mtmt -138.85 121.24 16.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 7.7 t -113.84 152.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.985 . . . . 0.0 110.294 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.574 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -110.83 160.48 16.71 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.441 -0.787 . . . . 0.0 108.912 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.87 94.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 108.426 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.993 HD23 HG21 ' A' ' 93' ' ' VAL . 5.8 mp -81.14 116.44 21.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -175.7 -161.72 0.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.941 -1.099 . . . . 0.0 110.26 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.843 HG23 ' HA2' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -46.78 -37.07 8.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.459 -0.776 . . . . 0.0 109.729 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 155.59 -103.52 0.24 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.588 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.0 mt 145.45 101.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 204' ' ' PRO . 0.4 OUTLIER -69.12 151.37 46.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.617 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 160.25 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.619 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -167.71 147.72 4.5 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 108.979 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.7 Cg_endo -77.14 -13.99 16.91 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.491 2.128 . . . . 0.0 110.477 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.31 5.27 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 108.918 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 38' ' ' HIS . 22.1 mt -110.22 159.44 17.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.106 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.72 76.97 1.56 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.39 145.8 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 108.747 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.534 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.83 -20.95 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.913 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -178.22 153.31 12.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.82 -177.24 37.88 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.507 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 178.18 113.46 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 92' ' ' LYS . 25.1 m -105.44 111.07 23.65 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.517 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.511 ' CG ' ' HG2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -89.92 -22.72 21.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.863 HG21 ' O ' ' A' ' 93' ' ' VAL . 1.8 t -62.2 135.25 94.94 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.412 -0.805 . . . . 0.0 108.937 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.448 2.098 . . . . 0.0 110.672 179.742 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.546 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.586 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -73.98 13.46 0.53 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.643 -1.286 . . . . 0.0 111.103 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 56' ' ' THR . 31.5 mt-30 -147.59 174.74 11.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.533 -1.354 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HB2' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -57.68 160.78 4.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.471 -0.768 . . . . 0.0 110.648 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.09 10.15 3.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB2' HG21 ' A' ' 33' ' ' THR . 1.3 t-20 -167.25 -65.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 109.353 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.27 -32.27 0.54 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -45.56 -65.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -46.02 -70.89 0.58 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 63' ' ' GLY . 22.6 m -33.59 -49.4 0.3 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.778 -0.837 . . . . 0.0 111.252 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.614 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.5 t-80 -57.92 -52.65 64.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.067 -1.021 . . . . 0.0 110.344 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.75 HG13 ' HB3' ' A' ' 219' ' ' PRO . 25.4 t -57.17 -37.81 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.078 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.76 -41.11 97.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.599 ' HA3' HG22 ' A' ' 202' ' ' THR . . . -68.26 -46.29 65.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.465 HG23 ' NE2' ' A' ' 220' ' ' HIS . 28.6 m -53.14 -29.22 30.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.431 -1.041 . . . . 0.0 108.974 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.0 mt -90.07 -24.31 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.555 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -120.22 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.938 -1.101 . . . . 0.0 111.9 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.051 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 37.62 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.745 . . . . 0.0 109.868 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 73' ' ' LEU . 15.0 mt -52.86 141.75 20.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.47 -1.394 . . . . 0.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -89.78 116.36 27.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -174.48 -105.87 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -45.98 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.348 -0.845 . . . . 0.0 109.224 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -72.07 169.87 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 77' ' ' ILE . . . 41.06 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.52 ' HB ' ' OG ' ' A' ' 3' ' ' SER . 27.4 m -115.91 -162.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.978 . . . . 0.0 109.1 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 3' ' ' SER . 1.9 tp -106.96 121.29 44.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.135 -0.978 . . . . 0.0 109.65 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 1.051 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -88.48 -146.19 12.07 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.682 HG12 HD11 ' A' ' 227' ' ' LEU . 1.9 t -112.23 -34.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -1.225 . . . . 0.0 109.841 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.784 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -121.7 128.97 25.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.045 -1.035 . . . . 0.0 109.072 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 38.1 Cg_endo -85.36 -62.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.646 2.231 . . . . 0.0 110.618 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.4 37.04 1.2 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.337 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.784 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -82.44 129.06 34.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.45 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -61.49 87.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.326 -0.859 . . . . 0.0 109.373 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 mt -76.49 124.33 27.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.078 -1.014 . . . . 0.0 109.741 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.557 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 7.0 m-85 -115.57 152.18 33.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.476 -0.765 . . . . 0.0 109.185 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -119.05 98.81 6.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.052 -1.03 . . . . 0.0 110.334 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.574 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -103.47 64.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.068 -1.02 . . . . 0.0 108.651 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 55' ' ' SER . 7.8 ttmt -37.34 121.91 0.87 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.549 0.69 . . . . 0.0 111.134 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.993 HG21 HD23 ' A' ' 31' ' ' LEU . 25.3 t -123.28 -36.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.01 HD21 HD13 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -130.16 179.56 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.843 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 154.79 -140.2 7.24 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 118.256 -1.926 . . . . 0.0 112.186 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 122.135 -0.627 . . . . 0.0 110.72 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.409 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.1 t -83.96 176.73 8.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.912 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' A' ' 101' ' ' SER . 44.5 t -68.27 -13.39 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.09 -22.84 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.3 m -85.67 -43.6 13.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.727 HD13 HD11 ' A' ' 124' ' ' LEU . 1.6 mt -71.21 -23.27 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.52 25.15 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.681 -0.637 . . . . 0.0 109.413 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.511 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 3.5 tp-100 -69.98 -32.79 71.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 -39.05 27.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.723 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 15.0 mt -73.7 -28.1 61.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -1.168 . . . . 0.0 109.707 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -92.33 -21.27 20.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.096 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.485 ' O ' ' CD2' ' A' ' 111' ' ' TRP . 64.7 t90 -76.85 -11.67 59.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.418 -0.801 . . . . 0.0 108.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.746 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -97.28 -1.37 44.88 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.302 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.62 -21.61 39.74 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -119.03 -5.84 10.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.132 . . . . 0.0 110.252 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -164.65 20.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.804 -1.185 . . . . 0.0 110.563 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -105.31 -152.77 21.29 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.732 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.713 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 10.6 mmt -120.56 -176.73 3.3 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.636 -0.92 . . . . 0.0 110.633 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.86 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -81.1 -25.75 36.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.217 -178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.86 HG22 ' CE1' ' A' ' 118' ' ' HIS . 2.4 t -114.77 158.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.575 -1.328 . . . . 0.0 109.738 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.55 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -167.29 145.12 4.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.839 ' O ' HD12 ' A' ' 122' ' ' LEU . 10.5 t-20 -115.35 162.18 17.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 109.454 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 121' ' ' ASN . 3.8 mp -144.97 113.56 6.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.196 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.515 ' C ' HD23 ' A' ' 124' ' ' LEU . 10.8 m -92.7 68.99 4.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.01 HD13 HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 178.54 177.02 0.47 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -0.925 . . . . 0.0 110.002 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 161' ' ' TYR . . . 172.17 -79.31 0.09 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER 81.86 162.0 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.762 -0.846 . . . . 0.0 110.032 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 34.8 Cg_endo -76.43 -14.55 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.514 2.143 . . . . 0.0 109.78 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.41 118.25 60.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.77 165.97 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.159 1.906 . . . . 0.0 110.344 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -168.68 106.41 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.899 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.7 -18.13 64.81 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.6 m -68.25 -29.21 67.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -42.05 37.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.12 -19.03 61.23 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.747 -1.181 . . . . 0.0 108.153 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 tt0 -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.723 ' HB1' ' HB3' ' A' ' 109' ' ' LEU . . . -76.61 -36.04 57.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.493 HG21 ' HB1' ' A' ' 166' ' ' ALA . 1.3 t -70.57 -29.67 39.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.3 -38.57 84.08 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.1 -25.12 58.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -85.95 -6.82 58.99 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.6 m -86.57 -51.99 5.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.1 -1.0 . . . . 0.0 109.141 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -18.27 45.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -20.55 16.52 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 78.51 0.5 Allowed Glycine 0 N--CA 1.478 1.465 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 118' ' ' HIS . 22.1 t -131.43 118.11 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -1.061 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.91 122.19 26.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -115.27 151.74 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.636 HG12 ' ND2' ' A' ' 121' ' ' ASN . 2.7 t -119.22 159.79 19.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -146.88 135.1 21.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.869 -1.144 . . . . 0.0 110.409 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.454 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -67.12 174.83 2.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.664 -0.648 . . . . 0.0 109.553 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 15.2 t -73.03 -82.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 145.57 120.65 1.34 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.428 ' C ' ' OG ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -86.35 60.11 6.04 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 121.922 -0.752 . . . . 0.0 109.598 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' C ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 171.61 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.164 -0.96 . . . . 0.0 110.898 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -19.69 -50.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.237 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 90.57 63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.786 0.803 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.16 -3.09 32.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 159' ' ' ILE . 15.0 m -134.22 122.83 23.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 0.0 109.562 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -51.18 179.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.806 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -105.92 173.3 6.37 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.554 1.169 . . . . 0.0 112.526 -177.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.565 ' O ' ' CA ' ' A' ' 125' ' ' GLY . 24.4 m-85 -108.94 144.75 30.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.1 Cg_endo -72.88 -31.82 4.91 Favored 'Cis proline' 0 C--N 1.297 -2.181 0 O-C-N 122.33 0.647 . . . . 0.0 111.27 4.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -4.1 -61.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.604 0.716 . . . . 0.0 111.656 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 162' ' ' PRO . 9.6 tpt180 -48.77 -65.9 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.724 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 38.1 p90 -121.75 -163.43 1.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.922 0.868 . . . . 0.0 110.676 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 165' ' ' TYR . . . 80.1 49.3 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.648 0.737 . . . . 0.0 109.589 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 166' ' ' ALA . 23.0 m-80 41.77 28.76 0.09 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -112.49 116.32 30.08 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.91 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.475 ' HB2' HG22 ' A' ' 148' ' ' VAL . 73.5 mmm -63.64 171.83 2.44 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.293 -0.88 . . . . 0.0 108.792 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -137.02 114.42 10.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.653 HG22 HG21 ' A' ' 221' ' ' VAL . 27.5 t -99.68 166.05 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -148.8 108.4 0.4 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -52.01 149.58 4.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.28 . . . . 0.0 109.541 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.479 ' HB2' ' C ' ' A' ' 180' ' ' ARG . 6.2 t0 -115.46 -149.5 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.131 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 177' ' ' ASN . 56.7 tt0 -40.3 -43.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.458 -0.776 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 7.4 m-20 164.47 119.86 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 44.0 t30 53.94 38.38 28.69 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.216 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -132.07 -18.12 2.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.94 . . . . 0.0 110.282 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.479 ' C ' ' HB2' ' A' ' 175' ' ' ASP . 1.8 ttp85 66.79 126.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 109.188 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -42.47 163.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.591 -0.693 . . . . 0.0 109.901 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.9 p -84.31 4.88 29.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.289 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.452 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 6.2 p90 -137.93 11.74 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 33.7 t -87.75 105.58 17.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.399 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.603 ' HG2' ' N ' ' A' ' 155' ' ' GLY . 1.5 mp0 -52.38 154.46 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -0.962 . . . . 0.0 110.118 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.75 168.2 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 173.12 144.47 4.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.72 131.31 50.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.322 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.43 -1.15 39.95 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.482 ' HG ' ' N ' ' A' ' 191' ' ' ASP . 6.6 tp -60.94 146.79 45.55 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.28 -1.129 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.4 OUTLIER -73.68 -80.05 0.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.059 -1.026 . . . . 0.0 110.368 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.696 HG13 HG22 ' A' ' 262' ' ' VAL . 0.2 OUTLIER -152.75 -169.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.781 -1.199 . . . . 0.0 109.516 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.547 ' N ' HG12 ' A' ' 192' ' ' ILE . 32.6 m -126.59 162.16 31.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.009 -1.057 . . . . 0.0 110.163 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.904 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -145.76 140.4 15.68 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 7' ' ' GLY . 34.6 Cg_endo -76.17 112.95 3.59 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.449 2.099 . . . . 0.0 111.115 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.573 ' O ' ' C ' ' A' ' 197' ' ' VAL . . . -114.12 -67.79 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 78.0 t 5.52 71.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.713 ' O ' HG13 ' A' ' 199' ' ' VAL . 9.5 t-20 99.13 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 198' ' ' ASN . 7.3 m -163.41 110.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 122.149 0.976 . . . . 0.0 109.259 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.538 ' CG ' ' OG ' ' A' ' 210' ' ' SER . 6.3 mt-30 -77.43 129.52 35.86 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.614 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -135.95 -153.46 0.51 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.042 -1.036 . . . . 0.0 109.64 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.599 HG22 ' HA3' ' A' ' 68' ' ' GLY . 9.8 t -102.94 177.32 4.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.665 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -144.63 -179.45 0.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.665 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -73.38 -151.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.98 1.787 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . -37.62 -29.7 0.05 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' PRO . 17.8 t -48.39 -97.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.256 -1.144 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 208' ' ' TYR . 5.2 t 175.53 -120.33 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.573 ' N ' HG23 ' A' ' 207' ' ' THR . 0.6 OUTLIER -78.33 -170.38 2.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.868 -1.145 . . . . 0.0 109.748 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.768 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.538 ' OG ' ' CG ' ' A' ' 200' ' ' GLN . 0.1 OUTLIER -174.21 139.34 0.62 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.56 HD12 ' SD ' ' A' ' 216' ' ' MET . 0.1 OUTLIER -175.63 162.29 2.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -106.08 173.5 6.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.438 -0.788 . . . . 0.0 109.226 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 147.18 147.61 4.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 151' ' ' SER . 23.2 m -73.92 -22.5 59.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.131 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.466 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 71.2 m -74.15 -9.94 59.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.56 ' SD ' HD12 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -86.45 -19.59 29.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.904 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -90.36 -14.06 33.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.659 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -71.07 -39.28 8.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 0.0 111.452 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.75 ' HB3' HG13 ' A' ' 66' ' ' VAL . 31.7 Cg_endo -73.25 -28.63 12.32 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.761 1.641 . . . . 0.0 110.561 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.465 ' NE2' HG23 ' A' ' 69' ' ' THR . 7.9 m80 -61.91 -35.67 79.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 171' ' ' VAL . 33.8 t -75.73 -39.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -27.67 67.27 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.86 2.37 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.833 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -45.39 -42.09 9.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 109.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.52 95.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.775 . . . . 0.0 109.171 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.86 -40.91 73.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.165 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.833 HD12 ' HA ' ' A' ' 224' ' ' ALA . 5.1 mt -61.88 -45.15 95.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 109.328 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 229' ' ' LYS . 75.7 t -57.9 -67.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.713 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -40.02 -43.04 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.709 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.475 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 14.9 tm0? -58.37 -54.11 50.71 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.224 -0.923 . . . . 0.0 110.018 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 228' ' ' VAL . 0.0 OUTLIER -56.79 -17.26 8.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.188 -0.945 . . . . 0.0 108.917 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 m-20 -156.57 81.18 3.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.6 Cg_endo -81.14 40.32 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.757 2.305 . . . . 0.0 110.663 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.41 7.68 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.0 109.762 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.416 ' CZ2' ' ND2' ' A' ' 232' ' ' ASN . 45.1 m0 -91.05 175.03 7.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.775 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.37 8.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 237' ' ' ASN . 2.0 m-80 -58.11 -32.75 68.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.13 -0.981 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.9 t -71.88 -63.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.31 -0.869 . . . . 0.0 109.09 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.8 OUTLIER -42.01 -42.06 2.73 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.379 0.609 . . . . 0.0 109.809 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 9.4 mm -63.06 -47.89 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.847 . . . . 0.0 109.302 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' ASN . 0.6 OUTLIER -58.41 -62.64 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -40.33 -43.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.439 -0.788 . . . . 0.0 110.422 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.462 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.9 t60 -70.67 -38.44 73.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.9 -1.125 . . . . 0.0 110.223 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.8 OUTLIER -73.3 -22.5 60.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.452 -0.78 . . . . 0.0 110.019 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -84.48 -34.33 23.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.349 -0.845 . . . . 0.0 108.942 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -85.97 -17.17 36.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.59 -0.694 . . . . 0.0 109.312 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 5.0 p -88.24 -34.26 17.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 109.402 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.04 133.83 11.05 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.463 ' OG1' ' OD1' ' A' ' 263' ' ' ASN . 2.9 m -57.87 152.4 16.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.704 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 259' ' ' SER . 25.8 p -120.48 98.63 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.884 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 C--N 1.306 -1.304 0 O-C-N 121.08 -1.012 . . . . 0.0 109.343 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.457 ' HA ' ' CE1' ' A' ' 186' ' ' TYR . 7.3 mt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.45 -46.43 10.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.9 -33.04 4.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.525 ' CB ' HG22 ' A' ' 192' ' ' ILE . 1.5 m -141.42 -98.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -1.135 . . . . 0.0 109.331 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.51 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 162.19 -124.56 1.31 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.169 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -84.65 135.11 34.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.592 -0.946 . . . . 0.0 110.163 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.696 HG22 HG13 ' A' ' 192' ' ' ILE . 1.4 t -78.6 144.44 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.463 ' OD1' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -160.88 118.28 2.38 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.604 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.395 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 2.3 tm-20 -63.12 -28.86 70.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.15 -18.19 50.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -107.11 9.87 30.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 269' ' ' ARG . 17.3 p -128.38 -67.53 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 268' ' ' THR . 8.3 tpt180 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.626 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.508 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -115.32 86.4 14.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.977 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 3' ' ' SER . 37.0 Cg_endo -80.87 -175.01 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.973 2.449 . . . . 0.0 111.575 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.635 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -55.58 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.442 0.639 . . . . 0.0 110.52 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 6' ' ' TRP . . . -40.12 -83.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.688 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.4 mp -41.65 102.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -1.029 . . . . 0.0 109.741 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER 167.9 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.202 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' NH2' HD22 ' A' ' 261' ' ' LEU . 1.2 ttp85 -93.47 4.44 53.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.316 -0.865 . . . . 0.0 109.895 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 11' ' ' VAL . 3.5 m -94.48 25.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.01 -1.056 . . . . 0.0 109.818 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 88.1 mm-40 43.03 46.96 4.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.67 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -81.45 -35.62 0.78 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 111.433 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.7 Cg_endo -74.42 -55.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.222 -1.491 . . . . 0.0 108.222 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.56 -34.63 3.45 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -71.47 -41.57 69.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.9 -1.125 . . . . 0.0 109.147 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.508 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 7.4 m170 -75.79 -2.9 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.702 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -115.08 -11.0 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.117 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -73.67 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 109.404 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.76 30.77 0.06 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.858 HD23 ' HG3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -142.89 145.4 33.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.184 . . . . 0.0 109.391 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -123.6 -9.93 7.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -0.835 . . . . 0.0 109.711 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -7.47 16.66 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 24' ' ' SER . 51.7 p -60.05 94.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.553 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.28 -4.47 2.85 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.228 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.621 ' CG1' ' CE1' ' A' ' 118' ' ' HIS . 5.3 t -97.49 160.99 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.907 -1.349 . . . . 0.0 109.904 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.3 OUTLIER -125.84 117.29 23.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 110.016 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.56 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 13.7 t -107.37 145.1 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.597 -0.689 . . . . 0.0 109.315 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -106.56 155.59 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' A' ' 70' ' ' ILE . 41.7 t -128.59 86.69 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.595 HD23 HG21 ' A' ' 93' ' ' VAL . 2.5 mp -81.72 90.33 6.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.665 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.541 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -157.03 -146.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 108.747 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -57.28 -73.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.586 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -166.46 -126.93 0.86 Allowed Glycine 0 N--CA 1.476 1.363 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 90' ' ' ALA . 8.0 mt -167.4 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 20.5 t -47.82 141.5 5.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.042 -1.036 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.58 141.92 56.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.243 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.606 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.4 157.12 21.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.35 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 35.8 Cg_endo -78.75 -6.01 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.736 2.291 . . . . 0.0 111.111 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.47 -21.48 19.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 0.0 109.993 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -117.09 150.16 39.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.045 -1.034 . . . . 0.0 109.712 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 116.42 31.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.523 -0.735 . . . . 0.0 109.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.41 111.56 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.114 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 62.6 mmt-85 -118.79 11.23 12.61 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.675 ' HA3' ' CD2' ' A' ' 89' ' ' TYR . . . -174.34 142.57 6.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.17 84.82 0.15 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.487 -1.339 . . . . 0.0 110.645 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 124.49 45.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 108.652 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.585 ' HB2' ' CE ' ' A' ' 92' ' ' LYS . 6.5 p -111.43 117.77 33.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.001 -1.062 . . . . 0.0 110.416 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.921 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 21.4 m-85 -86.12 -77.77 0.3 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.285 -0.884 . . . . 0.0 108.732 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 77.5 t -38.94 94.39 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.939 -0.475 . . . . 0.0 109.739 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 49' ' ' PHE . 37.4 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 C-N-CA 122.274 1.982 . . . . 0.0 111.822 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.486 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.515 HG22 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -77.33 0.22 23.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 58' ' ' ASP . 2.0 mt-30 -110.92 -172.42 2.03 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.108 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 29.2 t70 -32.43 142.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.569 0.699 . . . . 0.0 110.916 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.3 -40.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -144.39 -65.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.478 -1.013 . . . . 0.0 109.319 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.48 -31.25 0.52 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.545 ' CE1' ' CB ' ' A' ' 215' ' ' SER . 1.1 t60 -61.37 -43.43 98.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -57.4 -74.66 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.57 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -38.28 -49.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.51 -0.994 . . . . 0.0 110.557 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 12.9 t-80 -52.29 -50.79 61.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 70' ' ' ILE . 31.4 t -62.27 -29.58 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.404 -0.81 . . . . 0.0 109.584 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -61.3 -47.43 85.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.342 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.458 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -75.81 -23.09 73.3 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.564 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 8.3 m -74.58 -14.86 60.84 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.084 -1.245 . . . . 0.0 107.875 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 66' ' ' VAL . 62.6 mt -94.73 -35.46 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.503 -0.748 . . . . 0.0 110.829 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.671 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -165.5 27.93 0.05 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 0.0 112.37 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -44.19 153.87 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.444 -1.41 . . . . 0.0 108.635 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 79' ' ' VAL . 73.9 mt -75.86 171.95 13.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.95 -1.094 . . . . 0.0 110.205 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.797 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -103.64 51.57 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.555 ' O ' ' C ' ' A' ' 76' ' ' SER . 5.2 p30 -177.07 -115.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.568 ' O ' ' C ' ' A' ' 77' ' ' ILE . 12.3 m 22.28 71.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.335 -0.228 . . . . 0.0 110.956 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.58 ' O ' HD12 ' A' ' 77' ' ' ILE . 1.3 pp 14.79 57.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.664 0.745 . . . . 0.0 111.578 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' SER . . . -154.87 -161.27 10.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 79' ' ' VAL . 21.9 m -95.9 -161.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -1.132 . . . . 0.0 109.861 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD22 ' HB3' ' A' ' 74' ' ' ASN . 20.2 tp -143.42 123.45 13.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.838 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.83 -148.9 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.508 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 40.7 t -100.16 -25.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.086 -1.243 . . . . 0.0 109.325 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -99.65 137.14 20.18 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.977 . . . . 0.0 108.754 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.47 -61.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.72 2.28 . . . . 0.0 111.018 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -117.48 48.52 1.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.525 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -87.78 150.41 23.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.112 -0.992 . . . . 0.0 109.402 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 2.5 mt-10 -81.85 108.42 15.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 109.156 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 71' ' ' ALA . 8.6 mt -85.45 124.94 32.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.675 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 7.6 m-85 -113.76 143.18 45.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.166 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.735 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -111.97 95.4 5.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.127 -0.983 . . . . 0.0 109.64 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.921 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.63 62.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.083 -1.011 . . . . 0.0 108.897 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.585 ' CE ' ' HB2' ' A' ' 48' ' ' SER . 12.2 ttpp -36.81 116.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.282 0.563 . . . . 0.0 110.077 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG21 HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -122.58 0.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 32' ' ' ASP . 62.8 mt -119.34 174.7 6.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.46 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -119.6 146.08 18.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.008 179.769 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 155.18 20.85 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.769 -0.842 . . . . 0.0 109.654 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.513 HG21 ' OG ' ' A' ' 130' ' ' SER . 20.0 t -67.75 -20.74 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -20.53 60.37 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -86.3 -47.33 9.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.68 -0.637 . . . . 0.0 109.581 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.449 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.5 mt -67.2 -34.17 67.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.189 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' A' ' 110' ' ' GLU . . . -71.92 -43.57 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.917 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -69.56 -31.19 69.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.813 -1.18 . . . . 0.0 109.882 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -82.19 -18.16 67.66 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 -34.5 27.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -1.149 . . . . 0.0 110.022 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.52 ' HG2' ' OG ' ' A' ' 139' ' ' SER . 3.9 mt-10 -90.1 -19.19 24.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.891 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.608 ' CE2' ' O ' ' A' ' 115' ' ' ASN . 84.5 t90 -68.18 -25.04 65.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.132 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -90.5 5.9 45.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.898 -1.126 . . . . 0.0 109.412 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -94.91 -36.49 5.5 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -106.19 -23.15 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -1.095 . . . . 0.0 109.224 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.608 ' O ' ' CE2' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -173.06 89.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.641 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . 172.8 50.75 0.05 OUTLIER Glycine 0 C--N 1.291 -1.971 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.469 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.764 ' HE3' ' H ' ' A' ' 117' ' ' MET . 0.0 OUTLIER 62.52 163.3 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.473 -1.016 . . . . 0.0 112.062 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.777 ' CE1' HG23 ' A' ' 119' ' ' VAL . 9.7 p80 -98.15 -30.16 12.81 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.777 HG23 ' CE1' ' A' ' 118' ' ' HIS . 4.8 t -95.84 157.72 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.836 -1.165 . . . . 0.0 108.901 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -167.5 124.57 1.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 122' ' ' LEU . 42.9 t30 -102.53 166.96 10.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.872 HD23 HD21 ' A' ' 124' ' ' LEU . 3.5 mp -146.88 112.65 5.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.865 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.2 t -90.14 62.38 5.48 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.872 HD21 HD23 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -146.93 -174.12 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.63 0.729 . . . . 0.0 110.213 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.506 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 160.42 109.57 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.95 154.7 81.49 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.043 -1.269 . . . . 0.0 109.814 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -78.67 5.4 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.76 2.306 . . . . 0.0 110.099 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 m -110.63 82.43 2.88 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.726 -0.609 . . . . 0.0 109.992 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.4 Cg_endo -76.93 171.48 17.9 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.393 2.062 . . . . 0.0 110.754 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.513 ' OG ' HG21 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -144.01 134.47 24.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 108.977 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.56 66.17 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.9 m -70.91 -28.22 64.37 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -24.74 53.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.55 -55.72 5.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.135 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -53.77 -25.01 16.99 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.33 53.69 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.67 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.537 HG11 ' CG ' ' A' ' 167' ' ' ASN . 2.2 t -71.94 -19.36 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 142' ' ' SER . 1.2 t30 -76.1 -29.39 57.89 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.52 ' OG ' ' HG2' ' A' ' 110' ' ' GLU . 1.0 OUTLIER -88.13 -19.05 27.5 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.239 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 145' ' ' VAL . . . -93.39 -26.21 17.35 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.636 -1.29 . . . . 0.0 110.558 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.98 -34.14 13.17 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 138' ' ' ASN . 8.0 t -67.54 -24.69 65.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -81.14 -16.95 51.53 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.608 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 237' ' ' ASN . . . 91.7 50.34 2.73 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 118' ' ' HIS . 70.7 t -113.75 111.11 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 109.234 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.475 HD23 HG13 ' A' ' 119' ' ' VAL . 1.8 tp -69.96 126.39 29.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.043 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -120.19 137.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.736 HG22 ' HG3' ' A' ' 169' ' ' MET . 8.9 t -121.05 166.77 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.506 ' C ' HG21 ' A' ' 218' ' ' THR . . . -153.61 140.65 19.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.944 -1.098 . . . . 0.0 109.555 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.584 ' N ' HG21 ' A' ' 218' ' ' THR . . . -75.95 153.42 36.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.495 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 4.6 t -77.96 -71.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 185' ' ' GLN . . . 164.67 119.02 0.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -87.51 56.62 4.01 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 122.062 -0.669 . . . . 0.0 109.868 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.3 p -137.12 -108.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.613 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . -103.06 -95.98 2.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 167.58 74.16 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.324 -1.103 . . . . 0.0 109.89 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -106.91 43.63 1.65 Allowed Glycine 0 C--N 1.287 -2.166 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.2 p 80.53 131.68 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.832 -0.804 . . . . 0.0 109.657 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -55.08 -169.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.764 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -139.08 164.64 29.23 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.573 -0.704 . . . . 0.0 111.822 -178.072 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.504 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 1.5 m-85 -79.45 145.52 63.83 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.3 Cg_endo -71.53 -33.96 3.51 Favored 'Cis proline' 0 C--N 1.295 -2.256 0 O-C-N 122.566 0.772 . . . . 0.0 110.942 4.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -31.09 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.006 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -79.68 -49.14 12.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.802 -1.186 . . . . 0.0 109.987 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.496 ' O ' ' O ' ' A' ' 164' ' ' ARG . 2.7 m-85 -46.78 -179.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.006 0.908 . . . . 0.0 110.416 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.4 -8.12 23.62 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.746 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.537 ' CG ' HG11 ' A' ' 137' ' ' VAL . 1.8 p-10 -88.65 20.84 3.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -159.16 142.11 14.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 108.893 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.736 ' HG3' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.41 131.91 41.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 109.671 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 190' ' ' LEU . . . -95.47 114.82 26.62 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 108.857 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.3 t -94.19 165.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.569 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -144.23 -175.06 17.03 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -123.64 164.24 19.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -1.074 . . . . 0.0 109.056 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p -142.74 167.85 21.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.466 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.5 OUTLIER -66.43 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.33 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.73 -32.62 11.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.97 . . . . 0.0 109.862 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.65 -78.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.701 ' CG ' HD23 ' A' ' 251' ' ' LEU . 39.4 t-20 -173.07 45.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 109.741 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 24.4 t30 -135.9 167.27 21.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.044 -1.035 . . . . 0.0 109.553 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.497 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.5 ttt-85 -45.79 138.65 4.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.774 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.87 -134.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.643 -0.661 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 m -127.86 -31.53 2.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.883 -1.135 . . . . 0.0 109.734 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' SER . 24.5 p90 -123.47 -3.19 8.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.875 . . . . 0.0 109.65 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.3 OUTLIER -44.09 107.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 109.782 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -58.15 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.646 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.684 ' HE2' ' HB2' ' A' ' 188' ' ' ALA . 1.2 t80 -50.07 -167.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.758 0.789 . . . . 0.0 111.638 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.548 ' CA ' HD22 ' A' ' 190' ' ' LEU . . . -173.1 23.06 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.48 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' HE2' ' A' ' 186' ' ' TYR . . . -75.84 97.78 4.0 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.685 -0.891 . . . . 0.0 109.445 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.38 -22.67 28.79 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -45.15 154.74 0.14 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.505 -0.997 . . . . 0.0 109.626 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 192' ' ' ILE . 51.9 t0 -55.03 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.815 . . . . 0.0 110.891 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.669 HG22 ' OG ' ' A' ' 259' ' ' SER . 0.5 OUTLIER -146.7 -157.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.913 -1.117 . . . . 0.0 110.064 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 262' ' ' VAL . 30.3 m -143.0 168.55 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.796 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -151.56 160.85 31.1 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.41 -0.806 . . . . 0.0 109.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.6 Cg_endo -74.87 115.23 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.06 60.9 0.4 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.321 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.635 ' HB ' ' CZ2' ' A' ' 6' ' ' TRP . 47.5 t -97.62 70.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 40.6 t-20 111.62 119.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 216' ' ' MET . 1.7 m -156.27 112.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.07 0.938 . . . . 0.0 108.484 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.6 OUTLIER -89.86 171.2 9.77 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.624 0.726 . . . . 0.0 110.071 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.585 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 20.4 m -167.56 -146.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.726 . . . . 0.0 109.074 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.418 HG21 HD11 ' A' ' 41' ' ' LEU . 77.1 p -92.68 150.08 20.91 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 110.068 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.582 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 2.1 t80 -140.55 142.46 29.07 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.3 Cg_endo -72.04 156.94 55.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.312 2.008 . . . . 0.0 110.986 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 36.41 54.48 1.31 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.4 t -179.83 -107.62 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.094 -1.239 . . . . 0.0 109.719 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 208' ' ' TYR . 4.3 t -175.45 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.438 -0.789 . . . . 0.0 109.119 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.551 ' N ' HG23 ' A' ' 207' ' ' THR . 0.1 OUTLIER -89.24 142.76 27.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.738 -1.226 . . . . 0.0 109.632 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -125.71 111.39 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.642 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.3 OUTLIER -83.08 132.35 35.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 211' ' ' LEU . 1.0 OUTLIER -167.24 138.72 3.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.97 . . . . 0.0 109.876 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -88.89 147.51 24.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 108.927 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 170.55 146.3 5.1 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.003 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.7 p -66.51 -27.17 67.56 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.274 -1.133 . . . . 0.0 108.521 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.545 ' CB ' ' CE1' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -55.63 -22.37 22.27 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.62 ' CB ' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -85.57 -29.79 23.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -82.36 -23.0 35.25 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.165 -0.959 . . . . 0.0 110.369 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.654 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 4.9 m -66.41 -46.15 59.52 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.895 -1.128 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.2 Cg_endo -73.07 -12.98 26.08 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.919 1.746 . . . . 0.0 109.931 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -74.11 -42.4 60.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.734 HG22 HG11 ' A' ' 262' ' ' VAL . 74.2 t -70.74 -48.83 55.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -46.11 -43.23 14.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -61.51 -45.37 96.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.08 39.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -1.041 . . . . 0.0 109.472 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -52.04 -34.58 43.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -59.94 -47.24 86.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 0.0 109.214 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.5 HD13 ' HB1' ' A' ' 16' ' ' ALA . 67.3 mt -59.8 -29.23 68.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 229' ' ' LYS . 36.4 t -69.57 -62.22 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.31 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -41.9 -47.07 4.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.695 . . . . 0.0 109.714 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.534 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 15.3 tp60 -59.62 -49.38 77.99 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.167 -0.958 . . . . 0.0 109.751 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.858 ' HG3' HD23 ' A' ' 21' ' ' LEU . 6.0 tttm -54.31 -19.3 5.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.486 ' HB2' ' CD2' ' A' ' 235' ' ' TRP . 19.0 m120 -160.93 92.05 1.54 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 109.967 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.6 -11.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.415 2.077 . . . . 0.0 110.303 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.3 m -87.49 -8.87 55.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.486 ' CD2' ' HB2' ' A' ' 232' ' ' ASN . 25.3 m0 -69.65 179.62 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.556 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.18 178.22 5.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.523 ' HB3' ' HA2' ' A' ' 144' ' ' GLY . 18.7 p-10 -52.62 -25.63 11.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 109.42 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.67 -65.4 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.14 -0.975 . . . . 0.0 109.226 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 0.5 OUTLIER -44.76 -25.84 0.33 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.333 0.587 . . . . 0.0 109.967 -178.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.06 -63.65 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 242' ' ' ASN . 15.2 ttp180 -58.2 -63.43 1.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 241' ' ' ARG . 46.3 t30 -37.83 -44.85 0.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 110.705 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -43.85 93.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 110.082 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.519 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 1.4 mt -68.57 -34.0 75.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.362 -0.836 . . . . 0.0 110.95 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.53 55.78 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.78 -4.38 26.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.606 -0.684 . . . . 0.0 109.567 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.4 p -98.48 -28.36 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.9 -1.125 . . . . 0.0 109.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -42.27 142.55 0.75 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 250' ' ' SER . 18.9 m -75.13 164.87 26.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.225 -0.922 . . . . 0.0 109.007 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.574 ' N ' HG22 ' A' ' 249' ' ' THR . 20.5 p -133.04 116.64 16.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.021 -1.05 . . . . 0.0 110.226 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.701 HD23 ' CG ' ' A' ' 178' ' ' ASN . 6.8 mp . . . . . 0 N--CA 1.484 1.272 0 O-C-N 121.165 -0.959 . . . . 0.0 109.677 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 258' ' ' GLY . 13.3 m-30 -106.66 47.48 0.88 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 257' ' ' TYR . . . -30.66 -89.18 0.01 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.669 ' OG ' HG22 ' A' ' 192' ' ' ILE . 1.6 p -61.19 -96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.127 -1.219 . . . . 0.0 108.721 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 175.34 -132.35 2.15 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 28.3 tp -85.83 155.35 21.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.956 -0.732 . . . . 0.0 110.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 221' ' ' VAL . 2.7 t -92.13 145.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.437 -0.79 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.424 ' CG ' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -169.66 119.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.367 1.08 . . . . 0.0 108.714 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -75.19 -17.28 60.4 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.702 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.459 ' HA ' ' OG1' ' A' ' 268' ' ' THR . 56.3 tt0 -61.52 -20.46 63.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -84.27 -22.44 30.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.578 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -117.15 15.43 14.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.779 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 265' ' ' GLU . 11.0 p -118.88 -39.92 2.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 269' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.523 ' C ' ' O ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -22.51 85.2 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.867 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HG2' ' CG1' ' A' ' 8' ' ' ILE . 36.6 Cg_endo -80.97 -176.19 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.911 2.407 . . . . 0.0 110.897 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.612 ' CE2' ' O ' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -24.64 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.407 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -114.31 -83.01 1.12 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.005 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.841 HG22 ' N ' ' A' ' 9' ' ' SER . 1.7 mm 49.52 -86.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.858 -0.789 . . . . 0.0 109.268 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.841 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -61.43 -12.46 14.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.91 -1.119 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -27.79 67.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 8' ' ' ILE . 30.8 m -92.99 27.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG2' ' HB3' ' A' ' 265' ' ' GLU . 3.6 mp0 61.74 47.39 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.755 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -82.83 -31.48 0.52 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 111.676 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -75.11 -54.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 108.087 -1.543 . . . . 0.0 108.087 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.73 -35.75 1.97 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.61 -43.24 63.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.961 -1.087 . . . . 0.0 108.955 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.08 -2.99 33.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 -39.98 8.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.47 -55.72 9.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.44 -27.86 0.77 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 268' ' ' THR . 1.1 mt -49.95 111.58 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.207 -1.172 . . . . 0.0 109.305 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -96.42 -19.59 19.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -0.837 . . . . 0.0 109.927 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 78.18 -11.26 23.85 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 42.7 p -55.96 125.78 22.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -1.133 . . . . 0.0 109.609 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.83 -14.37 6.36 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.651 -1.261 . . . . 0.0 109.982 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.739 HG13 ' NE2' ' A' ' 118' ' ' HIS . 11.5 t -102.46 157.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.972 -1.311 . . . . 0.0 109.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -124.96 113.95 18.5 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.51 -0.744 . . . . 0.0 109.092 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.585 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 4.2 t -101.71 147.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 120' ' ' ALA . . . -110.17 159.5 17.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -0.9 . . . . 0.0 108.944 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.936 HG12 ' OD1' ' A' ' 32' ' ' ASP . 1.6 t -136.85 92.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 108.751 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.597 HD23 HG21 ' A' ' 93' ' ' VAL . 6.0 mp -79.97 88.9 5.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.936 ' OD1' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.98 -160.13 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -94.1 28.02 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.442 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 58' ' ' ASP . . . 121.46 123.48 2.97 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.662 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.607 HD11 ' CG2' ' A' ' 30' ' ' VAL . 3.9 mt -86.84 -17.09 9.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.726 0.774 . . . . 0.0 109.751 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 2.9 t 62.31 156.3 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.677 -0.639 . . . . 0.0 109.393 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.6 t -86.71 157.05 19.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.079 -1.013 . . . . 0.0 110.154 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.628 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -169.9 172.84 2.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.5 Cg_endo -81.05 -27.02 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.503 2.136 . . . . 0.0 109.875 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.779 ' HB3' HD11 ' A' ' 77' ' ' ILE . 14.4 p30 -115.19 25.34 10.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.387 -0.82 . . . . 0.0 109.292 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 43' ' ' ILE . 19.7 mt -128.9 21.23 5.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.759 . . . . 0.0 109.11 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 41' ' ' LEU . 7.8 p-10 -25.54 123.55 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -88.96 91.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.346 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 3.3 tpm_? -56.41 -21.25 23.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.876 -1.14 . . . . 0.0 108.073 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 171.17 138.26 2.49 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.65 169.81 34.02 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.317 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.624 -0.927 . . . . 0.0 108.692 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 92' ' ' LYS . 3.1 p -123.94 120.18 31.76 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.734 ' HE2' HG12 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -122.31 -39.24 2.59 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.12 -0.987 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.566 ' HB ' ' CE ' ' A' ' 92' ' ' LYS . 4.2 t -67.66 131.59 92.82 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.162 1.908 . . . . 0.0 108.762 178.55 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 1.6 t -64.45 -2.52 2.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.46 ' C ' ' HA3' ' A' ' 34' ' ' GLY . 32.0 mt-30 -88.27 155.77 19.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.031 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.916 ' OD2' HG22 ' A' ' 64' ' ' THR . 8.3 t0 -73.07 145.98 46.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 110.08 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.34 -17.73 6.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.43 -64.7 1.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -1.083 . . . . 0.0 109.518 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' CA ' ' OD2' ' A' ' 58' ' ' ASP . . . 156.74 -16.97 0.4 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.443 ' C ' ' CD2' ' A' ' 62' ' ' HIS . 2.9 t-160 -52.1 -61.47 2.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.274 . . . . 0.0 109.706 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -55.16 -77.02 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.014 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.916 HG22 ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -33.05 -67.02 0.13 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.731 -0.864 . . . . 0.0 110.73 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.786 ' CD2' HD21 ' A' ' 211' ' ' LEU . 12.6 t-80 -42.66 -48.91 5.59 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 70' ' ' ILE . 27.7 t -58.39 -41.03 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.086 -1.009 . . . . 0.0 109.623 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.79 -49.5 73.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.294 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -66.76 -33.56 84.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.507 HG23 ' CE1' ' A' ' 220' ' ' HIS . 6.3 m -67.64 -20.73 65.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.176 -1.19 . . . . 0.0 109.07 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 66' ' ' VAL . 79.8 mt -88.16 -28.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.376 -0.827 . . . . 0.0 109.844 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 83' ' ' ALA . . . -153.26 -37.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 111.484 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.767 ' HB1' ' CG1' ' A' ' 79' ' ' VAL . . . 32.81 72.51 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.522 -0.736 . . . . 0.0 109.92 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -38.32 150.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.684 ' CB ' HD12 ' A' ' 80' ' ' LEU . 33.2 t30 -138.19 92.25 2.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.012 -1.055 . . . . 0.0 110.962 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 76' ' ' SER . 1.1 m120 -97.66 -17.1 19.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.3 m 157.66 28.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.826 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 40' ' ' ASP . 5.8 pt -125.84 52.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.794 -1.191 . . . . 0.0 109.998 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 42.99 -172.9 0.01 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.817 0.676 . . . . 0.0 111.515 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.767 ' CG1' ' HB1' ' A' ' 72' ' ' ALA . 38.5 t 78.93 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 122.175 -0.603 . . . . 0.0 110.645 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' A' ' 74' ' ' ASN . 1.4 tp 56.64 92.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 109.87 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.633 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -71.65 -155.19 2.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 HD11 ' A' ' 227' ' ' LEU . 2.1 t -84.12 -51.29 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -1.221 . . . . 0.0 109.346 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -94.55 125.87 49.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.017 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.69 -60.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.701 2.267 . . . . 0.0 110.715 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 10.0 m120 -93.37 35.03 1.11 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.759 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -83.71 129.69 34.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 109.744 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 27' ' ' LYS . 1.8 mp0 -67.27 114.73 6.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.27 -0.893 . . . . 0.0 108.746 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 mt -97.93 115.55 28.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 110.616 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.571 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 28.1 m-85 -102.98 162.24 13.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -129.36 106.2 8.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.178 . . . . 0.0 110.37 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.734 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -107.13 67.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.566 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -42.6 104.38 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.9 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.597 HG21 HD23 ' A' ' 31' ' ' LEU . 4.0 t -123.74 -25.67 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.549 -0.719 . . . . 0.0 109.085 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.69 HD21 HD22 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -91.42 176.14 6.67 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 110.085 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -116.87 173.88 14.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.159 -1.201 . . . . 0.0 109.766 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.5 157.36 30.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.8 -0.823 . . . . 0.0 110.009 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.971 HG21 ' OG ' ' A' ' 130' ' ' SER . 2.3 t -67.82 -23.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -20.18 60.77 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.9 p -80.89 -52.36 7.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.584 0.707 . . . . 0.0 109.386 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.934 ' HB ' HD11 ' A' ' 133' ' ' LEU . 1.2 mt -65.95 -32.88 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.689 . . . . 0.0 109.584 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.83 -36.49 70.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -71.39 -41.47 69.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.71 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.51 -14.92 81.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 109' ' ' LEU . 14.0 mt -83.21 -29.39 28.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.308 -1.113 . . . . 0.0 109.015 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.5 -28.81 18.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.585 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 46.6 t90 -71.07 -15.32 62.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.671 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.13 -1.19 57.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.36 -0.838 . . . . 0.0 109.688 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.56 -33.71 2.62 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.703 -1.236 . . . . 0.0 111.136 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.68 -85.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.779 -1.424 . . . . 0.0 109.275 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -94.16 23.63 4.91 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.825 ' O ' ' HE2' ' A' ' 117' ' ' MET . . . -99.16 -146.0 19.48 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.991 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.825 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 4.6 mmt -133.15 179.43 6.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.434 -1.039 . . . . 0.0 110.33 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.739 ' NE2' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -88.42 -29.98 19.81 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.095 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 1.4 t -99.85 149.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 119.668 -1.895 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -164.94 115.09 1.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.812 ' C ' HD12 ' A' ' 122' ' ' LEU . 45.4 t30 -89.22 160.28 17.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.978 . . . . 0.0 109.767 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 121' ' ' ASN . 5.4 mp -147.76 109.47 4.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.999 -1.063 . . . . 0.0 109.877 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 67.86 3.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.966 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.69 HD22 HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -132.66 172.88 11.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.918 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.465 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.79 104.28 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.83 162.48 43.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.102 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.4 Cg_endo -81.21 9.12 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.12 2.547 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.9 102.25 19.03 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.262 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.3 Cg_endo -78.76 178.19 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.688 2.259 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.971 ' OG ' HG21 ' A' ' 102' ' ' VAL . 5.0 m -175.92 119.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 109.487 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -19.96 65.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 23.6 m -69.05 -27.36 65.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.934 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.3 tp -81.57 -37.98 26.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.574 ' CG ' ' CE2' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -76.68 -21.43 55.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.53 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.95 -25.6 53.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 -32.04 30.48 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.491 ' CG1' ' CG ' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -71.42 -36.1 59.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.453 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.13 -34.97 78.77 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.1 t -80.3 -19.1 47.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.68 -10.28 43.72 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.985 -1.072 . . . . 0.0 109.91 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 89.9 m -89.26 -40.15 13.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 109.133 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.21 -27.29 68.32 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.28 31.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.93 66.97 1.65 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 118' ' ' HIS . 14.5 t -117.05 109.75 28.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.401 -1.058 . . . . 0.0 109.597 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.9 104.89 3.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.168 -0.957 . . . . 0.0 109.337 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.781 HG12 HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.52 135.66 35.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.031 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.748 HG22 ' HB2' ' A' ' 169' ' ' MET . 3.0 t -112.86 156.82 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 170' ' ' ALA . . . -138.42 137.07 36.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 109.804 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.13 171.54 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -89.28 -79.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.601 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.622 ' O ' ' CB ' ' A' ' 153' ' ' ASN . . . -152.76 -116.98 0.68 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 152' ' ' GLY . 31.6 t30 135.6 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 123.395 0.678 . . . . 0.0 109.744 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.1 m -121.65 -98.02 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 109.6 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.416 ' HA2' ' CD ' ' A' ' 185' ' ' GLN . . . 179.06 47.38 0.08 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.27 172.56 6.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.16 . . . . 0.0 109.213 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.9 56.32 0.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.461 ' HA ' ' HA3' ' A' ' 187' ' ' GLY . 0.2 OUTLIER 175.27 156.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -1.135 . . . . 0.0 109.26 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 pt -100.12 -177.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.802 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -109.48 166.86 10.56 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.943 0.877 . . . . 0.0 112.518 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.56 ' OH ' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -85.03 149.41 53.02 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 164' ' ' ARG . 42.2 Cg_endo -71.68 -32.22 4.49 Favored 'Cis proline' 0 C--N 1.295 -2.254 0 O-C-N 122.408 0.688 . . . . 0.0 110.734 3.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -25.4 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.721 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -65.42 -55.81 15.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.938 -1.101 . . . . 0.0 109.714 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.574 ' CE2' ' CG ' ' A' ' 134' ' ' GLU . 1.4 m-85 -42.58 -177.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.542 1.163 . . . . 0.0 111.6 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -115.56 2.44 13.8 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.491 ' CG ' ' CG1' ' A' ' 137' ' ' VAL . 2.0 m120 -89.33 21.66 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 108.899 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.43 171.76 10.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.748 ' HB2' HG22 ' A' ' 148' ' ' VAL . 48.4 mtp -99.46 -177.82 3.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -151.5 115.39 4.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 192' ' ' ILE . 23.7 t -107.46 165.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.057 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.86 -173.31 13.3 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.495 ' C ' ' HB2' ' A' ' 181' ' ' ALA . . . -118.88 164.13 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.134 . . . . 0.0 109.655 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.753 ' CA ' ' HB2' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -138.15 175.6 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 0.0 109.69 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.483 ' N ' ' HA ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -89.91 -172.98 3.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.576 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -101.79 -21.49 14.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -80.78 -53.5 6.44 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.269 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -131.89 -94.09 0.37 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.472 -0.768 . . . . 0.0 109.751 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.656 ' CG ' HG21 ' A' ' 174' ' ' THR . 0.7 OUTLIER -160.03 -154.47 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.197 -0.939 . . . . 0.0 109.59 -178.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.489 ' N ' HG22 ' A' ' 174' ' ' THR . 0.0 OUTLIER 58.11 4.3 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.753 ' HB2' ' CA ' ' A' ' 174' ' ' THR . . . 36.24 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.582 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.9 t -145.92 21.84 1.42 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.175 -0.953 . . . . 0.0 108.996 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.45 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -168.66 26.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.833 . . . . 0.0 109.658 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -104.51 128.63 52.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 108.934 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CD ' ' HA2' ' A' ' 155' ' ' GLY . 64.8 mm-40 -90.06 147.36 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 110.021 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.517 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.58 169.22 12.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . -170.93 152.25 17.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -44.06 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 138.64 -0.78 2.51 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.263 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 65.0 tp -50.33 145.81 5.86 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.829 -1.395 . . . . 0.0 108.745 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.6 OUTLIER -104.56 -63.75 1.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 111.103 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 171' ' ' VAL . 1.2 tt -151.47 163.87 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.375 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.981 HG21 ' CE1' ' A' ' 257' ' ' TYR . 22.1 m -118.0 160.33 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.676 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.613 ' C ' ' HG1' ' A' ' 174' ' ' THR . . . -150.66 161.07 31.38 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.7 Cg_endo -75.21 126.08 9.6 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.14 1.893 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.429 ' C ' ' OD1' ' A' ' 212' ' ' ASN . . . -152.21 62.13 0.39 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.632 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.612 ' O ' ' CE2' ' A' ' 6' ' ' TRP . 74.5 t -135.76 89.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.6 ' O ' HG13 ' A' ' 199' ' ' VAL . 11.6 t-20 94.14 107.42 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.696 HG22 ' CG ' ' A' ' 212' ' ' ASN . 19.7 m -161.91 111.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.19 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 201' ' ' SER . 2.9 tt0 -85.97 147.37 26.26 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.6 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 7.4 t -146.76 -146.67 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.584 HG21 ' OD1' ' A' ' 40' ' ' ASP . 66.0 p -88.02 172.38 9.59 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.675 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -157.87 161.05 29.64 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.675 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.7 Cg_endo -70.42 165.29 32.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.136 1.891 . . . . 0.0 110.685 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 79.92 3.87 89.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.2 OUTLIER 77.69 32.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -1.088 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -129.79 158.03 40.56 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.493 ' OH ' HD12 ' A' ' 77' ' ' ILE . 11.7 m-30 -91.51 -174.67 3.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.536 ' HB2' ' CG ' ' A' ' 203' ' ' TYR . . . -164.25 157.19 17.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.872 -1.142 . . . . 0.0 110.219 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 3.5 m -113.21 120.31 40.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -166.88 161.8 15.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.696 ' CG ' HG22 ' A' ' 199' ' ' VAL . 0.2 OUTLIER -148.19 -160.48 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.973 -1.079 . . . . 0.0 111.153 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 130.49 157.95 9.15 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 214' ' ' THR . 0.0 OUTLIER -60.94 -19.13 60.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.859 -1.377 . . . . 0.0 108.644 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.1 m -71.86 -32.71 67.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.485 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -82.27 -19.8 38.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.445 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -87.45 -26.5 23.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.631 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 26.2 m -57.2 -42.8 97.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.725 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.9 Cg_endo -71.93 -26.55 18.55 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.715 1.61 . . . . 0.0 111.132 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.507 ' CE1' HG23 ' A' ' 69' ' ' THR . 0.4 OUTLIER -58.66 -40.37 83.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.677 HG22 HG21 ' A' ' 262' ' ' VAL . 60.4 t -70.33 -47.66 65.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -45.8 -31.89 2.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -73.78 -48.08 18.1 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -57.39 -65.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -1.232 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -45.64 -36.58 4.93 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -58.84 -49.5 77.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.02 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.603 HD11 HG12 ' A' ' 82' ' ' VAL . 10.6 mt -49.96 -39.42 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 96.2 t -61.41 -52.47 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 108.902 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 19.1 mttm -44.33 -40.98 5.71 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.459 -0.776 . . . . 0.0 109.172 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 13.1 tp60 -62.93 -45.42 92.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 108.882 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -60.86 -14.21 20.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.472 -0.768 . . . . 0.0 109.045 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.88 80.93 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.356 -0.84 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.5 Cg_endo -78.89 8.24 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.711 2.274 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.44 -12.8 28.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.986 -1.071 . . . . 0.0 109.778 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -69.84 -179.69 1.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.99 170.81 7.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.595 -0.691 . . . . 0.0 109.359 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -62.22 -22.68 66.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -79.26 -63.63 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.112 -0.993 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.0 OUTLIER -42.96 -48.66 5.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 -178.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 -49.15 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 0.0 109.546 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 243' ' ' HIS . 6.6 ttp180 -51.37 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ARG . 43.7 t30 -34.27 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.869 -0.519 . . . . 0.0 111.346 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 241' ' ' ARG . 1.6 t60 -72.52 -50.4 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.53 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.1 OUTLIER -67.68 -23.29 65.29 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.61 47.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.571 -0.706 . . . . 0.0 110.181 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.69 -9.31 57.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 110.376 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.3 p -94.11 -29.84 14.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.973 -1.079 . . . . 0.0 109.663 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -40.25 129.27 2.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.555 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.63 ' HB ' HD22 ' A' ' 263' ' ' ASN . 6.0 m -75.98 89.57 2.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 260' ' ' GLY . 3.3 t -81.9 140.13 34.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 111.82 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.5 mp . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 257' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.587 0.708 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 1.028 ' N ' HD13 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -87.94 -4.72 58.8 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.532 -0.73 . . . . 0.0 111.776 -176.642 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 129.74 2.5 5.25 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.629 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 0.7 OUTLIER 79.2 -10.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -1.072 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 250' ' ' SER . . . 134.36 -165.82 24.31 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.069 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.573 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 58.3 tp -107.13 164.4 12.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -98.95 158.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.42 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.63 HD22 ' HB ' ' A' ' 249' ' ' THR . 0.0 OUTLIER -167.36 119.92 0.93 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.36 -5.31 31.6 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.358 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 5.1 tt0 -83.23 -42.55 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 109.911 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.96 1.74 26.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -115.03 -26.57 7.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.671 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.483 HG21 HD13 ' A' ' 21' ' ' LEU . 4.7 p -82.91 -38.8 22.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.597 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.529 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.41 76.72 15.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' TRP . 33.0 Cg_endo -77.8 164.56 27.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.409 2.073 . . . . 0.0 110.33 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.518 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -45.49 -26.86 0.63 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA3' ' CG1' ' A' ' 199' ' ' VAL . . . -72.26 -101.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.686 HG22 ' O ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -43.09 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -1.105 . . . . 0.0 109.142 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER 165.19 -43.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -1.6 58.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -0.832 . . . . 0.0 109.501 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.692 HG11 ' HB3' ' A' ' 220' ' ' HIS . 20.1 m -101.3 14.94 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.125 -0.984 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.702 HE21 ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 68.97 24.68 6.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.647 -0.658 . . . . 0.0 110.845 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -68.26 -39.87 18.39 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.906 -1.121 . . . . 0.0 110.895 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 32.2 Cg_endo -75.18 -60.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.205 -1.498 . . . . 0.0 108.205 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HB3' HE21 ' A' ' 12' ' ' GLN . . . -45.99 -24.21 0.39 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.593 ' N ' ' NE2' ' A' ' 12' ' ' GLN . . . -81.19 -41.64 22.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.874 -1.141 . . . . 0.0 109.244 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 16.3 m170 -69.45 -19.68 63.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 109.626 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -87.15 -39.1 15.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.58 ' HB3' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.54 -17.58 62.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.45 8.7 26.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -74.03 132.04 41.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -115.43 -22.57 9.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.462 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 53.6 11.03 1.69 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.453 ' N ' ' C ' ' A' ' 22' ' ' THR . 5.2 t -76.19 1.64 15.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -1.217 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.6 17.91 35.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 27' ' ' LYS . 60.7 t -123.18 167.02 17.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 120.935 -1.333 . . . . 0.0 109.995 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' N ' HG12 ' A' ' 26' ' ' VAL . 1.7 mptt -134.74 137.06 43.13 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 39.1 t -135.01 129.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.024 -1.048 . . . . 0.0 110.296 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -84.83 155.66 21.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.895 HG12 ' OD2' ' A' ' 32' ' ' ASP . 6.5 t -134.22 87.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 108.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 HG23 ' A' ' 91' ' ' VAL . 8.2 mp -74.27 99.91 3.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.895 ' OD2' HG12 ' A' ' 30' ' ' VAL . 1.1 m-20 -134.82 -161.61 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 96' ' ' ALA . 2.9 t -105.2 3.95 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.775 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 59' ' ' GLY . . . 144.97 121.83 1.49 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 64' ' ' THR . 11.3 mt -90.08 -110.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.557 ' N ' HG22 ' A' ' 35' ' ' ILE . 48.2 t 176.46 146.94 0.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.213 -0.93 . . . . 0.0 110.071 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -86.04 93.38 8.97 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.438 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -114.9 169.38 6.74 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.469 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 77' ' ' ILE . 35.6 Cg_endo -77.38 -45.4 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.619 2.212 . . . . 0.0 110.04 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 73' ' ' LEU . 3.9 m-20 -74.27 -34.27 63.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.822 . . . . 0.0 109.261 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 67' ' ' ALA . 2.3 mt -57.3 135.11 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -109.71 94.7 5.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 43' ' ' ILE . 8.7 mm -85.63 99.91 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 9.3 tpt180 -86.53 -18.74 30.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.684 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.509 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 162.32 176.37 34.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.57 47.55 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.142 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' HG12 ' A' ' 91' ' ' VAL . . . -146.03 160.25 42.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.978 . . . . 0.0 109.446 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 64.3 p -134.03 115.6 14.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.513 ' HE2' HG12 ' A' ' 91' ' ' VAL . 45.3 m-85 -116.92 -54.98 2.39 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.509 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 22.9 t -39.81 128.45 1.53 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.585 -0.697 . . . . 0.0 109.91 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 122.345 2.03 . . . . 0.0 110.595 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.452 ' C ' ' HG3' ' A' ' 57' ' ' GLN . 1.4 m -63.36 -13.16 36.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.043 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.452 ' HG3' ' C ' ' A' ' 56' ' ' THR . 13.1 mt-30 -143.95 150.8 38.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 t0 62.08 92.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.805 . . . . 0.0 109.704 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -112.85 -25.63 4.45 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.82 -38.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -1.176 . . . . 0.0 109.75 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.07 -10.67 3.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -75.85 -70.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.155 -1.203 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 32' ' ' ASP . . . -48.17 -29.09 6.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.699 ' HA ' HG23 ' A' ' 35' ' ' ILE . 9.2 m -68.14 -53.15 27.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -1.073 . . . . 0.0 109.445 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 1.005 ' CD2' HD21 ' A' ' 211' ' ' LEU . 3.9 t-80 -55.89 -43.64 77.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.737 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 69' ' ' THR . 17.4 t -61.95 -34.2 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -62.36 -44.14 97.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.618 ' HA2' ' HB2' ' A' ' 72' ' ' ALA . . . -71.21 -42.02 58.63 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 66' ' ' VAL . 7.5 t -64.41 -15.3 60.32 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 120.366 -1.667 . . . . 0.0 107.851 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.007 HG21 HD21 ' A' ' 88' ' ' LEU . 31.7 mt -87.51 -38.84 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.321 -0.862 . . . . 0.0 109.93 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -178.64 36.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.769 -1.207 . . . . 0.0 111.853 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . . . -45.06 125.47 5.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.67 -1.269 . . . . 0.0 108.928 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 84' ' ' PRO . 85.5 mt -54.33 161.26 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 75' ' ' ASN . 10.4 t-20 -106.92 134.26 50.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 74' ' ' ASN . 74.2 m-20 -162.14 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.817 0.817 . . . . 0.0 109.081 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -155.12 -39.96 0.09 Allowed 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 39' ' ' PRO . 1.2 pt -103.38 67.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.456 -0.777 . . . . 0.0 109.595 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.94 158.62 13.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 201' ' ' SER . 27.6 m -80.39 -159.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.35 -1.088 . . . . 0.0 109.354 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.4 tp -141.53 116.52 9.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.968 -1.082 . . . . 0.0 109.771 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 175.83 54.78 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.64 -42.53 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -1.185 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . . . -93.17 141.96 24.71 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.736 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.691 ' O ' HD23 ' A' ' 73' ' ' LEU . 38.6 Cg_endo -84.25 -61.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.847 2.365 . . . . 0.0 110.692 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -120.48 49.87 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.436 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -79.17 159.59 27.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 108.979 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 25.9 mt-10 -89.37 89.16 7.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.979 -1.076 . . . . 0.0 108.972 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 70' ' ' ILE . 8.4 mt -75.6 142.89 42.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 110.236 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.56 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 4.1 m-85 -126.4 152.97 45.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.37 94.47 4.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.017 -1.052 . . . . 0.0 109.456 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -98.57 63.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.284 -0.885 . . . . 0.0 108.917 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -31.67 109.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.197 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -129.09 -10.37 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.374 -0.829 . . . . 0.0 109.433 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 124' ' ' LEU . 10.2 mt -103.81 -178.0 3.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 0.0 109.895 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.31 146.65 18.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.513 ' N ' ' OG1' ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.186 -1.185 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.04 155.59 32.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.879 -0.777 . . . . 0.0 109.8 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.716 HG13 HD12 ' A' ' 133' ' ' LEU . 3.5 t -69.56 -19.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -17.7 58.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.497 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.2 m -88.33 -35.42 17.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.52 HD13 HD13 ' A' ' 124' ' ' LEU . 2.9 mt -77.11 -37.98 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 108.729 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.23 67.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -63.19 -45.55 91.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.507 -0.746 . . . . 0.0 108.992 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.22 -21.52 77.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 109' ' ' LEU . 14.5 mt -82.57 -19.93 37.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -94.38 -30.23 14.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.376 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -69.24 -17.01 63.72 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.717 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.728 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -91.37 -11.54 37.53 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -80.86 -15.71 76.89 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -117.13 1.19 12.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.076 -1.249 . . . . 0.0 109.946 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 7.2 t30 172.46 29.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.999 -1.063 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.728 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -110.71 48.08 0.98 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.312 -1.423 . . . . 0.0 110.763 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.588 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 15.8 mmt 60.91 -173.79 0.13 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 111.452 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.68 ' CD2' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -95.74 -32.69 12.6 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.716 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.68 HG23 ' CD2' ' A' ' 118' ' ' HIS . 55.7 t -104.8 166.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.717 -1.239 . . . . 0.0 109.833 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.764 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -169.35 117.04 0.62 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.964 ' O ' HD12 ' A' ' 122' ' ' LEU . 8.0 t30 -96.31 152.96 18.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.964 HD12 ' O ' ' A' ' 121' ' ' ASN . 6.4 mp -133.88 102.79 5.57 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.92 66.3 9.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 109.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 105' ' ' ILE . 0.6 OUTLIER -152.86 172.22 17.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.333 -0.854 . . . . 0.0 109.617 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.571 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.58 104.42 0.18 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 160' ' ' SER . 0.3 OUTLIER -107.32 147.64 35.62 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.197 -1.178 . . . . 0.0 109.559 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.512 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 32.1 Cg_endo -74.0 -6.0 17.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.21 1.94 . . . . 0.0 108.934 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -103.95 100.32 20.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 32.7 Cg_endo -74.19 164.59 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.425 2.083 . . . . 0.0 110.944 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.585 ' CB ' HG11 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -151.05 135.92 17.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.91 63.59 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -77.88 -23.71 48.71 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.716 HD12 HG13 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -79.26 -40.57 30.21 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' OE2' ' CD1' ' A' ' 165' ' ' TYR . 1.9 mt-10 -76.85 -31.96 57.19 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.336 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -62.66 -26.82 68.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.48 60.83 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.917 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.495 ' CG1' ' CG ' ' A' ' 167' ' ' ASN . 1.3 t -63.26 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.54 -38.48 81.16 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.6 -23.75 53.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.91 -18.83 55.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.081 -1.012 . . . . 0.0 110.129 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -27.75 58.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.261 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -58.14 -30.81 66.63 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.162 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER -104.64 -12.0 16.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.476 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.85 62.16 4.98 Favored Glycine 0 N--CA 1.477 1.429 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 39.9 t -96.12 110.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.583 -0.951 . . . . 0.0 109.854 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.52 107.63 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.5 t -104.43 154.32 6.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.044 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 148' ' ' VAL . 12.0 p -141.13 112.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.607 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -100.9 149.82 23.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.124 -0.985 . . . . 0.0 110.384 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.496 ' CB ' ' OG1' ' A' ' 218' ' ' THR . . . -78.6 151.71 32.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.727 . . . . 0.0 109.472 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -55.98 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 155.19 115.02 0.52 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 185' ' ' GLN . 25.1 t30 -99.96 53.16 0.91 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.951 -0.735 . . . . 0.0 109.178 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.45 ' N ' ' OE1' ' A' ' 185' ' ' GLN . 2.4 p -94.6 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.437 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 150.55 39.2 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.49 172.97 7.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 109.365 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 186' ' ' TYR . . . -103.71 56.71 0.57 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.409 ' N ' ' HB2' ' A' ' 186' ' ' TYR . 1.6 p 172.36 124.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.042 -1.27 . . . . 0.0 109.862 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -59.23 -171.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.234 -0.917 . . . . 0.0 110.166 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.901 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -132.81 171.2 14.21 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.073 0.939 . . . . 0.0 112.795 -177.076 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.438 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 4.4 m-85 -82.61 146.41 53.22 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.607 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 41.4 Cg_endo -71.39 -30.29 5.63 Favored 'Cis proline' 0 C--N 1.293 -2.383 0 O-C-N 122.555 0.766 . . . . 0.0 110.436 3.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.901 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.625 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -70.5 -54.46 12.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 109.76 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -50.77 -170.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.177 0.989 . . . . 0.0 110.825 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.67 -16.73 8.19 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.495 ' CG ' ' CG1' ' A' ' 137' ' ' VAL . 13.1 m-80 -57.08 -18.65 15.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 108.962 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -132.53 149.36 52.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.477 ' HA ' ' OD2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -89.87 130.1 36.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.907 -1.121 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 163' ' ' ALA . . . -92.55 117.97 30.51 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.95 HG22 ' CG2' ' A' ' 192' ' ' ILE . 24.7 t -92.33 164.58 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.268 1.032 . . . . 0.0 110.562 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -136.14 145.63 17.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.54 162.28 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.28 . . . . 0.0 110.14 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.508 ' CG2' ' HB ' ' A' ' 193' ' ' VAL . 73.1 p -144.58 170.83 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.528 -0.732 . . . . 0.0 109.46 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 179' ' ' ASN . 0.7 OUTLIER -102.82 -166.59 1.29 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -67.67 -49.63 61.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.186 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' ASN . 8.3 m120 -59.59 -75.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.054 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' ASN . 1.5 m-20 162.77 41.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.0 109.642 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.454 ' HB3' ' OD1' ' A' ' 175' ' ' ASP . 0.9 OUTLIER -98.46 -149.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.687 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -107.82 18.99 20.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.468 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 76.14 -162.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.0 109.905 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 t -100.53 -34.83 9.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.965 . . . . 0.0 110.204 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -108.12 -81.35 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 183' ' ' PHE . 3.3 t 32.05 100.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.128 0.49 . . . . 0.0 111.145 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' SER . 1.4 mp0 -45.49 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 0.0 109.815 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.502 ' CZ ' HD21 ' A' ' 256' ' ' LEU . 1.2 t80 -52.49 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 110.565 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.969 ' HA2' HD13 ' A' ' 190' ' ' LEU . . . -145.26 20.97 1.91 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -35.76 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 79.2 50.51 5.76 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.969 HD13 ' HA2' ' A' ' 187' ' ' GLY . 4.6 tp -75.62 144.8 41.56 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.568 -0.96 . . . . 0.0 109.465 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 259' ' ' SER . 1.2 m-20 -93.43 -46.01 7.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.208 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.95 ' CG2' HG22 ' A' ' 171' ' ' VAL . 1.5 tt -157.95 177.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.497 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 260' ' ' GLY . 31.6 m -138.79 172.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 109.663 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -173.55 174.44 1.1 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.926 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.6 Cg_endo -75.94 121.39 6.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.608 2.205 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -137.17 45.14 1.09 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.644 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 23.8 t -134.1 85.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.438 -1.036 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.946 ' O ' HG13 ' A' ' 199' ' ' VAL . 19.5 t-20 103.33 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER 178.28 115.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 210' ' ' SER . 1.7 pt20 -101.45 161.52 13.57 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.62 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -156.69 -158.67 0.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.546 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.62 174.06 11.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.595 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.9 OUTLIER -150.05 147.15 21.5 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 108.529 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 31.6 Cg_endo -69.91 129.96 18.33 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.721 1.614 . . . . 0.0 110.336 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 40.82 43.55 3.17 Favored Glycine 0 C--N 1.286 -2.243 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.833 ' O ' HG22 ' A' ' 207' ' ' THR . 0.9 OUTLIER -167.56 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.998 -1.295 . . . . 0.0 111.35 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 206' ' ' SER . 7.0 t 52.01 -143.24 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 111.032 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.658 ' N ' HG23 ' A' ' 207' ' ' THR . 0.1 OUTLIER -95.62 165.78 12.16 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.026 0.917 . . . . 0.0 111.639 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -158.03 162.2 38.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.483 ' HA ' ' CB ' ' A' ' 200' ' ' GLN . 0.6 OUTLIER -109.03 133.91 52.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.865 -1.147 . . . . 0.0 110.131 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 1.005 HD21 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -154.65 157.53 38.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -121.36 160.8 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 167.5 161.78 17.77 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.8 m -81.12 -28.9 34.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -1.181 . . . . 0.0 109.257 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -14.06 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 1.7 mpp? -87.95 -15.03 37.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -89.69 -8.87 51.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.657 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 86.5 m -77.35 -36.05 1.43 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 112.232 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 218' ' ' THR . 32.2 Cg_endo -73.66 -24.62 15.68 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.141 1.228 . . . . 0.0 110.264 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.692 ' HB3' HG11 ' A' ' 11' ' ' VAL . 7.6 m80 -62.38 -40.4 96.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 262' ' ' VAL . 59.2 t -70.17 -40.41 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -51.5 -41.26 60.85 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -65.99 -59.64 7.28 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -42.1 -37.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.107 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.46 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.158 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -55.1 -41.38 71.56 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.013 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 224' ' ' ALA . 48.3 mt -55.62 -45.68 77.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.708 HG21 HD23 ' A' ' 244' ' ' LEU . 31.5 t -56.0 -59.02 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 0.0 109.495 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.578 ' HE2' HD11 ' A' ' 240' ' ' ILE . 3.3 ttmm -44.68 -39.07 4.8 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.304 -0.872 . . . . 0.0 109.521 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.462 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -59.2 -54.95 41.12 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -56.63 -15.75 4.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 108.907 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.601 ' ND2' ' CZ3' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -166.83 84.16 0.89 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 37.4 Cg_endo -80.77 15.25 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.754 2.303 . . . . 0.0 111.17 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.87 -24.24 12.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.601 ' CZ3' ' ND2' ' A' ' 232' ' ' ASN . 32.3 m0 -62.71 175.14 0.86 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.9 m -99.71 176.37 5.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.649 -0.657 . . . . 0.0 109.758 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 238' ' ' VAL . 36.0 p30 -60.59 -22.18 63.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.431 -0.793 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -76.61 -64.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.177 -0.952 . . . . 0.0 109.277 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 238' ' ' VAL . 5.6 mm-40 -43.36 -35.58 1.59 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.547 0.689 . . . . 0.0 109.274 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.578 HD11 ' HE2' ' A' ' 229' ' ' LYS . 58.5 mt -69.35 -46.28 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 110.187 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -63.53 -53.16 56.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.1 -28.36 66.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -71.21 -62.93 1.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.708 HD23 HG21 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -59.72 -21.17 60.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.516 -0.74 . . . . 0.0 109.302 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.4 tptt -74.63 -52.85 10.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.597 -0.689 . . . . 0.0 110.281 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -11.83 59.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 3.0 p -88.43 -32.75 18.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.769 -1.207 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -54.6 150.3 9.53 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -63.54 167.07 5.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.7 t -131.22 97.57 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.2 mp . . . . . 0 C--N 1.305 -1.358 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.517 HD22 ' NH1' ' A' ' 180' ' ' ARG . 1.1 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -61.04 -36.25 79.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -0.849 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 77.11 -120.42 5.61 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 191' ' ' ASP . 44.1 t -61.46 -78.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.548 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 153.34 -153.08 24.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.599 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 15.1 tp -69.53 164.47 23.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -1.19 . . . . 0.0 108.862 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -126.2 147.48 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -172.07 121.69 0.46 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.457 ' C ' ' OE1' ' A' ' 12' ' ' GLN . . . -70.01 -0.97 8.47 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.556 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.542 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 39.8 tt0 -62.47 -57.92 9.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.853 -1.155 . . . . 0.0 108.981 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -71.65 -7.1 45.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.48 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -95.11 -19.39 20.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.923 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 11.0 p -103.05 -52.15 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.0 -1.063 . . . . 0.0 109.318 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.817 ' HB3' HD22 ' A' ' 80' ' ' LEU . 13.3 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.826 0.822 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.618 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 10.6 m -158.69 51.53 0.45 Allowed Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.488 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 35.6 Cg_endo -77.32 156.18 32.89 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.703 1.602 . . . . 0.0 109.892 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.515 ' CD1' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -62.36 -15.28 47.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 110.005 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 220' ' ' HIS . . . -94.26 21.07 44.44 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -144.84 10.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -1.234 . . . . 0.0 109.639 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 t -101.13 -18.92 15.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -99.99 6.79 45.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.94 16.18 8.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 120.872 -1.142 . . . . 0.0 110.067 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 2.8 mp0 46.15 55.99 6.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.605 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.683 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -85.35 -34.34 0.51 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.549 -0.719 . . . . 0.0 111.972 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.0 Cg_endo -72.49 -57.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.0 -29.76 0.36 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 -45.35 38.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.069 . . . . 0.0 109.629 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.68 -17.77 64.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.363 -0.835 . . . . 0.0 110.433 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -39.67 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.882 -1.137 . . . . 0.0 109.829 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -52.38 -35.57 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.702 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.94 8.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.2 135.22 33.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -1.142 . . . . 0.0 109.219 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -130.34 10.13 5.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.798 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.961 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 66.71 -1.36 5.76 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.2 m -47.33 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 124.84 15.59 3.17 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 23' ' ' GLY . 6.0 t -107.57 148.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.993 -1.298 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.8 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -115.84 115.51 26.38 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.447 0.641 . . . . 0.0 110.56 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.45 127.65 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.527 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.23 156.38 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.112 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG12 ' CG ' ' A' ' 32' ' ' ASP . 74.4 t -129.14 86.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.146 -0.971 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.716 HD12 ' CG2' ' A' ' 91' ' ' VAL . 5.0 mp -71.07 100.6 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.537 ' CG ' HG12 ' A' ' 30' ' ' VAL . 43.3 p-10 -160.13 -160.49 0.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.875 -1.141 . . . . 0.0 109.673 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.767 HG21 ' O ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -64.75 -51.27 63.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.657 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . -162.97 -112.88 0.28 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.808 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.701 HG12 ' HB2' ' A' ' 67' ' ' ALA . 0.8 OUTLIER 153.81 -15.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 121.613 0.72 . . . . 0.0 109.152 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 51.37 168.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 110.6 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 37' ' ' THR . 11.4 t -105.12 45.67 0.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.926 0.87 . . . . 0.0 109.195 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -52.5 160.62 1.29 Allowed Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.709 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.05 -4.55 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.692 2.261 . . . . 0.0 110.451 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.661 ' O ' HD12 ' A' ' 73' ' ' LEU . 24.7 t0 -91.84 -60.89 1.75 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mt -70.34 151.51 45.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.215 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.67 ' OD1' HD11 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -105.32 73.95 1.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.295 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 37' ' ' THR . 12.1 mm -42.5 114.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.575 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -108.63 -18.8 13.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.677 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -175.19 -175.81 42.95 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.22 147.01 4.77 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.311 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.53 144.2 46.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.424 -1.045 . . . . 0.0 109.139 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.507 ' OG ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -120.76 121.02 37.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.146 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.857 ' HE2' HG12 ' A' ' 91' ' ' VAL . 3.1 m-85 -110.73 -38.51 5.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.192 -0.943 . . . . 0.0 109.868 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG23 ' HB3' ' A' ' 104' ' ' SER . 1.0 OUTLIER -42.93 -52.58 11.29 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.195 -0.941 . . . . 0.0 109.061 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 50' ' ' VAL . 38.9 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 123.07 2.513 . . . . 0.0 110.717 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.561 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 46.72 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 109.916 -177.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' SER . 7.3 mm100 -95.9 155.69 16.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.876 -1.14 . . . . 0.0 108.45 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLN . 5.0 m-20 52.17 172.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.003 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.767 ' O ' HG21 ' A' ' 33' ' ' THR . . . 164.44 46.62 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 1.1 t30 80.47 -27.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -1.038 . . . . 0.0 110.452 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' O ' ' C ' ' A' ' 62' ' ' HIS . . . 128.11 -72.82 0.46 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.589 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.563 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.9 t-80 -11.44 -59.95 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.445 0.641 . . . . 0.0 111.917 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.528 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.88 -69.47 1.28 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.69 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.7 m -38.39 -41.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.563 -0.963 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 2.0 t-80 -56.61 -63.22 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 219' ' ' PRO . 16.5 t -49.09 -32.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 108.782 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.701 ' HB2' HG12 ' A' ' 35' ' ' ILE . . . -55.39 -53.34 57.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.52 -22.11 74.85 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.723 HG23 ' CE1' ' A' ' 220' ' ' HIS . 6.6 m -73.94 -18.11 60.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.036 -1.273 . . . . 0.0 108.088 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 88' ' ' LEU . 56.8 mt -101.44 -25.84 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.492 -0.755 . . . . 0.0 111.309 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -162.02 25.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.316 -1.49 . . . . 0.0 112.647 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.722 ' HB1' ' HB ' ' A' ' 79' ' ' VAL . . . -39.86 114.52 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 109.34 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.67 HD11 ' OD1' ' A' ' 42' ' ' ASN . 23.6 mt -73.54 167.48 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.68 125.99 53.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 3.1 p-10 -168.68 -109.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -0.969 . . . . 0.0 109.101 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -82.44 -73.52 0.39 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.497 ' HB ' ' OH ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -52.29 178.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.587 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -132.79 122.93 3.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.41 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.722 ' HB ' ' HB1' ' A' ' 72' ' ' ALA . 1.8 t -162.7 -64.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.817 HD22 ' HB3' ' A' ' 3' ' ' SER . 1.1 tp 56.51 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.317 0.58 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.647 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -95.49 -143.44 14.54 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.474 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -106.57 -54.19 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.028 -1.278 . . . . 0.0 109.664 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -107.83 102.76 46.86 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 38.0 Cg_endo -85.57 -63.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.877 2.385 . . . . 0.0 110.919 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -17.39 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 143.33 56.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.253 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.8 ' OE1' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -79.56 126.16 30.53 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.978 -1.077 . . . . 0.0 109.082 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.499 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 15.0 mt -103.25 105.32 15.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.715 -1.241 . . . . 0.0 110.309 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.485 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 19.8 m-85 -85.72 142.35 29.07 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.27 -0.894 . . . . 0.0 108.775 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.423 ' CB ' HD12 ' A' ' 35' ' ' ILE . . . -105.23 104.68 14.46 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.615 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.82 66.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.121 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HD3' ' HD3' ' A' ' 51' ' ' PRO . 1.2 tttt -36.5 109.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.477 0.656 . . . . 0.0 110.018 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.547 HG11 HG23 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -125.06 -13.58 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.508 ' O ' HG21 ' A' ' 50' ' ' VAL . 5.2 mt -84.62 -170.96 3.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.986 0.898 . . . . 0.0 110.886 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.83 -99.54 2.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.519 ' HB3' ' CG2' ' A' ' 33' ' ' THR . . . . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.435 ' C ' ' OG ' ' A' ' 101' ' ' SER . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -177.94 142.72 0.3 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.731 -0.864 . . . . 0.0 108.703 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.883 HG22 ' HA ' ' A' ' 129' ' ' PRO . 21.0 t -68.45 -21.05 25.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.556 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -74.85 -25.17 58.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.876 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -79.61 -67.11 0.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.69 ' HB ' HD12 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -50.52 -24.0 2.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 102' ' ' VAL . . . -67.57 -56.42 9.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.68 -0.638 . . . . 0.0 110.051 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.607 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -65.69 -33.11 75.11 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.43 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.561 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -68.25 -30.83 73.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.439 HD13 HG23 ' A' ' 137' ' ' VAL . 36.1 mt -94.33 -4.67 48.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.116 -1.226 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.96 -5.9 12.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 109.449 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -86.3 -17.73 33.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.638 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -83.49 -1.54 53.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -82.33 -46.35 6.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 -77.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -1.099 . . . . 0.0 108.588 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.82 63.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.638 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -106.82 -156.24 20.8 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.475 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.57 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 14.2 mmt -140.63 -179.92 6.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.854 -0.792 . . . . 0.0 109.734 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.791 ' ND1' HG23 ' A' ' 119' ' ' VAL . 3.0 p80 -78.1 -31.04 49.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.444 -0.785 . . . . 0.0 110.088 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.791 HG23 ' ND1' ' A' ' 118' ' ' HIS . 94.7 t -130.67 165.05 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.73 -1.231 . . . . 0.0 110.956 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.609 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.06 158.65 8.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.719 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.8 m120 -129.3 163.91 24.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.658 -1.276 . . . . 0.0 110.547 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 121' ' ' ASN . 3.3 mp -139.49 99.55 3.76 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.471 -0.768 . . . . 0.0 108.945 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 67.73 10.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 108.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 122' ' ' LEU . 1.1 pp -163.85 -176.19 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.821 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 160' ' ' SER . . . 157.99 107.24 0.24 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -163.98 176.71 2.08 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.134 -1.215 . . . . 0.0 109.627 -179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 126' ' ' SER . 36.4 Cg_endo -81.34 -10.53 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.89 2.393 . . . . 0.0 109.766 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.658 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 1.1 t -50.03 -48.6 78.44 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.74 -0.6 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.883 ' HA ' HG22 ' A' ' 102' ' ' VAL . 31.1 Cg_endo -72.61 169.84 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.245 1.963 . . . . 0.0 110.955 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.25 179.58 5.2 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.701 1.239 . . . . 0.0 111.008 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 134' ' ' GLU . . . -63.52 -16.32 60.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -63.73 -36.01 82.46 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.69 HD12 ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -66.71 -34.97 79.02 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 1.7 tt0 -60.25 -58.92 6.45 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.863 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 138' ' ' ASN . 96.5 mm-40 -45.51 -25.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -67.79 -48.72 65.52 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.439 HG23 HD13 ' A' ' 109' ' ' LEU . 3.4 t -65.3 -26.14 38.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 11.9 t30 -62.33 -35.17 78.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 p -75.82 -25.38 56.26 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.1 -22.93 57.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.183 -0.948 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -30.5 67.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.966 . . . . 0.0 108.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.55 -34.19 49.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 108.969 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -98.71 -19.69 17.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 237' ' ' ASN . . . 82.98 14.13 75.86 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 145' ' ' VAL . 6.3 t -48.4 102.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -1.095 . . . . 0.0 108.931 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HB2' ' OD1' ' A' ' 237' ' ' ASN . 0.4 OUTLIER -69.1 103.55 1.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.285 -0.884 . . . . 0.0 109.426 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -102.51 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 218' ' ' THR . 1.0 OUTLIER -122.9 113.92 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.4 32.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.922 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.612 ' HB1' ' HB ' ' A' ' 214' ' ' THR . . . -64.08 172.53 2.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.809 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.613 ' CB ' HG21 ' A' ' 214' ' ' THR . 0.3 OUTLIER -69.0 -74.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 109.758 -179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 153.73 -13.01 0.56 Allowed Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.301 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 152' ' ' GLY . 4.4 m-20 22.9 48.62 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.3 OUTLIER 176.73 56.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.46 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . 161.79 51.84 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -54.51 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 110.252 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . 66.18 11.61 55.91 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 2.3 p 160.13 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -112.29 -175.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.944 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -85.93 168.79 13.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.305 1.05 . . . . 0.0 111.801 -178.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.457 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -104.38 137.86 19.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 175.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.721 ' O ' ' N ' ' A' ' 164' ' ' ARG . 39.6 Cg_endo -73.24 -53.31 0.16 OUTLIER 'Cis proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.174 -1.178 . . . . 0.0 110.656 3.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.944 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 29.95 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.254 1.026 . . . . 0.0 110.116 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 162' ' ' PRO . 3.8 ttm180 -42.39 -46.86 4.82 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.329 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 14.7 m-85 -44.4 173.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.11 -0.994 . . . . 0.0 110.913 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 168' ' ' ALA . . . -98.8 -47.87 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.67 -0.644 . . . . 0.0 110.493 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 166' ' ' ALA . 0.4 OUTLIER -42.24 -27.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.882 0.848 . . . . 0.0 109.751 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -125.55 145.55 50.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.473 ' SD ' ' HG3' ' A' ' 241' ' ' ARG . 12.7 mtm -96.12 153.92 17.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -108.43 122.82 47.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.8 t -90.72 165.75 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 0.0 109.76 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.618 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -131.09 -176.62 14.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.82 162.44 27.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.992 -1.299 . . . . 0.0 109.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.1 p -133.45 172.27 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.789 . . . . 0.0 109.249 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 -156.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -90.05 -41.51 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -78.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.535 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.72 30.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 110.042 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -112.22 156.36 22.48 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.145 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' A' ' 256' ' ' LEU . 6.7 ttp85 -60.96 134.6 57.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 0.0 109.475 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.776 ' HB1' ' CE1' ' A' ' 183' ' ' PHE . . . -45.68 173.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.451 -0.78 . . . . 0.0 109.701 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.0 OUTLIER -108.27 11.17 27.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 109.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.776 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 2.3 p90 -134.73 -12.37 2.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.039 -1.038 . . . . 0.0 110.645 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 t -67.01 138.88 57.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.526 ' HG2' ' N ' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -93.83 143.02 26.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.115 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.47 -174.34 3.04 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.596 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.03 -171.85 44.09 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -85.67 64.39 8.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.127 . . . . 0.0 109.177 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.63 31.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -85.53 138.26 32.32 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.132 -1.216 . . . . 0.0 109.66 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -86.0 -72.68 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.629 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 193' ' ' VAL . 0.3 OUTLIER -149.56 -162.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.245 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.795 HG22 ' CA ' ' A' ' 260' ' ' GLY . 27.2 m -143.28 175.97 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.962 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -167.61 177.16 1.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 108.946 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.962 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.2 Cg_endo -76.69 113.74 3.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 109.446 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.505 ' HA2' ' ND2' ' A' ' 212' ' ' ASN . . . -145.22 48.27 0.71 Allowed Glycine 0 N--CA 1.484 1.861 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.435 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 1.7 t -130.87 30.49 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.249 . . . . 0.0 109.068 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.597 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.1 OUTLIER 164.86 105.18 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.158 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.788 HG22 ' ND2' ' A' ' 212' ' ' ASN . 2.7 m -158.37 111.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -89.56 117.93 28.82 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.335 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -118.05 -151.45 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.929 . . . . 0.0 109.858 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.687 ' OG1' HG22 ' A' ' 64' ' ' THR . 0.1 OUTLIER -87.92 178.43 6.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.645 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -164.6 157.7 14.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.645 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.6 Cg_endo -70.07 166.0 29.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.233 1.956 . . . . 0.0 110.322 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 206' ' ' SER . . . 84.74 3.84 87.84 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 205' ' ' GLY . 6.9 t 74.84 43.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -1.078 . . . . 0.0 110.26 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -145.11 -179.91 6.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.554 ' CE2' HG22 ' A' ' 79' ' ' VAL . 2.9 m-30 -113.67 -174.13 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -165.31 164.77 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.828 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 50.5 m -124.8 114.56 19.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.504 -0.747 . . . . 0.0 109.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 211' ' ' LEU . 0.8 OUTLIER -173.96 138.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.407 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.788 ' ND2' HG22 ' A' ' 199' ' ' VAL . 2.9 t-20 -125.23 -157.43 0.78 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.165 0.983 . . . . 0.0 110.601 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 136.32 175.95 14.09 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 151' ' ' SER . 0.2 OUTLIER -56.68 -41.52 77.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.984 -1.303 . . . . 0.0 109.346 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.5 m -57.69 -29.86 65.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 0.0 110.447 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.486 ' O ' HG21 ' A' ' 69' ' ' THR . 1.4 mpp? -90.95 -26.26 19.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.496 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.12 -6.2 59.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.977 -1.077 . . . . 0.0 109.441 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.703 HG23 HG12 ' A' ' 148' ' ' VAL . 1.2 m -73.05 -47.56 8.07 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -71.71 -8.39 23.03 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.098 1.865 . . . . 0.0 111.466 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.723 ' CE1' HG23 ' A' ' 69' ' ' THR . 5.7 m80 -77.19 -47.14 21.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 262' ' ' VAL . 57.9 t -67.74 -41.39 85.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.565 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -57.65 -34.77 69.71 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.5 -54.83 26.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.69 ' HB1' ' HB2' ' A' ' 264' ' ' ALA . . . -51.06 -38.3 50.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 108.867 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -59.08 -44.96 91.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 0.0 109.154 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.61 52.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 108.985 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.9 mt -50.82 -31.53 17.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.025 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 224' ' ' ALA . 58.3 t -68.3 -52.1 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.473 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.515 ' HD2' ' ND1' ' A' ' 118' ' ' HIS . 27.3 tttp -46.78 -42.06 16.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 108.822 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.552 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -62.22 -45.95 91.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.357 -0.839 . . . . 0.0 109.444 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 11.6 tptm -56.4 -18.6 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 108.557 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.5 90.8 2.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 108.999 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.04 8.28 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.752 2.301 . . . . 0.0 110.876 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.14 8.33 10.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -82.33 -178.66 7.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.383 -0.823 . . . . 0.0 109.915 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -121.54 174.71 6.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.651 -0.655 . . . . 0.0 109.443 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -60.42 -27.05 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 238' ' ' VAL . 2.8 t -73.06 -63.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.098 -1.001 . . . . 0.0 109.61 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -49.04 -39.79 28.72 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.546 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 237' ' ' ASN . 84.0 mt -60.01 -58.12 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.486 -0.759 . . . . 0.0 109.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.473 ' HG3' ' SD ' ' A' ' 169' ' ' MET . 18.8 ttp180 -54.64 -72.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.9 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ARG . 4.8 t30 -35.03 -36.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.919 -0.488 . . . . 0.0 110.736 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.493 ' HD2' ' HB1' ' A' ' 267' ' ' ALA . 8.6 t60 -65.83 -51.56 57.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.996 -1.065 . . . . 0.0 110.107 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.517 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 3.6 mt -70.84 -23.84 62.42 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.295 -0.878 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -33.24 60.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -93.26 -14.97 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.2 p -87.32 -31.3 20.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.035 -1.041 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.616 ' HB3' ' CB ' ' A' ' 259' ' ' SER . . . -51.13 144.07 9.78 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 17.6 m -78.07 159.47 28.68 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.447 ' N ' HG22 ' A' ' 249' ' ' THR . 1.9 t -128.55 101.67 6.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.852 . . . . 0.0 109.945 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.666 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.576 ' CD1' ' CD2' ' A' ' 186' ' ' TYR . 2.0 mm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.615 0.722 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.47 ' O ' ' O ' ' A' ' 258' ' ' GLY . 72.3 m-85 -128.75 -83.74 0.57 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.73 -0.606 . . . . 0.0 109.601 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 50.39 99.39 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.616 ' CB ' ' HB3' ' A' ' 248' ' ' ALA . 0.9 OUTLIER 56.91 18.85 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.584 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.795 ' CA ' HG22 ' A' ' 193' ' ' VAL . . . -40.75 -61.04 1.99 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 249' ' ' THR . 5.9 tp -62.91 143.44 57.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.997 -1.296 . . . . 0.0 110.186 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.726 HG21 HG22 ' A' ' 221' ' ' VAL . 3.6 t -118.54 125.83 74.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 116.19 6.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.772 1.273 . . . . 0.0 108.663 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.69 ' HB2' ' HB1' ' A' ' 224' ' ' ALA . . . -77.64 -17.28 57.9 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.895 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 55.7 tt0 -55.65 -36.94 67.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 0.0 109.624 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.2 -19.47 39.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.493 ' HB1' ' HD2' ' A' ' 243' ' ' HIS . . . -98.23 -1.83 41.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.365 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.6 p -109.5 -39.06 5.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.655 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.589 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 5' ' ' PRO . 22.9 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 3' ' ' SER . 7.3 t -17.3 80.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.708 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -81.69 164.31 18.44 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.809 2.339 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -15.36 7.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.566 -0.709 . . . . 0.0 109.793 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 195' ' ' PRO . . . -83.16 -64.23 1.67 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.1 mp -65.87 173.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.294 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 2.5 t 88.94 -39.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -25.12 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.335 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 11' ' ' VAL . 34.0 m -91.55 20.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.939 -1.101 . . . . 0.0 110.089 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.541 ' OE1' ' CB ' ' A' ' 265' ' ' GLU . 0.0 OUTLIER 50.86 53.42 13.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 110.519 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.681 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.66 -30.41 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.944 -1.097 . . . . 0.0 111.988 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.8 Cg_endo -75.31 -59.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.11 -27.41 0.58 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.06 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -81.15 -40.56 23.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.922 -1.111 . . . . 0.0 108.935 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -73.11 -8.42 55.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.48 -39.02 5.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.599 -1.313 . . . . 0.0 110.23 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.41 68.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.868 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.09 -4.85 4.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.606 ' HB3' HD22 ' A' ' 227' ' ' LEU . 3.7 mm? -62.9 122.29 15.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.199 -1.177 . . . . 0.0 109.101 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -118.5 -30.81 5.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.535 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 78.8 -14.73 12.13 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.41 120.81 4.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -1.154 . . . . 0.0 109.001 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.09 0.71 30.0 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 23' ' ' GLY . 39.4 t -99.37 164.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.236 -1.155 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.594 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 6.4 mttt -142.29 129.34 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' A' ' 119' ' ' VAL . 16.0 t -133.04 158.54 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.611 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -112.17 144.42 41.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 108.918 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 88' ' ' LEU . 45.7 t -121.31 82.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.073 -1.017 . . . . 0.0 109.132 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.859 HD22 HD12 ' A' ' 122' ' ' LEU . 4.9 mp -64.7 91.64 0.09 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -144.72 -151.78 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.798 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.689 HG22 ' C ' ' A' ' 95' ' ' GLY . 72.9 p -80.35 -51.63 8.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.462 -1.398 . . . . 0.0 109.036 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -168.56 -114.47 0.3 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 160.83 100.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.5 t -44.75 150.47 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.193 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.33 115.27 21.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.422 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -139.16 157.26 71.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.2 Cg_endo -77.01 -37.48 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.6 2.2 . . . . 0.0 110.493 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -62.08 -18.94 62.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' CD2' ' HA2' ' A' ' 68' ' ' GLY . 14.5 mt -102.02 129.82 48.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.371 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 68.23 9.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.385 -0.822 . . . . 0.0 109.307 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -57.26 139.02 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.482 ' HG2' ' HG2' ' A' ' 87' ' ' GLU . 20.3 tpt85 -121.54 -33.92 3.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.261 -0.899 . . . . 0.0 109.687 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -156.27 18.97 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.22 166.2 13.92 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.726 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -145.33 174.58 10.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.976 . . . . 0.0 108.961 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 92' ' ' LYS . 81.2 p -125.84 107.18 10.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 110.28 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.726 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 2.7 m-85 -105.81 -36.83 6.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.675 HG13 ' HD2' ' A' ' 51' ' ' PRO . 2.1 t -41.82 145.97 0.65 Allowed Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HD2' HG13 ' A' ' 50' ' ' VAL . 34.0 Cg_endo . . . . . 0 C--N 1.311 -1.415 0 C-N-CA 122.575 2.183 . . . . 0.0 110.81 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 56' ' ' THR . 1.2 m -77.74 -0.85 28.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.594 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 41.1 mt-30 -141.51 117.72 10.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.041 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 14.2 t70 64.56 92.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.837 . . . . 0.0 109.513 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.29 -27.89 5.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.66 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.389 -1.065 . . . . 0.0 109.679 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 64' ' ' THR . . . 160.55 -42.18 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.216 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' GLY . 34.7 t-80 -54.16 -65.09 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 110.078 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -39.99 -74.77 0.13 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -40.1 -40.66 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 0.0 109.784 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.4 t-80 -55.37 -56.7 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 219' ' ' PRO . 78.5 t -57.49 -44.44 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -54.67 -32.72 59.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.483 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -79.39 -27.62 54.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -74.15 -15.61 61.02 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.953 HG21 HD21 ' A' ' 88' ' ' LEU . 16.7 mt -109.29 -21.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.455 -0.778 . . . . 0.0 110.049 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.948 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -117.56 -35.45 3.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 111.627 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 68' ' ' GLY . . . -15.24 106.15 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 121.468 0.652 . . . . 0.0 111.646 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 40' ' ' ASP . 6.7 mt -85.0 153.82 22.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 109.749 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 48.9 p-10 -72.62 141.64 48.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 8.7 m-20 158.17 130.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -35.61 -39.11 0.13 Allowed 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -86.68 64.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.127 -0.983 . . . . 0.0 109.349 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA3' ' OD2' ' A' ' 40' ' ' ASP . . . 158.35 160.17 10.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 80' ' ' LEU . 5.5 m -79.05 -112.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -1.112 . . . . 0.0 109.646 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.439 ' H ' HG23 ' A' ' 79' ' ' VAL . 5.6 tp -171.74 96.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.799 -1.188 . . . . 0.0 109.664 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 72' ' ' ALA . . . -78.92 -160.49 18.02 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.644 HG12 HD11 ' A' ' 227' ' ' LEU . 1.4 t -107.65 -32.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.291 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -115.53 117.98 39.84 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 109.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 22' ' ' THR . 37.6 Cg_endo -85.48 -59.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.724 2.282 . . . . 0.0 111.244 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.53 38.83 1.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.97 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -89.54 124.2 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 2.6 mt-10 -64.49 103.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.953 HD21 HG21 ' A' ' 70' ' ' ILE . 11.1 mt -97.44 92.9 6.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 110.851 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.444 ' CE2' ' HE3' ' A' ' 117' ' ' MET . 40.0 m-85 -77.63 146.57 36.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.25 106.59 17.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.767 -1.208 . . . . 0.0 109.029 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.698 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -95.1 67.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.988 0.899 . . . . 0.0 108.807 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 26.6 ttmt -35.12 94.05 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.005 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.607 HG21 HD23 ' A' ' 31' ' ' LEU . 2.2 t -118.39 -16.66 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 0.0 108.891 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.1 mt -116.47 175.17 5.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.389 -0.819 . . . . 0.0 110.167 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -107.36 -14.3 18.62 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.472 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 177.51 6.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.883 -0.775 . . . . 0.0 109.969 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 133' ' ' LEU . 1.5 t -66.19 -22.02 29.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 3.6 t -69.96 -26.4 64.09 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 93' ' ' VAL . 4.4 m -81.23 -44.49 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.538 -0.726 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.525 HG22 ' CD1' ' A' ' 109' ' ' LEU . 1.2 mt -68.14 -21.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.49 -52.22 16.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.681 -0.637 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 103' ' ' SER . 12.7 mm-40 -71.15 -30.4 66.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.689 -1.257 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -73.19 -24.07 76.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD1' HG22 ' A' ' 105' ' ' ILE . 25.0 mt -93.79 -24.2 17.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -1.179 . . . . 0.0 109.906 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.33 -30.52 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 69.4 t90 -72.65 -16.6 61.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.693 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -91.37 6.21 46.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -114.9 -50.38 0.48 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -70.08 -76.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.279 . . . . 0.0 108.732 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -105.71 41.07 1.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.621 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -92.39 -149.46 24.53 Favored Glycine 0 C--N 1.294 -1.782 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.594 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 7.1 mmt -140.3 -169.15 2.7 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.178 0.989 . . . . 0.0 110.933 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.485 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.0 m170 -70.21 -57.77 4.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.164 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.7 ' HB ' HG13 ' A' ' 28' ' ' VAL . 9.7 t -101.03 161.35 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 111.177 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.592 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -163.25 109.7 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 1.057 ' C ' HD13 ' A' ' 122' ' ' LEU . 7.0 m120 -110.72 153.49 25.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.911 -1.118 . . . . 0.0 111.077 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.057 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -134.89 134.07 40.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -89.61 70.27 7.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.294 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.608 HD21 ' CB ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -150.4 -177.74 6.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.621 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.07 106.93 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.18 158.97 40.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.205 -1.173 . . . . 0.0 109.58 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 128' ' ' SER . 36.0 Cg_endo -78.69 -17.1 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.633 2.222 . . . . 0.0 110.051 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -40.98 102.15 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.583 -0.698 . . . . 0.0 109.533 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 130' ' ' SER . 34.0 Cg_endo -77.42 166.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.409 2.073 . . . . 0.0 110.488 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 129' ' ' PRO . 2.1 m 172.53 121.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.436 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.58 -18.53 65.03 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.8 m -73.07 -25.73 61.01 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.583 ' CD1' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -79.62 -42.89 23.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.45 -25.82 57.77 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.546 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.4 tm0? -72.41 -22.75 61.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.3 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 167' ' ' ASN . 0.9 OUTLIER -64.06 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -59.45 -36.55 76.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.52 -24.48 50.0 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.29 59.42 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 121.232 -0.917 . . . . 0.0 109.917 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m -73.17 -36.53 66.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -24.76 58.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -105.15 -13.14 15.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.26 55.53 27.22 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.693 HG21 ' O ' ' A' ' 112' ' ' ALA . 15.3 t -89.36 107.13 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.704 -0.88 . . . . 0.0 109.766 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.05 101.95 0.45 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.063 -1.023 . . . . 0.0 109.071 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 1.4 t -88.81 150.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -146.06 120.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.713 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -115.44 151.33 34.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.124 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.68 173.82 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -72.78 -67.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.034 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . 172.67 -23.67 0.08 OUTLIER Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.77 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 154' ' ' SER . 44.4 t-20 67.52 37.12 3.51 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.831 -0.805 . . . . 0.0 109.96 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 1.0 OUTLIER 79.23 72.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 110.213 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -115.84 -33.09 1.6 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -172.12 -178.39 2.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -1.193 . . . . 0.0 109.534 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.34 58.41 4.91 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER 162.25 129.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.982 . . . . 0.0 109.196 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 158' ' ' SER . 1.8 pt -48.66 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.359 -0.838 . . . . 0.0 110.007 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.878 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -126.91 164.68 20.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.227 -0.921 . . . . 0.0 111.896 -177.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.1 OUTLIER -77.78 142.37 65.41 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 175.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.8 Cg_endo -72.0 -29.3 6.35 Favored 'Cis proline' 0 C--N 1.298 -2.113 0 O-C-N 122.546 0.761 . . . . 0.0 110.594 3.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -35.12 -26.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.732 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -100.35 -32.03 11.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.542 -1.349 . . . . 0.0 110.608 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.51 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.6 m-85 -46.18 -179.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.172 -0.955 . . . . 0.0 110.798 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -93.96 -25.64 17.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.566 -0.709 . . . . 0.0 111.049 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.471 HD22 HG13 ' A' ' 137' ' ' VAL . 2.2 t-20 -97.98 23.08 8.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.81 -1.181 . . . . 0.0 110.061 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 162' ' ' PRO . . . -153.01 114.61 4.26 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.537 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 0.6 OUTLIER -78.26 167.45 21.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.128 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -118.61 123.77 45.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.331 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 172' ' ' GLY . 25.0 t -92.86 166.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.141 -0.974 . . . . 0.0 109.242 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.571 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -138.66 -179.79 17.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.49 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -119.47 171.27 8.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 179' ' ' ASN . 1.5 p -122.86 167.88 12.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.536 ' CA ' ' HA ' ' A' ' 181' ' ' ALA . 49.6 p-10 -91.16 -177.57 4.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -69.51 -24.25 63.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.29 -79.22 0.17 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.464 ' O ' ' HB ' ' A' ' 174' ' ' THR . 0.1 OUTLIER -135.76 -79.4 0.42 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 110.363 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.593 ' HA ' HG22 ' A' ' 174' ' ' THR . 0.8 OUTLIER -125.0 -164.49 1.29 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.206 -0.934 . . . . 0.0 109.681 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 81.43 -31.31 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.626 -0.672 . . . . 0.0 110.932 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.536 ' HA ' ' CA ' ' A' ' 175' ' ' ASP . . . 42.99 -155.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.957 -1.089 . . . . 0.0 109.454 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -126.64 -45.81 1.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 110.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.27 26.37 10.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.349 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.5 t -81.15 112.31 18.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.636 ' NE2' ' HA ' ' A' ' 185' ' ' GLN . 4.9 tp60 -74.88 156.8 36.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.8 171.41 14.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.613 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.578 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -173.56 146.83 9.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.05 100.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.46 16.16 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 186' ' ' TYR . 7.1 tp -53.79 151.08 6.7 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.107 -1.231 . . . . 0.0 108.824 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.537 ' CB ' ' HB3' ' A' ' 169' ' ' MET . 22.4 t70 -99.54 -69.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.825 HD11 HG22 ' A' ' 262' ' ' VAL . 7.6 tt -159.45 141.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.367 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.516 HG21 HD21 ' A' ' 179' ' ' ASN . 22.1 m -98.32 172.96 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 1.002 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -164.1 178.13 1.56 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.05 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 1.002 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.7 Cg_endo -77.64 117.61 4.32 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.284 1.989 . . . . 0.0 110.134 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -143.67 33.24 1.78 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.666 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 62.7 t -119.31 59.03 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -1.192 . . . . 0.0 108.88 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.724 ' O ' HG13 ' A' ' 199' ' ' VAL . 12.9 t-20 123.9 121.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 198' ' ' ASN . 11.6 m -166.4 110.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.946 0.879 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.6 mt-30 -80.46 122.97 27.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.334 0.588 . . . . 0.0 109.531 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.594 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.8 t -125.31 -163.16 1.17 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.643 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.5 p -79.27 166.8 21.76 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 110.115 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.647 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -149.16 156.62 40.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.647 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.3 Cg_endo -69.96 159.94 51.46 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.183 1.922 . . . . 0.0 110.629 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.418 ' O ' ' OG ' ' A' ' 206' ' ' SER . . . 74.84 31.28 58.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 205' ' ' GLY . 80.9 p 49.86 40.15 19.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -1.076 . . . . 0.0 109.905 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.22 155.36 40.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -103.58 165.43 11.04 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.186 -0.946 . . . . 0.0 108.819 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -153.09 163.76 39.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.768 -1.208 . . . . 0.0 110.746 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.8 OUTLIER -121.27 108.21 13.46 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.522 HD23 ' C ' ' A' ' 210' ' ' SER . 11.0 mt -110.12 170.0 8.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.103 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 212' ' ' ASN . 2.4 p-10 -146.77 148.88 32.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.448 -0.782 . . . . 0.0 109.211 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.16 161.94 11.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 173' ' ' ALA . 90.3 m -77.37 -17.32 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -1.129 . . . . 0.0 109.222 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 36.0 m -75.37 -19.25 59.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.118 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.442 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -79.71 -17.44 53.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 109.556 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -89.8 -13.1 37.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 109.732 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.638 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.7 m -70.6 -42.73 14.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 111.489 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.9 Cg_endo -73.11 -15.45 25.77 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 121.672 1.581 . . . . 0.0 110.756 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -75.25 -40.44 58.91 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.466 HG22 HG21 ' A' ' 262' ' ' VAL . 88.2 t -68.82 -49.64 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.535 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.27 -31.99 62.01 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.387 -0.821 . . . . 0.0 108.995 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -64.24 -53.87 33.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -49.25 -52.19 28.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -1.179 . . . . 0.0 109.237 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.37 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.404 -0.81 . . . . 0.0 109.061 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -61.73 -44.23 97.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.308 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 82' ' ' VAL . 79.1 mt -55.8 -36.63 67.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.238 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.504 HG21 HD23 ' A' ' 244' ' ' LEU . 36.6 t -73.59 -40.88 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 109.995 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.76 ' NZ ' HD13 ' A' ' 240' ' ' ILE . 11.6 ttmm -52.38 -46.07 66.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.623 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.434 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.78 -45.16 93.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -20.66 3.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.848 . . . . 0.0 108.792 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.62 85.06 0.53 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.758 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 35.1 Cg_endo -77.05 -16.16 16.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.07 -0.6 32.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -81.27 -177.33 6.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.75 169.13 11.04 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.64 . . . . 0.0 109.577 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -60.11 -16.06 28.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.68 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.51 -63.74 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.481 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -50.82 -38.86 51.21 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.031 -178.382 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.76 HD13 ' NZ ' ' A' ' 229' ' ' LYS . 62.5 mt -70.62 -44.61 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 110.294 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 4.8 ttp85 -57.3 -29.24 63.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 110.415 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.49 -29.63 25.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.75 -1.219 . . . . 0.0 110.278 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.424 ' O ' HG23 ' A' ' 247' ' ' THR . 0.6 OUTLIER -75.5 -57.86 3.63 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.934 -1.104 . . . . 0.0 108.126 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.522 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -60.05 -38.12 81.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.753 -0.592 . . . . 0.0 110.253 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 21.6 tttt -69.34 -49.96 50.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -74.62 -6.37 48.26 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.826 -0.547 . . . . 0.0 110.862 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.5 p -94.15 -30.76 14.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.697 -1.252 . . . . 0.0 109.832 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -44.24 137.44 3.5 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.7 m -92.19 105.9 18.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.187 -0.945 . . . . 0.0 109.862 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.499 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.5 OUTLIER -75.43 135.61 40.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.442 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.484 1.258 0 O-C-N 121.309 -0.869 . . . . 0.0 109.686 179.666 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 256' ' ' LEU . 13.8 mt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 257' ' ' TYR . 4.2 m-30 -71.4 -24.39 62.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.697 0.76 . . . . 0.0 109.121 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.69 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 192' ' ' ILE . 44.9 m -54.02 -48.49 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.941 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 106.74 -131.37 10.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 261' ' ' LEU . 4.8 tp -81.65 179.17 7.94 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.365 -1.079 . . . . 0.0 109.898 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.825 HG22 HD11 ' A' ' 192' ' ' ILE . 0.4 OUTLIER -120.32 140.67 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.492 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.45 118.43 1.39 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.468 1.128 . . . . 0.0 108.533 178.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -80.43 -7.19 59.04 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.698 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.541 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -57.53 -54.02 51.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.771 -1.206 . . . . 0.0 109.792 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.6 33.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.085 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.417 ' HB1' ' CG2' ' A' ' 228' ' ' VAL . . . -103.61 -14.91 15.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.819 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.601 HG21 ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -106.04 -31.26 8.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.025 . . . . 0.0 109.981 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 268' ' ' THR . 1.4 ttp85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 1.9 m . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 t -131.83 81.27 63.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 109.208 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HG2' HG13 ' A' ' 8' ' ' ILE . 33.6 Cg_endo -77.27 157.23 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.507 2.138 . . . . 0.0 110.738 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -47.37 -38.0 12.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.648 -0.658 . . . . 0.0 109.916 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' TRP . . . -59.95 -43.81 97.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -107.33 50.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -1.155 . . . . 0.0 109.862 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -132.15 -42.88 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 109.593 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -86.61 -1.1 57.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.888 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 13' ' ' ALA . 16.2 m -88.42 20.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 120.994 -1.066 . . . . 0.0 109.85 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 263' ' ' ASN . 1.1 mt-30 41.4 42.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.745 . . . . 0.0 110.289 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.691 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -76.85 -35.37 1.42 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 111.481 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.2 Cg_endo -73.0 -56.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.623 ' HB1' ' HG3' ' A' ' 265' ' ' GLU . . . -42.93 -37.07 1.73 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.35 72.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.209 -0.932 . . . . 0.0 108.563 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 21.7 m170 -63.93 -14.34 52.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.89 -50.26 12.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.15 -14.58 25.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.52 -2.86 39.57 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 268' ' ' THR . 1.6 tp -51.72 162.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.154 . . . . 0.0 109.655 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 -32.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 64.82 8.86 36.35 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.546 ' CB ' ' HB3' ' A' ' 85' ' ' ASN . 8.6 p -52.75 -31.8 40.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.964 . . . . 0.0 110.07 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.03 32.9 4.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 27' ' ' LYS . 54.0 t -123.57 162.35 24.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.222 -1.164 . . . . 0.0 109.927 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.696 ' HZ2' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -133.94 132.5 40.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.56 ' N ' ' HE2' ' A' ' 27' ' ' LYS . 1.1 t -128.41 103.68 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 109.789 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.792 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -74.16 162.46 28.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 35' ' ' ILE . 42.6 t -135.16 89.08 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.011 -1.056 . . . . 0.0 108.894 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 7.1 mp -76.56 109.78 10.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD2' ' HA3' ' A' ' 63' ' ' GLY . 44.4 p-10 -173.71 -164.92 0.23 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.895 -1.128 . . . . 0.0 110.123 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 96' ' ' ALA . 19.6 p -42.9 -64.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.724 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -172.2 -116.19 0.39 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.697 HD11 HG11 ' A' ' 30' ' ' VAL . 0.6 OUTLIER 156.58 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.4 p -69.25 151.5 46.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 109.599 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 t -70.94 162.21 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -0.869 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.618 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -166.29 162.7 12.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.8 Cg_endo -79.04 -5.78 14.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.701 2.267 . . . . 0.0 110.349 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -109.56 -17.07 13.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.137 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.638 HD21 ' HA2' ' A' ' 68' ' ' GLY . 18.5 mt -100.7 141.29 33.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.267 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -111.8 67.05 0.64 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.104 -0.998 . . . . 0.0 109.229 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' CG2' ' A' ' 35' ' ' ILE . 31.9 mm -43.06 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.379 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -81.88 -15.82 52.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.238 -0.914 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -171.28 152.41 18.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 163.79 29.2 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.51 167.61 28.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.979 ' OG ' HG23 ' A' ' 56' ' ' THR . 1.5 m -148.81 111.74 4.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 110.156 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.755 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 9.0 m-85 -99.02 -40.61 7.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.571 ' HB ' ' NZ ' ' A' ' 92' ' ' LYS . 76.3 t -51.73 120.4 15.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 108.986 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.31 -1.457 0 C-N-CA 122.618 2.212 . . . . 0.0 111.218 -179.404 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.447 ' C ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 120.912 0.387 . . . . 0.0 110.39 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.979 HG23 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER 64.5 3.32 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.048 -1.033 . . . . 0.0 110.408 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 56' ' ' THR . 78.4 mm-40 -149.75 118.77 6.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.666 -1.271 . . . . 0.0 110.211 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' CB ' ' A' ' 204' ' ' PRO . 8.6 t0 57.27 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.404 -0.81 . . . . 0.0 110.106 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . -127.06 -8.07 4.75 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 63.8 t-20 176.31 -61.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -1.135 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.83 -18.33 0.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -68.13 0.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -1.086 . . . . 0.0 110.029 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' HA3' ' OD2' ' A' ' 32' ' ' ASP . . . -55.46 -22.83 32.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.7 m -72.42 -57.71 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.75 -1.441 . . . . 0.0 109.809 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.604 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.5 t-80 -59.04 -36.11 74.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 70' ' ' ILE . 67.1 t -67.92 -42.81 85.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.406 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' HG12 ' A' ' 35' ' ' ILE . . . -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.438 -0.789 . . . . 0.0 110.009 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.638 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -68.61 -40.27 86.04 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.432 HG21 ' HG2' ' A' ' 219' ' ' PRO . 28.2 m -63.72 -17.28 62.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.399 -1.059 . . . . 0.0 108.727 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.78 ' HB ' HD11 ' A' ' 88' ' ' LEU . 36.9 mt -93.85 -22.28 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.439 -0.788 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.785 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -131.59 -52.67 1.0 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 111.228 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 33.7 62.84 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.722 -0.611 . . . . 0.0 109.831 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.474 HD11 ' OD1' ' A' ' 42' ' ' ASN . 43.4 mt -43.34 147.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 1.7 m-20 -62.55 155.88 24.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 109.256 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m-20 145.8 129.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 28.5 t -37.03 -30.16 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.293 0.568 . . . . 0.0 109.765 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 75' ' ' ASN . 28.7 pt -84.65 143.54 11.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.92 155.07 0.38 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 80' ' ' LEU . 26.0 m -72.16 -141.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.317 -1.107 . . . . 0.0 109.683 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.52 HD11 ' OD1' ' A' ' 74' ' ' ASN . 67.5 tp -138.81 128.07 24.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.089 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 1.078 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -87.08 -177.07 49.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.68 -32.35 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -1.232 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -116.34 98.53 51.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.081 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -83.13 -60.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.812 2.341 . . . . 0.0 110.496 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.546 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -71.71 0.38 8.95 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.671 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.587 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -73.33 161.52 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.852 -1.155 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.536 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 2.1 mp0 -97.99 107.85 20.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.789 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 71' ' ' ALA . 2.5 mt -90.47 127.5 36.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.637 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.672 ' CD1' ' HE3' ' A' ' 27' ' ' LYS . 3.6 m-85 -111.99 178.11 4.42 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.014 -1.054 . . . . 0.0 109.943 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.25 90.2 2.5 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.792 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -96.1 64.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.216 -0.928 . . . . 0.0 109.111 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.571 ' NZ ' ' HB ' ' A' ' 50' ' ' VAL . 3.1 ttpm? -41.06 121.32 1.53 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.33 0.586 . . . . 0.0 109.611 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 104' ' ' SER . 1.2 t -131.7 3.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.953 . . . . 0.0 109.258 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.928 ' CD1' HD22 ' A' ' 124' ' ' LEU . 2.1 mp -141.29 173.92 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.669 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -98.31 -178.35 32.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.194 -1.18 . . . . 0.0 109.397 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.26 160.29 22.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.627 -0.925 . . . . 0.0 109.818 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.78 -18.7 22.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 107' ' ' GLN . 8.7 t -80.47 -14.71 58.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.83 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -87.84 -44.08 11.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.589 -0.694 . . . . 0.0 109.16 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.6 ' HA ' HG11 ' A' ' 93' ' ' VAL . 2.4 mt -76.88 -32.47 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.92 -36.2 59.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 tt0 -70.88 -42.5 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.883 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.54 73.26 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.46 -45.29 72.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -1.106 . . . . 0.0 108.944 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 107' ' ' GLN . 9.9 pt-20 -72.27 -24.18 61.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -69.99 -18.68 63.35 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.658 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.66 -0.69 48.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.322 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA3' ' NH1' ' A' ' 143' ' ' ARG . . . -107.15 -51.73 0.76 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -1.12 . . . . 0.0 109.143 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -120.99 34.65 5.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -102.37 -151.19 23.54 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.718 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.696 ' HG3' ' HZ2' ' A' ' 27' ' ' LYS . 2.6 mmt -144.14 -157.73 0.81 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.153 0.978 . . . . 0.0 110.965 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.646 ' NE2' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -90.83 -30.6 16.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.896 -178.094 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.646 HG22 ' NE2' ' A' ' 118' ' ' HIS . 2.1 t -111.51 154.14 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 119.857 -1.777 . . . . 0.0 110.502 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -163.39 105.62 0.98 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 0.0 108.908 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.57 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.9 m120 -85.45 -178.75 6.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.959 HD23 HD11 ' A' ' 124' ' ' LEU . 1.1 mp -152.38 100.23 2.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.524 ' C ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -85.46 65.47 9.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.959 HD11 HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.35 88.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -109.09 152.13 42.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.185 -1.185 . . . . 0.0 109.252 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -77.42 -23.43 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.426 2.084 . . . . 0.0 109.45 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -69.38 111.7 9.56 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.806 -0.559 . . . . 0.0 109.906 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.8 Cg_endo -82.66 170.63 12.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.407 2.071 . . . . 0.0 110.326 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.5 p -163.08 110.77 1.23 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.35 -29.49 70.23 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.2 m -58.23 -31.09 67.03 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -71.58 -36.58 70.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.261 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -59.44 5.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.81 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.2 OUTLIER -50.52 -23.4 2.47 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 108.723 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -73.72 -45.43 52.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.986 HG21 ' HA ' ' A' ' 166' ' ' ALA . 59.3 t -69.44 -21.68 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 8.4 m120 -62.94 -35.82 81.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -29.46 57.72 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -75.4 -13.24 60.38 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.1 m -80.52 -44.36 19.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.0 t -64.15 -13.8 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.517 ' NH1' ' HA3' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -96.85 -17.9 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.497 -0.752 . . . . 0.0 109.285 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.45 75.45 0.4 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.533 ' H ' HD22 ' A' ' 237' ' ' ASN . 36.0 t -124.75 102.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.978 . . . . 0.0 110.48 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 146' ' ' LEU . 17.6 tp -62.86 105.84 0.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.3 t -97.24 156.98 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 110.881 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.548 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -136.36 146.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -142.87 137.07 29.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.984 -1.073 . . . . 0.0 109.537 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.73 144.49 54.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 0.2 OUTLIER -44.0 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 109.434 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 154' ' ' SER . . . 172.66 -22.35 0.07 OUTLIER Glycine 0 N--CA 1.496 2.692 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.821 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' SER . 3.4 p-10 30.74 36.25 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 122.235 -0.568 . . . . 0.0 111.486 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 3.5 t 160.47 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 110.121 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . -165.43 70.57 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.312 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . 45.95 -172.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -1.165 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.2 47.59 3.86 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.44 135.22 17.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.332 -1.099 . . . . 0.0 108.632 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.415 HD11 ' HA3' ' A' ' 189' ' ' GLY . 2.6 pt -57.9 -179.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.998 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.12 170.58 7.87 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.506 1.146 . . . . 0.0 112.599 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.423 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 77.8 m-85 -104.43 139.07 19.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.4 Cg_endo -73.54 -43.94 0.62 Allowed 'Cis proline' 0 C--N 1.295 -2.278 0 O-C-N 123.042 1.022 . . . . 0.0 110.816 3.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.998 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 23.13 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.029 0.918 . . . . 0.0 110.057 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -39.88 -63.72 0.56 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.495 0.664 . . . . 0.0 109.791 177.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.712 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 46.7 p90 -106.87 -166.45 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.899 0.856 . . . . 0.0 111.221 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.986 ' HA ' HG21 ' A' ' 137' ' ' VAL . . . 86.39 34.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.926 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 147' ' ' VAL . 1.0 OUTLIER 45.92 26.32 0.38 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -110.88 114.4 27.71 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.82 127.48 32.96 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.011 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.542 ' N ' ' HB2' ' A' ' 191' ' ' ASP . . . -78.53 108.63 12.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 172' ' ' GLY . 35.3 t -84.48 163.77 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.847 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.718 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -132.89 -172.78 13.1 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -138.89 143.88 38.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.088 -1.242 . . . . 0.0 109.418 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 43.5 p -108.46 175.02 5.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 1.4 t70 -74.64 -163.93 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 109.665 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -53.56 -29.97 39.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -124.54 -79.91 0.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.991 . . . . 0.0 110.151 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 178' ' ' ASN . 9.5 p-10 -149.63 60.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 1.0 OUTLIER -125.19 162.52 24.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.956 -1.09 . . . . 0.0 109.666 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 7.5 mtp180 -62.56 112.82 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.52 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 184' ' ' SER . . . -43.68 171.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.48 -27.29 12.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 184' ' ' SER . 11.6 p90 -114.63 -21.71 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.998 -1.064 . . . . 0.0 109.804 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 181' ' ' ALA . 10.8 t -55.65 126.93 27.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 109.26 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.455 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 27.7 mm-40 -85.23 154.67 21.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -138.81 173.27 11.75 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.161 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 168.01 148.44 5.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -43.55 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -1.112 . . . . 0.0 109.395 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 148.3 -16.38 1.31 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 256' ' ' LEU . 12.0 tp -45.97 126.17 7.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -1.127 . . . . 0.0 109.763 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.542 ' HB2' ' N ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -81.27 -62.0 1.78 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.562 ' CD1' HG22 ' A' ' 262' ' ' VAL . 14.0 tt -155.65 168.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.412 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.718 HG12 ' HA3' ' A' ' 172' ' ' GLY . 3.0 m -122.11 161.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 0.0 110.073 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 1.072 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -150.09 -172.78 0.33 Allowed Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 1.008 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 31.9 Cg_endo -75.48 110.26 3.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.319 1.346 . . . . 0.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -130.25 41.02 1.58 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 26.8 t -142.88 91.58 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.903 ' O ' HG13 ' A' ' 199' ' ' VAL . 19.7 t-20 89.34 115.29 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 198' ' ' ASN . 2.5 m -173.49 118.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -99.87 142.62 31.11 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.491 0.663 . . . . 0.0 110.214 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.604 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -149.71 -148.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 109.304 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -94.13 158.51 15.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.229 -0.919 . . . . 0.0 110.087 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.625 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -135.4 155.82 78.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.625 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.7 Cg_endo -73.62 151.26 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.304 2.003 . . . . 0.0 111.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 30.61 73.15 0.05 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 9.1 t 168.45 -100.55 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.052 -1.263 . . . . 0.0 110.149 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.792 HG23 ' N ' ' A' ' 208' ' ' TYR . 6.5 t -172.41 -142.82 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.792 ' N ' HG23 ' A' ' 207' ' ' THR . 0.0 OUTLIER -91.06 157.27 17.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.528 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.28 139.44 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.2 OUTLIER -95.23 133.19 39.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 212' ' ' ASN . 1.1 pp -158.28 164.36 36.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.503 ' O ' HD12 ' A' ' 211' ' ' LEU . 2.0 m-80 -99.85 171.54 7.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 216' ' ' MET . . . 153.59 131.35 1.57 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 84.4 m -67.62 -25.32 65.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.495 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -68.43 -12.29 60.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.147 -0.971 . . . . 0.0 109.386 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.479 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -77.0 -26.6 54.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 1.072 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -86.98 0.63 54.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.596 -0.69 . . . . 0.0 109.548 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.618 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 1.8 m -80.44 -45.79 1.34 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.269 -0.895 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.6 Cg_endo -73.48 -18.31 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.735 1.624 . . . . 0.0 110.985 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -70.7 -40.74 72.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.912 -1.118 . . . . 0.0 108.591 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 262' ' ' VAL . 55.8 t -74.35 -39.56 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.81 64.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -73.36 -52.34 8.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 264' ' ' ALA . . . -53.15 -64.13 0.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 109.242 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.455 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -43.48 -46.13 6.71 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.21 44.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 109.072 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.528 ' HB3' HD23 ' A' ' 21' ' ' LEU . 17.7 mt -56.48 -37.9 70.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 84.3 t -56.58 -63.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.793 ' HE3' HD11 ' A' ' 240' ' ' ILE . 1.8 mtpt -48.18 -31.7 6.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 108.893 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.45 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.6 OUTLIER -61.79 -49.3 76.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -5.93 31.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 232' ' ' ASN . 1.9 p-10 -164.44 79.58 1.4 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.402 -0.811 . . . . 0.0 109.685 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 31.98 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.854 2.369 . . . . 0.0 111.149 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -12.15 5.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.78 -1.2 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.65 175.72 9.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.054 -1.029 . . . . 0.0 109.864 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.87 174.66 5.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.684 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.533 HD22 ' H ' ' A' ' 145' ' ' VAL . 1.3 m-20 -58.04 -28.3 64.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -77.68 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.266 -0.897 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' VAL . 16.1 mt-30 -42.9 -36.23 1.45 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.481 0.657 . . . . 0.0 109.488 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.793 HD11 ' HE3' ' A' ' 229' ' ' LYS . 50.4 mt -68.86 -56.33 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 109.633 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -43.31 -50.17 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 109.906 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -51.06 -60.98 2.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.784 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 247' ' ' THR . 24.6 t-80 -55.14 -57.12 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.066 . . . . 0.0 109.822 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 244' ' ' LEU . 0.8 OUTLIER -56.3 -18.46 10.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.477 -0.765 . . . . 0.0 109.95 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER -83.42 -39.71 20.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 109.271 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.69 -30.08 66.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.269 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.898 HG23 ' O ' ' A' ' 243' ' ' HIS . 1.7 p -78.92 -52.35 8.4 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.18 0.991 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -28.9 116.97 0.11 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 13.9 m -53.32 131.91 38.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.32 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.74 109.99 22.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.41 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.895 HD22 ' CD2' ' A' ' 257' ' ' TYR . 6.1 mp . . . . . 0 C--N 1.307 -1.272 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.624 ' O ' HD23 ' A' ' 190' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.895 ' CD2' HD22 ' A' ' 251' ' ' LEU . 27.9 m-85 -90.96 -61.42 1.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.38 -0.825 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.2 -120.69 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.518 ' HB3' ' CG1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -47.27 -44.05 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 108.995 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 249' ' ' THR . . . 110.97 -142.8 16.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -178.06 5.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.562 HG22 ' CD1' ' A' ' 192' ' ' ILE . 3.7 t -129.57 146.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.459 -0.775 . . . . 0.0 110.55 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.479 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.02 121.23 1.23 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.42 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 224' ' ' ALA . . . -94.23 -12.96 27.13 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.796 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.623 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 1.1 tm-20 -68.84 -15.74 63.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.812 -1.18 . . . . 0.0 109.685 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.25 1.89 39.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.76 ' HB2' HG21 ' A' ' 247' ' ' THR . . . -122.82 -17.49 6.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.634 HG21 ' CD2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -92.82 -38.88 11.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.776 -1.202 . . . . 0.0 109.364 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.457 ' OXT' ' O ' ' A' ' 268' ' ' THR . 10.2 ptm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.867 -1.064 . . . . 0.0 109.618 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.885 ' O ' HG13 ' A' ' 4' ' ' VAL . 1.1 m . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.371 0.605 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.885 HG13 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 170.43 100.21 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 109.22 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 8' ' ' ILE . 36.2 Cg_endo -78.8 174.77 11.79 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.632 2.221 . . . . 0.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -48.02 -28.87 3.04 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.511 -0.743 . . . . 0.0 109.924 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.62 -42.16 55.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CG1' ' NE2' ' A' ' 220' ' ' HIS . 34.2 mt -109.57 73.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.923 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -42.32 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -93.68 6.71 47.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 11' ' ' VAL . 15.8 m -98.2 19.71 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 109.647 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 34.8 mm-40 47.6 25.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 110.089 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.669 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.43 -42.3 83.97 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.9 . . . . 0.0 110.907 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.46 -44.09 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 18' ' ' ASN . . . -46.46 -37.06 7.25 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.67 64.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -64.93 -18.91 65.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.687 -0.633 . . . . 0.0 110.7 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 6.3 p-10 -113.1 -6.63 13.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.743 -1.223 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -83.2 -22.98 33.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.939 -1.1 . . . . 0.0 109.219 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.46 50.33 0.46 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' C ' HG22 ' A' ' 22' ' ' THR . 0.5 OUTLIER -139.25 179.8 6.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.957 . . . . 0.0 109.968 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.53 HG22 ' C ' ' A' ' 21' ' ' LEU . 1.1 t 157.76 100.09 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -55.65 0.93 0.09 OUTLIER Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.654 -0.653 . . . . 0.0 111.935 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 85' ' ' ASN . 71.9 m -28.45 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.811 1.306 . . . . 0.0 111.97 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -85.45 35.02 3.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 23' ' ' GLY . 44.1 t -125.78 165.43 23.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.124 -1.221 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' N ' HG12 ' A' ' 26' ' ' VAL . 16.5 mttm -135.91 117.42 14.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.481 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 119' ' ' VAL . 13.6 t -128.54 136.26 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.829 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.67 155.56 21.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 35' ' ' ILE . 2.2 t -130.84 85.04 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.132 -0.98 . . . . 0.0 108.953 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.95 HD23 HG21 ' A' ' 93' ' ' VAL . 6.9 mp -70.46 103.96 2.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 33' ' ' THR . 9.2 p30 -148.92 -143.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.234 -0.916 . . . . 0.0 109.152 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 33' ' ' THR . 13.4 t -135.68 79.71 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.035 -1.041 . . . . 0.0 110.054 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.43 ' HA3' ' ND2' ' A' ' 60' ' ' ASN . . . 90.69 120.8 2.3 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.885 HD12 ' HB2' ' A' ' 90' ' ' ALA . 2.8 mt -112.81 -24.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 122.111 0.958 . . . . 0.0 108.654 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 42.1 t 57.3 148.18 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.287 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -93.09 160.25 14.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.628 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -160.78 178.91 1.47 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 109.046 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.9 Cg_endo -78.0 -22.27 10.18 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.402 2.068 . . . . 0.0 110.183 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.571 ' HA ' HD12 ' A' ' 73' ' ' LEU . 74.9 m-20 -97.22 -55.14 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.336 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.581 HD21 ' C ' ' A' ' 67' ' ' ALA . 17.4 mt -55.22 156.9 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.91 63.87 1.53 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 0.0 109.205 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 43' ' ' ILE . 7.4 mm -49.96 115.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -104.85 -8.13 18.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.99 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -174.13 177.12 46.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.15 158.65 19.65 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.468 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -152.98 162.49 41.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.69 -0.888 . . . . 0.0 108.833 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -132.99 109.74 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.861 ' CE2' HG12 ' A' ' 91' ' ' VAL . 1.9 m-85 -107.61 -44.17 4.33 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.317 -0.864 . . . . 0.0 109.025 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.687 HG13 ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -41.33 151.53 0.29 Allowed Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD2' HG13 ' A' ' 50' ' ' VAL . 30.0 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.427 2.085 . . . . 0.0 111.005 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.428 HG22 ' OE1' ' A' ' 57' ' ' GLN . 11.0 t -79.03 0.97 25.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.029 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.428 ' OE1' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -119.37 106.68 12.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER 65.72 174.74 0.22 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 0.0 109.861 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.439 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 115.15 15.76 7.61 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.65 ' OD1' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -160.71 -71.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.985 . . . . 0.0 109.049 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.86 8.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -73.65 -57.19 4.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -1.22 . . . . 0.0 109.925 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.22 72.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.1 m -69.16 -40.91 77.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 27.1 t-80 -66.56 -53.16 37.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 69' ' ' THR . 39.4 t -58.99 -35.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 109.712 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.581 ' C ' HD21 ' A' ' 41' ' ' LEU . . . -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 110.235 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.611 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -70.16 -44.94 58.49 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.964 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 66' ' ' VAL . 12.3 t -64.46 -16.83 63.13 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.989 -1.301 . . . . 0.0 108.975 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 219' ' ' PRO . 78.7 mt -93.02 -24.91 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.819 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . . . -133.93 -43.1 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.879 -1.138 . . . . 0.0 110.902 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.762 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 8.05 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.106 0.479 . . . . 0.0 111.636 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 40' ' ' ASP . 22.2 mt -42.27 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.971 -1.081 . . . . 0.0 109.57 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.828 ' HB2' HD13 ' A' ' 80' ' ' LEU . 43.8 t30 -113.71 106.44 14.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -154.64 -100.63 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 109.605 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.7 p -132.06 -32.6 1.39 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.347 -0.846 . . . . 0.0 110.147 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.577 HG12 ' ND2' ' A' ' 75' ' ' ASN . 27.9 pt -91.31 138.11 20.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.073 -1.017 . . . . 0.0 110.302 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 3' ' ' SER . . . 60.13 158.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.543 ' C ' ' HB3' ' A' ' 3' ' ' SER . 5.6 m -70.19 -160.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.563 -0.963 . . . . 0.0 109.465 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 74' ' ' ASN . 4.5 tp -135.15 131.35 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.429 -0.794 . . . . 0.0 110.241 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.762 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -77.43 -145.71 2.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.96 -28.47 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.93 -1.335 . . . . 0.0 109.051 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -110.68 125.91 29.86 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.46 -61.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.417 2.078 . . . . 0.0 110.875 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.526 ' CB ' ' OG ' ' A' ' 24' ' ' SER . 1.2 m-20 -103.36 39.88 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.504 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -83.4 168.46 16.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.008 -1.058 . . . . 0.0 109.6 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 72.8 mt-10 -113.6 92.42 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.819 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 7.8 mt -97.13 135.81 38.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 109.635 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 27.7 m-85 -104.14 155.84 18.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.885 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -110.84 102.58 11.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 109.257 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.861 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -100.5 68.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.188 -0.945 . . . . 0.0 109.068 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 33' ' ' THR . 19.4 ttpt -36.61 103.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.345 0.593 . . . . 0.0 110.275 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.95 HG21 HD23 ' A' ' 31' ' ' LEU . 1.4 t -115.48 -20.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 108.798 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.29 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.402 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 33' ' ' THR . . . -91.18 179.21 42.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.65 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.179 -1.189 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.93 162.84 24.99 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.742 -0.858 . . . . 0.0 109.094 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 133' ' ' LEU . 58.2 t -68.67 -19.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 43.0 t -78.75 -19.86 51.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.0 m -79.2 -52.86 7.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 133' ' ' LEU . 1.3 mt -63.47 -25.2 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.34 78.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.642 -0.661 . . . . 0.0 109.423 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -71.51 -32.39 68.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.987 -1.071 . . . . 0.0 108.991 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.63 -31.08 70.56 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.66 -25.18 21.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.18 -1.188 . . . . 0.0 110.384 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.63 -26.04 23.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -63.54 -22.15 66.73 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.774 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -86.78 -22.43 25.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -62.41 -43.64 98.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 1.8 p-10 -85.18 -38.64 18.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 31.5 m-20 -146.14 85.02 1.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.774 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -115.32 -165.33 14.62 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 15.0 mmt -139.0 178.78 6.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.548 -0.972 . . . . 0.0 110.138 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.516 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.7 m170 -57.95 -39.99 79.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.557 -0.714 . . . . 0.0 110.732 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 120' ' ' ALA . 19.0 t -130.56 167.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.861 -1.149 . . . . 0.0 111.104 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.564 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -164.35 114.78 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 222' ' ' ALA . 10.7 m120 -100.3 151.13 21.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.903 -1.123 . . . . 0.0 110.708 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.402 HD11 HD22 ' A' ' 31' ' ' LEU . 6.9 mp -118.11 110.72 17.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.8 t -82.68 71.74 9.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 108.918 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.17 -174.14 2.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.351 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . 168.62 79.69 0.04 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -95.24 155.82 38.43 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.331 -1.099 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.41 -11.79 18.92 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.516 2.144 . . . . 0.0 109.571 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -83.27 115.54 59.68 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.619 -0.675 . . . . 0.0 109.442 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.58 167.92 21.98 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.258 1.972 . . . . 0.0 110.107 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -155.98 117.24 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.07 -20.8 65.87 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.2 m -69.32 -26.95 64.96 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.8 mp -78.35 -36.21 46.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -38.25 69.0 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.167 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -67.52 -22.61 65.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.87 -32.71 40.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.576 -0.85 . . . . 0.0 108.748 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' ' 167' ' ' ASN . 2.2 t -76.29 -26.38 17.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -65.87 -35.35 80.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 m -79.65 -23.8 42.3 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.83 60.39 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.5 m -79.57 -34.47 40.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.941 . . . . 0.0 108.628 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -56.98 -28.04 61.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.83 -13.51 16.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.21 78.44 0.59 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 117' ' ' MET . 5.1 t -127.3 92.03 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -1.138 . . . . 0.0 110.155 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tp -57.02 120.53 8.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 108.599 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -107.56 152.07 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 110.22 -178.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -141.62 103.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.42 150.33 21.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.06 -1.025 . . . . 0.0 110.412 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.678 ' HB2' ' OG1' ' A' ' 218' ' ' THR . . . -78.31 172.84 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.5 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -77.84 -79.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.0 109.254 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.75 -111.77 0.35 Allowed Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -176.3 28.72 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 29.3 t -128.36 -99.4 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.905 . . . . 0.0 109.73 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.39 55.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.32 -178.2 4.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 109.301 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.61 38.92 2.66 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -166.44 155.38 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -1.178 . . . . 0.0 108.672 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -172.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.868 -1.145 . . . . 0.0 110.751 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.815 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.0 OUTLIER -80.43 163.77 23.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.172 0.987 . . . . 0.0 112.108 -177.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.413 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.2 m-85 -112.43 132.34 22.2 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.6 Cg_endo -73.97 -42.77 0.78 Allowed 'Cis proline' 0 C--N 1.299 -2.077 0 O-C-N 123.139 1.073 . . . . 0.0 111.041 3.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 21.34 -73.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.869 0.843 . . . . 0.0 110.122 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -46.49 -71.59 0.07 Allowed 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.645 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.8 m-85 27.41 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.834 1.302 . . . . 0.0 113.03 178.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.5 -0.35 2.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.437 ' HB2' HG11 ' A' ' 137' ' ' VAL . 15.2 m120 -124.41 21.83 8.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.88 169.87 23.63 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.491 -0.755 . . . . 0.0 108.968 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.485 ' HB2' HG22 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -111.48 157.82 19.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.69 129.91 54.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 31.2 t -91.86 164.63 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.894 -1.129 . . . . 0.0 109.459 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.77 -171.69 12.9 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -120.75 164.93 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 179' ' ' ASN . 0.9 OUTLIER -133.39 173.81 11.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.34 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 0.3 OUTLIER -85.36 -152.0 0.15 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 177' ' ' ASN . 5.1 pt20 -84.96 -29.91 24.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 176' ' ' GLN . 53.4 m-20 -96.33 -97.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.962 . . . . 0.0 109.947 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.77 19.23 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 0.0 109.856 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 3.1 t-20 -72.47 -151.96 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 109.087 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.55 ' HB2' ' CE2' ' A' ' 257' ' ' TYR . 22.3 ttp85 -132.93 16.64 4.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 58.39 164.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.735 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 t -121.2 -4.64 9.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.953 . . . . 0.0 109.914 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.565 ' O ' ' CG ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -106.4 29.13 7.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 109.832 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.78 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 41.6 t -111.85 119.35 38.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 184' ' ' SER . 0.0 OUTLIER -43.89 113.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 109.176 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -113.71 168.15 10.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.915 . . . . 0.0 109.319 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.48 178.72 42.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.73 111.42 17.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 129.36 9.06 3.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 256' ' ' LEU . 14.2 tp -64.24 143.76 57.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.944 -1.327 . . . . 0.0 109.251 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 19.1 t70 -91.6 -70.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.763 HD13 HG13 ' A' ' 262' ' ' VAL . 13.0 tt -140.81 169.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.838 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 260' ' ' GLY . 29.2 m -120.17 162.82 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.73 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -158.48 165.52 18.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.8 Cg_endo -77.09 115.99 4.1 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.465 2.11 . . . . 0.0 110.475 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.44 24.25 3.74 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.66 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 55.4 t -102.96 68.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -1.066 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.841 ' O ' HG13 ' A' ' 199' ' ' VAL . 20.2 t-20 110.33 122.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.072 0.939 . . . . 0.0 108.597 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 198' ' ' ASN . 2.5 m -170.84 113.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -101.67 168.15 9.65 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.7 0.762 . . . . 0.0 110.125 -179.401 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 200' ' ' GLN . 4.3 m -168.32 -156.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' THR . . . . . 0.439 ' H ' HG23 ' A' ' 202' ' ' THR . 1.0 OUTLIER -77.35 172.08 13.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.667 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -152.98 160.59 30.77 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -71.34 164.01 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.285 1.99 . . . . 0.0 110.655 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.7 82.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.99 34.43 5.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -1.056 . . . . 0.0 109.373 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -126.76 160.33 31.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.288 -0.882 . . . . 0.0 109.852 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.93 169.42 8.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.3 164.01 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.78 -1.2 . . . . 0.0 110.961 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.9 OUTLIER -123.34 124.17 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mt -119.73 161.27 21.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.927 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 212' ' ' ASN . 1.1 p-10 -134.05 107.6 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -161.6 151.24 21.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.1 m -70.83 -21.89 62.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -1.114 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.443 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -72.24 -13.27 61.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.135 -0.978 . . . . 0.0 109.095 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.499 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -81.7 -13.52 57.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.724 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.73 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -88.9 -1.49 58.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.985 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 150' ' ' ALA . 1.1 m -75.83 -40.5 3.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.254 -0.904 . . . . 0.0 111.379 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.6 Cg_endo -72.32 -12.95 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.698 1.599 . . . . 0.0 111.242 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.569 ' NE2' ' CG1' ' A' ' 8' ' ' ILE . 18.1 m80 -77.17 -51.45 10.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.044 -1.035 . . . . 0.0 108.507 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 262' ' ' VAL . 98.8 t -63.07 -41.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.526 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -57.15 -40.42 77.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.805 . . . . 0.0 109.11 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.43 59.22 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.2 -51.99 60.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.25 . . . . 0.0 110.021 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.07 -32.99 56.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.374 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.77 97.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.102 -0.999 . . . . 0.0 108.821 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.3 mt -59.06 -51.31 70.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.823 . . . . 0.0 109.565 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' LYS . 76.3 t -57.54 -55.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 109.922 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.58 ' NZ ' HD11 ' A' ' 240' ' ' ILE . 4.1 ttmm -42.28 -42.4 3.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.495 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -61.84 -48.09 82.13 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -57.22 -17.05 9.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.165 -0.96 . . . . 0.0 108.951 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 235' ' ' TRP . 2.3 m120 -172.45 90.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.696 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.1 -38.58 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.75 2.3 . . . . 0.0 110.66 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 235' ' ' TRP . 0.0 OUTLIER -47.42 -46.16 26.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 110.215 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.548 ' CD2' ' HB3' ' A' ' 232' ' ' ASN . 47.4 m0 -45.3 170.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.081 -1.012 . . . . 0.0 110.063 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -113.11 176.85 4.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.731 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -54.21 -20.08 6.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.956 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 238' ' ' VAL . 2.4 t -78.33 -65.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.14 -0.975 . . . . 0.0 109.461 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 235' ' ' TRP . 1.0 OUTLIER -44.39 -43.17 7.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.58 HD11 ' NZ ' ' A' ' 229' ' ' LYS . 6.1 mt -59.65 -55.3 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -42.4 -35.81 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 110.435 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 245' ' ' LYS . 29.2 t-20 -72.55 -40.21 66.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.49 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' HIS . . . . . 0.478 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.9 OUTLIER -70.47 -47.08 62.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.879 -1.138 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.4 OUTLIER -70.45 -28.65 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.444 -0.785 . . . . 0.0 110.844 -178.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -73.36 -48.99 29.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 109.903 -179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.571 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 7.8 t-20 -74.06 -22.39 59.56 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.674 -0.641 . . . . 0.0 111.04 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 9.1 p -84.47 -32.2 24.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.791 -1.193 . . . . 0.0 109.95 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.52 130.28 44.35 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.74 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 250' ' ' SER . 2.4 m -48.48 164.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 249' ' ' THR . 49.0 m -129.15 97.8 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.496 HD13 ' HA2' ' A' ' 260' ' ' GLY . 5.8 mp . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.477 ' O ' ' HD2' ' A' ' 180' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' A' ' 180' ' ' ARG . 38.0 m-85 -76.2 -12.3 60.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 59.42 -154.3 30.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 250' ' ' SER . 6.0 t -44.92 -25.72 0.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.268 -1.137 . . . . 0.0 109.222 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.496 ' HA2' HD13 ' A' ' 251' ' ' LEU . . . 125.49 -132.6 8.04 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.556 ' O ' HD11 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -100.62 177.83 4.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -1.105 . . . . 0.0 109.309 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.763 HG13 HD13 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -111.41 156.86 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.414 ' CG ' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -170.75 121.08 0.57 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 122.35 1.071 . . . . 0.0 108.197 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 268' ' ' THR . . . -76.04 -17.61 59.58 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.031 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.495 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 29.5 tt0 -65.54 -43.2 90.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.049 . . . . 0.0 109.146 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.98 -13.98 62.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.265 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -110.81 12.7 22.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 264' ' ' ALA . 4.4 p -119.23 -39.02 2.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.476 ' HG3' ' OXT' ' A' ' 269' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.914 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . 1.015 ' O ' HG22 ' A' ' 4' ' ' VAL . 5.2 t . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.015 HG22 ' O ' ' A' ' 3' ' ' SER . 2.5 m 59.95 41.25 0.53 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.939 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.5 Cg_endo -82.24 -169.29 0.73 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.976 1.784 . . . . 0.0 110.454 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CG ' ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -32.92 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.285 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -83.08 -69.26 1.39 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.71 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 19.7 mm -33.57 90.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 122.042 -0.681 . . . . 0.0 110.323 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER 155.67 -55.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 17.7 tpp85 -75.42 -17.47 60.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.485 -0.759 . . . . 0.0 109.448 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 13' ' ' ALA . 19.4 m -88.62 23.3 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 76.9 mm-40 49.66 41.35 21.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.208 -0.933 . . . . 0.0 109.92 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.27 -33.02 0.52 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -73.63 -55.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 N-CA-C 108.528 -1.374 . . . . 0.0 108.528 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -42.36 -33.15 0.6 Allowed 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -72.18 -49.3 36.65 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 17' ' ' HIS . 2.2 m170 -69.09 -6.05 25.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.06 -55.36 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.44 -27.85 2.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 109.158 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.32 23.38 2.92 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.881 HD23 HD22 ' A' ' 227' ' ' LEU . 0.3 OUTLIER -67.17 173.13 4.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.179 -1.189 . . . . 0.0 109.34 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.596 ' HA ' ' HG3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -163.06 -35.55 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 110.553 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.868 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 73.68 -5.34 23.84 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -44.0 134.08 4.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.132 -1.216 . . . . 0.0 109.665 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 7.92 56.04 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 23' ' ' GLY . 27.0 t -107.86 164.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -1.217 . . . . 0.0 109.246 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 2.0 mptt -145.01 118.25 8.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.0 110.32 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 119' ' ' VAL . 2.5 t -125.92 128.01 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.68 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -82.3 159.97 23.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.547 HG21 HD22 ' A' ' 88' ' ' LEU . 10.7 t -134.43 87.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.78 -1.2 . . . . 0.0 109.794 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 93' ' ' VAL . 10.0 mp -66.74 126.17 28.15 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -177.79 -146.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.704 -1.247 . . . . 0.0 109.961 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -137.61 72.57 1.42 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.023 -1.048 . . . . 0.0 110.654 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 64' ' ' THR . . . 111.87 118.38 3.69 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.416 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 3.9 mm -115.26 -18.87 7.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.675 0.75 . . . . 0.0 109.11 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 33.0 104.61 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.818 0.818 . . . . 0.0 111.483 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -58.61 147.66 31.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 108.692 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.537 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -146.13 177.14 1.87 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.314 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 38' ' ' HIS . 33.6 Cg_endo -76.33 -4.95 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.215 1.943 . . . . 0.0 109.626 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 73' ' ' LEU . 2.6 t0 -114.97 -22.53 9.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.166 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.36 122.75 39.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -97.36 103.38 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 108.65 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 44' ' ' ARG . 3.9 mt -89.68 163.48 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.074 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.547 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 6.9 tpt180 -135.88 -32.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -163.51 161.94 34.53 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.44 165.71 36.75 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.971 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.44 165.02 17.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.522 -0.987 . . . . 0.0 109.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -126.53 142.07 51.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.575 ' HE2' HG12 ' A' ' 91' ' ' VAL . 32.9 m-85 -116.38 -53.01 2.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.385 -0.822 . . . . 0.0 109.776 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.3 125.54 71.45 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 C-N-CA 122.425 2.084 . . . . 0.0 111.31 -179.092 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.501 2.118 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.447 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 8.8 t -56.6 -14.63 3.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.134 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG3' HG23 ' A' ' 56' ' ' THR . 47.7 mt-30 -108.92 143.5 38.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 57' ' ' GLN . 40.8 t0 61.34 136.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.462 -0.774 . . . . 0.0 110.392 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.27 -39.39 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.843 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -169.1 -35.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -1.031 . . . . 0.0 108.927 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.84 -16.97 4.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -68.31 -58.06 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 109.296 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -61.76 6.28 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLY . 3.3 m -45.82 -41.13 10.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -1.109 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 5.2 t-80 -58.83 -56.81 17.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.733 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 219' ' ' PRO . 41.8 t -55.45 -35.08 36.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . . . -57.64 -44.74 85.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.719 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.627 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -75.15 -21.38 78.19 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.555 HG23 ' CE1' ' A' ' 220' ' ' HIS . 15.7 m -81.47 -11.51 59.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 108.166 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 66' ' ' VAL . 38.4 mt -103.51 -28.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -156.71 11.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.622 -1.299 . . . . 0.0 112.323 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -40.01 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.691 -1.256 . . . . 0.0 110.626 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 71' ' ' ALA . 9.7 mt -45.76 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.881 -1.137 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 32.0 t30 -92.74 155.23 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.451 -0.781 . . . . 0.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 9.0 p-10 154.43 124.71 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 75' ' ' ASN . 22.8 t -41.59 -27.26 0.09 Allowed 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.869 -0.519 . . . . 0.0 109.734 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.8 pt -83.52 68.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 208' ' ' TYR . . . 123.36 146.93 7.2 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 80' ' ' LEU . 10.2 m -64.31 -149.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 ' N ' HG23 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -158.06 141.34 15.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.583 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -97.86 -144.6 17.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG12 HD11 ' A' ' 227' ' ' LEU . 0.5 OUTLIER -91.48 -72.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 0.0 109.896 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -63.04 144.08 97.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.596 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 37.3 Cg_endo -86.69 -64.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.369 2.046 . . . . 0.0 110.113 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 21.6 t-20 -105.76 -87.08 0.47 Allowed 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.001 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 54.79 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.105 -0.997 . . . . 0.0 110.08 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 7.6 mt-10 -95.49 107.71 19.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 30' ' ' VAL . 5.5 mt -92.91 106.56 18.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 109.974 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 14.2 m-85 -87.88 153.86 20.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.534 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.457 ' CB ' HG13 ' A' ' 35' ' ' ILE . . . -119.0 108.92 15.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.791 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.68 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -111.32 65.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.989 . . . . 0.0 110.214 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' VAL . 14.5 ttmm -38.83 114.5 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -143.38 21.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 120.97 -1.081 . . . . 0.0 111.327 -177.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' GLY . 22.6 mt -150.29 168.55 23.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.241 -1.537 . . . . 0.0 111.77 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 94' ' ' LEU . . . -46.34 -166.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.022 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 CA-C-O 122.246 0.914 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.0 t -68.17 179.5 1.54 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.419 0.628 . . . . 0.0 109.407 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.562 ' CG2' ' OG ' ' A' ' 130' ' ' SER . 48.4 t -66.02 -14.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 m -75.07 -22.67 58.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.73 -53.34 4.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 109.261 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.589 ' HA ' HG22 ' A' ' 93' ' ' VAL . 2.3 mt -62.15 -45.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 102' ' ' VAL . . . -63.18 -47.28 83.31 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.414 ' HG2' ' CD1' ' A' ' 49' ' ' PHE . 25.1 tp60 -52.23 -39.26 60.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.862 . . . . 0.0 109.442 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.28 39.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.03 -11.05 45.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -1.116 . . . . 0.0 109.12 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.9 -25.7 15.34 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.334 -0.854 . . . . 0.0 109.45 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -72.98 -15.15 61.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.646 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -96.22 -11.82 25.5 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.947 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -84.46 -26.2 40.24 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 115' ' ' ASN . 3.8 m120 -123.3 28.84 6.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 108.999 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER 162.73 32.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.685 ' O ' ' HE1' ' A' ' 117' ' ' MET . . . -102.98 -147.54 18.97 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.685 ' HE1' ' O ' ' A' ' 116' ' ' GLY . 6.0 mmt -134.9 -178.74 5.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.614 -0.933 . . . . 0.0 109.779 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.942 ' ND1' HG23 ' A' ' 119' ' ' VAL . 10.7 p80 -66.0 -40.37 91.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.78 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.942 HG23 ' ND1' ' A' ' 118' ' ' HIS . 55.5 t -120.57 165.6 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.833 -1.167 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.608 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.02 132.08 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 1.023 ' O ' HD12 ' A' ' 122' ' ' LEU . 61.8 t30 -90.34 167.85 12.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.792 -1.192 . . . . 0.0 109.785 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.023 HD12 ' O ' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -149.54 105.24 3.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.98 . . . . 0.0 109.041 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 9.6 m -96.2 68.77 2.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 108.985 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.874 HD11 HD23 ' A' ' 122' ' ' LEU . 0.5 OUTLIER -111.35 -165.94 1.03 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.259 1.028 . . . . 0.0 110.091 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.42 105.03 1.51 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.488 ' CB ' ' HD2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -168.91 172.76 2.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.251 . . . . 0.0 109.84 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.555 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 34.8 Cg_endo -79.15 4.66 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.796 2.331 . . . . 0.0 109.916 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.624 ' N ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -117.83 44.09 0.49 Allowed Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.556 -0.715 . . . . 0.0 111.464 -178.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 128' ' ' SER . 37.5 Cg_endo -76.42 173.71 14.03 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.951 1.767 . . . . 0.0 110.532 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.562 ' OG ' ' CG2' ' A' ' 102' ' ' VAL . 3.0 m -149.65 131.5 15.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.31 66.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.463 ' HB ' HG11 ' A' ' 102' ' ' VAL . 3.3 m -66.28 -29.94 70.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.566 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -69.17 -35.22 76.06 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -63.37 -51.11 67.26 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -48.56 -26.49 2.23 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -69.53 -45.67 68.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.921 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.666 HG21 ' CZ ' ' A' ' 165' ' ' TYR . 0.9 OUTLIER -62.95 -30.31 49.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 21.6 m120 -60.33 -36.2 77.42 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.2 p -78.85 -22.54 45.95 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.14 54.41 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.096 -1.002 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 -46.53 16.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.038 -1.039 . . . . 0.0 108.747 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -29.98 8.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -86.2 -33.21 20.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.891 . . . . 0.0 109.092 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.76 61.93 1.49 Allowed Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.492 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 43.9 t -108.79 99.7 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.482 -1.01 . . . . 0.0 109.874 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' A' ' 119' ' ' VAL . 27.1 tp -58.52 111.03 1.1 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.942 -1.099 . . . . 0.0 108.079 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.725 ' CG1' HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -115.02 137.25 49.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 110.278 -178.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.638 HG13 ' OD1' ' A' ' 121' ' ' ASN . 1.5 p -113.92 150.92 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 163' ' ' ALA . . . -134.3 144.4 48.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.962 -1.087 . . . . 0.0 110.422 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -57.79 152.74 15.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 109.8 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -59.15 -73.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.051 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 138.8 121.7 1.94 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -99.79 55.1 0.94 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.539 ' OG ' ' HG2' ' A' ' 185' ' ' GLN . 0.0 OUTLIER -91.53 -86.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.841 . . . . 0.0 109.774 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 146.3 83.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 179.64 176.65 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.374 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.59 43.19 3.19 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.5 OUTLIER -158.79 166.25 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -1.072 . . . . 0.0 108.83 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -106.44 -174.48 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 109.666 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -71.33 157.84 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.817 0.818 . . . . 0.0 110.174 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -115.17 138.14 23.37 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 103.906 -2.628 . . . . 0.0 103.906 176.232 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.71 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.5 Cg_endo -72.64 -49.9 0.21 Allowed 'Cis proline' 0 C--N 1.295 -2.272 0 O-C-N 122.967 0.983 . . . . 0.0 111.826 4.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 36.21 -77.91 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -41.61 -55.23 2.98 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER 46.9 -178.88 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.26 -16.73 12.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.427 ' OD1' HG13 ' A' ' 137' ' ' VAL . 30.0 p-10 -129.44 13.8 6.04 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 165' ' ' TYR . . . -127.22 157.28 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.473 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -105.45 159.31 16.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.061 -1.024 . . . . 0.0 110.093 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -111.47 116.37 30.78 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 172' ' ' GLY . 24.5 t -81.84 167.42 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -134.93 -165.57 10.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -143.48 137.99 28.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.934 -1.333 . . . . 0.0 110.666 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 p -109.15 168.58 9.27 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 179' ' ' ASN . 4.2 t70 -95.61 -40.14 9.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.29 1.043 . . . . 0.0 109.804 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -152.27 -103.62 0.05 Allowed 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 177' ' ' ASN . 1.5 p30 -62.01 -48.85 78.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.722 -1.236 . . . . 0.0 107.72 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.503 ' HB2' HD21 ' A' ' 251' ' ' LEU . 0.5 OUTLIER 173.73 68.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 2.1 t-20 -97.03 -11.74 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.772 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.572 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 1.7 ttp180 82.07 12.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.366 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.875 ' HB1' ' CE1' ' A' ' 183' ' ' PHE . . . 53.97 -159.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.499 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.02 30.7 3.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.875 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 1.0 OUTLIER -152.36 -28.2 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.1 -1.0 . . . . 0.0 110.691 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -45.41 124.17 4.67 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.809 -1.182 . . . . 0.0 109.277 179.719 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.539 ' HG2' ' OG ' ' A' ' 154' ' ' SER . 1.3 mp0 -75.98 149.45 37.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.155 -0.966 . . . . 0.0 111.048 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.848 ' O ' HG23 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -68.09 -174.73 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.488 0.661 . . . . 0.0 110.67 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.54 ' CA ' HG12 ' A' ' 159' ' ' ILE . . . -173.27 150.24 11.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -83.11 68.9 9.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -1.051 . . . . 0.0 109.005 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 118.56 41.71 0.61 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.561 ' CD1' HD13 ' A' ' 159' ' ' ILE . 7.7 tp -41.22 150.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.469 -1.018 . . . . 0.0 109.283 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 0.5 OUTLIER -90.64 -60.85 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.542 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 262' ' ' VAL . 14.3 tt -155.5 171.23 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 109.566 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 260' ' ' GLY . 27.2 m -127.92 160.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.038 -1.039 . . . . 0.0 109.964 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -152.69 132.82 7.38 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 6' ' ' TRP . 31.7 Cg_endo -71.61 121.11 7.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.609 1.539 . . . . 0.0 110.283 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.27 61.23 0.55 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 50.1 t -102.08 66.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -1.186 . . . . 0.0 108.483 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASN . . . . . 0.65 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 45.9 t30 111.48 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 198' ' ' ASN . 11.8 m -159.37 111.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 122.273 1.035 . . . . 0.0 108.77 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.3 pm0 -87.61 124.83 33.93 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.495 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -135.85 -156.17 0.69 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.633 -0.667 . . . . 0.0 109.253 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 34.8 p -77.06 -177.92 4.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.042 0.925 . . . . 0.0 110.586 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' TYR . . . . . 0.632 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -156.94 151.83 21.07 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.632 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.4 Cg_endo -69.83 164.47 34.49 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.996 1.797 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 75.26 12.27 83.64 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 72.34 33.18 1.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.623 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -120.48 171.2 8.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.758 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 209' ' ' ALA . 87.6 m-85 -122.73 176.2 6.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 208' ' ' TYR . . . 176.91 175.38 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.654 -1.279 . . . . 0.0 110.782 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -135.07 131.07 36.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.527 -0.733 . . . . 0.0 109.419 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.664 HD12 ' HE1' ' A' ' 216' ' ' MET . 0.1 OUTLIER -148.01 108.06 4.05 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.969 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASN . . . . . 0.465 ' HB3' ' N ' ' A' ' 198' ' ' ASN . 18.8 p30 -63.87 169.4 4.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.389 -0.82 . . . . 0.0 108.908 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 156.69 7.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -75.39 -35.85 61.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.202 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -14.09 19.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 109.642 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' MET . . . . . 0.664 ' HE1' HD12 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -90.54 -24.01 20.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.899 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -89.52 -7.63 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 109.417 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.639 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 13.4 m -71.95 -41.52 9.03 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 111.505 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.718 ' HB3' HG13 ' A' ' 66' ' ' VAL . 30.1 Cg_endo -73.27 -21.08 20.51 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.699 1.599 . . . . 0.0 110.923 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 69' ' ' THR . 3.8 m80 -64.34 -42.08 96.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.72 -47.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -46.89 -35.36 6.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -70.77 -56.08 7.67 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -46.62 -41.51 14.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.948 -1.325 . . . . 0.0 109.444 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.7 99.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 108.809 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.1 -45.54 75.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.881 HD22 HD23 ' A' ' 21' ' ' LEU . 42.4 mt -59.21 -50.58 73.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 267' ' ' ALA . 95.7 t -56.0 -49.06 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.973 -1.079 . . . . 0.0 109.57 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.641 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.5 OUTLIER -48.54 -42.97 34.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.519 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLN . . . . . 0.467 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.15 -45.52 93.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.911 -1.118 . . . . 0.0 109.574 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.661 ' HE3' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.59 -10.11 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.222 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -174.19 72.93 0.34 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.4 Cg_endo -79.39 -0.84 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.638 2.225 . . . . 0.0 110.735 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 42.4 m -84.1 -3.76 58.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.143 -0.973 . . . . 0.0 109.842 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' TRP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 239' ' ' GLN . 31.6 m0 -81.89 176.24 9.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.188 -0.945 . . . . 0.0 109.938 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.7 OUTLIER -103.47 159.57 15.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' SER . 6.6 p30 -45.28 -37.17 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.102 . . . . 0.0 109.826 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.8 t -72.74 -62.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.224 -0.922 . . . . 0.0 110.163 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 3.6 tp60 -41.22 -50.15 3.6 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.567 0.698 . . . . 0.0 109.483 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.459 ' CD1' ' HG3' ' A' ' 229' ' ' LYS . 20.9 mt -57.07 -48.84 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.52 -0.737 . . . . 0.0 109.377 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -47.16 -38.56 12.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.76 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 22.9 t-20 -67.43 -38.13 84.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 109.743 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.85 -43.97 91.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.826 . . . . 0.0 110.442 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.8 OUTLIER -76.65 -29.89 56.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -78.87 -23.72 44.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 1.6 t30 -95.98 -17.87 20.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.6 p -90.46 -30.51 17.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.781 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.27 160.82 1.03 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.3 m -88.88 111.39 22.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.104 -0.998 . . . . 0.0 109.706 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -84.97 116.12 23.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.378 -0.826 . . . . 0.0 108.951 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 178' ' ' ASN . 6.1 mp . . . . . 0 C--N 1.305 -1.359 0 O-C-N 121.058 -1.026 . . . . 0.0 109.53 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.649 HD23 ' CZ ' ' A' ' 186' ' ' TYR . 2.7 tm? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.585 ' N ' HD13 ' A' ' 256' ' ' LEU . 87.1 m-85 -63.27 -23.69 67.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.45 -98.28 0.27 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 250' ' ' SER . 0.3 OUTLIER -84.07 -39.83 19.08 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.253 -1.146 . . . . 0.0 108.94 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.622 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 100.45 -122.1 7.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 261' ' ' LEU . 16.3 tp -87.7 161.25 17.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.813 -0.816 . . . . 0.0 108.804 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.883 HG22 HD11 ' A' ' 192' ' ' ILE . 1.5 t -119.54 154.41 22.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 110.289 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -151.12 117.46 5.66 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.206 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 268' ' ' THR . . . -82.33 6.01 18.35 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.796 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 67.1 tt0 -94.54 -23.96 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.723 -1.236 . . . . 0.0 109.264 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -95.99 -16.73 21.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.167 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 228' ' ' VAL . . . -98.53 -13.91 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' THR . . . . . 0.576 HG21 HD22 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -117.49 -9.85 10.77 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.055 -1.028 . . . . 0.0 109.066 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 268' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.73 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.533 ' HB2' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -83.09 -172.71 4.29 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -111.4 109.37 19.31 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.611 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.659 HG12 ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -132.38 153.71 81.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.799 . . . . 0.0 109.384 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.659 ' HD2' HG12 ' A' ' 4' ' ' VAL . 35.5 Cg_endo -77.68 171.94 16.6 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.857 2.371 . . . . 0.0 111.119 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.7 OUTLIER -52.14 -19.06 1.73 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.542 -0.724 . . . . 0.0 110.473 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -63.16 -52.25 48.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.726 ' O ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -83.9 -20.21 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -1.223 . . . . 0.0 109.662 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -64.34 -26.39 68.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.91 -1.118 . . . . 0.0 109.658 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 22.1 ttm105 -96.32 -0.66 49.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 110.627 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 8' ' ' ILE . 3.2 m -99.77 17.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.585 -1.322 . . . . 0.0 110.29 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' A' ' 265' ' ' GLU . 0.9 OUTLIER 39.91 45.81 1.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.56 -0.713 . . . . 0.0 109.827 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.713 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.22 -27.28 0.34 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.0 Cg_endo -74.28 -56.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.847 -1.251 . . . . 0.0 108.847 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 19' ' ' ARG . . . -43.76 -31.63 0.86 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.98 -43.9 51.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.683 ' ND1' HD21 ' A' ' 80' ' ' LEU . 6.3 m170 -66.85 -15.5 63.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -0.787 . . . . 0.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -96.25 -24.82 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 0.0 109.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -69.15 -32.04 71.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.73 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.65 -16.67 5.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 144.58 56.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -1.147 . . . . 0.0 109.179 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -133.53 1.5 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.023 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' C ' ' HG3' ' A' ' 230' ' ' GLN . . . 57.57 6.49 2.46 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 22' ' ' THR . 1.4 t -66.49 134.01 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.371 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.57 -4.74 37.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 27' ' ' LYS . 28.2 t -98.97 170.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -1.167 . . . . 0.0 109.275 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -140.46 128.85 22.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.894 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.658 HG13 ' CG1' ' A' ' 119' ' ' VAL . 1.9 t -133.97 134.88 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.761 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -92.35 154.51 18.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.23 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -127.56 87.0 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.983 -1.073 . . . . 0.0 108.768 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.66 HD12 ' HB ' ' A' ' 91' ' ' VAL . 5.5 mp -65.27 95.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 20.9 p-10 -144.93 -144.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.737 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -145.04 27.78 1.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.107 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.06 119.8 0.9 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.61 ' CG1' ' HB2' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -103.96 11.54 8.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.948 -0.736 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER 51.84 126.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.994 0.902 . . . . 0.0 111.17 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.84 115.36 10.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.003 -1.06 . . . . 0.0 108.882 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.538 ' NE2' ' HA ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -145.24 157.34 53.4 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.0 Cg_endo -78.52 0.96 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.702 2.268 . . . . 0.0 110.378 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.09 -15.95 14.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.103 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 202' ' ' THR . 0.3 OUTLIER -114.13 119.07 35.84 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 108.841 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -96.64 105.08 17.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 43' ' ' ILE . 1.7 mm -69.47 112.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.335 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.446 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 2.4 mmt85 -100.26 -19.78 16.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.173 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 156.71 28.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . -177.1 140.45 4.9 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.981 -1.305 . . . . 0.0 110.021 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.45 126.82 14.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -1.086 . . . . 0.0 109.297 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -104.3 116.53 32.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.134 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CD2' ' OE1' ' A' ' 107' ' ' GLN . 42.3 m-85 -104.1 -57.0 2.1 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.19 -0.944 . . . . 0.0 109.828 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.86 HG23 ' HD2' ' A' ' 51' ' ' PRO . 1.5 p -42.06 148.88 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.86 ' HD2' HG23 ' A' ' 50' ' ' VAL . 29.2 Cg_endo -66.63 -168.27 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.035 1.824 . . . . 0.0 109.986 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.538 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 57.88 94.76 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.43 94.69 16.63 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.352 -1.087 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 34.7 Cg_endo -78.76 -64.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.784 2.323 . . . . 0.0 109.053 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -175.11 137.59 0.41 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.36 0.6 . . . . 0.0 109.523 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -15.39 18.44 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.36 -0.837 . . . . 0.0 108.767 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 2.4 mp0 -128.67 112.24 14.03 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 13.8 t70 83.31 157.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.498 0.666 . . . . 0.0 109.768 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.96 -20.92 0.51 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.737 ' ND2' HG23 ' A' ' 33' ' ' THR . 0.4 OUTLIER -145.22 -83.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.617 -0.931 . . . . 0.0 108.899 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 64' ' ' THR . . . 159.55 -54.48 0.35 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 215' ' ' SER . 30.0 t-80 -46.31 -57.79 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 110.159 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -38.43 -57.58 1.81 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.532 ' CB ' ' HB3' ' A' ' 36' ' ' SER . 0.6 OUTLIER -51.13 -47.5 61.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -1.143 . . . . 0.0 109.434 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.59 ' CE1' ' CB ' ' A' ' 201' ' ' SER . 2.0 t60 -52.08 -55.84 18.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.325 -0.86 . . . . 0.0 109.473 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 219' ' ' PRO . 39.9 t -53.51 -34.01 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . . . -58.85 -55.56 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.222 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.38 75.54 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.732 HG21 ' O ' ' A' ' 216' ' ' MET . 21.4 m -73.84 -18.54 60.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 108.122 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 219' ' ' PRO . 4.9 mt -98.85 -30.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.624 ' CB ' ' HB3' ' A' ' 83' ' ' ALA . . . -170.13 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 112.101 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 81' ' ' GLY . . . -44.87 121.27 2.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.661 -1.274 . . . . 0.0 108.607 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 84' ' ' PRO . 17.0 mt -43.74 151.91 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.982 . . . . 0.0 110.532 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 46.5 t-20 -105.69 64.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.0 109.412 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.584 ' O ' ' CB ' ' A' ' 76' ' ' SER . 86.0 m-20 -94.53 -1.36 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.504 -0.748 . . . . 0.0 110.098 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 5.0 t 91.18 -34.47 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -85.51 133.5 29.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.88 -175.63 45.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 201' ' ' SER . 5.1 m -76.01 -174.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.2 -1.177 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.683 HD21 ' ND1' ' A' ' 17' ' ' HIS . 1.6 tp -141.0 113.58 8.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.306 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.86 ' H ' ' HB3' ' A' ' 72' ' ' ALA . . . -76.49 -165.74 21.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 6.8 t -80.28 -32.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.281 . . . . 0.0 109.453 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HB3' ' CB ' ' A' ' 71' ' ' ALA . . . -104.6 148.12 35.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.056 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' CG ' ' O ' ' A' ' 22' ' ' THR . 37.9 Cg_endo -84.87 -63.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 110.383 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 5.9 m-20 -113.92 -87.64 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.324 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 85' ' ' ASN . . . 59.8 170.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.449 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 26.0 mm-40 -93.38 85.51 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 2.7 mt -79.28 109.88 14.04 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.446 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 3.2 m-85 -91.18 -177.35 4.86 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.951 0.881 . . . . 0.0 110.448 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -147.28 96.09 2.65 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.761 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -99.81 78.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -51.88 89.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.576 HG13 ' HG ' ' A' ' 94' ' ' LEU . 12.6 p -98.72 -23.69 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 108.929 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.576 ' HG ' HG13 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -111.84 162.95 14.73 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.49 152.81 17.95 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.38 -18.29 3.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.172 -1.193 . . . . 0.0 109.04 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 m -52.98 -57.72 9.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.32 -21.25 0.12 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.816 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.8 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.739 -1.447 . . . . 0.0 110.015 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -52.63 179.06 0.08 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -76.44 174.64 10.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.641 -0.917 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.684 HG11 ' CB ' ' A' ' 130' ' ' SER . 5.2 t -68.62 -18.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -73.87 -18.37 60.93 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 93' ' ' VAL . 19.0 m -88.07 -52.29 5.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.501 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.3 mt -62.27 -30.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.0 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 132' ' ' THR . . . -75.52 -50.9 14.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 108.981 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.584 ' OE1' ' CD2' ' A' ' 49' ' ' PHE . 2.7 pp0? -61.82 -23.93 66.55 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 109.552 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.17 -36.62 20.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.602 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . 15.0 mt -80.37 -13.8 58.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 108.973 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -97.13 -32.88 11.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -67.56 -21.29 65.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.791 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -86.21 -19.37 30.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -55.54 -34.13 59.81 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 114' ' ' ASN . 0.1 OUTLIER -101.95 -61.7 1.35 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.464 -1.021 . . . . 0.0 109.161 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' O ' ' SD ' ' A' ' 117' ' ' MET . 1.3 m-20 -104.16 40.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 108.921 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.791 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -94.23 21.05 44.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.599 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 41.14 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.527 -0.984 . . . . 0.0 110.428 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.884 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -85.53 -22.14 28.26 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 111.239 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.884 HG23 ' CE1' ' A' ' 118' ' ' HIS . 83.5 t -129.38 165.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.327 -1.483 . . . . 0.0 110.232 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.63 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -166.7 128.1 1.7 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.611 ' OD1' HG13 ' A' ' 148' ' ' VAL . 50.8 t30 -105.8 153.68 21.56 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.57 -1.331 . . . . 0.0 110.128 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.769 HD13 ' CG1' ' A' ' 147' ' ' VAL . 5.0 mp -135.84 92.82 2.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 62.01 7.21 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.258 -0.901 . . . . 0.0 108.72 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 124' ' ' LEU . 4.0 pp -147.64 173.74 12.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.659 ' N ' HD12 ' A' ' 124' ' ' LEU . . . -176.92 97.45 0.11 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 2.4 m -96.52 146.71 31.78 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.63 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.1 Cg_endo -77.37 -5.38 15.59 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.474 2.116 . . . . 0.0 109.359 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.5 t -98.54 107.64 43.6 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.756 -0.59 . . . . 0.0 110.224 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 33.0 Cg_endo -76.97 165.83 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.01 1.807 . . . . 0.0 109.609 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.684 ' CB ' HG11 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -170.69 132.78 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.654 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.92 65.72 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.426 HG22 ' CB ' ' A' ' 106' ' ' ALA . 64.4 m -63.88 -31.99 73.36 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 133' ' ' LEU . 13.9 tp -75.85 -34.86 60.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -30.32 68.05 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.386 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 135' ' ' GLN . 4.0 tp60 -70.33 -25.61 63.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -75.9 -48.69 20.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.049 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.073 HG21 ' HB1' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -63.25 -26.46 40.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.3 -36.75 85.03 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.0 t -77.62 -17.77 57.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.887 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.52 -38.11 22.18 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.686 -1.259 . . . . 0.0 111.248 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.802 -1.186 . . . . 0.0 108.571 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -25.32 67.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -112.62 -16.58 12.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.126 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.46 84.99 1.16 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.95 105.23 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -1.028 . . . . 0.0 108.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.81 118.75 8.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.871 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.769 ' CG1' HD13 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -112.94 139.28 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.216 -0.928 . . . . 0.0 109.14 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 222' ' ' ALA . 14.5 p -127.17 68.14 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.918 -1.114 . . . . 0.0 110.114 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -52.63 156.51 1.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.076 -1.015 . . . . 0.0 110.95 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.45 -174.57 5.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.6 -0.688 . . . . 0.0 110.032 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.3 OUTLIER -91.95 -85.09 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.836 -0.54 . . . . 0.0 109.78 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -178.61 -114.29 0.41 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 154' ' ' SER . 0.4 OUTLIER 177.72 34.51 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER 87.06 102.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.321 0.581 . . . . 0.0 109.537 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -172.0 95.75 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 66.07 171.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -1.166 . . . . 0.0 109.647 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.78 51.9 4.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 0.8 OUTLIER -148.96 170.31 18.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -1.168 . . . . 0.0 109.645 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.11 -171.47 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.0 110.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.523 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -62.42 176.04 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.582 1.182 . . . . 0.0 112.186 -178.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 126' ' ' SER . 8.8 m-85 -128.73 127.6 23.5 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.8 Cg_endo -72.33 -45.73 0.43 Allowed 'Cis proline' 0 C--N 1.301 -1.944 0 O-C-N 123.14 1.074 . . . . 0.0 110.726 3.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . . . 27.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.158 0.98 . . . . 0.0 109.645 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.742 ' N ' ' O ' ' A' ' 162' ' ' PRO . 7.0 ttt180 -39.35 -60.25 0.95 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.758 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 55.0 p90 -120.02 -164.66 1.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 1.073 ' HB1' HG21 ' A' ' 137' ' ' VAL . . . 85.98 26.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.775 0.797 . . . . 0.0 109.011 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 55.01 20.26 3.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.32 131.67 51.41 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.44 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 4.4 mtp -76.19 151.49 36.89 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.34 129.21 55.73 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 192' ' ' ILE . 32.1 t -100.17 165.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 109.235 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.07 167.66 24.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -96.17 168.91 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' ' 194' ' ' ALA . 13.5 p -135.64 178.79 6.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 109.5 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 176' ' ' GLN . 14.2 t0 -108.41 -142.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.771 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 175' ' ' ASP . 12.0 tt0 -35.45 -63.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.988 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -122.16 -60.93 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.838 -1.164 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -138.77 -19.7 1.03 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.033 -1.042 . . . . 0.0 111.224 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -47.17 164.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.767 -1.208 . . . . 0.0 109.338 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -69.93 132.86 46.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.332 -0.855 . . . . 0.0 109.729 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -55.72 -154.25 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 m -117.15 -27.34 6.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -119.62 14.04 12.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.716 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 1.9 t -77.41 142.36 39.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.144 -0.973 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 158' ' ' SER . 12.2 tt0 -90.69 166.15 13.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -141.65 173.53 11.42 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 -179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.646 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.62 -178.63 48.39 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.11 68.06 5.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -1.178 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.77 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.469 HD21 ' CG1' ' A' ' 193' ' ' VAL . 3.2 tp -72.75 142.54 48.14 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.067 -1.255 . . . . 0.0 109.521 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 8.4 t0 -101.67 -57.34 2.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.728 HG22 HG22 ' A' ' 171' ' ' VAL . 3.8 tt -151.25 -178.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.6 HG22 ' CA ' ' A' ' 260' ' ' GLY . 6.0 m -149.66 -179.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.314 -0.867 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -175.01 172.78 1.1 Allowed Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 30.8 Cg_endo -72.0 116.55 4.75 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.067 1.845 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.94 44.69 1.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.646 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 40.6 t -124.45 54.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -1.092 . . . . 0.0 108.415 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.646 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 24.3 t-20 127.36 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 211' ' ' LEU . 22.7 m -160.33 105.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-O 122.32 1.057 . . . . 0.0 109.689 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -80.96 135.87 35.94 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.811 ' HA ' HG21 ' A' ' 79' ' ' VAL . 1.3 t -149.05 -157.09 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.597 HG21 HD21 ' A' ' 41' ' ' LEU . 5.0 t -84.02 176.18 9.02 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.983 0.896 . . . . 0.0 110.758 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.666 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -162.7 155.55 16.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.666 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.7 Cg_endo -70.41 161.99 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.008 1.805 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 81.71 15.04 76.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.538 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 5.5 m 68.8 35.17 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.674 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -133.89 161.8 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 110.366 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 201' ' ' SER . 0.0 OUTLIER -114.56 170.23 8.46 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.19 151.26 17.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.775 -1.203 . . . . 0.0 110.281 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -106.97 146.13 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.129 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.75 ' O ' HG22 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -152.99 162.31 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 7.6 p-10 -125.16 141.29 52.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.086 -1.009 . . . . 0.0 109.736 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.512 ' N ' ' SD ' ' A' ' 216' ' ' MET . . . 166.38 167.8 27.59 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -85.78 -17.53 35.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -1.092 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.569 ' O ' ' CD ' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -65.08 -39.46 93.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.46 -0.775 . . . . 0.0 109.118 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.732 ' O ' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -68.87 -44.96 72.22 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.051 0.929 . . . . 0.0 109.84 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -68.81 -19.65 64.29 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.861 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.632 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 28.6 m -64.5 -52.36 53.24 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.737 -1.227 . . . . 0.0 111.086 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -66.38 -9.88 25.55 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.864 1.709 . . . . 0.0 110.656 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.566 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -71.55 -39.24 70.79 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 1.071 HG22 HG21 ' A' ' 262' ' ' VAL . 47.0 t -76.63 -34.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.757 ' HB2' HG11 ' A' ' 148' ' ' VAL . . . -58.43 -39.1 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -71.4 -50.07 22.81 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -45.92 -51.46 13.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -1.194 . . . . 0.0 108.604 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -41.47 72.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -51.57 -49.57 61.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.117 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 227' ' ' LEU . 39.3 mt -54.63 -45.08 73.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 76.2 t -54.99 -65.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.539 ' CG ' HD11 ' A' ' 240' ' ' ILE . 0.0 OUTLIER -43.39 -37.71 2.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.21 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.449 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 9.8 tm0? -57.86 -57.01 14.66 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.083 -1.01 . . . . 0.0 109.897 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -54.23 -19.13 4.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.204 -0.935 . . . . 0.0 108.905 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.492 ' N ' ' HG3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -140.7 86.43 12.06 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.249 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.97 -2.93 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.677 2.251 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -10.81 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -73.73 178.49 4.76 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.73 173.62 8.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.253 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.24 -20.1 25.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.1 t -79.89 -65.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.969 -1.082 . . . . 0.0 109.106 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.1 mp0 -46.86 -34.68 5.59 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.539 HD11 ' CG ' ' A' ' 229' ' ' LYS . 24.0 mt -65.8 -48.33 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -50.25 -34.8 24.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.868 -1.145 . . . . 0.0 108.978 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 239' ' ' GLN . 10.0 t-20 -62.89 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.883 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 247' ' ' THR . 2.9 t60 -48.11 -51.47 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.907 . . . . 0.0 110.434 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.522 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.3 OUTLIER -63.17 -27.22 69.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 110.894 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 61.9 tttt -73.31 -52.04 15.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.024 -1.047 . . . . 0.0 110.228 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 14.0 t-20 -78.73 -10.11 59.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 110.454 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 243' ' ' HIS . 25.5 p -94.42 -37.41 11.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.893 -1.129 . . . . 0.0 110.121 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -64.82 136.1 56.51 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.401 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 259' ' ' SER . 15.5 m -45.93 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 108.913 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 0.7 OUTLIER -145.4 87.07 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 110.131 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 257' ' ' TYR . 5.8 mp -46.51 -50.8 16.56 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.584 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 122.08 -116.98 3.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.442 ' HG ' ' HD2' ' A' ' 257' ' ' TYR . 2.3 m 58.17 -179.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -1.063 . . . . 0.0 109.846 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.7 p -90.26 -23.8 21.11 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.264 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -175.48 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.905 -1.122 . . . . 0.0 110.466 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.5 -62.77 1.39 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.828 -1.17 . . . . 0.0 109.455 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.513 ' HB3' ' HB2' ' A' ' 251' ' ' LEU . 31.7 m-85 -88.78 -77.43 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.494 -0.754 . . . . 0.0 110.211 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 42.9 90.41 0.01 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 250' ' ' SER . 1.8 m 61.37 103.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.937 -1.331 . . . . 0.0 107.967 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.6 ' CA ' HG22 ' A' ' 193' ' ' VAL . . . -139.74 -27.09 0.24 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.371 -1.395 . . . . 0.0 111.651 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 261' ' ' LEU . 0.3 OUTLIER -104.24 146.62 28.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.335 -1.686 . . . . 0.0 108.949 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 1.071 HG21 HG22 ' A' ' 221' ' ' VAL . 1.6 t -117.68 155.2 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.98 . . . . 0.0 110.056 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.45 117.38 2.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.537 1.16 . . . . 0.0 107.942 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -12.67 61.85 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.975 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.492 ' HG2' ' NH1' ' A' ' 269' ' ' ARG . 11.5 tt0 -66.73 -41.33 88.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.004 -1.06 . . . . 0.0 109.137 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.485 ' HA ' ' NH2' ' A' ' 269' ' ' ARG . . . -82.38 -14.0 55.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -93.45 -16.41 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.183 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 269' ' ' ARG . 74.0 p -118.11 -60.46 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 265' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.573 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.521 HE21 ' HB3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -72.01 135.86 46.53 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -0.888 . . . . 0.0 109.377 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 24.6 p -92.56 129.15 38.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 109.788 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.28 81.89 30.41 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.023 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HD2' HG13 ' A' ' 8' ' ' ILE . 33.7 Cg_endo -77.7 159.84 31.51 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.621 2.214 . . . . 0.0 111.347 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CZ3' ' O ' ' A' ' 176' ' ' GLN . 2.6 p-90 -57.88 -26.3 61.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.683 -0.635 . . . . 0.0 110.573 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 8' ' ' ILE . . . -89.33 53.88 3.86 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.476 HG13 ' HD2' ' A' ' 5' ' ' PRO . 14.6 mm -151.55 -50.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 109.517 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -80.26 -13.02 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.42 -28.8 61.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 8' ' ' ILE . 2.8 m -88.61 24.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 1.0 OUTLIER 50.14 45.76 25.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.678 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -82.85 -32.3 0.55 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 111.774 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -74.31 -55.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.18 -28.45 0.77 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.61 -41.98 36.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 109.239 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -66.27 -24.25 66.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.524 -0.735 . . . . 0.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -92.73 -31.04 15.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.604 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -30.09 56.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.612 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.638 ' C ' HD23 ' A' ' 21' ' ' LEU . . . 121.46 19.63 3.43 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.869 ' CD1' HG21 ' A' ' 268' ' ' THR . 3.2 mt -101.9 120.62 40.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -1.151 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -97.98 -24.59 15.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.294 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' A' ' 230' ' ' GLN . . . 69.35 -1.31 13.35 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 p -71.74 117.73 13.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.116 -1.226 . . . . 0.0 109.389 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.13 -16.54 4.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 27' ' ' LYS . 19.1 t -89.75 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.218 -1.166 . . . . 0.0 109.395 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.571 ' N ' HG12 ' A' ' 26' ' ' VAL . 25.9 mttp -138.89 122.75 17.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.736 HG22 ' HB ' ' A' ' 119' ' ' VAL . 61.5 t -127.04 127.49 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -85.12 151.31 24.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.969 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 30' ' ' VAL . 35.2 t -115.14 78.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.983 HD23 HG21 ' A' ' 93' ' ' VAL . 5.6 mp -71.72 114.88 10.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 123' ' ' SER . 5.5 m-20 -175.75 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.513 1.149 . . . . 0.0 108.898 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 60' ' ' ASN . 7.5 p -141.97 -73.59 0.31 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.593 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -160.18 -129.04 1.01 Allowed Glycine 0 C--N 1.3 -1.437 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.687 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 1.4 mm -170.82 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 204' ' ' PRO . 1.1 m -46.68 129.89 11.36 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 109.202 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.74 104.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.637 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -130.52 151.52 78.79 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 109.005 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -12.39 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.555 2.17 . . . . 0.0 110.377 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 8.8 m-20 -88.21 -31.51 19.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.637 HD12 ' HB2' ' A' ' 38' ' ' HIS . 5.0 mt -89.34 115.79 27.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.4 t-20 -78.37 104.28 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 108.747 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 44' ' ' ARG . 1.4 mt -96.02 -177.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.632 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.1 tpt85 -152.69 -39.47 0.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -175.96 166.94 38.43 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.36 174.83 45.6 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.794 -1.416 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -170.1 153.15 4.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.389 -1.065 . . . . 0.0 109.816 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 1.4 p -121.02 142.01 50.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.008 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE2' ' CA ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -126.0 -26.88 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.0 111.187 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.931 HG23 ' CB ' ' A' ' 104' ' ' SER . 1.1 t -42.14 -51.86 10.1 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.855 -1.153 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 39.2 Cg_endo -86.23 -159.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.144 2.563 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 53' ' ' GLU . . . -90.64 -51.43 2.69 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER 174.44 62.52 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.706 -0.879 . . . . 0.0 109.425 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 37.4 Cg_endo -81.85 -90.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.596 2.197 . . . . 0.0 110.504 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 p -151.27 136.07 17.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.504 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -103.93 9.84 36.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.45 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 35.9 mt-30 -117.3 116.21 26.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 65.47 148.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.689 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 138.1 -6.4 3.4 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' OD1' ' HB2' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -142.21 -78.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.088 -1.242 . . . . 0.0 109.922 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.18 -47.11 1.0 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.267 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.488 ' NE2' ' CE ' ' A' ' 216' ' ' MET . 14.6 t-160 -56.36 -61.3 2.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 0.0 110.268 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -41.25 -41.92 3.06 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 25.6 m -61.25 -47.32 86.57 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.276 -1.132 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.482 ' CD2' ' CB ' ' A' ' 201' ' ' SER . 0.2 OUTLIER -55.14 -50.26 69.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 219' ' ' PRO . 30.1 t -60.03 -32.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.131 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . . . -58.49 -46.28 87.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 109.776 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.653 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -74.3 -25.75 69.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.868 HG21 ' HG2' ' A' ' 219' ' ' PRO . 83.1 m -79.31 -9.63 59.63 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.916 -1.344 . . . . 0.0 108.293 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.664 ' CG2' HD21 ' A' ' 88' ' ' LEU . 17.3 mt -106.46 -26.78 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.351 -0.843 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . . . -165.3 21.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.69 -1.257 . . . . 0.0 111.727 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.91 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . -41.53 127.77 3.09 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.918 -1.114 . . . . 0.0 109.322 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 84' ' ' PRO . 60.2 mt -58.98 163.14 3.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 74' ' ' ASN . 2.0 p-10 -118.91 72.85 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.553 -0.717 . . . . 0.0 109.206 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -116.79 -117.8 0.32 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.245 -0.909 . . . . 0.0 108.978 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 p -129.33 -48.71 1.19 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 109.52 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -90.59 69.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.203 -0.936 . . . . 0.0 109.832 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.47 158.1 13.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 201' ' ' SER . 33.7 m -69.33 -153.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -1.203 . . . . 0.0 109.388 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 74' ' ' ASN . 14.4 tp -151.47 118.41 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.941 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.91 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -98.68 -149.73 25.09 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG12 HD11 ' A' ' 227' ' ' LEU . 2.3 t -103.13 -38.05 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.303 . . . . 0.0 109.045 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -93.86 135.1 25.22 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CG ' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.94 -63.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.613 2.208 . . . . 0.0 111.103 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -119.07 47.5 1.66 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.91 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -80.93 164.38 22.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.097 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' OE1' ' CD ' ' A' ' 44' ' ' ARG . 40.1 mm-40 -85.61 104.24 15.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.664 HD21 ' CG2' ' A' ' 70' ' ' ILE . 6.3 mt -96.53 116.74 29.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 11.5 m-85 -97.4 156.01 16.65 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.632 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . . . -123.47 101.18 7.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.431 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -102.58 160.14 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.904 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 2.0 tttt -116.93 111.16 19.24 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.432 -0.793 . . . . 0.0 109.415 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.983 HG21 HD23 ' A' ' 31' ' ' LEU . 12.1 t -115.25 -28.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.392 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.608 HD11 HD22 ' A' ' 124' ' ' LEU . 3.1 mp -132.74 175.05 9.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 110.017 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.36 170.9 39.53 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.528 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -59.45 -26.05 64.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.243 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.0 t -87.82 -54.25 4.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.63 57.86 0.07 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 60.37 1.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.328 -1.101 . . . . 0.0 109.3 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.22 -179.37 44.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.07 162.86 13.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.748 -0.854 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.25 -15.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -19.73 57.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.931 ' CB ' HG23 ' A' ' 50' ' ' VAL . 60.6 p -87.98 -47.62 8.4 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.773 0.797 . . . . 0.0 109.094 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.543 HG23 HG11 ' A' ' 93' ' ' VAL . 2.2 mt -68.35 -34.13 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.91 -39.35 51.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.588 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 6.5 tt0 -70.52 -31.31 68.35 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.065 -1.022 . . . . 0.0 109.07 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.589 ' CA ' ' CE2' ' A' ' 49' ' ' PHE . . . -75.11 -39.49 37.16 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.4 mt -66.57 -33.13 74.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -1.088 . . . . 0.0 109.692 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 -17.98 23.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.421 ' HB2' ' O ' ' A' ' 107' ' ' GLN . 80.1 t90 -73.15 -18.02 61.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -90.85 6.72 43.28 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.223 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -96.99 -46.89 2.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.29 -80.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.147 -1.208 . . . . 0.0 108.274 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -95.83 62.56 2.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.728 ' CA ' ' HE3' ' A' ' 117' ' ' MET . . . -122.34 -161.21 11.19 Favored Glycine 0 C--N 1.286 -2.205 0 CA-C-O 122.575 1.097 . . . . 0.0 112.034 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.728 ' HE3' ' CA ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -126.41 162.87 24.58 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.446 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.415 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.736 ' HB ' HG22 ' A' ' 28' ' ' VAL . 2.5 t -105.91 156.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.837 -1.164 . . . . 0.0 109.611 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.2 121.34 1.69 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.723 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.786 ' C ' HD12 ' A' ' 122' ' ' LEU . 15.0 t30 -98.48 158.32 15.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.071 -1.018 . . . . 0.0 109.954 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.786 HD12 ' C ' ' A' ' 121' ' ' ASN . 7.0 mp -138.02 101.77 4.51 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 32' ' ' ASP . 20.6 p -85.53 62.11 7.27 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.608 HD22 HD11 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -143.9 178.87 7.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.433 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.587 ' CA ' ' CB ' ' A' ' 160' ' ' SER . . . 165.65 107.96 0.21 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.97 154.43 48.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.98 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.528 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 33.4 Cg_endo -77.18 -3.84 14.15 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.517 2.144 . . . . 0.0 109.195 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.408 ' O ' ' CE1' ' A' ' 161' ' ' TYR . 2.7 t -103.99 101.04 23.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 35.7 Cg_endo -77.95 166.03 25.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.335 2.023 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -153.73 125.21 7.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.65 66.56 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 15.5 m -67.08 -28.8 68.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.677 HD22 ' CE2' ' A' ' 161' ' ' TYR . 0.3 OUTLIER -70.37 -36.62 74.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -65.94 -58.44 5.54 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.431 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 134' ' ' GLU . 2.4 tp-100 -42.12 -28.13 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' GLU . . . -74.96 -49.61 19.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.707 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -33.14 46.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -61.61 -39.58 91.76 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -71.08 -22.94 62.04 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.99 -2.23 47.36 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.002 -1.062 . . . . 0.0 110.187 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -95.34 -34.16 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 108.859 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 64.4 m -66.1 -24.4 66.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 108.86 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -88.79 -13.1 40.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -0.821 . . . . 0.0 109.325 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.26 71.13 1.0 Allowed Glycine 0 C--N 1.302 -1.36 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 84.9 t -112.99 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.448 -1.03 . . . . 0.0 109.499 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.421 HD23 HG13 ' A' ' 119' ' ' VAL . 5.0 tp -60.48 100.81 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.094 -1.003 . . . . 0.0 108.772 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG12 HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -104.11 140.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.22 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.16 125.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 108.879 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -105.18 146.85 28.66 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.995 -1.066 . . . . 0.0 110.431 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -81.45 169.66 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.56 -68.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 143.23 121.63 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 154' ' ' SER . 12.7 p-10 -86.7 33.35 0.65 Allowed 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.756 -0.849 . . . . 0.0 109.917 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER 162.33 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.31 -103.4 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.56 -168.66 2.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.7 44.89 3.3 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -159.66 150.16 19.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -1.198 . . . . 0.0 109.045 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.404 HG12 ' H ' ' A' ' 159' ' ' ILE . 2.2 pt -80.85 176.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.39 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.939 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -108.66 163.44 13.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 111.823 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.677 ' CE2' HD22 ' A' ' 133' ' ' LEU . 10.2 p90 -89.89 146.06 34.49 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 164' ' ' ARG . 44.0 Cg_endo -71.37 -26.6 8.09 Favored 'Cis proline' 0 C--N 1.297 -2.179 0 O-C-N 122.404 0.687 . . . . 0.0 110.722 4.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.939 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.73 -178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -77.4 -47.55 19.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.719 -1.238 . . . . 0.0 110.011 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -48.0 -171.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.316 1.055 . . . . 0.0 110.906 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.23 1.34 12.45 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.736 -0.602 . . . . 0.0 110.104 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.68 18.98 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.147 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -168.24 161.56 12.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.9 mmm -104.2 138.71 40.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.591 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -100.75 127.1 47.3 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.528 -0.732 . . . . 0.0 109.294 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.4 t -98.55 165.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.189 -0.944 . . . . 0.0 109.717 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -135.39 -158.0 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -144.74 147.01 32.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.925 -1.338 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.34 155.69 25.78 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 4.2 p-10 -59.63 -160.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 109.664 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.53 ' O ' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -45.65 -67.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.465 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -102.12 -57.81 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.369 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.2 OUTLIER -176.17 106.63 0.08 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.403 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.693 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 1.1 t30 -136.65 -39.13 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.693 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 13.5 ttt180 116.51 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.692 0.758 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -39.24 161.32 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.185 0.516 . . . . 0.0 109.638 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -119.86 -49.09 2.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 0.0 110.475 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.504 ' CE2' ' OG1' ' A' ' 214' ' ' THR . 31.3 p90 -49.49 -21.41 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 214' ' ' THR . 1.6 t -69.94 117.2 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.015 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -57.54 116.94 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CG ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -121.41 167.8 12.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.528 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -165.34 -166.61 24.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.34 64.11 7.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.14 -1.212 . . . . 0.0 109.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 170.81 33.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' ASP . 5.3 tp -79.27 102.2 8.45 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.04 -1.271 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 24.4 t70 -41.79 -67.83 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 110.277 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.694 HD11 ' O ' ' A' ' 261' ' ' LEU . 3.9 tt -157.77 169.98 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.199 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 260' ' ' GLY . 7.9 m -108.76 162.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.695 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 1.02 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -152.88 -176.68 0.61 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 1.02 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.3 Cg_endo -78.15 115.48 3.75 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.771 1.648 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -144.09 18.48 2.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.627 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 10.3 t -109.14 55.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 108.729 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 199' ' ' VAL . 20.4 t-20 131.19 121.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 198' ' ' ASN . 16.4 m -164.63 111.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.94 0.876 . . . . 0.0 108.724 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 7.2 pt20 -99.68 125.2 45.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.728 ' HA ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -130.85 -166.57 1.71 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 109.304 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -83.5 172.96 11.89 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.655 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -147.5 165.36 19.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.655 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.5 Cg_endo -71.27 164.48 35.59 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.085 1.857 . . . . 0.0 110.533 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 92.0 -54.73 2.93 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 9.5 p 141.39 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -137.93 -178.37 5.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.934 -1.104 . . . . 0.0 110.371 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.536 ' N ' ' OG1' ' A' ' 207' ' ' THR . 36.7 m-85 -106.37 -160.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -172.97 163.04 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.987 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 42.3 p -151.72 108.55 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 108.875 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.87 160.74 39.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.719 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.85 133.22 55.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -169.09 148.54 12.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 173' ' ' ALA . 32.9 m -72.64 -31.44 65.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -1.186 . . . . 0.0 109.302 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.518 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 16.8 t -67.74 -9.18 41.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.488 ' CE ' ' NE2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -86.22 -22.26 27.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.898 . . . . 0.0 109.877 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.729 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -84.65 -17.31 39.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.654 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 32.9 m -62.87 -42.76 79.88 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 111.904 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.868 ' HG2' HG21 ' A' ' 69' ' ' THR . 30.2 Cg_endo -71.27 -13.47 30.86 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.575 1.517 . . . . 0.0 110.277 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.625 ' CE1' HG23 ' A' ' 69' ' ' THR . 8.4 m80 -72.42 -40.08 67.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.09 -39.29 74.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.78 -45.58 67.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -62.4 -45.19 96.44 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.58 -60.36 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.266 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -48.59 -33.68 10.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.763 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -60.93 -46.54 90.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 109.037 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.53 HD11 HG12 ' A' ' 82' ' ' VAL . 30.4 mt -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.594 HG21 HD23 ' A' ' 244' ' ' LEU . 97.5 t -64.75 -64.94 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 109.756 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.573 ' HE3' HG23 ' A' ' 119' ' ' VAL . 7.6 ttmm -42.97 -35.98 1.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.127 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.469 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 45.1 tp60 -60.95 -51.92 67.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 231' ' ' LYS . 3.1 ttpp -55.62 -18.56 8.0 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 3.5 m120 -165.49 82.78 1.1 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.383 -0.823 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.1 Cg_endo -78.81 0.24 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.689 2.259 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -6.36 48.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -75.84 -176.73 3.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.834 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.0 OUTLIER -111.1 164.76 12.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.389 0.614 . . . . 0.0 109.616 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -29.05 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -78.17 -61.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.141 -0.975 . . . . 0.0 109.422 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.7 OUTLIER -39.98 -37.78 0.63 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.019 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 236' ' ' SER . 2.5 mt -77.1 -46.63 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.634 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -49.67 -31.33 10.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 52.3 m-20 -72.93 -47.13 48.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.964 -1.085 . . . . 0.0 110.389 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.503 ' HA ' ' OD1' ' A' ' 246' ' ' ASN . 3.5 t60 -63.15 -35.88 81.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -81.87 -35.67 29.04 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -68.89 -34.43 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 243' ' ' HIS . 3.7 p-10 -84.65 -30.42 24.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.44 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 267' ' ' ALA . 1.7 p -72.06 -30.13 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.682 ' HB1' HD12 ' A' ' 192' ' ' ILE . . . -40.52 117.44 0.81 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.521 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' ALA . 0.2 OUTLIER -43.9 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -126.18 71.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 261' ' ' LEU . 1.9 mp -54.66 -62.36 1.71 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.968 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 253' ' ' SER . . . 113.55 -82.81 0.31 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 252' ' ' GLY . 5.2 t 46.54 -171.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.211 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 255' ' ' ASN . 0.2 OUTLIER -59.18 -61.48 2.61 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.881 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 254' ' ' THR . 17.9 p-10 177.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.645 ' CD2' ' CG ' ' A' ' 186' ' ' TYR . 2.6 tm? -41.65 -51.81 3.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.765 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -61.28 -57.53 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.14 -0.975 . . . . 0.0 109.089 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.48 -81.65 1.69 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 191' ' ' ASP . 57.7 m -78.53 -55.43 5.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.388 -1.066 . . . . 0.0 109.137 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 135.26 -135.53 7.95 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.694 ' O ' HD11 ' A' ' 192' ' ' ILE . 1.4 tp -105.06 178.1 4.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.349 -1.089 . . . . 0.0 109.076 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.574 HG22 HD13 ' A' ' 192' ' ' ILE . 3.0 t -122.67 156.29 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -166.23 119.6 1.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.327 1.06 . . . . 0.0 108.457 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.73 -13.01 61.24 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.152 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 15.8 tt0 -75.47 -25.96 57.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 109.664 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.21 55.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.679 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.45 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -113.67 -20.67 11.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.869 HG21 ' CD1' ' A' ' 21' ' ' LEU . 61.8 p -102.31 -46.51 4.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.119 -0.988 . . . . 0.0 109.229 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 269' ' ' ARG . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.427 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.231 0.539 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 151.54 12.82 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.168 -0.958 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.688 ' OG ' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -81.28 116.67 21.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.667 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 2.9 t -136.75 46.81 1.62 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.915 . . . . 0.0 110.108 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 36.4 Cg_endo -77.5 165.6 27.04 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.936 1.758 . . . . 0.0 110.424 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 7.1 p-90 -67.05 -13.19 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 109.464 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 11' ' ' VAL . . . -83.89 -15.75 69.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.57 ' CD1' ' NE2' ' A' ' 220' ' ' HIS . 1.1 mp -116.38 -6.75 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -1.202 . . . . 0.0 109.045 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.92 -22.43 21.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 21.37 12.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.036 -1.04 . . . . 0.0 110.621 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 7' ' ' GLY . 28.1 m -110.06 18.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.963 -1.086 . . . . 0.0 109.339 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 27.8 mm-40 57.07 17.63 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 110.571 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.683 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.54 -43.03 87.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.86 -53.87 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 N-CA-C 107.874 -1.625 . . . . 0.0 107.874 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB1' ' OE2' ' A' ' 265' ' ' GLU . . . -44.75 -30.74 1.01 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.47 54.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 16.0 m170 -65.62 -10.83 39.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.601 -0.687 . . . . 0.0 109.175 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -83.43 -56.87 3.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -36.21 63.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.456 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.92 4.01 9.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.657 HD13 HG21 ' A' ' 268' ' ' THR . 0.3 OUTLIER -63.82 137.68 58.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.133 . . . . 0.0 109.365 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -123.77 -12.4 7.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.086 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 71.55 -9.39 4.66 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -49.13 135.43 16.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -1.122 . . . . 0.0 109.336 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.18 0.55 47.78 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.569 HG13 ' CD2' ' A' ' 118' ' ' HIS . 47.5 t -112.44 163.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.127 -1.219 . . . . 0.0 109.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -148.83 131.35 15.78 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 ' HB ' ' A' ' 119' ' ' VAL . 17.4 t -128.69 154.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.325 -0.859 . . . . 0.0 109.723 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -98.76 150.17 22.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.911 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.636 ' CG2' HD22 ' A' ' 88' ' ' LEU . 39.0 t -122.7 80.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.919 -1.113 . . . . 0.0 108.387 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.039 HD23 HG21 ' A' ' 93' ' ' VAL . 6.6 mp -71.07 126.41 29.51 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.973 ' HA ' HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER 170.21 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.264 -0.897 . . . . 0.0 109.258 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.855 HG21 ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -49.05 -59.76 3.35 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . 179.38 -109.85 0.27 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 165.6 102.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 p -49.73 125.88 12.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.814 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 m -55.12 101.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.074 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.593 ' CD2' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -119.4 153.39 53.7 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.812 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 35.6 Cg_endo -78.5 -12.69 15.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.516 2.144 . . . . 0.0 109.939 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -90.25 -37.58 14.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD21 ' HA2' ' A' ' 68' ' ' GLY . 62.2 mt -88.87 113.49 24.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.792 . . . . 0.0 109.545 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 119.36 16.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 mm -92.66 94.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.073 -1.017 . . . . 0.0 109.395 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -79.81 -21.01 44.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.993 . . . . 0.0 109.265 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -169.32 163.9 37.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.91 119.5 0.83 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.37 163.47 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -1.096 . . . . 0.0 108.727 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.493 ' OG ' ' HD2' ' A' ' 92' ' ' LYS . 2.5 t -150.85 136.95 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 110.427 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.619 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -127.29 -30.31 2.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 94' ' ' LEU . 55.2 t -49.05 129.42 15.42 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.56 172.08 14.9 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.64 2.226 . . . . 0.0 111.125 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.82 -66.38 1.93 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -165.99 86.32 0.94 Allowed Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.599 -0.942 . . . . 0.0 109.241 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' SER . 35.4 Cg_endo -75.58 -95.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.396 2.064 . . . . 0.0 110.549 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 4.3 m 60.16 134.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -92.71 3.8 54.93 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.181 -0.95 . . . . 0.0 109.159 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 1.5 mt-30 -96.56 116.21 28.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.217 -0.927 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.7 OUTLIER 52.21 171.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.637 0.732 . . . . 0.0 110.133 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.57 -33.31 0.06 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.855 ' HB2' HG21 ' A' ' 33' ' ' THR . 9.1 t30 -175.68 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.345 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.62 -47.24 0.97 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -45.32 -50.07 12.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.398 -1.06 . . . . 0.0 110.155 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -54.54 -80.94 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.409 -0.901 . . . . 0.0 110.934 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 0.7 OUTLIER -33.42 -45.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.818 -0.813 . . . . 0.0 110.898 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.723 ' CD2' HD11 ' A' ' 211' ' ' LEU . 44.9 t-80 -57.51 -54.01 51.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.971 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 70' ' ' ILE . 13.5 t -58.76 -32.62 47.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.426 -0.796 . . . . 0.0 109.189 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 70' ' ' ILE . . . -59.72 -49.27 78.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.763 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -70.31 -28.65 71.05 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.492 HG21 ' HG2' ' A' ' 219' ' ' PRO . 7.7 m -71.59 -17.12 62.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.062 -1.258 . . . . 0.0 108.473 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 66' ' ' VAL . 30.3 mt -92.66 -32.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.401 -0.812 . . . . 0.0 110.411 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 83' ' ' ALA . . . -179.65 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.661 -1.274 . . . . 0.0 111.52 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.763 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -46.1 156.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.734 -1.229 . . . . 0.0 108.358 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 73' ' ' LEU . 96.6 mt -78.95 166.69 22.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.932 -1.105 . . . . 0.0 109.925 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.99 ' HB2' HD13 ' A' ' 80' ' ' LEU . 55.0 t30 -117.29 87.38 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.84 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -118.39 -118.92 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.291 -0.881 . . . . 0.0 108.737 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -113.45 -40.54 3.84 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 109.279 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.79 165.56 2.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.404 -0.81 . . . . 0.0 109.7 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.27 -167.23 53.16 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.688 HG12 ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -114.0 -167.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -1.178 . . . . 0.0 109.397 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.99 HD13 ' HB2' ' A' ' 74' ' ' ASN . 8.5 tp -130.36 122.37 27.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 80' ' ' LEU . . . -86.57 -149.31 13.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG12 HD11 ' A' ' 227' ' ' LEU . 2.0 t -97.79 -66.67 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.263 . . . . 0.0 109.666 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -71.45 134.3 84.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 22' ' ' THR . 40.1 Cg_endo -84.95 -60.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.752 2.302 . . . . 0.0 111.236 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -105.92 45.38 0.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.793 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -85.5 164.72 17.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.07 -1.018 . . . . 0.0 109.646 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 2.6 tt0 -101.55 80.19 2.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.636 HD22 ' CG2' ' A' ' 30' ' ' VAL . 6.6 mt -73.3 144.17 46.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.312 -0.867 . . . . 0.0 109.746 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.604 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 2.8 m-85 -118.48 161.52 19.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.401 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -130.03 92.32 3.28 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.643 -1.286 . . . . 0.0 109.914 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.89 149.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.131 -0.981 . . . . 0.0 109.315 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 4.4 mttp -100.29 105.61 17.17 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.039 HG21 HD23 ' A' ' 31' ' ' LEU . 2.1 t -104.55 -14.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.813 . . . . 0.0 110.08 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.973 HD11 ' HA ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.55 -174.7 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.771 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -110.75 -177.41 20.63 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.0 -6.96 25.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.452 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.78 33.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.88 8.85 57.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 t -142.15 66.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -1.185 . . . . 0.0 109.668 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.47 178.92 13.16 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.48 157.8 21.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.746 -0.855 . . . . 0.0 109.786 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 130' ' ' SER . 43.7 t -68.53 -19.61 24.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.526 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 33.4 t -72.91 -22.69 60.7 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.456 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 57.4 m -83.1 -63.8 1.29 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.568 HG23 ' CG1' ' A' ' 93' ' ' VAL . 2.3 mt -47.93 -27.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 110' ' ' GLU . . . -69.08 -47.91 64.03 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.619 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -64.79 -28.83 69.84 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.033 -1.042 . . . . 0.0 109.404 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.493 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -80.55 -26.77 53.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.949 HD22 ' ND2' ' A' ' 167' ' ' ASN . 16.4 mt -87.23 -24.15 24.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -1.227 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 7.1 pt-20 -100.63 -25.94 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.251 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.53 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 83.1 t90 -71.65 -17.06 62.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -93.42 -0.38 56.51 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.876 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.93 -28.47 10.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -97.2 -35.41 10.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -1.22 . . . . 0.0 109.503 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -140.12 27.66 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.394 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.834 ' O ' ' HE2' ' A' ' 117' ' ' MET . . . -87.99 -153.32 25.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.834 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 12.1 mmt -125.22 -176.54 3.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.366 -1.079 . . . . 0.0 110.432 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.724 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -71.84 -17.08 62.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.749 -0.595 . . . . 0.0 110.163 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.724 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.6 t -136.74 168.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.6 132.48 1.21 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 1.02 ' C ' HD13 ' A' ' 122' ' ' LEU . 1.6 m120 -130.91 147.39 52.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.0 109.741 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.02 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -142.07 124.78 15.93 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.094 -1.004 . . . . 0.0 109.187 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.749 ' C ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -93.17 62.14 3.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.897 -1.127 . . . . 0.0 109.065 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.819 HD23 ' N ' ' A' ' 124' ' ' LEU . 1.2 mt -99.72 -178.7 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 160' ' ' SER . . . 175.05 74.88 0.05 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 3.4 m -124.62 147.73 56.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 109.494 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -81.07 15.42 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.787 2.325 . . . . 0.0 110.119 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.534 ' N ' ' CD ' ' A' ' 129' ' ' PRO . 14.1 t -116.03 50.36 0.76 Allowed Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.602 -0.687 . . . . 0.0 111.48 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -72.57 178.58 6.07 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.343 2.028 . . . . 0.0 109.772 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.581 ' HB2' HG21 ' A' ' 102' ' ' VAL . 3.7 t -152.49 154.08 34.77 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.16 64.92 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.0 m -71.61 -26.76 62.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.2 tp -72.39 -38.3 68.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -68.08 -47.62 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.64 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -52.48 -26.47 12.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -67.32 -44.81 78.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.082 HG23 ' HA ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -52.29 -40.38 31.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.536 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.458 ' N ' HG12 ' A' ' 137' ' ' VAL . 1.6 m120 -58.07 -41.79 84.12 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -20.16 63.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.63 1.75 25.42 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.872 -1.143 . . . . 0.0 112.044 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -104.49 -41.24 5.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.427 -1.421 . . . . 0.0 108.409 178.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -20.03 57.8 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.38 -25.83 20.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.44 52.66 4.12 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.5 t -105.4 109.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -1.093 . . . . 0.0 109.267 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 146' ' ' LEU . 24.7 tp -58.5 123.13 15.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.053 -1.029 . . . . 0.0 109.104 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -120.25 141.69 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.015 . . . . 0.0 109.297 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' HG3' ' A' ' 169' ' ' MET . 1.2 t -137.97 123.91 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.544 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -118.75 147.94 43.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.004 -1.06 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -52.2 160.4 0.78 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.618 -0.676 . . . . 0.0 110.213 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -71.06 -79.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 185' ' ' GLN . . . 149.54 119.32 0.97 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.437 ' OD1' ' CG ' ' A' ' 183' ' ' PHE . 3.6 m-20 -91.59 57.66 3.33 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.799 -0.824 . . . . 0.0 109.391 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.07 -96.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.49 84.47 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -170.61 179.51 3.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.62 56.7 4.89 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -179.75 171.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -1.077 . . . . 0.0 108.675 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.626 HD12 ' CB ' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -118.85 -173.34 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.008 -1.057 . . . . 0.0 110.38 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.56 ' HB3' ' HA2' ' A' ' 125' ' ' GLY . 2.6 m -70.89 -174.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.806 1.289 . . . . 0.0 112.521 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.429 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 93.6 m-85 -123.81 126.97 25.59 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.723 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.3 Cg_endo -72.62 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.301 -1.949 0 C-N-CA 123.939 -1.276 . . . . 0.0 109.791 2.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . . . 31.7 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.238 1.018 . . . . 0.0 108.901 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 162' ' ' PRO . 17.5 ttm180 -44.12 -62.73 1.05 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.717 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -172.28 -166.12 0.38 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 165' ' ' TYR . . . 89.73 -7.09 0.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.746 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 1.082 ' HA ' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER 159.73 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.719 -0.613 . . . . 0.0 109.596 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 167' ' ' ASN . . . 164.77 149.49 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.433 -1.307 . . . . 0.0 112.648 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -80.19 -174.43 4.52 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 175.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.626 ' CB ' HD12 ' A' ' 159' ' ' ILE . . . -122.66 118.88 29.18 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.345 -1.472 . . . . 0.0 110.515 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 151' ' ' SER . 19.0 t -89.52 166.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -136.9 -176.89 14.61 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.582 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -130.31 150.21 51.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.979 . . . . 0.0 109.601 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 173' ' ' ALA . 33.2 p -157.79 155.06 29.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' THR . 18.8 p-10 -58.9 -150.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.846 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.543 ' HG2' ' ND2' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -94.48 -31.48 13.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.952 . . . . 0.0 109.983 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.543 ' ND2' ' HG2' ' A' ' 176' ' ' GLN . 0.0 OUTLIER -96.29 -89.39 0.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.96 80.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -140.28 165.18 28.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 12.0 mtm180 -98.38 19.07 15.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.354 -0.841 . . . . 0.0 109.647 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 64.15 -152.46 0.3 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.6 OUTLIER -112.0 9.86 20.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.393 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -150.48 -92.48 0.06 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' PHE . 3.7 t 39.29 80.76 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.476 -0.765 . . . . 0.0 110.455 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 152' ' ' GLY . 1.9 mp0 -65.67 146.27 55.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 0.0 109.122 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -123.54 166.41 15.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.126 -0.983 . . . . 0.0 109.541 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . 155.59 175.5 26.69 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -52.82 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.156 . . . . 0.0 109.273 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 170' ' ' ALA . . . 160.81 -33.76 0.4 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' A' ' 190' ' ' LEU . 7.9 tp -52.21 111.78 0.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.238 -1.154 . . . . 0.0 109.622 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.28 -28.75 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.85 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 248' ' ' ALA . 2.5 tt -156.8 166.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.607 -1.308 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.882 HG22 ' O ' ' A' ' 260' ' ' GLY . 12.4 m -123.68 174.63 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -0.821 . . . . 0.0 109.283 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.982 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -168.78 177.81 1.14 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.223 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.979 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.4 Cg_endo -76.61 119.33 5.15 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.455 2.103 . . . . 0.0 110.629 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.47 42.15 1.41 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 19.9 t -133.45 81.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.234 -1.156 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 10.4 t-20 84.22 122.83 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.011 0.91 . . . . 0.0 108.574 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 199' ' ' VAL . 19.3 m -156.81 108.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 122.137 0.97 . . . . 0.0 109.383 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 31.5 mt-30 -78.77 143.79 35.78 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.611 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -159.11 -162.1 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.329 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.514 HG21 HD11 ' A' ' 41' ' ' LEU . 15.0 t -86.04 -177.55 6.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.657 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -168.45 169.44 4.96 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.657 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -72.31 168.55 23.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.335 2.023 . . . . 0.0 110.538 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.53 72.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.514 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 4.2 p 56.36 36.7 27.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -1.113 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -122.58 147.68 46.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.078 -1.014 . . . . 0.0 109.807 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.22 19.28 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.49 165.67 4.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.028 . . . . 0.0 110.205 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.76 ' O ' HD23 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -103.33 146.3 28.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.482 -0.762 . . . . 0.0 109.435 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -139.01 107.91 5.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.777 . . . . 0.0 109.169 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.07 140.83 56.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.1 -1.0 . . . . 0.0 109.344 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.35 2.39 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.783 HG23 ' HB2' ' A' ' 173' ' ' ALA . 19.4 m -68.38 -23.58 64.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 0.0 109.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.538 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 9.9 t -67.11 -20.07 65.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.643 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.525 ' HG2' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -78.77 -10.49 59.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.982 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -86.38 -5.76 59.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.638 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.647 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -76.95 -39.05 2.13 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.5 Cg_endo -71.98 -25.59 19.46 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.527 1.484 . . . . 0.0 110.744 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.57 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 13.1 m80 -66.78 -37.75 85.19 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.72 -52.14 34.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' A' ' 121' ' ' ASN . . . -48.09 -33.2 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.378 -0.826 . . . . 0.0 108.94 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.4 -53.08 23.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -53.52 -62.44 1.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.419 -1.048 . . . . 0.0 109.286 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 244' ' ' LEU . . . -43.01 -40.88 3.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.23 78.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.216 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 82' ' ' VAL . 7.1 mt -52.94 -29.12 26.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.33 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 229' ' ' LYS . 96.1 t -74.19 -51.51 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.505 ' HD3' ' CD2' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -43.92 -47.62 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.453 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 28.3 tp60 -63.3 -41.8 98.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.3 tptt -62.98 -11.49 19.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.046 -1.034 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.96 90.89 1.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.19 -0.944 . . . . 0.0 109.764 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.429 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 36.9 Cg_endo -81.44 17.88 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.724 2.283 . . . . 0.0 110.834 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.3 t -122.12 5.32 9.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 110.004 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -91.5 -179.65 5.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.909 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.457 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.4 OUTLIER -110.37 167.73 9.98 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -58.64 -35.75 73.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 109.426 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 238' ' ' VAL . 3.0 t -66.66 -64.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.21 -0.931 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -45.34 -39.78 7.12 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.357 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 236' ' ' SER . 59.7 mt -57.72 -49.41 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.57 -0.706 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' ASN . 49.1 ttp180 -56.12 -60.65 3.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.58 ' HA ' ' HE3' ' A' ' 245' ' ' LYS . 2.3 t-20 -37.69 -62.72 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.66 -0.65 . . . . 0.0 110.91 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.563 ' O ' HG23 ' A' ' 247' ' ' THR . 2.1 t60 -50.4 -40.75 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.597 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.758 HD12 ' HB2' ' A' ' 225' ' ' ALA . 0.2 OUTLIER -70.63 -37.56 73.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 111.327 -178.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.629 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 4.0 ptpt -63.36 -55.46 24.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.868 -1.145 . . . . 0.0 109.975 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.629 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 2.8 p-10 -70.78 -27.1 63.66 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.547 -0.72 . . . . 0.0 111.035 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 267' ' ' ALA . 6.0 p -71.57 -30.75 66.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.802 -1.186 . . . . 0.0 109.627 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -52.33 130.76 31.91 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 261' ' ' LEU . 1.6 m -42.97 111.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.211 -0.931 . . . . 0.0 108.784 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.4 p -69.14 98.0 0.96 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -0.804 . . . . 0.0 110.369 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.631 HD13 ' HA2' ' A' ' 260' ' ' GLY . 3.5 mp -56.85 -65.43 0.62 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 253' ' ' SER . . . 171.77 -137.03 4.11 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 252' ' ' GLY . 10.7 p 43.24 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.09 . . . . 0.0 109.878 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 13.5 t -125.57 -3.27 7.29 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.835 -0.541 . . . . 0.0 109.927 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 254' ' ' THR . 9.8 t30 172.93 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.021 . . . . 0.0 110.181 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 256' ' ' LEU . 0.2 OUTLIER -50.24 -61.29 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.964 -1.085 . . . . 0.0 109.159 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -55.3 -60.97 2.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.154 -0.966 . . . . 0.0 108.475 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 124.71 58.97 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.432 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 3.1 t 83.73 -57.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.926 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.882 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 140.36 -171.29 24.03 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.525 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.773 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 12.7 tp -75.25 162.29 28.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.954 . . . . 0.0 109.695 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.37 154.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.182 -0.949 . . . . 0.0 109.969 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.43 ' CB ' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -160.71 117.18 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.652 1.215 . . . . 0.0 108.177 178.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.6 61.0 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.526 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.823 ' OE2' ' HB1' ' A' ' 15' ' ' ALA . 7.6 tp10 -82.47 -40.47 21.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.964 -1.085 . . . . 0.0 109.603 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.8 -11.75 59.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 0.0 109.301 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.636 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -89.69 -38.88 13.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.657 HG21 HD13 ' A' ' 21' ' ' LEU . 44.6 p -87.89 -52.9 5.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.442 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.425 ' C ' ' HD3' ' A' ' 269' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.429 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.362 0.601 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.451 ' HB3' HG13 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.53 165.88 24.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.253 -0.905 . . . . 0.0 109.874 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.1 m -101.3 55.19 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.864 . . . . 0.0 109.015 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.538 HG12 HG21 ' A' ' 8' ' ' ILE . 15.8 m -76.99 111.89 19.34 Favored Pre-proline 0 C--N 1.29 -2.007 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -80.48 -166.52 0.42 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.827 2.351 . . . . 0.0 111.813 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -33.29 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.219 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' HA3' ' NE2' ' A' ' 220' ' ' HIS . . . -52.06 -83.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.9 mm -43.84 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.479 -1.012 . . . . 0.0 109.187 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 162.78 -56.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -125.49 26.52 6.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.65 20.04 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.875 -1.14 . . . . 0.0 109.903 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG3' ' HB3' ' A' ' 263' ' ' ASN . 5.3 mm-40 65.83 15.59 10.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.577 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -66.33 -37.17 14.96 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.5 Cg_endo -73.02 -55.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.981 0 N-CA-C 108.424 -1.414 . . . . 0.0 108.424 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.74 -29.52 0.53 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 11.1 m170 -69.04 -7.29 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.817 . . . . 0.0 109.569 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.26 -22.58 14.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.112 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.871 ' HB3' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -81.26 4.89 18.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.34 47.13 5.03 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.871 HD21 ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -149.22 150.89 33.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -1.086 . . . . 0.0 109.102 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 24' ' ' SER . 1.7 t -161.15 38.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.866 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 56.94 9.79 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 22' ' ' THR . 55.5 p -57.78 119.45 6.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.77 27.92 9.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 27' ' ' LYS . 88.1 t -122.83 167.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -1.211 . . . . 0.0 109.789 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -136.24 132.62 36.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.117 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 119' ' ' VAL . 3.0 t -136.36 123.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 110.121 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.582 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -84.97 162.63 19.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.82 90.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.153 HD23 HG21 ' A' ' 93' ' ' VAL . 5.9 mp -79.83 102.37 9.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD2' ' HA2' ' A' ' 63' ' ' GLY . 47.9 p30 -166.2 -154.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.006 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 96' ' ' ALA . 6.6 p -43.0 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.564 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -164.06 -132.8 1.39 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.751 HG13 ' HB2' ' A' ' 90' ' ' ALA . 30.5 mm -165.58 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -62.88 137.47 58.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 109.171 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -63.05 122.39 15.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.591 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -133.18 154.54 81.22 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.4 Cg_endo -79.68 -31.91 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.715 2.276 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -86.33 -3.19 58.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.0 109.836 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.77 123.6 48.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.065 -1.022 . . . . 0.0 109.724 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.12 91.43 7.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 109.87 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.75 152.07 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.563 ' O ' ' CE1' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -160.71 23.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.338 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.614 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -170.0 144.76 8.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.93 114.69 0.71 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.1 157.68 44.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -1.032 . . . . 0.0 109.294 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 56' ' ' THR . 0.1 OUTLIER -165.28 133.75 3.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.993 -1.067 . . . . 0.0 110.139 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.8 -36.38 3.9 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.609 -0.682 . . . . 0.0 109.634 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HD3' ' A' ' 92' ' ' LYS . 11.2 t -43.69 107.49 0.59 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.374 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.89 167.68 23.36 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.706 2.271 . . . . 0.0 110.704 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.28 -41.59 2.47 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -177.49 89.01 0.24 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.369 -1.077 . . . . 0.0 109.188 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.567 ' O ' ' CB ' ' A' ' 55' ' ' SER . 36.2 Cg_endo -77.74 -82.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.867 2.378 . . . . 0.0 111.301 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 84.55 -50.04 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 48' ' ' SER . 0.1 OUTLIER 61.69 4.28 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.121 -0.987 . . . . 0.0 110.114 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' ASP . 30.2 mt-30 -147.03 138.69 24.25 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.753 -1.217 . . . . 0.0 109.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 57' ' ' GLN . 45.2 t0 57.8 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 60' ' ' ASN . . . -153.7 67.21 0.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 2.8 t-20 84.99 -33.43 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.885 . . . . 0.0 109.893 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.54 10.82 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLY . 20.5 t-160 -51.08 -66.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -40.85 -72.92 0.22 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 96.5 m -35.38 -48.07 0.46 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.827 -0.807 . . . . 0.0 110.735 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.533 ' NE2' ' HB2' ' A' ' 201' ' ' SER . 22.0 t-80 -51.73 -53.36 40.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.254 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.552 HG13 ' HG3' ' A' ' 219' ' ' PRO . 12.5 t -60.64 -31.35 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.34 -0.85 . . . . 0.0 108.785 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -55.79 -48.58 75.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.397 -0.814 . . . . 0.0 109.526 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 70' ' ' ILE . . . -67.41 -43.03 88.68 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.429 HG21 ' HG2' ' A' ' 219' ' ' PRO . 1.1 m -52.07 -21.88 3.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.449 -1.618 . . . . 0.0 107.773 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 83' ' ' ALA . 55.9 mt -94.3 -30.68 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.497 -0.752 . . . . 0.0 110.949 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -165.57 44.38 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.506 -1.371 . . . . 0.0 112.323 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -60.92 124.47 20.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.635 -1.291 . . . . 0.0 108.82 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 93.2 mt -79.33 156.75 27.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.992 -1.068 . . . . 0.0 109.314 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 20.0 t-20 -139.54 63.63 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.087 -1.008 . . . . 0.0 109.975 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -89.75 -13.92 35.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.042 0.925 . . . . 0.0 109.28 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.8 -45.93 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -115.1 157.25 15.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.526 -0.734 . . . . 0.0 109.135 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.83 164.35 35.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.43 -150.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.366 -1.079 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 6.3 tp -147.02 106.42 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.984 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.43 -163.48 4.62 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.798 HG12 HD11 ' A' ' 227' ' ' LEU . 0.6 OUTLIER -78.91 -53.67 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -1.108 . . . . 0.0 109.427 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -110.84 101.9 50.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.18 -0.95 . . . . 0.0 108.707 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 37.6 Cg_endo -83.03 -53.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.902 2.401 . . . . 0.0 111.303 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.48 18.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.152 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.18 23.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.525 -1.359 . . . . 0.0 109.203 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 44.0 mt-10 -74.33 150.57 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 109.082 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 71' ' ' ALA . 88.1 mt -125.25 97.98 5.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.953 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 m-30 -82.29 113.66 20.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.262 -0.899 . . . . 0.0 109.419 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.751 ' HB2' HG13 ' A' ' 35' ' ' ILE . . . -78.77 108.91 12.55 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.073 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.582 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -108.38 73.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.766 -1.209 . . . . 0.0 109.959 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -41.65 113.4 0.41 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.153 HG21 HD23 ' A' ' 31' ' ' LEU . 5.0 t -123.06 -24.71 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.135 -0.978 . . . . 0.0 109.928 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.72 HD11 HD22 ' A' ' 124' ' ' LEU . 3.9 mp -126.76 172.2 10.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 110.173 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.92 -158.65 16.5 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.803 ' HA ' HG22 ' A' ' 33' ' ' THR . . . -91.56 -47.86 7.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -1.167 . . . . 0.0 109.183 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.2 p -69.29 -41.01 77.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.351 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.72 41.82 0.16 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 t -116.78 63.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.25 179.36 48.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 m -121.47 157.35 30.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.872 -0.781 . . . . 0.0 109.983 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -28.89 44.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.549 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 75.1 m -72.52 -18.53 61.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 105' ' ' ILE . 9.2 p -77.44 -57.76 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.652 -0.655 . . . . 0.0 109.382 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.554 HG12 ' CG1' ' A' ' 93' ' ' VAL . 1.3 mt -63.4 -24.15 35.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.06 -44.54 79.89 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.624 -0.673 . . . . 0.0 109.572 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.607 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -77.39 -24.26 50.56 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.624 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -72.51 -27.98 68.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.68 -30.7 14.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -76.14 -30.06 58.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 108.96 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -65.67 -22.96 66.68 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.824 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -81.33 -21.85 38.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -56.52 -39.35 84.4 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.58 -49.97 6.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -127.93 70.27 1.34 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.824 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -105.79 23.72 28.79 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.617 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.2 OUTLIER 30.7 -159.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.129 0.966 . . . . 0.0 111.509 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.535 ' CB ' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -96.22 -20.21 18.74 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.437 -0.789 . . . . 0.0 111.026 -178.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 28' ' ' VAL . 2.6 t -136.51 158.5 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.435 -1.415 . . . . 0.0 111.351 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.81 128.51 2.42 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.962 HD22 HG21 ' A' ' 218' ' ' THR . 45.7 t30 -107.01 158.33 17.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.649 -1.282 . . . . 0.0 110.49 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.663 HD23 HD11 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -127.54 98.88 5.38 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -85.58 64.89 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.403 -0.81 . . . . 0.0 108.944 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.72 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -150.31 168.49 23.91 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.413 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.567 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -164.76 76.53 0.15 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -103.59 147.62 34.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.19 -1.182 . . . . 0.0 109.475 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -77.3 -34.59 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.295 1.997 . . . . 0.0 109.122 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -46.79 104.6 0.42 Allowed Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.71 -0.619 . . . . 0.0 109.38 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 34.5 Cg_endo -78.6 168.99 20.46 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.48 2.12 . . . . 0.0 110.161 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.3 p -173.34 120.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 110.622 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -24.88 65.76 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 79.7 m -63.37 -29.12 70.48 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.431 ' HB2' ' OG ' ' A' ' 130' ' ' SER . 2.1 tt -75.88 -35.87 59.7 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 6.5 tm-20 -77.04 -19.45 57.15 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.074 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -78.13 -24.01 47.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.05 -45.33 20.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.341 -0.943 . . . . 0.0 108.631 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.57 -28.92 42.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 134' ' ' GLU . 62.6 t30 -62.33 -34.77 77.28 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -79.88 -22.42 42.88 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.87 -27.69 63.03 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.4 m -69.4 -39.38 77.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -58.07 -23.93 56.53 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.231 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.65 -14.2 16.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.303 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.452 ' C ' ' HB2' ' A' ' 237' ' ' ASN . . . 68.16 75.37 0.51 Allowed Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.71 111.72 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.468 -1.019 . . . . 0.0 109.399 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.89 113.72 6.56 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -112.54 142.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.013 -1.054 . . . . 0.0 110.379 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 149' ' ' ALA . 2.7 t -119.44 167.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -153.64 128.16 9.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.974 -1.079 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.506 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -61.08 156.06 18.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -88.16 -54.18 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.562 ' CA ' ' HB2' ' A' ' 185' ' ' GLN . . . 146.79 128.75 1.92 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 154' ' ' SER . 51.1 p-10 -83.66 60.96 6.02 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 122.166 -0.608 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER 91.97 104.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.356 0.598 . . . . 0.0 109.953 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -173.45 61.97 0.13 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 77.29 164.22 0.23 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.324 -1.104 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.65 56.6 4.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -145.85 161.75 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.52 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.469 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -100.53 -174.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.376 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.871 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.02 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.142 0.972 . . . . 0.0 111.576 -178.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.453 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.7 m-85 -108.8 134.15 20.43 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.682 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.2 Cg_endo -72.95 -56.91 0.14 OUTLIER 'Cis proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.043 -1.232 . . . . 0.0 111.018 3.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 37.74 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.284 1.04 . . . . 0.0 109.412 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -43.73 -34.94 1.66 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.1 m-85 -44.67 -178.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.289 1.042 . . . . 0.0 111.615 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 167' ' ' ASN . . . -95.92 -60.01 1.73 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -44.67 -67.47 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.206 1.003 . . . . 0.0 108.65 179.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -71.97 139.29 48.57 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.8 mmm -104.71 143.29 33.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.999 -1.063 . . . . 0.0 109.912 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -94.99 108.16 20.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 34.6 t -87.53 165.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.27 -175.47 13.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -117.6 157.77 25.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -1.095 . . . . 0.0 109.199 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.944 HG22 ' OD1' ' A' ' 179' ' ' ASN . 18.6 p -135.35 168.13 19.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 110.049 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.08 -162.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -83.84 -19.86 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.72 -71.37 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 109.277 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 174' ' ' THR . 2.7 m-20 -153.14 -59.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.288 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 1.004 ' ND2' HG21 ' A' ' 193' ' ' VAL . 8.6 t-20 -147.23 148.9 31.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.574 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 163.08 -70.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.428 0.633 . . . . 0.0 109.541 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . 48.91 178.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.641 -0.662 . . . . 0.0 109.809 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -34.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 154' ' ' SER . 7.7 p90 -106.49 -3.61 20.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 0.7 OUTLIER -45.89 112.16 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.562 ' HB2' ' CA ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -67.96 105.61 2.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 108.846 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -109.22 -169.99 1.58 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.466 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.581 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . -174.77 -142.12 3.92 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.132 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.51 71.59 5.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -1.044 . . . . 0.0 110.42 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.01 64.81 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.769 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 192' ' ' ILE . 0.5 OUTLIER -61.74 149.49 39.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.29 -1.124 . . . . 0.0 109.161 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -61.54 -60.98 2.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.692 ' O ' HD21 ' A' ' 190' ' ' LEU . 14.7 tt -160.73 165.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 120.984 -1.072 . . . . 0.0 109.619 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 1.004 HG21 ' ND2' ' A' ' 179' ' ' ASN . 27.3 m -122.48 161.38 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.214 -0.929 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -153.41 158.18 32.75 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.446 ' CB ' ' HZ3' ' A' ' 6' ' ' TRP . 34.6 Cg_endo -76.02 121.22 6.08 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 121.984 1.789 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -163.13 52.88 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.287 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 45.1 t -100.87 64.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -1.185 . . . . 0.0 108.4 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.735 ' O ' HG13 ' A' ' 199' ' ' VAL . 12.6 t-20 119.45 129.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 216' ' ' MET . 6.2 m -165.51 116.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 121.965 0.888 . . . . 0.0 108.822 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 20.2 pt20 -94.73 138.18 32.88 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.556 0.694 . . . . 0.0 109.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.533 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -135.43 -152.79 0.48 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.0 109.188 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.7 p -88.62 178.94 6.37 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.216 -0.928 . . . . 0.0 110.537 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.674 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -145.45 164.09 28.29 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.674 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 33.5 Cg_endo -69.9 155.85 64.43 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.57 1.514 . . . . 0.0 110.437 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.05 -60.49 4.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 2.0 p 151.6 38.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.975 -0.72 . . . . 0.0 109.577 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -122.77 170.8 9.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.172 -0.955 . . . . 0.0 109.935 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -108.73 177.74 4.69 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.409 -0.807 . . . . 0.0 108.98 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -162.78 166.93 23.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.079 -1.013 . . . . 0.0 110.209 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.931 ' C ' HD23 ' A' ' 211' ' ' LEU . 0.4 OUTLIER -144.08 122.05 12.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.585 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.931 HD23 ' C ' ' A' ' 210' ' ' SER . 0.2 OUTLIER -136.33 156.19 48.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.083 -1.01 . . . . 0.0 109.878 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 212' ' ' ASN . 16.2 p30 -117.83 131.54 56.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 109.041 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.62 28.62 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.605 -1.283 . . . . 0.0 109.914 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 151' ' ' SER . 89.0 m -76.57 -29.02 56.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -1.081 . . . . 0.0 108.813 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.455 ' O ' ' HB ' ' A' ' 218' ' ' THR . 0.3 OUTLIER -59.35 -24.74 63.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 108.85 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.886 ' HB3' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -77.8 -29.29 50.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.422 ' HB2' ' HA3' ' A' ' 196' ' ' GLY . . . -84.51 -5.19 59.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.912 . . . . 0.0 108.751 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.962 HG21 HD22 ' A' ' 121' ' ' ASN . 0.9 OUTLIER -66.22 -52.72 36.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.436 -0.79 . . . . 0.0 110.15 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.6 Cg_endo -72.16 -9.16 24.06 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.259 1.972 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.517 ' NE2' ' HA3' ' A' ' 7' ' ' GLY . 1.6 m80 -74.7 -43.51 54.73 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.3 t -75.05 -39.86 44.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 219' ' ' PRO . . . -52.95 -35.43 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -69.66 -50.58 30.04 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -44.21 -49.72 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 108.955 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.88 86.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 108.881 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.07 -41.51 64.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 109.317 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.798 HD11 HG12 ' A' ' 82' ' ' VAL . 17.1 mt -62.19 -34.67 76.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 108.873 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 231' ' ' LYS . 99.1 t -62.15 -60.38 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 109.032 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.591 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -44.62 -41.86 6.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 108.992 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 24' ' ' SER . 1.4 tm0? -59.83 -57.53 12.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 228' ' ' VAL . 1.9 ptpt -62.21 -11.22 13.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.093 -1.004 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.527 ' OD1' ' CD1' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -156.42 80.79 3.68 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.803 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.15 -4.79 13.39 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.686 2.257 . . . . 0.0 110.086 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -14.21 22.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.527 ' CD1' ' OD1' ' A' ' 232' ' ' ASN . 29.5 m0 -71.67 175.79 5.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.117 . . . . 0.0 109.624 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 t -118.16 173.86 6.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.526 ' HA ' HD12 ' A' ' 240' ' ' ILE . 40.0 t30 -54.8 -17.14 3.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 -62.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.07 59.3 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.646 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 237' ' ' ASN . 77.7 mt -68.78 -54.26 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.452 -0.78 . . . . 0.0 110.854 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -66.85 -31.18 71.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.949 -1.094 . . . . 0.0 110.95 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 33.2 t-20 -73.04 -40.55 65.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.688 -1.257 . . . . 0.0 110.355 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.428 ' O ' HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -75.45 -32.68 60.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.776 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.3 OUTLIER -77.72 -32.35 52.82 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.244 -0.91 . . . . 0.0 109.969 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.1 tttt -80.97 -28.77 35.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 108.686 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 4.6 t-20 -83.59 -18.27 38.83 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 267' ' ' ALA . 2.6 p -88.49 -30.15 19.6 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.207 1.003 . . . . 0.0 109.226 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.16 126.68 9.56 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.298 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.414 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 17.2 m -74.89 145.32 42.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.451 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.4 OUTLIER -115.47 126.47 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.878 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.0 mp -71.76 -73.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 179.22 -32.27 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.58 ' HB2' ' CD2' ' A' ' 257' ' ' TYR . 71.0 m -68.77 172.32 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.255 . . . . 0.0 109.653 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.52 16.77 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.586 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.41 -28.54 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.99 . . . . 0.0 109.676 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' TYR . 0.3 OUTLIER -121.04 -69.64 0.83 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 109.411 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 179' ' ' ASN . 15.6 m-30 -44.33 -50.78 8.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.038 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 72.41 -128.68 13.56 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 191' ' ' ASP . 13.6 t -44.53 -45.02 9.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -1.128 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.583 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 121.25 -138.01 12.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 261' ' ' LEU . 13.3 tp -96.62 168.42 10.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -1.046 . . . . 0.0 109.178 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.55 HG13 ' CD1' ' A' ' 192' ' ' ILE . 0.0 OUTLIER -117.62 156.08 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.48 ' HB3' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.99 120.12 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.361 1.076 . . . . 0.0 108.771 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 268' ' ' THR . . . -75.26 0.97 14.76 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -35.31 40.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.58 -10.51 58.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -100.29 -26.71 13.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.696 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 264' ' ' ALA . 19.1 p -79.65 -42.06 25.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.728 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.44 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.396 0.617 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.704 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -62.0 138.54 58.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.403 -0.81 . . . . 0.0 110.424 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.487 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 58.4 m -96.76 115.48 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.618 HG12 HG21 ' A' ' 8' ' ' ILE . 1.2 m -145.22 115.0 4.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.42 171.29 17.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.437 2.092 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -15.96 1.31 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.455 -0.778 . . . . 0.0 110.737 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.89 24.58 6.61 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.645 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.618 HG21 HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -154.81 14.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.797 -1.413 . . . . 0.0 109.931 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -90.79 -37.36 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.709 -1.244 . . . . 0.0 110.351 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.595 ' HB3' HD21 ' A' ' 261' ' ' LEU . 4.4 mtm180 -92.91 23.34 4.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.045 . . . . 0.0 110.256 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG22 ' C ' ' A' ' 8' ' ' ILE . 11.1 m -111.82 19.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 63.2 mm-40 39.94 36.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.415 -0.803 . . . . 0.0 109.679 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -73.42 -32.7 1.69 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 112.156 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.5 Cg_endo -74.46 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 N-CA-C 108.797 -1.271 . . . . 0.0 108.797 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.35 -30.49 1.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.67 -44.34 61.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.254 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -71.66 -5.86 36.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.652 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.87 -24.72 13.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.028 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -46.99 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.07 -53.0 0.57 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 21' ' ' LEU . 2.3 mp -49.71 141.39 9.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -1.084 . . . . 0.0 109.346 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -164.17 59.1 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.925 -1.109 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . 46.19 21.04 0.6 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.493 ' N ' ' C ' ' A' ' 22' ' ' THR . 2.6 p -40.28 -24.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.7 -0.882 . . . . 0.0 111.329 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -152.28 54.36 0.46 Allowed Glycine 0 N--CA 1.493 2.458 0 C-N-CA 118.86 -1.638 . . . . 0.0 111.386 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 27' ' ' LYS . 60.7 t -122.75 168.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -1.22 . . . . 0.0 108.781 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.595 ' N ' HG12 ' A' ' 26' ' ' VAL . 5.4 mttm -136.63 117.54 14.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 110.214 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' TYR . 11.8 t -115.44 139.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -100.14 147.65 25.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 110.085 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 70' ' ' ILE . 93.2 t -119.25 83.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.697 HD12 HG21 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -75.59 96.35 3.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.894 -0.504 . . . . 0.0 109.983 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -167.5 -159.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.95 -1.094 . . . . 0.0 109.104 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.827 HG21 ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -44.5 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.047 -1.033 . . . . 0.0 109.124 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -168.62 -124.15 0.71 Allowed Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 34' ' ' GLY . 34.3 mm -161.45 93.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ILE . 16.6 p -40.62 118.9 1.01 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.863 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.07 103.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.406 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -139.36 154.07 71.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.395 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.71 1.26 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.695 2.264 . . . . 0.0 110.496 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' CG ' HG21 ' A' ' 202' ' ' THR . 3.0 p30 -108.55 1.1 21.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.641 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.38 116.6 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.05 138.22 58.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.3 mm -119.84 100.27 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.624 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -118.56 12.0 13.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.54 146.57 10.5 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.28 99.5 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.078 -1.248 . . . . 0.0 110.212 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.08 117.78 23.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -1.054 . . . . 0.0 108.163 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.511 ' HB3' HG22 ' A' ' 56' ' ' THR . 2.6 p -112.67 115.54 28.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 110.832 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.894 ' HZ ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -95.74 -36.7 11.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.906 HG13 ' HD2' ' A' ' 51' ' ' PRO . 9.9 t -45.22 149.49 0.92 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.906 ' HD2' HG13 ' A' ' 50' ' ' VAL . 27.9 Cg_endo -68.42 156.13 66.72 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.892 1.728 . . . . 0.0 110.927 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.8 -44.52 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 42.11 60.57 9.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.792 -0.829 . . . . 0.0 110.967 178.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.7 Cg_endo -81.28 -89.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.209 1.94 . . . . 0.0 109.879 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.714 ' C ' HG23 ' A' ' 56' ' ' THR . 72.2 m -135.38 -6.09 2.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.424 -0.798 . . . . 0.0 110.422 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' C ' ' A' ' 55' ' ' SER . 1.4 p 79.44 -8.98 1.53 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ASP . 2.2 mm-40 -100.99 172.87 6.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.814 . . . . 0.0 109.184 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 57' ' ' GLN . 0.9 OUTLIER 49.9 175.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.625 0.726 . . . . 0.0 110.191 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 156.33 -64.71 0.32 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.827 ' HB2' HG21 ' A' ' 33' ' ' THR . 0.1 OUTLIER -145.3 -61.87 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -1.113 . . . . 0.0 109.577 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.8 -35.79 0.67 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -54.99 -62.76 1.45 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -1.132 . . . . 0.0 109.47 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.96 -41.33 13.76 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.9 m -57.65 -44.59 85.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -1.126 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.61 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 0.3 OUTLIER -59.51 -59.48 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.505 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 219' ' ' PRO . 11.1 t -51.59 -30.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.269 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -62.54 -54.02 46.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.378 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -73.53 -17.15 78.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 219' ' ' PRO . 28.6 m -82.58 -14.51 54.71 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.058 -1.26 . . . . 0.0 107.87 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.44 HD12 HG22 ' A' ' 30' ' ' VAL . 46.3 mt -101.75 -27.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.535 -0.728 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -161.36 22.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.785 -1.197 . . . . 0.0 111.842 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 81' ' ' GLY . . . -38.73 100.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.031 -1.043 . . . . 0.0 109.323 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 72' ' ' ALA . 8.8 mt -44.58 172.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.29 -0.882 . . . . 0.0 110.514 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.512 ' ND2' ' H ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -105.18 103.53 13.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.443 -0.786 . . . . 0.0 109.433 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -142.01 -118.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.171 -0.956 . . . . 0.0 108.905 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.28 -39.29 0.53 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.699 ' O ' HD12 ' A' ' 77' ' ' ILE . 1.3 pp -88.42 65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.07 152.19 6.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 80' ' ' LEU . 17.4 m -68.28 -146.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.289 -1.124 . . . . 0.0 109.527 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 2' ' ' GLN . 24.9 tp -139.83 107.11 5.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.874 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 72' ' ' ALA . . . -65.98 -153.23 0.18 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.07 -32.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.239 . . . . 0.0 109.582 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -120.65 100.21 46.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.298 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 22' ' ' THR . 37.0 Cg_endo -81.72 -54.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.805 2.337 . . . . 0.0 110.534 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -82.55 30.93 0.41 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.684 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.618 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -94.56 168.64 10.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.939 -1.101 . . . . 0.0 109.222 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -96.12 92.03 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.146 -0.971 . . . . 0.0 108.87 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 1.5 mt -71.76 139.77 49.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.333 -0.854 . . . . 0.0 109.949 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 3.0 m-85 -120.82 147.95 44.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.93 98.82 6.38 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.347 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.894 HG12 ' HZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -96.39 61.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.132 -0.98 . . . . 0.0 108.76 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' VAL . 2.0 ttmt -34.73 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.468 0.652 . . . . 0.0 110.364 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -110.83 7.33 8.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.051 HD11 HD22 ' A' ' 124' ' ' LEU . 88.1 mt -145.99 173.62 12.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.245 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 33' ' ' THR . . . -159.55 144.17 9.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 59' ' ' GLY . . . -54.07 -71.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -1.126 . . . . 0.0 108.711 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.18 7.91 44.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 108.928 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' SER . . . -75.49 -52.69 6.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' GLY . 0.3 OUTLIER 45.48 77.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 108.742 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.55 179.91 50.24 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.703 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -95.36 -176.27 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.626 0.727 . . . . 0.0 109.534 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.03 -14.92 19.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 13.7 m -80.77 -18.06 48.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.69 -45.28 11.82 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.814 ' HA ' HG22 ' A' ' 93' ' ' VAL . 2.8 mt -70.97 -44.64 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.42 -0.912 . . . . 0.0 108.588 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -37.11 86.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 109.023 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 8.1 tp60 -65.16 -45.23 85.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.625 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -66.9 -31.87 79.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.63 HD21 HD21 ' A' ' 122' ' ' LEU . 10.3 mt -71.68 -28.5 63.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -1.198 . . . . 0.0 108.934 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.7 -22.28 46.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -63.62 -23.03 67.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -92.69 -15.64 26.48 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.935 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -66.86 -31.1 77.24 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -111.16 -28.49 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -1.102 . . . . 0.0 109.265 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -132.1 35.41 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.675 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -83.53 158.07 35.23 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -106.55 -179.93 4.08 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 -179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.543 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.6 m170 -50.31 -30.2 11.48 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 120' ' ' ALA . 6.1 t -136.68 160.82 37.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.018 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.661 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -168.04 106.63 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.565 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 9.7 m120 -91.54 156.56 17.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.825 -1.172 . . . . 0.0 111.046 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.63 HD21 HD21 ' A' ' 109' ' ' LEU . 6.6 mp -129.22 103.02 6.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -85.04 64.72 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.278 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.051 HD22 HD11 ' A' ' 94' ' ' LEU . 1.5 pp 177.66 175.48 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.988 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.522 ' O ' ' CD ' ' A' ' 129' ' ' PRO . . . 157.5 -99.6 0.19 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.602 ' CB ' ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER 62.55 -175.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.394 -1.062 . . . . 0.0 110.076 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 126' ' ' SER . 37.0 Cg_endo -83.21 -10.35 10.15 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.749 2.299 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.682 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -57.2 -44.13 99.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 111.96 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 128' ' ' SER . 30.1 Cg_endo -71.22 177.37 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.119 1.88 . . . . 0.0 111.022 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.7 t -118.43 173.9 6.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.45 1.119 . . . . 0.0 111.259 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.21 60.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.0 m -76.41 -26.77 55.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -39.74 61.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 165' ' ' TYR . 1.0 OUTLIER -66.92 -43.48 83.2 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.457 178.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -55.61 -26.75 45.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.94 75.46 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.325 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.68 -24.28 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.4 ' O ' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -68.78 -29.53 67.92 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.38 -22.75 35.3 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.67 -37.13 31.38 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 120.88 -1.137 . . . . 0.0 110.8 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 167' ' ' ASN . 4.5 m -73.32 -24.64 60.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.915 -1.116 . . . . 0.0 108.236 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 138' ' ' ASN . 3.2 m -55.63 -28.95 58.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -87.08 -28.49 22.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.469 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.41 -7.43 24.63 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 117' ' ' MET . 21.6 t -48.75 110.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.181 -1.188 . . . . 0.0 109.811 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.647 HD12 ' OD1' ' A' ' 237' ' ' ASN . 3.5 tp -68.23 96.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 108.794 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.0 t -88.05 154.66 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.064 -1.022 . . . . 0.0 109.916 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -140.87 104.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.645 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -92.96 148.22 22.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.902 . . . . 0.0 110.469 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.01 169.58 9.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB2' ' CG2' ' A' ' 214' ' ' THR . 0.1 OUTLIER -61.32 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.015 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . -168.68 -68.5 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.192 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 19.4 t-20 88.98 6.4 0.14 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.301 0.572 . . . . 0.0 109.822 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 153' ' ' ASN . 27.6 t 175.59 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . -132.76 -101.93 0.81 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.507 ' N ' ' HG2' ' A' ' 185' ' ' GLN . . . 178.61 78.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.348 -1.089 . . . . 0.0 109.605 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' TYR . . . 56.26 13.49 7.21 Favored Glycine 0 C--N 1.288 -2.136 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.38 147.52 33.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -1.222 . . . . 0.0 109.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.65 HG23 ' HA ' ' A' ' 186' ' ' TYR . 4.5 pt -74.56 176.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.989 -1.069 . . . . 0.0 109.85 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.932 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -102.58 165.8 10.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.798 . . . . 0.0 112.082 -177.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.496 ' O ' ' HA3' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -80.29 144.48 58.09 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 174.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 42.8 Cg_endo -72.97 -28.09 7.45 Favored 'Cis proline' 0 C--N 1.289 -2.579 0 O-C-N 122.676 0.829 . . . . 0.0 110.581 3.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.13 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.741 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 162' ' ' PRO . 19.3 ttp180 -67.95 -52.4 36.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.711 -1.243 . . . . 0.0 109.553 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -41.08 -178.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.645 1.212 . . . . 0.0 111.269 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.38 -0.38 9.85 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.502 ' HB3' ' OG1' ' A' ' 141' ' ' THR . 1.9 m-80 -87.12 22.51 2.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.438 -0.789 . . . . 0.0 109.427 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -171.32 145.91 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.422 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 29.8 mtp -81.4 152.95 27.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.008 -1.057 . . . . 0.0 109.938 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.16 132.56 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.9 t -99.24 165.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.032 -1.043 . . . . 0.0 110.136 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.53 173.69 20.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -135.02 152.38 51.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -1.221 . . . . 0.0 109.552 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 p -116.39 163.1 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.22 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 12.8 p-10 -62.38 179.01 0.35 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.036 -1.04 . . . . 0.0 109.248 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.93 -29.66 43.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -94.03 -90.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.422 -0.799 . . . . 0.0 109.647 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 7.0 t30 -150.02 -20.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.196 -0.94 . . . . 0.0 111.091 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.48 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.3 t30 -56.57 -160.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.711 -1.243 . . . . 0.0 109.647 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.579 ' HG2' ' CD1' ' A' ' 256' ' ' LEU . 0.3 OUTLIER -93.73 135.83 34.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.024 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 180' ' ' ARG . . . -43.59 161.75 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -101.37 12.52 37.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 109.564 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.577 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -153.32 29.9 0.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 110.082 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.423 ' OG ' ' CG2' ' A' ' 214' ' ' THR . 9.1 t -121.21 156.77 31.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.257 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.5 137.32 54.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 1.08 ' CD2' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -141.04 176.98 8.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.547 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 137.91 133.27 3.1 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.064 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . 35.65 102.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.12 -0.635 . . . . 0.0 111.613 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 159' ' ' ILE . . . 116.81 -5.25 18.66 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.77 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.08 HD22 ' CD2' ' A' ' 186' ' ' TYR . 8.9 tp -61.72 107.89 0.9 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.878 -1.366 . . . . 0.0 110.237 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 25.0 t70 -75.9 -56.63 4.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 259' ' ' SER . 2.5 tt -149.1 169.75 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.106 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 10.0 m -123.26 164.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -163.44 177.96 1.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 109.025 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.8 Cg_endo -76.49 116.98 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.408 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -134.63 54.95 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 37.4 t -149.01 101.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.524 -0.986 . . . . 0.0 108.586 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.627 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.3 OUTLIER 73.91 107.11 0.07 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.125 0.964 . . . . 0.0 111.276 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.704 HG22 ' CB ' ' A' ' 212' ' ' ASN . 17.4 m -163.41 109.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 16.9 pt20 -84.7 148.16 26.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.608 0.718 . . . . 0.0 110.773 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.61 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -145.31 -151.56 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.422 HG21 ' CG ' ' A' ' 40' ' ' ASP . 74.2 p -90.18 172.11 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.648 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -159.99 164.49 19.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.648 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -70.63 164.02 36.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.948 1.765 . . . . 0.0 110.393 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.84 78.88 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.76 32.42 22.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -1.114 . . . . 0.0 109.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -118.32 150.94 38.65 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.049 -1.032 . . . . 0.0 109.817 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -92.74 172.45 8.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -145.68 118.21 8.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.868 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.5 OUTLIER -91.19 111.56 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 211' ' ' LEU . 0.6 OUTLIER -175.47 147.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 110.361 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.704 ' CB ' HG22 ' A' ' 199' ' ' VAL . 11.3 t-20 -136.11 -162.86 1.32 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.859 0.838 . . . . 0.0 109.161 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 150.73 -174.78 29.97 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -70.54 -42.33 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.703 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.45 ' HA ' ' CB ' ' A' ' 150' ' ' ALA . 1.4 m -66.07 -16.07 63.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 110.403 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.553 ' HB3' ' OD1' ' A' ' 212' ' ' ASN . 1.5 mpp? -91.07 -16.6 27.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.115 . . . . 0.0 109.754 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -87.64 -13.18 43.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 108.688 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.643 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 2.6 m -63.07 -43.84 82.77 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.63 -0.669 . . . . 0.0 111.349 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.804 ' HG2' HG21 ' A' ' 69' ' ' THR . 29.2 Cg_endo -72.75 -26.7 15.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.123 1.882 . . . . 0.0 111.583 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.598 ' NE2' HG23 ' A' ' 69' ' ' THR . 16.7 m170 -67.11 -45.55 76.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.869 -1.144 . . . . 0.0 108.177 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 262' ' ' VAL . 67.2 t -67.63 -45.74 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.512 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -54.18 -33.93 59.27 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -64.74 -52.46 42.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.12 2.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -1.076 . . . . 0.0 109.168 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 244' ' ' LEU . . . -47.47 -26.73 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -64.75 -59.21 4.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 226' ' ' ALA . 4.8 mt -46.48 -36.91 7.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 108.45 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.16 -56.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.609 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.572 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.38 -39.32 6.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -48.5 81.48 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.298 -0.876 . . . . 0.0 109.02 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -67.26 -7.45 24.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.599 ' HB3' ' CG ' ' A' ' 235' ' ' TRP . 81.9 m-20 -160.21 78.88 2.56 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.4 -28.4 3.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.636 2.224 . . . . 0.0 111.099 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.85 0.68 54.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.599 ' CG ' ' HB3' ' A' ' 232' ' ' ASN . 11.9 m0 -71.56 -178.69 2.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 109.674 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.62 167.71 10.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.552 -0.718 . . . . 0.0 110.214 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.647 ' OD1' HD12 ' A' ' 146' ' ' LEU . 17.2 t-20 -51.2 -39.85 57.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 0.0 109.543 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -74.08 -59.34 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.278 -0.888 . . . . 0.0 109.465 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 238' ' ' VAL . 46.8 tp60 -39.76 -36.56 0.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.305 0.574 . . . . 0.0 110.121 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.87 -46.52 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 110.43 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 15.8 ttp180 -52.81 -40.47 63.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.919 -1.113 . . . . 0.0 110.523 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -63.14 -35.19 79.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -0.941 . . . . 0.0 110.612 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -71.62 -43.21 66.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.389 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 225' ' ' ALA . 0.4 OUTLIER -77.22 -22.48 52.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 110.245 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -82.77 -24.59 33.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 0.0 109.352 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -90.2 -21.87 21.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.918 . . . . 0.0 109.214 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 248' ' ' ALA . 2.3 p -87.66 -29.72 20.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 110.055 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -40.02 116.43 0.65 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.844 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.501 ' CG2' ' N ' ' A' ' 250' ' ' SER . 1.0 OUTLIER -65.76 163.77 15.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.93 . . . . 0.0 109.214 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.501 ' N ' ' CG2' ' A' ' 249' ' ' THR . 5.9 p -115.78 114.46 24.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.337 -0.852 . . . . 0.0 109.524 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.662 HD11 ' HB2' ' A' ' 261' ' ' LEU . 5.8 mp -63.26 -69.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.717 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 161.7 57.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.639 ' HB2' ' CD2' ' A' ' 257' ' ' TYR . 10.1 t -118.1 177.66 4.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -1.124 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.402 ' N ' ' OG ' ' A' ' 253' ' ' SER . 0.8 OUTLIER -114.53 -22.29 9.87 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 110.344 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -179.03 -24.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.743 -1.223 . . . . 0.0 111.169 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.579 ' CD1' ' HG2' ' A' ' 180' ' ' ARG . 2.7 tm? -53.35 -63.95 0.98 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.6 -1.312 . . . . 0.0 108.923 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.67 ' O ' HD23 ' A' ' 190' ' ' LEU . 4.7 m-85 -65.58 -47.31 76.2 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 259' ' ' SER . . . 55.89 58.36 14.49 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.48 ' CB ' ' HA ' ' A' ' 192' ' ' ILE . 0.0 OUTLIER 171.18 -84.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -1.191 . . . . 0.0 109.093 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 132.35 -163.3 24.02 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.662 ' HB2' HD11 ' A' ' 251' ' ' LEU . 5.0 tp -98.11 177.93 5.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.707 -0.878 . . . . 0.0 109.257 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 221' ' ' VAL . 0.6 OUTLIER -110.22 155.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 110.208 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.72 116.42 5.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.884 1.326 . . . . 0.0 108.657 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -79.78 -25.39 40.96 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.622 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.459 ' O ' ' OE2' ' A' ' 265' ' ' GLU . 7.6 tp10 -71.78 -41.89 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.589 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.55 0.76 18.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -113.69 -3.61 13.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.52 -35.85 4.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 142.74 44.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.481 -0.762 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.693 ' HB2' ' N ' ' A' ' 80' ' ' LEU . 1.9 p -65.97 89.07 0.12 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.972 -1.08 . . . . 0.0 110.585 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 3' ' ' SER . 0.1 OUTLIER -165.64 73.46 1.33 Allowed Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.432 -0.792 . . . . 0.0 109.169 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HD2' ' CG1' ' A' ' 8' ' ' ILE . 34.7 Cg_endo -77.46 165.31 27.54 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.51 2.14 . . . . 0.0 110.29 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -39.08 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.665 -0.647 . . . . 0.0 110.176 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PRO . . . -68.35 -62.64 4.02 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.57 ' O ' ' CB ' ' A' ' 9' ' ' SER . 47.0 mm -62.62 159.97 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -1.1 . . . . 0.0 109.515 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.634 ' OG ' HG12 ' A' ' 4' ' ' VAL . 4.4 m 89.38 -34.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.888 -0.508 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -27.89 61.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.297 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.69 22.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 0.0 109.662 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.497 ' HG2' ' CB ' ' A' ' 265' ' ' GLU . 6.8 tp-100 52.89 49.41 20.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.697 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.51 -30.24 0.44 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 112.053 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.32 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.88 -31.19 0.81 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HB1' HD13 ' A' ' 227' ' ' LEU . . . -66.1 -55.81 14.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.263 -0.898 . . . . 0.0 108.579 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.409 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 9.8 m-70 -66.35 -8.25 24.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.0 109.563 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -83.81 -35.95 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 5.91 8.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.85 43.73 5.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 2.2 mm? -99.71 133.67 43.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -1.094 . . . . 0.0 109.101 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.503 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -120.35 -37.96 2.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.494 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 81.31 -22.01 5.62 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -49.47 110.82 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.267 . . . . 0.0 109.078 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.73 -11.06 1.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG12 ' N ' ' A' ' 27' ' ' LYS . 48.2 t -110.57 170.04 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -1.235 . . . . 0.0 109.314 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 3.1 mttt -139.97 131.24 26.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.908 . . . . 0.0 109.364 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 119' ' ' VAL . 48.7 t -124.34 145.29 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.018 . . . . 0.0 110.448 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -101.97 146.77 27.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.905 HG11 HD11 ' A' ' 35' ' ' ILE . 25.6 t -120.63 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 109.27 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.752 HD12 ' CG2' ' A' ' 91' ' ' VAL . 4.8 mp -65.83 93.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -147.03 -156.43 0.71 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 20.7 p -67.53 -24.75 65.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.355 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 161.05 -105.32 0.26 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.905 HD11 HG11 ' A' ' 30' ' ' VAL . 10.3 mt 135.65 101.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.0 OUTLIER -71.88 139.22 48.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -55.18 165.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.626 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -177.24 160.51 1.45 Allowed Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.161 -0.962 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.4 Cg_endo -78.49 -23.5 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 110.181 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 73' ' ' LEU . 1.4 t0 -102.48 -2.98 27.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 73' ' ' LEU . 14.1 mt -102.46 160.88 14.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.266 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.549 ' ND2' ' O ' ' A' ' 86' ' ' ALA . 40.6 t-20 -112.51 119.35 37.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 43' ' ' ILE . 6.7 mm -123.48 96.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.679 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -90.57 -28.73 18.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 108.951 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.94 -176.1 38.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.64 128.46 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -131.51 165.1 24.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.444 -1.033 . . . . 0.0 108.551 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.501 ' OG ' ' CG ' ' A' ' 51' ' ' PRO . 46.2 t -149.1 142.59 25.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.084 . . . . 0.0 110.486 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.631 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 23.5 m-85 -123.92 -35.63 2.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.944 HG23 ' CB ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -41.96 -53.8 7.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.621 ' HB2' ' CD ' ' A' ' 54' ' ' PRO . 39.1 Cg_endo -81.46 -160.4 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.981 2.454 . . . . 0.0 111.633 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -124.13 40.23 1.98 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.71 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 9.7 tp10 77.39 33.2 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.269 -1.136 . . . . 0.0 112.952 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 37.5 Cg_endo -80.67 -72.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.74 1.627 . . . . 0.0 109.954 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 m -137.61 139.63 40.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -111.69 2.07 17.04 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' ASP . 5.5 mm-40 -103.72 156.21 17.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 8.8 t70 55.13 166.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 109.611 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . -171.78 -54.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 2.1 t30 -165.78 -83.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -1.077 . . . . 0.0 108.985 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . -175.74 -34.17 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.439 ' C ' ' CD2' ' A' ' 62' ' ' HIS . 3.0 t-160 -58.84 -64.73 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.406 -1.055 . . . . 0.0 109.531 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 32' ' ' ASP . . . -47.67 -67.38 1.56 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.447 ' HA ' HG12 ' A' ' 35' ' ' ILE . 2.0 m -40.11 -52.37 2.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 2.6 t-80 -52.81 -50.78 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.858 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.743 HG12 HD11 ' A' ' 70' ' ' ILE . 24.3 t -57.49 -32.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 109.231 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -59.52 -51.05 71.52 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.296 -0.877 . . . . 0.0 109.696 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -72.85 -17.88 78.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.539 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 6.4 m -80.65 -17.28 51.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.168 -1.195 . . . . 0.0 108.246 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.743 HD11 HG12 ' A' ' 66' ' ' VAL . 23.1 mt -92.62 -31.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.615 -0.678 . . . . 0.0 109.944 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -174.55 33.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.38 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -37.27 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 109.665 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 41' ' ' LEU . 12.8 mt -39.85 159.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.987 ' HB2' HD12 ' A' ' 80' ' ' LEU . 7.6 t-20 -114.72 166.29 11.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 74' ' ' ASN . 0.4 OUTLIER 172.18 -93.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.407 -0.808 . . . . 0.0 109.28 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 -38.17 0.77 Allowed 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.762 -0.586 . . . . 0.0 109.48 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.518 HD11 ' HG2' ' A' ' 39' ' ' PRO . 4.4 pt -111.2 168.95 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.01 155.31 1.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 20.0 m -75.4 -154.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.276 -1.132 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.987 HD12 ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -145.9 122.35 11.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.482 -0.761 . . . . 0.0 109.423 -178.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.75 -163.79 4.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 4.7 t -82.57 -36.84 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.325 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.0 147.17 32.6 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.3 Cg_endo -83.61 -61.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.873 2.382 . . . . 0.0 110.407 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 86' ' ' ALA . 79.2 m-20 -99.53 -87.87 0.35 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.01 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.549 ' O ' ' ND2' ' A' ' 42' ' ' ASN . . . 57.26 157.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.866 . . . . 0.0 109.701 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' HG3' ' CE ' ' A' ' 27' ' ' LYS . 20.5 mm-40 -108.97 94.74 5.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 108.774 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 70' ' ' ILE . 2.5 mt -79.98 150.75 30.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.07 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.519 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 3.9 m-85 -127.29 154.48 44.86 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -0.794 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -123.73 104.09 8.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.752 ' CG2' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -108.03 78.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -178.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 33' ' ' THR . 10.8 tttt -44.75 96.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.9 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.594 HG11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -114.02 -9.8 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 109.084 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.3 mt -115.62 174.11 6.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.348 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -111.19 147.83 17.84 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.2 -60.34 4.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -1.117 . . . . 0.0 109.666 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.23 -38.27 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.46 67.15 0.45 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -174.53 97.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -1.026 . . . . 0.0 108.945 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.62 -179.3 20.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 155.99 28.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.801 -0.823 . . . . 0.0 109.8 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.21 -15.25 19.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.557 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -72.27 -27.77 62.7 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.944 ' CB ' HG23 ' A' ' 50' ' ' VAL . 65.8 p -80.03 -53.47 6.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 109.34 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.585 ' HA ' HG21 ' A' ' 93' ' ' VAL . 2.2 mt -61.55 -33.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.445 ' O ' ' CD ' ' A' ' 110' ' ' GLU . . . -65.17 -46.44 80.85 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.528 -0.732 . . . . 0.0 110.0 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.631 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -68.31 -40.86 81.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.558 -1.339 . . . . 0.0 108.873 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . -61.77 -21.05 60.36 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 109' ' ' LEU . 19.7 mt -92.98 -51.01 5.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.903 -1.351 . . . . 0.0 110.579 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.445 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -76.56 -6.97 54.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.862 -1.149 . . . . 0.0 109.646 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.652 ' CZ3' ' HA2' ' A' ' 116' ' ' GLY . 70.9 t90 -89.47 -9.76 48.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.55 -11.93 44.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.515 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -86.95 -22.93 43.52 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 -76.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -110.01 10.34 24.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 110.925 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -104.46 52.13 0.76 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.011 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.626 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 37.91 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.189 0.995 . . . . 0.0 112.905 178.074 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.763 ' O ' HG13 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -94.72 -29.14 14.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.369 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.746 HG22 ' NE2' ' A' ' 118' ' ' HIS . 1.9 t -97.43 153.82 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.323 -1.486 . . . . 0.0 109.004 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -169.23 113.71 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.963 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 1.05 ' C ' HD13 ' A' ' 122' ' ' LEU . 5.3 m-20 -112.36 152.98 27.96 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.05 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -136.56 121.66 19.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.277 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.407 ' CB ' ' NE2' ' A' ' 62' ' ' HIS . 18.2 m -85.59 66.35 9.61 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.9 178.8 9.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 160' ' ' SER . . . 156.23 113.33 0.42 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.77 158.48 34.73 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.469 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 31.6 Cg_endo -74.71 -3.64 14.2 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.165 1.91 . . . . 0.0 108.646 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.7 t -117.66 76.33 10.27 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -77.18 163.67 30.17 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.335 2.023 . . . . 0.0 110.909 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.29 146.27 46.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.449 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.89 -14.79 63.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.2 m -79.65 -23.59 42.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.23 -40.39 30.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -75.61 -41.46 54.3 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.495 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -61.55 -23.6 66.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.07 -42.77 65.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 2.1 t -68.81 -26.25 32.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.06 -33.11 75.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.5 -22.48 35.06 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -79.39 -19.21 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.08 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -35.62 40.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.03 -1.044 . . . . 0.0 108.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.4 p -54.85 -30.63 58.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.11 -17.83 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.8 78.86 0.65 Allowed Glycine 0 N--CA 1.475 1.273 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 118' ' ' HIS . 48.6 t -119.17 111.95 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -1.082 . . . . 0.0 109.387 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.63 102.74 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.926 -1.109 . . . . 0.0 109.268 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -98.73 143.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -135.58 116.15 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.757 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -104.77 148.4 26.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 109.614 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.58 162.46 25.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.226 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -69.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.0 109.877 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 160.72 -17.2 0.2 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.309 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 214' ' ' THR . 59.1 t-20 41.12 35.72 0.4 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.638 -0.919 . . . . 0.0 109.918 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -90.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 156.22 70.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.67 170.4 14.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -1.109 . . . . 0.0 109.296 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.91 52.82 4.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.0 OUTLIER 162.77 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -1.123 . . . . 0.0 109.121 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.432 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.6 OUTLIER -89.07 -177.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.159 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.882 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -102.46 166.67 10.41 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.773 0.797 . . . . 0.0 111.595 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.566 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 2.4 m-85 -85.39 144.86 41.23 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 45.2 Cg_endo -75.21 -31.02 5.59 Favored 'Cis proline' 0 C--N 1.293 -2.346 0 O-C-N 122.429 0.699 . . . . 0.0 111.016 3.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -17.78 -47.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -52.57 -54.8 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.078 -1.014 . . . . 0.0 110.583 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -42.36 -178.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.558 1.171 . . . . 0.0 111.229 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.75 0.81 8.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.043 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.11 21.56 4.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 108.865 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.14 20.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.419 ' HA ' ' CG ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -112.23 132.49 54.9 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -106.87 123.07 47.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 172' ' ' GLY . 25.4 t -90.34 166.13 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -137.94 166.81 25.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -117.15 140.84 49.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -1.144 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.408 HG23 ' HB ' ' A' ' 193' ' ' VAL . 11.7 p -109.23 174.65 5.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.91 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.25 -147.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.652 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -69.62 -53.45 18.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -86.23 -82.75 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.923 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.535 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 33.4 p-10 -166.23 43.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -105.93 166.44 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' NH2' HG11 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -72.74 106.38 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.824 ' HB3' ' HB3' ' A' ' 184' ' ' SER . . . -43.55 130.9 5.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 109.43 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.6 m -60.75 -30.36 69.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.038 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.553 ' CD2' ' OD1' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -92.54 -14.43 28.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.824 ' HB3' ' HB3' ' A' ' 181' ' ' ALA . 11.5 t -76.99 154.89 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.23 140.41 37.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CE2' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -123.9 171.19 9.88 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.418 -0.801 . . . . 0.0 109.339 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.587 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.51 142.31 4.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.37 118.47 6.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -1.122 . . . . 0.0 109.185 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 122.9 -6.53 9.53 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 257' ' ' TYR . 49.3 tp -45.81 154.63 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.181 -1.188 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.5 OUTLIER -99.51 -55.53 2.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.454 ' CD1' HG13 ' A' ' 262' ' ' VAL . 3.5 tt -151.87 172.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 0.0 109.872 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.477 HG11 ' NH2' ' A' ' 180' ' ' ARG . 8.3 m -136.83 166.83 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.292 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.736 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -168.99 167.71 5.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.169 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.736 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.99 117.24 4.12 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.481 2.121 . . . . 0.0 110.284 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -142.6 22.08 2.36 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 31.6 t -89.01 58.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -1.149 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.775 ' O ' HG13 ' A' ' 199' ' ' VAL . 17.8 t-20 131.69 122.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 198' ' ' ASN . 4.8 m -167.01 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.075 0.94 . . . . 0.0 109.075 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 29.3 mt-30 -87.41 141.52 28.57 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.597 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.588 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -148.7 -147.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -96.4 166.4 11.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.017 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.652 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.11 159.13 40.62 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.652 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.6 Cg_endo -71.71 167.4 26.63 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.41 2.073 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 77.76 4.04 84.71 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 78.04 33.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -1.0 . . . . 0.0 109.404 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -127.89 157.59 40.1 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.106 -0.996 . . . . 0.0 109.708 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -94.98 179.55 5.18 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.601 ' HB2' ' CG ' ' A' ' 203' ' ' TYR . . . -156.54 178.55 10.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.844 -1.16 . . . . 0.0 110.914 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.731 ' O ' HD23 ' A' ' 211' ' ' LEU . 55.0 p -159.72 110.54 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 210' ' ' SER . 1.7 mt -126.7 162.69 25.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.46 125.1 35.66 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.544 ' HA2' ' CE2' ' A' ' 183' ' ' PHE . . . 175.32 159.46 21.42 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.645 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -61.6 -30.2 70.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.916 . . . . 0.0 109.291 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 13.7 m -61.13 -27.3 68.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.485 ' HG2' ' CG2' ' A' ' 199' ' ' VAL . 0.7 OUTLIER -74.54 -24.32 58.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.335 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.476 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -85.38 -24.71 27.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.783 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.598 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 96.5 m -53.35 -44.33 97.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 111.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.0 Cg_endo -73.95 -24.56 15.08 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.727 1.618 . . . . 0.0 110.847 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -62.35 -41.23 98.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 192' ' ' ILE . 42.2 t -71.27 -48.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -49.24 -28.59 4.78 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.4 -58.5 4.22 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.28 -61.24 2.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -1.162 . . . . 0.0 109.289 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 229' ' ' LYS . . . -47.03 -41.75 17.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . . . -55.6 -44.23 76.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.589 HD13 ' HB1' ' A' ' 16' ' ' ALA . 22.4 mt -57.9 -47.22 83.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.227 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 46.9 t -55.94 -52.85 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.158 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 233' ' ' PRO . 0.0 OUTLIER -49.21 -38.95 27.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.465 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -60.1 -54.1 49.96 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.011 -1.056 . . . . 0.0 108.714 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -51.36 -20.97 1.95 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 108.551 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 176.82 89.29 0.11 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.729 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.554 ' N ' ' O ' ' A' ' 229' ' ' LYS . 36.4 Cg_endo -79.98 -24.88 5.49 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.792 2.328 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -53.2 -21.54 5.32 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -56.99 176.56 0.1 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.993 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.6 OUTLIER -105.24 171.72 7.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 110.023 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 237' ' ' ASN . 7.0 m-80 -55.72 -45.95 77.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.488 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.3 t -74.33 -51.53 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -40.72 -41.16 1.47 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 109.345 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 236' ' ' SER . 2.9 mt -74.46 -45.08 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 242' ' ' ASN . 1.6 ttm-85 -47.96 -71.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 241' ' ' ARG . 1.2 m-80 -35.15 -36.63 0.06 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.812 -0.555 . . . . 0.0 110.701 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.736 ' O ' HG23 ' A' ' 247' ' ' THR . 1.4 t-80 -69.0 -52.63 26.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.522 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.488 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.0 OUTLIER -66.91 -17.19 64.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.938 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -45.32 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.3 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 246' ' ' ASN . 1.2 m-20 -91.15 -5.26 55.28 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.15 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 243' ' ' HIS . 70.5 p -103.33 -52.55 2.99 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.912 -1.117 . . . . 0.0 110.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -43.41 151.48 0.17 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.791 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 250' ' ' SER . 31.5 m -70.68 157.64 37.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.404 ' N ' HG22 ' A' ' 249' ' ' THR . 54.7 p -129.7 111.47 12.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 178' ' ' ASN . 4.0 mp -50.5 -59.22 4.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 109.373 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -170.91 -69.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.7 m -60.21 173.78 0.61 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -1.169 . . . . 0.0 109.251 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 76.0 p -143.56 28.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.674 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -159.33 -40.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 256' ' ' LEU . 2.7 tm? -76.35 -65.5 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.8 ' O ' HD23 ' A' ' 190' ' ' LEU . 8.2 m-30 -64.08 -74.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.106 -0.996 . . . . 0.0 108.333 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 156.61 -177.26 33.66 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.6 t -46.74 -24.8 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 108.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.28 -137.49 12.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 261' ' ' LEU . 12.9 tp -102.47 169.1 8.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.989 . . . . 0.0 108.494 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.454 HG13 ' CD1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -111.27 157.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.878 -1.139 . . . . 0.0 110.311 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -164.94 118.08 1.25 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.458 1.123 . . . . 0.0 107.977 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.51 64.17 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.093 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.497 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 79.3 tt0 -68.96 -16.58 63.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.0 109.8 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -98.75 0.18 43.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -0.977 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -132.49 1.32 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.156 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -101.67 -41.79 6.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.025 -1.047 . . . . 0.0 109.89 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.494 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 143.22 58.06 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.497 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.909 ' O ' HG13 ' A' ' 4' ' ' VAL . 51.9 m -62.05 111.92 2.13 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.941 -1.099 . . . . 0.0 110.056 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 178.3 66.2 0.1 Allowed Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 34.4 Cg_endo -76.67 173.98 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.457 2.105 . . . . 0.0 110.381 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -55.22 -11.94 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.588 -0.695 . . . . 0.0 110.899 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.66 -62.42 1.25 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.72 -1.238 . . . . 0.0 110.732 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -71.58 -0.78 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.114 -1.227 . . . . 0.0 110.247 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -104.61 -15.86 15.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.855 -1.153 . . . . 0.0 109.726 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.46 0.32 50.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.903 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 11' ' ' VAL . 3.3 m -114.5 26.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 O-C-N 120.764 -1.21 . . . . 0.0 110.258 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' HG3' ' HB2' ' A' ' 265' ' ' GLU . 21.2 mm100 46.59 55.88 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -89.07 -30.05 0.36 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.49 -0.756 . . . . 0.0 112.364 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.2 Cg_endo -74.15 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 109.026 -1.182 . . . . 0.0 109.026 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 -29.08 1.66 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.2 -39.52 40.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 109.161 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 27.4 m170 -65.76 -24.9 67.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -99.62 -16.68 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.787 -1.196 . . . . 0.0 110.631 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -66.55 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.017 -1.052 . . . . 0.0 109.742 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 1.056 ' C ' HD13 ' A' ' 21' ' ' LEU . . . 173.48 17.06 0.02 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.591 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.056 HD13 ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -134.85 153.99 51.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.505 -1.585 . . . . 0.0 108.659 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -138.92 42.23 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' HA2' ' NE2' ' A' ' 230' ' ' GLN . . . 50.52 14.79 1.05 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' ' C ' ' A' ' 22' ' ' THR . 0.6 OUTLIER -87.26 103.67 15.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -1.13 . . . . 0.0 109.884 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.74 -4.03 2.39 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.437 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG22 ' HD2' ' A' ' 229' ' ' LYS . 29.2 t -123.57 166.83 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 120.693 -1.475 . . . . 0.0 109.918 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -136.15 126.11 25.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.55 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 29' ' ' ALA . 57.8 t -113.41 161.79 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.513 -0.742 . . . . 0.0 109.708 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HB3' ' CB ' ' A' ' 120' ' ' ALA . . . -118.67 151.69 37.49 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.548 ' CG2' HD22 ' A' ' 88' ' ' LEU . 3.2 t -127.01 84.8 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.134 -0.979 . . . . 0.0 108.536 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.782 HD12 ' CG2' ' A' ' 91' ' ' VAL . 7.4 mp -73.13 93.46 1.82 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.4 p-10 -157.33 -161.78 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.973 -1.079 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.797 HG22 ' HA ' ' A' ' 96' ' ' ALA . 40.9 p -41.57 -51.55 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.84 . . . . 0.0 109.978 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.76 -47.12 0.48 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.642 HG23 ' HA ' ' A' ' 64' ' ' THR . 3.9 mt 73.95 105.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -65.47 158.13 27.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.815 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 101.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -104.96 148.56 36.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 32.9 Cg_endo -75.63 -17.13 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 110.583 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 41' ' ' LEU . 10.1 t70 -96.68 27.32 3.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.973 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.961 HD21 HG21 ' A' ' 202' ' ' THR . 13.9 mt -143.72 134.48 25.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.52 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 8.9 t30 -86.03 66.2 9.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.131 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 44' ' ' ARG . 3.4 mt -73.31 163.25 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.457 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -150.22 9.22 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.72 173.04 38.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.88 116.33 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . . . -116.06 163.92 15.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -1.086 . . . . 0.0 109.365 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -122.39 113.66 19.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 47' ' ' ALA . 7.5 m-85 -110.67 -21.81 11.92 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.692 HG21 ' O ' ' A' ' 94' ' ' LEU . 1.4 t -63.72 126.09 89.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 110.005 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -80.6 154.26 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.358 2.038 . . . . 0.0 109.712 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 85.02 -60.89 4.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' O ' HG12 ' A' ' 50' ' ' VAL . 2.3 mt-10 -113.25 87.73 11.5 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.576 ' O ' ' C ' ' A' ' 55' ' ' SER . 31.8 Cg_endo -72.24 -72.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.793 2.329 . . . . 0.0 111.78 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.576 ' C ' ' O ' ' A' ' 54' ' ' PRO . 1.4 m -14.65 129.74 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.741 0.781 . . . . 0.0 111.709 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.409 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 7.7 t -103.89 -11.29 17.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.381 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 3.0 pm0 -81.57 110.54 17.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.664 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 33.3 t70 63.18 153.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.456 ' HA3' ' HB ' ' A' ' 33' ' ' THR . . . -154.77 -63.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.43 ' OD1' ' HB1' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -131.74 -53.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.131 . . . . 0.0 109.305 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.19 -33.6 1.23 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.228 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -61.23 -48.09 83.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.24 . . . . 0.0 109.874 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.04 -43.58 96.86 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.642 ' HA ' HG23 ' A' ' 35' ' ' ILE . 59.9 m -61.0 -37.87 84.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -1.144 . . . . 0.0 109.614 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.749 ' CD2' HD11 ' A' ' 211' ' ' LEU . 7.9 t-80 -63.68 -53.75 46.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 109.747 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' A' ' 219' ' ' PRO . 3.7 t -60.89 -28.45 43.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.42 -0.8 . . . . 0.0 109.29 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 70' ' ' ILE . . . -63.23 -46.77 85.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.739 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -66.11 -42.84 94.25 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -58.12 -24.98 60.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.189 -1.183 . . . . 0.0 109.059 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 67' ' ' ALA . 32.9 mt -82.85 -30.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.895 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -137.6 -51.47 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.991 -1.068 . . . . 0.0 111.11 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.1 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 40.21 79.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 42' ' ' ASN . 13.6 mt -34.71 155.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.362 -0.836 . . . . 0.0 111.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.464 ' OD1' HD22 ' A' ' 80' ' ' LEU . 1.3 t30 -99.84 120.98 40.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.556 -0.715 . . . . 0.0 109.918 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -167.47 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.047 -1.033 . . . . 0.0 109.044 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 -7.39 0.26 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.212 -0.93 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.5 pt -106.8 67.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.66 -1.275 . . . . 0.0 109.513 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.03 177.01 14.66 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.496 ' C ' ' OG ' ' A' ' 3' ' ' SER . 25.7 m -81.32 -166.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.304 -1.115 . . . . 0.0 109.84 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.85 ' N ' ' HB3' ' A' ' 3' ' ' SER . 15.8 tp -133.73 140.7 47.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 0.0 109.51 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 1.1 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -91.76 -169.02 41.2 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 227' ' ' LEU . 1.6 t -88.25 -36.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.93 -1.335 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -126.24 102.93 26.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.12 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 37.9 Cg_endo -84.75 -62.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.652 2.235 . . . . 0.0 109.858 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.62 -27.17 10.53 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.088 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -47.0 139.04 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 109.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.2 mp0 -74.79 97.35 3.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.263 -0.898 . . . . 0.0 109.225 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.548 HD22 ' CG2' ' A' ' 30' ' ' VAL . 2.7 mt -80.97 120.18 24.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.051 -1.031 . . . . 0.0 109.443 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 11.9 m-85 -104.77 153.37 21.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.341 -0.85 . . . . 0.0 109.432 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.456 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -115.21 101.9 9.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.782 ' CG2' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -96.98 67.11 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -37.58 95.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.901 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 105' ' ' ILE . 3.3 t -113.7 -23.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.406 -0.809 . . . . 0.0 108.969 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.692 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -92.98 173.34 7.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.314 -0.866 . . . . 0.0 108.719 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -98.03 -17.69 29.17 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.797 ' HA ' HG22 ' A' ' 33' ' ' THR . . . 161.59 36.11 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 96' ' ' ALA . 2.5 m 80.97 8.73 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.68 -79.74 1.45 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -178.08 103.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -1.172 . . . . 0.0 109.434 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.48 178.64 51.57 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.13 152.51 42.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.892 -0.769 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 133' ' ' LEU . 41.0 t -68.27 -19.43 24.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -75.03 -18.51 60.33 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -91.3 -37.19 13.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.505 -0.747 . . . . 0.0 109.426 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.588 HG23 HG11 ' A' ' 93' ' ' VAL . 1.1 mt -77.04 -26.94 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 -44.33 18.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 104' ' ' SER . 10.1 pt20 -70.75 -31.11 67.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 0.0 109.009 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.93 -39.35 46.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -62.25 -39.66 93.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -1.128 . . . . 0.0 109.462 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 110' ' ' GLU . 1.6 tp10 -78.42 -19.64 52.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.132 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.674 ' CE3' ' HA3' ' A' ' 116' ' ' GLY . 84.8 t90 -65.95 -25.09 66.96 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.914 -1.116 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -88.45 -5.35 58.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.958 -1.089 . . . . 0.0 109.175 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -94.7 -6.59 60.69 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 19.7 t-20 -134.93 -4.71 2.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER 171.11 30.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.803 -1.186 . . . . 0.0 110.697 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.747 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -138.88 57.99 0.62 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.298 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.785 ' HE3' ' H ' ' A' ' 117' ' ' MET . 0.0 OUTLIER 63.22 175.57 0.16 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.447 -1.031 . . . . 0.0 112.26 176.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.685 ' CD2' ' N ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -104.0 -35.38 8.13 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.4 t -98.34 156.18 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.662 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.719 ' CB ' ' HB3' ' A' ' 29' ' ' ALA . . . -172.37 131.01 0.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 108.966 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 1.039 ' C ' HD13 ' A' ' 122' ' ' LEU . 3.0 m120 -117.58 148.25 42.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.039 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -125.22 114.48 19.03 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.132 -0.98 . . . . 0.0 108.951 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.446 ' C ' HD23 ' A' ' 124' ' ' LEU . 2.8 t -86.5 61.61 6.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.9 -173.71 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.872 0.844 . . . . 0.0 110.077 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 170.4 100.52 0.14 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -97.68 149.45 35.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.144 -1.209 . . . . 0.0 109.83 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.2 -5.39 15.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.351 2.034 . . . . 0.0 108.374 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.3 t -110.14 112.09 57.7 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.87 165.23 31.86 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.944 1.763 . . . . 0.0 109.881 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 120.54 6.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 110.5 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.34 65.49 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 52.9 m -63.38 -29.19 70.53 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -75.52 -35.31 60.77 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -75.14 -25.14 58.17 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.137 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.63 -24.23 59.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.48 -40.88 25.36 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.072 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.546 HG11 ' CB ' ' A' ' 167' ' ' ASN . 1.7 t -68.3 -30.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.72 -35.9 82.08 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.465 ' OG ' ' OE2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -78.17 -21.23 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' A' ' 145' ' ' VAL . . . -76.56 -29.7 56.77 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -73.96 -24.21 59.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 108.541 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -57.74 -38.82 76.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 0.0 108.878 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.34 -14.42 16.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 108.878 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.63 81.52 0.99 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 118' ' ' HIS . 94.1 t -119.23 109.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.6 tp -74.59 116.8 15.69 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.612 HG12 HD21 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -109.08 144.54 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -129.45 111.42 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.041 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.827 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -94.33 148.59 22.06 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.514 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -62.96 162.29 11.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.738 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 44.9 t -49.57 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 110.721 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.677 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 133.15 133.67 3.41 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -102.37 63.5 0.88 Allowed 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.617 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -117.69 75.2 0.98 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.435 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.63 ' O ' ' NE2' ' A' ' 185' ' ' GLN . . . -3.33 -62.2 0.0 OUTLIER Glycine 0 N--CA 1.507 3.409 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 154' ' ' SER . . . -46.77 173.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -1.102 . . . . 0.0 109.561 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.14 58.62 4.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 m -143.17 134.76 26.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.154 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.614 HD12 ' HB1' ' A' ' 163' ' ' ALA . 6.8 pt -87.19 177.68 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.972 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.5 OUTLIER -87.05 160.89 18.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.362 -0.836 . . . . 0.0 111.818 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.462 ' CZ ' ' HD2' ' A' ' 164' ' ' ARG . 5.1 m-85 -83.5 141.99 42.67 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.827 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 45.0 Cg_endo -74.73 -30.75 5.77 Favored 'Cis proline' 0 C--N 1.3 -2.023 0 O-C-N 122.421 0.695 . . . . 0.0 111.489 3.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.972 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -15.72 -50.21 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-O 121.124 0.488 . . . . 0.0 111.87 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 162' ' ' PRO . 10.9 ttm180 -50.39 -59.76 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.172 -0.955 . . . . 0.0 110.36 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -46.34 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.462 1.125 . . . . 0.0 111.046 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.93 -2.55 9.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.546 ' CB ' HG11 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -81.65 7.9 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 109.398 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . . . -153.77 139.99 18.49 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.544 ' SD ' HG23 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -85.28 146.66 26.94 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.013 -1.054 . . . . 0.0 109.626 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -109.73 123.76 50.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.3 t -84.3 166.08 2.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.965 -1.085 . . . . 0.0 109.764 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.577 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -129.85 -176.67 14.52 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.491 ' CB ' HG23 ' A' ' 214' ' ' THR . . . -134.35 150.03 50.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -1.2 . . . . 0.0 109.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 179' ' ' ASN . 71.0 p -134.21 153.35 51.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -172.05 1.86 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -23.56 64.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.054 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.79 -87.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.43 ' OD1' HD21 ' A' ' 251' ' ' LEU . 2.9 m-20 177.13 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.99 . . . . 0.0 109.824 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.686 ' O ' HG22 ' A' ' 174' ' ' THR . 7.7 t-20 -136.35 -161.21 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.662 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 mtp85 -87.87 12.51 12.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 72.2 4.42 5.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.56 -6.61 0.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 112.195 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.488 ' CE2' ' HB1' ' A' ' 181' ' ' ALA . 39.3 p90 -134.89 -5.58 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.318 -1.489 . . . . 0.0 110.286 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.3 t -78.08 132.17 37.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 108.403 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.677 ' HB2' ' O ' ' A' ' 152' ' ' GLY . 1.8 tp60 -88.79 149.29 23.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.097 . . . . 0.0 110.83 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.655 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -121.68 176.44 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 108.918 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.655 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.53 178.62 47.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.46 145.45 50.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.248 . . . . 0.0 109.577 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.61 7.8 88.19 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.36 141.03 58.7 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.127 -1.22 . . . . 0.0 108.719 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.543 ' OD1' ' CE ' ' A' ' 245' ' ' LYS . 35.9 t0 -84.4 -79.75 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 110.935 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.484 ' CG2' ' C ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -154.13 -161.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.072 . . . . 0.0 110.151 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 260' ' ' GLY . 26.9 m -124.94 168.91 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.908 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 1.026 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -159.92 177.2 2.16 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.946 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.7 Cg_endo -76.47 115.99 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.173 1.915 . . . . 0.0 110.571 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.31 53.44 0.65 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 39.0 t -138.12 87.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 199' ' ' VAL . 7.6 t30 81.53 119.88 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 198' ' ' ASN . 4.3 m -162.35 114.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.078 0.942 . . . . 0.0 108.974 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -76.31 122.84 25.01 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.751 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -131.72 -169.54 2.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.524 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.961 HG21 HD21 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.89 173.4 12.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.307 -0.871 . . . . 0.0 110.307 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.654 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -151.36 166.95 14.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.654 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.3 Cg_endo -73.45 166.11 30.71 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.127 1.885 . . . . 0.0 110.704 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.43 -60.7 4.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 4.7 p 150.81 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 122.025 -0.691 . . . . 0.0 109.826 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -142.8 -179.37 6.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.542 ' N ' ' OG1' ' A' ' 207' ' ' THR . 0.0 OUTLIER -130.89 165.71 22.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.532 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.95 149.15 15.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . 1.029 ' O ' HD23 ' A' ' 211' ' ' LEU . 1.1 t -93.09 140.18 29.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 1.029 HD23 ' O ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -145.94 151.19 37.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 213' ' ' GLY . 1.3 t-20 -104.95 168.45 9.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 212' ' ' ASN . . . 147.51 168.52 14.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.491 HG23 ' CB ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -85.43 -38.07 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -1.059 . . . . 0.0 109.049 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.545 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 1.4 t -60.04 -15.25 21.26 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.464 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 25.3 mmt -64.99 -35.34 80.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.393 -0.817 . . . . 0.0 109.599 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 1.026 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -84.44 -6.77 59.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.769 . . . . 0.0 110.783 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.627 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.5 m -69.06 -45.1 29.87 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 111.734 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.7 Cg_endo -73.37 -16.11 24.8 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.979 1.786 . . . . 0.0 111.118 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.443 ' NE2' HD12 ' A' ' 8' ' ' ILE . 6.4 m80 -74.57 -41.27 60.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 108.424 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 262' ' ' VAL . 60.2 t -71.18 -41.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.71 -37.96 69.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.097 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.23 -49.59 45.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.48 -60.49 3.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -1.192 . . . . 0.0 109.603 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -44.56 -47.53 10.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.779 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.59 57.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.963 -1.086 . . . . 0.0 109.184 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 82' ' ' VAL . 39.2 mt -52.13 -40.56 61.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.469 HG21 ' HG ' ' A' ' 244' ' ' LEU . 68.7 t -58.79 -49.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 108.759 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.57 ' HD2' HG22 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -45.68 -45.69 14.3 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -60.78 -48.67 80.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.426 -0.796 . . . . 0.0 110.132 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.417 ' C ' ' CG ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -59.14 -14.38 10.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.278 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.417 ' CG ' ' C ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -174.68 95.63 0.29 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.951 . . . . 0.0 110.004 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.7 -20.27 9.33 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.591 2.194 . . . . 0.0 110.379 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.99 -42.82 95.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 0.0 110.188 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -52.39 173.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.534 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.1 OUTLIER -135.8 158.63 43.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.995 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 236' ' ' SER . 1.1 m-80 -15.78 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 236' ' ' SER . 2.9 t -73.79 -65.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.013 -1.054 . . . . 0.0 110.329 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -40.51 -27.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.27 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 238' ' ' VAL . 63.7 mt -82.02 -49.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -56.27 -22.5 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.127 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 243' ' ' HIS . 2.4 t-20 -71.07 -69.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.768 -1.208 . . . . 0.0 110.339 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.413 ' N ' ' OD1' ' A' ' 242' ' ' ASN . 9.9 t60 -55.84 -39.72 71.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.81 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.1 OUTLIER -64.46 -43.06 95.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 111.001 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -77.48 -21.99 51.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.976 -1.078 . . . . 0.0 109.647 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.58 -19.94 28.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.071 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 267' ' ' ALA . 0.9 OUTLIER -87.91 -27.22 22.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.303 1.049 . . . . 0.0 109.107 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -46.68 131.63 11.37 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.726 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 92.9 m -52.96 133.95 37.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.018 . . . . 0.0 109.767 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 99.4 p -93.06 94.2 8.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 261' ' ' LEU . 5.7 mp -58.54 -63.96 1.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.178 -0.951 . . . . 0.0 109.936 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 157.1 66.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 0.2 OUTLIER -144.94 175.4 10.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.474 -1.015 . . . . 0.0 109.6 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 255' ' ' ASN . 28.8 p -111.7 -13.73 13.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.109 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 254' ' ' THR . 1.0 OUTLIER 178.51 -25.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.017 -1.052 . . . . 0.0 110.601 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.58 -49.99 74.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.95 -1.094 . . . . 0.0 109.953 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.513 ' HB2' ' OG ' ' A' ' 253' ' ' SER . 12.9 m-30 -83.98 10.09 10.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 38.93 74.84 0.11 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 2.8 t 84.56 -58.61 0.1 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.692 -0.887 . . . . 0.0 109.794 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.827 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 144.05 -131.57 4.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.487 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 52.6 tp -94.8 166.31 12.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.637 -0.919 . . . . 0.0 109.659 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 221' ' ' VAL . 5.5 t -104.97 156.64 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.351 -0.843 . . . . 0.0 109.725 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -168.09 118.88 0.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.303 1.049 . . . . 0.0 108.543 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 268' ' ' THR . . . -76.67 -15.89 59.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.718 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.474 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -67.65 -41.19 84.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.711 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.36 -8.42 59.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.404 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -99.59 -21.77 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.218 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.503 ' O ' ' C ' ' A' ' 269' ' ' ARG . 25.2 p -112.54 -55.69 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.181 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 268' ' ' THR . 3.1 ttt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 1.8 tm0? -70.57 172.15 9.06 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 66.8 m -98.31 127.62 44.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.026 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -140.52 106.45 6.5 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.85 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.97 178.02 8.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.367 2.044 . . . . 0.0 109.771 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -5.6 16.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.1 -63.29 1.74 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 9' ' ' SER . 1.7 mp -75.82 113.39 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.11 -1.229 . . . . 0.0 109.146 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 11.8 p 168.1 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.848 ' HB3' HD21 ' A' ' 261' ' ' LEU . 2.3 mmt180 -77.81 -21.68 51.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 220' ' ' HIS . 4.0 m -86.41 14.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.081 -1.012 . . . . 0.0 109.894 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.521 ' OE1' ' HB3' ' A' ' 15' ' ' ALA . 22.2 mm-40 45.05 57.92 4.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.476 -0.765 . . . . 0.0 109.69 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.701 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.07 -30.94 0.47 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.451 -0.781 . . . . 0.0 111.82 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 33.1 Cg_endo -76.14 -55.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.232 1.288 . . . . 0.0 109.0 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . . . -49.64 -27.34 4.52 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.203 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.87 -32.84 24.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.863 -1.148 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 22.1 m170 -75.75 -20.79 58.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.505 ' OD1' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -110.31 -25.77 9.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.584 -1.322 . . . . 0.0 110.38 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 3.9 tpm_? -56.16 -25.35 46.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.0 -1.062 . . . . 0.0 109.47 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.87 0.7 3.87 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 268' ' ' THR . 2.4 mt -102.81 151.83 21.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -1.178 . . . . 0.0 109.172 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.483 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -137.78 -2.66 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.183 -0.948 . . . . 0.0 110.853 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 22' ' ' THR . . . 48.83 18.6 1.11 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.483 ' N ' ' C ' ' A' ' 22' ' ' THR . 40.7 t -72.86 9.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.569 -0.96 . . . . 0.0 111.405 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.37 37.25 1.9 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.281 -1.437 . . . . 0.0 110.144 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 27' ' ' LYS . 53.2 t -120.93 163.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.857 -1.378 . . . . 0.0 110.025 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . 21.3 mttp -127.12 128.62 46.5 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.532 -0.73 . . . . 0.0 109.115 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 43.6 t -131.5 153.79 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.028 -1.045 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -115.23 160.27 19.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.066 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 35' ' ' ILE . 7.2 t -133.09 90.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.109 -0.994 . . . . 0.0 108.919 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.973 HD23 HG21 ' A' ' 93' ' ' VAL . 8.7 mp -80.44 123.43 28.05 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 7.8 p30 173.48 -164.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.908 -1.12 . . . . 0.0 109.815 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.3 p -42.38 -65.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -172.28 -132.37 1.49 Allowed Glycine 0 C--N 1.302 -1.341 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.701 HG13 ' HB2' ' A' ' 90' ' ' ALA . 30.3 mm -165.32 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.46 ' HB3' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -53.09 142.39 20.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.989 . . . . 0.0 109.267 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 117.16 13.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 152.74 72.36 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.196 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 -21.33 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.532 2.155 . . . . 0.0 110.713 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -81.01 -17.32 50.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD21 ' HA2' ' A' ' 68' ' ' GLY . 29.8 mt -101.39 149.75 23.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.07 88.26 2.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.134 -0.979 . . . . 0.0 109.392 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 43' ' ' ILE . 23.4 mm -65.92 100.01 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -93.81 -11.42 31.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.27 -0.894 . . . . 0.0 109.31 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -174.65 169.59 42.57 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.78 130.33 1.92 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.07 170.78 14.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.375 -1.074 . . . . 0.0 108.944 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 93.8 p -140.84 112.74 7.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.097 -1.002 . . . . 0.0 110.493 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.941 ' CE2' HG12 ' A' ' 91' ' ' VAL . 3.7 m-85 -106.92 -47.71 3.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.401 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.711 HG21 ' O ' ' A' ' 94' ' ' LEU . 2.6 t -39.99 144.54 0.52 Allowed Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HD2' HG13 ' A' ' 50' ' ' VAL . 32.2 Cg_endo -72.04 177.3 7.29 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.516 2.144 . . . . 0.0 110.43 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' PRO . . . 59.13 23.04 56.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -26.5 88.63 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 122.471 -0.429 . . . . 0.0 111.584 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 36.5 Cg_endo -81.88 -72.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.762 2.308 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.583 -0.698 . . . . 0.0 109.161 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 48' ' ' SER . 0.7 OUTLIER -77.86 -0.36 27.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 108.689 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -129.32 146.43 51.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 179.245 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 15.1 t70 64.03 154.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.72 -30.32 0.12 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -167.29 -55.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -1.171 . . . . 0.0 109.374 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.94 -10.37 3.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -54.18 11.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -1.168 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -58.62 -39.98 94.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 36' ' ' SER . 2.9 m -63.8 -32.74 74.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -1.096 . . . . 0.0 108.973 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.733 ' CE1' ' HG ' ' A' ' 201' ' ' SER . 0.6 OUTLIER -67.21 -57.25 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 110.257 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.975 HG13 ' HB3' ' A' ' 219' ' ' PRO . 13.4 t -60.17 -32.47 50.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.341 -0.849 . . . . 0.0 109.796 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' C ' HD21 ' A' ' 41' ' ' LEU . . . -65.17 -43.04 93.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.691 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -73.49 -38.33 52.16 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.521 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.48 HG21 ' CE1' ' A' ' 220' ' ' HIS . 29.8 m -65.09 -21.66 66.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 108.919 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 219' ' ' PRO . 49.6 mt -89.86 -23.58 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 109.352 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -126.46 -57.51 1.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 111.703 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.082 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 36.68 87.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 73' ' ' LEU . 19.7 mt -60.29 149.82 32.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.733 -1.229 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 11.4 p30 -91.77 87.29 6.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 76' ' ' SER . 14.8 p30 -126.84 -120.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.204 -0.935 . . . . 0.0 108.828 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.423 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -124.43 -34.51 2.89 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.076 -1.015 . . . . 0.0 109.38 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.0 pt -100.32 67.39 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.305 -0.872 . . . . 0.0 109.486 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.24 158.99 9.54 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 34.8 m -87.31 -135.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.175 -1.191 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.47 ' N ' HG23 ' A' ' 79' ' ' VAL . 31.6 tp -140.64 123.09 16.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.697 -1.252 . . . . 0.0 110.263 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 1.082 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -87.57 -153.02 24.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.458 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.87 -60.18 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.906 -1.35 . . . . 0.0 109.332 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.688 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -89.36 112.56 52.15 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.246 -0.909 . . . . 0.0 109.174 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -84.69 -62.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.519 2.146 . . . . 0.0 110.947 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' CB ' ' HA ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -81.74 18.5 1.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.24 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.688 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -80.99 143.69 32.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.876 -1.14 . . . . 0.0 109.11 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 4.9 pt-20 -84.69 115.1 22.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.913 -1.117 . . . . 0.0 109.198 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 88' ' ' LEU . 4.1 mt -92.4 123.75 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.93 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 13.0 m-85 -106.59 152.61 23.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.701 ' HB2' HG13 ' A' ' 35' ' ' ILE . . . -113.69 102.83 10.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.366 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.941 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.76 69.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 108.93 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -38.28 112.07 0.2 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.312 0.577 . . . . 0.0 110.199 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.973 HG21 HD23 ' A' ' 31' ' ' LEU . 2.1 t -120.19 -17.67 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.256 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.711 ' O ' HG21 ' A' ' 50' ' ' VAL . 76.5 mt -98.45 172.97 7.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . -122.48 12.4 8.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 95' ' ' GLY . . . 71.05 3.69 4.76 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.979 -0.718 . . . . 0.0 109.796 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.2 -38.33 11.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.04 -9.94 3.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.08 98.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.064 -1.257 . . . . 0.0 110.005 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.13 179.6 52.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.2 150.98 48.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.883 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.564 HG21 ' OG ' ' A' ' 130' ' ' SER . 44.9 t -68.47 -20.8 25.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -79.25 -55.04 5.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.87 HG23 HG11 ' A' ' 93' ' ' VAL . 1.3 mt -62.29 -25.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 -45.75 68.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.593 -0.692 . . . . 0.0 110.167 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.545 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -67.12 -39.41 86.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.933 -1.104 . . . . 0.0 108.638 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.85 -19.23 73.26 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.51 -42.45 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -1.233 . . . . 0.0 110.184 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 139' ' ' SER . 6.5 pt-20 -94.86 -2.64 50.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.005 -1.059 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 71.4 t90 -86.21 -14.95 42.38 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.825 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.51 -7.19 59.65 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.415 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -91.27 -46.42 3.82 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.654 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.67 -71.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.129 -1.218 . . . . 0.0 110.028 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -109.48 35.25 3.38 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.825 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -114.88 -153.92 10.62 Favored Glycine 0 C--N 1.291 -1.92 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.596 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.78 ' HE1' ' O ' ' A' ' 116' ' ' GLY . 17.9 mmt -118.59 -172.92 2.37 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.882 0.849 . . . . 0.0 111.46 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.849 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -86.16 -27.86 24.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.831 -0.543 . . . . 0.0 110.223 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.849 HG22 ' CE1' ' A' ' 118' ' ' HIS . 15.5 t -114.02 159.77 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.848 -1.157 . . . . 0.0 109.569 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.576 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -163.9 114.16 1.29 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.492 ' OD1' ' HB ' ' A' ' 148' ' ' VAL . 64.8 t30 -98.53 159.27 15.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.05 . . . . 0.0 110.441 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.609 HD23 HD21 ' A' ' 124' ' ' LEU . 3.7 mp -131.99 104.51 6.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.3 59.35 5.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.609 HD21 HD23 ' A' ' 122' ' ' LEU . 1.4 pp -154.49 -175.19 5.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.386 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 173.57 103.09 0.16 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.361 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.51 148.69 35.31 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.297 -1.119 . . . . 0.0 108.914 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -75.95 -2.1 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.348 2.032 . . . . 0.0 109.554 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 m -103.63 110.53 64.04 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.768 -0.583 . . . . 0.0 110.108 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.39 169.04 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.232 1.954 . . . . 0.0 109.33 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.564 ' OG ' HG21 ' A' ' 102' ' ' VAL . 1.4 m -159.52 126.83 4.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.872 -1.143 . . . . 0.0 110.965 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.34 65.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 m -64.32 -30.06 71.12 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -34.23 66.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.533 ' HA ' ' OH ' ' A' ' 165' ' ' TYR . 26.8 tt0 -68.29 -53.39 24.77 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.412 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -51.21 -25.97 6.29 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.06 -1.025 . . . . 0.0 108.296 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.69 -49.26 26.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.627 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.81 -20.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.86 -37.81 85.15 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.94 -27.79 60.34 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.99 -20.75 57.6 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 121.063 -1.023 . . . . 0.0 109.798 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -76.78 -33.56 58.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -24.62 58.33 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.829 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 143' ' ' ARG . 0.9 OUTLIER -106.42 -22.19 12.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.646 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.18 62.16 2.13 Favored Glycine 0 C--N 1.301 -1.411 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 48.4 t -103.22 118.84 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.43 115.43 17.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 108.797 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -111.34 132.45 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.129 -0.982 . . . . 0.0 109.884 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.785 HG12 ' O ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -114.18 166.66 7.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.806 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -150.6 132.72 15.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 0.0 109.67 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -53.26 155.79 2.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.435 -0.791 . . . . 0.0 109.499 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 185' ' ' GLN . 0.1 OUTLIER -61.81 -66.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 155.52 -16.08 0.48 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.6 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 153' ' ' ASN . 11.7 t-20 44.69 40.01 3.83 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.726 -0.867 . . . . 0.0 109.535 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.6 -26.79 9.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.64 102.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 175.19 -177.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 109.547 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 186' ' ' TYR . . . -94.29 59.56 1.94 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.4 t 169.86 154.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.182 . . . . 0.0 109.67 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.617 HD11 ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -114.13 -171.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.821 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.967 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.6 OUTLIER -85.89 162.53 18.55 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.011 0.91 . . . . 0.0 112.012 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.49 139.86 20.96 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.2 Cg_endo -74.9 -36.74 2.49 Favored 'Cis proline' 0 C--N 1.294 -2.291 0 O-C-N 122.836 0.914 . . . . 0.0 110.992 3.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.967 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 8.46 -71.93 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.961 0.886 . . . . 0.0 110.729 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.642 ' N ' ' O ' ' A' ' 162' ' ' PRO . 23.9 ttt-85 -45.93 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER 28.29 -161.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.801 1.286 . . . . 0.0 112.586 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -134.7 -31.0 1.07 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.449 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -100.93 19.13 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 147' ' ' VAL . . . -135.75 167.15 21.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.785 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -122.68 136.04 54.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.006 -1.059 . . . . 0.0 109.538 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 190' ' ' LEU . . . -98.06 154.06 17.98 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 18.9 t -111.98 167.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -135.18 -158.99 8.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 193' ' ' VAL . . . -127.2 166.65 17.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.312 -1.11 . . . . 0.0 109.929 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.612 ' CG2' HG23 ' A' ' 193' ' ' VAL . 22.8 p -139.19 150.74 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.543 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.461 ' OD2' ' HB3' ' A' ' 179' ' ' ASN . 3.5 p30 -76.44 -174.09 2.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 110.176 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.13 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -81.73 -89.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.127 -0.983 . . . . 0.0 109.345 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.767 ' C ' HD23 ' A' ' 251' ' ' LEU . 1.4 m120 -174.93 67.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 174' ' ' THR . 38.2 t30 -146.43 -176.08 5.03 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.137 -0.977 . . . . 0.0 109.714 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -66.04 3.7 0.8 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.56 -0.713 . . . . 0.0 111.887 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 66.88 -145.94 0.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.133 -1.604 . . . . 0.0 108.413 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.21 -43.71 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.845 -1.159 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -87.75 35.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.447 -0.783 . . . . 0.0 110.499 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.7 t -94.11 127.59 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 5.2 tp60 -66.23 114.38 5.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.561 ' CE1' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -106.02 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.805 -179.06 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 143.32 158.33 7.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.3 97.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.492 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.534 ' C ' HD11 ' A' ' 159' ' ' ILE . . . 151.68 -23.4 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.617 ' N ' HD11 ' A' ' 159' ' ' ILE . 11.0 tp -59.31 127.13 30.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.18 -1.188 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.499 ' O ' ' HA3' ' A' ' 258' ' ' GLY . 0.4 OUTLIER -90.95 -54.46 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.627 -179.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.791 HD12 ' HB2' ' A' ' 259' ' ' SER . 1.8 tt -158.02 167.48 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.168 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 260' ' ' GLY . 33.4 m -112.26 166.29 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.929 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -152.9 176.36 2.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 108.832 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.929 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.12 116.55 4.2 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.341 2.027 . . . . 0.0 110.465 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.15 16.86 1.53 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 18.6 t -88.3 61.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -1.085 . . . . 0.0 108.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.642 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 20.9 t-20 108.51 125.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 198' ' ' ASN . 23.7 m -162.65 111.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.955 0.883 . . . . 0.0 108.665 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 15.8 pt20 -89.22 127.62 35.77 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.733 ' HG ' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -135.13 -160.94 1.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.85 168.54 16.01 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 110.038 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.673 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.43 166.26 16.03 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.673 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.1 Cg_endo -73.79 168.8 23.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.135 1.89 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 71.04 17.22 75.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER 66.1 33.03 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -1.165 . . . . 0.0 109.713 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.56 163.14 23.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 201' ' ' SER . 2.7 m-85 -106.93 -172.95 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -171.0 139.62 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.5 m -106.75 108.78 20.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.43 154.26 21.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.943 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.36 84.84 2.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.97 150.88 22.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.7 m -65.02 -22.61 67.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -1.071 . . . . 0.0 109.469 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.65 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 3.4 t -71.36 -23.0 61.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.415 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -75.6 -16.12 60.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -93.46 3.72 55.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 109.876 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.672 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 23.7 m -77.4 -35.69 1.36 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.986 . . . . 0.0 111.972 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.975 ' HB3' HG13 ' A' ' 66' ' ' VAL . 30.6 Cg_endo -73.41 -29.02 11.62 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.301 1.334 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' A' ' 69' ' ' THR . 29.9 m80 -59.63 -40.85 88.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.834 -1.166 . . . . 0.0 108.057 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 262' ' ' VAL . 63.5 t -70.35 -43.32 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.36 -31.33 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -72.4 -59.77 4.38 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -43.69 -49.69 7.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.2 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.21 -45.91 72.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.365 -0.835 . . . . 0.0 108.776 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 229' ' ' LYS . . . -51.93 -49.78 62.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.868 . . . . 0.0 109.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.6 mt -49.35 -50.12 41.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 108.973 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.29 -45.36 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.595 ' HE3' ' CD2' ' A' ' 118' ' ' HIS . 12.3 tppt? -49.64 -43.17 46.71 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.447 -0.783 . . . . 0.0 108.986 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -61.64 -45.96 91.8 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.5 tppm? -62.53 -13.11 27.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 108.794 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -163.33 85.75 1.33 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.509 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 36.7 Cg_endo -80.4 31.85 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.37 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.5 t -146.94 11.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.873 -1.142 . . . . 0.0 109.914 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -87.36 -179.02 6.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 110.032 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.849 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -109.74 173.67 6.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.289 0.566 . . . . 0.0 109.648 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.585 ' OD1' HG23 ' A' ' 238' ' ' VAL . 8.5 p30 -62.99 -32.94 74.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.201 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.585 HG23 ' OD1' ' A' ' 237' ' ' ASN . 2.9 t -77.07 -61.98 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.925 0.869 . . . . 0.0 109.181 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 238' ' ' VAL . 4.1 mt-30 -42.65 -38.23 1.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.72 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 236' ' ' SER . 7.5 mt -74.04 -47.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 3.1 tmt_? -52.37 -20.66 2.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.414 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 1.6 t-20 -78.13 -38.06 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.852 -1.155 . . . . 0.0 109.945 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.41 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.0 t-160 -75.74 -40.47 55.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.153 -0.967 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.5 OUTLIER -73.64 -32.92 64.28 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.511 -0.743 . . . . 0.0 110.333 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 1.3 tmtt? -77.93 -42.32 33.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.093 . . . . 0.0 108.983 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 4.5 m-20 -67.77 -22.83 65.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.552 -0.718 . . . . 0.0 109.989 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.569 HG21 ' HB2' ' A' ' 267' ' ' ALA . 2.3 p -91.85 -26.09 18.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.916 -1.115 . . . . 0.0 110.04 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -37.01 114.46 0.32 Allowed 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.794 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 250' ' ' SER . 65.9 m -45.06 164.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 0.0 109.08 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.549 ' N ' HG22 ' A' ' 249' ' ' THR . 23.2 t -115.58 102.2 9.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 251' ' ' LEU . 6.4 mp -83.75 -35.69 24.19 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.265 -0.897 . . . . 0.0 110.0 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 130.73 69.01 0.1 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.589 ' HB3' ' CD1' ' A' ' 257' ' ' TYR . 0.3 OUTLIER -50.28 137.46 18.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -1.124 . . . . 0.0 109.99 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.71 HG23 ' OD1' ' A' ' 255' ' ' ASN . 1.6 t -98.93 -17.11 18.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 254' ' ' THR . 0.2 OUTLIER -167.93 -44.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 258' ' ' GLY . 2.5 tp -148.37 -65.6 0.24 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.344 -0.847 . . . . 0.0 109.802 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.647 ' O ' ' CG ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER 23.34 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 123.063 1.411 . . . . 0.0 111.774 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 256' ' ' LEU . . . 54.11 -136.14 42.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.791 ' HB2' HD12 ' A' ' 192' ' ' ILE . 6.8 m -101.54 -3.4 28.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.438 -1.037 . . . . 0.0 109.545 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 110.27 -112.63 3.35 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.755 -1.212 . . . . 0.0 110.726 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 10' ' ' ARG . 37.7 tp -115.49 159.22 21.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.511 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -110.59 159.86 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.825 . . . . 0.0 109.191 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -168.05 119.24 0.82 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.363 1.078 . . . . 0.0 108.731 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 268' ' ' THR . . . -69.97 -15.12 62.99 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.317 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.465 ' HB3' ' HG3' ' A' ' 12' ' ' GLN . 78.8 tt0 -74.33 -26.81 60.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.014 -1.054 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 247' ' ' THR . . . -90.79 3.28 54.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 247' ' ' THR . . . -128.69 0.82 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 264' ' ' ALA . 21.4 p -107.49 -42.49 4.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.222 -0.924 . . . . 0.0 109.09 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 268' ' ' THR . 9.5 mtm180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.521 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.491 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.64 -177.11 1.44 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.221 -0.924 . . . . 0.0 108.769 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 14.9 m -117.91 113.67 22.08 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.642 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.674 HG11 HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.28 148.65 60.42 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 108.982 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HB3' ' OE1' ' A' ' 200' ' ' GLN . 34.9 Cg_endo -77.78 166.29 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.382 2.055 . . . . 0.0 110.735 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 9' ' ' SER . 4.8 p-90 -50.11 -19.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.491 -0.756 . . . . 0.0 110.556 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.61 -43.92 98.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.674 HG21 HG11 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -90.6 -25.71 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.123 -1.222 . . . . 0.0 110.057 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 6' ' ' TRP . 18.7 t -64.31 -20.58 66.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.932 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -0.68 38.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 111.398 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.592 HG23 ' HB2' ' A' ' 13' ' ' ALA . 11.1 m -106.13 25.46 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 120.542 -1.349 . . . . 0.0 110.134 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.56 ' O ' ' HB3' ' A' ' 264' ' ' ALA . 2.9 mp0 47.08 28.89 0.99 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -70.14 -36.17 5.86 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 111.704 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.42 -57.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.509 -1.381 . . . . 0.0 108.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.18 -33.52 0.94 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.62 60.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.162 -0.961 . . . . 0.0 108.819 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 17' ' ' HIS . 1.3 m170 -73.08 -3.3 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.78 . . . . 0.0 109.444 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -53.35 5.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.076 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.644 ' HD2' HD13 ' A' ' 21' ' ' LEU . 1.9 ptp180 -54.86 -18.02 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.65 35.13 2.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -93.21 160.81 14.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.164 -1.198 . . . . 0.0 109.407 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -133.89 -53.32 0.86 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.762 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 83.73 -13.81 45.75 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 2.8 t -51.58 139.72 19.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -1.079 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.31 -15.81 11.83 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 27' ' ' LYS . 45.3 t -93.26 169.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -1.089 . . . . 0.0 109.173 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -137.25 120.41 16.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.163 -0.961 . . . . 0.0 109.389 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.81 134.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -90.31 146.54 24.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.356 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 30' ' ' VAL . 16.2 t -119.23 80.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.23 -0.919 . . . . 0.0 108.938 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.635 HD23 HG21 ' A' ' 93' ' ' VAL . 8.5 mp -72.08 87.44 1.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 109.364 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 54.8 p30 -151.78 -148.51 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 1.2 p -56.86 -72.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.098 -1.001 . . . . 0.0 109.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.584 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -170.99 -110.47 0.24 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.584 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 157.12 115.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 38' ' ' HIS . 2.6 m -83.91 60.38 5.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 111.425 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 37' ' ' THR . 15.0 t 23.18 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.773 0.797 . . . . 0.0 111.22 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.86 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -51.52 161.98 0.76 Allowed Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.11 -29.38 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.465 2.11 . . . . 0.0 110.332 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.632 ' OD1' HG21 ' A' ' 202' ' ' THR . 0.7 OUTLIER -95.26 18.05 13.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 109.565 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.86 HD12 ' HB2' ' A' ' 38' ' ' HIS . 83.5 mt -125.42 124.42 41.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.908 . . . . 0.0 109.291 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.9 t-20 -74.82 120.36 20.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 35' ' ' ILE . 21.7 mm -103.3 96.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.145 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HG2' ' CG ' ' A' ' 87' ' ' GLU . 4.8 tpm_? -88.28 -38.66 15.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.66 -166.11 32.68 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.5 171.16 16.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.65 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -156.3 160.24 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.991 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 56' ' ' THR . 26.5 m -122.88 106.4 10.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.932 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -102.46 -33.17 9.62 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 109.159 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.732 HG13 ' HD2' ' A' ' 51' ' ' PRO . 70.5 t -49.33 142.53 10.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 0.0 109.028 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.732 ' HD2' HG13 ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.56 -170.17 0.84 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.519 2.146 . . . . 0.0 110.449 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . 92.05 1.61 69.8 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 19.9 pt-20 39.61 56.51 6.46 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.97 . . . . 0.0 110.14 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.9 Cg_endo -77.29 -89.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.251 1.967 . . . . 0.0 110.187 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 3.3 p 161.4 136.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.794 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.473 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -52.26 -20.13 2.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 36' ' ' SER . 18.3 mt-30 -118.82 152.4 36.3 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.379 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 63.56 165.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.311 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 169.78 -35.26 0.18 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 6.6 t30 173.72 -62.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . 168.72 -36.3 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -22.69 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -1.098 . . . . 0.0 109.391 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 65' ' ' HIS . . . -72.48 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.832 HG23 HD11 ' A' ' 41' ' ' LEU . 37.7 m -34.01 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.744 -0.857 . . . . 0.0 110.931 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.626 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -71.95 -52.83 15.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 110.282 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 219' ' ' PRO . 46.1 t -63.57 -37.02 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.447 -0.783 . . . . 0.0 109.933 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.591 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -74.98 -28.2 62.99 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 220' ' ' HIS . 62.1 m -69.89 -18.56 63.41 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.34 -1.094 . . . . 0.0 108.341 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.416 HD12 ' O ' ' A' ' 66' ' ' VAL . 7.3 mt -94.03 -38.49 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 110.004 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.914 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -175.62 46.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.867 -1.146 . . . . 0.0 111.156 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -45.14 108.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.804 -1.185 . . . . 0.0 108.924 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.9 HD23 ' O ' ' A' ' 84' ' ' PRO . 80.4 mt -42.26 142.28 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 109.935 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -86.28 109.46 18.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.283 -0.885 . . . . 0.0 108.977 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 76' ' ' SER . 4.9 m-20 -124.28 -5.01 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 88.5 -17.62 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 pt -104.09 66.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.175 -0.953 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' ' OH ' ' A' ' 208' ' ' TYR . . . 147.56 -171.5 28.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 3' ' ' SER . 30.7 m -80.11 -163.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.324 -1.103 . . . . 0.0 109.6 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 8.2 tp -142.53 115.2 8.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.865 . . . . 0.0 109.611 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.52 177.11 22.51 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.523 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 2.0 t -65.03 -50.96 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.286 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.914 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . . . -85.77 148.08 47.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.355 -0.84 . . . . 0.0 108.943 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.9 ' O ' HD23 ' A' ' 73' ' ' LEU . 38.0 Cg_endo -82.73 -61.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.752 2.301 . . . . 0.0 109.719 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 68.9 m-80 -95.98 -86.46 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 58.32 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.582 -0.699 . . . . 0.0 110.388 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.485 ' CG ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 mp0 -70.24 93.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 3.3 mt -78.11 104.97 9.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.126 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -94.06 147.92 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 108.89 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.4 105.81 13.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.974 -1.079 . . . . 0.0 109.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.656 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -106.01 67.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.288 -0.882 . . . . 0.0 109.538 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 91' ' ' VAL . 15.3 ttmm -36.97 100.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.391 0.615 . . . . 0.0 109.58 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.647 HG13 ' HA ' ' A' ' 105' ' ' ILE . 0.9 OUTLIER -115.96 -16.68 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.029 HD11 HD22 ' A' ' 124' ' ' LEU . 39.3 mt -118.79 169.12 10.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.807 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 167.19 12.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 59' ' ' GLY . . . -66.58 -25.84 66.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -1.149 . . . . 0.0 109.246 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -49.81 74.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.78 2.33 14.5 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.8 74.28 1.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -1.145 . . . . 0.0 109.641 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.36 27.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.13 145.54 26.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.765 -0.844 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.822 HG21 ' OG ' ' A' ' 130' ' ' SER . 1.2 t -67.24 -32.27 56.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -21.85 66.7 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.642 ' HA ' ' NE2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -85.34 -62.31 1.56 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.669 -0.644 . . . . 0.0 109.268 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.647 ' HA ' HG13 ' A' ' 93' ' ' VAL . 1.3 mt -48.71 -27.12 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.42 -48.75 21.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.405 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.642 ' NE2' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -62.54 -20.38 64.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.212 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.53 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -82.66 -38.42 12.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.9 mt -65.37 -24.98 67.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.378 -1.072 . . . . 0.0 109.234 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -26.03 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.495 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 55.4 t90 -72.68 -14.78 61.65 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.933 -1.105 . . . . 0.0 108.476 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.733 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -94.29 7.99 43.44 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.584 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -103.4 -45.16 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -86.21 -83.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.919 -1.341 . . . . 0.0 108.391 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.91 49.52 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.733 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -112.61 -156.13 12.6 Favored Glycine 0 C--N 1.289 -2.082 0 CA-C-O 122.376 0.987 . . . . 0.0 111.525 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.636 ' HE3' ' C ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -122.3 163.05 20.36 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.276 0.56 . . . . 0.0 109.558 -178.272 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.774 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -72.79 -16.75 61.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 108.699 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 118' ' ' HIS . 4.7 t -125.02 161.09 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.03 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.988 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -159.77 156.98 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 108.793 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.467 ' C ' HD12 ' A' ' 122' ' ' LEU . 40.6 t30 -135.56 152.56 51.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.313 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 121' ' ' ASN . 3.4 mp -135.47 81.9 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.515 ' HG ' ' CB ' ' A' ' 215' ' ' SER . 5.0 t -71.32 84.16 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.011 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.029 HD22 HD11 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 177.43 176.54 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.391 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.532 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -176.07 93.85 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 0.6 OUTLIER -86.99 148.73 46.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.29 -1.124 . . . . 0.0 109.272 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.447 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -76.39 -9.26 18.81 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.385 2.057 . . . . 0.0 108.942 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -97.34 108.83 46.94 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 161' ' ' TYR . 31.9 Cg_endo -75.07 166.23 29.57 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.119 1.88 . . . . 0.0 109.831 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.822 ' OG ' HG21 ' A' ' 102' ' ' VAL . 43.8 m -157.75 118.96 3.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.987 -1.07 . . . . 0.0 110.532 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.68 66.03 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.9 m -61.75 -31.77 71.97 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.28 -33.72 61.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE1' ' OH ' ' A' ' 165' ' ' TYR . 4.4 tt0 -73.32 -22.79 60.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.802 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -25.56 58.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.1 -37.14 39.43 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.592 HG13 ' CG ' ' A' ' 167' ' ' ASN . 2.0 t -70.44 -29.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -64.19 -35.6 81.32 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.3 m -78.11 -22.8 48.36 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -91.52 -5.37 54.26 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -90.73 -43.15 10.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.214 -0.929 . . . . 0.0 109.143 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.5 m -64.21 -17.94 64.03 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.78 -14.12 23.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.455 -0.778 . . . . 0.0 109.371 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.84 62.85 4.22 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.96 115.49 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -1.074 . . . . 0.0 109.376 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.1 113.18 8.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.016 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.988 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -109.65 150.89 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 149' ' ' ALA . 2.7 t -123.56 166.59 18.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.51 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -157.38 135.42 10.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 110.264 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.492 ' N ' HG21 ' A' ' 218' ' ' THR . . . -61.17 171.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.4 OUTLIER -93.22 -39.07 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 109.944 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 132.53 120.91 2.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 47.11 1.29 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.905 -0.762 . . . . 0.0 109.473 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 155' ' ' GLY . 1.6 t -121.75 -91.93 0.55 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.455 ' N ' ' OG ' ' A' ' 154' ' ' SER . . . 150.51 95.95 0.14 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -158.23 173.26 16.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 0.0 109.634 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.98 42.24 3.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.6 t -163.64 160.53 22.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -1.149 . . . . 0.0 109.321 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.716 HD11 ' O ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -98.16 -173.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.09 -1.006 . . . . 0.0 110.148 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.532 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 69.7 m -67.28 -174.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.691 1.234 . . . . 0.0 111.389 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.465 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 12.7 m-85 -137.2 128.56 16.46 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.737 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.1 Cg_endo -70.91 -50.74 0.18 OUTLIER 'Cis proline' 0 C--N 1.3 -1.993 0 O-C-N 123.188 1.099 . . . . 0.0 110.419 4.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . 30.89 -77.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.615 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.737 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -36.51 -39.97 0.22 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.363 178.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.2 m-85 -49.73 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.344 -0.847 . . . . 0.0 110.241 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.86 0.1 11.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.592 ' CG ' HG13 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -87.01 16.95 4.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.165 -0.959 . . . . 0.0 108.934 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.47 153.53 7.75 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.404 ' HG3' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.2 129.8 42.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.921 -1.112 . . . . 0.0 109.509 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -91.41 133.63 35.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 172' ' ' GLY . 38.5 t -104.75 165.15 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.766 -1.209 . . . . 0.0 110.088 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.559 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -129.76 -169.98 12.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.14 155.51 44.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.454 HG23 ' HB ' ' A' ' 193' ' ' VAL . 2.6 p -125.32 -174.31 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 -176.59 3.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 109.798 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.35 -27.29 9.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.002 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -114.78 -93.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.034 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 13.4 p30 -142.49 16.81 2.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.909 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.36 153.03 22.81 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.047 -1.033 . . . . 0.0 108.833 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.507 ' N ' ' OH ' ' A' ' 257' ' ' TYR . 0.5 OUTLIER -73.18 136.45 44.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -50.33 -172.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.516 -0.74 . . . . 0.0 110.148 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.4 t -116.06 -17.59 10.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -111.35 -19.91 12.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.494 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 8.5 t -48.36 134.81 14.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 152' ' ' GLY . 0.9 OUTLIER -79.59 157.25 27.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.652 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.1 OUTLIER -134.49 173.23 11.87 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.393 -0.817 . . . . 0.0 109.032 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 150.31 147.77 4.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.716 ' O ' HD11 ' A' ' 159' ' ' ILE . . . -49.54 141.31 9.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.16 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.58 -11.24 46.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.5 tp -56.62 118.1 4.52 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.317 -1.108 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 259' ' ' SER . 0.5 OUTLIER -69.63 -75.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.985 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.597 HD12 HG13 ' A' ' 262' ' ' VAL . 0.4 OUTLIER -145.22 -158.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 260' ' ' GLY . 27.0 m -135.06 172.8 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.133 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -162.11 178.26 1.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.0 Cg_endo -76.19 114.02 3.81 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.097 1.864 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.05 40.07 1.44 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 53.9 t -123.46 82.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.652 ' HB3' ' O ' ' A' ' 197' ' ' VAL . 12.5 t-20 83.85 120.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.164 0.983 . . . . 0.0 108.449 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 199' ' ' VAL . 28.3 m -153.06 105.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 122.443 1.116 . . . . 0.0 109.105 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -83.54 109.31 17.28 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.327 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.626 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 1.4 t -123.99 -165.65 1.38 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 109.105 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.632 HG21 ' OD1' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -69.24 176.72 3.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.213 -0.929 . . . . 0.0 110.268 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.649 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.6 OUTLIER -161.99 149.09 11.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.649 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.4 Cg_endo -69.99 173.48 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.277 1.985 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 79.97 8.79 87.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 1.0 OUTLIER 67.67 55.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.5 -1.0 . . . . 0.0 109.861 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.791 HG23 ' N ' ' A' ' 208' ' ' TYR . 4.2 t -155.85 -147.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.732 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.791 ' N ' HG23 ' A' ' 207' ' ' THR . 10.5 m-85 -146.36 -177.34 5.57 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.241 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 203' ' ' TYR . . . 177.13 147.57 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.88 . . . . 0.0 110.373 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.613 ' C ' HD23 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -118.86 142.27 47.89 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.131 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -158.72 122.38 3.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.857 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.433 ' CB ' ' H ' ' A' ' 198' ' ' ASN . 1.6 p-10 -72.84 160.7 31.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.139 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.16 156.3 8.53 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.5 m -79.95 -27.36 39.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.187 . . . . 0.0 109.431 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.515 ' CB ' ' HG ' ' A' ' 123' ' ' SER . 0.3 OUTLIER -74.75 -13.76 60.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.646 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -20.94 28.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.676 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -95.35 -3.6 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.644 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 8.5 m -75.17 -43.94 4.56 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 111.307 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.71 ' HG2' HG21 ' A' ' 69' ' ' THR . 30.5 Cg_endo -72.27 -13.29 28.16 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.614 1.543 . . . . 0.0 110.155 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.84 ' CE1' HG23 ' A' ' 69' ' ' THR . 6.2 m80 -70.99 -44.24 66.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 222' ' ' ALA . 46.2 t -66.54 -51.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -44.26 -37.35 3.19 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.694 -0.802 . . . . 0.0 108.865 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -66.69 -52.8 31.63 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.68 -56.95 10.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 109.656 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.65 23.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.974 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.043 -1.036 . . . . 0.0 110.042 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 82' ' ' VAL . 38.4 mt -61.95 -46.65 88.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.035 -1.041 . . . . 0.0 109.658 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.556 ' O ' ' CG ' ' A' ' 231' ' ' LYS . 55.5 t -60.29 -43.7 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.436 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 118' ' ' HIS . 0.2 OUTLIER -53.09 -40.42 64.1 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.966 -1.084 . . . . 0.0 108.902 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -61.85 -56.02 23.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.266 -0.896 . . . . 0.0 110.348 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 228' ' ' VAL . 0.1 OUTLIER -52.0 -19.82 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.967 -1.083 . . . . 0.0 109.206 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.587 ' OD1' ' CG ' ' A' ' 235' ' ' TRP . 0.1 OUTLIER -132.85 94.11 22.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.915 . . . . 0.0 109.066 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.32 41.38 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.737 2.291 . . . . 0.0 110.862 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.9 t -164.22 13.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.0 111.869 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.587 ' CG ' ' OD1' ' A' ' 232' ' ' ASN . 26.4 m0 -92.89 174.31 7.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.434 -1.416 . . . . 0.0 109.559 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.5 OUTLIER -104.76 174.01 6.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.527 -0.733 . . . . 0.0 109.148 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -65.97 -25.58 67.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 109.736 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.7 t -78.77 -64.84 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.227 -0.92 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 238' ' ' VAL . 10.9 mm100 -44.68 -37.89 3.99 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.77 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 236' ' ' SER . 55.8 mt -68.4 -55.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 12.5 ttp180 -52.14 -21.89 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.029 . . . . 0.0 110.008 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -73.0 -59.8 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.69 ' O ' HG23 ' A' ' 247' ' ' THR . 19.8 t60 -52.61 -47.96 66.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.554 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -66.84 -37.82 85.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.344 -0.847 . . . . 0.0 110.05 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -59.05 -62.82 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.488 -0.758 . . . . 0.0 110.65 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -72.59 -10.71 60.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 111.558 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 243' ' ' HIS . 2.9 p -81.34 -31.16 33.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.429 -1.419 . . . . 0.0 109.846 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -42.92 115.63 0.77 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.966 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.495 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 0.0 OUTLIER -43.61 169.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.802 . . . . 0.0 109.928 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.7 p -121.94 106.2 11.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 109.881 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.768 HD22 ' H ' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -63.03 -57.8 9.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.165 -0.959 . . . . 0.0 109.356 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 135.03 99.64 0.61 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 257' ' ' TYR . 23.0 p -141.82 179.92 6.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -1.185 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 2.1 t -104.16 -24.52 13.15 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.59 -0.694 . . . . 0.0 109.958 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 254' ' ' THR . 2.6 t30 176.04 -24.33 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.353 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.5 -66.43 0.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.779 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 253' ' ' SER . 50.5 m-85 -47.56 -60.65 2.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.049 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.76 20.75 74.51 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 191' ' ' ASP . 0.3 OUTLIER -167.57 -100.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 0.0 109.836 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.795 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 157.86 -160.57 30.83 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.583 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.603 ' CB ' HD11 ' A' ' 251' ' ' LEU . 9.4 tp -104.65 129.87 52.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.518 -0.99 . . . . 0.0 109.461 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -58.73 172.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.085 -1.009 . . . . 0.0 109.943 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.754 HD21 ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.66 117.88 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 122.486 1.136 . . . . 0.0 108.408 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 12' ' ' GLN . . . -74.28 -18.85 60.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.469 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 10.4 tt0 -95.49 -2.18 49.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.61 0.34 36.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -130.06 -1.04 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.865 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 269' ' ' ARG . 1.4 p -113.13 -35.69 5.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.562 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.529 ' OXT' ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.623 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.56 ' O ' HG12 ' A' ' 79' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.352 0.596 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.55 149.37 34.84 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.299 -0.876 . . . . 0.0 109.63 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -74.26 108.75 7.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 0.0 109.62 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.7 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -143.07 44.09 0.5 Allowed Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 121.4 -0.812 . . . . 0.0 109.977 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.7 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.8 Cg_endo -78.06 172.39 15.6 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.653 1.568 . . . . 0.0 109.112 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -72.83 8.87 1.31 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 111.096 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -110.12 -64.97 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.7 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -56.46 -30.5 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.032 -1.275 . . . . 0.0 109.896 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 m -56.23 -34.56 66.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 109.849 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.03 -16.0 25.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.0 111.594 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 8' ' ' ILE . 3.0 m -85.35 15.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.299 -1.501 . . . . 0.0 110.387 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 74.6 mm-40 37.74 45.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.692 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -72.18 -35.17 3.21 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -72.9 -47.33 0.34 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 N-CA-C 108.162 -1.515 . . . . 0.0 108.162 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.25 -36.69 1.88 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -41.08 60.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.507 ' HE2' ' C ' ' A' ' 82' ' ' VAL . 2.2 m-70 -63.45 -16.85 61.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.294 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -106.78 -24.76 11.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.783 -1.198 . . . . 0.0 109.915 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.4 mmp_? -63.47 -64.86 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' C ' HD12 ' A' ' 21' ' ' LEU . . . 158.38 59.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.7 mp -144.05 132.18 21.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -1.056 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.426 ' C ' ' N ' ' A' ' 24' ' ' SER . 47.1 p -125.93 -8.08 6.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.364 -0.835 . . . . 0.0 109.986 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.87 11.5 4.39 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' ' C ' ' A' ' 22' ' ' THR . 12.3 p -60.16 -14.74 18.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 110.072 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.17 25.93 23.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 27' ' ' LYS . 57.7 t -132.0 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.001 -1.294 . . . . 0.0 110.091 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 22.9 mtmt -138.85 121.24 16.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 7.7 t -113.84 152.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.985 . . . . 0.0 110.294 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.574 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -110.83 160.48 16.71 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.441 -0.787 . . . . 0.0 108.912 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.87 94.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 108.426 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.993 HD23 HG21 ' A' ' 93' ' ' VAL . 5.8 mp -81.14 116.44 21.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -175.7 -161.72 0.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.941 -1.099 . . . . 0.0 110.26 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.843 HG23 ' HA2' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -46.78 -37.07 8.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.459 -0.776 . . . . 0.0 109.729 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 155.59 -103.52 0.24 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.588 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.0 mt 145.45 101.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 204' ' ' PRO . 0.4 OUTLIER -69.12 151.37 46.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.617 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 160.25 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.619 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -167.71 147.72 4.5 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 108.979 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.7 Cg_endo -77.14 -13.99 16.91 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.491 2.128 . . . . 0.0 110.477 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.31 5.27 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 108.918 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 38' ' ' HIS . 22.1 mt -110.22 159.44 17.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.106 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.72 76.97 1.56 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.39 145.8 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 108.747 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.534 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.83 -20.95 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.913 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -178.22 153.31 12.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.82 -177.24 37.88 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.507 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 178.18 113.46 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 92' ' ' LYS . 25.1 m -105.44 111.07 23.65 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.517 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.511 ' CG ' ' HG2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -89.92 -22.72 21.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.863 HG21 ' O ' ' A' ' 93' ' ' VAL . 1.8 t -62.2 135.25 94.94 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.412 -0.805 . . . . 0.0 108.937 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.19 164.09 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.448 2.098 . . . . 0.0 110.672 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . 162.08 -69.12 0.23 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.633 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER 169.34 -51.01 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.306 -1.114 . . . . 0.0 109.825 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 53' ' ' GLU . 35.5 Cg_endo -77.85 -72.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.922 1.748 . . . . 0.0 109.246 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER 86.84 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.586 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -73.98 13.46 0.53 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.643 -1.286 . . . . 0.0 111.103 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 56' ' ' THR . 31.5 mt-30 -147.59 174.74 11.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.533 -1.354 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HB2' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -57.68 160.78 4.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.471 -0.768 . . . . 0.0 110.648 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.09 10.15 3.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB2' HG21 ' A' ' 33' ' ' THR . 1.3 t-20 -167.25 -65.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 109.353 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.27 -32.27 0.54 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -45.56 -65.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -46.02 -70.89 0.58 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 63' ' ' GLY . 22.6 m -33.59 -49.4 0.3 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.778 -0.837 . . . . 0.0 111.252 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.614 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.5 t-80 -57.92 -52.65 64.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.067 -1.021 . . . . 0.0 110.344 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.75 HG13 ' HB3' ' A' ' 219' ' ' PRO . 25.4 t -57.17 -37.81 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.078 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.76 -41.11 97.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.599 ' HA3' HG22 ' A' ' 202' ' ' THR . . . -68.26 -46.29 65.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.465 HG23 ' NE2' ' A' ' 220' ' ' HIS . 28.6 m -53.14 -29.22 30.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.431 -1.041 . . . . 0.0 108.974 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.0 mt -90.07 -24.31 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.555 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -120.22 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.938 -1.101 . . . . 0.0 111.9 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.051 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 37.62 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.745 . . . . 0.0 109.868 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 73' ' ' LEU . 15.0 mt -52.86 141.75 20.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.47 -1.394 . . . . 0.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -89.78 116.36 27.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -174.48 -105.87 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -45.98 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.348 -0.845 . . . . 0.0 109.224 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -72.07 169.87 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 77' ' ' ILE . . . 41.06 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 1' ' ' ALA . 27.4 m -115.91 -162.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.978 . . . . 0.0 109.1 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 3' ' ' SER . 1.9 tp -106.96 121.29 44.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.135 -0.978 . . . . 0.0 109.65 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 1.051 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -88.48 -146.19 12.07 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.682 HG12 HD11 ' A' ' 227' ' ' LEU . 1.9 t -112.23 -34.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -1.225 . . . . 0.0 109.841 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.784 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -121.7 128.97 25.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.045 -1.035 . . . . 0.0 109.072 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 38.1 Cg_endo -85.36 -62.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.646 2.231 . . . . 0.0 110.618 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.4 37.04 1.2 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.337 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.784 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -82.44 129.06 34.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.45 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -61.49 87.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.326 -0.859 . . . . 0.0 109.373 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 mt -76.49 124.33 27.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.078 -1.014 . . . . 0.0 109.741 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.557 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 7.0 m-85 -115.57 152.18 33.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.476 -0.765 . . . . 0.0 109.185 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -119.05 98.81 6.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.052 -1.03 . . . . 0.0 110.334 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.574 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -103.47 64.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.068 -1.02 . . . . 0.0 108.651 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 55' ' ' SER . 7.8 ttmt -37.34 121.91 0.87 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.549 0.69 . . . . 0.0 111.134 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.993 HG21 HD23 ' A' ' 31' ' ' LEU . 25.3 t -123.28 -36.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.01 HD21 HD13 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -130.16 179.56 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.843 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 154.79 -140.2 7.24 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 118.256 -1.926 . . . . 0.0 112.186 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 97' ' ' SER . . . -36.99 -60.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.135 -0.627 . . . . 0.0 110.72 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 96' ' ' ALA . 42.6 m -41.16 -49.54 3.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.85 88.37 1.56 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.75 ' HA ' HD23 ' A' ' 94' ' ' LEU . 22.7 m 59.44 79.33 0.23 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 99' ' ' SER . . . -46.57 176.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.28 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.1 t -83.96 176.73 8.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.912 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' A' ' 101' ' ' SER . 44.5 t -68.27 -13.39 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.09 -22.84 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.3 m -85.67 -43.6 13.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.727 HD13 HD11 ' A' ' 124' ' ' LEU . 1.6 mt -71.21 -23.27 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.52 25.15 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.681 -0.637 . . . . 0.0 109.413 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.511 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 3.5 tp-100 -69.98 -32.79 71.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 -39.05 27.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.723 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 15.0 mt -73.7 -28.1 61.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -1.168 . . . . 0.0 109.707 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -92.33 -21.27 20.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.096 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.485 ' O ' ' CD2' ' A' ' 111' ' ' TRP . 64.7 t90 -76.85 -11.67 59.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.418 -0.801 . . . . 0.0 108.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.746 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -97.28 -1.37 44.88 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.302 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.62 -21.61 39.74 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -119.03 -5.84 10.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.132 . . . . 0.0 110.252 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -164.65 20.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.804 -1.185 . . . . 0.0 110.563 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -105.31 -152.77 21.29 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.732 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.713 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 10.6 mmt -120.56 -176.73 3.3 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.636 -0.92 . . . . 0.0 110.633 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.86 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -81.1 -25.75 36.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.217 -178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.86 HG22 ' CE1' ' A' ' 118' ' ' HIS . 2.4 t -114.77 158.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.575 -1.328 . . . . 0.0 109.738 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.55 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -167.29 145.12 4.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.839 ' O ' HD12 ' A' ' 122' ' ' LEU . 10.5 t-20 -115.35 162.18 17.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 109.454 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 121' ' ' ASN . 3.8 mp -144.97 113.56 6.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.196 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.515 ' C ' HD23 ' A' ' 124' ' ' LEU . 10.8 m -92.7 68.99 4.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.01 HD13 HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 178.54 177.02 0.47 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -0.925 . . . . 0.0 110.002 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 161' ' ' TYR . . . 172.17 -79.31 0.09 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER 81.86 162.0 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.762 -0.846 . . . . 0.0 110.032 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 34.8 Cg_endo -76.43 -14.55 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.514 2.143 . . . . 0.0 109.78 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.41 118.25 60.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.77 165.97 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.159 1.906 . . . . 0.0 110.344 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -168.68 106.41 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.899 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.7 -18.13 64.81 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.6 m -68.25 -29.21 67.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -42.05 37.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.12 -19.03 61.23 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.747 -1.181 . . . . 0.0 108.153 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 tt0 -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.723 ' HB1' ' HB3' ' A' ' 109' ' ' LEU . . . -76.61 -36.04 57.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.493 HG21 ' HB1' ' A' ' 166' ' ' ALA . 1.3 t -70.57 -29.67 39.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.3 -38.57 84.08 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.1 -25.12 58.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -85.95 -6.82 58.99 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.6 m -86.57 -51.99 5.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.1 -1.0 . . . . 0.0 109.141 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -18.27 45.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -20.55 16.52 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 78.51 0.5 Allowed Glycine 0 N--CA 1.478 1.465 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 118' ' ' HIS . 22.1 t -131.43 118.11 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -1.061 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.91 122.19 26.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -115.27 151.74 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.636 HG12 ' ND2' ' A' ' 121' ' ' ASN . 2.7 t -119.22 159.79 19.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -146.88 135.1 21.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.869 -1.144 . . . . 0.0 110.409 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.454 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -67.12 174.83 2.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.664 -0.648 . . . . 0.0 109.553 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 15.2 t -73.03 -82.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 145.57 120.65 1.34 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.428 ' C ' ' OG ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -86.35 60.11 6.04 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 121.922 -0.752 . . . . 0.0 109.598 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' C ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 171.61 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.164 -0.96 . . . . 0.0 110.898 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -19.69 -50.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.237 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 90.57 63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.786 0.803 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.16 -3.09 32.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 159' ' ' ILE . 15.0 m -134.22 122.83 23.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 0.0 109.562 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -51.18 179.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.806 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -105.92 173.3 6.37 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.554 1.169 . . . . 0.0 112.526 -177.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.565 ' O ' ' CA ' ' A' ' 125' ' ' GLY . 24.4 m-85 -108.94 144.75 30.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.1 Cg_endo -72.88 -31.82 4.91 Favored 'Cis proline' 0 C--N 1.297 -2.181 0 O-C-N 122.33 0.647 . . . . 0.0 111.27 4.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -4.1 -61.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.604 0.716 . . . . 0.0 111.656 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 162' ' ' PRO . 9.6 tpt180 -48.77 -65.9 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.724 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 38.1 p90 -121.75 -163.43 1.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.922 0.868 . . . . 0.0 110.676 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 165' ' ' TYR . . . 80.1 49.3 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.648 0.737 . . . . 0.0 109.589 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 166' ' ' ALA . 23.0 m-80 41.77 28.76 0.09 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -112.49 116.32 30.08 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.91 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.475 ' HB2' HG22 ' A' ' 148' ' ' VAL . 73.5 mmm -63.64 171.83 2.44 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.293 -0.88 . . . . 0.0 108.792 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -137.02 114.42 10.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.653 HG22 HG21 ' A' ' 221' ' ' VAL . 27.5 t -99.68 166.05 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -148.8 108.4 0.4 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -52.01 149.58 4.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.28 . . . . 0.0 109.541 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.479 ' HB2' ' C ' ' A' ' 180' ' ' ARG . 6.2 t0 -115.46 -149.5 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.131 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 177' ' ' ASN . 56.7 tt0 -40.3 -43.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.458 -0.776 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 7.4 m-20 164.47 119.86 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 44.0 t30 53.94 38.38 28.69 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.216 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -132.07 -18.12 2.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.94 . . . . 0.0 110.282 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.479 ' C ' ' HB2' ' A' ' 175' ' ' ASP . 1.8 ttp85 66.79 126.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 109.188 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -42.47 163.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.591 -0.693 . . . . 0.0 109.901 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.9 p -84.31 4.88 29.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.289 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.452 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 6.2 p90 -137.93 11.74 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 33.7 t -87.75 105.58 17.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.399 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.603 ' HG2' ' N ' ' A' ' 155' ' ' GLY . 1.5 mp0 -52.38 154.46 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -0.962 . . . . 0.0 110.118 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.75 168.2 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 173.12 144.47 4.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.72 131.31 50.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.322 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.43 -1.15 39.95 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.482 ' HG ' ' N ' ' A' ' 191' ' ' ASP . 6.6 tp -60.94 146.79 45.55 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.28 -1.129 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.4 OUTLIER -73.68 -80.05 0.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.059 -1.026 . . . . 0.0 110.368 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.696 HG13 HG22 ' A' ' 262' ' ' VAL . 0.2 OUTLIER -152.75 -169.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.781 -1.199 . . . . 0.0 109.516 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.547 ' N ' HG12 ' A' ' 192' ' ' ILE . 32.6 m -126.59 162.16 31.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.009 -1.057 . . . . 0.0 110.163 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.904 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -145.76 140.4 15.68 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 7' ' ' GLY . 34.6 Cg_endo -76.17 112.95 3.59 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.449 2.099 . . . . 0.0 111.115 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.573 ' O ' ' C ' ' A' ' 197' ' ' VAL . . . -114.12 -67.79 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 78.0 t 5.52 71.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.713 ' O ' HG13 ' A' ' 199' ' ' VAL . 9.5 t-20 99.13 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 198' ' ' ASN . 7.3 m -163.41 110.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 122.149 0.976 . . . . 0.0 109.259 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.538 ' CG ' ' OG ' ' A' ' 210' ' ' SER . 6.3 mt-30 -77.43 129.52 35.86 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.614 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -135.95 -153.46 0.51 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.042 -1.036 . . . . 0.0 109.64 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.599 HG22 ' HA3' ' A' ' 68' ' ' GLY . 9.8 t -102.94 177.32 4.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.665 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -144.63 -179.45 0.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.665 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -73.38 -151.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.98 1.787 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . -37.62 -29.7 0.05 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' PRO . 17.8 t -48.39 -97.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.256 -1.144 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 208' ' ' TYR . 5.2 t 175.53 -120.33 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.573 ' N ' HG23 ' A' ' 207' ' ' THR . 0.6 OUTLIER -78.33 -170.38 2.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.868 -1.145 . . . . 0.0 109.748 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.768 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.538 ' OG ' ' CG ' ' A' ' 200' ' ' GLN . 0.1 OUTLIER -174.21 139.34 0.62 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.56 HD12 ' SD ' ' A' ' 216' ' ' MET . 0.1 OUTLIER -175.63 162.29 2.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -106.08 173.5 6.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.438 -0.788 . . . . 0.0 109.226 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 147.18 147.61 4.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 151' ' ' SER . 23.2 m -73.92 -22.5 59.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.131 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.466 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 71.2 m -74.15 -9.94 59.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.56 ' SD ' HD12 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -86.45 -19.59 29.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.904 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -90.36 -14.06 33.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.659 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -71.07 -39.28 8.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 0.0 111.452 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.75 ' HB3' HG13 ' A' ' 66' ' ' VAL . 31.7 Cg_endo -73.25 -28.63 12.32 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.761 1.641 . . . . 0.0 110.561 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.465 ' NE2' HG23 ' A' ' 69' ' ' THR . 7.9 m80 -61.91 -35.67 79.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 171' ' ' VAL . 33.8 t -75.73 -39.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -27.67 67.27 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.86 2.37 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.833 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -45.39 -42.09 9.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 109.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.52 95.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.775 . . . . 0.0 109.171 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.86 -40.91 73.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.165 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.833 HD12 ' HA ' ' A' ' 224' ' ' ALA . 5.1 mt -61.88 -45.15 95.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 109.328 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 229' ' ' LYS . 75.7 t -57.9 -67.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.713 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -40.02 -43.04 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.709 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.475 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 14.9 tm0? -58.37 -54.11 50.71 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.224 -0.923 . . . . 0.0 110.018 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 228' ' ' VAL . 0.0 OUTLIER -56.79 -17.26 8.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.188 -0.945 . . . . 0.0 108.917 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 m-20 -156.57 81.18 3.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.6 Cg_endo -81.14 40.32 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.757 2.305 . . . . 0.0 110.663 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.41 7.68 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.0 109.762 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.416 ' CZ2' ' ND2' ' A' ' 232' ' ' ASN . 45.1 m0 -91.05 175.03 7.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.775 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.37 8.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 237' ' ' ASN . 2.0 m-80 -58.11 -32.75 68.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.13 -0.981 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.9 t -71.88 -63.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.31 -0.869 . . . . 0.0 109.09 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.8 OUTLIER -42.01 -42.06 2.73 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.379 0.609 . . . . 0.0 109.809 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 9.4 mm -63.06 -47.89 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.847 . . . . 0.0 109.302 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' ASN . 0.6 OUTLIER -58.41 -62.64 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -40.33 -43.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.439 -0.788 . . . . 0.0 110.422 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.462 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.9 t60 -70.67 -38.44 73.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.9 -1.125 . . . . 0.0 110.223 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.8 OUTLIER -73.3 -22.5 60.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.452 -0.78 . . . . 0.0 110.019 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -84.48 -34.33 23.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.349 -0.845 . . . . 0.0 108.942 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -85.97 -17.17 36.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.59 -0.694 . . . . 0.0 109.312 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 5.0 p -88.24 -34.26 17.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 109.402 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.04 133.83 11.05 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.463 ' OG1' ' OD1' ' A' ' 263' ' ' ASN . 2.9 m -57.87 152.4 16.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.704 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 259' ' ' SER . 25.8 p -120.48 98.63 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.884 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.4 mp -53.39 -62.53 1.6 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.08 -1.012 . . . . 0.0 109.343 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -178.65 -33.73 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.48 159.47 4.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.149 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.478 ' O ' ' OG1' ' A' ' 254' ' ' THR . 0.0 OUTLIER -141.17 30.17 1.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.669 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -167.77 -51.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.01 -1.056 . . . . 0.0 109.374 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.457 ' HA ' ' CE1' ' A' ' 186' ' ' TYR . 7.3 mt -63.43 -56.24 17.82 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 109.066 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.45 -46.43 10.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.9 -33.04 4.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.525 ' CB ' HG22 ' A' ' 192' ' ' ILE . 1.5 m -141.42 -98.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -1.135 . . . . 0.0 109.331 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.51 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 162.19 -124.56 1.31 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.169 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -84.65 135.11 34.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.592 -0.946 . . . . 0.0 110.163 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.696 HG22 HG13 ' A' ' 192' ' ' ILE . 1.4 t -78.6 144.44 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.463 ' OD1' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -160.88 118.28 2.38 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.604 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.395 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 2.3 tm-20 -63.12 -28.86 70.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.15 -18.19 50.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -107.11 9.87 30.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 269' ' ' ARG . 17.3 p -128.38 -67.53 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 268' ' ' THR . 8.3 tpt180 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.626 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.353 0.597 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.83 135.2 45.16 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.508 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -86.13 128.86 34.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -115.32 86.4 14.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.977 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 3' ' ' SER . 37.0 Cg_endo -80.87 -175.01 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.973 2.449 . . . . 0.0 111.575 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.635 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -55.58 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.442 0.639 . . . . 0.0 110.52 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 6' ' ' TRP . . . -40.12 -83.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.688 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.4 mp -41.65 102.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -1.029 . . . . 0.0 109.741 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER 167.9 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.202 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' NH2' HD22 ' A' ' 261' ' ' LEU . 1.2 ttp85 -93.47 4.44 53.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.316 -0.865 . . . . 0.0 109.895 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 11' ' ' VAL . 3.5 m -94.48 25.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.01 -1.056 . . . . 0.0 109.818 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 88.1 mm-40 43.03 46.96 4.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.67 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -81.45 -35.62 0.78 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 111.433 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.7 Cg_endo -74.42 -55.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.222 -1.491 . . . . 0.0 108.222 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.56 -34.63 3.45 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -71.47 -41.57 69.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.9 -1.125 . . . . 0.0 109.147 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.508 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 7.4 m170 -75.79 -2.9 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.702 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -115.08 -11.0 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.117 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -73.67 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 109.404 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.76 30.77 0.06 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.858 HD23 ' HG3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -142.89 145.4 33.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.184 . . . . 0.0 109.391 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -123.6 -9.93 7.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -0.835 . . . . 0.0 109.711 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -7.47 16.66 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 24' ' ' SER . 51.7 p -60.05 94.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.553 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.28 -4.47 2.85 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.228 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.621 ' CG1' ' CE1' ' A' ' 118' ' ' HIS . 5.3 t -97.49 160.99 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.907 -1.349 . . . . 0.0 109.904 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.3 OUTLIER -125.84 117.29 23.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 110.016 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.56 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 13.7 t -107.37 145.1 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.597 -0.689 . . . . 0.0 109.315 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -106.56 155.59 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' A' ' 70' ' ' ILE . 41.7 t -128.59 86.69 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.595 HD23 HG21 ' A' ' 93' ' ' VAL . 2.5 mp -81.72 90.33 6.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.665 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.541 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -157.03 -146.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 108.747 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -57.28 -73.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.586 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -166.46 -126.93 0.86 Allowed Glycine 0 N--CA 1.476 1.363 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 90' ' ' ALA . 8.0 mt -167.4 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 20.5 t -47.82 141.5 5.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.042 -1.036 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.58 141.92 56.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.243 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.606 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.4 157.12 21.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.35 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 35.8 Cg_endo -78.75 -6.01 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.736 2.291 . . . . 0.0 111.111 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.47 -21.48 19.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 0.0 109.993 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -117.09 150.16 39.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.045 -1.034 . . . . 0.0 109.712 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 116.42 31.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.523 -0.735 . . . . 0.0 109.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.41 111.56 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.114 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 62.6 mmt-85 -118.79 11.23 12.61 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.675 ' HA3' ' CD2' ' A' ' 89' ' ' TYR . . . -174.34 142.57 6.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.17 84.82 0.15 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.487 -1.339 . . . . 0.0 110.645 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 124.49 45.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 108.652 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.585 ' HB2' ' CE ' ' A' ' 92' ' ' LYS . 6.5 p -111.43 117.77 33.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.001 -1.062 . . . . 0.0 110.416 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.921 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 21.4 m-85 -86.12 -77.77 0.3 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.285 -0.884 . . . . 0.0 108.732 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 77.5 t -38.94 94.39 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.939 -0.475 . . . . 0.0 109.739 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 49' ' ' PHE . 37.4 Cg_endo -87.63 154.59 7.61 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.274 1.982 . . . . 0.0 111.822 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . 100.1 26.95 8.05 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.387 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.662 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.4 OUTLIER 178.84 -70.41 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 CA-C-N 120.716 2.258 . . . . 0.0 114.138 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.662 ' HD3' ' CB ' ' A' ' 53' ' ' GLU . 39.4 Cg_endo -76.79 -102.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.429 1.42 . . . . 0.0 112.849 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.631 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 3.5 t 144.4 175.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.515 HG22 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -77.33 0.22 23.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 58' ' ' ASP . 2.0 mt-30 -110.92 -172.42 2.03 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.108 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 29.2 t70 -32.43 142.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.569 0.699 . . . . 0.0 110.916 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.3 -40.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -144.39 -65.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.478 -1.013 . . . . 0.0 109.319 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.48 -31.25 0.52 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.545 ' CE1' ' CB ' ' A' ' 215' ' ' SER . 1.1 t60 -61.37 -43.43 98.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -57.4 -74.66 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.57 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -38.28 -49.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.51 -0.994 . . . . 0.0 110.557 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 12.9 t-80 -52.29 -50.79 61.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 70' ' ' ILE . 31.4 t -62.27 -29.58 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.404 -0.81 . . . . 0.0 109.584 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -61.3 -47.43 85.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.342 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.458 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -75.81 -23.09 73.3 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.564 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 8.3 m -74.58 -14.86 60.84 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.084 -1.245 . . . . 0.0 107.875 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 66' ' ' VAL . 62.6 mt -94.73 -35.46 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.503 -0.748 . . . . 0.0 110.829 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.671 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -165.5 27.93 0.05 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 0.0 112.37 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -44.19 153.87 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.444 -1.41 . . . . 0.0 108.635 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 79' ' ' VAL . 73.9 mt -75.86 171.95 13.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.95 -1.094 . . . . 0.0 110.205 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.797 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -103.64 51.57 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.555 ' O ' ' C ' ' A' ' 76' ' ' SER . 5.2 p30 -177.07 -115.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.568 ' O ' ' C ' ' A' ' 77' ' ' ILE . 12.3 m 22.28 71.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.335 -0.228 . . . . 0.0 110.956 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.58 ' O ' HD12 ' A' ' 77' ' ' ILE . 1.3 pp 14.79 57.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.664 0.745 . . . . 0.0 111.578 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' SER . . . -154.87 -161.27 10.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 79' ' ' VAL . 21.9 m -95.9 -161.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -1.132 . . . . 0.0 109.861 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD22 ' HB3' ' A' ' 74' ' ' ASN . 20.2 tp -143.42 123.45 13.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.838 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.83 -148.9 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.508 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 40.7 t -100.16 -25.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.086 -1.243 . . . . 0.0 109.325 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -99.65 137.14 20.18 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.977 . . . . 0.0 108.754 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.47 -61.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.72 2.28 . . . . 0.0 111.018 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -117.48 48.52 1.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.525 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -87.78 150.41 23.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.112 -0.992 . . . . 0.0 109.402 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 2.5 mt-10 -81.85 108.42 15.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 109.156 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 71' ' ' ALA . 8.6 mt -85.45 124.94 32.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.675 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 7.6 m-85 -113.76 143.18 45.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.166 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.735 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -111.97 95.4 5.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.127 -0.983 . . . . 0.0 109.64 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.921 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.63 62.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.083 -1.011 . . . . 0.0 108.897 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.585 ' CE ' ' HB2' ' A' ' 48' ' ' SER . 12.2 ttpp -36.81 116.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.282 0.563 . . . . 0.0 110.077 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG21 HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -122.58 0.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 32' ' ' ASP . 62.8 mt -119.34 174.7 6.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.46 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -119.6 146.08 18.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.26 -19.38 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.008 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.805 . . . . 0.0 109.347 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.34 42.97 0.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.7 p -178.1 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.095 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.81 179.4 17.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 155.18 20.85 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.769 -0.842 . . . . 0.0 109.654 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.513 HG21 ' OG ' ' A' ' 130' ' ' SER . 20.0 t -67.75 -20.74 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -20.53 60.37 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -86.3 -47.33 9.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.68 -0.637 . . . . 0.0 109.581 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.449 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.5 mt -67.2 -34.17 67.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.189 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' A' ' 110' ' ' GLU . . . -71.92 -43.57 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.917 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -69.56 -31.19 69.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.813 -1.18 . . . . 0.0 109.882 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -82.19 -18.16 67.66 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 -34.5 27.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -1.149 . . . . 0.0 110.022 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.52 ' HG2' ' OG ' ' A' ' 139' ' ' SER . 3.9 mt-10 -90.1 -19.19 24.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.891 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.608 ' CE2' ' O ' ' A' ' 115' ' ' ASN . 84.5 t90 -68.18 -25.04 65.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.132 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -90.5 5.9 45.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.898 -1.126 . . . . 0.0 109.412 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -94.91 -36.49 5.5 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -106.19 -23.15 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -1.095 . . . . 0.0 109.224 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.608 ' O ' ' CE2' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -173.06 89.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.641 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . 172.8 50.75 0.05 OUTLIER Glycine 0 C--N 1.291 -1.971 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.469 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.764 ' HE3' ' H ' ' A' ' 117' ' ' MET . 0.0 OUTLIER 62.52 163.3 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.473 -1.016 . . . . 0.0 112.062 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.777 ' CE1' HG23 ' A' ' 119' ' ' VAL . 9.7 p80 -98.15 -30.16 12.81 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.777 HG23 ' CE1' ' A' ' 118' ' ' HIS . 4.8 t -95.84 157.72 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.836 -1.165 . . . . 0.0 108.901 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -167.5 124.57 1.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 122' ' ' LEU . 42.9 t30 -102.53 166.96 10.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.872 HD23 HD21 ' A' ' 124' ' ' LEU . 3.5 mp -146.88 112.65 5.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.865 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.2 t -90.14 62.38 5.48 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.872 HD21 HD23 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -146.93 -174.12 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.63 0.729 . . . . 0.0 110.213 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.506 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 160.42 109.57 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.95 154.7 81.49 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.043 -1.269 . . . . 0.0 109.814 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -78.67 5.4 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.76 2.306 . . . . 0.0 110.099 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 m -110.63 82.43 2.88 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.726 -0.609 . . . . 0.0 109.992 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.4 Cg_endo -76.93 171.48 17.9 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.393 2.062 . . . . 0.0 110.754 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.513 ' OG ' HG21 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -144.01 134.47 24.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 108.977 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.56 66.17 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.9 m -70.91 -28.22 64.37 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -24.74 53.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.55 -55.72 5.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.135 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -53.77 -25.01 16.99 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.33 53.69 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.67 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.537 HG11 ' CG ' ' A' ' 167' ' ' ASN . 2.2 t -71.94 -19.36 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 142' ' ' SER . 1.2 t30 -76.1 -29.39 57.89 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.52 ' OG ' ' HG2' ' A' ' 110' ' ' GLU . 1.0 OUTLIER -88.13 -19.05 27.5 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.239 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 145' ' ' VAL . . . -93.39 -26.21 17.35 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.636 -1.29 . . . . 0.0 110.558 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.98 -34.14 13.17 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 138' ' ' ASN . 8.0 t -67.54 -24.69 65.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -81.14 -16.95 51.53 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.608 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 237' ' ' ASN . . . 91.7 50.34 2.73 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 118' ' ' HIS . 70.7 t -113.75 111.11 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 109.234 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.475 HD23 HG13 ' A' ' 119' ' ' VAL . 1.8 tp -69.96 126.39 29.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.043 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -120.19 137.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.736 HG22 ' HG3' ' A' ' 169' ' ' MET . 8.9 t -121.05 166.77 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.506 ' C ' HG21 ' A' ' 218' ' ' THR . . . -153.61 140.65 19.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.944 -1.098 . . . . 0.0 109.555 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.584 ' N ' HG21 ' A' ' 218' ' ' THR . . . -75.95 153.42 36.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.495 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 4.6 t -77.96 -71.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 185' ' ' GLN . . . 164.67 119.02 0.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -87.51 56.62 4.01 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 122.062 -0.669 . . . . 0.0 109.868 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.3 p -137.12 -108.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.613 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . -103.06 -95.98 2.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 167.58 74.16 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.324 -1.103 . . . . 0.0 109.89 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -106.91 43.63 1.65 Allowed Glycine 0 C--N 1.287 -2.166 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.2 p 80.53 131.68 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.832 -0.804 . . . . 0.0 109.657 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -55.08 -169.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.764 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -139.08 164.64 29.23 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.573 -0.704 . . . . 0.0 111.822 -178.072 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.504 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 1.5 m-85 -79.45 145.52 63.83 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.3 Cg_endo -71.53 -33.96 3.51 Favored 'Cis proline' 0 C--N 1.295 -2.256 0 O-C-N 122.566 0.772 . . . . 0.0 110.942 4.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -31.09 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.006 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -79.68 -49.14 12.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.802 -1.186 . . . . 0.0 109.987 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.496 ' O ' ' O ' ' A' ' 164' ' ' ARG . 2.7 m-85 -46.78 -179.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.006 0.908 . . . . 0.0 110.416 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.4 -8.12 23.62 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.746 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.537 ' CG ' HG11 ' A' ' 137' ' ' VAL . 1.8 p-10 -88.65 20.84 3.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -159.16 142.11 14.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 108.893 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.736 ' HG3' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.41 131.91 41.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 109.671 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 190' ' ' LEU . . . -95.47 114.82 26.62 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 108.857 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.3 t -94.19 165.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.569 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -144.23 -175.06 17.03 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -123.64 164.24 19.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -1.074 . . . . 0.0 109.056 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p -142.74 167.85 21.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.466 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.5 OUTLIER -66.43 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.33 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.73 -32.62 11.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.97 . . . . 0.0 109.862 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.65 -78.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.701 ' CG ' HD23 ' A' ' 251' ' ' LEU . 39.4 t-20 -173.07 45.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 109.741 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 24.4 t30 -135.9 167.27 21.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.044 -1.035 . . . . 0.0 109.553 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.497 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.5 ttt-85 -45.79 138.65 4.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.774 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.87 -134.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.643 -0.661 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 m -127.86 -31.53 2.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.883 -1.135 . . . . 0.0 109.734 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' SER . 24.5 p90 -123.47 -3.19 8.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.875 . . . . 0.0 109.65 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.3 OUTLIER -44.09 107.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 109.782 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -58.15 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.646 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.684 ' HE2' ' HB2' ' A' ' 188' ' ' ALA . 1.2 t80 -50.07 -167.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.758 0.789 . . . . 0.0 111.638 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.548 ' CA ' HD22 ' A' ' 190' ' ' LEU . . . -173.1 23.06 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.48 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' HE2' ' A' ' 186' ' ' TYR . . . -75.84 97.78 4.0 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.685 -0.891 . . . . 0.0 109.445 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.38 -22.67 28.79 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -45.15 154.74 0.14 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.505 -0.997 . . . . 0.0 109.626 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 192' ' ' ILE . 51.9 t0 -55.03 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.815 . . . . 0.0 110.891 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.669 HG22 ' OG ' ' A' ' 259' ' ' SER . 0.5 OUTLIER -146.7 -157.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.913 -1.117 . . . . 0.0 110.064 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 262' ' ' VAL . 30.3 m -143.0 168.55 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.796 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -151.56 160.85 31.1 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.41 -0.806 . . . . 0.0 109.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.6 Cg_endo -74.87 115.23 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.06 60.9 0.4 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.321 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.635 ' HB ' ' CZ2' ' A' ' 6' ' ' TRP . 47.5 t -97.62 70.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 40.6 t-20 111.62 119.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 216' ' ' MET . 1.7 m -156.27 112.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.07 0.938 . . . . 0.0 108.484 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.6 OUTLIER -89.86 171.2 9.77 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.624 0.726 . . . . 0.0 110.071 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.585 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 20.4 m -167.56 -146.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.726 . . . . 0.0 109.074 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.418 HG21 HD11 ' A' ' 41' ' ' LEU . 77.1 p -92.68 150.08 20.91 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 110.068 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.582 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 2.1 t80 -140.55 142.46 29.07 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.3 Cg_endo -72.04 156.94 55.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.312 2.008 . . . . 0.0 110.986 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 36.41 54.48 1.31 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.4 t -179.83 -107.62 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.094 -1.239 . . . . 0.0 109.719 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 208' ' ' TYR . 4.3 t -175.45 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.438 -0.789 . . . . 0.0 109.119 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.551 ' N ' HG23 ' A' ' 207' ' ' THR . 0.1 OUTLIER -89.24 142.76 27.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.738 -1.226 . . . . 0.0 109.632 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -125.71 111.39 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.642 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.3 OUTLIER -83.08 132.35 35.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 211' ' ' LEU . 1.0 OUTLIER -167.24 138.72 3.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.97 . . . . 0.0 109.876 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -88.89 147.51 24.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 108.927 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 170.55 146.3 5.1 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.003 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.7 p -66.51 -27.17 67.56 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.274 -1.133 . . . . 0.0 108.521 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.545 ' CB ' ' CE1' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -55.63 -22.37 22.27 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.62 ' CB ' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -85.57 -29.79 23.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -82.36 -23.0 35.25 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.165 -0.959 . . . . 0.0 110.369 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.654 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 4.9 m -66.41 -46.15 59.52 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.895 -1.128 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.2 Cg_endo -73.07 -12.98 26.08 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.919 1.746 . . . . 0.0 109.931 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -74.11 -42.4 60.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.734 HG22 HG11 ' A' ' 262' ' ' VAL . 74.2 t -70.74 -48.83 55.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -46.11 -43.23 14.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -61.51 -45.37 96.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.08 39.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -1.041 . . . . 0.0 109.472 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -52.04 -34.58 43.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -59.94 -47.24 86.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 0.0 109.214 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.5 HD13 ' HB1' ' A' ' 16' ' ' ALA . 67.3 mt -59.8 -29.23 68.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 229' ' ' LYS . 36.4 t -69.57 -62.22 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.31 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -41.9 -47.07 4.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.695 . . . . 0.0 109.714 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.534 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 15.3 tp60 -59.62 -49.38 77.99 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.167 -0.958 . . . . 0.0 109.751 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.858 ' HG3' HD23 ' A' ' 21' ' ' LEU . 6.0 tttm -54.31 -19.3 5.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.486 ' HB2' ' CD2' ' A' ' 235' ' ' TRP . 19.0 m120 -160.93 92.05 1.54 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 109.967 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.6 -11.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.415 2.077 . . . . 0.0 110.303 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.3 m -87.49 -8.87 55.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.486 ' CD2' ' HB2' ' A' ' 232' ' ' ASN . 25.3 m0 -69.65 179.62 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.556 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.18 178.22 5.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.523 ' HB3' ' HA2' ' A' ' 144' ' ' GLY . 18.7 p-10 -52.62 -25.63 11.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 109.42 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.67 -65.4 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.14 -0.975 . . . . 0.0 109.226 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 0.5 OUTLIER -44.76 -25.84 0.33 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.333 0.587 . . . . 0.0 109.967 -178.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.06 -63.65 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 242' ' ' ASN . 15.2 ttp180 -58.2 -63.43 1.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 241' ' ' ARG . 46.3 t30 -37.83 -44.85 0.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 110.705 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -43.85 93.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 110.082 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.519 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 1.4 mt -68.57 -34.0 75.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.362 -0.836 . . . . 0.0 110.95 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.53 55.78 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.78 -4.38 26.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.606 -0.684 . . . . 0.0 109.567 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.4 p -98.48 -28.36 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.9 -1.125 . . . . 0.0 109.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -42.27 142.55 0.75 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 250' ' ' SER . 18.9 m -75.13 164.87 26.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.225 -0.922 . . . . 0.0 109.007 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.574 ' N ' HG22 ' A' ' 249' ' ' THR . 20.5 p -133.04 116.64 16.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.021 -1.05 . . . . 0.0 110.226 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.701 HD23 ' CG ' ' A' ' 178' ' ' ASN . 6.8 mp -86.5 -72.28 0.51 Allowed 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.165 -0.959 . . . . 0.0 109.677 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 253' ' ' SER . . . 166.2 -116.27 0.68 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 257' ' ' TYR . 4.6 m 72.89 174.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.339 -1.095 . . . . 0.0 110.117 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.559 HG23 ' ND2' ' A' ' 255' ' ' ASN . 6.7 t -83.79 -29.65 27.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.173 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.559 ' ND2' HG23 ' A' ' 254' ' ' THR . 8.6 p30 176.45 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.128 . . . . 0.0 110.202 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.13 -31.97 53.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.029 . . . . 0.0 109.002 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.517 ' HB2' ' CB ' ' A' ' 253' ' ' SER . 13.3 m-30 -106.66 47.48 0.88 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 257' ' ' TYR . . . -30.66 -89.18 0.01 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.669 ' OG ' HG22 ' A' ' 192' ' ' ILE . 1.6 p -61.19 -96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.127 -1.219 . . . . 0.0 108.721 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 175.34 -132.35 2.15 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 28.3 tp -85.83 155.35 21.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.956 -0.732 . . . . 0.0 110.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 221' ' ' VAL . 2.7 t -92.13 145.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.437 -0.79 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.424 ' CG ' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -169.66 119.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.367 1.08 . . . . 0.0 108.714 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -75.19 -17.28 60.4 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.702 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.459 ' HA ' ' OG1' ' A' ' 268' ' ' THR . 56.3 tt0 -61.52 -20.46 63.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -84.27 -22.44 30.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.578 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -117.15 15.43 14.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.779 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 265' ' ' GLU . 11.0 p -118.88 -39.92 2.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 269' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.588 ' HB1' ' HA ' ' A' ' 76' ' ' SER . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.607 ' HG3' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -48.78 144.76 4.24 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.166 -0.959 . . . . 0.0 109.32 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -114.15 52.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.53 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.523 ' C ' ' O ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -22.51 85.2 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.867 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HG2' ' CG1' ' A' ' 8' ' ' ILE . 36.6 Cg_endo -80.97 -176.19 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.911 2.407 . . . . 0.0 110.897 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.612 ' CE2' ' O ' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -24.64 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.407 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -114.31 -83.01 1.12 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.005 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.841 HG22 ' N ' ' A' ' 9' ' ' SER . 1.7 mm 49.52 -86.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.858 -0.789 . . . . 0.0 109.268 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.841 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -61.43 -12.46 14.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.91 -1.119 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -27.79 67.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 8' ' ' ILE . 30.8 m -92.99 27.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG2' ' HB3' ' A' ' 265' ' ' GLU . 3.6 mp0 61.74 47.39 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.755 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -82.83 -31.48 0.52 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 111.676 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -75.11 -54.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 108.087 -1.543 . . . . 0.0 108.087 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.73 -35.75 1.97 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.61 -43.24 63.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.961 -1.087 . . . . 0.0 108.955 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.08 -2.99 33.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 -39.98 8.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.47 -55.72 9.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.44 -27.86 0.77 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 268' ' ' THR . 1.1 mt -49.95 111.58 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.207 -1.172 . . . . 0.0 109.305 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -96.42 -19.59 19.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -0.837 . . . . 0.0 109.927 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 78.18 -11.26 23.85 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 42.7 p -55.96 125.78 22.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -1.133 . . . . 0.0 109.609 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.83 -14.37 6.36 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.651 -1.261 . . . . 0.0 109.982 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.739 HG13 ' NE2' ' A' ' 118' ' ' HIS . 11.5 t -102.46 157.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.972 -1.311 . . . . 0.0 109.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -124.96 113.95 18.5 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.51 -0.744 . . . . 0.0 109.092 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.585 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 4.2 t -101.71 147.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 120' ' ' ALA . . . -110.17 159.5 17.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -0.9 . . . . 0.0 108.944 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.936 HG12 ' OD1' ' A' ' 32' ' ' ASP . 1.6 t -136.85 92.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 108.751 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.597 HD23 HG21 ' A' ' 93' ' ' VAL . 6.0 mp -79.97 88.9 5.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.936 ' OD1' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.98 -160.13 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -94.1 28.02 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.442 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 58' ' ' ASP . . . 121.46 123.48 2.97 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.662 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.607 HD11 ' CG2' ' A' ' 30' ' ' VAL . 3.9 mt -86.84 -17.09 9.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.726 0.774 . . . . 0.0 109.751 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 2.9 t 62.31 156.3 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.677 -0.639 . . . . 0.0 109.393 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.6 t -86.71 157.05 19.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.079 -1.013 . . . . 0.0 110.154 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.628 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -169.9 172.84 2.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.5 Cg_endo -81.05 -27.02 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.503 2.136 . . . . 0.0 109.875 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.779 ' HB3' HD11 ' A' ' 77' ' ' ILE . 14.4 p30 -115.19 25.34 10.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.387 -0.82 . . . . 0.0 109.292 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 43' ' ' ILE . 19.7 mt -128.9 21.23 5.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.759 . . . . 0.0 109.11 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 41' ' ' LEU . 7.8 p-10 -25.54 123.55 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -88.96 91.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.346 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 3.3 tpm_? -56.41 -21.25 23.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.876 -1.14 . . . . 0.0 108.073 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 171.17 138.26 2.49 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.65 169.81 34.02 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.317 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.624 -0.927 . . . . 0.0 108.692 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 92' ' ' LYS . 3.1 p -123.94 120.18 31.76 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.734 ' HE2' HG12 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -122.31 -39.24 2.59 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.12 -0.987 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.566 ' HB ' ' CE ' ' A' ' 92' ' ' LYS . 4.2 t -67.66 131.59 92.82 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.34 171.22 15.17 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.162 1.908 . . . . 0.0 108.762 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' C ' ' CG ' ' A' ' 53' ' ' GLU . . . 155.55 -88.31 0.12 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' H ' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -158.42 -56.35 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.227 -1.161 . . . . 0.0 111.745 -178.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 53' ' ' GLU . 36.6 Cg_endo -77.97 -97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.159 1.239 . . . . 0.0 111.111 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.3 OUTLIER 173.22 -148.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.005 -1.059 . . . . 0.0 109.071 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 1.6 t -64.45 -2.52 2.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.46 ' C ' ' HA3' ' A' ' 34' ' ' GLY . 32.0 mt-30 -88.27 155.77 19.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.031 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.916 ' OD2' HG22 ' A' ' 64' ' ' THR . 8.3 t0 -73.07 145.98 46.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 110.08 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.34 -17.73 6.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.43 -64.7 1.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -1.083 . . . . 0.0 109.518 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' CA ' ' OD2' ' A' ' 58' ' ' ASP . . . 156.74 -16.97 0.4 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.443 ' C ' ' CD2' ' A' ' 62' ' ' HIS . 2.9 t-160 -52.1 -61.47 2.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.274 . . . . 0.0 109.706 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -55.16 -77.02 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.014 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.916 HG22 ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -33.05 -67.02 0.13 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.731 -0.864 . . . . 0.0 110.73 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.786 ' CD2' HD21 ' A' ' 211' ' ' LEU . 12.6 t-80 -42.66 -48.91 5.59 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 70' ' ' ILE . 27.7 t -58.39 -41.03 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.086 -1.009 . . . . 0.0 109.623 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.79 -49.5 73.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.294 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -66.76 -33.56 84.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.507 HG23 ' CE1' ' A' ' 220' ' ' HIS . 6.3 m -67.64 -20.73 65.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.176 -1.19 . . . . 0.0 109.07 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 66' ' ' VAL . 79.8 mt -88.16 -28.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.376 -0.827 . . . . 0.0 109.844 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 83' ' ' ALA . . . -153.26 -37.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 111.484 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.767 ' HB1' ' CG1' ' A' ' 79' ' ' VAL . . . 32.81 72.51 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.522 -0.736 . . . . 0.0 109.92 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -38.32 150.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.684 ' CB ' HD12 ' A' ' 80' ' ' LEU . 33.2 t30 -138.19 92.25 2.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.012 -1.055 . . . . 0.0 110.962 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 76' ' ' SER . 1.1 m120 -97.66 -17.1 19.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.588 ' HA ' ' HB1' ' A' ' 1' ' ' ALA . 1.3 m 157.66 28.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.826 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 40' ' ' ASP . 5.8 pt -125.84 52.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.794 -1.191 . . . . 0.0 109.998 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 42.99 -172.9 0.01 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.817 0.676 . . . . 0.0 111.515 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.767 ' CG1' ' HB1' ' A' ' 72' ' ' ALA . 38.5 t 78.93 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 122.175 -0.603 . . . . 0.0 110.645 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' A' ' 74' ' ' ASN . 1.4 tp 56.64 92.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 109.87 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.633 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -71.65 -155.19 2.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 HD11 ' A' ' 227' ' ' LEU . 2.1 t -84.12 -51.29 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -1.221 . . . . 0.0 109.346 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -94.55 125.87 49.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.017 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.69 -60.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.701 2.267 . . . . 0.0 110.715 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 10.0 m120 -93.37 35.03 1.11 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.759 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -83.71 129.69 34.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 109.744 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 27' ' ' LYS . 1.8 mp0 -67.27 114.73 6.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.27 -0.893 . . . . 0.0 108.746 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 mt -97.93 115.55 28.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 110.616 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.571 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 28.1 m-85 -102.98 162.24 13.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -129.36 106.2 8.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.178 . . . . 0.0 110.37 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.734 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -107.13 67.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.566 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -42.6 104.38 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.9 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.597 HG21 HD23 ' A' ' 31' ' ' LEU . 4.0 t -123.74 -25.67 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.549 -0.719 . . . . 0.0 109.085 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.69 HD21 HD22 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -91.42 176.14 6.67 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 110.085 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -116.87 173.88 14.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 -18.53 12.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.159 -1.201 . . . . 0.0 109.766 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.35 -55.08 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.78 29.17 0.7 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -146.0 77.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -1.16 . . . . 0.0 108.834 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.76 179.79 52.94 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.281 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.5 157.36 30.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.8 -0.823 . . . . 0.0 110.009 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.971 HG21 ' OG ' ' A' ' 130' ' ' SER . 2.3 t -67.82 -23.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -20.18 60.77 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.9 p -80.89 -52.36 7.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.584 0.707 . . . . 0.0 109.386 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.934 ' HB ' HD11 ' A' ' 133' ' ' LEU . 1.2 mt -65.95 -32.88 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.689 . . . . 0.0 109.584 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.83 -36.49 70.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -71.39 -41.47 69.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.71 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.51 -14.92 81.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 109' ' ' LEU . 14.0 mt -83.21 -29.39 28.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.308 -1.113 . . . . 0.0 109.015 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.5 -28.81 18.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.585 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 46.6 t90 -71.07 -15.32 62.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.671 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.13 -1.19 57.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.36 -0.838 . . . . 0.0 109.688 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.56 -33.71 2.62 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.703 -1.236 . . . . 0.0 111.136 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.68 -85.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.779 -1.424 . . . . 0.0 109.275 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -94.16 23.63 4.91 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.825 ' O ' ' HE2' ' A' ' 117' ' ' MET . . . -99.16 -146.0 19.48 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.991 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.825 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 4.6 mmt -133.15 179.43 6.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.434 -1.039 . . . . 0.0 110.33 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.739 ' NE2' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -88.42 -29.98 19.81 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.095 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 1.4 t -99.85 149.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 119.668 -1.895 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -164.94 115.09 1.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.812 ' C ' HD12 ' A' ' 122' ' ' LEU . 45.4 t30 -89.22 160.28 17.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.978 . . . . 0.0 109.767 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 121' ' ' ASN . 5.4 mp -147.76 109.47 4.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.999 -1.063 . . . . 0.0 109.877 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 67.86 3.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.966 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.69 HD22 HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -132.66 172.88 11.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.918 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.465 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.79 104.28 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.83 162.48 43.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.102 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.4 Cg_endo -81.21 9.12 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.12 2.547 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.9 102.25 19.03 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.262 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.3 Cg_endo -78.76 178.19 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.688 2.259 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.971 ' OG ' HG21 ' A' ' 102' ' ' VAL . 5.0 m -175.92 119.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 109.487 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -19.96 65.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 23.6 m -69.05 -27.36 65.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.934 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.3 tp -81.57 -37.98 26.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.574 ' CG ' ' CE2' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -76.68 -21.43 55.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.53 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.95 -25.6 53.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 -32.04 30.48 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.491 ' CG1' ' CG ' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -71.42 -36.1 59.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.453 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.13 -34.97 78.77 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.1 t -80.3 -19.1 47.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.68 -10.28 43.72 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.985 -1.072 . . . . 0.0 109.91 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 89.9 m -89.26 -40.15 13.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 109.133 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.21 -27.29 68.32 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.28 31.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.93 66.97 1.65 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 118' ' ' HIS . 14.5 t -117.05 109.75 28.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.401 -1.058 . . . . 0.0 109.597 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.9 104.89 3.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.168 -0.957 . . . . 0.0 109.337 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.781 HG12 HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.52 135.66 35.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.031 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.748 HG22 ' HB2' ' A' ' 169' ' ' MET . 3.0 t -112.86 156.82 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 170' ' ' ALA . . . -138.42 137.07 36.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 109.804 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.13 171.54 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -89.28 -79.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.601 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.622 ' O ' ' CB ' ' A' ' 153' ' ' ASN . . . -152.76 -116.98 0.68 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 152' ' ' GLY . 31.6 t30 135.6 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 123.395 0.678 . . . . 0.0 109.744 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.1 m -121.65 -98.02 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 109.6 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.416 ' HA2' ' CD ' ' A' ' 185' ' ' GLN . . . 179.06 47.38 0.08 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.27 172.56 6.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.16 . . . . 0.0 109.213 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.9 56.32 0.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.461 ' HA ' ' HA3' ' A' ' 187' ' ' GLY . 0.2 OUTLIER 175.27 156.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -1.135 . . . . 0.0 109.26 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 pt -100.12 -177.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.802 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -109.48 166.86 10.56 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.943 0.877 . . . . 0.0 112.518 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.56 ' OH ' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -85.03 149.41 53.02 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 164' ' ' ARG . 42.2 Cg_endo -71.68 -32.22 4.49 Favored 'Cis proline' 0 C--N 1.295 -2.254 0 O-C-N 122.408 0.688 . . . . 0.0 110.734 3.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -25.4 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.721 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -65.42 -55.81 15.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.938 -1.101 . . . . 0.0 109.714 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.574 ' CE2' ' CG ' ' A' ' 134' ' ' GLU . 1.4 m-85 -42.58 -177.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.542 1.163 . . . . 0.0 111.6 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -115.56 2.44 13.8 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.491 ' CG ' ' CG1' ' A' ' 137' ' ' VAL . 2.0 m120 -89.33 21.66 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 108.899 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.43 171.76 10.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.748 ' HB2' HG22 ' A' ' 148' ' ' VAL . 48.4 mtp -99.46 -177.82 3.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -151.5 115.39 4.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 192' ' ' ILE . 23.7 t -107.46 165.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.057 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.86 -173.31 13.3 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.495 ' C ' ' HB2' ' A' ' 181' ' ' ALA . . . -118.88 164.13 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.134 . . . . 0.0 109.655 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.753 ' CA ' ' HB2' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -138.15 175.6 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 0.0 109.69 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.483 ' N ' ' HA ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -89.91 -172.98 3.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.576 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -101.79 -21.49 14.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -80.78 -53.5 6.44 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.269 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -131.89 -94.09 0.37 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.472 -0.768 . . . . 0.0 109.751 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.656 ' CG ' HG21 ' A' ' 174' ' ' THR . 0.7 OUTLIER -160.03 -154.47 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.197 -0.939 . . . . 0.0 109.59 -178.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.489 ' N ' HG22 ' A' ' 174' ' ' THR . 0.0 OUTLIER 58.11 4.3 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.753 ' HB2' ' CA ' ' A' ' 174' ' ' THR . . . 36.24 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.582 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.9 t -145.92 21.84 1.42 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.175 -0.953 . . . . 0.0 108.996 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.45 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -168.66 26.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.833 . . . . 0.0 109.658 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -104.51 128.63 52.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 108.934 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CD ' ' HA2' ' A' ' 155' ' ' GLY . 64.8 mm-40 -90.06 147.36 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 110.021 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.517 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.58 169.22 12.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . -170.93 152.25 17.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -44.06 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 138.64 -0.78 2.51 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.263 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 65.0 tp -50.33 145.81 5.86 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.829 -1.395 . . . . 0.0 108.745 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.6 OUTLIER -104.56 -63.75 1.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 111.103 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 171' ' ' VAL . 1.2 tt -151.47 163.87 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.375 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.981 HG21 ' CE1' ' A' ' 257' ' ' TYR . 22.1 m -118.0 160.33 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.676 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.613 ' C ' ' HG1' ' A' ' 174' ' ' THR . . . -150.66 161.07 31.38 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.7 Cg_endo -75.21 126.08 9.6 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.14 1.893 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.429 ' C ' ' OD1' ' A' ' 212' ' ' ASN . . . -152.21 62.13 0.39 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.632 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.612 ' O ' ' CE2' ' A' ' 6' ' ' TRP . 74.5 t -135.76 89.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.6 ' O ' HG13 ' A' ' 199' ' ' VAL . 11.6 t-20 94.14 107.42 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.696 HG22 ' CG ' ' A' ' 212' ' ' ASN . 19.7 m -161.91 111.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.19 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 201' ' ' SER . 2.9 tt0 -85.97 147.37 26.26 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.6 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 7.4 t -146.76 -146.67 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.584 HG21 ' OD1' ' A' ' 40' ' ' ASP . 66.0 p -88.02 172.38 9.59 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.675 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -157.87 161.05 29.64 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.675 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.7 Cg_endo -70.42 165.29 32.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.136 1.891 . . . . 0.0 110.685 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 79.92 3.87 89.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.2 OUTLIER 77.69 32.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -1.088 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -129.79 158.03 40.56 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.493 ' OH ' HD12 ' A' ' 77' ' ' ILE . 11.7 m-30 -91.51 -174.67 3.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.536 ' HB2' ' CG ' ' A' ' 203' ' ' TYR . . . -164.25 157.19 17.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.872 -1.142 . . . . 0.0 110.219 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 3.5 m -113.21 120.31 40.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -166.88 161.8 15.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.696 ' CG ' HG22 ' A' ' 199' ' ' VAL . 0.2 OUTLIER -148.19 -160.48 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.973 -1.079 . . . . 0.0 111.153 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 130.49 157.95 9.15 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 214' ' ' THR . 0.0 OUTLIER -60.94 -19.13 60.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.859 -1.377 . . . . 0.0 108.644 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.1 m -71.86 -32.71 67.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.485 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -82.27 -19.8 38.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.445 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -87.45 -26.5 23.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.631 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 26.2 m -57.2 -42.8 97.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.725 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.9 Cg_endo -71.93 -26.55 18.55 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.715 1.61 . . . . 0.0 111.132 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.507 ' CE1' HG23 ' A' ' 69' ' ' THR . 0.4 OUTLIER -58.66 -40.37 83.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.677 HG22 HG21 ' A' ' 262' ' ' VAL . 60.4 t -70.33 -47.66 65.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -45.8 -31.89 2.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -73.78 -48.08 18.1 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -57.39 -65.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -1.232 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -45.64 -36.58 4.93 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -58.84 -49.5 77.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.02 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.603 HD11 HG12 ' A' ' 82' ' ' VAL . 10.6 mt -49.96 -39.42 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 96.2 t -61.41 -52.47 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 108.902 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 19.1 mttm -44.33 -40.98 5.71 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.459 -0.776 . . . . 0.0 109.172 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 13.1 tp60 -62.93 -45.42 92.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 108.882 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -60.86 -14.21 20.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.472 -0.768 . . . . 0.0 109.045 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.88 80.93 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.356 -0.84 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.5 Cg_endo -78.89 8.24 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.711 2.274 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.44 -12.8 28.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.986 -1.071 . . . . 0.0 109.778 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -69.84 -179.69 1.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.99 170.81 7.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.595 -0.691 . . . . 0.0 109.359 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -62.22 -22.68 66.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -79.26 -63.63 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.112 -0.993 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.0 OUTLIER -42.96 -48.66 5.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 -178.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 -49.15 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 0.0 109.546 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 243' ' ' HIS . 6.6 ttp180 -51.37 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ARG . 43.7 t30 -34.27 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.869 -0.519 . . . . 0.0 111.346 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 241' ' ' ARG . 1.6 t60 -72.52 -50.4 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.53 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.1 OUTLIER -67.68 -23.29 65.29 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.61 47.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.571 -0.706 . . . . 0.0 110.181 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.69 -9.31 57.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 110.376 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.3 p -94.11 -29.84 14.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.973 -1.079 . . . . 0.0 109.663 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -40.25 129.27 2.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.555 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.63 ' HB ' HD22 ' A' ' 263' ' ' ASN . 6.0 m -75.98 89.57 2.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 260' ' ' GLY . 3.3 t -81.9 140.13 34.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 111.82 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.5 mp -59.79 -45.02 93.59 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -176.47 -36.47 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 3.5 m -62.08 176.33 0.59 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.393 -1.063 . . . . 0.0 109.679 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 10.8 t -140.53 10.02 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.969 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 254' ' ' THR . 2.7 t30 177.88 -52.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.702 -1.248 . . . . 0.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 257' ' ' TYR . 0.2 OUTLIER -45.27 -53.8 7.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 1.028 ' N ' HD13 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -87.94 -4.72 58.8 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.532 -0.73 . . . . 0.0 111.776 -176.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 129.74 2.5 5.25 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.629 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 0.7 OUTLIER 79.2 -10.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -1.072 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 250' ' ' SER . . . 134.36 -165.82 24.31 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.069 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.573 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 58.3 tp -107.13 164.4 12.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -98.95 158.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.42 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.63 HD22 ' HB ' ' A' ' 249' ' ' THR . 0.0 OUTLIER -167.36 119.92 0.93 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.36 -5.31 31.6 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.358 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 5.1 tt0 -83.23 -42.55 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 109.911 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.96 1.74 26.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -115.03 -26.57 7.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.671 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.483 HG21 HD13 ' A' ' 21' ' ' LEU . 4.7 p -82.91 -38.8 22.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.597 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.529 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.265 0.555 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.429 ' O ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -61.04 140.92 57.73 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -75.53 122.05 23.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.808 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.1 t -143.41 76.72 15.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' TRP . 33.0 Cg_endo -77.8 164.56 27.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.409 2.073 . . . . 0.0 110.33 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.518 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -45.49 -26.86 0.63 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA3' ' CG1' ' A' ' 199' ' ' VAL . . . -72.26 -101.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.686 HG22 ' O ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -43.09 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -1.105 . . . . 0.0 109.142 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER 165.19 -43.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -1.6 58.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -0.832 . . . . 0.0 109.501 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.692 HG11 ' HB3' ' A' ' 220' ' ' HIS . 20.1 m -101.3 14.94 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.125 -0.984 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.702 HE21 ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 68.97 24.68 6.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.647 -0.658 . . . . 0.0 110.845 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -68.26 -39.87 18.39 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.906 -1.121 . . . . 0.0 110.895 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 32.2 Cg_endo -75.18 -60.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.205 -1.498 . . . . 0.0 108.205 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HB3' HE21 ' A' ' 12' ' ' GLN . . . -45.99 -24.21 0.39 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.593 ' N ' ' NE2' ' A' ' 12' ' ' GLN . . . -81.19 -41.64 22.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.874 -1.141 . . . . 0.0 109.244 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 16.3 m170 -69.45 -19.68 63.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 109.626 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -87.15 -39.1 15.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.58 ' HB3' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.54 -17.58 62.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.45 8.7 26.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -74.03 132.04 41.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -115.43 -22.57 9.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.462 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 53.6 11.03 1.69 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.453 ' N ' ' C ' ' A' ' 22' ' ' THR . 5.2 t -76.19 1.64 15.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -1.217 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.6 17.91 35.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 27' ' ' LYS . 60.7 t -123.18 167.02 17.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 120.935 -1.333 . . . . 0.0 109.995 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' N ' HG12 ' A' ' 26' ' ' VAL . 1.7 mptt -134.74 137.06 43.13 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 39.1 t -135.01 129.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.024 -1.048 . . . . 0.0 110.296 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -84.83 155.66 21.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.895 HG12 ' OD2' ' A' ' 32' ' ' ASP . 6.5 t -134.22 87.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 108.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 HG23 ' A' ' 91' ' ' VAL . 8.2 mp -74.27 99.91 3.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.895 ' OD2' HG12 ' A' ' 30' ' ' VAL . 1.1 m-20 -134.82 -161.61 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 96' ' ' ALA . 2.9 t -105.2 3.95 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.775 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 59' ' ' GLY . . . 144.97 121.83 1.49 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 64' ' ' THR . 11.3 mt -90.08 -110.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.557 ' N ' HG22 ' A' ' 35' ' ' ILE . 48.2 t 176.46 146.94 0.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.213 -0.93 . . . . 0.0 110.071 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -86.04 93.38 8.97 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.438 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -114.9 169.38 6.74 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.469 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 77' ' ' ILE . 35.6 Cg_endo -77.38 -45.4 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.619 2.212 . . . . 0.0 110.04 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 73' ' ' LEU . 3.9 m-20 -74.27 -34.27 63.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.822 . . . . 0.0 109.261 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 67' ' ' ALA . 2.3 mt -57.3 135.11 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -109.71 94.7 5.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 43' ' ' ILE . 8.7 mm -85.63 99.91 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 9.3 tpt180 -86.53 -18.74 30.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.684 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.509 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 162.32 176.37 34.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.57 47.55 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.142 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' HG12 ' A' ' 91' ' ' VAL . . . -146.03 160.25 42.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.978 . . . . 0.0 109.446 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 64.3 p -134.03 115.6 14.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.513 ' HE2' HG12 ' A' ' 91' ' ' VAL . 45.3 m-85 -116.92 -54.98 2.39 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.509 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 22.9 t -39.81 128.45 1.53 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.585 -0.697 . . . . 0.0 109.91 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.32 -178.63 4.75 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.345 2.03 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . 110.9 -20.8 23.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.621 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 15.8 tt0 69.36 52.37 0.45 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.312 -1.11 . . . . 0.0 110.478 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.4 Cg_endo -77.34 -82.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.281 1.988 . . . . 0.0 109.775 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 54' ' ' PRO . 2.1 m 165.41 135.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.717 . . . . 0.0 109.469 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.452 ' C ' ' HG3' ' A' ' 57' ' ' GLN . 1.4 m -63.36 -13.16 36.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.043 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.452 ' HG3' ' C ' ' A' ' 56' ' ' THR . 13.1 mt-30 -143.95 150.8 38.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 t0 62.08 92.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.805 . . . . 0.0 109.704 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -112.85 -25.63 4.45 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.82 -38.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -1.176 . . . . 0.0 109.75 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.07 -10.67 3.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -75.85 -70.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.155 -1.203 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 32' ' ' ASP . . . -48.17 -29.09 6.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.699 ' HA ' HG23 ' A' ' 35' ' ' ILE . 9.2 m -68.14 -53.15 27.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -1.073 . . . . 0.0 109.445 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 1.005 ' CD2' HD21 ' A' ' 211' ' ' LEU . 3.9 t-80 -55.89 -43.64 77.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.737 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 69' ' ' THR . 17.4 t -61.95 -34.2 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -62.36 -44.14 97.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.618 ' HA2' ' HB2' ' A' ' 72' ' ' ALA . . . -71.21 -42.02 58.63 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 66' ' ' VAL . 7.5 t -64.41 -15.3 60.32 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 120.366 -1.667 . . . . 0.0 107.851 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.007 HG21 HD21 ' A' ' 88' ' ' LEU . 31.7 mt -87.51 -38.84 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.321 -0.862 . . . . 0.0 109.93 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -178.64 36.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.769 -1.207 . . . . 0.0 111.853 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . . . -45.06 125.47 5.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.67 -1.269 . . . . 0.0 108.928 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 84' ' ' PRO . 85.5 mt -54.33 161.26 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 75' ' ' ASN . 10.4 t-20 -106.92 134.26 50.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 74' ' ' ASN . 74.2 m-20 -162.14 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.817 0.817 . . . . 0.0 109.081 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -155.12 -39.96 0.09 Allowed 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 39' ' ' PRO . 1.2 pt -103.38 67.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.456 -0.777 . . . . 0.0 109.595 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.94 158.62 13.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 201' ' ' SER . 27.6 m -80.39 -159.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.35 -1.088 . . . . 0.0 109.354 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.4 tp -141.53 116.52 9.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.968 -1.082 . . . . 0.0 109.771 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 175.83 54.78 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.64 -42.53 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -1.185 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . . . -93.17 141.96 24.71 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.736 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.691 ' O ' HD23 ' A' ' 73' ' ' LEU . 38.6 Cg_endo -84.25 -61.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.847 2.365 . . . . 0.0 110.692 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -120.48 49.87 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.436 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -79.17 159.59 27.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 108.979 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 25.9 mt-10 -89.37 89.16 7.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.979 -1.076 . . . . 0.0 108.972 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 70' ' ' ILE . 8.4 mt -75.6 142.89 42.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 110.236 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.56 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 4.1 m-85 -126.4 152.97 45.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.37 94.47 4.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.017 -1.052 . . . . 0.0 109.456 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -98.57 63.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.284 -0.885 . . . . 0.0 108.917 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -31.67 109.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.197 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -129.09 -10.37 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.374 -0.829 . . . . 0.0 109.433 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 124' ' ' LEU . 10.2 mt -103.81 -178.0 3.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 0.0 109.895 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.31 146.65 18.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.513 ' N ' ' OG1' ' A' ' 33' ' ' THR . . . -67.17 -39.26 86.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -1.185 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.0 t -73.0 -37.5 66.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.22 68.27 0.38 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.45 94.59 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -1.021 . . . . 0.0 109.192 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.26 -178.98 19.43 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.04 155.59 32.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.879 -0.777 . . . . 0.0 109.8 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.716 HG13 HD12 ' A' ' 133' ' ' LEU . 3.5 t -69.56 -19.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -17.7 58.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.497 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.2 m -88.33 -35.42 17.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.52 HD13 HD13 ' A' ' 124' ' ' LEU . 2.9 mt -77.11 -37.98 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 108.729 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.23 67.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -63.19 -45.55 91.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.507 -0.746 . . . . 0.0 108.992 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.22 -21.52 77.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 109' ' ' LEU . 14.5 mt -82.57 -19.93 37.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -94.38 -30.23 14.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.376 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -69.24 -17.01 63.72 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.717 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.728 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -91.37 -11.54 37.53 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -80.86 -15.71 76.89 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -117.13 1.19 12.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.076 -1.249 . . . . 0.0 109.946 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 7.2 t30 172.46 29.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.999 -1.063 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.728 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -110.71 48.08 0.98 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.312 -1.423 . . . . 0.0 110.763 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.588 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 15.8 mmt 60.91 -173.79 0.13 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 111.452 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.68 ' CD2' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -95.74 -32.69 12.6 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.716 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.68 HG23 ' CD2' ' A' ' 118' ' ' HIS . 55.7 t -104.8 166.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.717 -1.239 . . . . 0.0 109.833 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.764 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -169.35 117.04 0.62 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.964 ' O ' HD12 ' A' ' 122' ' ' LEU . 8.0 t30 -96.31 152.96 18.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.964 HD12 ' O ' ' A' ' 121' ' ' ASN . 6.4 mp -133.88 102.79 5.57 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.92 66.3 9.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 109.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 105' ' ' ILE . 0.6 OUTLIER -152.86 172.22 17.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.333 -0.854 . . . . 0.0 109.617 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.571 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.58 104.42 0.18 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 160' ' ' SER . 0.3 OUTLIER -107.32 147.64 35.62 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.197 -1.178 . . . . 0.0 109.559 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.512 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 32.1 Cg_endo -74.0 -6.0 17.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.21 1.94 . . . . 0.0 108.934 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -103.95 100.32 20.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 32.7 Cg_endo -74.19 164.59 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.425 2.083 . . . . 0.0 110.944 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.585 ' CB ' HG11 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -151.05 135.92 17.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.91 63.59 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -77.88 -23.71 48.71 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.716 HD12 HG13 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -79.26 -40.57 30.21 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' OE2' ' CD1' ' A' ' 165' ' ' TYR . 1.9 mt-10 -76.85 -31.96 57.19 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.336 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -62.66 -26.82 68.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.48 60.83 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.917 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.495 ' CG1' ' CG ' ' A' ' 167' ' ' ASN . 1.3 t -63.26 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.54 -38.48 81.16 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.6 -23.75 53.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.91 -18.83 55.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.081 -1.012 . . . . 0.0 110.129 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -27.75 58.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.261 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -58.14 -30.81 66.63 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.162 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER -104.64 -12.0 16.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.476 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.85 62.16 4.98 Favored Glycine 0 N--CA 1.477 1.429 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 39.9 t -96.12 110.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.583 -0.951 . . . . 0.0 109.854 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.52 107.63 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.5 t -104.43 154.32 6.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.044 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.575 HG13 ' O ' ' A' ' 148' ' ' VAL . 12.0 p -141.13 112.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.607 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -100.9 149.82 23.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.124 -0.985 . . . . 0.0 110.384 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.496 ' CB ' ' OG1' ' A' ' 218' ' ' THR . . . -78.6 151.71 32.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.727 . . . . 0.0 109.472 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -55.98 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 155.19 115.02 0.52 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 185' ' ' GLN . 25.1 t30 -99.96 53.16 0.91 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.951 -0.735 . . . . 0.0 109.178 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.45 ' N ' ' OE1' ' A' ' 185' ' ' GLN . 2.4 p -94.6 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.437 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 150.55 39.2 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.49 172.97 7.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 109.365 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 186' ' ' TYR . . . -103.71 56.71 0.57 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.409 ' N ' ' HB2' ' A' ' 186' ' ' TYR . 1.6 p 172.36 124.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.042 -1.27 . . . . 0.0 109.862 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -59.23 -171.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.234 -0.917 . . . . 0.0 110.166 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.901 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -132.81 171.2 14.21 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.073 0.939 . . . . 0.0 112.795 -177.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.438 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 4.4 m-85 -82.61 146.41 53.22 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.607 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 41.4 Cg_endo -71.39 -30.29 5.63 Favored 'Cis proline' 0 C--N 1.293 -2.383 0 O-C-N 122.555 0.766 . . . . 0.0 110.436 3.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.901 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.625 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -70.5 -54.46 12.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 109.76 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -50.77 -170.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.177 0.989 . . . . 0.0 110.825 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.67 -16.73 8.19 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.495 ' CG ' ' CG1' ' A' ' 137' ' ' VAL . 13.1 m-80 -57.08 -18.65 15.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 108.962 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -132.53 149.36 52.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.477 ' HA ' ' OD2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -89.87 130.1 36.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.907 -1.121 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 163' ' ' ALA . . . -92.55 117.97 30.51 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.95 HG22 ' CG2' ' A' ' 192' ' ' ILE . 24.7 t -92.33 164.58 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.268 1.032 . . . . 0.0 110.562 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -136.14 145.63 17.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.54 162.28 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.28 . . . . 0.0 110.14 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.508 ' CG2' ' HB ' ' A' ' 193' ' ' VAL . 73.1 p -144.58 170.83 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.528 -0.732 . . . . 0.0 109.46 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 179' ' ' ASN . 0.7 OUTLIER -102.82 -166.59 1.29 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -67.67 -49.63 61.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.186 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' ASN . 8.3 m120 -59.59 -75.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.054 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' ASN . 1.5 m-20 162.77 41.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.0 109.642 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.454 ' HB3' ' OD1' ' A' ' 175' ' ' ASP . 0.9 OUTLIER -98.46 -149.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.687 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -107.82 18.99 20.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.468 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 76.14 -162.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.0 109.905 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 t -100.53 -34.83 9.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.965 . . . . 0.0 110.204 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -108.12 -81.35 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 183' ' ' PHE . 3.3 t 32.05 100.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.128 0.49 . . . . 0.0 111.145 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' SER . 1.4 mp0 -45.49 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 0.0 109.815 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.502 ' CZ ' HD21 ' A' ' 256' ' ' LEU . 1.2 t80 -52.49 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 110.565 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.969 ' HA2' HD13 ' A' ' 190' ' ' LEU . . . -145.26 20.97 1.91 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -35.76 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 79.2 50.51 5.76 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.969 HD13 ' HA2' ' A' ' 187' ' ' GLY . 4.6 tp -75.62 144.8 41.56 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.568 -0.96 . . . . 0.0 109.465 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 259' ' ' SER . 1.2 m-20 -93.43 -46.01 7.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.208 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.95 ' CG2' HG22 ' A' ' 171' ' ' VAL . 1.5 tt -157.95 177.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.497 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 260' ' ' GLY . 31.6 m -138.79 172.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 109.663 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -173.55 174.44 1.1 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.926 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.6 Cg_endo -75.94 121.39 6.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.608 2.205 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -137.17 45.14 1.09 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.644 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 23.8 t -134.1 85.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.438 -1.036 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.946 ' O ' HG13 ' A' ' 199' ' ' VAL . 19.5 t-20 103.33 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER 178.28 115.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 210' ' ' SER . 1.7 pt20 -101.45 161.52 13.57 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.62 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -156.69 -158.67 0.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.546 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.62 174.06 11.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.595 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.9 OUTLIER -150.05 147.15 21.5 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 108.529 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 31.6 Cg_endo -69.91 129.96 18.33 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.721 1.614 . . . . 0.0 110.336 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 40.82 43.55 3.17 Favored Glycine 0 C--N 1.286 -2.243 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.833 ' O ' HG22 ' A' ' 207' ' ' THR . 0.9 OUTLIER -167.56 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.998 -1.295 . . . . 0.0 111.35 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 206' ' ' SER . 7.0 t 52.01 -143.24 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 111.032 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.658 ' N ' HG23 ' A' ' 207' ' ' THR . 0.1 OUTLIER -95.62 165.78 12.16 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.026 0.917 . . . . 0.0 111.639 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -158.03 162.2 38.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.483 ' HA ' ' CB ' ' A' ' 200' ' ' GLN . 0.6 OUTLIER -109.03 133.91 52.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.865 -1.147 . . . . 0.0 110.131 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 1.005 HD21 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -154.65 157.53 38.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -121.36 160.8 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 167.5 161.78 17.77 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.8 m -81.12 -28.9 34.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -1.181 . . . . 0.0 109.257 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -14.06 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 1.7 mpp? -87.95 -15.03 37.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -89.69 -8.87 51.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.657 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 86.5 m -77.35 -36.05 1.43 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 112.232 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 218' ' ' THR . 32.2 Cg_endo -73.66 -24.62 15.68 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.141 1.228 . . . . 0.0 110.264 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.692 ' HB3' HG11 ' A' ' 11' ' ' VAL . 7.6 m80 -62.38 -40.4 96.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 262' ' ' VAL . 59.2 t -70.17 -40.41 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -51.5 -41.26 60.85 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -65.99 -59.64 7.28 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -42.1 -37.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.107 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.46 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.158 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -55.1 -41.38 71.56 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.013 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 224' ' ' ALA . 48.3 mt -55.62 -45.68 77.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.708 HG21 HD23 ' A' ' 244' ' ' LEU . 31.5 t -56.0 -59.02 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 0.0 109.495 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.578 ' HE2' HD11 ' A' ' 240' ' ' ILE . 3.3 ttmm -44.68 -39.07 4.8 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.304 -0.872 . . . . 0.0 109.521 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.462 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -59.2 -54.95 41.12 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -56.63 -15.75 4.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 108.907 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.601 ' ND2' ' CZ3' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -166.83 84.16 0.89 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 37.4 Cg_endo -80.77 15.25 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.754 2.303 . . . . 0.0 111.17 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.87 -24.24 12.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.601 ' CZ3' ' ND2' ' A' ' 232' ' ' ASN . 32.3 m0 -62.71 175.14 0.86 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.9 m -99.71 176.37 5.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.649 -0.657 . . . . 0.0 109.758 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 238' ' ' VAL . 36.0 p30 -60.59 -22.18 63.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.431 -0.793 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -76.61 -64.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.177 -0.952 . . . . 0.0 109.277 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 238' ' ' VAL . 5.6 mm-40 -43.36 -35.58 1.59 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.547 0.689 . . . . 0.0 109.274 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.578 HD11 ' HE2' ' A' ' 229' ' ' LYS . 58.5 mt -69.35 -46.28 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 110.187 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -63.53 -53.16 56.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.1 -28.36 66.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -71.21 -62.93 1.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.708 HD23 HG21 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -59.72 -21.17 60.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.516 -0.74 . . . . 0.0 109.302 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.4 tptt -74.63 -52.85 10.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.597 -0.689 . . . . 0.0 110.281 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -11.83 59.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 3.0 p -88.43 -32.75 18.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.769 -1.207 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -54.6 150.3 9.53 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -63.54 167.07 5.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.7 t -131.22 97.57 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.2 mp -48.79 -27.68 3.15 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 115.33 37.24 1.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 1.5 m -164.34 157.59 17.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -1.2 . . . . 0.0 109.534 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.6 p -137.49 23.08 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.463 ' OD1' ' HG ' ' A' ' 256' ' ' LEU . 19.7 t-20 -96.92 -71.95 0.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.517 HD22 ' NH1' ' A' ' 180' ' ' ARG . 1.1 mt -92.33 -52.1 4.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.775 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -61.04 -36.25 79.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -0.849 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 77.11 -120.42 5.61 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 191' ' ' ASP . 44.1 t -61.46 -78.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.548 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 153.34 -153.08 24.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.599 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 15.1 tp -69.53 164.47 23.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -1.19 . . . . 0.0 108.862 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -126.2 147.48 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -172.07 121.69 0.46 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.457 ' C ' ' OE1' ' A' ' 12' ' ' GLN . . . -70.01 -0.97 8.47 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.556 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.542 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 39.8 tt0 -62.47 -57.92 9.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.853 -1.155 . . . . 0.0 108.981 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -71.65 -7.1 45.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.48 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -95.11 -19.39 20.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.923 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 11.0 p -103.05 -52.15 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.0 -1.063 . . . . 0.0 109.318 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.71 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.979 ' O ' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -69.44 101.11 1.5 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.817 ' HB3' HD22 ' A' ' 80' ' ' LEU . 13.3 m 35.55 46.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.826 0.822 . . . . 0.0 110.299 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 2' ' ' GLN . 10.6 m -158.69 51.53 0.45 Allowed Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.488 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 35.6 Cg_endo -77.32 156.18 32.89 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.703 1.602 . . . . 0.0 109.892 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.515 ' CD1' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -62.36 -15.28 47.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 110.005 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 220' ' ' HIS . . . -94.26 21.07 44.44 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -144.84 10.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -1.234 . . . . 0.0 109.639 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 t -101.13 -18.92 15.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -99.99 6.79 45.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.94 16.18 8.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 120.872 -1.142 . . . . 0.0 110.067 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 2.8 mp0 46.15 55.99 6.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.605 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.683 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -85.35 -34.34 0.51 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.549 -0.719 . . . . 0.0 111.972 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.0 Cg_endo -72.49 -57.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.0 -29.76 0.36 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 -45.35 38.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.069 . . . . 0.0 109.629 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.68 -17.77 64.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.363 -0.835 . . . . 0.0 110.433 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -39.67 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.882 -1.137 . . . . 0.0 109.829 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -52.38 -35.57 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.702 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.94 8.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.2 135.22 33.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -1.142 . . . . 0.0 109.219 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -130.34 10.13 5.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.798 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.961 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 66.71 -1.36 5.76 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.2 m -47.33 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 124.84 15.59 3.17 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 23' ' ' GLY . 6.0 t -107.57 148.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.993 -1.298 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.8 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -115.84 115.51 26.38 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.447 0.641 . . . . 0.0 110.56 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.45 127.65 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.527 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.23 156.38 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.112 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG12 ' CG ' ' A' ' 32' ' ' ASP . 74.4 t -129.14 86.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.146 -0.971 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.716 HD12 ' CG2' ' A' ' 91' ' ' VAL . 5.0 mp -71.07 100.6 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.537 ' CG ' HG12 ' A' ' 30' ' ' VAL . 43.3 p-10 -160.13 -160.49 0.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.875 -1.141 . . . . 0.0 109.673 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.767 HG21 ' O ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -64.75 -51.27 63.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.657 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . -162.97 -112.88 0.28 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.808 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.701 HG12 ' HB2' ' A' ' 67' ' ' ALA . 0.8 OUTLIER 153.81 -15.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 121.613 0.72 . . . . 0.0 109.152 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 51.37 168.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 110.6 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 37' ' ' THR . 11.4 t -105.12 45.67 0.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.926 0.87 . . . . 0.0 109.195 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -52.5 160.62 1.29 Allowed Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.709 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.05 -4.55 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.692 2.261 . . . . 0.0 110.451 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.661 ' O ' HD12 ' A' ' 73' ' ' LEU . 24.7 t0 -91.84 -60.89 1.75 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mt -70.34 151.51 45.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.215 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.67 ' OD1' HD11 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -105.32 73.95 1.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.295 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 37' ' ' THR . 12.1 mm -42.5 114.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.575 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -108.63 -18.8 13.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.677 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -175.19 -175.81 42.95 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.22 147.01 4.77 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.311 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.53 144.2 46.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.424 -1.045 . . . . 0.0 109.139 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.507 ' OG ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -120.76 121.02 37.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.146 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.857 ' HE2' HG12 ' A' ' 91' ' ' VAL . 3.1 m-85 -110.73 -38.51 5.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.192 -0.943 . . . . 0.0 109.868 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG23 ' HB3' ' A' ' 104' ' ' SER . 1.0 OUTLIER -42.93 -52.58 11.29 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.195 -0.941 . . . . 0.0 109.061 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 50' ' ' VAL . 38.9 Cg_endo -84.33 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.07 2.513 . . . . 0.0 110.717 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' H ' ' HD3' ' A' ' 54' ' ' PRO . . . 178.56 32.58 0.05 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 69.29 53.65 0.49 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.601 -0.941 . . . . 0.0 110.893 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 38.3 Cg_endo -83.89 -80.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.305 2.004 . . . . 0.0 110.353 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.561 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.3 OUTLIER -129.0 -25.7 2.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.841 -0.537 . . . . 0.0 110.398 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 46.72 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 109.916 -177.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' SER . 7.3 mm100 -95.9 155.69 16.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.876 -1.14 . . . . 0.0 108.45 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLN . 5.0 m-20 52.17 172.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.003 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.767 ' O ' HG21 ' A' ' 33' ' ' THR . . . 164.44 46.62 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 1.1 t30 80.47 -27.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -1.038 . . . . 0.0 110.452 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' O ' ' C ' ' A' ' 62' ' ' HIS . . . 128.11 -72.82 0.46 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.589 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.563 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.9 t-80 -11.44 -59.95 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.445 0.641 . . . . 0.0 111.917 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.88 -69.47 1.28 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.69 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.7 m -38.39 -41.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.563 -0.963 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 2.0 t-80 -56.61 -63.22 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 219' ' ' PRO . 16.5 t -49.09 -32.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 108.782 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.701 ' HB2' HG12 ' A' ' 35' ' ' ILE . . . -55.39 -53.34 57.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.52 -22.11 74.85 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.723 HG23 ' CE1' ' A' ' 220' ' ' HIS . 6.6 m -73.94 -18.11 60.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.036 -1.273 . . . . 0.0 108.088 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 88' ' ' LEU . 56.8 mt -101.44 -25.84 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.492 -0.755 . . . . 0.0 111.309 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -162.02 25.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.316 -1.49 . . . . 0.0 112.647 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.722 ' HB1' ' HB ' ' A' ' 79' ' ' VAL . . . -39.86 114.52 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 109.34 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.67 HD11 ' OD1' ' A' ' 42' ' ' ASN . 23.6 mt -73.54 167.48 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.68 125.99 53.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 3.1 p-10 -168.68 -109.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -0.969 . . . . 0.0 109.101 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -82.44 -73.52 0.39 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.497 ' HB ' ' OH ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -52.29 178.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.587 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -132.79 122.93 3.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.41 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.722 ' HB ' ' HB1' ' A' ' 72' ' ' ALA . 1.8 t -162.7 -64.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.817 HD22 ' HB3' ' A' ' 3' ' ' SER . 1.1 tp 56.51 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.317 0.58 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.647 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -95.49 -143.44 14.54 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.474 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -106.57 -54.19 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.028 -1.278 . . . . 0.0 109.664 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -107.83 102.76 46.86 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 38.0 Cg_endo -85.57 -63.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.877 2.385 . . . . 0.0 110.919 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -17.39 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 143.33 56.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.253 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.8 ' OE1' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -79.56 126.16 30.53 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.978 -1.077 . . . . 0.0 109.082 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.499 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 15.0 mt -103.25 105.32 15.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.715 -1.241 . . . . 0.0 110.309 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.485 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 19.8 m-85 -85.72 142.35 29.07 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.27 -0.894 . . . . 0.0 108.775 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.423 ' CB ' HD12 ' A' ' 35' ' ' ILE . . . -105.23 104.68 14.46 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.615 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.82 66.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.121 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HD3' ' HD3' ' A' ' 51' ' ' PRO . 1.2 tttt -36.5 109.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.477 0.656 . . . . 0.0 110.018 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.547 HG11 HG23 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -125.06 -13.58 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.508 ' O ' HG21 ' A' ' 50' ' ' VAL . 5.2 mt -84.62 -170.96 3.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.986 0.898 . . . . 0.0 110.886 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.416 ' CA ' ' N ' ' A' ' 99' ' ' SER . . . -101.83 -99.54 2.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 97' ' ' SER . . . 48.67 83.91 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 96' ' ' ALA . 3.2 t 81.0 -8.21 1.45 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 99' ' ' SER . . . -122.46 -29.45 1.31 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' GLY . 0.9 OUTLIER 72.81 108.18 0.07 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.238 -1.154 . . . . 0.0 109.05 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 99' ' ' SER . . . -47.0 176.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -177.94 142.72 0.3 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.731 -0.864 . . . . 0.0 108.703 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.883 HG22 ' HA ' ' A' ' 129' ' ' PRO . 21.0 t -68.45 -21.05 25.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.556 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -74.85 -25.17 58.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.876 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -79.61 -67.11 0.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.69 ' HB ' HD12 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -50.52 -24.0 2.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 102' ' ' VAL . . . -67.57 -56.42 9.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.68 -0.638 . . . . 0.0 110.051 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.607 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -65.69 -33.11 75.11 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.43 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.561 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -68.25 -30.83 73.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.439 HD13 HG23 ' A' ' 137' ' ' VAL . 36.1 mt -94.33 -4.67 48.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.116 -1.226 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.96 -5.9 12.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 109.449 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -86.3 -17.73 33.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.638 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -83.49 -1.54 53.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -82.33 -46.35 6.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 -77.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -1.099 . . . . 0.0 108.588 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.82 63.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.638 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -106.82 -156.24 20.8 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.475 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.57 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 14.2 mmt -140.63 -179.92 6.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.854 -0.792 . . . . 0.0 109.734 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.791 ' ND1' HG23 ' A' ' 119' ' ' VAL . 3.0 p80 -78.1 -31.04 49.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.444 -0.785 . . . . 0.0 110.088 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.791 HG23 ' ND1' ' A' ' 118' ' ' HIS . 94.7 t -130.67 165.05 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.73 -1.231 . . . . 0.0 110.956 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.609 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.06 158.65 8.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.719 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.8 m120 -129.3 163.91 24.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.658 -1.276 . . . . 0.0 110.547 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 121' ' ' ASN . 3.3 mp -139.49 99.55 3.76 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.471 -0.768 . . . . 0.0 108.945 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 67.73 10.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 108.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 122' ' ' LEU . 1.1 pp -163.85 -176.19 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.821 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 160' ' ' SER . . . 157.99 107.24 0.24 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -163.98 176.71 2.08 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.134 -1.215 . . . . 0.0 109.627 -179.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 126' ' ' SER . 36.4 Cg_endo -81.34 -10.53 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.89 2.393 . . . . 0.0 109.766 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.658 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 1.1 t -50.03 -48.6 78.44 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.74 -0.6 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.883 ' HA ' HG22 ' A' ' 102' ' ' VAL . 31.1 Cg_endo -72.61 169.84 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.245 1.963 . . . . 0.0 110.955 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.25 179.58 5.2 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.701 1.239 . . . . 0.0 111.008 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 134' ' ' GLU . . . -63.52 -16.32 60.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -63.73 -36.01 82.46 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.69 HD12 ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -66.71 -34.97 79.02 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 1.7 tt0 -60.25 -58.92 6.45 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.863 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 138' ' ' ASN . 96.5 mm-40 -45.51 -25.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -67.79 -48.72 65.52 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.439 HG23 HD13 ' A' ' 109' ' ' LEU . 3.4 t -65.3 -26.14 38.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 11.9 t30 -62.33 -35.17 78.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 p -75.82 -25.38 56.26 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.1 -22.93 57.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.183 -0.948 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -30.5 67.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.966 . . . . 0.0 108.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.55 -34.19 49.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 108.969 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -98.71 -19.69 17.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 237' ' ' ASN . . . 82.98 14.13 75.86 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 145' ' ' VAL . 6.3 t -48.4 102.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -1.095 . . . . 0.0 108.931 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HB2' ' OD1' ' A' ' 237' ' ' ASN . 0.4 OUTLIER -69.1 103.55 1.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.285 -0.884 . . . . 0.0 109.426 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -102.51 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 218' ' ' THR . 1.0 OUTLIER -122.9 113.92 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.4 32.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.922 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.612 ' HB1' ' HB ' ' A' ' 214' ' ' THR . . . -64.08 172.53 2.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.809 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.613 ' CB ' HG21 ' A' ' 214' ' ' THR . 0.3 OUTLIER -69.0 -74.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 109.758 -179.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 153.73 -13.01 0.56 Allowed Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.301 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 152' ' ' GLY . 4.4 m-20 22.9 48.62 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.3 OUTLIER 176.73 56.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.46 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . 161.79 51.84 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -54.51 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 110.252 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . 66.18 11.61 55.91 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 2.3 p 160.13 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -112.29 -175.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.944 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -85.93 168.79 13.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.305 1.05 . . . . 0.0 111.801 -178.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.457 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -104.38 137.86 19.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 175.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.721 ' O ' ' N ' ' A' ' 164' ' ' ARG . 39.6 Cg_endo -73.24 -53.31 0.16 OUTLIER 'Cis proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.174 -1.178 . . . . 0.0 110.656 3.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.944 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 29.95 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.254 1.026 . . . . 0.0 110.116 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 162' ' ' PRO . 3.8 ttm180 -42.39 -46.86 4.82 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.329 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 14.7 m-85 -44.4 173.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.11 -0.994 . . . . 0.0 110.913 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 168' ' ' ALA . . . -98.8 -47.87 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.67 -0.644 . . . . 0.0 110.493 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 166' ' ' ALA . 0.4 OUTLIER -42.24 -27.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.882 0.848 . . . . 0.0 109.751 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -125.55 145.55 50.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.473 ' SD ' ' HG3' ' A' ' 241' ' ' ARG . 12.7 mtm -96.12 153.92 17.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -108.43 122.82 47.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.8 t -90.72 165.75 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 0.0 109.76 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.618 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -131.09 -176.62 14.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.82 162.44 27.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.992 -1.299 . . . . 0.0 109.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.1 p -133.45 172.27 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.789 . . . . 0.0 109.249 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 -156.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -90.05 -41.51 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -78.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.535 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.72 30.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 110.042 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -112.22 156.36 22.48 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.145 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' A' ' 256' ' ' LEU . 6.7 ttp85 -60.96 134.6 57.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 0.0 109.475 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.776 ' HB1' ' CE1' ' A' ' 183' ' ' PHE . . . -45.68 173.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.451 -0.78 . . . . 0.0 109.701 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.0 OUTLIER -108.27 11.17 27.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 109.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.776 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 2.3 p90 -134.73 -12.37 2.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.039 -1.038 . . . . 0.0 110.645 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 t -67.01 138.88 57.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.526 ' HG2' ' N ' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -93.83 143.02 26.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.115 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.47 -174.34 3.04 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.596 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.03 -171.85 44.09 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -85.67 64.39 8.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.127 . . . . 0.0 109.177 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.63 31.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -85.53 138.26 32.32 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.132 -1.216 . . . . 0.0 109.66 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -86.0 -72.68 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.629 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 193' ' ' VAL . 0.3 OUTLIER -149.56 -162.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.245 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.795 HG22 ' CA ' ' A' ' 260' ' ' GLY . 27.2 m -143.28 175.97 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.962 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -167.61 177.16 1.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 108.946 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.962 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.2 Cg_endo -76.69 113.74 3.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 109.446 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.505 ' HA2' ' ND2' ' A' ' 212' ' ' ASN . . . -145.22 48.27 0.71 Allowed Glycine 0 N--CA 1.484 1.861 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.435 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 1.7 t -130.87 30.49 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.249 . . . . 0.0 109.068 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.597 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.1 OUTLIER 164.86 105.18 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.158 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.788 HG22 ' ND2' ' A' ' 212' ' ' ASN . 2.7 m -158.37 111.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -89.56 117.93 28.82 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.335 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -118.05 -151.45 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.929 . . . . 0.0 109.858 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.687 ' OG1' HG22 ' A' ' 64' ' ' THR . 0.1 OUTLIER -87.92 178.43 6.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.645 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -164.6 157.7 14.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.645 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.6 Cg_endo -70.07 166.0 29.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.233 1.956 . . . . 0.0 110.322 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 206' ' ' SER . . . 84.74 3.84 87.84 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 205' ' ' GLY . 6.9 t 74.84 43.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -1.078 . . . . 0.0 110.26 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -145.11 -179.91 6.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.554 ' CE2' HG22 ' A' ' 79' ' ' VAL . 2.9 m-30 -113.67 -174.13 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -165.31 164.77 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.828 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 50.5 m -124.8 114.56 19.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.504 -0.747 . . . . 0.0 109.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 211' ' ' LEU . 0.8 OUTLIER -173.96 138.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.407 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.788 ' ND2' HG22 ' A' ' 199' ' ' VAL . 2.9 t-20 -125.23 -157.43 0.78 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.165 0.983 . . . . 0.0 110.601 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 136.32 175.95 14.09 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 151' ' ' SER . 0.2 OUTLIER -56.68 -41.52 77.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.984 -1.303 . . . . 0.0 109.346 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.5 m -57.69 -29.86 65.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 0.0 110.447 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.486 ' O ' HG21 ' A' ' 69' ' ' THR . 1.4 mpp? -90.95 -26.26 19.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.496 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.12 -6.2 59.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.977 -1.077 . . . . 0.0 109.441 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.703 HG23 HG12 ' A' ' 148' ' ' VAL . 1.2 m -73.05 -47.56 8.07 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -71.71 -8.39 23.03 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.098 1.865 . . . . 0.0 111.466 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.723 ' CE1' HG23 ' A' ' 69' ' ' THR . 5.7 m80 -77.19 -47.14 21.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 262' ' ' VAL . 57.9 t -67.74 -41.39 85.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.565 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -57.65 -34.77 69.71 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.5 -54.83 26.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.69 ' HB1' ' HB2' ' A' ' 264' ' ' ALA . . . -51.06 -38.3 50.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 108.867 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -59.08 -44.96 91.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 0.0 109.154 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.61 52.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 108.985 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.9 mt -50.82 -31.53 17.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.025 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 224' ' ' ALA . 58.3 t -68.3 -52.1 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.473 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.515 ' HD2' ' ND1' ' A' ' 118' ' ' HIS . 27.3 tttp -46.78 -42.06 16.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 108.822 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.552 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -62.22 -45.95 91.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.357 -0.839 . . . . 0.0 109.444 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 11.6 tptm -56.4 -18.6 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 108.557 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.5 90.8 2.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 108.999 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.04 8.28 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.752 2.301 . . . . 0.0 110.876 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.14 8.33 10.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -82.33 -178.66 7.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.383 -0.823 . . . . 0.0 109.915 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -121.54 174.71 6.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.651 -0.655 . . . . 0.0 109.443 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -60.42 -27.05 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 238' ' ' VAL . 2.8 t -73.06 -63.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.098 -1.001 . . . . 0.0 109.61 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -49.04 -39.79 28.72 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.546 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 237' ' ' ASN . 84.0 mt -60.01 -58.12 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.486 -0.759 . . . . 0.0 109.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.473 ' HG3' ' SD ' ' A' ' 169' ' ' MET . 18.8 ttp180 -54.64 -72.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.9 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ARG . 4.8 t30 -35.03 -36.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.919 -0.488 . . . . 0.0 110.736 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.493 ' HD2' ' HB1' ' A' ' 267' ' ' ALA . 8.6 t60 -65.83 -51.56 57.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.996 -1.065 . . . . 0.0 110.107 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.517 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 3.6 mt -70.84 -23.84 62.42 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.295 -0.878 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -33.24 60.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -93.26 -14.97 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.2 p -87.32 -31.3 20.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.035 -1.041 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.616 ' HB3' ' CB ' ' A' ' 259' ' ' SER . . . -51.13 144.07 9.78 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 17.6 m -78.07 159.47 28.68 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.447 ' N ' HG22 ' A' ' 249' ' ' THR . 1.9 t -128.55 101.67 6.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.852 . . . . 0.0 109.945 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -50.04 -38.9 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 119.78 67.41 0.29 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 257' ' ' TYR . 3.2 m -132.34 -177.58 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -1.092 . . . . 0.0 109.635 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.727 HG22 ' N ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -80.11 -74.1 0.32 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.727 ' N ' HG22 ' A' ' 254' ' ' THR . 12.2 t-20 -138.0 2.17 2.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.382 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.576 ' CD1' ' CD2' ' A' ' 186' ' ' TYR . 2.0 mm? -80.89 -10.81 59.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.957 -1.089 . . . . 0.0 109.636 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 253' ' ' SER . 72.3 m-85 -128.75 -83.74 0.57 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.73 -0.606 . . . . 0.0 109.601 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 50.39 99.39 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.616 ' CB ' ' HB3' ' A' ' 248' ' ' ALA . 0.9 OUTLIER 56.91 18.85 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.584 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.795 ' CA ' HG22 ' A' ' 193' ' ' VAL . . . -40.75 -61.04 1.99 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 249' ' ' THR . 5.9 tp -62.91 143.44 57.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.997 -1.296 . . . . 0.0 110.186 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.726 HG21 HG22 ' A' ' 221' ' ' VAL . 3.6 t -118.54 125.83 74.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 116.19 6.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.772 1.273 . . . . 0.0 108.663 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.69 ' HB2' ' HB1' ' A' ' 224' ' ' ALA . . . -77.64 -17.28 57.9 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.895 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 55.7 tt0 -55.65 -36.94 67.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 0.0 109.624 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.2 -19.47 39.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.493 ' HB1' ' HD2' ' A' ' 243' ' ' HIS . . . -98.23 -1.83 41.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.365 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.6 p -109.5 -39.06 5.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.655 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.589 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.746 ' HB2' ' HA ' ' A' ' 76' ' ' SER . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.437 ' CG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.1 126.48 27.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.205 -0.935 . . . . 0.0 109.732 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 5' ' ' PRO . 22.9 m -120.19 47.29 1.79 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 3' ' ' SER . 7.3 t -17.3 80.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.708 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -81.69 164.31 18.44 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.809 2.339 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -15.36 7.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.566 -0.709 . . . . 0.0 109.793 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 195' ' ' PRO . . . -83.16 -64.23 1.67 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.1 mp -65.87 173.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.294 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 2.5 t 88.94 -39.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -25.12 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.335 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 11' ' ' VAL . 34.0 m -91.55 20.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.939 -1.101 . . . . 0.0 110.089 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.541 ' OE1' ' CB ' ' A' ' 265' ' ' GLU . 0.0 OUTLIER 50.86 53.42 13.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 110.519 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.681 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.66 -30.41 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.944 -1.097 . . . . 0.0 111.988 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.8 Cg_endo -75.31 -59.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.11 -27.41 0.58 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.06 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -81.15 -40.56 23.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.922 -1.111 . . . . 0.0 108.935 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -73.11 -8.42 55.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.48 -39.02 5.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.599 -1.313 . . . . 0.0 110.23 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.41 68.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.868 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.09 -4.85 4.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.606 ' HB3' HD22 ' A' ' 227' ' ' LEU . 3.7 mm? -62.9 122.29 15.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.199 -1.177 . . . . 0.0 109.101 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -118.5 -30.81 5.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.535 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 78.8 -14.73 12.13 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.41 120.81 4.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -1.154 . . . . 0.0 109.001 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.09 0.71 30.0 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 23' ' ' GLY . 39.4 t -99.37 164.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.236 -1.155 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.594 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 6.4 mttt -142.29 129.34 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' A' ' 119' ' ' VAL . 16.0 t -133.04 158.54 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.611 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -112.17 144.42 41.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 108.918 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 88' ' ' LEU . 45.7 t -121.31 82.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.073 -1.017 . . . . 0.0 109.132 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.859 HD22 HD12 ' A' ' 122' ' ' LEU . 4.9 mp -64.7 91.64 0.09 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -144.72 -151.78 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.798 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.689 HG22 ' C ' ' A' ' 95' ' ' GLY . 72.9 p -80.35 -51.63 8.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.462 -1.398 . . . . 0.0 109.036 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -168.56 -114.47 0.3 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 160.83 100.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.5 t -44.75 150.47 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.193 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.33 115.27 21.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.422 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -139.16 157.26 71.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.2 Cg_endo -77.01 -37.48 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.6 2.2 . . . . 0.0 110.493 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -62.08 -18.94 62.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' CD2' ' HA2' ' A' ' 68' ' ' GLY . 14.5 mt -102.02 129.82 48.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.371 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 68.23 9.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.385 -0.822 . . . . 0.0 109.307 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -57.26 139.02 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.482 ' HG2' ' HG2' ' A' ' 87' ' ' GLU . 20.3 tpt85 -121.54 -33.92 3.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.261 -0.899 . . . . 0.0 109.687 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -156.27 18.97 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.22 166.2 13.92 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.726 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -145.33 174.58 10.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.976 . . . . 0.0 108.961 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 92' ' ' LYS . 81.2 p -125.84 107.18 10.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 110.28 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.726 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 2.7 m-85 -105.81 -36.83 6.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG13 ' HD2' ' A' ' 51' ' ' PRO . 2.1 t -41.82 145.97 0.65 Allowed Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HD2' HG13 ' A' ' 50' ' ' VAL . 34.0 Cg_endo -75.28 -63.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.575 2.183 . . . . 0.0 110.81 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -29.77 -38.13 0.02 OUTLIER Glycine 0 N--CA 1.499 2.886 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER 60.95 60.49 3.28 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 35.2 Cg_endo -77.98 -78.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.427 2.085 . . . . 0.0 110.022 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 54' ' ' PRO . 6.4 m -167.52 136.49 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.443 -0.785 . . . . 0.0 109.089 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 56' ' ' THR . 1.2 m -77.74 -0.85 28.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.594 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 41.1 mt-30 -141.51 117.72 10.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.041 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 14.2 t70 64.56 92.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.837 . . . . 0.0 109.513 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.29 -27.89 5.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.66 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.389 -1.065 . . . . 0.0 109.679 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 64' ' ' THR . . . 160.55 -42.18 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.216 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' GLY . 34.7 t-80 -54.16 -65.09 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 110.078 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -39.99 -74.77 0.13 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -40.1 -40.66 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 0.0 109.784 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.4 t-80 -55.37 -56.7 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 219' ' ' PRO . 78.5 t -57.49 -44.44 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -54.67 -32.72 59.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.483 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -79.39 -27.62 54.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -74.15 -15.61 61.02 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.953 HG21 HD21 ' A' ' 88' ' ' LEU . 16.7 mt -109.29 -21.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.455 -0.778 . . . . 0.0 110.049 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.948 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -117.56 -35.45 3.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 111.627 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 68' ' ' GLY . . . -15.24 106.15 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 121.468 0.652 . . . . 0.0 111.646 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 40' ' ' ASP . 6.7 mt -85.0 153.82 22.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 109.749 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 48.9 p-10 -72.62 141.64 48.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 8.7 m-20 158.17 130.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.746 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -35.61 -39.11 0.13 Allowed 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -86.68 64.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.127 -0.983 . . . . 0.0 109.349 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA3' ' OD2' ' A' ' 40' ' ' ASP . . . 158.35 160.17 10.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 80' ' ' LEU . 5.5 m -79.05 -112.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -1.112 . . . . 0.0 109.646 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.439 ' H ' HG23 ' A' ' 79' ' ' VAL . 5.6 tp -171.74 96.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.799 -1.188 . . . . 0.0 109.664 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 72' ' ' ALA . . . -78.92 -160.49 18.02 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.644 HG12 HD11 ' A' ' 227' ' ' LEU . 1.4 t -107.65 -32.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.291 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -115.53 117.98 39.84 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 109.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 22' ' ' THR . 37.6 Cg_endo -85.48 -59.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.724 2.282 . . . . 0.0 111.244 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.53 38.83 1.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.97 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -89.54 124.2 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 2.6 mt-10 -64.49 103.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.953 HD21 HG21 ' A' ' 70' ' ' ILE . 11.1 mt -97.44 92.9 6.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 110.851 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.444 ' CE2' ' HE3' ' A' ' 117' ' ' MET . 40.0 m-85 -77.63 146.57 36.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.25 106.59 17.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.767 -1.208 . . . . 0.0 109.029 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.698 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -95.1 67.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.988 0.899 . . . . 0.0 108.807 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 26.6 ttmt -35.12 94.05 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.005 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.607 HG21 HD23 ' A' ' 31' ' ' LEU . 2.2 t -118.39 -16.66 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 0.0 108.891 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.1 mt -116.47 175.17 5.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.389 -0.819 . . . . 0.0 110.167 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -107.36 -14.3 18.62 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 95' ' ' GLY . . . 150.54 -83.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.3 23.28 7.64 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 99' ' ' SER . . . -95.75 -95.34 1.76 Allowed Glycine 0 N--CA 1.479 1.524 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 98' ' ' GLY . 2.9 p 149.1 100.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.92 -178.8 0.18 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 177.51 6.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.883 -0.775 . . . . 0.0 109.969 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 133' ' ' LEU . 1.5 t -66.19 -22.02 29.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 3.6 t -69.96 -26.4 64.09 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 93' ' ' VAL . 4.4 m -81.23 -44.49 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.538 -0.726 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.525 HG22 ' CD1' ' A' ' 109' ' ' LEU . 1.2 mt -68.14 -21.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.49 -52.22 16.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.681 -0.637 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 103' ' ' SER . 12.7 mm-40 -71.15 -30.4 66.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.689 -1.257 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -73.19 -24.07 76.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD1' HG22 ' A' ' 105' ' ' ILE . 25.0 mt -93.79 -24.2 17.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -1.179 . . . . 0.0 109.906 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.33 -30.52 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 69.4 t90 -72.65 -16.6 61.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.693 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -91.37 6.21 46.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -114.9 -50.38 0.48 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -70.08 -76.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.279 . . . . 0.0 108.732 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -105.71 41.07 1.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.621 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -92.39 -149.46 24.53 Favored Glycine 0 C--N 1.294 -1.782 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.594 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 7.1 mmt -140.3 -169.15 2.7 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.178 0.989 . . . . 0.0 110.933 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.485 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.0 m170 -70.21 -57.77 4.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.164 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.7 ' HB ' HG13 ' A' ' 28' ' ' VAL . 9.7 t -101.03 161.35 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 111.177 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.592 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -163.25 109.7 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 1.057 ' C ' HD13 ' A' ' 122' ' ' LEU . 7.0 m120 -110.72 153.49 25.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.911 -1.118 . . . . 0.0 111.077 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.057 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -134.89 134.07 40.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -89.61 70.27 7.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.294 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.608 HD21 ' CB ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -150.4 -177.74 6.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.621 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.07 106.93 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.18 158.97 40.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.205 -1.173 . . . . 0.0 109.58 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 128' ' ' SER . 36.0 Cg_endo -78.69 -17.1 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.633 2.222 . . . . 0.0 110.051 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -40.98 102.15 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.583 -0.698 . . . . 0.0 109.533 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 130' ' ' SER . 34.0 Cg_endo -77.42 166.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.409 2.073 . . . . 0.0 110.488 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 129' ' ' PRO . 2.1 m 172.53 121.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.436 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.58 -18.53 65.03 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.8 m -73.07 -25.73 61.01 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.583 ' CD1' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -79.62 -42.89 23.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.45 -25.82 57.77 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.546 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.4 tm0? -72.41 -22.75 61.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.3 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 167' ' ' ASN . 0.9 OUTLIER -64.06 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -59.45 -36.55 76.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.52 -24.48 50.0 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.29 59.42 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 121.232 -0.917 . . . . 0.0 109.917 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m -73.17 -36.53 66.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -24.76 58.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -105.15 -13.14 15.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.26 55.53 27.22 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.693 HG21 ' O ' ' A' ' 112' ' ' ALA . 15.3 t -89.36 107.13 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.704 -0.88 . . . . 0.0 109.766 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.05 101.95 0.45 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.063 -1.023 . . . . 0.0 109.071 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 1.4 t -88.81 150.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -146.06 120.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.713 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -115.44 151.33 34.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.124 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.68 173.82 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -72.78 -67.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.034 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . 172.67 -23.67 0.08 OUTLIER Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.77 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 154' ' ' SER . 44.4 t-20 67.52 37.12 3.51 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.831 -0.805 . . . . 0.0 109.96 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 1.0 OUTLIER 79.23 72.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 110.213 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -115.84 -33.09 1.6 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -172.12 -178.39 2.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -1.193 . . . . 0.0 109.534 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.34 58.41 4.91 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER 162.25 129.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.982 . . . . 0.0 109.196 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 158' ' ' SER . 1.8 pt -48.66 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.359 -0.838 . . . . 0.0 110.007 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.878 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -126.91 164.68 20.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.227 -0.921 . . . . 0.0 111.896 -177.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.1 OUTLIER -77.78 142.37 65.41 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 175.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.8 Cg_endo -72.0 -29.3 6.35 Favored 'Cis proline' 0 C--N 1.298 -2.113 0 O-C-N 122.546 0.761 . . . . 0.0 110.594 3.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -35.12 -26.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.732 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -100.35 -32.03 11.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.542 -1.349 . . . . 0.0 110.608 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.51 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.6 m-85 -46.18 -179.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.172 -0.955 . . . . 0.0 110.798 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -93.96 -25.64 17.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.566 -0.709 . . . . 0.0 111.049 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.471 HD22 HG13 ' A' ' 137' ' ' VAL . 2.2 t-20 -97.98 23.08 8.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.81 -1.181 . . . . 0.0 110.061 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 162' ' ' PRO . . . -153.01 114.61 4.26 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.537 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 0.6 OUTLIER -78.26 167.45 21.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.128 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -118.61 123.77 45.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.331 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 172' ' ' GLY . 25.0 t -92.86 166.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.141 -0.974 . . . . 0.0 109.242 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.571 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -138.66 -179.79 17.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.49 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -119.47 171.27 8.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 179' ' ' ASN . 1.5 p -122.86 167.88 12.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.536 ' CA ' ' HA ' ' A' ' 181' ' ' ALA . 49.6 p-10 -91.16 -177.57 4.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -69.51 -24.25 63.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.29 -79.22 0.17 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.464 ' O ' ' HB ' ' A' ' 174' ' ' THR . 0.1 OUTLIER -135.76 -79.4 0.42 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 110.363 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.593 ' HA ' HG22 ' A' ' 174' ' ' THR . 0.8 OUTLIER -125.0 -164.49 1.29 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.206 -0.934 . . . . 0.0 109.681 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 81.43 -31.31 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.626 -0.672 . . . . 0.0 110.932 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.536 ' HA ' ' CA ' ' A' ' 175' ' ' ASP . . . 42.99 -155.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.957 -1.089 . . . . 0.0 109.454 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -126.64 -45.81 1.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 110.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.27 26.37 10.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.349 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.5 t -81.15 112.31 18.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.636 ' NE2' ' HA ' ' A' ' 185' ' ' GLN . 4.9 tp60 -74.88 156.8 36.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.8 171.41 14.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.613 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.578 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -173.56 146.83 9.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.05 100.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.46 16.16 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 186' ' ' TYR . 7.1 tp -53.79 151.08 6.7 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.107 -1.231 . . . . 0.0 108.824 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.537 ' CB ' ' HB3' ' A' ' 169' ' ' MET . 22.4 t70 -99.54 -69.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.825 HD11 HG22 ' A' ' 262' ' ' VAL . 7.6 tt -159.45 141.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.367 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.516 HG21 HD21 ' A' ' 179' ' ' ASN . 22.1 m -98.32 172.96 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 1.002 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -164.1 178.13 1.56 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.05 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 1.002 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.7 Cg_endo -77.64 117.61 4.32 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.284 1.989 . . . . 0.0 110.134 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -143.67 33.24 1.78 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.666 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 62.7 t -119.31 59.03 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -1.192 . . . . 0.0 108.88 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.724 ' O ' HG13 ' A' ' 199' ' ' VAL . 12.9 t-20 123.9 121.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 198' ' ' ASN . 11.6 m -166.4 110.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.946 0.879 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.6 mt-30 -80.46 122.97 27.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.334 0.588 . . . . 0.0 109.531 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.594 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.8 t -125.31 -163.16 1.17 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.643 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.5 p -79.27 166.8 21.76 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 110.115 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.647 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -149.16 156.62 40.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.647 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.3 Cg_endo -69.96 159.94 51.46 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.183 1.922 . . . . 0.0 110.629 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.418 ' O ' ' OG ' ' A' ' 206' ' ' SER . . . 74.84 31.28 58.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 205' ' ' GLY . 80.9 p 49.86 40.15 19.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -1.076 . . . . 0.0 109.905 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.22 155.36 40.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -103.58 165.43 11.04 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.186 -0.946 . . . . 0.0 108.819 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -153.09 163.76 39.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.768 -1.208 . . . . 0.0 110.746 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.8 OUTLIER -121.27 108.21 13.46 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.522 HD23 ' C ' ' A' ' 210' ' ' SER . 11.0 mt -110.12 170.0 8.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.103 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 212' ' ' ASN . 2.4 p-10 -146.77 148.88 32.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.448 -0.782 . . . . 0.0 109.211 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.16 161.94 11.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 173' ' ' ALA . 90.3 m -77.37 -17.32 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -1.129 . . . . 0.0 109.222 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 36.0 m -75.37 -19.25 59.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.118 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.442 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -79.71 -17.44 53.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 109.556 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -89.8 -13.1 37.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 109.732 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.638 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.7 m -70.6 -42.73 14.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 111.489 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.9 Cg_endo -73.11 -15.45 25.77 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 121.672 1.581 . . . . 0.0 110.756 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -75.25 -40.44 58.91 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.466 HG22 HG21 ' A' ' 262' ' ' VAL . 88.2 t -68.82 -49.64 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.535 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.27 -31.99 62.01 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.387 -0.821 . . . . 0.0 108.995 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -64.24 -53.87 33.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -49.25 -52.19 28.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -1.179 . . . . 0.0 109.237 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.37 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.404 -0.81 . . . . 0.0 109.061 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -61.73 -44.23 97.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.308 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 82' ' ' VAL . 79.1 mt -55.8 -36.63 67.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.238 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.504 HG21 HD23 ' A' ' 244' ' ' LEU . 36.6 t -73.59 -40.88 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 109.995 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.76 ' NZ ' HD13 ' A' ' 240' ' ' ILE . 11.6 ttmm -52.38 -46.07 66.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.623 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.434 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.78 -45.16 93.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -20.66 3.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.848 . . . . 0.0 108.792 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.62 85.06 0.53 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.758 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 35.1 Cg_endo -77.05 -16.16 16.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.07 -0.6 32.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -81.27 -177.33 6.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.75 169.13 11.04 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.64 . . . . 0.0 109.577 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -60.11 -16.06 28.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.68 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.51 -63.74 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.481 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -50.82 -38.86 51.21 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.031 -178.382 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.76 HD13 ' NZ ' ' A' ' 229' ' ' LYS . 62.5 mt -70.62 -44.61 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 110.294 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 4.8 ttp85 -57.3 -29.24 63.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 110.415 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.49 -29.63 25.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.75 -1.219 . . . . 0.0 110.278 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.424 ' O ' HG23 ' A' ' 247' ' ' THR . 0.6 OUTLIER -75.5 -57.86 3.63 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.934 -1.104 . . . . 0.0 108.126 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.522 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -60.05 -38.12 81.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.753 -0.592 . . . . 0.0 110.253 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 21.6 tttt -69.34 -49.96 50.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -74.62 -6.37 48.26 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.826 -0.547 . . . . 0.0 110.862 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.5 p -94.15 -30.76 14.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.697 -1.252 . . . . 0.0 109.832 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -44.24 137.44 3.5 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.7 m -92.19 105.9 18.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.187 -0.945 . . . . 0.0 109.862 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.499 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.5 OUTLIER -75.43 135.61 40.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.442 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.3 -78.11 0.1 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.309 -0.869 . . . . 0.0 109.686 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -149.62 31.71 1.12 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.2 m -123.99 159.53 29.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.05 -1.265 . . . . 0.0 109.355 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.9 p -138.37 24.78 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.605 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -171.79 -34.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 256' ' ' LEU . 13.8 mt -70.61 -74.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.912 . . . . 0.0 109.167 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 257' ' ' TYR . 4.2 m-30 -71.4 -24.39 62.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.697 0.76 . . . . 0.0 109.121 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.69 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 192' ' ' ILE . 44.9 m -54.02 -48.49 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.941 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 106.74 -131.37 10.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 261' ' ' LEU . 4.8 tp -81.65 179.17 7.94 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.365 -1.079 . . . . 0.0 109.898 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.825 HG22 HD11 ' A' ' 192' ' ' ILE . 0.4 OUTLIER -120.32 140.67 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.492 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.45 118.43 1.39 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.468 1.128 . . . . 0.0 108.533 178.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -80.43 -7.19 59.04 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.698 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.541 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -57.53 -54.02 51.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.771 -1.206 . . . . 0.0 109.792 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.6 33.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.085 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.417 ' HB1' ' CG2' ' A' ' 228' ' ' VAL . . . -103.61 -14.91 15.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.819 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.601 HG21 ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -106.04 -31.26 8.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.025 . . . . 0.0 109.981 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 268' ' ' THR . 1.4 ttp85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.534 ' NE2' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -70.2 169.49 13.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.297 -0.877 . . . . 0.0 109.339 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 1.9 m -77.25 116.38 17.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 t -131.83 81.27 63.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 109.208 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HG2' HG13 ' A' ' 8' ' ' ILE . 33.6 Cg_endo -77.27 157.23 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.507 2.138 . . . . 0.0 110.738 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -47.37 -38.0 12.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.648 -0.658 . . . . 0.0 109.916 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' TRP . . . -59.95 -43.81 97.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -107.33 50.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -1.155 . . . . 0.0 109.862 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -132.15 -42.88 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 109.593 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -86.61 -1.1 57.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.888 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 13' ' ' ALA . 16.2 m -88.42 20.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 120.994 -1.066 . . . . 0.0 109.85 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 263' ' ' ASN . 1.1 mt-30 41.4 42.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.745 . . . . 0.0 110.289 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.691 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -76.85 -35.37 1.42 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 111.481 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.2 Cg_endo -73.0 -56.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.623 ' HB1' ' HG3' ' A' ' 265' ' ' GLU . . . -42.93 -37.07 1.73 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.35 72.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.209 -0.932 . . . . 0.0 108.563 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 21.7 m170 -63.93 -14.34 52.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.89 -50.26 12.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.15 -14.58 25.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.52 -2.86 39.57 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 268' ' ' THR . 1.6 tp -51.72 162.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.154 . . . . 0.0 109.655 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 -32.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 64.82 8.86 36.35 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.546 ' CB ' ' HB3' ' A' ' 85' ' ' ASN . 8.6 p -52.75 -31.8 40.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.964 . . . . 0.0 110.07 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.03 32.9 4.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 27' ' ' LYS . 54.0 t -123.57 162.35 24.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.222 -1.164 . . . . 0.0 109.927 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.696 ' HZ2' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -133.94 132.5 40.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.56 ' N ' ' HE2' ' A' ' 27' ' ' LYS . 1.1 t -128.41 103.68 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 109.789 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.792 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -74.16 162.46 28.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 35' ' ' ILE . 42.6 t -135.16 89.08 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.011 -1.056 . . . . 0.0 108.894 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 7.1 mp -76.56 109.78 10.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD2' ' HA3' ' A' ' 63' ' ' GLY . 44.4 p-10 -173.71 -164.92 0.23 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.895 -1.128 . . . . 0.0 110.123 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 96' ' ' ALA . 19.6 p -42.9 -64.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.724 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -172.2 -116.19 0.39 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.697 HD11 HG11 ' A' ' 30' ' ' VAL . 0.6 OUTLIER 156.58 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.4 p -69.25 151.5 46.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 109.599 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 t -70.94 162.21 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -0.869 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.618 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -166.29 162.7 12.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.8 Cg_endo -79.04 -5.78 14.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.701 2.267 . . . . 0.0 110.349 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -109.56 -17.07 13.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.137 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.638 HD21 ' HA2' ' A' ' 68' ' ' GLY . 18.5 mt -100.7 141.29 33.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.267 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -111.8 67.05 0.64 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.104 -0.998 . . . . 0.0 109.229 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' CG2' ' A' ' 35' ' ' ILE . 31.9 mm -43.06 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.379 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -81.88 -15.82 52.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.238 -0.914 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -171.28 152.41 18.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 163.79 29.2 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.51 167.61 28.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.979 ' OG ' HG23 ' A' ' 56' ' ' THR . 1.5 m -148.81 111.74 4.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 110.156 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.755 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 9.0 m-85 -99.02 -40.61 7.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.571 ' HB ' ' NZ ' ' A' ' 92' ' ' LYS . 76.3 t -51.73 120.4 15.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 108.986 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' GLY . 36.8 Cg_endo -79.71 -68.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.618 2.212 . . . . 0.0 111.218 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -33.43 -52.54 0.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HG3' ' C ' ' A' ' 52' ' ' GLY . 14.8 mt-10 -136.66 99.81 10.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.296 . . . . 0.0 109.974 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.661 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 36.5 Cg_endo -78.37 -95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.643 2.228 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 82.26 -66.27 0.1 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.041 -1.037 . . . . 0.0 110.39 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.979 HG23 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER 64.5 3.32 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.048 -1.033 . . . . 0.0 110.408 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 56' ' ' THR . 78.4 mm-40 -149.75 118.77 6.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.666 -1.271 . . . . 0.0 110.211 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' CB ' ' A' ' 204' ' ' PRO . 8.6 t0 57.27 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.404 -0.81 . . . . 0.0 110.106 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . -127.06 -8.07 4.75 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 63.8 t-20 176.31 -61.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -1.135 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.83 -18.33 0.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -68.13 0.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -1.086 . . . . 0.0 110.029 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' HA3' ' OD2' ' A' ' 32' ' ' ASP . . . -55.46 -22.83 32.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.7 m -72.42 -57.71 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.75 -1.441 . . . . 0.0 109.809 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.604 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.5 t-80 -59.04 -36.11 74.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 70' ' ' ILE . 67.1 t -67.92 -42.81 85.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.406 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' HG12 ' A' ' 35' ' ' ILE . . . -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.438 -0.789 . . . . 0.0 110.009 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.638 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -68.61 -40.27 86.04 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.432 HG21 ' HG2' ' A' ' 219' ' ' PRO . 28.2 m -63.72 -17.28 62.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.399 -1.059 . . . . 0.0 108.727 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.78 ' HB ' HD11 ' A' ' 88' ' ' LEU . 36.9 mt -93.85 -22.28 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.439 -0.788 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.785 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -131.59 -52.67 1.0 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 111.228 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 33.7 62.84 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.722 -0.611 . . . . 0.0 109.831 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.474 HD11 ' OD1' ' A' ' 42' ' ' ASN . 43.4 mt -43.34 147.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 1.7 m-20 -62.55 155.88 24.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 109.256 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m-20 145.8 129.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 28.5 t -37.03 -30.16 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.293 0.568 . . . . 0.0 109.765 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 75' ' ' ASN . 28.7 pt -84.65 143.54 11.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.92 155.07 0.38 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 80' ' ' LEU . 26.0 m -72.16 -141.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.317 -1.107 . . . . 0.0 109.683 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.534 HD22 ' NE2' ' A' ' 2' ' ' GLN . 67.5 tp -138.81 128.07 24.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.089 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 1.078 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -87.08 -177.07 49.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.68 -32.35 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -1.232 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -116.34 98.53 51.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.081 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -83.13 -60.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.812 2.341 . . . . 0.0 110.496 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.546 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -71.71 0.38 8.95 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.671 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.587 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -73.33 161.52 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.852 -1.155 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.536 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 2.1 mp0 -97.99 107.85 20.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.789 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 71' ' ' ALA . 2.5 mt -90.47 127.5 36.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.637 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.672 ' CD1' ' HE3' ' A' ' 27' ' ' LYS . 3.6 m-85 -111.99 178.11 4.42 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.014 -1.054 . . . . 0.0 109.943 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.25 90.2 2.5 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.792 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -96.1 64.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.216 -0.928 . . . . 0.0 109.111 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' A' ' 54' ' ' PRO . 3.1 ttpm? -41.06 121.32 1.53 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.33 0.586 . . . . 0.0 109.611 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 104' ' ' SER . 1.2 t -131.7 3.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.953 . . . . 0.0 109.258 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.928 ' CD1' HD22 ' A' ' 124' ' ' LEU . 2.1 mp -141.29 173.92 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.669 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -98.31 -178.35 32.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 33' ' ' THR . . . -76.54 -63.07 1.42 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -1.18 . . . . 0.0 109.397 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.3 m -49.77 -29.95 8.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.932 . . . . 0.0 109.235 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.76 47.68 0.89 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -124.58 65.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -1.132 . . . . 0.0 109.852 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.55 38.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.26 160.29 22.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.627 -0.925 . . . . 0.0 109.818 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.78 -18.7 22.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 107' ' ' GLN . 8.7 t -80.47 -14.71 58.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.83 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -87.84 -44.08 11.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.589 -0.694 . . . . 0.0 109.16 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.6 ' HA ' HG11 ' A' ' 93' ' ' VAL . 2.4 mt -76.88 -32.47 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.92 -36.2 59.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 tt0 -70.88 -42.5 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.883 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.54 73.26 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.46 -45.29 72.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -1.106 . . . . 0.0 108.944 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 107' ' ' GLN . 9.9 pt-20 -72.27 -24.18 61.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -69.99 -18.68 63.35 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.658 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.66 -0.69 48.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.322 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA3' ' NH1' ' A' ' 143' ' ' ARG . . . -107.15 -51.73 0.76 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -1.12 . . . . 0.0 109.143 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -120.99 34.65 5.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -102.37 -151.19 23.54 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.718 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.696 ' HG3' ' HZ2' ' A' ' 27' ' ' LYS . 2.6 mmt -144.14 -157.73 0.81 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.153 0.978 . . . . 0.0 110.965 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.646 ' NE2' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -90.83 -30.6 16.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.896 -178.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.646 HG22 ' NE2' ' A' ' 118' ' ' HIS . 2.1 t -111.51 154.14 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 119.857 -1.777 . . . . 0.0 110.502 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -163.39 105.62 0.98 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 0.0 108.908 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.57 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.9 m120 -85.45 -178.75 6.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.959 HD23 HD11 ' A' ' 124' ' ' LEU . 1.1 mp -152.38 100.23 2.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.524 ' C ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -85.46 65.47 9.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.959 HD11 HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.35 88.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -109.09 152.13 42.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.185 -1.185 . . . . 0.0 109.252 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -77.42 -23.43 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.426 2.084 . . . . 0.0 109.45 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -69.38 111.7 9.56 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.806 -0.559 . . . . 0.0 109.906 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.8 Cg_endo -82.66 170.63 12.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.407 2.071 . . . . 0.0 110.326 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.5 p -163.08 110.77 1.23 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.35 -29.49 70.23 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.2 m -58.23 -31.09 67.03 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -71.58 -36.58 70.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.261 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -59.44 5.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.81 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.2 OUTLIER -50.52 -23.4 2.47 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 108.723 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -73.72 -45.43 52.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.986 HG21 ' HA ' ' A' ' 166' ' ' ALA . 59.3 t -69.44 -21.68 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 8.4 m120 -62.94 -35.82 81.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -29.46 57.72 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -75.4 -13.24 60.38 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.1 m -80.52 -44.36 19.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.0 t -64.15 -13.8 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.517 ' NH1' ' HA3' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -96.85 -17.9 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.497 -0.752 . . . . 0.0 109.285 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.45 75.45 0.4 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.533 ' H ' HD22 ' A' ' 237' ' ' ASN . 36.0 t -124.75 102.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.978 . . . . 0.0 110.48 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 146' ' ' LEU . 17.6 tp -62.86 105.84 0.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.3 t -97.24 156.98 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 110.881 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.548 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -136.36 146.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -142.87 137.07 29.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.984 -1.073 . . . . 0.0 109.537 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.73 144.49 54.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 0.2 OUTLIER -44.0 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 109.434 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 154' ' ' SER . . . 172.66 -22.35 0.07 OUTLIER Glycine 0 N--CA 1.496 2.692 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.821 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' SER . 3.4 p-10 30.74 36.25 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 122.235 -0.568 . . . . 0.0 111.486 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 3.5 t 160.47 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 110.121 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . -165.43 70.57 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.312 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . 45.95 -172.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -1.165 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.2 47.59 3.86 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.44 135.22 17.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.332 -1.099 . . . . 0.0 108.632 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.415 HD11 ' HA3' ' A' ' 189' ' ' GLY . 2.6 pt -57.9 -179.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.998 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.12 170.58 7.87 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.506 1.146 . . . . 0.0 112.599 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.423 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 77.8 m-85 -104.43 139.07 19.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.4 Cg_endo -73.54 -43.94 0.62 Allowed 'Cis proline' 0 C--N 1.295 -2.278 0 O-C-N 123.042 1.022 . . . . 0.0 110.816 3.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.998 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 23.13 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.029 0.918 . . . . 0.0 110.057 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -39.88 -63.72 0.56 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.495 0.664 . . . . 0.0 109.791 177.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.712 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 46.7 p90 -106.87 -166.45 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.899 0.856 . . . . 0.0 111.221 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.986 ' HA ' HG21 ' A' ' 137' ' ' VAL . . . 86.39 34.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.926 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 147' ' ' VAL . 1.0 OUTLIER 45.92 26.32 0.38 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -110.88 114.4 27.71 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.82 127.48 32.96 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.011 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.542 ' N ' ' HB2' ' A' ' 191' ' ' ASP . . . -78.53 108.63 12.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 172' ' ' GLY . 35.3 t -84.48 163.77 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.847 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.718 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -132.89 -172.78 13.1 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -138.89 143.88 38.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.088 -1.242 . . . . 0.0 109.418 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 43.5 p -108.46 175.02 5.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 1.4 t70 -74.64 -163.93 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 109.665 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -53.56 -29.97 39.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -124.54 -79.91 0.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.991 . . . . 0.0 110.151 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 178' ' ' ASN . 9.5 p-10 -149.63 60.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 1.0 OUTLIER -125.19 162.52 24.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.956 -1.09 . . . . 0.0 109.666 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 7.5 mtp180 -62.56 112.82 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.52 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 184' ' ' SER . . . -43.68 171.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.48 -27.29 12.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 184' ' ' SER . 11.6 p90 -114.63 -21.71 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.998 -1.064 . . . . 0.0 109.804 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 181' ' ' ALA . 10.8 t -55.65 126.93 27.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 109.26 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.455 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 27.7 mm-40 -85.23 154.67 21.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -138.81 173.27 11.75 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.161 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 168.01 148.44 5.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -43.55 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -1.112 . . . . 0.0 109.395 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 148.3 -16.38 1.31 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 256' ' ' LEU . 12.0 tp -45.97 126.17 7.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -1.127 . . . . 0.0 109.763 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.542 ' HB2' ' N ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -81.27 -62.0 1.78 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.562 ' CD1' HG22 ' A' ' 262' ' ' VAL . 14.0 tt -155.65 168.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.412 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.718 HG12 ' HA3' ' A' ' 172' ' ' GLY . 3.0 m -122.11 161.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 0.0 110.073 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 1.072 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -150.09 -172.78 0.33 Allowed Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 1.008 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 31.9 Cg_endo -75.48 110.26 3.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.319 1.346 . . . . 0.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -130.25 41.02 1.58 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 26.8 t -142.88 91.58 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.903 ' O ' HG13 ' A' ' 199' ' ' VAL . 19.7 t-20 89.34 115.29 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 198' ' ' ASN . 2.5 m -173.49 118.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -99.87 142.62 31.11 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.491 0.663 . . . . 0.0 110.214 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.604 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -149.71 -148.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 109.304 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -94.13 158.51 15.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.229 -0.919 . . . . 0.0 110.087 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.625 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -135.4 155.82 78.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.625 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.7 Cg_endo -73.62 151.26 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.304 2.003 . . . . 0.0 111.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 30.61 73.15 0.05 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 9.1 t 168.45 -100.55 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.052 -1.263 . . . . 0.0 110.149 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.792 HG23 ' N ' ' A' ' 208' ' ' TYR . 6.5 t -172.41 -142.82 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.792 ' N ' HG23 ' A' ' 207' ' ' THR . 0.0 OUTLIER -91.06 157.27 17.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.528 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.28 139.44 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.2 OUTLIER -95.23 133.19 39.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 212' ' ' ASN . 1.1 pp -158.28 164.36 36.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.503 ' O ' HD12 ' A' ' 211' ' ' LEU . 2.0 m-80 -99.85 171.54 7.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 216' ' ' MET . . . 153.59 131.35 1.57 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 84.4 m -67.62 -25.32 65.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.495 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -68.43 -12.29 60.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.147 -0.971 . . . . 0.0 109.386 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.479 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -77.0 -26.6 54.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 1.072 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -86.98 0.63 54.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.596 -0.69 . . . . 0.0 109.548 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.618 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 1.8 m -80.44 -45.79 1.34 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.269 -0.895 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.6 Cg_endo -73.48 -18.31 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.735 1.624 . . . . 0.0 110.985 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -70.7 -40.74 72.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.912 -1.118 . . . . 0.0 108.591 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 262' ' ' VAL . 55.8 t -74.35 -39.56 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.81 64.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -73.36 -52.34 8.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 264' ' ' ALA . . . -53.15 -64.13 0.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 109.242 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.455 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -43.48 -46.13 6.71 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.21 44.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 109.072 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.528 ' HB3' HD23 ' A' ' 21' ' ' LEU . 17.7 mt -56.48 -37.9 70.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 84.3 t -56.58 -63.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.793 ' HE3' HD11 ' A' ' 240' ' ' ILE . 1.8 mtpt -48.18 -31.7 6.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 108.893 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.45 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.6 OUTLIER -61.79 -49.3 76.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -5.93 31.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 232' ' ' ASN . 1.9 p-10 -164.44 79.58 1.4 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.402 -0.811 . . . . 0.0 109.685 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 31.98 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.854 2.369 . . . . 0.0 111.149 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -12.15 5.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.78 -1.2 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.65 175.72 9.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.054 -1.029 . . . . 0.0 109.864 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.87 174.66 5.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.684 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.533 HD22 ' H ' ' A' ' 145' ' ' VAL . 1.3 m-20 -58.04 -28.3 64.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -77.68 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.266 -0.897 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' VAL . 16.1 mt-30 -42.9 -36.23 1.45 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.481 0.657 . . . . 0.0 109.488 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.793 HD11 ' HE3' ' A' ' 229' ' ' LYS . 50.4 mt -68.86 -56.33 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 109.633 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -43.31 -50.17 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 109.906 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -51.06 -60.98 2.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.784 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 247' ' ' THR . 24.6 t-80 -55.14 -57.12 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.066 . . . . 0.0 109.822 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 244' ' ' LEU . 0.8 OUTLIER -56.3 -18.46 10.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.477 -0.765 . . . . 0.0 109.95 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER -83.42 -39.71 20.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 109.271 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.69 -30.08 66.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.269 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.898 HG23 ' O ' ' A' ' 243' ' ' HIS . 1.7 p -78.92 -52.35 8.4 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.18 0.991 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -28.9 116.97 0.11 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 13.9 m -53.32 131.91 38.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.32 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.74 109.99 22.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.41 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.895 HD22 ' CD2' ' A' ' 257' ' ' TYR . 6.1 mp -70.12 -76.31 0.1 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 175.78 31.42 0.04 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.534 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 162.02 40.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 109.423 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.8 p -124.38 8.58 8.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.653 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.41 -70.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 108.852 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.624 ' O ' HD23 ' A' ' 190' ' ' LEU . 0.3 OUTLIER -52.61 -56.81 12.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.523 -0.735 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.895 ' CD2' HD22 ' A' ' 251' ' ' LEU . 27.9 m-85 -90.96 -61.42 1.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.38 -0.825 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.2 -120.69 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.518 ' HB3' ' CG1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -47.27 -44.05 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 108.995 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 249' ' ' THR . . . 110.97 -142.8 16.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -178.06 5.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.562 HG22 ' CD1' ' A' ' 192' ' ' ILE . 3.7 t -129.57 146.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.459 -0.775 . . . . 0.0 110.55 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.479 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.02 121.23 1.23 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.42 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 224' ' ' ALA . . . -94.23 -12.96 27.13 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.796 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.623 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 1.1 tm-20 -68.84 -15.74 63.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.812 -1.18 . . . . 0.0 109.685 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.25 1.89 39.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.76 ' HB2' HG21 ' A' ' 247' ' ' THR . . . -122.82 -17.49 6.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.634 HG21 ' CD2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -92.82 -38.88 11.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.776 -1.202 . . . . 0.0 109.364 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.457 ' OXT' ' O ' ' A' ' 268' ' ' THR . 10.2 ptm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.867 -1.064 . . . . 0.0 109.618 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -71.03 166.19 21.88 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.885 ' O ' HG13 ' A' ' 4' ' ' VAL . 1.1 m -66.87 103.53 1.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.414 -0.804 . . . . 0.0 109.878 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.885 HG13 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 170.43 100.21 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 109.22 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 8' ' ' ILE . 36.2 Cg_endo -78.8 174.77 11.79 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.632 2.221 . . . . 0.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -48.02 -28.87 3.04 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.511 -0.743 . . . . 0.0 109.924 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.62 -42.16 55.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CG1' ' NE2' ' A' ' 220' ' ' HIS . 34.2 mt -109.57 73.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.923 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -42.32 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -93.68 6.71 47.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 11' ' ' VAL . 15.8 m -98.2 19.71 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 109.647 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 34.8 mm-40 47.6 25.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 110.089 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.669 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.43 -42.3 83.97 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.9 . . . . 0.0 110.907 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.46 -44.09 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 18' ' ' ASN . . . -46.46 -37.06 7.25 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.67 64.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -64.93 -18.91 65.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.687 -0.633 . . . . 0.0 110.7 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 6.3 p-10 -113.1 -6.63 13.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.743 -1.223 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -83.2 -22.98 33.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.939 -1.1 . . . . 0.0 109.219 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.46 50.33 0.46 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' C ' HG22 ' A' ' 22' ' ' THR . 0.5 OUTLIER -139.25 179.8 6.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.957 . . . . 0.0 109.968 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.53 HG22 ' C ' ' A' ' 21' ' ' LEU . 1.1 t 157.76 100.09 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -55.65 0.93 0.09 OUTLIER Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.654 -0.653 . . . . 0.0 111.935 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 85' ' ' ASN . 71.9 m -28.45 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.811 1.306 . . . . 0.0 111.97 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -85.45 35.02 3.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 23' ' ' GLY . 44.1 t -125.78 165.43 23.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.124 -1.221 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' N ' HG12 ' A' ' 26' ' ' VAL . 16.5 mttm -135.91 117.42 14.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.481 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 119' ' ' VAL . 13.6 t -128.54 136.26 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.829 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.67 155.56 21.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 35' ' ' ILE . 2.2 t -130.84 85.04 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.132 -0.98 . . . . 0.0 108.953 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.95 HD23 HG21 ' A' ' 93' ' ' VAL . 6.9 mp -70.46 103.96 2.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 33' ' ' THR . 9.2 p30 -148.92 -143.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.234 -0.916 . . . . 0.0 109.152 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 33' ' ' THR . 13.4 t -135.68 79.71 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.035 -1.041 . . . . 0.0 110.054 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' HA3' ' ND2' ' A' ' 60' ' ' ASN . . . 90.69 120.8 2.3 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.885 HD12 ' HB2' ' A' ' 90' ' ' ALA . 2.8 mt -112.81 -24.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 122.111 0.958 . . . . 0.0 108.654 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 42.1 t 57.3 148.18 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.287 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -93.09 160.25 14.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.628 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -160.78 178.91 1.47 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 109.046 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.9 Cg_endo -78.0 -22.27 10.18 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.402 2.068 . . . . 0.0 110.183 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.571 ' HA ' HD12 ' A' ' 73' ' ' LEU . 74.9 m-20 -97.22 -55.14 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.336 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.581 HD21 ' C ' ' A' ' 67' ' ' ALA . 17.4 mt -55.22 156.9 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.91 63.87 1.53 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 0.0 109.205 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 43' ' ' ILE . 7.4 mm -49.96 115.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -104.85 -8.13 18.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.99 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -174.13 177.12 46.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.15 158.65 19.65 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.468 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -152.98 162.49 41.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.69 -0.888 . . . . 0.0 108.833 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -132.99 109.74 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.861 ' CE2' HG12 ' A' ' 91' ' ' VAL . 1.9 m-85 -107.61 -44.17 4.33 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.317 -0.864 . . . . 0.0 109.025 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.687 HG13 ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -41.33 151.53 0.29 Allowed Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD2' HG13 ' A' ' 50' ' ' VAL . 30.0 Cg_endo -69.81 171.22 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.427 2.085 . . . . 0.0 111.005 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.63 -42.2 2.91 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp0 43.7 58.31 12.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.933 . . . . 0.0 111.058 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.2 Cg_endo -79.46 -71.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.511 2.141 . . . . 0.0 109.472 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.4 p -168.61 135.2 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.428 HG22 ' OE1' ' A' ' 57' ' ' GLN . 11.0 t -79.03 0.97 25.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.029 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.428 ' OE1' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -119.37 106.68 12.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER 65.72 174.74 0.22 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 0.0 109.861 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 115.15 15.76 7.61 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.65 ' OD1' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -160.71 -71.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.985 . . . . 0.0 109.049 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.86 8.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -73.65 -57.19 4.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -1.22 . . . . 0.0 109.925 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.22 72.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.1 m -69.16 -40.91 77.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 27.1 t-80 -66.56 -53.16 37.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 69' ' ' THR . 39.4 t -58.99 -35.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 109.712 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.581 ' C ' HD21 ' A' ' 41' ' ' LEU . . . -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 110.235 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.611 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -70.16 -44.94 58.49 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.964 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 66' ' ' VAL . 12.3 t -64.46 -16.83 63.13 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.989 -1.301 . . . . 0.0 108.975 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 219' ' ' PRO . 78.7 mt -93.02 -24.91 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.819 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . . . -133.93 -43.1 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.879 -1.138 . . . . 0.0 110.902 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.762 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 8.05 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.106 0.479 . . . . 0.0 111.636 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 40' ' ' ASP . 22.2 mt -42.27 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.971 -1.081 . . . . 0.0 109.57 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.828 ' HB2' HD13 ' A' ' 80' ' ' LEU . 43.8 t30 -113.71 106.44 14.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -154.64 -100.63 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 109.605 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.7 p -132.06 -32.6 1.39 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.347 -0.846 . . . . 0.0 110.147 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.577 HG12 ' ND2' ' A' ' 75' ' ' ASN . 27.9 pt -91.31 138.11 20.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.073 -1.017 . . . . 0.0 110.302 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 3' ' ' SER . . . 60.13 158.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.543 ' C ' ' HB3' ' A' ' 3' ' ' SER . 5.6 m -70.19 -160.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.563 -0.963 . . . . 0.0 109.465 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 74' ' ' ASN . 4.5 tp -135.15 131.35 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.429 -0.794 . . . . 0.0 110.241 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.762 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -77.43 -145.71 2.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.96 -28.47 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.93 -1.335 . . . . 0.0 109.051 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -110.68 125.91 29.86 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.46 -61.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.417 2.078 . . . . 0.0 110.875 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.526 ' CB ' ' OG ' ' A' ' 24' ' ' SER . 1.2 m-20 -103.36 39.88 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.504 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -83.4 168.46 16.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.008 -1.058 . . . . 0.0 109.6 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 72.8 mt-10 -113.6 92.42 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.819 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 7.8 mt -97.13 135.81 38.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 109.635 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.474 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 27.7 m-85 -104.14 155.84 18.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.885 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -110.84 102.58 11.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 109.257 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.861 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -100.5 68.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.188 -0.945 . . . . 0.0 109.068 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 33' ' ' THR . 19.4 ttpt -36.61 103.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.345 0.593 . . . . 0.0 110.275 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.95 HG21 HD23 ' A' ' 31' ' ' LEU . 1.4 t -115.48 -20.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 108.798 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.29 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.402 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 33' ' ' THR . . . -91.18 179.21 42.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.65 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -78.34 -19.65 53.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -1.189 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 t -116.05 -25.46 7.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.67 80.21 0.38 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.38 76.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -1.103 . . . . 0.0 109.375 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.85 -179.61 22.05 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.93 162.84 24.99 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.742 -0.858 . . . . 0.0 109.094 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 133' ' ' LEU . 58.2 t -68.67 -19.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 43.0 t -78.75 -19.86 51.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.0 m -79.2 -52.86 7.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 133' ' ' LEU . 1.3 mt -63.47 -25.2 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.34 78.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.642 -0.661 . . . . 0.0 109.423 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -71.51 -32.39 68.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.987 -1.071 . . . . 0.0 108.991 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.63 -31.08 70.56 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.66 -25.18 21.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.18 -1.188 . . . . 0.0 110.384 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.63 -26.04 23.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -63.54 -22.15 66.73 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.774 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -86.78 -22.43 25.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -62.41 -43.64 98.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 1.8 p-10 -85.18 -38.64 18.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 31.5 m-20 -146.14 85.02 1.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.774 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -115.32 -165.33 14.62 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 15.0 mmt -139.0 178.78 6.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.548 -0.972 . . . . 0.0 110.138 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.516 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.7 m170 -57.95 -39.99 79.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.557 -0.714 . . . . 0.0 110.732 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 120' ' ' ALA . 19.0 t -130.56 167.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.861 -1.149 . . . . 0.0 111.104 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.564 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -164.35 114.78 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 222' ' ' ALA . 10.7 m120 -100.3 151.13 21.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.903 -1.123 . . . . 0.0 110.708 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.402 HD11 HD22 ' A' ' 31' ' ' LEU . 6.9 mp -118.11 110.72 17.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.8 t -82.68 71.74 9.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 108.918 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.17 -174.14 2.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.351 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . 168.62 79.69 0.04 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -95.24 155.82 38.43 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.331 -1.099 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.41 -11.79 18.92 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.516 2.144 . . . . 0.0 109.571 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -83.27 115.54 59.68 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.619 -0.675 . . . . 0.0 109.442 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.58 167.92 21.98 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.258 1.972 . . . . 0.0 110.107 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -155.98 117.24 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.07 -20.8 65.87 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.2 m -69.32 -26.95 64.96 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.8 mp -78.35 -36.21 46.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -38.25 69.0 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.167 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -67.52 -22.61 65.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.87 -32.71 40.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.576 -0.85 . . . . 0.0 108.748 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' ' 167' ' ' ASN . 2.2 t -76.29 -26.38 17.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -65.87 -35.35 80.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 m -79.65 -23.8 42.3 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.83 60.39 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.5 m -79.57 -34.47 40.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.941 . . . . 0.0 108.628 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -56.98 -28.04 61.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.83 -13.51 16.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.21 78.44 0.59 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 117' ' ' MET . 5.1 t -127.3 92.03 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -1.138 . . . . 0.0 110.155 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tp -57.02 120.53 8.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 108.599 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -107.56 152.07 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 110.22 -178.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -141.62 103.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.42 150.33 21.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.06 -1.025 . . . . 0.0 110.412 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.678 ' HB2' ' OG1' ' A' ' 218' ' ' THR . . . -78.31 172.84 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.5 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -77.84 -79.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.0 109.254 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.75 -111.77 0.35 Allowed Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -176.3 28.72 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 29.3 t -128.36 -99.4 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.905 . . . . 0.0 109.73 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.39 55.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.32 -178.2 4.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 109.301 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.61 38.92 2.66 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -166.44 155.38 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -1.178 . . . . 0.0 108.672 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -172.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.868 -1.145 . . . . 0.0 110.751 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.815 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.0 OUTLIER -80.43 163.77 23.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.172 0.987 . . . . 0.0 112.108 -177.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.413 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.2 m-85 -112.43 132.34 22.2 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.6 Cg_endo -73.97 -42.77 0.78 Allowed 'Cis proline' 0 C--N 1.299 -2.077 0 O-C-N 123.139 1.073 . . . . 0.0 111.041 3.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 21.34 -73.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.869 0.843 . . . . 0.0 110.122 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -46.49 -71.59 0.07 Allowed 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.645 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.8 m-85 27.41 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.834 1.302 . . . . 0.0 113.03 178.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.5 -0.35 2.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.437 ' HB2' HG11 ' A' ' 137' ' ' VAL . 15.2 m120 -124.41 21.83 8.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.88 169.87 23.63 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.491 -0.755 . . . . 0.0 108.968 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.485 ' HB2' HG22 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -111.48 157.82 19.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.69 129.91 54.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 31.2 t -91.86 164.63 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.894 -1.129 . . . . 0.0 109.459 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.77 -171.69 12.9 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -120.75 164.93 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 179' ' ' ASN . 0.9 OUTLIER -133.39 173.81 11.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.34 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 0.3 OUTLIER -85.36 -152.0 0.15 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 177' ' ' ASN . 5.1 pt20 -84.96 -29.91 24.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 176' ' ' GLN . 53.4 m-20 -96.33 -97.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.962 . . . . 0.0 109.947 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.77 19.23 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 0.0 109.856 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 3.1 t-20 -72.47 -151.96 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 109.087 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.55 ' HB2' ' CE2' ' A' ' 257' ' ' TYR . 22.3 ttp85 -132.93 16.64 4.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 58.39 164.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.735 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 t -121.2 -4.64 9.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.953 . . . . 0.0 109.914 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.565 ' O ' ' CG ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -106.4 29.13 7.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 109.832 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.78 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 41.6 t -111.85 119.35 38.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 184' ' ' SER . 0.0 OUTLIER -43.89 113.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 109.176 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -113.71 168.15 10.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.915 . . . . 0.0 109.319 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.48 178.72 42.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.73 111.42 17.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 129.36 9.06 3.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 256' ' ' LEU . 14.2 tp -64.24 143.76 57.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.944 -1.327 . . . . 0.0 109.251 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 19.1 t70 -91.6 -70.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.763 HD13 HG13 ' A' ' 262' ' ' VAL . 13.0 tt -140.81 169.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.838 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 260' ' ' GLY . 29.2 m -120.17 162.82 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.73 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -158.48 165.52 18.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.8 Cg_endo -77.09 115.99 4.1 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.465 2.11 . . . . 0.0 110.475 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.44 24.25 3.74 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.66 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 55.4 t -102.96 68.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -1.066 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.841 ' O ' HG13 ' A' ' 199' ' ' VAL . 20.2 t-20 110.33 122.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.072 0.939 . . . . 0.0 108.597 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 198' ' ' ASN . 2.5 m -170.84 113.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -101.67 168.15 9.65 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.7 0.762 . . . . 0.0 110.125 -179.401 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 200' ' ' GLN . 4.3 m -168.32 -156.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' THR . . . . . 0.439 ' H ' HG23 ' A' ' 202' ' ' THR . 1.0 OUTLIER -77.35 172.08 13.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.667 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -152.98 160.59 30.77 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -71.34 164.01 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.285 1.99 . . . . 0.0 110.655 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.7 82.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.99 34.43 5.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -1.056 . . . . 0.0 109.373 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -126.76 160.33 31.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.288 -0.882 . . . . 0.0 109.852 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.93 169.42 8.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.3 164.01 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.78 -1.2 . . . . 0.0 110.961 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.9 OUTLIER -123.34 124.17 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mt -119.73 161.27 21.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.927 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 212' ' ' ASN . 1.1 p-10 -134.05 107.6 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -161.6 151.24 21.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.1 m -70.83 -21.89 62.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -1.114 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.443 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -72.24 -13.27 61.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.135 -0.978 . . . . 0.0 109.095 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.499 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -81.7 -13.52 57.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.724 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.73 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -88.9 -1.49 58.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.985 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 150' ' ' ALA . 1.1 m -75.83 -40.5 3.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.254 -0.904 . . . . 0.0 111.379 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.6 Cg_endo -72.32 -12.95 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.698 1.599 . . . . 0.0 111.242 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.569 ' NE2' ' CG1' ' A' ' 8' ' ' ILE . 18.1 m80 -77.17 -51.45 10.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.044 -1.035 . . . . 0.0 108.507 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 262' ' ' VAL . 98.8 t -63.07 -41.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.526 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -57.15 -40.42 77.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.805 . . . . 0.0 109.11 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.43 59.22 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.2 -51.99 60.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.25 . . . . 0.0 110.021 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.07 -32.99 56.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.374 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.77 97.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.102 -0.999 . . . . 0.0 108.821 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.3 mt -59.06 -51.31 70.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.823 . . . . 0.0 109.565 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' LYS . 76.3 t -57.54 -55.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 109.922 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.58 ' NZ ' HD11 ' A' ' 240' ' ' ILE . 4.1 ttmm -42.28 -42.4 3.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.495 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -61.84 -48.09 82.13 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -57.22 -17.05 9.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.165 -0.96 . . . . 0.0 108.951 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 235' ' ' TRP . 2.3 m120 -172.45 90.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.696 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.1 -38.58 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.75 2.3 . . . . 0.0 110.66 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 235' ' ' TRP . 0.0 OUTLIER -47.42 -46.16 26.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 110.215 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.548 ' CD2' ' HB3' ' A' ' 232' ' ' ASN . 47.4 m0 -45.3 170.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.081 -1.012 . . . . 0.0 110.063 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -113.11 176.85 4.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.731 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -54.21 -20.08 6.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.956 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 238' ' ' VAL . 2.4 t -78.33 -65.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.14 -0.975 . . . . 0.0 109.461 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 235' ' ' TRP . 1.0 OUTLIER -44.39 -43.17 7.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.58 HD11 ' NZ ' ' A' ' 229' ' ' LYS . 6.1 mt -59.65 -55.3 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -42.4 -35.81 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 110.435 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 245' ' ' LYS . 29.2 t-20 -72.55 -40.21 66.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.49 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' HIS . . . . . 0.478 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.9 OUTLIER -70.47 -47.08 62.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.879 -1.138 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.4 OUTLIER -70.45 -28.65 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.444 -0.785 . . . . 0.0 110.844 -178.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -73.36 -48.99 29.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 109.903 -179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.571 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 7.8 t-20 -74.06 -22.39 59.56 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.674 -0.641 . . . . 0.0 111.04 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 9.1 p -84.47 -32.2 24.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.791 -1.193 . . . . 0.0 109.95 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.52 130.28 44.35 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.74 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 250' ' ' SER . 2.4 m -48.48 164.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 249' ' ' THR . 49.0 m -129.15 97.8 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.496 HD13 ' HA2' ' A' ' 260' ' ' GLY . 5.8 mp -57.21 -50.97 71.17 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.69 42.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 1.4 t -174.14 -172.87 0.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.82 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.9 t -147.55 13.22 1.05 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -122.45 -78.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.477 ' O ' ' HD2' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -59.3 -66.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' A' ' 180' ' ' ARG . 38.0 m-85 -76.2 -12.3 60.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 59.42 -154.3 30.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 250' ' ' SER . 6.0 t -44.92 -25.72 0.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.268 -1.137 . . . . 0.0 109.222 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.496 ' HA2' HD13 ' A' ' 251' ' ' LEU . . . 125.49 -132.6 8.04 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.556 ' O ' HD11 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -100.62 177.83 4.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -1.105 . . . . 0.0 109.309 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.763 HG13 HD13 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -111.41 156.86 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.414 ' CG ' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -170.75 121.08 0.57 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 122.35 1.071 . . . . 0.0 108.197 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 268' ' ' THR . . . -76.04 -17.61 59.58 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.031 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.495 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 29.5 tt0 -65.54 -43.2 90.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.049 . . . . 0.0 109.146 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.98 -13.98 62.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.265 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -110.81 12.7 22.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 264' ' ' ALA . 4.4 p -119.23 -39.02 2.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.476 ' HG3' ' OXT' ' A' ' 269' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.914 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.363 0.601 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' O ' ' A' ' 3' ' ' SER . 0.9 OUTLIER -66.37 176.0 2.0 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 1.015 ' O ' HG22 ' A' ' 4' ' ' VAL . 5.2 t -54.68 -158.38 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.015 HG22 ' O ' ' A' ' 3' ' ' SER . 2.5 m 59.95 41.25 0.53 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.939 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.5 Cg_endo -82.24 -169.29 0.73 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.976 1.784 . . . . 0.0 110.454 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CG ' ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -32.92 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.285 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -83.08 -69.26 1.39 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.71 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 19.7 mm -33.57 90.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 122.042 -0.681 . . . . 0.0 110.323 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER 155.67 -55.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 17.7 tpp85 -75.42 -17.47 60.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.485 -0.759 . . . . 0.0 109.448 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 13' ' ' ALA . 19.4 m -88.62 23.3 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 76.9 mm-40 49.66 41.35 21.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.208 -0.933 . . . . 0.0 109.92 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.27 -33.02 0.52 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -73.63 -55.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 N-CA-C 108.528 -1.374 . . . . 0.0 108.528 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -42.36 -33.15 0.6 Allowed 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -72.18 -49.3 36.65 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 17' ' ' HIS . 2.2 m170 -69.09 -6.05 25.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.06 -55.36 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.44 -27.85 2.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 109.158 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.32 23.38 2.92 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.881 HD23 HD22 ' A' ' 227' ' ' LEU . 0.3 OUTLIER -67.17 173.13 4.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.179 -1.189 . . . . 0.0 109.34 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.596 ' HA ' ' HG3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -163.06 -35.55 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 110.553 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.868 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 73.68 -5.34 23.84 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -44.0 134.08 4.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.132 -1.216 . . . . 0.0 109.665 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 7.92 56.04 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 23' ' ' GLY . 27.0 t -107.86 164.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -1.217 . . . . 0.0 109.246 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 2.0 mptt -145.01 118.25 8.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.0 110.32 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 119' ' ' VAL . 2.5 t -125.92 128.01 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.68 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -82.3 159.97 23.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.547 HG21 HD22 ' A' ' 88' ' ' LEU . 10.7 t -134.43 87.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.78 -1.2 . . . . 0.0 109.794 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 93' ' ' VAL . 10.0 mp -66.74 126.17 28.15 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -177.79 -146.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.704 -1.247 . . . . 0.0 109.961 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -137.61 72.57 1.42 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.023 -1.048 . . . . 0.0 110.654 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 64' ' ' THR . . . 111.87 118.38 3.69 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.416 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 3.9 mm -115.26 -18.87 7.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.675 0.75 . . . . 0.0 109.11 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 33.0 104.61 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.818 0.818 . . . . 0.0 111.483 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -58.61 147.66 31.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 108.692 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.537 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -146.13 177.14 1.87 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.314 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 38' ' ' HIS . 33.6 Cg_endo -76.33 -4.95 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.215 1.943 . . . . 0.0 109.626 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 73' ' ' LEU . 2.6 t0 -114.97 -22.53 9.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.166 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.36 122.75 39.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -97.36 103.38 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 108.65 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 44' ' ' ARG . 3.9 mt -89.68 163.48 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.074 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.547 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 6.9 tpt180 -135.88 -32.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -163.51 161.94 34.53 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.44 165.71 36.75 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.971 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.44 165.02 17.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.522 -0.987 . . . . 0.0 109.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -126.53 142.07 51.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.575 ' HE2' HG12 ' A' ' 91' ' ' VAL . 32.9 m-85 -116.38 -53.01 2.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.385 -0.822 . . . . 0.0 109.776 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.975 HG11 ' O ' ' A' ' 98' ' ' GLY . 81.1 t -57.3 125.54 71.45 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 108.724 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -74.96 176.49 9.84 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.425 2.084 . . . . 0.0 111.31 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' C ' ' HD3' ' A' ' 54' ' ' PRO . . . 120.78 10.15 7.16 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.675 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.5 tt0 54.26 44.99 2.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.498 -1.001 . . . . 0.0 111.163 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.675 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.5 Cg_endo -78.55 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.917 1.745 . . . . 0.0 110.432 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 69.3 m 117.13 135.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.447 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 8.8 t -56.6 -14.63 3.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.134 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG3' HG23 ' A' ' 56' ' ' THR . 47.7 mt-30 -108.92 143.5 38.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 57' ' ' GLN . 40.8 t0 61.34 136.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.462 -0.774 . . . . 0.0 110.392 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.27 -39.39 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.843 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -169.1 -35.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -1.031 . . . . 0.0 108.927 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.84 -16.97 4.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -68.31 -58.06 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 109.296 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -61.76 6.28 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLY . 3.3 m -45.82 -41.13 10.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -1.109 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 5.2 t-80 -58.83 -56.81 17.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.733 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 219' ' ' PRO . 41.8 t -55.45 -35.08 36.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . . . -57.64 -44.74 85.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.719 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.627 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -75.15 -21.38 78.19 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.555 HG23 ' CE1' ' A' ' 220' ' ' HIS . 15.7 m -81.47 -11.51 59.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 108.166 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 66' ' ' VAL . 38.4 mt -103.51 -28.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -156.71 11.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.622 -1.299 . . . . 0.0 112.323 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -40.01 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.691 -1.256 . . . . 0.0 110.626 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 71' ' ' ALA . 9.7 mt -45.76 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.881 -1.137 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 32.0 t30 -92.74 155.23 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.451 -0.781 . . . . 0.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 9.0 p-10 154.43 124.71 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 75' ' ' ASN . 22.8 t -41.59 -27.26 0.09 Allowed 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.869 -0.519 . . . . 0.0 109.734 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.8 pt -83.52 68.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 208' ' ' TYR . . . 123.36 146.93 7.2 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 80' ' ' LEU . 10.2 m -64.31 -149.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 ' N ' HG23 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -158.06 141.34 15.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.583 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -97.86 -144.6 17.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG12 HD11 ' A' ' 227' ' ' LEU . 0.5 OUTLIER -91.48 -72.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 0.0 109.896 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -63.04 144.08 97.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.596 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 37.3 Cg_endo -86.69 -64.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.369 2.046 . . . . 0.0 110.113 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 21.6 t-20 -105.76 -87.08 0.47 Allowed 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.001 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 54.79 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.105 -0.997 . . . . 0.0 110.08 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 7.6 mt-10 -95.49 107.71 19.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 30' ' ' VAL . 5.5 mt -92.91 106.56 18.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 109.974 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 14.2 m-85 -87.88 153.86 20.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.534 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.457 ' CB ' HG13 ' A' ' 35' ' ' ILE . . . -119.0 108.92 15.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.791 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.68 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -111.32 65.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.989 . . . . 0.0 110.214 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' VAL . 14.5 ttmm -38.83 114.5 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -143.38 21.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 120.97 -1.081 . . . . 0.0 111.327 -177.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.556 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 22.6 mt -150.29 168.55 23.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.241 -1.537 . . . . 0.0 111.77 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 94' ' ' LEU . . . -46.34 -166.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.022 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' A' ' 60' ' ' ASN . . . 62.38 13.73 6.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER 150.77 -13.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.975 ' O ' HG11 ' A' ' 50' ' ' VAL . . . -113.73 -100.27 2.4 Favored Glycine 0 N--CA 1.477 1.395 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.528 ' HB2' ' HA2' ' A' ' 95' ' ' GLY . 1.5 t 52.35 68.96 0.74 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.75 178.54 16.42 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.734 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.0 t -68.17 179.5 1.54 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.419 0.628 . . . . 0.0 109.407 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.562 ' CG2' ' OG ' ' A' ' 130' ' ' SER . 48.4 t -66.02 -14.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 m -75.07 -22.67 58.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.73 -53.34 4.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 109.261 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.589 ' HA ' HG22 ' A' ' 93' ' ' VAL . 2.3 mt -62.15 -45.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 102' ' ' VAL . . . -63.18 -47.28 83.31 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.414 ' HG2' ' CD1' ' A' ' 49' ' ' PHE . 25.1 tp60 -52.23 -39.26 60.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.862 . . . . 0.0 109.442 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.28 39.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.03 -11.05 45.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -1.116 . . . . 0.0 109.12 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.9 -25.7 15.34 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.334 -0.854 . . . . 0.0 109.45 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -72.98 -15.15 61.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.646 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -96.22 -11.82 25.5 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.947 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -84.46 -26.2 40.24 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 115' ' ' ASN . 3.8 m120 -123.3 28.84 6.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 108.999 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER 162.73 32.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.685 ' O ' ' HE1' ' A' ' 117' ' ' MET . . . -102.98 -147.54 18.97 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.685 ' HE1' ' O ' ' A' ' 116' ' ' GLY . 6.0 mmt -134.9 -178.74 5.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.614 -0.933 . . . . 0.0 109.779 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.942 ' ND1' HG23 ' A' ' 119' ' ' VAL . 10.7 p80 -66.0 -40.37 91.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.78 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.942 HG23 ' ND1' ' A' ' 118' ' ' HIS . 55.5 t -120.57 165.6 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.833 -1.167 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.608 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.02 132.08 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 1.023 ' O ' HD12 ' A' ' 122' ' ' LEU . 61.8 t30 -90.34 167.85 12.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.792 -1.192 . . . . 0.0 109.785 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.023 HD12 ' O ' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -149.54 105.24 3.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.98 . . . . 0.0 109.041 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 9.6 m -96.2 68.77 2.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 108.985 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.874 HD11 HD23 ' A' ' 122' ' ' LEU . 0.5 OUTLIER -111.35 -165.94 1.03 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.259 1.028 . . . . 0.0 110.091 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.42 105.03 1.51 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.488 ' CB ' ' HD2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -168.91 172.76 2.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.251 . . . . 0.0 109.84 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.555 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 34.8 Cg_endo -79.15 4.66 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.796 2.331 . . . . 0.0 109.916 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.624 ' N ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -117.83 44.09 0.49 Allowed Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.556 -0.715 . . . . 0.0 111.464 -178.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 128' ' ' SER . 37.5 Cg_endo -76.42 173.71 14.03 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.951 1.767 . . . . 0.0 110.532 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.562 ' OG ' ' CG2' ' A' ' 102' ' ' VAL . 3.0 m -149.65 131.5 15.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.31 66.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.463 ' HB ' HG11 ' A' ' 102' ' ' VAL . 3.3 m -66.28 -29.94 70.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.566 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -69.17 -35.22 76.06 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -63.37 -51.11 67.26 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -48.56 -26.49 2.23 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -69.53 -45.67 68.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.921 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.666 HG21 ' CZ ' ' A' ' 165' ' ' TYR . 0.9 OUTLIER -62.95 -30.31 49.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 21.6 m120 -60.33 -36.2 77.42 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.2 p -78.85 -22.54 45.95 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.14 54.41 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.096 -1.002 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 -46.53 16.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.038 -1.039 . . . . 0.0 108.747 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -29.98 8.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -86.2 -33.21 20.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.891 . . . . 0.0 109.092 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.76 61.93 1.49 Allowed Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.492 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 43.9 t -108.79 99.7 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.482 -1.01 . . . . 0.0 109.874 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' A' ' 119' ' ' VAL . 27.1 tp -58.52 111.03 1.1 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.942 -1.099 . . . . 0.0 108.079 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.725 ' CG1' HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -115.02 137.25 49.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 110.278 -178.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.638 HG13 ' OD1' ' A' ' 121' ' ' ASN . 1.5 p -113.92 150.92 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 163' ' ' ALA . . . -134.3 144.4 48.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.962 -1.087 . . . . 0.0 110.422 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -57.79 152.74 15.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 109.8 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -59.15 -73.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.051 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 138.8 121.7 1.94 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -99.79 55.1 0.94 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.539 ' OG ' ' HG2' ' A' ' 185' ' ' GLN . 0.0 OUTLIER -91.53 -86.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.841 . . . . 0.0 109.774 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 146.3 83.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 179.64 176.65 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.374 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.59 43.19 3.19 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.5 OUTLIER -158.79 166.25 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -1.072 . . . . 0.0 108.83 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -106.44 -174.48 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 109.666 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -71.33 157.84 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.817 0.818 . . . . 0.0 110.174 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -115.17 138.14 23.37 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 103.906 -2.628 . . . . 0.0 103.906 176.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.71 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.5 Cg_endo -72.64 -49.9 0.21 Allowed 'Cis proline' 0 C--N 1.295 -2.272 0 O-C-N 122.967 0.983 . . . . 0.0 111.826 4.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 36.21 -77.91 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -41.61 -55.23 2.98 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER 46.9 -178.88 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.26 -16.73 12.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.427 ' OD1' HG13 ' A' ' 137' ' ' VAL . 30.0 p-10 -129.44 13.8 6.04 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 165' ' ' TYR . . . -127.22 157.28 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.473 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -105.45 159.31 16.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.061 -1.024 . . . . 0.0 110.093 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -111.47 116.37 30.78 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 172' ' ' GLY . 24.5 t -81.84 167.42 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -134.93 -165.57 10.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -143.48 137.99 28.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.934 -1.333 . . . . 0.0 110.666 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 p -109.15 168.58 9.27 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 179' ' ' ASN . 4.2 t70 -95.61 -40.14 9.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.29 1.043 . . . . 0.0 109.804 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -152.27 -103.62 0.05 Allowed 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 177' ' ' ASN . 1.5 p30 -62.01 -48.85 78.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.722 -1.236 . . . . 0.0 107.72 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.503 ' HB2' HD21 ' A' ' 251' ' ' LEU . 0.5 OUTLIER 173.73 68.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 2.1 t-20 -97.03 -11.74 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.772 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.572 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 1.7 ttp180 82.07 12.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.366 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.875 ' HB1' ' CE1' ' A' ' 183' ' ' PHE . . . 53.97 -159.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.499 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.02 30.7 3.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.875 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 1.0 OUTLIER -152.36 -28.2 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.1 -1.0 . . . . 0.0 110.691 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -45.41 124.17 4.67 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.809 -1.182 . . . . 0.0 109.277 179.719 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.539 ' HG2' ' OG ' ' A' ' 154' ' ' SER . 1.3 mp0 -75.98 149.45 37.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.155 -0.966 . . . . 0.0 111.048 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.848 ' O ' HG23 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -68.09 -174.73 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.488 0.661 . . . . 0.0 110.67 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.54 ' CA ' HG12 ' A' ' 159' ' ' ILE . . . -173.27 150.24 11.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -83.11 68.9 9.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -1.051 . . . . 0.0 109.005 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 118.56 41.71 0.61 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.561 ' CD1' HD13 ' A' ' 159' ' ' ILE . 7.7 tp -41.22 150.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.469 -1.018 . . . . 0.0 109.283 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 0.5 OUTLIER -90.64 -60.85 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.542 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 262' ' ' VAL . 14.3 tt -155.5 171.23 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 109.566 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 260' ' ' GLY . 27.2 m -127.92 160.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.038 -1.039 . . . . 0.0 109.964 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -152.69 132.82 7.38 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 6' ' ' TRP . 31.7 Cg_endo -71.61 121.11 7.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.609 1.539 . . . . 0.0 110.283 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.27 61.23 0.55 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 50.1 t -102.08 66.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -1.186 . . . . 0.0 108.483 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASN . . . . . 0.65 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 45.9 t30 111.48 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 198' ' ' ASN . 11.8 m -159.37 111.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 122.273 1.035 . . . . 0.0 108.77 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.3 pm0 -87.61 124.83 33.93 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.495 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -135.85 -156.17 0.69 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.633 -0.667 . . . . 0.0 109.253 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 34.8 p -77.06 -177.92 4.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.042 0.925 . . . . 0.0 110.586 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' TYR . . . . . 0.632 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -156.94 151.83 21.07 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.632 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.4 Cg_endo -69.83 164.47 34.49 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.996 1.797 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 75.26 12.27 83.64 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 72.34 33.18 1.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.623 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -120.48 171.2 8.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.758 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 209' ' ' ALA . 87.6 m-85 -122.73 176.2 6.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 208' ' ' TYR . . . 176.91 175.38 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.654 -1.279 . . . . 0.0 110.782 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -135.07 131.07 36.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.527 -0.733 . . . . 0.0 109.419 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.664 HD12 ' HE1' ' A' ' 216' ' ' MET . 0.1 OUTLIER -148.01 108.06 4.05 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.969 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.465 ' HB3' ' N ' ' A' ' 198' ' ' ASN . 18.8 p30 -63.87 169.4 4.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.389 -0.82 . . . . 0.0 108.908 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 156.69 7.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -75.39 -35.85 61.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.202 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -14.09 19.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 109.642 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' MET . . . . . 0.664 ' HE1' HD12 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -90.54 -24.01 20.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.899 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -89.52 -7.63 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 109.417 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.639 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 13.4 m -71.95 -41.52 9.03 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 111.505 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.718 ' HB3' HG13 ' A' ' 66' ' ' VAL . 30.1 Cg_endo -73.27 -21.08 20.51 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.699 1.599 . . . . 0.0 110.923 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 69' ' ' THR . 3.8 m80 -64.34 -42.08 96.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.72 -47.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -46.89 -35.36 6.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -70.77 -56.08 7.67 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -46.62 -41.51 14.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.948 -1.325 . . . . 0.0 109.444 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.7 99.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 108.809 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.1 -45.54 75.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.881 HD22 HD23 ' A' ' 21' ' ' LEU . 42.4 mt -59.21 -50.58 73.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 267' ' ' ALA . 95.7 t -56.0 -49.06 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.973 -1.079 . . . . 0.0 109.57 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.641 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.5 OUTLIER -48.54 -42.97 34.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.519 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLN . . . . . 0.467 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.15 -45.52 93.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.911 -1.118 . . . . 0.0 109.574 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.661 ' HE3' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.59 -10.11 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.222 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -174.19 72.93 0.34 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.4 Cg_endo -79.39 -0.84 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.638 2.225 . . . . 0.0 110.735 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 42.4 m -84.1 -3.76 58.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.143 -0.973 . . . . 0.0 109.842 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' TRP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 239' ' ' GLN . 31.6 m0 -81.89 176.24 9.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.188 -0.945 . . . . 0.0 109.938 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.7 OUTLIER -103.47 159.57 15.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' SER . 6.6 p30 -45.28 -37.17 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.102 . . . . 0.0 109.826 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.8 t -72.74 -62.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.224 -0.922 . . . . 0.0 110.163 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 3.6 tp60 -41.22 -50.15 3.6 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.567 0.698 . . . . 0.0 109.483 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.459 ' CD1' ' HG3' ' A' ' 229' ' ' LYS . 20.9 mt -57.07 -48.84 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.52 -0.737 . . . . 0.0 109.377 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -47.16 -38.56 12.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.76 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 22.9 t-20 -67.43 -38.13 84.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 109.743 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.85 -43.97 91.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.826 . . . . 0.0 110.442 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.8 OUTLIER -76.65 -29.89 56.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -78.87 -23.72 44.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 1.6 t30 -95.98 -17.87 20.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.6 p -90.46 -30.51 17.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.781 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.27 160.82 1.03 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.3 m -88.88 111.39 22.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.104 -0.998 . . . . 0.0 109.706 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -84.97 116.12 23.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.378 -0.826 . . . . 0.0 108.951 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 178' ' ' ASN . 6.1 mp -65.53 -72.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.058 -1.026 . . . . 0.0 109.53 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.18 28.84 0.1 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.29 145.84 34.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.228 -1.16 . . . . 0.0 109.333 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 43.3 p -131.95 6.72 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.405 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -114.58 -21.11 10.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.649 HD23 ' CZ ' ' A' ' 186' ' ' TYR . 2.7 tm? -117.46 -70.08 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.344 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.585 ' N ' HD13 ' A' ' 256' ' ' LEU . 87.1 m-85 -63.27 -23.69 67.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.45 -98.28 0.27 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 250' ' ' SER . 0.3 OUTLIER -84.07 -39.83 19.08 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.253 -1.146 . . . . 0.0 108.94 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.622 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 100.45 -122.1 7.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 261' ' ' LEU . 16.3 tp -87.7 161.25 17.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.813 -0.816 . . . . 0.0 108.804 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.883 HG22 HD11 ' A' ' 192' ' ' ILE . 1.5 t -119.54 154.41 22.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 110.289 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -151.12 117.46 5.66 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.206 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 268' ' ' THR . . . -82.33 6.01 18.35 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.796 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 67.1 tt0 -94.54 -23.96 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.723 -1.236 . . . . 0.0 109.264 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -95.99 -16.73 21.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.167 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 228' ' ' VAL . . . -98.53 -13.91 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' THR . . . . . 0.576 HG21 HD22 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -117.49 -9.85 10.77 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.055 -1.028 . . . . 0.0 109.066 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 268' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.73 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.389 0.614 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.659 HG12 ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -132.38 153.71 81.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.799 . . . . 0.0 109.384 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.659 ' HD2' HG12 ' A' ' 4' ' ' VAL . 35.5 Cg_endo -77.68 171.94 16.6 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.857 2.371 . . . . 0.0 111.119 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.7 OUTLIER -52.14 -19.06 1.73 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.542 -0.724 . . . . 0.0 110.473 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -63.16 -52.25 48.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.726 ' O ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -83.9 -20.21 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -1.223 . . . . 0.0 109.662 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -64.34 -26.39 68.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.91 -1.118 . . . . 0.0 109.658 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 22.1 ttm105 -96.32 -0.66 49.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 110.627 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 8' ' ' ILE . 3.2 m -99.77 17.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.585 -1.322 . . . . 0.0 110.29 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' A' ' 265' ' ' GLU . 0.9 OUTLIER 39.91 45.81 1.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.56 -0.713 . . . . 0.0 109.827 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.713 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.22 -27.28 0.34 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.0 Cg_endo -74.28 -56.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.847 -1.251 . . . . 0.0 108.847 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 19' ' ' ARG . . . -43.76 -31.63 0.86 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.98 -43.9 51.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.683 ' ND1' HD21 ' A' ' 80' ' ' LEU . 6.3 m170 -66.85 -15.5 63.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -0.787 . . . . 0.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -96.25 -24.82 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 0.0 109.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -69.15 -32.04 71.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.73 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.65 -16.67 5.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 144.58 56.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -1.147 . . . . 0.0 109.179 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -133.53 1.5 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.023 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.449 ' C ' ' HG3' ' A' ' 230' ' ' GLN . . . 57.57 6.49 2.46 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 22' ' ' THR . 1.4 t -66.49 134.01 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.371 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.57 -4.74 37.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 27' ' ' LYS . 28.2 t -98.97 170.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -1.167 . . . . 0.0 109.275 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -140.46 128.85 22.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.894 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.658 HG13 ' CG1' ' A' ' 119' ' ' VAL . 1.9 t -133.97 134.88 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.761 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -92.35 154.51 18.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.23 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -127.56 87.0 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.983 -1.073 . . . . 0.0 108.768 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.66 HD12 ' HB ' ' A' ' 91' ' ' VAL . 5.5 mp -65.27 95.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 20.9 p-10 -144.93 -144.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.737 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -145.04 27.78 1.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.107 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.06 119.8 0.9 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.61 ' CG1' ' HB2' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -103.96 11.54 8.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.948 -0.736 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER 51.84 126.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.994 0.902 . . . . 0.0 111.17 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.84 115.36 10.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.003 -1.06 . . . . 0.0 108.882 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.538 ' NE2' ' HA ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -145.24 157.34 53.4 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.0 Cg_endo -78.52 0.96 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.702 2.268 . . . . 0.0 110.378 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.09 -15.95 14.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.103 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 202' ' ' THR . 0.3 OUTLIER -114.13 119.07 35.84 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 108.841 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -96.64 105.08 17.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 43' ' ' ILE . 1.7 mm -69.47 112.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.335 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.446 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 2.4 mmt85 -100.26 -19.78 16.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.173 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 156.71 28.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . -177.1 140.45 4.9 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.981 -1.305 . . . . 0.0 110.021 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.45 126.82 14.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -1.086 . . . . 0.0 109.297 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -104.3 116.53 32.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.134 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CD2' ' OE1' ' A' ' 107' ' ' GLN . 42.3 m-85 -104.1 -57.0 2.1 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.19 -0.944 . . . . 0.0 109.828 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.86 HG23 ' HD2' ' A' ' 51' ' ' PRO . 1.5 p -42.06 148.88 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.86 ' HD2' HG23 ' A' ' 50' ' ' VAL . 29.2 Cg_endo . . . . . 0 C--N 1.311 -1.421 0 C-N-CA 122.035 1.824 . . . . 0.0 109.986 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.36 0.6 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -15.39 18.44 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.36 -0.837 . . . . 0.0 108.767 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 2.4 mp0 -128.67 112.24 14.03 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 13.8 t70 83.31 157.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.498 0.666 . . . . 0.0 109.768 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.96 -20.92 0.51 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.737 ' ND2' HG23 ' A' ' 33' ' ' THR . 0.4 OUTLIER -145.22 -83.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.617 -0.931 . . . . 0.0 108.899 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 64' ' ' THR . . . 159.55 -54.48 0.35 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 215' ' ' SER . 30.0 t-80 -46.31 -57.79 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 110.159 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -38.43 -57.58 1.81 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.532 ' CB ' ' HB3' ' A' ' 36' ' ' SER . 0.6 OUTLIER -51.13 -47.5 61.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -1.143 . . . . 0.0 109.434 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.602 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -52.08 -55.84 18.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.325 -0.86 . . . . 0.0 109.473 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 219' ' ' PRO . 39.9 t -53.51 -34.01 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . . . -58.85 -55.56 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.222 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.38 75.54 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.732 HG21 ' O ' ' A' ' 216' ' ' MET . 21.4 m -73.84 -18.54 60.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 108.122 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 219' ' ' PRO . 4.9 mt -98.85 -30.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.624 ' CB ' ' HB3' ' A' ' 83' ' ' ALA . . . -170.13 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 112.101 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 81' ' ' GLY . . . -44.87 121.27 2.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.661 -1.274 . . . . 0.0 108.607 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 84' ' ' PRO . 17.0 mt -43.74 151.91 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.982 . . . . 0.0 110.532 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 46.5 t-20 -105.69 64.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.0 109.412 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.584 ' O ' ' CB ' ' A' ' 76' ' ' SER . 86.0 m-20 -94.53 -1.36 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.504 -0.748 . . . . 0.0 110.098 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 5.0 t 91.18 -34.47 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -85.51 133.5 29.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.88 -175.63 45.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 201' ' ' SER . 5.1 m -76.01 -174.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.2 -1.177 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.683 HD21 ' ND1' ' A' ' 17' ' ' HIS . 1.6 tp -141.0 113.58 8.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.306 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.86 ' H ' ' HB3' ' A' ' 72' ' ' ALA . . . -76.49 -165.74 21.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 6.8 t -80.28 -32.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.281 . . . . 0.0 109.453 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HB3' ' CB ' ' A' ' 71' ' ' ALA . . . -104.6 148.12 35.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.056 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' CG ' ' O ' ' A' ' 22' ' ' THR . 37.9 Cg_endo -84.87 -63.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 110.383 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 5.9 m-20 -113.92 -87.64 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.324 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 85' ' ' ASN . . . 59.8 170.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.449 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.446 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 26.0 mm-40 -93.38 85.51 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 2.7 mt -79.28 109.88 14.04 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.446 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 3.2 m-85 -91.18 -177.35 4.86 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.951 0.881 . . . . 0.0 110.448 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -147.28 96.09 2.65 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.761 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -99.81 78.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -51.88 89.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.576 HG13 ' HG ' ' A' ' 94' ' ' LEU . 12.6 p -98.72 -23.69 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 108.929 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.576 ' HG ' HG13 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -111.84 162.95 14.73 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.49 152.81 17.95 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.172 -1.193 . . . . 0.0 109.04 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -76.44 174.64 10.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.641 -0.917 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.684 HG11 ' CB ' ' A' ' 130' ' ' SER . 5.2 t -68.62 -18.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -73.87 -18.37 60.93 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 93' ' ' VAL . 19.0 m -88.07 -52.29 5.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.501 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.3 mt -62.27 -30.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.0 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 132' ' ' THR . . . -75.52 -50.9 14.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 108.981 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.584 ' OE1' ' CD2' ' A' ' 49' ' ' PHE . 2.7 pp0? -61.82 -23.93 66.55 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 109.552 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.17 -36.62 20.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.602 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . 15.0 mt -80.37 -13.8 58.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 108.973 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -97.13 -32.88 11.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -67.56 -21.29 65.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.791 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -86.21 -19.37 30.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -55.54 -34.13 59.81 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 114' ' ' ASN . 0.1 OUTLIER -101.95 -61.7 1.35 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.464 -1.021 . . . . 0.0 109.161 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.455 ' O ' ' SD ' ' A' ' 117' ' ' MET . 1.3 m-20 -104.16 40.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 108.921 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.791 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -94.23 21.05 44.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.599 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 41.14 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.527 -0.984 . . . . 0.0 110.428 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.884 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -85.53 -22.14 28.26 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 111.239 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.884 HG23 ' CE1' ' A' ' 118' ' ' HIS . 83.5 t -129.38 165.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.327 -1.483 . . . . 0.0 110.232 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.63 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -166.7 128.1 1.7 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.762 ' ND2' HG13 ' A' ' 148' ' ' VAL . 6.3 t-20 -105.8 153.68 21.56 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.57 -1.331 . . . . 0.0 110.128 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.769 HD13 ' CG1' ' A' ' 147' ' ' VAL . 5.0 mp -135.84 92.82 2.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 62.01 7.21 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.258 -0.901 . . . . 0.0 108.72 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 124' ' ' LEU . 4.0 pp -147.64 173.74 12.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.659 ' N ' HD12 ' A' ' 124' ' ' LEU . . . -176.92 97.45 0.11 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 2.4 m -96.52 146.71 31.78 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.63 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.1 Cg_endo -77.37 -5.38 15.59 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.474 2.116 . . . . 0.0 109.359 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.5 t -98.54 107.64 43.6 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.756 -0.59 . . . . 0.0 110.224 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 33.0 Cg_endo -76.97 165.83 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.01 1.807 . . . . 0.0 109.609 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.684 ' CB ' HG11 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -170.69 132.78 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.654 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.92 65.72 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.426 HG22 ' CB ' ' A' ' 106' ' ' ALA . 64.4 m -63.88 -31.99 73.36 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 133' ' ' LEU . 13.9 tp -75.85 -34.86 60.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -30.32 68.05 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.386 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 135' ' ' GLN . 4.0 tp60 -70.33 -25.61 63.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -75.9 -48.69 20.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.049 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.073 HG21 ' HB1' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -63.25 -26.46 40.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.3 -36.75 85.03 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.0 t -77.62 -17.77 57.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.887 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.52 -38.11 22.18 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.686 -1.259 . . . . 0.0 111.248 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.802 -1.186 . . . . 0.0 108.571 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -25.32 67.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -112.62 -16.58 12.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.126 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.46 84.99 1.16 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.95 105.23 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -1.028 . . . . 0.0 108.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.81 118.75 8.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.871 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.769 ' CG1' HD13 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -112.94 139.28 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.216 -0.928 . . . . 0.0 109.14 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.762 HG13 ' ND2' ' A' ' 121' ' ' ASN . 14.5 p -127.17 68.14 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.918 -1.114 . . . . 0.0 110.114 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -52.63 156.51 1.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.076 -1.015 . . . . 0.0 110.95 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.45 -174.57 5.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.6 -0.688 . . . . 0.0 110.032 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.3 OUTLIER -91.95 -85.09 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.836 -0.54 . . . . 0.0 109.78 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -178.61 -114.29 0.41 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 154' ' ' SER . 0.4 OUTLIER 177.72 34.51 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER 87.06 102.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.321 0.581 . . . . 0.0 109.537 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.534 ' N ' ' NE2' ' A' ' 185' ' ' GLN . . . -172.0 95.75 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 66.07 171.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -1.166 . . . . 0.0 109.647 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.78 51.9 4.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 0.8 OUTLIER -148.96 170.31 18.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -1.168 . . . . 0.0 109.645 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.11 -171.47 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.0 110.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.523 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -62.42 176.04 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.582 1.182 . . . . 0.0 112.186 -178.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 126' ' ' SER . 8.8 m-85 -128.73 127.6 23.5 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.8 Cg_endo -72.33 -45.73 0.43 Allowed 'Cis proline' 0 C--N 1.301 -1.944 0 O-C-N 123.14 1.074 . . . . 0.0 110.726 3.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . . . 27.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.158 0.98 . . . . 0.0 109.645 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.742 ' N ' ' O ' ' A' ' 162' ' ' PRO . 7.0 ttt180 -39.35 -60.25 0.95 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.758 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 55.0 p90 -120.02 -164.66 1.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 1.073 ' HB1' HG21 ' A' ' 137' ' ' VAL . . . 85.98 26.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.775 0.797 . . . . 0.0 109.011 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 55.01 20.26 3.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.32 131.67 51.41 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.44 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 4.4 mtp -76.19 151.49 36.89 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.34 129.21 55.73 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 192' ' ' ILE . 32.1 t -100.17 165.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 109.235 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.07 167.66 24.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -96.17 168.91 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' ' 194' ' ' ALA . 13.5 p -135.64 178.79 6.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 109.5 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 176' ' ' GLN . 14.2 t0 -108.41 -142.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.771 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 175' ' ' ASP . 12.0 tt0 -35.45 -63.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.988 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -122.16 -60.93 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.838 -1.164 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.77 -19.7 1.03 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.033 -1.042 . . . . 0.0 111.224 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -47.17 164.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.767 -1.208 . . . . 0.0 109.338 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -69.93 132.86 46.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.332 -0.855 . . . . 0.0 109.729 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -55.72 -154.25 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 m -117.15 -27.34 6.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -119.62 14.04 12.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.716 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 1.9 t -77.41 142.36 39.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.144 -0.973 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.534 ' NE2' ' N ' ' A' ' 155' ' ' GLY . 5.9 tt0 -90.69 166.15 13.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -141.65 173.53 11.42 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 -179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.646 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.62 -178.63 48.39 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.11 68.06 5.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -1.178 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.77 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.469 HD21 ' CG1' ' A' ' 193' ' ' VAL . 3.2 tp -72.75 142.54 48.14 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.067 -1.255 . . . . 0.0 109.521 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 8.4 t0 -101.67 -57.34 2.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.728 HG22 HG22 ' A' ' 171' ' ' VAL . 3.8 tt -151.25 -178.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.6 HG22 ' CA ' ' A' ' 260' ' ' GLY . 6.0 m -149.66 -179.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.314 -0.867 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -175.01 172.78 1.1 Allowed Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 30.8 Cg_endo -72.0 116.55 4.75 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.067 1.845 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.94 44.69 1.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.646 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 40.6 t -124.45 54.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -1.092 . . . . 0.0 108.415 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.646 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 24.3 t-20 127.36 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 211' ' ' LEU . 22.7 m -160.33 105.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-O 122.32 1.057 . . . . 0.0 109.689 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -80.96 135.87 35.94 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.811 ' HA ' HG21 ' A' ' 79' ' ' VAL . 1.3 t -149.05 -157.09 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.597 HG21 HD21 ' A' ' 41' ' ' LEU . 5.0 t -84.02 176.18 9.02 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.983 0.896 . . . . 0.0 110.758 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.666 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -162.7 155.55 16.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.666 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.7 Cg_endo -70.41 161.99 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.008 1.805 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 81.71 15.04 76.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.538 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 5.5 m 68.8 35.17 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.674 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -133.89 161.8 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 110.366 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 201' ' ' SER . 0.0 OUTLIER -114.56 170.23 8.46 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.19 151.26 17.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.775 -1.203 . . . . 0.0 110.281 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -106.97 146.13 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.129 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.75 ' O ' HG22 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -152.99 162.31 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 7.6 p-10 -125.16 141.29 52.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.086 -1.009 . . . . 0.0 109.736 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.512 ' N ' ' SD ' ' A' ' 216' ' ' MET . . . 166.38 167.8 27.59 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -85.78 -17.53 35.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -1.092 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.569 ' O ' ' CD ' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -65.08 -39.46 93.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.46 -0.775 . . . . 0.0 109.118 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.732 ' O ' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -68.87 -44.96 72.22 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.051 0.929 . . . . 0.0 109.84 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -68.81 -19.65 64.29 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.861 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.632 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 28.6 m -64.5 -52.36 53.24 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.737 -1.227 . . . . 0.0 111.086 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -66.38 -9.88 25.55 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.864 1.709 . . . . 0.0 110.656 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.566 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -71.55 -39.24 70.79 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 1.071 HG22 HG21 ' A' ' 262' ' ' VAL . 47.0 t -76.63 -34.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.757 ' HB2' HG11 ' A' ' 148' ' ' VAL . . . -58.43 -39.1 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -71.4 -50.07 22.81 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -45.92 -51.46 13.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -1.194 . . . . 0.0 108.604 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -41.47 72.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -51.57 -49.57 61.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.117 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 227' ' ' LEU . 39.3 mt -54.63 -45.08 73.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 76.2 t -54.99 -65.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.539 ' CG ' HD11 ' A' ' 240' ' ' ILE . 0.0 OUTLIER -43.39 -37.71 2.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.21 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.449 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 9.8 tm0? -57.86 -57.01 14.66 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.083 -1.01 . . . . 0.0 109.897 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -54.23 -19.13 4.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.204 -0.935 . . . . 0.0 108.905 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.492 ' N ' ' HG3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -140.7 86.43 12.06 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.249 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.97 -2.93 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.677 2.251 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -10.81 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -73.73 178.49 4.76 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.73 173.62 8.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.253 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.24 -20.1 25.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.1 t -79.89 -65.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.969 -1.082 . . . . 0.0 109.106 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.1 mp0 -46.86 -34.68 5.59 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.539 HD11 ' CG ' ' A' ' 229' ' ' LYS . 24.0 mt -65.8 -48.33 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -50.25 -34.8 24.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.868 -1.145 . . . . 0.0 108.978 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 239' ' ' GLN . 4.5 t30 -62.89 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.883 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 247' ' ' THR . 2.9 t60 -48.11 -51.47 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.907 . . . . 0.0 110.434 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.522 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.3 OUTLIER -63.17 -27.22 69.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 110.894 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 61.9 tttt -73.31 -52.04 15.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.024 -1.047 . . . . 0.0 110.228 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 14.0 t-20 -78.73 -10.11 59.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 110.454 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 243' ' ' HIS . 25.5 p -94.42 -37.41 11.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.893 -1.129 . . . . 0.0 110.121 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -64.82 136.1 56.51 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.401 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 259' ' ' SER . 15.5 m -45.93 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 108.913 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 0.7 OUTLIER -145.4 87.07 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 110.131 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 257' ' ' TYR . 5.8 mp . . . . . 0 C--N 1.306 -1.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.584 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.401 0.62 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.513 ' HB3' ' HB2' ' A' ' 251' ' ' LEU . 31.7 m-85 -88.78 -77.43 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.494 -0.754 . . . . 0.0 110.211 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 42.9 90.41 0.01 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 250' ' ' SER . 1.8 m 61.37 103.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.937 -1.331 . . . . 0.0 107.967 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.6 ' CA ' HG22 ' A' ' 193' ' ' VAL . . . -139.74 -27.09 0.24 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.371 -1.395 . . . . 0.0 111.651 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 261' ' ' LEU . 0.3 OUTLIER -104.24 146.62 28.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.335 -1.686 . . . . 0.0 108.949 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 1.071 HG21 HG22 ' A' ' 221' ' ' VAL . 1.6 t -117.68 155.2 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.98 . . . . 0.0 110.056 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.45 117.38 2.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.537 1.16 . . . . 0.0 107.942 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -12.67 61.85 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.975 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.492 ' HG2' ' NH1' ' A' ' 269' ' ' ARG . 11.5 tt0 -66.73 -41.33 88.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.004 -1.06 . . . . 0.0 109.137 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.485 ' HA ' ' NH2' ' A' ' 269' ' ' ARG . . . -82.38 -14.0 55.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -93.45 -16.41 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.183 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 269' ' ' ARG . 74.0 p -118.11 -60.46 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 265' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.573 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 24.6 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.321 0.581 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.28 81.89 30.41 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.023 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HD2' HG13 ' A' ' 8' ' ' ILE . 33.7 Cg_endo -77.7 159.84 31.51 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.621 2.214 . . . . 0.0 111.347 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CZ3' ' O ' ' A' ' 176' ' ' GLN . 2.6 p-90 -57.88 -26.3 61.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.683 -0.635 . . . . 0.0 110.573 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 8' ' ' ILE . . . -89.33 53.88 3.86 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.476 HG13 ' HD2' ' A' ' 5' ' ' PRO . 14.6 mm -151.55 -50.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 109.517 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -80.26 -13.02 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.42 -28.8 61.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 8' ' ' ILE . 2.8 m -88.61 24.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 1.0 OUTLIER 50.14 45.76 25.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.678 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -82.85 -32.3 0.55 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 111.774 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -74.31 -55.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.18 -28.45 0.77 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.61 -41.98 36.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 109.239 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -66.27 -24.25 66.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.524 -0.735 . . . . 0.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -92.73 -31.04 15.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.604 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -30.09 56.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.612 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.638 ' C ' HD23 ' A' ' 21' ' ' LEU . . . 121.46 19.63 3.43 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.869 ' CD1' HG21 ' A' ' 268' ' ' THR . 3.2 mt -101.9 120.62 40.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -1.151 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -97.98 -24.59 15.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.294 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' A' ' 230' ' ' GLN . . . 69.35 -1.31 13.35 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 p -71.74 117.73 13.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.116 -1.226 . . . . 0.0 109.389 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.13 -16.54 4.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 27' ' ' LYS . 19.1 t -89.75 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.218 -1.166 . . . . 0.0 109.395 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.571 ' N ' HG12 ' A' ' 26' ' ' VAL . 25.9 mttp -138.89 122.75 17.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.736 HG22 ' HB ' ' A' ' 119' ' ' VAL . 61.5 t -127.04 127.49 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -85.12 151.31 24.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.969 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 30' ' ' VAL . 35.2 t -115.14 78.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.983 HD23 HG21 ' A' ' 93' ' ' VAL . 5.6 mp -71.72 114.88 10.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 123' ' ' SER . 5.5 m-20 -175.75 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.513 1.149 . . . . 0.0 108.898 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 60' ' ' ASN . 7.5 p -141.97 -73.59 0.31 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.593 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -160.18 -129.04 1.01 Allowed Glycine 0 C--N 1.3 -1.437 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.687 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 1.4 mm -170.82 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 204' ' ' PRO . 1.1 m -46.68 129.89 11.36 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 109.202 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.74 104.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.637 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -130.52 151.52 78.79 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 109.005 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -12.39 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.555 2.17 . . . . 0.0 110.377 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 8.8 m-20 -88.21 -31.51 19.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.637 HD12 ' HB2' ' A' ' 38' ' ' HIS . 5.0 mt -89.34 115.79 27.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.4 t-20 -78.37 104.28 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 108.747 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 44' ' ' ARG . 1.4 mt -96.02 -177.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.632 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.1 tpt85 -152.69 -39.47 0.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -175.96 166.94 38.43 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.36 174.83 45.6 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.794 -1.416 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -170.1 153.15 4.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.389 -1.065 . . . . 0.0 109.816 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 1.4 p -121.02 142.01 50.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.008 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE2' ' CA ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -126.0 -26.88 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.0 111.187 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.931 HG23 ' CB ' ' A' ' 104' ' ' SER . 1.1 t -42.14 -51.86 10.1 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.855 -1.153 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 39.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 C-N-CA 123.144 2.563 . . . . 0.0 109.704 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.479 0.657 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -103.93 9.84 36.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.45 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 35.9 mt-30 -117.3 116.21 26.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 65.47 148.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.689 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 138.1 -6.4 3.4 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.528 ' OD1' ' HB2' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -142.21 -78.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.088 -1.242 . . . . 0.0 109.922 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.18 -47.11 1.0 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.267 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.488 ' NE2' ' CE ' ' A' ' 216' ' ' MET . 14.6 t-160 -56.36 -61.3 2.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 0.0 110.268 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -41.25 -41.92 3.06 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 25.6 m -61.25 -47.32 86.57 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.276 -1.132 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.482 ' CD2' ' CB ' ' A' ' 201' ' ' SER . 0.2 OUTLIER -55.14 -50.26 69.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 219' ' ' PRO . 30.1 t -60.03 -32.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.131 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . . . -58.49 -46.28 87.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 109.776 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.653 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -74.3 -25.75 69.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.868 HG21 ' HG2' ' A' ' 219' ' ' PRO . 83.1 m -79.31 -9.63 59.63 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.916 -1.344 . . . . 0.0 108.293 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.664 ' CG2' HD21 ' A' ' 88' ' ' LEU . 17.3 mt -106.46 -26.78 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.351 -0.843 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . . . -165.3 21.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.69 -1.257 . . . . 0.0 111.727 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.91 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . -41.53 127.77 3.09 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.918 -1.114 . . . . 0.0 109.322 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 84' ' ' PRO . 60.2 mt -58.98 163.14 3.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.538 ' HB3' HD13 ' A' ' 80' ' ' LEU . 6.0 p30 -118.91 72.85 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.553 -0.717 . . . . 0.0 109.206 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -116.79 -117.8 0.32 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.245 -0.909 . . . . 0.0 108.978 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 p -129.33 -48.71 1.19 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 109.52 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -90.59 69.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.203 -0.936 . . . . 0.0 109.832 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.47 158.1 13.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 201' ' ' SER . 33.7 m -69.33 -153.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -1.203 . . . . 0.0 109.388 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 74' ' ' ASN . 14.4 tp -151.47 118.41 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.941 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.91 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -98.68 -149.73 25.09 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.53 HG12 HD11 ' A' ' 227' ' ' LEU . 2.3 t -103.13 -38.05 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.303 . . . . 0.0 109.045 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -93.86 135.1 25.22 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CG ' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.94 -63.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.613 2.208 . . . . 0.0 111.103 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -119.07 47.5 1.66 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.91 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -80.93 164.38 22.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.097 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.502 ' OE1' ' CD ' ' A' ' 44' ' ' ARG . 40.1 mm-40 -85.61 104.24 15.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.664 HD21 ' CG2' ' A' ' 70' ' ' ILE . 6.3 mt -96.53 116.74 29.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 11.5 m-85 -97.4 156.01 16.65 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.632 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . . . -123.47 101.18 7.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.431 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -102.58 160.14 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.904 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 2.0 tttt -116.93 111.16 19.24 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.432 -0.793 . . . . 0.0 109.415 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.983 HG21 HD23 ' A' ' 31' ' ' LEU . 12.1 t -115.25 -28.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.392 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.608 HD11 HD22 ' A' ' 124' ' ' LEU . 3.1 mp -132.74 175.05 9.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 110.017 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.36 170.9 39.53 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.528 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.243 . . . . 0.0 108.9 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.07 162.86 13.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.748 -0.854 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.25 -15.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -19.73 57.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.931 ' CB ' HG23 ' A' ' 50' ' ' VAL . 60.6 p -87.98 -47.62 8.4 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.773 0.797 . . . . 0.0 109.094 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.543 HG23 HG11 ' A' ' 93' ' ' VAL . 2.2 mt -68.35 -34.13 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.91 -39.35 51.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.588 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 1.9 tt0 -70.52 -31.31 68.35 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.065 -1.022 . . . . 0.0 109.07 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.589 ' CA ' ' CE2' ' A' ' 49' ' ' PHE . . . -75.11 -39.49 37.16 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.4 mt -66.57 -33.13 74.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -1.088 . . . . 0.0 109.692 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 -17.98 23.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.421 ' HB2' ' O ' ' A' ' 107' ' ' GLN . 80.1 t90 -73.15 -18.02 61.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -90.85 6.72 43.28 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.223 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -96.99 -46.89 2.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.29 -80.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.147 -1.208 . . . . 0.0 108.274 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -95.83 62.56 2.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.728 ' CA ' ' HE3' ' A' ' 117' ' ' MET . . . -122.34 -161.21 11.19 Favored Glycine 0 C--N 1.286 -2.205 0 CA-C-O 122.575 1.097 . . . . 0.0 112.034 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.728 ' HE3' ' CA ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -126.41 162.87 24.58 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.446 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.415 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.736 ' HB ' HG22 ' A' ' 28' ' ' VAL . 2.5 t -105.91 156.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.837 -1.164 . . . . 0.0 109.611 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.2 121.34 1.69 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.723 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.947 HD22 HG13 ' A' ' 148' ' ' VAL . 13.2 t-20 -98.48 158.32 15.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.071 -1.018 . . . . 0.0 109.954 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.786 HD12 ' C ' ' A' ' 121' ' ' ASN . 7.0 mp -138.02 101.77 4.51 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 32' ' ' ASP . 20.6 p -85.53 62.11 7.27 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.608 HD22 HD11 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -143.9 178.87 7.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.433 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.587 ' CA ' ' CB ' ' A' ' 160' ' ' SER . . . 165.65 107.96 0.21 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.97 154.43 48.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.98 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.528 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 33.4 Cg_endo -77.18 -3.84 14.15 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.517 2.144 . . . . 0.0 109.195 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.408 ' O ' ' CE1' ' A' ' 161' ' ' TYR . 2.7 t -103.99 101.04 23.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 35.7 Cg_endo -77.95 166.03 25.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.335 2.023 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -153.73 125.21 7.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.65 66.56 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 15.5 m -67.08 -28.8 68.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.677 HD22 ' CE2' ' A' ' 161' ' ' TYR . 0.3 OUTLIER -70.37 -36.62 74.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -65.94 -58.44 5.54 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.431 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 134' ' ' GLU . 2.4 tp-100 -42.12 -28.13 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' GLU . . . -74.96 -49.61 19.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.707 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -33.14 46.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -61.61 -39.58 91.76 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -71.08 -22.94 62.04 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.99 -2.23 47.36 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.002 -1.062 . . . . 0.0 110.187 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -95.34 -34.16 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 108.859 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 64.4 m -66.1 -24.4 66.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 108.86 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -88.79 -13.1 40.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -0.821 . . . . 0.0 109.325 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.26 71.13 1.0 Allowed Glycine 0 C--N 1.302 -1.36 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 84.9 t -112.99 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.448 -1.03 . . . . 0.0 109.499 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.421 HD23 HG13 ' A' ' 119' ' ' VAL . 5.0 tp -60.48 100.81 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.094 -1.003 . . . . 0.0 108.772 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.519 HG12 HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -104.11 140.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.22 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.947 HG13 HD22 ' A' ' 121' ' ' ASN . 3.7 p -129.16 125.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 108.879 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -105.18 146.85 28.66 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.995 -1.066 . . . . 0.0 110.431 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -81.45 169.66 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.56 -68.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 143.23 121.63 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 154' ' ' SER . 12.7 p-10 -86.7 33.35 0.65 Allowed 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.756 -0.849 . . . . 0.0 109.917 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER 162.33 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.31 -103.4 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.56 -168.66 2.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.7 44.89 3.3 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -159.66 150.16 19.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -1.198 . . . . 0.0 109.045 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.404 HG12 ' H ' ' A' ' 159' ' ' ILE . 2.2 pt -80.85 176.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.39 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.939 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -108.66 163.44 13.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 111.823 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.677 ' CE2' HD22 ' A' ' 133' ' ' LEU . 10.2 p90 -89.89 146.06 34.49 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 164' ' ' ARG . 44.0 Cg_endo -71.37 -26.6 8.09 Favored 'Cis proline' 0 C--N 1.297 -2.179 0 O-C-N 122.404 0.687 . . . . 0.0 110.722 4.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.939 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.73 -178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -77.4 -47.55 19.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.719 -1.238 . . . . 0.0 110.011 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -48.0 -171.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.316 1.055 . . . . 0.0 110.906 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.23 1.34 12.45 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.736 -0.602 . . . . 0.0 110.104 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.68 18.98 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.147 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -168.24 161.56 12.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.9 mmm -104.2 138.71 40.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.591 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -100.75 127.1 47.3 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.528 -0.732 . . . . 0.0 109.294 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.4 t -98.55 165.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.189 -0.944 . . . . 0.0 109.717 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -135.39 -158.0 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -144.74 147.01 32.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.925 -1.338 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.34 155.69 25.78 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 4.2 p-10 -59.63 -160.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 109.664 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.53 ' O ' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -45.65 -67.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.465 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -102.12 -57.81 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.369 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.2 OUTLIER -176.17 106.63 0.08 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.403 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.693 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 1.1 t30 -136.65 -39.13 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.693 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 13.5 ttt180 116.51 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.692 0.758 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -39.24 161.32 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.185 0.516 . . . . 0.0 109.638 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -119.86 -49.09 2.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 0.0 110.475 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.504 ' CE2' ' OG1' ' A' ' 214' ' ' THR . 31.3 p90 -49.49 -21.41 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 214' ' ' THR . 1.6 t -69.94 117.2 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.015 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.54 116.94 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CG ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -121.41 167.8 12.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.528 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -165.34 -166.61 24.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.34 64.11 7.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.14 -1.212 . . . . 0.0 109.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 170.81 33.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' ASP . 5.3 tp -79.27 102.2 8.45 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.04 -1.271 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 24.4 t70 -41.79 -67.83 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 110.277 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.694 HD11 ' O ' ' A' ' 261' ' ' LEU . 3.9 tt -157.77 169.98 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.199 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 260' ' ' GLY . 7.9 m -108.76 162.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.695 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 1.02 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -152.88 -176.68 0.61 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 1.02 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.3 Cg_endo -78.15 115.48 3.75 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.771 1.648 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -144.09 18.48 2.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.627 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 10.3 t -109.14 55.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 108.729 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 199' ' ' VAL . 20.4 t-20 131.19 121.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 198' ' ' ASN . 16.4 m -164.63 111.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.94 0.876 . . . . 0.0 108.724 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.8 OUTLIER -99.68 125.2 45.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.728 ' HA ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -130.85 -166.57 1.71 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 109.304 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -83.5 172.96 11.89 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.655 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -147.5 165.36 19.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.655 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.5 Cg_endo -71.27 164.48 35.59 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.085 1.857 . . . . 0.0 110.533 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 92.0 -54.73 2.93 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 9.5 p 141.39 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -137.93 -178.37 5.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.934 -1.104 . . . . 0.0 110.371 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.536 ' N ' ' OG1' ' A' ' 207' ' ' THR . 36.7 m-85 -106.37 -160.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -172.97 163.04 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.987 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 42.3 p -151.72 108.55 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 108.875 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.87 160.74 39.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.719 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.85 133.22 55.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -169.09 148.54 12.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 173' ' ' ALA . 32.9 m -72.64 -31.44 65.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -1.186 . . . . 0.0 109.302 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.518 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 16.8 t -67.74 -9.18 41.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.488 ' CE ' ' NE2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -86.22 -22.26 27.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.898 . . . . 0.0 109.877 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.729 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -84.65 -17.31 39.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.654 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 32.9 m -62.87 -42.76 79.88 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 111.904 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.868 ' HG2' HG21 ' A' ' 69' ' ' THR . 30.2 Cg_endo -71.27 -13.47 30.86 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.575 1.517 . . . . 0.0 110.277 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.625 ' CE1' HG23 ' A' ' 69' ' ' THR . 8.4 m80 -72.42 -40.08 67.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.09 -39.29 74.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.78 -45.58 67.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -62.4 -45.19 96.44 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.58 -60.36 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.266 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -48.59 -33.68 10.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.763 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -60.93 -46.54 90.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 109.037 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.53 HD11 HG12 ' A' ' 82' ' ' VAL . 30.4 mt -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.594 HG21 HD23 ' A' ' 244' ' ' LEU . 97.5 t -64.75 -64.94 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 109.756 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.573 ' HE3' HG23 ' A' ' 119' ' ' VAL . 7.6 ttmm -42.97 -35.98 1.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.127 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.469 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 45.1 tp60 -60.95 -51.92 67.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 231' ' ' LYS . 3.1 ttpp -55.62 -18.56 8.0 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 3.5 m120 -165.49 82.78 1.1 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.383 -0.823 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.1 Cg_endo -78.81 0.24 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.689 2.259 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -6.36 48.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -75.84 -176.73 3.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.834 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.0 OUTLIER -111.1 164.76 12.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.389 0.614 . . . . 0.0 109.616 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -29.05 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -78.17 -61.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.141 -0.975 . . . . 0.0 109.422 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.7 OUTLIER -39.98 -37.78 0.63 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.019 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 236' ' ' SER . 2.5 mt -77.1 -46.63 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.634 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -49.67 -31.33 10.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 52.3 m-20 -72.93 -47.13 48.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.964 -1.085 . . . . 0.0 110.389 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.503 ' HA ' ' OD1' ' A' ' 246' ' ' ASN . 3.5 t60 -63.15 -35.88 81.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -81.87 -35.67 29.04 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -68.89 -34.43 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 243' ' ' HIS . 3.7 p-10 -84.65 -30.42 24.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.44 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 267' ' ' ALA . 1.7 p -72.06 -30.13 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.682 ' HB1' HD12 ' A' ' 192' ' ' ILE . . . -40.52 117.44 0.81 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.521 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' ALA . 0.2 OUTLIER -43.9 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -126.18 71.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 261' ' ' LEU . 1.9 mp . . . . . 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.968 . . . . 0.0 109.741 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.645 ' CD2' ' CG ' ' A' ' 186' ' ' TYR . 2.6 tm? . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.234 0.54 . . . . 0.0 109.765 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -61.28 -57.53 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.14 -0.975 . . . . 0.0 109.089 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.48 -81.65 1.69 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 191' ' ' ASP . 57.7 m -78.53 -55.43 5.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.388 -1.066 . . . . 0.0 109.137 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 135.26 -135.53 7.95 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.694 ' O ' HD11 ' A' ' 192' ' ' ILE . 1.4 tp -105.06 178.1 4.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.349 -1.089 . . . . 0.0 109.076 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.574 HG22 HD13 ' A' ' 192' ' ' ILE . 3.0 t -122.67 156.29 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -166.23 119.6 1.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.327 1.06 . . . . 0.0 108.457 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.73 -13.01 61.24 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.152 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 15.8 tt0 -75.47 -25.96 57.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 109.664 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.21 55.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.679 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.45 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -113.67 -20.67 11.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.869 HG21 ' CD1' ' A' ' 21' ' ' LEU . 61.8 p -102.31 -46.51 4.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.119 -0.988 . . . . 0.0 109.229 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 269' ' ' ARG . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.427 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.688 ' OG ' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.298 0.57 . . . . 0.0 109.641 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.667 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 2.9 t -136.75 46.81 1.62 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.915 . . . . 0.0 110.108 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 36.4 Cg_endo -77.5 165.6 27.04 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.936 1.758 . . . . 0.0 110.424 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 7.1 p-90 -67.05 -13.19 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 109.464 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 11' ' ' VAL . . . -83.89 -15.75 69.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.57 ' CD1' ' NE2' ' A' ' 220' ' ' HIS . 1.1 mp -116.38 -6.75 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -1.202 . . . . 0.0 109.045 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.92 -22.43 21.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 21.37 12.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.036 -1.04 . . . . 0.0 110.621 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 7' ' ' GLY . 28.1 m -110.06 18.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.963 -1.086 . . . . 0.0 109.339 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 27.8 mm-40 57.07 17.63 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 110.571 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.683 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.54 -43.03 87.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.86 -53.87 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 N-CA-C 107.874 -1.625 . . . . 0.0 107.874 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB1' ' OE2' ' A' ' 265' ' ' GLU . . . -44.75 -30.74 1.01 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.47 54.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 16.0 m170 -65.62 -10.83 39.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.601 -0.687 . . . . 0.0 109.175 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -83.43 -56.87 3.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -36.21 63.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.456 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.92 4.01 9.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.657 HD13 HG21 ' A' ' 268' ' ' THR . 0.3 OUTLIER -63.82 137.68 58.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.133 . . . . 0.0 109.365 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -123.77 -12.4 7.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.086 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 71.55 -9.39 4.66 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -49.13 135.43 16.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -1.122 . . . . 0.0 109.336 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.18 0.55 47.78 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 27' ' ' LYS . 47.5 t -112.44 163.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.127 -1.219 . . . . 0.0 109.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -148.83 131.35 15.78 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 ' HB ' ' A' ' 119' ' ' VAL . 17.4 t -128.69 154.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.325 -0.859 . . . . 0.0 109.723 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -98.76 150.17 22.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.911 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.636 ' CG2' HD22 ' A' ' 88' ' ' LEU . 39.0 t -122.7 80.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.919 -1.113 . . . . 0.0 108.387 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.039 HD23 HG21 ' A' ' 93' ' ' VAL . 6.6 mp -71.07 126.41 29.51 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.973 ' HA ' HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER 170.21 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.264 -0.897 . . . . 0.0 109.258 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.855 HG21 ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -49.05 -59.76 3.35 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . 179.38 -109.85 0.27 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 165.6 102.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 p -49.73 125.88 12.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.814 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 m -55.12 101.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.074 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.593 ' CD2' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -119.4 153.39 53.7 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.812 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 35.6 Cg_endo -78.5 -12.69 15.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.516 2.144 . . . . 0.0 109.939 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -90.25 -37.58 14.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD21 ' HA2' ' A' ' 68' ' ' GLY . 62.2 mt -88.87 113.49 24.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.792 . . . . 0.0 109.545 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 119.36 16.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 mm -92.66 94.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.073 -1.017 . . . . 0.0 109.395 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.504 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -79.81 -21.01 44.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.993 . . . . 0.0 109.265 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -169.32 163.9 37.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.91 119.5 0.83 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.37 163.47 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -1.096 . . . . 0.0 108.727 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.493 ' OG ' ' HD2' ' A' ' 92' ' ' LYS . 2.5 t -150.85 136.95 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 110.427 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.619 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -127.29 -30.31 2.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 94' ' ' LEU . 55.2 t -49.05 129.42 15.42 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.313 -1.321 0 C-N-CA 122.64 2.226 . . . . 0.0 111.125 -179.569 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.69 0.757 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -92.71 3.8 54.93 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.181 -0.95 . . . . 0.0 109.159 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 1.5 mt-30 -96.56 116.21 28.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.217 -0.927 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.458 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.7 OUTLIER 52.21 171.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.637 0.732 . . . . 0.0 110.133 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.57 -33.31 0.06 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.855 ' HB2' HG21 ' A' ' 33' ' ' THR . 1.3 t-20 -175.68 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.345 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.62 -47.24 0.97 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -45.32 -50.07 12.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.398 -1.06 . . . . 0.0 110.155 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -54.54 -80.94 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.409 -0.901 . . . . 0.0 110.934 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 0.7 OUTLIER -33.42 -45.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.818 -0.813 . . . . 0.0 110.898 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.723 ' CD2' HD11 ' A' ' 211' ' ' LEU . 44.9 t-80 -57.51 -54.01 51.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.971 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 70' ' ' ILE . 13.5 t -58.76 -32.62 47.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.426 -0.796 . . . . 0.0 109.189 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 70' ' ' ILE . . . -59.72 -49.27 78.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.763 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -70.31 -28.65 71.05 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.492 HG21 ' HG2' ' A' ' 219' ' ' PRO . 7.7 m -71.59 -17.12 62.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.062 -1.258 . . . . 0.0 108.473 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 66' ' ' VAL . 30.3 mt -92.66 -32.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.401 -0.812 . . . . 0.0 110.411 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 83' ' ' ALA . . . -179.65 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.661 -1.274 . . . . 0.0 111.52 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.763 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -46.1 156.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.734 -1.229 . . . . 0.0 108.358 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 73' ' ' LEU . 96.6 mt -78.95 166.69 22.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.932 -1.105 . . . . 0.0 109.925 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.99 ' HB2' HD13 ' A' ' 80' ' ' LEU . 55.0 t30 -117.29 87.38 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.84 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -118.39 -118.92 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.291 -0.881 . . . . 0.0 108.737 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -113.45 -40.54 3.84 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 109.279 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.79 165.56 2.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.404 -0.81 . . . . 0.0 109.7 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.27 -167.23 53.16 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.688 HG12 ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -114.0 -167.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -1.178 . . . . 0.0 109.397 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.99 HD13 ' HB2' ' A' ' 74' ' ' ASN . 8.5 tp -130.36 122.37 27.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 80' ' ' LEU . . . -86.57 -149.31 13.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG12 HD11 ' A' ' 227' ' ' LEU . 2.0 t -97.79 -66.67 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.263 . . . . 0.0 109.666 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -71.45 134.3 84.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 22' ' ' THR . 40.1 Cg_endo -84.95 -60.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.752 2.302 . . . . 0.0 111.236 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -105.92 45.38 0.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.793 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -85.5 164.72 17.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.07 -1.018 . . . . 0.0 109.646 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 2.6 tt0 -101.55 80.19 2.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.636 HD22 ' CG2' ' A' ' 30' ' ' VAL . 6.6 mt -73.3 144.17 46.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.312 -0.867 . . . . 0.0 109.746 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.604 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 2.8 m-85 -118.48 161.52 19.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.401 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -130.03 92.32 3.28 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.643 -1.286 . . . . 0.0 109.914 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.89 149.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.131 -0.981 . . . . 0.0 109.315 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 4.4 mttp -100.29 105.61 17.17 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.039 HG21 HD23 ' A' ' 31' ' ' LEU . 2.1 t -104.55 -14.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.813 . . . . 0.0 110.08 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.973 HD11 ' HA ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.55 -174.7 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.771 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -110.75 -177.41 20.63 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HB1' ' ND2' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.452 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.48 157.8 21.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.746 -0.855 . . . . 0.0 109.786 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 130' ' ' SER . 43.7 t -68.53 -19.61 24.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.526 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 33.4 t -72.91 -22.69 60.7 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.456 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 57.4 m -83.1 -63.8 1.29 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.568 HG23 ' CG1' ' A' ' 93' ' ' VAL . 2.3 mt -47.93 -27.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 110' ' ' GLU . . . -69.08 -47.91 64.03 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.619 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -64.79 -28.83 69.84 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.033 -1.042 . . . . 0.0 109.404 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.493 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -80.55 -26.77 53.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.949 HD22 ' ND2' ' A' ' 167' ' ' ASN . 16.4 mt -87.23 -24.15 24.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -1.227 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 7.1 pt-20 -100.63 -25.94 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.251 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.53 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 83.1 t90 -71.65 -17.06 62.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -93.42 -0.38 56.51 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.876 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.93 -28.47 10.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -97.2 -35.41 10.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -1.22 . . . . 0.0 109.503 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -140.12 27.66 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.394 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.834 ' O ' ' HE2' ' A' ' 117' ' ' MET . . . -87.99 -153.32 25.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.834 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 12.1 mmt -125.22 -176.54 3.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.366 -1.079 . . . . 0.0 110.432 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.666 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -71.84 -17.08 62.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.749 -0.595 . . . . 0.0 110.163 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.666 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.6 t -136.74 168.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.6 132.48 1.21 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 1.02 ' C ' HD13 ' A' ' 122' ' ' LEU . 1.6 m120 -130.91 147.39 52.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.0 109.741 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.02 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -142.07 124.78 15.93 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.094 -1.004 . . . . 0.0 109.187 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.749 ' C ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -93.17 62.14 3.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.897 -1.127 . . . . 0.0 109.065 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.819 HD23 ' N ' ' A' ' 124' ' ' LEU . 1.2 mt -99.72 -178.7 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 160' ' ' SER . . . 175.05 74.88 0.05 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 3.4 m -124.62 147.73 56.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 109.494 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -81.07 15.42 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.787 2.325 . . . . 0.0 110.119 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.534 ' N ' ' CD ' ' A' ' 129' ' ' PRO . 14.1 t -116.03 50.36 0.76 Allowed Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.602 -0.687 . . . . 0.0 111.48 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -72.57 178.58 6.07 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.343 2.028 . . . . 0.0 109.772 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.581 ' HB2' HG21 ' A' ' 102' ' ' VAL . 3.7 t -152.49 154.08 34.77 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.16 64.92 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.0 m -71.61 -26.76 62.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.2 tp -72.39 -38.3 68.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -68.08 -47.62 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.64 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -26.47 12.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -67.32 -44.81 78.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.082 HG23 ' HA ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -52.29 -40.38 31.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.458 ' N ' HG12 ' A' ' 137' ' ' VAL . 1.6 m120 -58.07 -41.79 84.12 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -20.16 63.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.63 1.75 25.42 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.872 -1.143 . . . . 0.0 112.044 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -104.49 -41.24 5.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.427 -1.421 . . . . 0.0 108.409 178.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -20.03 57.8 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.38 -25.83 20.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.44 52.66 4.12 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.5 t -105.4 109.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -1.093 . . . . 0.0 109.267 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 146' ' ' LEU . 24.7 tp -58.5 123.13 15.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.053 -1.029 . . . . 0.0 109.104 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -120.25 141.69 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.015 . . . . 0.0 109.297 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' HG3' ' A' ' 169' ' ' MET . 1.2 t -137.97 123.91 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.544 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -118.75 147.94 43.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.004 -1.06 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -52.2 160.4 0.78 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.618 -0.676 . . . . 0.0 110.213 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -71.06 -79.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 185' ' ' GLN . . . 149.54 119.32 0.97 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.437 ' OD1' ' CG ' ' A' ' 183' ' ' PHE . 3.6 m-20 -91.59 57.66 3.33 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.799 -0.824 . . . . 0.0 109.391 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.07 -96.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.49 84.47 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -170.61 179.51 3.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.62 56.7 4.89 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -179.75 171.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -1.077 . . . . 0.0 108.675 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.626 HD12 ' CB ' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -118.85 -173.34 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.008 -1.057 . . . . 0.0 110.38 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.56 ' HB3' ' HA2' ' A' ' 125' ' ' GLY . 2.6 m -70.89 -174.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.806 1.289 . . . . 0.0 112.521 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.429 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 93.6 m-85 -123.81 126.97 25.59 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.723 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.3 Cg_endo -72.62 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.301 -1.949 0 C-N-CA 123.939 -1.276 . . . . 0.0 109.791 2.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . . . 31.7 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.238 1.018 . . . . 0.0 108.901 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 162' ' ' PRO . 17.5 ttm180 -44.12 -62.73 1.05 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.717 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -172.28 -166.12 0.38 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 165' ' ' TYR . . . 89.73 -7.09 0.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.746 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 1.082 ' HA ' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER 159.73 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.719 -0.613 . . . . 0.0 109.596 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 167' ' ' ASN . . . 164.77 149.49 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.433 -1.307 . . . . 0.0 112.648 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -80.19 -174.43 4.52 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 175.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.626 ' CB ' HD12 ' A' ' 159' ' ' ILE . . . -122.66 118.88 29.18 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.345 -1.472 . . . . 0.0 110.515 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 151' ' ' SER . 19.0 t -89.52 166.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -136.9 -176.89 14.61 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.582 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -130.31 150.21 51.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.979 . . . . 0.0 109.601 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 173' ' ' ALA . 33.2 p -157.79 155.06 29.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' THR . 18.8 p-10 -58.9 -150.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.846 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.543 ' HG2' ' ND2' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -94.48 -31.48 13.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.952 . . . . 0.0 109.983 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.543 ' ND2' ' HG2' ' A' ' 176' ' ' GLN . 0.0 OUTLIER -96.29 -89.39 0.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.96 80.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -140.28 165.18 28.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 12.0 mtm180 -98.38 19.07 15.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.354 -0.841 . . . . 0.0 109.647 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 64.15 -152.46 0.3 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.6 OUTLIER -112.0 9.86 20.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.393 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -150.48 -92.48 0.06 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' PHE . 3.7 t 39.29 80.76 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.476 -0.765 . . . . 0.0 110.455 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 152' ' ' GLY . 1.9 mp0 -65.67 146.27 55.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 0.0 109.122 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -123.54 166.41 15.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.126 -0.983 . . . . 0.0 109.541 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . 155.59 175.5 26.69 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -52.82 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.156 . . . . 0.0 109.273 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 170' ' ' ALA . . . 160.81 -33.76 0.4 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' A' ' 190' ' ' LEU . 7.9 tp -52.21 111.78 0.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.238 -1.154 . . . . 0.0 109.622 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.28 -28.75 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.85 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 248' ' ' ALA . 2.5 tt -156.8 166.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.607 -1.308 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.882 HG22 ' O ' ' A' ' 260' ' ' GLY . 12.4 m -123.68 174.63 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -0.821 . . . . 0.0 109.283 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.982 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -168.78 177.81 1.14 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.223 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.979 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.4 Cg_endo -76.61 119.33 5.15 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.455 2.103 . . . . 0.0 110.629 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.47 42.15 1.41 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 19.9 t -133.45 81.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.234 -1.156 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER 84.22 122.83 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.011 0.91 . . . . 0.0 108.574 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 199' ' ' VAL . 19.3 m -156.81 108.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 122.137 0.97 . . . . 0.0 109.383 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 31.5 mt-30 -78.77 143.79 35.78 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.611 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -159.11 -162.1 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.329 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.514 HG21 HD11 ' A' ' 41' ' ' LEU . 15.0 t -86.04 -177.55 6.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.657 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -168.45 169.44 4.96 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.657 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -72.31 168.55 23.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.335 2.023 . . . . 0.0 110.538 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.53 72.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.514 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 4.2 p 56.36 36.7 27.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -1.113 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -122.58 147.68 46.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.078 -1.014 . . . . 0.0 109.807 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.22 19.28 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.49 165.67 4.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.028 . . . . 0.0 110.205 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.76 ' O ' HD23 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -103.33 146.3 28.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.482 -0.762 . . . . 0.0 109.435 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -139.01 107.91 5.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.777 . . . . 0.0 109.169 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.07 140.83 56.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.1 -1.0 . . . . 0.0 109.344 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.35 2.39 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.783 HG23 ' HB2' ' A' ' 173' ' ' ALA . 19.4 m -68.38 -23.58 64.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 0.0 109.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.538 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 9.9 t -67.11 -20.07 65.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.643 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.525 ' HG2' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -78.77 -10.49 59.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.982 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -86.38 -5.76 59.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.638 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.647 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -76.95 -39.05 2.13 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.5 Cg_endo -71.98 -25.59 19.46 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.527 1.484 . . . . 0.0 110.744 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.57 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 13.1 m80 -66.78 -37.75 85.19 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.72 -52.14 34.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' A' ' 121' ' ' ASN . . . -48.09 -33.2 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.378 -0.826 . . . . 0.0 108.94 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.4 -53.08 23.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -53.52 -62.44 1.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.419 -1.048 . . . . 0.0 109.286 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 244' ' ' LEU . . . -43.01 -40.88 3.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.23 78.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.216 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 82' ' ' VAL . 7.1 mt -52.94 -29.12 26.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.33 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 229' ' ' LYS . 96.1 t -74.19 -51.51 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.547 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -43.92 -47.62 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.453 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 28.3 tp60 -63.3 -41.8 98.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.3 tptt -62.98 -11.49 19.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.046 -1.034 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.96 90.89 1.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.19 -0.944 . . . . 0.0 109.764 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.429 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 36.9 Cg_endo -81.44 17.88 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.724 2.283 . . . . 0.0 110.834 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.3 t -122.12 5.32 9.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 110.004 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -91.5 -179.65 5.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.909 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.457 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.4 OUTLIER -110.37 167.73 9.98 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -58.64 -35.75 73.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 109.426 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 238' ' ' VAL . 3.0 t -66.66 -64.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.21 -0.931 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -45.34 -39.78 7.12 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.357 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 236' ' ' SER . 59.7 mt -57.72 -49.41 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.57 -0.706 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' ASN . 49.1 ttp180 -56.12 -60.65 3.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.58 ' HA ' ' HE3' ' A' ' 245' ' ' LYS . 2.3 t-20 -37.69 -62.72 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.66 -0.65 . . . . 0.0 110.91 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.563 ' O ' HG23 ' A' ' 247' ' ' THR . 2.1 t60 -50.4 -40.75 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.597 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.758 HD12 ' HB2' ' A' ' 225' ' ' ALA . 0.2 OUTLIER -70.63 -37.56 73.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 111.327 -178.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.629 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 4.0 ptpt -63.36 -55.46 24.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.868 -1.145 . . . . 0.0 109.975 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.629 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -70.78 -27.1 63.66 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.547 -0.72 . . . . 0.0 111.035 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 267' ' ' ALA . 6.0 p -71.57 -30.75 66.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.802 -1.186 . . . . 0.0 109.627 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -52.33 130.76 31.91 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 261' ' ' LEU . 1.6 m -42.97 111.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.211 -0.931 . . . . 0.0 108.784 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.4 p -69.14 98.0 0.96 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -0.804 . . . . 0.0 110.369 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.631 HD13 ' HA2' ' A' ' 260' ' ' GLY . 3.5 mp . . . . . 0 C--N 1.305 -1.342 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 256' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -55.3 -60.97 2.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.154 -0.966 . . . . 0.0 108.475 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 124.71 58.97 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.432 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 3.1 t 83.73 -57.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.926 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.882 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 140.36 -171.29 24.03 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.525 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.773 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 12.7 tp -75.25 162.29 28.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.954 . . . . 0.0 109.695 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.37 154.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.182 -0.949 . . . . 0.0 109.969 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.43 ' CB ' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -160.71 117.18 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.652 1.215 . . . . 0.0 108.177 178.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.6 61.0 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.526 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.823 ' OE2' ' HB1' ' A' ' 15' ' ' ALA . 7.6 tp10 -82.47 -40.47 21.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.964 -1.085 . . . . 0.0 109.603 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.8 -11.75 59.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 0.0 109.301 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.636 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -89.69 -38.88 13.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.657 HG21 HD13 ' A' ' 21' ' ' LEU . 44.6 p -87.89 -52.9 5.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.442 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.425 ' C ' ' HD3' ' A' ' 269' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.429 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.1 m . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 121.76 0.791 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.538 HG12 HG21 ' A' ' 8' ' ' ILE . 15.8 m -76.99 111.89 19.34 Favored Pre-proline 0 C--N 1.29 -2.007 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -80.48 -166.52 0.42 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.827 2.351 . . . . 0.0 111.813 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -33.29 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.219 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.517 ' HA3' ' NE2' ' A' ' 220' ' ' HIS . . . -52.06 -83.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.9 mm -43.84 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.479 -1.012 . . . . 0.0 109.187 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 162.78 -56.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -125.49 26.52 6.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.65 20.04 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.875 -1.14 . . . . 0.0 109.903 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG3' ' HB3' ' A' ' 263' ' ' ASN . 5.3 mm-40 65.83 15.59 10.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.577 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -66.33 -37.17 14.96 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.5 Cg_endo -73.02 -55.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.981 0 N-CA-C 108.424 -1.414 . . . . 0.0 108.424 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.74 -29.52 0.53 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 11.1 m170 -69.04 -7.29 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.817 . . . . 0.0 109.569 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.26 -22.58 14.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.112 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.871 ' HB3' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -81.26 4.89 18.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.34 47.13 5.03 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.871 HD21 ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -149.22 150.89 33.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -1.086 . . . . 0.0 109.102 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 24' ' ' SER . 1.7 t -161.15 38.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.866 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 56.94 9.79 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 22' ' ' THR . 55.5 p -57.78 119.45 6.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.77 27.92 9.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 27' ' ' LYS . 88.1 t -122.83 167.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -1.211 . . . . 0.0 109.789 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -136.24 132.62 36.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.117 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 119' ' ' VAL . 3.0 t -136.36 123.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 110.121 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.582 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -84.97 162.63 19.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.82 90.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.153 HD23 HG21 ' A' ' 93' ' ' VAL . 5.9 mp -79.83 102.37 9.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD2' ' HA2' ' A' ' 63' ' ' GLY . 47.9 p30 -166.2 -154.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.006 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 96' ' ' ALA . 6.6 p -43.0 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.564 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -164.06 -132.8 1.39 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.751 HG13 ' HB2' ' A' ' 90' ' ' ALA . 30.5 mm -165.58 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -62.88 137.47 58.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 109.171 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -63.05 122.39 15.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.591 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -133.18 154.54 81.22 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.4 Cg_endo -79.68 -31.91 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.715 2.276 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -86.33 -3.19 58.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.0 109.836 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.77 123.6 48.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.065 -1.022 . . . . 0.0 109.724 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.12 91.43 7.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 109.87 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.75 152.07 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.563 ' O ' ' CE1' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -160.71 23.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.338 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.614 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -170.0 144.76 8.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.93 114.69 0.71 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.1 157.68 44.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -1.032 . . . . 0.0 109.294 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 56' ' ' THR . 0.1 OUTLIER -165.28 133.75 3.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.993 -1.067 . . . . 0.0 110.139 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.8 -36.38 3.9 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.609 -0.682 . . . . 0.0 109.634 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HD3' ' A' ' 92' ' ' LYS . 11.2 t -43.69 107.49 0.59 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.374 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--N 1.315 -1.229 0 C-N-CA 122.706 2.271 . . . . 0.0 110.704 -179.738 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.129 0.49 . . . . 0.0 109.858 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 48' ' ' SER . 0.1 OUTLIER 61.69 4.28 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.121 -0.987 . . . . 0.0 110.114 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' ASP . 30.2 mt-30 -147.03 138.69 24.25 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.753 -1.217 . . . . 0.0 109.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 57' ' ' GLN . 45.2 t0 57.8 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 60' ' ' ASN . . . -153.7 67.21 0.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 2.8 t-20 84.99 -33.43 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.885 . . . . 0.0 109.893 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.54 10.82 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLY . 20.5 t-160 -51.08 -66.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -40.85 -72.92 0.22 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 96.5 m -35.38 -48.07 0.46 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.827 -0.807 . . . . 0.0 110.735 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.533 ' NE2' ' HB2' ' A' ' 201' ' ' SER . 22.0 t-80 -51.73 -53.36 40.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.254 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.552 HG13 ' HG3' ' A' ' 219' ' ' PRO . 12.5 t -60.64 -31.35 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.34 -0.85 . . . . 0.0 108.785 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -55.79 -48.58 75.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.397 -0.814 . . . . 0.0 109.526 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 70' ' ' ILE . . . -67.41 -43.03 88.68 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.429 HG21 ' HG2' ' A' ' 219' ' ' PRO . 1.1 m -52.07 -21.88 3.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.449 -1.618 . . . . 0.0 107.773 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 83' ' ' ALA . 55.9 mt -94.3 -30.68 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.497 -0.752 . . . . 0.0 110.949 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -165.57 44.38 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.506 -1.371 . . . . 0.0 112.323 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -60.92 124.47 20.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.635 -1.291 . . . . 0.0 108.82 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 93.2 mt -79.33 156.75 27.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.992 -1.068 . . . . 0.0 109.314 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 42.3 t30 -139.54 63.63 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.087 -1.008 . . . . 0.0 109.975 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -89.75 -13.92 35.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.042 0.925 . . . . 0.0 109.28 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.8 -45.93 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -115.1 157.25 15.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.526 -0.734 . . . . 0.0 109.135 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.83 164.35 35.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.43 -150.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.366 -1.079 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 6.3 tp -147.02 106.42 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.984 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.43 -163.48 4.62 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.798 HG12 HD11 ' A' ' 227' ' ' LEU . 0.6 OUTLIER -78.91 -53.67 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -1.108 . . . . 0.0 109.427 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -110.84 101.9 50.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.18 -0.95 . . . . 0.0 108.707 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 37.6 Cg_endo -83.03 -53.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.902 2.401 . . . . 0.0 111.303 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.48 18.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.152 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.18 23.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.525 -1.359 . . . . 0.0 109.203 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 44.0 mt-10 -74.33 150.57 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 109.082 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 71' ' ' ALA . 88.1 mt -125.25 97.98 5.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.953 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 m-30 -82.29 113.66 20.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.262 -0.899 . . . . 0.0 109.419 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.751 ' HB2' HG13 ' A' ' 35' ' ' ILE . . . -78.77 108.91 12.55 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.073 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.582 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -108.38 73.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.766 -1.209 . . . . 0.0 109.959 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.6 OUTLIER -41.65 113.4 0.41 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.153 HG21 HD23 ' A' ' 31' ' ' LEU . 5.0 t -123.06 -24.71 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.135 -0.978 . . . . 0.0 109.928 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.72 HD11 HD22 ' A' ' 124' ' ' LEU . 3.9 mp -126.76 172.2 10.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 110.173 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.92 -158.65 16.5 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.803 ' HA ' HG22 ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.217 -1.167 . . . . 0.0 109.183 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 m -121.47 157.35 30.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.872 -0.781 . . . . 0.0 109.983 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -28.89 44.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.549 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 75.1 m -72.52 -18.53 61.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 105' ' ' ILE . 9.2 p -77.44 -57.76 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.652 -0.655 . . . . 0.0 109.382 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.554 HG12 ' CG1' ' A' ' 93' ' ' VAL . 1.3 mt -63.4 -24.15 35.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.06 -44.54 79.89 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.624 -0.673 . . . . 0.0 109.572 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.607 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -77.39 -24.26 50.56 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.624 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -72.51 -27.98 68.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.68 -30.7 14.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -76.14 -30.06 58.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 108.96 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -65.67 -22.96 66.68 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.824 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -81.33 -21.85 38.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -56.52 -39.35 84.4 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.58 -49.97 6.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -127.93 70.27 1.34 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.824 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -105.79 23.72 28.79 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.617 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.2 OUTLIER 30.7 -159.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.129 0.966 . . . . 0.0 111.509 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.535 ' CB ' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -96.22 -20.21 18.74 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.437 -0.789 . . . . 0.0 111.026 -178.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 28' ' ' VAL . 2.6 t -136.51 158.5 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.435 -1.415 . . . . 0.0 111.351 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.81 128.51 2.42 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.601 ' ND2' HG12 ' A' ' 148' ' ' VAL . 11.9 t-20 -107.01 158.33 17.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.649 -1.282 . . . . 0.0 110.49 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.663 HD23 HD11 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -127.54 98.88 5.38 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -85.58 64.89 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.403 -0.81 . . . . 0.0 108.944 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.72 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -150.31 168.49 23.91 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.413 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.567 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -164.76 76.53 0.15 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -103.59 147.62 34.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.19 -1.182 . . . . 0.0 109.475 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -77.3 -34.59 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.295 1.997 . . . . 0.0 109.122 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -46.79 104.6 0.42 Allowed Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.71 -0.619 . . . . 0.0 109.38 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 34.5 Cg_endo -78.6 168.99 20.46 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.48 2.12 . . . . 0.0 110.161 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.3 p -173.34 120.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 110.622 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -24.88 65.76 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 79.7 m -63.37 -29.12 70.48 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.431 ' HB2' ' OG ' ' A' ' 130' ' ' SER . 2.1 tt -75.88 -35.87 59.7 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 6.5 tm-20 -77.04 -19.45 57.15 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.074 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -78.13 -24.01 47.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.05 -45.33 20.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.341 -0.943 . . . . 0.0 108.631 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.57 -28.92 42.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 134' ' ' GLU . 62.6 t30 -62.33 -34.77 77.28 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -79.88 -22.42 42.88 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.87 -27.69 63.03 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.4 m -69.4 -39.38 77.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -58.07 -23.93 56.53 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.231 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.65 -14.2 16.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.303 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.452 ' C ' ' HB2' ' A' ' 237' ' ' ASN . . . 68.16 75.37 0.51 Allowed Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.71 111.72 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.468 -1.019 . . . . 0.0 109.399 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.89 113.72 6.56 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -112.54 142.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.013 -1.054 . . . . 0.0 110.379 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.601 HG12 ' ND2' ' A' ' 121' ' ' ASN . 2.7 t -119.44 167.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -153.64 128.16 9.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.974 -1.079 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.506 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -61.08 156.06 18.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -88.16 -54.18 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.562 ' CA ' ' HB2' ' A' ' 185' ' ' GLN . . . 146.79 128.75 1.92 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 154' ' ' SER . 51.1 p-10 -83.66 60.96 6.02 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 122.166 -0.608 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER 91.97 104.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.356 0.598 . . . . 0.0 109.953 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -173.45 61.97 0.13 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 77.29 164.22 0.23 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.324 -1.104 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.65 56.6 4.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -145.85 161.75 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.52 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.469 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -100.53 -174.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.376 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.871 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.02 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.142 0.972 . . . . 0.0 111.576 -178.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.453 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.7 m-85 -108.8 134.15 20.43 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.682 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.2 Cg_endo -72.95 -56.91 0.14 OUTLIER 'Cis proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.043 -1.232 . . . . 0.0 111.018 3.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 37.74 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.284 1.04 . . . . 0.0 109.412 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -43.73 -34.94 1.66 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.1 m-85 -44.67 -178.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.289 1.042 . . . . 0.0 111.615 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 167' ' ' ASN . . . -95.92 -60.01 1.73 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -44.67 -67.47 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.206 1.003 . . . . 0.0 108.65 179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -71.97 139.29 48.57 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.8 mmm -104.71 143.29 33.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.999 -1.063 . . . . 0.0 109.912 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -94.99 108.16 20.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 34.6 t -87.53 165.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.27 -175.47 13.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -117.6 157.77 25.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -1.095 . . . . 0.0 109.199 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.944 HG22 ' OD1' ' A' ' 179' ' ' ASN . 18.6 p -135.35 168.13 19.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 110.049 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.08 -162.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -83.84 -19.86 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -71.37 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 109.277 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 174' ' ' THR . 2.7 m-20 -153.14 -59.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.288 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 1.004 ' ND2' HG21 ' A' ' 193' ' ' VAL . 8.6 t-20 -147.23 148.9 31.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.574 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 163.08 -70.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.428 0.633 . . . . 0.0 109.541 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . 48.91 178.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.641 -0.662 . . . . 0.0 109.809 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -34.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 154' ' ' SER . 7.7 p90 -106.49 -3.61 20.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 0.7 OUTLIER -45.89 112.16 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.562 ' HB2' ' CA ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -67.96 105.61 2.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 108.846 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -109.22 -169.99 1.58 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.466 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.581 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . -174.77 -142.12 3.92 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.132 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.51 71.59 5.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -1.044 . . . . 0.0 110.42 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.01 64.81 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.769 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 192' ' ' ILE . 0.5 OUTLIER -61.74 149.49 39.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.29 -1.124 . . . . 0.0 109.161 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -61.54 -60.98 2.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.692 ' O ' HD21 ' A' ' 190' ' ' LEU . 14.7 tt -160.73 165.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 120.984 -1.072 . . . . 0.0 109.619 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 1.004 HG21 ' ND2' ' A' ' 179' ' ' ASN . 27.3 m -122.48 161.38 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.214 -0.929 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -153.41 158.18 32.75 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.446 ' CB ' ' HZ3' ' A' ' 6' ' ' TRP . 34.6 Cg_endo -76.02 121.22 6.08 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 121.984 1.789 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -163.13 52.88 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.287 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 45.1 t -100.87 64.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -1.185 . . . . 0.0 108.4 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.735 ' O ' HG13 ' A' ' 199' ' ' VAL . 12.6 t-20 119.45 129.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 216' ' ' MET . 6.2 m -165.51 116.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 121.965 0.888 . . . . 0.0 108.822 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 20.2 pt20 -94.73 138.18 32.88 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.556 0.694 . . . . 0.0 109.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.533 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -135.43 -152.79 0.48 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.0 109.188 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.7 p -88.62 178.94 6.37 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.216 -0.928 . . . . 0.0 110.537 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.674 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -145.45 164.09 28.29 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.674 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 33.5 Cg_endo -69.9 155.85 64.43 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.57 1.514 . . . . 0.0 110.437 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.05 -60.49 4.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 2.0 p 151.6 38.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.975 -0.72 . . . . 0.0 109.577 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -122.77 170.8 9.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.172 -0.955 . . . . 0.0 109.935 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -108.73 177.74 4.69 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.409 -0.807 . . . . 0.0 108.98 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -162.78 166.93 23.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.079 -1.013 . . . . 0.0 110.209 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.931 ' C ' HD23 ' A' ' 211' ' ' LEU . 0.4 OUTLIER -144.08 122.05 12.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.585 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.931 HD23 ' C ' ' A' ' 210' ' ' SER . 0.2 OUTLIER -136.33 156.19 48.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.083 -1.01 . . . . 0.0 109.878 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 212' ' ' ASN . 16.2 p30 -117.83 131.54 56.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 109.041 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.62 28.62 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.605 -1.283 . . . . 0.0 109.914 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 151' ' ' SER . 89.0 m -76.57 -29.02 56.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -1.081 . . . . 0.0 108.813 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.455 ' O ' ' HB ' ' A' ' 218' ' ' THR . 0.3 OUTLIER -59.35 -24.74 63.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 108.85 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.886 ' HB3' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -77.8 -29.29 50.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.422 ' HB2' ' HA3' ' A' ' 196' ' ' GLY . . . -84.51 -5.19 59.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.912 . . . . 0.0 108.751 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.613 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 0.9 OUTLIER -66.22 -52.72 36.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.436 -0.79 . . . . 0.0 110.15 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.6 Cg_endo -72.16 -9.16 24.06 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.259 1.972 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.517 ' NE2' ' HA3' ' A' ' 7' ' ' GLY . 1.6 m80 -74.7 -43.51 54.73 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.3 t -75.05 -39.86 44.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 219' ' ' PRO . . . -52.95 -35.43 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -69.66 -50.58 30.04 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -44.21 -49.72 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 108.955 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.88 86.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 108.881 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.07 -41.51 64.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 109.317 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.798 HD11 HG12 ' A' ' 82' ' ' VAL . 17.1 mt -62.19 -34.67 76.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 108.873 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 231' ' ' LYS . 99.1 t -62.15 -60.38 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 109.032 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.591 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -44.62 -41.86 6.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 108.992 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 24' ' ' SER . 1.4 tm0? -59.83 -57.53 12.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 228' ' ' VAL . 1.9 ptpt -62.21 -11.22 13.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.093 -1.004 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.527 ' OD1' ' CD1' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -156.42 80.79 3.68 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.803 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.15 -4.79 13.39 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.686 2.257 . . . . 0.0 110.086 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -14.21 22.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.527 ' CD1' ' OD1' ' A' ' 232' ' ' ASN . 29.5 m0 -71.67 175.79 5.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.117 . . . . 0.0 109.624 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 t -118.16 173.86 6.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.526 ' HA ' HD12 ' A' ' 240' ' ' ILE . 40.0 t30 -54.8 -17.14 3.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 -62.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.07 59.3 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.646 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 237' ' ' ASN . 77.7 mt -68.78 -54.26 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.452 -0.78 . . . . 0.0 110.854 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -66.85 -31.18 71.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.949 -1.094 . . . . 0.0 110.95 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 33.2 t-20 -73.04 -40.55 65.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.688 -1.257 . . . . 0.0 110.355 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.428 ' O ' HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -75.45 -32.68 60.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.776 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.3 OUTLIER -77.72 -32.35 52.82 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.244 -0.91 . . . . 0.0 109.969 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.1 tttt -80.97 -28.77 35.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 108.686 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 4.6 t-20 -83.59 -18.27 38.83 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 267' ' ' ALA . 2.6 p -88.49 -30.15 19.6 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.207 1.003 . . . . 0.0 109.226 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.16 126.68 9.56 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.298 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.414 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 17.2 m -74.89 145.32 42.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.451 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.4 OUTLIER -115.47 126.47 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.878 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.0 mp . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 179' ' ' ASN . 15.6 m-30 -44.33 -50.78 8.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.038 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 72.41 -128.68 13.56 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 191' ' ' ASP . 13.6 t -44.53 -45.02 9.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -1.128 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.583 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 121.25 -138.01 12.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 261' ' ' LEU . 13.3 tp -96.62 168.42 10.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -1.046 . . . . 0.0 109.178 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.55 HG13 ' CD1' ' A' ' 192' ' ' ILE . 0.0 OUTLIER -117.62 156.08 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.48 ' HB3' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.99 120.12 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.361 1.076 . . . . 0.0 108.771 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 268' ' ' THR . . . -75.26 0.97 14.76 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -35.31 40.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.58 -10.51 58.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -100.29 -26.71 13.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.696 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 264' ' ' ALA . 19.1 p -79.65 -42.06 25.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.728 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.44 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.487 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 58.4 m . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.618 HG12 HG21 ' A' ' 8' ' ' ILE . 1.2 m -145.22 115.0 4.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.42 171.29 17.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.437 2.092 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -15.96 1.31 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.455 -0.778 . . . . 0.0 110.737 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.89 24.58 6.61 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.645 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.618 HG21 HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -154.81 14.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.797 -1.413 . . . . 0.0 109.931 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -90.79 -37.36 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.709 -1.244 . . . . 0.0 110.351 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.595 ' HB3' HD21 ' A' ' 261' ' ' LEU . 4.4 mtm180 -92.91 23.34 4.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.045 . . . . 0.0 110.256 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.447 HG22 ' C ' ' A' ' 8' ' ' ILE . 11.1 m -111.82 19.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.459 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 63.2 mm-40 39.94 36.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.415 -0.803 . . . . 0.0 109.679 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -73.42 -32.7 1.69 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 112.156 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.5 Cg_endo -74.46 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 N-CA-C 108.797 -1.271 . . . . 0.0 108.797 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.35 -30.49 1.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.67 -44.34 61.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.254 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -71.66 -5.86 36.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.652 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.87 -24.72 13.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.028 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -46.99 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.07 -53.0 0.57 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 21' ' ' LEU . 2.3 mp -49.71 141.39 9.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -1.084 . . . . 0.0 109.346 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -164.17 59.1 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.925 -1.109 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . 46.19 21.04 0.6 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.493 ' N ' ' C ' ' A' ' 22' ' ' THR . 2.6 p -40.28 -24.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.7 -0.882 . . . . 0.0 111.329 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -152.28 54.36 0.46 Allowed Glycine 0 N--CA 1.493 2.458 0 C-N-CA 118.86 -1.638 . . . . 0.0 111.386 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 27' ' ' LYS . 60.7 t -122.75 168.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -1.22 . . . . 0.0 108.781 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.595 ' N ' HG12 ' A' ' 26' ' ' VAL . 5.4 mttm -136.63 117.54 14.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 110.214 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' TYR . 11.8 t -115.44 139.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -100.14 147.65 25.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 110.085 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 70' ' ' ILE . 93.2 t -119.25 83.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.697 HD12 HG21 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -75.59 96.35 3.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.894 -0.504 . . . . 0.0 109.983 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -167.5 -159.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.95 -1.094 . . . . 0.0 109.104 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.827 HG21 ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -44.5 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.047 -1.033 . . . . 0.0 109.124 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -168.62 -124.15 0.71 Allowed Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 34' ' ' GLY . 34.3 mm -161.45 93.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ILE . 16.6 p -40.62 118.9 1.01 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.863 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.07 103.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.406 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -139.36 154.07 71.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.395 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.71 1.26 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.695 2.264 . . . . 0.0 110.496 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' CG ' HG21 ' A' ' 202' ' ' THR . 3.0 p30 -108.55 1.1 21.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.641 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.38 116.6 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.05 138.22 58.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.3 mm -119.84 100.27 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.624 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -118.56 12.0 13.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.54 146.57 10.5 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.28 99.5 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.078 -1.248 . . . . 0.0 110.212 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.08 117.78 23.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -1.054 . . . . 0.0 108.163 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.511 ' HB3' HG22 ' A' ' 56' ' ' THR . 2.6 p -112.67 115.54 28.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 110.832 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.894 ' HZ ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -95.74 -36.7 11.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.906 HG13 ' HD2' ' A' ' 51' ' ' PRO . 9.9 t -45.22 149.49 0.92 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.906 ' HD2' HG13 ' A' ' 50' ' ' VAL . 27.9 Cg_endo . . . . . 0 C--N 1.306 -1.664 0 C-N-CA 121.892 1.728 . . . . 0.0 110.927 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.714 ' C ' HG23 ' A' ' 56' ' ' THR . 72.2 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.182 0.515 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' C ' ' A' ' 55' ' ' SER . 1.4 p 79.44 -8.98 1.53 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ASP . 2.2 mm-40 -100.99 172.87 6.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.814 . . . . 0.0 109.184 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 57' ' ' GLN . 0.9 OUTLIER 49.9 175.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.625 0.726 . . . . 0.0 110.191 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 156.33 -64.71 0.32 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.827 ' HB2' HG21 ' A' ' 33' ' ' THR . 0.1 OUTLIER -145.3 -61.87 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -1.113 . . . . 0.0 109.577 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.8 -35.79 0.67 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -54.99 -62.76 1.45 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -1.132 . . . . 0.0 109.47 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.96 -41.33 13.76 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.9 m -57.65 -44.59 85.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -1.126 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.61 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 0.3 OUTLIER -59.51 -59.48 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.505 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 219' ' ' PRO . 11.1 t -51.59 -30.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.269 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -62.54 -54.02 46.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.378 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -73.53 -17.15 78.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 219' ' ' PRO . 28.6 m -82.58 -14.51 54.71 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.058 -1.26 . . . . 0.0 107.87 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.44 HD12 HG22 ' A' ' 30' ' ' VAL . 46.3 mt -101.75 -27.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.535 -0.728 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -161.36 22.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.785 -1.197 . . . . 0.0 111.842 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 81' ' ' GLY . . . -38.73 100.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.031 -1.043 . . . . 0.0 109.323 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 72' ' ' ALA . 8.8 mt -44.58 172.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.29 -0.882 . . . . 0.0 110.514 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.817 HD22 HD11 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -105.18 103.53 13.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.443 -0.786 . . . . 0.0 109.433 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -142.01 -118.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.171 -0.956 . . . . 0.0 108.905 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.28 -39.29 0.53 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.699 ' O ' HD12 ' A' ' 77' ' ' ILE . 1.3 pp -88.42 65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.07 152.19 6.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 80' ' ' LEU . 17.4 m -68.28 -146.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.289 -1.124 . . . . 0.0 109.527 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.817 HD11 HD22 ' A' ' 74' ' ' ASN . 24.9 tp -139.83 107.11 5.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.874 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 72' ' ' ALA . . . -65.98 -153.23 0.18 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.07 -32.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.239 . . . . 0.0 109.582 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -120.65 100.21 46.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.298 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 22' ' ' THR . 37.0 Cg_endo -81.72 -54.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.805 2.337 . . . . 0.0 110.534 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -82.55 30.93 0.41 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.684 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.618 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -94.56 168.64 10.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.939 -1.101 . . . . 0.0 109.222 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -96.12 92.03 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.146 -0.971 . . . . 0.0 108.87 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 1.5 mt -71.76 139.77 49.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.333 -0.854 . . . . 0.0 109.949 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 3.0 m-85 -120.82 147.95 44.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.93 98.82 6.38 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.347 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.894 HG12 ' HZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -96.39 61.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.132 -0.98 . . . . 0.0 108.76 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' VAL . 2.0 ttmt -34.73 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.468 0.652 . . . . 0.0 110.364 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -110.83 7.33 8.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.051 HD11 HD22 ' A' ' 124' ' ' LEU . 88.1 mt -145.99 173.62 12.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.245 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 33' ' ' THR . . . -159.55 144.17 9.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 59' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.286 -1.126 . . . . 0.0 108.711 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -95.36 -176.27 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.626 0.727 . . . . 0.0 109.534 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.03 -14.92 19.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 13.7 m -80.77 -18.06 48.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.69 -45.28 11.82 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.814 ' HA ' HG22 ' A' ' 93' ' ' VAL . 2.8 mt -70.97 -44.64 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.42 -0.912 . . . . 0.0 108.588 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -37.11 86.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 109.023 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 8.1 tp60 -65.16 -45.23 85.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.625 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -66.9 -31.87 79.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.63 HD21 HD21 ' A' ' 122' ' ' LEU . 10.3 mt -71.68 -28.5 63.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -1.198 . . . . 0.0 108.934 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.7 -22.28 46.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -63.62 -23.03 67.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -92.69 -15.64 26.48 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.935 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -66.86 -31.1 77.24 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.16 -28.49 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -1.102 . . . . 0.0 109.265 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -132.1 35.41 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.675 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -83.53 158.07 35.23 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -106.55 -179.93 4.08 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 -179.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.543 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.6 m170 -50.31 -30.2 11.48 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 120' ' ' ALA . 6.1 t -136.68 160.82 37.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.018 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.661 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -168.04 106.63 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.565 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 9.7 m120 -91.54 156.56 17.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.825 -1.172 . . . . 0.0 111.046 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.63 HD21 HD21 ' A' ' 109' ' ' LEU . 6.6 mp -129.22 103.02 6.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -85.04 64.72 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.278 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.051 HD22 HD11 ' A' ' 94' ' ' LEU . 1.5 pp 177.66 175.48 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.988 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.522 ' O ' ' CD ' ' A' ' 129' ' ' PRO . . . 157.5 -99.6 0.19 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.602 ' CB ' ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER 62.55 -175.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.394 -1.062 . . . . 0.0 110.076 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 126' ' ' SER . 37.0 Cg_endo -83.21 -10.35 10.15 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.749 2.299 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.682 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -57.2 -44.13 99.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 111.96 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 128' ' ' SER . 30.1 Cg_endo -71.22 177.37 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.119 1.88 . . . . 0.0 111.022 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.7 t -118.43 173.9 6.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.45 1.119 . . . . 0.0 111.259 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.21 60.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.0 m -76.41 -26.77 55.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -39.74 61.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 165' ' ' TYR . 1.0 OUTLIER -66.92 -43.48 83.2 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.457 178.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -55.61 -26.75 45.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.94 75.46 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.325 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.68 -24.28 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.4 ' O ' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -68.78 -29.53 67.92 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.38 -22.75 35.3 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.67 -37.13 31.38 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 120.88 -1.137 . . . . 0.0 110.8 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 167' ' ' ASN . 4.5 m -73.32 -24.64 60.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.915 -1.116 . . . . 0.0 108.236 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 138' ' ' ASN . 3.2 m -55.63 -28.95 58.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -87.08 -28.49 22.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.469 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.41 -7.43 24.63 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 117' ' ' MET . 21.6 t -48.75 110.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.181 -1.188 . . . . 0.0 109.811 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.647 HD12 ' OD1' ' A' ' 237' ' ' ASN . 3.5 tp -68.23 96.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 108.794 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.0 t -88.05 154.66 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.064 -1.022 . . . . 0.0 109.916 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -140.87 104.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.645 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -92.96 148.22 22.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.902 . . . . 0.0 110.469 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.01 169.58 9.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB2' ' CG2' ' A' ' 214' ' ' THR . 0.1 OUTLIER -61.32 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.015 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . -168.68 -68.5 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.192 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 19.4 t-20 88.98 6.4 0.14 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.301 0.572 . . . . 0.0 109.822 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 153' ' ' ASN . 27.6 t 175.59 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . -132.76 -101.93 0.81 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.507 ' N ' ' HG2' ' A' ' 185' ' ' GLN . . . 178.61 78.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.348 -1.089 . . . . 0.0 109.605 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' TYR . . . 56.26 13.49 7.21 Favored Glycine 0 C--N 1.288 -2.136 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.38 147.52 33.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -1.222 . . . . 0.0 109.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.65 HG23 ' HA ' ' A' ' 186' ' ' TYR . 4.5 pt -74.56 176.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.989 -1.069 . . . . 0.0 109.85 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.932 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -102.58 165.8 10.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.798 . . . . 0.0 112.082 -177.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.496 ' O ' ' HA3' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -80.29 144.48 58.09 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 174.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 42.8 Cg_endo -72.97 -28.09 7.45 Favored 'Cis proline' 0 C--N 1.289 -2.579 0 O-C-N 122.676 0.829 . . . . 0.0 110.581 3.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.13 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.741 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 162' ' ' PRO . 19.3 ttp180 -67.95 -52.4 36.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.711 -1.243 . . . . 0.0 109.553 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -41.08 -178.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.645 1.212 . . . . 0.0 111.269 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.38 -0.38 9.85 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.502 ' HB3' ' OG1' ' A' ' 141' ' ' THR . 1.9 m-80 -87.12 22.51 2.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.438 -0.789 . . . . 0.0 109.427 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -171.32 145.91 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.422 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 29.8 mtp -81.4 152.95 27.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.008 -1.057 . . . . 0.0 109.938 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.16 132.56 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.9 t -99.24 165.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.032 -1.043 . . . . 0.0 110.136 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.53 173.69 20.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -135.02 152.38 51.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -1.221 . . . . 0.0 109.552 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 p -116.39 163.1 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.22 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 12.8 p-10 -62.38 179.01 0.35 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.036 -1.04 . . . . 0.0 109.248 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.93 -29.66 43.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -94.03 -90.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.422 -0.799 . . . . 0.0 109.647 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 7.0 t30 -150.02 -20.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.196 -0.94 . . . . 0.0 111.091 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.48 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.3 t30 -56.57 -160.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.711 -1.243 . . . . 0.0 109.647 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.579 ' HG2' ' CD1' ' A' ' 256' ' ' LEU . 0.3 OUTLIER -93.73 135.83 34.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.024 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 180' ' ' ARG . . . -43.59 161.75 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -101.37 12.52 37.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 109.564 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.577 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -153.32 29.9 0.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 110.082 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.423 ' OG ' ' CG2' ' A' ' 214' ' ' THR . 9.1 t -121.21 156.77 31.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.257 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.5 137.32 54.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 1.08 ' CD2' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -141.04 176.98 8.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.547 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 137.91 133.27 3.1 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.064 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . 35.65 102.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.12 -0.635 . . . . 0.0 111.613 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 159' ' ' ILE . . . 116.81 -5.25 18.66 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.77 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.08 HD22 ' CD2' ' A' ' 186' ' ' TYR . 8.9 tp -61.72 107.89 0.9 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.878 -1.366 . . . . 0.0 110.237 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 25.0 t70 -75.9 -56.63 4.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 259' ' ' SER . 2.5 tt -149.1 169.75 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.106 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 10.0 m -123.26 164.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -163.44 177.96 1.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 109.025 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.8 Cg_endo -76.49 116.98 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.408 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -134.63 54.95 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 37.4 t -149.01 101.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.524 -0.986 . . . . 0.0 108.586 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.627 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.3 OUTLIER 73.91 107.11 0.07 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.125 0.964 . . . . 0.0 111.276 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.704 HG22 ' CB ' ' A' ' 212' ' ' ASN . 17.4 m -163.41 109.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 16.9 pt20 -84.7 148.16 26.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.608 0.718 . . . . 0.0 110.773 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.61 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -145.31 -151.56 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.422 HG21 ' CG ' ' A' ' 40' ' ' ASP . 74.2 p -90.18 172.11 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.648 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -159.99 164.49 19.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.648 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -70.63 164.02 36.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.948 1.765 . . . . 0.0 110.393 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.84 78.88 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.76 32.42 22.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -1.114 . . . . 0.0 109.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -118.32 150.94 38.65 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.049 -1.032 . . . . 0.0 109.817 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -92.74 172.45 8.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -145.68 118.21 8.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.868 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.5 OUTLIER -91.19 111.56 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 211' ' ' LEU . 0.6 OUTLIER -175.47 147.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 110.361 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.704 ' CB ' HG22 ' A' ' 199' ' ' VAL . 11.3 t-20 -136.11 -162.86 1.32 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.859 0.838 . . . . 0.0 109.161 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 150.73 -174.78 29.97 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -70.54 -42.33 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.703 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.45 ' HA ' ' CB ' ' A' ' 150' ' ' ALA . 1.4 m -66.07 -16.07 63.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 110.403 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.553 ' HB3' ' OD1' ' A' ' 212' ' ' ASN . 1.5 mpp? -91.07 -16.6 27.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.115 . . . . 0.0 109.754 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -87.64 -13.18 43.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 108.688 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.643 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 2.6 m -63.07 -43.84 82.77 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.63 -0.669 . . . . 0.0 111.349 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.804 ' HG2' HG21 ' A' ' 69' ' ' THR . 29.2 Cg_endo -72.75 -26.7 15.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.123 1.882 . . . . 0.0 111.583 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.598 ' NE2' HG23 ' A' ' 69' ' ' THR . 16.7 m170 -67.11 -45.55 76.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.869 -1.144 . . . . 0.0 108.177 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 262' ' ' VAL . 67.2 t -67.63 -45.74 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.512 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -54.18 -33.93 59.27 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -64.74 -52.46 42.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.12 2.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -1.076 . . . . 0.0 109.168 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 244' ' ' LEU . . . -47.47 -26.73 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -64.75 -59.21 4.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 226' ' ' ALA . 4.8 mt -46.48 -36.91 7.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 108.45 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.16 -56.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.609 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.572 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.38 -39.32 6.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -48.5 81.48 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.298 -0.876 . . . . 0.0 109.02 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -67.26 -7.45 24.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.599 ' HB3' ' CG ' ' A' ' 235' ' ' TRP . 81.9 m-20 -160.21 78.88 2.56 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.4 -28.4 3.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.636 2.224 . . . . 0.0 111.099 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.85 0.68 54.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.599 ' CG ' ' HB3' ' A' ' 232' ' ' ASN . 11.9 m0 -71.56 -178.69 2.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 109.674 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.62 167.71 10.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.552 -0.718 . . . . 0.0 110.214 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.647 ' OD1' HD12 ' A' ' 146' ' ' LEU . 17.2 t-20 -51.2 -39.85 57.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 0.0 109.543 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -74.08 -59.34 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.278 -0.888 . . . . 0.0 109.465 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 238' ' ' VAL . 8.1 tp-100 -39.76 -36.56 0.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.305 0.574 . . . . 0.0 110.121 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.87 -46.52 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 110.43 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 15.8 ttp180 -52.81 -40.47 63.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.919 -1.113 . . . . 0.0 110.523 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -63.14 -35.19 79.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -0.941 . . . . 0.0 110.612 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -71.62 -43.21 66.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.389 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 225' ' ' ALA . 0.4 OUTLIER -77.22 -22.48 52.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 110.245 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -82.77 -24.59 33.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 0.0 109.352 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -90.2 -21.87 21.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.918 . . . . 0.0 109.214 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 248' ' ' ALA . 2.3 p -87.66 -29.72 20.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 110.055 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -40.02 116.43 0.65 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.844 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.535 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 1.0 OUTLIER -65.76 163.77 15.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.93 . . . . 0.0 109.214 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.501 ' N ' ' CG2' ' A' ' 249' ' ' THR . 5.9 p -115.78 114.46 24.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.337 -0.852 . . . . 0.0 109.524 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.662 HD11 ' HB2' ' A' ' 261' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.717 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.579 ' CD1' ' HG2' ' A' ' 180' ' ' ARG . 2.7 tm? . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.67 ' O ' HD23 ' A' ' 190' ' ' LEU . 4.7 m-85 -65.58 -47.31 76.2 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 259' ' ' SER . . . 55.89 58.36 14.49 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.48 ' CB ' ' HA ' ' A' ' 192' ' ' ILE . 0.0 OUTLIER 171.18 -84.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -1.191 . . . . 0.0 109.093 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 132.35 -163.3 24.02 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.662 ' HB2' HD11 ' A' ' 251' ' ' LEU . 5.0 tp -98.11 177.93 5.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.707 -0.878 . . . . 0.0 109.257 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 221' ' ' VAL . 0.6 OUTLIER -110.22 155.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 110.208 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.535 ' ND2' ' OG1' ' A' ' 249' ' ' THR . 0.1 OUTLIER -150.72 116.42 5.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.884 1.326 . . . . 0.0 108.657 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -79.78 -25.39 40.96 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.622 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.459 ' O ' ' OE2' ' A' ' 265' ' ' GLU . 7.6 tp10 -71.78 -41.89 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.589 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.55 0.76 18.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -113.69 -3.61 13.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.52 -35.85 4.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.693 ' HB2' ' N ' ' A' ' 80' ' ' LEU . 1.9 p . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.152 0.501 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 3' ' ' SER . 0.1 OUTLIER -165.64 73.46 1.33 Allowed Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.432 -0.792 . . . . 0.0 109.169 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HD2' ' CG1' ' A' ' 8' ' ' ILE . 34.7 Cg_endo -77.46 165.31 27.54 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.51 2.14 . . . . 0.0 110.29 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -39.08 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.665 -0.647 . . . . 0.0 110.176 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PRO . . . -68.35 -62.64 4.02 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.57 ' O ' ' CB ' ' A' ' 9' ' ' SER . 47.0 mm -62.62 159.97 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -1.1 . . . . 0.0 109.515 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.634 ' OG ' HG12 ' A' ' 4' ' ' VAL . 4.4 m 89.38 -34.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.888 -0.508 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -27.89 61.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.297 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.69 22.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 0.0 109.662 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.497 ' HG2' ' CB ' ' A' ' 265' ' ' GLU . 6.8 tp-100 52.89 49.41 20.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.697 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.51 -30.24 0.44 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 112.053 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.32 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.88 -31.19 0.81 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HB1' HD13 ' A' ' 227' ' ' LEU . . . -66.1 -55.81 14.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.263 -0.898 . . . . 0.0 108.579 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.409 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 9.8 m-70 -66.35 -8.25 24.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.0 109.563 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -83.81 -35.95 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 5.91 8.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.85 43.73 5.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 2.2 mm? -99.71 133.67 43.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -1.094 . . . . 0.0 109.101 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.503 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -120.35 -37.96 2.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.494 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 81.31 -22.01 5.62 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -49.47 110.82 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.267 . . . . 0.0 109.078 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.73 -11.06 1.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG12 ' N ' ' A' ' 27' ' ' LYS . 48.2 t -110.57 170.04 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -1.235 . . . . 0.0 109.314 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 3.1 mttt -139.97 131.24 26.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.908 . . . . 0.0 109.364 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 119' ' ' VAL . 48.7 t -124.34 145.29 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.018 . . . . 0.0 110.448 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -101.97 146.77 27.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.905 HG11 HD11 ' A' ' 35' ' ' ILE . 25.6 t -120.63 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 109.27 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.752 HD12 ' CG2' ' A' ' 91' ' ' VAL . 4.8 mp -65.83 93.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -147.03 -156.43 0.71 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 20.7 p -67.53 -24.75 65.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.355 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 161.05 -105.32 0.26 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.905 HD11 HG11 ' A' ' 30' ' ' VAL . 10.3 mt 135.65 101.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.0 OUTLIER -71.88 139.22 48.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -55.18 165.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.626 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -177.24 160.51 1.45 Allowed Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.161 -0.962 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.4 Cg_endo -78.49 -23.5 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 110.181 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 73' ' ' LEU . 1.4 t0 -102.48 -2.98 27.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 73' ' ' LEU . 14.1 mt -102.46 160.88 14.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.266 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.51 119.35 37.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 43' ' ' ILE . 6.7 mm -123.48 96.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.679 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -90.57 -28.73 18.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 108.951 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.94 -176.1 38.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.64 128.46 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -131.51 165.1 24.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.444 -1.033 . . . . 0.0 108.551 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.501 ' OG ' ' CG ' ' A' ' 51' ' ' PRO . 46.2 t -149.1 142.59 25.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.084 . . . . 0.0 110.486 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.631 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 23.5 m-85 -123.92 -35.63 2.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.944 HG23 ' CB ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -41.96 -53.8 7.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 50' ' ' VAL . 39.1 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 122.981 2.454 . . . . 0.0 111.633 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -111.69 2.07 17.04 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' ASP . 5.5 mm-40 -103.72 156.21 17.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 8.8 t70 55.13 166.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 109.611 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . -171.78 -54.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 2.1 t30 -165.78 -83.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -1.077 . . . . 0.0 108.985 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . -175.74 -34.17 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.439 ' C ' ' CD2' ' A' ' 62' ' ' HIS . 3.0 t-160 -58.84 -64.73 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.406 -1.055 . . . . 0.0 109.531 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 32' ' ' ASP . . . -47.67 -67.38 1.56 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.447 ' HA ' HG12 ' A' ' 35' ' ' ILE . 2.0 m -40.11 -52.37 2.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 2.6 t-80 -52.81 -50.78 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.858 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.743 HG12 HD11 ' A' ' 70' ' ' ILE . 24.3 t -57.49 -32.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 109.231 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -59.52 -51.05 71.52 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.296 -0.877 . . . . 0.0 109.696 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -72.85 -17.88 78.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.539 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 6.4 m -80.65 -17.28 51.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.168 -1.195 . . . . 0.0 108.246 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.743 HD11 HG12 ' A' ' 66' ' ' VAL . 23.1 mt -92.62 -31.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.615 -0.678 . . . . 0.0 109.944 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -174.55 33.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.38 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -37.27 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 109.665 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 41' ' ' LEU . 12.8 mt -39.85 159.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.987 ' HB2' HD12 ' A' ' 80' ' ' LEU . 7.6 t-20 -114.72 166.29 11.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 74' ' ' ASN . 0.4 OUTLIER 172.18 -93.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.407 -0.808 . . . . 0.0 109.28 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 -38.17 0.77 Allowed 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.762 -0.586 . . . . 0.0 109.48 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.518 HD11 ' HG2' ' A' ' 39' ' ' PRO . 4.4 pt -111.2 168.95 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.01 155.31 1.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 20.0 m -75.4 -154.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.276 -1.132 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.987 HD12 ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -145.9 122.35 11.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.482 -0.761 . . . . 0.0 109.423 -178.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.75 -163.79 4.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 4.7 t -82.57 -36.84 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.325 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.0 147.17 32.6 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.3 Cg_endo -83.61 -61.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.873 2.382 . . . . 0.0 110.407 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 86' ' ' ALA . 6.6 m120 -99.53 -87.87 0.35 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.01 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 57.26 157.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.866 . . . . 0.0 109.701 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' HG3' ' CE ' ' A' ' 27' ' ' LYS . 20.5 mm-40 -108.97 94.74 5.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 108.774 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 70' ' ' ILE . 2.5 mt -79.98 150.75 30.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.07 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.519 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 3.9 m-85 -127.29 154.48 44.86 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -0.794 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -123.73 104.09 8.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.752 ' CG2' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -108.03 78.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -178.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 33' ' ' THR . 10.8 tttt -44.75 96.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.9 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.594 HG11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -114.02 -9.8 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 109.084 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.3 mt -115.62 174.11 6.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.348 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -111.19 147.83 17.84 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -1.117 . . . . 0.0 109.666 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 155.99 28.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.801 -0.823 . . . . 0.0 109.8 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.21 -15.25 19.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.557 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -72.27 -27.77 62.7 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.944 ' CB ' HG23 ' A' ' 50' ' ' VAL . 65.8 p -80.03 -53.47 6.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 109.34 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.585 ' HA ' HG21 ' A' ' 93' ' ' VAL . 2.2 mt -61.55 -33.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.445 ' O ' ' CD ' ' A' ' 110' ' ' GLU . . . -65.17 -46.44 80.85 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.528 -0.732 . . . . 0.0 110.0 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.631 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -68.31 -40.86 81.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.558 -1.339 . . . . 0.0 108.873 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . -61.77 -21.05 60.36 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 109' ' ' LEU . 19.7 mt -92.98 -51.01 5.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.903 -1.351 . . . . 0.0 110.579 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.445 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -76.56 -6.97 54.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.862 -1.149 . . . . 0.0 109.646 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.652 ' CZ3' ' HA2' ' A' ' 116' ' ' GLY . 70.9 t90 -89.47 -9.76 48.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.55 -11.93 44.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.515 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -86.95 -22.93 43.52 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 -76.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -110.01 10.34 24.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 110.925 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -104.46 52.13 0.76 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.011 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.626 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 37.91 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.189 0.995 . . . . 0.0 112.905 178.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.763 ' O ' HG13 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -94.72 -29.14 14.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.369 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.746 HG22 ' NE2' ' A' ' 118' ' ' HIS . 1.9 t -97.43 153.82 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.323 -1.486 . . . . 0.0 109.004 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -169.23 113.71 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.963 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 1.05 ' C ' HD13 ' A' ' 122' ' ' LEU . 2.3 m120 -112.36 152.98 27.96 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.05 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -136.56 121.66 19.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.277 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.407 ' CB ' ' NE2' ' A' ' 62' ' ' HIS . 18.2 m -85.59 66.35 9.61 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.9 178.8 9.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 160' ' ' SER . . . 156.23 113.33 0.42 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.77 158.48 34.73 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.469 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 31.6 Cg_endo -74.71 -3.64 14.2 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.165 1.91 . . . . 0.0 108.646 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.7 t -117.66 76.33 10.27 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -77.18 163.67 30.17 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.335 2.023 . . . . 0.0 110.909 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.29 146.27 46.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.449 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.89 -14.79 63.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.2 m -79.65 -23.59 42.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.23 -40.39 30.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -75.61 -41.46 54.3 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.495 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -61.55 -23.6 66.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.07 -42.77 65.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 2.1 t -68.81 -26.25 32.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.06 -33.11 75.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.5 -22.48 35.06 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -79.39 -19.21 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.08 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -35.62 40.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.03 -1.044 . . . . 0.0 108.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.4 p -54.85 -30.63 58.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.11 -17.83 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.8 78.86 0.65 Allowed Glycine 0 N--CA 1.475 1.273 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 118' ' ' HIS . 48.6 t -119.17 111.95 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -1.082 . . . . 0.0 109.387 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.63 102.74 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.926 -1.109 . . . . 0.0 109.268 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -98.73 143.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.536 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 0.9 OUTLIER -135.58 116.15 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.757 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -104.77 148.4 26.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 109.614 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.58 162.46 25.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.226 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -69.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.0 109.877 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 160.72 -17.2 0.2 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.309 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 214' ' ' THR . 59.1 t-20 41.12 35.72 0.4 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.638 -0.919 . . . . 0.0 109.918 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -90.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 156.22 70.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.67 170.4 14.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -1.109 . . . . 0.0 109.296 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.91 52.82 4.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.0 OUTLIER 162.77 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -1.123 . . . . 0.0 109.121 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.432 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.6 OUTLIER -89.07 -177.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.159 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.882 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -102.46 166.67 10.41 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.773 0.797 . . . . 0.0 111.595 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.566 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 2.4 m-85 -85.39 144.86 41.23 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 45.2 Cg_endo -75.21 -31.02 5.59 Favored 'Cis proline' 0 C--N 1.293 -2.346 0 O-C-N 122.429 0.699 . . . . 0.0 111.016 3.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -17.78 -47.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -52.57 -54.8 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.078 -1.014 . . . . 0.0 110.583 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -42.36 -178.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.558 1.171 . . . . 0.0 111.229 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.75 0.81 8.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.043 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.11 21.56 4.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 108.865 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.14 20.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.419 ' HA ' ' CG ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -112.23 132.49 54.9 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -106.87 123.07 47.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 172' ' ' GLY . 25.4 t -90.34 166.13 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -137.94 166.81 25.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -117.15 140.84 49.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -1.144 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.408 HG23 ' HB ' ' A' ' 193' ' ' VAL . 11.7 p -109.23 174.65 5.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.91 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.25 -147.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.652 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -69.62 -53.45 18.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -86.23 -82.75 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.923 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.535 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 33.4 p-10 -166.23 43.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -105.93 166.44 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' NH2' HG11 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -72.74 106.38 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.824 ' HB3' ' HB3' ' A' ' 184' ' ' SER . . . -43.55 130.9 5.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 109.43 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.6 m -60.75 -30.36 69.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.038 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.553 ' CD2' ' OD1' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -92.54 -14.43 28.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.824 ' HB3' ' HB3' ' A' ' 181' ' ' ALA . 11.5 t -76.99 154.89 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.23 140.41 37.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CE2' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -123.9 171.19 9.88 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.418 -0.801 . . . . 0.0 109.339 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.587 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.51 142.31 4.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.37 118.47 6.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -1.122 . . . . 0.0 109.185 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 122.9 -6.53 9.53 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 257' ' ' TYR . 49.3 tp -45.81 154.63 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.181 -1.188 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.5 OUTLIER -99.51 -55.53 2.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.454 ' CD1' HG13 ' A' ' 262' ' ' VAL . 3.5 tt -151.87 172.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 0.0 109.872 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.477 HG11 ' NH2' ' A' ' 180' ' ' ARG . 8.3 m -136.83 166.83 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.292 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.736 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -168.99 167.71 5.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.169 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.736 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.99 117.24 4.12 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.481 2.121 . . . . 0.0 110.284 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -142.6 22.08 2.36 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 31.6 t -89.01 58.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -1.149 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.775 ' O ' HG13 ' A' ' 199' ' ' VAL . 17.8 t-20 131.69 122.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 198' ' ' ASN . 4.8 m -167.01 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.075 0.94 . . . . 0.0 109.075 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 29.3 mt-30 -87.41 141.52 28.57 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.597 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.588 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -148.7 -147.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -96.4 166.4 11.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.017 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.652 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.11 159.13 40.62 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.652 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.6 Cg_endo -71.71 167.4 26.63 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.41 2.073 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 77.76 4.04 84.71 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 78.04 33.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -1.0 . . . . 0.0 109.404 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -127.89 157.59 40.1 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.106 -0.996 . . . . 0.0 109.708 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -94.98 179.55 5.18 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.601 ' HB2' ' CG ' ' A' ' 203' ' ' TYR . . . -156.54 178.55 10.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.844 -1.16 . . . . 0.0 110.914 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.731 ' O ' HD23 ' A' ' 211' ' ' LEU . 55.0 p -159.72 110.54 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 210' ' ' SER . 1.7 mt -126.7 162.69 25.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 212' ' ' ASN . 2.1 p-10 -129.46 125.1 35.66 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.544 ' HA2' ' CE2' ' A' ' 183' ' ' PHE . . . 175.32 159.46 21.42 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.645 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -61.6 -30.2 70.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.916 . . . . 0.0 109.291 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 13.7 m -61.13 -27.3 68.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.485 ' HG2' ' CG2' ' A' ' 199' ' ' VAL . 0.7 OUTLIER -74.54 -24.32 58.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.335 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.476 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -85.38 -24.71 27.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.783 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.598 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 96.5 m -53.35 -44.33 97.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 111.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.0 Cg_endo -73.95 -24.56 15.08 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.727 1.618 . . . . 0.0 110.847 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -62.35 -41.23 98.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 192' ' ' ILE . 42.2 t -71.27 -48.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -49.24 -28.59 4.78 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.4 -58.5 4.22 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.28 -61.24 2.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -1.162 . . . . 0.0 109.289 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 229' ' ' LYS . . . -47.03 -41.75 17.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . . . -55.6 -44.23 76.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.589 HD13 ' HB1' ' A' ' 16' ' ' ALA . 22.4 mt -57.9 -47.22 83.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.227 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 46.9 t -55.94 -52.85 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.158 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 233' ' ' PRO . 0.0 OUTLIER -49.21 -38.95 27.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.465 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -60.1 -54.1 49.96 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.011 -1.056 . . . . 0.0 108.714 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -51.36 -20.97 1.95 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 108.551 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 176.82 89.29 0.11 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.729 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.554 ' N ' ' O ' ' A' ' 229' ' ' LYS . 36.4 Cg_endo -79.98 -24.88 5.49 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.792 2.328 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -53.2 -21.54 5.32 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -56.99 176.56 0.1 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.993 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.6 OUTLIER -105.24 171.72 7.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 110.023 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 237' ' ' ASN . 7.0 m-80 -55.72 -45.95 77.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.488 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.3 t -74.33 -51.53 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -40.72 -41.16 1.47 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 109.345 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 236' ' ' SER . 2.9 mt -74.46 -45.08 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 242' ' ' ASN . 1.6 ttm-85 -47.96 -71.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 241' ' ' ARG . 1.2 m-80 -35.15 -36.63 0.06 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.812 -0.555 . . . . 0.0 110.701 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.736 ' O ' HG23 ' A' ' 247' ' ' THR . 1.4 t60 -69.0 -52.63 26.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.522 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.488 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.0 OUTLIER -66.91 -17.19 64.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.938 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -45.32 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.3 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 246' ' ' ASN . 1.2 m-20 -91.15 -5.26 55.28 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.15 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 243' ' ' HIS . 70.5 p -103.33 -52.55 2.99 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.912 -1.117 . . . . 0.0 110.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -43.41 151.48 0.17 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.791 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 250' ' ' SER . 31.5 m -70.68 157.64 37.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.404 ' N ' HG22 ' A' ' 249' ' ' THR . 54.7 p -129.7 111.47 12.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 178' ' ' ASN . 4.0 mp . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 109.373 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 256' ' ' LEU . 2.7 tm? . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.8 ' O ' HD23 ' A' ' 190' ' ' LEU . 8.2 m-30 -64.08 -74.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.106 -0.996 . . . . 0.0 108.333 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 156.61 -177.26 33.66 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.6 t -46.74 -24.8 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 108.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.28 -137.49 12.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 261' ' ' LEU . 12.9 tp -102.47 169.1 8.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.989 . . . . 0.0 108.494 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.454 HG13 ' CD1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -111.27 157.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.878 -1.139 . . . . 0.0 110.311 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -164.94 118.08 1.25 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.458 1.123 . . . . 0.0 107.977 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.51 64.17 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.093 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.497 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 79.3 tt0 -68.96 -16.58 63.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.0 109.8 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -98.75 0.18 43.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -0.977 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -132.49 1.32 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.156 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -101.67 -41.79 6.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.025 -1.047 . . . . 0.0 109.89 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.494 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.909 ' O ' HG13 ' A' ' 4' ' ' VAL . 51.9 m . . . . . 0 C--O 1.213 -0.856 0 CA-C-O 121.086 0.47 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 178.3 66.2 0.1 Allowed Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 34.4 Cg_endo -76.67 173.98 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.457 2.105 . . . . 0.0 110.381 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -55.22 -11.94 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.588 -0.695 . . . . 0.0 110.899 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.66 -62.42 1.25 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.72 -1.238 . . . . 0.0 110.732 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -71.58 -0.78 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.114 -1.227 . . . . 0.0 110.247 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -104.61 -15.86 15.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.855 -1.153 . . . . 0.0 109.726 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.46 0.32 50.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.903 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 11' ' ' VAL . 3.3 m -114.5 26.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 O-C-N 120.764 -1.21 . . . . 0.0 110.258 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.474 ' HG3' ' HB2' ' A' ' 265' ' ' GLU . 21.2 mm100 46.59 55.88 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -89.07 -30.05 0.36 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.49 -0.756 . . . . 0.0 112.364 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.2 Cg_endo -74.15 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 109.026 -1.182 . . . . 0.0 109.026 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 -29.08 1.66 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.2 -39.52 40.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 109.161 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 27.4 m170 -65.76 -24.9 67.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -99.62 -16.68 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.787 -1.196 . . . . 0.0 110.631 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -66.55 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.017 -1.052 . . . . 0.0 109.742 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 1.056 ' C ' HD13 ' A' ' 21' ' ' LEU . . . 173.48 17.06 0.02 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.591 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.056 HD13 ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -134.85 153.99 51.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.505 -1.585 . . . . 0.0 108.659 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -138.92 42.23 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' HA2' ' NE2' ' A' ' 230' ' ' GLN . . . 50.52 14.79 1.05 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' ' C ' ' A' ' 22' ' ' THR . 0.6 OUTLIER -87.26 103.67 15.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -1.13 . . . . 0.0 109.884 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.74 -4.03 2.39 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.437 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG22 ' HD2' ' A' ' 229' ' ' LYS . 29.2 t -123.57 166.83 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 120.693 -1.475 . . . . 0.0 109.918 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -136.15 126.11 25.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.55 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 29' ' ' ALA . 57.8 t -113.41 161.79 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.513 -0.742 . . . . 0.0 109.708 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HB3' ' CB ' ' A' ' 120' ' ' ALA . . . -118.67 151.69 37.49 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.548 ' CG2' HD22 ' A' ' 88' ' ' LEU . 3.2 t -127.01 84.8 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.134 -0.979 . . . . 0.0 108.536 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.782 HD12 ' CG2' ' A' ' 91' ' ' VAL . 7.4 mp -73.13 93.46 1.82 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.4 p-10 -157.33 -161.78 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.973 -1.079 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.797 HG22 ' HA ' ' A' ' 96' ' ' ALA . 40.9 p -41.57 -51.55 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.84 . . . . 0.0 109.978 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.76 -47.12 0.48 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.642 HG23 ' HA ' ' A' ' 64' ' ' THR . 3.9 mt 73.95 105.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -65.47 158.13 27.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.815 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 101.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -104.96 148.56 36.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 32.9 Cg_endo -75.63 -17.13 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 110.583 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 41' ' ' LEU . 10.1 t70 -96.68 27.32 3.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.973 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.961 HD21 HG21 ' A' ' 202' ' ' THR . 13.9 mt -143.72 134.48 25.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.52 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 26.4 t-20 -86.03 66.2 9.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.131 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 44' ' ' ARG . 3.4 mt -73.31 163.25 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.457 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -150.22 9.22 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.72 173.04 38.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.88 116.33 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . . . -116.06 163.92 15.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -1.086 . . . . 0.0 109.365 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.39 113.66 19.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 47' ' ' ALA . 7.5 m-85 -110.67 -21.81 11.92 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.692 HG21 ' O ' ' A' ' 94' ' ' LEU . 1.4 t -63.72 126.09 89.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 110.005 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 C--N 1.312 -1.383 0 C-N-CA 122.358 2.038 . . . . 0.0 109.712 178.321 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.439 ' O ' ' HD2' ' A' ' 92' ' ' LYS . 1.4 m . . . . . 0 N--CA 1.506 2.328 0 CA-C-O 121.741 0.781 . . . . 0.0 111.709 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.409 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 7.7 t -103.89 -11.29 17.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.381 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 3.0 pm0 -81.57 110.54 17.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.664 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 33.3 t70 63.18 153.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.456 ' HA3' ' HB ' ' A' ' 33' ' ' THR . . . -154.77 -63.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.43 ' OD1' ' HB1' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -131.74 -53.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.131 . . . . 0.0 109.305 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.19 -33.6 1.23 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.228 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -61.23 -48.09 83.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.24 . . . . 0.0 109.874 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.04 -43.58 96.86 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.642 ' HA ' HG23 ' A' ' 35' ' ' ILE . 59.9 m -61.0 -37.87 84.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -1.144 . . . . 0.0 109.614 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.749 ' CD2' HD11 ' A' ' 211' ' ' LEU . 7.9 t-80 -63.68 -53.75 46.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 109.747 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' A' ' 219' ' ' PRO . 3.7 t -60.89 -28.45 43.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.42 -0.8 . . . . 0.0 109.29 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 70' ' ' ILE . . . -63.23 -46.77 85.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.739 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -66.11 -42.84 94.25 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -58.12 -24.98 60.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.189 -1.183 . . . . 0.0 109.059 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 67' ' ' ALA . 32.9 mt -82.85 -30.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.895 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -137.6 -51.47 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.991 -1.068 . . . . 0.0 111.11 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.1 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 40.21 79.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 42' ' ' ASN . 13.6 mt -34.71 155.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.362 -0.836 . . . . 0.0 111.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.464 ' OD1' HD22 ' A' ' 80' ' ' LEU . 1.3 t30 -99.84 120.98 40.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.556 -0.715 . . . . 0.0 109.918 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -167.47 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.047 -1.033 . . . . 0.0 109.044 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 -7.39 0.26 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.212 -0.93 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.5 pt -106.8 67.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.66 -1.275 . . . . 0.0 109.513 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.03 177.01 14.66 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.496 ' C ' ' OG ' ' A' ' 3' ' ' SER . 25.7 m -81.32 -166.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.304 -1.115 . . . . 0.0 109.84 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.85 ' N ' ' HB3' ' A' ' 3' ' ' SER . 15.8 tp -133.73 140.7 47.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 0.0 109.51 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 1.1 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -91.76 -169.02 41.2 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 227' ' ' LEU . 1.6 t -88.25 -36.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.93 -1.335 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -126.24 102.93 26.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.12 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 37.9 Cg_endo -84.75 -62.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.652 2.235 . . . . 0.0 109.858 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.62 -27.17 10.53 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.088 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -47.0 139.04 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 109.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.2 mp0 -74.79 97.35 3.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.263 -0.898 . . . . 0.0 109.225 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.548 HD22 ' CG2' ' A' ' 30' ' ' VAL . 2.7 mt -80.97 120.18 24.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.051 -1.031 . . . . 0.0 109.443 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 11.9 m-85 -104.77 153.37 21.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.341 -0.85 . . . . 0.0 109.432 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.456 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -115.21 101.9 9.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.782 ' CG2' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -96.98 67.11 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -37.58 95.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.901 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 105' ' ' ILE . 3.3 t -113.7 -23.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.406 -0.809 . . . . 0.0 108.969 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.692 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -92.98 173.34 7.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.314 -0.866 . . . . 0.0 108.719 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -98.03 -17.69 29.17 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.797 ' HA ' HG22 ' A' ' 33' ' ' THR . . . . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.13 152.51 42.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.892 -0.769 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 133' ' ' LEU . 41.0 t -68.27 -19.43 24.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -75.03 -18.51 60.33 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -91.3 -37.19 13.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.505 -0.747 . . . . 0.0 109.426 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.588 HG23 HG11 ' A' ' 93' ' ' VAL . 1.1 mt -77.04 -26.94 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 -44.33 18.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 104' ' ' SER . 10.1 pt20 -70.75 -31.11 67.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 0.0 109.009 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.93 -39.35 46.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -62.25 -39.66 93.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -1.128 . . . . 0.0 109.462 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 110' ' ' GLU . 1.6 tp10 -78.42 -19.64 52.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.132 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.674 ' CE3' ' HA3' ' A' ' 116' ' ' GLY . 84.8 t90 -65.95 -25.09 66.96 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.914 -1.116 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -88.45 -5.35 58.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.958 -1.089 . . . . 0.0 109.175 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -94.7 -6.59 60.69 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 19.7 t-20 -134.93 -4.71 2.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER 171.11 30.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.803 -1.186 . . . . 0.0 110.697 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.747 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -138.88 57.99 0.62 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.298 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.785 ' HE3' ' H ' ' A' ' 117' ' ' MET . 0.0 OUTLIER 63.22 175.57 0.16 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.447 -1.031 . . . . 0.0 112.26 176.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.685 ' CD2' ' N ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -104.0 -35.38 8.13 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.4 t -98.34 156.18 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.662 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.719 ' CB ' ' HB3' ' A' ' 29' ' ' ALA . . . -172.37 131.01 0.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 108.966 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 1.039 ' C ' HD13 ' A' ' 122' ' ' LEU . 3.0 m120 -117.58 148.25 42.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.039 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -125.22 114.48 19.03 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.132 -0.98 . . . . 0.0 108.951 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.446 ' C ' HD23 ' A' ' 124' ' ' LEU . 2.8 t -86.5 61.61 6.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.9 -173.71 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.872 0.844 . . . . 0.0 110.077 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 170.4 100.52 0.14 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -97.68 149.45 35.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.144 -1.209 . . . . 0.0 109.83 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.2 -5.39 15.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.351 2.034 . . . . 0.0 108.374 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.3 t -110.14 112.09 57.7 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.87 165.23 31.86 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.944 1.763 . . . . 0.0 109.881 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 120.54 6.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 110.5 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.34 65.49 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 52.9 m -63.38 -29.19 70.53 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -75.52 -35.31 60.77 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -75.14 -25.14 58.17 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.137 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.63 -24.23 59.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.48 -40.88 25.36 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.072 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.546 HG11 ' CB ' ' A' ' 167' ' ' ASN . 1.7 t -68.3 -30.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.72 -35.9 82.08 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.465 ' OG ' ' OE2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -78.17 -21.23 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' A' ' 145' ' ' VAL . . . -76.56 -29.7 56.77 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -73.96 -24.21 59.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 108.541 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -57.74 -38.82 76.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 0.0 108.878 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.34 -14.42 16.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 108.878 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.63 81.52 0.99 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 118' ' ' HIS . 94.1 t -119.23 109.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.6 tp -74.59 116.8 15.69 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.612 HG12 HD21 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -109.08 144.54 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -129.45 111.42 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.041 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.827 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -94.33 148.59 22.06 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.514 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -62.96 162.29 11.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.738 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 44.9 t -49.57 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 110.721 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.677 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 133.15 133.67 3.41 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -102.37 63.5 0.88 Allowed 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.617 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -117.69 75.2 0.98 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.435 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 154' ' ' SER . . . -3.33 -62.2 0.0 OUTLIER Glycine 0 N--CA 1.507 3.409 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 154' ' ' SER . . . -46.77 173.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -1.102 . . . . 0.0 109.561 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.14 58.62 4.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 m -143.17 134.76 26.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.154 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.614 HD12 ' HB1' ' A' ' 163' ' ' ALA . 6.8 pt -87.19 177.68 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.972 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.5 OUTLIER -87.05 160.89 18.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.362 -0.836 . . . . 0.0 111.818 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.462 ' CZ ' ' HD2' ' A' ' 164' ' ' ARG . 5.1 m-85 -83.5 141.99 42.67 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.827 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 45.0 Cg_endo -74.73 -30.75 5.77 Favored 'Cis proline' 0 C--N 1.3 -2.023 0 O-C-N 122.421 0.695 . . . . 0.0 111.489 3.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.972 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -15.72 -50.21 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-O 121.124 0.488 . . . . 0.0 111.87 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 162' ' ' PRO . 10.9 ttm180 -50.39 -59.76 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.172 -0.955 . . . . 0.0 110.36 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -46.34 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.462 1.125 . . . . 0.0 111.046 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.93 -2.55 9.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.546 ' CB ' HG11 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -81.65 7.9 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 109.398 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . . . -153.77 139.99 18.49 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.544 ' SD ' HG23 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -85.28 146.66 26.94 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.013 -1.054 . . . . 0.0 109.626 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -109.73 123.76 50.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.3 t -84.3 166.08 2.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.965 -1.085 . . . . 0.0 109.764 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.577 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -129.85 -176.67 14.52 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.491 ' CB ' HG23 ' A' ' 214' ' ' THR . . . -134.35 150.03 50.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -1.2 . . . . 0.0 109.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 179' ' ' ASN . 71.0 p -134.21 153.35 51.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -172.05 1.86 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -23.56 64.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.054 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.79 -87.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.582 ' ND2' HD21 ' A' ' 251' ' ' LEU . 0.3 OUTLIER 177.13 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.99 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.686 ' O ' HG22 ' A' ' 174' ' ' THR . 7.7 t-20 -136.35 -161.21 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.662 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 mtp85 -87.87 12.51 12.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 72.2 4.42 5.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.56 -6.61 0.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 112.195 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.488 ' CE2' ' HB1' ' A' ' 181' ' ' ALA . 39.3 p90 -134.89 -5.58 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.318 -1.489 . . . . 0.0 110.286 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.3 t -78.08 132.17 37.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 108.403 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.677 ' HB2' ' O ' ' A' ' 152' ' ' GLY . 0.8 OUTLIER -88.79 149.29 23.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.097 . . . . 0.0 110.83 -178.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.655 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -121.68 176.44 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 108.918 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.655 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.53 178.62 47.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.46 145.45 50.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.248 . . . . 0.0 109.577 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.61 7.8 88.19 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.36 141.03 58.7 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.127 -1.22 . . . . 0.0 108.719 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.543 ' OD1' ' CE ' ' A' ' 245' ' ' LYS . 35.9 t0 -84.4 -79.75 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 110.935 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.484 ' CG2' ' C ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -154.13 -161.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.072 . . . . 0.0 110.151 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 260' ' ' GLY . 26.9 m -124.94 168.91 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.908 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 1.026 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -159.92 177.2 2.16 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.946 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.7 Cg_endo -76.47 115.99 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.173 1.915 . . . . 0.0 110.571 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.31 53.44 0.65 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 39.0 t -138.12 87.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 199' ' ' VAL . 7.6 t30 81.53 119.88 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 198' ' ' ASN . 4.3 m -162.35 114.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.078 0.942 . . . . 0.0 108.974 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -76.31 122.84 25.01 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.751 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -131.72 -169.54 2.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.524 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.961 HG21 HD21 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.89 173.4 12.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.307 -0.871 . . . . 0.0 110.307 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.654 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -151.36 166.95 14.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.654 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.3 Cg_endo -73.45 166.11 30.71 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.127 1.885 . . . . 0.0 110.704 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.43 -60.7 4.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 4.7 p 150.81 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 122.025 -0.691 . . . . 0.0 109.826 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -142.8 -179.37 6.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.542 ' N ' ' OG1' ' A' ' 207' ' ' THR . 0.0 OUTLIER -130.89 165.71 22.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.532 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.95 149.15 15.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 1.029 ' O ' HD23 ' A' ' 211' ' ' LEU . 1.1 t -93.09 140.18 29.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 1.029 HD23 ' O ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -145.94 151.19 37.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 213' ' ' GLY . 1.3 t-20 -104.95 168.45 9.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 212' ' ' ASN . . . 147.51 168.52 14.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.491 HG23 ' CB ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -85.43 -38.07 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -1.059 . . . . 0.0 109.049 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.545 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 1.4 t -60.04 -15.25 21.26 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.464 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 25.3 mmt -64.99 -35.34 80.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.393 -0.817 . . . . 0.0 109.599 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 1.026 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -84.44 -6.77 59.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.769 . . . . 0.0 110.783 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.627 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.5 m -69.06 -45.1 29.87 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 111.734 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.7 Cg_endo -73.37 -16.11 24.8 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.979 1.786 . . . . 0.0 111.118 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.443 ' NE2' HD12 ' A' ' 8' ' ' ILE . 6.4 m80 -74.57 -41.27 60.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 108.424 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 262' ' ' VAL . 60.2 t -71.18 -41.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.71 -37.96 69.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.097 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.23 -49.59 45.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.48 -60.49 3.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -1.192 . . . . 0.0 109.603 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -44.56 -47.53 10.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.779 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.59 57.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.963 -1.086 . . . . 0.0 109.184 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 82' ' ' VAL . 39.2 mt -52.13 -40.56 61.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.469 HG21 ' HG ' ' A' ' 244' ' ' LEU . 68.7 t -58.79 -49.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 108.759 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.57 ' HD2' HG22 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -45.68 -45.69 14.3 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -60.78 -48.67 80.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.426 -0.796 . . . . 0.0 110.132 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.417 ' C ' ' CG ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -59.14 -14.38 10.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.278 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.417 ' CG ' ' C ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -174.68 95.63 0.29 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.951 . . . . 0.0 110.004 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.7 -20.27 9.33 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.591 2.194 . . . . 0.0 110.379 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.99 -42.82 95.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 0.0 110.188 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -52.39 173.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.534 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.1 OUTLIER -135.8 158.63 43.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.995 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 236' ' ' SER . 1.5 m120 -15.78 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 236' ' ' SER . 2.9 t -73.79 -65.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.013 -1.054 . . . . 0.0 110.329 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -40.51 -27.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.27 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 238' ' ' VAL . 63.7 mt -82.02 -49.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -56.27 -22.5 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.127 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 243' ' ' HIS . 2.4 t-20 -71.07 -69.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.768 -1.208 . . . . 0.0 110.339 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.413 ' N ' ' OD1' ' A' ' 242' ' ' ASN . 9.9 t60 -55.84 -39.72 71.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.81 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.1 OUTLIER -64.46 -43.06 95.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 111.001 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -77.48 -21.99 51.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.976 -1.078 . . . . 0.0 109.647 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.58 -19.94 28.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.071 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 267' ' ' ALA . 0.9 OUTLIER -87.91 -27.22 22.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.303 1.049 . . . . 0.0 109.107 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -46.68 131.63 11.37 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.726 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 92.9 m -52.96 133.95 37.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.018 . . . . 0.0 109.767 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 99.4 p -93.06 94.2 8.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.582 HD21 ' ND2' ' A' ' 178' ' ' ASN . 5.7 mp . . . . . 0 C--N 1.304 -1.387 0 O-C-N 121.178 -0.951 . . . . 0.0 109.936 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.964 0.412 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.462 ' OH ' ' OD1' ' A' ' 179' ' ' ASN . 12.9 m-30 -83.98 10.09 10.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 38.93 74.84 0.11 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 2.8 t 84.56 -58.61 0.1 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.692 -0.887 . . . . 0.0 109.794 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.827 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 144.05 -131.57 4.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.487 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 52.6 tp -94.8 166.31 12.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.637 -0.919 . . . . 0.0 109.659 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 221' ' ' VAL . 5.5 t -104.97 156.64 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.351 -0.843 . . . . 0.0 109.725 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -168.09 118.88 0.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.303 1.049 . . . . 0.0 108.543 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 268' ' ' THR . . . -76.67 -15.89 59.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.718 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.474 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -67.65 -41.19 84.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.711 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.36 -8.42 59.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.404 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -99.59 -21.77 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.218 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.503 ' O ' ' C ' ' A' ' 269' ' ' ARG . 25.2 p -112.54 -55.69 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.181 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 268' ' ' THR . 3.1 ttt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 66.8 m . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -140.52 106.45 6.5 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.85 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.97 178.02 8.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.367 2.044 . . . . 0.0 109.771 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -5.6 16.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.1 -63.29 1.74 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 9' ' ' SER . 1.7 mp -75.82 113.39 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.11 -1.229 . . . . 0.0 109.146 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 11.8 p 168.1 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.848 ' HB3' HD21 ' A' ' 261' ' ' LEU . 2.3 mmt180 -77.81 -21.68 51.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 220' ' ' HIS . 4.0 m -86.41 14.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.081 -1.012 . . . . 0.0 109.894 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.521 ' OE1' ' HB3' ' A' ' 15' ' ' ALA . 22.2 mm-40 45.05 57.92 4.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.476 -0.765 . . . . 0.0 109.69 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.701 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.07 -30.94 0.47 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.451 -0.781 . . . . 0.0 111.82 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 33.1 Cg_endo -76.14 -55.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.232 1.288 . . . . 0.0 109.0 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . . . -49.64 -27.34 4.52 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.203 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.87 -32.84 24.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.863 -1.148 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 22.1 m170 -75.75 -20.79 58.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.505 ' OD1' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -110.31 -25.77 9.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.584 -1.322 . . . . 0.0 110.38 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 3.9 tpm_? -56.16 -25.35 46.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.0 -1.062 . . . . 0.0 109.47 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.87 0.7 3.87 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 268' ' ' THR . 2.4 mt -102.81 151.83 21.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -1.178 . . . . 0.0 109.172 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.483 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -137.78 -2.66 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.183 -0.948 . . . . 0.0 110.853 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 22' ' ' THR . . . 48.83 18.6 1.11 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.483 ' N ' ' C ' ' A' ' 22' ' ' THR . 40.7 t -72.86 9.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.569 -0.96 . . . . 0.0 111.405 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.37 37.25 1.9 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.281 -1.437 . . . . 0.0 110.144 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 27' ' ' LYS . 53.2 t -120.93 163.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.857 -1.378 . . . . 0.0 110.025 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . 21.3 mttp -127.12 128.62 46.5 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.532 -0.73 . . . . 0.0 109.115 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 43.6 t -131.5 153.79 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.028 -1.045 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -115.23 160.27 19.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.066 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 35' ' ' ILE . 7.2 t -133.09 90.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.109 -0.994 . . . . 0.0 108.919 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.973 HD23 HG21 ' A' ' 93' ' ' VAL . 8.7 mp -80.44 123.43 28.05 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 7.8 p30 173.48 -164.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.908 -1.12 . . . . 0.0 109.815 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.3 p -42.38 -65.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -172.28 -132.37 1.49 Allowed Glycine 0 C--N 1.302 -1.341 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.701 HG13 ' HB2' ' A' ' 90' ' ' ALA . 30.3 mm -165.32 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.46 ' HB3' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -53.09 142.39 20.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.989 . . . . 0.0 109.267 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 117.16 13.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 152.74 72.36 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.196 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 -21.33 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.532 2.155 . . . . 0.0 110.713 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -81.01 -17.32 50.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD21 ' HA2' ' A' ' 68' ' ' GLY . 29.8 mt -101.39 149.75 23.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.07 88.26 2.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.134 -0.979 . . . . 0.0 109.392 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 43' ' ' ILE . 23.4 mm -65.92 100.01 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -93.81 -11.42 31.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.27 -0.894 . . . . 0.0 109.31 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -174.65 169.59 42.57 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.78 130.33 1.92 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.07 170.78 14.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.375 -1.074 . . . . 0.0 108.944 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 93.8 p -140.84 112.74 7.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.097 -1.002 . . . . 0.0 110.493 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.941 ' CE2' HG12 ' A' ' 91' ' ' VAL . 3.7 m-85 -106.92 -47.71 3.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.401 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.711 HG21 ' O ' ' A' ' 94' ' ' LEU . 2.6 t -39.99 144.54 0.52 Allowed Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HD2' HG13 ' A' ' 50' ' ' VAL . 32.2 Cg_endo . . . . . 0 C--N 1.313 -1.317 0 C-N-CA 122.516 2.144 . . . . 0.0 110.43 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 48' ' ' SER . 0.7 OUTLIER -77.86 -0.36 27.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 108.689 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -129.32 146.43 51.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 179.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 15.1 t70 64.03 154.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.72 -30.32 0.12 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -167.29 -55.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -1.171 . . . . 0.0 109.374 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.94 -10.37 3.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -54.18 11.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -1.168 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -58.62 -39.98 94.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 36' ' ' SER . 2.9 m -63.8 -32.74 74.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -1.096 . . . . 0.0 108.973 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.733 ' CE1' ' HG ' ' A' ' 201' ' ' SER . 0.6 OUTLIER -67.21 -57.25 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 110.257 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.975 HG13 ' HB3' ' A' ' 219' ' ' PRO . 13.4 t -60.17 -32.47 50.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.341 -0.849 . . . . 0.0 109.796 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.4 ' C ' HD21 ' A' ' 41' ' ' LEU . . . -65.17 -43.04 93.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.691 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -73.49 -38.33 52.16 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.521 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.48 HG21 ' CE1' ' A' ' 220' ' ' HIS . 29.8 m -65.09 -21.66 66.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 108.919 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 219' ' ' PRO . 49.6 mt -89.86 -23.58 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 109.352 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -126.46 -57.51 1.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 111.703 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.082 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 36.68 87.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 73' ' ' LEU . 19.7 mt -60.29 149.82 32.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.733 -1.229 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 11.4 p30 -91.77 87.29 6.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 76' ' ' SER . 14.8 p30 -126.84 -120.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.204 -0.935 . . . . 0.0 108.828 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.423 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -124.43 -34.51 2.89 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.076 -1.015 . . . . 0.0 109.38 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.0 pt -100.32 67.39 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.305 -0.872 . . . . 0.0 109.486 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.24 158.99 9.54 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 34.8 m -87.31 -135.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.175 -1.191 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.47 ' N ' HG23 ' A' ' 79' ' ' VAL . 31.6 tp -140.64 123.09 16.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.697 -1.252 . . . . 0.0 110.263 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 1.082 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -87.57 -153.02 24.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.458 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.87 -60.18 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.906 -1.35 . . . . 0.0 109.332 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.688 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -89.36 112.56 52.15 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.246 -0.909 . . . . 0.0 109.174 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -84.69 -62.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.519 2.146 . . . . 0.0 110.947 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.468 ' CB ' ' HA ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -81.74 18.5 1.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.24 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.688 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -80.99 143.69 32.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.876 -1.14 . . . . 0.0 109.11 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 4.9 pt-20 -84.69 115.1 22.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.913 -1.117 . . . . 0.0 109.198 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 88' ' ' LEU . 4.1 mt -92.4 123.75 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.93 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 13.0 m-85 -106.59 152.61 23.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.701 ' HB2' HG13 ' A' ' 35' ' ' ILE . . . -113.69 102.83 10.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.366 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.941 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.76 69.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 108.93 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -38.28 112.07 0.2 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.312 0.577 . . . . 0.0 110.199 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.973 HG21 HD23 ' A' ' 31' ' ' LEU . 2.1 t -120.19 -17.67 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.256 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.711 ' O ' HG21 ' A' ' 50' ' ' VAL . 76.5 mt -98.45 172.97 7.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . -122.48 12.4 8.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 C--N 1.288 -2.079 0 O-C-N 121.979 -0.718 . . . . 0.0 109.796 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.2 150.98 48.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.883 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.564 HG21 ' OG ' ' A' ' 130' ' ' SER . 44.9 t -68.47 -20.8 25.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -79.25 -55.04 5.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.87 HG23 HG11 ' A' ' 93' ' ' VAL . 1.3 mt -62.29 -25.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 -45.75 68.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.593 -0.692 . . . . 0.0 110.167 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.545 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -67.12 -39.41 86.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.933 -1.104 . . . . 0.0 108.638 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.85 -19.23 73.26 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.51 -42.45 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -1.233 . . . . 0.0 110.184 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 139' ' ' SER . 6.5 pt-20 -94.86 -2.64 50.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.005 -1.059 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 71.4 t90 -86.21 -14.95 42.38 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.825 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.51 -7.19 59.65 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.415 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -91.27 -46.42 3.82 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.654 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.67 -71.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.129 -1.218 . . . . 0.0 110.028 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -109.48 35.25 3.38 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.825 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -114.88 -153.92 10.62 Favored Glycine 0 C--N 1.291 -1.92 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.596 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.78 ' HE1' ' O ' ' A' ' 116' ' ' GLY . 17.9 mmt -118.59 -172.92 2.37 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.882 0.849 . . . . 0.0 111.46 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.653 ' CE1' ' CE ' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -86.16 -27.86 24.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.831 -0.543 . . . . 0.0 110.223 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.646 HG22 ' NE2' ' A' ' 118' ' ' HIS . 15.5 t -114.02 159.77 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.848 -1.157 . . . . 0.0 109.569 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.576 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -163.9 114.16 1.29 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.64 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 6.4 t-20 -98.53 159.27 15.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.05 . . . . 0.0 110.441 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.609 HD23 HD21 ' A' ' 124' ' ' LEU . 3.7 mp -131.99 104.51 6.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.3 59.35 5.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.609 HD21 HD23 ' A' ' 122' ' ' LEU . 1.4 pp -154.49 -175.19 5.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.386 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 173.57 103.09 0.16 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.361 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.51 148.69 35.31 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.297 -1.119 . . . . 0.0 108.914 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -75.95 -2.1 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.348 2.032 . . . . 0.0 109.554 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 m -103.63 110.53 64.04 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.768 -0.583 . . . . 0.0 110.108 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.39 169.04 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.232 1.954 . . . . 0.0 109.33 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.564 ' OG ' HG21 ' A' ' 102' ' ' VAL . 1.4 m -159.52 126.83 4.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.872 -1.143 . . . . 0.0 110.965 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.34 65.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 m -64.32 -30.06 71.12 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -34.23 66.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.533 ' HA ' ' OH ' ' A' ' 165' ' ' TYR . 26.8 tt0 -68.29 -53.39 24.77 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.412 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -51.21 -25.97 6.29 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.06 -1.025 . . . . 0.0 108.296 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.69 -49.26 26.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.627 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.81 -20.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.86 -37.81 85.15 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.94 -27.79 60.34 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.99 -20.75 57.6 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 121.063 -1.023 . . . . 0.0 109.798 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -76.78 -33.56 58.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -24.62 58.33 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.829 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 143' ' ' ARG . 0.9 OUTLIER -106.42 -22.19 12.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.646 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.18 62.16 2.13 Favored Glycine 0 C--N 1.301 -1.411 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 48.4 t -103.22 118.84 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.43 115.43 17.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 108.797 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -111.34 132.45 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.129 -0.982 . . . . 0.0 109.884 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.785 HG12 ' O ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -114.18 166.66 7.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.806 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -150.6 132.72 15.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 0.0 109.67 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -53.26 155.79 2.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.435 -0.791 . . . . 0.0 109.499 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 185' ' ' GLN . 0.1 OUTLIER -61.81 -66.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 155.52 -16.08 0.48 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.6 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 153' ' ' ASN . 11.7 t-20 44.69 40.01 3.83 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.726 -0.867 . . . . 0.0 109.535 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.6 -26.79 9.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.64 102.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 175.19 -177.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 109.547 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 186' ' ' TYR . . . -94.29 59.56 1.94 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.4 t 169.86 154.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.182 . . . . 0.0 109.67 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.617 HD11 ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -114.13 -171.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.821 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.967 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.6 OUTLIER -85.89 162.53 18.55 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.011 0.91 . . . . 0.0 112.012 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.49 139.86 20.96 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.2 Cg_endo -74.9 -36.74 2.49 Favored 'Cis proline' 0 C--N 1.294 -2.291 0 O-C-N 122.836 0.914 . . . . 0.0 110.992 3.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.967 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 8.46 -71.93 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.961 0.886 . . . . 0.0 110.729 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.642 ' N ' ' O ' ' A' ' 162' ' ' PRO . 23.9 ttt-85 -45.93 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER 28.29 -161.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.801 1.286 . . . . 0.0 112.586 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -134.7 -31.0 1.07 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.449 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -100.93 19.13 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 147' ' ' VAL . . . -135.75 167.15 21.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.785 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -122.68 136.04 54.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.006 -1.059 . . . . 0.0 109.538 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 190' ' ' LEU . . . -98.06 154.06 17.98 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 18.9 t -111.98 167.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -135.18 -158.99 8.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 193' ' ' VAL . . . -127.2 166.65 17.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.312 -1.11 . . . . 0.0 109.929 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.612 ' CG2' HG23 ' A' ' 193' ' ' VAL . 22.8 p -139.19 150.74 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.543 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.461 ' OD2' ' HB3' ' A' ' 179' ' ' ASN . 3.5 p30 -76.44 -174.09 2.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 110.176 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.13 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -81.73 -89.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.127 -0.983 . . . . 0.0 109.345 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.767 ' C ' HD23 ' A' ' 251' ' ' LEU . 1.4 m120 -174.93 67.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 174' ' ' THR . 38.2 t30 -146.43 -176.08 5.03 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.137 -0.977 . . . . 0.0 109.714 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -66.04 3.7 0.8 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.56 -0.713 . . . . 0.0 111.887 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 66.88 -145.94 0.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.133 -1.604 . . . . 0.0 108.413 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.21 -43.71 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.845 -1.159 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -87.75 35.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.447 -0.783 . . . . 0.0 110.499 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.7 t -94.11 127.59 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 5.2 tp60 -66.23 114.38 5.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.561 ' CE1' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -106.02 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.805 -179.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 143.32 158.33 7.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.3 97.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.492 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.534 ' C ' HD11 ' A' ' 159' ' ' ILE . . . 151.68 -23.4 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.617 ' N ' HD11 ' A' ' 159' ' ' ILE . 11.0 tp -59.31 127.13 30.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.18 -1.188 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.499 ' O ' ' HA3' ' A' ' 258' ' ' GLY . 0.4 OUTLIER -90.95 -54.46 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.627 -179.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.791 HD12 ' HB2' ' A' ' 259' ' ' SER . 1.8 tt -158.02 167.48 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.168 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 260' ' ' GLY . 33.4 m -112.26 166.29 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.929 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -152.9 176.36 2.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 108.832 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.929 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.12 116.55 4.2 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.341 2.027 . . . . 0.0 110.465 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.15 16.86 1.53 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 18.6 t -88.3 61.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -1.085 . . . . 0.0 108.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.642 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER 108.51 125.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 198' ' ' ASN . 23.7 m -162.65 111.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.955 0.883 . . . . 0.0 108.665 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.2 pt20 -89.22 127.62 35.77 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.733 ' HG ' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -135.13 -160.94 1.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.85 168.54 16.01 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 110.038 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.673 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.43 166.26 16.03 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.673 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.1 Cg_endo -73.79 168.8 23.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.135 1.89 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 71.04 17.22 75.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER 66.1 33.03 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -1.165 . . . . 0.0 109.713 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.56 163.14 23.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 201' ' ' SER . 2.7 m-85 -106.93 -172.95 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -171.0 139.62 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.5 m -106.75 108.78 20.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.43 154.26 21.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.943 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.36 84.84 2.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.97 150.88 22.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.7 m -65.02 -22.61 67.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -1.071 . . . . 0.0 109.469 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.65 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 3.4 t -71.36 -23.0 61.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.415 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -75.6 -16.12 60.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -93.46 3.72 55.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 109.876 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.672 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 23.7 m -77.4 -35.69 1.36 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.986 . . . . 0.0 111.972 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.975 ' HB3' HG13 ' A' ' 66' ' ' VAL . 30.6 Cg_endo -73.41 -29.02 11.62 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.301 1.334 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' A' ' 69' ' ' THR . 29.9 m80 -59.63 -40.85 88.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.834 -1.166 . . . . 0.0 108.057 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 262' ' ' VAL . 63.5 t -70.35 -43.32 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.36 -31.33 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -72.4 -59.77 4.38 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -43.69 -49.69 7.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.2 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.21 -45.91 72.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.365 -0.835 . . . . 0.0 108.776 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 229' ' ' LYS . . . -51.93 -49.78 62.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.868 . . . . 0.0 109.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.6 mt -49.35 -50.12 41.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 108.973 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.29 -45.36 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.653 ' CE ' ' CE1' ' A' ' 118' ' ' HIS . 12.3 tppt? -49.64 -43.17 46.71 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.447 -0.783 . . . . 0.0 108.986 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.64 -45.96 91.8 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.5 tppm? -62.53 -13.11 27.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 108.794 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -163.33 85.75 1.33 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.509 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 36.7 Cg_endo -80.4 31.85 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.37 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.5 t -146.94 11.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.873 -1.142 . . . . 0.0 109.914 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -87.36 -179.02 6.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 110.032 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.849 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -109.74 173.67 6.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.289 0.566 . . . . 0.0 109.648 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.585 ' OD1' HG23 ' A' ' 238' ' ' VAL . 8.5 p30 -62.99 -32.94 74.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.201 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.585 HG23 ' OD1' ' A' ' 237' ' ' ASN . 2.9 t -77.07 -61.98 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.925 0.869 . . . . 0.0 109.181 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 238' ' ' VAL . 4.1 mt-30 -42.65 -38.23 1.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.72 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 236' ' ' SER . 7.5 mt -74.04 -47.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 3.1 tmt_? -52.37 -20.66 2.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.414 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 1.6 t-20 -78.13 -38.06 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.852 -1.155 . . . . 0.0 109.945 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.41 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.0 t-160 -75.74 -40.47 55.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.153 -0.967 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.5 OUTLIER -73.64 -32.92 64.28 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.511 -0.743 . . . . 0.0 110.333 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 1.3 tmtt? -77.93 -42.32 33.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.093 . . . . 0.0 108.983 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 0.9 OUTLIER -67.77 -22.83 65.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.552 -0.718 . . . . 0.0 109.989 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.569 HG21 ' HB2' ' A' ' 267' ' ' ALA . 2.3 p -91.85 -26.09 18.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.916 -1.115 . . . . 0.0 110.04 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -37.01 114.46 0.32 Allowed 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.794 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 250' ' ' SER . 65.9 m -45.06 164.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 0.0 109.08 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.549 ' N ' HG22 ' A' ' 249' ' ' THR . 23.2 t -115.58 102.2 9.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 251' ' ' LEU . 6.4 mp . . . . . 0 C--N 1.306 -1.324 0 O-C-N 121.265 -0.897 . . . . 0.0 110.0 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 258' ' ' GLY . 2.5 tp . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.647 ' O ' ' CG ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER 23.34 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 123.063 1.411 . . . . 0.0 111.774 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 256' ' ' LEU . . . 54.11 -136.14 42.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.791 ' HB2' HD12 ' A' ' 192' ' ' ILE . 6.8 m -101.54 -3.4 28.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.438 -1.037 . . . . 0.0 109.545 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 110.27 -112.63 3.35 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.755 -1.212 . . . . 0.0 110.726 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 10' ' ' ARG . 37.7 tp -115.49 159.22 21.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.511 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -110.59 159.86 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.825 . . . . 0.0 109.191 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -168.05 119.24 0.82 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.363 1.078 . . . . 0.0 108.731 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 268' ' ' THR . . . -69.97 -15.12 62.99 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.317 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.465 ' HB3' ' HG3' ' A' ' 12' ' ' GLN . 78.8 tt0 -74.33 -26.81 60.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.014 -1.054 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 247' ' ' THR . . . -90.79 3.28 54.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 247' ' ' THR . . . -128.69 0.82 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 264' ' ' ALA . 21.4 p -107.49 -42.49 4.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.222 -0.924 . . . . 0.0 109.09 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 268' ' ' THR . 9.5 mtm180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.521 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 14.9 m . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.455 0.645 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.674 HG11 HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.28 148.65 60.42 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 108.982 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HB3' ' OE1' ' A' ' 200' ' ' GLN . 34.9 Cg_endo -77.78 166.29 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.382 2.055 . . . . 0.0 110.735 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 9' ' ' SER . 4.8 p-90 -50.11 -19.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.491 -0.756 . . . . 0.0 110.556 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.61 -43.92 98.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.674 HG21 HG11 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -90.6 -25.71 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.123 -1.222 . . . . 0.0 110.057 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 6' ' ' TRP . 18.7 t -64.31 -20.58 66.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.932 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -0.68 38.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 111.398 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.592 HG23 ' HB2' ' A' ' 13' ' ' ALA . 11.1 m -106.13 25.46 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 120.542 -1.349 . . . . 0.0 110.134 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.56 ' O ' ' HB3' ' A' ' 264' ' ' ALA . 2.9 mp0 47.08 28.89 0.99 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -70.14 -36.17 5.86 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 111.704 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.42 -57.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.509 -1.381 . . . . 0.0 108.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.18 -33.52 0.94 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.62 60.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.162 -0.961 . . . . 0.0 108.819 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 17' ' ' HIS . 1.3 m170 -73.08 -3.3 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.78 . . . . 0.0 109.444 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -53.35 5.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.076 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.644 ' HD2' HD13 ' A' ' 21' ' ' LEU . 1.9 ptp180 -54.86 -18.02 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.65 35.13 2.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -93.21 160.81 14.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.164 -1.198 . . . . 0.0 109.407 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -133.89 -53.32 0.86 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.762 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 83.73 -13.81 45.75 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 2.8 t -51.58 139.72 19.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -1.079 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.31 -15.81 11.83 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 27' ' ' LYS . 45.3 t -93.26 169.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -1.089 . . . . 0.0 109.173 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -137.25 120.41 16.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.163 -0.961 . . . . 0.0 109.389 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.81 134.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -90.31 146.54 24.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.356 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 30' ' ' VAL . 16.2 t -119.23 80.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.23 -0.919 . . . . 0.0 108.938 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.635 HD23 HG21 ' A' ' 93' ' ' VAL . 8.5 mp -72.08 87.44 1.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 109.364 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 54.8 p30 -151.78 -148.51 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 1.2 p -56.86 -72.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.098 -1.001 . . . . 0.0 109.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.584 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -170.99 -110.47 0.24 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.584 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 157.12 115.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 38' ' ' HIS . 2.6 m -83.91 60.38 5.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 111.425 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 37' ' ' THR . 15.0 t 23.18 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.773 0.797 . . . . 0.0 111.22 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.86 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -51.52 161.98 0.76 Allowed Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.11 -29.38 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.465 2.11 . . . . 0.0 110.332 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.632 ' OD1' HG21 ' A' ' 202' ' ' THR . 0.7 OUTLIER -95.26 18.05 13.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 109.565 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.86 HD12 ' HB2' ' A' ' 38' ' ' HIS . 83.5 mt -125.42 124.42 41.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.908 . . . . 0.0 109.291 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.9 t-20 -74.82 120.36 20.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 35' ' ' ILE . 21.7 mm -103.3 96.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.145 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HG2' ' CG ' ' A' ' 87' ' ' GLU . 4.8 tpm_? -88.28 -38.66 15.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.66 -166.11 32.68 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.5 171.16 16.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.65 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -156.3 160.24 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.991 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 56' ' ' THR . 26.5 m -122.88 106.4 10.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.932 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -102.46 -33.17 9.62 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 109.159 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.732 HG13 ' HD2' ' A' ' 51' ' ' PRO . 70.5 t -49.33 142.53 10.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 0.0 109.028 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.732 ' HD2' HG13 ' A' ' 50' ' ' VAL . 33.6 Cg_endo . . . . . 0 C--N 1.31 -1.481 0 C-N-CA 122.519 2.146 . . . . 0.0 110.449 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.403 ' O ' ' HE3' ' A' ' 92' ' ' LYS . 3.3 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.457 0.646 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.473 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -52.26 -20.13 2.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 36' ' ' SER . 18.3 mt-30 -118.82 152.4 36.3 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.379 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 63.56 165.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.311 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 169.78 -35.26 0.18 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 6.6 t30 173.72 -62.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . 168.72 -36.3 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -22.69 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -1.098 . . . . 0.0 109.391 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 65' ' ' HIS . . . -72.48 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.832 HG23 HD11 ' A' ' 41' ' ' LEU . 37.7 m -34.01 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.744 -0.857 . . . . 0.0 110.931 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.626 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -71.95 -52.83 15.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 110.282 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 219' ' ' PRO . 46.1 t -63.57 -37.02 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.447 -0.783 . . . . 0.0 109.933 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.591 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -74.98 -28.2 62.99 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 220' ' ' HIS . 62.1 m -69.89 -18.56 63.41 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.34 -1.094 . . . . 0.0 108.341 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.416 HD12 ' O ' ' A' ' 66' ' ' VAL . 7.3 mt -94.03 -38.49 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 110.004 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.914 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -175.62 46.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.867 -1.146 . . . . 0.0 111.156 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -45.14 108.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.804 -1.185 . . . . 0.0 108.924 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.9 HD23 ' O ' ' A' ' 84' ' ' PRO . 80.4 mt -42.26 142.28 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 109.935 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -86.28 109.46 18.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.283 -0.885 . . . . 0.0 108.977 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 76' ' ' SER . 4.9 m-20 -124.28 -5.01 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 88.5 -17.62 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 pt -104.09 66.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.175 -0.953 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' ' OH ' ' A' ' 208' ' ' TYR . . . 147.56 -171.5 28.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 3' ' ' SER . 30.7 m -80.11 -163.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.324 -1.103 . . . . 0.0 109.6 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.2 tp -142.53 115.2 8.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.865 . . . . 0.0 109.611 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.52 177.11 22.51 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.523 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 2.0 t -65.03 -50.96 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.286 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.914 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . . . -85.77 148.08 47.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.355 -0.84 . . . . 0.0 108.943 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.9 ' O ' HD23 ' A' ' 73' ' ' LEU . 38.0 Cg_endo -82.73 -61.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.752 2.301 . . . . 0.0 109.719 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 68.9 m-80 -95.98 -86.46 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 58.32 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.582 -0.699 . . . . 0.0 110.388 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.485 ' CG ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 mp0 -70.24 93.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 3.3 mt -78.11 104.97 9.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.126 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -94.06 147.92 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 108.89 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.4 105.81 13.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.974 -1.079 . . . . 0.0 109.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.656 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -106.01 67.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.288 -0.882 . . . . 0.0 109.538 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 91' ' ' VAL . 15.3 ttmm -36.97 100.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.391 0.615 . . . . 0.0 109.58 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.647 HG13 ' HA ' ' A' ' 105' ' ' ILE . 0.9 OUTLIER -115.96 -16.68 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.029 HD11 HD22 ' A' ' 124' ' ' LEU . 39.3 mt -118.79 169.12 10.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.807 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 167.19 12.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 59' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.247 -1.149 . . . . 0.0 109.246 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.13 145.54 26.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.765 -0.844 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.822 HG21 ' OG ' ' A' ' 130' ' ' SER . 1.2 t -67.24 -32.27 56.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -21.85 66.7 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.492 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -85.34 -62.31 1.56 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.669 -0.644 . . . . 0.0 109.268 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.647 ' HA ' HG13 ' A' ' 93' ' ' VAL . 1.3 mt -48.71 -27.12 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.42 -48.75 21.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.405 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -62.54 -20.38 64.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.212 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.53 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -82.66 -38.42 12.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.9 mt -65.37 -24.98 67.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.378 -1.072 . . . . 0.0 109.234 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -26.03 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.495 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 55.4 t90 -72.68 -14.78 61.65 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.933 -1.105 . . . . 0.0 108.476 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.733 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -94.29 7.99 43.44 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.584 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -103.4 -45.16 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -86.21 -83.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.919 -1.341 . . . . 0.0 108.391 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.91 49.52 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.733 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -112.61 -156.13 12.6 Favored Glycine 0 C--N 1.289 -2.082 0 CA-C-O 122.376 0.987 . . . . 0.0 111.525 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.636 ' HE3' ' C ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -122.3 163.05 20.36 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.276 0.56 . . . . 0.0 109.558 -178.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.64 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -72.79 -16.75 61.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 108.699 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.7 t -125.02 161.09 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.03 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.988 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -159.77 156.98 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 108.793 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.512 HD21 HG22 ' A' ' 218' ' ' THR . 14.1 t-20 -135.56 152.56 51.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.313 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 121' ' ' ASN . 3.4 mp -135.47 81.9 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.515 ' HG ' ' CB ' ' A' ' 215' ' ' SER . 5.0 t -71.32 84.16 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.011 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.029 HD22 HD11 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 177.43 176.54 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.391 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.532 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -176.07 93.85 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 0.6 OUTLIER -86.99 148.73 46.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.29 -1.124 . . . . 0.0 109.272 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.447 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -76.39 -9.26 18.81 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.385 2.057 . . . . 0.0 108.942 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -97.34 108.83 46.94 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 161' ' ' TYR . 31.9 Cg_endo -75.07 166.23 29.57 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.119 1.88 . . . . 0.0 109.831 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.822 ' OG ' HG21 ' A' ' 102' ' ' VAL . 43.8 m -157.75 118.96 3.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.987 -1.07 . . . . 0.0 110.532 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.68 66.03 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.9 m -61.75 -31.77 71.97 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.28 -33.72 61.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE1' ' OH ' ' A' ' 165' ' ' TYR . 4.4 tt0 -73.32 -22.79 60.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.802 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -25.56 58.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.1 -37.14 39.43 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.592 HG13 ' CG ' ' A' ' 167' ' ' ASN . 2.0 t -70.44 -29.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -64.19 -35.6 81.32 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.3 m -78.11 -22.8 48.36 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -91.52 -5.37 54.26 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -90.73 -43.15 10.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.214 -0.929 . . . . 0.0 109.143 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.5 m -64.21 -17.94 64.03 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.78 -14.12 23.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.455 -0.778 . . . . 0.0 109.371 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.84 62.85 4.22 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.96 115.49 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -1.074 . . . . 0.0 109.376 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.1 113.18 8.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.016 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.988 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -109.65 150.89 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 149' ' ' ALA . 2.7 t -123.56 166.59 18.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.51 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -157.38 135.42 10.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 110.264 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.492 ' N ' HG21 ' A' ' 218' ' ' THR . . . -61.17 171.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.4 OUTLIER -93.22 -39.07 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 109.944 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 132.53 120.91 2.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 47.11 1.29 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.905 -0.762 . . . . 0.0 109.473 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 155' ' ' GLY . 1.6 t -121.75 -91.93 0.55 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.455 ' N ' ' OG ' ' A' ' 154' ' ' SER . . . 150.51 95.95 0.14 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB3' HE22 ' A' ' 185' ' ' GLN . . . -158.23 173.26 16.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 0.0 109.634 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.98 42.24 3.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.493 ' O ' ' NE2' ' A' ' 185' ' ' GLN . 1.6 t -163.64 160.53 22.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -1.149 . . . . 0.0 109.321 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.716 HD11 ' O ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -98.16 -173.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.09 -1.006 . . . . 0.0 110.148 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.532 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 69.7 m -67.28 -174.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.691 1.234 . . . . 0.0 111.389 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.465 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 12.7 m-85 -137.2 128.56 16.46 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.737 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.1 Cg_endo -70.91 -50.74 0.18 OUTLIER 'Cis proline' 0 C--N 1.3 -1.993 0 O-C-N 123.188 1.099 . . . . 0.0 110.419 4.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . 30.89 -77.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.615 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.737 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -36.51 -39.97 0.22 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.363 178.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.2 m-85 -49.73 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.344 -0.847 . . . . 0.0 110.241 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.86 0.1 11.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.592 ' CG ' HG13 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -87.01 16.95 4.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.165 -0.959 . . . . 0.0 108.934 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.47 153.53 7.75 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.404 ' HG3' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.2 129.8 42.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.921 -1.112 . . . . 0.0 109.509 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -91.41 133.63 35.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 172' ' ' GLY . 38.5 t -104.75 165.15 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.766 -1.209 . . . . 0.0 110.088 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.559 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -129.76 -169.98 12.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.14 155.51 44.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.454 HG23 ' HB ' ' A' ' 193' ' ' VAL . 2.6 p -125.32 -174.31 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 -176.59 3.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 109.798 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.413 ' NE2' ' OD1' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -51.35 -27.29 9.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.002 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.413 ' OD1' ' NE2' ' A' ' 176' ' ' GLN . 27.4 m120 -114.78 -93.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.034 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 13.4 p30 -142.49 16.81 2.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.909 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.36 153.03 22.81 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.047 -1.033 . . . . 0.0 108.833 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.507 ' N ' ' OH ' ' A' ' 257' ' ' TYR . 0.5 OUTLIER -73.18 136.45 44.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -50.33 -172.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.516 -0.74 . . . . 0.0 110.148 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.4 t -116.06 -17.59 10.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -111.35 -19.91 12.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.494 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 8.5 t -48.36 134.81 14.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -79.59 157.25 27.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.652 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.1 OUTLIER -134.49 173.23 11.87 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.393 -0.817 . . . . 0.0 109.032 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 150.31 147.77 4.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.716 ' O ' HD11 ' A' ' 159' ' ' ILE . . . -49.54 141.31 9.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.16 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.58 -11.24 46.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.5 tp -56.62 118.1 4.52 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.317 -1.108 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 259' ' ' SER . 0.5 OUTLIER -69.63 -75.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.985 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.597 HD12 HG13 ' A' ' 262' ' ' VAL . 0.4 OUTLIER -145.22 -158.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 260' ' ' GLY . 27.0 m -135.06 172.8 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.133 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -162.11 178.26 1.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.0 Cg_endo -76.19 114.02 3.81 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.097 1.864 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.05 40.07 1.44 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 53.9 t -123.46 82.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.652 ' HB3' ' O ' ' A' ' 197' ' ' VAL . 12.5 t-20 83.85 120.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.164 0.983 . . . . 0.0 108.449 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 199' ' ' VAL . 28.3 m -153.06 105.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 122.443 1.116 . . . . 0.0 109.105 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -83.54 109.31 17.28 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.327 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.626 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 1.4 t -123.99 -165.65 1.38 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 109.105 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.632 HG21 ' OD1' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -69.24 176.72 3.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.213 -0.929 . . . . 0.0 110.268 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.649 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.6 OUTLIER -161.99 149.09 11.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.649 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.4 Cg_endo -69.99 173.48 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.277 1.985 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 79.97 8.79 87.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 1.0 OUTLIER 67.67 55.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.5 -1.0 . . . . 0.0 109.861 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.791 HG23 ' N ' ' A' ' 208' ' ' TYR . 4.2 t -155.85 -147.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.732 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.791 ' N ' HG23 ' A' ' 207' ' ' THR . 10.5 m-85 -146.36 -177.34 5.57 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.241 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 203' ' ' TYR . . . 177.13 147.57 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.88 . . . . 0.0 110.373 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.613 ' C ' HD23 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -118.86 142.27 47.89 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -158.72 122.38 3.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.857 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.433 ' CB ' ' H ' ' A' ' 198' ' ' ASN . 1.6 p-10 -72.84 160.7 31.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.139 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.16 156.3 8.53 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.5 m -79.95 -27.36 39.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.187 . . . . 0.0 109.431 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.515 ' CB ' ' HG ' ' A' ' 123' ' ' SER . 0.3 OUTLIER -74.75 -13.76 60.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.646 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -20.94 28.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.676 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -95.35 -3.6 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.644 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 8.5 m -75.17 -43.94 4.56 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 111.307 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.71 ' HG2' HG21 ' A' ' 69' ' ' THR . 30.5 Cg_endo -72.27 -13.29 28.16 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.614 1.543 . . . . 0.0 110.155 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.84 ' CE1' HG23 ' A' ' 69' ' ' THR . 6.2 m80 -70.99 -44.24 66.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 222' ' ' ALA . 46.2 t -66.54 -51.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -44.26 -37.35 3.19 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.694 -0.802 . . . . 0.0 108.865 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -66.69 -52.8 31.63 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.68 -56.95 10.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 109.656 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.65 23.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.974 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.043 -1.036 . . . . 0.0 110.042 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 82' ' ' VAL . 38.4 mt -61.95 -46.65 88.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.035 -1.041 . . . . 0.0 109.658 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.556 ' O ' ' CG ' ' A' ' 231' ' ' LYS . 55.5 t -60.29 -43.7 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.436 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -53.09 -40.42 64.1 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.966 -1.084 . . . . 0.0 108.902 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -61.85 -56.02 23.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.266 -0.896 . . . . 0.0 110.348 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 228' ' ' VAL . 0.1 OUTLIER -52.0 -19.82 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.967 -1.083 . . . . 0.0 109.206 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.587 ' OD1' ' CG ' ' A' ' 235' ' ' TRP . 0.1 OUTLIER -132.85 94.11 22.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.915 . . . . 0.0 109.066 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.32 41.38 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.737 2.291 . . . . 0.0 110.862 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.9 t -164.22 13.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.0 111.869 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.587 ' CG ' ' OD1' ' A' ' 232' ' ' ASN . 26.4 m0 -92.89 174.31 7.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.434 -1.416 . . . . 0.0 109.559 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.5 OUTLIER -104.76 174.01 6.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.527 -0.733 . . . . 0.0 109.148 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -65.97 -25.58 67.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 109.736 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.7 t -78.77 -64.84 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.227 -0.92 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 238' ' ' VAL . 10.9 mm100 -44.68 -37.89 3.99 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.77 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 236' ' ' SER . 55.8 mt -68.4 -55.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 12.5 ttp180 -52.14 -21.89 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.029 . . . . 0.0 110.008 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -73.0 -59.8 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.69 ' O ' HG23 ' A' ' 247' ' ' THR . 19.8 t60 -52.61 -47.96 66.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.554 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -66.84 -37.82 85.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.344 -0.847 . . . . 0.0 110.05 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -59.05 -62.82 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.488 -0.758 . . . . 0.0 110.65 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -72.59 -10.71 60.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 111.558 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 243' ' ' HIS . 2.9 p -81.34 -31.16 33.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.429 -1.419 . . . . 0.0 109.846 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -42.92 115.63 0.77 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.966 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -43.61 169.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.802 . . . . 0.0 109.928 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.7 p -121.94 106.2 11.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 109.881 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.768 HD22 ' H ' ' A' ' 251' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.307 0 O-C-N 121.165 -0.959 . . . . 0.0 109.356 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.217 0.532 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.507 ' OH ' ' N ' ' A' ' 180' ' ' ARG . 50.5 m-85 -47.56 -60.65 2.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.049 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.76 20.75 74.51 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 191' ' ' ASP . 0.3 OUTLIER -167.57 -100.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 0.0 109.836 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.795 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 157.86 -160.57 30.83 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.583 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.603 ' CB ' HD11 ' A' ' 251' ' ' LEU . 9.4 tp -104.65 129.87 52.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.518 -0.99 . . . . 0.0 109.461 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -58.73 172.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.085 -1.009 . . . . 0.0 109.943 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.66 117.88 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 122.486 1.136 . . . . 0.0 108.408 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 12' ' ' GLN . . . -74.28 -18.85 60.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.469 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 10.4 tt0 -95.49 -2.18 49.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.61 0.34 36.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -130.06 -1.04 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.865 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 269' ' ' ARG . 1.4 p -113.13 -35.69 5.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.562 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.529 ' OXT' ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.623 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.347 0.594 . . . . 0.0 109.62 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.7 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -143.07 44.09 0.5 Allowed Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 121.4 -0.812 . . . . 0.0 109.977 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.7 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.8 Cg_endo -78.06 172.39 15.6 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.653 1.568 . . . . 0.0 109.112 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -72.83 8.87 1.31 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 111.096 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -110.12 -64.97 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.7 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -56.46 -30.5 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.032 -1.275 . . . . 0.0 109.896 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 m -56.23 -34.56 66.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 109.849 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.03 -16.0 25.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.0 111.594 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 8' ' ' ILE . 3.0 m -85.35 15.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.299 -1.501 . . . . 0.0 110.387 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 74.6 mm-40 37.74 45.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.692 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -72.18 -35.17 3.21 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -72.9 -47.33 0.34 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 N-CA-C 108.162 -1.515 . . . . 0.0 108.162 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.25 -36.69 1.88 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -41.08 60.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.507 ' HE2' ' C ' ' A' ' 82' ' ' VAL . 2.2 m-70 -63.45 -16.85 61.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.294 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -106.78 -24.76 11.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.783 -1.198 . . . . 0.0 109.915 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.4 mmp_? -63.47 -64.86 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.413 ' C ' HD12 ' A' ' 21' ' ' LEU . . . 158.38 59.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.7 mp -144.05 132.18 21.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -1.056 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.426 ' C ' ' N ' ' A' ' 24' ' ' SER . 47.1 p -125.93 -8.08 6.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.364 -0.835 . . . . 0.0 109.986 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.87 11.5 4.39 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' ' C ' ' A' ' 22' ' ' THR . 12.3 p -60.16 -14.74 18.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 110.072 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.17 25.93 23.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 27' ' ' LYS . 57.7 t -132.0 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.001 -1.294 . . . . 0.0 110.091 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 22.9 mtmt -138.85 121.24 16.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 7.7 t -113.84 152.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.985 . . . . 0.0 110.294 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.574 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -110.83 160.48 16.71 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.441 -0.787 . . . . 0.0 108.912 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.87 94.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 108.426 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.993 HD23 HG21 ' A' ' 93' ' ' VAL . 5.8 mp -81.14 116.44 21.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -175.7 -161.72 0.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.941 -1.099 . . . . 0.0 110.26 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.843 HG23 ' HA2' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -46.78 -37.07 8.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.459 -0.776 . . . . 0.0 109.729 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 155.59 -103.52 0.24 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.588 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.0 mt 145.45 101.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 204' ' ' PRO . 0.4 OUTLIER -69.12 151.37 46.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.617 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 160.25 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.619 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -167.71 147.72 4.5 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 108.979 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.7 Cg_endo -77.14 -13.99 16.91 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.491 2.128 . . . . 0.0 110.477 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.31 5.27 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 108.918 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 38' ' ' HIS . 22.1 mt -110.22 159.44 17.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.106 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.72 76.97 1.56 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.39 145.8 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 108.747 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.534 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.83 -20.95 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.913 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -178.22 153.31 12.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.82 -177.24 37.88 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.507 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 178.18 113.46 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 92' ' ' LYS . 25.1 m -105.44 111.07 23.65 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.517 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.511 ' CG ' ' HG2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -89.92 -22.72 21.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.863 HG21 ' O ' ' A' ' 93' ' ' VAL . 1.8 t -62.2 135.25 94.94 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.412 -0.805 . . . . 0.0 108.937 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.448 2.098 . . . . 0.0 110.672 179.742 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.546 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.586 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -73.98 13.46 0.53 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.643 -1.286 . . . . 0.0 111.103 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 56' ' ' THR . 31.5 mt-30 -147.59 174.74 11.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.533 -1.354 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HB2' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -57.68 160.78 4.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.471 -0.768 . . . . 0.0 110.648 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.09 10.15 3.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB2' HG21 ' A' ' 33' ' ' THR . 1.3 t-20 -167.25 -65.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 109.353 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.27 -32.27 0.54 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -45.56 -65.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -46.02 -70.89 0.58 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 63' ' ' GLY . 22.6 m -33.59 -49.4 0.3 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.778 -0.837 . . . . 0.0 111.252 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.614 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.5 t-80 -57.92 -52.65 64.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.067 -1.021 . . . . 0.0 110.344 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.75 HG13 ' HB3' ' A' ' 219' ' ' PRO . 25.4 t -57.17 -37.81 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.078 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.76 -41.11 97.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.599 ' HA3' HG22 ' A' ' 202' ' ' THR . . . -68.26 -46.29 65.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.465 HG23 ' NE2' ' A' ' 220' ' ' HIS . 28.6 m -53.14 -29.22 30.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.431 -1.041 . . . . 0.0 108.974 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.0 mt -90.07 -24.31 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.555 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -120.22 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.938 -1.101 . . . . 0.0 111.9 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.051 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 37.62 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.745 . . . . 0.0 109.868 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 73' ' ' LEU . 15.0 mt -52.86 141.75 20.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.47 -1.394 . . . . 0.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 74' ' ' ASN . 2.1 p-10 -89.78 116.36 27.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.513 ' N ' ' ND2' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -174.48 -105.87 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -45.98 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.348 -0.845 . . . . 0.0 109.224 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -72.07 169.87 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 77' ' ' ILE . . . 41.06 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.52 ' HB ' ' OG ' ' A' ' 3' ' ' SER . 27.4 m -115.91 -162.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.978 . . . . 0.0 109.1 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 3' ' ' SER . 1.9 tp -106.96 121.29 44.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.135 -0.978 . . . . 0.0 109.65 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 1.051 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -88.48 -146.19 12.07 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.682 HG12 HD11 ' A' ' 227' ' ' LEU . 1.9 t -112.23 -34.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -1.225 . . . . 0.0 109.841 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.784 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -121.7 128.97 25.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.045 -1.035 . . . . 0.0 109.072 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 38.1 Cg_endo -85.36 -62.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.646 2.231 . . . . 0.0 110.618 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.4 37.04 1.2 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.337 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.784 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -82.44 129.06 34.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.45 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -61.49 87.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.326 -0.859 . . . . 0.0 109.373 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 mt -76.49 124.33 27.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.078 -1.014 . . . . 0.0 109.741 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.557 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 7.0 m-85 -115.57 152.18 33.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.476 -0.765 . . . . 0.0 109.185 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -119.05 98.81 6.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.052 -1.03 . . . . 0.0 110.334 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.574 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -103.47 64.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.068 -1.02 . . . . 0.0 108.651 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 55' ' ' SER . 7.8 ttmt -37.34 121.91 0.87 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.549 0.69 . . . . 0.0 111.134 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.993 HG21 HD23 ' A' ' 31' ' ' LEU . 25.3 t -123.28 -36.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.01 HD21 HD13 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -130.16 179.56 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.843 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 154.79 -140.2 7.24 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 118.256 -1.926 . . . . 0.0 112.186 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 122.135 -0.627 . . . . 0.0 110.72 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.409 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.1 t -83.96 176.73 8.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.912 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' A' ' 101' ' ' SER . 44.5 t -68.27 -13.39 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.09 -22.84 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.3 m -85.67 -43.6 13.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.727 HD13 HD11 ' A' ' 124' ' ' LEU . 1.6 mt -71.21 -23.27 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.52 25.15 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.681 -0.637 . . . . 0.0 109.413 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.511 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 3.5 tp-100 -69.98 -32.79 71.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 -39.05 27.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.723 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 15.0 mt -73.7 -28.1 61.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -1.168 . . . . 0.0 109.707 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -92.33 -21.27 20.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.096 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.485 ' O ' ' CD2' ' A' ' 111' ' ' TRP . 64.7 t90 -76.85 -11.67 59.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.418 -0.801 . . . . 0.0 108.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.746 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -97.28 -1.37 44.88 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.302 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.62 -21.61 39.74 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -119.03 -5.84 10.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.132 . . . . 0.0 110.252 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -164.65 20.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.804 -1.185 . . . . 0.0 110.563 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -105.31 -152.77 21.29 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.732 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.713 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 10.6 mmt -120.56 -176.73 3.3 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.636 -0.92 . . . . 0.0 110.633 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.677 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -81.1 -25.75 36.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.217 -178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.677 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 2.4 t -114.77 158.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.575 -1.328 . . . . 0.0 109.738 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.55 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -167.29 145.12 4.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.839 ' O ' HD12 ' A' ' 122' ' ' LEU . 10.5 t-20 -115.35 162.18 17.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 109.454 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 121' ' ' ASN . 3.8 mp -144.97 113.56 6.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.196 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.515 ' C ' HD23 ' A' ' 124' ' ' LEU . 10.8 m -92.7 68.99 4.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.01 HD13 HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 178.54 177.02 0.47 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -0.925 . . . . 0.0 110.002 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 161' ' ' TYR . . . 172.17 -79.31 0.09 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER 81.86 162.0 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.762 -0.846 . . . . 0.0 110.032 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 34.8 Cg_endo -76.43 -14.55 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.514 2.143 . . . . 0.0 109.78 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.41 118.25 60.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.77 165.97 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.159 1.906 . . . . 0.0 110.344 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -168.68 106.41 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.899 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.7 -18.13 64.81 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.6 m -68.25 -29.21 67.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -42.05 37.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.12 -19.03 61.23 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.747 -1.181 . . . . 0.0 108.153 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 tt0 -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.723 ' HB1' ' HB3' ' A' ' 109' ' ' LEU . . . -76.61 -36.04 57.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.493 HG21 ' HB1' ' A' ' 166' ' ' ALA . 1.3 t -70.57 -29.67 39.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -38.57 84.08 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.1 -25.12 58.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -85.95 -6.82 58.99 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.6 m -86.57 -51.99 5.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.1 -1.0 . . . . 0.0 109.141 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -18.27 45.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -20.55 16.52 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 78.51 0.5 Allowed Glycine 0 N--CA 1.478 1.465 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 118' ' ' HIS . 22.1 t -131.43 118.11 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -1.061 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.91 122.19 26.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -115.27 151.74 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.636 HG12 ' ND2' ' A' ' 121' ' ' ASN . 2.7 t -119.22 159.79 19.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -146.88 135.1 21.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.869 -1.144 . . . . 0.0 110.409 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.454 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -67.12 174.83 2.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.664 -0.648 . . . . 0.0 109.553 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 15.2 t -73.03 -82.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 145.57 120.65 1.34 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.428 ' C ' ' OG ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -86.35 60.11 6.04 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 121.922 -0.752 . . . . 0.0 109.598 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' C ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 171.61 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.164 -0.96 . . . . 0.0 110.898 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -19.69 -50.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.237 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 90.57 63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.786 0.803 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.16 -3.09 32.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 159' ' ' ILE . 15.0 m -134.22 122.83 23.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 0.0 109.562 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -51.18 179.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.806 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -105.92 173.3 6.37 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.554 1.169 . . . . 0.0 112.526 -177.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.565 ' O ' ' CA ' ' A' ' 125' ' ' GLY . 24.4 m-85 -108.94 144.75 30.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.1 Cg_endo -72.88 -31.82 4.91 Favored 'Cis proline' 0 C--N 1.297 -2.181 0 O-C-N 122.33 0.647 . . . . 0.0 111.27 4.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -4.1 -61.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.604 0.716 . . . . 0.0 111.656 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 162' ' ' PRO . 9.6 tpt180 -48.77 -65.9 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.724 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 38.1 p90 -121.75 -163.43 1.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.922 0.868 . . . . 0.0 110.676 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 165' ' ' TYR . . . 80.1 49.3 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.648 0.737 . . . . 0.0 109.589 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 166' ' ' ALA . 23.0 m-80 41.77 28.76 0.09 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -112.49 116.32 30.08 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.91 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.475 ' HB2' HG22 ' A' ' 148' ' ' VAL . 73.5 mmm -63.64 171.83 2.44 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.293 -0.88 . . . . 0.0 108.792 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -137.02 114.42 10.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.653 HG22 HG21 ' A' ' 221' ' ' VAL . 27.5 t -99.68 166.05 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -148.8 108.4 0.4 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -52.01 149.58 4.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.28 . . . . 0.0 109.541 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.479 ' HB2' ' C ' ' A' ' 180' ' ' ARG . 6.2 t0 -115.46 -149.5 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.131 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 177' ' ' ASN . 56.7 tt0 -40.3 -43.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.458 -0.776 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 7.4 m-20 164.47 119.86 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.94 38.38 28.69 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.216 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -132.07 -18.12 2.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.94 . . . . 0.0 110.282 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.479 ' C ' ' HB2' ' A' ' 175' ' ' ASP . 1.8 ttp85 66.79 126.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 109.188 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -42.47 163.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.591 -0.693 . . . . 0.0 109.901 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.9 p -84.31 4.88 29.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.289 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.452 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 6.2 p90 -137.93 11.74 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 33.7 t -87.75 105.58 17.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.399 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.603 ' HG2' ' N ' ' A' ' 155' ' ' GLY . 1.5 mp0 -52.38 154.46 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -0.962 . . . . 0.0 110.118 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.75 168.2 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 173.12 144.47 4.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.72 131.31 50.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.322 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.43 -1.15 39.95 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.482 ' HG ' ' N ' ' A' ' 191' ' ' ASP . 6.6 tp -60.94 146.79 45.55 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.28 -1.129 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.4 OUTLIER -73.68 -80.05 0.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.059 -1.026 . . . . 0.0 110.368 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.696 HG13 HG22 ' A' ' 262' ' ' VAL . 0.2 OUTLIER -152.75 -169.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.781 -1.199 . . . . 0.0 109.516 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.547 ' N ' HG12 ' A' ' 192' ' ' ILE . 32.6 m -126.59 162.16 31.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.009 -1.057 . . . . 0.0 110.163 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.904 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -145.76 140.4 15.68 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 7' ' ' GLY . 34.6 Cg_endo -76.17 112.95 3.59 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.449 2.099 . . . . 0.0 111.115 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.573 ' O ' ' C ' ' A' ' 197' ' ' VAL . . . -114.12 -67.79 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 78.0 t 5.52 71.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.713 ' O ' HG13 ' A' ' 199' ' ' VAL . 9.5 t-20 99.13 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 198' ' ' ASN . 7.3 m -163.41 110.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 122.149 0.976 . . . . 0.0 109.259 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.538 ' CG ' ' OG ' ' A' ' 210' ' ' SER . 6.3 mt-30 -77.43 129.52 35.86 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.614 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -135.95 -153.46 0.51 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.042 -1.036 . . . . 0.0 109.64 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.599 HG22 ' HA3' ' A' ' 68' ' ' GLY . 9.8 t -102.94 177.32 4.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.665 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -144.63 -179.45 0.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.665 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -73.38 -151.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.98 1.787 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . -37.62 -29.7 0.05 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' PRO . 17.8 t -48.39 -97.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.256 -1.144 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 208' ' ' TYR . 5.2 t 175.53 -120.33 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.573 ' N ' HG23 ' A' ' 207' ' ' THR . 0.6 OUTLIER -78.33 -170.38 2.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.868 -1.145 . . . . 0.0 109.748 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.768 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.538 ' OG ' ' CG ' ' A' ' 200' ' ' GLN . 0.1 OUTLIER -174.21 139.34 0.62 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.56 HD12 ' SD ' ' A' ' 216' ' ' MET . 0.1 OUTLIER -175.63 162.29 2.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -106.08 173.5 6.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.438 -0.788 . . . . 0.0 109.226 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 147.18 147.61 4.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 151' ' ' SER . 23.2 m -73.92 -22.5 59.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.131 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.466 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 71.2 m -74.15 -9.94 59.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.56 ' SD ' HD12 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -86.45 -19.59 29.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.904 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -90.36 -14.06 33.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.659 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -71.07 -39.28 8.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 0.0 111.452 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.75 ' HB3' HG13 ' A' ' 66' ' ' VAL . 31.7 Cg_endo -73.25 -28.63 12.32 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.761 1.641 . . . . 0.0 110.561 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.465 ' NE2' HG23 ' A' ' 69' ' ' THR . 7.9 m80 -61.91 -35.67 79.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 171' ' ' VAL . 33.8 t -75.73 -39.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -27.67 67.27 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.86 2.37 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.833 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -45.39 -42.09 9.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 109.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.52 95.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.775 . . . . 0.0 109.171 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.86 -40.91 73.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.165 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.833 HD12 ' HA ' ' A' ' 224' ' ' ALA . 5.1 mt -61.88 -45.15 95.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 109.328 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 229' ' ' LYS . 75.7 t -57.9 -67.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.573 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -40.02 -43.04 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.709 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.475 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 14.9 tm0? -58.37 -54.11 50.71 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.224 -0.923 . . . . 0.0 110.018 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 228' ' ' VAL . 0.0 OUTLIER -56.79 -17.26 8.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.188 -0.945 . . . . 0.0 108.917 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 m-20 -156.57 81.18 3.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.6 Cg_endo -81.14 40.32 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.757 2.305 . . . . 0.0 110.663 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.41 7.68 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.0 109.762 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.416 ' CZ2' ' ND2' ' A' ' 232' ' ' ASN . 45.1 m0 -91.05 175.03 7.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.775 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.37 8.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 237' ' ' ASN . 2.0 m-80 -58.11 -32.75 68.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.13 -0.981 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.9 t -71.88 -63.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.31 -0.869 . . . . 0.0 109.09 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.8 OUTLIER -42.01 -42.06 2.73 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.379 0.609 . . . . 0.0 109.809 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 9.4 mm -63.06 -47.89 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.847 . . . . 0.0 109.302 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' ASN . 0.6 OUTLIER -58.41 -62.64 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -40.33 -43.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.439 -0.788 . . . . 0.0 110.422 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.462 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.9 t60 -70.67 -38.44 73.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.9 -1.125 . . . . 0.0 110.223 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.8 OUTLIER -73.3 -22.5 60.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.452 -0.78 . . . . 0.0 110.019 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -84.48 -34.33 23.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.349 -0.845 . . . . 0.0 108.942 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -85.97 -17.17 36.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.59 -0.694 . . . . 0.0 109.312 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 5.0 p -88.24 -34.26 17.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 109.402 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.04 133.83 11.05 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.463 ' OG1' ' OD1' ' A' ' 263' ' ' ASN . 2.9 m -57.87 152.4 16.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.704 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 259' ' ' SER . 25.8 p -120.48 98.63 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.884 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 C--N 1.306 -1.304 0 O-C-N 121.08 -1.012 . . . . 0.0 109.343 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.457 ' HA ' ' CE1' ' A' ' 186' ' ' TYR . 7.3 mt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.45 -46.43 10.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.9 -33.04 4.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.525 ' CB ' HG22 ' A' ' 192' ' ' ILE . 1.5 m -141.42 -98.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -1.135 . . . . 0.0 109.331 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.51 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 162.19 -124.56 1.31 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.169 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -84.65 135.11 34.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.592 -0.946 . . . . 0.0 110.163 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.696 HG22 HG13 ' A' ' 192' ' ' ILE . 1.4 t -78.6 144.44 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.463 ' OD1' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -160.88 118.28 2.38 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.604 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.395 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 2.3 tm-20 -63.12 -28.86 70.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.15 -18.19 50.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -107.11 9.87 30.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 269' ' ' ARG . 17.3 p -128.38 -67.53 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 268' ' ' THR . 8.3 tpt180 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.626 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.508 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -115.32 86.4 14.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.977 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 3' ' ' SER . 37.0 Cg_endo -80.87 -175.01 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.973 2.449 . . . . 0.0 111.575 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.635 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -55.58 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.442 0.639 . . . . 0.0 110.52 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 6' ' ' TRP . . . -40.12 -83.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.688 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.4 mp -41.65 102.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -1.029 . . . . 0.0 109.741 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER 167.9 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.202 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' NH2' HD22 ' A' ' 261' ' ' LEU . 1.2 ttp85 -93.47 4.44 53.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.316 -0.865 . . . . 0.0 109.895 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 11' ' ' VAL . 3.5 m -94.48 25.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.01 -1.056 . . . . 0.0 109.818 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 88.1 mm-40 43.03 46.96 4.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.67 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -81.45 -35.62 0.78 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 111.433 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.7 Cg_endo -74.42 -55.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.222 -1.491 . . . . 0.0 108.222 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.56 -34.63 3.45 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -71.47 -41.57 69.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.9 -1.125 . . . . 0.0 109.147 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.508 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 7.4 m170 -75.79 -2.9 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.702 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -115.08 -11.0 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.117 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -73.67 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 109.404 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.76 30.77 0.06 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.858 HD23 ' HG3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -142.89 145.4 33.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.184 . . . . 0.0 109.391 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -123.6 -9.93 7.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -0.835 . . . . 0.0 109.711 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -7.47 16.66 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 24' ' ' SER . 51.7 p -60.05 94.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.553 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.28 -4.47 2.85 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.228 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.621 ' CG1' ' CE1' ' A' ' 118' ' ' HIS . 5.3 t -97.49 160.99 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.907 -1.349 . . . . 0.0 109.904 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.3 OUTLIER -125.84 117.29 23.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 110.016 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.56 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 13.7 t -107.37 145.1 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.597 -0.689 . . . . 0.0 109.315 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -106.56 155.59 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' A' ' 70' ' ' ILE . 41.7 t -128.59 86.69 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.595 HD23 HG21 ' A' ' 93' ' ' VAL . 2.5 mp -81.72 90.33 6.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.665 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.541 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -157.03 -146.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 108.747 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -57.28 -73.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.586 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -166.46 -126.93 0.86 Allowed Glycine 0 N--CA 1.476 1.363 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 90' ' ' ALA . 8.0 mt -167.4 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 20.5 t -47.82 141.5 5.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.042 -1.036 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.58 141.92 56.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.243 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.606 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.4 157.12 21.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.35 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 35.8 Cg_endo -78.75 -6.01 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.736 2.291 . . . . 0.0 111.111 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.47 -21.48 19.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 0.0 109.993 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -117.09 150.16 39.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.045 -1.034 . . . . 0.0 109.712 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 116.42 31.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.523 -0.735 . . . . 0.0 109.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.41 111.56 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.114 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 62.6 mmt-85 -118.79 11.23 12.61 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.675 ' HA3' ' CD2' ' A' ' 89' ' ' TYR . . . -174.34 142.57 6.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.17 84.82 0.15 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.487 -1.339 . . . . 0.0 110.645 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 124.49 45.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 108.652 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.585 ' HB2' ' CE ' ' A' ' 92' ' ' LYS . 6.5 p -111.43 117.77 33.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.001 -1.062 . . . . 0.0 110.416 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.921 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 21.4 m-85 -86.12 -77.77 0.3 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.285 -0.884 . . . . 0.0 108.732 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 77.5 t -38.94 94.39 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.939 -0.475 . . . . 0.0 109.739 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 49' ' ' PHE . 37.4 Cg_endo . . . . . 0 C--N 1.303 -1.827 0 C-N-CA 122.274 1.982 . . . . 0.0 111.822 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.486 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.501 2.12 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.515 HG22 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -77.33 0.22 23.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 58' ' ' ASP . 2.0 mt-30 -110.92 -172.42 2.03 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.108 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 29.2 t70 -32.43 142.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.569 0.699 . . . . 0.0 110.916 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.3 -40.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -144.39 -65.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.478 -1.013 . . . . 0.0 109.319 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.48 -31.25 0.52 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.543 ' CE1' ' OG ' ' A' ' 215' ' ' SER . 2.5 t-160 -61.37 -43.43 98.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -57.4 -74.66 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.57 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -38.28 -49.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.51 -0.994 . . . . 0.0 110.557 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 12.9 t-80 -52.29 -50.79 61.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 70' ' ' ILE . 31.4 t -62.27 -29.58 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.404 -0.81 . . . . 0.0 109.584 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -61.3 -47.43 85.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.342 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.458 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -75.81 -23.09 73.3 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.564 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 8.3 m -74.58 -14.86 60.84 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.084 -1.245 . . . . 0.0 107.875 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 66' ' ' VAL . 62.6 mt -94.73 -35.46 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.503 -0.748 . . . . 0.0 110.829 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.671 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -165.5 27.93 0.05 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 0.0 112.37 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -44.19 153.87 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.444 -1.41 . . . . 0.0 108.635 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 79' ' ' VAL . 73.9 mt -75.86 171.95 13.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.95 -1.094 . . . . 0.0 110.205 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.797 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -103.64 51.57 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.555 ' O ' ' C ' ' A' ' 76' ' ' SER . 0.1 OUTLIER -177.07 -115.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.568 ' O ' ' C ' ' A' ' 77' ' ' ILE . 12.3 m 22.28 71.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.335 -0.228 . . . . 0.0 110.956 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.58 ' O ' HD12 ' A' ' 77' ' ' ILE . 1.3 pp 14.79 57.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.664 0.745 . . . . 0.0 111.578 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' SER . . . -154.87 -161.27 10.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 79' ' ' VAL . 21.9 m -95.9 -161.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -1.132 . . . . 0.0 109.861 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD22 ' HB3' ' A' ' 74' ' ' ASN . 20.2 tp -143.42 123.45 13.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.838 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.83 -148.9 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.508 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 40.7 t -100.16 -25.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.086 -1.243 . . . . 0.0 109.325 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -99.65 137.14 20.18 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.977 . . . . 0.0 108.754 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.47 -61.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.72 2.28 . . . . 0.0 111.018 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -117.48 48.52 1.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.525 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -87.78 150.41 23.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.112 -0.992 . . . . 0.0 109.402 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 2.5 mt-10 -81.85 108.42 15.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 109.156 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 71' ' ' ALA . 8.6 mt -85.45 124.94 32.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.675 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 7.6 m-85 -113.76 143.18 45.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.166 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.735 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -111.97 95.4 5.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.127 -0.983 . . . . 0.0 109.64 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.921 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.63 62.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.083 -1.011 . . . . 0.0 108.897 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.585 ' CE ' ' HB2' ' A' ' 48' ' ' SER . 12.2 ttpp -36.81 116.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.282 0.563 . . . . 0.0 110.077 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG21 HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -122.58 0.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 32' ' ' ASP . 62.8 mt -119.34 174.7 6.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.46 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -119.6 146.08 18.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.008 179.769 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 155.18 20.85 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.769 -0.842 . . . . 0.0 109.654 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.513 HG21 ' OG ' ' A' ' 130' ' ' SER . 20.0 t -67.75 -20.74 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -20.53 60.37 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -86.3 -47.33 9.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.68 -0.637 . . . . 0.0 109.581 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.449 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.5 mt -67.2 -34.17 67.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.189 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' A' ' 110' ' ' GLU . . . -71.92 -43.57 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.917 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -69.56 -31.19 69.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.813 -1.18 . . . . 0.0 109.882 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -82.19 -18.16 67.66 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 -34.5 27.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -1.149 . . . . 0.0 110.022 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.52 ' HG2' ' OG ' ' A' ' 139' ' ' SER . 3.9 mt-10 -90.1 -19.19 24.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.891 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.608 ' CE2' ' O ' ' A' ' 115' ' ' ASN . 84.5 t90 -68.18 -25.04 65.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.132 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -90.5 5.9 45.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.898 -1.126 . . . . 0.0 109.412 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -94.91 -36.49 5.5 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -106.19 -23.15 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -1.095 . . . . 0.0 109.224 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.608 ' O ' ' CE2' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -173.06 89.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.641 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . 172.8 50.75 0.05 OUTLIER Glycine 0 C--N 1.291 -1.971 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.469 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.764 ' HE3' ' H ' ' A' ' 117' ' ' MET . 0.0 OUTLIER 62.52 163.3 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.473 -1.016 . . . . 0.0 112.062 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.777 ' CE1' HG23 ' A' ' 119' ' ' VAL . 9.7 p80 -98.15 -30.16 12.81 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.777 HG23 ' CE1' ' A' ' 118' ' ' HIS . 4.8 t -95.84 157.72 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.836 -1.165 . . . . 0.0 108.901 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -167.5 124.57 1.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 122' ' ' LEU . 15.7 t-20 -102.53 166.96 10.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.872 HD23 HD21 ' A' ' 124' ' ' LEU . 3.5 mp -146.88 112.65 5.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.865 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.2 t -90.14 62.38 5.48 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.872 HD21 HD23 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -146.93 -174.12 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.63 0.729 . . . . 0.0 110.213 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.506 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 160.42 109.57 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.95 154.7 81.49 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.043 -1.269 . . . . 0.0 109.814 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -78.67 5.4 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.76 2.306 . . . . 0.0 110.099 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 m -110.63 82.43 2.88 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.726 -0.609 . . . . 0.0 109.992 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.4 Cg_endo -76.93 171.48 17.9 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.393 2.062 . . . . 0.0 110.754 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.513 ' OG ' HG21 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -144.01 134.47 24.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 108.977 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.56 66.17 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.9 m -70.91 -28.22 64.37 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -24.74 53.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.55 -55.72 5.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.135 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.77 -25.01 16.99 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.33 53.69 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.67 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.616 HG11 ' ND2' ' A' ' 167' ' ' ASN . 2.2 t -71.94 -19.36 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 142' ' ' SER . 1.2 t30 -76.1 -29.39 57.89 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.52 ' OG ' ' HG2' ' A' ' 110' ' ' GLU . 1.0 OUTLIER -88.13 -19.05 27.5 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.239 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 145' ' ' VAL . . . -93.39 -26.21 17.35 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.636 -1.29 . . . . 0.0 110.558 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.98 -34.14 13.17 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 138' ' ' ASN . 8.0 t -67.54 -24.69 65.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -81.14 -16.95 51.53 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 237' ' ' ASN . . . 91.7 50.34 2.73 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 118' ' ' HIS . 70.7 t -113.75 111.11 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 109.234 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.475 HD23 HG13 ' A' ' 119' ' ' VAL . 1.8 tp -69.96 126.39 29.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.043 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -120.19 137.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.736 HG22 ' HG3' ' A' ' 169' ' ' MET . 8.9 t -121.05 166.77 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.506 ' C ' HG21 ' A' ' 218' ' ' THR . . . -153.61 140.65 19.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.944 -1.098 . . . . 0.0 109.555 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.584 ' N ' HG21 ' A' ' 218' ' ' THR . . . -75.95 153.42 36.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.495 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 4.6 t -77.96 -71.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 185' ' ' GLN . . . 164.67 119.02 0.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -87.51 56.62 4.01 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 122.062 -0.669 . . . . 0.0 109.868 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.3 p -137.12 -108.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.613 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . -103.06 -95.98 2.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 167.58 74.16 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.324 -1.103 . . . . 0.0 109.89 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -106.91 43.63 1.65 Allowed Glycine 0 C--N 1.287 -2.166 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.2 p 80.53 131.68 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.832 -0.804 . . . . 0.0 109.657 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -55.08 -169.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.764 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -139.08 164.64 29.23 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.573 -0.704 . . . . 0.0 111.822 -178.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.504 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 1.5 m-85 -79.45 145.52 63.83 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.3 Cg_endo -71.53 -33.96 3.51 Favored 'Cis proline' 0 C--N 1.295 -2.256 0 O-C-N 122.566 0.772 . . . . 0.0 110.942 4.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -31.09 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.006 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -79.68 -49.14 12.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.802 -1.186 . . . . 0.0 109.987 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.496 ' O ' ' O ' ' A' ' 164' ' ' ARG . 2.7 m-85 -46.78 -179.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.006 0.908 . . . . 0.0 110.416 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.4 -8.12 23.62 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.746 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.616 ' ND2' HG11 ' A' ' 137' ' ' VAL . 10.7 p30 -88.65 20.84 3.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -159.16 142.11 14.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 108.893 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.736 ' HG3' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.41 131.91 41.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 109.671 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 190' ' ' LEU . . . -95.47 114.82 26.62 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 108.857 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.3 t -94.19 165.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.569 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -144.23 -175.06 17.03 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -123.64 164.24 19.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -1.074 . . . . 0.0 109.056 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p -142.74 167.85 21.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.466 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.5 OUTLIER -66.43 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.33 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.73 -32.62 11.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.97 . . . . 0.0 109.862 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.65 -78.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.701 ' CG ' HD23 ' A' ' 251' ' ' LEU . 39.4 t-20 -173.07 45.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 109.741 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 24.4 t30 -135.9 167.27 21.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.044 -1.035 . . . . 0.0 109.553 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.497 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.5 ttt-85 -45.79 138.65 4.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.774 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.87 -134.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.643 -0.661 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 m -127.86 -31.53 2.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.883 -1.135 . . . . 0.0 109.734 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' SER . 24.5 p90 -123.47 -3.19 8.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.875 . . . . 0.0 109.65 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.3 OUTLIER -44.09 107.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 109.782 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -58.15 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.646 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.684 ' HE2' ' HB2' ' A' ' 188' ' ' ALA . 1.2 t80 -50.07 -167.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.758 0.789 . . . . 0.0 111.638 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.548 ' CA ' HD22 ' A' ' 190' ' ' LEU . . . -173.1 23.06 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.48 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' HE2' ' A' ' 186' ' ' TYR . . . -75.84 97.78 4.0 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.685 -0.891 . . . . 0.0 109.445 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.38 -22.67 28.79 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -45.15 154.74 0.14 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.505 -0.997 . . . . 0.0 109.626 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 192' ' ' ILE . 51.9 t0 -55.03 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.815 . . . . 0.0 110.891 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.669 HG22 ' OG ' ' A' ' 259' ' ' SER . 0.5 OUTLIER -146.7 -157.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.913 -1.117 . . . . 0.0 110.064 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 262' ' ' VAL . 30.3 m -143.0 168.55 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.796 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -151.56 160.85 31.1 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.41 -0.806 . . . . 0.0 109.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.6 Cg_endo -74.87 115.23 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.06 60.9 0.4 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.321 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.635 ' HB ' ' CZ2' ' A' ' 6' ' ' TRP . 47.5 t -97.62 70.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER 111.62 119.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 216' ' ' MET . 1.7 m -156.27 112.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.07 0.938 . . . . 0.0 108.484 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.6 OUTLIER -89.86 171.2 9.77 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.624 0.726 . . . . 0.0 110.071 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.585 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 20.4 m -167.56 -146.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.726 . . . . 0.0 109.074 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.418 HG21 HD11 ' A' ' 41' ' ' LEU . 77.1 p -92.68 150.08 20.91 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 110.068 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.582 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 2.1 t80 -140.55 142.46 29.07 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.3 Cg_endo -72.04 156.94 55.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.312 2.008 . . . . 0.0 110.986 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 36.41 54.48 1.31 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.4 t -179.83 -107.62 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.094 -1.239 . . . . 0.0 109.719 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 208' ' ' TYR . 4.3 t -175.45 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.438 -0.789 . . . . 0.0 109.119 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.551 ' N ' HG23 ' A' ' 207' ' ' THR . 0.1 OUTLIER -89.24 142.76 27.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.738 -1.226 . . . . 0.0 109.632 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -125.71 111.39 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.642 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.3 OUTLIER -83.08 132.35 35.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 211' ' ' LEU . 1.0 OUTLIER -167.24 138.72 3.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.97 . . . . 0.0 109.876 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -88.89 147.51 24.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 108.927 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 170.55 146.3 5.1 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.003 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.7 p -66.51 -27.17 67.56 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.274 -1.133 . . . . 0.0 108.521 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.543 ' OG ' ' CE1' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -55.63 -22.37 22.27 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.62 ' CB ' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -85.57 -29.79 23.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -82.36 -23.0 35.25 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.165 -0.959 . . . . 0.0 110.369 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.654 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 4.9 m -66.41 -46.15 59.52 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.895 -1.128 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.2 Cg_endo -73.07 -12.98 26.08 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.919 1.746 . . . . 0.0 109.931 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -74.11 -42.4 60.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.734 HG22 HG11 ' A' ' 262' ' ' VAL . 74.2 t -70.74 -48.83 55.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -46.11 -43.23 14.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -61.51 -45.37 96.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.08 39.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -1.041 . . . . 0.0 109.472 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -52.04 -34.58 43.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -59.94 -47.24 86.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 0.0 109.214 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.5 HD13 ' HB1' ' A' ' 16' ' ' ALA . 67.3 mt -59.8 -29.23 68.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 229' ' ' LYS . 36.4 t -69.57 -62.22 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.31 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -41.9 -47.07 4.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.695 . . . . 0.0 109.714 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.534 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 5.0 tp-100 -59.62 -49.38 77.99 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.167 -0.958 . . . . 0.0 109.751 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.858 ' HG3' HD23 ' A' ' 21' ' ' LEU . 6.0 tttm -54.31 -19.3 5.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.486 ' HB2' ' CD2' ' A' ' 235' ' ' TRP . 19.0 m120 -160.93 92.05 1.54 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 109.967 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.6 -11.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.415 2.077 . . . . 0.0 110.303 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.3 m -87.49 -8.87 55.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.486 ' CD2' ' HB2' ' A' ' 232' ' ' ASN . 25.3 m0 -69.65 179.62 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.556 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.18 178.22 5.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.523 ' HB3' ' HA2' ' A' ' 144' ' ' GLY . 18.7 p-10 -52.62 -25.63 11.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 109.42 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.67 -65.4 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.14 -0.975 . . . . 0.0 109.226 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 0.5 OUTLIER -44.76 -25.84 0.33 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.333 0.587 . . . . 0.0 109.967 -178.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.06 -63.65 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 242' ' ' ASN . 15.2 ttp180 -58.2 -63.43 1.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 241' ' ' ARG . 46.3 t30 -37.83 -44.85 0.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 110.705 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -43.85 93.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 110.082 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.519 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 1.4 mt -68.57 -34.0 75.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.362 -0.836 . . . . 0.0 110.95 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.53 55.78 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.78 -4.38 26.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.606 -0.684 . . . . 0.0 109.567 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.4 p -98.48 -28.36 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.9 -1.125 . . . . 0.0 109.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -42.27 142.55 0.75 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 250' ' ' SER . 18.9 m -75.13 164.87 26.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.225 -0.922 . . . . 0.0 109.007 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.574 ' N ' HG22 ' A' ' 249' ' ' THR . 20.5 p -133.04 116.64 16.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.021 -1.05 . . . . 0.0 110.226 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.701 HD23 ' CG ' ' A' ' 178' ' ' ASN . 6.8 mp . . . . . 0 N--CA 1.484 1.272 0 O-C-N 121.165 -0.959 . . . . 0.0 109.677 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' A' ' 258' ' ' GLY . 13.3 m-30 -106.66 47.48 0.88 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 257' ' ' TYR . . . -30.66 -89.18 0.01 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.669 ' OG ' HG22 ' A' ' 192' ' ' ILE . 1.6 p -61.19 -96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.127 -1.219 . . . . 0.0 108.721 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 175.34 -132.35 2.15 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 28.3 tp -85.83 155.35 21.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.956 -0.732 . . . . 0.0 110.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 221' ' ' VAL . 2.7 t -92.13 145.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.437 -0.79 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -169.66 119.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.367 1.08 . . . . 0.0 108.714 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -75.19 -17.28 60.4 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.702 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.459 ' HA ' ' OG1' ' A' ' 268' ' ' THR . 56.3 tt0 -61.52 -20.46 63.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -84.27 -22.44 30.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.578 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -117.15 15.43 14.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.779 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 265' ' ' GLU . 11.0 p -118.88 -39.92 2.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 269' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.523 ' C ' ' O ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -22.51 85.2 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.867 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HG2' ' CG1' ' A' ' 8' ' ' ILE . 36.6 Cg_endo -80.97 -176.19 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.911 2.407 . . . . 0.0 110.897 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.612 ' CE2' ' O ' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -24.64 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.407 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -114.31 -83.01 1.12 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.005 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.841 HG22 ' N ' ' A' ' 9' ' ' SER . 1.7 mm 49.52 -86.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.858 -0.789 . . . . 0.0 109.268 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.841 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -61.43 -12.46 14.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.91 -1.119 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -27.79 67.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 8' ' ' ILE . 30.8 m -92.99 27.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG2' ' HB3' ' A' ' 265' ' ' GLU . 3.6 mp0 61.74 47.39 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.755 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -82.83 -31.48 0.52 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 111.676 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -75.11 -54.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 108.087 -1.543 . . . . 0.0 108.087 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.73 -35.75 1.97 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.61 -43.24 63.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.961 -1.087 . . . . 0.0 108.955 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.08 -2.99 33.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 -39.98 8.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.47 -55.72 9.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.44 -27.86 0.77 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 268' ' ' THR . 1.1 mt -49.95 111.58 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.207 -1.172 . . . . 0.0 109.305 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -96.42 -19.59 19.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -0.837 . . . . 0.0 109.927 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 78.18 -11.26 23.85 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 42.7 p -55.96 125.78 22.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -1.133 . . . . 0.0 109.609 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.83 -14.37 6.36 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.651 -1.261 . . . . 0.0 109.982 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.739 HG13 ' NE2' ' A' ' 118' ' ' HIS . 11.5 t -102.46 157.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.972 -1.311 . . . . 0.0 109.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -124.96 113.95 18.5 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.51 -0.744 . . . . 0.0 109.092 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.585 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 4.2 t -101.71 147.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 120' ' ' ALA . . . -110.17 159.5 17.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -0.9 . . . . 0.0 108.944 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.936 HG12 ' OD1' ' A' ' 32' ' ' ASP . 1.6 t -136.85 92.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 108.751 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.597 HD23 HG21 ' A' ' 93' ' ' VAL . 6.0 mp -79.97 88.9 5.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.936 ' OD1' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.98 -160.13 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -94.1 28.02 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.442 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 58' ' ' ASP . . . 121.46 123.48 2.97 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.662 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.607 HD11 ' CG2' ' A' ' 30' ' ' VAL . 3.9 mt -86.84 -17.09 9.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.726 0.774 . . . . 0.0 109.751 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 2.9 t 62.31 156.3 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.677 -0.639 . . . . 0.0 109.393 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.6 t -86.71 157.05 19.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.079 -1.013 . . . . 0.0 110.154 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.628 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -169.9 172.84 2.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.5 Cg_endo -81.05 -27.02 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.503 2.136 . . . . 0.0 109.875 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.779 ' HB3' HD11 ' A' ' 77' ' ' ILE . 14.4 p30 -115.19 25.34 10.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.387 -0.82 . . . . 0.0 109.292 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 43' ' ' ILE . 19.7 mt -128.9 21.23 5.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.759 . . . . 0.0 109.11 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 41' ' ' LEU . 7.8 p-10 -25.54 123.55 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -88.96 91.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.346 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 3.3 tpm_? -56.41 -21.25 23.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.876 -1.14 . . . . 0.0 108.073 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 171.17 138.26 2.49 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.65 169.81 34.02 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.317 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.624 -0.927 . . . . 0.0 108.692 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 92' ' ' LYS . 3.1 p -123.94 120.18 31.76 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.734 ' HE2' HG12 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -122.31 -39.24 2.59 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.12 -0.987 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.566 ' HB ' ' CE ' ' A' ' 92' ' ' LYS . 4.2 t -67.66 131.59 92.82 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 C--N 1.31 -1.467 0 C-N-CA 122.162 1.908 . . . . 0.0 108.762 178.55 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 1.6 t -64.45 -2.52 2.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.46 ' C ' ' HA3' ' A' ' 34' ' ' GLY . 7.4 mt-30 -88.27 155.77 19.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.031 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.916 ' OD2' HG22 ' A' ' 64' ' ' THR . 8.3 t0 -73.07 145.98 46.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 110.08 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.34 -17.73 6.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.43 -64.7 1.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -1.083 . . . . 0.0 109.518 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.532 ' CA ' ' OD2' ' A' ' 58' ' ' ASP . . . 156.74 -16.97 0.4 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.443 ' C ' ' CD2' ' A' ' 62' ' ' HIS . 2.9 t-160 -52.1 -61.47 2.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.274 . . . . 0.0 109.706 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -55.16 -77.02 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.014 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.916 HG22 ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -33.05 -67.02 0.13 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.731 -0.864 . . . . 0.0 110.73 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.786 ' CD2' HD21 ' A' ' 211' ' ' LEU . 12.6 t-80 -42.66 -48.91 5.59 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 70' ' ' ILE . 27.7 t -58.39 -41.03 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.086 -1.009 . . . . 0.0 109.623 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.79 -49.5 73.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.294 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -66.76 -33.56 84.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.507 HG23 ' CE1' ' A' ' 220' ' ' HIS . 6.3 m -67.64 -20.73 65.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.176 -1.19 . . . . 0.0 109.07 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 66' ' ' VAL . 79.8 mt -88.16 -28.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.376 -0.827 . . . . 0.0 109.844 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 83' ' ' ALA . . . -153.26 -37.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 111.484 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.767 ' HB1' ' CG1' ' A' ' 79' ' ' VAL . . . 32.81 72.51 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.522 -0.736 . . . . 0.0 109.92 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -38.32 150.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.684 ' CB ' HD12 ' A' ' 80' ' ' LEU . 6.3 t-20 -138.19 92.25 2.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.012 -1.055 . . . . 0.0 110.962 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 76' ' ' SER . 0.6 OUTLIER -97.66 -17.1 19.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.3 m 157.66 28.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.826 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 40' ' ' ASP . 5.8 pt -125.84 52.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.794 -1.191 . . . . 0.0 109.998 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 42.99 -172.9 0.01 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.817 0.676 . . . . 0.0 111.515 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.767 ' CG1' ' HB1' ' A' ' 72' ' ' ALA . 38.5 t 78.93 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 122.175 -0.603 . . . . 0.0 110.645 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' A' ' 74' ' ' ASN . 1.4 tp 56.64 92.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 109.87 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.633 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -71.65 -155.19 2.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 HD11 ' A' ' 227' ' ' LEU . 2.1 t -84.12 -51.29 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -1.221 . . . . 0.0 109.346 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -94.55 125.87 49.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.017 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.69 -60.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.701 2.267 . . . . 0.0 110.715 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 10.0 m120 -93.37 35.03 1.11 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.759 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -83.71 129.69 34.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 109.744 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 27' ' ' LYS . 1.8 mp0 -67.27 114.73 6.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.27 -0.893 . . . . 0.0 108.746 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 mt -97.93 115.55 28.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 110.616 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.571 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 28.1 m-85 -102.98 162.24 13.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -129.36 106.2 8.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.178 . . . . 0.0 110.37 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.734 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -107.13 67.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.566 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -42.6 104.38 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.9 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.597 HG21 HD23 ' A' ' 31' ' ' LEU . 4.0 t -123.74 -25.67 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.549 -0.719 . . . . 0.0 109.085 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.69 HD21 HD22 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -91.42 176.14 6.67 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 110.085 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -116.87 173.88 14.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.159 -1.201 . . . . 0.0 109.766 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.5 157.36 30.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.8 -0.823 . . . . 0.0 110.009 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.971 HG21 ' OG ' ' A' ' 130' ' ' SER . 2.3 t -67.82 -23.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -20.18 60.77 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.9 p -80.89 -52.36 7.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.584 0.707 . . . . 0.0 109.386 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.934 ' HB ' HD11 ' A' ' 133' ' ' LEU . 1.2 mt -65.95 -32.88 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.689 . . . . 0.0 109.584 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.83 -36.49 70.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -71.39 -41.47 69.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.71 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.51 -14.92 81.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 109' ' ' LEU . 14.0 mt -83.21 -29.39 28.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.308 -1.113 . . . . 0.0 109.015 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.5 -28.81 18.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.585 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 46.6 t90 -71.07 -15.32 62.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.671 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.13 -1.19 57.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.36 -0.838 . . . . 0.0 109.688 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.56 -33.71 2.62 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.703 -1.236 . . . . 0.0 111.136 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.68 -85.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.779 -1.424 . . . . 0.0 109.275 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -94.16 23.63 4.91 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.825 ' O ' ' HE2' ' A' ' 117' ' ' MET . . . -99.16 -146.0 19.48 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.991 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.825 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 4.6 mmt -133.15 179.43 6.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.434 -1.039 . . . . 0.0 110.33 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.739 ' NE2' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -88.42 -29.98 19.81 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.095 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 1.4 t -99.85 149.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 119.668 -1.895 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -164.94 115.09 1.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.812 ' C ' HD12 ' A' ' 122' ' ' LEU . 10.2 t-20 -89.22 160.28 17.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.978 . . . . 0.0 109.767 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 121' ' ' ASN . 5.4 mp -147.76 109.47 4.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.999 -1.063 . . . . 0.0 109.877 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 67.86 3.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.966 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.69 HD22 HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -132.66 172.88 11.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.918 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.465 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.79 104.28 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.83 162.48 43.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.102 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.4 Cg_endo -81.21 9.12 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.12 2.547 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.9 102.25 19.03 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.262 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.3 Cg_endo -78.76 178.19 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.688 2.259 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.971 ' OG ' HG21 ' A' ' 102' ' ' VAL . 5.0 m -175.92 119.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 109.487 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -19.96 65.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 23.6 m -69.05 -27.36 65.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.934 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.3 tp -81.57 -37.98 26.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.574 ' CG ' ' CE2' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -76.68 -21.43 55.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.53 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.95 -25.6 53.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 -32.04 30.48 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.53 ' CG1' ' ND2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -71.42 -36.1 59.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.13 -34.97 78.77 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.1 t -80.3 -19.1 47.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.68 -10.28 43.72 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.985 -1.072 . . . . 0.0 109.91 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 89.9 m -89.26 -40.15 13.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 109.133 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.21 -27.29 68.32 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.28 31.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.93 66.97 1.65 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 118' ' ' HIS . 14.5 t -117.05 109.75 28.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.401 -1.058 . . . . 0.0 109.597 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.9 104.89 3.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.168 -0.957 . . . . 0.0 109.337 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.781 HG12 HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.52 135.66 35.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.031 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.748 HG22 ' HB2' ' A' ' 169' ' ' MET . 3.0 t -112.86 156.82 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 170' ' ' ALA . . . -138.42 137.07 36.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 109.804 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.13 171.54 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -89.28 -79.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.601 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.622 ' O ' ' CB ' ' A' ' 153' ' ' ASN . . . -152.76 -116.98 0.68 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 152' ' ' GLY . 22.7 t-20 135.6 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 123.395 0.678 . . . . 0.0 109.744 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.1 m -121.65 -98.02 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 109.6 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.416 ' HA2' ' CD ' ' A' ' 185' ' ' GLN . . . 179.06 47.38 0.08 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.27 172.56 6.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.16 . . . . 0.0 109.213 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.9 56.32 0.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.461 ' HA ' ' HA3' ' A' ' 187' ' ' GLY . 0.2 OUTLIER 175.27 156.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -1.135 . . . . 0.0 109.26 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 pt -100.12 -177.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.802 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -109.48 166.86 10.56 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.943 0.877 . . . . 0.0 112.518 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.56 ' OH ' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -85.03 149.41 53.02 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 164' ' ' ARG . 42.2 Cg_endo -71.68 -32.22 4.49 Favored 'Cis proline' 0 C--N 1.295 -2.254 0 O-C-N 122.408 0.688 . . . . 0.0 110.734 3.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -25.4 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.721 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -65.42 -55.81 15.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.938 -1.101 . . . . 0.0 109.714 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.574 ' CE2' ' CG ' ' A' ' 134' ' ' GLU . 1.4 m-85 -42.58 -177.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.542 1.163 . . . . 0.0 111.6 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -115.56 2.44 13.8 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.53 ' ND2' ' CG1' ' A' ' 137' ' ' VAL . 9.3 m-20 -89.33 21.66 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 108.899 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.43 171.76 10.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.748 ' HB2' HG22 ' A' ' 148' ' ' VAL . 48.4 mtp -99.46 -177.82 3.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -151.5 115.39 4.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 192' ' ' ILE . 23.7 t -107.46 165.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.057 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.86 -173.31 13.3 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.495 ' C ' ' HB2' ' A' ' 181' ' ' ALA . . . -118.88 164.13 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.134 . . . . 0.0 109.655 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.753 ' CA ' ' HB2' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -138.15 175.6 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 0.0 109.69 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.483 ' N ' ' HA ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -89.91 -172.98 3.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.576 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -101.79 -21.49 14.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.78 -53.5 6.44 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.269 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -131.89 -94.09 0.37 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.472 -0.768 . . . . 0.0 109.751 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.656 ' CG ' HG21 ' A' ' 174' ' ' THR . 0.7 OUTLIER -160.03 -154.47 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.197 -0.939 . . . . 0.0 109.59 -178.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.489 ' N ' HG22 ' A' ' 174' ' ' THR . 0.0 OUTLIER 58.11 4.3 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.753 ' HB2' ' CA ' ' A' ' 174' ' ' THR . . . 36.24 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.582 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.9 t -145.92 21.84 1.42 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.175 -0.953 . . . . 0.0 108.996 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -168.66 26.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.833 . . . . 0.0 109.658 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -104.51 128.63 52.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 108.934 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CD ' ' HA2' ' A' ' 155' ' ' GLY . 64.8 mm-40 -90.06 147.36 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 110.021 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.517 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.58 169.22 12.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . -170.93 152.25 17.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -44.06 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 138.64 -0.78 2.51 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.263 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 65.0 tp -50.33 145.81 5.86 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.829 -1.395 . . . . 0.0 108.745 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.6 OUTLIER -104.56 -63.75 1.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 111.103 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 171' ' ' VAL . 1.2 tt -151.47 163.87 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.375 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.981 HG21 ' CE1' ' A' ' 257' ' ' TYR . 22.1 m -118.0 160.33 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.676 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.613 ' C ' ' HG1' ' A' ' 174' ' ' THR . . . -150.66 161.07 31.38 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.7 Cg_endo -75.21 126.08 9.6 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.14 1.893 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.429 ' C ' ' OD1' ' A' ' 212' ' ' ASN . . . -152.21 62.13 0.39 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.632 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.612 ' O ' ' CE2' ' A' ' 6' ' ' TRP . 74.5 t -135.76 89.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.6 ' O ' HG13 ' A' ' 199' ' ' VAL . 11.6 t-20 94.14 107.42 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.696 HG22 ' CG ' ' A' ' 212' ' ' ASN . 19.7 m -161.91 111.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.19 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 201' ' ' SER . 2.9 tt0 -85.97 147.37 26.26 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.6 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 7.4 t -146.76 -146.67 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.584 HG21 ' OD1' ' A' ' 40' ' ' ASP . 66.0 p -88.02 172.38 9.59 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.675 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -157.87 161.05 29.64 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.675 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.7 Cg_endo -70.42 165.29 32.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.136 1.891 . . . . 0.0 110.685 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 79.92 3.87 89.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.2 OUTLIER 77.69 32.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -1.088 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -129.79 158.03 40.56 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.493 ' OH ' HD12 ' A' ' 77' ' ' ILE . 11.7 m-30 -91.51 -174.67 3.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.536 ' HB2' ' CG ' ' A' ' 203' ' ' TYR . . . -164.25 157.19 17.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.872 -1.142 . . . . 0.0 110.219 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 3.5 m -113.21 120.31 40.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -166.88 161.8 15.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.696 ' CG ' HG22 ' A' ' 199' ' ' VAL . 0.2 OUTLIER -148.19 -160.48 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.973 -1.079 . . . . 0.0 111.153 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 130.49 157.95 9.15 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 214' ' ' THR . 0.0 OUTLIER -60.94 -19.13 60.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.859 -1.377 . . . . 0.0 108.644 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.1 m -71.86 -32.71 67.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.485 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -82.27 -19.8 38.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.445 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -87.45 -26.5 23.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.631 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 26.2 m -57.2 -42.8 97.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.725 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.9 Cg_endo -71.93 -26.55 18.55 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.715 1.61 . . . . 0.0 111.132 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.507 ' CE1' HG23 ' A' ' 69' ' ' THR . 0.4 OUTLIER -58.66 -40.37 83.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.677 HG22 HG21 ' A' ' 262' ' ' VAL . 60.4 t -70.33 -47.66 65.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -45.8 -31.89 2.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -73.78 -48.08 18.1 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -57.39 -65.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -1.232 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -45.64 -36.58 4.93 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -58.84 -49.5 77.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.02 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.603 HD11 HG12 ' A' ' 82' ' ' VAL . 10.6 mt -49.96 -39.42 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 96.2 t -61.41 -52.47 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 108.902 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 19.1 mttm -44.33 -40.98 5.71 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.459 -0.776 . . . . 0.0 109.172 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 13.1 tp60 -62.93 -45.42 92.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 108.882 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -60.86 -14.21 20.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.472 -0.768 . . . . 0.0 109.045 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.88 80.93 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.356 -0.84 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.5 Cg_endo -78.89 8.24 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.711 2.274 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.44 -12.8 28.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.986 -1.071 . . . . 0.0 109.778 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -69.84 -179.69 1.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.99 170.81 7.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.595 -0.691 . . . . 0.0 109.359 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -62.22 -22.68 66.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -79.26 -63.63 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.112 -0.993 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.0 OUTLIER -42.96 -48.66 5.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 -178.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 -49.15 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 0.0 109.546 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 243' ' ' HIS . 6.6 ttp180 -51.37 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ARG . 43.7 t30 -34.27 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.869 -0.519 . . . . 0.0 111.346 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 241' ' ' ARG . 1.6 t60 -72.52 -50.4 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.53 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.1 OUTLIER -67.68 -23.29 65.29 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.61 47.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.571 -0.706 . . . . 0.0 110.181 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.69 -9.31 57.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 110.376 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.3 p -94.11 -29.84 14.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.973 -1.079 . . . . 0.0 109.663 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -40.25 129.27 2.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.555 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 249' ' ' THR . 6.0 m -75.98 89.57 2.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 260' ' ' GLY . 3.3 t -81.9 140.13 34.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 111.82 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.5 mp . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 257' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.587 0.708 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 1.028 ' N ' HD13 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -87.94 -4.72 58.8 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.532 -0.73 . . . . 0.0 111.776 -176.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 129.74 2.5 5.25 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.629 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 0.7 OUTLIER 79.2 -10.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -1.072 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 250' ' ' SER . . . 134.36 -165.82 24.31 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.069 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.573 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 58.3 tp -107.13 164.4 12.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -98.95 158.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.42 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.469 ' ND2' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -167.36 119.92 0.93 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.36 -5.31 31.6 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.358 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 5.1 tt0 -83.23 -42.55 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 109.911 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.96 1.74 26.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -115.03 -26.57 7.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.671 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.483 HG21 HD13 ' A' ' 21' ' ' LEU . 4.7 p -82.91 -38.8 22.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.597 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.529 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.41 76.72 15.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' TRP . 33.0 Cg_endo -77.8 164.56 27.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.409 2.073 . . . . 0.0 110.33 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.518 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -45.49 -26.86 0.63 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA3' ' CG1' ' A' ' 199' ' ' VAL . . . -72.26 -101.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.686 HG22 ' O ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -43.09 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -1.105 . . . . 0.0 109.142 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER 165.19 -43.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -1.6 58.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -0.832 . . . . 0.0 109.501 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.692 HG11 ' HB3' ' A' ' 220' ' ' HIS . 20.1 m -101.3 14.94 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.125 -0.984 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.702 HE21 ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 68.97 24.68 6.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.647 -0.658 . . . . 0.0 110.845 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -68.26 -39.87 18.39 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.906 -1.121 . . . . 0.0 110.895 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 32.2 Cg_endo -75.18 -60.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.205 -1.498 . . . . 0.0 108.205 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HB3' HE21 ' A' ' 12' ' ' GLN . . . -45.99 -24.21 0.39 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.593 ' N ' ' NE2' ' A' ' 12' ' ' GLN . . . -81.19 -41.64 22.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.874 -1.141 . . . . 0.0 109.244 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 16.3 m170 -69.45 -19.68 63.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 109.626 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -87.15 -39.1 15.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.58 ' HB3' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.54 -17.58 62.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.45 8.7 26.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -74.03 132.04 41.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -115.43 -22.57 9.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.462 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 53.6 11.03 1.69 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.453 ' N ' ' C ' ' A' ' 22' ' ' THR . 5.2 t -76.19 1.64 15.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -1.217 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.6 17.91 35.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 27' ' ' LYS . 60.7 t -123.18 167.02 17.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 120.935 -1.333 . . . . 0.0 109.995 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' N ' HG12 ' A' ' 26' ' ' VAL . 1.7 mptt -134.74 137.06 43.13 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 39.1 t -135.01 129.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.024 -1.048 . . . . 0.0 110.296 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -84.83 155.66 21.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.895 HG12 ' OD2' ' A' ' 32' ' ' ASP . 6.5 t -134.22 87.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 108.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 HG23 ' A' ' 91' ' ' VAL . 8.2 mp -74.27 99.91 3.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.895 ' OD2' HG12 ' A' ' 30' ' ' VAL . 1.1 m-20 -134.82 -161.61 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 96' ' ' ALA . 2.9 t -105.2 3.95 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.775 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 59' ' ' GLY . . . 144.97 121.83 1.49 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 64' ' ' THR . 11.3 mt -90.08 -110.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.557 ' N ' HG22 ' A' ' 35' ' ' ILE . 48.2 t 176.46 146.94 0.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.213 -0.93 . . . . 0.0 110.071 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -86.04 93.38 8.97 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.438 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -114.9 169.38 6.74 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.469 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 77' ' ' ILE . 35.6 Cg_endo -77.38 -45.4 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.619 2.212 . . . . 0.0 110.04 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 73' ' ' LEU . 3.9 m-20 -74.27 -34.27 63.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.822 . . . . 0.0 109.261 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 67' ' ' ALA . 2.3 mt -57.3 135.11 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -109.71 94.7 5.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 43' ' ' ILE . 8.7 mm -85.63 99.91 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 9.3 tpt180 -86.53 -18.74 30.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.684 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.509 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 162.32 176.37 34.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.57 47.55 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.142 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' HG12 ' A' ' 91' ' ' VAL . . . -146.03 160.25 42.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.978 . . . . 0.0 109.446 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 64.3 p -134.03 115.6 14.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.513 ' HE2' HG12 ' A' ' 91' ' ' VAL . 45.3 m-85 -116.92 -54.98 2.39 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.509 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 22.9 t -39.81 128.45 1.53 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.585 -0.697 . . . . 0.0 109.91 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.314 -1.248 0 C-N-CA 122.345 2.03 . . . . 0.0 110.595 -179.925 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.374 0.607 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.452 ' C ' ' HG3' ' A' ' 57' ' ' GLN . 1.4 m -63.36 -13.16 36.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.043 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.452 ' HG3' ' C ' ' A' ' 56' ' ' THR . 13.1 mt-30 -143.95 150.8 38.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 t0 62.08 92.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.805 . . . . 0.0 109.704 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -112.85 -25.63 4.45 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.82 -38.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -1.176 . . . . 0.0 109.75 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.07 -10.67 3.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -75.85 -70.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.155 -1.203 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 32' ' ' ASP . . . -48.17 -29.09 6.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.699 ' HA ' HG23 ' A' ' 35' ' ' ILE . 9.2 m -68.14 -53.15 27.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -1.073 . . . . 0.0 109.445 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 1.005 ' CD2' HD21 ' A' ' 211' ' ' LEU . 3.9 t-80 -55.89 -43.64 77.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.737 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 69' ' ' THR . 17.4 t -61.95 -34.2 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -62.36 -44.14 97.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.618 ' HA2' ' HB2' ' A' ' 72' ' ' ALA . . . -71.21 -42.02 58.63 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 66' ' ' VAL . 7.5 t -64.41 -15.3 60.32 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 120.366 -1.667 . . . . 0.0 107.851 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.007 HG21 HD21 ' A' ' 88' ' ' LEU . 31.7 mt -87.51 -38.84 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.321 -0.862 . . . . 0.0 109.93 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -178.64 36.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.769 -1.207 . . . . 0.0 111.853 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . . . -45.06 125.47 5.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.67 -1.269 . . . . 0.0 108.928 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 84' ' ' PRO . 85.5 mt -54.33 161.26 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 75' ' ' ASN . 10.4 t-20 -106.92 134.26 50.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 74' ' ' ASN . 74.2 m-20 -162.14 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.817 0.817 . . . . 0.0 109.081 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -155.12 -39.96 0.09 Allowed 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 39' ' ' PRO . 1.2 pt -103.38 67.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.456 -0.777 . . . . 0.0 109.595 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.94 158.62 13.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 201' ' ' SER . 27.6 m -80.39 -159.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.35 -1.088 . . . . 0.0 109.354 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.4 tp -141.53 116.52 9.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.968 -1.082 . . . . 0.0 109.771 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 175.83 54.78 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.64 -42.53 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -1.185 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . . . -93.17 141.96 24.71 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.736 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.691 ' O ' HD23 ' A' ' 73' ' ' LEU . 38.6 Cg_endo -84.25 -61.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.847 2.365 . . . . 0.0 110.692 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -120.48 49.87 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.436 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -79.17 159.59 27.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 108.979 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 25.9 mt-10 -89.37 89.16 7.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.979 -1.076 . . . . 0.0 108.972 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 70' ' ' ILE . 8.4 mt -75.6 142.89 42.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 110.236 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.56 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 4.1 m-85 -126.4 152.97 45.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.37 94.47 4.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.017 -1.052 . . . . 0.0 109.456 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -98.57 63.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.284 -0.885 . . . . 0.0 108.917 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -31.67 109.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.197 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -129.09 -10.37 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.374 -0.829 . . . . 0.0 109.433 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 124' ' ' LEU . 10.2 mt -103.81 -178.0 3.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 0.0 109.895 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.31 146.65 18.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.513 ' N ' ' OG1' ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.186 -1.185 . . . . 0.0 109.471 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.04 155.59 32.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.879 -0.777 . . . . 0.0 109.8 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.716 HG13 HD12 ' A' ' 133' ' ' LEU . 3.5 t -69.56 -19.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -17.7 58.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.497 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.2 m -88.33 -35.42 17.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.52 HD13 HD13 ' A' ' 124' ' ' LEU . 2.9 mt -77.11 -37.98 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 108.729 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.23 67.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -63.19 -45.55 91.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.507 -0.746 . . . . 0.0 108.992 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.22 -21.52 77.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 109' ' ' LEU . 14.5 mt -82.57 -19.93 37.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -94.38 -30.23 14.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.376 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -69.24 -17.01 63.72 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.717 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.728 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -91.37 -11.54 37.53 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -80.86 -15.71 76.89 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -117.13 1.19 12.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.076 -1.249 . . . . 0.0 109.946 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 7.2 t30 172.46 29.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.999 -1.063 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.728 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -110.71 48.08 0.98 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.312 -1.423 . . . . 0.0 110.763 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.588 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 15.8 mmt 60.91 -173.79 0.13 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 111.452 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.765 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -95.74 -32.69 12.6 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.716 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.765 HG23 ' CE1' ' A' ' 118' ' ' HIS . 55.7 t -104.8 166.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.717 -1.239 . . . . 0.0 109.833 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.764 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -169.35 117.04 0.62 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.964 ' O ' HD12 ' A' ' 122' ' ' LEU . 16.5 t-20 -96.31 152.96 18.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.964 HD12 ' O ' ' A' ' 121' ' ' ASN . 6.4 mp -133.88 102.79 5.57 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.92 66.3 9.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 109.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 105' ' ' ILE . 0.6 OUTLIER -152.86 172.22 17.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.333 -0.854 . . . . 0.0 109.617 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.571 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.58 104.42 0.18 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 160' ' ' SER . 0.3 OUTLIER -107.32 147.64 35.62 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.197 -1.178 . . . . 0.0 109.559 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.512 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 32.1 Cg_endo -74.0 -6.0 17.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.21 1.94 . . . . 0.0 108.934 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -103.95 100.32 20.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 32.7 Cg_endo -74.19 164.59 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.425 2.083 . . . . 0.0 110.944 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.585 ' CB ' HG11 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -151.05 135.92 17.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.91 63.59 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -77.88 -23.71 48.71 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.716 HD12 HG13 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -79.26 -40.57 30.21 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.415 ' OE2' ' CD1' ' A' ' 165' ' ' TYR . 1.9 mt-10 -76.85 -31.96 57.19 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.336 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -62.66 -26.82 68.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.48 60.83 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.917 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.495 ' CG1' ' CG ' ' A' ' 167' ' ' ASN . 1.3 t -63.26 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.54 -38.48 81.16 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.6 -23.75 53.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.91 -18.83 55.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.081 -1.012 . . . . 0.0 110.129 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -27.75 58.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.261 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -58.14 -30.81 66.63 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.162 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER -104.64 -12.0 16.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.476 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.85 62.16 4.98 Favored Glycine 0 N--CA 1.477 1.429 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 39.9 t -96.12 110.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.583 -0.951 . . . . 0.0 109.854 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.52 107.63 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.5 t -104.43 154.32 6.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.044 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.953 HG13 HD22 ' A' ' 121' ' ' ASN . 12.0 p -141.13 112.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.607 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -100.9 149.82 23.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.124 -0.985 . . . . 0.0 110.384 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.496 ' CB ' ' OG1' ' A' ' 218' ' ' THR . . . -78.6 151.71 32.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.727 . . . . 0.0 109.472 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -55.98 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 155.19 115.02 0.52 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 185' ' ' GLN . 1.7 t-20 -99.96 53.16 0.91 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.951 -0.735 . . . . 0.0 109.178 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.45 ' N ' ' OE1' ' A' ' 185' ' ' GLN . 2.4 p -94.6 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.437 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 150.55 39.2 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.49 172.97 7.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 109.365 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 186' ' ' TYR . . . -103.71 56.71 0.57 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.409 ' N ' ' HB2' ' A' ' 186' ' ' TYR . 1.6 p 172.36 124.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.042 -1.27 . . . . 0.0 109.862 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -59.23 -171.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.234 -0.917 . . . . 0.0 110.166 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.901 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -132.81 171.2 14.21 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.073 0.939 . . . . 0.0 112.795 -177.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.438 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 4.4 m-85 -82.61 146.41 53.22 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.607 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 41.4 Cg_endo -71.39 -30.29 5.63 Favored 'Cis proline' 0 C--N 1.293 -2.383 0 O-C-N 122.555 0.766 . . . . 0.0 110.436 3.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.901 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.625 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -70.5 -54.46 12.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 109.76 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -50.77 -170.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.177 0.989 . . . . 0.0 110.825 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.67 -16.73 8.19 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.495 ' CG ' ' CG1' ' A' ' 137' ' ' VAL . 4.4 m120 -57.08 -18.65 15.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 108.962 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -132.53 149.36 52.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.477 ' HA ' ' OD2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -89.87 130.1 36.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.907 -1.121 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 163' ' ' ALA . . . -92.55 117.97 30.51 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.95 HG22 ' CG2' ' A' ' 192' ' ' ILE . 24.7 t -92.33 164.58 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.268 1.032 . . . . 0.0 110.562 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -136.14 145.63 17.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.54 162.28 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.28 . . . . 0.0 110.14 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.508 ' CG2' ' HB ' ' A' ' 193' ' ' VAL . 73.1 p -144.58 170.83 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.528 -0.732 . . . . 0.0 109.46 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 179' ' ' ASN . 0.7 OUTLIER -102.82 -166.59 1.29 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -67.67 -49.63 61.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.186 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' ASN . 8.3 m120 -59.59 -75.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.054 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' ASN . 1.5 m-20 162.77 41.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.0 109.642 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.454 ' HB3' ' OD1' ' A' ' 175' ' ' ASP . 0.9 OUTLIER -98.46 -149.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.687 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -107.82 18.99 20.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.468 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 76.14 -162.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.0 109.905 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 t -100.53 -34.83 9.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.965 . . . . 0.0 110.204 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -108.12 -81.35 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 183' ' ' PHE . 3.3 t 32.05 100.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.128 0.49 . . . . 0.0 111.145 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' SER . 1.4 mp0 -45.49 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 0.0 109.815 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.502 ' CZ ' HD21 ' A' ' 256' ' ' LEU . 1.2 t80 -52.49 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 110.565 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.969 ' HA2' HD13 ' A' ' 190' ' ' LEU . . . -145.26 20.97 1.91 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -35.76 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 79.2 50.51 5.76 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.969 HD13 ' HA2' ' A' ' 187' ' ' GLY . 4.6 tp -75.62 144.8 41.56 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.568 -0.96 . . . . 0.0 109.465 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 259' ' ' SER . 1.2 m-20 -93.43 -46.01 7.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.208 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.95 ' CG2' HG22 ' A' ' 171' ' ' VAL . 1.5 tt -157.95 177.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.497 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 260' ' ' GLY . 31.6 m -138.79 172.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 109.663 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -173.55 174.44 1.1 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.926 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.6 Cg_endo -75.94 121.39 6.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.608 2.205 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -137.17 45.14 1.09 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.644 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 23.8 t -134.1 85.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.438 -1.036 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.946 ' O ' HG13 ' A' ' 199' ' ' VAL . 19.5 t-20 103.33 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER 178.28 115.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 210' ' ' SER . 1.7 pt20 -101.45 161.52 13.57 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.62 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -156.69 -158.67 0.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.546 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.62 174.06 11.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.595 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.9 OUTLIER -150.05 147.15 21.5 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 108.529 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 31.6 Cg_endo -69.91 129.96 18.33 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.721 1.614 . . . . 0.0 110.336 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 40.82 43.55 3.17 Favored Glycine 0 C--N 1.286 -2.243 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.833 ' O ' HG22 ' A' ' 207' ' ' THR . 0.9 OUTLIER -167.56 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.998 -1.295 . . . . 0.0 111.35 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 206' ' ' SER . 7.0 t 52.01 -143.24 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 111.032 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.658 ' N ' HG23 ' A' ' 207' ' ' THR . 0.1 OUTLIER -95.62 165.78 12.16 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.026 0.917 . . . . 0.0 111.639 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -158.03 162.2 38.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.483 ' HA ' ' CB ' ' A' ' 200' ' ' GLN . 0.6 OUTLIER -109.03 133.91 52.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.865 -1.147 . . . . 0.0 110.131 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 1.005 HD21 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -154.65 157.53 38.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -121.36 160.8 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 167.5 161.78 17.77 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.8 m -81.12 -28.9 34.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -1.181 . . . . 0.0 109.257 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -14.06 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 1.7 mpp? -87.95 -15.03 37.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -89.69 -8.87 51.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.657 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 86.5 m -77.35 -36.05 1.43 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 112.232 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 218' ' ' THR . 32.2 Cg_endo -73.66 -24.62 15.68 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.141 1.228 . . . . 0.0 110.264 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.692 ' HB3' HG11 ' A' ' 11' ' ' VAL . 7.6 m80 -62.38 -40.4 96.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 262' ' ' VAL . 59.2 t -70.17 -40.41 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -51.5 -41.26 60.85 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -65.99 -59.64 7.28 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -42.1 -37.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.107 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.46 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.158 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -55.1 -41.38 71.56 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.013 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 224' ' ' ALA . 48.3 mt -55.62 -45.68 77.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.708 HG21 HD23 ' A' ' 244' ' ' LEU . 31.5 t -56.0 -59.02 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 0.0 109.495 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.6 ' HD2' ' CE1' ' A' ' 118' ' ' HIS . 3.3 ttmm -44.68 -39.07 4.8 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.304 -0.872 . . . . 0.0 109.521 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.462 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -59.2 -54.95 41.12 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -56.63 -15.75 4.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 108.907 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.601 ' ND2' ' CZ3' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -166.83 84.16 0.89 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 37.4 Cg_endo -80.77 15.25 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.754 2.303 . . . . 0.0 111.17 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.87 -24.24 12.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.601 ' CZ3' ' ND2' ' A' ' 232' ' ' ASN . 32.3 m0 -62.71 175.14 0.86 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.9 m -99.71 176.37 5.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.649 -0.657 . . . . 0.0 109.758 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 238' ' ' VAL . 36.0 p30 -60.59 -22.18 63.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.431 -0.793 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -76.61 -64.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.177 -0.952 . . . . 0.0 109.277 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 238' ' ' VAL . 5.6 mm-40 -43.36 -35.58 1.59 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.547 0.689 . . . . 0.0 109.274 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.578 HD11 ' HE2' ' A' ' 229' ' ' LYS . 58.5 mt -69.35 -46.28 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 110.187 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -63.53 -53.16 56.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.1 -28.36 66.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -71.21 -62.93 1.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.708 HD23 HG21 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -59.72 -21.17 60.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.516 -0.74 . . . . 0.0 109.302 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.4 tptt -74.63 -52.85 10.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.597 -0.689 . . . . 0.0 110.281 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -11.83 59.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 3.0 p -88.43 -32.75 18.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.769 -1.207 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -54.6 150.3 9.53 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -63.54 167.07 5.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.7 t -131.22 97.57 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.2 mp . . . . . 0 C--N 1.305 -1.358 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.517 HD22 ' NH1' ' A' ' 180' ' ' ARG . 1.1 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -61.04 -36.25 79.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -0.849 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 77.11 -120.42 5.61 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 191' ' ' ASP . 44.1 t -61.46 -78.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.548 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 153.34 -153.08 24.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.599 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 15.1 tp -69.53 164.47 23.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -1.19 . . . . 0.0 108.862 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -126.2 147.48 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -172.07 121.69 0.46 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.457 ' C ' ' OE1' ' A' ' 12' ' ' GLN . . . -70.01 -0.97 8.47 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.556 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.542 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 39.8 tt0 -62.47 -57.92 9.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.853 -1.155 . . . . 0.0 108.981 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -71.65 -7.1 45.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.48 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -95.11 -19.39 20.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.923 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 11.0 p -103.05 -52.15 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.0 -1.063 . . . . 0.0 109.318 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.817 ' HB3' HD22 ' A' ' 80' ' ' LEU . 13.3 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.826 0.822 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.618 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 10.6 m -158.69 51.53 0.45 Allowed Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.488 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 35.6 Cg_endo -77.32 156.18 32.89 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.703 1.602 . . . . 0.0 109.892 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.515 ' CD1' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -62.36 -15.28 47.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 110.005 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 220' ' ' HIS . . . -94.26 21.07 44.44 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -144.84 10.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -1.234 . . . . 0.0 109.639 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 t -101.13 -18.92 15.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -99.99 6.79 45.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.94 16.18 8.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 120.872 -1.142 . . . . 0.0 110.067 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 2.8 mp0 46.15 55.99 6.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.605 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.683 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -85.35 -34.34 0.51 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.549 -0.719 . . . . 0.0 111.972 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.0 Cg_endo -72.49 -57.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.0 -29.76 0.36 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 -45.35 38.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.069 . . . . 0.0 109.629 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.68 -17.77 64.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.363 -0.835 . . . . 0.0 110.433 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -39.67 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.882 -1.137 . . . . 0.0 109.829 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -52.38 -35.57 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.702 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.94 8.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.2 135.22 33.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -1.142 . . . . 0.0 109.219 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -130.34 10.13 5.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.798 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.961 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 66.71 -1.36 5.76 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.2 m -47.33 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 124.84 15.59 3.17 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 23' ' ' GLY . 6.0 t -107.57 148.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.993 -1.298 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.8 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -115.84 115.51 26.38 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.447 0.641 . . . . 0.0 110.56 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.45 127.65 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.527 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.23 156.38 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.112 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG12 ' CG ' ' A' ' 32' ' ' ASP . 74.4 t -129.14 86.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.146 -0.971 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.716 HD12 ' CG2' ' A' ' 91' ' ' VAL . 5.0 mp -71.07 100.6 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.537 ' CG ' HG12 ' A' ' 30' ' ' VAL . 43.3 p-10 -160.13 -160.49 0.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.875 -1.141 . . . . 0.0 109.673 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.767 HG21 ' O ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -64.75 -51.27 63.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.657 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . -162.97 -112.88 0.28 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.808 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.701 HG12 ' HB2' ' A' ' 67' ' ' ALA . 0.8 OUTLIER 153.81 -15.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 121.613 0.72 . . . . 0.0 109.152 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 51.37 168.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 110.6 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 37' ' ' THR . 11.4 t -105.12 45.67 0.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.926 0.87 . . . . 0.0 109.195 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -52.5 160.62 1.29 Allowed Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.709 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.05 -4.55 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.692 2.261 . . . . 0.0 110.451 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.661 ' O ' HD12 ' A' ' 73' ' ' LEU . 24.7 t0 -91.84 -60.89 1.75 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mt -70.34 151.51 45.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.215 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.67 ' OD1' HD11 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -105.32 73.95 1.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.295 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 37' ' ' THR . 12.1 mm -42.5 114.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.575 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -108.63 -18.8 13.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.677 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -175.19 -175.81 42.95 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.22 147.01 4.77 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.311 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.53 144.2 46.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.424 -1.045 . . . . 0.0 109.139 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.507 ' OG ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -120.76 121.02 37.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.146 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.857 ' HE2' HG12 ' A' ' 91' ' ' VAL . 3.1 m-85 -110.73 -38.51 5.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.192 -0.943 . . . . 0.0 109.868 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.876 HG23 ' HB3' ' A' ' 104' ' ' SER . 1.0 OUTLIER -42.93 -52.58 11.29 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.195 -0.941 . . . . 0.0 109.061 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 50' ' ' VAL . 38.9 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 123.07 2.513 . . . . 0.0 110.717 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.561 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.859 0.361 . . . . 0.0 110.398 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 46.72 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 109.916 -177.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' SER . 7.3 mm100 -95.9 155.69 16.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.876 -1.14 . . . . 0.0 108.45 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLN . 5.0 m-20 52.17 172.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.003 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.767 ' O ' HG21 ' A' ' 33' ' ' THR . . . 164.44 46.62 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 1.1 t30 80.47 -27.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -1.038 . . . . 0.0 110.452 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.563 ' O ' ' C ' ' A' ' 62' ' ' HIS . . . 128.11 -72.82 0.46 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.589 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.563 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.9 t-80 -11.44 -59.95 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.445 0.641 . . . . 0.0 111.917 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.528 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.88 -69.47 1.28 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.69 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.7 m -38.39 -41.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.563 -0.963 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 2.0 t-80 -56.61 -63.22 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 219' ' ' PRO . 16.5 t -49.09 -32.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 108.782 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.701 ' HB2' HG12 ' A' ' 35' ' ' ILE . . . -55.39 -53.34 57.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.52 -22.11 74.85 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.723 HG23 ' CE1' ' A' ' 220' ' ' HIS . 6.6 m -73.94 -18.11 60.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.036 -1.273 . . . . 0.0 108.088 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 88' ' ' LEU . 56.8 mt -101.44 -25.84 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.492 -0.755 . . . . 0.0 111.309 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -162.02 25.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.316 -1.49 . . . . 0.0 112.647 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.722 ' HB1' ' HB ' ' A' ' 79' ' ' VAL . . . -39.86 114.52 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 109.34 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.67 HD11 ' OD1' ' A' ' 42' ' ' ASN . 23.6 mt -73.54 167.48 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.68 125.99 53.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 3.1 p-10 -168.68 -109.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -0.969 . . . . 0.0 109.101 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -82.44 -73.52 0.39 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.497 ' HB ' ' OH ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -52.29 178.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.587 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -132.79 122.93 3.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.41 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.722 ' HB ' ' HB1' ' A' ' 72' ' ' ALA . 1.8 t -162.7 -64.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.817 HD22 ' HB3' ' A' ' 3' ' ' SER . 1.1 tp 56.51 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.317 0.58 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.647 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -95.49 -143.44 14.54 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.474 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -106.57 -54.19 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.028 -1.278 . . . . 0.0 109.664 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -107.83 102.76 46.86 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 38.0 Cg_endo -85.57 -63.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.877 2.385 . . . . 0.0 110.919 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -17.39 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 143.33 56.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.253 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.8 ' OE1' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -79.56 126.16 30.53 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.978 -1.077 . . . . 0.0 109.082 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.499 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 15.0 mt -103.25 105.32 15.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.715 -1.241 . . . . 0.0 110.309 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.485 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 19.8 m-85 -85.72 142.35 29.07 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.27 -0.894 . . . . 0.0 108.775 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.423 ' CB ' HD12 ' A' ' 35' ' ' ILE . . . -105.23 104.68 14.46 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.615 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.82 66.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.121 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HD3' ' HD3' ' A' ' 51' ' ' PRO . 1.2 tttt -36.5 109.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.477 0.656 . . . . 0.0 110.018 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.547 HG11 HG23 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -125.06 -13.58 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.508 ' O ' HG21 ' A' ' 50' ' ' VAL . 5.2 mt -84.62 -170.96 3.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.986 0.898 . . . . 0.0 110.886 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.83 -99.54 2.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.519 ' HB3' ' CG2' ' A' ' 33' ' ' THR . . . . . . . . 0 C--N 1.292 -1.926 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.435 ' C ' ' OG ' ' A' ' 101' ' ' SER . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -177.94 142.72 0.3 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.731 -0.864 . . . . 0.0 108.703 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.883 HG22 ' HA ' ' A' ' 129' ' ' PRO . 21.0 t -68.45 -21.05 25.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.556 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -74.85 -25.17 58.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.876 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -79.61 -67.11 0.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.69 ' HB ' HD12 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -50.52 -24.0 2.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 102' ' ' VAL . . . -67.57 -56.42 9.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.68 -0.638 . . . . 0.0 110.051 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.607 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -65.69 -33.11 75.11 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.43 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.561 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -68.25 -30.83 73.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.439 HD13 HG23 ' A' ' 137' ' ' VAL . 36.1 mt -94.33 -4.67 48.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.116 -1.226 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.96 -5.9 12.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 109.449 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -86.3 -17.73 33.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.638 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -83.49 -1.54 53.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -82.33 -46.35 6.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 -77.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -1.099 . . . . 0.0 108.588 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.82 63.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.638 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -106.82 -156.24 20.8 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.475 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.57 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 14.2 mmt -140.63 -179.92 6.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.854 -0.792 . . . . 0.0 109.734 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.791 ' ND1' HG23 ' A' ' 119' ' ' VAL . 3.0 p80 -78.1 -31.04 49.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.444 -0.785 . . . . 0.0 110.088 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.791 HG23 ' ND1' ' A' ' 118' ' ' HIS . 94.7 t -130.67 165.05 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.73 -1.231 . . . . 0.0 110.956 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.609 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.06 158.65 8.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.719 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.8 m120 -129.3 163.91 24.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.658 -1.276 . . . . 0.0 110.547 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 121' ' ' ASN . 3.3 mp -139.49 99.55 3.76 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.471 -0.768 . . . . 0.0 108.945 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 67.73 10.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 108.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 122' ' ' LEU . 1.1 pp -163.85 -176.19 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.821 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 160' ' ' SER . . . 157.99 107.24 0.24 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -163.98 176.71 2.08 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.134 -1.215 . . . . 0.0 109.627 -179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 126' ' ' SER . 36.4 Cg_endo -81.34 -10.53 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.89 2.393 . . . . 0.0 109.766 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.658 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 1.1 t -50.03 -48.6 78.44 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.74 -0.6 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.883 ' HA ' HG22 ' A' ' 102' ' ' VAL . 31.1 Cg_endo -72.61 169.84 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.245 1.963 . . . . 0.0 110.955 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.25 179.58 5.2 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.701 1.239 . . . . 0.0 111.008 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 134' ' ' GLU . . . -63.52 -16.32 60.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -63.73 -36.01 82.46 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.69 HD12 ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -66.71 -34.97 79.02 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 1.7 tt0 -60.25 -58.92 6.45 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.863 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 138' ' ' ASN . 96.5 mm-40 -45.51 -25.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -67.79 -48.72 65.52 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.439 HG23 HD13 ' A' ' 109' ' ' LEU . 3.4 t -65.3 -26.14 38.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 11.9 t30 -62.33 -35.17 78.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 p -75.82 -25.38 56.26 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.1 -22.93 57.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.183 -0.948 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -30.5 67.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.966 . . . . 0.0 108.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.55 -34.19 49.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 108.969 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -98.71 -19.69 17.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 237' ' ' ASN . . . 82.98 14.13 75.86 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 145' ' ' VAL . 6.3 t -48.4 102.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -1.095 . . . . 0.0 108.931 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HB2' ' OD1' ' A' ' 237' ' ' ASN . 0.4 OUTLIER -69.1 103.55 1.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.285 -0.884 . . . . 0.0 109.426 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -102.51 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 218' ' ' THR . 1.0 OUTLIER -122.9 113.92 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.4 32.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.922 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.612 ' HB1' ' HB ' ' A' ' 214' ' ' THR . . . -64.08 172.53 2.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.809 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.613 ' CB ' HG21 ' A' ' 214' ' ' THR . 0.3 OUTLIER -69.0 -74.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 109.758 -179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 153.73 -13.01 0.56 Allowed Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.301 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 152' ' ' GLY . 4.4 m-20 22.9 48.62 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.3 OUTLIER 176.73 56.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.46 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . 161.79 51.84 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -54.51 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 110.252 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . 66.18 11.61 55.91 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 2.3 p 160.13 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -112.29 -175.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.944 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -85.93 168.79 13.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.305 1.05 . . . . 0.0 111.801 -178.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.457 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -104.38 137.86 19.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 175.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.721 ' O ' ' N ' ' A' ' 164' ' ' ARG . 39.6 Cg_endo -73.24 -53.31 0.16 OUTLIER 'Cis proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.174 -1.178 . . . . 0.0 110.656 3.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.944 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 29.95 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.254 1.026 . . . . 0.0 110.116 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 162' ' ' PRO . 3.8 ttm180 -42.39 -46.86 4.82 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.329 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 14.7 m-85 -44.4 173.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.11 -0.994 . . . . 0.0 110.913 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 168' ' ' ALA . . . -98.8 -47.87 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.67 -0.644 . . . . 0.0 110.493 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.504 ' ND2' ' C ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -42.24 -27.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.882 0.848 . . . . 0.0 109.751 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -125.55 145.55 50.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.473 ' SD ' ' HG3' ' A' ' 241' ' ' ARG . 12.7 mtm -96.12 153.92 17.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -108.43 122.82 47.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.8 t -90.72 165.75 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 0.0 109.76 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.618 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -131.09 -176.62 14.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.82 162.44 27.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.992 -1.299 . . . . 0.0 109.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.1 p -133.45 172.27 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.789 . . . . 0.0 109.249 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 -156.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -90.05 -41.51 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -78.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.535 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.72 30.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 110.042 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.22 156.36 22.48 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.145 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' A' ' 256' ' ' LEU . 6.7 ttp85 -60.96 134.6 57.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 0.0 109.475 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.776 ' HB1' ' CE1' ' A' ' 183' ' ' PHE . . . -45.68 173.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.451 -0.78 . . . . 0.0 109.701 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.0 OUTLIER -108.27 11.17 27.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 109.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.776 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 2.3 p90 -134.73 -12.37 2.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.039 -1.038 . . . . 0.0 110.645 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 t -67.01 138.88 57.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.526 ' HG2' ' N ' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -93.83 143.02 26.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.115 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.47 -174.34 3.04 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.596 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.03 -171.85 44.09 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -85.67 64.39 8.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.127 . . . . 0.0 109.177 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.63 31.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -85.53 138.26 32.32 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.132 -1.216 . . . . 0.0 109.66 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -86.0 -72.68 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.629 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 193' ' ' VAL . 0.3 OUTLIER -149.56 -162.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.245 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.795 HG22 ' CA ' ' A' ' 260' ' ' GLY . 27.2 m -143.28 175.97 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.962 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -167.61 177.16 1.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 108.946 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.962 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.2 Cg_endo -76.69 113.74 3.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 109.446 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.505 ' HA2' ' ND2' ' A' ' 212' ' ' ASN . . . -145.22 48.27 0.71 Allowed Glycine 0 N--CA 1.484 1.861 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.435 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 1.7 t -130.87 30.49 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.249 . . . . 0.0 109.068 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.597 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.1 OUTLIER 164.86 105.18 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.158 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.788 HG22 ' ND2' ' A' ' 212' ' ' ASN . 2.7 m -158.37 111.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.56 ' NE2' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -89.56 117.93 28.82 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.335 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -118.05 -151.45 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.929 . . . . 0.0 109.858 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.687 ' OG1' HG22 ' A' ' 64' ' ' THR . 0.1 OUTLIER -87.92 178.43 6.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.645 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -164.6 157.7 14.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.645 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.6 Cg_endo -70.07 166.0 29.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.233 1.956 . . . . 0.0 110.322 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 206' ' ' SER . . . 84.74 3.84 87.84 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 205' ' ' GLY . 6.9 t 74.84 43.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -1.078 . . . . 0.0 110.26 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -145.11 -179.91 6.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.554 ' CE2' HG22 ' A' ' 79' ' ' VAL . 2.9 m-30 -113.67 -174.13 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -165.31 164.77 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.828 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 50.5 m -124.8 114.56 19.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.504 -0.747 . . . . 0.0 109.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 211' ' ' LEU . 0.8 OUTLIER -173.96 138.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.407 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.788 ' ND2' HG22 ' A' ' 199' ' ' VAL . 2.9 t-20 -125.23 -157.43 0.78 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.165 0.983 . . . . 0.0 110.601 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 136.32 175.95 14.09 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 151' ' ' SER . 0.2 OUTLIER -56.68 -41.52 77.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.984 -1.303 . . . . 0.0 109.346 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.5 m -57.69 -29.86 65.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 0.0 110.447 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.486 ' O ' HG21 ' A' ' 69' ' ' THR . 1.4 mpp? -90.95 -26.26 19.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.496 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.12 -6.2 59.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.977 -1.077 . . . . 0.0 109.441 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.703 HG23 HG12 ' A' ' 148' ' ' VAL . 1.2 m -73.05 -47.56 8.07 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -71.71 -8.39 23.03 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.098 1.865 . . . . 0.0 111.466 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.723 ' CE1' HG23 ' A' ' 69' ' ' THR . 5.7 m80 -77.19 -47.14 21.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 262' ' ' VAL . 57.9 t -67.74 -41.39 85.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.565 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -57.65 -34.77 69.71 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.5 -54.83 26.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.69 ' HB1' ' HB2' ' A' ' 264' ' ' ALA . . . -51.06 -38.3 50.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 108.867 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -59.08 -44.96 91.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 0.0 109.154 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.61 52.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 108.985 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.9 mt -50.82 -31.53 17.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.025 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 224' ' ' ALA . 58.3 t -68.3 -52.1 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.473 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.515 ' HD2' ' ND1' ' A' ' 118' ' ' HIS . 27.3 tttp -46.78 -42.06 16.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 108.822 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.552 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -62.22 -45.95 91.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.357 -0.839 . . . . 0.0 109.444 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 11.6 tptm -56.4 -18.6 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 108.557 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.5 90.8 2.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 108.999 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.04 8.28 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.752 2.301 . . . . 0.0 110.876 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.14 8.33 10.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -82.33 -178.66 7.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.383 -0.823 . . . . 0.0 109.915 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -121.54 174.71 6.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.651 -0.655 . . . . 0.0 109.443 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -60.42 -27.05 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 238' ' ' VAL . 2.8 t -73.06 -63.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.098 -1.001 . . . . 0.0 109.61 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -49.04 -39.79 28.72 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.546 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 237' ' ' ASN . 84.0 mt -60.01 -58.12 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.486 -0.759 . . . . 0.0 109.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.473 ' HG3' ' SD ' ' A' ' 169' ' ' MET . 18.8 ttp180 -54.64 -72.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.9 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ARG . 4.8 t30 -35.03 -36.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.919 -0.488 . . . . 0.0 110.736 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.493 ' HD2' ' HB1' ' A' ' 267' ' ' ALA . 8.6 t60 -65.83 -51.56 57.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.996 -1.065 . . . . 0.0 110.107 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.517 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 3.6 mt -70.84 -23.84 62.42 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.295 -0.878 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -33.24 60.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 246' ' ' ASN . 2.8 t-20 -93.26 -14.97 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.2 p -87.32 -31.3 20.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.035 -1.041 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.616 ' HB3' ' CB ' ' A' ' 259' ' ' SER . . . -51.13 144.07 9.78 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 17.6 m -78.07 159.47 28.68 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.447 ' N ' HG22 ' A' ' 249' ' ' THR . 1.9 t -128.55 101.67 6.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.852 . . . . 0.0 109.945 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.666 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.576 ' CD1' ' CD2' ' A' ' 186' ' ' TYR . 2.0 mm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.615 0.722 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.47 ' O ' ' O ' ' A' ' 258' ' ' GLY . 72.3 m-85 -128.75 -83.74 0.57 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.73 -0.606 . . . . 0.0 109.601 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 50.39 99.39 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.616 ' CB ' ' HB3' ' A' ' 248' ' ' ALA . 0.9 OUTLIER 56.91 18.85 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.584 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.795 ' CA ' HG22 ' A' ' 193' ' ' VAL . . . -40.75 -61.04 1.99 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 249' ' ' THR . 5.9 tp -62.91 143.44 57.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.997 -1.296 . . . . 0.0 110.186 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.726 HG21 HG22 ' A' ' 221' ' ' VAL . 3.6 t -118.54 125.83 74.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 116.19 6.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.772 1.273 . . . . 0.0 108.663 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.69 ' HB2' ' HB1' ' A' ' 224' ' ' ALA . . . -77.64 -17.28 57.9 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.895 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 55.7 tt0 -55.65 -36.94 67.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 0.0 109.624 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.2 -19.47 39.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.493 ' HB1' ' HD2' ' A' ' 243' ' ' HIS . . . -98.23 -1.83 41.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.365 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.6 p -109.5 -39.06 5.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.655 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.589 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 5' ' ' PRO . 22.9 m . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 3' ' ' SER . 7.3 t -17.3 80.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.708 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -81.69 164.31 18.44 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.809 2.339 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -15.36 7.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.566 -0.709 . . . . 0.0 109.793 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 195' ' ' PRO . . . -83.16 -64.23 1.67 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.1 mp -65.87 173.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.294 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 2.5 t 88.94 -39.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -25.12 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.335 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 11' ' ' VAL . 34.0 m -91.55 20.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.939 -1.101 . . . . 0.0 110.089 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.541 ' OE1' ' CB ' ' A' ' 265' ' ' GLU . 0.0 OUTLIER 50.86 53.42 13.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 110.519 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.681 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.66 -30.41 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.944 -1.097 . . . . 0.0 111.988 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.8 Cg_endo -75.31 -59.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.11 -27.41 0.58 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.06 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -81.15 -40.56 23.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.922 -1.111 . . . . 0.0 108.935 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -73.11 -8.42 55.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.48 -39.02 5.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.599 -1.313 . . . . 0.0 110.23 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.41 68.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.868 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.09 -4.85 4.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.606 ' HB3' HD22 ' A' ' 227' ' ' LEU . 3.7 mm? -62.9 122.29 15.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.199 -1.177 . . . . 0.0 109.101 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -118.5 -30.81 5.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.535 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 78.8 -14.73 12.13 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.41 120.81 4.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -1.154 . . . . 0.0 109.001 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.09 0.71 30.0 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 23' ' ' GLY . 39.4 t -99.37 164.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.236 -1.155 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.594 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 6.4 mttt -142.29 129.34 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' A' ' 119' ' ' VAL . 16.0 t -133.04 158.54 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.611 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -112.17 144.42 41.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 108.918 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 88' ' ' LEU . 45.7 t -121.31 82.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.073 -1.017 . . . . 0.0 109.132 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.859 HD22 HD12 ' A' ' 122' ' ' LEU . 4.9 mp -64.7 91.64 0.09 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -144.72 -151.78 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.798 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.689 HG22 ' C ' ' A' ' 95' ' ' GLY . 72.9 p -80.35 -51.63 8.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.462 -1.398 . . . . 0.0 109.036 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -168.56 -114.47 0.3 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 160.83 100.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.5 t -44.75 150.47 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.193 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.33 115.27 21.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.422 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -139.16 157.26 71.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.2 Cg_endo -77.01 -37.48 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.6 2.2 . . . . 0.0 110.493 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -62.08 -18.94 62.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' CD2' ' HA2' ' A' ' 68' ' ' GLY . 14.5 mt -102.02 129.82 48.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.371 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 68.23 9.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.385 -0.822 . . . . 0.0 109.307 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -57.26 139.02 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.482 ' HG2' ' HG2' ' A' ' 87' ' ' GLU . 20.3 tpt85 -121.54 -33.92 3.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.261 -0.899 . . . . 0.0 109.687 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -156.27 18.97 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.22 166.2 13.92 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.726 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -145.33 174.58 10.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.976 . . . . 0.0 108.961 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 92' ' ' LYS . 81.2 p -125.84 107.18 10.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 110.28 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.726 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 2.7 m-85 -105.81 -36.83 6.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.675 HG13 ' HD2' ' A' ' 51' ' ' PRO . 2.1 t -41.82 145.97 0.65 Allowed Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HD2' HG13 ' A' ' 50' ' ' VAL . 34.0 Cg_endo . . . . . 0 C--N 1.311 -1.415 0 C-N-CA 122.575 2.183 . . . . 0.0 110.81 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 56' ' ' THR . 1.2 m -77.74 -0.85 28.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.594 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 20.4 mt-30 -141.51 117.72 10.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.041 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 14.2 t70 64.56 92.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.837 . . . . 0.0 109.513 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.29 -27.89 5.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.66 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.389 -1.065 . . . . 0.0 109.679 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 64' ' ' THR . . . 160.55 -42.18 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.216 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' GLY . 34.7 t-80 -54.16 -65.09 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 110.078 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -39.99 -74.77 0.13 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -40.1 -40.66 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 0.0 109.784 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.4 t-80 -55.37 -56.7 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 219' ' ' PRO . 78.5 t -57.49 -44.44 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -54.67 -32.72 59.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.483 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -79.39 -27.62 54.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -74.15 -15.61 61.02 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.953 HG21 HD21 ' A' ' 88' ' ' LEU . 16.7 mt -109.29 -21.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.455 -0.778 . . . . 0.0 110.049 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.948 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -117.56 -35.45 3.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 111.627 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 68' ' ' GLY . . . -15.24 106.15 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 121.468 0.652 . . . . 0.0 111.646 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 40' ' ' ASP . 6.7 mt -85.0 153.82 22.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 109.749 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 48.9 p-10 -72.62 141.64 48.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 8.7 m-20 158.17 130.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -35.61 -39.11 0.13 Allowed 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -86.68 64.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.127 -0.983 . . . . 0.0 109.349 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA3' ' OD2' ' A' ' 40' ' ' ASP . . . 158.35 160.17 10.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 80' ' ' LEU . 5.5 m -79.05 -112.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -1.112 . . . . 0.0 109.646 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.439 ' H ' HG23 ' A' ' 79' ' ' VAL . 5.6 tp -171.74 96.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.799 -1.188 . . . . 0.0 109.664 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 72' ' ' ALA . . . -78.92 -160.49 18.02 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.644 HG12 HD11 ' A' ' 227' ' ' LEU . 1.4 t -107.65 -32.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.291 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -115.53 117.98 39.84 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 109.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 22' ' ' THR . 37.6 Cg_endo -85.48 -59.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.724 2.282 . . . . 0.0 111.244 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.53 38.83 1.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.97 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -89.54 124.2 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 2.6 mt-10 -64.49 103.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.953 HD21 HG21 ' A' ' 70' ' ' ILE . 11.1 mt -97.44 92.9 6.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 110.851 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.444 ' CE2' ' HE3' ' A' ' 117' ' ' MET . 40.0 m-85 -77.63 146.57 36.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.25 106.59 17.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.767 -1.208 . . . . 0.0 109.029 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.698 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -95.1 67.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.988 0.899 . . . . 0.0 108.807 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 26.6 ttmt -35.12 94.05 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.005 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.607 HG21 HD23 ' A' ' 31' ' ' LEU . 2.2 t -118.39 -16.66 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 0.0 108.891 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.1 mt -116.47 175.17 5.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.389 -0.819 . . . . 0.0 110.167 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -107.36 -14.3 18.62 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 95' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.472 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 177.51 6.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.883 -0.775 . . . . 0.0 109.969 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 133' ' ' LEU . 1.5 t -66.19 -22.02 29.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 3.6 t -69.96 -26.4 64.09 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 93' ' ' VAL . 4.4 m -81.23 -44.49 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.538 -0.726 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.525 HG22 ' CD1' ' A' ' 109' ' ' LEU . 1.2 mt -68.14 -21.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.49 -52.22 16.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.681 -0.637 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 103' ' ' SER . 12.7 mm-40 -71.15 -30.4 66.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.689 -1.257 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -73.19 -24.07 76.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD1' HG22 ' A' ' 105' ' ' ILE . 25.0 mt -93.79 -24.2 17.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -1.179 . . . . 0.0 109.906 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.33 -30.52 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 69.4 t90 -72.65 -16.6 61.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.693 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -91.37 6.21 46.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -114.9 -50.38 0.48 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -70.08 -76.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.279 . . . . 0.0 108.732 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -105.71 41.07 1.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.621 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -92.39 -149.46 24.53 Favored Glycine 0 C--N 1.294 -1.782 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.594 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 7.1 mmt -140.3 -169.15 2.7 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.178 0.989 . . . . 0.0 110.933 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.485 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.0 m170 -70.21 -57.77 4.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.164 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.7 ' HB ' HG13 ' A' ' 28' ' ' VAL . 9.7 t -101.03 161.35 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 111.177 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.592 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -163.25 109.7 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 1.057 ' C ' HD13 ' A' ' 122' ' ' LEU . 7.0 m120 -110.72 153.49 25.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.911 -1.118 . . . . 0.0 111.077 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.057 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -134.89 134.07 40.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -89.61 70.27 7.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.294 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.608 HD21 ' CB ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -150.4 -177.74 6.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.621 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.07 106.93 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.18 158.97 40.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.205 -1.173 . . . . 0.0 109.58 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 128' ' ' SER . 36.0 Cg_endo -78.69 -17.1 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.633 2.222 . . . . 0.0 110.051 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -40.98 102.15 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.583 -0.698 . . . . 0.0 109.533 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 130' ' ' SER . 34.0 Cg_endo -77.42 166.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.409 2.073 . . . . 0.0 110.488 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 129' ' ' PRO . 2.1 m 172.53 121.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.436 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.58 -18.53 65.03 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.8 m -73.07 -25.73 61.01 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.583 ' CD1' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -79.62 -42.89 23.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.45 -25.82 57.77 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.546 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.4 tm0? -72.41 -22.75 61.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.3 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 167' ' ' ASN . 0.9 OUTLIER -64.06 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -59.45 -36.55 76.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.52 -24.48 50.0 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.29 59.42 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 121.232 -0.917 . . . . 0.0 109.917 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m -73.17 -36.53 66.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -24.76 58.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -105.15 -13.14 15.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.26 55.53 27.22 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.693 HG21 ' O ' ' A' ' 112' ' ' ALA . 15.3 t -89.36 107.13 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.704 -0.88 . . . . 0.0 109.766 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.05 101.95 0.45 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.063 -1.023 . . . . 0.0 109.071 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 1.4 t -88.81 150.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -146.06 120.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.713 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -115.44 151.33 34.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.124 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.68 173.82 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -72.78 -67.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.034 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . 172.67 -23.67 0.08 OUTLIER Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.77 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 154' ' ' SER . 44.4 t-20 67.52 37.12 3.51 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.831 -0.805 . . . . 0.0 109.96 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 1.0 OUTLIER 79.23 72.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 110.213 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -115.84 -33.09 1.6 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -172.12 -178.39 2.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -1.193 . . . . 0.0 109.534 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.34 58.41 4.91 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER 162.25 129.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.982 . . . . 0.0 109.196 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 158' ' ' SER . 1.8 pt -48.66 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.359 -0.838 . . . . 0.0 110.007 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.878 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -126.91 164.68 20.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.227 -0.921 . . . . 0.0 111.896 -177.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.1 OUTLIER -77.78 142.37 65.41 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 175.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.8 Cg_endo -72.0 -29.3 6.35 Favored 'Cis proline' 0 C--N 1.298 -2.113 0 O-C-N 122.546 0.761 . . . . 0.0 110.594 3.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -35.12 -26.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.732 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -100.35 -32.03 11.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.542 -1.349 . . . . 0.0 110.608 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.51 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.6 m-85 -46.18 -179.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.172 -0.955 . . . . 0.0 110.798 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -93.96 -25.64 17.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.566 -0.709 . . . . 0.0 111.049 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.471 HD22 HG13 ' A' ' 137' ' ' VAL . 2.2 t-20 -97.98 23.08 8.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.81 -1.181 . . . . 0.0 110.061 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 162' ' ' PRO . . . -153.01 114.61 4.26 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.537 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 0.6 OUTLIER -78.26 167.45 21.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.128 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -118.61 123.77 45.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.331 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 172' ' ' GLY . 25.0 t -92.86 166.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.141 -0.974 . . . . 0.0 109.242 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.571 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -138.66 -179.79 17.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.49 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -119.47 171.27 8.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 179' ' ' ASN . 1.5 p -122.86 167.88 12.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.536 ' CA ' ' HA ' ' A' ' 181' ' ' ALA . 49.6 p-10 -91.16 -177.57 4.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -69.51 -24.25 63.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.29 -79.22 0.17 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.464 ' O ' ' HB ' ' A' ' 174' ' ' THR . 0.1 OUTLIER -135.76 -79.4 0.42 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 110.363 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.593 ' HA ' HG22 ' A' ' 174' ' ' THR . 0.8 OUTLIER -125.0 -164.49 1.29 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.206 -0.934 . . . . 0.0 109.681 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 81.43 -31.31 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.626 -0.672 . . . . 0.0 110.932 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.536 ' HA ' ' CA ' ' A' ' 175' ' ' ASP . . . 42.99 -155.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.957 -1.089 . . . . 0.0 109.454 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -126.64 -45.81 1.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 110.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.27 26.37 10.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.349 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.5 t -81.15 112.31 18.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 154' ' ' SER . 3.3 tp-100 -74.88 156.8 36.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.8 171.41 14.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.613 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.578 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -173.56 146.83 9.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.05 100.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.46 16.16 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 186' ' ' TYR . 7.1 tp -53.79 151.08 6.7 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.107 -1.231 . . . . 0.0 108.824 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.537 ' CB ' ' HB3' ' A' ' 169' ' ' MET . 22.4 t70 -99.54 -69.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.825 HD11 HG22 ' A' ' 262' ' ' VAL . 7.6 tt -159.45 141.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.367 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.516 HG21 HD21 ' A' ' 179' ' ' ASN . 22.1 m -98.32 172.96 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 1.002 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -164.1 178.13 1.56 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.05 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 1.002 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.7 Cg_endo -77.64 117.61 4.32 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.284 1.989 . . . . 0.0 110.134 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -143.67 33.24 1.78 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.666 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 62.7 t -119.31 59.03 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -1.192 . . . . 0.0 108.88 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.724 ' O ' HG13 ' A' ' 199' ' ' VAL . 12.9 t-20 123.9 121.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 198' ' ' ASN . 11.6 m -166.4 110.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.946 0.879 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.6 mt-30 -80.46 122.97 27.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.334 0.588 . . . . 0.0 109.531 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.594 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.8 t -125.31 -163.16 1.17 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.643 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.5 p -79.27 166.8 21.76 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 110.115 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.647 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -149.16 156.62 40.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.647 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.3 Cg_endo -69.96 159.94 51.46 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.183 1.922 . . . . 0.0 110.629 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.418 ' O ' ' OG ' ' A' ' 206' ' ' SER . . . 74.84 31.28 58.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 205' ' ' GLY . 80.9 p 49.86 40.15 19.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -1.076 . . . . 0.0 109.905 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.22 155.36 40.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -103.58 165.43 11.04 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.186 -0.946 . . . . 0.0 108.819 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -153.09 163.76 39.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.768 -1.208 . . . . 0.0 110.746 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.8 OUTLIER -121.27 108.21 13.46 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.522 HD23 ' C ' ' A' ' 210' ' ' SER . 11.0 mt -110.12 170.0 8.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.103 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 212' ' ' ASN . 2.4 p-10 -146.77 148.88 32.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.448 -0.782 . . . . 0.0 109.211 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.16 161.94 11.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 173' ' ' ALA . 90.3 m -77.37 -17.32 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -1.129 . . . . 0.0 109.222 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 36.0 m -75.37 -19.25 59.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.118 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.442 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -79.71 -17.44 53.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 109.556 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -89.8 -13.1 37.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 109.732 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.638 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.7 m -70.6 -42.73 14.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 111.489 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.9 Cg_endo -73.11 -15.45 25.77 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 121.672 1.581 . . . . 0.0 110.756 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -75.25 -40.44 58.91 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.466 HG22 HG21 ' A' ' 262' ' ' VAL . 88.2 t -68.82 -49.64 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.535 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.27 -31.99 62.01 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.387 -0.821 . . . . 0.0 108.995 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -64.24 -53.87 33.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -49.25 -52.19 28.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -1.179 . . . . 0.0 109.237 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.37 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.404 -0.81 . . . . 0.0 109.061 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -61.73 -44.23 97.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.308 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 82' ' ' VAL . 79.1 mt -55.8 -36.63 67.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.238 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.504 HG21 HD23 ' A' ' 244' ' ' LEU . 36.6 t -73.59 -40.88 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 109.995 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.76 ' NZ ' HD13 ' A' ' 240' ' ' ILE . 11.6 ttmm -52.38 -46.07 66.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.623 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.434 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.78 -45.16 93.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -20.66 3.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.848 . . . . 0.0 108.792 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.62 85.06 0.53 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.758 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 35.1 Cg_endo -77.05 -16.16 16.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.07 -0.6 32.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -81.27 -177.33 6.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.75 169.13 11.04 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.64 . . . . 0.0 109.577 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -60.11 -16.06 28.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.68 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.51 -63.74 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.481 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -50.82 -38.86 51.21 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.031 -178.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.76 HD13 ' NZ ' ' A' ' 229' ' ' LYS . 62.5 mt -70.62 -44.61 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 110.294 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 4.8 ttp85 -57.3 -29.24 63.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 110.415 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.49 -29.63 25.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.75 -1.219 . . . . 0.0 110.278 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.424 ' O ' HG23 ' A' ' 247' ' ' THR . 0.6 OUTLIER -75.5 -57.86 3.63 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.934 -1.104 . . . . 0.0 108.126 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.522 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -60.05 -38.12 81.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.753 -0.592 . . . . 0.0 110.253 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 21.6 tttt -69.34 -49.96 50.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -74.62 -6.37 48.26 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.826 -0.547 . . . . 0.0 110.862 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.5 p -94.15 -30.76 14.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.697 -1.252 . . . . 0.0 109.832 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -44.24 137.44 3.5 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.7 m -92.19 105.9 18.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.187 -0.945 . . . . 0.0 109.862 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.499 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.5 OUTLIER -75.43 135.61 40.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.442 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.484 1.258 0 O-C-N 121.309 -0.869 . . . . 0.0 109.686 179.666 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 256' ' ' LEU . 13.8 mt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 257' ' ' TYR . 4.2 m-30 -71.4 -24.39 62.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.697 0.76 . . . . 0.0 109.121 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.69 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 192' ' ' ILE . 44.9 m -54.02 -48.49 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.941 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 106.74 -131.37 10.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 261' ' ' LEU . 4.8 tp -81.65 179.17 7.94 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.365 -1.079 . . . . 0.0 109.898 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.825 HG22 HD11 ' A' ' 192' ' ' ILE . 0.4 OUTLIER -120.32 140.67 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.492 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.45 118.43 1.39 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.468 1.128 . . . . 0.0 108.533 178.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -80.43 -7.19 59.04 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.698 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.541 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -57.53 -54.02 51.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.771 -1.206 . . . . 0.0 109.792 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.6 33.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.085 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.417 ' HB1' ' CG2' ' A' ' 228' ' ' VAL . . . -103.61 -14.91 15.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.819 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.601 HG21 ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -106.04 -31.26 8.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.025 . . . . 0.0 109.981 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 268' ' ' THR . 1.4 ttp85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 1.9 m . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 t -131.83 81.27 63.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 109.208 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HG2' HG13 ' A' ' 8' ' ' ILE . 33.6 Cg_endo -77.27 157.23 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.507 2.138 . . . . 0.0 110.738 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -47.37 -38.0 12.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.648 -0.658 . . . . 0.0 109.916 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' TRP . . . -59.95 -43.81 97.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -107.33 50.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -1.155 . . . . 0.0 109.862 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -132.15 -42.88 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 109.593 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -86.61 -1.1 57.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.888 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 13' ' ' ALA . 16.2 m -88.42 20.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 120.994 -1.066 . . . . 0.0 109.85 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 263' ' ' ASN . 1.1 mt-30 41.4 42.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.745 . . . . 0.0 110.289 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.691 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -76.85 -35.37 1.42 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 111.481 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.2 Cg_endo -73.0 -56.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.623 ' HB1' ' HG3' ' A' ' 265' ' ' GLU . . . -42.93 -37.07 1.73 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.35 72.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.209 -0.932 . . . . 0.0 108.563 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 21.7 m170 -63.93 -14.34 52.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.89 -50.26 12.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.15 -14.58 25.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.52 -2.86 39.57 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 268' ' ' THR . 1.6 tp -51.72 162.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.154 . . . . 0.0 109.655 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 -32.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 64.82 8.86 36.35 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.546 ' CB ' ' HB3' ' A' ' 85' ' ' ASN . 8.6 p -52.75 -31.8 40.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.964 . . . . 0.0 110.07 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.03 32.9 4.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 27' ' ' LYS . 54.0 t -123.57 162.35 24.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.222 -1.164 . . . . 0.0 109.927 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.696 ' HZ2' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -133.94 132.5 40.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.56 ' N ' ' HE2' ' A' ' 27' ' ' LYS . 1.1 t -128.41 103.68 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 109.789 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.792 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -74.16 162.46 28.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 35' ' ' ILE . 42.6 t -135.16 89.08 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.011 -1.056 . . . . 0.0 108.894 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 7.1 mp -76.56 109.78 10.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD2' ' HA3' ' A' ' 63' ' ' GLY . 44.4 p-10 -173.71 -164.92 0.23 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.895 -1.128 . . . . 0.0 110.123 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 96' ' ' ALA . 19.6 p -42.9 -64.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.724 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -172.2 -116.19 0.39 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.697 HD11 HG11 ' A' ' 30' ' ' VAL . 0.6 OUTLIER 156.58 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.4 p -69.25 151.5 46.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 109.599 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 t -70.94 162.21 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -0.869 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.618 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -166.29 162.7 12.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.8 Cg_endo -79.04 -5.78 14.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.701 2.267 . . . . 0.0 110.349 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -109.56 -17.07 13.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.137 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.638 HD21 ' HA2' ' A' ' 68' ' ' GLY . 18.5 mt -100.7 141.29 33.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.267 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -111.8 67.05 0.64 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.104 -0.998 . . . . 0.0 109.229 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' CG2' ' A' ' 35' ' ' ILE . 31.9 mm -43.06 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.379 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -81.88 -15.82 52.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.238 -0.914 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -171.28 152.41 18.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 163.79 29.2 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.51 167.61 28.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.979 ' OG ' HG23 ' A' ' 56' ' ' THR . 1.5 m -148.81 111.74 4.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 110.156 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.755 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 9.0 m-85 -99.02 -40.61 7.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.571 ' HB ' ' NZ ' ' A' ' 92' ' ' LYS . 76.3 t -51.73 120.4 15.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 108.986 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.31 -1.457 0 C-N-CA 122.618 2.212 . . . . 0.0 111.218 -179.404 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.447 ' C ' ' OG1' ' A' ' 56' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 CA-C-O 120.912 0.387 . . . . 0.0 110.39 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.979 HG23 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER 64.5 3.32 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.048 -1.033 . . . . 0.0 110.408 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 56' ' ' THR . 78.4 mm-40 -149.75 118.77 6.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.666 -1.271 . . . . 0.0 110.211 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' CB ' ' A' ' 204' ' ' PRO . 8.6 t0 57.27 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.404 -0.81 . . . . 0.0 110.106 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . -127.06 -8.07 4.75 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 63.8 t-20 176.31 -61.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -1.135 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.83 -18.33 0.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -68.13 0.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -1.086 . . . . 0.0 110.029 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' HA3' ' OD2' ' A' ' 32' ' ' ASP . . . -55.46 -22.83 32.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.7 m -72.42 -57.71 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.75 -1.441 . . . . 0.0 109.809 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.604 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.5 t-80 -59.04 -36.11 74.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 70' ' ' ILE . 67.1 t -67.92 -42.81 85.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.406 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' HG12 ' A' ' 35' ' ' ILE . . . -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.438 -0.789 . . . . 0.0 110.009 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.638 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -68.61 -40.27 86.04 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.432 HG21 ' HG2' ' A' ' 219' ' ' PRO . 28.2 m -63.72 -17.28 62.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.399 -1.059 . . . . 0.0 108.727 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.78 ' HB ' HD11 ' A' ' 88' ' ' LEU . 36.9 mt -93.85 -22.28 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.439 -0.788 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.785 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -131.59 -52.67 1.0 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 111.228 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 33.7 62.84 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.722 -0.611 . . . . 0.0 109.831 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.474 HD11 ' OD1' ' A' ' 42' ' ' ASN . 43.4 mt -43.34 147.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 1.7 m-20 -62.55 155.88 24.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 109.256 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m-20 145.8 129.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 28.5 t -37.03 -30.16 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.293 0.568 . . . . 0.0 109.765 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 75' ' ' ASN . 28.7 pt -84.65 143.54 11.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.92 155.07 0.38 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 80' ' ' LEU . 26.0 m -72.16 -141.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.317 -1.107 . . . . 0.0 109.683 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.52 HD11 ' OD1' ' A' ' 74' ' ' ASN . 67.5 tp -138.81 128.07 24.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.089 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 1.078 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -87.08 -177.07 49.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.68 -32.35 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -1.232 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -116.34 98.53 51.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.081 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -83.13 -60.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.812 2.341 . . . . 0.0 110.496 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.546 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -71.71 0.38 8.95 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.671 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.587 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -73.33 161.52 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.852 -1.155 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.536 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 2.1 mp0 -97.99 107.85 20.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.789 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 71' ' ' ALA . 2.5 mt -90.47 127.5 36.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.637 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.672 ' CD1' ' HE3' ' A' ' 27' ' ' LYS . 3.6 m-85 -111.99 178.11 4.42 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.014 -1.054 . . . . 0.0 109.943 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.25 90.2 2.5 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.792 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -96.1 64.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.216 -0.928 . . . . 0.0 109.111 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.571 ' NZ ' ' HB ' ' A' ' 50' ' ' VAL . 3.1 ttpm? -41.06 121.32 1.53 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.33 0.586 . . . . 0.0 109.611 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 104' ' ' SER . 1.2 t -131.7 3.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.953 . . . . 0.0 109.258 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.928 ' CD1' HD22 ' A' ' 124' ' ' LEU . 2.1 mp -141.29 173.92 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.669 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -98.31 -178.35 32.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 33' ' ' THR . . . . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.194 -1.18 . . . . 0.0 109.397 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.26 160.29 22.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.627 -0.925 . . . . 0.0 109.818 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.78 -18.7 22.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 107' ' ' GLN . 8.7 t -80.47 -14.71 58.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.83 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -87.84 -44.08 11.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.589 -0.694 . . . . 0.0 109.16 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.6 ' HA ' HG11 ' A' ' 93' ' ' VAL . 2.4 mt -76.88 -32.47 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.92 -36.2 59.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 tt0 -70.88 -42.5 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.883 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.54 73.26 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.46 -45.29 72.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -1.106 . . . . 0.0 108.944 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 107' ' ' GLN . 9.9 pt-20 -72.27 -24.18 61.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -69.99 -18.68 63.35 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.658 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.66 -0.69 48.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.322 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA3' ' NH1' ' A' ' 143' ' ' ARG . . . -107.15 -51.73 0.76 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -1.12 . . . . 0.0 109.143 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -120.99 34.65 5.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -102.37 -151.19 23.54 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.718 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.696 ' HG3' ' HZ2' ' A' ' 27' ' ' LYS . 2.6 mmt -144.14 -157.73 0.81 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.153 0.978 . . . . 0.0 110.965 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.646 ' NE2' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -90.83 -30.6 16.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.896 -178.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.646 HG22 ' NE2' ' A' ' 118' ' ' HIS . 2.1 t -111.51 154.14 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 119.857 -1.777 . . . . 0.0 110.502 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.604 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -163.39 105.62 0.98 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 0.0 108.908 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.57 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.9 m120 -85.45 -178.75 6.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.959 HD23 HD11 ' A' ' 124' ' ' LEU . 1.1 mp -152.38 100.23 2.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.524 ' C ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -85.46 65.47 9.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.959 HD11 HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.35 88.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -109.09 152.13 42.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.185 -1.185 . . . . 0.0 109.252 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -77.42 -23.43 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.426 2.084 . . . . 0.0 109.45 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -69.38 111.7 9.56 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.806 -0.559 . . . . 0.0 109.906 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.8 Cg_endo -82.66 170.63 12.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.407 2.071 . . . . 0.0 110.326 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.5 p -163.08 110.77 1.23 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.35 -29.49 70.23 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.2 m -58.23 -31.09 67.03 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -71.58 -36.58 70.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -59.44 5.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.81 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.2 OUTLIER -50.52 -23.4 2.47 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 108.723 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -73.72 -45.43 52.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.986 HG21 ' HA ' ' A' ' 166' ' ' ALA . 59.3 t -69.44 -21.68 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 8.4 m120 -62.94 -35.82 81.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -29.46 57.72 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -75.4 -13.24 60.38 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.1 m -80.52 -44.36 19.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.0 t -64.15 -13.8 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.517 ' NH1' ' HA3' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -96.85 -17.9 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.497 -0.752 . . . . 0.0 109.285 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.45 75.45 0.4 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 36.0 t -124.75 102.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.978 . . . . 0.0 110.48 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 146' ' ' LEU . 17.6 tp -62.86 105.84 0.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.3 t -97.24 156.98 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 110.881 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.548 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -136.36 146.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -142.87 137.07 29.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.984 -1.073 . . . . 0.0 109.537 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.73 144.49 54.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 0.2 OUTLIER -44.0 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 109.434 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 154' ' ' SER . . . 172.66 -22.35 0.07 OUTLIER Glycine 0 N--CA 1.496 2.692 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.821 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' SER . 3.4 p-10 30.74 36.25 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 122.235 -0.568 . . . . 0.0 111.486 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 3.5 t 160.47 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 110.121 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . -165.43 70.57 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.312 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . 45.95 -172.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -1.165 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.2 47.59 3.86 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.44 135.22 17.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.332 -1.099 . . . . 0.0 108.632 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.415 HD11 ' HA3' ' A' ' 189' ' ' GLY . 2.6 pt -57.9 -179.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.998 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.12 170.58 7.87 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.506 1.146 . . . . 0.0 112.599 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.423 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 77.8 m-85 -104.43 139.07 19.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.4 Cg_endo -73.54 -43.94 0.62 Allowed 'Cis proline' 0 C--N 1.295 -2.278 0 O-C-N 123.042 1.022 . . . . 0.0 110.816 3.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.998 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 23.13 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.029 0.918 . . . . 0.0 110.057 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -39.88 -63.72 0.56 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.495 0.664 . . . . 0.0 109.791 177.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.712 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 46.7 p90 -106.87 -166.45 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.899 0.856 . . . . 0.0 111.221 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.986 ' HA ' HG21 ' A' ' 137' ' ' VAL . . . 86.39 34.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.926 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 147' ' ' VAL . 1.0 OUTLIER 45.92 26.32 0.38 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -110.88 114.4 27.71 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.82 127.48 32.96 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.011 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.542 ' N ' ' HB2' ' A' ' 191' ' ' ASP . . . -78.53 108.63 12.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 172' ' ' GLY . 35.3 t -84.48 163.77 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.847 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.718 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -132.89 -172.78 13.1 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -138.89 143.88 38.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.088 -1.242 . . . . 0.0 109.418 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 43.5 p -108.46 175.02 5.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 1.4 t70 -74.64 -163.93 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 109.665 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -53.56 -29.97 39.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.54 -79.91 0.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.991 . . . . 0.0 110.151 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 178' ' ' ASN . 9.5 p-10 -149.63 60.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 1.0 OUTLIER -125.19 162.52 24.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.956 -1.09 . . . . 0.0 109.666 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 7.5 mtp180 -62.56 112.82 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.52 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 184' ' ' SER . . . -43.68 171.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.48 -27.29 12.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 184' ' ' SER . 11.6 p90 -114.63 -21.71 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.998 -1.064 . . . . 0.0 109.804 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 181' ' ' ALA . 10.8 t -55.65 126.93 27.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 109.26 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.455 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 27.7 mm-40 -85.23 154.67 21.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -138.81 173.27 11.75 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.161 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.551 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 168.01 148.44 5.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -43.55 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -1.112 . . . . 0.0 109.395 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 148.3 -16.38 1.31 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 256' ' ' LEU . 12.0 tp -45.97 126.17 7.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -1.127 . . . . 0.0 109.763 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.542 ' HB2' ' N ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -81.27 -62.0 1.78 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.562 ' CD1' HG22 ' A' ' 262' ' ' VAL . 14.0 tt -155.65 168.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.412 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.718 HG12 ' HA3' ' A' ' 172' ' ' GLY . 3.0 m -122.11 161.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 0.0 110.073 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 1.072 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -150.09 -172.78 0.33 Allowed Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 1.008 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 31.9 Cg_endo -75.48 110.26 3.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.319 1.346 . . . . 0.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -130.25 41.02 1.58 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 26.8 t -142.88 91.58 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.903 ' O ' HG13 ' A' ' 199' ' ' VAL . 19.7 t-20 89.34 115.29 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 198' ' ' ASN . 2.5 m -173.49 118.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -99.87 142.62 31.11 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.491 0.663 . . . . 0.0 110.214 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.604 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -149.71 -148.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 109.304 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -94.13 158.51 15.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.229 -0.919 . . . . 0.0 110.087 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.625 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -135.4 155.82 78.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.625 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.7 Cg_endo -73.62 151.26 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.304 2.003 . . . . 0.0 111.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 30.61 73.15 0.05 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 9.1 t 168.45 -100.55 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.052 -1.263 . . . . 0.0 110.149 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.792 HG23 ' N ' ' A' ' 208' ' ' TYR . 6.5 t -172.41 -142.82 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.792 ' N ' HG23 ' A' ' 207' ' ' THR . 0.0 OUTLIER -91.06 157.27 17.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.528 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.28 139.44 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.2 OUTLIER -95.23 133.19 39.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 212' ' ' ASN . 1.1 pp -158.28 164.36 36.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.503 ' O ' HD12 ' A' ' 211' ' ' LEU . 2.0 m-80 -99.85 171.54 7.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 216' ' ' MET . . . 153.59 131.35 1.57 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 84.4 m -67.62 -25.32 65.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.495 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -68.43 -12.29 60.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.147 -0.971 . . . . 0.0 109.386 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.479 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -77.0 -26.6 54.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 1.072 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -86.98 0.63 54.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.596 -0.69 . . . . 0.0 109.548 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.618 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 1.8 m -80.44 -45.79 1.34 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.269 -0.895 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.6 Cg_endo -73.48 -18.31 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.735 1.624 . . . . 0.0 110.985 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -70.7 -40.74 72.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.912 -1.118 . . . . 0.0 108.591 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 262' ' ' VAL . 55.8 t -74.35 -39.56 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.81 64.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -73.36 -52.34 8.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 264' ' ' ALA . . . -53.15 -64.13 0.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 109.242 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.455 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -43.48 -46.13 6.71 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.21 44.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 109.072 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.528 ' HB3' HD23 ' A' ' 21' ' ' LEU . 17.7 mt -56.48 -37.9 70.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 84.3 t -56.58 -63.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.793 ' HE3' HD11 ' A' ' 240' ' ' ILE . 1.8 mtpt -48.18 -31.7 6.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 108.893 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.45 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.6 OUTLIER -61.79 -49.3 76.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -5.93 31.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 6.7 p30 -164.44 79.58 1.4 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.402 -0.811 . . . . 0.0 109.685 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 31.98 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.854 2.369 . . . . 0.0 111.149 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -12.15 5.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.78 -1.2 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.65 175.72 9.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.054 -1.029 . . . . 0.0 109.864 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.87 174.66 5.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.684 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.519 ' N ' ' ND2' ' A' ' 237' ' ' ASN . 0.8 OUTLIER -58.04 -28.3 64.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -77.68 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.266 -0.897 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' VAL . 16.1 mt-30 -42.9 -36.23 1.45 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.481 0.657 . . . . 0.0 109.488 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.793 HD11 ' HE3' ' A' ' 229' ' ' LYS . 50.4 mt -68.86 -56.33 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 109.633 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -43.31 -50.17 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 109.906 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -51.06 -60.98 2.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.784 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 247' ' ' THR . 2.5 t60 -55.14 -57.12 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.066 . . . . 0.0 109.822 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 244' ' ' LEU . 0.8 OUTLIER -56.3 -18.46 10.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.477 -0.765 . . . . 0.0 109.95 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER -83.42 -39.71 20.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 109.271 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.69 -30.08 66.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.269 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.898 HG23 ' O ' ' A' ' 243' ' ' HIS . 1.7 p -78.92 -52.35 8.4 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.18 0.991 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -28.9 116.97 0.11 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 13.9 m -53.32 131.91 38.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.32 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.74 109.99 22.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.41 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.895 HD22 ' CD2' ' A' ' 257' ' ' TYR . 6.1 mp . . . . . 0 C--N 1.307 -1.272 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.624 ' O ' HD23 ' A' ' 190' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.895 ' CD2' HD22 ' A' ' 251' ' ' LEU . 27.9 m-85 -90.96 -61.42 1.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.38 -0.825 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.2 -120.69 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.518 ' HB3' ' CG1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -47.27 -44.05 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 108.995 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 249' ' ' THR . . . 110.97 -142.8 16.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -178.06 5.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.562 HG22 ' CD1' ' A' ' 192' ' ' ILE . 3.7 t -129.57 146.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.459 -0.775 . . . . 0.0 110.55 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.479 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.02 121.23 1.23 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 224' ' ' ALA . . . -94.23 -12.96 27.13 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.796 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.623 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 1.1 tm-20 -68.84 -15.74 63.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.812 -1.18 . . . . 0.0 109.685 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.25 1.89 39.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.76 ' HB2' HG21 ' A' ' 247' ' ' THR . . . -122.82 -17.49 6.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.634 HG21 ' CD2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -92.82 -38.88 11.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.776 -1.202 . . . . 0.0 109.364 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.457 ' OXT' ' O ' ' A' ' 268' ' ' THR . 10.2 ptm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.867 -1.064 . . . . 0.0 109.618 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.885 ' O ' HG13 ' A' ' 4' ' ' VAL . 1.1 m . . . . . 0 C--O 1.214 -0.786 0 CA-C-O 121.371 0.605 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.885 HG13 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 170.43 100.21 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 109.22 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 8' ' ' ILE . 36.2 Cg_endo -78.8 174.77 11.79 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.632 2.221 . . . . 0.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -48.02 -28.87 3.04 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.511 -0.743 . . . . 0.0 109.924 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.62 -42.16 55.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CG1' ' NE2' ' A' ' 220' ' ' HIS . 34.2 mt -109.57 73.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.923 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -42.32 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -93.68 6.71 47.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 11' ' ' VAL . 15.8 m -98.2 19.71 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 109.647 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 34.8 mm-40 47.6 25.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 110.089 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.669 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.43 -42.3 83.97 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.9 . . . . 0.0 110.907 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.46 -44.09 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 18' ' ' ASN . . . -46.46 -37.06 7.25 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.67 64.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -64.93 -18.91 65.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.687 -0.633 . . . . 0.0 110.7 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 6.3 p-10 -113.1 -6.63 13.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.743 -1.223 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -83.2 -22.98 33.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.939 -1.1 . . . . 0.0 109.219 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.46 50.33 0.46 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' C ' HG22 ' A' ' 22' ' ' THR . 0.5 OUTLIER -139.25 179.8 6.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.957 . . . . 0.0 109.968 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.53 HG22 ' C ' ' A' ' 21' ' ' LEU . 1.1 t 157.76 100.09 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -55.65 0.93 0.09 OUTLIER Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.654 -0.653 . . . . 0.0 111.935 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 85' ' ' ASN . 71.9 m -28.45 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.811 1.306 . . . . 0.0 111.97 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -85.45 35.02 3.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 23' ' ' GLY . 44.1 t -125.78 165.43 23.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.124 -1.221 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' N ' HG12 ' A' ' 26' ' ' VAL . 16.5 mttm -135.91 117.42 14.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.481 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 119' ' ' VAL . 13.6 t -128.54 136.26 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.829 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.67 155.56 21.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 35' ' ' ILE . 2.2 t -130.84 85.04 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.132 -0.98 . . . . 0.0 108.953 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.95 HD23 HG21 ' A' ' 93' ' ' VAL . 6.9 mp -70.46 103.96 2.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 33' ' ' THR . 9.2 p30 -148.92 -143.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.234 -0.916 . . . . 0.0 109.152 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 33' ' ' THR . 13.4 t -135.68 79.71 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.035 -1.041 . . . . 0.0 110.054 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.43 ' HA3' ' ND2' ' A' ' 60' ' ' ASN . . . 90.69 120.8 2.3 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.885 HD12 ' HB2' ' A' ' 90' ' ' ALA . 2.8 mt -112.81 -24.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 122.111 0.958 . . . . 0.0 108.654 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 42.1 t 57.3 148.18 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.287 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -93.09 160.25 14.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.628 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -160.78 178.91 1.47 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 109.046 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.9 Cg_endo -78.0 -22.27 10.18 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.402 2.068 . . . . 0.0 110.183 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.571 ' HA ' HD12 ' A' ' 73' ' ' LEU . 74.9 m-20 -97.22 -55.14 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.336 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.581 HD21 ' C ' ' A' ' 67' ' ' ALA . 17.4 mt -55.22 156.9 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.91 63.87 1.53 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 0.0 109.205 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 43' ' ' ILE . 7.4 mm -49.96 115.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -104.85 -8.13 18.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.99 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -174.13 177.12 46.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.15 158.65 19.65 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.468 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -152.98 162.49 41.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.69 -0.888 . . . . 0.0 108.833 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -132.99 109.74 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.861 ' CE2' HG12 ' A' ' 91' ' ' VAL . 1.9 m-85 -107.61 -44.17 4.33 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.317 -0.864 . . . . 0.0 109.025 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.687 HG13 ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -41.33 151.53 0.29 Allowed Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD2' HG13 ' A' ' 50' ' ' VAL . 30.0 Cg_endo . . . . . 0 C--N 1.309 -1.548 0 C-N-CA 122.427 2.085 . . . . 0.0 111.005 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.428 HG22 ' OE1' ' A' ' 57' ' ' GLN . 11.0 t -79.03 0.97 25.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.029 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.428 ' OE1' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -119.37 106.68 12.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER 65.72 174.74 0.22 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 0.0 109.861 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.439 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 115.15 15.76 7.61 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.65 ' OD1' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -160.71 -71.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.985 . . . . 0.0 109.049 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.86 8.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -73.65 -57.19 4.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -1.22 . . . . 0.0 109.925 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.22 72.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.1 m -69.16 -40.91 77.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 27.1 t-80 -66.56 -53.16 37.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 69' ' ' THR . 39.4 t -58.99 -35.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 109.712 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.581 ' C ' HD21 ' A' ' 41' ' ' LEU . . . -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 110.235 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.611 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -70.16 -44.94 58.49 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.964 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 66' ' ' VAL . 12.3 t -64.46 -16.83 63.13 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.989 -1.301 . . . . 0.0 108.975 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 219' ' ' PRO . 78.7 mt -93.02 -24.91 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.819 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . . . -133.93 -43.1 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.879 -1.138 . . . . 0.0 110.902 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.762 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 8.05 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.106 0.479 . . . . 0.0 111.636 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 40' ' ' ASP . 22.2 mt -42.27 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.971 -1.081 . . . . 0.0 109.57 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.828 ' HB2' HD13 ' A' ' 80' ' ' LEU . 43.8 t30 -113.71 106.44 14.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -154.64 -100.63 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 109.605 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.7 p -132.06 -32.6 1.39 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.347 -0.846 . . . . 0.0 110.147 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.577 HG12 ' ND2' ' A' ' 75' ' ' ASN . 27.9 pt -91.31 138.11 20.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.073 -1.017 . . . . 0.0 110.302 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 3' ' ' SER . . . 60.13 158.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.543 ' C ' ' HB3' ' A' ' 3' ' ' SER . 5.6 m -70.19 -160.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.563 -0.963 . . . . 0.0 109.465 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 74' ' ' ASN . 4.5 tp -135.15 131.35 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.429 -0.794 . . . . 0.0 110.241 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.762 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -77.43 -145.71 2.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.96 -28.47 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.93 -1.335 . . . . 0.0 109.051 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -110.68 125.91 29.86 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.46 -61.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.417 2.078 . . . . 0.0 110.875 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.526 ' CB ' ' OG ' ' A' ' 24' ' ' SER . 1.2 m-20 -103.36 39.88 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.504 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -83.4 168.46 16.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.008 -1.058 . . . . 0.0 109.6 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 72.8 mt-10 -113.6 92.42 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.819 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 7.8 mt -97.13 135.81 38.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 109.635 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 27.7 m-85 -104.14 155.84 18.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.885 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -110.84 102.58 11.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 109.257 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.861 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -100.5 68.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.188 -0.945 . . . . 0.0 109.068 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 33' ' ' THR . 19.4 ttpt -36.61 103.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.345 0.593 . . . . 0.0 110.275 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.95 HG21 HD23 ' A' ' 31' ' ' LEU . 1.4 t -115.48 -20.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 108.798 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.29 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.402 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 33' ' ' THR . . . -91.18 179.21 42.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.65 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.179 -1.189 . . . . 0.0 109.493 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.93 162.84 24.99 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.742 -0.858 . . . . 0.0 109.094 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 133' ' ' LEU . 58.2 t -68.67 -19.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 43.0 t -78.75 -19.86 51.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.0 m -79.2 -52.86 7.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 133' ' ' LEU . 1.3 mt -63.47 -25.2 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.34 78.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.642 -0.661 . . . . 0.0 109.423 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -71.51 -32.39 68.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.987 -1.071 . . . . 0.0 108.991 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.63 -31.08 70.56 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.66 -25.18 21.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.18 -1.188 . . . . 0.0 110.384 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.63 -26.04 23.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -63.54 -22.15 66.73 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.774 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -86.78 -22.43 25.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -62.41 -43.64 98.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 1.8 p-10 -85.18 -38.64 18.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 31.5 m-20 -146.14 85.02 1.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.774 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -115.32 -165.33 14.62 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 15.0 mmt -139.0 178.78 6.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.548 -0.972 . . . . 0.0 110.138 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.516 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.7 m170 -57.95 -39.99 79.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.557 -0.714 . . . . 0.0 110.732 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 120' ' ' ALA . 19.0 t -130.56 167.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.861 -1.149 . . . . 0.0 111.104 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.564 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -164.35 114.78 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 222' ' ' ALA . 10.7 m120 -100.3 151.13 21.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.903 -1.123 . . . . 0.0 110.708 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.402 HD11 HD22 ' A' ' 31' ' ' LEU . 6.9 mp -118.11 110.72 17.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.8 t -82.68 71.74 9.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 108.918 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.17 -174.14 2.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.351 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . 168.62 79.69 0.04 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -95.24 155.82 38.43 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.331 -1.099 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.41 -11.79 18.92 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.516 2.144 . . . . 0.0 109.571 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -83.27 115.54 59.68 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.619 -0.675 . . . . 0.0 109.442 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.58 167.92 21.98 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.258 1.972 . . . . 0.0 110.107 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -155.98 117.24 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.07 -20.8 65.87 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.2 m -69.32 -26.95 64.96 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.8 mp -78.35 -36.21 46.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -38.25 69.0 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.167 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -67.52 -22.61 65.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.87 -32.71 40.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.576 -0.85 . . . . 0.0 108.748 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' ' 167' ' ' ASN . 2.2 t -76.29 -26.38 17.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.87 -35.35 80.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 m -79.65 -23.8 42.3 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.83 60.39 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.5 m -79.57 -34.47 40.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.941 . . . . 0.0 108.628 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -56.98 -28.04 61.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.83 -13.51 16.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.21 78.44 0.59 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 117' ' ' MET . 5.1 t -127.3 92.03 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -1.138 . . . . 0.0 110.155 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tp -57.02 120.53 8.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 108.599 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -107.56 152.07 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 110.22 -178.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -141.62 103.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.42 150.33 21.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.06 -1.025 . . . . 0.0 110.412 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.678 ' HB2' ' OG1' ' A' ' 218' ' ' THR . . . -78.31 172.84 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.5 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -77.84 -79.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.0 109.254 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.75 -111.77 0.35 Allowed Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -176.3 28.72 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 29.3 t -128.36 -99.4 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.905 . . . . 0.0 109.73 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.39 55.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.32 -178.2 4.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 109.301 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.61 38.92 2.66 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -166.44 155.38 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -1.178 . . . . 0.0 108.672 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -172.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.868 -1.145 . . . . 0.0 110.751 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.815 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.0 OUTLIER -80.43 163.77 23.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.172 0.987 . . . . 0.0 112.108 -177.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.413 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.2 m-85 -112.43 132.34 22.2 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.6 Cg_endo -73.97 -42.77 0.78 Allowed 'Cis proline' 0 C--N 1.299 -2.077 0 O-C-N 123.139 1.073 . . . . 0.0 111.041 3.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 21.34 -73.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.869 0.843 . . . . 0.0 110.122 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -46.49 -71.59 0.07 Allowed 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.645 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.8 m-85 27.41 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.834 1.302 . . . . 0.0 113.03 178.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.5 -0.35 2.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.437 ' HB2' HG11 ' A' ' 137' ' ' VAL . 15.2 m120 -124.41 21.83 8.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.88 169.87 23.63 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.491 -0.755 . . . . 0.0 108.968 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.485 ' HB2' HG22 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -111.48 157.82 19.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.69 129.91 54.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 31.2 t -91.86 164.63 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.894 -1.129 . . . . 0.0 109.459 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.77 -171.69 12.9 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -120.75 164.93 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 179' ' ' ASN . 0.9 OUTLIER -133.39 173.81 11.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.34 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 0.3 OUTLIER -85.36 -152.0 0.15 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 177' ' ' ASN . 5.1 pt20 -84.96 -29.91 24.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 176' ' ' GLN . 53.4 m-20 -96.33 -97.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.962 . . . . 0.0 109.947 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.77 19.23 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 0.0 109.856 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 3.1 t-20 -72.47 -151.96 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 109.087 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.55 ' HB2' ' CE2' ' A' ' 257' ' ' TYR . 22.3 ttp85 -132.93 16.64 4.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 58.39 164.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.735 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 t -121.2 -4.64 9.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.953 . . . . 0.0 109.914 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.565 ' O ' ' CG ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -106.4 29.13 7.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 109.832 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.78 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 41.6 t -111.85 119.35 38.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 184' ' ' SER . 0.0 OUTLIER -43.89 113.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 109.176 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -113.71 168.15 10.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.915 . . . . 0.0 109.319 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.48 178.72 42.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.73 111.42 17.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 129.36 9.06 3.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 256' ' ' LEU . 14.2 tp -64.24 143.76 57.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.944 -1.327 . . . . 0.0 109.251 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 19.1 t70 -91.6 -70.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.763 HD13 HG13 ' A' ' 262' ' ' VAL . 13.0 tt -140.81 169.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.838 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 260' ' ' GLY . 29.2 m -120.17 162.82 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.73 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -158.48 165.52 18.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.8 Cg_endo -77.09 115.99 4.1 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.465 2.11 . . . . 0.0 110.475 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.44 24.25 3.74 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.66 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 55.4 t -102.96 68.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -1.066 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.841 ' O ' HG13 ' A' ' 199' ' ' VAL . 0.7 OUTLIER 110.33 122.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.072 0.939 . . . . 0.0 108.597 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 198' ' ' ASN . 2.5 m -170.84 113.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -101.67 168.15 9.65 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.7 0.762 . . . . 0.0 110.125 -179.401 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 200' ' ' GLN . 4.3 m -168.32 -156.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . 0.439 ' H ' HG23 ' A' ' 202' ' ' THR . 1.0 OUTLIER -77.35 172.08 13.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.667 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -152.98 160.59 30.77 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -71.34 164.01 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.285 1.99 . . . . 0.0 110.655 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.7 82.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.99 34.43 5.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -1.056 . . . . 0.0 109.373 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -126.76 160.33 31.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.288 -0.882 . . . . 0.0 109.852 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.93 169.42 8.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.3 164.01 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.78 -1.2 . . . . 0.0 110.961 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.9 OUTLIER -123.34 124.17 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mt -119.73 161.27 21.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.927 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 212' ' ' ASN . 1.1 p-10 -134.05 107.6 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -161.6 151.24 21.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.1 m -70.83 -21.89 62.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -1.114 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.443 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -72.24 -13.27 61.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.135 -0.978 . . . . 0.0 109.095 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.499 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -81.7 -13.52 57.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.724 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.73 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -88.9 -1.49 58.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.985 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 150' ' ' ALA . 1.1 m -75.83 -40.5 3.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.254 -0.904 . . . . 0.0 111.379 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.6 Cg_endo -72.32 -12.95 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.698 1.599 . . . . 0.0 111.242 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.569 ' NE2' ' CG1' ' A' ' 8' ' ' ILE . 18.1 m80 -77.17 -51.45 10.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.044 -1.035 . . . . 0.0 108.507 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 262' ' ' VAL . 98.8 t -63.07 -41.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.526 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -57.15 -40.42 77.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.805 . . . . 0.0 109.11 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.43 59.22 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.2 -51.99 60.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.25 . . . . 0.0 110.021 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.07 -32.99 56.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.374 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.77 97.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.102 -0.999 . . . . 0.0 108.821 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.3 mt -59.06 -51.31 70.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.823 . . . . 0.0 109.565 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' LYS . 76.3 t -57.54 -55.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 109.922 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.58 ' NZ ' HD11 ' A' ' 240' ' ' ILE . 4.1 ttmm -42.28 -42.4 3.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.495 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -61.84 -48.09 82.13 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -57.22 -17.05 9.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.165 -0.96 . . . . 0.0 108.951 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 235' ' ' TRP . 2.3 m120 -172.45 90.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.696 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.1 -38.58 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.75 2.3 . . . . 0.0 110.66 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 235' ' ' TRP . 0.0 OUTLIER -47.42 -46.16 26.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 110.215 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.548 ' CD2' ' HB3' ' A' ' 232' ' ' ASN . 47.4 m0 -45.3 170.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.081 -1.012 . . . . 0.0 110.063 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -113.11 176.85 4.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.731 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -54.21 -20.08 6.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.956 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 238' ' ' VAL . 2.4 t -78.33 -65.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.14 -0.975 . . . . 0.0 109.461 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 235' ' ' TRP . 1.0 OUTLIER -44.39 -43.17 7.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.58 HD11 ' NZ ' ' A' ' 229' ' ' LYS . 6.1 mt -59.65 -55.3 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -42.4 -35.81 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 110.435 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 245' ' ' LYS . 29.2 t-20 -72.55 -40.21 66.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.49 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . 0.478 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.9 OUTLIER -70.47 -47.08 62.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.879 -1.138 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.4 OUTLIER -70.45 -28.65 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.444 -0.785 . . . . 0.0 110.844 -178.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -73.36 -48.99 29.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 109.903 -179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.571 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 7.8 t-20 -74.06 -22.39 59.56 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.674 -0.641 . . . . 0.0 111.04 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 9.1 p -84.47 -32.2 24.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.791 -1.193 . . . . 0.0 109.95 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.52 130.28 44.35 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.74 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 250' ' ' SER . 2.4 m -48.48 164.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 249' ' ' THR . 49.0 m -129.15 97.8 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.496 HD13 ' HA2' ' A' ' 260' ' ' GLY . 5.8 mp . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.477 ' O ' ' HD2' ' A' ' 180' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' A' ' 180' ' ' ARG . 38.0 m-85 -76.2 -12.3 60.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 59.42 -154.3 30.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 250' ' ' SER . 6.0 t -44.92 -25.72 0.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.268 -1.137 . . . . 0.0 109.222 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.496 ' HA2' HD13 ' A' ' 251' ' ' LEU . . . 125.49 -132.6 8.04 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.556 ' O ' HD11 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -100.62 177.83 4.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -1.105 . . . . 0.0 109.309 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.763 HG13 HD13 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -111.41 156.86 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.414 ' CG ' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -170.75 121.08 0.57 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 122.35 1.071 . . . . 0.0 108.197 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 268' ' ' THR . . . -76.04 -17.61 59.58 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.031 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.495 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 29.5 tt0 -65.54 -43.2 90.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.049 . . . . 0.0 109.146 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.98 -13.98 62.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.265 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -110.81 12.7 22.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 264' ' ' ALA . 4.4 p -119.23 -39.02 2.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.476 ' HG3' ' OXT' ' A' ' 269' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.914 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 1.015 ' O ' HG22 ' A' ' 4' ' ' VAL . 5.2 t . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.015 HG22 ' O ' ' A' ' 3' ' ' SER . 2.5 m 59.95 41.25 0.53 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.939 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.5 Cg_endo -82.24 -169.29 0.73 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.976 1.784 . . . . 0.0 110.454 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CG ' ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -32.92 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -83.08 -69.26 1.39 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.71 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 19.7 mm -33.57 90.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 122.042 -0.681 . . . . 0.0 110.323 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER 155.67 -55.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 17.7 tpp85 -75.42 -17.47 60.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.485 -0.759 . . . . 0.0 109.448 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 13' ' ' ALA . 19.4 m -88.62 23.3 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 20.8 mm100 49.66 41.35 21.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.208 -0.933 . . . . 0.0 109.92 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.27 -33.02 0.52 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -73.63 -55.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 N-CA-C 108.528 -1.374 . . . . 0.0 108.528 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -42.36 -33.15 0.6 Allowed 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -72.18 -49.3 36.65 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 17' ' ' HIS . 2.2 m170 -69.09 -6.05 25.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.06 -55.36 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.44 -27.85 2.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 109.158 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.32 23.38 2.92 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.881 HD23 HD22 ' A' ' 227' ' ' LEU . 0.3 OUTLIER -67.17 173.13 4.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.179 -1.189 . . . . 0.0 109.34 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.596 ' HA ' ' HG3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -163.06 -35.55 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 110.553 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.868 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 73.68 -5.34 23.84 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -44.0 134.08 4.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.132 -1.216 . . . . 0.0 109.665 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 7.92 56.04 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 23' ' ' GLY . 27.0 t -107.86 164.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -1.217 . . . . 0.0 109.246 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 2.0 mptt -145.01 118.25 8.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.0 110.32 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 119' ' ' VAL . 2.5 t -125.92 128.01 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.68 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -82.3 159.97 23.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.547 HG21 HD22 ' A' ' 88' ' ' LEU . 10.7 t -134.43 87.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.78 -1.2 . . . . 0.0 109.794 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 93' ' ' VAL . 10.0 mp -66.74 126.17 28.15 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -177.79 -146.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.704 -1.247 . . . . 0.0 109.961 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -137.61 72.57 1.42 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.023 -1.048 . . . . 0.0 110.654 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 64' ' ' THR . . . 111.87 118.38 3.69 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.416 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 3.9 mm -115.26 -18.87 7.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.675 0.75 . . . . 0.0 109.11 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 33.0 104.61 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.818 0.818 . . . . 0.0 111.483 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -58.61 147.66 31.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 108.692 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.537 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -146.13 177.14 1.87 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.314 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 38' ' ' HIS . 33.6 Cg_endo -76.33 -4.95 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.215 1.943 . . . . 0.0 109.626 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 73' ' ' LEU . 2.6 t0 -114.97 -22.53 9.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.166 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.36 122.75 39.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -97.36 103.38 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 108.65 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 44' ' ' ARG . 3.9 mt -89.68 163.48 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.074 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.547 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 6.9 tpt180 -135.88 -32.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -163.51 161.94 34.53 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.44 165.71 36.75 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.971 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.44 165.02 17.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.522 -0.987 . . . . 0.0 109.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -126.53 142.07 51.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.575 ' HE2' HG12 ' A' ' 91' ' ' VAL . 32.9 m-85 -116.38 -53.01 2.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.385 -0.822 . . . . 0.0 109.776 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 81.1 t -57.3 125.54 71.45 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.312 -1.355 0 C-N-CA 122.425 2.084 . . . . 0.0 111.31 -179.092 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 N--CA 1.501 2.118 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.447 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 8.8 t -56.6 -14.63 3.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.134 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG3' HG23 ' A' ' 56' ' ' THR . 47.7 mt-30 -108.92 143.5 38.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 57' ' ' GLN . 40.8 t0 61.34 136.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.462 -0.774 . . . . 0.0 110.392 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.27 -39.39 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.843 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -169.1 -35.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -1.031 . . . . 0.0 108.927 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.84 -16.97 4.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -68.31 -58.06 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 109.296 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -61.76 6.28 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLY . 3.3 m -45.82 -41.13 10.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -1.109 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 5.2 t-80 -58.83 -56.81 17.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.733 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 219' ' ' PRO . 41.8 t -55.45 -35.08 36.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . . . -57.64 -44.74 85.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.719 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.627 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -75.15 -21.38 78.19 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.555 HG23 ' CE1' ' A' ' 220' ' ' HIS . 15.7 m -81.47 -11.51 59.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 108.166 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 66' ' ' VAL . 38.4 mt -103.51 -28.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -156.71 11.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.622 -1.299 . . . . 0.0 112.323 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -40.01 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.691 -1.256 . . . . 0.0 110.626 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 71' ' ' ALA . 9.7 mt -45.76 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.881 -1.137 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 6.8 t-20 -92.74 155.23 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.451 -0.781 . . . . 0.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 9.0 p-10 154.43 124.71 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 75' ' ' ASN . 22.8 t -41.59 -27.26 0.09 Allowed 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.869 -0.519 . . . . 0.0 109.734 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.8 pt -83.52 68.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 208' ' ' TYR . . . 123.36 146.93 7.2 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 80' ' ' LEU . 10.2 m -64.31 -149.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 ' N ' HG23 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -158.06 141.34 15.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.583 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -97.86 -144.6 17.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG12 HD11 ' A' ' 227' ' ' LEU . 0.5 OUTLIER -91.48 -72.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 0.0 109.896 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -63.04 144.08 97.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.596 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 37.3 Cg_endo -86.69 -64.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.369 2.046 . . . . 0.0 110.113 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 21.6 t-20 -105.76 -87.08 0.47 Allowed 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.001 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 54.79 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.105 -0.997 . . . . 0.0 110.08 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 7.6 mt-10 -95.49 107.71 19.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 30' ' ' VAL . 5.5 mt -92.91 106.56 18.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 109.974 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 14.2 m-85 -87.88 153.86 20.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.534 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.457 ' CB ' HG13 ' A' ' 35' ' ' ILE . . . -119.0 108.92 15.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.791 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.68 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -111.32 65.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.989 . . . . 0.0 110.214 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' VAL . 14.5 ttmm -38.83 114.5 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -143.38 21.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 120.97 -1.081 . . . . 0.0 111.327 -177.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' ' O ' ' A' ' 95' ' ' GLY . 22.6 mt -150.29 168.55 23.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.241 -1.537 . . . . 0.0 111.77 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 94' ' ' LEU . . . -46.34 -166.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.022 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 CA-C-O 122.246 0.914 . . . . 0.0 111.734 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.0 t -68.17 179.5 1.54 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.419 0.628 . . . . 0.0 109.407 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.562 ' CG2' ' OG ' ' A' ' 130' ' ' SER . 48.4 t -66.02 -14.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 m -75.07 -22.67 58.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.73 -53.34 4.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 109.261 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.589 ' HA ' HG22 ' A' ' 93' ' ' VAL . 2.3 mt -62.15 -45.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 102' ' ' VAL . . . -63.18 -47.28 83.31 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.414 ' HG2' ' CD1' ' A' ' 49' ' ' PHE . 25.1 tp60 -52.23 -39.26 60.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.862 . . . . 0.0 109.442 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.28 39.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.03 -11.05 45.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -1.116 . . . . 0.0 109.12 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.9 -25.7 15.34 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.334 -0.854 . . . . 0.0 109.45 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -72.98 -15.15 61.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.646 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -96.22 -11.82 25.5 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.947 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -84.46 -26.2 40.24 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 115' ' ' ASN . 3.8 m120 -123.3 28.84 6.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 108.999 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER 162.73 32.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.685 ' O ' ' HE1' ' A' ' 117' ' ' MET . . . -102.98 -147.54 18.97 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.685 ' HE1' ' O ' ' A' ' 116' ' ' GLY . 6.0 mmt -134.9 -178.74 5.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.614 -0.933 . . . . 0.0 109.779 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.942 ' ND1' HG23 ' A' ' 119' ' ' VAL . 10.7 p80 -66.0 -40.37 91.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.78 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.942 HG23 ' ND1' ' A' ' 118' ' ' HIS . 55.5 t -120.57 165.6 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.833 -1.167 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.608 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.02 132.08 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 1.023 ' O ' HD12 ' A' ' 122' ' ' LEU . 4.9 t-20 -90.34 167.85 12.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.792 -1.192 . . . . 0.0 109.785 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.023 HD12 ' O ' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -149.54 105.24 3.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.98 . . . . 0.0 109.041 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 9.6 m -96.2 68.77 2.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 108.985 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.874 HD11 HD23 ' A' ' 122' ' ' LEU . 0.5 OUTLIER -111.35 -165.94 1.03 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.259 1.028 . . . . 0.0 110.091 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.42 105.03 1.51 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.488 ' CB ' ' HD2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -168.91 172.76 2.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.251 . . . . 0.0 109.84 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.555 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 34.8 Cg_endo -79.15 4.66 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.796 2.331 . . . . 0.0 109.916 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.624 ' N ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -117.83 44.09 0.49 Allowed Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.556 -0.715 . . . . 0.0 111.464 -178.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 128' ' ' SER . 37.5 Cg_endo -76.42 173.71 14.03 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.951 1.767 . . . . 0.0 110.532 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.562 ' OG ' ' CG2' ' A' ' 102' ' ' VAL . 3.0 m -149.65 131.5 15.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.31 66.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.463 ' HB ' HG11 ' A' ' 102' ' ' VAL . 3.3 m -66.28 -29.94 70.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.566 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -69.17 -35.22 76.06 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -63.37 -51.11 67.26 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -48.56 -26.49 2.23 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -69.53 -45.67 68.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.921 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.666 HG21 ' CZ ' ' A' ' 165' ' ' TYR . 0.9 OUTLIER -62.95 -30.31 49.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 21.6 m120 -60.33 -36.2 77.42 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.2 p -78.85 -22.54 45.95 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.14 54.41 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.096 -1.002 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 -46.53 16.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.038 -1.039 . . . . 0.0 108.747 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -29.98 8.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -86.2 -33.21 20.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.891 . . . . 0.0 109.092 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.76 61.93 1.49 Allowed Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.492 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 43.9 t -108.79 99.7 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.482 -1.01 . . . . 0.0 109.874 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' A' ' 119' ' ' VAL . 27.1 tp -58.52 111.03 1.1 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.942 -1.099 . . . . 0.0 108.079 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.725 ' CG1' HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -115.02 137.25 49.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 110.278 -178.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.964 HG13 HD22 ' A' ' 121' ' ' ASN . 1.5 p -113.92 150.92 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 163' ' ' ALA . . . -134.3 144.4 48.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.962 -1.087 . . . . 0.0 110.422 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -57.79 152.74 15.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 109.8 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -59.15 -73.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.051 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 138.8 121.7 1.94 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -99.79 55.1 0.94 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.539 ' OG ' ' HG2' ' A' ' 185' ' ' GLN . 0.0 OUTLIER -91.53 -86.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.841 . . . . 0.0 109.774 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 146.3 83.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 179.64 176.65 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.374 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.59 43.19 3.19 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.5 OUTLIER -158.79 166.25 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -1.072 . . . . 0.0 108.83 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -106.44 -174.48 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 109.666 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -71.33 157.84 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.817 0.818 . . . . 0.0 110.174 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -115.17 138.14 23.37 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 103.906 -2.628 . . . . 0.0 103.906 176.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.71 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.5 Cg_endo -72.64 -49.9 0.21 Allowed 'Cis proline' 0 C--N 1.295 -2.272 0 O-C-N 122.967 0.983 . . . . 0.0 111.826 4.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 36.21 -77.91 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -41.61 -55.23 2.98 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER 46.9 -178.88 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.26 -16.73 12.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.427 ' OD1' HG13 ' A' ' 137' ' ' VAL . 30.0 p-10 -129.44 13.8 6.04 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 165' ' ' TYR . . . -127.22 157.28 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.473 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -105.45 159.31 16.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.061 -1.024 . . . . 0.0 110.093 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -111.47 116.37 30.78 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 172' ' ' GLY . 24.5 t -81.84 167.42 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -134.93 -165.57 10.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -143.48 137.99 28.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.934 -1.333 . . . . 0.0 110.666 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 p -109.15 168.58 9.27 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 179' ' ' ASN . 4.2 t70 -95.61 -40.14 9.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.29 1.043 . . . . 0.0 109.804 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -152.27 -103.62 0.05 Allowed 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 177' ' ' ASN . 1.5 p30 -62.01 -48.85 78.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.722 -1.236 . . . . 0.0 107.72 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.503 ' HB2' HD21 ' A' ' 251' ' ' LEU . 0.5 OUTLIER 173.73 68.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 2.1 t-20 -97.03 -11.74 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.772 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.572 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 1.7 ttp180 82.07 12.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.366 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.875 ' HB1' ' CE1' ' A' ' 183' ' ' PHE . . . 53.97 -159.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.499 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.02 30.7 3.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.875 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 1.0 OUTLIER -152.36 -28.2 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.1 -1.0 . . . . 0.0 110.691 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -45.41 124.17 4.67 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.809 -1.182 . . . . 0.0 109.277 179.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.539 ' HG2' ' OG ' ' A' ' 154' ' ' SER . 1.3 mp0 -75.98 149.45 37.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.155 -0.966 . . . . 0.0 111.048 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.848 ' O ' HG23 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -68.09 -174.73 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.488 0.661 . . . . 0.0 110.67 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.54 ' CA ' HG12 ' A' ' 159' ' ' ILE . . . -173.27 150.24 11.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -83.11 68.9 9.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -1.051 . . . . 0.0 109.005 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 118.56 41.71 0.61 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.561 ' CD1' HD13 ' A' ' 159' ' ' ILE . 7.7 tp -41.22 150.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.469 -1.018 . . . . 0.0 109.283 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 0.5 OUTLIER -90.64 -60.85 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.542 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 262' ' ' VAL . 14.3 tt -155.5 171.23 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 109.566 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 260' ' ' GLY . 27.2 m -127.92 160.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.038 -1.039 . . . . 0.0 109.964 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -152.69 132.82 7.38 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 6' ' ' TRP . 31.7 Cg_endo -71.61 121.11 7.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.609 1.539 . . . . 0.0 110.283 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.27 61.23 0.55 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 50.1 t -102.08 66.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -1.186 . . . . 0.0 108.483 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASN . . . . . 0.65 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 2.2 t-20 111.48 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 198' ' ' ASN . 11.8 m -159.37 111.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 122.273 1.035 . . . . 0.0 108.77 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.3 pm0 -87.61 124.83 33.93 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.495 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -135.85 -156.17 0.69 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.633 -0.667 . . . . 0.0 109.253 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 34.8 p -77.06 -177.92 4.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.042 0.925 . . . . 0.0 110.586 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' TYR . . . . . 0.632 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -156.94 151.83 21.07 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.632 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.4 Cg_endo -69.83 164.47 34.49 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.996 1.797 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 75.26 12.27 83.64 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 72.34 33.18 1.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.623 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -120.48 171.2 8.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.758 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 209' ' ' ALA . 87.6 m-85 -122.73 176.2 6.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 208' ' ' TYR . . . 176.91 175.38 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.654 -1.279 . . . . 0.0 110.782 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -135.07 131.07 36.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.527 -0.733 . . . . 0.0 109.419 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.664 HD12 ' HE1' ' A' ' 216' ' ' MET . 0.1 OUTLIER -148.01 108.06 4.05 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.969 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . 0.465 ' HB3' ' N ' ' A' ' 198' ' ' ASN . 18.8 p30 -63.87 169.4 4.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.389 -0.82 . . . . 0.0 108.908 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 156.69 7.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -75.39 -35.85 61.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.202 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -14.09 19.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 109.642 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' MET . . . . . 0.664 ' HE1' HD12 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -90.54 -24.01 20.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.899 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -89.52 -7.63 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 109.417 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.639 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 13.4 m -71.95 -41.52 9.03 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 111.505 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.718 ' HB3' HG13 ' A' ' 66' ' ' VAL . 30.1 Cg_endo -73.27 -21.08 20.51 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.699 1.599 . . . . 0.0 110.923 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 69' ' ' THR . 3.8 m80 -64.34 -42.08 96.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.72 -47.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -46.89 -35.36 6.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -70.77 -56.08 7.67 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -46.62 -41.51 14.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.948 -1.325 . . . . 0.0 109.444 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.7 99.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 108.809 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.1 -45.54 75.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.881 HD22 HD23 ' A' ' 21' ' ' LEU . 42.4 mt -59.21 -50.58 73.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 267' ' ' ALA . 95.7 t -56.0 -49.06 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.973 -1.079 . . . . 0.0 109.57 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.641 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.5 OUTLIER -48.54 -42.97 34.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.519 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLN . . . . . 0.467 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.15 -45.52 93.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.911 -1.118 . . . . 0.0 109.574 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.661 ' HE3' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.59 -10.11 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.222 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 231' ' ' LYS . 5.0 m-80 -174.19 72.93 0.34 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.4 Cg_endo -79.39 -0.84 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.638 2.225 . . . . 0.0 110.735 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 42.4 m -84.1 -3.76 58.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.143 -0.973 . . . . 0.0 109.842 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' TRP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 239' ' ' GLN . 31.6 m0 -81.89 176.24 9.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.188 -0.945 . . . . 0.0 109.938 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.7 OUTLIER -103.47 159.57 15.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' SER . 6.6 p30 -45.28 -37.17 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.102 . . . . 0.0 109.826 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.8 t -72.74 -62.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.224 -0.922 . . . . 0.0 110.163 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 3.6 tp60 -41.22 -50.15 3.6 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.567 0.698 . . . . 0.0 109.483 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.459 ' CD1' ' HG3' ' A' ' 229' ' ' LYS . 20.9 mt -57.07 -48.84 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.52 -0.737 . . . . 0.0 109.377 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -47.16 -38.56 12.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.76 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 22.9 t-20 -67.43 -38.13 84.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 109.743 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.85 -43.97 91.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.826 . . . . 0.0 110.442 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.8 OUTLIER -76.65 -29.89 56.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -78.87 -23.72 44.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 1.6 t30 -95.98 -17.87 20.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.6 p -90.46 -30.51 17.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.781 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.27 160.82 1.03 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.3 m -88.88 111.39 22.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.104 -0.998 . . . . 0.0 109.706 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -84.97 116.12 23.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.378 -0.826 . . . . 0.0 108.951 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 178' ' ' ASN . 6.1 mp . . . . . 0 C--N 1.305 -1.359 0 O-C-N 121.058 -1.026 . . . . 0.0 109.53 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.649 HD23 ' CZ ' ' A' ' 186' ' ' TYR . 2.7 tm? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.585 ' N ' HD13 ' A' ' 256' ' ' LEU . 87.1 m-85 -63.27 -23.69 67.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.45 -98.28 0.27 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 250' ' ' SER . 0.3 OUTLIER -84.07 -39.83 19.08 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.253 -1.146 . . . . 0.0 108.94 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.622 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 100.45 -122.1 7.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 261' ' ' LEU . 16.3 tp -87.7 161.25 17.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.813 -0.816 . . . . 0.0 108.804 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.883 HG22 HD11 ' A' ' 192' ' ' ILE . 1.5 t -119.54 154.41 22.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 110.289 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -151.12 117.46 5.66 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.206 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 268' ' ' THR . . . -82.33 6.01 18.35 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.796 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 67.1 tt0 -94.54 -23.96 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.723 -1.236 . . . . 0.0 109.264 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -95.99 -16.73 21.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.167 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 228' ' ' VAL . . . -98.53 -13.91 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . 0.576 HG21 HD22 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -117.49 -9.85 10.77 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.055 -1.028 . . . . 0.0 109.066 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 268' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.73 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.533 ' HB2' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -83.09 -172.71 4.29 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.371 -0.831 . . . . 0.0 109.406 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -111.4 109.37 19.31 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.611 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.659 HG12 ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -132.38 153.71 81.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.799 . . . . 0.0 109.384 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.659 ' HD2' HG12 ' A' ' 4' ' ' VAL . 35.5 Cg_endo -77.68 171.94 16.6 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.857 2.371 . . . . 0.0 111.119 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.7 OUTLIER -52.14 -19.06 1.73 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.542 -0.724 . . . . 0.0 110.473 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.556 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -63.16 -52.25 48.87 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.726 ' O ' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -83.9 -20.21 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -1.223 . . . . 0.0 109.662 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 6' ' ' TRP . 0.8 OUTLIER -64.34 -26.39 68.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.91 -1.118 . . . . 0.0 109.658 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 22.1 ttm105 -96.32 -0.66 49.24 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 110.627 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 8' ' ' ILE . 3.2 m -99.77 17.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.585 -1.322 . . . . 0.0 110.29 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' A' ' 265' ' ' GLU . 0.9 OUTLIER 39.91 45.81 1.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.56 -0.713 . . . . 0.0 109.827 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.713 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.22 -27.28 0.34 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.57 -0.706 . . . . 0.0 112.321 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.713 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.0 Cg_endo -74.28 -56.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.958 0 N-CA-C 108.847 -1.251 . . . . 0.0 108.847 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 19' ' ' ARG . . . -43.76 -31.63 0.86 Allowed 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.98 -43.9 51.32 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 109.205 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.683 ' ND1' HD21 ' A' ' 80' ' ' LEU . 6.3 m170 -66.85 -15.5 63.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.44 -0.787 . . . . 0.0 109.671 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -96.25 -24.82 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 0.0 109.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -69.15 -32.04 71.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.73 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.65 -16.67 5.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 144.58 56.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.25 -1.147 . . . . 0.0 109.179 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -133.53 1.5 3.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.023 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' C ' ' HG3' ' A' ' 230' ' ' GLN . . . 57.57 6.49 2.46 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 22' ' ' THR . 1.4 t -66.49 134.01 51.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -1.171 . . . . 0.0 109.371 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.57 -4.74 37.24 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 27' ' ' LYS . 28.2 t -98.97 170.81 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.216 -1.167 . . . . 0.0 109.275 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -140.46 128.85 22.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.894 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.658 HG13 ' CG1' ' A' ' 119' ' ' VAL . 1.9 t -133.97 134.88 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.761 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -92.35 154.51 18.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.23 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.4 t -127.56 87.0 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.983 -1.073 . . . . 0.0 108.768 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.66 HD12 ' HB ' ' A' ' 91' ' ' VAL . 5.5 mp -65.27 95.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 20.9 p-10 -144.93 -144.72 0.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.242 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.737 HG23 ' ND2' ' A' ' 60' ' ' ASN . 0.5 OUTLIER -145.04 27.78 1.27 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.107 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.06 119.8 0.9 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.61 ' CG1' ' HB2' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -103.96 11.54 8.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.948 -0.736 . . . . 0.0 109.679 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER 51.84 126.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.994 0.902 . . . . 0.0 111.17 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.84 115.36 10.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.003 -1.06 . . . . 0.0 108.882 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.538 ' NE2' ' HA ' ' A' ' 206' ' ' SER . 0.0 OUTLIER -145.24 157.34 53.4 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.074 -1.016 . . . . 0.0 110.062 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.0 Cg_endo -78.52 0.96 9.48 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.702 2.268 . . . . 0.0 110.378 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -105.09 -15.95 14.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.103 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.597 HD21 HG21 ' A' ' 202' ' ' THR . 0.3 OUTLIER -114.13 119.07 35.84 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 108.841 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -96.64 105.08 17.13 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.033 -1.042 . . . . 0.0 109.04 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 43' ' ' ILE . 1.7 mm -69.47 112.4 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.335 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.446 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 2.4 mmt85 -100.26 -19.78 16.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.173 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.19 156.71 28.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . -177.1 140.45 4.9 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.981 -1.305 . . . . 0.0 110.021 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.45 126.82 14.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -1.086 . . . . 0.0 109.297 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.9 m -104.3 116.53 32.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.134 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.584 ' CD2' ' OE1' ' A' ' 107' ' ' GLN . 42.3 m-85 -104.1 -57.0 2.1 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.19 -0.944 . . . . 0.0 109.828 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.86 HG23 ' HD2' ' A' ' 51' ' ' PRO . 1.5 p -42.06 148.88 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.86 ' HD2' HG23 ' A' ' 50' ' ' VAL . 29.2 Cg_endo -66.63 -168.27 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.035 1.824 . . . . 0.0 109.986 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.538 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 57.88 94.76 0.01 OUTLIER Glycine 0 N--CA 1.486 1.969 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -178.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -109.43 94.69 16.63 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.352 -1.087 . . . . 0.0 110.962 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 34.7 Cg_endo -78.76 -64.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.784 2.323 . . . . 0.0 109.053 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -175.11 137.59 0.41 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.36 0.6 . . . . 0.0 109.523 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.61 -15.39 18.44 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.36 -0.837 . . . . 0.0 108.767 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.547 ' O ' ' CB ' ' A' ' 58' ' ' ASP . 2.4 mp0 -128.67 112.24 14.03 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.511 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 13.8 t70 83.31 157.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.498 0.666 . . . . 0.0 109.768 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.96 -20.92 0.51 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.801 -1.72 . . . . 0.0 108.801 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.737 ' ND2' HG23 ' A' ' 33' ' ' THR . 0.4 OUTLIER -145.22 -83.83 0.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.617 -0.931 . . . . 0.0 108.899 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 64' ' ' THR . . . 159.55 -54.48 0.35 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 215' ' ' SER . 30.0 t-80 -46.31 -57.79 4.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 110.159 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -38.43 -57.58 1.81 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.532 ' CB ' ' HB3' ' A' ' 36' ' ' SER . 0.6 OUTLIER -51.13 -47.5 61.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -1.143 . . . . 0.0 109.434 -179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.602 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -52.08 -55.84 18.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.325 -0.86 . . . . 0.0 109.473 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 219' ' ' PRO . 39.9 t -53.51 -34.01 22.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.61 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . . . -58.85 -55.56 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 110.222 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.1 -21.38 75.54 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.732 HG21 ' O ' ' A' ' 216' ' ' MET . 21.4 m -73.84 -18.54 60.93 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.218 -1.166 . . . . 0.0 108.122 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 219' ' ' PRO . 4.9 mt -98.85 -30.55 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 110.006 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.624 ' CB ' ' HB3' ' A' ' 83' ' ' ALA . . . -170.13 41.09 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.571 -1.331 . . . . 0.0 112.101 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 81' ' ' GLY . . . -44.87 121.27 2.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.661 -1.274 . . . . 0.0 108.607 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 84' ' ' PRO . 17.0 mt -43.74 151.91 0.18 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.128 -0.982 . . . . 0.0 110.532 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 46.5 t-20 -105.69 64.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.0 109.412 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.584 ' O ' ' CB ' ' A' ' 76' ' ' SER . 86.0 m-20 -94.53 -1.36 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.504 -0.748 . . . . 0.0 110.098 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 5.0 t 91.18 -34.47 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.7 pt -85.51 133.5 29.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.88 -175.63 45.27 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 201' ' ' SER . 5.1 m -76.01 -174.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.2 -1.177 . . . . 0.0 109.944 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.683 HD21 ' ND1' ' A' ' 17' ' ' HIS . 1.6 tp -141.0 113.58 8.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.306 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.86 ' H ' ' HB3' ' A' ' 72' ' ' ALA . . . -76.49 -165.74 21.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 6.8 t -80.28 -32.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.022 -1.281 . . . . 0.0 109.453 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HB3' ' CB ' ' A' ' 71' ' ' ALA . . . -104.6 148.12 35.51 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.056 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' CG ' ' O ' ' A' ' 22' ' ' THR . 37.9 Cg_endo -84.87 -63.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.842 2.361 . . . . 0.0 110.383 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 5.9 m-20 -113.92 -87.64 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.324 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 85' ' ' ASN . . . 59.8 170.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.209 -0.932 . . . . 0.0 109.449 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' OE2' ' HD2' ' A' ' 44' ' ' ARG . 26.0 mm-40 -93.38 85.51 4.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.253 -0.904 . . . . 0.0 109.23 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 2.7 mt -79.28 109.88 14.04 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.446 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 3.2 m-85 -91.18 -177.35 4.86 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.951 0.881 . . . . 0.0 110.448 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -147.28 96.09 2.65 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.761 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -99.81 78.85 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.369 -0.832 . . . . 0.0 109.938 -178.356 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.9 OUTLIER -51.88 89.8 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.576 HG13 ' HG ' ' A' ' 94' ' ' LEU . 12.6 p -98.72 -23.69 4.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.369 -0.832 . . . . 0.0 108.929 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.576 ' HG ' HG13 ' A' ' 93' ' ' VAL . 1.0 OUTLIER -111.84 162.95 14.73 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -103.49 152.81 17.95 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.38 -18.29 3.98 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.172 -1.193 . . . . 0.0 109.04 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 m -52.98 -57.72 9.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.358 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.32 -21.25 0.12 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.816 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.8 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.739 -1.447 . . . . 0.0 110.015 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -52.63 179.06 0.08 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 m -76.44 174.64 10.03 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.641 -0.917 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.684 HG11 ' CB ' ' A' ' 130' ' ' SER . 5.2 t -68.62 -18.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.51 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -73.87 -18.37 60.93 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 93' ' ' VAL . 19.0 m -88.07 -52.29 5.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.501 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.3 mt -62.27 -30.78 49.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.0 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 132' ' ' THR . . . -75.52 -50.9 14.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 108.981 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.584 ' OE1' ' CD2' ' A' ' 49' ' ' PHE . 2.7 pp0? -61.82 -23.93 66.55 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.168 -0.957 . . . . 0.0 109.552 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.17 -36.62 20.71 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.602 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . 15.0 mt -80.37 -13.8 58.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -1.161 . . . . 0.0 108.973 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -97.13 -32.88 11.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -67.56 -21.29 65.45 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.791 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -86.21 -19.37 30.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -55.54 -34.13 59.81 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 107.563 -2.215 . . . . 0.0 107.563 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 114' ' ' ASN . 0.1 OUTLIER -101.95 -61.7 1.35 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.464 -1.021 . . . . 0.0 109.161 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.455 ' O ' ' SD ' ' A' ' 117' ' ' MET . 1.3 m-20 -104.16 40.77 1.4 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.392 -0.818 . . . . 0.0 108.921 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.791 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -94.23 21.05 44.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.599 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 41.14 -166.04 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.527 -0.984 . . . . 0.0 110.428 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.884 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -85.53 -22.14 28.26 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.678 -0.639 . . . . 0.0 111.239 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.884 HG23 ' CE1' ' A' ' 118' ' ' HIS . 83.5 t -129.38 165.58 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.327 -1.483 . . . . 0.0 110.232 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.63 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -166.7 128.1 1.7 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.762 ' ND2' HG13 ' A' ' 148' ' ' VAL . 6.3 t-20 -105.8 153.68 21.56 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.57 -1.331 . . . . 0.0 110.128 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.769 HD13 ' CG1' ' A' ' 147' ' ' VAL . 5.0 mp -135.84 92.82 2.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 62.01 7.21 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.258 -0.901 . . . . 0.0 108.72 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 124' ' ' LEU . 4.0 pp -147.64 173.74 12.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.972 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.659 ' N ' HD12 ' A' ' 124' ' ' LEU . . . -176.92 97.45 0.11 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 2.4 m -96.52 146.71 31.78 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.63 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.1 Cg_endo -77.37 -5.38 15.59 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.474 2.116 . . . . 0.0 109.359 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.5 t -98.54 107.64 43.6 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.756 -0.59 . . . . 0.0 110.224 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 33.0 Cg_endo -76.97 165.83 27.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.01 1.807 . . . . 0.0 109.609 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.684 ' CB ' HG11 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -170.69 132.78 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.654 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.09 -19.92 65.72 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.426 HG22 ' CB ' ' A' ' 106' ' ' ALA . 64.4 m -63.88 -31.99 73.36 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 133' ' ' LEU . 13.9 tp -75.85 -34.86 60.07 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -30.32 68.05 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.386 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 135' ' ' GLN . 4.0 tp60 -70.33 -25.61 63.38 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.602 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -75.9 -48.69 20.32 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.049 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.073 HG21 ' HB1' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -63.25 -26.46 40.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.3 -36.75 85.03 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 26.0 t -77.62 -17.77 57.46 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.887 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.52 -38.11 22.18 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.686 -1.259 . . . . 0.0 111.248 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.802 -1.186 . . . . 0.0 108.571 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -25.32 67.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -112.62 -16.58 12.8 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.126 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.46 84.99 1.16 Allowed Glycine 0 N--CA 1.475 1.258 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.95 105.23 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -1.028 . . . . 0.0 108.592 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.81 118.75 8.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 109.871 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.769 ' CG1' HD13 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -112.94 139.28 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.216 -0.928 . . . . 0.0 109.14 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.762 HG13 ' ND2' ' A' ' 121' ' ' ASN . 14.5 p -127.17 68.14 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.918 -1.114 . . . . 0.0 110.114 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -52.63 156.51 1.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.076 -1.015 . . . . 0.0 110.95 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.45 -174.57 5.35 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.6 -0.688 . . . . 0.0 110.032 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.3 OUTLIER -91.95 -85.09 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.836 -0.54 . . . . 0.0 109.78 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.508 ' N ' ' OG ' ' A' ' 151' ' ' SER . . . -178.61 -114.29 0.41 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.58 ' O ' ' CB ' ' A' ' 154' ' ' SER . 0.4 OUTLIER 177.72 34.51 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.58 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.2 OUTLIER 87.06 102.12 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.321 0.581 . . . . 0.0 109.537 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.534 ' N ' ' NE2' ' A' ' 185' ' ' GLN . . . -172.0 95.75 0.11 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 66.07 171.42 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.219 -1.166 . . . . 0.0 109.647 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.78 51.9 4.37 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 185' ' ' GLN . 0.8 OUTLIER -148.96 170.31 18.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -1.168 . . . . 0.0 109.645 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.11 -171.47 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.0 110.33 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.523 ' HB3' ' HA3' ' A' ' 125' ' ' GLY . 0.0 OUTLIER -62.42 176.04 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 122.582 1.182 . . . . 0.0 112.186 -178.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 126' ' ' SER . 8.8 m-85 -128.73 127.6 23.5 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.742 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.8 Cg_endo -72.33 -45.73 0.43 Allowed 'Cis proline' 0 C--N 1.301 -1.944 0 O-C-N 123.14 1.074 . . . . 0.0 110.726 3.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . . . 27.29 -76.95 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 CA-C-O 122.158 0.98 . . . . 0.0 109.645 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.742 ' N ' ' O ' ' A' ' 162' ' ' PRO . 7.0 ttt180 -39.35 -60.25 0.95 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.758 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 55.0 p90 -120.02 -164.66 1.1 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.945 . . . . 0.0 110.728 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 1.073 ' HB1' HG21 ' A' ' 137' ' ' VAL . . . 85.98 26.16 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.775 0.797 . . . . 0.0 109.011 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 55.01 20.26 3.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -104.32 131.67 51.41 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.44 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 4.4 mtp -76.19 151.49 36.89 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.34 129.21 55.73 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.728 HG22 HG22 ' A' ' 192' ' ' ILE . 32.1 t -100.17 165.3 2.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 109.235 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.07 167.66 24.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -96.17 168.91 10.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.311 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' ' 194' ' ' ALA . 13.5 p -135.64 178.79 6.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 109.5 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 176' ' ' GLN . 14.2 t0 -108.41 -142.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.455 -0.778 . . . . 0.0 109.771 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 175' ' ' ASP . 12.0 tt0 -35.45 -63.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.575 -0.703 . . . . 0.0 110.988 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -122.16 -60.93 1.53 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.838 -1.164 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -138.77 -19.7 1.03 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.033 -1.042 . . . . 0.0 111.224 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -47.17 164.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.767 -1.208 . . . . 0.0 109.338 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -69.93 132.86 46.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.332 -0.855 . . . . 0.0 109.729 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -55.72 -154.25 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.49 -0.756 . . . . 0.0 110.334 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.6 m -117.15 -27.34 6.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -119.62 14.04 12.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.716 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.656 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 1.9 t -77.41 142.36 39.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.144 -0.973 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.534 ' NE2' ' N ' ' A' ' 155' ' ' GLY . 5.9 tt0 -90.69 166.15 13.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.646 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -141.65 173.53 11.42 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 -179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.646 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.62 -178.63 48.39 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.11 68.06 5.14 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.197 -1.178 . . . . 0.0 109.443 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 169.07 31.77 0.02 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.469 HD21 ' CG1' ' A' ' 193' ' ' VAL . 3.2 tp -72.75 142.54 48.14 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.067 -1.255 . . . . 0.0 109.521 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 8.4 t0 -101.67 -57.34 2.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.728 HG22 HG22 ' A' ' 171' ' ' VAL . 3.8 tt -151.25 -178.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.94 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.6 HG22 ' CA ' ' A' ' 260' ' ' GLY . 6.0 m -149.66 -179.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.314 -0.867 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -175.01 172.78 1.1 Allowed Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 30.8 Cg_endo -72.0 116.55 4.75 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.067 1.845 . . . . 0.0 110.559 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.94 44.69 1.18 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.646 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 40.6 t -124.45 54.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -1.092 . . . . 0.0 108.415 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.646 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 24.3 t-20 127.36 124.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 211' ' ' LEU . 22.7 m -160.33 105.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-O 122.32 1.057 . . . . 0.0 109.689 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -80.96 135.87 35.94 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.811 ' HA ' HG21 ' A' ' 79' ' ' VAL . 1.3 t -149.05 -157.09 0.78 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.597 HG21 HD21 ' A' ' 41' ' ' LEU . 5.0 t -84.02 176.18 9.02 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.983 0.896 . . . . 0.0 110.758 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.666 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -162.7 155.55 16.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.666 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.7 Cg_endo -70.41 161.99 44.03 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.008 1.805 . . . . 0.0 110.477 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 81.71 15.04 76.62 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.538 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 5.5 m 68.8 35.17 3.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -1.16 . . . . 0.0 109.674 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.8 OUTLIER -133.89 161.8 33.78 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 110.366 -179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 201' ' ' SER . 0.0 OUTLIER -114.56 170.23 8.46 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.19 151.26 17.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.775 -1.203 . . . . 0.0 110.281 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -106.97 146.13 31.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 110.129 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.75 ' O ' HG22 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -152.99 162.31 41.48 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 197' ' ' VAL . 7.6 p-10 -125.16 141.29 52.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.086 -1.009 . . . . 0.0 109.736 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.512 ' N ' ' SD ' ' A' ' 216' ' ' MET . . . 166.38 167.8 27.59 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -85.78 -17.53 35.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -1.092 . . . . 0.0 108.589 179.087 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.569 ' O ' ' CD ' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -65.08 -39.46 93.23 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.46 -0.775 . . . . 0.0 109.118 179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.732 ' O ' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -68.87 -44.96 72.22 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.051 0.929 . . . . 0.0 109.84 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -68.81 -19.65 64.29 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.861 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.632 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 28.6 m -64.5 -52.36 53.24 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 120.737 -1.227 . . . . 0.0 111.086 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -66.38 -9.88 25.55 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.864 1.709 . . . . 0.0 110.656 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.566 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 0.8 OUTLIER -71.55 -39.24 70.79 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 1.071 HG22 HG21 ' A' ' 262' ' ' VAL . 47.0 t -76.63 -34.86 24.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.757 ' HB2' HG11 ' A' ' 148' ' ' VAL . . . -58.43 -39.1 78.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -71.4 -50.07 22.81 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -45.92 -51.46 13.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -1.194 . . . . 0.0 108.604 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -41.47 72.47 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -51.57 -49.57 61.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.117 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 227' ' ' LEU . 39.3 mt -54.63 -45.08 73.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 76.2 t -54.99 -65.22 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.539 ' CG ' HD11 ' A' ' 240' ' ' ILE . 0.0 OUTLIER -43.39 -37.71 2.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.389 -0.82 . . . . 0.0 109.21 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.449 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 9.8 tm0? -57.86 -57.01 14.66 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.083 -1.01 . . . . 0.0 109.897 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.492 ' HG3' ' N ' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -54.23 -19.13 4.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.204 -0.935 . . . . 0.0 108.905 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.492 ' N ' ' HG3' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -140.7 86.43 12.06 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.606 -0.684 . . . . 0.0 109.249 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.97 -2.93 13.02 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.677 2.251 . . . . 0.0 110.493 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.43 -10.81 16.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.327 -0.858 . . . . 0.0 109.334 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -73.73 178.49 4.76 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.73 173.62 8.9 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.253 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.24 -20.1 25.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.836 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.1 t -79.89 -65.52 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.969 -1.082 . . . . 0.0 109.106 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.1 mp0 -46.86 -34.68 5.59 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.539 HD11 ' CG ' ' A' ' 229' ' ' LYS . 24.0 mt -65.8 -48.33 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -50.25 -34.8 24.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.868 -1.145 . . . . 0.0 108.978 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 239' ' ' GLN . 4.5 t30 -62.89 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.883 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 247' ' ' THR . 2.9 t60 -48.11 -51.47 24.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.907 . . . . 0.0 110.434 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.522 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.3 OUTLIER -63.17 -27.22 69.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.229 -0.92 . . . . 0.0 110.894 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 61.9 tttt -73.31 -52.04 15.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.024 -1.047 . . . . 0.0 110.228 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 14.0 t-20 -78.73 -10.11 59.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 0.0 110.454 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 243' ' ' HIS . 25.5 p -94.42 -37.41 11.45 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.893 -1.129 . . . . 0.0 110.121 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -64.82 136.1 56.51 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.401 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 259' ' ' SER . 15.5 m -45.93 169.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 108.913 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 259' ' ' SER . 0.7 OUTLIER -145.4 87.07 1.78 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 110.131 -179.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 257' ' ' TYR . 5.8 mp -46.51 -50.8 16.56 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.584 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 122.08 -116.98 3.22 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.442 ' HG ' ' HD2' ' A' ' 257' ' ' TYR . 2.3 m 58.17 -179.2 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -1.063 . . . . 0.0 109.846 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.7 p -90.26 -23.8 21.11 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.264 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -175.48 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.905 -1.122 . . . . 0.0 110.466 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.5 -62.77 1.39 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.828 -1.17 . . . . 0.0 109.455 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.513 ' HB3' ' HB2' ' A' ' 251' ' ' LEU . 31.7 m-85 -88.78 -77.43 0.37 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.494 -0.754 . . . . 0.0 110.211 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 42.9 90.41 0.01 OUTLIER Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 250' ' ' SER . 1.8 m 61.37 103.53 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.937 -1.331 . . . . 0.0 107.967 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.6 ' CA ' HG22 ' A' ' 193' ' ' VAL . . . -139.74 -27.09 0.24 Allowed Glycine 0 N--CA 1.488 2.157 0 C-N-CA 119.371 -1.395 . . . . 0.0 111.651 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 261' ' ' LEU . 0.3 OUTLIER -104.24 146.62 28.52 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.335 -1.686 . . . . 0.0 108.949 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 1.071 HG21 HG22 ' A' ' 221' ' ' VAL . 1.6 t -117.68 155.2 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.131 -0.98 . . . . 0.0 110.056 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.45 117.38 2.76 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.537 1.16 . . . . 0.0 107.942 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -12.67 61.85 Favored 'General case' 0 C--N 1.276 -2.611 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.975 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.492 ' HG2' ' NH1' ' A' ' 269' ' ' ARG . 11.5 tt0 -66.73 -41.33 88.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.004 -1.06 . . . . 0.0 109.137 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.485 ' HA ' ' NH2' ' A' ' 269' ' ' ARG . . . -82.38 -14.0 55.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 109.165 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -93.45 -16.41 24.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.183 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.49 ' O ' ' C ' ' A' ' 269' ' ' ARG . 74.0 p -118.11 -60.46 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 265' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.573 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.81 HE22 HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -72.01 135.86 46.53 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -0.888 . . . . 0.0 109.377 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 24.6 p -92.56 129.15 38.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.962 . . . . 0.0 109.788 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.28 81.89 30.41 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.023 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HD2' HG13 ' A' ' 8' ' ' ILE . 33.7 Cg_endo -77.7 159.84 31.51 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.621 2.214 . . . . 0.0 111.347 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.53 ' CZ3' ' O ' ' A' ' 176' ' ' GLN . 2.6 p-90 -57.88 -26.3 61.93 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.683 -0.635 . . . . 0.0 110.573 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 8' ' ' ILE . . . -89.33 53.88 3.86 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.476 HG13 ' HD2' ' A' ' 5' ' ' PRO . 14.6 mm -151.55 -50.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.155 -1.203 . . . . 0.0 109.517 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -80.26 -13.02 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.414 -179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.42 -28.8 61.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 8' ' ' ILE . 2.8 m -88.61 24.19 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 1.0 OUTLIER 50.14 45.76 25.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.678 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -82.85 -32.3 0.55 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 111.774 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -74.31 -55.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.18 -28.45 0.77 Allowed 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.61 -41.98 36.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.032 . . . . 0.0 109.239 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -66.27 -24.25 66.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.524 -0.735 . . . . 0.0 110.532 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -92.73 -31.04 15.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.903 -1.123 . . . . 0.0 109.604 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.79 -30.09 56.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.338 -0.851 . . . . 0.0 109.612 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.638 ' C ' HD23 ' A' ' 21' ' ' LEU . . . 121.46 19.63 3.43 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.869 ' CD1' HG21 ' A' ' 268' ' ' THR . 3.2 mt -101.9 120.62 40.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -1.151 . . . . 0.0 109.741 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -97.98 -24.59 15.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -0.8 . . . . 0.0 109.294 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' A' ' 230' ' ' GLN . . . 69.35 -1.31 13.35 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.3 p -71.74 117.73 13.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.116 -1.226 . . . . 0.0 109.389 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.13 -16.54 4.67 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 27' ' ' LYS . 19.1 t -89.75 172.06 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.218 -1.166 . . . . 0.0 109.395 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.571 ' N ' HG12 ' A' ' 26' ' ' VAL . 25.9 mttp -138.89 122.75 17.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.736 HG22 ' HB ' ' A' ' 119' ' ' VAL . 61.5 t -127.04 127.49 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -85.12 151.31 24.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.969 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.624 ' O ' HG12 ' A' ' 30' ' ' VAL . 35.2 t -115.14 78.65 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.983 HD23 HG21 ' A' ' 93' ' ' VAL . 5.6 mp -71.72 114.88 10.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.456 ' OD1' ' OG ' ' A' ' 123' ' ' SER . 5.5 m-20 -175.75 -72.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.513 1.149 . . . . 0.0 108.898 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.506 HG21 ' CB ' ' A' ' 60' ' ' ASN . 7.5 p -141.97 -73.59 0.31 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.593 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -160.18 -129.04 1.01 Allowed Glycine 0 C--N 1.3 -1.437 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.687 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 1.4 mm -170.82 98.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 204' ' ' PRO . 1.1 m -46.68 129.89 11.36 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 109.202 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.74 104.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.637 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -130.52 151.52 78.79 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 109.005 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.35 -12.39 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.555 2.17 . . . . 0.0 110.377 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 8.8 m-20 -88.21 -31.51 19.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.423 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.637 HD12 ' HB2' ' A' ' 38' ' ' HIS . 5.0 mt -89.34 115.79 27.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 110.028 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 6.4 t-20 -78.37 104.28 8.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 108.747 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 44' ' ' ARG . 1.4 mt -96.02 -177.1 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.898 . . . . 0.0 110.375 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.632 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.1 tpt85 -152.69 -39.47 0.1 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -175.96 166.94 38.43 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.36 174.83 45.6 Favored Glycine 0 N--CA 1.494 2.502 0 O-C-N 120.794 -1.416 . . . . 0.0 110.433 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -170.1 153.15 4.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.389 -1.065 . . . . 0.0 109.816 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.514 ' HB2' ' HD2' ' A' ' 92' ' ' LYS . 1.4 p -121.02 142.01 50.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.16 -0.962 . . . . 0.0 110.008 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.589 ' CE2' ' CA ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -126.0 -26.88 3.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.0 111.187 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.931 HG23 ' CB ' ' A' ' 104' ' ' SER . 1.1 t -42.14 -51.86 10.1 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 120.855 -1.153 . . . . 0.0 108.492 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 50' ' ' VAL . 39.2 Cg_endo -86.23 -159.64 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.144 2.563 . . . . 0.0 109.704 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 53' ' ' GLU . . . -90.64 -51.43 2.69 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.584 -2.206 . . . . 0.0 107.584 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.535 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER 174.44 62.52 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.706 -0.879 . . . . 0.0 109.425 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 37.4 Cg_endo -81.85 -90.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.596 2.197 . . . . 0.0 110.504 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 p -151.27 136.07 17.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.504 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -103.93 9.84 36.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.45 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 35.9 mt-30 -117.3 116.21 26.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 110.012 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.45 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 65.47 148.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.405 -0.809 . . . . 0.0 109.689 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 138.1 -6.4 3.4 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.528 ' OD1' ' HB2' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -142.21 -78.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.088 -1.242 . . . . 0.0 109.922 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.18 -47.11 1.0 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.267 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.488 ' NE2' ' CE ' ' A' ' 216' ' ' MET . 14.6 t-160 -56.36 -61.3 2.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 0.0 110.268 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' HIS . . . -41.25 -41.92 3.06 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 25.6 m -61.25 -47.32 86.57 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.276 -1.132 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.482 ' CD2' ' CB ' ' A' ' 201' ' ' SER . 0.2 OUTLIER -55.14 -50.26 69.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.595 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 219' ' ' PRO . 30.1 t -60.03 -32.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.131 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . . . -58.49 -46.28 87.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 109.776 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.653 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -74.3 -25.75 69.94 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.868 HG21 ' HG2' ' A' ' 219' ' ' PRO . 83.1 m -79.31 -9.63 59.63 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.916 -1.344 . . . . 0.0 108.293 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.664 ' CG2' HD21 ' A' ' 88' ' ' LEU . 17.3 mt -106.46 -26.78 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.351 -0.843 . . . . 0.0 110.064 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB3' ' CD1' ' A' ' 88' ' ' LEU . . . -165.3 21.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.69 -1.257 . . . . 0.0 111.727 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.91 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . -41.53 127.77 3.09 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.918 -1.114 . . . . 0.0 109.322 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 84' ' ' PRO . 60.2 mt -58.98 163.14 3.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 110.094 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.538 ' HB3' HD13 ' A' ' 80' ' ' LEU . 6.0 p30 -118.91 72.85 0.9 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.553 -0.717 . . . . 0.0 109.206 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -116.79 -117.8 0.32 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.245 -0.909 . . . . 0.0 108.978 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 p -129.33 -48.71 1.19 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.18 -0.95 . . . . 0.0 109.52 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -90.59 69.78 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.203 -0.936 . . . . 0.0 109.832 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.47 158.1 13.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.728 HG11 ' HA ' ' A' ' 201' ' ' SER . 33.7 m -69.33 -153.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.155 -1.203 . . . . 0.0 109.388 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.81 HD22 HE22 ' A' ' 2' ' ' GLN . 14.4 tp -151.47 118.41 5.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.941 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.91 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -98.68 -149.73 25.09 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.53 HG12 HD11 ' A' ' 227' ' ' LEU . 2.3 t -103.13 -38.05 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.985 -1.303 . . . . 0.0 109.045 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -93.86 135.1 25.22 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.522 ' CG ' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.94 -63.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.613 2.208 . . . . 0.0 111.103 -178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -119.07 47.5 1.66 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.91 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -80.93 164.38 22.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.097 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' OE1' ' CD ' ' A' ' 44' ' ' ARG . 40.1 mm-40 -85.61 104.24 15.16 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.664 HD21 ' CG2' ' A' ' 70' ' ' ILE . 6.3 mt -96.53 116.74 29.58 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.09 -1.006 . . . . 0.0 109.739 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 11.5 m-85 -97.4 156.01 16.65 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.632 ' HB2' ' CG1' ' A' ' 35' ' ' ILE . . . -123.47 101.18 7.19 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.431 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -102.58 160.14 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 108.904 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 2.0 tttt -116.93 111.16 19.24 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.432 -0.793 . . . . 0.0 109.415 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.983 HG21 HD23 ' A' ' 31' ' ' LEU . 12.1 t -115.25 -28.91 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 109.392 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.608 HD11 HD22 ' A' ' 124' ' ' LEU . 3.1 mp -132.74 175.05 9.67 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.167 -0.958 . . . . 0.0 110.017 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -88.36 170.9 39.53 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.528 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -59.45 -26.05 64.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.243 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.0 t -87.82 -54.25 4.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.63 57.86 0.07 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 60.37 1.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.328 -1.101 . . . . 0.0 109.3 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.22 -179.37 44.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.07 162.86 13.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.748 -0.854 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.25 -15.34 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 31.2 t -76.73 -19.73 57.32 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.931 ' CB ' HG23 ' A' ' 50' ' ' VAL . 60.6 p -87.98 -47.62 8.4 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.773 0.797 . . . . 0.0 109.094 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.543 HG23 HG11 ' A' ' 93' ' ' VAL . 2.2 mt -68.35 -34.13 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -76.91 -39.35 51.14 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.406 -0.809 . . . . 0.0 109.554 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.588 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 1.9 tt0 -70.52 -31.31 68.35 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.065 -1.022 . . . . 0.0 109.07 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.589 ' CA ' ' CE2' ' A' ' 49' ' ' PHE . . . -75.11 -39.49 37.16 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.4 mt -66.57 -33.13 74.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -1.088 . . . . 0.0 109.692 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.42 -17.98 23.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.421 ' HB2' ' O ' ' A' ' 107' ' ' GLN . 80.1 t90 -73.15 -18.02 61.32 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -90.85 6.72 43.28 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.223 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -96.99 -46.89 2.34 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.29 -80.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.147 -1.208 . . . . 0.0 108.274 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -95.83 62.56 2.29 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.728 ' CA ' ' HE3' ' A' ' 117' ' ' MET . . . -122.34 -161.21 11.19 Favored Glycine 0 C--N 1.286 -2.205 0 CA-C-O 122.575 1.097 . . . . 0.0 112.034 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.728 ' HE3' ' CA ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -126.41 162.87 24.58 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.446 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -69.51 -35.35 75.42 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.738 -1.185 . . . . 0.0 109.415 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.736 ' HB ' HG22 ' A' ' 28' ' ' VAL . 2.5 t -105.91 156.8 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.837 -1.164 . . . . 0.0 109.611 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.2 121.34 1.69 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.723 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.947 HD22 HG13 ' A' ' 148' ' ' VAL . 13.2 t-20 -98.48 158.32 15.67 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.071 -1.018 . . . . 0.0 109.954 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.786 HD12 ' C ' ' A' ' 121' ' ' ASN . 7.0 mp -138.02 101.77 4.51 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.456 ' OG ' ' OD1' ' A' ' 32' ' ' ASP . 20.6 p -85.53 62.11 7.27 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.608 HD22 HD11 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -143.9 178.87 7.54 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.566 -0.709 . . . . 0.0 109.433 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.587 ' CA ' ' CB ' ' A' ' 160' ' ' SER . . . 165.65 107.96 0.21 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.97 154.43 48.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.98 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.528 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 33.4 Cg_endo -77.18 -3.84 14.15 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.517 2.144 . . . . 0.0 109.195 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.408 ' O ' ' CE1' ' A' ' 161' ' ' TYR . 2.7 t -103.99 101.04 23.15 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 35.7 Cg_endo -77.95 166.03 25.57 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.335 2.023 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -153.73 125.21 7.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.34 -24.65 66.56 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 15.5 m -67.08 -28.8 68.48 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.677 HD22 ' CE2' ' A' ' 161' ' ' TYR . 0.3 OUTLIER -70.37 -36.62 74.25 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 179.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -65.94 -58.44 5.54 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.431 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 134' ' ' GLU . 2.4 tp-100 -42.12 -28.13 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' GLU . . . -74.96 -49.61 19.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.707 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -33.14 46.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 108.521 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -61.61 -39.58 91.76 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -71.08 -22.94 62.04 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.99 -2.23 47.36 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.002 -1.062 . . . . 0.0 110.187 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 29.0 m -95.34 -34.16 12.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 108.859 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 64.4 m -66.1 -24.4 66.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.396 -0.815 . . . . 0.0 108.86 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -88.79 -13.1 40.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.386 -0.821 . . . . 0.0 109.325 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.26 71.13 1.0 Allowed Glycine 0 C--N 1.302 -1.36 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 84.9 t -112.99 106.04 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.448 -1.03 . . . . 0.0 109.499 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.421 HD23 HG13 ' A' ' 119' ' ' VAL . 5.0 tp -60.48 100.81 0.11 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.094 -1.003 . . . . 0.0 108.772 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG12 HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -104.11 140.75 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 110.22 -179.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.947 HG13 HD22 ' A' ' 121' ' ' ASN . 3.7 p -129.16 125.67 62.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.411 -0.806 . . . . 0.0 108.879 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -105.18 146.85 28.66 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.995 -1.066 . . . . 0.0 110.431 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.518 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -81.45 169.66 16.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.56 -68.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 143.23 121.63 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 154' ' ' SER . 12.7 p-10 -86.7 33.35 0.65 Allowed 'General case' 0 C--N 1.289 -2.053 0 O-C-N 121.756 -0.849 . . . . 0.0 109.917 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.8 OUTLIER 162.33 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -172.31 -103.4 0.17 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.56 -168.66 2.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.328 -1.101 . . . . 0.0 109.605 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.7 44.89 3.3 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -159.66 150.16 19.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -1.198 . . . . 0.0 109.045 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.404 HG12 ' H ' ' A' ' 159' ' ' ILE . 2.2 pt -80.85 176.57 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.115 -0.991 . . . . 0.0 109.39 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.939 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -108.66 163.44 13.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 111.823 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.677 ' CE2' HD22 ' A' ' 133' ' ' LEU . 10.2 p90 -89.89 146.06 34.49 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 164' ' ' ARG . 44.0 Cg_endo -71.37 -26.6 8.09 Favored 'Cis proline' 0 C--N 1.297 -2.179 0 O-C-N 122.404 0.687 . . . . 0.0 110.722 4.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.939 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.73 -178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -77.4 -47.55 19.51 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.719 -1.238 . . . . 0.0 110.011 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.531 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -48.0 -171.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.316 1.055 . . . . 0.0 110.906 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.23 1.34 12.45 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.736 -0.602 . . . . 0.0 110.104 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -85.68 18.98 2.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 109.147 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -168.24 161.56 12.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.9 mmm -104.2 138.71 40.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.591 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -100.75 127.1 47.3 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.528 -0.732 . . . . 0.0 109.294 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.561 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.4 t -98.55 165.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.189 -0.944 . . . . 0.0 109.717 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -135.39 -158.0 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -144.74 147.01 32.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.925 -1.338 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.34 155.69 25.78 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 4.2 p-10 -59.63 -160.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.054 . . . . 0.0 109.664 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.53 ' O ' ' CZ3' ' A' ' 6' ' ' TRP . 0.1 OUTLIER -45.65 -67.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.465 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -102.12 -57.81 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.369 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.521 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 0.2 OUTLIER -176.17 106.63 0.08 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.475 -0.766 . . . . 0.0 109.403 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.693 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 1.1 t30 -136.65 -39.13 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.943 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.693 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 13.5 ttt180 116.51 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.692 0.758 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . -39.24 161.32 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.185 0.516 . . . . 0.0 109.638 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 11.0 t -119.86 -49.09 2.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.02 -1.05 . . . . 0.0 110.475 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.504 ' CE2' ' OG1' ' A' ' 214' ' ' THR . 31.3 p90 -49.49 -21.41 0.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.432 ' HB2' ' OG1' ' A' ' 214' ' ' THR . 1.6 t -69.94 117.2 11.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.077 -1.015 . . . . 0.0 109.597 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.54 116.94 3.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.105 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CG ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -121.41 167.8 12.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.324 -179.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.528 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -165.34 -166.61 24.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.34 64.11 7.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.14 -1.212 . . . . 0.0 109.3 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 170.81 33.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' ASP . 5.3 tp -79.27 102.2 8.45 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.04 -1.271 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 24.4 t70 -41.79 -67.83 0.23 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.416 -0.803 . . . . 0.0 110.277 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.694 HD11 ' O ' ' A' ' 261' ' ' LEU . 3.9 tt -157.77 169.98 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.068 . . . . 0.0 110.199 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 260' ' ' GLY . 7.9 m -108.76 162.51 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.695 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 1.02 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -152.88 -176.68 0.61 Allowed Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 1.02 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.3 Cg_endo -78.15 115.48 3.75 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.771 1.648 . . . . 0.0 110.302 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -144.09 18.48 2.13 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.627 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 10.3 t -109.14 55.85 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -1.174 . . . . 0.0 108.729 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.683 ' O ' HG13 ' A' ' 199' ' ' VAL . 20.4 t-20 131.19 121.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 198' ' ' ASN . 16.4 m -164.63 111.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-O 121.94 0.876 . . . . 0.0 108.724 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.8 OUTLIER -99.68 125.2 45.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.728 ' HA ' HG11 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -130.85 -166.57 1.71 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.413 -0.804 . . . . 0.0 109.304 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -83.5 172.96 11.89 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.278 -0.889 . . . . 0.0 109.313 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.655 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -147.5 165.36 19.02 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.655 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.5 Cg_endo -71.27 164.48 35.59 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.085 1.857 . . . . 0.0 110.533 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 92.0 -54.73 2.93 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 9.5 p 141.39 37.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.536 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -137.93 -178.37 5.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.934 -1.104 . . . . 0.0 110.371 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.536 ' N ' ' OG1' ' A' ' 207' ' ' THR . 36.7 m-85 -106.37 -160.14 0.73 Allowed 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -172.97 163.04 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.987 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 42.3 p -151.72 108.55 3.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.416 -0.802 . . . . 0.0 108.875 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.87 160.74 39.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.233 -0.917 . . . . 0.0 109.719 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.85 133.22 55.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -169.09 148.54 12.33 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.536 HG23 ' HB2' ' A' ' 173' ' ' ALA . 32.9 m -72.64 -31.44 65.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -1.186 . . . . 0.0 109.302 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.518 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 16.8 t -67.74 -9.18 41.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 109.537 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.488 ' CE ' ' NE2' ' A' ' 62' ' ' HIS . 0.0 OUTLIER -86.22 -22.26 27.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.898 . . . . 0.0 109.877 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.729 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -84.65 -17.31 39.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.654 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 32.9 m -62.87 -42.76 79.88 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 0.0 111.904 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.868 ' HG2' HG21 ' A' ' 69' ' ' THR . 30.2 Cg_endo -71.27 -13.47 30.86 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.575 1.517 . . . . 0.0 110.277 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.625 ' CE1' HG23 ' A' ' 69' ' ' THR . 8.4 m80 -72.42 -40.08 67.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.09 -39.29 74.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.78 -45.58 67.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.39 -0.819 . . . . 0.0 108.885 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -62.4 -45.19 96.44 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.58 -60.36 3.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -1.093 . . . . 0.0 109.266 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -48.59 -33.68 10.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.48 -0.763 . . . . 0.0 109.067 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -60.93 -46.54 90.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 109.037 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.53 HD11 HG12 ' A' ' 82' ' ' VAL . 30.4 mt -56.42 -36.91 69.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.248 -0.908 . . . . 0.0 109.149 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.594 HG21 HD23 ' A' ' 244' ' ' LEU . 97.5 t -64.75 -64.94 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.382 -0.824 . . . . 0.0 109.756 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.573 ' HE3' HG23 ' A' ' 119' ' ' VAL . 7.6 ttmm -42.97 -35.98 1.4 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.42 -0.8 . . . . 0.0 109.127 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.469 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 45.1 tp60 -60.95 -51.92 67.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.305 -0.872 . . . . 0.0 109.207 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 231' ' ' LYS . 3.1 ttpp -55.62 -18.56 8.0 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 3.5 m120 -165.49 82.78 1.1 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.383 -0.823 . . . . 0.0 109.541 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.1 Cg_endo -78.81 0.24 10.16 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.689 2.259 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -6.36 48.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.134 -0.979 . . . . 0.0 109.853 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -75.84 -176.73 3.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.409 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.834 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.0 OUTLIER -111.1 164.76 12.51 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.389 0.614 . . . . 0.0 109.616 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -29.05 23.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.538 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -78.17 -61.04 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.141 -0.975 . . . . 0.0 109.422 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.7 OUTLIER -39.98 -37.78 0.63 Allowed 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.019 -178.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 236' ' ' SER . 2.5 mt -77.1 -46.63 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.634 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -49.67 -31.33 10.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.111 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 246' ' ' ASN . 52.3 m-20 -72.93 -47.13 48.3 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.964 -1.085 . . . . 0.0 110.389 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.503 ' HA ' ' OD1' ' A' ' 246' ' ' ASN . 3.5 t60 -63.15 -35.88 81.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -81.87 -35.67 29.04 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -68.89 -34.43 75.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.737 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 243' ' ' HIS . 3.7 p-10 -84.65 -30.42 24.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.391 -0.818 . . . . 0.0 110.44 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 267' ' ' ALA . 1.7 p -72.06 -30.13 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.987 -1.071 . . . . 0.0 110.26 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.682 ' HB1' HD12 ' A' ' 192' ' ' ILE . . . -40.52 117.44 0.81 Allowed 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.521 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 248' ' ' ALA . 0.2 OUTLIER -43.9 163.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 6.1 t -126.18 71.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 261' ' ' LEU . 1.9 mp -54.66 -62.36 1.71 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.152 -0.968 . . . . 0.0 109.741 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 253' ' ' SER . . . 113.55 -82.81 0.31 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 252' ' ' GLY . 5.2 t 46.54 -171.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -1.133 . . . . 0.0 110.211 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 255' ' ' ASN . 0.2 OUTLIER -59.18 -61.48 2.61 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.881 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 254' ' ' THR . 17.9 p-10 177.43 -26.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.645 ' CD2' ' CG ' ' A' ' 186' ' ' TYR . 2.6 tm? -41.65 -51.81 3.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.765 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -61.28 -57.53 11.98 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.14 -0.975 . . . . 0.0 109.089 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 86.48 -81.65 1.69 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 191' ' ' ASP . 57.7 m -78.53 -55.43 5.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.388 -1.066 . . . . 0.0 109.137 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.556 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 135.26 -135.53 7.95 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.694 ' O ' HD11 ' A' ' 192' ' ' ILE . 1.4 tp -105.06 178.1 4.66 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.349 -1.089 . . . . 0.0 109.076 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.574 HG22 HD13 ' A' ' 192' ' ' ILE . 3.0 t -122.67 156.29 27.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.995 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -166.23 119.6 1.09 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.327 1.06 . . . . 0.0 108.457 178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.73 -13.01 61.24 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.152 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 15.8 tt0 -75.47 -25.96 57.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.024 -1.047 . . . . 0.0 109.664 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.21 55.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.679 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.45 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -113.67 -20.67 11.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.869 HG21 ' CD1' ' A' ' 21' ' ' LEU . 61.8 p -102.31 -46.51 4.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.119 -0.988 . . . . 0.0 109.229 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 269' ' ' ARG . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.427 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.231 0.539 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.36 151.54 12.82 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.168 -0.958 . . . . 0.0 109.413 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.688 ' OG ' HG12 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -81.28 116.67 21.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.641 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.667 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 2.9 t -136.75 46.81 1.62 Allowed Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.235 -0.915 . . . . 0.0 110.108 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 36.4 Cg_endo -77.5 165.6 27.04 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.936 1.758 . . . . 0.0 110.424 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 7.1 p-90 -67.05 -13.19 61.68 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.43 -0.794 . . . . 0.0 109.464 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.519 ' O ' ' CG1' ' A' ' 11' ' ' VAL . . . -83.89 -15.75 69.41 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.57 ' CD1' ' NE2' ' A' ' 220' ' ' HIS . 1.1 mp -116.38 -6.75 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -1.202 . . . . 0.0 109.045 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.92 -22.43 21.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.935 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 21.37 12.86 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.036 -1.04 . . . . 0.0 110.621 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 7' ' ' GLY . 28.1 m -110.06 18.46 6.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.963 -1.086 . . . . 0.0 109.339 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 27.8 mm-40 57.07 17.63 3.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.573 -0.704 . . . . 0.0 110.571 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.683 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.54 -43.03 87.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.069 -1.019 . . . . 0.0 110.577 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.86 -53.87 0.13 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 N-CA-C 107.874 -1.625 . . . . 0.0 107.874 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.823 ' HB1' ' OE2' ' A' ' 265' ' ' GLU . . . -44.75 -30.74 1.01 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.47 54.97 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 16.0 m170 -65.62 -10.83 39.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.601 -0.687 . . . . 0.0 109.175 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -83.43 -56.87 3.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.353 -0.842 . . . . 0.0 109.671 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -36.21 63.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.456 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.92 4.01 9.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.657 HD13 HG21 ' A' ' 268' ' ' THR . 0.3 OUTLIER -63.82 137.68 58.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.133 . . . . 0.0 109.365 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -123.77 -12.4 7.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 110.086 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 71.55 -9.39 4.66 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -49.13 135.43 16.44 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -1.122 . . . . 0.0 109.336 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.18 0.55 47.78 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 27' ' ' LYS . 47.5 t -112.44 163.79 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.127 -1.219 . . . . 0.0 109.776 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -148.83 131.35 15.78 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.587 HG22 ' HB ' ' A' ' 119' ' ' VAL . 17.4 t -128.69 154.05 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.325 -0.859 . . . . 0.0 109.723 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -98.76 150.17 22.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 108.911 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.636 ' CG2' HD22 ' A' ' 88' ' ' LEU . 39.0 t -122.7 80.32 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.919 -1.113 . . . . 0.0 108.387 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.039 HD23 HG21 ' A' ' 93' ' ' VAL . 6.6 mp -71.07 126.41 29.51 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.973 ' HA ' HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER 170.21 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.264 -0.897 . . . . 0.0 109.258 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.855 HG21 ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -49.05 -59.76 3.35 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.144 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . 179.38 -109.85 0.27 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 165.6 102.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.8 p -49.73 125.88 12.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 109.814 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.9 m -55.12 101.24 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.074 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.593 ' CD2' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -119.4 153.39 53.7 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.186 -0.946 . . . . 0.0 109.812 -179.528 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.593 ' HD2' ' CD2' ' A' ' 38' ' ' HIS . 35.6 Cg_endo -78.5 -12.69 15.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.516 2.144 . . . . 0.0 109.939 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -90.25 -37.58 14.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD21 ' HA2' ' A' ' 68' ' ' GLY . 62.2 mt -88.87 113.49 24.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.792 . . . . 0.0 109.545 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 119.36 16.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 mm -92.66 94.78 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.073 -1.017 . . . . 0.0 109.395 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.504 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -79.81 -21.01 44.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.993 . . . . 0.0 109.265 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -169.32 163.9 37.51 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.91 119.5 0.83 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.37 163.47 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -1.096 . . . . 0.0 108.727 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.493 ' OG ' ' HD2' ' A' ' 92' ' ' LYS . 2.5 t -150.85 136.95 18.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 110.427 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.619 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 0.7 OUTLIER -127.29 -30.31 2.65 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.587 -0.696 . . . . 0.0 109.636 -179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 94' ' ' LEU . 55.2 t -49.05 129.42 15.42 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.235 -0.915 . . . . 0.0 109.511 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.56 172.08 14.9 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.64 2.226 . . . . 0.0 111.125 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.82 -66.38 1.93 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -165.99 86.32 0.94 Allowed Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.599 -0.942 . . . . 0.0 109.241 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' SER . 35.4 Cg_endo -75.58 -95.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.396 2.064 . . . . 0.0 110.549 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' PRO . 4.3 m 60.16 134.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.124 -0.985 . . . . 0.0 109.417 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 p -92.71 3.8 54.93 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.181 -0.95 . . . . 0.0 109.159 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 58' ' ' ASP . 1.5 mt-30 -96.56 116.21 28.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.217 -0.927 . . . . 0.0 109.293 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.458 ' CG ' ' O ' ' A' ' 57' ' ' GLN . 0.7 OUTLIER 52.21 171.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.637 0.732 . . . . 0.0 110.133 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.57 -33.31 0.06 OUTLIER Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.855 ' HB2' HG21 ' A' ' 33' ' ' THR . 1.3 t-20 -175.68 -41.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 109.345 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.62 -47.24 0.97 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -45.32 -50.07 12.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.398 -1.06 . . . . 0.0 110.155 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -54.54 -80.94 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.409 -0.901 . . . . 0.0 110.934 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 0.7 OUTLIER -33.42 -45.28 0.16 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.818 -0.813 . . . . 0.0 110.898 -178.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.723 ' CD2' HD11 ' A' ' 211' ' ' LEU . 44.9 t-80 -57.51 -54.01 51.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.154 -0.966 . . . . 0.0 109.971 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 70' ' ' ILE . 13.5 t -58.76 -32.62 47.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.426 -0.796 . . . . 0.0 109.189 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 70' ' ' ILE . . . -59.72 -49.27 78.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.844 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.763 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -70.31 -28.65 71.05 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.492 HG21 ' HG2' ' A' ' 219' ' ' PRO . 7.7 m -71.59 -17.12 62.31 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.062 -1.258 . . . . 0.0 108.473 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.686 HD11 HG12 ' A' ' 66' ' ' VAL . 30.3 mt -92.66 -32.9 5.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.401 -0.812 . . . . 0.0 110.411 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 83' ' ' ALA . . . -179.65 35.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.661 -1.274 . . . . 0.0 111.52 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.763 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -46.1 156.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.734 -1.229 . . . . 0.0 108.358 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 73' ' ' LEU . 96.6 mt -78.95 166.69 22.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.932 -1.105 . . . . 0.0 109.925 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.99 ' HB2' HD13 ' A' ' 80' ' ' LEU . 55.0 t30 -117.29 87.38 2.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.84 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -118.39 -118.92 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.291 -0.881 . . . . 0.0 108.737 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -113.45 -40.54 3.84 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.954 -1.091 . . . . 0.0 109.279 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -102.79 165.56 2.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.404 -0.81 . . . . 0.0 109.7 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.27 -167.23 53.16 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.688 HG12 ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -114.0 -167.16 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -1.178 . . . . 0.0 109.397 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.99 HD13 ' HB2' ' A' ' 74' ' ' ASN . 8.5 tp -130.36 122.37 27.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 80' ' ' LEU . . . -86.57 -149.31 13.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG12 HD11 ' A' ' 227' ' ' LEU . 2.0 t -97.79 -66.67 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.263 . . . . 0.0 109.666 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -71.45 134.3 84.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 22' ' ' THR . 40.1 Cg_endo -84.95 -60.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.752 2.302 . . . . 0.0 111.236 -178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -105.92 45.38 0.98 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.793 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -85.5 164.72 17.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.07 -1.018 . . . . 0.0 109.646 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 2.6 tt0 -101.55 80.19 2.03 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.636 HD22 ' CG2' ' A' ' 30' ' ' VAL . 6.6 mt -73.3 144.17 46.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.312 -0.867 . . . . 0.0 109.746 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.604 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 2.8 m-85 -118.48 161.52 19.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.401 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . . . -130.03 92.32 3.28 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.643 -1.286 . . . . 0.0 109.914 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.89 149.55 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 O-C-N 121.131 -0.981 . . . . 0.0 109.315 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.493 ' HD2' ' OG ' ' A' ' 48' ' ' SER . 4.4 mttp -100.29 105.61 17.17 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.039 HG21 HD23 ' A' ' 31' ' ' LEU . 2.1 t -104.55 -14.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.398 -0.813 . . . . 0.0 110.08 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.973 HD11 ' HA ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -143.55 -174.7 4.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.771 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -110.75 -177.41 20.63 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' HB1' ' ND2' ' A' ' 60' ' ' ASN . . . -68.0 -6.96 25.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -1.168 . . . . 0.0 109.452 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.78 33.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.119 -0.988 . . . . 0.0 109.522 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.88 8.85 57.82 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.7 t -142.15 66.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -1.185 . . . . 0.0 109.668 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.47 178.92 13.16 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.48 157.8 21.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.746 -0.855 . . . . 0.0 109.786 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 130' ' ' SER . 43.7 t -68.53 -19.61 24.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.526 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 33.4 t -72.91 -22.69 60.7 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.456 ' HA ' ' HG3' ' A' ' 107' ' ' GLN . 57.4 m -83.1 -63.8 1.29 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.568 HG23 ' CG1' ' A' ' 93' ' ' VAL . 2.3 mt -47.93 -27.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 110' ' ' GLU . . . -69.08 -47.91 64.03 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.619 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -64.79 -28.83 69.84 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.033 -1.042 . . . . 0.0 109.404 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.493 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -80.55 -26.77 53.5 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.949 HD22 ' ND2' ' A' ' 167' ' ' ASN . 16.4 mt -87.23 -24.15 24.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -1.227 . . . . 0.0 110.024 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 106' ' ' ALA . 7.1 pt-20 -100.63 -25.94 13.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.251 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.53 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 83.1 t90 -71.65 -17.06 62.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.598 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -93.42 -0.38 56.51 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.876 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -94.93 -28.47 10.01 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -97.2 -35.41 10.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -1.22 . . . . 0.0 109.503 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -140.12 27.66 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.394 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.834 ' O ' ' HE2' ' A' ' 117' ' ' MET . . . -87.99 -153.32 25.6 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.834 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 12.1 mmt -125.22 -176.54 3.6 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.366 -1.079 . . . . 0.0 110.432 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.666 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -71.84 -17.08 62.17 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.749 -0.595 . . . . 0.0 110.163 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.666 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.6 t -136.74 168.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.6 132.48 1.21 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 1.02 ' C ' HD13 ' A' ' 122' ' ' LEU . 1.6 m120 -130.91 147.39 52.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 0.0 109.741 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.02 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -142.07 124.78 15.93 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.094 -1.004 . . . . 0.0 109.187 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.749 ' C ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -93.17 62.14 3.47 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.897 -1.127 . . . . 0.0 109.065 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.819 HD23 ' N ' ' A' ' 124' ' ' LEU . 1.2 mt -99.72 -178.7 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.558 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 160' ' ' SER . . . 175.05 74.88 0.05 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 3.4 m -124.62 147.73 56.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.277 -1.131 . . . . 0.0 109.494 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -81.07 15.42 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.787 2.325 . . . . 0.0 110.119 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.534 ' N ' ' CD ' ' A' ' 129' ' ' PRO . 14.1 t -116.03 50.36 0.76 Allowed Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.602 -0.687 . . . . 0.0 111.48 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -72.57 178.58 6.07 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.343 2.028 . . . . 0.0 109.772 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.581 ' HB2' HG21 ' A' ' 102' ' ' VAL . 3.7 t -152.49 154.08 34.77 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.161 -0.962 . . . . 0.0 110.77 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.97 -19.16 64.92 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 90.0 m -71.61 -26.76 62.71 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.2 tp -72.39 -38.3 68.5 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -68.08 -47.62 67.76 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.64 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -26.47 12.99 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -67.32 -44.81 78.22 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.082 HG23 ' HA ' ' A' ' 167' ' ' ASN . 0.5 OUTLIER -52.29 -40.38 31.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.458 ' N ' HG12 ' A' ' 137' ' ' VAL . 1.6 m120 -58.07 -41.79 84.12 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -20.16 63.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -106.63 1.75 25.42 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.872 -1.143 . . . . 0.0 112.044 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -104.49 -41.24 5.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.427 -1.421 . . . . 0.0 108.409 178.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -20.03 57.8 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.38 -25.83 20.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 81.44 52.66 4.12 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 86.5 t -105.4 109.79 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.342 -1.093 . . . . 0.0 109.267 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 146' ' ' LEU . 24.7 tp -58.5 123.13 15.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.053 -1.029 . . . . 0.0 109.104 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 168' ' ' ALA . 0.4 OUTLIER -120.25 141.69 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.077 -1.015 . . . . 0.0 109.297 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.459 HG23 ' HG3' ' A' ' 169' ' ' MET . 1.2 t -137.97 123.91 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.498 -0.751 . . . . 0.0 109.166 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.544 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -118.75 147.94 43.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.004 -1.06 . . . . 0.0 110.227 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -52.2 160.4 0.78 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.618 -0.676 . . . . 0.0 110.213 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -71.06 -79.21 0.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' O ' ' OE1' ' A' ' 185' ' ' GLN . . . 149.54 119.32 0.97 Allowed Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.437 ' OD1' ' CG ' ' A' ' 183' ' ' PHE . 3.6 m-20 -91.59 57.66 3.33 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.799 -0.824 . . . . 0.0 109.391 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.07 -96.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.49 84.47 0.05 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -170.61 179.51 3.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.132 . . . . 0.0 109.619 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.62 56.7 4.89 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -179.75 171.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -1.077 . . . . 0.0 108.675 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.626 HD12 ' CB ' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -118.85 -173.34 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.008 -1.057 . . . . 0.0 110.38 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.56 ' HB3' ' HA2' ' A' ' 125' ' ' GLY . 2.6 m -70.89 -174.6 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.806 1.289 . . . . 0.0 112.521 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.429 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 93.6 m-85 -123.81 126.97 25.59 Favored Pre-proline 0 C--N 1.302 -1.472 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.723 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.3 Cg_endo -72.62 -50.72 0.18 OUTLIER 'Cis proline' 0 C--N 1.301 -1.949 0 C-N-CA 123.939 -1.276 . . . . 0.0 109.791 2.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 149' ' ' ALA . . . 31.7 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 122.238 1.018 . . . . 0.0 108.901 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.723 ' N ' ' O ' ' A' ' 162' ' ' PRO . 17.5 ttm180 -44.12 -62.73 1.05 Allowed 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.717 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -172.28 -166.12 0.38 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 165' ' ' TYR . . . 89.73 -7.09 0.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.746 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 1.082 ' HA ' HG23 ' A' ' 137' ' ' VAL . 0.9 OUTLIER 159.73 39.51 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.719 -0.613 . . . . 0.0 109.596 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 167' ' ' ASN . . . 164.77 149.49 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.433 -1.307 . . . . 0.0 112.648 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -80.19 -174.43 4.52 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 175.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.626 ' CB ' HD12 ' A' ' 159' ' ' ILE . . . -122.66 118.88 29.18 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.345 -1.472 . . . . 0.0 110.515 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.569 ' O ' ' CB ' ' A' ' 151' ' ' SER . 19.0 t -89.52 166.94 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -136.9 -176.89 14.61 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.582 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -130.31 150.21 51.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.536 -0.979 . . . . 0.0 109.601 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 173' ' ' ALA . 33.2 p -157.79 155.06 29.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.216 -0.927 . . . . 0.0 108.957 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' THR . 18.8 p-10 -58.9 -150.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.846 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.543 ' HG2' ' ND2' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -94.48 -31.48 13.93 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.178 -0.952 . . . . 0.0 109.983 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.543 ' ND2' ' HG2' ' A' ' 176' ' ' GLN . 0.0 OUTLIER -96.29 -89.39 0.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.958 -1.089 . . . . 0.0 109.605 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -144.96 80.27 1.61 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 110.024 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -140.28 165.18 28.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.223 -0.923 . . . . 0.0 109.317 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.5 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 12.0 mtm180 -98.38 19.07 15.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.354 -0.841 . . . . 0.0 109.647 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 64.15 -152.46 0.3 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.6 OUTLIER -112.0 9.86 20.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.878 . . . . 0.0 109.393 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -150.48 -92.48 0.06 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 183' ' ' PHE . 3.7 t 39.29 80.76 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.476 -0.765 . . . . 0.0 110.455 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 152' ' ' GLY . 1.9 mp0 -65.67 146.27 55.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.359 -0.838 . . . . 0.0 109.122 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -123.54 166.41 15.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.126 -0.983 . . . . 0.0 109.541 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . 155.59 175.5 26.69 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -52.82 91.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.234 -1.156 . . . . 0.0 109.273 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 170' ' ' ALA . . . 160.81 -33.76 0.4 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' A' ' 190' ' ' LEU . 7.9 tp -52.21 111.78 0.69 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.238 -1.154 . . . . 0.0 109.622 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.28 -28.75 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.85 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 248' ' ' ALA . 2.5 tt -156.8 166.61 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.607 -1.308 . . . . 0.0 110.02 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.882 HG22 ' O ' ' A' ' 260' ' ' GLY . 12.4 m -123.68 174.63 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -0.821 . . . . 0.0 109.283 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.982 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -168.78 177.81 1.14 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.223 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.979 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.4 Cg_endo -76.61 119.33 5.15 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.455 2.103 . . . . 0.0 110.629 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -132.47 42.15 1.41 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 19.9 t -133.45 81.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.234 -1.156 . . . . 0.0 109.252 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.1 OUTLIER 84.22 122.83 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 122.011 0.91 . . . . 0.0 108.574 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.59 ' O ' HG23 ' A' ' 199' ' ' VAL . 19.3 m -156.81 108.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-O 122.137 0.97 . . . . 0.0 109.383 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 31.5 mt-30 -78.77 143.79 35.78 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.511 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.611 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -159.11 -162.1 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.329 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.514 HG21 HD11 ' A' ' 41' ' ' LEU . 15.0 t -86.04 -177.55 6.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.806 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.657 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -168.45 169.44 4.96 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.657 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -72.31 168.55 23.89 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.335 2.023 . . . . 0.0 110.538 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 67.01 23.53 72.88 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.514 ' HA ' ' NE2' ' A' ' 38' ' ' HIS . 4.2 p 56.36 36.7 27.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.309 -1.113 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -122.58 147.68 46.12 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.078 -1.014 . . . . 0.0 109.807 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.22 19.28 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.49 165.67 4.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.028 . . . . 0.0 110.205 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.76 ' O ' HD23 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -103.33 146.3 28.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.482 -0.762 . . . . 0.0 109.435 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -139.01 107.91 5.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.456 -0.777 . . . . 0.0 109.169 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -68.07 140.83 56.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.1 -1.0 . . . . 0.0 109.344 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.35 2.39 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.14 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.783 HG23 ' HB2' ' A' ' 173' ' ' ALA . 19.4 m -68.38 -23.58 64.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 0.0 109.868 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.538 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 9.9 t -67.11 -20.07 65.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.991 -1.068 . . . . 0.0 109.643 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.525 ' HG2' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -78.77 -10.49 59.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.277 -0.889 . . . . 0.0 109.852 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.982 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -86.38 -5.76 59.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.54 -0.725 . . . . 0.0 110.638 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.647 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -76.95 -39.05 2.13 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 111.721 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.5 Cg_endo -71.98 -25.59 19.46 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.527 1.484 . . . . 0.0 110.744 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.57 ' NE2' ' CD1' ' A' ' 8' ' ' ILE . 13.1 m80 -66.78 -37.75 85.19 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.72 -52.14 34.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' A' ' 121' ' ' ASN . . . -48.09 -33.2 7.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.378 -0.826 . . . . 0.0 108.94 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.4 -53.08 23.02 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -53.52 -62.44 1.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.419 -1.048 . . . . 0.0 109.286 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 244' ' ' LEU . . . -43.01 -40.88 3.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.489 -0.757 . . . . 0.0 109.373 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.3 -49.23 78.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.216 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.589 HD11 HG12 ' A' ' 82' ' ' VAL . 7.1 mt -52.94 -29.12 26.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.179 -0.951 . . . . 0.0 109.33 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 229' ' ' LYS . 96.1 t -74.19 -51.51 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.342 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.547 ' CG ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -43.92 -47.62 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.453 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 28.3 tp60 -63.3 -41.8 98.98 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 13.3 tptt -62.98 -11.49 19.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.046 -1.034 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -161.96 90.89 1.4 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.19 -0.944 . . . . 0.0 109.764 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.429 ' HA ' ' HE2' ' A' ' 229' ' ' LYS . 36.9 Cg_endo -81.44 17.88 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.724 2.283 . . . . 0.0 110.834 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.3 t -122.12 5.32 9.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.097 -1.002 . . . . 0.0 110.004 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -91.5 -179.65 5.43 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.909 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.457 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.4 OUTLIER -110.37 167.73 9.98 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -58.64 -35.75 73.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.037 -1.039 . . . . 0.0 109.426 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 238' ' ' VAL . 3.0 t -66.66 -64.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.21 -0.931 . . . . 0.0 109.526 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.487 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.1 OUTLIER -45.34 -39.78 7.12 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.357 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 236' ' ' SER . 59.7 mt -57.72 -49.41 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.57 -0.706 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 242' ' ' ASN . 49.1 ttp180 -56.12 -60.65 3.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.303 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.58 ' HA ' ' HE3' ' A' ' 245' ' ' LYS . 2.3 t-20 -37.69 -62.72 0.51 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.66 -0.65 . . . . 0.0 110.91 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.563 ' O ' HG23 ' A' ' 247' ' ' THR . 2.1 t60 -50.4 -40.75 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 110.597 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.758 HD12 ' HB2' ' A' ' 225' ' ' ALA . 0.2 OUTLIER -70.63 -37.56 73.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 0.0 111.327 -178.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.629 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 4.0 ptpt -63.36 -55.46 24.32 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.868 -1.145 . . . . 0.0 109.975 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.629 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -70.78 -27.1 63.66 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.547 -0.72 . . . . 0.0 111.035 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.636 HG21 ' HA ' ' A' ' 267' ' ' ALA . 6.0 p -71.57 -30.75 66.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.802 -1.186 . . . . 0.0 109.627 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -52.33 130.76 31.91 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.487 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 261' ' ' LEU . 1.6 m -42.97 111.8 0.3 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.211 -0.931 . . . . 0.0 108.784 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.4 p -69.14 98.0 0.96 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.414 -0.804 . . . . 0.0 110.369 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.631 HD13 ' HA2' ' A' ' 260' ' ' GLY . 3.5 mp -56.85 -65.43 0.62 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.277 -0.889 . . . . 0.0 109.663 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 253' ' ' SER . . . 171.77 -137.03 4.11 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 252' ' ' GLY . 10.7 p 43.24 -168.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -1.09 . . . . 0.0 109.878 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 13.5 t -125.57 -3.27 7.29 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.835 -0.541 . . . . 0.0 109.927 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 254' ' ' THR . 2.9 t-20 172.93 -23.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.066 -1.021 . . . . 0.0 110.181 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 256' ' ' LEU . 0.2 OUTLIER -50.24 -61.29 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.964 -1.085 . . . . 0.0 109.159 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -55.3 -60.97 2.67 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.154 -0.966 . . . . 0.0 108.475 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.573 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 124.71 58.97 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.432 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 3.1 t 83.73 -57.46 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.926 . . . . 0.0 110.033 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.882 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 140.36 -171.29 24.03 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.525 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.773 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 12.7 tp -75.25 162.29 28.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.579 -0.954 . . . . 0.0 109.695 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.37 154.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.182 -0.949 . . . . 0.0 109.969 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.43 ' CB ' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -160.71 117.18 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.652 1.215 . . . . 0.0 108.177 178.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.89 -12.6 61.0 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.526 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.823 ' OE2' ' HB1' ' A' ' 15' ' ' ALA . 7.6 tp10 -82.47 -40.47 21.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.964 -1.085 . . . . 0.0 109.603 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.8 -11.75 59.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 0.0 109.301 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.636 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -89.69 -38.88 13.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.928 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.657 HG21 HD13 ' A' ' 21' ' ' LEU . 44.6 p -87.89 -52.9 5.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 0.0 109.442 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.425 ' C ' ' HD3' ' A' ' 269' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.575 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.429 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.362 0.601 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.451 ' HB3' HG13 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.53 165.88 24.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.253 -0.905 . . . . 0.0 109.874 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.1 m -101.3 55.19 0.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.317 -0.864 . . . . 0.0 109.015 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.538 HG12 HG21 ' A' ' 8' ' ' ILE . 15.8 m -76.99 111.89 19.34 Favored Pre-proline 0 C--N 1.29 -2.007 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.625 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -80.48 -166.52 0.42 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.827 2.351 . . . . 0.0 111.813 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -33.29 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.219 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.517 ' HA3' ' NE2' ' A' ' 220' ' ' HIS . . . -52.06 -83.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 8' ' ' ILE . 2.9 mm -43.84 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.479 -1.012 . . . . 0.0 109.187 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER 162.78 -56.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -125.49 26.52 6.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.959 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.65 20.04 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.875 -1.14 . . . . 0.0 109.903 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG3' ' HB3' ' A' ' 263' ' ' ASN . 5.3 mm-40 65.83 15.59 10.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.385 -0.822 . . . . 0.0 110.577 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -66.33 -37.17 14.96 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.5 Cg_endo -73.02 -55.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.319 -0.981 0 N-CA-C 108.424 -1.414 . . . . 0.0 108.424 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.74 -29.52 0.53 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 -48.03 42.64 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 11.1 m170 -69.04 -7.29 34.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.817 . . . . 0.0 109.569 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.26 -22.58 14.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.112 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.871 ' HB3' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -81.26 4.89 18.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.019 -1.051 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.34 47.13 5.03 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.871 HD21 ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -149.22 150.89 33.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.354 -1.086 . . . . 0.0 109.102 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 24' ' ' SER . 1.7 t -161.15 38.37 0.14 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.866 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 56.94 9.79 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 22' ' ' THR . 55.5 p -57.78 119.45 6.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -1.069 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.77 27.92 9.97 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 27' ' ' LYS . 88.1 t -122.83 167.66 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -1.211 . . . . 0.0 109.789 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HG2' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -136.24 132.62 36.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.117 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG13 ' HB ' ' A' ' 119' ' ' VAL . 3.0 t -136.36 123.33 32.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 110.121 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.582 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -84.97 162.63 19.32 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.82 90.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.153 HD23 HG21 ' A' ' 93' ' ' VAL . 5.9 mp -79.83 102.37 9.06 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.489 ' OD2' ' HA2' ' A' ' 63' ' ' GLY . 47.9 p30 -166.2 -154.23 0.18 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.006 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.803 HG22 ' HA ' ' A' ' 96' ' ' ALA . 6.6 p -43.0 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.564 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -164.06 -132.8 1.39 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.751 HG13 ' HB2' ' A' ' 90' ' ' ALA . 30.5 mm -165.58 96.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 204' ' ' PRO . 0.3 OUTLIER -62.88 137.47 58.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 109.171 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.3 m -63.05 122.39 15.95 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.342 -0.849 . . . . 0.0 109.591 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 203' ' ' TYR . 0.0 OUTLIER -133.18 154.54 81.22 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.4 Cg_endo -79.68 -31.91 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.715 2.276 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -86.33 -3.19 58.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.0 109.836 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.77 123.6 48.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.065 -1.022 . . . . 0.0 109.724 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.12 91.43 7.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -0.862 . . . . 0.0 109.87 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.75 152.07 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.563 ' O ' ' CE1' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -160.71 23.41 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.325 -0.86 . . . . 0.0 109.338 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.614 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -170.0 144.76 8.71 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -147.93 114.69 0.71 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.1 157.68 44.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.446 -1.032 . . . . 0.0 109.294 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 56' ' ' THR . 0.1 OUTLIER -165.28 133.75 3.25 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.993 -1.067 . . . . 0.0 110.139 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -116.8 -36.38 3.9 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.609 -0.682 . . . . 0.0 109.634 -179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HD3' ' A' ' 92' ' ' LYS . 11.2 t -43.69 107.49 0.59 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.238 -0.914 . . . . 0.0 109.374 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.89 167.68 23.36 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.706 2.271 . . . . 0.0 110.704 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.28 -41.59 2.47 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -177.49 89.01 0.24 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.369 -1.077 . . . . 0.0 109.188 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.567 ' O ' ' CB ' ' A' ' 55' ' ' SER . 36.2 Cg_endo -77.74 -82.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.867 2.378 . . . . 0.0 111.301 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 84.55 -50.04 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.54 -0.725 . . . . 0.0 109.858 -179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 48' ' ' SER . 0.1 OUTLIER 61.69 4.28 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.121 -0.987 . . . . 0.0 110.114 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 58' ' ' ASP . 30.2 mt-30 -147.03 138.69 24.25 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.753 -1.217 . . . . 0.0 109.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 57' ' ' GLN . 45.2 t0 57.8 116.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 60' ' ' ASN . . . -153.7 67.21 0.32 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 59' ' ' GLY . 2.8 t-20 84.99 -33.43 0.05 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.696 -0.885 . . . . 0.0 109.893 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.87 -24.54 10.82 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.42 ' O ' ' C ' ' A' ' 63' ' ' GLY . 20.5 t-160 -51.08 -66.51 0.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.146 . . . . 0.0 109.666 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.489 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -40.85 -72.92 0.22 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 96.5 m -35.38 -48.07 0.46 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.827 -0.807 . . . . 0.0 110.735 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.533 ' NE2' ' HB2' ' A' ' 201' ' ' SER . 22.0 t-80 -51.73 -53.36 40.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.134 -0.979 . . . . 0.0 109.254 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.552 HG13 ' HG3' ' A' ' 219' ' ' PRO . 12.5 t -60.64 -31.35 48.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 121.34 -0.85 . . . . 0.0 108.785 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -55.79 -48.58 75.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.397 -0.814 . . . . 0.0 109.526 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.42 ' C ' ' N ' ' A' ' 70' ' ' ILE . . . -67.41 -43.03 88.68 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.429 HG21 ' HG2' ' A' ' 219' ' ' PRO . 1.1 m -52.07 -21.88 3.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.449 -1.618 . . . . 0.0 107.773 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 83' ' ' ALA . 55.9 mt -94.3 -30.68 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.497 -0.752 . . . . 0.0 110.949 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -165.57 44.38 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.506 -1.371 . . . . 0.0 112.323 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -60.92 124.47 20.57 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.635 -1.291 . . . . 0.0 108.82 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 40' ' ' ASP . 93.2 mt -79.33 156.75 27.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.992 -1.068 . . . . 0.0 109.314 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 42.3 t30 -139.54 63.63 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.087 -1.008 . . . . 0.0 109.975 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -89.75 -13.92 35.73 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 122.042 0.925 . . . . 0.0 109.28 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.8 -45.93 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -115.1 157.25 15.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.526 -0.734 . . . . 0.0 109.135 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.83 164.35 35.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.8 m -90.43 -150.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.366 -1.079 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.5 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 6.3 tp -147.02 106.42 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.984 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.43 -163.48 4.62 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.798 HG12 HD11 ' A' ' 227' ' ' LEU . 0.6 OUTLIER -78.91 -53.67 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.316 -1.108 . . . . 0.0 109.427 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -110.84 101.9 50.89 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.18 -0.95 . . . . 0.0 108.707 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD2' ' OG1' ' A' ' 22' ' ' THR . 37.6 Cg_endo -83.03 -53.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.902 2.401 . . . . 0.0 111.303 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.48 18.39 0.09 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 115.879 -0.6 . . . . 0.0 112.152 -178.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.18 23.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.525 -1.359 . . . . 0.0 109.203 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 44.0 mt-10 -74.33 150.57 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 109.082 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.545 HD11 ' HB3' ' A' ' 71' ' ' ALA . 88.1 mt -125.25 97.98 5.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.953 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.621 ' CZ ' ' HG2' ' A' ' 27' ' ' LYS . 14.3 m-30 -82.29 113.66 20.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.262 -0.899 . . . . 0.0 109.419 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.751 ' HB2' HG13 ' A' ' 35' ' ' ILE . . . -78.77 108.91 12.55 Favored 'General case' 0 C--N 1.291 -1.944 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.073 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.582 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -108.38 73.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.766 -1.209 . . . . 0.0 109.959 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -41.65 113.4 0.41 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.153 HG21 HD23 ' A' ' 31' ' ' LEU . 5.0 t -123.06 -24.71 2.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.135 -0.978 . . . . 0.0 109.928 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.72 HD11 HD22 ' A' ' 124' ' ' LEU . 3.9 mp -126.76 172.2 10.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 110.173 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -79.92 -158.65 16.5 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.803 ' HA ' HG22 ' A' ' 33' ' ' THR . . . -91.56 -47.86 7.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.217 -1.167 . . . . 0.0 109.183 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 95.2 p -69.29 -41.01 77.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.351 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.72 41.82 0.16 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.9 t -116.78 63.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.438 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.25 179.36 48.15 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 m -121.47 157.35 30.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.872 -0.781 . . . . 0.0 109.983 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -28.89 44.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.549 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 75.1 m -72.52 -18.53 61.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 105' ' ' ILE . 9.2 p -77.44 -57.76 3.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.652 -0.655 . . . . 0.0 109.382 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.554 HG12 ' CG1' ' A' ' 93' ' ' VAL . 1.3 mt -63.4 -24.15 35.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.06 -44.54 79.89 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.624 -0.673 . . . . 0.0 109.572 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.607 ' HB2' ' CD2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -77.39 -24.26 50.56 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.624 179.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 49' ' ' PHE . . . -72.51 -27.98 68.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 71.5 mt -94.68 -30.7 14.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.131 -1.217 . . . . 0.0 109.564 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -76.14 -30.06 58.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 108.96 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -65.67 -22.96 66.68 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.824 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -81.33 -21.85 38.9 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -56.52 -39.35 84.4 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.58 -49.97 6.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -127.93 70.27 1.34 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.824 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -105.79 23.72 28.79 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.617 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 0.2 OUTLIER 30.7 -159.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.129 0.966 . . . . 0.0 111.509 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.535 ' CB ' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -96.22 -20.21 18.74 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.437 -0.789 . . . . 0.0 111.026 -178.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 28' ' ' VAL . 2.6 t -136.51 158.5 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.435 -1.415 . . . . 0.0 111.351 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -164.81 128.51 2.42 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.601 ' ND2' HG12 ' A' ' 148' ' ' VAL . 11.9 t-20 -107.01 158.33 17.12 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.649 -1.282 . . . . 0.0 110.49 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.663 HD23 HD11 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -127.54 98.88 5.38 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -85.58 64.89 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.403 -0.81 . . . . 0.0 108.944 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.72 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -150.31 168.49 23.91 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.428 -0.795 . . . . 0.0 109.413 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.567 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -164.76 76.53 0.15 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -103.59 147.62 34.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.19 -1.182 . . . . 0.0 109.475 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.464 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -77.3 -34.59 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.295 1.997 . . . . 0.0 109.122 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.4 m -46.79 104.6 0.42 Allowed Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.71 -0.619 . . . . 0.0 109.38 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 34.5 Cg_endo -78.6 168.99 20.46 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.48 2.12 . . . . 0.0 110.161 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.3 p -173.34 120.48 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.005 -1.059 . . . . 0.0 110.622 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.35 -24.88 65.76 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 79.7 m -63.37 -29.12 70.48 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.431 ' HB2' ' OG ' ' A' ' 130' ' ' SER . 2.1 tt -75.88 -35.87 59.7 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 6.5 tm-20 -77.04 -19.45 57.15 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.074 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -78.13 -24.01 47.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.05 -45.33 20.38 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.341 -0.943 . . . . 0.0 108.631 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.57 -28.92 42.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 134' ' ' GLU . 62.6 t30 -62.33 -34.77 77.28 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.4 t -79.88 -22.42 42.88 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.87 -27.69 63.03 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.4 m -69.4 -39.38 77.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -58.07 -23.93 56.53 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.231 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.65 -14.2 16.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.0 109.303 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.452 ' C ' ' HB2' ' A' ' 237' ' ' ASN . . . 68.16 75.37 0.51 Allowed Glycine 0 C--N 1.302 -1.331 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 t -120.71 111.72 33.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.468 -1.019 . . . . 0.0 109.399 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.89 113.72 6.56 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -112.54 142.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.013 -1.054 . . . . 0.0 110.379 -178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.601 HG12 ' ND2' ' A' ' 121' ' ' ASN . 2.7 t -119.44 167.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -153.64 128.16 9.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.974 -1.079 . . . . 0.0 109.972 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.506 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -61.08 156.06 18.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.331 -0.855 . . . . 0.0 109.984 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.5 OUTLIER -88.16 -54.18 4.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 110.333 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.562 ' CA ' ' HB2' ' A' ' 185' ' ' GLN . . . 146.79 128.75 1.92 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 154' ' ' SER . 51.1 p-10 -83.66 60.96 6.02 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 122.166 -0.608 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 0.9 OUTLIER 91.97 104.52 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 121.356 0.598 . . . . 0.0 109.953 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.711 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -173.45 61.97 0.13 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 77.29 164.22 0.23 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.324 -1.104 . . . . 0.0 109.299 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.65 56.6 4.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.4 OUTLIER -145.85 161.75 39.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.52 -179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.469 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -100.53 -174.79 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.376 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.871 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.02 173.78 6.17 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.142 0.972 . . . . 0.0 111.576 -178.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.453 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.7 m-85 -108.8 134.15 20.43 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 176.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.682 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.2 Cg_endo -72.95 -56.91 0.14 OUTLIER 'Cis proline' 0 C--N 1.295 -2.256 0 C-N-CA 124.043 -1.232 . . . . 0.0 111.018 3.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.871 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 37.74 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.284 1.04 . . . . 0.0 109.412 -178.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -43.73 -34.94 1.66 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 178.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.1 m-85 -44.67 -178.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.289 1.042 . . . . 0.0 111.615 -178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 167' ' ' ASN . . . -95.92 -60.01 1.73 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 166' ' ' ALA . 0.1 OUTLIER -44.67 -67.47 0.28 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.206 1.003 . . . . 0.0 108.65 179.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -71.97 139.29 48.57 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.8 mmm -104.71 143.29 33.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.999 -1.063 . . . . 0.0 109.912 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -94.99 108.16 20.22 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 34.6 t -87.53 165.26 2.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.085 -1.01 . . . . 0.0 109.549 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -138.27 -175.47 13.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -117.6 157.77 25.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -1.095 . . . . 0.0 109.199 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.944 HG22 ' OD1' ' A' ' 179' ' ' ASN . 18.6 p -135.35 168.13 19.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.116 -0.99 . . . . 0.0 110.049 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.08 -162.92 0.48 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -83.84 -19.86 34.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.72 -71.37 0.38 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 109.277 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 174' ' ' THR . 2.7 m-20 -153.14 -59.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.506 -0.746 . . . . 0.0 109.288 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 1.004 ' ND2' HG21 ' A' ' 193' ' ' VAL . 8.6 t-20 -147.23 148.9 31.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.376 -0.827 . . . . 0.0 109.574 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 163.08 -70.07 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.428 0.633 . . . . 0.0 109.541 179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 180' ' ' ARG . . . 48.91 178.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.641 -0.662 . . . . 0.0 109.809 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.85 -34.83 1.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 154' ' ' SER . 7.7 p90 -106.49 -3.61 20.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.609 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 0.7 OUTLIER -45.89 112.16 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.562 ' HB2' ' CA ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -67.96 105.61 2.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.231 -0.918 . . . . 0.0 108.846 179.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.581 ' CD2' ' N ' ' A' ' 187' ' ' GLY . 0.5 OUTLIER -109.22 -169.99 1.58 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.466 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.581 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . -174.77 -142.12 3.92 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.132 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.51 71.59 5.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.425 -1.044 . . . . 0.0 110.42 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.01 64.81 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.769 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 192' ' ' ILE . 0.5 OUTLIER -61.74 149.49 39.62 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.29 -1.124 . . . . 0.0 109.161 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -61.54 -60.98 2.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -179.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.692 ' O ' HD21 ' A' ' 190' ' ' LEU . 14.7 tt -160.73 165.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 120.984 -1.072 . . . . 0.0 109.619 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 1.004 HG21 ' ND2' ' A' ' 179' ' ' ASN . 27.3 m -122.48 161.38 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.214 -0.929 . . . . 0.0 109.877 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -153.41 158.18 32.75 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.446 ' CB ' ' HZ3' ' A' ' 6' ' ' TRP . 34.6 Cg_endo -76.02 121.22 6.08 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 121.984 1.789 . . . . 0.0 110.15 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 217' ' ' ALA . . . -163.13 52.88 0.3 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.287 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 45.1 t -100.87 64.4 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -1.185 . . . . 0.0 108.4 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.735 ' O ' HG13 ' A' ' 199' ' ' VAL . 12.6 t-20 119.45 129.76 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 216' ' ' MET . 6.2 m -165.51 116.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-O 121.965 0.888 . . . . 0.0 108.822 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 20.2 pt20 -94.73 138.18 32.88 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 121.556 0.694 . . . . 0.0 109.666 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.533 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -135.43 -152.79 0.48 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.0 109.188 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.7 p -88.62 178.94 6.37 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.216 -0.928 . . . . 0.0 110.537 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.674 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -145.45 164.09 28.29 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.674 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 33.5 Cg_endo -69.9 155.85 64.43 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.57 1.514 . . . . 0.0 110.437 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.605 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.05 -60.49 4.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.605 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 2.0 p 151.6 38.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.975 -0.72 . . . . 0.0 109.577 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -122.77 170.8 9.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.172 -0.955 . . . . 0.0 109.935 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -108.73 177.74 4.69 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.409 -0.807 . . . . 0.0 108.98 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -162.78 166.93 23.64 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.079 -1.013 . . . . 0.0 110.209 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.931 ' C ' HD23 ' A' ' 211' ' ' LEU . 0.4 OUTLIER -144.08 122.05 12.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.325 -0.859 . . . . 0.0 109.585 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.931 HD23 ' C ' ' A' ' 210' ' ' SER . 0.2 OUTLIER -136.33 156.19 48.99 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.083 -1.01 . . . . 0.0 109.878 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 212' ' ' ASN . 16.2 p30 -117.83 131.54 56.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.48 -0.763 . . . . 0.0 109.041 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 172.91 164.62 28.62 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.605 -1.283 . . . . 0.0 109.914 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 151' ' ' SER . 89.0 m -76.57 -29.02 56.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -1.081 . . . . 0.0 108.813 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.455 ' O ' ' HB ' ' A' ' 218' ' ' THR . 0.3 OUTLIER -59.35 -24.74 63.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 108.85 179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.886 ' HB3' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -77.8 -29.29 50.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.291 -0.881 . . . . 0.0 109.263 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.422 ' HB2' ' HA3' ' A' ' 196' ' ' GLY . . . -84.51 -5.19 59.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.242 -0.912 . . . . 0.0 108.751 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.613 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 0.9 OUTLIER -66.22 -52.72 36.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.436 -0.79 . . . . 0.0 110.15 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.6 Cg_endo -72.16 -9.16 24.06 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.259 1.972 . . . . 0.0 111.118 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.517 ' NE2' ' HA3' ' A' ' 7' ' ' GLY . 1.6 m80 -74.7 -43.51 54.73 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 84.3 t -75.05 -39.86 44.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 219' ' ' PRO . . . -52.95 -35.43 58.72 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -69.66 -50.58 30.04 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -44.21 -49.72 9.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -1.188 . . . . 0.0 108.955 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.93 -43.88 86.57 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.337 -0.852 . . . . 0.0 108.881 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -53.07 -41.51 64.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.917 . . . . 0.0 109.317 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.798 HD11 HG12 ' A' ' 82' ' ' VAL . 17.1 mt -62.19 -34.67 76.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 108.873 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 231' ' ' LYS . 99.1 t -62.15 -60.38 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.937 . . . . 0.0 109.032 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.591 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -44.62 -41.86 6.96 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 108.992 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 24' ' ' SER . 1.4 tm0? -59.83 -57.53 12.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 228' ' ' VAL . 1.9 ptpt -62.21 -11.22 13.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.093 -1.004 . . . . 0.0 109.221 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.527 ' OD1' ' CD1' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -156.42 80.79 3.68 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.803 . . . . 0.0 109.735 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.15 -4.79 13.39 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.686 2.257 . . . . 0.0 110.086 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -14.21 22.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.313 -0.867 . . . . 0.0 110.139 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.527 ' CD1' ' OD1' ' A' ' 232' ' ' ASN . 29.5 m0 -71.67 175.79 5.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.912 -1.117 . . . . 0.0 109.624 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 t -118.16 173.86 6.55 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.526 ' HA ' HD12 ' A' ' 240' ' ' ILE . 40.0 t30 -54.8 -17.14 3.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.369 -0.832 . . . . 0.0 109.965 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.63 -62.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.07 59.3 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.646 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 237' ' ' ASN . 77.7 mt -68.78 -54.26 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.452 -0.78 . . . . 0.0 110.854 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -66.85 -31.18 71.61 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.949 -1.094 . . . . 0.0 110.95 -178.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.502 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 33.2 t-20 -73.04 -40.55 65.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.688 -1.257 . . . . 0.0 110.355 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.428 ' O ' HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -75.45 -32.68 60.74 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.099 -1.001 . . . . 0.0 109.776 -179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.3 OUTLIER -77.72 -32.35 52.82 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.244 -0.91 . . . . 0.0 109.969 -179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.1 tttt -80.97 -28.77 35.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.1 -1.0 . . . . 0.0 108.686 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 4.6 t-20 -83.59 -18.27 38.83 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 267' ' ' ALA . 2.6 p -88.49 -30.15 19.6 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 122.207 1.003 . . . . 0.0 109.226 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.16 126.68 9.56 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.298 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.414 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 17.2 m -74.89 145.32 42.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.451 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.4 OUTLIER -115.47 126.47 54.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.878 -179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.0 mp -71.76 -73.69 0.18 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 179.22 -32.27 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.58 ' HB2' ' CD2' ' A' ' 257' ' ' TYR . 71.0 m -68.77 172.32 6.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.067 -1.255 . . . . 0.0 109.653 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.52 16.77 1.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.586 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.443 HD22 HD12 ' A' ' 256' ' ' LEU . 0.2 OUTLIER -122.41 -28.54 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.99 . . . . 0.0 109.676 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.443 HD12 HD22 ' A' ' 255' ' ' ASN . 0.3 OUTLIER -121.04 -69.64 0.83 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.155 -0.965 . . . . 0.0 109.411 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.611 ' CD1' ' ND2' ' A' ' 179' ' ' ASN . 15.6 m-30 -44.33 -50.78 8.92 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.178 -0.951 . . . . 0.0 109.038 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 72.41 -128.68 13.56 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 191' ' ' ASP . 13.6 t -44.53 -45.02 9.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -1.128 . . . . 0.0 109.226 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.583 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 121.25 -138.01 12.21 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 261' ' ' LEU . 13.3 tp -96.62 168.42 10.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.422 -1.046 . . . . 0.0 109.178 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.55 HG13 ' CD1' ' A' ' 192' ' ' ILE . 0.0 OUTLIER -117.62 156.08 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.272 -0.893 . . . . 0.0 109.258 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.48 ' HB3' ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.99 120.12 0.98 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.361 1.076 . . . . 0.0 108.771 179.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 268' ' ' THR . . . -75.26 0.97 14.76 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.133 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.48 -35.31 40.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -83.58 -10.51 58.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.658 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -100.29 -26.71 13.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.696 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 264' ' ' ALA . 19.1 p -79.65 -42.06 25.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.728 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.505 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 CA-C-O 118.083 -0.96 . . . . 0.0 109.44 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.396 0.617 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.704 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -62.0 138.54 58.39 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.403 -0.81 . . . . 0.0 110.424 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.487 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 58.4 m -96.76 115.48 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.618 HG12 HG21 ' A' ' 8' ' ' ILE . 1.2 m -145.22 115.0 4.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 0.0 109.384 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.42 171.29 17.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.437 2.092 . . . . 0.0 110.69 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -53.51 -15.96 1.31 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.455 -0.778 . . . . 0.0 110.737 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.89 24.58 6.61 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.645 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.618 HG21 HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -154.81 14.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.797 -1.413 . . . . 0.0 109.931 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.2 p -90.79 -37.36 13.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.709 -1.244 . . . . 0.0 110.351 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.595 ' HB3' HD21 ' A' ' 261' ' ' LEU . 4.4 mtm180 -92.91 23.34 4.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.045 . . . . 0.0 110.256 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG22 ' C ' ' A' ' 8' ' ' ILE . 11.1 m -111.82 19.43 6.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 63.2 mm-40 39.94 36.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.415 -0.803 . . . . 0.0 109.679 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -73.42 -32.7 1.69 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 112.156 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.5 Cg_endo -74.46 -58.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -1.019 0 N-CA-C 108.797 -1.271 . . . . 0.0 108.797 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.35 -30.49 1.32 Allowed 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.67 -44.34 61.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.254 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -71.66 -5.86 36.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.385 -0.822 . . . . 0.0 109.652 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.87 -24.72 13.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.056 -1.028 . . . . 0.0 109.877 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -46.99 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 109.859 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 145.07 -53.0 0.57 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 21' ' ' LEU . 2.3 mp -49.71 141.39 9.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -1.084 . . . . 0.0 109.346 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -164.17 59.1 0.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.925 -1.109 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLY . . . 46.19 21.04 0.6 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.493 ' N ' ' C ' ' A' ' 22' ' ' THR . 2.6 p -40.28 -24.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.7 -0.882 . . . . 0.0 111.329 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -152.28 54.36 0.46 Allowed Glycine 0 N--CA 1.493 2.458 0 C-N-CA 118.86 -1.638 . . . . 0.0 111.386 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 27' ' ' LYS . 60.7 t -122.75 168.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.126 -1.22 . . . . 0.0 108.781 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.595 ' N ' HG12 ' A' ' 26' ' ' VAL . 5.4 mttm -136.63 117.54 14.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 110.214 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 89' ' ' TYR . 11.8 t -115.44 139.71 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -0.907 . . . . 0.0 109.394 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.616 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -100.14 147.65 25.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.097 -1.002 . . . . 0.0 110.085 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 70' ' ' ILE . 93.2 t -119.25 83.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.697 HD12 HG21 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -75.59 96.35 3.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.894 -0.504 . . . . 0.0 109.983 -179.485 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -167.5 -159.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.95 -1.094 . . . . 0.0 109.104 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.827 HG21 ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -44.5 -73.9 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.047 -1.033 . . . . 0.0 109.124 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -168.62 -124.15 0.71 Allowed Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 34' ' ' GLY . 34.3 mm -161.45 93.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 35' ' ' ILE . 16.6 p -40.62 118.9 1.01 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.863 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.07 103.62 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.406 ' HB3' ' OD2' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -139.36 154.07 71.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.395 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.71 1.26 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.695 2.264 . . . . 0.0 110.496 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' CG ' HG21 ' A' ' 202' ' ' THR . 3.0 p30 -108.55 1.1 21.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.641 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 mt -119.38 116.6 26.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.05 138.22 58.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.349 -0.844 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.3 mm -119.84 100.27 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.624 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -118.56 12.0 13.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.383 -0.823 . . . . 0.0 109.296 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.54 146.57 10.5 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.28 99.5 0.17 Allowed Glycine 0 N--CA 1.489 2.217 0 O-C-N 121.078 -1.248 . . . . 0.0 110.212 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.08 117.78 23.91 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -1.054 . . . . 0.0 108.163 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.511 ' HB3' HG22 ' A' ' 56' ' ' THR . 2.6 p -112.67 115.54 28.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 110.832 -178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.894 ' HZ ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -95.74 -36.7 11.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.906 HG13 ' HD2' ' A' ' 51' ' ' PRO . 9.9 t -45.22 149.49 0.92 Allowed Pre-proline 0 N--CA 1.488 1.445 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.906 ' HD2' HG13 ' A' ' 50' ' ' VAL . 27.9 Cg_endo -68.42 156.13 66.72 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.892 1.728 . . . . 0.0 110.927 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 112.8 -44.52 1.49 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.541 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 42.11 60.57 9.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.792 -0.829 . . . . 0.0 110.967 178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.7 Cg_endo -81.28 -89.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.209 1.94 . . . . 0.0 109.879 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.714 ' C ' HG23 ' A' ' 56' ' ' THR . 72.2 m -135.38 -6.09 2.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.424 -0.798 . . . . 0.0 110.422 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' C ' ' A' ' 55' ' ' SER . 1.4 p 79.44 -8.98 1.53 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 58' ' ' ASP . 2.2 mm-40 -100.99 172.87 6.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.814 . . . . 0.0 109.184 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 57' ' ' GLN . 0.9 OUTLIER 49.9 175.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.625 0.726 . . . . 0.0 110.191 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 156.33 -64.71 0.32 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.827 ' HB2' HG21 ' A' ' 33' ' ' THR . 0.1 OUTLIER -145.3 -61.87 0.34 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -1.113 . . . . 0.0 109.577 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 154.8 -35.79 0.67 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -54.99 -62.76 1.45 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.275 -1.132 . . . . 0.0 109.47 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.96 -41.33 13.76 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.459 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.9 m -57.65 -44.59 85.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -1.126 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.61 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 0.3 OUTLIER -59.51 -59.48 5.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.293 -0.879 . . . . 0.0 109.505 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.635 HG22 ' HG3' ' A' ' 219' ' ' PRO . 11.1 t -51.59 -30.18 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.269 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -62.54 -54.02 46.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.364 -0.835 . . . . 0.0 110.378 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -73.53 -17.15 78.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 219' ' ' PRO . 28.6 m -82.58 -14.51 54.71 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.058 -1.26 . . . . 0.0 107.87 178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.44 HD12 HG22 ' A' ' 30' ' ' VAL . 46.3 mt -101.75 -27.77 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.535 -0.728 . . . . 0.0 109.977 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -161.36 22.69 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.785 -1.197 . . . . 0.0 111.842 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 81' ' ' GLY . . . -38.73 100.63 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.031 -1.043 . . . . 0.0 109.323 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 72' ' ' ALA . 8.8 mt -44.58 172.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.29 -0.882 . . . . 0.0 110.514 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.817 HD22 HD11 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -105.18 103.53 13.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.443 -0.786 . . . . 0.0 109.433 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -142.01 -118.88 0.1 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.171 -0.956 . . . . 0.0 108.905 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.28 -39.29 0.53 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.163 -0.961 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.699 ' O ' HD12 ' A' ' 77' ' ' ILE . 1.3 pp -88.42 65.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.07 152.19 6.37 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 80' ' ' LEU . 17.4 m -68.28 -146.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.289 -1.124 . . . . 0.0 109.527 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.817 HD11 HD22 ' A' ' 74' ' ' ASN . 24.9 tp -139.83 107.11 5.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.874 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 72' ' ' ALA . . . -65.98 -153.23 0.18 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.07 -32.17 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.093 -1.239 . . . . 0.0 109.582 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.618 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -120.65 100.21 46.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 109.298 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 22' ' ' THR . 37.0 Cg_endo -81.72 -54.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.805 2.337 . . . . 0.0 110.534 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -82.55 30.93 0.41 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.684 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.618 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -94.56 168.64 10.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.939 -1.101 . . . . 0.0 109.222 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -96.12 92.03 6.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.146 -0.971 . . . . 0.0 108.87 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 1.5 mt -71.76 139.77 49.2 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.333 -0.854 . . . . 0.0 109.949 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 28' ' ' VAL . 3.0 m-85 -120.82 147.95 44.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.93 98.82 6.38 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.347 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.894 HG12 ' HZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -96.39 61.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.132 -0.98 . . . . 0.0 108.76 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 91' ' ' VAL . 2.0 ttmt -34.73 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.468 0.652 . . . . 0.0 110.364 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -110.83 7.33 8.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.051 HD11 HD22 ' A' ' 124' ' ' LEU . 88.1 mt -145.99 173.62 12.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.245 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 33' ' ' THR . . . -159.55 144.17 9.9 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 59' ' ' GLY . . . -54.07 -71.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.286 -1.126 . . . . 0.0 108.711 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.18 7.91 44.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 108.928 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 99' ' ' SER . . . -75.49 -52.69 6.43 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 98' ' ' GLY . 0.3 OUTLIER 45.48 77.9 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -1.146 . . . . 0.0 108.742 -179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.55 179.91 50.24 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 120.144 -1.027 . . . . 0.0 110.703 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -95.36 -176.27 3.74 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.626 0.727 . . . . 0.0 109.534 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.03 -14.92 19.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 107' ' ' GLN . 13.7 m -80.77 -18.06 48.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.69 -45.28 11.82 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.814 ' HA ' HG22 ' A' ' 93' ' ' VAL . 2.8 mt -70.97 -44.64 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.42 -0.912 . . . . 0.0 108.588 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.26 -37.11 86.32 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.518 -0.739 . . . . 0.0 109.023 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 8.1 tp60 -65.16 -45.23 85.78 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.625 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -66.9 -31.87 79.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.63 HD21 HD21 ' A' ' 122' ' ' LEU . 10.3 mt -71.68 -28.5 63.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -1.198 . . . . 0.0 108.934 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.7 -22.28 46.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -63.62 -23.03 67.21 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 108.674 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.675 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -92.69 -15.64 26.48 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.935 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -66.86 -31.1 77.24 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.212 -1.955 . . . . 0.0 108.212 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -111.16 -28.49 8.26 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -1.102 . . . . 0.0 109.265 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -132.1 35.41 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.675 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -83.53 158.07 35.23 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -106.55 -179.93 4.08 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.276 -1.132 . . . . 0.0 109.301 -179.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.543 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.6 m170 -50.31 -30.2 11.48 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.462 -0.774 . . . . 0.0 110.586 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 120' ' ' ALA . 6.1 t -136.68 160.82 37.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.018 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.661 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -168.04 106.63 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.565 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 9.7 m120 -91.54 156.56 17.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.825 -1.172 . . . . 0.0 111.046 -178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.63 HD21 HD21 ' A' ' 109' ' ' LEU . 6.6 mp -129.22 103.02 6.71 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 124' ' ' LEU . 0.8 OUTLIER -85.04 64.72 8.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.898 . . . . 0.0 109.278 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.051 HD22 HD11 ' A' ' 94' ' ' LEU . 1.5 pp 177.66 175.48 0.46 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.988 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.522 ' O ' ' CD ' ' A' ' 129' ' ' PRO . . . 157.5 -99.6 0.19 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.313 -1.915 . . . . 0.0 108.313 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.602 ' CB ' ' CD ' ' A' ' 127' ' ' PRO . 0.1 OUTLIER 62.55 -175.28 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.394 -1.062 . . . . 0.0 110.076 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 126' ' ' SER . 37.0 Cg_endo -83.21 -10.35 10.15 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.749 2.299 . . . . 0.0 110.11 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.682 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -57.2 -44.13 99.55 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.61 -0.681 . . . . 0.0 111.96 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.682 ' HD2' ' N ' ' A' ' 128' ' ' SER . 30.1 Cg_endo -71.22 177.37 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.119 1.88 . . . . 0.0 111.022 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.7 t -118.43 173.9 6.56 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.45 1.119 . . . . 0.0 111.259 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.58 -12.21 60.99 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 22.0 m -76.41 -26.77 55.9 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -39.74 61.48 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.508 ' OE1' ' CE1' ' A' ' 165' ' ' TYR . 1.0 OUTLIER -66.92 -43.48 83.2 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.457 178.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -55.61 -26.75 45.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.94 75.46 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.188 -1.005 . . . . 0.0 108.325 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.68 -24.28 28.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.4 ' O ' ' OG ' ' A' ' 142' ' ' SER . 1.0 OUTLIER -68.78 -29.53 67.92 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.38 -22.75 35.3 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.67 -37.13 31.38 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 120.88 -1.137 . . . . 0.0 110.8 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 167' ' ' ASN . 4.5 m -73.32 -24.64 60.41 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.915 -1.116 . . . . 0.0 108.236 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 138' ' ' ASN . 3.2 m -55.63 -28.95 58.19 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -87.08 -28.49 22.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.469 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.41 -7.43 24.63 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 117' ' ' MET . 21.6 t -48.75 110.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.181 -1.188 . . . . 0.0 109.811 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.647 HD12 ' OD1' ' A' ' 237' ' ' ASN . 3.5 tp -68.23 96.46 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.953 . . . . 0.0 108.794 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.0 t -88.05 154.66 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.064 -1.022 . . . . 0.0 109.916 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.8 OUTLIER -140.87 104.24 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.645 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -92.96 148.22 22.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.902 . . . . 0.0 110.469 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.01 169.58 9.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.417 -0.802 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB2' ' CG2' ' A' ' 214' ' ' THR . 0.1 OUTLIER -61.32 -79.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 110.015 -179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.573 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . -168.68 -68.5 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.722 -1.228 . . . . 0.0 110.192 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 152' ' ' GLY . 19.4 t-20 88.98 6.4 0.14 Allowed 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.301 0.572 . . . . 0.0 109.822 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 153' ' ' ASN . 27.6 t 175.59 74.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . -132.76 -101.93 0.81 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.507 ' N ' ' HG2' ' A' ' 185' ' ' GLN . . . 178.61 78.99 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.348 -1.089 . . . . 0.0 109.605 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' TYR . . . 56.26 13.49 7.21 Favored Glycine 0 C--N 1.288 -2.136 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.38 147.52 33.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.122 -1.222 . . . . 0.0 109.049 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.65 HG23 ' HA ' ' A' ' 186' ' ' TYR . 4.5 pt -74.56 176.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.989 -1.069 . . . . 0.0 109.85 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.932 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -102.58 165.8 10.88 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.798 . . . . 0.0 112.082 -177.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.496 ' O ' ' HA3' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -80.29 144.48 58.09 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 174.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 42.8 Cg_endo -72.97 -28.09 7.45 Favored 'Cis proline' 0 C--N 1.289 -2.579 0 O-C-N 122.676 0.829 . . . . 0.0 110.581 3.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.932 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.13 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.741 -177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.569 ' N ' ' O ' ' A' ' 162' ' ' PRO . 19.3 ttp180 -67.95 -52.4 36.42 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.711 -1.243 . . . . 0.0 109.553 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -41.08 -178.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.645 1.212 . . . . 0.0 111.269 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -121.38 -0.38 9.85 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.502 ' HB3' ' OG1' ' A' ' 141' ' ' THR . 1.9 m-80 -87.12 22.51 2.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.438 -0.789 . . . . 0.0 109.427 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -171.32 145.91 2.23 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.422 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 29.8 mtp -81.4 152.95 27.19 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.008 -1.057 . . . . 0.0 109.938 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.16 132.56 55.98 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.9 t -99.24 165.63 2.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.032 -1.043 . . . . 0.0 110.136 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.576 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.53 173.69 20.38 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -135.02 152.38 51.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -1.221 . . . . 0.0 109.552 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 p -116.39 163.1 16.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.22 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 178' ' ' ASN . 12.8 p-10 -62.38 179.01 0.35 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.036 -1.04 . . . . 0.0 109.248 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -53.93 -29.66 43.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 109.302 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -94.03 -90.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.422 -0.799 . . . . 0.0 109.647 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 175' ' ' ASP . 7.0 t30 -150.02 -20.94 0.25 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.196 -0.94 . . . . 0.0 111.091 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.48 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.3 t30 -56.57 -160.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.711 -1.243 . . . . 0.0 109.647 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.579 ' HG2' ' CD1' ' A' ' 256' ' ' LEU . 0.3 OUTLIER -93.73 135.83 34.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.194 -0.941 . . . . 0.0 109.024 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 180' ' ' ARG . . . -43.59 161.75 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.203 -0.936 . . . . 0.0 109.16 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -101.37 12.52 37.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 109.564 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.577 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -153.32 29.9 0.49 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 110.082 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.423 ' OG ' ' CG2' ' A' ' 214' ' ' THR . 9.1 t -121.21 156.77 31.7 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.257 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -120.5 137.32 54.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.667 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 1.08 ' CD2' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -141.04 176.98 8.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.547 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 137.91 133.27 3.1 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.338 -1.41 . . . . 0.0 111.064 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . 35.65 102.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.12 -0.635 . . . . 0.0 111.613 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 159' ' ' ILE . . . 116.81 -5.25 18.66 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.77 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.08 HD22 ' CD2' ' A' ' 186' ' ' TYR . 8.9 tp -61.72 107.89 0.9 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.878 -1.366 . . . . 0.0 110.237 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 25.0 t70 -75.9 -56.63 4.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.48 ' HA ' ' CB ' ' A' ' 259' ' ' SER . 2.5 tt -149.1 169.75 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.106 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 260' ' ' GLY . 10.0 m -123.26 164.47 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.175 -0.953 . . . . 0.0 109.651 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -163.44 177.96 1.67 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.337 -0.852 . . . . 0.0 109.025 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.8 Cg_endo -76.49 116.98 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.257 1.971 . . . . 0.0 110.408 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -134.63 54.95 0.74 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 37.4 t -149.01 101.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.524 -0.986 . . . . 0.0 108.586 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.627 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.3 OUTLIER 73.91 107.11 0.07 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.125 0.964 . . . . 0.0 111.276 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.704 HG22 ' CB ' ' A' ' 212' ' ' ASN . 17.4 m -163.41 109.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 16.9 pt20 -84.7 148.16 26.53 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.608 0.718 . . . . 0.0 110.773 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.61 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -145.31 -151.56 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.422 HG21 ' CG ' ' A' ' 40' ' ' ASP . 74.2 p -90.18 172.11 9.03 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.21 -0.931 . . . . 0.0 110.365 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.648 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -159.99 164.49 19.9 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.648 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -70.63 164.02 36.91 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.948 1.765 . . . . 0.0 110.393 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.85 21.84 78.88 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.76 32.42 22.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -1.114 . . . . 0.0 109.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -118.32 150.94 38.65 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.049 -1.032 . . . . 0.0 109.817 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -92.74 172.45 8.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -145.68 118.21 8.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.071 -1.018 . . . . 0.0 109.868 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.5 OUTLIER -91.19 111.56 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 109.355 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 211' ' ' LEU . 0.6 OUTLIER -175.47 147.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.021 . . . . 0.0 110.361 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.704 ' CB ' HG22 ' A' ' 199' ' ' VAL . 11.3 t-20 -136.11 -162.86 1.32 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.859 0.838 . . . . 0.0 109.161 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 150.73 -174.78 29.97 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 0.1 OUTLIER -70.54 -42.33 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -1.132 . . . . 0.0 109.703 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.45 ' HA ' ' CB ' ' A' ' 150' ' ' ALA . 1.4 m -66.07 -16.07 63.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.405 -0.809 . . . . 0.0 110.403 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.553 ' HB3' ' OD1' ' A' ' 212' ' ' ASN . 1.5 mpp? -91.07 -16.6 27.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.917 -1.115 . . . . 0.0 109.754 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.639 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -87.64 -13.18 43.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 108.688 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.643 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 2.6 m -63.07 -43.84 82.77 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.63 -0.669 . . . . 0.0 111.349 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.804 ' HG2' HG21 ' A' ' 69' ' ' THR . 29.2 Cg_endo -72.75 -26.7 15.71 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.123 1.882 . . . . 0.0 111.583 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.598 ' NE2' HG23 ' A' ' 69' ' ' THR . 16.7 m170 -67.11 -45.55 76.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.869 -1.144 . . . . 0.0 108.177 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 262' ' ' VAL . 67.2 t -67.63 -45.74 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.512 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -54.18 -33.93 59.27 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -64.74 -52.46 42.33 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.9 -61.12 2.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -1.076 . . . . 0.0 109.168 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 244' ' ' LEU . . . -47.47 -26.73 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -64.75 -59.21 4.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 226' ' ' ALA . 4.8 mt -46.48 -36.91 7.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 108.45 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.16 -56.36 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.609 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.572 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.38 -39.32 6.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.161 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -48.5 81.48 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.298 -0.876 . . . . 0.0 109.02 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 0.0 OUTLIER -67.26 -7.45 24.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.599 ' HB3' ' CG ' ' A' ' 235' ' ' TRP . 81.9 m-20 -160.21 78.88 2.56 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.391 -0.818 . . . . 0.0 109.296 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.4 -28.4 3.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.636 2.224 . . . . 0.0 111.099 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.85 0.68 54.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 110.066 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.599 ' CG ' ' HB3' ' A' ' 232' ' ' ASN . 11.9 m0 -71.56 -178.69 2.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.169 -0.957 . . . . 0.0 109.674 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.62 167.71 10.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.552 -0.718 . . . . 0.0 110.214 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.647 ' OD1' HD12 ' A' ' 146' ' ' LEU . 17.2 t-20 -51.2 -39.85 57.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.471 -0.768 . . . . 0.0 109.543 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.0 t -74.08 -59.34 3.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.278 -0.888 . . . . 0.0 109.465 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 238' ' ' VAL . 8.1 tp-100 -39.76 -36.56 0.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.305 0.574 . . . . 0.0 110.121 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 66.6 mt -77.87 -46.52 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 110.43 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 15.8 ttp180 -52.81 -40.47 63.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.919 -1.113 . . . . 0.0 110.523 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -63.14 -35.19 79.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.195 -0.941 . . . . 0.0 110.612 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -71.62 -43.21 66.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.984 -1.072 . . . . 0.0 110.389 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 225' ' ' ALA . 0.4 OUTLIER -77.22 -22.48 52.21 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.117 -0.99 . . . . 0.0 110.245 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -82.77 -24.59 33.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.03 -1.044 . . . . 0.0 109.352 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -90.2 -21.87 21.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.918 . . . . 0.0 109.214 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 248' ' ' ALA . 2.3 p -87.66 -29.72 20.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.218 -0.926 . . . . 0.0 110.055 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -40.02 116.43 0.65 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.844 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.535 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 1.0 OUTLIER -65.76 163.77 15.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.211 -0.93 . . . . 0.0 109.214 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.501 ' N ' ' CG2' ' A' ' 249' ' ' THR . 5.9 p -115.78 114.46 24.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.337 -0.852 . . . . 0.0 109.524 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.662 HD11 ' HB2' ' A' ' 261' ' ' LEU . 5.8 mp -63.26 -69.92 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.22 -0.925 . . . . 0.0 109.717 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 161.7 57.42 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.639 ' HB2' ' CD2' ' A' ' 257' ' ' TYR . 10.1 t -118.1 177.66 4.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.29 -1.124 . . . . 0.0 109.492 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.402 ' N ' ' OG ' ' A' ' 253' ' ' SER . 0.8 OUTLIER -114.53 -22.29 9.87 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.35 -0.843 . . . . 0.0 110.344 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.443 ' ND2' ' C ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -179.03 -24.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.743 -1.223 . . . . 0.0 111.169 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.579 ' CD1' ' HG2' ' A' ' 180' ' ' ARG . 2.7 tm? -53.35 -63.95 0.98 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.6 -1.312 . . . . 0.0 108.923 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.67 ' O ' HD23 ' A' ' 190' ' ' LEU . 4.7 m-85 -65.58 -47.31 76.2 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.434 ' C ' ' OG ' ' A' ' 259' ' ' SER . . . 55.89 58.36 14.49 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.48 ' CB ' ' HA ' ' A' ' 192' ' ' ILE . 0.0 OUTLIER 171.18 -84.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -1.191 . . . . 0.0 109.093 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 193' ' ' VAL . . . 132.35 -163.3 24.02 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.662 ' HB2' HD11 ' A' ' 251' ' ' LEU . 5.0 tp -98.11 177.93 5.25 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.707 -0.878 . . . . 0.0 109.257 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 221' ' ' VAL . 0.6 OUTLIER -110.22 155.58 11.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.358 -0.839 . . . . 0.0 110.208 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.535 ' ND2' ' OG1' ' A' ' 249' ' ' THR . 0.1 OUTLIER -150.72 116.42 5.5 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.884 1.326 . . . . 0.0 108.657 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -79.78 -25.39 40.96 Favored 'General case' 0 C--N 1.273 -2.737 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.622 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.459 ' O ' ' OE2' ' A' ' 265' ' ' GLU . 7.6 tp10 -71.78 -41.89 67.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.589 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -76.55 0.76 18.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -113.69 -3.61 13.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.804 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.52 -35.85 4.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.917 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.469 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.71 142.74 44.39 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.481 -0.762 . . . . 0.0 109.269 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.693 ' HB2' ' N ' ' A' ' 80' ' ' LEU . 1.9 p -65.97 89.07 0.12 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.972 -1.08 . . . . 0.0 110.585 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 3' ' ' SER . 0.1 OUTLIER -165.64 73.46 1.33 Allowed Pre-proline 0 C--N 1.291 -1.969 0 O-C-N 121.432 -0.792 . . . . 0.0 109.169 179.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' HD2' ' CG1' ' A' ' 8' ' ' ILE . 34.7 Cg_endo -77.46 165.31 27.54 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.51 2.14 . . . . 0.0 110.29 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -39.08 -29.21 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.665 -0.647 . . . . 0.0 110.176 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 5' ' ' PRO . . . -68.35 -62.64 4.02 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.57 ' O ' ' CB ' ' A' ' 9' ' ' SER . 47.0 mm -62.62 159.97 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.329 -1.1 . . . . 0.0 109.515 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.634 ' OG ' HG12 ' A' ' 4' ' ' VAL . 4.4 m 89.38 -34.86 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.888 -0.508 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.77 -27.89 61.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.095 -1.003 . . . . 0.0 109.297 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.1 m -92.69 22.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.28 -0.887 . . . . 0.0 109.662 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.497 ' HG2' ' CB ' ' A' ' 265' ' ' GLU . 6.8 tp-100 52.89 49.41 20.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 109.669 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.697 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.51 -30.24 0.44 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 112.053 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.697 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.32 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.949 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.88 -31.19 0.81 Allowed 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HB1' HD13 ' A' ' 227' ' ' LEU . . . -66.1 -55.81 14.63 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.263 -0.898 . . . . 0.0 108.579 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.409 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 9.8 m-70 -66.35 -8.25 24.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.461 -0.775 . . . . 0.0 109.563 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -83.81 -35.95 23.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.0 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.5 5.91 8.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 110.088 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.85 43.73 5.95 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 2.2 mm? -99.71 133.67 43.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -1.094 . . . . 0.0 109.101 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.503 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -120.35 -37.96 2.97 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.494 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 230' ' ' GLN . . . 81.31 -22.01 5.62 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 t -49.47 110.82 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.046 -1.267 . . . . 0.0 109.078 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.73 -11.06 1.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG12 ' N ' ' A' ' 27' ' ' LYS . 48.2 t -110.57 170.04 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -1.235 . . . . 0.0 109.314 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 3.1 mttt -139.97 131.24 26.65 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.248 -0.908 . . . . 0.0 109.364 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 119' ' ' VAL . 48.7 t -124.34 145.29 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.072 -1.018 . . . . 0.0 110.448 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -101.97 146.77 27.41 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.905 HG11 HD11 ' A' ' 35' ' ' ILE . 25.6 t -120.63 79.89 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.201 -0.937 . . . . 0.0 109.27 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.752 HD12 ' CG2' ' A' ' 91' ' ' VAL . 4.8 mp -65.83 93.65 0.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -147.03 -156.43 0.71 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 20.7 p -67.53 -24.75 65.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 110.355 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 161.05 -105.32 0.26 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.905 HD11 HG11 ' A' ' 30' ' ' VAL . 10.3 mt 135.65 101.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.0 OUTLIER -71.88 139.22 48.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -55.18 165.94 0.64 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.259 -0.901 . . . . 0.0 109.935 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.626 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -177.24 160.51 1.45 Allowed Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.161 -0.962 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.4 Cg_endo -78.49 -23.5 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.646 2.231 . . . . 0.0 110.181 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 73' ' ' LEU . 1.4 t0 -102.48 -2.98 27.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 73' ' ' LEU . 14.1 mt -102.46 160.88 14.17 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.266 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.51 119.35 37.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.405 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 43' ' ' ILE . 6.7 mm -123.48 96.34 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.679 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -90.57 -28.73 18.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 108.951 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.94 -176.1 38.22 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.64 128.46 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.192 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -131.51 165.1 24.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.444 -1.033 . . . . 0.0 108.551 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.501 ' OG ' ' CG ' ' A' ' 51' ' ' PRO . 46.2 t -149.1 142.59 25.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.084 . . . . 0.0 110.486 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.631 ' CG ' ' HB2' ' A' ' 107' ' ' GLN . 23.5 m-85 -123.92 -35.63 2.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.944 HG23 ' CB ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -41.96 -53.8 7.83 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.563 -0.71 . . . . 0.0 109.754 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.621 ' HB2' ' CD ' ' A' ' 54' ' ' PRO . 39.1 Cg_endo -81.46 -160.4 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.981 2.454 . . . . 0.0 111.633 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . -124.13 40.23 1.98 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.71 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 9.7 tp10 77.39 33.2 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.269 -1.136 . . . . 0.0 112.952 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 37.5 Cg_endo -80.67 -72.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.74 1.627 . . . . 0.0 109.954 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 m -137.61 139.63 40.46 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -111.69 2.07 17.04 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 58' ' ' ASP . 5.5 mm-40 -103.72 156.21 17.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.72 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 8.8 t70 55.13 166.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 109.611 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 58' ' ' ASP . . . -171.78 -54.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' CG ' ' N ' ' A' ' 61' ' ' GLY . 2.1 t30 -165.78 -83.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -1.077 . . . . 0.0 108.985 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' N ' ' CG ' ' A' ' 60' ' ' ASN . . . -175.74 -34.17 0.04 OUTLIER Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.439 ' C ' ' CD2' ' A' ' 62' ' ' HIS . 3.0 t-160 -58.84 -64.73 0.83 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.406 -1.055 . . . . 0.0 109.531 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 32' ' ' ASP . . . -47.67 -67.38 1.56 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.447 ' HA ' HG12 ' A' ' 35' ' ' ILE . 2.0 m -40.11 -52.37 2.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 2.6 t-80 -52.81 -50.78 62.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.858 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.743 HG12 HD11 ' A' ' 70' ' ' ILE . 24.3 t -57.49 -32.65 42.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.393 -0.817 . . . . 0.0 109.231 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -59.52 -51.05 71.52 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.296 -0.877 . . . . 0.0 109.696 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -72.85 -17.88 78.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.539 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 6.4 m -80.65 -17.28 51.73 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.168 -1.195 . . . . 0.0 108.246 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.743 HD11 HG12 ' A' ' 66' ' ' VAL . 23.1 mt -92.62 -31.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.615 -0.678 . . . . 0.0 109.944 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' O ' ' C ' ' A' ' 72' ' ' ALA . . . -174.55 33.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.38 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -37.27 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.21 -0.931 . . . . 0.0 109.665 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 41' ' ' LEU . 12.8 mt -39.85 159.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.558 -0.714 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.987 ' HB2' HD12 ' A' ' 80' ' ' LEU . 7.6 t-20 -114.72 166.29 11.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.917 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 74' ' ' ASN . 0.4 OUTLIER 172.18 -93.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.407 -0.808 . . . . 0.0 109.28 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 -38.17 0.77 Allowed 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.762 -0.586 . . . . 0.0 109.48 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.518 HD11 ' HG2' ' A' ' 39' ' ' PRO . 4.4 pt -111.2 168.95 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.159 -0.963 . . . . 0.0 109.812 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 70.01 155.31 1.28 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.588 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 20.0 m -75.4 -154.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.276 -1.132 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.987 HD12 ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -145.9 122.35 11.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.482 -0.761 . . . . 0.0 109.423 -178.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.75 -163.79 4.07 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 4.7 t -82.57 -36.84 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.325 . . . . 0.0 109.241 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.0 147.17 32.6 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.3 Cg_endo -83.61 -61.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.873 2.382 . . . . 0.0 110.407 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' ' 86' ' ' ALA . 6.6 m120 -99.53 -87.87 0.35 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.01 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 57.26 157.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.866 . . . . 0.0 109.701 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' HG3' ' CE ' ' A' ' 27' ' ' LYS . 20.5 mm-40 -108.97 94.74 5.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 108.774 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.535 HD11 ' HB ' ' A' ' 70' ' ' ILE . 2.5 mt -79.98 150.75 30.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.07 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.519 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 3.9 m-85 -127.29 154.48 44.86 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.429 -0.794 . . . . 0.0 109.141 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.444 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -123.73 104.09 8.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 109.068 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.752 ' CG2' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -108.03 78.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.309 -0.869 . . . . 0.0 109.773 -178.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 33' ' ' THR . 10.8 tttt -44.75 96.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.9 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.594 HG11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -114.02 -9.8 12.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.249 -0.907 . . . . 0.0 109.084 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.3 mt -115.62 174.11 6.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.348 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -111.19 147.83 17.84 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.2 -60.34 4.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -1.117 . . . . 0.0 109.666 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.23 -38.27 11.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.46 67.15 0.45 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -174.53 97.22 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.455 -1.026 . . . . 0.0 108.945 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -111.62 -179.3 20.06 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.35 155.99 28.61 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.801 -0.823 . . . . 0.0 109.8 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.21 -15.25 19.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.557 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -72.27 -27.77 62.7 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.944 ' CB ' HG23 ' A' ' 50' ' ' VAL . 65.8 p -80.03 -53.47 6.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 109.34 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.585 ' HA ' HG21 ' A' ' 93' ' ' VAL . 2.2 mt -61.55 -33.48 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.458 -0.776 . . . . 0.0 109.094 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.445 ' O ' ' CD ' ' A' ' 110' ' ' GLU . . . -65.17 -46.44 80.85 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.528 -0.732 . . . . 0.0 110.0 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.631 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -68.31 -40.86 81.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.558 -1.339 . . . . 0.0 108.873 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . -61.77 -21.05 60.36 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 109' ' ' LEU . 19.7 mt -92.98 -51.01 5.26 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.903 -1.351 . . . . 0.0 110.579 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.445 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 0.6 OUTLIER -76.56 -6.97 54.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.862 -1.149 . . . . 0.0 109.646 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.652 ' CZ3' ' HA2' ' A' ' 116' ' ' GLY . 70.9 t90 -89.47 -9.76 48.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.713 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.55 -11.93 44.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.53 -0.731 . . . . 0.0 109.515 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -86.95 -22.93 43.52 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.13 -76.98 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.151 -1.205 . . . . 0.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -110.01 10.34 24.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.277 -0.889 . . . . 0.0 110.925 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -104.46 52.13 0.76 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 118.976 -1.583 . . . . 0.0 110.011 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.626 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 37.91 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.189 0.995 . . . . 0.0 112.905 178.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.763 ' O ' HG13 ' A' ' 145' ' ' VAL . 0.1 OUTLIER -94.72 -29.14 14.95 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.369 -176.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.746 HG22 ' NE2' ' A' ' 118' ' ' HIS . 1.9 t -97.43 153.82 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.323 -1.486 . . . . 0.0 109.004 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 147' ' ' VAL . . . -169.23 113.71 0.55 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 108.963 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 1.05 ' C ' HD13 ' A' ' 122' ' ' LEU . 2.3 m120 -112.36 152.98 27.96 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.05 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -136.56 121.66 19.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.277 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.407 ' CB ' ' NE2' ' A' ' 62' ' ' HIS . 18.2 m -85.59 66.35 9.61 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.9 178.8 9.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.704 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 160' ' ' SER . . . 156.23 113.33 0.42 Allowed Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.77 158.48 34.73 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.469 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 31.6 Cg_endo -74.71 -3.64 14.2 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.165 1.91 . . . . 0.0 108.646 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.7 t -117.66 76.33 10.27 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HD3' ' C ' ' A' ' 127' ' ' PRO . 33.8 Cg_endo -77.18 163.67 30.17 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.335 2.023 . . . . 0.0 110.909 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.29 146.27 46.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.449 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.89 -14.79 63.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.2 m -79.65 -23.59 42.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.6 tt -79.23 -40.39 30.78 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -75.61 -41.46 54.3 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.495 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -61.55 -23.6 66.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -72.07 -42.77 65.83 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 140' ' ' ALA . 2.1 t -68.81 -26.25 32.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.06 -33.11 75.02 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.5 -22.48 35.06 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -79.39 -19.21 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.08 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.45 -35.62 40.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.03 -1.044 . . . . 0.0 108.948 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.4 p -54.85 -30.63 58.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.11 -17.83 21.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 75.8 78.86 0.65 Allowed Glycine 0 N--CA 1.475 1.273 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 118' ' ' HIS . 48.6 t -119.17 111.95 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.361 -1.082 . . . . 0.0 109.387 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.63 102.74 0.6 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.926 -1.109 . . . . 0.0 109.268 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -98.73 143.55 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.191 -0.943 . . . . 0.0 109.55 -179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.536 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 0.9 OUTLIER -135.58 116.15 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.757 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -104.77 148.4 26.66 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.985 . . . . 0.0 109.614 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.58 162.46 25.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.402 -0.811 . . . . 0.0 109.226 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -69.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.0 109.877 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 160.72 -17.2 0.2 Allowed Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.542 -1.313 . . . . 0.0 111.309 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' A' ' 214' ' ' THR . 59.1 t-20 41.12 35.72 0.4 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.638 -0.919 . . . . 0.0 109.918 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -90.69 0.49 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -0.999 . . . . 0.0 109.683 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 156.22 70.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -130.67 170.4 14.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -1.109 . . . . 0.0 109.296 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.91 52.82 4.61 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.0 OUTLIER 162.77 170.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -1.123 . . . . 0.0 109.121 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.432 HG12 ' HA3' ' A' ' 187' ' ' GLY . 0.6 OUTLIER -89.07 -177.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.159 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.882 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -102.46 166.67 10.41 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.773 0.797 . . . . 0.0 111.595 -178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.566 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 2.4 m-85 -85.39 144.86 41.23 Favored Pre-proline 0 C--N 1.301 -1.5 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 174.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.757 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 45.2 Cg_endo -75.21 -31.02 5.59 Favored 'Cis proline' 0 C--N 1.293 -2.346 0 O-C-N 122.429 0.699 . . . . 0.0 111.016 3.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -17.78 -47.72 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.587 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -52.57 -54.8 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.078 -1.014 . . . . 0.0 110.583 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.558 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -42.36 -178.8 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 122.558 1.171 . . . . 0.0 111.229 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.75 0.81 8.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.587 -0.696 . . . . 0.0 110.043 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -91.11 21.56 4.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.091 -1.006 . . . . 0.0 108.865 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -158.23 171.14 20.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.419 ' HA ' ' CG ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -112.23 132.49 54.9 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.013 -1.075 . . . . 0.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -106.87 123.07 47.63 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 172' ' ' GLY . 25.4 t -90.34 166.13 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -137.94 166.81 25.06 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -117.15 140.84 49.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -1.144 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.408 HG23 ' HB ' ' A' ' 193' ' ' VAL . 11.7 p -109.23 174.65 5.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.91 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.25 -147.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.828 . . . . 0.0 109.652 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -69.62 -53.45 18.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -86.23 -82.75 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.923 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.535 ' HB2' ' CD2' ' A' ' 251' ' ' LEU . 33.4 p-10 -166.23 43.07 0.06 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -105.93 166.44 10.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 109.632 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' NH2' HG11 ' A' ' 193' ' ' VAL . 0.5 OUTLIER -72.74 106.38 4.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.824 ' HB3' ' HB3' ' A' ' 184' ' ' SER . . . -43.55 130.9 5.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 109.43 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.6 m -60.75 -30.36 69.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.086 -1.009 . . . . 0.0 110.038 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.553 ' CD2' ' OD1' ' A' ' 153' ' ' ASN . 0.2 OUTLIER -92.54 -14.43 28.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.964 . . . . 0.0 109.918 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.824 ' HB3' ' HB3' ' A' ' 181' ' ' ALA . 11.5 t -76.99 154.89 33.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.358 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -104.23 140.41 37.88 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CE2' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -123.9 171.19 9.88 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.418 -0.801 . . . . 0.0 109.339 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.587 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.51 142.31 4.48 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.37 118.47 6.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -1.122 . . . . 0.0 109.185 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 122.9 -6.53 9.53 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.8 HD23 ' O ' ' A' ' 257' ' ' TYR . 49.3 tp -45.81 154.63 0.21 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.181 -1.188 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.5 OUTLIER -99.51 -55.53 2.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.145 -0.972 . . . . 0.0 110.957 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.454 ' CD1' HG13 ' A' ' 262' ' ' VAL . 3.5 tt -151.87 172.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 0.0 109.872 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.477 HG11 ' NH2' ' A' ' 180' ' ' ARG . 8.3 m -136.83 166.83 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.207 -0.933 . . . . 0.0 109.292 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.736 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -168.99 167.71 5.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 109.169 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.736 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.99 117.24 4.12 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.481 2.121 . . . . 0.0 110.284 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -142.6 22.08 2.36 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 31.6 t -89.01 58.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -1.149 . . . . 0.0 109.472 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.775 ' O ' HG13 ' A' ' 199' ' ' VAL . 17.8 t-20 131.69 122.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 198' ' ' ASN . 4.8 m -167.01 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.075 0.94 . . . . 0.0 109.075 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 29.3 mt-30 -87.41 141.52 28.57 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.597 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.588 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -148.7 -147.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -96.4 166.4 11.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.278 -0.889 . . . . 0.0 110.017 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.652 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.11 159.13 40.62 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.652 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.6 Cg_endo -71.71 167.4 26.63 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.41 2.073 . . . . 0.0 110.325 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 77.76 4.04 84.71 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 78.04 33.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.499 -1.0 . . . . 0.0 109.404 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -127.89 157.59 40.1 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.106 -0.996 . . . . 0.0 109.708 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -94.98 179.55 5.18 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 109.062 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.601 ' HB2' ' CG ' ' A' ' 203' ' ' TYR . . . -156.54 178.55 10.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.844 -1.16 . . . . 0.0 110.914 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.731 ' O ' HD23 ' A' ' 211' ' ' LEU . 55.0 p -159.72 110.54 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 210' ' ' SER . 1.7 mt -126.7 162.69 25.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.119 -0.988 . . . . 0.0 110.151 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 212' ' ' ASN . 2.1 p-10 -129.46 125.1 35.66 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.544 ' HA2' ' CE2' ' A' ' 183' ' ' PHE . . . 175.32 159.46 21.42 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.645 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -61.6 -30.2 70.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.644 -0.916 . . . . 0.0 109.291 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 13.7 m -61.13 -27.3 68.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.485 ' HG2' ' CG2' ' A' ' 199' ' ' VAL . 0.7 OUTLIER -74.54 -24.32 58.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.335 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.476 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -85.38 -24.71 27.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.783 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.598 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 96.5 m -53.35 -44.33 97.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 111.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.0 Cg_endo -73.95 -24.56 15.08 Favored 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.727 1.618 . . . . 0.0 110.847 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -62.35 -41.23 98.42 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.416 HG21 HG21 ' A' ' 192' ' ' ILE . 42.2 t -71.27 -48.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -49.24 -28.59 4.78 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.4 -58.5 4.22 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.28 -61.24 2.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -1.162 . . . . 0.0 109.289 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 229' ' ' LYS . . . -47.03 -41.75 17.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.556 -0.715 . . . . 0.0 109.984 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.422 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . . . -55.6 -44.23 76.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.392 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.589 HD13 ' HB1' ' A' ' 16' ' ' ALA . 22.4 mt -57.9 -47.22 83.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.815 . . . . 0.0 109.227 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 46.9 t -55.94 -52.85 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.158 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 233' ' ' PRO . 0.0 OUTLIER -49.21 -38.95 27.94 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.465 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -60.1 -54.1 49.96 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.011 -1.056 . . . . 0.0 108.714 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -51.36 -20.97 1.95 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 108.551 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 176.82 89.29 0.11 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 109.729 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.554 ' N ' ' O ' ' A' ' 229' ' ' LYS . 36.4 Cg_endo -79.98 -24.88 5.49 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.792 2.328 . . . . 0.0 110.221 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.8 m -53.2 -21.54 5.32 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.399 -0.813 . . . . 0.0 109.432 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -56.99 176.56 0.1 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.167 -0.958 . . . . 0.0 109.282 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.993 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.6 OUTLIER -105.24 171.72 7.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.351 -0.843 . . . . 0.0 110.023 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 237' ' ' ASN . 7.0 m-80 -55.72 -45.95 77.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.488 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 239' ' ' GLN . 3.3 t -74.33 -51.53 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -40.72 -41.16 1.47 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.491 0.662 . . . . 0.0 109.345 -178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 236' ' ' SER . 2.9 mt -74.46 -45.08 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.463 ' O ' ' C ' ' A' ' 242' ' ' ASN . 1.6 ttm-85 -47.96 -71.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.463 ' C ' ' O ' ' A' ' 241' ' ' ARG . 1.2 m-80 -35.15 -36.63 0.06 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.812 -0.555 . . . . 0.0 110.701 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.736 ' O ' HG23 ' A' ' 247' ' ' THR . 1.4 t60 -69.0 -52.63 26.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.0 109.522 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.488 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.0 OUTLIER -66.91 -17.19 64.78 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.938 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.93 -45.32 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.3 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 246' ' ' ASN . 1.2 m-20 -91.15 -5.26 55.28 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.15 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 243' ' ' HIS . 70.5 p -103.33 -52.55 2.99 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.912 -1.117 . . . . 0.0 110.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -43.41 151.48 0.17 Allowed 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.791 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 250' ' ' SER . 31.5 m -70.68 157.64 37.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.404 ' N ' HG22 ' A' ' 249' ' ' THR . 54.7 p -129.7 111.47 12.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 178' ' ' ASN . 4.0 mp -50.5 -59.22 4.24 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.25 -0.906 . . . . 0.0 109.373 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -170.91 -69.5 0.04 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 56.7 m -60.21 173.78 0.61 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -1.169 . . . . 0.0 109.251 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 76.0 p -143.56 28.75 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.674 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -159.33 -40.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 256' ' ' LEU . 2.7 tm? -76.35 -65.5 0.92 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.439 -0.788 . . . . 0.0 109.094 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.8 ' O ' HD23 ' A' ' 190' ' ' LEU . 8.2 m-30 -64.08 -74.09 0.11 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.106 -0.996 . . . . 0.0 108.333 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 156.61 -177.26 33.66 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.6 t -46.74 -24.8 0.62 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 108.98 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 119.28 -137.49 12.67 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 261' ' ' LEU . 12.9 tp -102.47 169.1 8.88 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.989 . . . . 0.0 108.494 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.454 HG13 ' CD1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -111.27 157.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.878 -1.139 . . . . 0.0 110.311 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -164.94 118.08 1.25 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 122.458 1.123 . . . . 0.0 107.977 178.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.51 64.17 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.093 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.497 ' CB ' ' HG2' ' A' ' 12' ' ' GLN . 79.3 tt0 -68.96 -16.58 63.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.0 109.8 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -98.75 0.18 43.98 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.137 -0.977 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -132.49 1.32 3.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.129 -0.982 . . . . 0.0 110.156 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -101.67 -41.79 6.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.025 -1.047 . . . . 0.0 109.89 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.494 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.07 143.22 58.06 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.253 -0.904 . . . . 0.0 109.497 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.909 ' O ' HG13 ' A' ' 4' ' ' VAL . 51.9 m -62.05 111.92 2.13 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.941 -1.099 . . . . 0.0 110.056 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.909 HG13 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 178.3 66.2 0.1 Allowed Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 34.4 Cg_endo -76.67 173.98 13.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.457 2.105 . . . . 0.0 110.381 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.567 ' CH2' ' HB3' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -55.22 -11.94 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.588 -0.695 . . . . 0.0 110.899 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.66 -62.42 1.25 Allowed Glycine 0 N--CA 1.493 2.45 0 O-C-N 120.72 -1.238 . . . . 0.0 110.732 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 8' ' ' ILE . 0.7 OUTLIER -71.58 -0.78 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.114 -1.227 . . . . 0.0 110.247 -179.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 m -104.61 -15.86 15.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.855 -1.153 . . . . 0.0 109.726 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.46 0.32 50.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.903 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 11' ' ' VAL . 3.3 m -114.5 26.46 3.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 O-C-N 120.764 -1.21 . . . . 0.0 110.258 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' HG3' ' HB2' ' A' ' 265' ' ' GLU . 21.2 mm100 46.59 55.88 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -89.07 -30.05 0.36 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.49 -0.756 . . . . 0.0 112.364 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.694 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.2 Cg_endo -74.15 -55.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.035 0 N-CA-C 109.026 -1.182 . . . . 0.0 109.026 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 -29.08 1.66 Allowed 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.2 -39.52 40.37 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.91 -1.119 . . . . 0.0 109.161 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 27.4 m170 -65.76 -24.9 67.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.431 -0.793 . . . . 0.0 110.504 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -99.62 -16.68 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.787 -1.196 . . . . 0.0 110.631 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -66.55 0.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.017 -1.052 . . . . 0.0 109.742 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 1.056 ' C ' HD13 ' A' ' 21' ' ' LEU . . . 173.48 17.06 0.02 OUTLIER Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.814 -1.184 . . . . 0.0 111.591 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.056 HD13 ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -134.85 153.99 51.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.505 -1.585 . . . . 0.0 108.659 178.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -138.92 42.23 2.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' HA2' ' NE2' ' A' ' 230' ' ' GLN . . . 50.52 14.79 1.05 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.466 ' N ' ' C ' ' A' ' 22' ' ' THR . 0.6 OUTLIER -87.26 103.67 15.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -1.13 . . . . 0.0 109.884 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.74 -4.03 2.39 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.437 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG22 ' HD2' ' A' ' 229' ' ' LYS . 29.2 t -123.57 166.83 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 120.693 -1.475 . . . . 0.0 109.918 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -136.15 126.11 25.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.414 -0.804 . . . . 0.0 109.55 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 29' ' ' ALA . 57.8 t -113.41 161.79 12.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.513 -0.742 . . . . 0.0 109.708 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HB3' ' CB ' ' A' ' 120' ' ' ALA . . . -118.67 151.69 37.49 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.358 -0.838 . . . . 0.0 108.917 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.548 ' CG2' HD22 ' A' ' 88' ' ' LEU . 3.2 t -127.01 84.8 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.134 -0.979 . . . . 0.0 108.536 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.782 HD12 ' CG2' ' A' ' 91' ' ' VAL . 7.4 mp -73.13 93.46 1.82 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 25.4 p-10 -157.33 -161.78 1.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.973 -1.079 . . . . 0.0 109.891 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.797 HG22 ' HA ' ' A' ' 96' ' ' ALA . 40.9 p -41.57 -51.55 3.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.84 . . . . 0.0 109.978 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.76 -47.12 0.48 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.661 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.642 HG23 ' HA ' ' A' ' 64' ' ' THR . 3.9 mt 73.95 105.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -65.47 158.13 27.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 109.815 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 101.71 0.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -104.96 148.56 36.34 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.635 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 32.9 Cg_endo -75.63 -17.13 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.645 2.23 . . . . 0.0 110.583 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 41' ' ' LEU . 10.1 t70 -96.68 27.32 3.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.973 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.961 HD21 HG21 ' A' ' 202' ' ' THR . 13.9 mt -143.72 134.48 25.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.539 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.52 ' N ' ' HG ' ' A' ' 73' ' ' LEU . 26.4 t-20 -86.03 66.2 9.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.131 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 44' ' ' ARG . 3.4 mt -73.31 163.25 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 109.457 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -150.22 9.22 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.486 -0.759 . . . . 0.0 110.09 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.72 173.04 38.95 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 90' ' ' ALA . . . 177.88 116.33 0.48 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' ' CE1' ' A' ' 49' ' ' PHE . . . -116.06 163.92 15.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.355 -1.086 . . . . 0.0 109.365 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -122.39 113.66 19.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.215 -0.928 . . . . 0.0 110.111 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 47' ' ' ALA . 7.5 m-85 -110.67 -21.81 11.92 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.15 -0.969 . . . . 0.0 109.353 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.692 HG21 ' O ' ' A' ' 94' ' ' LEU . 1.4 t -63.72 126.09 89.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 110.005 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -80.6 154.26 20.69 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.358 2.038 . . . . 0.0 109.712 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.51 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 85.02 -60.89 4.75 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' O ' HG12 ' A' ' 50' ' ' VAL . 2.3 mt-10 -113.25 87.73 11.5 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.576 ' O ' ' C ' ' A' ' 55' ' ' SER . 31.8 Cg_endo -72.24 -72.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.793 2.329 . . . . 0.0 111.78 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.576 ' C ' ' O ' ' A' ' 54' ' ' PRO . 1.4 m -14.65 129.74 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.741 0.781 . . . . 0.0 111.709 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.409 ' HA ' ' HG3' ' A' ' 92' ' ' LYS . 7.7 t -103.89 -11.29 17.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.534 -0.729 . . . . 0.0 109.381 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 3.0 pm0 -81.57 110.54 17.04 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.89 . . . . 0.0 109.664 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 33.3 t70 63.18 153.17 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.441 -0.787 . . . . 0.0 110.45 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.456 ' HA3' ' HB ' ' A' ' 33' ' ' THR . . . -154.77 -63.44 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.43 ' OD1' ' HB1' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -131.74 -53.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -1.131 . . . . 0.0 109.305 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.19 -33.6 1.23 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.228 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -61.23 -48.09 83.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.24 . . . . 0.0 109.874 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.04 -43.58 96.86 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.642 ' HA ' HG23 ' A' ' 35' ' ' ILE . 59.9 m -61.0 -37.87 84.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.255 -1.144 . . . . 0.0 109.614 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.749 ' CD2' HD11 ' A' ' 211' ' ' LEU . 7.9 t-80 -63.68 -53.75 46.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.0 109.747 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.481 HG13 ' HB3' ' A' ' 219' ' ' PRO . 3.7 t -60.89 -28.45 43.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.42 -0.8 . . . . 0.0 109.29 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.598 ' HA ' HD12 ' A' ' 70' ' ' ILE . . . -63.23 -46.77 85.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.246 -0.909 . . . . 0.0 109.739 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -66.11 -42.84 94.25 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m -58.12 -24.98 60.76 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.189 -1.183 . . . . 0.0 109.059 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 67' ' ' ALA . 32.9 mt -82.85 -30.59 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.895 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 88' ' ' LEU . . . -137.6 -51.47 0.63 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.991 -1.068 . . . . 0.0 111.11 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.1 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 40.21 79.93 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 42' ' ' ASN . 13.6 mt -34.71 155.74 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.362 -0.836 . . . . 0.0 111.386 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.464 ' OD1' HD22 ' A' ' 80' ' ' LEU . 1.3 t30 -99.84 120.98 40.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.556 -0.715 . . . . 0.0 109.918 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.462 ' N ' ' ND2' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -167.47 -113.37 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.047 -1.033 . . . . 0.0 109.044 179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.03 -7.39 0.26 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.212 -0.93 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.5 pt -106.8 67.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 120.66 -1.275 . . . . 0.0 109.513 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.03 177.01 14.66 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.496 ' C ' ' OG ' ' A' ' 3' ' ' SER . 25.7 m -81.32 -166.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.304 -1.115 . . . . 0.0 109.84 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.85 ' N ' ' HB3' ' A' ' 3' ' ' SER . 15.8 tp -133.73 140.7 47.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.629 -0.669 . . . . 0.0 109.51 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 1.1 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -91.76 -169.02 41.2 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 227' ' ' LEU . 1.6 t -88.25 -36.71 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.93 -1.335 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -126.24 102.93 26.58 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.872 . . . . 0.0 109.12 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 42' ' ' ASN . 37.9 Cg_endo -84.75 -62.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.652 2.235 . . . . 0.0 109.858 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.62 -27.17 10.53 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.088 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -47.0 139.04 5.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 109.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.464 ' HG3' ' HD3' ' A' ' 44' ' ' ARG . 1.2 mp0 -74.79 97.35 3.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.263 -0.898 . . . . 0.0 109.225 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.548 HD22 ' CG2' ' A' ' 30' ' ' VAL . 2.7 mt -80.97 120.18 24.44 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.051 -1.031 . . . . 0.0 109.443 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.599 ' CG ' ' SD ' ' A' ' 117' ' ' MET . 11.9 m-85 -104.77 153.37 21.4 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.341 -0.85 . . . . 0.0 109.432 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.456 ' O ' ' HA2' ' A' ' 46' ' ' GLY . . . -115.21 101.9 9.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 108.882 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.782 ' CG2' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -96.98 67.11 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.252 -0.905 . . . . 0.0 109.309 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -37.58 95.94 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.484 0.659 . . . . 0.0 109.901 -179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 105' ' ' ILE . 3.3 t -113.7 -23.22 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.406 -0.809 . . . . 0.0 108.969 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.692 ' O ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -92.98 173.34 7.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.314 -0.866 . . . . 0.0 108.719 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.714 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -98.03 -17.69 29.17 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.797 ' HA ' HG22 ' A' ' 33' ' ' THR . . . 161.59 36.11 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 96' ' ' ALA . 2.5 m 80.97 8.73 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.68 -79.74 1.45 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -178.08 103.43 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -1.172 . . . . 0.0 109.434 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.48 178.64 51.57 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.13 152.51 42.27 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.892 -0.769 . . . . 0.0 110.336 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 133' ' ' LEU . 41.0 t -68.27 -19.43 24.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.2 t -75.03 -18.51 60.33 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.47 ' HA ' ' HG2' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -91.3 -37.19 13.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.505 -0.747 . . . . 0.0 109.426 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.588 HG23 HG11 ' A' ' 93' ' ' VAL . 1.1 mt -77.04 -26.94 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.76 -44.33 18.77 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.47 ' HG2' ' HA ' ' A' ' 104' ' ' SER . 10.1 pt20 -70.75 -31.11 67.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.266 -0.896 . . . . 0.0 109.009 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.93 -39.35 46.84 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.5 mt -62.25 -39.66 93.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -1.128 . . . . 0.0 109.462 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 110' ' ' GLU . 1.6 tp10 -78.42 -19.64 52.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.132 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.674 ' CE3' ' HA3' ' A' ' 116' ' ' GLY . 84.8 t90 -65.95 -25.09 66.96 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.914 -1.116 . . . . 0.0 109.098 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -88.45 -5.35 58.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.958 -1.089 . . . . 0.0 109.175 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -94.7 -6.59 60.69 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 19.7 t-20 -134.93 -4.71 2.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -1.159 . . . . 0.0 110.558 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 0.7 OUTLIER 171.11 30.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.803 -1.186 . . . . 0.0 110.697 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.747 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -138.88 57.99 0.62 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 118.951 -1.595 . . . . 0.0 111.298 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.785 ' HE3' ' H ' ' A' ' 117' ' ' MET . 0.0 OUTLIER 63.22 175.57 0.16 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.447 -1.031 . . . . 0.0 112.26 176.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.685 ' CD2' ' N ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -104.0 -35.38 8.13 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.486 ' HB ' HG22 ' A' ' 28' ' ' VAL . 3.4 t -98.34 156.18 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.662 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.719 ' CB ' ' HB3' ' A' ' 29' ' ' ALA . . . -172.37 131.01 0.59 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 108.966 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 1.039 ' C ' HD13 ' A' ' 122' ' ' LEU . 3.0 m120 -117.58 148.25 42.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 109.507 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.039 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -125.22 114.48 19.03 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.132 -0.98 . . . . 0.0 108.951 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.446 ' C ' HD23 ' A' ' 124' ' ' LEU . 2.8 t -86.5 61.61 6.92 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.612 HD21 ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -136.9 -173.71 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.872 0.844 . . . . 0.0 110.077 -178.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 170.4 100.52 0.14 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.6 m -97.68 149.45 35.73 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.144 -1.209 . . . . 0.0 109.83 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.2 -5.39 15.7 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.351 2.034 . . . . 0.0 108.374 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.3 t -110.14 112.09 57.7 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -74.87 165.23 31.86 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.944 1.763 . . . . 0.0 109.881 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.28 120.54 6.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 110.5 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.34 65.49 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 52.9 m -63.38 -29.19 70.53 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -75.52 -35.31 60.77 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -75.14 -25.14 58.17 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.761 -1.176 . . . . 0.0 109.137 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -73.63 -24.23 59.99 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -80.48 -40.88 25.36 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.072 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.546 HG11 ' CB ' ' A' ' 167' ' ' ASN . 1.7 t -68.3 -30.68 48.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -63.72 -35.9 82.08 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.465 ' OG ' ' OE2' ' A' ' 110' ' ' GLU . 0.1 OUTLIER -78.17 -21.23 50.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' A' ' 145' ' ' VAL . . . -76.56 -29.7 56.77 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.87 -1.144 . . . . 0.0 109.963 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -73.96 -24.21 59.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.197 -0.94 . . . . 0.0 108.541 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 m -57.74 -38.82 76.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 0.0 108.878 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.34 -14.42 16.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 108.878 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.63 81.52 0.99 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 118' ' ' HIS . 94.1 t -119.23 109.35 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 10.6 tp -74.59 116.8 15.69 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.612 HG12 HD21 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -109.08 144.54 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 0.0 109.572 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -129.45 111.42 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.225 -0.922 . . . . 0.0 109.041 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.827 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -94.33 148.59 22.06 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.802 . . . . 0.0 109.614 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.514 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -62.96 162.29 11.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.738 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 44.9 t -49.57 -72.62 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 110.721 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.677 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 133.15 133.67 3.41 Favored Glycine 0 C--O 1.207 -1.534 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -102.37 63.5 0.88 Allowed 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.617 ' O ' ' N ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -117.69 75.2 0.98 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.435 -178.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 154' ' ' SER . . . -3.33 -62.2 0.0 OUTLIER Glycine 0 N--CA 1.507 3.409 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 154' ' ' SER . . . -46.77 173.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -1.102 . . . . 0.0 109.561 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.14 58.62 4.23 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 m -143.17 134.76 26.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -1.154 . . . . 0.0 109.648 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.614 HD12 ' HB1' ' A' ' 163' ' ' ALA . 6.8 pt -87.19 177.68 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.194 -0.941 . . . . 0.0 109.536 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.972 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.5 OUTLIER -87.05 160.89 18.45 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.362 -0.836 . . . . 0.0 111.818 -178.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.462 ' CZ ' ' HD2' ' A' ' 164' ' ' ARG . 5.1 m-85 -83.5 141.99 42.67 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 175.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.827 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 45.0 Cg_endo -74.73 -30.75 5.77 Favored 'Cis proline' 0 C--N 1.3 -2.023 0 O-C-N 122.421 0.695 . . . . 0.0 111.489 3.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.972 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -15.72 -50.21 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 CA-C-O 121.124 0.488 . . . . 0.0 111.87 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' A' ' 162' ' ' PRO . 10.9 ttm180 -50.39 -59.76 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.172 -0.955 . . . . 0.0 110.36 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.533 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -46.34 -173.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.462 1.125 . . . . 0.0 111.046 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.93 -2.55 9.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.551 -0.718 . . . . 0.0 110.187 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.546 ' CB ' HG11 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -81.65 7.9 11.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.069 -1.019 . . . . 0.0 109.398 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . . . -153.77 139.99 18.49 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.544 ' SD ' HG23 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -85.28 146.66 26.94 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.013 -1.054 . . . . 0.0 109.626 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -109.73 123.76 50.06 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.3 t -84.3 166.08 2.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.965 -1.085 . . . . 0.0 109.764 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.577 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -129.85 -176.67 14.52 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.491 ' CB ' HG23 ' A' ' 214' ' ' THR . . . -134.35 150.03 50.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -1.2 . . . . 0.0 109.543 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 179' ' ' ASN . 71.0 p -134.21 153.35 51.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -172.05 1.86 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.909 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -23.56 64.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.054 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.79 -87.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.582 ' ND2' HD21 ' A' ' 251' ' ' LEU . 0.3 OUTLIER 177.13 68.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.115 -0.99 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.686 ' O ' HG22 ' A' ' 174' ' ' THR . 7.7 t-20 -136.35 -161.21 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.662 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 2.5 mtp85 -87.87 12.51 12.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.979 . . . . 0.0 109.748 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 72.2 4.42 5.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 64.56 -6.61 0.29 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.389 -0.819 . . . . 0.0 112.195 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.488 ' CE2' ' HB1' ' A' ' 181' ' ' ALA . 39.3 p90 -134.89 -5.58 2.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.318 -1.489 . . . . 0.0 110.286 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 38.3 t -78.08 132.17 37.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.012 -1.055 . . . . 0.0 108.403 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.677 ' HB2' ' O ' ' A' ' 152' ' ' GLY . 0.8 OUTLIER -88.79 149.29 23.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.944 -1.097 . . . . 0.0 110.83 -178.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.655 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -121.68 176.44 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 108.918 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.655 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 177.53 178.62 47.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.46 145.45 50.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.248 . . . . 0.0 109.577 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 80.61 7.8 88.19 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.36 141.03 58.7 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.127 -1.22 . . . . 0.0 108.719 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.543 ' OD1' ' CE ' ' A' ' 245' ' ' LYS . 35.9 t0 -84.4 -79.75 0.21 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.031 -1.043 . . . . 0.0 110.935 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.484 ' CG2' ' C ' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -154.13 -161.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.072 . . . . 0.0 110.151 -178.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 260' ' ' GLY . 26.9 m -124.94 168.91 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 109.908 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 1.026 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -159.92 177.2 2.16 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.946 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.7 Cg_endo -76.47 115.99 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.173 1.915 . . . . 0.0 110.571 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.31 53.44 0.65 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 39.0 t -138.12 87.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 199' ' ' VAL . 7.6 t30 81.53 119.88 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 198' ' ' ASN . 4.3 m -162.35 114.43 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-O 122.078 0.942 . . . . 0.0 108.974 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -76.31 122.84 25.01 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.751 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -131.72 -169.54 2.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.524 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.961 HG21 HD21 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.89 173.4 12.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.307 -0.871 . . . . 0.0 110.307 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.654 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -151.36 166.95 14.01 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.654 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.3 Cg_endo -73.45 166.11 30.71 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.127 1.885 . . . . 0.0 110.704 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.594 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 86.43 -60.7 4.51 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 4.7 p 150.81 39.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 122.025 -0.691 . . . . 0.0 109.826 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -142.8 -179.37 6.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.981 -1.074 . . . . 0.0 110.443 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.542 ' N ' ' OG1' ' A' ' 207' ' ' THR . 0.0 OUTLIER -130.89 165.71 22.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.532 -179.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.95 149.15 15.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.18 -0.95 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 1.029 ' O ' HD23 ' A' ' 211' ' ' LEU . 1.1 t -93.09 140.18 29.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 1.029 HD23 ' O ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -145.94 151.19 37.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 213' ' ' GLY . 1.3 t-20 -104.95 168.45 9.05 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 212' ' ' ASN . . . 147.51 168.52 14.1 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.491 HG23 ' CB ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -85.43 -38.07 19.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.4 -1.059 . . . . 0.0 109.049 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.545 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 1.4 t -60.04 -15.25 21.26 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.464 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 25.3 mmt -64.99 -35.34 80.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.393 -0.817 . . . . 0.0 109.599 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 1.026 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -84.44 -6.77 59.41 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.469 -0.769 . . . . 0.0 110.783 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.627 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.5 m -69.06 -45.1 29.87 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 111.734 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.7 Cg_endo -73.37 -16.11 24.8 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.979 1.786 . . . . 0.0 111.118 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.443 ' NE2' HD12 ' A' ' 8' ' ' ILE . 6.4 m80 -74.57 -41.27 60.83 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 108.424 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 262' ' ' VAL . 60.2 t -71.18 -41.12 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.455 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.71 -37.96 69.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.097 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -68.23 -49.59 45.13 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.48 -60.49 3.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.173 -1.192 . . . . 0.0 109.603 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -44.56 -47.53 10.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.48 -0.763 . . . . 0.0 109.779 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.59 57.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.963 -1.086 . . . . 0.0 109.184 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 82' ' ' VAL . 39.2 mt -52.13 -40.56 61.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.469 HG21 ' HG ' ' A' ' 244' ' ' LEU . 68.7 t -58.79 -49.48 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 108.759 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.57 ' HD2' HG22 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -45.68 -45.69 14.3 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -60.78 -48.67 80.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.426 -0.796 . . . . 0.0 110.132 -179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.417 ' C ' ' CG ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -59.14 -14.38 10.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.278 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.417 ' CG ' ' C ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -174.68 95.63 0.29 Allowed Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.179 -0.951 . . . . 0.0 110.004 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.7 -20.27 9.33 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.591 2.194 . . . . 0.0 110.379 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.99 -42.82 95.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 0.0 110.188 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -52.39 173.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.134 -0.979 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.534 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.1 OUTLIER -135.8 158.63 43.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.995 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.534 ' C ' ' O ' ' A' ' 236' ' ' SER . 1.5 m120 -15.78 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 236' ' ' SER . 2.9 t -73.79 -65.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.013 -1.054 . . . . 0.0 110.329 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -40.51 -27.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.27 -178.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 238' ' ' VAL . 63.7 mt -82.02 -49.11 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 0.0 108.975 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -56.27 -22.5 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.035 -1.041 . . . . 0.0 109.127 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 243' ' ' HIS . 2.4 t-20 -71.07 -69.02 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.768 -1.208 . . . . 0.0 110.339 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.413 ' N ' ' OD1' ' A' ' 242' ' ' ASN . 9.9 t60 -55.84 -39.72 71.83 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.15 -0.969 . . . . 0.0 109.81 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.1 OUTLIER -64.46 -43.06 95.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.638 -0.664 . . . . 0.0 111.001 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -77.48 -21.99 51.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.976 -1.078 . . . . 0.0 109.647 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -86.58 -19.94 28.66 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.548 -0.72 . . . . 0.0 109.071 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 267' ' ' ALA . 0.9 OUTLIER -87.91 -27.22 22.3 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 122.303 1.049 . . . . 0.0 109.107 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -46.68 131.63 11.37 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.726 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 92.9 m -52.96 133.95 37.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.072 -1.018 . . . . 0.0 109.767 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 99.4 p -93.06 94.2 8.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.722 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.582 HD21 ' ND2' ' A' ' 178' ' ' ASN . 5.7 mp -58.54 -63.96 1.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.178 -0.951 . . . . 0.0 109.936 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 157.1 66.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 0.2 OUTLIER -144.94 175.4 10.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.474 -1.015 . . . . 0.0 109.6 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 255' ' ' ASN . 28.8 p -111.7 -13.73 13.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.109 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 254' ' ' THR . 1.0 OUTLIER 178.51 -25.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.017 -1.052 . . . . 0.0 110.601 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.58 -49.99 74.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.95 -1.094 . . . . 0.0 109.953 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.513 ' HB2' ' OG ' ' A' ' 253' ' ' SER . 12.9 m-30 -83.98 10.09 10.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.008 . . . . 0.0 109.877 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.571 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 38.93 74.84 0.11 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.571 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 2.8 t 84.56 -58.61 0.1 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.692 -0.887 . . . . 0.0 109.794 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.827 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 144.05 -131.57 4.48 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.487 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 52.6 tp -94.8 166.31 12.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.637 -0.919 . . . . 0.0 109.659 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 221' ' ' VAL . 5.5 t -104.97 156.64 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.351 -0.843 . . . . 0.0 109.725 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -168.09 118.88 0.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.303 1.049 . . . . 0.0 108.543 178.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 268' ' ' THR . . . -76.67 -15.89 59.68 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.718 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.474 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 1.0 OUTLIER -67.65 -41.19 84.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.711 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.36 -8.42 59.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.086 -1.009 . . . . 0.0 109.696 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.404 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -99.59 -21.77 15.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.218 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.503 ' O ' ' C ' ' A' ' 269' ' ' ARG . 25.2 p -112.54 -55.69 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.89 . . . . 0.0 109.181 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 268' ' ' THR . 3.1 ttt180 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.854 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.437 0.637 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 1.8 tm0? -70.57 172.15 9.06 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.501 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 66.8 m -98.31 127.62 44.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.058 -1.026 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -140.52 106.45 6.5 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 109.85 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.97 178.02 8.16 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.367 2.044 . . . . 0.0 109.771 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -5.6 16.15 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.35 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.1 -63.29 1.74 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 9' ' ' SER . 1.7 mp -75.82 113.39 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.11 -1.229 . . . . 0.0 109.146 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 8' ' ' ILE . 11.8 p 168.1 -50.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.145 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.848 ' HB3' HD21 ' A' ' 261' ' ' LEU . 2.3 mmt180 -77.81 -21.68 51.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 109.812 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 220' ' ' HIS . 4.0 m -86.41 14.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.081 -1.012 . . . . 0.0 109.894 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.521 ' OE1' ' HB3' ' A' ' 15' ' ' ALA . 22.2 mm-40 45.05 57.92 4.39 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.476 -0.765 . . . . 0.0 109.69 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.701 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.07 -30.94 0.47 Allowed Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.451 -0.781 . . . . 0.0 111.82 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 33.1 Cg_endo -76.14 -55.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 121.232 1.288 . . . . 0.0 109.0 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . . . -49.64 -27.34 4.52 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.203 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.87 -32.84 24.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.863 -1.148 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.535 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 22.1 m170 -75.75 -20.79 58.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.862 . . . . 0.0 110.862 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.505 ' OD1' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -110.31 -25.77 9.94 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.584 -1.322 . . . . 0.0 110.38 -179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 3.9 tpm_? -56.16 -25.35 46.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.0 -1.062 . . . . 0.0 109.47 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.87 0.7 3.87 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' CD1' HG21 ' A' ' 268' ' ' THR . 2.4 mt -102.81 151.83 21.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -1.178 . . . . 0.0 109.172 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.483 ' C ' ' N ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -137.78 -2.66 1.91 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.183 -0.948 . . . . 0.0 110.853 -179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 22' ' ' THR . . . 48.83 18.6 1.11 Allowed Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.483 ' N ' ' C ' ' A' ' 22' ' ' THR . 40.7 t -72.86 9.97 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.569 -0.96 . . . . 0.0 111.405 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.37 37.25 1.9 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.281 -1.437 . . . . 0.0 110.144 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 27' ' ' LYS . 53.2 t -120.93 163.12 18.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.857 -1.378 . . . . 0.0 110.025 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 87' ' ' GLU . 21.3 mttp -127.12 128.62 46.5 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.532 -0.73 . . . . 0.0 109.115 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 43.6 t -131.5 153.79 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.028 -1.045 . . . . 0.0 110.254 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.633 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -115.23 160.27 19.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.391 -0.818 . . . . 0.0 109.066 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.654 HG11 HD11 ' A' ' 35' ' ' ILE . 7.2 t -133.09 90.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.109 -0.994 . . . . 0.0 108.919 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.973 HD23 HG21 ' A' ' 93' ' ' VAL . 8.7 mp -80.44 123.43 28.05 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 7.8 p30 173.48 -164.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.908 -1.12 . . . . 0.0 109.815 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.554 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 31.3 p -42.38 -65.24 0.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -172.28 -132.37 1.49 Allowed Glycine 0 C--N 1.302 -1.341 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.701 HG13 ' HB2' ' A' ' 90' ' ' ALA . 30.3 mm -165.32 93.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.46 ' HB3' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -53.09 142.39 20.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.989 . . . . 0.0 109.267 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.59 117.16 13.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.14 152.74 72.36 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.196 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 -21.33 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.532 2.155 . . . . 0.0 110.713 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -81.01 -17.32 50.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 109.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD21 ' HA2' ' A' ' 68' ' ' GLY . 29.8 mt -101.39 149.75 23.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 109.355 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.07 88.26 2.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.134 -0.979 . . . . 0.0 109.392 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 43' ' ' ILE . 23.4 mm -65.92 100.01 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -93.81 -11.42 31.28 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.27 -0.894 . . . . 0.0 109.31 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.637 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -174.65 169.59 42.57 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.78 130.33 1.92 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.07 170.78 14.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.375 -1.074 . . . . 0.0 108.944 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 93.8 p -140.84 112.74 7.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.097 -1.002 . . . . 0.0 110.493 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.941 ' CE2' HG12 ' A' ' 91' ' ' VAL . 3.7 m-85 -106.92 -47.71 3.65 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.291 -0.881 . . . . 0.0 109.401 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.711 HG21 ' O ' ' A' ' 94' ' ' LEU . 2.6 t -39.99 144.54 0.52 Allowed Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' HD2' HG13 ' A' ' 50' ' ' VAL . 32.2 Cg_endo -72.04 177.3 7.29 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.516 2.144 . . . . 0.0 110.43 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 54' ' ' PRO . . . 59.13 23.04 56.87 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -26.5 88.63 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 122.471 -0.429 . . . . 0.0 111.584 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.519 ' N ' ' O ' ' A' ' 52' ' ' GLY . 36.5 Cg_endo -81.88 -72.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.762 2.308 . . . . 0.0 109.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.583 -0.698 . . . . 0.0 109.161 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 48' ' ' SER . 0.7 OUTLIER -77.86 -0.36 27.06 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 108.689 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -129.32 146.43 51.21 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 179.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 15.1 t70 64.03 154.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.361 -0.837 . . . . 0.0 109.859 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.72 -30.32 0.12 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -167.29 -55.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -1.171 . . . . 0.0 109.374 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.94 -10.37 3.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.37 -54.18 11.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -1.168 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA2' ' OD2' ' A' ' 32' ' ' ASP . . . -58.62 -39.98 94.07 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 36' ' ' SER . 2.9 m -63.8 -32.74 74.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -1.096 . . . . 0.0 108.973 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.733 ' CE1' ' HG ' ' A' ' 201' ' ' SER . 0.6 OUTLIER -67.21 -57.25 7.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.434 -0.791 . . . . 0.0 110.257 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.975 HG13 ' HB3' ' A' ' 219' ' ' PRO . 13.4 t -60.17 -32.47 50.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.341 -0.849 . . . . 0.0 109.796 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' C ' HD21 ' A' ' 41' ' ' LEU . . . -65.17 -43.04 93.01 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.691 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.475 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -73.49 -38.33 52.16 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.521 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.48 HG21 ' CE1' ' A' ' 220' ' ' HIS . 29.8 m -65.09 -21.66 66.84 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.293 -1.122 . . . . 0.0 108.919 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 219' ' ' PRO . 49.6 mt -89.86 -23.58 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.17 -0.956 . . . . 0.0 109.352 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -126.46 -57.51 1.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.044 -1.035 . . . . 0.0 111.703 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.082 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 36.68 87.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.481 -0.762 . . . . 0.0 109.897 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 73' ' ' LEU . 19.7 mt -60.29 149.82 32.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.733 -1.229 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 11.4 p30 -91.77 87.29 6.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.526 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 76' ' ' SER . 14.8 p30 -126.84 -120.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.204 -0.935 . . . . 0.0 108.828 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.423 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -124.43 -34.51 2.89 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.076 -1.015 . . . . 0.0 109.38 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.0 pt -100.32 67.39 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.305 -0.872 . . . . 0.0 109.486 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 160.24 158.99 9.54 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 3' ' ' SER . 34.8 m -87.31 -135.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.175 -1.191 . . . . 0.0 109.521 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.47 ' N ' HG23 ' A' ' 79' ' ' VAL . 31.6 tp -140.64 123.09 16.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.697 -1.252 . . . . 0.0 110.263 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 1.082 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -87.57 -153.02 24.44 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.458 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -103.87 -60.18 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.906 -1.35 . . . . 0.0 109.332 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.688 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -89.36 112.56 52.15 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.246 -0.909 . . . . 0.0 109.174 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -84.69 -62.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.519 2.146 . . . . 0.0 110.947 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.468 ' CB ' ' HA ' ' A' ' 24' ' ' SER . 1.0 OUTLIER -81.74 18.5 1.24 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.24 -178.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.688 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -80.99 143.69 32.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.876 -1.14 . . . . 0.0 109.11 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 4.9 pt-20 -84.69 115.1 22.49 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.913 -1.117 . . . . 0.0 109.198 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 88' ' ' LEU . 4.1 mt -92.4 123.75 35.95 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.93 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.637 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 13.0 m-85 -106.59 152.61 23.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.701 ' HB2' HG13 ' A' ' 35' ' ' ILE . . . -113.69 102.83 10.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.366 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.941 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.76 69.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 108.93 -179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 33' ' ' THR . 0.0 OUTLIER -38.28 112.07 0.2 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.312 0.577 . . . . 0.0 110.199 -179.254 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.973 HG21 HD23 ' A' ' 31' ' ' LEU . 2.1 t -120.19 -17.67 6.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.495 -0.753 . . . . 0.0 109.256 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.711 ' O ' HG21 ' A' ' 50' ' ' VAL . 76.5 mt -98.45 172.97 7.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 96' ' ' ALA . . . -122.48 12.4 8.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 95' ' ' GLY . . . 71.05 3.69 4.76 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 121.979 -0.718 . . . . 0.0 109.796 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.2 -38.33 11.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.04 -9.94 3.6 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.08 98.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.064 -1.257 . . . . 0.0 110.005 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.13 179.6 52.77 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.2 150.98 48.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.698 -0.883 . . . . 0.0 110.284 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.564 HG21 ' OG ' ' A' ' 130' ' ' SER . 44.9 t -68.47 -20.8 25.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.545 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -71.83 -22.31 61.57 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 60.2 p -79.25 -55.04 5.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.87 HG23 HG11 ' A' ' 93' ' ' VAL . 1.3 mt -62.29 -25.92 38.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -69.48 -45.75 68.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.593 -0.692 . . . . 0.0 110.167 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.545 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -67.12 -39.41 86.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.933 -1.104 . . . . 0.0 108.638 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.85 -19.23 73.26 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.51 -42.45 14.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -1.233 . . . . 0.0 110.184 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 139' ' ' SER . 6.5 pt-20 -94.86 -2.64 50.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.005 -1.059 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CB ' ' O ' ' A' ' 107' ' ' GLN . 71.4 t90 -86.21 -14.95 42.38 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.825 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.51 -7.19 59.65 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.415 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -91.27 -46.42 3.82 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.654 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -71.67 -71.89 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.129 -1.218 . . . . 0.0 110.028 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -109.48 35.25 3.38 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.825 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -114.88 -153.92 10.62 Favored Glycine 0 C--N 1.291 -1.92 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.596 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.78 ' HE1' ' O ' ' A' ' 116' ' ' GLY . 17.9 mmt -118.59 -172.92 2.37 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.882 0.849 . . . . 0.0 111.46 -177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.653 ' CE1' ' CE ' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -86.16 -27.86 24.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.831 -0.543 . . . . 0.0 110.223 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.646 HG22 ' NE2' ' A' ' 118' ' ' HIS . 15.5 t -114.02 159.77 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.848 -1.157 . . . . 0.0 109.569 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.576 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -163.9 114.16 1.29 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.64 ' ND2' ' HB ' ' A' ' 148' ' ' VAL . 6.4 t-20 -98.53 159.27 15.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.019 -1.05 . . . . 0.0 110.441 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.609 HD23 HD21 ' A' ' 124' ' ' LEU . 3.7 mp -131.99 104.51 6.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.493 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.3 59.35 5.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.609 HD21 HD23 ' A' ' 122' ' ' LEU . 1.4 pp -154.49 -175.19 5.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.386 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 160' ' ' SER . . . 173.57 103.09 0.16 Allowed Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.361 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.51 148.69 35.31 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.297 -1.119 . . . . 0.0 108.914 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -75.95 -2.1 12.2 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.348 2.032 . . . . 0.0 109.554 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.7 m -103.63 110.53 64.04 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.768 -0.583 . . . . 0.0 110.108 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -77.39 169.04 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.232 1.954 . . . . 0.0 109.33 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.564 ' OG ' HG21 ' A' ' 102' ' ' VAL . 1.4 m -159.52 126.83 4.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.872 -1.143 . . . . 0.0 110.965 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.34 65.38 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 m -64.32 -30.06 71.12 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.89 -34.23 66.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.533 ' HA ' ' OH ' ' A' ' 165' ' ' TYR . 26.8 tt0 -68.29 -53.39 24.77 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.412 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -51.21 -25.97 6.29 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.06 -1.025 . . . . 0.0 108.296 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -73.69 -49.26 26.65 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.627 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.81 -20.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.86 -37.81 85.15 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 177.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -74.94 -27.79 60.34 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.99 -20.75 57.6 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 121.063 -1.023 . . . . 0.0 109.798 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.1 m -76.78 -33.56 58.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.84 -24.62 58.33 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 108.829 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 143' ' ' ARG . 0.9 OUTLIER -106.42 -22.19 12.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 0.0 109.646 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 80.18 62.16 2.13 Favored Glycine 0 C--N 1.301 -1.411 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 48.4 t -103.22 118.84 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -1.104 . . . . 0.0 109.634 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.43 115.43 17.2 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.291 -0.881 . . . . 0.0 108.797 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -111.34 132.45 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.129 -0.982 . . . . 0.0 109.884 -179.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.785 HG12 ' O ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -114.18 166.66 7.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.806 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -150.6 132.72 15.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 0.0 109.67 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.65 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -53.26 155.79 2.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.435 -0.791 . . . . 0.0 109.499 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 185' ' ' GLN . 0.1 OUTLIER -61.81 -66.91 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -0.884 . . . . 0.0 109.633 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 155.52 -16.08 0.48 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.912 -1.137 . . . . 0.0 110.6 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 153' ' ' ASN . 11.7 t-20 44.69 40.01 3.83 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.726 -0.867 . . . . 0.0 109.535 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.6 -26.79 9.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.64 102.76 0.09 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 175.19 -177.4 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 109.547 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 186' ' ' TYR . . . -94.29 59.56 1.94 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.4 t 169.86 154.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.182 . . . . 0.0 109.67 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.617 HD11 ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -114.13 -171.91 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.821 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.967 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.6 OUTLIER -85.89 162.53 18.55 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 122.011 0.91 . . . . 0.0 112.012 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -100.49 139.86 20.96 Favored Pre-proline 0 C--N 1.302 -1.466 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.2 Cg_endo -74.9 -36.74 2.49 Favored 'Cis proline' 0 C--N 1.294 -2.291 0 O-C-N 122.836 0.914 . . . . 0.0 110.992 3.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.967 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 8.46 -71.93 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.961 0.886 . . . . 0.0 110.729 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.642 ' N ' ' O ' ' A' ' 162' ' ' PRO . 23.9 ttt-85 -45.93 -72.74 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.594 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.2 OUTLIER 28.29 -161.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.801 1.286 . . . . 0.0 112.586 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -134.7 -31.0 1.07 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.449 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -100.93 19.13 17.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.783 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 147' ' ' VAL . . . -135.75 167.15 21.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.785 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -122.68 136.04 54.76 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.006 -1.059 . . . . 0.0 109.538 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 190' ' ' LEU . . . -98.06 154.06 17.98 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.378 -0.826 . . . . 0.0 109.202 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 18.9 t -111.98 167.5 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.61 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -135.18 -158.99 8.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 193' ' ' VAL . . . -127.2 166.65 17.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.312 -1.11 . . . . 0.0 109.929 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.612 ' CG2' HG23 ' A' ' 193' ' ' VAL . 22.8 p -139.19 150.74 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.543 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.461 ' OD2' ' HB3' ' A' ' 179' ' ' ASN . 3.5 p30 -76.44 -174.09 2.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 110.176 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.13 66.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.0 109.83 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -81.73 -89.88 0.07 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.127 -0.983 . . . . 0.0 109.345 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.767 ' C ' HD23 ' A' ' 251' ' ' LEU . 1.4 m120 -174.93 67.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 110.074 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 174' ' ' THR . 38.2 t30 -146.43 -176.08 5.03 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.137 -0.977 . . . . 0.0 109.714 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -66.04 3.7 0.8 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.56 -0.713 . . . . 0.0 111.887 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 66.88 -145.94 0.16 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.133 -1.604 . . . . 0.0 108.413 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.21 -43.71 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.845 -1.159 . . . . 0.0 109.955 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -87.75 35.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.447 -0.783 . . . . 0.0 110.499 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.7 t -94.11 127.59 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 151' ' ' SER . 5.2 tp60 -66.23 114.38 5.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.201 -0.937 . . . . 0.0 109.182 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.561 ' CE1' ' HA2' ' A' ' 157' ' ' GLY . 0.0 OUTLIER -106.02 175.93 5.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.805 -179.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 186' ' ' TYR . . . 143.32 158.33 7.51 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -57.3 97.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -1.166 . . . . 0.0 109.492 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.534 ' C ' HD11 ' A' ' 159' ' ' ILE . . . 151.68 -23.4 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.617 ' N ' HD11 ' A' ' 159' ' ' ILE . 11.0 tp -59.31 127.13 30.57 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.18 -1.188 . . . . 0.0 109.051 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.499 ' O ' ' HA3' ' A' ' 258' ' ' GLY . 0.4 OUTLIER -90.95 -54.46 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.627 -179.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.791 HD12 ' HB2' ' A' ' 259' ' ' SER . 1.8 tt -158.02 167.48 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.219 -0.925 . . . . 0.0 109.168 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 260' ' ' GLY . 33.4 m -112.26 166.29 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.929 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -152.9 176.36 2.46 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 108.832 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.929 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 35.3 Cg_endo -77.12 116.55 4.2 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.341 2.027 . . . . 0.0 110.465 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -147.15 16.86 1.53 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 18.6 t -88.3 61.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -1.085 . . . . 0.0 108.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.642 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.5 OUTLIER 108.51 125.65 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 198' ' ' ASN . 23.7 m -162.65 111.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.955 0.883 . . . . 0.0 108.665 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.2 pt20 -89.22 127.62 35.77 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.733 ' HG ' ' CE1' ' A' ' 65' ' ' HIS . 0.8 OUTLIER -135.13 -160.94 1.1 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.85 168.54 16.01 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 110.038 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.673 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -148.43 166.26 16.03 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.673 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.1 Cg_endo -73.79 168.8 23.89 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.135 1.89 . . . . 0.0 110.239 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 71.04 17.22 75.45 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER 66.1 33.03 7.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -1.165 . . . . 0.0 109.713 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.56 163.14 23.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.526 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 201' ' ' SER . 2.7 m-85 -106.93 -172.95 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -171.0 139.62 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.93 -1.106 . . . . 0.0 110.611 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.5 m -106.75 108.78 20.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.43 154.26 21.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.943 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.36 84.84 2.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -141.97 150.88 22.4 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.7 m -65.02 -22.61 67.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -1.071 . . . . 0.0 109.469 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.65 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 3.4 t -71.36 -23.0 61.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 109.704 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.415 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -75.6 -16.12 60.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.567 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -93.46 3.72 55.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 109.876 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.672 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 23.7 m -77.4 -35.69 1.36 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.123 -0.986 . . . . 0.0 111.972 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.975 ' HB3' HG13 ' A' ' 66' ' ' VAL . 30.6 Cg_endo -73.41 -29.02 11.62 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.301 1.334 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.48 ' CE1' HG21 ' A' ' 69' ' ' THR . 29.9 m80 -59.63 -40.85 88.96 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.834 -1.166 . . . . 0.0 108.057 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 262' ' ' VAL . 63.5 t -70.35 -43.32 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -52.36 -31.33 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -72.4 -59.77 4.38 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 223' ' ' GLY . . . -43.69 -49.69 7.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -1.112 . . . . 0.0 109.2 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.21 -45.91 72.35 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.365 -0.835 . . . . 0.0 108.776 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 229' ' ' LYS . . . -51.93 -49.78 62.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.868 . . . . 0.0 109.144 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.6 mt -49.35 -50.12 41.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 108.973 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.9 t -55.29 -45.36 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 109.196 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.653 ' CE ' ' CE1' ' A' ' 118' ' ' HIS . 12.3 tppt? -49.64 -43.17 46.71 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.447 -0.783 . . . . 0.0 108.986 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.64 -45.96 91.8 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.313 -0.867 . . . . 0.0 109.328 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.5 tppm? -62.53 -13.11 27.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.32 -0.863 . . . . 0.0 108.794 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -163.33 85.75 1.33 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.509 ' HA ' ' HD2' ' A' ' 229' ' ' LYS . 36.7 Cg_endo -80.4 31.85 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.987 2.458 . . . . 0.0 111.37 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.5 t -146.94 11.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.873 -1.142 . . . . 0.0 109.914 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -87.36 -179.02 6.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 110.032 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.849 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -109.74 173.67 6.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.289 0.566 . . . . 0.0 109.648 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.585 ' OD1' HG23 ' A' ' 238' ' ' VAL . 8.5 p30 -62.99 -32.94 74.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 109.201 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.585 HG23 ' OD1' ' A' ' 237' ' ' ASN . 2.9 t -77.07 -61.98 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.925 0.869 . . . . 0.0 109.181 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 238' ' ' VAL . 4.1 mt-30 -42.65 -38.23 1.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.72 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 236' ' ' SER . 7.5 mt -74.04 -47.95 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.632 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 3.1 tmt_? -52.37 -20.66 2.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.414 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 1.6 t-20 -78.13 -38.06 44.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.852 -1.155 . . . . 0.0 109.945 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.41 ' O ' ' OG1' ' A' ' 247' ' ' THR . 2.0 t-160 -75.74 -40.47 55.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.153 -0.967 . . . . 0.0 109.465 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.5 OUTLIER -73.64 -32.92 64.28 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.511 -0.743 . . . . 0.0 110.333 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 1.3 tmtt? -77.93 -42.32 33.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.093 . . . . 0.0 108.983 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 0.9 OUTLIER -67.77 -22.83 65.19 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.552 -0.718 . . . . 0.0 109.989 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.569 HG21 ' HB2' ' A' ' 267' ' ' ALA . 2.3 p -91.85 -26.09 18.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.916 -1.115 . . . . 0.0 110.04 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -37.01 114.46 0.32 Allowed 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.794 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.549 HG22 ' N ' ' A' ' 250' ' ' SER . 65.9 m -45.06 164.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 0.0 109.08 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.549 ' N ' HG22 ' A' ' 249' ' ' THR . 23.2 t -115.58 102.2 9.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.023 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 251' ' ' LEU . 6.4 mp -83.75 -35.69 24.19 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.265 -0.897 . . . . 0.0 110.0 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 130.73 69.01 0.1 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.589 ' HB3' ' CD1' ' A' ' 257' ' ' TYR . 0.3 OUTLIER -50.28 137.46 18.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.29 -1.124 . . . . 0.0 109.99 -179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.71 HG23 ' OD1' ' A' ' 255' ' ' ASN . 1.6 t -98.93 -17.11 18.52 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 254' ' ' THR . 0.2 OUTLIER -167.93 -44.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 258' ' ' GLY . 2.5 tp -148.37 -65.6 0.24 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.344 -0.847 . . . . 0.0 109.802 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.647 ' O ' ' CG ' ' A' ' 257' ' ' TYR . 0.0 OUTLIER 23.34 40.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 123.063 1.411 . . . . 0.0 111.774 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 256' ' ' LEU . . . 54.11 -136.14 42.77 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.791 ' HB2' HD12 ' A' ' 192' ' ' ILE . 6.8 m -101.54 -3.4 28.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.438 -1.037 . . . . 0.0 109.545 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 110.27 -112.63 3.35 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.755 -1.212 . . . . 0.0 110.726 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 10' ' ' ARG . 37.7 tp -115.49 159.22 21.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 110.013 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.511 ' N ' ' HG ' ' A' ' 261' ' ' LEU . 0.1 OUTLIER -110.59 159.86 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.825 . . . . 0.0 109.191 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -168.05 119.24 0.82 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.363 1.078 . . . . 0.0 108.731 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 268' ' ' THR . . . -69.97 -15.12 62.99 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.317 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.465 ' HB3' ' HG3' ' A' ' 12' ' ' GLN . 78.8 tt0 -74.33 -26.81 60.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.014 -1.054 . . . . 0.0 109.571 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 247' ' ' THR . . . -90.79 3.28 54.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.566 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.569 ' HB2' HG21 ' A' ' 247' ' ' THR . . . -128.69 0.82 5.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.272 -0.893 . . . . 0.0 109.697 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 264' ' ' ALA . 21.4 p -107.49 -42.49 4.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.222 -0.924 . . . . 0.0 109.09 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 268' ' ' THR . 9.5 mtm180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.521 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.491 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.64 -177.11 1.44 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.221 -0.924 . . . . 0.0 108.769 179.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 14.9 m -117.91 113.67 22.08 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.219 -0.926 . . . . 0.0 109.642 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.674 HG11 HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -138.28 148.65 60.42 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 108.982 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HB3' ' OE1' ' A' ' 200' ' ' GLN . 34.9 Cg_endo -77.78 166.29 25.54 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.382 2.055 . . . . 0.0 110.735 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 9' ' ' SER . 4.8 p-90 -50.11 -19.89 0.86 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.491 -0.756 . . . . 0.0 110.556 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.61 -43.92 98.41 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.674 HG21 HG11 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -90.6 -25.71 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.123 -1.222 . . . . 0.0 110.057 -179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' A' ' 6' ' ' TRP . 18.7 t -64.31 -20.58 66.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 109.932 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.98 -0.68 38.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 111.398 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.592 HG23 ' HB2' ' A' ' 13' ' ' ALA . 11.1 m -106.13 25.46 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 120.542 -1.349 . . . . 0.0 110.134 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.56 ' O ' ' HB3' ' A' ' 264' ' ' ALA . 2.9 mp0 47.08 28.89 0.99 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -70.14 -36.17 5.86 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 111.704 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 29.4 Cg_endo -72.42 -57.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.509 -1.381 . . . . 0.0 108.509 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.18 -33.52 0.94 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.96 -49.62 60.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.162 -0.961 . . . . 0.0 108.819 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 17' ' ' HIS . 1.3 m170 -73.08 -3.3 25.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.78 . . . . 0.0 109.444 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.3 -53.35 5.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.332 -0.855 . . . . 0.0 110.076 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.644 ' HD2' HD13 ' A' ' 21' ' ' LEU . 1.9 ptp180 -54.86 -18.02 4.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.65 35.13 2.68 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.644 HD13 ' HD2' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -93.21 160.81 14.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.164 -1.198 . . . . 0.0 109.407 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.467 ' O ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -133.89 -53.32 0.86 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.319 -0.863 . . . . 0.0 109.762 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 83.73 -13.81 45.75 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 85' ' ' ASN . 2.8 t -51.58 139.72 19.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -1.079 . . . . 0.0 109.443 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.31 -15.81 11.83 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 27' ' ' LYS . 45.3 t -93.26 169.95 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.349 -1.089 . . . . 0.0 109.173 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' N ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -137.25 120.41 16.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.163 -0.961 . . . . 0.0 109.389 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.81 134.13 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.656 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -90.31 146.54 24.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.356 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.667 ' O ' HG12 ' A' ' 30' ' ' VAL . 16.2 t -119.23 80.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.23 -0.919 . . . . 0.0 108.938 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.635 HD23 HG21 ' A' ' 93' ' ' VAL . 8.5 mp -72.08 87.44 1.07 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.683 -0.636 . . . . 0.0 109.364 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD2' ' CG1' ' A' ' 30' ' ' VAL . 54.8 p30 -151.78 -148.51 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 109.229 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 92' ' ' LYS . 1.2 p -56.86 -72.8 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.098 -1.001 . . . . 0.0 109.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.584 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -170.99 -110.47 0.24 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.584 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.8 OUTLIER 157.12 115.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 38' ' ' HIS . 2.6 m -83.91 60.38 5.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 111.425 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 37' ' ' THR . 15.0 t 23.18 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.773 0.797 . . . . 0.0 111.22 178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.86 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -51.52 161.98 0.76 Allowed Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.11 -29.38 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.465 2.11 . . . . 0.0 110.332 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.632 ' OD1' HG21 ' A' ' 202' ' ' THR . 0.7 OUTLIER -95.26 18.05 13.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 109.565 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.86 HD12 ' HB2' ' A' ' 38' ' ' HIS . 83.5 mt -125.42 124.42 41.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.908 . . . . 0.0 109.291 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.9 t-20 -74.82 120.36 20.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 35' ' ' ILE . 21.7 mm -103.3 96.92 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.145 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HG2' ' CG ' ' A' ' 87' ' ' GLU . 4.8 tpm_? -88.28 -38.66 15.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.151 -0.968 . . . . 0.0 109.843 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.66 -166.11 32.68 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.5 171.16 16.31 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.65 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -156.3 160.24 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.516 -0.991 . . . . 0.0 109.206 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 56' ' ' THR . 26.5 m -122.88 106.4 10.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.932 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.65 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 0.8 OUTLIER -102.46 -33.17 9.62 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.352 -0.842 . . . . 0.0 109.159 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.732 HG13 ' HD2' ' A' ' 51' ' ' PRO . 70.5 t -49.33 142.53 10.75 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.431 -0.793 . . . . 0.0 109.028 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.732 ' HD2' HG13 ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.56 -170.17 0.84 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.519 2.146 . . . . 0.0 110.449 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 53' ' ' GLU . . . 92.05 1.61 69.8 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 19.9 pt-20 39.61 56.51 6.46 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.551 -0.97 . . . . 0.0 110.14 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.9 Cg_endo -77.29 -89.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.251 1.967 . . . . 0.0 110.187 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 3.3 p 161.4 136.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.825 . . . . 0.0 109.794 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.473 ' HA ' ' OG ' ' A' ' 48' ' ' SER . 0.2 OUTLIER -52.26 -20.13 2.48 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 36' ' ' SER . 18.3 mt-30 -118.82 152.4 36.3 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.379 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 63.56 165.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.311 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . 169.78 -35.26 0.18 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 6.6 t30 173.72 -62.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -1.092 . . . . 0.0 109.428 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' HIS . . . 168.72 -36.3 0.2 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -22.69 4.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -1.098 . . . . 0.0 109.391 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 65' ' ' HIS . . . -72.48 -94.17 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.832 HG23 HD11 ' A' ' 41' ' ' LEU . 37.7 m -34.01 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.744 -0.857 . . . . 0.0 110.931 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.626 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.2 t-80 -71.95 -52.83 15.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 110.282 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 219' ' ' PRO . 46.1 t -63.57 -37.02 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.72 -42.65 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.447 -0.783 . . . . 0.0 109.933 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.591 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -74.98 -28.2 62.99 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.84 HG23 ' CE1' ' A' ' 220' ' ' HIS . 62.1 m -69.89 -18.56 63.41 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.34 -1.094 . . . . 0.0 108.341 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.416 HD12 ' O ' ' A' ' 66' ' ' VAL . 7.3 mt -94.03 -38.49 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.477 -0.764 . . . . 0.0 110.004 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.914 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -175.62 46.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.867 -1.146 . . . . 0.0 111.156 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -45.14 108.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.804 -1.185 . . . . 0.0 108.924 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.9 HD23 ' O ' ' A' ' 84' ' ' PRO . 80.4 mt -42.26 142.28 0.79 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.168 -0.958 . . . . 0.0 109.935 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 74' ' ' ASN . 0.1 OUTLIER -86.28 109.46 18.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.283 -0.885 . . . . 0.0 108.977 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 76' ' ' SER . 4.9 m-20 -124.28 -5.01 7.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.069 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 88.5 -17.62 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 pt -104.09 66.66 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.175 -0.953 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.492 ' HA3' ' OH ' ' A' ' 208' ' ' TYR . . . 147.56 -171.5 28.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 3' ' ' SER . 30.7 m -80.11 -163.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.324 -1.103 . . . . 0.0 109.6 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 ' HB2' ' OE1' ' A' ' 2' ' ' GLN . 8.2 tp -142.53 115.2 8.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.865 . . . . 0.0 109.611 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -67.52 177.11 22.51 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.523 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 2.0 t -65.03 -50.96 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.286 . . . . 0.0 109.394 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.914 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . . . -85.77 148.08 47.71 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.355 -0.84 . . . . 0.0 108.943 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.9 ' O ' HD23 ' A' ' 73' ' ' LEU . 38.0 Cg_endo -82.73 -61.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.752 2.301 . . . . 0.0 109.719 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 68.9 m-80 -95.98 -86.46 0.31 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 58.32 126.99 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.582 -0.699 . . . . 0.0 110.388 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.485 ' CG ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 mp0 -70.24 93.23 0.82 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' ASN . 3.3 mt -78.11 104.97 9.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.133 -0.979 . . . . 0.0 110.126 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -94.06 147.92 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 0.0 108.89 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -115.4 105.81 13.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.974 -1.079 . . . . 0.0 109.131 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.656 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.1 OUTLIER -106.01 67.56 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.288 -0.882 . . . . 0.0 109.538 -179.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 91' ' ' VAL . 15.3 ttmm -36.97 100.08 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.391 0.615 . . . . 0.0 109.58 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.647 HG13 ' HA ' ' A' ' 105' ' ' ILE . 0.9 OUTLIER -115.96 -16.68 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 109.575 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.029 HD11 HD22 ' A' ' 124' ' ' LEU . 39.3 mt -118.79 169.12 10.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.807 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -112.15 167.19 12.32 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 59' ' ' GLY . . . -66.58 -25.84 66.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -1.149 . . . . 0.0 109.246 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -49.81 74.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.395 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.78 2.33 14.5 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.8 74.28 1.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -1.145 . . . . 0.0 109.641 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.36 27.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.13 145.54 26.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.765 -0.844 . . . . 0.0 110.063 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.822 HG21 ' OG ' ' A' ' 130' ' ' SER . 1.2 t -67.24 -32.27 56.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -21.85 66.7 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.492 ' HA ' ' OE1' ' A' ' 107' ' ' GLN . 0.6 OUTLIER -85.34 -62.31 1.56 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.669 -0.644 . . . . 0.0 109.268 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.647 ' HA ' HG13 ' A' ' 93' ' ' VAL . 1.3 mt -48.71 -27.12 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.42 -48.75 21.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.405 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.492 ' OE1' ' HA ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -62.54 -20.38 64.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.212 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.53 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -82.66 -38.42 12.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.9 mt -65.37 -24.98 67.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.378 -1.072 . . . . 0.0 109.234 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -26.03 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -0.951 . . . . 0.0 110.384 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.495 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 55.4 t90 -72.68 -14.78 61.65 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.933 -1.105 . . . . 0.0 108.476 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.733 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -94.29 7.99 43.44 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.258 -0.977 . . . . 0.0 108.584 178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -103.4 -45.16 1.6 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -86.21 -83.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.919 -1.341 . . . . 0.0 108.391 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -89.91 49.52 1.73 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.733 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -112.61 -156.13 12.6 Favored Glycine 0 C--N 1.289 -2.082 0 CA-C-O 122.376 0.987 . . . . 0.0 111.525 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.636 ' HE3' ' C ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -122.3 163.05 20.36 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.276 0.56 . . . . 0.0 109.558 -178.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.64 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -72.79 -16.75 61.62 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -0.879 . . . . 0.0 108.699 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 4.7 t -125.02 161.09 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 109.03 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.988 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -159.77 156.98 28.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 108.793 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.512 HD21 HG22 ' A' ' 218' ' ' THR . 14.1 t-20 -135.56 152.56 51.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.156 -0.965 . . . . 0.0 109.313 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD12 ' C ' ' A' ' 121' ' ' ASN . 3.4 mp -135.47 81.9 1.92 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.515 ' HG ' ' CB ' ' A' ' 215' ' ' SER . 5.0 t -71.32 84.16 0.78 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.011 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.029 HD22 HD11 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 177.43 176.54 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.922 . . . . 0.0 109.391 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.532 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . -176.07 93.85 0.09 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 161' ' ' TYR . 0.6 OUTLIER -86.99 148.73 46.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.29 -1.124 . . . . 0.0 109.272 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.447 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 34.2 Cg_endo -76.39 -9.26 18.81 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.385 2.057 . . . . 0.0 108.942 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.6 t -97.34 108.83 46.94 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.46 ' HB3' ' CE2' ' A' ' 161' ' ' TYR . 31.9 Cg_endo -75.07 166.23 29.57 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.119 1.88 . . . . 0.0 109.831 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.822 ' OG ' HG21 ' A' ' 102' ' ' VAL . 43.8 m -157.75 118.96 3.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.987 -1.07 . . . . 0.0 110.532 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.77 -22.68 66.03 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 35.9 m -61.75 -31.77 71.97 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.28 -33.72 61.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.429 ' OE1' ' OH ' ' A' ' 165' ' ' TYR . 4.4 tt0 -73.32 -22.79 60.25 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.802 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -25.56 58.98 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.1 -37.14 39.43 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.592 HG13 ' CG ' ' A' ' 167' ' ' ASN . 2.0 t -70.44 -29.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -64.19 -35.6 81.32 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.396 -2.075 . . . . 0.0 105.396 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.3 m -78.11 -22.8 48.36 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -91.52 -5.37 54.26 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 27.7 m -90.73 -43.15 10.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.214 -0.929 . . . . 0.0 109.143 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.5 m -64.21 -17.94 64.03 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -95.78 -14.12 23.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.455 -0.778 . . . . 0.0 109.371 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.84 62.85 4.22 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 21.7 t -111.96 115.49 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.374 -1.074 . . . . 0.0 109.376 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 tt -72.1 113.18 8.86 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.196 -0.94 . . . . 0.0 109.016 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.988 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.4 OUTLIER -109.65 150.89 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.879 . . . . 0.0 109.268 -179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 149' ' ' ALA . 2.7 t -123.56 166.59 18.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.51 ' N ' ' CG1' ' A' ' 148' ' ' VAL . . . -157.38 135.42 10.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 110.264 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.492 ' N ' HG21 ' A' ' 218' ' ' THR . . . -61.17 171.59 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.795 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.4 OUTLIER -93.22 -39.07 11.21 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.259 -0.901 . . . . 0.0 109.944 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 132.53 120.91 2.19 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 47.11 1.29 Allowed 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.905 -0.762 . . . . 0.0 109.473 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 155' ' ' GLY . 1.6 t -121.75 -91.93 0.55 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.455 ' N ' ' OG ' ' A' ' 154' ' ' SER . . . 150.51 95.95 0.14 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.475 ' HB3' HE22 ' A' ' 185' ' ' GLN . . . -158.23 173.26 16.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -1.119 . . . . 0.0 109.634 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.98 42.24 3.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.493 ' O ' ' NE2' ' A' ' 185' ' ' GLN . 1.6 t -163.64 160.53 22.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -1.149 . . . . 0.0 109.321 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.716 HD11 ' O ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -98.16 -173.4 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.09 -1.006 . . . . 0.0 110.148 -179.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.532 ' HB3' ' CA ' ' A' ' 125' ' ' GLY . 69.7 m -67.28 -174.97 0.42 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.691 1.234 . . . . 0.0 111.389 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.465 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 12.7 m-85 -137.2 128.56 16.46 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.737 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.1 Cg_endo -70.91 -50.74 0.18 OUTLIER 'Cis proline' 0 C--N 1.3 -1.993 0 O-C-N 123.188 1.099 . . . . 0.0 110.419 4.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 162' ' ' PRO . . . 30.89 -77.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.005 0.907 . . . . 0.0 109.615 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.737 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -36.51 -39.97 0.22 Allowed 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.363 178.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.478 ' O ' ' O ' ' A' ' 164' ' ' ARG . 3.2 m-85 -49.73 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.344 -0.847 . . . . 0.0 110.241 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -117.86 0.1 11.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.695 -0.628 . . . . 0.0 109.775 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.592 ' CG ' HG13 ' A' ' 137' ' ' VAL . 0.4 OUTLIER -87.01 16.95 4.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.165 -0.959 . . . . 0.0 108.934 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.47 153.53 7.75 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.404 ' HG3' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.2 129.8 42.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.921 -1.112 . . . . 0.0 109.509 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -91.41 133.63 35.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 172' ' ' GLY . 38.5 t -104.75 165.15 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.766 -1.209 . . . . 0.0 110.088 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.559 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -129.76 -169.98 12.64 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.14 155.51 44.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.454 HG23 ' HB ' ' A' ' 193' ' ' VAL . 2.6 p -125.32 -174.31 3.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 -176.59 3.13 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.534 -0.729 . . . . 0.0 109.798 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.413 ' NE2' ' OD1' ' A' ' 177' ' ' ASN . 0.0 OUTLIER -51.35 -27.29 9.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.395 -0.816 . . . . 0.0 110.002 -179.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.413 ' OD1' ' NE2' ' A' ' 176' ' ' GLN . 27.4 m120 -114.78 -93.63 0.48 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 110.034 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . 13.4 p30 -142.49 16.81 2.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.909 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.36 153.03 22.81 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.047 -1.033 . . . . 0.0 108.833 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.507 ' N ' ' OH ' ' A' ' 257' ' ' TYR . 0.5 OUTLIER -73.18 136.45 44.75 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.054 -1.029 . . . . 0.0 109.564 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -50.33 -172.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.516 -0.74 . . . . 0.0 110.148 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.4 t -116.06 -17.59 10.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.074 -1.016 . . . . 0.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -111.35 -19.91 12.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.494 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 8.5 t -48.36 134.81 14.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.285 -0.884 . . . . 0.0 109.485 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -79.59 157.25 27.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.386 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.652 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.1 OUTLIER -134.49 173.23 11.87 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.393 -0.817 . . . . 0.0 109.032 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.652 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 150.31 147.77 4.62 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.716 ' O ' HD11 ' A' ' 159' ' ' ILE . . . -49.54 141.31 9.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.16 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.58 -11.24 46.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.5 tp -56.62 118.1 4.52 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.317 -1.108 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 259' ' ' SER . 0.5 OUTLIER -69.63 -75.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.985 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.597 HD12 HG13 ' A' ' 262' ' ' VAL . 0.4 OUTLIER -145.22 -158.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.032 -1.042 . . . . 0.0 110.158 -179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.795 HG22 ' O ' ' A' ' 260' ' ' GLY . 27.0 m -135.06 172.8 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 110.133 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -162.11 178.26 1.65 Allowed Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.0 Cg_endo -76.19 114.02 3.81 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.097 1.864 . . . . 0.0 110.236 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -140.05 40.07 1.44 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.652 ' O ' ' HB3' ' A' ' 198' ' ' ASN . 53.9 t -123.46 82.38 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.652 ' HB3' ' O ' ' A' ' 197' ' ' VAL . 12.5 t-20 83.85 120.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.164 0.983 . . . . 0.0 108.449 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 199' ' ' VAL . 28.3 m -153.06 105.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 122.443 1.116 . . . . 0.0 109.105 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -83.54 109.31 17.28 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.327 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.626 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 1.4 t -123.99 -165.65 1.38 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 109.105 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.632 HG21 ' OD1' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -69.24 176.72 3.13 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.213 -0.929 . . . . 0.0 110.268 -179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.649 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.6 OUTLIER -161.99 149.09 11.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.649 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.4 Cg_endo -69.99 173.48 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.277 1.985 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 206' ' ' SER . . . 79.97 8.79 87.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 1.0 OUTLIER 67.67 55.79 0.6 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.5 -1.0 . . . . 0.0 109.861 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.791 HG23 ' N ' ' A' ' 208' ' ' TYR . 4.2 t -155.85 -147.95 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.323 -0.861 . . . . 0.0 109.732 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.791 ' N ' HG23 ' A' ' 207' ' ' THR . 10.5 m-85 -146.36 -177.34 5.57 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.241 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 203' ' ' TYR . . . 177.13 147.57 0.12 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.88 . . . . 0.0 110.373 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.613 ' C ' HD23 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -118.86 142.27 47.89 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -158.72 122.38 3.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.071 -1.018 . . . . 0.0 109.857 -179.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.433 ' CB ' ' H ' ' A' ' 198' ' ' ASN . 1.6 p-10 -72.84 160.7 31.74 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.364 -0.835 . . . . 0.0 109.139 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 163.16 156.3 8.53 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.5 m -79.95 -27.36 39.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.181 -1.187 . . . . 0.0 109.431 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.515 ' CB ' ' HG ' ' A' ' 123' ' ' SER . 0.3 OUTLIER -74.75 -13.76 60.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.646 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -20.94 28.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.956 . . . . 0.0 109.676 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -95.35 -3.6 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.644 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 8.5 m -75.17 -43.94 4.56 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 111.307 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.71 ' HG2' HG21 ' A' ' 69' ' ' THR . 30.5 Cg_endo -72.27 -13.29 28.16 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.614 1.543 . . . . 0.0 110.155 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.84 ' CE1' HG23 ' A' ' 69' ' ' THR . 6.2 m80 -70.99 -44.24 66.36 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 222' ' ' ALA . 46.2 t -66.54 -51.13 60.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -44.26 -37.35 3.19 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.694 -0.802 . . . . 0.0 108.865 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -66.69 -52.8 31.63 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.68 -56.95 10.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -1.212 . . . . 0.0 109.656 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -49.18 -37.65 23.21 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.974 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.87 -40.99 97.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.043 -1.036 . . . . 0.0 110.042 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 82' ' ' VAL . 38.4 mt -61.95 -46.65 88.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.035 -1.041 . . . . 0.0 109.658 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.556 ' O ' ' CG ' ' A' ' 231' ' ' LYS . 55.5 t -60.29 -43.7 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.436 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 232' ' ' ASN . 0.2 OUTLIER -53.09 -40.42 64.1 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.966 -1.084 . . . . 0.0 108.902 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -61.85 -56.02 23.71 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.266 -0.896 . . . . 0.0 110.348 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 228' ' ' VAL . 0.1 OUTLIER -52.0 -19.82 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.967 -1.083 . . . . 0.0 109.206 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.587 ' OD1' ' CG ' ' A' ' 235' ' ' TRP . 0.1 OUTLIER -132.85 94.11 22.04 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.915 . . . . 0.0 109.066 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -84.32 41.38 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.737 2.291 . . . . 0.0 110.862 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 1.9 t -164.22 13.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.635 -1.291 . . . . 0.0 111.869 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.587 ' CG ' ' OD1' ' A' ' 232' ' ' ASN . 26.4 m0 -92.89 174.31 7.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.434 -1.416 . . . . 0.0 109.559 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.5 OUTLIER -104.76 174.01 6.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.527 -0.733 . . . . 0.0 109.148 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -65.97 -25.58 67.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.944 . . . . 0.0 109.736 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.412 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.7 t -78.77 -64.84 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.227 -0.92 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 238' ' ' VAL . 10.9 mm100 -44.68 -37.89 3.99 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.77 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 236' ' ' SER . 55.8 mt -68.4 -55.91 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.363 -0.836 . . . . 0.0 109.906 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 12.5 ttp180 -52.14 -21.89 3.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.054 -1.029 . . . . 0.0 110.008 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -73.0 -59.8 2.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.69 ' O ' HG23 ' A' ' 247' ' ' THR . 19.8 t60 -52.61 -47.96 66.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.383 -0.823 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.554 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -66.84 -37.82 85.21 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.344 -0.847 . . . . 0.0 110.05 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -59.05 -62.82 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.488 -0.758 . . . . 0.0 110.65 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -72.59 -10.71 60.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.512 -0.742 . . . . 0.0 111.558 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 243' ' ' HIS . 2.9 p -81.34 -31.16 33.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.429 -1.419 . . . . 0.0 109.846 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 249' ' ' THR . . . -42.92 115.63 0.77 Allowed 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.966 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.544 ' OG1' ' ND2' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -43.61 169.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.416 -0.802 . . . . 0.0 109.928 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.7 p -121.94 106.2 11.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 109.881 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.768 HD22 ' H ' ' A' ' 251' ' ' LEU . 0.2 OUTLIER -63.03 -57.8 9.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.165 -0.959 . . . . 0.0 109.356 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 135.03 99.64 0.61 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 257' ' ' TYR . 23.0 p -141.82 179.92 6.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -1.185 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 2.1 t -104.16 -24.52 13.15 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.59 -0.694 . . . . 0.0 109.958 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 254' ' ' THR . 2.6 t30 176.04 -24.33 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.353 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.5 -66.43 0.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.934 -1.104 . . . . 0.0 109.779 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 253' ' ' SER . 50.5 m-85 -47.56 -60.65 2.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.333 -0.855 . . . . 0.0 109.049 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 68.76 20.75 74.51 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 191' ' ' ASP . 0.3 OUTLIER -167.57 -100.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.26 . . . . 0.0 109.836 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.795 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 157.86 -160.57 30.83 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.307 -1.425 . . . . 0.0 110.583 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.603 ' CB ' HD11 ' A' ' 251' ' ' LEU . 9.4 tp -104.65 129.87 52.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.518 -0.99 . . . . 0.0 109.461 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.597 HG13 HD12 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -58.73 172.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.085 -1.009 . . . . 0.0 109.943 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.66 117.88 1.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 122.486 1.136 . . . . 0.0 108.408 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 12' ' ' GLN . . . -74.28 -18.85 60.66 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.469 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 269' ' ' ARG . 10.4 tt0 -95.49 -2.18 49.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.502 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.61 0.34 36.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.16 -0.962 . . . . 0.0 109.817 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -130.06 -1.04 4.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.865 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 269' ' ' ARG . 1.4 p -113.13 -35.69 5.3 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.135 -0.978 . . . . 0.0 109.562 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.529 ' OXT' ' CG ' ' A' ' 269' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.623 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.56 ' O ' HG12 ' A' ' 79' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.352 0.596 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.55 149.37 34.84 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.299 -0.876 . . . . 0.0 109.63 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -74.26 108.75 7.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.088 -1.008 . . . . 0.0 109.62 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.7 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -143.07 44.09 0.5 Allowed Pre-proline 0 C--N 1.294 -1.846 0 O-C-N 121.4 -0.812 . . . . 0.0 109.977 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.7 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.8 Cg_endo -78.06 172.39 15.6 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 121.653 1.568 . . . . 0.0 109.112 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -72.83 8.87 1.31 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.07 -1.019 . . . . 0.0 111.096 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.525 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -110.12 -64.97 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.7 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.613 ' HA ' HG22 ' A' ' 11' ' ' VAL . 0.2 OUTLIER -56.46 -30.5 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.032 -1.275 . . . . 0.0 109.896 -179.183 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 m -56.23 -34.56 66.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.98 -1.075 . . . . 0.0 109.849 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.03 -16.0 25.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.119 -0.988 . . . . 0.0 111.594 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 8' ' ' ILE . 3.0 m -85.35 15.64 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.299 -1.501 . . . . 0.0 110.387 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 74.6 mm-40 37.74 45.47 0.65 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 0.0 110.832 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.692 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -72.18 -35.17 3.21 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 111.411 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -72.9 -47.33 0.34 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 N-CA-C 108.162 -1.515 . . . . 0.0 108.162 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.25 -36.69 1.88 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.99 -41.08 60.23 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.507 ' HE2' ' C ' ' A' ' 82' ' ' VAL . 2.2 m-70 -63.45 -16.85 61.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.656 -0.652 . . . . 0.0 110.294 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -106.78 -24.76 11.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.783 -1.198 . . . . 0.0 109.915 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.44 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.4 mmp_? -63.47 -64.86 0.78 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.413 ' C ' HD12 ' A' ' 21' ' ' LEU . . . 158.38 59.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 20' ' ' GLY . 1.7 mp -144.05 132.18 21.76 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.406 -1.056 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.426 ' C ' ' N ' ' A' ' 24' ' ' SER . 47.1 p -125.93 -8.08 6.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.364 -0.835 . . . . 0.0 109.986 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.87 11.5 4.39 Favored Glycine 0 N--CA 1.482 1.74 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.426 ' N ' ' C ' ' A' ' 22' ' ' THR . 12.3 p -60.16 -14.74 18.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 110.072 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -105.17 25.93 23.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.592 HG12 ' N ' ' A' ' 27' ' ' LYS . 57.7 t -132.0 164.97 33.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.001 -1.294 . . . . 0.0 110.091 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' HB3' ' A' ' 117' ' ' MET . 22.9 mtmt -138.85 121.24 16.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 7.7 t -113.84 152.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.985 . . . . 0.0 110.294 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.574 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -110.83 160.48 16.71 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.441 -0.787 . . . . 0.0 108.912 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -140.87 94.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.169 -0.957 . . . . 0.0 108.426 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.993 HD23 HG21 ' A' ' 93' ' ' VAL . 5.8 mp -81.14 116.44 21.05 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -175.7 -161.72 0.09 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.941 -1.099 . . . . 0.0 110.26 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.843 HG23 ' HA2' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -46.78 -37.07 8.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.459 -0.776 . . . . 0.0 109.729 -179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . 155.59 -103.52 0.24 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.588 ' CB ' ' O ' ' A' ' 34' ' ' GLY . 2.0 mt 145.45 101.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 204' ' ' PRO . 0.4 OUTLIER -69.12 151.37 46.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.617 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.56 160.25 7.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.619 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -167.71 147.72 4.5 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 0.0 108.979 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.7 Cg_endo -77.14 -13.99 16.91 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.491 2.128 . . . . 0.0 110.477 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.31 5.27 34.45 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.92 . . . . 0.0 108.918 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 38' ' ' HIS . 22.1 mt -110.22 159.44 17.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 109.106 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.72 76.97 1.56 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.087 -1.008 . . . . 0.0 109.513 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.39 145.8 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.092 -1.005 . . . . 0.0 108.747 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.534 ' CB ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -127.83 -20.95 3.79 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.913 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.557 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -178.22 153.31 12.74 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.82 -177.24 37.88 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.507 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 178.18 113.46 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 92' ' ' LYS . 25.1 m -105.44 111.07 23.65 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.267 -0.896 . . . . 0.0 110.517 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.511 ' CG ' ' HG2' ' A' ' 107' ' ' GLN . 0.4 OUTLIER -89.92 -22.72 21.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.863 HG21 ' O ' ' A' ' 93' ' ' VAL . 1.8 t -62.2 135.25 94.94 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.412 -0.805 . . . . 0.0 108.937 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.19 164.09 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.448 2.098 . . . . 0.0 110.672 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 53' ' ' GLU . . . 162.08 -69.12 0.23 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.824 -1.311 . . . . 0.0 109.824 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.633 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.7 OUTLIER 169.34 -51.01 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.306 -1.114 . . . . 0.0 109.825 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 53' ' ' GLU . 35.5 Cg_endo -77.85 -72.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 121.922 1.748 . . . . 0.0 109.246 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER 86.84 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.586 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.504 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -73.98 13.46 0.53 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.643 -1.286 . . . . 0.0 111.103 -178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 56' ' ' THR . 31.5 mt-30 -147.59 174.74 11.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.533 -1.354 . . . . 0.0 110.477 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HB2' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -57.68 160.78 4.14 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.471 -0.768 . . . . 0.0 110.648 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -139.09 10.15 3.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' HB2' HG21 ' A' ' 33' ' ' THR . 1.3 t-20 -167.25 -65.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -1.117 . . . . 0.0 109.353 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.27 -32.27 0.54 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -45.56 -65.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -1.178 . . . . 0.0 110.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -46.02 -70.89 0.58 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.474 ' C ' ' O ' ' A' ' 63' ' ' GLY . 22.6 m -33.59 -49.4 0.3 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.778 -0.837 . . . . 0.0 111.252 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.614 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.5 t-80 -57.92 -52.65 64.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.067 -1.021 . . . . 0.0 110.344 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.75 HG13 ' HB3' ' A' ' 219' ' ' PRO . 25.4 t -57.17 -37.81 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 110.078 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.76 -41.11 97.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 110.161 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.599 ' HA3' HG22 ' A' ' 202' ' ' THR . . . -68.26 -46.29 65.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.465 HG23 ' NE2' ' A' ' 220' ' ' HIS . 28.6 m -53.14 -29.22 30.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.431 -1.041 . . . . 0.0 108.974 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.0 mt -90.07 -24.31 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 110.04 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.555 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -120.22 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.938 -1.101 . . . . 0.0 111.9 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.051 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 37.62 87.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.509 -0.745 . . . . 0.0 109.868 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' A' ' 73' ' ' LEU . 15.0 mt -52.86 141.75 20.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.47 -1.394 . . . . 0.0 109.682 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 74' ' ' ASN . 2.1 p-10 -89.78 116.36 27.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 109.665 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.513 ' N ' ' ND2' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -174.48 -105.87 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -45.98 1.55 Allowed 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.348 -0.845 . . . . 0.0 109.224 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.488 HG23 ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -72.07 169.87 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 77' ' ' ILE . . . 41.06 -163.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 1' ' ' ALA . 27.4 m -115.91 -162.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.978 . . . . 0.0 109.1 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 3' ' ' SER . 1.9 tp -106.96 121.29 44.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.135 -0.978 . . . . 0.0 109.65 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 1.051 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -88.48 -146.19 12.07 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.682 HG12 HD11 ' A' ' 227' ' ' LEU . 1.9 t -112.23 -34.4 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -1.225 . . . . 0.0 109.841 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.784 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -121.7 128.97 25.38 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.045 -1.035 . . . . 0.0 109.072 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 83' ' ' ALA . 38.1 Cg_endo -85.36 -62.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.646 2.231 . . . . 0.0 110.618 -178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -95.4 37.04 1.2 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.337 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.784 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -82.44 129.06 34.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.45 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' HG3' ' CB ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -61.49 87.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.326 -0.859 . . . . 0.0 109.373 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.555 HD12 ' HB2' ' A' ' 71' ' ' ALA . 2.6 mt -76.49 124.33 27.41 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.078 -1.014 . . . . 0.0 109.741 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.557 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 7.0 m-85 -115.57 152.18 33.54 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.476 -0.765 . . . . 0.0 109.185 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -119.05 98.81 6.36 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.052 -1.03 . . . . 0.0 110.334 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.574 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -103.47 64.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 O-C-N 121.068 -1.02 . . . . 0.0 108.651 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.546 ' HE3' ' HA ' ' A' ' 55' ' ' SER . 7.8 ttmt -37.34 121.91 0.87 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.549 0.69 . . . . 0.0 111.134 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.993 HG21 HD23 ' A' ' 31' ' ' LEU . 25.3 t -123.28 -36.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.01 HD21 HD13 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -130.16 179.56 5.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.843 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 154.79 -140.2 7.24 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 118.256 -1.926 . . . . 0.0 112.186 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 97' ' ' SER . . . -36.99 -60.44 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 122.135 -0.627 . . . . 0.0 110.72 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.464 ' C ' ' O ' ' A' ' 96' ' ' ALA . 42.6 m -41.16 -49.54 3.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.85 88.37 1.56 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.75 ' HA ' HD23 ' A' ' 94' ' ' LEU . 22.7 m 59.44 79.33 0.23 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 99' ' ' SER . . . -46.57 176.99 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.883 -1.151 . . . . 0.0 110.28 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.1 t -83.96 176.73 8.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.649 -0.912 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' A' ' 101' ' ' SER . 44.5 t -68.27 -13.39 16.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 178.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.09 -22.84 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.3 m -85.67 -43.6 13.28 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.727 HD13 HD11 ' A' ' 124' ' ' LEU . 1.6 mt -71.21 -23.27 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.81 -43.52 25.15 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.681 -0.637 . . . . 0.0 109.413 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.511 ' HG2' ' CG ' ' A' ' 49' ' ' PHE . 3.5 tp-100 -69.98 -32.79 71.17 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 -39.05 27.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.723 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 15.0 mt -73.7 -28.1 61.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -1.168 . . . . 0.0 109.707 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -92.33 -21.27 20.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.145 -0.972 . . . . 0.0 109.096 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.485 ' O ' ' CD2' ' A' ' 111' ' ' TRP . 64.7 t90 -76.85 -11.67 59.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.418 -0.801 . . . . 0.0 108.906 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.746 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -97.28 -1.37 44.88 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.471 -1.292 . . . . 0.0 109.302 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.62 -21.61 39.74 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -119.03 -5.84 10.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -1.132 . . . . 0.0 110.252 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -164.65 20.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.804 -1.185 . . . . 0.0 110.563 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -105.31 -152.77 21.29 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.412 -1.375 . . . . 0.0 109.732 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.713 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 10.6 mmt -120.56 -176.73 3.3 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.636 -0.92 . . . . 0.0 110.633 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.677 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -81.1 -25.75 36.73 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.217 -178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.677 ' CG2' ' CE1' ' A' ' 118' ' ' HIS . 2.4 t -114.77 158.38 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.575 -1.328 . . . . 0.0 109.738 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.55 ' HB3' HG13 ' A' ' 147' ' ' VAL . . . -167.29 145.12 4.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.839 ' O ' HD12 ' A' ' 122' ' ' LEU . 10.5 t-20 -115.35 162.18 17.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.919 -1.113 . . . . 0.0 109.454 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 121' ' ' ASN . 3.8 mp -144.97 113.56 6.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.196 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.515 ' C ' HD23 ' A' ' 124' ' ' LEU . 10.8 m -92.7 68.99 4.73 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.157 -0.965 . . . . 0.0 109.381 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.01 HD13 HD21 ' A' ' 94' ' ' LEU . 0.6 OUTLIER 178.54 177.02 0.47 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.22 -0.925 . . . . 0.0 110.002 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.565 ' CA ' ' O ' ' A' ' 161' ' ' TYR . . . 172.17 -79.31 0.09 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER 81.86 162.0 0.12 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.762 -0.846 . . . . 0.0 110.032 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HD2' ' OG ' ' A' ' 126' ' ' SER . 34.8 Cg_endo -76.43 -14.55 18.09 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.514 2.143 . . . . 0.0 109.78 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.41 118.25 60.43 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.77 165.97 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.159 1.906 . . . . 0.0 110.344 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.8 m -168.68 106.41 0.45 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.371 -0.831 . . . . 0.0 109.899 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.7 -18.13 64.81 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.6 m -68.25 -29.21 67.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.41 -42.05 37.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.12 -19.03 61.23 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.747 -1.181 . . . . 0.0 108.153 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 3.2 tt0 -74.43 -26.54 60.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.723 ' HB1' ' HB3' ' A' ' 109' ' ' LEU . . . -76.61 -36.04 57.72 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.493 HG21 ' HB1' ' A' ' 166' ' ' ALA . 1.3 t -70.57 -29.67 39.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -38.57 84.08 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.1 -25.12 58.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -85.95 -6.82 58.99 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 53.6 m -86.57 -51.99 5.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.1 -1.0 . . . . 0.0 109.141 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.03 -18.27 45.11 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -20.55 16.52 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 78.51 0.5 Allowed Glycine 0 N--CA 1.478 1.465 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 118' ' ' HIS . 22.1 t -131.43 118.11 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -1.061 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tp -80.91 122.19 26.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.209 -0.932 . . . . 0.0 108.961 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.55 HG13 ' HB3' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -115.27 151.74 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.636 HG12 ' ND2' ' A' ' 121' ' ' ASN . 2.7 t -119.22 159.79 19.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -146.88 135.1 21.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.869 -1.144 . . . . 0.0 110.409 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.454 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -67.12 174.83 2.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.664 -0.648 . . . . 0.0 109.553 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 15.2 t -73.03 -82.25 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 145.57 120.65 1.34 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.381 -1.888 . . . . 0.0 108.381 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.428 ' C ' ' OG ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -86.35 60.11 6.04 Favored 'General case' 0 C--N 1.288 -2.105 0 O-C-N 121.922 -0.752 . . . . 0.0 109.598 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.535 ' O ' ' C ' ' A' ' 155' ' ' GLY . 0.0 OUTLIER 171.61 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.164 -0.96 . . . . 0.0 110.898 179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 156' ' ' ALA . . . -19.69 -50.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.237 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 155' ' ' GLY . . . 90.57 63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.786 0.803 . . . . 0.0 110.496 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 73.16 -3.09 32.18 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 159' ' ' ILE . 15.0 m -134.22 122.83 23.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.082 -1.246 . . . . 0.0 109.562 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -51.18 179.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.806 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -105.92 173.3 6.37 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.554 1.169 . . . . 0.0 112.526 -177.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.565 ' O ' ' CA ' ' A' ' 125' ' ' GLY . 24.4 m-85 -108.94 144.75 30.28 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 164' ' ' ARG . 43.1 Cg_endo -72.88 -31.82 4.91 Favored 'Cis proline' 0 C--N 1.297 -2.181 0 O-C-N 122.33 0.647 . . . . 0.0 111.27 4.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -4.1 -61.25 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.604 0.716 . . . . 0.0 111.656 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.632 ' N ' ' O ' ' A' ' 162' ' ' PRO . 9.6 tpt180 -48.77 -65.9 0.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.604 -0.685 . . . . 0.0 109.919 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.724 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 38.1 p90 -121.75 -163.43 1.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.922 0.868 . . . . 0.0 110.676 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 165' ' ' TYR . . . 80.1 49.3 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.648 0.737 . . . . 0.0 109.589 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 166' ' ' ALA . 23.0 m-80 41.77 28.76 0.09 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -112.49 116.32 30.08 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.305 -0.872 . . . . 0.0 109.91 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.475 ' HB2' HG22 ' A' ' 148' ' ' VAL . 73.5 mmm -63.64 171.83 2.44 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.293 -0.88 . . . . 0.0 108.792 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -137.02 114.42 10.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 0.0 109.813 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.653 HG22 HG21 ' A' ' 221' ' ' VAL . 27.5 t -99.68 166.05 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.029 -1.044 . . . . 0.0 109.653 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -148.8 108.4 0.4 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -52.01 149.58 4.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.28 . . . . 0.0 109.541 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.479 ' HB2' ' C ' ' A' ' 180' ' ' ARG . 6.2 t0 -115.46 -149.5 0.45 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -0.871 . . . . 0.0 110.131 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 177' ' ' ASN . 56.7 tt0 -40.3 -43.62 1.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.458 -0.776 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.466 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 7.4 m-20 164.47 119.86 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.94 38.38 28.69 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.216 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -132.07 -18.12 2.67 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.197 -0.94 . . . . 0.0 110.282 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.479 ' C ' ' HB2' ' A' ' 175' ' ' ASP . 1.8 ttp85 66.79 126.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 109.188 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -42.47 163.64 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.591 -0.693 . . . . 0.0 109.901 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.9 p -84.31 4.88 29.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.289 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.452 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 6.2 p90 -137.93 11.74 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 181' ' ' ALA . 33.7 t -87.75 105.58 17.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.399 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.603 ' HG2' ' N ' ' A' ' 155' ' ' GLY . 1.5 mp0 -52.38 154.46 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -0.962 . . . . 0.0 110.118 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.514 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.75 168.2 19.99 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.514 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 173.12 144.47 4.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -58.72 131.31 50.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -1.149 . . . . 0.0 109.322 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 105.43 -1.15 39.95 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.482 ' HG ' ' N ' ' A' ' 191' ' ' ASP . 6.6 tp -60.94 146.79 45.55 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.28 -1.129 . . . . 0.0 109.371 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.4 OUTLIER -73.68 -80.05 0.08 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.059 -1.026 . . . . 0.0 110.368 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.696 HG13 HG22 ' A' ' 262' ' ' VAL . 0.2 OUTLIER -152.75 -169.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.781 -1.199 . . . . 0.0 109.516 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.547 ' N ' HG12 ' A' ' 192' ' ' ILE . 32.6 m -126.59 162.16 31.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 121.009 -1.057 . . . . 0.0 110.163 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.904 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -145.76 140.4 15.68 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.509 ' HG2' ' HA2' ' A' ' 7' ' ' GLY . 34.6 Cg_endo -76.17 112.95 3.59 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.449 2.099 . . . . 0.0 111.115 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.573 ' O ' ' C ' ' A' ' 197' ' ' VAL . . . -114.12 -67.79 0.47 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 78.0 t 5.52 71.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 CA-C-O 121.321 0.582 . . . . 0.0 111.489 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.713 ' O ' HG13 ' A' ' 199' ' ' VAL . 9.5 t-20 99.13 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 198' ' ' ASN . 7.3 m -163.41 110.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 122.149 0.976 . . . . 0.0 109.259 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.538 ' CG ' ' OG ' ' A' ' 210' ' ' SER . 6.3 mt-30 -77.43 129.52 35.86 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.614 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.2 OUTLIER -135.95 -153.46 0.51 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.042 -1.036 . . . . 0.0 109.64 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.599 HG22 ' HA3' ' A' ' 68' ' ' GLY . 9.8 t -102.94 177.32 4.87 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.665 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -144.63 -179.45 0.95 Allowed Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.665 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 37.0 Cg_endo -73.38 -151.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.98 1.787 . . . . 0.0 109.515 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . -37.62 -29.7 0.05 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 204' ' ' PRO . 17.8 t -48.39 -97.33 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.256 -1.144 . . . . 0.0 109.926 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.573 HG23 ' N ' ' A' ' 208' ' ' TYR . 5.2 t 175.53 -120.33 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.573 ' N ' HG23 ' A' ' 207' ' ' THR . 0.6 OUTLIER -78.33 -170.38 2.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.868 -1.145 . . . . 0.0 109.748 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -173.24 -178.67 1.78 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.319 -0.863 . . . . 0.0 109.768 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.538 ' OG ' ' CG ' ' A' ' 200' ' ' GLN . 0.1 OUTLIER -174.21 139.34 0.62 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.56 HD12 ' SD ' ' A' ' 216' ' ' MET . 0.1 OUTLIER -175.63 162.29 2.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.258 -0.901 . . . . 0.0 109.719 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -106.08 173.5 6.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.438 -0.788 . . . . 0.0 109.226 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 147.18 147.61 4.58 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 151' ' ' SER . 23.2 m -73.92 -22.5 59.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.131 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.466 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 71.2 m -74.15 -9.94 59.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.382 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.56 ' SD ' HD12 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -86.45 -19.59 29.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.314 -0.866 . . . . 0.0 109.6 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.904 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -90.36 -14.06 33.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.659 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 0.3 OUTLIER -71.07 -39.28 8.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 0.0 111.452 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.75 ' HB3' HG13 ' A' ' 66' ' ' VAL . 31.7 Cg_endo -73.25 -28.63 12.32 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.761 1.641 . . . . 0.0 110.561 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.465 ' NE2' HG23 ' A' ' 69' ' ' THR . 7.9 m80 -61.91 -35.67 79.05 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 171' ' ' VAL . 33.8 t -75.73 -39.06 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.14 -27.67 67.27 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 -63.86 2.37 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.833 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -45.39 -42.09 9.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -1.168 . . . . 0.0 109.334 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -60.53 -44.52 95.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.459 -0.775 . . . . 0.0 109.171 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.86 -40.91 73.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.165 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.833 HD12 ' HA ' ' A' ' 224' ' ' ALA . 5.1 mt -61.88 -45.15 95.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.333 -0.854 . . . . 0.0 109.328 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 229' ' ' LYS . 75.7 t -57.9 -67.7 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.573 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -40.02 -43.04 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.709 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.475 ' O ' ' HD3' ' A' ' 233' ' ' PRO . 14.9 tm0? -58.37 -54.11 50.71 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.224 -0.923 . . . . 0.0 110.018 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 228' ' ' VAL . 0.0 OUTLIER -56.79 -17.26 8.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.188 -0.945 . . . . 0.0 108.917 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 m-20 -156.57 81.18 3.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.532 -0.73 . . . . 0.0 109.709 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 36.6 Cg_endo -81.14 40.32 0.98 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.757 2.305 . . . . 0.0 110.663 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.41 7.68 3.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.136 -0.978 . . . . 0.0 109.762 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.416 ' CZ2' ' ND2' ' A' ' 232' ' ' ASN . 45.1 m0 -91.05 175.03 7.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.148 -0.97 . . . . 0.0 109.775 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.37 8.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.433 -0.792 . . . . 0.0 108.989 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 237' ' ' ASN . 2.0 m-80 -58.11 -32.75 68.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.13 -0.981 . . . . 0.0 109.126 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.9 t -71.88 -63.64 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.31 -0.869 . . . . 0.0 109.09 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 238' ' ' VAL . 0.8 OUTLIER -42.01 -42.06 2.73 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.379 0.609 . . . . 0.0 109.809 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 9.4 mm -63.06 -47.89 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.847 . . . . 0.0 109.302 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' ASN . 0.6 OUTLIER -58.41 -62.64 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -40.33 -43.12 1.69 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.439 -0.788 . . . . 0.0 110.422 -179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.462 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.9 t60 -70.67 -38.44 73.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.9 -1.125 . . . . 0.0 110.223 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.8 OUTLIER -73.3 -22.5 60.34 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.452 -0.78 . . . . 0.0 110.019 -179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -84.48 -34.33 23.41 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.349 -0.845 . . . . 0.0 108.942 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -85.97 -17.17 36.09 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.59 -0.694 . . . . 0.0 109.312 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 5.0 p -88.24 -34.26 17.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.164 -0.96 . . . . 0.0 109.402 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -47.04 133.83 11.05 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.463 ' OG1' ' OD1' ' A' ' 263' ' ' ASN . 2.9 m -57.87 152.4 16.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.172 -0.955 . . . . 0.0 109.704 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 259' ' ' SER . 25.8 p -120.48 98.63 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.884 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.4 mp -53.39 -62.53 1.6 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.08 -1.012 . . . . 0.0 109.343 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -178.65 -33.73 0.06 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.48 159.47 4.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.246 -1.149 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.478 ' O ' ' OG1' ' A' ' 254' ' ' THR . 0.0 OUTLIER -141.17 30.17 1.8 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.669 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -167.77 -51.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.01 -1.056 . . . . 0.0 109.374 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.457 ' HA ' ' CE1' ' A' ' 186' ' ' TYR . 7.3 mt -63.43 -56.24 17.82 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 109.066 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -85.45 -46.43 10.9 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.256 -0.902 . . . . 0.0 109.368 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 89.9 -33.04 4.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.525 ' CB ' HG22 ' A' ' 192' ' ' ILE . 1.5 m -141.42 -98.84 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -1.135 . . . . 0.0 109.331 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.51 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 162.19 -124.56 1.31 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.472 -1.347 . . . . 0.0 110.169 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -84.65 135.11 34.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.592 -0.946 . . . . 0.0 110.163 -179.252 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.696 HG22 HG13 ' A' ' 192' ' ' ILE . 1.4 t -78.6 144.44 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.463 ' OD1' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -160.88 118.28 2.38 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.512 1.149 . . . . 0.0 108.604 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.76 -28.23 62.49 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.395 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 2.3 tm-20 -63.12 -28.86 70.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.261 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -80.15 -18.19 50.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.379 -0.826 . . . . 0.0 109.245 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -107.11 9.87 30.29 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 269' ' ' ARG . 17.3 p -128.38 -67.53 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 268' ' ' THR . 8.3 tpt180 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.626 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.353 0.597 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.83 135.2 45.16 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.368 -0.832 . . . . 0.0 110.551 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.508 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -86.13 128.86 34.96 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -115.32 86.4 14.53 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.977 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 3' ' ' SER . 37.0 Cg_endo -80.87 -175.01 2.46 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.973 2.449 . . . . 0.0 111.575 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.635 ' CZ2' ' HB ' ' A' ' 197' ' ' VAL . 0.0 OUTLIER -55.58 -74.7 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.442 0.639 . . . . 0.0 110.52 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 6' ' ' TRP . . . -40.12 -83.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.688 HD12 ' H ' ' A' ' 8' ' ' ILE . 2.4 mp -41.65 102.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.451 -1.029 . . . . 0.0 109.741 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.4 OUTLIER 167.9 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.815 . . . . 0.0 109.202 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' NH2' HD22 ' A' ' 261' ' ' LEU . 1.2 ttp85 -93.47 4.44 53.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.316 -0.865 . . . . 0.0 109.895 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' H ' HG22 ' A' ' 11' ' ' VAL . 3.5 m -94.48 25.44 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.01 -1.056 . . . . 0.0 109.818 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 11' ' ' VAL . 88.1 mm-40 43.03 46.96 4.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.159 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.67 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -81.45 -35.62 0.78 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 111.433 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.7 Cg_endo -74.42 -55.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.034 0 N-CA-C 108.222 -1.491 . . . . 0.0 108.222 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.56 -34.63 3.45 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' HD12 ' A' ' 21' ' ' LEU . . . -71.47 -41.57 69.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.9 -1.125 . . . . 0.0 109.147 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.508 ' NE2' ' O ' ' A' ' 82' ' ' VAL . 7.4 m170 -75.79 -2.9 32.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.478 -0.764 . . . . 0.0 109.702 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -115.08 -11.0 12.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 110.117 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -73.67 0.18 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 109.404 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.76 30.77 0.06 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.858 HD23 ' HG3' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -142.89 145.4 33.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.188 -1.184 . . . . 0.0 109.391 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -123.6 -9.93 7.89 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.365 -0.835 . . . . 0.0 109.711 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -7.47 16.66 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 24' ' ' SER . 51.7 p -60.05 94.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -1.121 . . . . 0.0 109.553 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 139.28 -4.47 2.85 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.228 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.621 ' CG1' ' CE1' ' A' ' 118' ' ' HIS . 5.3 t -97.49 160.99 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.907 -1.349 . . . . 0.0 109.904 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB3' ' HG3' ' A' ' 117' ' ' MET . 0.3 OUTLIER -125.84 117.29 23.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 110.016 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.56 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 13.7 t -107.37 145.1 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.597 -0.689 . . . . 0.0 109.315 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -106.56 155.59 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 109.613 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG22 ' CD1' ' A' ' 70' ' ' ILE . 41.7 t -128.59 86.69 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.595 HD23 HG21 ' A' ' 93' ' ' VAL . 2.5 mp -81.72 90.33 6.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.665 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.541 ' HA ' HD12 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -157.03 -146.7 0.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 108.747 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.514 ' O ' ' CG ' ' A' ' 92' ' ' LYS . 0.6 OUTLIER -57.28 -73.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.586 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -166.46 -126.93 0.86 Allowed Glycine 0 N--CA 1.476 1.363 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.735 HD12 ' HB2' ' A' ' 90' ' ' ALA . 8.0 mt -167.4 88.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 20.5 t -47.82 141.5 5.58 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.042 -1.036 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.58 141.92 56.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.387 -0.821 . . . . 0.0 109.243 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.606 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -161.4 157.12 21.28 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.226 -0.921 . . . . 0.0 109.35 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 35.8 Cg_endo -78.75 -6.01 15.01 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.736 2.291 . . . . 0.0 111.111 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -93.47 -21.48 19.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.89 -1.131 . . . . 0.0 109.993 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 38' ' ' HIS . 0.2 OUTLIER -117.09 150.16 39.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.045 -1.034 . . . . 0.0 109.712 -179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.19 116.42 31.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.523 -0.735 . . . . 0.0 109.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.41 111.56 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.114 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 87' ' ' GLU . 62.6 mmt-85 -118.79 11.23 12.61 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.675 ' HA3' ' CD2' ' A' ' 89' ' ' TYR . . . -174.34 142.57 6.49 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -154.17 84.82 0.15 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.487 -1.339 . . . . 0.0 110.645 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 124.49 45.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 108.652 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.585 ' HB2' ' CE ' ' A' ' 92' ' ' LYS . 6.5 p -111.43 117.77 33.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.001 -1.062 . . . . 0.0 110.416 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.921 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 21.4 m-85 -86.12 -77.77 0.3 Allowed 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.285 -0.884 . . . . 0.0 108.732 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' ' NZ ' ' A' ' 92' ' ' LYS . 77.5 t -38.94 94.39 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.939 -0.475 . . . . 0.0 109.739 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' CD ' ' O ' ' A' ' 49' ' ' PHE . 37.4 Cg_endo -87.63 154.59 7.61 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.274 1.982 . . . . 0.0 111.822 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 53' ' ' GLU . . . 100.1 26.95 8.05 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.387 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.662 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.4 OUTLIER 178.84 -70.41 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.978 0 CA-C-N 120.716 2.258 . . . . 0.0 114.138 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.662 ' HD3' ' CB ' ' A' ' 53' ' ' GLU . 39.4 Cg_endo -76.79 -102.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 C-N-CA 121.429 1.42 . . . . 0.0 112.849 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.631 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 3.5 t 144.4 175.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.515 HG22 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER -77.33 0.22 23.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.462 ' O ' ' C ' ' A' ' 58' ' ' ASP . 2.0 mt-30 -110.92 -172.42 2.03 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.108 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 36' ' ' SER . 29.2 t70 -32.43 142.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.569 0.699 . . . . 0.0 110.916 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.3 -40.25 0.06 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -144.39 -65.63 0.35 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.478 -1.013 . . . . 0.0 109.319 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.48 -31.25 0.52 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.543 ' CE1' ' OG ' ' A' ' 215' ' ' SER . 2.5 t-160 -61.37 -43.43 98.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -1.147 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -57.4 -74.66 0.31 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.57 ' CG2' ' N ' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -38.28 -49.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.51 -0.994 . . . . 0.0 110.557 -179.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 12.9 t-80 -52.29 -50.79 61.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.159 -0.963 . . . . 0.0 109.458 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 70' ' ' ILE . 31.4 t -62.27 -29.58 46.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.404 -0.81 . . . . 0.0 109.584 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 64' ' ' THR . . . -61.3 -47.43 85.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.342 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.458 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -75.81 -23.09 73.3 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.714 -1.754 . . . . 0.0 108.714 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.564 ' CG2' ' HG2' ' A' ' 219' ' ' PRO . 8.3 m -74.58 -14.86 60.84 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.084 -1.245 . . . . 0.0 107.875 178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.545 HD11 HG12 ' A' ' 66' ' ' VAL . 62.6 mt -94.73 -35.46 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.503 -0.748 . . . . 0.0 110.829 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.671 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -165.5 27.93 0.05 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.552 -1.342 . . . . 0.0 112.37 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 71' ' ' ALA . . . -44.19 153.87 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.444 -1.41 . . . . 0.0 108.635 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 79' ' ' VAL . 73.9 mt -75.86 171.95 13.53 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.95 -1.094 . . . . 0.0 110.205 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.797 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -103.64 51.57 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 0.0 109.917 -179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.555 ' O ' ' C ' ' A' ' 76' ' ' SER . 0.1 OUTLIER -177.07 -115.31 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.568 ' O ' ' C ' ' A' ' 77' ' ' ILE . 12.3 m 22.28 71.59 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 O-C-N 122.335 -0.228 . . . . 0.0 110.956 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.58 ' O ' HD12 ' A' ' 77' ' ' ILE . 1.3 pp 14.79 57.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.664 0.745 . . . . 0.0 111.578 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 76' ' ' SER . . . -154.87 -161.27 10.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.418 ' H ' HG22 ' A' ' 79' ' ' VAL . 21.9 m -95.9 -161.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.275 -1.132 . . . . 0.0 109.861 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD22 ' HB3' ' A' ' 74' ' ' ASN . 20.2 tp -143.42 123.45 13.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.879 . . . . 0.0 109.838 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.83 -148.9 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.508 ' O ' ' NE2' ' A' ' 17' ' ' HIS . 40.7 t -100.16 -25.98 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.086 -1.243 . . . . 0.0 109.325 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -99.65 137.14 20.18 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.977 . . . . 0.0 108.754 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.47 -61.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.72 2.28 . . . . 0.0 111.018 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -117.48 48.52 1.34 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.525 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -87.78 150.41 23.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.112 -0.992 . . . . 0.0 109.402 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 44' ' ' ARG . 2.5 mt-10 -81.85 108.42 15.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 109.156 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 71' ' ' ALA . 8.6 mt -85.45 124.94 32.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.675 ' CD2' ' HA3' ' A' ' 45' ' ' GLY . 7.6 m-85 -113.76 143.18 45.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.54 -0.725 . . . . 0.0 109.166 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.735 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -111.97 95.4 5.45 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.127 -0.983 . . . . 0.0 109.64 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.921 HG12 ' CZ ' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -99.63 62.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.083 -1.011 . . . . 0.0 108.897 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.585 ' CE ' ' HB2' ' A' ' 48' ' ' SER . 12.2 ttpp -36.81 116.66 0.45 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.282 0.563 . . . . 0.0 110.077 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG21 HD23 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -122.58 0.48 6.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 32' ' ' ASP . 62.8 mt -119.34 174.7 6.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.46 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -119.6 146.08 18.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.26 -19.38 33.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.008 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.01 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.413 -0.805 . . . . 0.0 109.347 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.34 42.97 0.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.7 p -178.1 77.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.095 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -67.81 179.4 17.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 155.18 20.85 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.769 -0.842 . . . . 0.0 109.654 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.513 HG21 ' OG ' ' A' ' 130' ' ' SER . 20.0 t -67.75 -20.74 26.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 -20.53 60.37 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -86.3 -47.33 9.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.68 -0.637 . . . . 0.0 109.581 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.449 ' HA ' ' CG2' ' A' ' 93' ' ' VAL . 1.5 mt -67.2 -34.17 67.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.321 -0.862 . . . . 0.0 109.189 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' A' ' 110' ' ' GLU . . . -71.92 -43.57 65.07 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.917 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.483 ' OE1' ' HB3' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -69.56 -31.19 69.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.813 -1.18 . . . . 0.0 109.882 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.423 ' HA2' ' CZ ' ' A' ' 49' ' ' PHE . . . -82.19 -18.16 67.66 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.78 -34.5 27.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -1.149 . . . . 0.0 110.022 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.52 ' HG2' ' OG ' ' A' ' 139' ' ' SER . 3.9 mt-10 -90.1 -19.19 24.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.891 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.608 ' CE2' ' O ' ' A' ' 115' ' ' ASN . 84.5 t90 -68.18 -25.04 65.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.132 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.641 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -90.5 5.9 45.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.898 -1.126 . . . . 0.0 109.412 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -94.91 -36.49 5.5 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.209 -1.956 . . . . 0.0 108.209 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -106.19 -23.15 12.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -1.095 . . . . 0.0 109.224 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.608 ' O ' ' CE2' ' A' ' 111' ' ' TRP . 0.0 OUTLIER -173.06 89.38 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.386 -0.821 . . . . 0.0 108.994 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.641 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . 172.8 50.75 0.05 OUTLIER Glycine 0 C--N 1.291 -1.971 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.469 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.764 ' HE3' ' H ' ' A' ' 117' ' ' MET . 0.0 OUTLIER 62.52 163.3 0.09 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.473 -1.016 . . . . 0.0 112.062 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.777 ' CE1' HG23 ' A' ' 119' ' ' VAL . 9.7 p80 -98.15 -30.16 12.81 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.777 HG23 ' CE1' ' A' ' 118' ' ' HIS . 4.8 t -95.84 157.72 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.836 -1.165 . . . . 0.0 108.901 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -167.5 124.57 1.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.627 ' C ' HD12 ' A' ' 122' ' ' LEU . 15.7 t-20 -102.53 166.96 10.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.872 HD23 HD21 ' A' ' 124' ' ' LEU . 3.5 mp -146.88 112.65 5.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.0 109.865 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.2 t -90.14 62.38 5.48 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.872 HD21 HD23 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -146.93 -174.12 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.63 0.729 . . . . 0.0 110.213 -179.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.506 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 160.42 109.57 0.25 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.95 154.7 81.49 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.043 -1.269 . . . . 0.0 109.814 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.546 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -78.67 5.4 5.62 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.76 2.306 . . . . 0.0 110.099 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 m -110.63 82.43 2.88 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 121.726 -0.609 . . . . 0.0 109.992 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.4 Cg_endo -76.93 171.48 17.9 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.393 2.062 . . . . 0.0 110.754 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.513 ' OG ' HG21 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -144.01 134.47 24.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 108.977 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.52 -22.56 66.17 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.9 m -70.91 -28.22 64.37 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -24.74 53.01 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.55 -55.72 5.27 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.135 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -53.77 -25.01 16.99 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.33 53.69 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.67 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.616 HG11 ' ND2' ' A' ' 167' ' ' ASN . 2.2 t -71.94 -19.36 19.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 142' ' ' SER . 1.2 t30 -76.1 -29.39 57.89 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.52 ' OG ' ' HG2' ' A' ' 110' ' ' GLU . 1.0 OUTLIER -88.13 -19.05 27.5 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.239 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 145' ' ' VAL . . . -93.39 -26.21 17.35 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 120.636 -1.29 . . . . 0.0 110.558 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.98 -34.14 13.17 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 138' ' ' ASN . 8.0 t -67.54 -24.69 65.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -81.14 -16.95 51.53 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 237' ' ' ASN . . . 91.7 50.34 2.73 Favored Glycine 0 N--CA 1.474 1.183 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 118' ' ' HIS . 70.7 t -113.75 111.11 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -1.207 . . . . 0.0 109.234 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.475 HD23 HG13 ' A' ' 119' ' ' VAL . 1.8 tp -69.96 126.39 29.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.043 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -120.19 137.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.148 -0.97 . . . . 0.0 109.922 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.736 HG22 ' HG3' ' A' ' 169' ' ' MET . 8.9 t -121.05 166.77 15.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.506 ' C ' HG21 ' A' ' 218' ' ' THR . . . -153.61 140.65 19.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.944 -1.098 . . . . 0.0 109.555 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.584 ' N ' HG21 ' A' ' 218' ' ' THR . . . -75.95 153.42 36.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.495 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 4.6 t -77.96 -71.7 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 185' ' ' GLN . . . 164.67 119.02 0.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -87.51 56.62 4.01 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 122.062 -0.669 . . . . 0.0 109.868 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.3 p -137.12 -108.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.156 -0.965 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.613 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . -103.06 -95.98 2.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 167.58 74.16 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.324 -1.103 . . . . 0.0 109.89 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -106.91 43.63 1.65 Allowed Glycine 0 C--N 1.287 -2.166 0 N-CA-C 108.459 -1.856 . . . . 0.0 108.459 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 1.2 p 80.53 131.68 0.05 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.832 -0.804 . . . . 0.0 109.657 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -55.08 -169.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.913 . . . . 0.0 110.364 -179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.764 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -139.08 164.64 29.23 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.573 -0.704 . . . . 0.0 111.822 -178.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.504 ' O ' ' HA2' ' A' ' 125' ' ' GLY . 1.5 m-85 -79.45 145.52 63.83 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.3 Cg_endo -71.53 -33.96 3.51 Favored 'Cis proline' 0 C--N 1.295 -2.256 0 O-C-N 122.566 0.772 . . . . 0.0 110.942 4.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.764 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -31.09 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.006 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -79.68 -49.14 12.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.802 -1.186 . . . . 0.0 109.987 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.496 ' O ' ' O ' ' A' ' 164' ' ' ARG . 2.7 m-85 -46.78 -179.52 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.006 0.908 . . . . 0.0 110.416 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -100.4 -8.12 23.62 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.746 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.616 ' ND2' HG11 ' A' ' 137' ' ' VAL . 10.7 p30 -88.65 20.84 3.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -159.16 142.11 14.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 108.893 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.736 ' HG3' HG22 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -95.41 131.91 41.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.159 -0.963 . . . . 0.0 109.671 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 190' ' ' LEU . . . -95.47 114.82 26.62 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 108.857 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 25.3 t -94.19 165.71 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.569 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -144.23 -175.06 17.03 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -123.64 164.24 19.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -1.074 . . . . 0.0 109.056 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p -142.74 167.85 21.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.466 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 179' ' ' ASN . 0.5 OUTLIER -66.43 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.33 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.73 -32.62 11.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.147 -0.97 . . . . 0.0 109.862 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.65 -78.23 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.701 ' CG ' HD23 ' A' ' 251' ' ' LEU . 39.4 t-20 -173.07 45.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.132 -0.98 . . . . 0.0 109.741 -179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 175' ' ' ASP . 24.4 t30 -135.9 167.27 21.51 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.044 -1.035 . . . . 0.0 109.553 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.497 ' HA ' ' OH ' ' A' ' 257' ' ' TYR . 8.5 ttt-85 -45.79 138.65 4.64 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.774 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.87 -134.18 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.643 -0.661 . . . . 0.0 109.409 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.0 m -127.86 -31.53 2.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.883 -1.135 . . . . 0.0 109.734 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' SER . 24.5 p90 -123.47 -3.19 8.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.875 . . . . 0.0 109.65 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.3 OUTLIER -44.09 107.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.207 -0.933 . . . . 0.0 109.782 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 155' ' ' GLY . 0.3 OUTLIER -58.15 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.646 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.684 ' HE2' ' HB2' ' A' ' 188' ' ' ALA . 1.2 t80 -50.07 -167.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.758 0.789 . . . . 0.0 111.638 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.548 ' CA ' HD22 ' A' ' 190' ' ' LEU . . . -173.1 23.06 0.07 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.48 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.684 ' HB2' ' HE2' ' A' ' 186' ' ' TYR . . . -75.84 97.78 4.0 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.685 -0.891 . . . . 0.0 109.445 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 91.38 -22.67 28.79 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -45.15 154.74 0.14 Allowed 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.505 -0.997 . . . . 0.0 109.626 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 192' ' ' ILE . 51.9 t0 -55.03 -87.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.815 . . . . 0.0 110.891 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.669 HG22 ' OG ' ' A' ' 259' ' ' SER . 0.5 OUTLIER -146.7 -157.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.913 -1.117 . . . . 0.0 110.064 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 262' ' ' VAL . 30.3 m -143.0 168.55 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.094 -1.004 . . . . 0.0 109.796 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -151.56 160.85 31.1 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.41 -0.806 . . . . 0.0 109.074 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.6 Cg_endo -74.87 115.23 4.23 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.338 2.025 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -152.06 60.9 0.4 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.321 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.635 ' HB ' ' CZ2' ' A' ' 6' ' ' TRP . 47.5 t -97.62 70.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 0.3 OUTLIER 111.62 119.68 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -177.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 216' ' ' MET . 1.7 m -156.27 112.9 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-O 122.07 0.938 . . . . 0.0 108.484 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.6 OUTLIER -89.86 171.2 9.77 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.624 0.726 . . . . 0.0 110.071 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.585 ' HB2' ' CD2' ' A' ' 65' ' ' HIS . 20.4 m -167.56 -146.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.539 -0.726 . . . . 0.0 109.074 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.418 HG21 HD11 ' A' ' 41' ' ' LEU . 77.1 p -92.68 150.08 20.91 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.128 -0.982 . . . . 0.0 110.068 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.582 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 2.1 t80 -140.55 142.46 29.07 Favored Pre-proline 0 N--CA 1.487 1.384 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.3 Cg_endo -72.04 156.94 55.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.312 2.008 . . . . 0.0 110.986 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 36.41 54.48 1.31 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 26.4 t -179.83 -107.62 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.094 -1.239 . . . . 0.0 109.719 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.551 HG23 ' N ' ' A' ' 208' ' ' TYR . 4.3 t -175.45 -118.81 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.438 -0.789 . . . . 0.0 109.119 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.551 ' N ' HG23 ' A' ' 207' ' ' THR . 0.1 OUTLIER -89.24 142.76 27.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.738 -1.226 . . . . 0.0 109.632 -179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -125.71 111.39 14.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.642 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.3 OUTLIER -83.08 132.35 35.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.437 -0.789 . . . . 0.0 109.697 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 211' ' ' LEU . 1.0 OUTLIER -167.24 138.72 3.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.147 -0.97 . . . . 0.0 109.876 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -88.89 147.51 24.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.342 -0.849 . . . . 0.0 108.927 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 170.55 146.3 5.1 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.003 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 9.7 p -66.51 -27.17 67.56 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.274 -1.133 . . . . 0.0 108.521 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.543 ' OG ' ' CE1' ' A' ' 62' ' ' HIS . 0.1 OUTLIER -55.63 -22.37 22.27 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.62 ' CB ' HG21 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -85.57 -29.79 23.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -82.36 -23.0 35.25 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.165 -0.959 . . . . 0.0 110.369 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.654 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 4.9 m -66.41 -46.15 59.52 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.895 -1.128 . . . . 0.0 110.952 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.2 Cg_endo -73.07 -12.98 26.08 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.919 1.746 . . . . 0.0 109.931 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -74.11 -42.4 60.12 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.734 HG22 HG11 ' A' ' 262' ' ' VAL . 74.2 t -70.74 -48.83 55.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -46.11 -43.23 14.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -61.51 -45.37 96.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -52.84 -54.08 39.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -1.041 . . . . 0.0 109.472 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -52.04 -34.58 43.94 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -59.94 -47.24 86.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 0.0 109.214 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.5 HD13 ' HB1' ' A' ' 16' ' ' ALA . 67.3 mt -59.8 -29.23 68.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 229' ' ' LYS . 36.4 t -69.57 -62.22 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.31 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' ' CE1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -41.9 -47.07 4.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.695 . . . . 0.0 109.714 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.534 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 5.0 tp-100 -59.62 -49.38 77.99 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.167 -0.958 . . . . 0.0 109.751 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.858 ' HG3' HD23 ' A' ' 21' ' ' LEU . 6.0 tttm -54.31 -19.3 5.16 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.486 ' HB2' ' CD2' ' A' ' 235' ' ' TRP . 19.0 m120 -160.93 92.05 1.54 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.344 -0.848 . . . . 0.0 109.967 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.6 -11.9 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.415 2.077 . . . . 0.0 110.303 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.3 m -87.49 -8.87 55.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.249 -0.907 . . . . 0.0 109.463 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.486 ' CD2' ' HB2' ' A' ' 232' ' ' ASN . 25.3 m0 -69.65 179.62 2.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.556 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.18 178.22 5.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.461 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.523 ' HB3' ' HA2' ' A' ' 144' ' ' GLY . 18.7 p-10 -52.62 -25.63 11.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 109.42 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.67 -65.4 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.14 -0.975 . . . . 0.0 109.226 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 0.5 OUTLIER -44.76 -25.84 0.33 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.333 0.587 . . . . 0.0 109.967 -178.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 11.7 mt -92.06 -63.65 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.619 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 242' ' ' ASN . 15.2 ttp180 -58.2 -63.43 1.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 109.857 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.462 ' C ' ' O ' ' A' ' 241' ' ' ARG . 46.3 t30 -37.83 -44.85 0.78 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.459 -0.775 . . . . 0.0 110.705 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.39 -43.85 93.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 110.082 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.519 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 1.4 mt -68.57 -34.0 75.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.362 -0.836 . . . . 0.0 110.95 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -23.53 55.78 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.78 -4.38 26.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.606 -0.684 . . . . 0.0 109.567 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.4 p -98.48 -28.36 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.9 -1.125 . . . . 0.0 109.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -42.27 142.55 0.75 Allowed 'General case' 0 C--N 1.282 -2.339 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 250' ' ' SER . 18.9 m -75.13 164.87 26.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.225 -0.922 . . . . 0.0 109.007 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.574 ' N ' HG22 ' A' ' 249' ' ' THR . 20.5 p -133.04 116.64 16.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.021 -1.05 . . . . 0.0 110.226 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.701 HD23 ' CG ' ' A' ' 178' ' ' ASN . 6.8 mp -86.5 -72.28 0.51 Allowed 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.165 -0.959 . . . . 0.0 109.677 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 253' ' ' SER . . . 166.2 -116.27 0.68 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.517 ' CB ' ' HB2' ' A' ' 257' ' ' TYR . 4.6 m 72.89 174.51 0.29 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.339 -1.095 . . . . 0.0 110.117 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 255' ' ' ASN . 6.7 t -83.79 -29.65 27.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 0.0 110.173 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' A' ' 256' ' ' LEU . 0.8 OUTLIER 176.45 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.894 -1.128 . . . . 0.0 110.202 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.422 ' HG ' ' ND2' ' A' ' 255' ' ' ASN . 2.2 mt -54.13 -31.97 53.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.029 . . . . 0.0 109.002 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.517 ' HB2' ' CB ' ' A' ' 253' ' ' SER . 13.3 m-30 -106.66 47.48 0.88 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 257' ' ' TYR . . . -30.66 -89.18 0.01 OUTLIER Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.669 ' OG ' HG22 ' A' ' 192' ' ' ILE . 1.6 p -61.19 -96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.127 -1.219 . . . . 0.0 108.721 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 175.34 -132.35 2.15 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' A' ' 262' ' ' VAL . 28.3 tp -85.83 155.35 21.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.956 -0.732 . . . . 0.0 110.112 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.734 HG11 HG22 ' A' ' 221' ' ' VAL . 2.7 t -92.13 145.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.437 -0.79 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -169.66 119.99 0.66 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.367 1.08 . . . . 0.0 108.714 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -75.19 -17.28 60.4 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.702 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.459 ' HA ' ' OG1' ' A' ' 268' ' ' THR . 56.3 tt0 -61.52 -20.46 63.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.563 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -84.27 -22.44 30.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.578 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -117.15 15.43 14.98 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.779 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.459 ' OG1' ' HA ' ' A' ' 265' ' ' GLU . 11.0 p -118.88 -39.92 2.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 109.741 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 269' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.413 -179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.588 ' HB1' ' HA ' ' A' ' 76' ' ' SER . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.607 ' HG3' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -48.78 144.76 4.24 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.166 -0.959 . . . . 0.0 109.32 179.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -114.15 52.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.148 -0.97 . . . . 0.0 109.53 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.523 ' C ' ' O ' ' A' ' 3' ' ' SER . 0.5 OUTLIER -22.51 85.2 0.03 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.867 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.589 ' HG2' ' CG1' ' A' ' 8' ' ' ILE . 36.6 Cg_endo -80.97 -176.19 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.911 2.407 . . . . 0.0 110.897 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.612 ' CE2' ' O ' ' A' ' 197' ' ' VAL . 0.4 OUTLIER -24.64 -71.12 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.407 179.148 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -114.31 -83.01 1.12 Allowed Glycine 0 N--CA 1.489 2.177 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.005 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.841 HG22 ' N ' ' A' ' 9' ' ' SER . 1.7 mm 49.52 -86.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.858 -0.789 . . . . 0.0 109.268 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.841 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -61.43 -12.46 14.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.91 -1.119 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -27.79 67.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 8' ' ' ILE . 30.8 m -92.99 27.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.241 -0.912 . . . . 0.0 109.627 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG2' ' HB3' ' A' ' 265' ' ' GLU . 3.6 mp0 61.74 47.39 6.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.755 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.68 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -82.83 -31.48 0.52 Allowed Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 111.676 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.68 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.9 Cg_endo -75.11 -54.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.924 0 N-CA-C 108.087 -1.543 . . . . 0.0 108.087 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.73 -35.75 1.97 Allowed 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.61 -43.24 63.55 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.961 -1.087 . . . . 0.0 108.955 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -76.08 -2.99 33.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.437 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.14 -39.98 8.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.292 -0.88 . . . . 0.0 109.084 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.47 -55.72 9.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.44 -27.86 0.77 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 268' ' ' THR . 1.1 mt -49.95 111.58 0.54 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.207 -1.172 . . . . 0.0 109.305 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.465 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -96.42 -19.59 19.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.36 -0.837 . . . . 0.0 109.927 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 230' ' ' GLN . . . 78.18 -11.26 23.85 Favored Glycine 0 N--CA 1.482 1.764 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 -178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 85' ' ' ASN . 42.7 p -55.96 125.78 22.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -1.133 . . . . 0.0 109.609 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.83 -14.37 6.36 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.651 -1.261 . . . . 0.0 109.982 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.739 HG13 ' NE2' ' A' ' 118' ' ' HIS . 11.5 t -102.46 157.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.972 -1.311 . . . . 0.0 109.506 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -124.96 113.95 18.5 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.51 -0.744 . . . . 0.0 109.092 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.585 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 4.2 t -101.71 147.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 0.0 109.75 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 120' ' ' ALA . . . -110.17 159.5 17.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.261 -0.9 . . . . 0.0 108.944 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.936 HG12 ' OD1' ' A' ' 32' ' ' ASP . 1.6 t -136.85 92.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.175 -0.953 . . . . 0.0 108.751 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.597 HD23 HG21 ' A' ' 93' ' ' VAL . 6.0 mp -79.97 88.9 5.31 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.936 ' OD1' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -136.98 -160.13 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 t -94.1 28.02 2.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.009 . . . . 0.0 110.442 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 58' ' ' ASP . . . 121.46 123.48 2.97 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.662 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.607 HD11 ' CG2' ' A' ' 30' ' ' VAL . 3.9 mt -86.84 -17.09 9.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-O 121.726 0.774 . . . . 0.0 109.751 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.516 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 2.9 t 62.31 156.3 0.05 OUTLIER 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.677 -0.639 . . . . 0.0 109.393 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.6 t -86.71 157.05 19.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.079 -1.013 . . . . 0.0 110.154 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.628 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -169.9 172.84 2.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.19 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.5 Cg_endo -81.05 -27.02 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.503 2.136 . . . . 0.0 109.875 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.779 ' HB3' HD11 ' A' ' 77' ' ' ILE . 14.4 p30 -115.19 25.34 10.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.387 -0.82 . . . . 0.0 109.292 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 43' ' ' ILE . 19.7 mt -128.9 21.23 5.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.486 -0.759 . . . . 0.0 109.11 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' C ' ' O ' ' A' ' 41' ' ' LEU . 7.8 p-10 -25.54 123.55 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.402 0.62 . . . . 0.0 111.511 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -88.96 91.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.356 -0.84 . . . . 0.0 109.346 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.433 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 3.3 tpm_? -56.41 -21.25 23.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 120.876 -1.14 . . . . 0.0 108.073 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 171.17 138.26 2.49 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.65 169.81 34.02 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.317 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.689 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -153.26 165.64 35.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.624 -0.927 . . . . 0.0 108.692 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 92' ' ' LYS . 3.1 p -123.94 120.18 31.76 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.082 -1.011 . . . . 0.0 110.296 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.734 ' HE2' HG12 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -122.31 -39.24 2.59 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.12 -0.987 . . . . 0.0 110.074 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.566 ' HB ' ' CE ' ' A' ' 92' ' ' LYS . 4.2 t -67.66 131.59 92.82 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.252 -0.905 . . . . 0.0 110.098 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.34 171.22 15.17 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.162 1.908 . . . . 0.0 108.762 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' C ' ' CG ' ' A' ' 53' ' ' GLU . . . 155.55 -88.31 0.12 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 118.689 -1.72 . . . . 0.0 110.842 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.56 ' H ' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -158.42 -56.35 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 O-C-N 121.227 -1.161 . . . . 0.0 111.745 -178.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 53' ' ' GLU . 36.6 Cg_endo -77.97 -97.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 121.159 1.239 . . . . 0.0 111.111 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 0.3 OUTLIER 173.22 -148.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.005 -1.059 . . . . 0.0 109.071 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 48' ' ' SER . 1.6 t -64.45 -2.52 2.33 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.46 ' C ' ' HA3' ' A' ' 34' ' ' GLY . 7.4 mt-30 -88.27 155.77 19.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 109.031 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.916 ' OD2' HG22 ' A' ' 64' ' ' THR . 8.3 t0 -73.07 145.98 46.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.952 . . . . 0.0 110.08 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -115.34 -17.73 6.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.43 -64.7 1.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -1.083 . . . . 0.0 109.518 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.532 ' CA ' ' OD2' ' A' ' 58' ' ' ASP . . . 156.74 -16.97 0.4 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.443 ' C ' ' CD2' ' A' ' 62' ' ' HIS . 2.9 t-160 -52.1 -61.47 2.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.034 -1.274 . . . . 0.0 109.706 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -55.16 -77.02 0.17 Allowed Glycine 0 N--CA 1.491 2.352 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.014 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.916 HG22 ' OD2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -33.05 -67.02 0.13 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.731 -0.864 . . . . 0.0 110.73 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.786 ' CD2' HD21 ' A' ' 211' ' ' LEU . 12.6 t-80 -42.66 -48.91 5.59 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.343 -0.848 . . . . 0.0 110.106 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 70' ' ' ILE . 27.7 t -58.39 -41.03 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.086 -1.009 . . . . 0.0 109.623 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.79 -49.5 73.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.294 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -66.76 -33.56 84.6 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.507 HG23 ' CE1' ' A' ' 220' ' ' HIS . 6.3 m -67.64 -20.73 65.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.176 -1.19 . . . . 0.0 109.07 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 66' ' ' VAL . 79.8 mt -88.16 -28.0 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.376 -0.827 . . . . 0.0 109.844 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.537 ' HB1' ' O ' ' A' ' 83' ' ' ALA . . . -153.26 -37.06 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.882 -1.136 . . . . 0.0 111.484 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.767 ' HB1' ' CG1' ' A' ' 79' ' ' VAL . . . 32.81 72.51 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.522 -0.736 . . . . 0.0 109.92 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -38.32 150.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.684 ' CB ' HD12 ' A' ' 80' ' ' LEU . 6.3 t-20 -138.19 92.25 2.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.012 -1.055 . . . . 0.0 110.962 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' CB ' ' A' ' 76' ' ' SER . 0.6 OUTLIER -97.66 -17.1 19.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.588 ' HA ' ' HB1' ' A' ' 1' ' ' ALA . 1.3 m 157.66 28.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.826 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 40' ' ' ASP . 5.8 pt -125.84 52.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 120.794 -1.191 . . . . 0.0 109.998 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 42.99 -172.9 0.01 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.817 0.676 . . . . 0.0 111.515 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.767 ' CG1' ' HB1' ' A' ' 72' ' ' ALA . 38.5 t 78.93 -87.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 122.175 -0.603 . . . . 0.0 110.645 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' A' ' 74' ' ' ASN . 1.4 tp 56.64 92.8 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.148 -0.97 . . . . 0.0 109.87 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.633 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -71.65 -155.19 2.07 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 HD11 ' A' ' 227' ' ' LEU . 2.1 t -84.12 -51.29 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -1.221 . . . . 0.0 109.346 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -94.55 125.87 49.99 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.017 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 22' ' ' THR . 38.1 Cg_endo -84.69 -60.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.701 2.267 . . . . 0.0 110.715 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.506 ' HB2' ' HB3' ' A' ' 24' ' ' SER . 10.0 m120 -93.37 35.03 1.11 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.759 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -83.71 129.69 34.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.03 -1.044 . . . . 0.0 109.744 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 27' ' ' LYS . 1.8 mp0 -67.27 114.73 6.23 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.27 -0.893 . . . . 0.0 108.746 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.7 mt -97.93 115.55 28.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 0.0 110.616 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.571 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 28.1 m-85 -102.98 162.24 13.09 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -129.36 106.2 8.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.816 -1.178 . . . . 0.0 110.37 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.734 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -107.13 67.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.566 ' CE ' ' HB ' ' A' ' 50' ' ' VAL . 0.7 OUTLIER -42.6 104.38 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.9 -178.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.597 HG21 HD23 ' A' ' 31' ' ' LEU . 4.0 t -123.74 -25.67 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.549 -0.719 . . . . 0.0 109.085 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.69 HD21 HD22 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -91.42 176.14 6.67 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.339 -0.851 . . . . 0.0 110.085 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -116.87 173.88 14.93 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.57 -18.53 12.12 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.159 -1.201 . . . . 0.0 109.766 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.35 -55.08 3.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 109.508 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.78 29.17 0.7 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.2 t -146.0 77.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -1.16 . . . . 0.0 108.834 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.76 179.79 52.94 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.281 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.5 157.36 30.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.8 -0.823 . . . . 0.0 110.009 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.971 HG21 ' OG ' ' A' ' 130' ' ' SER . 2.3 t -67.82 -23.35 29.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -20.18 60.77 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 56.9 p -80.89 -52.36 7.56 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.584 0.707 . . . . 0.0 109.386 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.934 ' HB ' HD11 ' A' ' 133' ' ' LEU . 1.2 mt -65.95 -32.88 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.597 -0.689 . . . . 0.0 109.584 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -71.83 -36.49 70.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -71.39 -41.47 69.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.71 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.51 -14.92 81.62 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 109' ' ' LEU . 14.0 mt -83.21 -29.39 28.56 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.308 -1.113 . . . . 0.0 109.015 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.5 -28.81 18.3 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.846 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.585 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 46.6 t90 -71.07 -15.32 62.53 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.671 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -88.13 -1.19 57.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.36 -0.838 . . . . 0.0 109.688 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.56 -33.71 2.62 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.703 -1.236 . . . . 0.0 111.136 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.68 -85.95 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.779 -1.424 . . . . 0.0 109.275 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -94.16 23.63 4.91 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.825 ' O ' ' HE2' ' A' ' 117' ' ' MET . . . -99.16 -146.0 19.48 Favored Glycine 0 C--N 1.296 -1.661 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.991 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.825 ' HE2' ' O ' ' A' ' 116' ' ' GLY . 4.6 mmt -133.15 179.43 6.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.434 -1.039 . . . . 0.0 110.33 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.739 ' NE2' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -88.42 -29.98 19.81 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.095 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 28' ' ' VAL . 1.4 t -99.85 149.78 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 119.668 -1.895 . . . . 0.0 109.632 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -164.94 115.09 1.12 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.812 ' C ' HD12 ' A' ' 122' ' ' LEU . 10.2 t-20 -89.22 160.28 17.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.136 -0.978 . . . . 0.0 109.767 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.812 HD12 ' C ' ' A' ' 121' ' ' ASN . 5.4 mp -147.76 109.47 4.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.999 -1.063 . . . . 0.0 109.877 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 67.86 3.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.228 -0.92 . . . . 0.0 108.966 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.69 HD22 HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -132.66 172.88 11.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.918 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.465 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.79 104.28 0.17 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.83 162.48 43.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.203 -1.175 . . . . 0.0 110.102 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.4 Cg_endo -81.21 9.12 3.98 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 123.12 2.547 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.9 102.25 19.03 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.718 -0.614 . . . . 0.0 110.262 -178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.3 Cg_endo -78.76 178.19 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.688 2.259 . . . . 0.0 110.586 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.971 ' OG ' HG21 ' A' ' 102' ' ' VAL . 5.0 m -175.92 119.01 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.46 -0.775 . . . . 0.0 109.487 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.59 -19.96 65.32 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 23.6 m -69.05 -27.36 65.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.934 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.3 tp -81.57 -37.98 26.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.574 ' CG ' ' CE2' ' A' ' 165' ' ' TYR . 0.0 OUTLIER -76.68 -21.43 55.4 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.53 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -76.95 -25.6 53.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 -32.04 30.48 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.53 ' CG1' ' ND2' ' A' ' 167' ' ' ASN . 0.9 OUTLIER -71.42 -36.1 59.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -63.13 -34.97 78.77 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.1 t -80.3 -19.1 47.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -90.68 -10.28 43.72 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.985 -1.072 . . . . 0.0 109.91 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 89.9 m -89.26 -40.15 13.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.105 -0.997 . . . . 0.0 109.133 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.21 -27.29 68.32 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -19.28 31.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.326 -0.859 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 78.93 66.97 1.65 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 118' ' ' HIS . 14.5 t -117.05 109.75 28.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.401 -1.058 . . . . 0.0 109.597 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 33.4 tp -70.9 104.89 3.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.168 -0.957 . . . . 0.0 109.337 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.781 HG12 HD13 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -100.52 135.66 35.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.031 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.748 HG22 ' HB2' ' A' ' 169' ' ' MET . 3.0 t -112.86 156.82 13.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 170' ' ' ALA . . . -138.42 137.07 36.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 109.804 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.13 171.54 2.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.9 OUTLIER -89.28 -79.48 0.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.601 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.622 ' O ' ' CB ' ' A' ' 153' ' ' ASN . . . -152.76 -116.98 0.68 Allowed Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.622 ' CB ' ' O ' ' A' ' 152' ' ' GLY . 22.7 t-20 135.6 23.17 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 123.395 0.678 . . . . 0.0 109.744 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.1 m -121.65 -98.02 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.674 -1.266 . . . . 0.0 109.6 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.416 ' HA2' ' CD ' ' A' ' 185' ' ' GLN . . . 179.06 47.38 0.08 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -112.27 172.56 6.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.16 . . . . 0.0 109.213 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -102.9 56.32 0.62 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.461 ' HA ' ' HA3' ' A' ' 187' ' ' GLY . 0.2 OUTLIER 175.27 156.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.27 -1.135 . . . . 0.0 109.26 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 pt -100.12 -177.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.955 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.802 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -109.48 166.86 10.56 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.943 0.877 . . . . 0.0 112.518 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.56 ' OH ' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -85.03 149.41 53.02 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 174.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.577 ' O ' ' N ' ' A' ' 164' ' ' ARG . 42.2 Cg_endo -71.68 -32.22 4.49 Favored 'Cis proline' 0 C--N 1.295 -2.254 0 O-C-N 122.408 0.688 . . . . 0.0 110.734 3.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -25.4 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.721 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.577 ' N ' ' O ' ' A' ' 162' ' ' PRO . 1.0 OUTLIER -65.42 -55.81 15.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.938 -1.101 . . . . 0.0 109.714 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.574 ' CE2' ' CG ' ' A' ' 134' ' ' GLU . 1.4 m-85 -42.58 -177.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 122.542 1.163 . . . . 0.0 111.6 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -115.56 2.44 13.8 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.523 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.53 ' ND2' ' CG1' ' A' ' 137' ' ' VAL . 9.3 m-20 -89.33 21.66 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 108.899 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -167.43 171.76 10.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.748 ' HB2' HG22 ' A' ' 148' ' ' VAL . 48.4 mtp -99.46 -177.82 3.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 191' ' ' ASP . . . -151.5 115.39 4.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 192' ' ' ILE . 23.7 t -107.46 165.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.073 -1.017 . . . . 0.0 110.057 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.567 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.86 -173.31 13.3 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.495 ' C ' ' HB2' ' A' ' 181' ' ' ALA . . . -118.88 164.13 15.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.134 . . . . 0.0 109.655 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.753 ' CA ' ' HB2' ' A' ' 181' ' ' ALA . 0.6 OUTLIER -138.15 175.6 9.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.28 -0.887 . . . . 0.0 109.69 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.483 ' N ' ' HA ' ' A' ' 181' ' ' ALA . 0.2 OUTLIER -89.91 -172.98 3.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 109.576 179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -101.79 -21.49 14.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.78 -53.5 6.44 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.569 -0.707 . . . . 0.0 109.269 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -131.89 -94.09 0.37 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.472 -0.768 . . . . 0.0 109.751 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.656 ' CG ' HG21 ' A' ' 174' ' ' THR . 0.7 OUTLIER -160.03 -154.47 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.197 -0.939 . . . . 0.0 109.59 -178.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.489 ' N ' HG22 ' A' ' 174' ' ' THR . 0.0 OUTLIER 58.11 4.3 0.3 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.753 ' HB2' ' CA ' ' A' ' 174' ' ' THR . . . 36.24 -159.18 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.182 -0.949 . . . . 0.0 110.582 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.9 t -145.92 21.84 1.42 Allowed 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.175 -0.953 . . . . 0.0 108.996 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.466 ' CE2' ' ND2' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -168.66 26.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.833 . . . . 0.0 109.658 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.1 t -104.51 128.63 52.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 108.934 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.416 ' CD ' ' HA2' ' A' ' 155' ' ' GLY . 64.8 mm-40 -90.06 147.36 23.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 110.021 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.517 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.58 169.22 12.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.517 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . -170.93 152.25 17.99 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -44.06 96.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.332 -1.099 . . . . 0.0 109.249 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 138.64 -0.78 2.51 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.263 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 65.0 tp -50.33 145.81 5.86 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 120.829 -1.395 . . . . 0.0 108.745 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 170' ' ' ALA . 0.6 OUTLIER -104.56 -63.75 1.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 111.103 -178.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 171' ' ' VAL . 1.2 tt -151.47 163.87 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 0.0 109.375 -178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.981 HG21 ' CE1' ' A' ' 257' ' ' TYR . 22.1 m -118.0 160.33 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.676 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.613 ' C ' ' HG1' ' A' ' 174' ' ' THR . . . -150.66 161.07 31.38 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 32.7 Cg_endo -75.21 126.08 9.6 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.14 1.893 . . . . 0.0 109.663 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.429 ' C ' ' OD1' ' A' ' 212' ' ' ASN . . . -152.21 62.13 0.39 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.632 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.612 ' O ' ' CE2' ' A' ' 6' ' ' TRP . 74.5 t -135.76 89.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.6 ' O ' HG13 ' A' ' 199' ' ' VAL . 11.6 t-20 94.14 107.42 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.696 HG22 ' CG ' ' A' ' 212' ' ' ASN . 19.7 m -161.91 111.6 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.19 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 201' ' ' SER . 2.9 tt0 -85.97 147.37 26.26 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.6 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 7.4 t -146.76 -146.67 0.2 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.584 HG21 ' OD1' ' A' ' 40' ' ' ASP . 66.0 p -88.02 172.38 9.59 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.675 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -157.87 161.05 29.64 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.675 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.7 Cg_endo -70.42 165.29 32.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.136 1.891 . . . . 0.0 110.685 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 79.92 3.87 89.43 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.2 OUTLIER 77.69 32.52 0.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -1.088 . . . . 0.0 109.558 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.5 OUTLIER -129.79 158.03 40.56 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.493 ' OH ' HD12 ' A' ' 77' ' ' ILE . 11.7 m-30 -91.51 -174.67 3.97 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.536 ' HB2' ' CG ' ' A' ' 203' ' ' TYR . . . -164.25 157.19 17.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.872 -1.142 . . . . 0.0 110.219 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 3.5 m -113.21 120.31 40.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.055 -1.028 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -166.88 161.8 15.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.696 ' CG ' HG22 ' A' ' 199' ' ' VAL . 0.2 OUTLIER -148.19 -160.48 1.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.973 -1.079 . . . . 0.0 111.153 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 130.49 157.95 9.15 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.217 -1.953 . . . . 0.0 108.217 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 214' ' ' THR . 0.0 OUTLIER -60.94 -19.13 60.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.859 -1.377 . . . . 0.0 108.644 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.1 m -71.86 -32.71 67.76 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.485 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.5 OUTLIER -82.27 -19.8 38.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.566 -0.709 . . . . 0.0 109.445 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 219' ' ' PRO . . . -87.45 -26.5 23.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.631 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 26.2 m -57.2 -42.8 97.99 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.725 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.9 Cg_endo -71.93 -26.55 18.55 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 121.715 1.61 . . . . 0.0 111.132 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.507 ' CE1' HG23 ' A' ' 69' ' ' THR . 0.4 OUTLIER -58.66 -40.37 83.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.677 HG22 HG21 ' A' ' 262' ' ' VAL . 60.4 t -70.33 -47.66 65.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 221' ' ' VAL . . . -45.8 -31.89 2.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -73.78 -48.08 18.1 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 225' ' ' ALA . . . -57.39 -65.01 0.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -1.232 . . . . 0.0 109.107 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.442 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -45.64 -36.58 4.93 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -58.84 -49.5 77.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 0.0 109.02 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.603 HD11 HG12 ' A' ' 82' ' ' VAL . 10.6 mt -49.96 -39.42 40.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.442 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 96.2 t -61.41 -52.47 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.411 -0.806 . . . . 0.0 108.902 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.544 ' HD2' ' CG2' ' A' ' 119' ' ' VAL . 19.1 mttm -44.33 -40.98 5.71 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.459 -0.776 . . . . 0.0 109.172 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.541 ' CB ' ' HA2' ' A' ' 23' ' ' GLY . 13.1 tp60 -62.93 -45.42 92.58 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.385 -0.822 . . . . 0.0 108.882 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -60.86 -14.21 20.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.472 -0.768 . . . . 0.0 109.045 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 174.88 80.93 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.356 -0.84 . . . . 0.0 109.783 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.512 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.5 Cg_endo -78.89 8.24 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.711 2.274 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.44 -12.8 28.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.986 -1.071 . . . . 0.0 109.778 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -69.84 -179.69 1.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 110.11 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.99 170.81 7.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.595 -0.691 . . . . 0.0 109.359 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -62.22 -22.68 66.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -79.26 -63.63 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.112 -0.993 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 238' ' ' VAL . 1.0 OUTLIER -42.96 -48.66 5.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 109.53 -178.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 71.9 mt -61.66 -49.15 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 0.0 109.546 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 243' ' ' HIS . 6.6 ttp180 -51.37 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.927 . . . . 0.0 109.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' ARG . 43.7 t30 -34.27 -33.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.869 -0.519 . . . . 0.0 111.346 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 241' ' ' ARG . 1.6 t60 -72.52 -50.4 26.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.816 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.53 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.1 OUTLIER -67.68 -23.29 65.29 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.99 -42.61 47.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.571 -0.706 . . . . 0.0 110.181 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.69 -9.31 57.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.0 110.376 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.3 p -94.11 -29.84 14.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.973 -1.079 . . . . 0.0 109.663 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -40.25 129.27 2.31 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.555 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 249' ' ' THR . 6.0 m -75.98 89.57 2.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 260' ' ' GLY . 3.3 t -81.9 140.13 34.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.386 -0.821 . . . . 0.0 111.82 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.5 mp -59.79 -45.02 93.59 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -176.47 -36.47 0.05 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 3.5 m -62.08 176.33 0.59 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.393 -1.063 . . . . 0.0 109.679 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 255' ' ' ASN . 10.8 t -140.53 10.02 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.969 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 254' ' ' THR . 2.7 t30 177.88 -52.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.702 -1.248 . . . . 0.0 111.001 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 1.028 HD13 ' N ' ' A' ' 257' ' ' TYR . 0.2 OUTLIER -45.27 -53.8 7.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 110.279 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 1.028 ' N ' HD13 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -87.94 -4.72 58.8 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.532 -0.73 . . . . 0.0 111.776 -176.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 259' ' ' SER . . . 129.74 2.5 5.25 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.629 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 258' ' ' GLY . 0.7 OUTLIER 79.2 -10.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.378 -1.072 . . . . 0.0 109.921 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.529 ' CA ' ' HA ' ' A' ' 250' ' ' SER . . . 134.36 -165.82 24.31 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.906 -1.616 . . . . 0.0 112.069 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.573 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 58.3 tp -107.13 164.4 12.19 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -98.95 158.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.42 -179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.469 ' ND2' ' OG1' ' A' ' 249' ' ' THR . 0.0 OUTLIER -167.36 119.92 0.93 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.36 -5.31 31.6 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.358 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.412 ' HB3' ' HG2' ' A' ' 12' ' ' GLN . 5.1 tt0 -83.23 -42.55 17.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 109.911 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -79.96 1.74 26.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 109.791 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -115.03 -26.57 7.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.157 -0.964 . . . . 0.0 109.671 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.483 HG21 HD13 ' A' ' 21' ' ' LEU . 4.7 p -82.91 -38.8 22.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.073 -1.017 . . . . 0.0 109.597 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.529 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.265 0.555 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.429 ' O ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -61.04 140.92 57.73 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.145 -0.972 . . . . 0.0 109.46 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 p -75.53 122.05 23.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.045 -1.034 . . . . 0.0 108.808 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 2' ' ' GLN . 2.1 t -143.41 76.72 15.98 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.175 -0.953 . . . . 0.0 109.999 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 6' ' ' TRP . 33.0 Cg_endo -77.8 164.56 27.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.409 2.073 . . . . 0.0 110.33 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.518 ' CD1' ' C ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -45.49 -26.86 0.63 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.532 ' HA3' ' CG1' ' A' ' 199' ' ' VAL . . . -72.26 -101.98 0.06 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.686 HG22 ' O ' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -43.09 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -1.105 . . . . 0.0 109.142 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER 165.19 -43.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -1.6 58.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -0.832 . . . . 0.0 109.501 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.692 HG11 ' HB3' ' A' ' 220' ' ' HIS . 20.1 m -101.3 14.94 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.125 -0.984 . . . . 0.0 109.524 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.702 HE21 ' HB3' ' A' ' 15' ' ' ALA . 0.0 OUTLIER 68.97 24.68 6.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.647 -0.658 . . . . 0.0 110.845 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -68.26 -39.87 18.39 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 120.906 -1.121 . . . . 0.0 110.895 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 32.2 Cg_endo -75.18 -60.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 N-CA-C 108.205 -1.498 . . . . 0.0 108.205 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HB3' HE21 ' A' ' 12' ' ' GLN . . . -45.99 -24.21 0.39 Allowed 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.593 ' N ' ' NE2' ' A' ' 12' ' ' GLN . . . -81.19 -41.64 22.03 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.874 -1.141 . . . . 0.0 109.244 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 16.3 m170 -69.45 -19.68 63.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.05 -1.031 . . . . 0.0 109.626 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -87.15 -39.1 15.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.64 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.58 ' HB3' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -63.54 -17.58 62.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 109.682 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.45 8.7 26.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -74.03 132.04 41.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.316 -1.109 . . . . 0.0 109.232 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.3 OUTLIER -115.43 -22.57 9.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.462 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 53.6 11.03 1.69 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 -178.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.453 ' N ' ' C ' ' A' ' 22' ' ' THR . 5.2 t -76.19 1.64 15.29 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.131 -1.217 . . . . 0.0 109.629 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.6 17.91 35.75 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 27' ' ' LYS . 60.7 t -123.18 167.02 17.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 120.935 -1.333 . . . . 0.0 109.995 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' N ' HG12 ' A' ' 26' ' ' VAL . 1.7 mptt -134.74 137.06 43.13 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.47 ' HA ' ' HB ' ' A' ' 119' ' ' VAL . 39.1 t -135.01 129.26 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.024 -1.048 . . . . 0.0 110.296 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 89' ' ' TYR . . . -84.83 155.66 21.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.895 HG12 ' OD2' ' A' ' 32' ' ' ASP . 6.5 t -134.22 87.29 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.074 -1.016 . . . . 0.0 108.722 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.513 HD12 HG23 ' A' ' 91' ' ' VAL . 8.2 mp -74.27 99.91 3.58 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.895 ' OD2' HG12 ' A' ' 30' ' ' VAL . 1.1 m-20 -134.82 -161.61 1.17 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.04 -1.038 . . . . 0.0 109.459 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 96' ' ' ALA . 2.9 t -105.2 3.95 30.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -0.971 . . . . 0.0 109.775 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 59' ' ' GLY . . . 144.97 121.83 1.49 Allowed Glycine 0 N--CA 1.482 1.755 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 64' ' ' THR . 11.3 mt -90.08 -110.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.557 ' N ' HG22 ' A' ' 35' ' ' ILE . 48.2 t 176.46 146.94 0.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.213 -0.93 . . . . 0.0 110.071 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -86.04 93.38 8.97 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.438 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -114.9 169.38 6.74 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.469 -179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 77' ' ' ILE . 35.6 Cg_endo -77.38 -45.4 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.619 2.212 . . . . 0.0 110.04 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 73' ' ' LEU . 3.9 m-20 -74.27 -34.27 63.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.822 . . . . 0.0 109.261 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 67' ' ' ALA . 2.3 mt -57.3 135.11 56.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -109.71 94.7 5.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 43' ' ' ILE . 8.7 mm -85.63 99.91 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 9.3 tpt180 -86.53 -18.74 30.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 109.684 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.509 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . 162.32 176.37 34.33 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.57 47.55 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.142 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB3' HG12 ' A' ' 91' ' ' VAL . . . -146.03 160.25 42.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.538 -0.978 . . . . 0.0 109.446 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 64.3 p -134.03 115.6 14.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.513 ' HE2' HG12 ' A' ' 91' ' ' VAL . 45.3 m-85 -116.92 -54.98 2.39 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.295 -0.878 . . . . 0.0 110.188 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.509 ' O ' ' HE2' ' A' ' 92' ' ' LYS . 22.9 t -39.81 128.45 1.53 Allowed Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.585 -0.697 . . . . 0.0 109.91 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.32 -178.63 4.75 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.345 2.03 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 53' ' ' GLU . . . 110.9 -20.8 23.83 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.621 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 15.8 tt0 69.36 52.37 0.45 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.312 -1.11 . . . . 0.0 110.478 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.4 Cg_endo -77.34 -82.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.281 1.988 . . . . 0.0 109.775 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 54' ' ' PRO . 2.1 m 165.41 135.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.717 . . . . 0.0 109.469 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.452 ' C ' ' HG3' ' A' ' 57' ' ' GLN . 1.4 m -63.36 -13.16 36.35 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.043 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.452 ' HG3' ' C ' ' A' ' 56' ' ' THR . 13.1 mt-30 -143.95 150.8 38.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.439 -0.788 . . . . 0.0 109.6 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 36.7 t0 62.08 92.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.805 . . . . 0.0 109.704 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' HA3' ' A' ' 34' ' ' GLY . . . -112.85 -25.63 4.45 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.82 -38.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -1.176 . . . . 0.0 109.75 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.07 -10.67 3.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -75.85 -70.35 0.44 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.155 -1.203 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA3' ' CB ' ' A' ' 32' ' ' ASP . . . -48.17 -29.09 6.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.699 ' HA ' HG23 ' A' ' 35' ' ' ILE . 9.2 m -68.14 -53.15 27.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -1.073 . . . . 0.0 109.445 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 1.005 ' CD2' HD21 ' A' ' 211' ' ' LEU . 3.9 t-80 -55.89 -43.64 77.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.503 -0.748 . . . . 0.0 109.737 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 69' ' ' THR . 17.4 t -61.95 -34.2 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.291 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 41' ' ' LEU . . . -62.36 -44.14 97.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.618 ' HA2' ' HB2' ' A' ' 72' ' ' ALA . . . -71.21 -42.02 58.63 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 66' ' ' VAL . 7.5 t -64.41 -15.3 60.32 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 120.366 -1.667 . . . . 0.0 107.851 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.007 HG21 HD21 ' A' ' 88' ' ' LEU . 31.7 mt -87.51 -38.84 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.321 -0.862 . . . . 0.0 109.93 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.723 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -178.64 36.18 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.769 -1.207 . . . . 0.0 111.853 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.618 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . . . -45.06 125.47 5.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.67 -1.269 . . . . 0.0 108.928 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 84' ' ' PRO . 85.5 mt -54.33 161.26 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.45 ' O ' ' OD1' ' A' ' 75' ' ' ASN . 10.4 t-20 -106.92 134.26 50.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.409 -0.807 . . . . 0.0 109.565 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 74' ' ' ASN . 74.2 m-20 -162.14 -93.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.817 0.817 . . . . 0.0 109.081 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.4 p -155.12 -39.96 0.09 Allowed 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 39' ' ' PRO . 1.2 pt -103.38 67.74 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.456 -0.777 . . . . 0.0 109.595 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.94 158.62 13.07 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 201' ' ' SER . 27.6 m -80.39 -159.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.35 -1.088 . . . . 0.0 109.354 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.4 tp -141.53 116.52 9.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.968 -1.082 . . . . 0.0 109.771 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.67 175.83 54.78 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.9 t -60.64 -42.53 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -1.185 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.723 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . . . -93.17 141.96 24.71 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.736 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.691 ' O ' HD23 ' A' ' 73' ' ' LEU . 38.6 Cg_endo -84.25 -61.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.847 2.365 . . . . 0.0 110.692 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -120.48 49.87 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.436 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.543 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -79.17 159.59 27.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 108.979 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 25.9 mt-10 -89.37 89.16 7.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.979 -1.076 . . . . 0.0 108.972 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 70' ' ' ILE . 8.4 mt -75.6 142.89 42.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 0.0 110.236 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.56 ' HB2' ' HA ' ' A' ' 29' ' ' ALA . 4.1 m-85 -126.4 152.97 45.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -121.37 94.47 4.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.017 -1.052 . . . . 0.0 109.456 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -98.57 63.09 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.284 -0.885 . . . . 0.0 108.917 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.509 ' HE2' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -31.67 109.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.197 -179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -129.09 -10.37 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.374 -0.829 . . . . 0.0 109.433 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 124' ' ' LEU . 10.2 mt -103.81 -178.0 3.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 0.0 109.895 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.31 146.65 18.86 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.513 ' N ' ' OG1' ' A' ' 33' ' ' THR . . . -67.17 -39.26 86.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -1.185 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.0 t -73.0 -37.5 66.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.234 -0.916 . . . . 0.0 109.537 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.22 68.27 0.38 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.45 94.59 0.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.465 -1.021 . . . . 0.0 109.192 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -113.26 -178.98 19.43 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.04 155.59 32.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.879 -0.777 . . . . 0.0 109.8 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.716 HG13 HD12 ' A' ' 133' ' ' LEU . 3.5 t -69.56 -19.16 22.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -17.7 58.69 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.497 ' O ' HG22 ' A' ' 93' ' ' VAL . 1.2 m -88.33 -35.42 17.21 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.52 HD13 HD13 ' A' ' 124' ' ' LEU . 2.9 mt -77.11 -37.98 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 108.729 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.72 -39.23 67.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -63.19 -45.55 91.2 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.507 -0.746 . . . . 0.0 108.992 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.22 -21.52 77.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 109' ' ' LEU . 14.5 mt -82.57 -19.93 37.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -94.38 -30.23 14.59 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.376 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 68.7 t90 -69.24 -17.01 63.72 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.316 -0.954 . . . . 0.0 108.717 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.728 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -91.37 -11.54 37.53 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.782 -1.167 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 143' ' ' ARG . . . -80.86 -15.71 76.89 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.814 -1.715 . . . . 0.0 108.814 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 115' ' ' ASN . 1.0 OUTLIER -117.13 1.19 12.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.076 -1.249 . . . . 0.0 109.946 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 114' ' ' ASN . 7.2 t30 172.46 29.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.999 -1.063 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.728 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -110.71 48.08 0.98 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.312 -1.423 . . . . 0.0 110.763 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.588 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 15.8 mmt 60.91 -173.79 0.13 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.182 -1.187 . . . . 0.0 111.452 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.765 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -95.74 -32.69 12.6 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.716 -179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.765 HG23 ' CE1' ' A' ' 118' ' ' HIS . 55.7 t -104.8 166.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.717 -1.239 . . . . 0.0 109.833 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.764 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -169.35 117.04 0.62 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.964 ' O ' HD12 ' A' ' 122' ' ' LEU . 16.5 t-20 -96.31 152.96 18.1 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 109.461 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.964 HD12 ' O ' ' A' ' 121' ' ' ASN . 6.4 mp -133.88 102.79 5.57 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.237 -0.914 . . . . 0.0 109.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.92 66.3 9.65 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.398 -0.813 . . . . 0.0 109.097 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.52 HD13 HD13 ' A' ' 105' ' ' ILE . 0.6 OUTLIER -152.86 172.22 17.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.333 -0.854 . . . . 0.0 109.617 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.571 ' CA ' ' HB2' ' A' ' 160' ' ' SER . . . 174.58 104.42 0.18 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 160' ' ' SER . 0.3 OUTLIER -107.32 147.64 35.62 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.197 -1.178 . . . . 0.0 109.559 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.512 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 32.1 Cg_endo -74.0 -6.0 17.87 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.21 1.94 . . . . 0.0 108.934 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.6 m -103.95 100.32 20.04 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 32.7 Cg_endo -74.19 164.59 33.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.425 2.083 . . . . 0.0 110.944 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.585 ' CB ' HG11 ' A' ' 102' ' ' VAL . 0.6 OUTLIER -151.05 135.92 17.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.42 -16.91 63.59 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.9 m -77.88 -23.71 48.71 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.716 HD12 HG13 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -79.26 -40.57 30.21 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' OE2' ' CD1' ' A' ' 165' ' ' TYR . 1.9 mt-10 -76.85 -31.96 57.19 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.773 -1.171 . . . . 0.0 108.336 179.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -62.66 -26.82 68.84 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.48 60.83 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.606 -0.838 . . . . 0.0 108.917 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.495 ' CG1' ' CG ' ' A' ' 167' ' ' ASN . 1.3 t -63.26 -29.07 46.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.54 -38.48 81.16 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.6 -23.75 53.44 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.91 -18.83 55.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.081 -1.012 . . . . 0.0 110.129 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -27.75 58.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.261 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.1 m -58.14 -30.81 66.63 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.261 -0.899 . . . . 0.0 109.162 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.544 ' CG ' ' O ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER -104.64 -12.0 16.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.857 . . . . 0.0 109.476 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.85 62.16 4.98 Favored Glycine 0 N--CA 1.477 1.429 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 39.9 t -96.12 110.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.583 -0.951 . . . . 0.0 109.854 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.52 107.63 2.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 108.969 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.5 t -104.43 154.32 6.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.044 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.953 HG13 HD22 ' A' ' 121' ' ' ASN . 12.0 p -141.13 112.45 3.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.607 ' HB2' ' HG2' ' A' ' 162' ' ' PRO . . . -100.9 149.82 23.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.124 -0.985 . . . . 0.0 110.384 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.496 ' CB ' ' OG1' ' A' ' 218' ' ' THR . . . -78.6 151.71 32.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.727 . . . . 0.0 109.472 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.519 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -55.98 -81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.206 -0.934 . . . . 0.0 108.917 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 155.19 115.02 0.52 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 185' ' ' GLN . 1.7 t-20 -99.96 53.16 0.91 Allowed 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.951 -0.735 . . . . 0.0 109.178 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.45 ' N ' ' OE1' ' A' ' 185' ' ' GLN . 2.4 p -94.6 -69.75 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 109.816 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.437 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 150.55 39.2 0.03 OUTLIER Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -120.49 172.97 7.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -1.106 . . . . 0.0 109.365 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 186' ' ' TYR . . . -103.71 56.71 0.57 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.409 ' N ' ' HB2' ' A' ' 186' ' ' TYR . 1.6 p 172.36 124.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.042 -1.27 . . . . 0.0 109.862 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -59.23 -171.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.234 -0.917 . . . . 0.0 110.166 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.901 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.8 OUTLIER -132.81 171.2 14.21 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 122.073 0.939 . . . . 0.0 112.795 -177.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.438 ' CE1' ' CB ' ' A' ' 164' ' ' ARG . 4.4 m-85 -82.61 146.41 53.22 Favored Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.607 ' HG2' ' HB2' ' A' ' 149' ' ' ALA . 41.4 Cg_endo -71.39 -30.29 5.63 Favored 'Cis proline' 0 C--N 1.293 -2.383 0 O-C-N 122.555 0.766 . . . . 0.0 110.436 3.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.901 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -29.84 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.625 -178.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -70.5 -54.46 12.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.74 -1.225 . . . . 0.0 109.76 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' ' O ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -50.77 -170.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.177 0.989 . . . . 0.0 110.825 -179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -120.67 -16.73 8.19 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.517 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.495 ' CG ' ' CG1' ' A' ' 137' ' ' VAL . 4.4 m120 -57.08 -18.65 15.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 108.962 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -132.53 149.36 52.33 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.477 ' HA ' ' OD2' ' A' ' 191' ' ' ASP . 0.2 OUTLIER -89.87 130.1 36.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.907 -1.121 . . . . 0.0 110.075 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 163' ' ' ALA . . . -92.55 117.97 30.51 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.95 HG22 ' CG2' ' A' ' 192' ' ' ILE . 24.7 t -92.33 164.58 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.268 1.032 . . . . 0.0 110.562 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -136.14 145.63 17.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.54 162.28 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.024 -1.28 . . . . 0.0 110.14 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.508 ' CG2' ' HB ' ' A' ' 193' ' ' VAL . 73.1 p -144.58 170.83 15.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.528 -0.732 . . . . 0.0 109.46 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 179' ' ' ASN . 0.7 OUTLIER -102.82 -166.59 1.29 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.729 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -67.67 -49.63 61.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 110.186 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.531 ' O ' ' CB ' ' A' ' 178' ' ' ASN . 8.3 m120 -59.59 -75.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.054 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 177' ' ' ASN . 1.5 m-20 162.77 41.0 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.0 109.642 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.454 ' HB3' ' OD1' ' A' ' 175' ' ' ASP . 0.9 OUTLIER -98.46 -149.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 109.522 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.687 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 0.3 OUTLIER -107.82 18.99 20.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.468 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 76.14 -162.98 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.484 -0.76 . . . . 0.0 109.905 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.3 t -100.53 -34.83 9.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.965 . . . . 0.0 110.204 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -108.12 -81.35 0.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' ' O ' ' A' ' 183' ' ' PHE . 3.3 t 32.05 100.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.128 0.49 . . . . 0.0 111.145 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.492 ' O ' ' O ' ' A' ' 184' ' ' SER . 1.4 mp0 -45.49 172.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.043 -1.036 . . . . 0.0 109.815 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.502 ' CZ ' HD21 ' A' ' 256' ' ' LEU . 1.2 t80 -52.49 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.314 -0.866 . . . . 0.0 110.565 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.969 ' HA2' HD13 ' A' ' 190' ' ' LEU . . . -145.26 20.97 1.91 Allowed Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 187' ' ' GLY . . . -35.76 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 79.2 50.51 5.76 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.969 HD13 ' HA2' ' A' ' 187' ' ' GLY . 4.6 tp -75.62 144.8 41.56 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.568 -0.96 . . . . 0.0 109.465 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 259' ' ' SER . 1.2 m-20 -93.43 -46.01 7.53 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.208 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.95 ' CG2' HG22 ' A' ' 171' ' ' VAL . 1.5 tt -157.95 177.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.497 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 260' ' ' GLY . 31.6 m -138.79 172.65 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.384 -0.822 . . . . 0.0 109.663 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -173.55 174.44 1.1 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.343 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.926 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.6 Cg_endo -75.94 121.39 6.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.608 2.205 . . . . 0.0 110.545 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -137.17 45.14 1.09 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.644 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 23.8 t -134.1 85.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.438 -1.036 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.946 ' O ' HG13 ' A' ' 199' ' ' VAL . 19.5 t-20 103.33 120.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER 178.28 115.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 210' ' ' SER . 1.7 pt20 -101.45 161.52 13.57 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.62 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -156.69 -158.67 0.8 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.194 -0.941 . . . . 0.0 109.546 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.62 174.06 11.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.868 . . . . 0.0 109.461 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.595 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.9 OUTLIER -150.05 147.15 21.5 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.193 -0.942 . . . . 0.0 108.529 -179.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 31.6 Cg_endo -69.91 129.96 18.33 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.721 1.614 . . . . 0.0 110.336 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 40.82 43.55 3.17 Favored Glycine 0 C--N 1.286 -2.243 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.833 ' O ' HG22 ' A' ' 207' ' ' THR . 0.9 OUTLIER -167.56 22.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.998 -1.295 . . . . 0.0 111.35 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 206' ' ' SER . 7.0 t 52.01 -143.24 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.666 -0.646 . . . . 0.0 111.032 178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.658 ' N ' HG23 ' A' ' 207' ' ' THR . 0.1 OUTLIER -95.62 165.78 12.16 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.026 0.917 . . . . 0.0 111.639 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 200' ' ' GLN . . . -158.03 162.2 38.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.483 ' HA ' ' CB ' ' A' ' 200' ' ' GLN . 0.6 OUTLIER -109.03 133.91 52.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.865 -1.147 . . . . 0.0 110.131 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 1.005 HD21 ' CD2' ' A' ' 65' ' ' HIS . 0.3 OUTLIER -154.65 157.53 38.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 109.26 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -121.36 160.8 23.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 0.0 109.637 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 167.5 161.78 17.77 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.8 m -81.12 -28.9 34.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -1.181 . . . . 0.0 109.257 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -14.06 62.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 1.7 mpp? -87.95 -15.03 37.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.777 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -89.69 -8.87 51.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.657 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 86.5 m -77.35 -36.05 1.43 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 112.232 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 218' ' ' THR . 32.2 Cg_endo -73.66 -24.62 15.68 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 121.141 1.228 . . . . 0.0 110.264 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.692 ' HB3' HG11 ' A' ' 11' ' ' VAL . 7.6 m80 -62.38 -40.4 96.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 262' ' ' VAL . 59.2 t -70.17 -40.41 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -51.5 -41.26 60.85 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 224' ' ' ALA . . . -65.99 -59.64 7.28 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.545 ' HA ' HD12 ' A' ' 227' ' ' LEU . . . -42.1 -37.53 1.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -1.107 . . . . 0.0 109.577 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.46 75.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.158 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -55.1 -41.38 71.56 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.231 -0.918 . . . . 0.0 109.013 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 224' ' ' ALA . 48.3 mt -55.62 -45.68 77.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.708 HG21 HD23 ' A' ' 244' ' ' LEU . 31.5 t -56.0 -59.02 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 0.0 109.495 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.6 ' HD2' ' CE1' ' A' ' 118' ' ' HIS . 3.3 ttmm -44.68 -39.07 4.8 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.304 -0.872 . . . . 0.0 109.521 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.462 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.5 OUTLIER -59.2 -54.95 41.12 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.274 -0.891 . . . . 0.0 110.021 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -56.63 -15.75 4.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.12 -0.987 . . . . 0.0 108.907 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.601 ' ND2' ' CZ3' ' A' ' 235' ' ' TRP . 0.7 OUTLIER -166.83 84.16 0.89 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.247 -0.908 . . . . 0.0 109.708 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' A' ' 229' ' ' LYS . 37.4 Cg_endo -80.77 15.25 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.754 2.303 . . . . 0.0 111.17 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.87 -24.24 12.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.024 -1.048 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.601 ' CZ3' ' ND2' ' A' ' 232' ' ' ASN . 32.3 m0 -62.71 175.14 0.86 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.9 m -99.71 176.37 5.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.649 -0.657 . . . . 0.0 109.758 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 238' ' ' VAL . 36.0 p30 -60.59 -22.18 63.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.431 -0.793 . . . . 0.0 109.485 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -76.61 -64.74 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.177 -0.952 . . . . 0.0 109.277 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 238' ' ' VAL . 5.6 mm-40 -43.36 -35.58 1.59 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.547 0.689 . . . . 0.0 109.274 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.578 HD11 ' HE2' ' A' ' 229' ' ' LYS . 58.5 mt -69.35 -46.28 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.503 -0.748 . . . . 0.0 110.187 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.487 ' CB ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -63.53 -53.16 56.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.075 -1.016 . . . . 0.0 110.391 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.1 -28.36 66.43 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.067 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -71.21 -62.93 1.22 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 109.31 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.708 HD23 HG21 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -59.72 -21.17 60.3 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.516 -0.74 . . . . 0.0 109.302 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 2.4 tptt -74.63 -52.85 10.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.597 -0.689 . . . . 0.0 110.281 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -11.83 59.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.641 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 3.0 p -88.43 -32.75 18.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.769 -1.207 . . . . 0.0 109.74 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 261' ' ' LEU . . . -54.6 150.3 9.53 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 261' ' ' LEU . 0.2 OUTLIER -63.54 167.07 5.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 0.0 109.439 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 8.7 t -131.22 97.57 4.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.903 . . . . 0.0 109.68 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 251' ' ' LEU . 8.2 mp -48.79 -27.68 3.15 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.207 -0.933 . . . . 0.0 109.427 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 115.33 37.24 1.12 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 1.5 m -164.34 157.59 17.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -1.2 . . . . 0.0 109.534 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.6 p -137.49 23.08 2.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.463 ' OD1' ' HG ' ' A' ' 256' ' ' LEU . 19.7 t-20 -96.92 -71.95 0.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.596 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.517 HD22 ' NH1' ' A' ' 180' ' ' ARG . 1.1 mt -92.33 -52.1 4.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.775 . . . . 0.0 109.561 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -61.04 -36.25 79.06 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -0.849 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 77.11 -120.42 5.61 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 191' ' ' ASP . 44.1 t -61.46 -78.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -1.089 . . . . 0.0 109.397 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.548 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 153.34 -153.08 24.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.599 ' O ' ' HB1' ' A' ' 248' ' ' ALA . 15.1 tp -69.53 164.47 23.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -1.19 . . . . 0.0 108.862 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -126.2 147.48 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.967 . . . . 0.0 109.867 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.457 ' OD1' ' O ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -172.07 121.69 0.46 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.457 ' C ' ' OE1' ' A' ' 12' ' ' GLN . . . -70.01 -0.97 8.47 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.556 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.542 ' HB2' ' HG3' ' A' ' 12' ' ' GLN . 39.8 tt0 -62.47 -57.92 9.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.853 -1.155 . . . . 0.0 108.981 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -71.65 -7.1 45.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.317 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.48 ' HA ' HG21 ' A' ' 247' ' ' THR . . . -95.11 -19.39 20.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.923 . . . . 0.0 109.49 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 11.0 p -103.05 -52.15 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.0 -1.063 . . . . 0.0 109.318 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.71 ' HB1' HG23 ' A' ' 4' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.979 ' O ' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -69.44 101.11 1.5 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.817 ' HB3' HD22 ' A' ' 80' ' ' LEU . 13.3 m 35.55 46.48 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.826 0.822 . . . . 0.0 110.299 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 2' ' ' GLN . 10.6 m -158.69 51.53 0.45 Allowed Pre-proline 0 C--N 1.285 -2.2 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.488 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 35.6 Cg_endo -77.32 156.18 32.89 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.703 1.602 . . . . 0.0 109.892 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.515 ' CD1' ' HB3' ' A' ' 198' ' ' ASN . 0.0 OUTLIER -62.36 -15.28 47.54 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.536 -0.728 . . . . 0.0 110.005 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 220' ' ' HIS . . . -94.26 21.07 44.44 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -144.84 10.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.101 -1.234 . . . . 0.0 109.639 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.3 t -101.13 -18.92 15.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 0.0 109.611 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -99.99 6.79 45.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 m -111.94 16.18 8.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 120.872 -1.142 . . . . 0.0 110.067 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 2.8 mp0 46.15 55.99 6.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.372 -0.83 . . . . 0.0 109.605 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.683 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -85.35 -34.34 0.51 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.549 -0.719 . . . . 0.0 111.972 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.0 Cg_endo -72.49 -57.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.023 0 N-CA-C 108.704 -1.306 . . . . 0.0 108.704 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -43.0 -29.76 0.36 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 -45.35 38.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.069 . . . . 0.0 109.629 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -67.68 -17.77 64.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.363 -0.835 . . . . 0.0 110.433 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.3 -39.67 11.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.882 -1.137 . . . . 0.0 109.829 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 tpt85 -52.38 -35.57 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.189 -0.944 . . . . 0.0 109.702 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.17 -1.94 8.34 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.2 135.22 33.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -1.142 . . . . 0.0 109.219 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -130.34 10.13 5.26 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.044 -1.035 . . . . 0.0 109.798 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.961 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 66.71 -1.36 5.76 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 -178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 22' ' ' THR . 6.2 m -47.33 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.184 -1.186 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . 124.84 15.59 3.17 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 23' ' ' GLY . 6.0 t -107.57 148.97 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.993 -1.298 . . . . 0.0 109.483 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.8 ' HA ' ' OE1' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -115.84 115.51 26.38 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.447 0.641 . . . . 0.0 110.56 179.514 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.45 127.65 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 118.988 -1.085 . . . . 0.0 110.527 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.23 156.38 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.112 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG12 ' CG ' ' A' ' 32' ' ' ASP . 74.4 t -129.14 86.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 O-C-N 121.146 -0.971 . . . . 0.0 109.517 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.716 HD12 ' CG2' ' A' ' 91' ' ' VAL . 5.0 mp -71.07 100.6 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.537 ' CG ' HG12 ' A' ' 30' ' ' VAL . 43.3 p-10 -160.13 -160.49 0.8 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.875 -1.141 . . . . 0.0 109.673 -178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.767 HG21 ' O ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -64.75 -51.27 63.23 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 110.657 -179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.559 ' O ' ' CB ' ' A' ' 35' ' ' ILE . . . -162.97 -112.88 0.28 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.808 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.701 HG12 ' HB2' ' A' ' 67' ' ' ALA . 0.8 OUTLIER 153.81 -15.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 121.613 0.72 . . . . 0.0 109.152 -179.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 51.37 168.0 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 110.6 179.072 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 37' ' ' THR . 11.4 t -105.12 45.67 0.95 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.926 0.87 . . . . 0.0 109.195 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -52.5 160.62 1.29 Allowed Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.709 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.05 -4.55 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.692 2.261 . . . . 0.0 110.451 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.661 ' O ' HD12 ' A' ' 73' ' ' LEU . 24.7 t0 -91.84 -60.89 1.75 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.119 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 mt -70.34 151.51 45.17 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.382 -0.824 . . . . 0.0 109.215 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.67 ' OD1' HD11 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -105.32 73.95 1.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.295 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 37' ' ' THR . 12.1 mm -42.5 114.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 109.635 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.575 ' CB ' ' HB2' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -108.63 -18.8 13.63 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.677 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -175.19 -175.81 42.95 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.22 147.01 4.77 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.311 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.53 144.2 46.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.424 -1.045 . . . . 0.0 109.139 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.507 ' OG ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -120.76 121.02 37.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.092 -1.005 . . . . 0.0 110.146 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.857 ' HE2' HG12 ' A' ' 91' ' ' VAL . 3.1 m-85 -110.73 -38.51 5.13 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.192 -0.943 . . . . 0.0 109.868 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.876 HG23 ' HB3' ' A' ' 104' ' ' SER . 1.0 OUTLIER -42.93 -52.58 11.29 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.195 -0.941 . . . . 0.0 109.061 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.604 ' HD3' ' CB ' ' A' ' 50' ' ' VAL . 38.9 Cg_endo -84.33 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 123.07 2.513 . . . . 0.0 110.717 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' H ' ' HD3' ' A' ' 54' ' ' PRO . . . 178.56 32.58 0.05 OUTLIER Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.65 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 69.29 53.65 0.49 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.601 -0.941 . . . . 0.0 110.893 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 38.3 Cg_endo -83.89 -80.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.305 2.004 . . . . 0.0 110.353 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.561 ' O ' ' CG2' ' A' ' 56' ' ' THR . 0.3 OUTLIER -129.0 -25.7 2.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.841 -0.537 . . . . 0.0 110.398 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 55' ' ' SER . 0.9 OUTLIER 46.72 14.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 109.916 -177.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 55' ' ' SER . 7.3 mm100 -95.9 155.69 16.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.876 -1.14 . . . . 0.0 108.45 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.485 ' O ' ' O ' ' A' ' 57' ' ' GLN . 5.0 m-20 52.17 172.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.167 -0.958 . . . . 0.0 109.003 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.767 ' O ' HG21 ' A' ' 33' ' ' THR . . . 164.44 46.62 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 1.1 t30 80.47 -27.77 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.435 -1.038 . . . . 0.0 110.452 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.563 ' O ' ' C ' ' A' ' 62' ' ' HIS . . . 128.11 -72.82 0.46 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.589 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.563 ' C ' ' O ' ' A' ' 61' ' ' GLY . 1.9 t-80 -11.44 -59.95 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 CA-C-O 121.445 0.641 . . . . 0.0 111.917 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.528 ' CA ' ' OD2' ' A' ' 32' ' ' ASP . . . -59.88 -69.47 1.28 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.69 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.7 m -38.39 -41.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.563 -0.963 . . . . 0.0 109.969 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.574 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 2.0 t-80 -56.61 -63.22 1.27 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 219' ' ' PRO . 16.5 t -49.09 -32.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 108.782 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.701 ' HB2' HG12 ' A' ' 35' ' ' ILE . . . -55.39 -53.34 57.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.496 -0.752 . . . . 0.0 110.299 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.52 -22.11 74.85 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.723 HG23 ' CE1' ' A' ' 220' ' ' HIS . 6.6 m -73.94 -18.11 60.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.036 -1.273 . . . . 0.0 108.088 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 88' ' ' LEU . 56.8 mt -101.44 -25.84 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.492 -0.755 . . . . 0.0 111.309 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 83' ' ' ALA . . . -162.02 25.82 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.316 -1.49 . . . . 0.0 112.647 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.722 ' HB1' ' HB ' ' A' ' 79' ' ' VAL . . . -39.86 114.52 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 109.34 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.67 HD11 ' OD1' ' A' ' 42' ' ' ASN . 23.6 mt -73.54 167.48 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.697 -1.252 . . . . 0.0 110.153 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -109.68 125.99 53.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 3.1 p-10 -168.68 -109.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -0.969 . . . . 0.0 109.101 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.0 t -82.44 -73.52 0.39 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.441 -0.787 . . . . 0.0 109.132 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.497 ' HB ' ' OH ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -52.29 178.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.471 -0.768 . . . . 0.0 109.587 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -132.79 122.93 3.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.41 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.722 ' HB ' ' HB1' ' A' ' 72' ' ' ALA . 1.8 t -162.7 -64.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.817 HD22 ' HB3' ' A' ' 3' ' ' SER . 1.1 tp 56.51 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.317 0.58 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.647 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -95.49 -143.44 14.54 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.474 ' O ' ' HD3' ' A' ' 84' ' ' PRO . 0.6 OUTLIER -106.57 -54.19 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.028 -1.278 . . . . 0.0 109.664 179.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 71' ' ' ALA . . . -107.83 102.76 46.86 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 82' ' ' VAL . 38.0 Cg_endo -85.57 -63.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.877 2.385 . . . . 0.0 110.919 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.88 -17.39 0.96 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.636 -178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.16 143.33 56.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.695 -1.253 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.8 ' OE1' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -79.56 126.16 30.53 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.978 -1.077 . . . . 0.0 109.082 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.499 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 15.0 mt -103.25 105.32 15.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.715 -1.241 . . . . 0.0 110.309 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.485 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 19.8 m-85 -85.72 142.35 29.07 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.27 -0.894 . . . . 0.0 108.775 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.423 ' CB ' HD12 ' A' ' 35' ' ' ILE . . . -105.23 104.68 14.46 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.615 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -97.82 66.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.121 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.514 ' HD3' ' HD3' ' A' ' 51' ' ' PRO . 1.2 tttt -36.5 109.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.477 0.656 . . . . 0.0 110.018 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.547 HG11 HG23 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -125.06 -13.58 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.424 -0.797 . . . . 0.0 109.092 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.508 ' O ' HG21 ' A' ' 50' ' ' VAL . 5.2 mt -84.62 -170.96 3.37 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.986 0.898 . . . . 0.0 110.886 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.416 ' CA ' ' N ' ' A' ' 99' ' ' SER . . . -101.83 -99.54 2.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.537 ' O ' ' CB ' ' A' ' 97' ' ' SER . . . 48.67 83.91 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' A' ' 96' ' ' ALA . 3.2 t 81.0 -8.21 1.45 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 99' ' ' SER . . . -122.46 -29.45 1.31 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' GLY . 0.9 OUTLIER 72.81 108.18 0.07 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.238 -1.154 . . . . 0.0 109.05 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 99' ' ' SER . . . -47.0 176.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -177.94 142.72 0.3 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.731 -0.864 . . . . 0.0 108.703 -179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.883 HG22 ' HA ' ' A' ' 129' ' ' PRO . 21.0 t -68.45 -21.05 25.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.556 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.8 OUTLIER -74.85 -25.17 58.79 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.876 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -79.61 -67.11 0.79 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.69 ' HB ' HD12 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -50.52 -24.0 2.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 102' ' ' VAL . . . -67.57 -56.42 9.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.68 -0.638 . . . . 0.0 110.051 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.607 ' HB2' ' CG ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -65.69 -33.11 75.11 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.43 -179.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.561 ' HA2' ' CE2' ' A' ' 49' ' ' PHE . . . -68.25 -30.83 73.78 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.439 HD13 HG23 ' A' ' 137' ' ' VAL . 36.1 mt -94.33 -4.67 48.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.116 -1.226 . . . . 0.0 109.465 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -115.96 -5.9 12.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 109.449 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -86.3 -17.73 33.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.638 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -83.49 -1.54 53.86 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -82.33 -46.35 6.56 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.6 -77.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -1.099 . . . . 0.0 108.588 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.82 63.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.638 ' CA ' ' HA ' ' A' ' 112' ' ' ALA . . . -106.82 -156.24 20.8 Favored Glycine 0 N--CA 1.486 2.027 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.475 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.57 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 14.2 mmt -140.63 -179.92 6.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.854 -0.792 . . . . 0.0 109.734 -178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.791 ' ND1' HG23 ' A' ' 119' ' ' VAL . 3.0 p80 -78.1 -31.04 49.83 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.444 -0.785 . . . . 0.0 110.088 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.791 HG23 ' ND1' ' A' ' 118' ' ' HIS . 94.7 t -130.67 165.05 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.73 -1.231 . . . . 0.0 110.956 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.609 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.06 158.65 8.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.719 ' O ' HD12 ' A' ' 122' ' ' LEU . 9.8 m120 -129.3 163.91 24.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.658 -1.276 . . . . 0.0 110.547 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 121' ' ' ASN . 3.3 mp -139.49 99.55 3.76 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.471 -0.768 . . . . 0.0 108.945 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.85 67.73 10.23 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.28 -0.887 . . . . 0.0 108.922 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 122' ' ' LEU . 1.1 pp -163.85 -176.19 4.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.821 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 160' ' ' SER . . . 157.99 107.24 0.24 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.539 ' O ' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -163.98 176.71 2.08 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.134 -1.215 . . . . 0.0 109.627 -179.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 126' ' ' SER . 36.4 Cg_endo -81.34 -10.53 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.89 2.393 . . . . 0.0 109.766 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.658 ' N ' ' HD2' ' A' ' 129' ' ' PRO . 1.1 t -50.03 -48.6 78.44 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.74 -0.6 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.883 ' HA ' HG22 ' A' ' 102' ' ' VAL . 31.1 Cg_endo -72.61 169.84 20.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.245 1.963 . . . . 0.0 110.955 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.25 179.58 5.2 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 122.701 1.239 . . . . 0.0 111.008 -178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 134' ' ' GLU . . . -63.52 -16.32 60.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.1 m -63.73 -36.01 82.46 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.69 HD12 ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -66.71 -34.97 79.02 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.365 -1.716 . . . . 0.0 106.365 178.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 165' ' ' TYR . 1.7 tt0 -60.25 -58.92 6.45 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.863 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 138' ' ' ASN . 96.5 mm-40 -45.51 -25.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -67.79 -48.72 65.52 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.131 -1.028 . . . . 0.0 109.279 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.439 HG23 HD13 ' A' ' 109' ' ' LEU . 3.4 t -65.3 -26.14 38.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 11.9 t30 -62.33 -35.17 78.25 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.8 p -75.82 -25.38 56.26 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.1 -22.93 57.93 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.183 -0.948 . . . . 0.0 109.74 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -30.5 67.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.966 . . . . 0.0 108.904 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.55 -34.19 49.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 108.969 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -98.71 -19.69 17.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 237' ' ' ASN . . . 82.98 14.13 75.86 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 145' ' ' VAL . 6.3 t -48.4 102.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -1.095 . . . . 0.0 108.931 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HB2' ' OD1' ' A' ' 237' ' ' ASN . 0.4 OUTLIER -69.1 103.55 1.91 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.285 -0.884 . . . . 0.0 109.426 -179.739 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -102.51 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 218' ' ' THR . 1.0 OUTLIER -122.9 113.92 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.63 141.4 32.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 109.922 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.612 ' HB1' ' HB ' ' A' ' 214' ' ' THR . . . -64.08 172.53 2.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.809 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.613 ' CB ' HG21 ' A' ' 214' ' ' THR . 0.3 OUTLIER -69.0 -74.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.253 -0.905 . . . . 0.0 109.758 -179.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 153' ' ' ASN . . . 153.73 -13.01 0.56 Allowed Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.301 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.537 ' C ' ' O ' ' A' ' 152' ' ' GLY . 4.4 m-20 22.9 48.62 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 152' ' ' GLY . 0.3 OUTLIER 176.73 56.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.26 -0.9 . . . . 0.0 109.46 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . 161.79 51.84 0.02 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -54.51 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 110.252 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.516 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . 66.18 11.61 55.91 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 107.529 -2.229 . . . . 0.0 107.529 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 2.3 p 160.13 168.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -112.29 -175.18 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.015 -1.053 . . . . 0.0 110.007 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.944 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -85.93 168.79 13.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.305 1.05 . . . . 0.0 111.801 -178.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.457 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -104.38 137.86 19.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 175.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.721 ' O ' ' N ' ' A' ' 164' ' ' ARG . 39.6 Cg_endo -73.24 -53.31 0.16 OUTLIER 'Cis proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.174 -1.178 . . . . 0.0 110.656 3.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.944 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 29.95 -77.06 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 122.254 1.026 . . . . 0.0 110.116 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 162' ' ' PRO . 3.8 ttm180 -42.39 -46.86 4.82 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.329 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 134' ' ' GLU . 14.7 m-85 -44.4 173.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.11 -0.994 . . . . 0.0 110.913 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 168' ' ' ALA . . . -98.8 -47.87 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.67 -0.644 . . . . 0.0 110.493 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.504 ' ND2' ' C ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -42.24 -27.53 0.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.882 0.848 . . . . 0.0 109.751 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -125.55 145.55 50.07 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.473 ' SD ' ' HG3' ' A' ' 241' ' ' ARG . 12.7 mtm -96.12 153.92 17.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.158 -0.964 . . . . 0.0 110.175 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -108.43 122.82 47.81 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.57 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 24.8 t -90.72 165.75 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.033 -1.042 . . . . 0.0 109.76 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.618 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -131.09 -176.62 14.49 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -128.82 162.44 27.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.992 -1.299 . . . . 0.0 109.872 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 33.1 p -133.45 172.27 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.789 . . . . 0.0 109.249 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 -156.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -0.934 . . . . 0.0 109.229 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -90.05 -41.51 11.65 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.991 . . . . 0.0 109.286 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -78.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 109.535 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.72 30.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.274 -0.891 . . . . 0.0 110.042 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.22 156.36 22.48 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.078 -1.014 . . . . 0.0 109.145 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' A' ' 256' ' ' LEU . 6.7 ttp85 -60.96 134.6 57.26 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 0.0 109.475 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.776 ' HB1' ' CE1' ' A' ' 183' ' ' PHE . . . -45.68 173.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.451 -0.78 . . . . 0.0 109.701 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.0 OUTLIER -108.27 11.17 27.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.156 -0.965 . . . . 0.0 109.981 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.776 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 2.3 p90 -134.73 -12.37 2.29 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.039 -1.038 . . . . 0.0 110.645 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.2 t -67.01 138.88 57.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.526 ' HG2' ' N ' ' A' ' 153' ' ' ASN . 0.1 OUTLIER -93.83 143.02 26.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.159 -0.963 . . . . 0.0 109.115 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -125.47 -174.34 3.04 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.596 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.03 -171.85 44.09 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -85.67 64.39 8.59 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -1.127 . . . . 0.0 109.177 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 171.63 31.72 0.03 OUTLIER Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -85.53 138.26 32.32 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.132 -1.216 . . . . 0.0 109.66 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -86.0 -72.68 0.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 109.629 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 193' ' ' VAL . 0.3 OUTLIER -149.56 -162.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.099 -1.0 . . . . 0.0 110.245 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.795 HG22 ' CA ' ' A' ' 260' ' ' GLY . 27.2 m -143.28 175.97 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 109.406 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.962 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -167.61 177.16 1.42 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 108.946 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.962 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 33.2 Cg_endo -76.69 113.74 3.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.26 1.973 . . . . 0.0 109.446 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.505 ' HA2' ' ND2' ' A' ' 212' ' ' ASN . . . -145.22 48.27 0.71 Allowed Glycine 0 N--CA 1.484 1.861 0 C-N-CA 119.343 -1.408 . . . . 0.0 110.435 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 198' ' ' ASN . 1.7 t -130.87 30.49 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.249 . . . . 0.0 109.068 178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.597 ' N ' ' HB2' ' A' ' 212' ' ' ASN . 0.1 OUTLIER 164.86 105.18 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.158 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.788 HG22 ' ND2' ' A' ' 212' ' ' ASN . 2.7 m -158.37 111.97 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.56 ' NE2' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -89.56 117.93 28.82 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.335 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.9 t -118.05 -151.45 0.48 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.213 -0.929 . . . . 0.0 109.858 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.687 ' OG1' HG22 ' A' ' 64' ' ' THR . 0.1 OUTLIER -87.92 178.43 6.69 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.421 -0.799 . . . . 0.0 110.08 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.645 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -164.6 157.7 14.72 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.645 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 35.6 Cg_endo -70.07 166.0 29.45 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.233 1.956 . . . . 0.0 110.322 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.482 ' O ' ' HB3' ' A' ' 206' ' ' SER . . . 84.74 3.84 87.84 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 205' ' ' GLY . 6.9 t 74.84 43.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.368 -1.078 . . . . 0.0 110.26 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 208' ' ' TYR . 0.0 OUTLIER -145.11 -179.91 6.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.554 ' CE2' HG22 ' A' ' 79' ' ' VAL . 2.9 m-30 -113.67 -174.13 2.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -165.31 164.77 19.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.097 -1.002 . . . . 0.0 109.828 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 50.5 m -124.8 114.56 19.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.504 -0.747 . . . . 0.0 109.128 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.438 ' O ' HD12 ' A' ' 211' ' ' LEU . 0.8 OUTLIER -173.96 138.75 0.63 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.407 -179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.788 ' ND2' HG22 ' A' ' 199' ' ' VAL . 2.9 t-20 -125.23 -157.43 0.78 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 122.165 0.983 . . . . 0.0 110.601 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 136.32 175.95 14.09 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.276 -1.929 . . . . 0.0 108.276 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 151' ' ' SER . 0.2 OUTLIER -56.68 -41.52 77.44 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.984 -1.303 . . . . 0.0 109.346 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.5 m -57.69 -29.86 65.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.521 -0.737 . . . . 0.0 110.447 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.486 ' O ' HG21 ' A' ' 69' ' ' THR . 1.4 mpp? -90.95 -26.26 19.36 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.979 -1.076 . . . . 0.0 110.496 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.12 -6.2 59.31 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.977 -1.077 . . . . 0.0 109.441 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.703 HG23 HG12 ' A' ' 148' ' ' VAL . 1.2 m -73.05 -47.56 8.07 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.364 -0.835 . . . . 0.0 110.924 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 218' ' ' THR . 29.2 Cg_endo -71.71 -8.39 23.03 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.098 1.865 . . . . 0.0 111.466 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.723 ' CE1' HG23 ' A' ' 69' ' ' THR . 5.7 m80 -77.19 -47.14 21.09 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.726 HG22 HG21 ' A' ' 262' ' ' VAL . 57.9 t -67.74 -41.39 85.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.565 ' HB2' HD21 ' A' ' 121' ' ' ASN . . . -57.65 -34.77 69.71 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -64.5 -54.83 26.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.69 ' HB1' ' HB2' ' A' ' 264' ' ' ALA . . . -51.06 -38.3 50.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.16 -1.2 . . . . 0.0 108.867 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -59.08 -44.96 91.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 0.0 109.154 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.61 52.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 0.0 108.985 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 69.9 mt -50.82 -31.53 17.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.289 -0.882 . . . . 0.0 109.025 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 224' ' ' ALA . 58.3 t -68.3 -52.1 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 0.0 109.473 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.515 ' HD2' ' ND1' ' A' ' 118' ' ' HIS . 27.3 tttp -46.78 -42.06 16.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 108.822 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.552 ' HG3' ' CA ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -62.22 -45.95 91.03 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.357 -0.839 . . . . 0.0 109.444 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 11.6 tptm -56.4 -18.6 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 108.557 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.5 90.8 2.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.825 . . . . 0.0 108.999 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.04 8.28 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.752 2.301 . . . . 0.0 110.876 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.14 8.33 10.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -82.33 -178.66 7.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.383 -0.823 . . . . 0.0 109.915 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -121.54 174.71 6.61 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.651 -0.655 . . . . 0.0 109.443 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -60.42 -27.05 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.358 -0.839 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 238' ' ' VAL . 2.8 t -73.06 -63.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.098 -1.001 . . . . 0.0 109.61 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -49.04 -39.79 28.72 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.546 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 237' ' ' ASN . 84.0 mt -60.01 -58.12 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.486 -0.759 . . . . 0.0 109.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.473 ' HG3' ' SD ' ' A' ' 169' ' ' MET . 18.8 ttp180 -54.64 -72.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.139 -0.976 . . . . 0.0 109.9 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 241' ' ' ARG . 4.8 t30 -35.03 -36.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.919 -0.488 . . . . 0.0 110.736 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.493 ' HD2' ' HB1' ' A' ' 267' ' ' ALA . 8.6 t60 -65.83 -51.56 57.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.996 -1.065 . . . . 0.0 110.107 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.517 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 3.6 mt -70.84 -23.84 62.42 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.295 -0.878 . . . . 0.0 110.584 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.85 -33.24 60.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.968 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 246' ' ' ASN . 2.8 t-20 -93.26 -14.97 26.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.517 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.2 p -87.32 -31.3 20.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.035 -1.041 . . . . 0.0 109.762 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.616 ' HB3' ' CB ' ' A' ' 259' ' ' SER . . . -51.13 144.07 9.78 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 261' ' ' LEU . 17.6 m -78.07 159.47 28.68 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.447 ' N ' HG22 ' A' ' 249' ' ' THR . 1.9 t -128.55 101.67 6.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.852 . . . . 0.0 109.945 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -50.04 -38.9 40.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 119.78 67.41 0.29 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 257' ' ' TYR . 3.2 m -132.34 -177.58 4.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -1.092 . . . . 0.0 109.635 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.727 HG22 ' N ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -80.11 -74.1 0.32 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.556 -0.715 . . . . 0.0 109.229 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.727 ' N ' HG22 ' A' ' 254' ' ' THR . 55.4 t30 -138.0 2.17 2.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.028 -1.045 . . . . 0.0 110.382 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.576 ' CD1' ' CD2' ' A' ' 186' ' ' TYR . 2.0 mm? -80.89 -10.81 59.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.957 -1.089 . . . . 0.0 109.636 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 253' ' ' SER . 72.3 m-85 -128.75 -83.74 0.57 Allowed 'General case' 0 C--N 1.29 -2.013 0 O-C-N 121.73 -0.606 . . . . 0.0 109.601 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 257' ' ' TYR . . . 50.39 99.39 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.616 ' CB ' ' HB3' ' A' ' 248' ' ' ALA . 0.9 OUTLIER 56.91 18.85 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.584 -179.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.795 ' CA ' HG22 ' A' ' 193' ' ' VAL . . . -40.75 -61.04 1.99 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 249' ' ' THR . 5.9 tp -62.91 143.44 57.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.997 -1.296 . . . . 0.0 110.186 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.726 HG21 HG22 ' A' ' 221' ' ' VAL . 3.6 t -118.54 125.83 74.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.44 116.19 6.33 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.772 1.273 . . . . 0.0 108.663 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.69 ' HB2' ' HB1' ' A' ' 224' ' ' ALA . . . -77.64 -17.28 57.9 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.895 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 55.7 tt0 -55.65 -36.94 67.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 0.0 109.624 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -82.2 -19.47 39.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.477 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.493 ' HB1' ' HD2' ' A' ' 243' ' ' HIS . . . -98.23 -1.83 41.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.365 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.6 p -109.5 -39.06 5.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.119 -0.988 . . . . 0.0 109.655 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.589 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.746 ' HB2' ' HA ' ' A' ' 76' ' ' SER . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.437 ' CG ' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -61.1 126.48 27.52 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.205 -0.935 . . . . 0.0 109.732 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 5' ' ' PRO . 22.9 m -120.19 47.29 1.79 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 3' ' ' SER . 7.3 t -17.3 80.26 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.148 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.708 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.564 ' N ' ' O ' ' A' ' 3' ' ' SER . 36.6 Cg_endo -81.69 164.31 18.44 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.809 2.339 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -15.36 7.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.566 -0.709 . . . . 0.0 109.793 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 195' ' ' PRO . . . -83.16 -64.23 1.67 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 9' ' ' SER . 1.1 mp -65.87 173.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.294 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 8' ' ' ILE . 2.5 t 88.94 -39.12 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.48 -25.12 29.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.484 -0.76 . . . . 0.0 110.335 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 11' ' ' VAL . 34.0 m -91.55 20.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.939 -1.101 . . . . 0.0 110.089 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.541 ' OE1' ' CB ' ' A' ' 265' ' ' GLU . 0.0 OUTLIER 50.86 53.42 13.05 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.375 -0.828 . . . . 0.0 110.519 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.681 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -88.66 -30.41 0.37 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.944 -1.097 . . . . 0.0 111.988 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 31.8 Cg_endo -75.31 -59.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 N-CA-C 109.222 -1.107 . . . . 0.0 109.222 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -45.11 -27.41 0.58 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.06 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -81.15 -40.56 23.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.922 -1.111 . . . . 0.0 108.935 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -73.11 -8.42 55.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -110.48 -39.02 5.05 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.599 -1.313 . . . . 0.0 110.23 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.22 -30.41 68.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.868 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.09 -4.85 4.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.606 ' HB3' HD22 ' A' ' 227' ' ' LEU . 3.7 mm? -62.9 122.29 15.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.199 -1.177 . . . . 0.0 109.101 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -118.5 -30.81 5.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.376 -0.828 . . . . 0.0 109.535 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 78.8 -14.73 12.13 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.41 120.81 4.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.239 -1.154 . . . . 0.0 109.001 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.09 0.71 30.0 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 23' ' ' GLY . 39.4 t -99.37 164.89 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.236 -1.155 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.594 ' CB ' ' HB3' ' A' ' 117' ' ' MET . 6.4 mttt -142.29 129.34 20.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 0.0 109.755 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.7 HG13 ' HB ' ' A' ' 119' ' ' VAL . 16.0 t -133.04 158.54 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 109.611 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -112.17 144.42 41.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 108.918 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 88' ' ' LEU . 45.7 t -121.31 82.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.073 -1.017 . . . . 0.0 109.132 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.859 HD22 HD12 ' A' ' 122' ' ' LEU . 4.9 mp -64.7 91.64 0.09 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -144.72 -151.78 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.206 -0.934 . . . . 0.0 108.798 -179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.689 HG22 ' C ' ' A' ' 95' ' ' GLY . 72.9 p -80.35 -51.63 8.64 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.462 -1.398 . . . . 0.0 109.036 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -168.56 -114.47 0.3 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.68 HG22 ' O ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 160.83 100.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.5 t -44.75 150.47 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.193 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.33 115.27 21.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.422 ' HB2' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -139.16 157.26 71.46 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.057 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 36.2 Cg_endo -77.01 -37.48 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.6 2.2 . . . . 0.0 110.493 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.611 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -62.08 -18.94 62.3 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' CD2' ' HA2' ' A' ' 68' ' ' GLY . 14.5 mt -102.02 129.82 48.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.371 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -83.84 68.23 9.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.385 -0.822 . . . . 0.0 109.307 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -57.26 139.02 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.482 ' HG2' ' HG2' ' A' ' 87' ' ' GLU . 20.3 tpt85 -121.54 -33.92 3.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.261 -0.899 . . . . 0.0 109.687 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.16 -156.27 18.97 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.22 166.2 13.92 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.726 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -145.33 174.58 10.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.976 . . . . 0.0 108.961 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 92' ' ' LYS . 81.2 p -125.84 107.18 10.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 110.28 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.726 ' CZ ' ' HB3' ' A' ' 47' ' ' ALA . 2.7 m-85 -105.81 -36.83 6.9 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.675 HG13 ' HD2' ' A' ' 51' ' ' PRO . 2.1 t -41.82 145.97 0.65 Allowed Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HD2' HG13 ' A' ' 50' ' ' VAL . 34.0 Cg_endo -75.28 -63.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.575 2.183 . . . . 0.0 110.81 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -29.77 -38.13 0.02 OUTLIER Glycine 0 N--CA 1.499 2.886 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.538 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER 60.95 60.49 3.28 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 35.2 Cg_endo -77.98 -78.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.427 2.085 . . . . 0.0 110.022 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 54' ' ' PRO . 6.4 m -167.52 136.49 2.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.443 -0.785 . . . . 0.0 109.089 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' A' ' 56' ' ' THR . 1.2 m -77.74 -0.85 28.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.217 -0.927 . . . . 0.0 108.594 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' ASP . 20.4 mt-30 -141.51 117.72 10.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 109.041 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 57' ' ' GLN . 14.2 t70 64.56 92.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.837 . . . . 0.0 109.513 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -107.29 -27.89 5.12 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -167.66 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.389 -1.065 . . . . 0.0 109.679 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 64' ' ' THR . . . 160.55 -42.18 0.43 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.216 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 63' ' ' GLY . 34.7 t-80 -54.16 -65.09 0.63 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.093 -1.239 . . . . 0.0 110.078 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 64' ' ' THR . . . -39.99 -74.77 0.13 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -40.1 -40.66 1.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 0.0 109.784 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 3.4 t-80 -55.37 -56.7 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.5 -0.75 . . . . 0.0 109.85 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 219' ' ' PRO . 78.5 t -57.49 -44.44 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -54.67 -32.72 59.7 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.483 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -79.39 -27.62 54.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 m -74.15 -15.61 61.02 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.087 -1.243 . . . . 0.0 108.524 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.953 HG21 HD21 ' A' ' 88' ' ' LEU . 16.7 mt -109.29 -21.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.455 -0.778 . . . . 0.0 110.049 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.948 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -117.56 -35.45 3.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.098 -1.001 . . . . 0.0 111.627 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 68' ' ' GLY . . . -15.24 106.15 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 121.468 0.652 . . . . 0.0 111.646 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 40' ' ' ASP . 6.7 mt -85.0 153.82 22.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.409 -0.807 . . . . 0.0 109.749 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 48.9 p-10 -72.62 141.64 48.34 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 8.7 m-20 158.17 130.16 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.746 ' HA ' ' HB2' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -35.61 -39.11 0.13 Allowed 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -86.68 64.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.127 -0.983 . . . . 0.0 109.349 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' HA3' ' OD2' ' A' ' 40' ' ' ASP . . . 158.35 160.17 10.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 80' ' ' LEU . 5.5 m -79.05 -112.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -1.112 . . . . 0.0 109.646 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.439 ' H ' HG23 ' A' ' 79' ' ' VAL . 5.6 tp -171.74 96.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.799 -1.188 . . . . 0.0 109.664 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.607 ' CA ' ' HB3' ' A' ' 72' ' ' ALA . . . -78.92 -160.49 18.02 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.644 HG12 HD11 ' A' ' 227' ' ' LEU . 1.4 t -107.65 -32.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -1.112 . . . . 0.0 109.291 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -115.53 117.98 39.84 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 109.205 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 22' ' ' THR . 37.6 Cg_endo -85.48 -59.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.724 2.282 . . . . 0.0 111.244 -179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -94.53 38.83 1.1 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.97 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.662 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -89.54 124.2 34.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.147 -0.97 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 44' ' ' ARG . 2.6 mt-10 -64.49 103.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.953 HD21 HG21 ' A' ' 70' ' ' ILE . 11.1 mt -97.44 92.9 6.17 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.917 -1.114 . . . . 0.0 110.851 -178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.444 ' CE2' ' HE3' ' A' ' 117' ' ' MET . 40.0 m-85 -77.63 146.57 36.05 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.25 106.59 17.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.767 -1.208 . . . . 0.0 109.029 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.698 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -95.1 67.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.988 0.899 . . . . 0.0 108.807 -179.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 26.6 ttmt -35.12 94.05 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.005 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.607 HG21 HD23 ' A' ' 31' ' ' LEU . 2.2 t -118.39 -16.66 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 0.0 108.891 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 35.1 mt -116.47 175.17 5.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.389 -0.819 . . . . 0.0 110.167 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 96' ' ' ALA . . . -107.36 -14.3 18.62 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 95' ' ' GLY . . . 150.54 -83.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.3 23.28 7.64 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 178.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.604 ' O ' ' CB ' ' A' ' 99' ' ' SER . . . -95.75 -95.34 1.76 Allowed Glycine 0 N--CA 1.479 1.524 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 98' ' ' GLY . 2.9 p 149.1 100.18 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.92 -178.8 0.18 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.26 177.51 6.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.883 -0.775 . . . . 0.0 109.969 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.583 HG22 ' CD1' ' A' ' 133' ' ' LEU . 1.5 t -66.19 -22.02 29.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 3.6 t -69.96 -26.4 64.09 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 93' ' ' VAL . 4.4 m -81.23 -44.49 17.69 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.538 -0.726 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.525 HG22 ' CD1' ' A' ' 109' ' ' LEU . 1.2 mt -68.14 -21.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -72.49 -52.22 16.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.681 -0.637 . . . . 0.0 110.027 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 103' ' ' SER . 12.7 mm-40 -71.15 -30.4 66.41 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.689 -1.257 . . . . 0.0 108.838 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CG2' ' A' ' 93' ' ' VAL . . . -73.19 -24.07 76.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD1' HG22 ' A' ' 105' ' ' ILE . 25.0 mt -93.79 -24.2 17.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -1.179 . . . . 0.0 109.906 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -88.33 -30.52 19.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.053 -1.029 . . . . 0.0 109.717 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.458 ' O ' ' CE3' ' A' ' 111' ' ' TRP . 69.4 t90 -72.65 -16.6 61.7 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.693 ' O ' HG21 ' A' ' 145' ' ' VAL . . . -91.37 6.21 46.28 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 143' ' ' ARG . . . -114.9 -50.38 0.48 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -70.08 -76.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.279 . . . . 0.0 108.732 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -105.71 41.07 1.44 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.621 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -92.39 -149.46 24.53 Favored Glycine 0 C--N 1.294 -1.782 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -177.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.594 ' HB3' ' CB ' ' A' ' 27' ' ' LYS . 7.1 mmt -140.3 -169.15 2.7 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 122.178 0.989 . . . . 0.0 110.933 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.485 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 6.0 m170 -70.21 -57.77 4.53 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.164 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.7 ' HB ' HG13 ' A' ' 28' ' ' VAL . 9.7 t -101.03 161.35 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.004 . . . . 0.0 111.177 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.592 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . . . -163.25 109.7 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 1.057 ' C ' HD13 ' A' ' 122' ' ' LEU . 7.0 m120 -110.72 153.49 25.21 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.911 -1.118 . . . . 0.0 111.077 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.057 HD13 ' C ' ' A' ' 121' ' ' ASN . 0.0 OUTLIER -134.89 134.07 40.32 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -89.61 70.27 7.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.294 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.608 HD21 ' CB ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -150.4 -177.74 6.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.621 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.07 106.93 0.19 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.18 158.97 40.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.205 -1.173 . . . . 0.0 109.58 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 128' ' ' SER . 36.0 Cg_endo -78.69 -17.1 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.633 2.222 . . . . 0.0 110.051 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -40.98 102.15 0.26 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.583 -0.698 . . . . 0.0 109.533 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.454 ' O ' ' OG ' ' A' ' 130' ' ' SER . 34.0 Cg_endo -77.42 166.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.409 2.073 . . . . 0.0 110.488 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 129' ' ' PRO . 2.1 m 172.53 121.69 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.479 -0.763 . . . . 0.0 109.436 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' GLN . . . -67.58 -18.53 65.03 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 88.8 m -73.07 -25.73 61.01 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.583 ' CD1' HG22 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -79.62 -42.89 23.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -75.45 -25.82 57.77 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.6 -1.24 . . . . 0.0 108.546 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 131' ' ' ALA . 1.4 tm0? -72.41 -22.75 61.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.3 36.16 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 167' ' ' ASN . 0.9 OUTLIER -64.06 -30.53 50.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 178.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -59.45 -36.55 76.14 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.52 -24.48 50.0 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.29 59.42 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 121.232 -0.917 . . . . 0.0 109.917 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.8 m -73.17 -36.53 66.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 109.526 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.84 -24.76 58.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.491 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -105.15 -13.14 15.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 62.26 55.53 27.22 Favored Glycine 0 N--CA 1.477 1.417 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.693 HG21 ' O ' ' A' ' 112' ' ' ALA . 15.3 t -89.36 107.13 17.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.704 -0.88 . . . . 0.0 109.766 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 15.6 tp -64.05 101.95 0.45 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.063 -1.023 . . . . 0.0 109.071 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 1.4 t -88.81 150.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.743 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -146.06 120.93 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.713 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -115.44 151.33 34.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 110.124 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -56.68 173.82 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -72.78 -67.55 0.55 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.034 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 153' ' ' ASN . . . 172.67 -23.67 0.08 OUTLIER Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.806 -1.187 . . . . 0.0 110.77 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 154' ' ' SER . 44.4 t-20 67.52 37.12 3.51 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.831 -0.805 . . . . 0.0 109.96 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 1.0 OUTLIER 79.23 72.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 110.213 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -115.84 -33.09 1.6 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -172.12 -178.39 2.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.173 -1.193 . . . . 0.0 109.534 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 158' ' ' SER . . . -85.34 58.41 4.91 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 0.5 OUTLIER 162.25 129.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.531 -0.982 . . . . 0.0 109.196 -179.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 158' ' ' SER . 1.8 pt -48.66 178.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.359 -0.838 . . . . 0.0 110.007 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.878 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.9 OUTLIER -126.91 164.68 20.9 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.227 -0.921 . . . . 0.0 111.896 -177.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 161' ' ' TYR . 0.1 OUTLIER -77.78 142.37 65.41 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 175.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.8 Cg_endo -72.0 -29.3 6.35 Favored 'Cis proline' 0 C--N 1.298 -2.113 0 O-C-N 122.546 0.761 . . . . 0.0 110.594 3.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.878 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . -35.12 -26.04 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.732 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.561 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER -100.35 -32.03 11.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.542 -1.349 . . . . 0.0 110.608 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.51 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.6 m-85 -46.18 -179.78 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.172 -0.955 . . . . 0.0 110.798 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -93.96 -25.64 17.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.566 -0.709 . . . . 0.0 111.049 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.471 HD22 HG13 ' A' ' 137' ' ' VAL . 2.2 t-20 -97.98 23.08 8.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.81 -1.181 . . . . 0.0 110.061 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.499 ' CB ' ' HB2' ' A' ' 162' ' ' PRO . . . -153.01 114.61 4.26 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.537 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 0.6 OUTLIER -78.26 167.45 21.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.128 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -118.61 123.77 45.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.406 -0.809 . . . . 0.0 109.331 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 172' ' ' GLY . 25.0 t -92.86 166.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.141 -0.974 . . . . 0.0 109.242 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.571 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -138.66 -179.79 17.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.49 ' HB2' HG23 ' A' ' 214' ' ' THR . . . -119.47 171.27 8.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 179' ' ' ASN . 1.5 p -122.86 167.88 12.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 109.502 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.536 ' CA ' ' HA ' ' A' ' 181' ' ' ALA . 49.6 p-10 -91.16 -177.57 4.92 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.129 -0.982 . . . . 0.0 109.51 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -69.51 -24.25 63.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.313 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.29 -79.22 0.17 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.464 ' O ' ' HB ' ' A' ' 174' ' ' THR . 0.1 OUTLIER -135.76 -79.4 0.42 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.308 -0.87 . . . . 0.0 110.363 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.593 ' HA ' HG22 ' A' ' 174' ' ' THR . 0.8 OUTLIER -125.0 -164.49 1.29 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.206 -0.934 . . . . 0.0 109.681 -178.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.534 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 0.0 OUTLIER 81.43 -31.31 0.11 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.626 -0.672 . . . . 0.0 110.932 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.536 ' HA ' ' CA ' ' A' ' 175' ' ' ASP . . . 42.99 -155.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.957 -1.089 . . . . 0.0 109.454 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.9 t -126.64 -45.81 1.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 110.308 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -115.27 26.37 10.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 110.349 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.5 t -81.15 112.31 18.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 109.231 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 154' ' ' SER . 3.3 tp-100 -74.88 156.8 36.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.009 -1.057 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -136.8 171.41 14.54 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.613 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.578 ' N ' ' CD1' ' A' ' 186' ' ' TYR . . . -173.56 146.83 9.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -49.05 100.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 109.36 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 126.46 16.16 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 186' ' ' TYR . 7.1 tp -53.79 151.08 6.7 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.107 -1.231 . . . . 0.0 108.824 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.537 ' CB ' ' HB3' ' A' ' 169' ' ' MET . 22.4 t70 -99.54 -69.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.905 -1.122 . . . . 0.0 110.439 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.825 HD11 HG22 ' A' ' 262' ' ' VAL . 7.6 tt -159.45 141.01 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.029 -1.069 . . . . 0.0 110.367 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.516 HG21 HD21 ' A' ' 179' ' ' ASN . 22.1 m -98.32 172.96 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.485 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 1.002 ' HB1' ' HD2' ' A' ' 195' ' ' PRO . . . -164.1 178.13 1.56 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.05 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 1.002 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.7 Cg_endo -77.64 117.61 4.32 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.284 1.989 . . . . 0.0 110.134 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -143.67 33.24 1.78 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.666 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 62.7 t -119.31 59.03 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -1.192 . . . . 0.0 108.88 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.724 ' O ' HG13 ' A' ' 199' ' ' VAL . 12.9 t-20 123.9 121.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 198' ' ' ASN . 11.6 m -166.4 110.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.946 0.879 . . . . 0.0 109.088 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.6 mt-30 -80.46 122.97 27.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.334 0.588 . . . . 0.0 109.531 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.594 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 1.8 t -125.31 -163.16 1.17 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.826 . . . . 0.0 109.643 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.5 p -79.27 166.8 21.76 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.452 -0.78 . . . . 0.0 110.115 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.647 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -149.16 156.62 40.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.647 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.3 Cg_endo -69.96 159.94 51.46 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.183 1.922 . . . . 0.0 110.629 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.418 ' O ' ' OG ' ' A' ' 206' ' ' SER . . . 74.84 31.28 58.35 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 205' ' ' GLY . 80.9 p 49.86 40.15 19.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -1.076 . . . . 0.0 109.905 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -125.22 155.36 40.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -103.58 165.43 11.04 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.186 -0.946 . . . . 0.0 108.819 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 200' ' ' GLN . . . -153.09 163.76 39.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.768 -1.208 . . . . 0.0 110.746 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.8 OUTLIER -121.27 108.21 13.46 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.522 HD23 ' C ' ' A' ' 210' ' ' SER . 11.0 mt -110.12 170.0 8.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.103 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 212' ' ' ASN . 2.4 p-10 -146.77 148.88 32.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.448 -0.782 . . . . 0.0 109.211 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 158.16 161.94 11.39 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.696 -1.361 . . . . 0.0 109.696 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 173' ' ' ALA . 90.3 m -77.37 -17.32 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -1.129 . . . . 0.0 109.222 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 36.0 m -75.37 -19.25 59.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.308 -0.87 . . . . 0.0 109.118 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.442 ' C ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -79.71 -17.44 53.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.394 -0.816 . . . . 0.0 109.556 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.693 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -89.8 -13.1 37.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 109.732 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.638 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 12.7 m -70.6 -42.73 14.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 111.489 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.9 Cg_endo -73.11 -15.45 25.77 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 121.672 1.581 . . . . 0.0 110.756 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -75.25 -40.44 58.91 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.466 HG22 HG21 ' A' ' 262' ' ' VAL . 88.2 t -68.82 -49.64 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.535 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -55.27 -31.99 62.01 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.387 -0.821 . . . . 0.0 108.995 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -64.24 -53.87 33.56 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -49.25 -52.19 28.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.197 -1.179 . . . . 0.0 109.237 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -50.33 -37.37 36.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.404 -0.81 . . . . 0.0 109.061 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 223' ' ' GLY . . . -61.73 -44.23 97.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.308 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 82' ' ' VAL . 79.1 mt -55.8 -36.63 67.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.238 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.504 HG21 HD23 ' A' ' 244' ' ' LEU . 36.6 t -73.59 -40.88 55.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.181 -0.949 . . . . 0.0 109.995 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.76 ' NZ ' HD13 ' A' ' 240' ' ' ILE . 11.6 ttmm -52.38 -46.07 66.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.962 -1.086 . . . . 0.0 108.623 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.434 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.78 -45.16 93.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.355 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.96 -20.66 3.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.342 -0.848 . . . . 0.0 108.792 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -170.62 85.06 0.53 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.758 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 230' ' ' GLN . 35.1 Cg_endo -77.05 -16.16 16.0 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.682 2.255 . . . . 0.0 110.699 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.07 -0.6 32.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 109.795 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -81.27 -177.33 6.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.916 . . . . 0.0 109.929 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.75 169.13 11.04 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.64 . . . . 0.0 109.577 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -60.11 -16.06 28.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.68 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.51 -63.74 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.285 -0.884 . . . . 0.0 109.482 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.481 ' HA ' ' OE1' ' A' ' 239' ' ' GLN . 0.0 OUTLIER -50.82 -38.86 51.21 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.031 -178.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.76 HD13 ' NZ ' ' A' ' 229' ' ' LYS . 62.5 mt -70.62 -44.61 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 110.294 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 4.8 ttp85 -57.3 -29.24 63.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.62 -1.3 . . . . 0.0 110.415 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.49 -29.63 25.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.75 -1.219 . . . . 0.0 110.278 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.424 ' O ' HG23 ' A' ' 247' ' ' THR . 0.6 OUTLIER -75.5 -57.86 3.63 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.934 -1.104 . . . . 0.0 108.126 179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.522 ' HA ' ' OG1' ' A' ' 247' ' ' THR . 0.2 OUTLIER -60.05 -38.12 81.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.753 -0.592 . . . . 0.0 110.253 179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 21.6 tttt -69.34 -49.96 50.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.938 -1.101 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -74.62 -6.37 48.26 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.826 -0.547 . . . . 0.0 110.862 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 244' ' ' LEU . 1.5 p -94.15 -30.76 14.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.697 -1.252 . . . . 0.0 109.832 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -44.24 137.44 3.5 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 93.7 m -92.19 105.9 18.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.187 -0.945 . . . . 0.0 109.862 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.499 ' HA ' ' HA3' ' A' ' 260' ' ' GLY . 0.5 OUTLIER -75.43 135.61 40.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.043 -1.036 . . . . 0.0 110.442 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.3 -78.11 0.1 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.309 -0.869 . . . . 0.0 109.686 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -149.62 31.71 1.12 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 4.2 m -123.99 159.53 29.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.05 -1.265 . . . . 0.0 109.355 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.9 p -138.37 24.78 2.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.233 -0.917 . . . . 0.0 109.605 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -171.79 -34.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.277 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 256' ' ' LEU . 13.8 mt -70.61 -74.86 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.242 -0.912 . . . . 0.0 109.167 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 257' ' ' TYR . 4.2 m-30 -71.4 -24.39 62.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.697 0.76 . . . . 0.0 109.121 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 69.69 -107.64 2.19 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 192' ' ' ILE . 44.9 m -54.02 -48.49 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.249 . . . . 0.0 108.941 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 250' ' ' SER . . . 106.74 -131.37 10.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 261' ' ' LEU . 4.8 tp -81.65 179.17 7.94 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.365 -1.079 . . . . 0.0 109.898 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.825 HG22 HD11 ' A' ' 192' ' ' ILE . 0.4 OUTLIER -120.32 140.67 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.492 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -164.45 118.43 1.39 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.468 1.128 . . . . 0.0 108.533 178.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -80.43 -7.19 59.04 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.698 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.541 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -57.53 -54.02 51.56 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.771 -1.206 . . . . 0.0 109.792 -179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -73.09 -4.6 33.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.138 -0.976 . . . . 0.0 110.085 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.417 ' HB1' ' CG2' ' A' ' 228' ' ' VAL . . . -103.61 -14.91 15.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.819 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.601 HG21 ' HG ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -106.04 -31.26 8.82 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.025 . . . . 0.0 109.981 -179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 268' ' ' THR . 1.4 ttp85 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.534 ' NE2' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -70.2 169.49 13.55 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.297 -0.877 . . . . 0.0 109.339 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 1.9 m -77.25 116.38 17.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.235 -0.916 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 t -131.83 81.27 63.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.893 . . . . 0.0 109.208 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HG2' HG13 ' A' ' 8' ' ' ILE . 33.6 Cg_endo -77.27 157.23 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.507 2.138 . . . . 0.0 110.738 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -47.37 -38.0 12.26 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.648 -0.658 . . . . 0.0 109.916 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' TRP . . . -59.95 -43.81 97.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -107.33 50.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -1.155 . . . . 0.0 109.862 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -132.15 -42.88 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 109.593 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -86.61 -1.1 57.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.931 . . . . 0.0 109.888 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG23 ' HB2' ' A' ' 13' ' ' ALA . 16.2 m -88.42 20.08 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 120.994 -1.066 . . . . 0.0 109.85 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' OE1' ' CB ' ' A' ' 263' ' ' ASN . 1.1 mt-30 41.4 42.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.507 -0.745 . . . . 0.0 110.289 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.691 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -76.85 -35.37 1.42 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 111.481 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.2 Cg_endo -73.0 -56.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.939 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.623 ' HB1' ' HG3' ' A' ' 265' ' ' GLU . . . -42.93 -37.07 1.73 Allowed 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.68 -48.35 72.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.209 -0.932 . . . . 0.0 108.563 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 17' ' ' HIS . 21.7 m170 -63.93 -14.34 52.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.179 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -77.89 -50.26 12.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.15 -14.58 25.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.591 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.52 -2.86 39.57 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.634 ' CD2' HG21 ' A' ' 268' ' ' THR . 1.6 tp -51.72 162.52 0.4 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.154 . . . . 0.0 109.655 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.89 -32.77 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 110.403 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA2' ' HG3' ' A' ' 230' ' ' GLN . . . 64.82 8.86 36.35 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.546 ' CB ' ' HB3' ' A' ' 85' ' ' ASN . 8.6 p -52.75 -31.8 40.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.56 -0.964 . . . . 0.0 110.07 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -91.03 32.9 4.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 27' ' ' LYS . 54.0 t -123.57 162.35 24.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.222 -1.164 . . . . 0.0 109.927 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.696 ' HZ2' ' HG3' ' A' ' 117' ' ' MET . 0.0 OUTLIER -133.94 132.5 40.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.487 -0.758 . . . . 0.0 109.799 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.56 ' N ' ' HE2' ' A' ' 27' ' ' LYS . 1.1 t -128.41 103.68 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.449 -0.782 . . . . 0.0 109.789 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.792 ' HB1' ' CG2' ' A' ' 91' ' ' VAL . . . -74.16 162.46 28.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 35' ' ' ILE . 42.6 t -135.16 89.08 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.011 -1.056 . . . . 0.0 108.894 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.497 ' HG ' ' HB ' ' A' ' 91' ' ' VAL . 7.1 mp -76.56 109.78 10.58 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.479 ' OD2' ' HA3' ' A' ' 63' ' ' GLY . 44.4 p-10 -173.71 -164.92 0.23 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.895 -1.128 . . . . 0.0 110.123 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 96' ' ' ALA . 19.6 p -42.9 -64.78 0.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.724 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.55 ' O ' ' CG1' ' A' ' 35' ' ' ILE . . . -172.2 -116.19 0.39 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.697 HD11 HG11 ' A' ' 30' ' ' VAL . 0.6 OUTLIER 156.58 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 204' ' ' PRO . 1.4 p -69.25 151.5 46.19 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.195 -0.941 . . . . 0.0 109.599 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.2 t -70.94 162.21 29.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -0.869 . . . . 0.0 109.72 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.618 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -166.29 162.7 12.02 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.8 Cg_endo -79.04 -5.78 14.68 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.701 2.267 . . . . 0.0 110.349 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -109.56 -17.07 13.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.137 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.638 HD21 ' HA2' ' A' ' 68' ' ' GLY . 18.5 mt -100.7 141.29 33.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.267 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' ARG . 0.6 OUTLIER -111.8 67.05 0.64 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.104 -0.998 . . . . 0.0 109.229 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' CG2' ' A' ' 35' ' ' ILE . 31.9 mm -43.06 94.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.379 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -81.88 -15.82 52.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.238 -0.914 . . . . 0.0 109.917 -179.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -171.28 152.41 18.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.18 163.79 29.2 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -159.51 167.61 28.2 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.979 ' OG ' HG23 ' A' ' 56' ' ' THR . 1.5 m -148.81 111.74 4.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 110.156 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.755 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 9.0 m-85 -99.02 -40.61 7.95 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.347 -0.846 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.571 ' HB ' ' NZ ' ' A' ' 92' ' ' LYS . 76.3 t -51.73 120.4 15.76 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.831 . . . . 0.0 108.986 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 52' ' ' GLY . 36.8 Cg_endo -79.71 -68.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.618 2.212 . . . . 0.0 111.218 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 51' ' ' PRO . . . -33.43 -52.54 0.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HG3' ' C ' ' A' ' 52' ' ' GLY . 14.8 mt-10 -136.66 99.81 10.31 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.296 . . . . 0.0 109.974 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.661 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 36.5 Cg_endo -78.37 -95.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.643 2.228 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.554 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER 82.26 -66.27 0.1 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.041 -1.037 . . . . 0.0 110.39 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.979 HG23 ' OG ' ' A' ' 48' ' ' SER . 0.1 OUTLIER 64.5 3.32 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.048 -1.033 . . . . 0.0 110.408 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.441 ' HG2' ' C ' ' A' ' 56' ' ' THR . 78.4 mm-40 -149.75 118.77 6.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.666 -1.271 . . . . 0.0 110.211 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.493 ' OD1' ' CB ' ' A' ' 204' ' ' PRO . 8.6 t0 57.27 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.404 -0.81 . . . . 0.0 110.106 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 60' ' ' ASN . . . -127.06 -8.07 4.75 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' GLY . 63.8 t-20 176.31 -61.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.271 -1.135 . . . . 0.0 109.162 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.83 -18.33 0.65 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -68.13 0.37 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -1.086 . . . . 0.0 110.029 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' HA3' ' OD2' ' A' ' 32' ' ' ASP . . . -55.46 -22.83 32.73 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.7 m -72.42 -57.71 3.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.75 -1.441 . . . . 0.0 109.809 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.604 ' CD2' ' HB3' ' A' ' 201' ' ' SER . 1.5 t-80 -59.04 -36.11 74.45 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.299 -0.876 . . . . 0.0 109.717 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 70' ' ' ILE . 67.1 t -67.92 -42.81 85.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.406 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' HG12 ' A' ' 35' ' ' ILE . . . -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.438 -0.789 . . . . 0.0 110.009 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.638 ' HA2' HD21 ' A' ' 41' ' ' LEU . . . -68.61 -40.27 86.04 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.432 HG21 ' HG2' ' A' ' 219' ' ' PRO . 28.2 m -63.72 -17.28 62.84 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.399 -1.059 . . . . 0.0 108.727 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.78 ' HB ' HD11 ' A' ' 88' ' ' LEU . 36.9 mt -93.85 -22.28 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.439 -0.788 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.785 ' HB2' HD12 ' A' ' 88' ' ' LEU . . . -131.59 -52.67 1.0 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.047 . . . . 0.0 111.228 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.078 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 33.7 62.84 0.41 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.722 -0.611 . . . . 0.0 109.831 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.474 HD11 ' OD1' ' A' ' 42' ' ' ASN . 43.4 mt -43.34 147.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.117 -0.989 . . . . 0.0 110.287 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 1.7 m-20 -62.55 155.88 24.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.755 . . . . 0.0 109.256 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 15.7 m-20 145.8 129.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 75' ' ' ASN . 28.5 t -37.03 -30.16 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.293 0.568 . . . . 0.0 109.765 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 75' ' ' ASN . 28.7 pt -84.65 143.54 11.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 66.92 155.07 0.38 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.479 HG23 ' N ' ' A' ' 80' ' ' LEU . 26.0 m -72.16 -141.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.317 -1.107 . . . . 0.0 109.683 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.534 HD22 ' NE2' ' A' ' 2' ' ' GLN . 67.5 tp -138.81 128.07 24.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.975 -1.078 . . . . 0.0 110.089 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 1.078 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -87.08 -177.07 49.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.68 -32.35 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.105 -1.232 . . . . 0.0 109.264 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -116.34 98.53 51.61 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.341 -0.85 . . . . 0.0 109.081 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -83.13 -60.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.812 2.341 . . . . 0.0 110.496 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.546 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -71.71 0.38 8.95 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.671 -178.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.587 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -73.33 161.52 30.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.852 -1.155 . . . . 0.0 109.457 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.536 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 2.1 mp0 -97.99 107.85 20.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 0.0 109.789 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 71' ' ' ALA . 2.5 mt -90.47 127.5 36.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.12 -0.987 . . . . 0.0 109.637 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.672 ' CD1' ' HE3' ' A' ' 27' ' ' LYS . 3.6 m-85 -111.99 178.11 4.42 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.014 -1.054 . . . . 0.0 109.943 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.25 90.2 2.5 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.792 ' CG2' ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -96.1 64.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.216 -0.928 . . . . 0.0 109.111 -179.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' A' ' 54' ' ' PRO . 3.1 ttpm? -41.06 121.32 1.53 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.33 0.586 . . . . 0.0 109.611 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 104' ' ' SER . 1.2 t -131.7 3.14 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.953 . . . . 0.0 109.258 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.928 ' CD1' HD22 ' A' ' 124' ' ' LEU . 2.1 mp -141.29 173.92 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.14 -0.975 . . . . 0.0 109.669 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -98.31 -178.35 32.86 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 33' ' ' THR . . . -76.54 -63.07 1.42 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.194 -1.18 . . . . 0.0 109.397 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.3 m -49.77 -29.95 8.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.932 . . . . 0.0 109.235 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 108.76 47.68 0.89 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -124.58 65.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -1.132 . . . . 0.0 109.852 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.84 -179.55 38.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.26 160.29 22.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.627 -0.925 . . . . 0.0 109.818 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.78 -18.7 22.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 107' ' ' GLN . 8.7 t -80.47 -14.71 58.04 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.83 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -87.84 -44.08 11.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.589 -0.694 . . . . 0.0 109.16 179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.6 ' HA ' HG11 ' A' ' 93' ' ' VAL . 2.4 mt -76.88 -32.47 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -75.92 -36.2 59.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 110' ' ' GLU . 1.2 tt0 -70.88 -42.5 69.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.883 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.26 -28.54 73.26 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.46 -45.29 72.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.32 -1.106 . . . . 0.0 108.944 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 107' ' ' GLN . 9.9 pt-20 -72.27 -24.18 61.31 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -69.99 -18.68 63.35 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.658 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . . . -82.66 -0.69 48.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.322 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA3' ' NH1' ' A' ' 143' ' ' ARG . . . -107.15 -51.73 0.76 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -63.66 1.22 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.295 -1.12 . . . . 0.0 109.143 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -120.99 34.65 5.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 112' ' ' ALA . . . -102.37 -151.19 23.54 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.141 -1.028 . . . . 0.0 111.718 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.696 ' HG3' ' HZ2' ' A' ' 27' ' ' LYS . 2.6 mmt -144.14 -157.73 0.81 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.153 0.978 . . . . 0.0 110.965 -177.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.646 ' NE2' HG22 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -90.83 -30.6 16.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.896 -178.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.646 HG22 ' NE2' ' A' ' 118' ' ' HIS . 2.1 t -111.51 154.14 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 119.857 -1.777 . . . . 0.0 110.502 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.604 ' O ' HG13 ' A' ' 147' ' ' VAL . . . -163.39 105.62 0.98 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 0.0 108.908 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.57 ' O ' HD12 ' A' ' 122' ' ' LEU . 5.9 m120 -85.45 -178.75 6.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.674 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.959 HD23 HD11 ' A' ' 124' ' ' LEU . 1.1 mp -152.38 100.23 2.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.524 ' C ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -85.46 65.47 9.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.959 HD11 HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -146.44 175.32 10.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.543 -0.723 . . . . 0.0 109.191 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.35 88.61 0.08 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -109.09 152.13 42.33 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.185 -1.185 . . . . 0.0 109.252 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 36.0 Cg_endo -77.42 -23.43 10.04 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.426 2.084 . . . . 0.0 109.45 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 m -69.38 111.7 9.56 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.806 -0.559 . . . . 0.0 109.906 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 127' ' ' PRO . 36.8 Cg_endo -82.66 170.63 12.69 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.407 2.071 . . . . 0.0 110.326 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 133' ' ' LEU . 2.5 p -163.08 110.77 1.23 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.976 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.35 -29.49 70.23 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.2 m -58.23 -31.09 67.03 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -71.58 -36.58 70.93 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -59.44 5.27 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.81 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.2 OUTLIER -50.52 -23.4 2.47 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 108.723 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -73.72 -45.43 52.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.986 HG21 ' HA ' ' A' ' 166' ' ' ALA . 59.3 t -69.44 -21.68 24.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 8.4 m120 -62.94 -35.82 81.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -29.46 57.72 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 137' ' ' VAL . . . -75.4 -13.24 60.38 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.1 m -80.52 -44.36 19.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.0 t -64.15 -13.8 50.74 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.517 ' NH1' ' HA3' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -96.85 -17.9 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.497 -0.752 . . . . 0.0 109.285 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.45 75.45 0.4 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 118' ' ' HIS . 36.0 t -124.75 102.04 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.978 . . . . 0.0 110.48 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 146' ' ' LEU . 17.6 tp -62.86 105.84 0.73 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.604 HG13 ' O ' ' A' ' 120' ' ' ALA . 2.3 t -97.24 156.98 3.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 110.881 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.548 ' HB ' ' ND2' ' A' ' 121' ' ' ASN . 1.1 t -136.36 146.09 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 163' ' ' ALA . . . -142.87 137.07 29.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.984 -1.073 . . . . 0.0 109.537 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -68.73 144.49 54.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.399 -0.813 . . . . 0.0 110.041 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 171' ' ' VAL . 0.2 OUTLIER -44.0 -77.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 109.434 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 154' ' ' SER . . . 172.66 -22.35 0.07 OUTLIER Glycine 0 N--CA 1.496 2.692 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.821 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 154' ' ' SER . 3.4 p-10 30.74 36.25 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 122.235 -0.568 . . . . 0.0 111.486 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 153' ' ' ASN . 3.5 t 160.47 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 110.121 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 156' ' ' ALA . . . -165.43 70.57 0.19 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.867 -1.159 . . . . 0.0 110.312 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . 45.95 -172.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -1.165 . . . . 0.0 109.765 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.2 47.59 3.86 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.44 135.22 17.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.332 -1.099 . . . . 0.0 108.632 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.415 HD11 ' HA3' ' A' ' 189' ' ' GLY . 2.6 pt -57.9 -179.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 109.954 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.998 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.7 OUTLIER -107.12 170.58 7.87 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 122.506 1.146 . . . . 0.0 112.599 -177.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.423 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 77.8 m-85 -104.43 139.07 19.75 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.759 ' O ' ' N ' ' A' ' 164' ' ' ARG . 41.4 Cg_endo -73.54 -43.94 0.62 Allowed 'Cis proline' 0 C--N 1.295 -2.278 0 O-C-N 123.042 1.022 . . . . 0.0 110.816 3.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.998 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 23.13 -74.25 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.029 0.918 . . . . 0.0 110.057 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.759 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -39.88 -63.72 0.56 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.495 0.664 . . . . 0.0 109.791 177.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.712 ' O ' ' HB3' ' A' ' 166' ' ' ALA . 46.7 p90 -106.87 -166.45 1.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.899 0.856 . . . . 0.0 111.221 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.986 ' HA ' HG21 ' A' ' 137' ' ' VAL . . . 86.39 34.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.926 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.436 ' O ' ' HB ' ' A' ' 147' ' ' VAL . 1.0 OUTLIER 45.92 26.32 0.38 Allowed 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 147' ' ' VAL . . . -110.88 114.4 27.71 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.82 127.48 32.96 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.011 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.542 ' N ' ' HB2' ' A' ' 191' ' ' ASP . . . -78.53 108.63 12.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 172' ' ' GLY . 35.3 t -84.48 163.77 2.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.847 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.718 ' HA3' HG12 ' A' ' 193' ' ' VAL . . . -132.89 -172.78 13.1 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 214' ' ' THR . . . -138.89 143.88 38.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.088 -1.242 . . . . 0.0 109.418 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 43.5 p -108.46 175.02 5.62 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.564 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 1.4 t70 -74.64 -163.93 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.377 -0.827 . . . . 0.0 109.665 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -53.56 -29.97 39.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 0.0 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.54 -79.91 0.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.991 . . . . 0.0 110.151 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 178' ' ' ASN . 9.5 p-10 -149.63 60.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 1.0 OUTLIER -125.19 162.52 24.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.956 -1.09 . . . . 0.0 109.666 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 181' ' ' ALA . 7.5 mtp180 -62.56 112.82 2.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.52 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 184' ' ' SER . . . -43.68 171.73 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.314 -0.866 . . . . 0.0 110.179 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.48 -27.29 12.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.175 -0.953 . . . . 0.0 110.234 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 184' ' ' SER . 11.6 p90 -114.63 -21.71 10.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.998 -1.064 . . . . 0.0 109.804 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 181' ' ' ALA . 10.8 t -55.65 126.93 27.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 109.26 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.455 ' CD ' ' O ' ' A' ' 156' ' ' ALA . 27.7 mm-40 -85.23 154.67 21.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 109.984 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.551 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -138.81 173.27 11.75 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.495 -0.753 . . . . 0.0 109.161 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.551 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 168.01 148.44 5.7 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -43.55 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -1.112 . . . . 0.0 109.395 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 187' ' ' GLY . . . 148.3 -16.38 1.31 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.624 HD23 ' O ' ' A' ' 256' ' ' LEU . 12.0 tp -45.97 126.17 7.09 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -1.127 . . . . 0.0 109.763 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.542 ' HB2' ' N ' ' A' ' 170' ' ' ALA . 0.3 OUTLIER -81.27 -62.0 1.78 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 110.354 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.562 ' CD1' HG22 ' A' ' 262' ' ' VAL . 14.0 tt -155.65 168.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.008 . . . . 0.0 109.412 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.718 HG12 ' HA3' ' A' ' 172' ' ' GLY . 3.0 m -122.11 161.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.964 -1.085 . . . . 0.0 110.073 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 1.072 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -150.09 -172.78 0.33 Allowed Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 1.008 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 31.9 Cg_endo -75.48 110.26 3.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.319 1.346 . . . . 0.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -130.25 41.02 1.58 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.585 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 26.8 t -142.88 91.58 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.903 ' O ' HG13 ' A' ' 199' ' ' VAL . 19.7 t-20 89.34 115.29 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.903 HG13 ' O ' ' A' ' 198' ' ' ASN . 2.5 m -173.49 118.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -99.87 142.62 31.11 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.491 0.663 . . . . 0.0 110.214 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.604 ' HB3' ' CD2' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -149.71 -148.44 0.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 0.0 109.304 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 3.4 p -94.13 158.51 15.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.229 -0.919 . . . . 0.0 110.087 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.625 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -135.4 155.82 78.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.625 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.7 Cg_endo -73.62 151.26 46.67 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.304 2.003 . . . . 0.0 111.386 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 204' ' ' PRO . . . 30.61 73.15 0.05 OUTLIER Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 9.1 t 168.45 -100.55 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.052 -1.263 . . . . 0.0 110.149 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.792 HG23 ' N ' ' A' ' 208' ' ' TYR . 6.5 t -172.41 -142.82 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.792 ' N ' HG23 ' A' ' 207' ' ' THR . 0.0 OUTLIER -91.06 157.27 17.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 0.0 109.528 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.28 139.44 17.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.2 OUTLIER -95.23 133.19 39.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.327 -0.858 . . . . 0.0 109.544 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 212' ' ' ASN . 1.1 pp -158.28 164.36 36.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 109.774 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.503 ' O ' HD12 ' A' ' 211' ' ' LEU . 2.0 m-80 -99.85 171.54 7.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.885 . . . . 0.0 109.549 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 216' ' ' MET . . . 153.59 131.35 1.57 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 173' ' ' ALA . 84.4 m -67.62 -25.32 65.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.495 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -68.43 -12.29 60.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.147 -0.971 . . . . 0.0 109.386 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.479 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.0 OUTLIER -77.0 -26.6 54.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 1.072 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -86.98 0.63 54.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.596 -0.69 . . . . 0.0 109.548 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.618 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 1.8 m -80.44 -45.79 1.34 Allowed Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.269 -0.895 . . . . 0.0 111.073 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 218' ' ' THR . 31.6 Cg_endo -73.48 -18.31 22.96 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.735 1.624 . . . . 0.0 110.985 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -70.7 -40.74 72.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.912 -1.118 . . . . 0.0 108.591 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 262' ' ' VAL . 55.8 t -74.35 -39.56 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -56.58 -31.81 64.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -73.36 -52.34 8.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 264' ' ' ALA . . . -53.15 -64.13 0.92 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -1.115 . . . . 0.0 109.242 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.455 ' O ' ' HB ' ' A' ' 228' ' ' VAL . . . -43.48 -46.13 6.71 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.21 44.63 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.138 -0.976 . . . . 0.0 109.072 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.528 ' HB3' HD23 ' A' ' 21' ' ' LEU . 17.7 mt -56.48 -37.9 70.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 225' ' ' ALA . 84.3 t -56.58 -63.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 109.322 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.793 ' HE3' HD11 ' A' ' 240' ' ' ILE . 1.8 mtpt -48.18 -31.7 6.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 108.893 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.45 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.6 OUTLIER -61.79 -49.3 76.91 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.36 -5.93 31.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.451 ' O ' ' OD1' ' A' ' 232' ' ' ASN . 6.7 p30 -164.44 79.58 1.4 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.402 -0.811 . . . . 0.0 109.685 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.73 31.98 0.51 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.854 2.369 . . . . 0.0 111.149 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.45 -12.15 5.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.78 -1.2 . . . . 0.0 110.102 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.65 175.72 9.06 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.054 -1.029 . . . . 0.0 109.864 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.87 174.66 5.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.464 -0.773 . . . . 0.0 109.684 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.519 ' N ' ' ND2' ' A' ' 237' ' ' ASN . 0.8 OUTLIER -58.04 -28.3 64.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.348 -0.845 . . . . 0.0 109.339 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.6 t -77.68 -64.6 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.266 -0.897 . . . . 0.0 109.234 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' VAL . 16.1 mt-30 -42.9 -36.23 1.45 Allowed 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.481 0.657 . . . . 0.0 109.488 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.793 HD11 ' HE3' ' A' ' 229' ' ' LYS . 50.4 mt -68.86 -56.33 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 109.633 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -43.31 -50.17 6.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.968 . . . . 0.0 109.906 -179.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -51.06 -60.98 2.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 0.0 110.784 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 247' ' ' THR . 2.5 t60 -55.14 -57.12 13.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.066 . . . . 0.0 109.822 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 244' ' ' LEU . 0.8 OUTLIER -56.3 -18.46 10.73 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.477 -0.765 . . . . 0.0 109.95 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.9 OUTLIER -83.42 -39.71 20.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 0.0 109.271 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.69 -30.08 66.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.583 -0.698 . . . . 0.0 109.269 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.898 HG23 ' O ' ' A' ' 243' ' ' HIS . 1.7 p -78.92 -52.35 8.4 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.18 0.991 . . . . 0.0 109.701 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 247' ' ' THR . . . -28.9 116.97 0.11 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 260' ' ' GLY . 13.9 m -53.32 131.91 38.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.32 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.74 109.99 22.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.41 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.895 HD22 ' CD2' ' A' ' 257' ' ' TYR . 6.1 mp -70.12 -76.31 0.1 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.122 -0.986 . . . . 0.0 109.714 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 175.78 31.42 0.04 OUTLIER Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.584 -1.293 . . . . 0.0 110.534 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.43 162.02 40.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 109.423 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.8 p -124.38 8.58 8.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.653 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -130.41 -70.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 108.852 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.624 ' O ' HD23 ' A' ' 190' ' ' LEU . 0.3 OUTLIER -52.61 -56.81 12.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.523 -0.735 . . . . 0.0 109.154 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.895 ' CD2' HD22 ' A' ' 251' ' ' LEU . 27.9 m-85 -90.96 -61.42 1.67 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.38 -0.825 . . . . 0.0 109.463 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 85.2 -120.69 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.518 ' HB3' ' CG1' ' A' ' 192' ' ' ILE . 0.1 OUTLIER -47.27 -44.05 22.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -1.173 . . . . 0.0 108.995 179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 249' ' ' THR . . . 110.97 -142.8 16.97 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.1 -178.06 5.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.637 -0.919 . . . . 0.0 109.572 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.562 HG22 ' CD1' ' A' ' 192' ' ' ILE . 3.7 t -129.57 146.28 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.459 -0.775 . . . . 0.0 110.55 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.479 ' CB ' ' OE1' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -166.02 121.23 1.23 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.42 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 224' ' ' ALA . . . -94.23 -12.96 27.13 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.796 -178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.623 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 1.1 tm-20 -68.84 -15.74 63.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.812 -1.18 . . . . 0.0 109.685 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -101.25 1.89 39.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.475 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.76 ' HB2' HG21 ' A' ' 247' ' ' THR . . . -122.82 -17.49 6.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.634 HG21 ' CD2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -92.82 -38.88 11.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.776 -1.202 . . . . 0.0 109.364 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.457 ' OXT' ' O ' ' A' ' 268' ' ' THR . 10.2 ptm180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.867 -1.064 . . . . 0.0 109.618 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -71.03 166.19 21.88 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.18 -0.95 . . . . 0.0 110.171 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.885 ' O ' HG13 ' A' ' 4' ' ' VAL . 1.1 m -66.87 103.53 1.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.414 -0.804 . . . . 0.0 109.878 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.885 HG13 ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 170.43 100.21 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.562 -0.711 . . . . 0.0 109.22 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 8' ' ' ILE . 36.2 Cg_endo -78.8 174.77 11.79 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.632 2.221 . . . . 0.0 110.899 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 195' ' ' PRO . 0.0 OUTLIER -48.02 -28.87 3.04 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.511 -0.743 . . . . 0.0 109.924 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.62 -42.16 55.44 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.569 ' CG1' ' NE2' ' A' ' 220' ' ' HIS . 34.2 mt -109.57 73.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -1.196 . . . . 0.0 109.923 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.24 -42.32 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -93.68 6.71 47.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 11' ' ' VAL . 15.8 m -98.2 19.71 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.18 -0.95 . . . . 0.0 109.647 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' CG ' ' HB2' ' A' ' 265' ' ' GLU . 34.8 mm-40 47.6 25.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 110.089 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.669 ' N ' ' HD2' ' A' ' 14' ' ' PRO . . . -61.43 -42.3 83.97 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.9 . . . . 0.0 110.907 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 13' ' ' ALA . 30.6 Cg_endo -73.46 -44.09 0.58 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 107.898 -1.616 . . . . 0.0 107.898 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' ' OD1' ' A' ' 18' ' ' ASN . . . -46.46 -37.06 7.25 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.66 -38.67 64.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -64.93 -18.91 65.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.687 -0.633 . . . . 0.0 110.7 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 15' ' ' ALA . 6.3 p-10 -113.1 -6.63 13.68 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.743 -1.223 . . . . 0.0 110.121 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -83.2 -22.98 33.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.939 -1.1 . . . . 0.0 109.219 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.46 50.33 0.46 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' C ' HG22 ' A' ' 22' ' ' THR . 0.5 OUTLIER -139.25 179.8 6.32 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.957 . . . . 0.0 109.968 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.53 HG22 ' C ' ' A' ' 21' ' ' LEU . 1.1 t 157.76 100.09 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -55.65 0.93 0.09 OUTLIER Glycine 0 N--CA 1.497 2.705 0 O-C-N 121.654 -0.653 . . . . 0.0 111.935 -179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 85' ' ' ASN . 71.9 m -28.45 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 118.811 1.306 . . . . 0.0 111.97 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 23' ' ' GLY . . . -85.45 35.02 3.21 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 23' ' ' GLY . 44.1 t -125.78 165.43 23.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.124 -1.221 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' N ' HG12 ' A' ' 26' ' ' VAL . 16.5 mttm -135.91 117.42 14.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.481 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.53 HG13 ' HB ' ' A' ' 119' ' ' VAL . 13.6 t -128.54 136.26 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.322 -0.861 . . . . 0.0 109.829 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.67 155.56 21.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 35' ' ' ILE . 2.2 t -130.84 85.04 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.132 -0.98 . . . . 0.0 108.953 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.95 HD23 HG21 ' A' ' 93' ' ' VAL . 6.9 mp -70.46 103.96 2.61 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 33' ' ' THR . 9.2 p30 -148.92 -143.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.234 -0.916 . . . . 0.0 109.152 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 33' ' ' THR . 13.4 t -135.68 79.71 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.035 -1.041 . . . . 0.0 110.054 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' HA3' ' ND2' ' A' ' 60' ' ' ASN . . . 90.69 120.8 2.3 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.885 HD12 ' HB2' ' A' ' 90' ' ' ALA . 2.8 mt -112.81 -24.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 CA-C-O 122.111 0.958 . . . . 0.0 108.654 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 35' ' ' ILE . 42.1 t 57.3 148.18 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.287 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -93.09 160.25 14.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 109.146 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.628 ' CG ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -160.78 178.91 1.47 Allowed Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 109.046 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' ' CG ' ' A' ' 38' ' ' HIS . 34.9 Cg_endo -78.0 -22.27 10.18 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.402 2.068 . . . . 0.0 110.183 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.571 ' HA ' HD12 ' A' ' 73' ' ' LEU . 74.9 m-20 -97.22 -55.14 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.336 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.581 HD21 ' C ' ' A' ' 67' ' ' ALA . 17.4 mt -55.22 156.9 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.35 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.91 63.87 1.53 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.201 -0.937 . . . . 0.0 109.205 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 43' ' ' ILE . 7.4 mm -49.96 115.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.565 -0.709 . . . . 0.0 109.462 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -104.85 -8.13 18.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.99 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 89' ' ' TYR . . . -174.13 177.12 46.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 175.15 158.65 19.65 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.468 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 49' ' ' PHE . . . -152.98 162.49 41.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.69 -0.888 . . . . 0.0 108.833 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.458 ' HB3' ' HE2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -132.99 109.74 9.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.861 ' CE2' HG12 ' A' ' 91' ' ' VAL . 1.9 m-85 -107.61 -44.17 4.33 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.317 -0.864 . . . . 0.0 109.025 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.687 HG13 ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -41.33 151.53 0.29 Allowed Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD2' HG13 ' A' ' 50' ' ' VAL . 30.0 Cg_endo -69.81 171.22 14.92 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.427 2.085 . . . . 0.0 111.005 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.63 -42.2 2.91 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.556 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp0 43.7 58.31 12.71 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.614 -0.933 . . . . 0.0 111.058 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.2 Cg_endo -79.46 -71.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.511 2.141 . . . . 0.0 109.472 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.4 p -168.61 135.2 1.89 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.428 HG22 ' OE1' ' A' ' 57' ' ' GLN . 11.0 t -79.03 0.97 25.6 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.416 -0.803 . . . . 0.0 109.029 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.428 ' OE1' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -119.37 106.68 12.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 -179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER 65.72 174.74 0.22 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.905 . . . . 0.0 109.861 179.105 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' C ' ' ND2' ' A' ' 60' ' ' ASN . . . 115.15 15.76 7.61 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.65 ' OD1' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -160.71 -71.39 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.985 . . . . 0.0 109.049 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.86 8.99 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -73.65 -57.19 4.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -1.22 . . . . 0.0 109.925 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.22 72.09 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.1 m -69.16 -40.91 77.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' CD2' ' HB2' ' A' ' 201' ' ' SER . 27.1 t-80 -66.56 -53.16 37.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 69' ' ' THR . 39.4 t -58.99 -35.95 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 109.712 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.581 ' C ' HD21 ' A' ' 41' ' ' LEU . . . -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 110.235 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.611 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -70.16 -44.94 58.49 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.493 -1.337 . . . . 0.0 109.964 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 66' ' ' VAL . 12.3 t -64.46 -16.83 63.13 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.989 -1.301 . . . . 0.0 108.975 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.476 HD11 ' HB3' ' A' ' 219' ' ' PRO . 78.7 mt -93.02 -24.91 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 110.259 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.819 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . . . -133.93 -43.1 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.879 -1.138 . . . . 0.0 110.902 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.762 ' HB3' ' N ' ' A' ' 81' ' ' GLY . . . 8.05 92.87 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.106 0.479 . . . . 0.0 111.636 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' A' ' 40' ' ' ASP . 22.2 mt -42.27 163.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.971 -1.081 . . . . 0.0 109.57 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.828 ' HB2' HD13 ' A' ' 80' ' ' LEU . 43.8 t30 -113.71 106.44 14.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.977 . . . . 0.0 109.547 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' HG12 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -154.64 -100.63 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.222 -0.924 . . . . 0.0 109.605 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.7 p -132.06 -32.6 1.39 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.347 -0.846 . . . . 0.0 110.147 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.577 HG12 ' ND2' ' A' ' 75' ' ' ASN . 27.9 pt -91.31 138.11 20.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.073 -1.017 . . . . 0.0 110.302 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.47 ' O ' ' OG ' ' A' ' 3' ' ' SER . . . 60.13 158.04 0.05 OUTLIER Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.543 ' C ' ' HB3' ' A' ' 3' ' ' SER . 5.6 m -70.19 -160.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.563 -0.963 . . . . 0.0 109.465 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 74' ' ' ASN . 4.5 tp -135.15 131.35 36.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.429 -0.794 . . . . 0.0 110.241 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.762 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -77.43 -145.71 2.3 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.96 -28.47 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.93 -1.335 . . . . 0.0 109.051 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 86' ' ' ALA . . . -110.68 125.91 29.86 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -85.46 -61.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.417 2.078 . . . . 0.0 110.875 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.526 ' CB ' ' OG ' ' A' ' 24' ' ' SER . 1.2 m-20 -103.36 39.88 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.504 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . . . -83.4 168.46 16.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.008 -1.058 . . . . 0.0 109.6 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HG2' ' HG3' ' A' ' 44' ' ' ARG . 72.8 mt-10 -113.6 92.42 3.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 108.986 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.819 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 7.8 mt -97.13 135.81 38.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 109.635 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.474 ' CD1' ' HA3' ' A' ' 45' ' ' GLY . 27.7 m-85 -104.14 155.84 18.37 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.885 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . -110.84 102.58 11.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.82 -1.175 . . . . 0.0 109.257 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.861 HG12 ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -100.5 68.32 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.188 -0.945 . . . . 0.0 109.068 -179.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' ' 33' ' ' THR . 19.4 ttpt -36.61 103.29 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.345 0.593 . . . . 0.0 110.275 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.95 HG21 HD23 ' A' ' 31' ' ' LEU . 1.4 t -115.48 -20.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 108.798 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mt -106.29 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.336 -0.853 . . . . 0.0 109.402 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 33' ' ' THR . . . -91.18 179.21 42.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.65 ' HB2' ' OD1' ' A' ' 60' ' ' ASN . . . -78.34 -19.65 53.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -1.189 . . . . 0.0 109.493 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.6 t -116.05 -25.46 7.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.852 . . . . 0.0 109.217 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.67 80.21 0.38 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.38 76.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -1.103 . . . . 0.0 109.375 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -107.85 -179.61 22.05 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.93 162.84 24.99 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.742 -0.858 . . . . 0.0 109.094 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.413 HG13 HD13 ' A' ' 133' ' ' LEU . 58.2 t -68.67 -19.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 107' ' ' GLN . 43.0 t -78.75 -19.86 51.3 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.0 m -79.2 -52.86 7.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 133' ' ' LEU . 1.3 mt -63.47 -25.2 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.34 78.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.642 -0.661 . . . . 0.0 109.423 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -71.51 -32.39 68.16 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.987 -1.071 . . . . 0.0 108.991 179.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.63 -31.08 70.56 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.66 -25.18 21.39 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.18 -1.188 . . . . 0.0 110.384 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.63 -26.04 23.24 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.975 -1.078 . . . . 0.0 110.038 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -63.54 -22.15 66.73 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.774 ' HB1' ' HA3' ' A' ' 116' ' ' GLY . . . -86.78 -22.43 25.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 143' ' ' ARG . . . -62.41 -43.64 98.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 115' ' ' ASN . 1.8 p-10 -85.18 -38.64 18.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 31.5 m-20 -146.14 85.02 1.66 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.774 ' HA3' ' HB1' ' A' ' 112' ' ' ALA . . . -115.32 -165.33 14.62 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.134 -1.187 . . . . 0.0 110.134 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 27' ' ' LYS . 15.0 mmt -139.0 178.78 6.91 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.548 -0.972 . . . . 0.0 110.138 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.516 ' ND1' ' HD3' ' A' ' 229' ' ' LYS . 1.7 m170 -57.95 -39.99 79.45 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.557 -0.714 . . . . 0.0 110.732 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 120' ' ' ALA . 19.0 t -130.56 167.38 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.861 -1.149 . . . . 0.0 111.104 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.564 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -164.35 114.78 1.23 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 222' ' ' ALA . 10.7 m120 -100.3 151.13 21.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.903 -1.123 . . . . 0.0 110.708 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.402 HD11 HD22 ' A' ' 31' ' ' LEU . 6.9 mp -118.11 110.72 17.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.8 t -82.68 71.74 9.76 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.157 -0.965 . . . . 0.0 108.918 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.17 -174.14 2.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.351 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.539 ' CA ' ' HB3' ' A' ' 160' ' ' SER . . . 168.62 79.69 0.04 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.2 m -95.24 155.82 38.43 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.331 -1.099 . . . . 0.0 109.252 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.41 -11.79 18.92 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.516 2.144 . . . . 0.0 109.571 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.3 t -83.27 115.54 59.68 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 121.619 -0.675 . . . . 0.0 109.442 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.58 167.92 21.98 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.258 1.972 . . . . 0.0 110.107 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.0 m -155.98 117.24 3.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 110.038 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.07 -20.8 65.87 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.2 m -69.32 -26.95 64.96 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.529 HD11 ' HB ' ' A' ' 105' ' ' ILE . 2.8 mp -78.35 -36.21 46.43 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -38.25 69.0 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.167 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -67.52 -22.61 65.43 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.87 -32.71 40.44 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.576 -0.85 . . . . 0.0 108.748 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' ' 167' ' ' ASN . 2.2 t -76.29 -26.38 17.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.87 -35.35 80.41 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 105.343 -2.095 . . . . 0.0 105.343 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.1 m -79.65 -23.8 42.3 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.33 -26.83 60.39 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 121.193 -0.942 . . . . 0.0 109.776 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.5 m -79.57 -34.47 40.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.195 -0.941 . . . . 0.0 108.628 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.4 t -56.98 -28.04 61.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -102.83 -13.51 16.96 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 74.21 78.44 0.59 Allowed Glycine 0 N--CA 1.475 1.247 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 117' ' ' MET . 5.1 t -127.3 92.03 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.265 -1.138 . . . . 0.0 110.155 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tp -57.02 120.53 8.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 108.599 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -107.56 152.07 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.185 -0.947 . . . . 0.0 110.22 -178.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 148' ' ' VAL . 0.9 OUTLIER -141.62 103.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.42 150.33 21.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.06 -1.025 . . . . 0.0 110.412 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.678 ' HB2' ' OG1' ' A' ' 218' ' ' THR . . . -78.31 172.84 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.484 -0.76 . . . . 0.0 109.802 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.5 ' O ' ' OG ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -77.84 -79.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.0 109.254 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 176.75 -111.77 0.35 Allowed Glycine 0 N--CA 1.483 1.827 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -176.3 28.72 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 29.3 t -128.36 -99.4 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.905 . . . . 0.0 109.73 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.39 55.22 0.03 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.32 -178.2 4.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 109.301 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.61 38.92 2.66 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -166.44 155.38 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -1.178 . . . . 0.0 108.672 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -172.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.868 -1.145 . . . . 0.0 110.751 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.815 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.0 OUTLIER -80.43 163.77 23.56 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.172 0.987 . . . . 0.0 112.108 -177.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.413 ' HA ' ' C ' ' A' ' 162' ' ' PRO . 22.2 m-85 -112.43 132.34 22.2 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 176.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 164' ' ' ARG . 40.6 Cg_endo -73.97 -42.77 0.78 Allowed 'Cis proline' 0 C--N 1.299 -2.077 0 O-C-N 123.139 1.073 . . . . 0.0 111.041 3.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 21.34 -73.94 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.869 0.843 . . . . 0.0 110.122 -178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.761 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.6 OUTLIER -46.49 -71.59 0.07 Allowed 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.645 ' O ' ' O ' ' A' ' 164' ' ' ARG . 1.8 m-85 27.41 -167.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.834 1.302 . . . . 0.0 113.03 178.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.5 -0.35 2.66 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.437 ' HB2' HG11 ' A' ' 137' ' ' VAL . 15.2 m120 -124.41 21.83 8.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -157.88 169.87 23.63 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.491 -0.755 . . . . 0.0 108.968 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.485 ' HB2' HG22 ' A' ' 148' ' ' VAL . 1.0 OUTLIER -111.48 157.82 19.86 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.158 -0.964 . . . . 0.0 109.551 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 191' ' ' ASP . . . -119.69 129.91 54.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 172' ' ' GLY . 31.2 t -91.86 164.63 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 120.894 -1.129 . . . . 0.0 109.459 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.563 ' N ' ' CG1' ' A' ' 171' ' ' VAL . . . -131.77 -171.69 12.9 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 184' ' ' SER . . . -120.75 164.93 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -1.137 . . . . 0.0 109.621 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 179' ' ' ASN . 0.9 OUTLIER -133.39 173.81 11.07 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.394 -0.816 . . . . 0.0 109.34 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.545 ' HB2' ' HB3' ' A' ' 179' ' ' ASN . 0.3 OUTLIER -85.36 -152.0 0.15 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.61 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 177' ' ' ASN . 5.1 pt20 -84.96 -29.91 24.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 176' ' ' GLN . 53.4 m-20 -96.33 -97.01 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.162 -0.962 . . . . 0.0 109.947 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.77 19.23 2.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.947 -1.096 . . . . 0.0 109.856 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 175' ' ' ASP . 3.1 t-20 -72.47 -151.96 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.065 -1.022 . . . . 0.0 109.087 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.55 ' HB2' ' CE2' ' A' ' 257' ' ' TYR . 22.3 ttp85 -132.93 16.64 4.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 109.856 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 58.39 164.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.735 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.8 t -121.2 -4.64 9.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.953 . . . . 0.0 109.914 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.565 ' O ' ' CG ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -106.4 29.13 7.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.012 . . . . 0.0 109.832 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.78 ' HB2' ' HB3' ' A' ' 173' ' ' ALA . 41.6 t -111.85 119.35 38.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.971 . . . . 0.0 109.763 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 184' ' ' SER . 0.0 OUTLIER -43.89 113.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 109.176 179.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.544 ' CG ' ' N ' ' A' ' 187' ' ' GLY . 0.0 OUTLIER -113.71 168.15 10.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.237 -0.915 . . . . 0.0 109.319 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.544 ' N ' ' CG ' ' A' ' 186' ' ' TYR . . . 171.48 178.72 42.07 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -80.73 111.42 17.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 129.36 9.06 3.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 256' ' ' LEU . 14.2 tp -64.24 143.76 57.64 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.944 -1.327 . . . . 0.0 109.251 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 170' ' ' ALA . 19.1 t70 -91.6 -70.81 0.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.257 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.763 HD13 HG13 ' A' ' 262' ' ' VAL . 13.0 tt -140.81 169.62 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.838 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 260' ' ' GLY . 29.2 m -120.17 162.82 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.73 ' HB3' ' HB1' ' A' ' 217' ' ' ALA . . . -158.48 165.52 18.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 109.223 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 194' ' ' ALA . 34.8 Cg_endo -77.09 115.99 4.1 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.465 2.11 . . . . 0.0 110.475 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.44 24.25 3.74 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.66 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 55.4 t -102.96 68.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -1.066 . . . . 0.0 109.088 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.841 ' O ' HG13 ' A' ' 199' ' ' VAL . 0.7 OUTLIER 110.33 122.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.072 0.939 . . . . 0.0 108.597 -179.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 198' ' ' ASN . 2.5 m -170.84 113.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -101.67 168.15 9.65 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.7 0.762 . . . . 0.0 110.125 -179.401 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 200' ' ' GLN . 4.3 m -168.32 -156.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . 0.439 ' H ' HG23 ' A' ' 202' ' ' THR . 1.0 OUTLIER -77.35 172.08 13.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.349 -0.844 . . . . 0.0 109.732 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.667 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.0 OUTLIER -152.98 160.59 30.77 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 36.2 Cg_endo -71.34 164.01 37.18 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.285 1.99 . . . . 0.0 110.655 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 76.82 14.7 82.3 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.99 34.43 5.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.406 -1.056 . . . . 0.0 109.373 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.549 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.7 OUTLIER -126.76 160.33 31.15 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.288 -0.882 . . . . 0.0 109.852 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -110.93 169.42 8.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.3 164.01 22.46 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.78 -1.2 . . . . 0.0 110.961 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.9 OUTLIER -123.34 124.17 42.36 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.1 mt -119.73 161.27 21.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.032 . . . . 0.0 109.927 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 212' ' ' ASN . 1.1 p-10 -134.05 107.6 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -161.6 151.24 21.38 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.1 m -70.83 -21.89 62.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -1.114 . . . . 0.0 109.457 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.443 ' HA ' ' HB1' ' A' ' 150' ' ' ALA . 0.6 OUTLIER -72.24 -13.27 61.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.135 -0.978 . . . . 0.0 109.095 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.499 ' O ' ' HD2' ' A' ' 219' ' ' PRO . 0.1 OUTLIER -81.7 -13.52 57.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.724 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.73 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -88.9 -1.49 58.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.26 -0.9 . . . . 0.0 109.985 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.678 ' OG1' ' HB2' ' A' ' 150' ' ' ALA . 1.1 m -75.83 -40.5 3.17 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.254 -0.904 . . . . 0.0 111.379 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 218' ' ' THR . 30.6 Cg_endo -72.32 -12.95 27.92 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.698 1.599 . . . . 0.0 111.242 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.569 ' NE2' ' CG1' ' A' ' 8' ' ' ILE . 18.1 m80 -77.17 -51.45 10.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.044 -1.035 . . . . 0.0 108.507 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 262' ' ' VAL . 98.8 t -63.07 -41.97 94.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.526 ' CB ' ' OD1' ' A' ' 121' ' ' ASN . . . -57.15 -40.42 77.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.411 -0.805 . . . . 0.0 109.11 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.43 59.22 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.2 -51.99 60.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.075 -1.25 . . . . 0.0 110.021 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.07 -32.99 56.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.232 -0.918 . . . . 0.0 109.374 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.77 97.87 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.102 -0.999 . . . . 0.0 108.821 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 54.3 mt -59.06 -51.31 70.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.384 -0.823 . . . . 0.0 109.565 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' LYS . 76.3 t -57.54 -55.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.186 -0.946 . . . . 0.0 109.922 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.58 ' NZ ' HD11 ' A' ' 240' ' ' ILE . 4.1 ttmm -42.28 -42.4 3.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.37 -0.831 . . . . 0.0 109.468 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.495 ' HB2' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -61.84 -48.09 82.13 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 0.2 OUTLIER -57.22 -17.05 9.75 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.165 -0.96 . . . . 0.0 108.951 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 235' ' ' TRP . 2.3 m120 -172.45 90.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 109.696 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.1 -38.58 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.75 2.3 . . . . 0.0 110.66 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 235' ' ' TRP . 0.0 OUTLIER -47.42 -46.16 26.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.423 -0.798 . . . . 0.0 110.215 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.548 ' CD2' ' HB3' ' A' ' 232' ' ' ASN . 47.4 m0 -45.3 170.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.081 -1.012 . . . . 0.0 110.063 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.431 ' O ' HD12 ' A' ' 240' ' ' ILE . 0.1 OUTLIER -113.11 176.85 4.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.843 . . . . 0.0 109.731 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -54.21 -20.08 6.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.672 -0.642 . . . . 0.0 109.956 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 238' ' ' VAL . 2.4 t -78.33 -65.39 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.14 -0.975 . . . . 0.0 109.461 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 235' ' ' TRP . 1.0 OUTLIER -44.39 -43.17 7.44 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.58 HD11 ' NZ ' ' A' ' 229' ' ' LYS . 6.1 mt -59.65 -55.3 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -42.4 -35.81 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.011 -1.056 . . . . 0.0 110.435 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 245' ' ' LYS . 29.2 t-20 -72.55 -40.21 66.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.49 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . 0.478 ' O ' ' OG1' ' A' ' 247' ' ' THR . 0.9 OUTLIER -70.47 -47.08 62.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.879 -1.138 . . . . 0.0 110.018 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.4 OUTLIER -70.45 -28.65 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.444 -0.785 . . . . 0.0 110.844 -178.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -73.36 -48.99 29.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 109.903 -179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.571 ' N ' ' HG3' ' A' ' 245' ' ' LYS . 7.8 t-20 -74.06 -22.39 59.56 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.674 -0.641 . . . . 0.0 111.04 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 243' ' ' HIS . 9.1 p -84.47 -32.2 24.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.791 -1.193 . . . . 0.0 109.95 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.52 130.28 44.35 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.74 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 250' ' ' SER . 2.4 m -48.48 164.0 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.083 -1.011 . . . . 0.0 108.982 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.523 ' N ' ' CG2' ' A' ' 249' ' ' THR . 49.0 m -129.15 97.8 4.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.496 HD13 ' HA2' ' A' ' 260' ' ' GLY . 5.8 mp -57.21 -50.97 71.17 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.411 -0.806 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 153.69 42.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 1.4 t -174.14 -172.87 0.74 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -1.121 . . . . 0.0 109.82 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.9 t -147.55 13.22 1.05 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -122.45 -78.04 0.6 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.568 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.477 ' O ' ' HD2' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -59.3 -66.38 0.52 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.55 ' CE2' ' HB2' ' A' ' 180' ' ' ARG . 38.0 m-85 -76.2 -12.3 60.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 259' ' ' SER . . . 59.42 -154.3 30.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 250' ' ' SER . 6.0 t -44.92 -25.72 0.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.268 -1.137 . . . . 0.0 109.222 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.496 ' HA2' HD13 ' A' ' 251' ' ' LEU . . . 125.49 -132.6 8.04 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.556 ' O ' HD11 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -100.62 177.83 4.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -1.105 . . . . 0.0 109.309 179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.763 HG13 HD13 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -111.41 156.86 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.315 -0.865 . . . . 0.0 110.103 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.414 ' CG ' ' C ' ' A' ' 262' ' ' VAL . 0.0 OUTLIER -170.75 121.08 0.57 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 122.35 1.071 . . . . 0.0 108.197 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.532 ' O ' HG23 ' A' ' 268' ' ' THR . . . -76.04 -17.61 59.58 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.031 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.495 ' HB2' ' CG ' ' A' ' 12' ' ' GLN . 29.5 tt0 -65.54 -43.2 90.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.021 -1.049 . . . . 0.0 109.146 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -70.98 -13.98 62.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.265 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -110.81 12.7 22.37 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.5 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 264' ' ' ALA . 4.4 p -119.23 -39.02 2.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.312 -0.868 . . . . 0.0 109.53 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.476 ' HG3' ' OXT' ' A' ' 269' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.914 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.363 0.601 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' O ' ' A' ' 3' ' ' SER . 0.9 OUTLIER -66.37 176.0 2.0 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.397 -0.814 . . . . 0.0 109.57 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 1.015 ' O ' HG22 ' A' ' 4' ' ' VAL . 5.2 t -54.68 -158.38 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.015 HG22 ' O ' ' A' ' 3' ' ' SER . 2.5 m 59.95 41.25 0.53 Allowed Pre-proline 0 C--N 1.293 -1.872 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.939 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 37.5 Cg_endo -82.24 -169.29 0.73 Allowed 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.976 1.784 . . . . 0.0 110.454 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.601 ' CG ' ' O ' ' A' ' 198' ' ' ASN . 0.1 OUTLIER -32.92 -76.41 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -83.08 -69.26 1.39 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.71 ' HB ' ' HD2' ' A' ' 5' ' ' PRO . 19.7 mm -33.57 90.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 122.042 -0.681 . . . . 0.0 110.323 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 7' ' ' GLY . 0.3 OUTLIER 155.67 -55.15 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 17.7 tpp85 -75.42 -17.47 60.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.485 -0.759 . . . . 0.0 109.448 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 13' ' ' ALA . 19.4 m -88.62 23.3 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' A' ' 265' ' ' GLU . 20.8 mm100 49.66 41.35 21.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.208 -0.933 . . . . 0.0 109.92 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.686 ' N ' ' CD ' ' A' ' 14' ' ' PRO . . . -84.27 -33.02 0.52 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 111.654 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 13' ' ' ALA . 30.3 Cg_endo -73.63 -55.35 0.09 OUTLIER 'Trans proline' 0 C--N 1.32 -0.935 0 N-CA-C 108.528 -1.374 . . . . 0.0 108.528 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 14' ' ' PRO . . . -42.36 -33.15 0.6 Allowed 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . -72.18 -49.3 36.65 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 17' ' ' HIS . 2.2 m170 -69.09 -6.05 25.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.06 -55.36 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.44 -27.85 2.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.09 -1.006 . . . . 0.0 109.158 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.32 23.38 2.92 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.881 HD23 HD22 ' A' ' 227' ' ' LEU . 0.3 OUTLIER -67.17 173.13 4.01 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.179 -1.189 . . . . 0.0 109.34 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.596 ' HA ' ' HG3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -163.06 -35.55 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.269 -0.894 . . . . 0.0 110.553 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.868 ' O ' HG23 ' A' ' 26' ' ' VAL . . . 73.68 -5.34 23.84 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 108.445 -1.862 . . . . 0.0 108.445 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -44.0 134.08 4.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.132 -1.216 . . . . 0.0 109.665 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.89 7.92 56.04 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 23' ' ' GLY . 27.0 t -107.86 164.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -1.217 . . . . 0.0 109.246 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' O ' ' CD2' ' A' ' 118' ' ' HIS . 2.0 mptt -145.01 118.25 8.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.0 110.32 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 119' ' ' VAL . 2.5 t -125.92 128.01 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.68 ' HB1' HG21 ' A' ' 91' ' ' VAL . . . -82.3 159.97 23.01 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.547 HG21 HD22 ' A' ' 88' ' ' LEU . 10.7 t -134.43 87.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.78 -1.2 . . . . 0.0 109.794 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 93' ' ' VAL . 10.0 mp -66.74 126.17 28.15 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -177.79 -146.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.704 -1.247 . . . . 0.0 109.961 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -137.61 72.57 1.42 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.023 -1.048 . . . . 0.0 110.654 -178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 64' ' ' THR . . . 111.87 118.38 3.69 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.416 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 67' ' ' ALA . 3.9 mm -115.26 -18.87 7.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-O 121.675 0.75 . . . . 0.0 109.11 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 35' ' ' ILE . 0.8 OUTLIER 33.0 104.61 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.818 0.818 . . . . 0.0 111.483 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -58.61 147.66 31.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 108.692 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.537 ' CB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -146.13 177.14 1.87 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.314 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 38' ' ' HIS . 33.6 Cg_endo -76.33 -4.95 15.7 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.215 1.943 . . . . 0.0 109.626 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 73' ' ' LEU . 2.6 t0 -114.97 -22.53 9.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.473 -0.767 . . . . 0.0 109.166 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.36 122.75 39.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.201 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -97.36 103.38 15.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 108.65 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 44' ' ' ARG . 3.9 mt -89.68 163.48 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.074 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.547 ' N ' ' CG2' ' A' ' 43' ' ' ILE . 6.9 tpt180 -135.88 -32.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 89' ' ' TYR . . . -163.51 161.94 34.53 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.44 165.71 36.75 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.971 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.44 165.02 17.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.522 -0.987 . . . . 0.0 109.265 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 t -126.53 142.07 51.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.575 ' HE2' HG12 ' A' ' 91' ' ' VAL . 32.9 m-85 -116.38 -53.01 2.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.385 -0.822 . . . . 0.0 109.776 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.975 HG11 ' O ' ' A' ' 98' ' ' GLY . 81.1 t -57.3 125.54 71.45 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 108.724 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -74.96 176.49 9.84 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.425 2.084 . . . . 0.0 111.31 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' C ' ' HD3' ' A' ' 54' ' ' PRO . . . 120.78 10.15 7.16 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.675 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.5 tt0 54.26 44.99 2.02 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.498 -1.001 . . . . 0.0 111.163 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.675 ' HD3' ' N ' ' A' ' 53' ' ' GLU . 36.5 Cg_endo -78.55 -69.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 121.917 1.745 . . . . 0.0 110.432 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 69.3 m 117.13 135.01 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.447 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 8.8 t -56.6 -14.63 3.34 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.209 -0.932 . . . . 0.0 109.134 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG3' HG23 ' A' ' 56' ' ' THR . 47.7 mt-30 -108.92 143.5 38.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.089 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 57' ' ' GLN . 40.8 t0 61.34 136.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.462 -0.774 . . . . 0.0 110.392 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.408 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -157.27 -39.39 0.02 OUTLIER Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.843 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -169.1 -35.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.447 -1.031 . . . . 0.0 108.927 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.84 -16.97 4.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -68.31 -58.06 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.53 -0.982 . . . . 0.0 109.296 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -52.1 -61.76 6.28 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLY . 3.3 m -45.82 -41.13 10.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -1.109 . . . . 0.0 110.107 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.609 ' CE1' ' HB2' ' A' ' 201' ' ' SER . 5.2 t-80 -58.83 -56.81 17.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.051 -1.031 . . . . 0.0 109.733 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.718 HG13 ' HB3' ' A' ' 219' ' ' PRO . 41.8 t -55.45 -35.08 36.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . . . -57.64 -44.74 85.84 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.863 . . . . 0.0 109.719 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.627 ' CA ' ' HB2' ' A' ' 72' ' ' ALA . . . -75.15 -21.38 78.19 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.555 HG23 ' CE1' ' A' ' 220' ' ' HIS . 15.7 m -81.47 -11.51 59.2 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -1.181 . . . . 0.0 108.166 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 66' ' ' VAL . 38.4 mt -103.51 -28.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.518 -0.739 . . . . 0.0 110.044 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 83' ' ' ALA . . . -156.71 11.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.622 -1.299 . . . . 0.0 112.323 -179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' ' CA ' ' A' ' 68' ' ' GLY . . . -40.01 94.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.691 -1.256 . . . . 0.0 110.626 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 71' ' ' ALA . 9.7 mt -45.76 172.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.881 -1.137 . . . . 0.0 110.171 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 75' ' ' ASN . 6.8 t-20 -92.74 155.23 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.451 -0.781 . . . . 0.0 109.646 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 74' ' ' ASN . 9.0 p-10 154.43 124.71 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 75' ' ' ASN . 22.8 t -41.59 -27.26 0.09 Allowed 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.869 -0.519 . . . . 0.0 109.734 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.8 pt -83.52 68.6 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.673 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.443 ' HA2' ' CE2' ' A' ' 208' ' ' TYR . . . 123.36 146.93 7.2 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 80' ' ' LEU . 10.2 m -64.31 -149.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.279 -1.13 . . . . 0.0 109.597 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 ' N ' HG23 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -158.06 141.34 15.17 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.293 -0.879 . . . . 0.0 109.288 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.583 ' N ' ' HB3' ' A' ' 72' ' ' ALA . . . -97.86 -144.6 17.31 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG12 HD11 ' A' ' 227' ' ' LEU . 0.5 OUTLIER -91.48 -72.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -1.033 . . . . 0.0 109.896 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 71' ' ' ALA . . . -63.04 144.08 97.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 109.312 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.596 ' HG3' ' HA ' ' A' ' 22' ' ' THR . 37.3 Cg_endo -86.69 -64.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.369 2.046 . . . . 0.0 110.113 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 86' ' ' ALA . 21.6 t-20 -105.76 -87.08 0.47 Allowed 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.001 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 85' ' ' ASN . . . 54.79 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.105 -0.997 . . . . 0.0 110.08 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HB2' ' HG3' ' A' ' 27' ' ' LYS . 7.6 mt-10 -95.49 107.71 19.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.055 -1.028 . . . . 0.0 109.258 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 30' ' ' VAL . 5.5 mt -92.91 106.56 18.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 109.974 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE2' ' HA3' ' A' ' 45' ' ' GLY . 14.2 m-85 -87.88 153.86 20.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.164 -0.96 . . . . 0.0 108.534 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.457 ' CB ' HG13 ' A' ' 35' ' ' ILE . . . -119.0 108.92 15.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.791 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.68 HG21 ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -111.32 65.56 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.989 . . . . 0.0 110.214 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 91' ' ' VAL . 14.5 ttmm -38.83 114.5 0.39 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -143.38 21.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 120.97 -1.081 . . . . 0.0 111.327 -177.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.556 ' O ' ' HA3' ' A' ' 98' ' ' GLY . 22.6 mt -150.29 168.55 23.74 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.241 -1.537 . . . . 0.0 111.77 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 94' ' ' LEU . . . -46.34 -166.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.553 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.022 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' A' ' 60' ' ' ASN . . . 62.38 13.73 6.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER 150.77 -13.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.975 ' O ' HG11 ' A' ' 50' ' ' VAL . . . -113.73 -100.27 2.4 Favored Glycine 0 N--CA 1.477 1.395 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.528 ' HB2' ' HA2' ' A' ' 95' ' ' GLY . 1.5 t 52.35 68.96 0.74 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.75 178.54 16.42 Favored Glycine 0 N--CA 1.484 1.874 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.734 -177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 102' ' ' VAL . 11.0 t -68.17 179.5 1.54 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.419 0.628 . . . . 0.0 109.407 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.562 ' CG2' ' OG ' ' A' ' 130' ' ' SER . 48.4 t -66.02 -14.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.1 m -75.07 -22.67 58.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.73 -53.34 4.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.611 -0.681 . . . . 0.0 109.261 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.589 ' HA ' HG22 ' A' ' 93' ' ' VAL . 2.3 mt -62.15 -45.52 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 102' ' ' VAL . . . -63.18 -47.28 83.31 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.414 ' HG2' ' CD1' ' A' ' 49' ' ' PHE . 25.1 tp60 -52.23 -39.26 60.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.32 -0.862 . . . . 0.0 109.442 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -67.15 -51.28 39.81 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.03 -11.05 45.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -1.116 . . . . 0.0 109.12 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -96.9 -25.7 15.34 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.334 -0.854 . . . . 0.0 109.45 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 76.7 t90 -72.98 -15.15 61.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.646 ' HA ' ' CA ' ' A' ' 116' ' ' GLY . . . -96.22 -11.82 25.5 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.111 -1.035 . . . . 0.0 108.947 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -84.46 -26.2 40.24 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 115' ' ' ASN . 3.8 m120 -123.3 28.84 6.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 108.999 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER 162.73 32.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.685 ' O ' ' HE1' ' A' ' 117' ' ' MET . . . -102.98 -147.54 18.97 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.685 ' HE1' ' O ' ' A' ' 116' ' ' GLY . 6.0 mmt -134.9 -178.74 5.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.614 -0.933 . . . . 0.0 109.779 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.942 ' ND1' HG23 ' A' ' 119' ' ' VAL . 10.7 p80 -66.0 -40.37 91.1 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.78 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.942 HG23 ' ND1' ' A' ' 118' ' ' HIS . 55.5 t -120.57 165.6 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.833 -1.167 . . . . 0.0 110.249 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.608 ' N ' HG12 ' A' ' 119' ' ' VAL . . . -169.02 132.08 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 1.023 ' O ' HD12 ' A' ' 122' ' ' LEU . 4.9 t-20 -90.34 167.85 12.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.792 -1.192 . . . . 0.0 109.785 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.023 HD12 ' O ' ' A' ' 121' ' ' ASN . 1.0 OUTLIER -149.54 105.24 3.43 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.131 -0.98 . . . . 0.0 109.041 -178.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.423 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 9.6 m -96.2 68.77 2.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.221 -0.924 . . . . 0.0 108.985 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.874 HD11 HD23 ' A' ' 122' ' ' LEU . 0.5 OUTLIER -111.35 -165.94 1.03 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.259 1.028 . . . . 0.0 110.091 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.42 105.03 1.51 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.488 ' CB ' ' HD2' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -168.91 172.76 2.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.251 . . . . 0.0 109.84 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.555 ' C ' ' HD3' ' A' ' 129' ' ' PRO . 34.8 Cg_endo -79.15 4.66 6.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.796 2.331 . . . . 0.0 109.916 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.624 ' N ' ' HD3' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -117.83 44.09 0.49 Allowed Pre-proline 0 C--N 1.301 -1.505 0 O-C-N 121.556 -0.715 . . . . 0.0 111.464 -178.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 128' ' ' SER . 37.5 Cg_endo -76.42 173.71 14.03 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.951 1.767 . . . . 0.0 110.532 179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.562 ' OG ' ' CG2' ' A' ' 102' ' ' VAL . 3.0 m -149.65 131.5 15.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 110.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.8 -23.31 66.04 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.463 ' HB ' HG11 ' A' ' 102' ' ' VAL . 3.3 m -66.28 -29.94 70.27 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.566 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -69.17 -35.22 76.06 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -63.37 -51.11 67.26 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -48.56 -26.49 2.23 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 133' ' ' LEU . . . -69.53 -45.67 68.27 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.412 -0.915 . . . . 0.0 108.921 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.666 HG21 ' CZ ' ' A' ' 165' ' ' TYR . 0.9 OUTLIER -62.95 -30.31 49.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 135' ' ' GLN . 21.6 m120 -60.33 -36.2 77.42 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.2 p -78.85 -22.54 45.95 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.14 54.41 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.096 -1.002 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -79.96 -46.53 16.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.038 -1.039 . . . . 0.0 108.747 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -29.98 8.21 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -86.2 -33.21 20.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.275 -0.891 . . . . 0.0 109.092 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 87.76 61.93 1.49 Allowed Glycine 0 C--N 1.3 -1.44 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.492 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 43.9 t -108.79 99.7 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.482 -1.01 . . . . 0.0 109.874 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.738 ' HB3' HG22 ' A' ' 119' ' ' VAL . 27.1 tp -58.52 111.03 1.1 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.942 -1.099 . . . . 0.0 108.079 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.725 ' CG1' HD13 ' A' ' 122' ' ' LEU . 0.2 OUTLIER -115.02 137.25 49.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.183 -0.948 . . . . 0.0 110.278 -178.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.964 HG13 HD22 ' A' ' 121' ' ' ASN . 1.5 p -113.92 150.92 15.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' A' ' 163' ' ' ALA . . . -134.3 144.4 48.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.962 -1.087 . . . . 0.0 110.422 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.501 ' HA ' ' OG1' ' A' ' 218' ' ' THR . . . -57.79 152.74 15.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 109.8 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -59.15 -73.68 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.984 . . . . 0.0 110.051 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 185' ' ' GLN . . . 138.8 121.7 1.94 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -99.79 55.1 0.94 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.539 ' OG ' ' HG2' ' A' ' 185' ' ' GLN . 0.0 OUTLIER -91.53 -86.81 0.22 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.355 -0.841 . . . . 0.0 109.774 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' HA2' ' NE2' ' A' ' 185' ' ' GLN . . . 146.3 83.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 179.64 176.65 0.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.374 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.59 43.19 3.19 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 186' ' ' TYR . 0.5 OUTLIER -158.79 166.25 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -1.072 . . . . 0.0 108.83 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -106.44 -174.48 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 109.666 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.716 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -71.33 157.84 37.39 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.817 0.818 . . . . 0.0 110.174 -179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -115.17 138.14 23.37 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 103.906 -2.628 . . . . 0.0 103.906 176.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.71 ' O ' ' N ' ' A' ' 164' ' ' ARG . 38.5 Cg_endo -72.64 -49.9 0.21 Allowed 'Cis proline' 0 C--N 1.295 -2.272 0 O-C-N 122.967 0.983 . . . . 0.0 111.826 4.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 160' ' ' SER . . . 36.21 -77.91 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.71 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.2 OUTLIER -41.61 -55.23 2.98 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER 46.9 -178.88 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.274 1.035 . . . . 0.0 111.079 178.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.26 -16.73 12.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.427 ' OD1' HG13 ' A' ' 137' ' ' VAL . 30.0 p-10 -129.44 13.8 6.04 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 165' ' ' TYR . . . -127.22 157.28 40.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.473 ' HB3' ' OD2' ' A' ' 191' ' ' ASP . 0.1 OUTLIER -105.45 159.31 16.02 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.061 -1.024 . . . . 0.0 110.093 -179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . -111.47 116.37 30.78 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 172' ' ' GLY . 24.5 t -81.84 167.42 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 171' ' ' VAL . . . -134.93 -165.57 10.85 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 194' ' ' ALA . . . -143.48 137.99 28.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.934 -1.333 . . . . 0.0 110.666 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 p -109.15 168.58 9.27 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 179' ' ' ASN . 4.2 t70 -95.61 -40.14 9.57 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.29 1.043 . . . . 0.0 109.804 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -152.27 -103.62 0.05 Allowed 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 177' ' ' ASN . 1.5 p30 -62.01 -48.85 78.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.722 -1.236 . . . . 0.0 107.72 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.503 ' HB2' HD21 ' A' ' 251' ' ' LEU . 0.5 OUTLIER 173.73 68.25 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.572 ' O ' ' CB ' ' A' ' 180' ' ' ARG . 2.1 t-20 -97.03 -11.74 24.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.772 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.572 ' CB ' ' O ' ' A' ' 179' ' ' ASN . 1.7 ttp180 82.07 12.76 0.59 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.366 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.875 ' HB1' ' CE1' ' A' ' 183' ' ' PHE . . . 53.97 -159.2 0.16 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.455 -0.778 . . . . 0.0 109.499 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.02 30.7 3.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.064 -1.022 . . . . 0.0 110.099 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.875 ' CE1' ' HB1' ' A' ' 181' ' ' ALA . 1.0 OUTLIER -152.36 -28.2 0.16 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.1 -1.0 . . . . 0.0 110.691 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 183' ' ' PHE . 0.2 OUTLIER -45.41 124.17 4.67 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.809 -1.182 . . . . 0.0 109.277 179.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.539 ' HG2' ' OG ' ' A' ' 154' ' ' SER . 1.3 mp0 -75.98 149.45 37.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.155 -0.966 . . . . 0.0 111.048 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.848 ' O ' HG23 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -68.09 -174.73 0.51 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.488 0.661 . . . . 0.0 110.67 -179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.54 ' CA ' HG12 ' A' ' 159' ' ' ILE . . . -173.27 150.24 11.99 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -83.11 68.9 9.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.413 -1.051 . . . . 0.0 109.005 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 190' ' ' LEU . . . 118.56 41.71 0.61 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.561 ' CD1' HD13 ' A' ' 159' ' ' ILE . 7.7 tp -41.22 150.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.469 -1.018 . . . . 0.0 109.283 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 169' ' ' MET . 0.5 OUTLIER -90.64 -60.85 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.542 -179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.883 HD11 HG22 ' A' ' 262' ' ' VAL . 14.3 tt -155.5 171.23 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 109.566 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 260' ' ' GLY . 27.2 m -127.92 160.34 37.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.038 -1.039 . . . . 0.0 109.964 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 173' ' ' ALA . . . -152.69 132.82 7.38 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 6' ' ' TRP . 31.7 Cg_endo -71.61 121.11 7.4 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 121.609 1.539 . . . . 0.0 110.283 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -141.27 61.23 0.55 Allowed Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.65 ' O ' ' CB ' ' A' ' 198' ' ' ASN . 50.1 t -102.08 66.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -1.186 . . . . 0.0 108.483 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASN . . . . . 0.65 ' CB ' ' O ' ' A' ' 197' ' ' VAL . 2.2 t-20 111.48 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 198' ' ' ASN . 11.8 m -159.37 111.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 CA-C-O 122.273 1.035 . . . . 0.0 108.77 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 210' ' ' SER . 3.3 pm0 -87.61 124.83 33.93 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.495 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . 0.609 ' HB2' ' CE1' ' A' ' 65' ' ' HIS . 0.4 OUTLIER -135.85 -156.17 0.69 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.633 -0.667 . . . . 0.0 109.253 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 34.8 p -77.06 -177.92 4.72 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.042 0.925 . . . . 0.0 110.586 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' TYR . . . . . 0.632 ' CG ' ' HD2' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -156.94 151.83 21.07 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.632 ' HD2' ' CG ' ' A' ' 203' ' ' TYR . 34.4 Cg_endo -69.83 164.47 34.49 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.996 1.797 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 206' ' ' SER . . . 75.26 12.27 83.64 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 205' ' ' GLY . 0.7 OUTLIER 72.34 33.18 1.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -1.119 . . . . 0.0 109.623 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 203' ' ' TYR . 0.6 OUTLIER -120.48 171.2 8.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.758 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.516 ' O ' ' HB2' ' A' ' 209' ' ' ALA . 87.6 m-85 -122.73 176.2 6.09 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 208' ' ' TYR . . . 176.91 175.38 0.37 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.654 -1.279 . . . . 0.0 110.782 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 0.0 OUTLIER -135.07 131.07 36.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.527 -0.733 . . . . 0.0 109.419 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.664 HD12 ' HE1' ' A' ' 216' ' ' MET . 0.1 OUTLIER -148.01 108.06 4.05 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.969 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.465 ' HB3' ' N ' ' A' ' 198' ' ' ASN . 18.8 p30 -63.87 169.4 4.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.389 -0.82 . . . . 0.0 108.908 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 156.69 7.36 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.572 HG23 ' HB2' ' A' ' 173' ' ' ALA . 0.2 OUTLIER -75.39 -35.85 61.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.202 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -14.09 19.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.421 -0.799 . . . . 0.0 109.642 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' MET . . . . . 0.664 ' HE1' HD12 ' A' ' 211' ' ' LEU . 0.0 OUTLIER -90.54 -24.01 20.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.899 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 194' ' ' ALA . . . -89.52 -7.63 54.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.13 -0.981 . . . . 0.0 109.417 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.639 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 13.4 m -71.95 -41.52 9.03 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 111.505 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.718 ' HB3' HG13 ' A' ' 66' ' ' VAL . 30.1 Cg_endo -73.27 -21.08 20.51 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 C-N-CA 121.699 1.599 . . . . 0.0 110.923 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 69' ' ' THR . 3.8 m80 -64.34 -42.08 96.44 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.72 -47.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -46.89 -35.36 6.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -70.77 -56.08 7.67 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -46.62 -41.51 14.77 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.948 -1.325 . . . . 0.0 109.444 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.61 -41.7 99.15 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.0 108.809 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.1 -45.54 75.47 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 109.68 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.881 HD22 HD23 ' A' ' 21' ' ' LEU . 42.4 mt -59.21 -50.58 73.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.111 -0.993 . . . . 0.0 110.247 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 267' ' ' ALA . 95.7 t -56.0 -49.06 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.973 -1.079 . . . . 0.0 109.57 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.641 ' HD3' ' CE1' ' A' ' 118' ' ' HIS . 0.5 OUTLIER -48.54 -42.97 34.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 109.519 -179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLN . . . . . 0.467 ' HG3' ' HA2' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -62.15 -45.52 93.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.911 -1.118 . . . . 0.0 109.574 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.661 ' HE3' HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -65.59 -10.11 32.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -0.817 . . . . 0.0 109.222 179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 231' ' ' LYS . 5.0 m-80 -174.19 72.93 0.34 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.459 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . 0.545 ' N ' ' O ' ' A' ' 229' ' ' LYS . 35.4 Cg_endo -79.39 -0.84 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.638 2.225 . . . . 0.0 110.735 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 42.4 m -84.1 -3.76 58.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.143 -0.973 . . . . 0.0 109.842 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' TRP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 239' ' ' GLN . 31.6 m0 -81.89 176.24 9.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.188 -0.945 . . . . 0.0 109.938 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 237' ' ' ASN . 0.7 OUTLIER -103.47 159.57 15.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 236' ' ' SER . 6.6 p30 -45.28 -37.17 4.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.102 . . . . 0.0 109.826 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 239' ' ' GLN . 2.8 t -72.74 -62.65 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.224 -0.922 . . . . 0.0 110.163 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 235' ' ' TRP . 3.6 tp60 -41.22 -50.15 3.6 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.567 0.698 . . . . 0.0 109.483 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.459 ' CD1' ' HG3' ' A' ' 229' ' ' LYS . 20.9 mt -57.07 -48.84 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.52 -0.737 . . . . 0.0 109.377 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -47.16 -38.56 12.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.089 -1.007 . . . . 0.0 109.76 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' A' ' 246' ' ' ASN . 22.9 t-20 -67.43 -38.13 84.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.149 -0.969 . . . . 0.0 109.743 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -64.85 -43.97 91.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.378 -0.826 . . . . 0.0 110.442 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 244' ' ' LEU . 0.8 OUTLIER -76.65 -29.89 56.6 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 110.259 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 0.1 OUTLIER -78.87 -23.72 44.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 109.535 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 242' ' ' ASN . 1.6 t30 -95.98 -17.87 20.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.141 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 2.6 p -90.46 -30.51 17.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.082 -1.011 . . . . 0.0 109.781 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.27 160.82 1.03 Allowed 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.31 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.3 m -88.88 111.39 22.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.104 -0.998 . . . . 0.0 109.706 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 259' ' ' SER . 0.3 OUTLIER -84.97 116.12 23.19 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.378 -0.826 . . . . 0.0 108.951 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 178' ' ' ASN . 6.1 mp -65.53 -72.19 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.058 -1.026 . . . . 0.0 109.53 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -172.18 28.84 0.1 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.29 145.84 34.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.228 -1.16 . . . . 0.0 109.333 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 43.3 p -131.95 6.72 4.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.405 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -114.58 -21.11 10.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.822 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.649 HD23 ' CZ ' ' A' ' 186' ' ' TYR . 2.7 tm? -117.46 -70.08 0.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.161 -0.962 . . . . 0.0 109.344 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.585 ' N ' HD13 ' A' ' 256' ' ' LEU . 87.1 m-85 -63.27 -23.69 67.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 64.45 -98.28 0.27 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 250' ' ' SER . 0.3 OUTLIER -84.07 -39.83 19.08 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.253 -1.146 . . . . 0.0 108.94 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.622 ' O ' HG22 ' A' ' 193' ' ' VAL . . . 100.45 -122.1 7.47 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 261' ' ' LEU . 16.3 tp -87.7 161.25 17.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.813 -0.816 . . . . 0.0 108.804 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.883 HG22 HD11 ' A' ' 192' ' ' ILE . 1.5 t -119.54 154.41 22.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 110.289 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 263' ' ' ASN . 0.0 OUTLIER -151.12 117.46 5.66 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.206 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 268' ' ' THR . . . -82.33 6.01 18.35 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.796 -178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 67.1 tt0 -94.54 -23.96 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.723 -1.236 . . . . 0.0 109.264 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -95.99 -16.73 21.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.167 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 228' ' ' VAL . . . -98.53 -13.91 20.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . 0.576 HG21 HD22 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -117.49 -9.85 10.77 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.055 -1.028 . . . . 0.0 109.066 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 268' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.73 -179.874 . . . . . . . . 2 2 . 1 stop_ save_